data_2lt2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lt2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.7 p . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.18 -36.32 68.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.95 -1.094 . . . . 0.0 109.639 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -64.31 -40.5 96.05 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.249 -0.907 . . . . 0.0 109.442 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.421 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 76.8 mm-40 -70.25 -50.81 35.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 0.0 110.643 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.66 -33.37 75.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.419 -0.801 . . . . 0.0 110.441 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.4 -45.15 94.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.967 -1.083 . . . . 0.0 110.378 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.417 ' HB2' ' CE ' ' A' ' 110' ' ' LYS . . . -66.31 -42.28 88.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.091 -1.006 . . . . 0.0 111.642 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' ' 17' ' ' VAL . 21.2 tt -68.56 -39.26 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.552 -1.343 . . . . 0.0 111.151 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.423 ' N ' HG22 ' A' ' 16' ' ' ILE . 89.9 t -63.1 -39.13 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.886 -1.134 . . . . 0.0 108.622 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -63.37 -36.16 82.78 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.3 -0.96 . . . . 0.0 109.241 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.26 -41.38 96.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -0.87 . . . . 0.0 109.533 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.0 -43.11 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.445 -0.784 . . . . 0.0 109.572 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -58.28 -43.11 87.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 109.896 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -64.5 -35.56 81.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.422 -0.799 . . . . 0.0 111.115 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.81 -39.57 93.8 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.976 -1.078 . . . . 0.0 110.175 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -60.39 -16.47 35.83 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.036 -1.04 . . . . 0.0 110.985 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 97.9 mttt -94.79 0.66 55.09 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.139 -0.976 . . . . 0.0 109.556 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -112.73 -16.94 12.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.949 -1.095 . . . . 0.0 109.66 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.6 t -154.17 159.05 41.22 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.935 -1.103 . . . . 0.0 109.687 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.4 p -86.23 -6.55 58.95 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.194 -0.941 . . . . 0.0 110.587 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.49 170.41 50.75 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -129.66 132.79 46.79 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.128 -1.219 . . . . 0.0 111.181 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.3 mt -115.79 132.83 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -138.88 149.88 45.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.136 -0.977 . . . . 0.0 109.82 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.416 ' CG2' HD11 ' A' ' 67' ' ' ILE . 53.4 t -118.22 137.04 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.387 -0.821 . . . . 0.0 111.006 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -122.05 120.33 34.02 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.2 tp -112.16 126.01 54.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.496 -0.753 . . . . 0.0 111.396 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -141.59 167.59 21.78 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.409 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.5 mttt -78.38 -75.57 0.22 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.935 -1.103 . . . . 0.0 113.411 -177.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 t -142.12 157.62 44.69 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.119 -0.988 . . . . 0.0 110.063 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.9 m -110.38 170.45 8.08 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.374 -0.829 . . . . 0.0 110.999 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -108.03 -9.46 15.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.398 -0.814 . . . . 0.0 110.556 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.421 HG13 ' N ' ' A' ' 42' ' ' ASP . 27.3 pt -127.56 -122.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.726 -1.234 . . . . 0.0 110.47 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.421 ' N ' HG13 ' A' ' 41' ' ' ILE . 97.5 m-20 -111.39 138.06 48.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.113 -1.617 . . . . 0.0 109.755 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.0 t -64.99 -42.79 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.444 -0.785 . . . . 0.0 111.426 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -59.9 -46.32 89.71 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.9 -1.125 . . . . 0.0 110.409 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -71.55 -40.67 69.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.977 -1.077 . . . . 0.0 108.282 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -61.4 -40.86 95.92 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.404 -0.81 . . . . 0.0 110.965 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.23 81.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.621 -1.3 . . . . 0.0 109.71 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 64.0 ttp -62.98 -43.34 99.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.209 -0.932 . . . . 0.0 109.792 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -64.01 -45.03 90.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.987 -1.071 . . . . 0.0 109.762 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.29 -43.53 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.306 -0.871 . . . . 0.0 110.003 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 6.9 t80 -57.84 -47.47 82.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.88 -1.137 . . . . 0.0 109.547 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -73.87 -35.64 64.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.992 -1.067 . . . . 0.0 109.843 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.09 -38.8 87.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.141 -0.974 . . . . 0.0 108.657 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.6 mt -80.22 3.25 21.39 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.359 -0.838 . . . . 0.0 110.141 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 29.8 tttt 57.14 32.46 21.73 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.936 -1.103 . . . . 0.0 111.706 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.462 ' HB2' ' CE1' ' A' ' 51' ' ' PHE . 98.9 mtp -66.39 -12.16 55.41 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.336 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -76.62 -1.74 29.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.939 -1.101 . . . . 0.0 109.529 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -75.44 63.22 1.44 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.889 -1.132 . . . . 0.0 110.129 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.3 p -134.62 150.27 50.67 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -65.2 -42.89 93.07 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.622 -0.674 . . . . 0.0 112.455 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 94.4 mt -96.33 -1.83 47.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.914 -1.116 . . . . 0.0 111.514 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 57.25 48.4 15.14 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 122.536 1.16 . . . . 0.0 110.797 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.8 p30 -122.45 53.04 1.27 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.885 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.42 146.92 16.61 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.479 ' CG2' ' CD1' ' A' ' 84' ' ' ILE . 72.7 t -128.06 134.72 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.116 -1.226 . . . . 0.0 110.361 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.402 HD12 ' HE1' ' A' ' 56' ' ' MET . 36.6 tp -116.67 128.18 55.11 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.59 -0.694 . . . . 0.0 109.381 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.416 HD11 ' CG2' ' A' ' 33' ' ' VAL . 86.0 mt -102.99 112.33 36.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.473 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -99.23 117.32 33.43 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.25 -0.906 . . . . 0.0 109.247 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 72.5 t -118.91 130.88 73.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-O 122.101 0.953 . . . . 0.0 110.709 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.86 101.12 12.16 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 37' ' ' LYS . 27.3 m -70.43 -20.28 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.006 . . . . 0.0 111.048 -178.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -67.51 -44.02 79.43 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.792 -1.192 . . . . 0.0 109.016 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -102.52 3.63 37.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.284 -0.885 . . . . 0.0 110.759 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.4 tttt 56.74 48.77 15.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.831 -1.168 . . . . 0.0 111.123 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 76.7 p -122.4 164.02 18.75 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.095 -1.003 . . . . 0.0 109.917 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -143.57 141.37 30.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.489 -0.757 . . . . 0.0 110.146 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.4 t -126.82 136.06 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.428 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 66.7 mt -113.84 122.66 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.955 -1.091 . . . . 0.0 109.769 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -128.6 112.92 14.8 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.555 -0.716 . . . . 0.0 110.68 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -96.18 165.82 24.2 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -75.28 175.05 8.71 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.346 -1.09 . . . . 0.0 109.642 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -59.24 -26.96 65.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 110.657 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.28 -52.25 42.16 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.604 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.479 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 82.2 mt -64.94 -44.2 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.785 -1.42 . . . . 0.0 108.579 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -61.66 -38.07 86.37 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.004 -1.06 . . . . 0.0 111.34 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -73.05 -22.91 60.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.033 -1.042 . . . . 0.0 112.676 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.5 p -101.16 -19.48 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.78 -1.2 . . . . 0.0 112.472 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.477 HG23 ' CD1' ' A' ' 93' ' ' TRP . 19.5 m -119.54 163.61 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.712 -1.243 . . . . 0.0 111.642 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 61.9 p -108.66 -179.94 4.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.47 -0.769 . . . . 0.0 111.525 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -61.83 -38.63 88.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 109.231 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -60.1 -39.93 87.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.46 -0.775 . . . . 0.0 109.421 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.459 ' CD2' ' HB ' ' A' ' 88' ' ' VAL . 90.5 t80 -66.2 -24.29 66.59 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.158 -0.964 . . . . 0.0 109.537 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.477 ' CD1' HG23 ' A' ' 88' ' ' VAL . 5.2 m95 -87.97 -25.33 23.22 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.919 0.866 . . . . 0.0 110.656 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -57.52 -37.05 72.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.885 . . . . 0.0 111.999 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.4 p -67.67 -31.57 71.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.713 -1.242 . . . . 0.0 109.275 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.277 15.9 m -60.89 -49.06 78.99 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 122.444 1.116 . . . . 0.0 111.097 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -69.44 -38.21 77.72 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.911 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -63.6 -42.62 98.24 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.939 -1.1 . . . . 0.0 110.566 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.01 -49.56 69.72 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.801 -1.187 . . . . 0.0 111.515 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.81 -42.26 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.954 -1.091 . . . . 0.0 109.503 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -62.13 -44.42 96.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.346 -0.846 . . . . 0.0 111.18 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.2 tp -63.66 -42.17 98.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -0.963 . . . . 0.0 111.813 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.442 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 97.6 mm-40 -72.86 -43.82 62.11 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.361 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -58.68 -39.56 81.04 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.55 -33.21 72.34 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -78.2 -18.42 55.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 0.0 109.695 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.23 2.04 44.68 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.832 -1.175 . . . . 0.0 111.182 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.2 94.23 5.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.725 -1.456 . . . . 0.0 109.541 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -63.05 -42.34 99.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.767 -0.583 . . . . 0.0 111.066 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.421 ' NZ ' ' HA ' ' A' ' 12' ' ' GLU . 85.7 tttt -64.44 -48.31 75.8 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.868 -1.145 . . . . 0.0 112.006 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -62.65 -37.96 88.41 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 118.752 -1.179 . . . . 0.0 109.638 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.442 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -64.22 -50.61 59.03 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.04 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.7 mt -64.6 -43.85 92.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.161 -1.199 . . . . 0.0 111.164 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 83.6 t -64.93 -48.57 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.694 -1.254 . . . . 0.0 110.511 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -63.51 -38.35 90.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 109.624 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.91 -41.99 99.77 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.6 mt -63.32 -43.74 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -1.195 . . . . 0.0 108.975 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -58.96 -50.83 72.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.124 -0.985 . . . . 0.0 110.499 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.16 -41.11 97.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 109.052 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -42.63 95.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.883 . . . . 0.0 110.671 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.32 -44.01 96.06 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.962 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 97.1 mtp -67.8 -43.0 80.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.921 -1.34 . . . . 0.0 109.394 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 92' ' ' PHE . . . -64.45 -46.89 81.18 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.255 -0.903 . . . . 0.0 108.885 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 76.6 mt -62.15 -40.73 96.94 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.478 -0.764 . . . . 0.0 109.126 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.74 -34.49 62.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.383 -0.823 . . . . 0.0 110.671 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.16 -42.77 99.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.05 -1.031 . . . . 0.0 108.954 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -75.12 -40.0 60.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.624 -0.673 . . . . 0.0 109.791 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -130.94 92.08 34.8 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.383 -0.823 . . . . 0.0 109.393 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.13 151.39 83.81 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.472 1.248 . . . . 0.0 110.044 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 73.9 t90 -72.67 131.85 42.92 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.596 -0.69 . . . . 0.0 110.826 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -108.41 149.77 28.29 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.474 ' HA ' ' CH2' ' A' ' 130' ' ' TRP . 87.8 tttt -57.88 -28.91 64.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -0.999 . . . . 0.0 110.799 -177.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -89.47 8.37 31.31 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.797 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -43.88 136.93 3.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.297 -0.877 . . . . 0.0 111.65 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.425 ' CD1' ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -112.24 143.58 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.355 0.598 . . . . 0.0 110.764 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -96.4 93.44 6.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.009 -1.057 . . . . 0.0 109.789 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.1 -35.8 76.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.66 -0.65 . . . . 0.0 111.901 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 mp -112.08 152.09 44.09 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.101 -0.999 . . . . 0.0 111.928 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -76.09 -170.81 0.92 Allowed 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.633 1.333 . . . . 0.0 108.694 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -122.97 2.95 9.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.661 -1.274 . . . . 0.0 110.066 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.4 m -64.02 139.87 58.81 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.854 -1.154 . . . . 0.0 110.805 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.0 mt -73.49 140.33 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.437 -0.79 . . . . 0.0 110.876 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 24.4 m -97.13 139.77 32.63 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.47 -0.769 . . . . 0.0 109.341 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -131.36 147.99 52.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.093 -1.004 . . . . 0.0 110.979 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.137 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.752 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.0 p . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.96 -40.32 66.74 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.969 -1.082 . . . . 0.0 109.917 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -61.04 -43.87 98.25 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.632 -0.667 . . . . 0.0 109.769 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.46 -45.77 68.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.289 -0.882 . . . . 0.0 111.011 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -66.46 -34.49 78.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.954 . . . . 0.0 109.715 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.06 -46.19 85.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.923 -1.11 . . . . 0.0 110.404 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.72 -41.92 95.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.063 -1.023 . . . . 0.0 111.451 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.451 HG21 ' N ' ' A' ' 17' ' ' VAL . 18.5 tt -68.41 -39.44 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.869 -1.144 . . . . 0.0 110.549 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.451 ' N ' HG21 ' A' ' 16' ' ' ILE . 77.6 t -63.77 -41.5 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -60.93 -40.34 92.85 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.435 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.12 -36.03 78.63 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.379 -0.826 . . . . 0.0 109.341 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.3 mm -62.9 -42.1 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -58.81 -42.83 90.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.819 -0.551 . . . . 0.0 110.041 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -65.26 -40.61 94.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.052 -1.03 . . . . 0.0 111.113 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.07 -40.84 95.2 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.843 -1.161 . . . . 0.0 110.495 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -60.66 -13.98 17.87 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.441 -1.412 . . . . 0.0 111.127 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.488 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.8 mttt -95.15 0.98 54.7 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.067 -1.021 . . . . 0.0 109.449 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -112.91 -16.66 12.66 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.35 -0.844 . . . . 0.0 110.298 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.0 t -151.51 157.93 42.94 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.073 -1.017 . . . . 0.0 110.206 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.4 p -87.74 -7.36 57.45 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.488 -0.758 . . . . 0.0 110.194 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.31 172.92 49.6 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -132.02 133.86 44.9 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.162 -1.199 . . . . 0.0 111.725 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.5 mt -117.57 134.5 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 121.184 0.516 . . . . 0.0 110.124 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -139.86 156.44 46.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.395 -0.815 . . . . 0.0 110.166 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 p -124.29 138.24 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.265 -0.897 . . . . 0.0 110.62 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.41 ' ND1' ' OG ' ' A' ' 143' ' ' SER . 57.0 t60 -121.42 119.82 33.18 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.1 tp -111.48 135.26 52.29 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.116 0.96 . . . . 0.0 111.974 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 76.4 tt0 -151.61 166.21 31.93 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.445 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 98.7 mttt -78.41 -72.0 0.4 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.896 -1.127 . . . . 0.0 112.889 -176.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.8 t -142.72 157.88 44.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.915 -1.116 . . . . 0.0 109.937 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.6 p -102.51 164.88 11.41 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.465 -0.772 . . . . 0.0 111.138 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -105.42 -24.56 12.62 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.455 -0.778 . . . . 0.0 109.377 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.411 HG13 ' N ' ' A' ' 42' ' ' ASP . 24.8 pt -111.9 -121.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.099 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.411 ' N ' HG13 ' A' ' 41' ' ' ILE . 97.0 m-20 -110.61 141.43 43.82 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.248 -1.532 . . . . 0.0 109.589 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.7 t -64.35 -43.22 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.355 -0.841 . . . . 0.0 111.21 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -61.18 -46.25 91.25 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.877 -1.139 . . . . 0.0 110.29 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -70.42 -40.14 74.0 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.897 -1.127 . . . . 0.0 108.413 177.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -62.9 -41.8 99.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.344 -0.847 . . . . 0.0 111.185 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.74 -39.29 80.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.947 -1.096 . . . . 0.0 110.187 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 66.3 ttp -63.0 -42.49 99.86 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.096 -1.003 . . . . 0.0 109.934 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -65.41 -40.66 93.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.021 -1.049 . . . . 0.0 109.82 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.8 t -69.58 -43.67 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.454 -0.779 . . . . 0.0 109.441 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.486 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 3.6 t80 -58.16 -46.85 84.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.048 -1.032 . . . . 0.0 108.824 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -73.15 -35.58 66.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.023 -1.048 . . . . 0.0 109.56 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -61.91 -37.32 84.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.012 -1.055 . . . . 0.0 109.329 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 98.6 mt -82.22 3.52 27.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.576 -0.702 . . . . 0.0 110.694 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.4 mttp 56.64 33.39 22.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.453 -0.78 . . . . 0.0 111.706 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.486 ' HB2' ' CE1' ' A' ' 51' ' ' PHE . 90.8 mtp -66.89 -14.25 62.56 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.416 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -75.68 -3.18 33.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.108 -0.995 . . . . 0.0 110.318 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -76.93 65.68 2.65 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.048 -1.033 . . . . 0.0 109.849 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.2 p -134.94 150.62 50.42 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.395 -0.816 . . . . 0.0 109.434 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -64.51 -47.32 79.32 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 84.6 mt -96.29 -1.06 48.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.863 -1.148 . . . . 0.0 111.332 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 76.0 mt-30 60.94 45.29 9.64 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 122.61 1.195 . . . . 0.0 111.479 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.444 ' HA ' HG13 ' A' ' 84' ' ' ILE . 34.8 m-80 -120.03 51.34 1.2 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.132 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.18 141.03 15.33 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.268 -1.933 . . . . 0.0 108.268 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.479 ' CG2' ' CD1' ' A' ' 84' ' ' ILE . 55.6 t -122.51 134.36 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.816 -1.402 . . . . 0.0 110.367 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.417 ' HB2' ' CD2' ' A' ' 51' ' ' PHE . 41.1 tp -116.76 124.51 49.79 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.962 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 98.7 mt -102.36 105.2 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.965 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 34' ' ' HIS . 56.1 t80 -92.65 121.64 34.27 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.357 -0.839 . . . . 0.0 110.0 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.9 t -122.42 130.13 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.348 -0.845 . . . . 0.0 111.034 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.77 99.76 11.11 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.407 HG22 ' HA ' ' A' ' 37' ' ' LYS . 32.7 m -68.35 -20.53 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.97 -1.081 . . . . 0.0 110.451 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.442 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 66.1 mm-40 -70.85 -47.92 56.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.946 -1.096 . . . . 0.0 109.575 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -97.67 3.37 50.32 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.215 -0.928 . . . . 0.0 110.586 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt 54.44 46.08 25.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.103 -0.998 . . . . 0.0 110.99 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.4 m -121.72 132.69 54.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.082 -1.011 . . . . 0.0 110.303 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 76' ' ' PHE . 53.4 p90 -112.13 139.55 47.56 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.445 -0.785 . . . . 0.0 110.468 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 50.4 t -130.43 140.57 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.299 -0.876 . . . . 0.0 109.37 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.52 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 90.3 mt -118.07 127.98 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.783 -1.198 . . . . 0.0 111.032 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -130.42 116.47 18.29 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.638 -0.664 . . . . 0.0 110.285 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.43 167.4 15.64 Favored Glycine 0 N--CA 1.483 1.769 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.48 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 73.7 m-20 -77.86 178.2 7.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.546 -0.973 . . . . 0.0 110.848 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -62.05 -27.21 68.73 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.644 -0.66 . . . . 0.0 110.139 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.37 -55.54 26.98 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.615 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.479 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 76.5 mt -66.18 -44.56 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.703 -1.469 . . . . 0.0 108.546 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -61.31 -36.44 80.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.049 -1.032 . . . . 0.0 111.003 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -76.74 -21.84 54.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 111.524 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.415 HG13 ' N ' ' A' ' 88' ' ' VAL . 10.5 p -103.45 -23.37 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.724 -1.235 . . . . 0.0 112.462 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.442 HG22 ' CG2' ' A' ' 84' ' ' ILE . 20.3 m -118.88 164.41 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.64 -1.287 . . . . 0.0 111.011 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.5 p -109.34 178.52 4.42 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.406 -0.809 . . . . 0.0 112.434 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -62.89 -35.65 80.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.878 . . . . 0.0 109.137 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -61.47 -37.78 84.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.162 -0.961 . . . . 0.0 109.008 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.506 ' CZ ' ' HB1' ' A' ' 123' ' ' ALA . 54.4 t80 -68.26 -25.21 65.06 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 108.984 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.52 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 4.8 m95 -86.63 -26.29 24.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.75 0.786 . . . . 0.0 110.846 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -58.84 -34.4 71.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.202 -0.936 . . . . 0.0 111.902 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 49.2 p -68.46 -32.65 72.81 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.276 -1.37 . . . . 0.0 108.683 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.429 HG21 ' CD1' ' A' ' 78' ' ' ILE 0.268 16.6 m -59.74 -48.4 81.83 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 122.316 1.055 . . . . 0.0 110.852 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.44 -37.58 74.39 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.11 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -63.35 -43.85 96.52 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.824 -1.172 . . . . 0.0 110.125 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.03 -48.25 77.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.89 -1.131 . . . . 0.0 110.935 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 94.2 mt -67.7 -42.67 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.064 -1.022 . . . . 0.0 110.06 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -64.53 -41.67 96.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.124 -0.985 . . . . 0.0 110.648 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.8 mt -63.73 -42.31 97.92 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.96 -1.088 . . . . 0.0 112.048 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.412 ' HB2' ' HA3' ' A' ' 112' ' ' GLY . 99.7 mm-40 -74.99 -39.18 61.39 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.293 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -61.65 -40.31 94.45 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -62.01 -32.9 73.42 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.689 -0.632 . . . . 0.0 110.036 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -84.67 -17.21 39.26 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.828 -1.17 . . . . 0.0 109.916 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.89 10.53 34.66 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.09 -1.052 . . . . 0.0 110.503 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -104.6 79.58 1.57 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.854 -1.38 . . . . 0.0 109.35 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -60.68 -43.76 97.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.787 -0.571 . . . . 0.0 111.138 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -62.33 -49.39 75.79 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.126 -0.984 . . . . 0.0 111.984 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -63.09 -37.89 89.01 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.887 -1.133 . . . . 0.0 110.313 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.412 ' HA3' ' HB2' ' A' ' 103' ' ' GLN . . . -64.47 -49.33 65.8 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.28 -43.35 98.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -1.143 . . . . 0.0 110.446 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.8 t -66.45 -46.99 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.084 -1.01 . . . . 0.0 110.074 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.78 -40.14 94.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.229 -0.919 . . . . 0.0 109.636 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.19 -41.9 99.62 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 93.9 mt -65.32 -44.27 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.371 -1.076 . . . . 0.0 110.298 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -57.2 -48.51 78.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.946 -1.096 . . . . 0.0 109.3 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.56 -42.05 98.37 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.481 -0.762 . . . . 0.0 109.506 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.57 -41.97 91.41 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.3 -0.875 . . . . 0.0 110.132 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.62 -44.7 89.16 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 98.7 mmm -65.49 -46.54 79.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.047 -1.266 . . . . 0.0 109.513 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.506 ' HB1' ' CZ ' ' A' ' 92' ' ' PHE . . . -63.85 -44.73 92.29 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.21 -0.931 . . . . 0.0 109.128 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 37.8 mt -62.43 -40.41 96.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.937 . . . . 0.0 109.142 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.93 -35.04 61.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.151 -0.968 . . . . 0.0 110.454 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.09 -43.91 97.8 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.059 -1.025 . . . . 0.0 108.567 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -72.39 -44.03 63.1 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.422 0.63 . . . . 0.0 109.81 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -127.84 96.51 32.04 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.387 -0.82 . . . . 0.0 109.742 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.41 148.65 84.41 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.874 1.46 . . . . 0.0 110.304 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.488 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 72.6 t90 -73.87 133.09 43.1 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.422 -0.799 . . . . 0.0 110.262 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -111.34 147.79 34.37 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -54.18 -25.77 24.43 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.919 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -94.51 10.29 35.16 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 118.502 -1.279 . . . . 0.0 111.198 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -43.19 134.51 3.62 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.38 -0.825 . . . . 0.0 111.24 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.522 HD13 HG21 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -110.09 140.37 29.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.7 -178.596 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 45.6 p-10 -97.89 92.59 5.89 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.042 0.925 . . . . 0.0 110.206 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.09 -35.19 79.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.533 -0.729 . . . . 0.0 112.252 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 138' ' ' LEU . 5.0 mp -108.96 152.78 42.6 Favored Pre-proline 0 N--CA 1.486 1.354 0 O-C-N 120.826 -1.172 . . . . 0.0 111.854 -178.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -75.13 -169.05 0.58 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 N-CA-C 108.0 -1.577 . . . . 0.0 108.0 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -123.74 4.66 8.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.572 -1.33 . . . . 0.0 110.418 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 61.7 p -62.38 171.86 1.74 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.074 -1.016 . . . . 0.0 110.556 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.0 mt -103.14 140.59 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.389 -0.819 . . . . 0.0 109.96 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.41 ' OG ' ' ND1' ' A' ' 34' ' ' HIS . 28.6 t -95.95 136.29 36.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.527 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -128.8 147.09 50.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.078 -1.013 . . . . 0.0 111.629 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.051 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.232 0.539 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.03 -39.11 68.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 110.565 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -59.65 -46.21 89.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.125 -0.984 . . . . 0.0 110.759 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.42 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 99.7 mt-10 -70.08 -44.0 70.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 0.0 111.533 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.99 -39.02 89.95 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.024 -1.047 . . . . 0.0 110.082 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.57 -45.57 93.59 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.938 -1.101 . . . . 0.0 110.539 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.06 -47.02 78.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.125 -0.984 . . . . 0.0 111.663 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.415 HG23 ' N ' ' A' ' 17' ' ' VAL . 20.0 tt -63.79 -33.7 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.678 -1.264 . . . . 0.0 109.983 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.415 ' N ' HG23 ' A' ' 16' ' ' ILE . 55.9 t -64.91 -40.84 90.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -62.56 -35.13 78.5 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.104 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.73 -41.62 97.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.393 -0.817 . . . . 0.0 109.692 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.414 HG21 ' ND2' ' A' ' 140' ' ' ASN . 96.6 mt -64.03 -43.14 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 0.0 109.493 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -58.41 -44.45 89.04 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.464 -0.772 . . . . 0.0 110.183 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -63.28 -37.54 87.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.375 -0.828 . . . . 0.0 110.772 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.37 -40.64 96.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.077 -1.015 . . . . 0.0 110.187 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -60.99 -16.42 42.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.141 -0.974 . . . . 0.0 110.675 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.446 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.6 mttt -93.07 -1.3 56.65 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.059 -1.026 . . . . 0.0 109.229 177.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -110.93 -13.65 14.08 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 120.905 -1.122 . . . . 0.0 109.545 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.9 t -151.28 158.67 44.16 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.977 -1.077 . . . . 0.0 110.329 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 94.2 p -89.31 -10.17 47.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 110.271 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.38 174.1 38.84 Favored Glycine 0 N--CA 1.485 1.967 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.421 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 55.7 mp0 -131.09 136.28 48.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.221 -1.164 . . . . 0.0 110.968 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.3 mt -120.73 134.78 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.692 -0.63 . . . . 0.0 110.308 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -139.24 159.26 42.58 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.22 -0.925 . . . . 0.0 109.508 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 p -129.15 143.87 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.395 -0.816 . . . . 0.0 110.942 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -127.64 126.94 42.93 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.613 0.721 . . . . 0.0 109.578 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.4 tp -116.01 131.18 57.01 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.968 0.89 . . . . 0.0 111.46 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -146.53 162.87 37.41 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.437 ' HB3' ' CG ' ' A' ' 72' ' ' GLU . 99.1 mttt -77.38 -74.51 0.25 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.053 -1.029 . . . . 0.0 112.66 -177.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.5 t -138.65 155.66 48.11 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.747 0.784 . . . . 0.0 109.796 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.422 ' HB2' ' NE ' ' A' ' 46' ' ' ARG . 13.3 p -106.72 168.39 9.21 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.7 -0.625 . . . . 0.0 110.693 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -106.84 -22.9 12.55 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.183 -0.948 . . . . 0.0 110.8 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.413 HG13 ' N ' ' A' ' 42' ' ' ASP . 18.4 pt -114.05 -121.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.348 -0.845 . . . . 0.0 109.957 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.413 ' N ' HG13 ' A' ' 41' ' ' ILE . 91.5 m-20 -110.72 137.4 48.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.071 -1.643 . . . . 0.0 109.067 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.44 -44.21 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 111.104 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -59.17 -45.82 90.01 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.762 -1.211 . . . . 0.0 110.375 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -71.98 -39.14 69.5 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.422 ' NE ' ' HB2' ' A' ' 39' ' ' SER . 57.1 ttm-85 -61.35 -44.44 97.17 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.3 -0.875 . . . . 0.0 110.91 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.25 -37.97 89.38 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.952 -1.093 . . . . 0.0 109.444 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 50.9 ttp -63.75 -43.81 95.34 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.341 -0.849 . . . . 0.0 110.258 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -65.92 -46.8 76.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.999 -1.063 . . . . 0.0 110.28 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.8 t -66.3 -43.66 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.978 -1.076 . . . . 0.0 109.821 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.474 ' CD1' ' HB2' ' A' ' 66' ' ' LEU . 25.9 t80 -58.83 -47.21 85.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.036 -1.04 . . . . 0.0 110.403 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -75.33 -37.11 60.9 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.668 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -60.59 -39.67 88.95 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.135 -0.978 . . . . 0.0 110.17 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.425 ' CD1' ' HE3' ' A' ' 56' ' ' MET . 91.5 mt -80.09 4.19 18.02 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.01 -1.056 . . . . 0.0 110.658 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.4 tttt 61.25 28.05 17.67 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.938 -1.101 . . . . 0.0 111.983 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.425 ' HE3' ' CD1' ' A' ' 54' ' ' LEU . 54.6 mtt -66.84 -24.56 66.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.02 -1.05 . . . . 0.0 108.669 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -70.46 -8.4 50.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.253 -0.904 . . . . 0.0 111.194 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -85.76 85.79 7.38 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.568 -1.332 . . . . 0.0 111.196 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.6 p -135.0 154.16 51.83 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -61.57 -41.09 96.89 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.069 -1.019 . . . . 0.0 111.929 -177.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.9 mt -100.03 4.63 44.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.008 -1.057 . . . . 0.0 111.21 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 56.28 41.73 28.79 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.303 1.049 . . . . 0.0 111.156 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.411 ' HA ' HG13 ' A' ' 84' ' ' ILE . 88.5 m-20 -119.49 54.31 1.0 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.682 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.415 ' N ' ' OD2' ' A' ' 81' ' ' ASP . . . -100.65 140.23 14.8 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.464 ' CG2' ' CD1' ' A' ' 84' ' ' ILE . 40.9 t -123.7 134.48 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.997 -1.296 . . . . 0.0 110.507 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.474 ' HB2' ' CD1' ' A' ' 51' ' ' PHE . 43.9 tp -116.74 125.93 52.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.367 -0.833 . . . . 0.0 110.108 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 92.9 mt -104.04 105.57 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.043 -1.063 . . . . 0.0 109.493 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -90.7 122.47 33.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.975 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.8 t -122.14 131.04 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 122.024 0.916 . . . . 0.0 111.305 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.28 102.17 12.53 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.429 HG21 ' N ' ' A' ' 72' ' ' GLU . 17.4 m -70.12 -20.67 23.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 110.999 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.437 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 78.2 mm-40 -68.6 -46.25 69.83 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.634 -1.291 . . . . 0.0 109.598 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -99.4 1.9 44.7 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.515 -0.74 . . . . 0.0 110.438 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.411 ' HE3' ' CZ ' ' A' ' 109' ' ' PHE . 38.6 tttt 58.59 48.74 11.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.777 -1.202 . . . . 0.0 110.226 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.9 p -122.47 163.25 20.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.976 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -146.34 145.81 30.45 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.27 -0.894 . . . . 0.0 110.591 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.2 t -132.27 138.8 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.449 -0.782 . . . . 0.0 109.173 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.465 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 71.2 mt -115.14 125.36 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.925 -1.109 . . . . 0.0 109.9 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -131.45 117.92 19.49 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.279 -0.888 . . . . 0.0 110.678 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.47 168.84 16.68 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.415 ' OD2' ' N ' ' A' ' 64' ' ' GLY . 47.3 m-20 -81.73 179.19 7.93 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.606 -0.938 . . . . 0.0 110.444 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -61.6 -28.3 69.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.34 -0.85 . . . . 0.0 111.169 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.67 -56.18 22.82 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.59 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.464 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 81.0 mt -65.41 -45.48 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.774 -1.427 . . . . 0.0 108.423 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -60.55 -38.93 86.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.005 -1.059 . . . . 0.0 111.661 -177.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -71.85 -24.13 61.64 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.072 -1.017 . . . . 0.0 111.878 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 88' ' ' VAL . 8.9 p -102.96 -21.36 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.731 -1.231 . . . . 0.0 113.218 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.485 ' HB ' ' CD2' ' A' ' 92' ' ' PHE . 16.7 m -117.95 162.89 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.829 -1.17 . . . . 0.0 110.964 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.1 p -109.36 -178.71 3.63 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.226 1.012 . . . . 0.0 113.077 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -63.14 -36.29 83.12 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.618 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -64.88 -38.94 92.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.12 -0.987 . . . . 0.0 109.156 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.485 ' CD2' ' HB ' ' A' ' 88' ' ' VAL . 66.1 t80 -65.62 -24.45 67.05 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.194 -0.941 . . . . 0.0 109.16 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.465 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 5.5 m95 -86.55 -26.4 24.54 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.184 0.992 . . . . 0.0 110.355 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -60.11 -36.8 78.25 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.918 -1.114 . . . . 0.0 112.141 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 m -63.33 -34.49 77.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.778 -1.201 . . . . 0.0 108.517 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.273 9.4 m -60.14 -49.92 75.72 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 122.145 0.974 . . . . 0.0 112.592 -179.3 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -67.79 -35.44 78.67 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.48 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -64.1 -43.15 96.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.992 -1.067 . . . . 0.0 110.772 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.65 -48.49 79.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.755 -1.216 . . . . 0.0 110.27 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.8 mt -67.64 -42.67 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.919 -1.113 . . . . 0.0 110.353 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -63.18 -44.6 94.96 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 111.413 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 77.4 mt -63.91 -41.06 97.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.311 -0.868 . . . . 0.0 112.303 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.409 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 98.8 mm-40 -73.93 -40.35 63.15 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 118.615 -1.234 . . . . 0.0 108.892 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -58.82 -41.06 85.94 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.2 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -64.18 -32.68 74.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.401 -0.812 . . . . 0.0 110.779 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -78.02 -19.68 53.92 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.79 -1.194 . . . . 0.0 109.87 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.59 3.39 34.91 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.889 -1.148 . . . . 0.0 111.383 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -105.6 90.55 3.44 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.634 -1.509 . . . . 0.0 110.404 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.411 ' CZ ' ' HE3' ' A' ' 74' ' ' LYS . 21.3 m-85 -64.24 -41.2 97.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.884 -0.51 . . . . 0.0 111.42 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.42 ' NZ ' ' HA ' ' A' ' 12' ' ' GLU . 85.7 tttt -62.98 -49.37 74.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.948 -1.095 . . . . 0.0 111.317 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -62.78 -40.82 98.48 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.055 -1.058 . . . . 0.0 109.888 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.409 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -61.71 -49.36 77.11 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.03 -43.73 91.42 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.323 -1.104 . . . . 0.0 111.757 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.401 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 81.2 t -64.49 -46.54 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.843 -1.16 . . . . 0.0 109.504 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.33 -41.4 96.81 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.456 -0.778 . . . . 0.0 110.803 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.51 -44.91 93.59 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 93.1 mt -65.25 -43.62 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.083 -1.245 . . . . 0.0 110.192 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 114' ' ' VAL . 79.7 mm-40 -55.34 -51.17 67.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.889 -1.132 . . . . 0.0 109.678 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.39 -42.41 99.4 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.3 -0.875 . . . . 0.0 109.088 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.409 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -58.14 -42.6 86.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.18 -0.95 . . . . 0.0 110.152 178.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.6 -44.11 96.98 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 9.4 ttm -67.37 -46.46 73.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.018 -1.284 . . . . 0.0 109.806 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.48 ' HB2' ' CE1' ' A' ' 92' ' ' PHE . . . -61.99 -46.24 90.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.238 -0.914 . . . . 0.0 109.21 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.409 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 66.1 mt -62.66 -40.35 96.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.421 -0.799 . . . . 0.0 108.917 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.73 -34.33 58.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.322 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.11 -43.06 99.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.015 -1.053 . . . . 0.0 109.094 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -75.88 -37.48 58.85 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.616 0.722 . . . . 0.0 109.641 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -128.51 96.2 30.96 Favored Pre-proline 0 N--CA 1.485 1.307 0 O-C-N 121.703 -0.623 . . . . 0.0 109.911 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.98 148.3 81.64 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 O-C-N 123.583 1.307 . . . . 0.0 109.825 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.446 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 65.2 t90 -75.84 136.58 40.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.346 -0.846 . . . . 0.0 110.812 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 99.6 mttt -115.52 151.02 35.61 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 109.078 178.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.92 -29.49 67.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.976 -1.077 . . . . 0.0 111.195 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -91.01 8.23 36.37 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.961 -1.096 . . . . 0.0 111.109 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 42.9 t0 -43.11 139.03 1.95 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.211 -0.931 . . . . 0.0 111.686 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.43 ' CD1' ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -112.92 144.42 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.72 0.771 . . . . 0.0 111.476 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -99.38 92.7 5.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.68 -1.262 . . . . 0.0 110.028 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.58 -39.88 77.08 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.44 150.68 40.93 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.02 -1.05 . . . . 0.0 111.995 -178.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.71 -179.24 3.6 Favored 'Trans proline' 0 N--CA 1.486 1.046 0 O-C-N 123.527 1.278 . . . . 0.0 109.438 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.414 ' ND2' HG21 ' A' ' 20' ' ' ILE . 18.0 m120 -119.44 3.21 11.28 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.45 -1.406 . . . . 0.0 110.462 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.4 p -63.81 167.81 5.64 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.826 -1.171 . . . . 0.0 110.686 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 93.8 mt -94.69 136.27 26.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.649 0.738 . . . . 0.0 111.088 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 27.8 t -94.1 133.99 37.01 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.04 138.89 52.17 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.264 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.054 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.725 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.9 p . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.61 -35.92 68.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.965 -1.084 . . . . 0.0 109.493 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -61.71 -46.39 89.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.544 -0.722 . . . . 0.0 110.454 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -68.91 -47.88 64.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.277 -0.889 . . . . 0.0 111.474 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.427 ' O ' ' CG2' ' A' ' 17' ' ' VAL . 98.7 mt-10 -61.88 -39.53 92.26 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.035 -1.04 . . . . 0.0 110.245 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.54 -44.5 96.94 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.166 -0.959 . . . . 0.0 111.226 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.59 -46.63 81.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.841 -1.162 . . . . 0.0 110.809 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.429 HG21 ' N ' ' A' ' 17' ' ' VAL . 21.4 tt -65.58 -35.24 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.836 -1.165 . . . . 0.0 109.869 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.429 ' N ' HG21 ' A' ' 16' ' ' ILE . 53.4 t -63.26 -38.5 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 21' ' ' ARG . 63.7 t0 -63.12 -36.36 83.35 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.328 -0.857 . . . . 0.0 109.454 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.37 -38.68 90.51 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.179 -0.951 . . . . 0.0 109.04 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.46 -44.04 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.187 -0.946 . . . . 0.0 109.745 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.432 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 58.6 mtm180 -61.25 -42.19 98.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 110.383 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -64.87 -38.06 89.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.181 -0.95 . . . . 0.0 111.796 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.51 -39.1 93.16 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.886 -1.134 . . . . 0.0 110.527 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.82 -16.22 26.74 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.766 -1.209 . . . . 0.0 110.328 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.476 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.7 mttt -94.86 0.56 54.91 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.057 -1.027 . . . . 0.0 109.968 177.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -114.07 -15.67 12.24 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.751 -1.218 . . . . 0.0 109.714 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 t -151.68 155.91 39.28 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.97 -1.082 . . . . 0.0 109.459 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.9 m -85.84 -6.35 59.1 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.206 -0.934 . . . . 0.0 110.052 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.2 173.5 52.77 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 55.8 mp0 -131.08 136.99 48.9 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.12 -1.224 . . . . 0.0 111.183 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 94.9 mt -118.01 134.68 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.778 -0.576 . . . . 0.0 110.104 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -139.4 151.95 46.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 110.005 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.437 HG23 ' CD1' ' A' ' 67' ' ' ILE . 60.7 t -120.97 136.75 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.409 -0.807 . . . . 0.0 110.4 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -122.31 126.33 47.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.44 -0.787 . . . . 0.0 109.137 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.7 tp -112.48 126.68 55.58 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.846 0.832 . . . . 0.0 111.449 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.428 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 82.8 tt0 -142.79 165.07 28.38 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.428 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 99.0 mttt -81.65 -77.49 0.22 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -176.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.0 t -142.34 158.07 44.11 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.188 -0.945 . . . . 0.0 109.809 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.2 m -113.78 177.51 4.61 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.147 -0.97 . . . . 0.0 111.523 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -102.78 -20.11 14.46 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.615 -0.678 . . . . 0.0 109.871 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.0 mt -112.16 -120.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.015 -1.053 . . . . 0.0 109.519 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -114.46 148.35 37.94 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 119.952 -1.717 . . . . 0.0 108.227 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.492 HG11 ' CE2' ' A' ' 68' ' ' TYR . 63.1 t -60.97 -42.48 93.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 O-C-N 121.118 -0.989 . . . . 0.0 110.269 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -60.13 -45.78 91.87 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.198 -0.939 . . . . 0.0 110.861 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -71.66 -45.49 61.81 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.859 -1.151 . . . . 0.0 109.104 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -60.13 -43.28 95.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.106 -0.996 . . . . 0.0 111.611 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.77 83.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.567 -1.333 . . . . 0.0 110.381 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.1 ttp -62.3 -41.8 98.83 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.138 -0.976 . . . . 0.0 109.716 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -63.41 -42.0 98.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.136 -0.978 . . . . 0.0 109.192 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.2 t -67.06 -42.32 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.5 -0.75 . . . . 0.0 109.659 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.47 ' CZ ' ' OD1' ' A' ' 81' ' ' ASP . 5.8 t80 -58.55 -47.66 83.46 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.93 -1.106 . . . . 0.0 109.415 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -73.0 -35.67 66.88 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 109.966 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -60.16 -35.67 75.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.873 -1.142 . . . . 0.0 109.053 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.82 5.16 26.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.267 -0.896 . . . . 0.0 110.33 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 55.01 32.91 19.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.97 -1.081 . . . . 0.0 111.123 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.469 ' HB2' ' CE1' ' A' ' 51' ' ' PHE . 94.0 mtp -65.94 -12.59 55.95 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.793 -1.192 . . . . 0.0 109.927 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -76.69 -1.61 28.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.723 -1.236 . . . . 0.0 109.781 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -74.87 65.1 1.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.855 -1.153 . . . . 0.0 110.262 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.4 p -134.8 148.78 50.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.074 -1.016 . . . . 0.0 109.272 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -62.56 -43.79 97.93 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.599 -0.688 . . . . 0.0 112.841 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.7 mt -98.18 2.27 48.28 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.903 -1.123 . . . . 0.0 111.804 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 56.53 32.76 21.41 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 122.437 1.113 . . . . 0.0 111.088 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.412 ' HA ' HG13 ' A' ' 84' ' ' ILE . 3.2 m-80 -108.31 53.38 0.69 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.949 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.58 139.37 14.37 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.9 t -123.42 133.78 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -1.157 . . . . 0.0 109.829 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 37.9 tp -117.18 133.06 56.45 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.093 -1.004 . . . . 0.0 109.495 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.437 ' CD1' HG23 ' A' ' 33' ' ' VAL . 83.8 mt -104.32 108.38 24.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 118.809 -1.157 . . . . 0.0 109.369 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.492 ' CE2' HG11 ' A' ' 43' ' ' VAL . 69.3 t80 -95.57 121.06 36.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.318 -0.864 . . . . 0.0 110.014 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.9 t -120.67 130.77 74.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.953 0.883 . . . . 0.0 110.841 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.5 103.26 15.0 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 37' ' ' LYS . 21.5 m -71.88 -18.99 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.992 -1.067 . . . . 0.0 111.048 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -70.27 -46.68 63.88 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.531 -1.356 . . . . 0.0 109.342 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -101.61 4.74 41.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.077 -1.015 . . . . 0.0 110.427 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.7 tttt 53.88 46.91 24.71 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.824 -1.172 . . . . 0.0 110.618 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.9 m -121.07 135.43 55.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.986 -1.071 . . . . 0.0 109.709 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.454 ' CG ' HG23 ' A' ' 100' ' ' ILE . 42.9 p90 -112.15 133.9 54.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.457 -0.777 . . . . 0.0 109.885 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.8 t -126.89 135.67 63.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 120.935 -1.103 . . . . 0.0 108.063 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.408 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 81.6 mt -114.4 128.16 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.888 -1.133 . . . . 0.0 110.679 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -132.27 113.85 13.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.734 -0.603 . . . . 0.0 110.539 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.38 176.82 26.88 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.47 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 92.5 m-20 -82.5 -178.64 7.14 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.629 -0.924 . . . . 0.0 110.437 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.74 -23.34 67.14 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.448 -0.783 . . . . 0.0 109.634 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.15 -54.07 29.56 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.636 -1.268 . . . . 0.0 111.075 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.429 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 2.6 mt -66.33 -45.9 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.734 -1.45 . . . . 0.0 108.456 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -61.67 -37.62 84.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.058 -1.026 . . . . 0.0 111.521 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -75.61 -20.96 58.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.881 -1.137 . . . . 0.0 111.961 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.25 -22.02 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.861 -1.149 . . . . 0.0 112.341 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.446 ' HB ' ' CD2' ' A' ' 92' ' ' PHE . 21.4 m -121.01 162.27 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 120.483 -1.385 . . . . 0.0 111.168 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.1 p -104.51 177.64 4.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.313 -0.867 . . . . 0.0 112.177 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.0 -35.68 79.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.683 -0.635 . . . . 0.0 109.437 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -63.82 -37.19 86.47 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 123' ' ' ALA . 56.6 t80 -65.85 -24.31 66.85 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.09 -1.007 . . . . 0.0 108.606 177.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.408 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 6.8 m95 -87.12 -28.42 22.51 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.796 0.808 . . . . 0.0 110.784 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -57.09 -36.64 70.85 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.493 -0.754 . . . . 0.0 112.327 -176.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 64.5 p -67.38 -32.82 74.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.796 -1.19 . . . . 0.0 109.346 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.284 8.5 m -59.26 -47.78 84.07 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.67 1.224 . . . . 0.0 110.521 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -69.13 -38.54 78.88 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.897 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -64.27 -44.73 90.81 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.687 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.22 -49.42 75.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.694 -1.254 . . . . 0.0 110.967 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.454 HG23 ' CG ' ' A' ' 76' ' ' PHE . 95.9 mt -67.24 -42.4 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.073 -1.017 . . . . 0.0 110.26 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 76' ' ' PHE . 57.8 tt0 -63.58 -40.39 96.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.916 -1.115 . . . . 0.0 110.814 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 40.4 mt -63.39 -42.62 98.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.117 -0.989 . . . . 0.0 111.929 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.445 ' CB ' ' CA ' ' A' ' 112' ' ' GLY . 88.0 mm-40 -75.15 -40.48 59.6 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.904 -1.119 . . . . 0.0 108.885 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.429 ' CD1' HG22 ' A' ' 100' ' ' ILE . 3.7 m-85 -60.26 -41.8 94.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 108.936 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.78 -29.71 70.91 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.541 -0.724 . . . . 0.0 109.554 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -81.34 -20.02 41.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.027 -1.046 . . . . 0.0 110.003 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.73 -0.94 34.11 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.744 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -102.45 95.99 6.63 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.531 -1.57 . . . . 0.0 110.854 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -63.13 -41.45 99.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.847 -0.533 . . . . 0.0 111.774 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -65.5 -49.07 70.39 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.371 -0.932 . . . . 0.0 112.446 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.76 -39.75 95.02 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 118.859 -1.136 . . . . 0.0 110.594 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.445 ' CA ' ' CB ' ' A' ' 103' ' ' GLN . . . -62.41 -48.05 85.06 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.48 -1.343 . . . . 0.0 109.946 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.5 mt -63.65 -44.33 94.12 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.504 -0.998 . . . . 0.0 110.308 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 78.7 t -65.23 -47.57 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.95 -1.094 . . . . 0.0 110.858 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -65.76 -41.12 92.49 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 110.805 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.07 -41.21 98.59 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 98.1 mt -63.54 -42.99 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.141 -1.211 . . . . 0.0 109.585 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -59.19 -47.29 85.85 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.941 -1.099 . . . . 0.0 109.624 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.37 -42.54 99.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.383 -0.823 . . . . 0.0 109.333 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -58.71 -42.64 89.14 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.124 -0.985 . . . . 0.0 109.657 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.89 -43.04 96.61 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.637 -1.268 . . . . 0.0 109.99 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 90.8 mtp -67.19 -45.35 77.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.15 -1.206 . . . . 0.0 110.488 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 92' ' ' PHE . . . -64.24 -42.52 96.49 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.301 -0.96 . . . . 0.0 108.626 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.4 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 73.7 mt -64.56 -39.82 94.44 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.546 -0.721 . . . . 0.0 109.58 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.71 -34.19 58.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.029 -1.044 . . . . 0.0 110.472 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -63.05 -42.91 99.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.024 -1.047 . . . . 0.0 109.492 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.412 ' HB3' ' CE1' ' A' ' 128' ' ' PHE . 53.9 m-85 -70.22 -42.64 72.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.473 -0.767 . . . . 0.0 110.014 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.412 ' CE1' ' HB3' ' A' ' 127' ' ' TYR . 83.1 m-85 -127.92 101.72 22.81 Favored Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 121.495 -0.753 . . . . 0.0 109.931 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.2 152.07 80.19 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.81 1.426 . . . . 0.0 109.877 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.476 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 43.4 t90 -78.79 137.64 37.82 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.624 -0.672 . . . . 0.0 111.173 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -115.28 149.18 38.21 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.318 -0.864 . . . . 0.0 109.526 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -57.81 -28.52 64.12 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 111.236 -177.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -91.13 9.96 28.88 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.921 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.428 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 66.3 t0 -43.12 137.09 2.63 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.358 -0.839 . . . . 0.0 111.575 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.502 HD12 HG21 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -110.43 136.12 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.734 0.778 . . . . 0.0 111.484 -178.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -115.12 100.68 8.34 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -101.26 -4.45 27.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.896 -1.127 . . . . 0.0 111.933 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.86 145.41 30.66 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.938 -1.101 . . . . 0.0 110.983 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -70.32 166.38 28.48 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.669 1.352 . . . . 0.0 109.468 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.432 ' ND2' ' HG2' ' A' ' 21' ' ' ARG . 62.8 m-80 -109.66 7.46 24.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.568 -1.333 . . . . 0.0 110.77 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.6 p -65.85 171.15 4.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.911 -1.118 . . . . 0.0 111.329 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 91.1 mt -97.88 140.43 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 121.387 0.613 . . . . 0.0 110.707 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 18.1 t -94.48 134.32 37.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 109.829 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -129.1 148.1 51.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 110.451 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 CA-C-O 117.964 -1.465 . . . . 0.0 109.784 -179.796 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.3 p . . . . . 0 N--CA 1.495 1.796 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.42 -35.61 68.0 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.953 -1.092 . . . . 0.0 109.857 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -58.9 -46.36 88.07 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.395 -0.816 . . . . 0.0 109.99 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.43 ' HA ' ' CE ' ' A' ' 110' ' ' LYS . 98.9 mt-10 -69.2 -46.17 68.08 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.311 -0.868 . . . . 0.0 111.067 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -64.76 -39.53 93.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.136 -0.977 . . . . 0.0 110.755 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.47 -45.17 94.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.162 -0.961 . . . . 0.0 110.877 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.51 -41.09 98.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.972 . . . . 0.0 110.481 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.2 mt -64.64 -43.47 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 111.208 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.432 ' CG2' HG12 ' A' ' 142' ' ' ILE . 45.4 t -60.99 -42.77 94.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 108.788 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -61.27 -37.67 83.98 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.492 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.76 94.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.506 -0.746 . . . . 0.0 109.811 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 91.5 mt -63.83 -43.42 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 109.404 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -55.59 -44.63 77.14 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.502 -0.749 . . . . 0.0 109.682 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -63.19 -37.41 87.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.473 -0.767 . . . . 0.0 110.986 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.45 -37.94 89.22 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.977 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.425 ' OE1' ' ND2' ' A' ' 140' ' ' ASN . 3.3 mp0 -60.83 -15.34 29.07 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.804 -1.185 . . . . 0.0 111.091 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.7 mttt -94.61 -1.53 53.07 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 120.912 -1.118 . . . . 0.0 109.499 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -111.15 -15.09 13.76 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.857 -1.152 . . . . 0.0 110.188 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.1 t -152.68 160.28 43.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.023 -1.048 . . . . 0.0 109.45 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.1 m -88.17 -5.52 58.37 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.986 -1.071 . . . . 0.0 110.344 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.93 170.04 52.14 Favored Glycine 0 N--CA 1.482 1.723 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -129.68 136.86 50.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.258 -1.142 . . . . 0.0 110.723 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.2 mt -119.22 134.96 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.595 -0.69 . . . . 0.0 110.71 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -139.47 153.24 47.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.389 -0.82 . . . . 0.0 109.923 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.7 t -123.42 141.01 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.302 -0.874 . . . . 0.0 110.952 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -122.95 124.82 44.05 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.8 tp -112.61 129.0 56.53 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.938 0.875 . . . . 0.0 111.286 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -146.42 164.77 31.4 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -79.73 -73.88 0.33 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.112 -0.992 . . . . 0.0 112.898 -177.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.33 157.24 46.23 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.262 -0.899 . . . . 0.0 110.133 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.8 m -103.06 165.07 11.24 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.624 -0.673 . . . . 0.0 110.166 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -104.23 -14.23 15.9 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.353 -0.842 . . . . 0.0 109.794 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.426 HG13 ' N ' ' A' ' 42' ' ' ASP . 29.8 pt -124.8 -122.01 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.052 -1.03 . . . . 0.0 110.052 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.426 ' N ' HG13 ' A' ' 41' ' ' ILE . 95.3 m-20 -110.73 139.17 46.26 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.16 -1.587 . . . . 0.0 109.359 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 84.3 t -64.59 -43.92 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.299 -0.875 . . . . 0.0 111.902 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -60.05 -45.42 92.91 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.72 -1.237 . . . . 0.0 110.123 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -70.98 -38.1 72.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.851 -1.156 . . . . 0.0 109.365 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 50.1 ttt85 -65.97 -43.1 88.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.774 -1.203 . . . . 0.0 110.266 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.75 -37.59 88.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.87 -1.144 . . . . 0.0 110.224 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 62.3 ttp -64.23 -43.23 95.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.137 -0.977 . . . . 0.0 109.153 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -63.85 -41.97 97.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.937 -1.102 . . . . 0.0 109.251 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 74.2 t -67.61 -42.87 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.502 -0.749 . . . . 0.0 109.833 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -59.8 -46.85 87.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.88 -1.138 . . . . 0.0 109.491 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -74.94 -36.12 62.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.967 -1.083 . . . . 0.0 109.764 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -61.07 -38.42 86.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.067 -1.02 . . . . 0.0 109.442 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.5 mt -81.89 4.05 23.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.0 110.048 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.43 33.96 23.4 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.288 -0.883 . . . . 0.0 111.941 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.431 ' CE ' ' HB2' ' A' ' 66' ' ' LEU . 95.7 mtp -69.22 -15.02 63.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.089 -1.007 . . . . 0.0 109.922 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 44.9 p-10 -78.45 -5.32 52.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.831 -1.168 . . . . 0.0 110.138 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 65.1 t-20 -88.64 78.8 7.67 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.788 -1.195 . . . . 0.0 110.409 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.3 m -137.02 154.91 50.26 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.19 -44.44 97.28 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 111.599 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 90.5 mt -99.94 -2.4 34.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.757 -1.215 . . . . 0.0 111.389 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 87.7 mt-30 59.32 49.92 8.37 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.245 1.021 . . . . 0.0 111.265 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -122.22 54.15 1.2 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.479 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.92 143.33 16.16 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.46 ' CG2' ' CD1' ' A' ' 84' ' ' ILE . 54.0 t -124.12 134.75 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.907 -1.349 . . . . 0.0 110.715 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.431 ' HB2' ' CE ' ' A' ' 56' ' ' MET . 39.7 tp -117.1 125.16 50.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.568 -0.708 . . . . 0.0 109.893 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 67' ' ' ILE . 83.2 mt -102.3 110.88 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.602 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -96.37 120.75 37.25 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.168 -0.957 . . . . 0.0 110.027 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.9 t -122.39 131.11 73.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.297 -0.877 . . . . 0.0 110.922 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.91 90.52 4.45 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.4 m -60.26 -24.16 29.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.298 -0.876 . . . . 0.0 111.375 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -67.51 -41.12 84.94 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.989 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -103.33 4.06 35.98 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.072 -1.017 . . . . 0.0 110.685 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 45.2 tttt 55.86 45.72 23.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.827 -1.171 . . . . 0.0 110.752 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 72.4 p -119.97 163.37 17.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.966 . . . . 0.0 109.32 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -142.79 146.09 33.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.104 -0.998 . . . . 0.0 110.578 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.7 t -134.74 138.47 49.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.515 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 88.7 mt -117.17 125.65 74.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 118.977 -1.089 . . . . 0.0 110.416 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -128.07 114.22 16.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.806 -0.559 . . . . 0.0 110.325 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.89 171.1 22.36 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -81.14 174.44 11.57 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.493 -1.004 . . . . 0.0 110.013 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.02 -26.67 66.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.989 . . . . 0.0 111.656 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.88 -52.11 45.19 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.807 -1.187 . . . . 0.0 110.416 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.46 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 97.1 mt -64.71 -43.47 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.783 -1.422 . . . . 0.0 108.122 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -63.4 -36.93 85.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.518 -1.364 . . . . 0.0 111.476 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -74.21 -20.92 60.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.845 -1.159 . . . . 0.0 112.166 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 84' ' ' ILE . 32.9 m -105.64 -18.51 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.745 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.449 ' HB ' ' CD1' ' A' ' 92' ' ' PHE . 4.0 m -119.82 160.28 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 120.67 -1.268 . . . . 0.0 111.47 -178.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.1 m -107.17 176.71 5.08 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.81 0.814 . . . . 0.0 112.005 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -61.86 -36.95 82.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.611 -0.681 . . . . 0.0 109.48 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -62.19 -38.22 88.28 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.422 -0.911 . . . . 0.0 108.922 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.48 ' CE2' ' CB ' ' A' ' 123' ' ' ALA . 55.3 t80 -64.05 -26.62 68.64 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.539 -0.726 . . . . 0.0 109.356 178.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.515 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 4.9 m95 -86.95 -25.81 24.17 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.938 0.875 . . . . 0.0 110.989 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -56.92 -36.78 70.59 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.429 -0.795 . . . . 0.0 111.712 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.8 m -64.32 -33.66 76.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.767 -1.208 . . . . 0.0 108.983 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.279 7.4 m -59.82 -49.89 75.94 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 122.358 1.075 . . . . 0.0 111.379 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.69 -38.6 87.09 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.707 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -64.01 -45.03 90.78 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.946 -1.102 . . . . 0.0 110.439 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.1 -50.91 72.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.592 -1.318 . . . . 0.0 110.484 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 86.8 mt -67.81 -42.72 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.905 -1.122 . . . . 0.0 110.17 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -62.62 -46.72 86.94 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.516 -0.74 . . . . 0.0 111.086 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.425 HD22 ' N ' ' A' ' 102' ' ' LEU . 4.3 mm? -63.53 -41.54 98.46 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.007 -1.058 . . . . 0.0 112.043 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.408 ' HB2' ' HA3' ' A' ' 112' ' ' GLY . 99.4 mm-40 -72.15 -40.24 68.16 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.176 -1.41 . . . . 0.0 108.594 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -59.26 -40.82 87.2 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.784 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -62.38 -34.55 76.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -0.868 . . . . 0.0 110.928 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -83.6 -17.34 41.99 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.528 -1.357 . . . . 0.0 110.319 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.26 11.38 25.78 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.172 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -107.94 83.0 1.72 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.873 -1.369 . . . . 0.0 110.451 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -62.5 -43.71 98.15 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.151 -0.968 . . . . 0.0 111.026 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.43 ' CE ' ' HA ' ' A' ' 12' ' ' GLU . 60.9 tttm -61.13 -47.85 84.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 0.0 111.446 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -64.1 -37.85 88.94 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.954 -1.091 . . . . 0.0 110.843 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 103' ' ' GLN . . . -62.49 -49.04 77.39 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.496 -1.335 . . . . 0.0 109.823 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.47 -43.96 97.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -1.161 . . . . 0.0 110.926 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 76.4 t -65.91 -46.82 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.906 -1.121 . . . . 0.0 110.325 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -65.01 -40.1 94.39 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.538 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.89 -43.74 93.21 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.3 mt -64.51 -44.33 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -1.14 . . . . 0.0 109.368 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -58.98 -49.08 79.25 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.045 -1.034 . . . . 0.0 109.632 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.34 -41.21 98.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.205 -0.934 . . . . 0.0 109.447 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.417 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -57.58 -42.04 82.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.202 -0.937 . . . . 0.0 110.072 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.59 -43.56 96.32 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.67 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 96.6 mtp -68.33 -45.37 73.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.914 -1.345 . . . . 0.0 110.285 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.48 ' CB ' ' CE2' ' A' ' 92' ' ' PHE . . . -63.56 -45.93 88.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.118 -0.989 . . . . 0.0 108.761 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.417 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 72.7 mt -61.87 -40.5 95.58 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.47 -34.08 56.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 110.4 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.58 -44.65 93.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.002 -1.061 . . . . 0.0 109.366 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -71.54 -41.47 69.09 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.45 0.643 . . . . 0.0 109.65 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -130.54 97.69 21.35 Favored Pre-proline 0 C--N 1.307 -1.251 0 O-C-N 121.514 -0.741 . . . . 0.0 109.828 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.75 152.87 80.39 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.575 1.303 . . . . 0.0 110.707 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.481 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 47.7 t90 -76.57 127.07 32.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.556 -0.715 . . . . 0.0 110.689 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -103.35 146.96 27.69 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.151 -0.968 . . . . 0.0 109.041 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -56.71 -28.44 60.96 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.103 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.4 p30 -93.68 6.76 47.26 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.012 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 135' ' ' ILE . 67.1 t0 -42.55 140.24 1.31 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.705 0.764 . . . . 0.0 111.622 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.455 ' CD1' ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -115.38 146.08 20.28 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 CA-C-O 121.576 0.703 . . . . 0.0 110.891 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -103.23 97.45 7.53 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.356 -1.465 . . . . 0.0 110.58 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -68.14 -35.72 78.56 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.1 mp -110.87 151.06 42.69 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.895 -1.128 . . . . 0.0 111.923 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -72.48 -174.69 1.52 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 N-CA-C 108.448 -1.405 . . . . 0.0 108.448 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.425 ' ND2' ' OE1' ' A' ' 24' ' ' GLU . 10.5 m120 -123.02 2.51 9.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.592 -1.318 . . . . 0.0 110.116 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -58.2 170.25 0.71 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.934 -1.104 . . . . 0.0 111.348 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.432 HG12 ' CG2' ' A' ' 17' ' ' VAL . 49.6 mm -95.17 133.17 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.66 -0.65 . . . . 0.0 111.039 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 69.5 m -93.08 131.24 38.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.534 -0.729 . . . . 0.0 109.093 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -127.03 135.99 51.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.884 -1.135 . . . . 0.0 110.591 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.398 0 CA-C-O 117.935 -1.481 . . . . 0.0 109.72 -179.768 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.0 p . . . . . 0 N--CA 1.495 1.81 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.73 -39.73 68.55 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.797 -1.19 . . . . 0.0 109.422 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -62.8 -40.36 97.12 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.473 -0.767 . . . . 0.0 109.51 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -73.62 -46.59 45.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.105 -0.997 . . . . 0.0 110.696 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.431 ' O ' ' CG2' ' A' ' 17' ' ' VAL . 96.8 mt-10 -67.04 -34.56 77.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.112 -0.993 . . . . 0.0 110.265 178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -64.77 -44.7 89.19 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.753 -1.217 . . . . 0.0 110.075 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.94 -47.02 79.18 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.134 -0.979 . . . . 0.0 111.409 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.406 HG23 ' O ' ' A' ' 13' ' ' GLU . 20.4 tt -64.06 -36.25 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.773 -1.205 . . . . 0.0 110.174 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 13' ' ' GLU . 55.4 t -61.28 -38.36 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -64.25 -36.18 83.25 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.775 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.98 -40.15 94.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.06 -1.025 . . . . 0.0 109.566 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 83.6 mt -63.14 -43.79 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 109.399 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -62.2 -43.72 98.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.45 -0.781 . . . . 0.0 110.694 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -63.08 -38.9 93.04 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.162 -0.961 . . . . 0.0 111.41 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.9 -37.89 88.74 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.206 -0.997 . . . . 0.0 109.291 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.2 -15.99 29.22 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.101 -0.999 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.478 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 75.5 mmtt -94.88 -3.6 48.48 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.013 -1.054 . . . . 0.0 109.544 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -108.69 -13.48 14.79 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 121.176 -0.953 . . . . 0.0 109.813 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.8 t -156.35 161.15 40.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.014 -1.054 . . . . 0.0 110.049 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.3 m -87.21 -12.13 47.73 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.371 -0.831 . . . . 0.0 108.78 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.39 167.09 40.89 Favored Glycine 0 N--CA 1.477 1.394 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.424 ' OE2' ' N ' ' A' ' 137' ' ' GLU . 97.8 mt-10 -135.59 141.6 45.16 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 118.9 -1.12 . . . . 0.0 112.229 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.6 mt -123.61 135.77 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.237 0.541 . . . . 0.0 110.547 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 143' ' ' SER . 68.8 ttt180 -139.88 163.06 33.65 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.198 -0.939 . . . . 0.0 109.746 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 p -131.97 142.4 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.157 -0.964 . . . . 0.0 111.687 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -126.98 125.56 41.7 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.452 -0.78 . . . . 0.0 109.442 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.5 tp -108.4 128.56 54.88 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 122.07 0.938 . . . . 0.0 112.019 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.41 ' OE2' ' CZ ' ' A' ' 46' ' ' ARG . 82.2 tt0 -144.87 159.68 42.51 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.406 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 97.8 mttt -79.32 -75.66 0.24 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.063 -1.023 . . . . 0.0 112.94 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.6 t -136.57 155.34 50.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.299 -0.876 . . . . 0.0 110.214 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.5 p -103.77 170.79 7.72 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.415 -0.803 . . . . 0.0 110.365 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.414 ' OE1' ' N ' ' A' ' 40' ' ' GLU . 56.0 mp0 -108.37 -12.61 15.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.472 -0.768 . . . . 0.0 110.414 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.8 pt -124.31 -122.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.149 -0.969 . . . . 0.0 108.586 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -111.84 140.81 46.18 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 120.434 -1.416 . . . . 0.0 109.687 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.409 HG13 ' CE1' ' A' ' 68' ' ' TYR . 94.4 t -64.15 -42.74 96.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.372 -0.83 . . . . 0.0 110.683 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -59.92 -46.75 88.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.955 -1.091 . . . . 0.0 109.938 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -69.81 -36.8 75.96 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.79 -1.194 . . . . 0.0 108.772 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.41 ' CZ ' ' OE2' ' A' ' 36' ' ' GLU . 61.3 ttt85 -64.1 -42.85 96.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -0.916 . . . . 0.0 110.949 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.6 83.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.722 -1.236 . . . . 0.0 110.499 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 60.2 ttp -62.89 -42.28 99.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.034 -1.042 . . . . 0.0 108.975 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -65.88 -44.7 84.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.137 -0.977 . . . . 0.0 110.361 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.44 -43.44 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.365 -0.834 . . . . 0.0 110.411 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.488 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 2.9 t80 -58.77 -47.92 83.0 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.7 -1.25 . . . . 0.0 108.996 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -72.16 -35.66 69.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.043 -1.036 . . . . 0.0 109.703 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -60.54 -39.35 87.57 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.6 mt -80.2 5.26 15.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.155 -0.966 . . . . 0.0 110.361 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 55.76 33.94 22.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.818 -1.176 . . . . 0.0 111.926 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.488 ' HB2' ' CE1' ' A' ' 51' ' ' PHE . 94.1 mtp -65.55 -11.01 40.04 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.988 -1.07 . . . . 0.0 110.236 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -77.53 0.57 22.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.819 -1.176 . . . . 0.0 110.284 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -74.57 62.25 1.01 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.851 -1.156 . . . . 0.0 110.062 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 65.3 p -135.19 148.47 49.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.107 -0.996 . . . . 0.0 109.631 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -64.44 -40.98 96.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.75 -0.594 . . . . 0.0 112.276 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 95.7 mt -98.66 -0.15 43.53 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.904 -1.122 . . . . 0.0 111.448 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 85.7 mt-30 57.71 45.77 18.38 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 122.5 1.143 . . . . 0.0 111.148 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.426 ' HA ' HG13 ' A' ' 84' ' ' ILE . 38.0 p30 -118.96 53.61 1.0 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.072 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.39 140.98 15.13 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.465 ' CG2' ' CD1' ' A' ' 84' ' ' ILE . 67.3 t -125.55 134.74 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.043 -1.269 . . . . 0.0 110.34 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.448 ' HB2' ' CD2' ' A' ' 51' ' ' PHE . 38.5 tp -117.51 133.68 55.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.339 -0.851 . . . . 0.0 110.24 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.2 mt -106.82 108.83 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 118.75 -1.18 . . . . 0.0 109.557 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.409 ' CE1' HG13 ' A' ' 43' ' ' VAL . 61.2 t80 -95.45 117.71 30.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 110.181 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.1 t -118.19 128.34 75.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 121.726 0.774 . . . . 0.0 110.356 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.26 88.49 5.17 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.73 -23.81 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.036 -1.04 . . . . 0.0 110.907 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 47.7 tp10 -67.73 -41.89 82.73 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.779 -1.2 . . . . 0.0 108.85 178.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -104.77 8.6 34.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.053 -1.03 . . . . 0.0 111.259 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 104' ' ' PHE . 85.3 tttt 52.12 45.17 28.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.875 -1.141 . . . . 0.0 110.407 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.8 p -122.33 159.15 28.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.803 -1.186 . . . . 0.0 109.135 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -141.53 148.37 39.24 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.21 -0.932 . . . . 0.0 110.364 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 66.1 t -134.19 137.13 52.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.523 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 75.8 mt -113.74 127.83 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.859 -1.151 . . . . 0.0 110.174 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -135.02 114.67 12.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.576 -0.702 . . . . 0.0 110.624 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -99.77 171.47 23.88 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.474 ' OD1' ' CE1' ' A' ' 51' ' ' PHE . 78.1 m-20 -75.33 171.28 14.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.399 -1.059 . . . . 0.0 110.653 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -58.64 -26.46 63.78 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.592 -0.692 . . . . 0.0 110.444 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.1 -53.34 30.48 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.465 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 87.6 mt -63.51 -44.74 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.944 -1.327 . . . . 0.0 107.893 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -62.21 -36.87 83.26 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.833 -1.167 . . . . 0.0 111.396 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -70.63 -24.26 62.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.861 -1.15 . . . . 0.0 111.78 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 84' ' ' ILE . 25.7 m -105.74 -16.45 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 120.642 -1.286 . . . . 0.0 112.909 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 84' ' ' ILE . 18.8 m -116.45 162.07 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 120.338 -1.476 . . . . 0.0 112.002 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.3 t -109.41 174.46 5.86 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.597 0.713 . . . . 0.0 111.809 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 33.0 p-10 -61.61 -35.85 79.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 110.147 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -62.42 -40.59 97.03 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.821 -1.174 . . . . 0.0 109.781 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.479 ' CZ ' ' HB1' ' A' ' 123' ' ' ALA . 87.8 t80 -63.15 -25.52 68.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.123 -0.985 . . . . 0.0 109.333 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.523 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 4.2 m95 -86.88 -24.64 24.82 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.955 0.883 . . . . 0.0 110.876 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -57.1 -38.81 73.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.063 -1.023 . . . . 0.0 112.455 -177.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.9 p -63.61 -31.84 73.14 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.53 -1.268 . . . . 0.0 109.199 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.272 15.1 m -59.93 -48.06 83.22 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.379 1.085 . . . . 0.0 111.031 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -68.98 -38.57 79.41 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.25 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -64.03 -44.26 93.08 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.827 -1.171 . . . . 0.0 110.669 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.88 -49.77 73.54 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.832 -1.167 . . . . 0.0 111.348 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 91.4 mt -67.34 -42.42 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.073 -1.017 . . . . 0.0 110.329 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -65.16 -40.92 95.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.243 -0.911 . . . . 0.0 110.602 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.8 tp -62.22 -42.13 99.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.209 -0.932 . . . . 0.0 111.13 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.421 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 95.8 mm-40 -76.9 -40.0 48.89 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.136 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.415 ' O ' ' CE ' ' A' ' 74' ' ' LYS . 2.8 m-85 -58.41 -41.82 85.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.145 -0.972 . . . . 0.0 108.55 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.43 -32.12 73.47 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.635 -0.665 . . . . 0.0 110.444 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -78.69 -20.07 51.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.741 -1.225 . . . . 0.0 109.911 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.17 4.7 41.15 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.41 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -103.66 86.31 2.6 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.743 -1.445 . . . . 0.0 110.097 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -61.62 -43.03 99.62 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.371 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -61.71 -47.95 82.96 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.97 -1.081 . . . . 0.0 111.377 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -64.55 -38.11 89.87 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.21 -0.932 . . . . 0.0 110.488 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.421 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -63.84 -49.54 67.4 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.51 -44.73 93.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.145 -1.209 . . . . 0.0 110.959 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.03 -47.77 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.137 -0.977 . . . . 0.0 110.115 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -62.84 -40.88 98.77 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.922 -1.111 . . . . 0.0 110.571 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.29 -42.24 97.23 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -43.99 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.228 -1.16 . . . . 0.0 109.698 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -58.28 -54.62 44.93 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.05 -1.031 . . . . 0.0 110.597 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.34 -39.97 92.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.122 -0.986 . . . . 0.0 108.691 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.55 -41.58 90.41 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.312 -0.867 . . . . 0.0 109.713 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.17 -44.3 97.34 Favored Glycine 0 N--CA 1.495 2.607 0 O-C-N 120.761 -1.212 . . . . 0.0 111.01 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 64.6 ttp -67.91 -48.03 67.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.874 -1.368 . . . . 0.0 109.898 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.479 ' HB1' ' CZ ' ' A' ' 92' ' ' PHE . . . -59.99 -46.52 89.19 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.058 -1.026 . . . . 0.0 109.234 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.96 -41.01 97.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 109.45 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.14 -32.23 54.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 110.335 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.77 -44.41 96.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.129 -0.982 . . . . 0.0 109.848 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -72.37 -41.79 65.97 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.537 0.684 . . . . 0.0 110.276 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -132.05 100.71 15.55 Favored Pre-proline 0 C--N 1.304 -1.404 0 O-C-N 121.54 -0.725 . . . . 0.0 109.657 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.42 150.72 80.78 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.57 1.3 . . . . 0.0 110.932 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.478 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 60.3 t90 -75.13 133.84 41.42 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.645 -0.659 . . . . 0.0 110.546 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -114.06 153.59 29.16 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 109.495 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.44 -28.98 65.77 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.035 -1.04 . . . . 0.0 110.63 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -93.3 7.54 43.96 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.311 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.401 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 52.2 t0 -42.43 138.43 1.78 Allowed 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.77 0.795 . . . . 0.0 111.361 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.434 ' CD1' ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -114.36 148.2 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 121.896 0.855 . . . . 0.0 111.967 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -108.55 96.03 6.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.641 -1.287 . . . . 0.0 110.382 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.424 ' N ' ' OE2' ' A' ' 30' ' ' GLU . 81.2 mm-40 -67.81 -32.31 72.77 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.594 -0.692 . . . . 0.0 111.662 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 33.7 mt -110.06 154.46 42.72 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.185 -0.947 . . . . 0.0 111.856 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -79.4 -167.27 0.48 Allowed 'Trans proline' 0 C--N 1.319 -1.014 0 N-CA-C 108.436 -1.409 . . . . 0.0 108.436 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -124.0 3.21 8.69 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.468 -1.395 . . . . 0.0 110.392 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.3 p -63.24 166.75 5.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.884 -1.135 . . . . 0.0 111.13 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.8 mt -96.09 137.87 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.823 -0.548 . . . . 0.0 110.258 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 32' ' ' ARG . 25.1 t -96.35 137.23 35.73 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.208 -0.933 . . . . 0.0 109.713 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -128.13 145.15 51.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.004 -1.06 . . . . 0.0 110.284 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.903 0 CA-C-O 117.972 -1.46 . . . . 0.0 110.296 179.898 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 p . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.59 -37.03 65.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.948 -1.095 . . . . 0.0 109.864 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -60.87 -45.46 94.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 110.498 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -70.02 -45.38 67.33 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.239 -0.913 . . . . 0.0 110.8 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.18 -37.18 86.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.111 -0.993 . . . . 0.0 110.384 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -66.0 -44.0 86.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.968 -1.082 . . . . 0.0 111.959 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.18 -44.4 88.56 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.747 -1.221 . . . . 0.0 111.106 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.401 HD11 ' HB3' ' A' ' 113' ' ' LEU . 17.2 tt -65.92 -34.69 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.848 -1.158 . . . . 0.0 109.917 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.429 HG12 ' ND2' ' A' ' 140' ' ' ASN . 55.1 t -63.65 -40.49 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.88 -36.64 83.99 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.441 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.82 -38.71 91.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.205 -0.934 . . . . 0.0 108.904 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.432 ' CG2' ' HB2' ' A' ' 140' ' ' ASN . 30.5 mm -62.87 -43.66 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.401 -0.812 . . . . 0.0 108.9 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.95 -43.3 98.92 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.542 -0.723 . . . . 0.0 109.976 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -64.71 -39.26 93.35 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.26 -0.9 . . . . 0.0 111.258 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.95 -39.27 93.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.045 -1.034 . . . . 0.0 109.616 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.12 -17.62 41.52 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.026 -1.046 . . . . 0.0 110.126 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.5 mttt -93.61 -3.3 52.84 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 121.178 -0.951 . . . . 0.0 109.733 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -107.57 -15.49 14.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.905 -1.122 . . . . 0.0 109.885 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.6 t -152.75 160.54 43.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.036 -1.04 . . . . 0.0 109.732 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.9 p -86.96 -8.73 56.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.959 -1.088 . . . . 0.0 109.534 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.66 170.84 42.28 Favored Glycine 0 N--CA 1.482 1.725 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -131.35 137.07 48.59 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.526 -0.985 . . . . 0.0 111.342 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -121.23 134.1 65.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.804 -0.56 . . . . 0.0 109.8 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -137.49 151.09 48.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.129 -0.982 . . . . 0.0 109.65 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.6 t -121.7 138.06 53.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.545 -0.722 . . . . 0.0 110.791 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.427 ' ND1' ' O ' ' A' ' 143' ' ' SER . 60.3 t60 -123.18 127.01 48.05 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.456 ' CD1' ' CG1' ' A' ' 71' ' ' VAL . 32.5 tp -113.93 125.81 54.46 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.85 0.833 . . . . 0.0 111.832 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -143.22 161.75 37.44 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -77.35 -71.36 0.41 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.994 -1.066 . . . . 0.0 113.469 -177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.418 ' CG2' ' OE1' ' A' ' 72' ' ' GLU . 8.0 t -140.13 159.01 43.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 110.462 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.9 m -107.1 164.72 11.92 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.824 -0.547 . . . . 0.0 110.128 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -105.8 -11.04 16.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.146 -0.971 . . . . 0.0 110.315 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.8 pt -125.13 -122.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.912 -1.118 . . . . 0.0 109.075 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -110.89 140.39 45.4 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.073 -1.642 . . . . 0.0 109.204 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.4 t -64.61 -42.92 96.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.283 -0.886 . . . . 0.0 110.986 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -59.43 -47.0 87.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.97 -1.081 . . . . 0.0 110.917 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -69.09 -39.0 79.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.59 -1.319 . . . . 0.0 108.359 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -59.78 -44.11 94.07 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.44 -0.788 . . . . 0.0 110.548 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.71 -36.98 85.15 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.887 -1.133 . . . . 0.0 110.006 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.4 ttp -62.77 -43.46 98.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.936 . . . . 0.0 109.402 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -65.76 -42.13 91.27 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.774 -1.204 . . . . 0.0 110.296 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.9 t -69.0 -43.21 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.246 -0.909 . . . . 0.0 110.777 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 56' ' ' MET . 2.0 t80 -59.2 -46.65 87.86 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.758 -1.214 . . . . 0.0 108.929 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -74.48 -35.86 63.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.144 -0.972 . . . . 0.0 109.858 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -61.45 -38.39 87.03 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.172 -0.955 . . . . 0.0 109.782 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.1 mt -80.21 5.89 13.32 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.362 -0.836 . . . . 0.0 110.336 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.1 mttt 54.67 30.6 13.66 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 120.877 -1.139 . . . . 0.0 110.532 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.447 ' HB2' ' CD1' ' A' ' 51' ' ' PHE . 98.4 mtp -64.75 -12.25 45.22 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.938 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -75.89 -0.54 21.71 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.751 -1.218 . . . . 0.0 110.509 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -76.2 64.42 2.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.763 -1.211 . . . . 0.0 110.224 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.3 p -135.4 149.58 49.68 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.288 -0.882 . . . . 0.0 109.622 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.72 -43.28 96.99 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.424 ' HB2' ' ND2' ' A' ' 63' ' ' ASN . 95.8 mt -99.11 1.47 45.14 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.814 -1.179 . . . . 0.0 111.643 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 56.01 45.63 23.38 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 122.734 1.254 . . . . 0.0 110.803 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.424 ' ND2' ' HB2' ' A' ' 61' ' ' LEU . 24.6 p30 -118.05 55.25 0.89 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.238 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.99 142.87 15.66 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.48 ' CG2' ' CD1' ' A' ' 84' ' ' ILE . 61.0 t -127.72 136.19 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.165 -1.197 . . . . 0.0 110.779 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.7 tp -116.71 127.44 54.39 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.783 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 90.0 mt -100.84 107.23 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.958 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -94.05 115.15 27.44 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.091 -1.006 . . . . 0.0 109.749 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.8 t -117.67 132.46 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 122.09 0.948 . . . . 0.0 111.126 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.37 87.27 3.58 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.456 ' CG1' ' CD1' ' A' ' 35' ' ' LEU . 28.9 m -58.89 -25.35 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.458 -0.776 . . . . 0.0 111.834 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.418 ' OE1' ' CG2' ' A' ' 38' ' ' THR . 71.3 tt0 -67.14 -43.36 82.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.743 -1.223 . . . . 0.0 108.64 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -99.64 5.38 45.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.47 -0.769 . . . . 0.0 110.457 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.2 tttt 54.47 46.57 24.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.922 -1.111 . . . . 0.0 111.034 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.7 p -121.63 167.74 12.56 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.784 -1.198 . . . . 0.0 109.791 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -147.42 142.07 26.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.149 -0.97 . . . . 0.0 110.706 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.4 t -130.11 138.8 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.476 -0.765 . . . . 0.0 109.259 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.467 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 71.1 mt -117.54 126.37 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.804 -1.185 . . . . 0.0 110.248 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -133.25 115.46 15.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.545 -0.722 . . . . 0.0 110.735 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.8 170.74 20.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.441 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 94.2 m-20 -82.67 -178.59 7.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.482 -1.011 . . . . 0.0 110.582 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.67 -26.69 68.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 110.765 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.46 -57.9 14.64 Favored Glycine 0 N--CA 1.485 1.966 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.522 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.48 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 79.3 mt -64.97 -44.52 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.801 -1.411 . . . . 0.0 108.917 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -61.47 -38.37 87.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.082 -1.011 . . . . 0.0 111.455 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -72.15 -19.4 61.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.915 -1.115 . . . . 0.0 112.23 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.8 m -108.27 -17.91 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.784 -1.198 . . . . 0.0 112.536 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.458 ' HB ' ' CD2' ' A' ' 92' ' ' PHE . 18.8 m -120.8 160.43 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.674 -1.266 . . . . 0.0 111.397 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.0 p -108.18 -175.5 2.79 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.956 0.884 . . . . 0.0 112.552 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -63.41 -35.63 81.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.662 -0.649 . . . . 0.0 109.74 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -62.3 -38.47 89.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 109.321 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.458 ' CD2' ' HB ' ' A' ' 88' ' ' VAL . 72.7 t80 -66.79 -27.64 67.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.563 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.467 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 7.3 m95 -86.06 -29.46 23.39 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.06 0.933 . . . . 0.0 110.254 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -55.83 -40.07 72.27 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.554 -0.716 . . . . 0.0 112.225 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 69.3 p -64.77 -30.46 71.47 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.412 -1.315 . . . . 0.0 108.594 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.419 ' CG2' HD13 ' A' ' 78' ' ' ILE 0.262 7.6 m -59.91 -49.43 77.73 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 122.333 1.063 . . . . 0.0 111.092 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -69.27 -37.9 78.12 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.941 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -63.85 -42.88 97.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.912 -1.117 . . . . 0.0 110.454 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.11 -48.6 73.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.736 -1.228 . . . . 0.0 110.927 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.4 mt -67.0 -42.7 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.845 -1.159 . . . . 0.0 110.175 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -61.78 -42.12 98.6 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.448 -0.782 . . . . 0.0 110.957 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.9 tp -63.81 -43.19 97.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.095 -1.003 . . . . 0.0 112.319 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.434 ' HB3' ' CA ' ' A' ' 112' ' ' GLY . 5.0 tp60 -76.07 -38.67 56.81 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.322 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -61.98 -41.4 97.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.016 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.51 -33.62 75.25 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.767 -0.583 . . . . 0.0 110.472 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -77.23 -18.29 57.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.981 -1.075 . . . . 0.0 109.499 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.8 2.52 42.89 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.714 -1.232 . . . . 0.0 111.393 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -100.22 91.32 4.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.669 -1.489 . . . . 0.0 109.972 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -62.04 -44.93 95.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.624 -0.673 . . . . 0.0 111.812 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.0 mppt? -62.64 -47.17 84.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.846 -1.159 . . . . 0.0 112.322 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -64.33 -37.85 88.95 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.725 -1.234 . . . . 0.0 110.634 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.434 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -65.03 -50.68 56.58 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.42 -1.371 . . . . 0.0 109.899 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.401 ' HB3' HD11 ' A' ' 16' ' ' ILE . 32.6 mt -62.6 -45.15 94.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.147 -1.208 . . . . 0.0 110.405 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.0 t -64.47 -48.02 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.001 -1.062 . . . . 0.0 110.736 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.06 -41.48 97.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.046 -1.034 . . . . 0.0 110.215 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.25 -40.58 98.78 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 75.9 mt -63.69 -44.03 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -1.072 . . . . 0.0 109.709 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -58.9 -45.12 91.03 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.052 -1.03 . . . . 0.0 109.027 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.35 -41.63 98.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.364 -0.835 . . . . 0.0 109.066 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.43 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -59.82 -43.53 94.5 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.434 -0.791 . . . . 0.0 109.942 178.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.13 -45.55 86.22 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 120.352 -0.927 . . . . 0.0 110.84 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 99.1 mmm -66.24 -44.96 82.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.979 -1.306 . . . . 0.0 109.655 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.406 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -64.53 -46.18 84.0 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.427 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.43 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 52.1 mt -62.55 -39.12 92.61 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.398 -0.813 . . . . 0.0 108.884 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.27 -35.18 62.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.161 -0.962 . . . . 0.0 110.794 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.8 -39.45 88.96 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.825 -1.172 . . . . 0.0 109.774 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -84.05 -34.6 24.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.5 -0.75 . . . . 0.0 110.328 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -125.93 96.6 37.14 Favored Pre-proline 0 C--N 1.303 -1.422 0 O-C-N 121.2 -0.938 . . . . 0.0 109.128 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.88 149.04 65.55 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 O-C-N 123.866 1.456 . . . . 0.0 110.047 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.476 ' CD1' ' OD2' ' A' ' 134' ' ' ASP . 59.7 t90 -75.52 131.08 39.83 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.245 -0.91 . . . . 0.0 110.731 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -110.17 150.33 28.8 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 108.912 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.06 -29.4 65.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.996 -1.065 . . . . 0.0 110.414 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -92.34 8.39 38.61 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.817 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.476 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 66.2 t0 -42.32 138.02 1.84 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.304 -0.873 . . . . 0.0 111.995 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.438 ' CD1' ' O ' ' A' ' 135' ' ' ILE . 1.3 pp -115.9 152.96 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.533 0.683 . . . . 0.0 111.131 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -113.59 99.35 7.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.832 -1.168 . . . . 0.0 110.041 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -67.95 -39.46 83.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.685 -0.635 . . . . 0.0 112.267 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.27 152.11 39.75 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.144 -0.972 . . . . 0.0 111.498 -178.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -76.64 -166.57 0.39 Allowed 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.528 1.278 . . . . 0.0 108.786 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.432 ' HB2' ' CG2' ' A' ' 20' ' ' ILE . 1.1 p-10 -122.98 2.48 9.35 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.834 -1.166 . . . . 0.0 109.94 178.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.8 m -64.66 135.9 56.4 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.832 -1.167 . . . . 0.0 111.432 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.9 mt -70.93 138.59 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.669 -0.644 . . . . 0.0 109.73 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.427 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 32.2 t -98.98 100.01 11.13 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.075 -1.015 . . . . 0.0 109.717 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.403 ' HG2' ' HB3' ' A' ' 35' ' ' LEU . 98.9 mttt -100.67 147.58 25.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.827 -1.171 . . . . 0.0 109.038 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 CA-C-O 118.018 -1.434 . . . . 0.0 109.62 -179.808 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.436 HG23 ' N ' ' A' ' 10' ' ' ALA . 71.9 m . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.24 0.543 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.436 ' N ' HG23 ' A' ' 9' ' ' THR . . . -58.8 -37.53 76.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 109.825 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -49.88 -60.92 2.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -0.855 . . . . 0.0 110.611 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.432 ' HB3' ' HG2' ' A' ' 110' ' ' LYS . 98.6 mt-10 -63.37 -40.94 98.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.576 -0.703 . . . . 0.0 110.962 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.412 ' HA ' ' HE2' ' A' ' 110' ' ' LYS . 98.7 mt-10 -62.61 -37.22 85.41 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.972 -1.08 . . . . 0.0 110.462 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -64.12 -44.35 92.49 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.903 -1.123 . . . . 0.0 110.276 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.93 -41.59 99.53 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.231 -0.918 . . . . 0.0 111.123 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 17' ' ' VAL . 19.6 tt -68.36 -27.36 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.854 -1.154 . . . . 0.0 110.19 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.434 ' N ' HG23 ' A' ' 16' ' ' ILE . 71.1 t -66.69 -41.13 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.08 -35.06 79.51 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.652 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.66 94.12 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.265 -0.897 . . . . 0.0 109.547 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.411 ' CG2' ' HB2' ' A' ' 140' ' ' ASN . 96.6 mt -64.52 -43.38 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.14 -0.975 . . . . 0.0 110.102 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -61.21 -41.0 96.08 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.45 -0.782 . . . . 0.0 109.716 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -64.53 -38.24 90.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.544 -0.722 . . . . 0.0 111.302 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.74 -39.72 94.11 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.957 -1.089 . . . . 0.0 109.508 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -59.56 -16.55 25.93 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.025 -1.047 . . . . 0.0 110.618 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 97.3 mttt -95.0 -0.57 53.68 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.144 -0.973 . . . . 0.0 109.197 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -111.07 -15.36 13.73 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 120.903 -1.123 . . . . 0.0 110.151 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.7 t -152.91 158.6 42.36 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.045 -1.034 . . . . 0.0 110.061 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 97.6 p -87.29 -10.13 53.15 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.322 -0.861 . . . . 0.0 109.819 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.13 170.62 37.33 Favored Glycine 0 N--CA 1.48 1.571 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -130.54 134.01 46.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.231 -1.158 . . . . 0.0 111.524 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.8 mt -121.34 134.92 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-O 121.393 0.615 . . . . 0.0 110.097 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -137.46 153.49 50.08 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.4 HG22 HG23 ' A' ' 142' ' ' ILE . 27.4 m -121.21 141.19 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 111.417 -177.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -125.57 128.19 47.55 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.62 0.724 . . . . 0.0 109.657 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.9 tp -117.53 128.96 55.48 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.6 0.714 . . . . 0.0 111.43 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 83.3 tt0 -147.0 166.94 25.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.6 -0.687 . . . . 0.0 109.301 177.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.409 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 97.6 mttt -81.83 -76.94 0.23 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.335 -0.853 . . . . 0.0 113.241 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.41 ' HB ' ' HG2' ' A' ' 72' ' ' GLU . 3.9 t -139.9 154.74 47.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.042 -1.036 . . . . 0.0 110.429 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.419 ' CB ' ' HD2' ' A' ' 46' ' ' ARG . 63.7 p -104.74 169.5 8.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.481 -0.762 . . . . 0.0 110.668 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -103.97 -18.31 14.64 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.327 -0.858 . . . . 0.0 109.803 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.7 pt -117.17 -122.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.22 -0.925 . . . . 0.0 109.884 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -112.13 139.79 47.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.129 -1.607 . . . . 0.0 109.996 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.0 t -61.3 -44.07 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.284 -0.885 . . . . 0.0 110.994 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -60.43 -46.66 89.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.948 -1.095 . . . . 0.0 110.165 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -70.14 -36.54 74.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.003 -1.061 . . . . 0.0 108.694 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HD2' ' CB ' ' A' ' 39' ' ' SER . 59.8 ttt85 -64.83 -41.84 95.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.162 -0.961 . . . . 0.0 110.765 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.1 -36.99 80.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.87 -1.144 . . . . 0.0 110.049 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.0 ttp -62.95 -45.97 89.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.358 -0.839 . . . . 0.0 110.079 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -64.1 -42.12 97.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.991 -1.068 . . . . 0.0 109.461 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 72.4 t -66.44 -43.1 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.346 -0.846 . . . . 0.0 110.323 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.475 ' CZ ' ' OD1' ' A' ' 81' ' ' ASP . 6.9 t80 -58.98 -46.7 87.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.986 -1.071 . . . . 0.0 108.871 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -72.77 -35.9 67.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.021 -1.049 . . . . 0.0 109.651 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -61.09 -39.24 89.18 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.995 -1.066 . . . . 0.0 109.316 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.9 mt -80.58 3.92 20.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 110.152 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 54.54 33.1 18.24 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.029 -1.044 . . . . 0.0 111.46 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.416 ' CE ' ' HB2' ' A' ' 66' ' ' LEU . 90.4 mtp -65.44 -12.61 54.05 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.81 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -76.65 -1.88 29.93 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.941 -1.1 . . . . 0.0 109.958 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -75.49 64.22 1.58 Allowed 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.056 -1.028 . . . . 0.0 109.748 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.2 p -135.05 149.7 50.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 109.238 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.26 -41.91 99.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.617 -0.677 . . . . 0.0 112.665 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.402 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 84.1 mt -99.62 0.17 41.57 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.796 -1.19 . . . . 0.0 111.743 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.422 ' O ' ' CB ' ' A' ' 81' ' ' ASP . 86.5 mt-30 58.55 46.85 14.22 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.451 1.119 . . . . 0.0 111.028 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -119.98 50.89 1.23 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.402 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.1 142.42 16.11 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.252 -1.939 . . . . 0.0 108.252 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.469 ' CG2' ' CD1' ' A' ' 84' ' ' ILE . 54.4 t -126.94 134.79 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.993 -1.298 . . . . 0.0 110.401 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.416 ' HB2' ' CE ' ' A' ' 56' ' ' MET . 39.2 tp -117.17 125.03 50.56 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.068 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 98.6 mt -102.69 101.85 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.571 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -88.54 124.32 33.9 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.312 -0.867 . . . . 0.0 110.057 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.1 t -119.57 131.87 70.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.909 0.861 . . . . 0.0 110.373 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.46 87.02 2.91 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.56 -20.84 21.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.893 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.41 ' HG2' ' HB ' ' A' ' 38' ' ' THR . 49.6 tp10 -70.92 -45.41 64.28 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.092 -1.005 . . . . 0.0 109.097 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -100.52 5.92 44.18 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.032 -1.043 . . . . 0.0 110.693 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.9 tttt 54.79 46.57 24.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.089 -1.007 . . . . 0.0 111.415 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 82.5 p -125.52 157.8 36.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.307 -0.871 . . . . 0.0 109.903 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -138.01 145.85 42.38 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.049 -1.032 . . . . 0.0 110.102 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.5 t -132.48 136.09 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.116 -0.99 . . . . 0.0 109.637 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.48 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 81.8 mt -113.12 127.81 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.63 -1.294 . . . . 0.0 110.459 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -130.21 116.19 18.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.592 -0.692 . . . . 0.0 109.998 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.59 166.21 15.87 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.475 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 31.3 m-20 -76.42 175.56 9.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.402 -1.058 . . . . 0.0 110.606 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -60.86 -25.74 66.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.446 -0.783 . . . . 0.0 110.348 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.5 -53.68 30.65 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 120.095 -1.05 . . . . 0.0 110.593 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.469 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 83.1 mt -64.28 -44.74 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.961 -1.317 . . . . 0.0 107.471 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -61.95 -37.79 86.07 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.004 -1.06 . . . . 0.0 111.286 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -73.63 -20.28 60.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.836 -1.165 . . . . 0.0 111.88 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.6 p -105.73 -21.61 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.859 -1.151 . . . . 0.0 112.512 -178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.47 ' HB ' ' CD1' ' A' ' 92' ' ' PHE . 17.0 m -118.75 162.45 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 120.602 -1.311 . . . . 0.0 111.708 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.6 p -105.05 177.48 4.84 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.766 0.793 . . . . 0.0 112.108 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -63.74 -37.32 86.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 109.733 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -61.72 -39.27 90.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.229 -0.919 . . . . 0.0 109.382 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.47 ' CD1' ' HB ' ' A' ' 88' ' ' VAL . 30.9 t80 -62.61 -26.63 68.71 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.48 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 4.6 m95 -84.05 -27.92 27.97 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.722 0.772 . . . . 0.0 110.682 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -56.97 -34.68 68.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.251 -0.905 . . . . 0.0 112.68 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.4 m -64.96 -36.21 83.65 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 118.448 -1.301 . . . . 0.0 109.088 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.278 8.5 m -57.92 -47.31 83.21 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 122.307 1.051 . . . . 0.0 111.082 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -69.24 -38.8 78.67 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.361 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -63.68 -43.99 95.04 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.675 -1.21 . . . . 0.0 109.988 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.7 -49.11 74.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.764 -1.21 . . . . 0.0 111.016 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 92.7 mt -67.33 -42.93 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.81 -1.181 . . . . 0.0 110.031 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -65.38 -42.41 92.73 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.213 -0.93 . . . . 0.0 110.876 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -62.49 -41.21 98.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.114 -0.991 . . . . 0.0 111.075 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.45 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 98.6 mm-40 -75.89 -38.54 57.72 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.728 -1.189 . . . . 0.0 108.894 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -61.03 -41.81 97.28 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -63.32 -33.59 75.86 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.926 -0.484 . . . . 0.0 110.641 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -77.43 -18.18 57.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.89 -1.132 . . . . 0.0 109.317 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.38 1.09 31.16 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.752 -1.213 . . . . 0.0 111.003 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -103.47 91.02 3.87 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.635 -1.509 . . . . 0.0 110.853 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -62.58 -44.98 94.96 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.782 -0.574 . . . . 0.0 110.758 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.432 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 29.8 tptt -63.85 -48.92 74.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.145 -0.972 . . . . 0.0 112.568 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -61.08 -38.39 86.08 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.525 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.45 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -62.99 -45.26 96.0 Favored Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.608 -1.282 . . . . 0.0 109.947 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.2 mt -64.74 -44.52 89.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.113 -1.227 . . . . 0.0 110.733 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.422 HG22 ' CD1' ' A' ' 16' ' ' ILE . 99.4 t -64.91 -47.94 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 110.082 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -63.66 -41.42 98.2 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.663 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.59 -43.09 99.74 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.7 -43.42 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.933 -1.334 . . . . 0.0 110.077 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.74 -50.9 71.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 110.164 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -61.92 -42.2 98.82 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.085 -1.009 . . . . 0.0 109.07 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.414 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -57.66 -37.64 73.74 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.385 -0.822 . . . . 0.0 109.43 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.49 -45.37 68.29 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 99.1 mmm -68.16 -42.92 79.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.99 -1.3 . . . . 0.0 110.139 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.437 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . . . -65.9 -47.17 75.71 Favored 'General case' 0 C--O 1.203 -1.39 0 O-C-N 121.169 -0.957 . . . . 0.0 108.846 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.414 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 78.0 mt -61.99 -39.16 91.26 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.54 -34.18 61.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.19 -0.944 . . . . 0.0 110.487 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -61.2 -41.21 96.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.872 -1.142 . . . . 0.0 108.968 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.456 ' CE1' ' CE2' ' A' ' 92' ' ' PHE . 91.8 m-85 -80.25 -36.83 34.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 0.0 110.791 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -129.23 93.01 37.29 Favored Pre-proline 0 C--N 1.304 -1.383 0 O-C-N 121.3 -0.875 . . . . 0.0 109.674 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.98 153.25 78.53 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.85 1.448 . . . . 0.0 111.227 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 49.9 t90 -77.6 132.74 38.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.675 -0.641 . . . . 0.0 111.133 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -112.09 150.22 31.01 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -58.45 -31.23 67.58 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.557 -1.34 . . . . 0.0 111.018 -177.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -89.22 8.08 32.1 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.914 -1.115 . . . . 0.0 110.593 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.469 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 64.9 t0 -43.09 137.9 2.32 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.99 0.9 . . . . 0.0 111.038 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -111.92 141.98 25.74 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 O-C-N 121.614 -0.679 . . . . 0.0 110.476 -178.025 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -95.57 93.93 7.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.012 -1.055 . . . . 0.0 110.061 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -69.5 -42.39 74.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.702 -0.624 . . . . 0.0 112.543 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 16.8 mt -106.06 151.19 40.03 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 120.973 -1.08 . . . . 0.0 111.334 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.01 -175.09 1.55 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 N-CA-C 108.948 -1.212 . . . . 0.0 108.948 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.411 ' HB2' ' CG2' ' A' ' 20' ' ' ILE . 21.3 p30 -118.86 4.04 11.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.765 -1.209 . . . . 0.0 110.102 178.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.3 p -62.72 175.12 0.87 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.1 -1.0 . . . . 0.0 110.302 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.4 HG23 HG22 ' A' ' 33' ' ' VAL . 80.5 mt -107.59 141.15 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.482 -0.761 . . . . 0.0 111.462 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.4 t -94.81 133.38 38.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.473 -0.767 . . . . 0.0 109.803 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -127.48 129.37 47.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 110.827 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 118.054 -1.414 . . . . 0.0 109.856 179.576 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.085 0.469 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.61 -38.22 66.54 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.011 -1.056 . . . . 0.0 109.115 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.22 -46.03 86.63 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.673 0.749 . . . . 0.0 110.181 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -69.83 -42.42 73.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.47 -0.769 . . . . 0.0 111.179 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -63.64 -37.42 87.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.142 -0.974 . . . . 0.0 109.892 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.65 -44.81 92.74 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.053 -1.03 . . . . 0.0 110.672 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.67 -44.12 87.27 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.994 -1.067 . . . . 0.0 111.788 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.3 tt -67.71 -36.52 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.73 -1.231 . . . . 0.0 110.44 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.2 t -62.42 -39.57 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 21' ' ' ARG . 29.4 t0 -62.87 -35.01 78.58 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.464 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.93 -39.57 95.0 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.322 -0.862 . . . . 0.0 110.104 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.55 -43.85 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.114 -0.991 . . . . 0.0 109.883 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.433 ' CZ ' ' HA ' ' A' ' 18' ' ' ASP . 74.7 mtm180 -60.21 -42.04 94.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.872 . . . . 0.0 110.896 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -63.16 -36.2 82.84 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.125 -0.985 . . . . 0.0 110.33 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.6 -39.27 88.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.092 -1.005 . . . . 0.0 110.164 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -60.67 -16.32 37.89 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.943 -1.098 . . . . 0.0 110.851 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.473 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.6 mttt -95.11 -4.2 46.65 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.172 -0.955 . . . . 0.0 109.628 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -105.12 -16.99 14.63 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.068 -1.02 . . . . 0.0 109.462 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.8 t -152.4 161.83 42.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.114 -0.991 . . . . 0.0 109.864 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.1 p -87.81 -7.47 57.22 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.311 -0.868 . . . . 0.0 109.887 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.98 170.4 47.25 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -129.5 132.74 46.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.241 -1.152 . . . . 0.0 111.217 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.2 mt -117.42 134.34 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.693 -0.63 . . . . 0.0 110.147 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.424 ' HB3' ' CE ' ' A' ' 56' ' ' MET . 75.2 ttt180 -139.8 149.36 43.41 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.05 -1.031 . . . . 0.0 110.101 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.3 t -117.44 137.32 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.236 -0.915 . . . . 0.0 111.199 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -122.66 125.94 46.61 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.441 HD12 ' CG1' ' A' ' 71' ' ' VAL . 44.8 tp -115.35 135.85 53.71 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.091 0.948 . . . . 0.0 112.045 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 81.4 tt0 -150.12 164.33 35.87 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 177.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.416 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 99.0 mttt -79.48 -74.58 0.28 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.454 -0.779 . . . . 0.0 112.108 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.8 t -140.95 154.93 46.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 109.634 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.0 p -106.0 168.91 8.81 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.495 -0.753 . . . . 0.0 110.615 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -109.66 -18.54 13.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.116 -0.99 . . . . 0.0 110.83 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 42' ' ' ASP . 32.0 pt -114.06 -123.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.981 -1.075 . . . . 0.0 109.85 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.422 ' N ' HG13 ' A' ' 41' ' ' ILE . 99.3 m-20 -111.77 136.67 50.73 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.461 -1.4 . . . . 0.0 109.727 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.82 -45.21 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.681 -0.637 . . . . 0.0 112.619 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -60.22 -47.17 87.1 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.751 -1.218 . . . . 0.0 110.322 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -71.28 -40.91 70.63 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.927 -1.108 . . . . 0.0 108.992 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 66.7 ttt-85 -63.06 -43.51 98.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.128 -0.983 . . . . 0.0 110.891 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.88 85.72 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.544 -1.347 . . . . 0.0 109.428 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.8 ttp -61.69 -41.99 98.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.009 -1.057 . . . . 0.0 108.939 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.86 -44.43 93.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.069 -1.02 . . . . 0.0 109.73 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.46 -43.78 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.417 -0.802 . . . . 0.0 110.533 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.462 ' CE2' ' OD1' ' A' ' 57' ' ' ASP . 64.4 t80 -59.88 -47.39 85.96 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.007 -1.058 . . . . 0.0 109.966 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -74.98 -34.49 61.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.946 -1.096 . . . . 0.0 109.326 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -62.19 -36.62 82.46 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.949 -1.094 . . . . 0.0 109.137 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.19 2.81 26.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.18 -0.95 . . . . 0.0 110.049 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 55.54 33.52 21.25 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 121.142 -0.974 . . . . 0.0 111.892 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.424 ' CE ' ' HB3' ' A' ' 32' ' ' ARG . 95.7 mtp -66.19 -11.65 51.01 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 118.872 -1.131 . . . . 0.0 109.664 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.462 ' OD1' ' CE2' ' A' ' 51' ' ' PHE . 94.4 m-20 -77.19 -0.59 25.65 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.047 -1.033 . . . . 0.0 109.334 176.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -76.15 62.17 1.68 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.175 -0.953 . . . . 0.0 109.92 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.7 m -132.72 146.33 51.77 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.02 -42.48 99.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.568 -0.708 . . . . 0.0 111.427 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.2 mt -95.57 -0.05 52.41 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.011 -1.055 . . . . 0.0 111.265 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 57.3 45.33 20.4 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.406 1.098 . . . . 0.0 111.187 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -118.74 54.04 0.97 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.253 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.87 139.23 14.31 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.435 ' CG2' HD13 ' A' ' 84' ' ' ILE . 53.8 t -123.78 136.59 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.151 -1.206 . . . . 0.0 110.802 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 38.9 tp -117.89 128.13 54.53 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.347 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.4 HD11 HG21 ' A' ' 67' ' ' ILE . 97.1 mt -104.79 104.75 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 118.876 -1.129 . . . . 0.0 109.467 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -90.12 122.2 32.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.32 -0.863 . . . . 0.0 109.893 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -121.07 134.23 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.066 0.936 . . . . 0.0 110.924 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.44 98.42 8.2 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.441 ' CG1' HD12 ' A' ' 35' ' ' LEU . 33.3 m -66.36 -22.25 29.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.197 -0.939 . . . . 0.0 110.607 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.401 ' N ' HG21 ' A' ' 71' ' ' VAL . 78.6 mm-40 -68.93 -44.06 73.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.033 -1.042 . . . . 0.0 109.542 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.7 4.9 41.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.079 -1.013 . . . . 0.0 111.044 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 ttmt 55.5 46.74 22.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.879 -1.138 . . . . 0.0 110.352 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 70.5 p -122.4 165.88 15.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -0.901 . . . . 0.0 109.749 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 46.3 p90 -146.38 146.66 30.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.512 -0.743 . . . . 0.0 110.369 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.1 t -133.78 136.88 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.389 -0.819 . . . . 0.0 109.114 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.44 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 81.6 mt -115.2 127.34 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.617 -1.302 . . . . 0.0 110.713 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -129.96 119.24 22.89 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.745 . . . . 0.0 111.223 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.28 149.49 17.47 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -62.82 175.28 0.86 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.568 -0.96 . . . . 0.0 110.1 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.84 -26.88 67.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.226 -0.921 . . . . 0.0 111.702 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.76 -53.85 32.12 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.609 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.435 HD13 ' CG2' ' A' ' 65' ' ' VAL . 75.0 mt -63.11 -44.82 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.802 -1.411 . . . . 0.0 108.347 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -60.97 -38.51 86.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.966 -1.083 . . . . 0.0 111.627 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -71.0 -22.0 62.22 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.857 -1.152 . . . . 0.0 111.748 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.5 m -104.97 -15.77 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.92 -1.113 . . . . 0.0 112.884 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.491 ' HB ' ' CD2' ' A' ' 92' ' ' PHE . 21.8 m -121.04 163.51 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.591 -1.318 . . . . 0.0 112.089 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.3 m -110.93 178.27 4.4 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.6 0.714 . . . . 0.0 112.158 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 33.8 p-10 -63.12 -36.4 83.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 110.059 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 65.8 t0 -62.87 -38.64 91.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.109 -0.994 . . . . 0.0 108.986 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.491 ' CD2' ' HB ' ' A' ' 88' ' ' VAL . 78.6 t80 -67.07 -25.28 66.17 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.239 -0.913 . . . . 0.0 109.376 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.44 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 4.8 m95 -86.5 -23.49 25.92 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.796 0.808 . . . . 0.0 110.36 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -58.1 -36.23 72.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.91 . . . . 0.0 112.057 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.5 p -67.25 -31.28 71.51 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.541 -1.264 . . . . 0.0 108.895 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.272 10.0 m -60.08 -48.91 79.75 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 122.352 1.072 . . . . 0.0 111.111 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.38 -36.71 74.28 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.994 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -64.59 -44.23 91.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.933 -1.104 . . . . 0.0 110.482 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.12 -50.68 69.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.557 -1.34 . . . . 0.0 111.282 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 92.9 mt -66.35 -42.9 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.769 -1.207 . . . . 0.0 110.279 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -63.26 -41.75 99.09 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.296 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.7 mt -63.33 -41.71 98.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.196 -0.94 . . . . 0.0 111.775 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.43 ' HB3' ' CA ' ' A' ' 112' ' ' GLY . 31.6 tp60 -76.36 -40.17 51.88 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.69 -1.204 . . . . 0.0 108.963 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.414 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 1.2 m-85 -59.89 -40.64 89.41 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.62 -34.79 77.76 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.858 -0.526 . . . . 0.0 110.073 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -76.7 -18.7 58.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.989 -1.069 . . . . 0.0 109.712 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.08 -0.22 38.37 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.771 -1.204 . . . . 0.0 111.208 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -99.49 89.37 4.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.633 -1.51 . . . . 0.0 109.548 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -64.16 -41.78 97.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.869 -0.52 . . . . 0.0 111.816 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -61.43 -48.19 82.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.047 -1.033 . . . . 0.0 110.798 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.413 ' HA ' ' CG1' ' A' ' 114' ' ' VAL . 87.3 mt-30 -64.3 -35.9 82.37 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.117 -0.99 . . . . 0.0 110.427 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.43 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -65.76 -48.76 64.05 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.184 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.9 mt -65.6 -44.73 85.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.082 -1.246 . . . . 0.0 111.409 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.413 ' CG1' ' HA ' ' A' ' 111' ' ' GLN . 11.5 p -65.06 -46.31 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.184 -0.947 . . . . 0.0 110.5 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -64.45 -42.11 96.14 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.992 -1.067 . . . . 0.0 109.929 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.45 -42.17 93.69 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.79 -43.04 97.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.232 -1.157 . . . . 0.0 109.78 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -59.17 -50.98 71.98 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.973 -1.08 . . . . 0.0 110.616 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.89 -42.94 99.95 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.878 -1.138 . . . . 0.0 109.28 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.8 -43.43 76.85 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.286 -0.884 . . . . 0.0 109.365 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.81 -42.98 99.59 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 98.8 mmm -67.53 -46.84 71.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.015 -1.285 . . . . 0.0 110.472 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 92' ' ' PHE . . . -63.94 -45.99 86.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.255 -0.903 . . . . 0.0 109.29 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.86 -40.42 95.3 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.4 -34.43 57.71 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.47 -0.769 . . . . 0.0 110.27 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -63.05 -44.17 96.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.061 -1.025 . . . . 0.0 109.133 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -73.08 -39.11 66.12 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.571 0.7 . . . . 0.0 109.961 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -131.67 98.36 18.05 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.634 -0.666 . . . . 0.0 110.178 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.45 154.13 69.41 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.647 1.34 . . . . 0.0 111.041 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.473 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 30.7 t90 -75.77 158.57 32.06 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.905 0.86 . . . . 0.0 110.948 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -140.47 151.42 44.84 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.33 -31.87 71.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.025 -1.047 . . . . 0.0 111.096 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -89.61 5.51 45.37 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.047 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.436 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 68.2 t0 -42.11 139.84 1.26 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.04 0.924 . . . . 0.0 111.71 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.416 ' CD1' ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -113.87 142.7 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 121.817 0.818 . . . . 0.0 111.757 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -102.31 96.53 7.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.942 -1.099 . . . . 0.0 110.462 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -69.86 -33.41 72.22 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.649 -0.657 . . . . 0.0 112.673 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.9 mp -112.45 150.2 42.25 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.07 -1.019 . . . . 0.0 112.176 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.85 -170.47 0.7 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.667 1.351 . . . . 0.0 109.228 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.414 ' N ' ' OD1' ' A' ' 140' ' ' ASN . 18.5 p-10 -125.37 1.85 7.73 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.71 -1.243 . . . . 0.0 110.287 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.6 p -60.85 167.94 2.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.999 -1.063 . . . . 0.0 110.866 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 47.5 mm -95.09 134.33 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.435 0.636 . . . . 0.0 110.691 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 10.5 m -91.22 132.78 35.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 0.0 109.946 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.11 144.99 51.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.145 -0.972 . . . . 0.0 110.544 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.844 179.488 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.127 0.489 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.14 -36.67 63.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.2 -0.937 . . . . 0.0 109.6 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.65 -38.46 89.39 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 109.545 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.417 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 97.5 mt-10 -70.63 -46.54 63.13 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.013 -1.055 . . . . 0.0 110.365 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.26 -34.58 78.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.381 -0.824 . . . . 0.0 109.572 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.91 -46.34 88.28 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.231 -0.918 . . . . 0.0 110.667 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.31 -43.81 85.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 111.773 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.5 tt -66.61 -36.62 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.665 -1.272 . . . . 0.0 110.49 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.77 -40.69 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.44 -39.08 92.21 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.755 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.0 92.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.322 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.57 -42.58 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.495 -0.753 . . . . 0.0 109.251 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -59.15 -42.57 91.02 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.211 -0.931 . . . . 0.0 110.304 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -64.91 -36.44 84.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.405 -0.81 . . . . 0.0 110.659 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.36 90.85 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.761 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -60.4 -14.86 21.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.089 -1.007 . . . . 0.0 111.175 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.473 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.5 mttt -95.49 -1.72 50.14 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.958 -1.089 . . . . 0.0 109.749 177.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -109.57 -14.51 14.36 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 120.896 -1.128 . . . . 0.0 109.593 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.0 t -154.4 160.55 41.72 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.882 -1.136 . . . . 0.0 110.485 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.2 m -88.86 -7.2 56.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.206 -0.934 . . . . 0.0 110.273 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.87 171.0 48.5 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -130.96 137.17 49.14 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.268 -1.137 . . . . 0.0 111.216 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.427 HD13 HG22 ' A' ' 31' ' ' ILE . 83.3 mt -119.63 134.71 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.712 -0.618 . . . . 0.0 110.317 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.4 mmm-85 -138.69 150.7 46.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.249 -0.907 . . . . 0.0 110.197 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.24 139.54 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.456 -0.777 . . . . 0.0 111.118 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -124.9 128.62 48.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.563 -0.711 . . . . 0.0 109.237 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.9 tp -115.82 128.87 56.16 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.902 0.858 . . . . 0.0 111.814 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -144.7 165.12 28.94 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.413 ' HA ' HG22 ' A' ' 71' ' ' VAL . 97.1 mttt -78.95 -74.05 0.3 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.226 -0.921 . . . . 0.0 113.1 -177.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.6 t -140.25 156.18 46.58 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.772 -1.205 . . . . 0.0 110.167 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.9 p -102.56 168.01 9.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.427 -0.796 . . . . 0.0 110.505 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -107.19 -14.32 14.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.308 -0.87 . . . . 0.0 110.632 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.426 HG13 ' N ' ' A' ' 42' ' ' ASP . 19.2 pt -123.34 -121.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.976 -1.077 . . . . 0.0 109.735 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.426 ' N ' HG13 ' A' ' 41' ' ' ILE . 94.2 m-20 -111.34 140.34 46.0 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 120.191 -1.568 . . . . 0.0 109.217 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.76 -44.24 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.211 -0.931 . . . . 0.0 111.815 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -58.16 -45.86 86.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.049 -1.032 . . . . 0.0 109.648 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -71.64 -38.83 70.69 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.917 -1.114 . . . . 0.0 108.94 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.423 ' NH1' ' OH ' ' A' ' 68' ' ' TYR . 75.4 ttt180 -63.45 -42.58 98.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.972 -1.08 . . . . 0.0 110.927 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.13 -38.78 86.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.696 -1.253 . . . . 0.0 110.294 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 64.3 ttp -62.81 -44.05 97.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.064 -1.022 . . . . 0.0 109.405 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.427 ' OD1' ' ND2' ' A' ' 53' ' ' ASN . 63.5 t0 -63.52 -45.61 89.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.021 -1.049 . . . . 0.0 109.488 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 83.3 t -66.35 -44.31 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.35 -0.844 . . . . 0.0 110.947 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.452 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 4.5 t80 -58.27 -47.66 82.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.904 -1.122 . . . . 0.0 108.992 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -70.29 -36.24 74.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.054 -1.029 . . . . 0.0 109.238 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.427 ' ND2' ' OD1' ' A' ' 49' ' ' ASP . 72.7 m-20 -61.18 -37.55 83.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.096 -1.002 . . . . 0.0 110.012 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.8 mt -82.16 5.87 18.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.985 -1.072 . . . . 0.0 110.727 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 55.73 32.74 20.02 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.309 -0.87 . . . . 0.0 110.92 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.452 ' HB2' ' CE1' ' A' ' 51' ' ' PHE . 92.8 mtp -69.13 -25.41 64.38 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.341 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -68.76 -7.61 35.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.347 -0.845 . . . . 0.0 110.48 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -86.98 80.78 8.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.752 -1.218 . . . . 0.0 110.727 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.8 p -137.04 156.82 47.94 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -62.09 -43.97 97.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.092 -1.005 . . . . 0.0 112.817 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 88.1 mt -100.02 2.31 43.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.091 -1.006 . . . . 0.0 111.301 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 57.75 31.47 20.49 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.973 0.892 . . . . 0.0 111.272 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.405 ' HA ' HG13 ' A' ' 84' ' ' ILE . 99.7 m-20 -108.96 56.46 0.62 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.812 0.815 . . . . 0.0 110.465 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.411 ' O ' ' CD1' ' A' ' 84' ' ' ILE . . . -103.59 141.19 15.17 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.407 HG21 HD12 ' A' ' 84' ' ' ILE . 47.9 t -123.35 135.05 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.07 -1.253 . . . . 0.0 110.593 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.0 tp -116.79 130.39 56.69 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.88 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 83.6 mt -104.78 108.27 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 118.826 -1.15 . . . . 0.0 109.395 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.423 ' OH ' ' NH1' ' A' ' 46' ' ' ARG . 42.3 t80 -93.73 122.69 36.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.531 -0.731 . . . . 0.0 110.331 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -123.63 133.42 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 122.173 0.987 . . . . 0.0 111.32 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.17 97.45 7.3 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.413 HG22 ' HA ' ' A' ' 37' ' ' LYS . 35.8 m -67.38 -18.67 24.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.968 -1.083 . . . . 0.0 111.245 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -69.37 -46.52 66.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.754 -1.216 . . . . 0.0 109.445 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.23 3.69 41.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.155 -0.966 . . . . 0.0 110.797 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.4 tttt 56.13 45.77 22.8 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.943 -1.098 . . . . 0.0 110.39 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 96.0 m -119.78 132.87 55.73 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.243 -0.911 . . . . 0.0 109.812 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.421 ' O ' ' CD1' ' A' ' 76' ' ' PHE . 50.9 p90 -114.52 136.7 52.73 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.532 -0.73 . . . . 0.0 109.924 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 72.0 t -126.69 136.92 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.49 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 82.7 mt -115.35 125.36 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.771 -1.205 . . . . 0.0 110.324 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -128.97 114.89 16.99 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.513 -0.742 . . . . 0.0 110.488 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.65 145.83 16.54 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -56.93 175.47 0.13 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.516 -0.99 . . . . 0.0 109.803 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.06 -24.59 63.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.091 -1.006 . . . . 0.0 110.639 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.79 -51.79 38.33 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.655 -1.26 . . . . 0.0 110.632 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.422 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 3.8 mt -64.15 -44.71 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.914 -1.345 . . . . 0.0 108.447 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -64.26 -36.68 84.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.365 -0.834 . . . . 0.0 111.727 -177.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -75.64 -20.95 58.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.785 -1.197 . . . . 0.0 111.938 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.7 p -103.08 -21.95 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.851 -1.156 . . . . 0.0 113.132 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.479 ' HB ' ' CD2' ' A' ' 92' ' ' PHE . 14.3 m -118.68 164.08 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.626 -1.296 . . . . 0.0 111.433 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.2 p -105.45 174.76 5.74 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.922 0.867 . . . . 0.0 111.634 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.01 -37.95 86.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.459 -0.776 . . . . 0.0 110.071 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -61.46 -37.57 84.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.946 . . . . 0.0 108.81 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 123' ' ' ALA . 86.3 t80 -64.86 -27.2 68.71 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.446 -0.784 . . . . 0.0 108.968 177.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.49 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 5.4 m95 -86.12 -26.22 25.34 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.975 0.893 . . . . 0.0 109.888 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -58.97 -36.38 74.77 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.024 -1.048 . . . . 0.0 112.334 -176.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.9 p -66.56 -32.03 73.11 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.535 -1.266 . . . . 0.0 108.596 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.402 HG23 HD13 ' A' ' 78' ' ' ILE 0.276 7.5 m -60.21 -49.46 77.53 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 122.264 1.031 . . . . 0.0 111.141 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -68.29 -38.03 81.25 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.697 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -64.04 -41.39 97.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.013 -1.054 . . . . 0.0 110.617 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.16 -48.95 74.03 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.639 -1.288 . . . . 0.0 110.841 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 91.9 mt -67.05 -42.78 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 110.406 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -64.17 -41.43 97.14 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.296 -0.877 . . . . 0.0 110.94 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 44.3 tp -62.79 -43.02 99.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.312 -0.868 . . . . 0.0 111.754 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.474 ' CB ' ' CA ' ' A' ' 112' ' ' GLY . 3.0 tp60 -76.69 -40.08 50.0 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.779 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -58.95 -41.94 88.65 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.166 0.984 . . . . 0.0 108.449 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.12 -35.01 72.7 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -79.79 -17.23 53.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.349 -0.844 . . . . 0.0 110.169 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.62 2.5 43.47 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 119.73 -1.224 . . . . 0.0 111.573 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -104.53 94.81 5.52 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.689 -1.477 . . . . 0.0 110.859 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -62.76 -46.32 88.6 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.626 -0.671 . . . . 0.0 112.3 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.417 ' NZ ' ' HA ' ' A' ' 12' ' ' GLU . 75.3 tttt -61.62 -47.76 83.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.12 -0.988 . . . . 0.0 111.838 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -63.46 -40.03 96.05 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.377 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.474 ' CA ' ' CB ' ' A' ' 103' ' ' GLN . . . -65.21 -47.83 76.46 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.355 -1.402 . . . . 0.0 109.624 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.405 ' O ' HG12 ' A' ' 117' ' ' ILE . 85.2 mt -64.24 -46.01 85.64 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.506 -0.996 . . . . 0.0 111.523 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.1 -48.14 89.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.296 -0.877 . . . . 0.0 110.943 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -61.63 -33.52 74.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.028 -1.045 . . . . 0.0 109.108 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.14 -40.33 98.39 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 113' ' ' LEU . 36.1 mm -63.36 -43.84 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.064 -1.257 . . . . 0.0 109.741 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.05 -49.74 76.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.277 -0.889 . . . . 0.0 110.723 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -64.73 -43.92 91.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.057 -1.027 . . . . 0.0 110.351 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.31 95.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.895 . . . . 0.0 110.593 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.82 -44.06 81.41 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 97.0 mtp -66.56 -46.18 76.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.011 -1.288 . . . . 0.0 109.901 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 92' ' ' PHE . . . -64.09 -43.89 94.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.969 -1.082 . . . . 0.0 108.974 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 31.2 mt -63.02 -40.49 97.9 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.397 -0.815 . . . . 0.0 109.093 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.42 -34.08 56.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.128 -0.983 . . . . 0.0 110.09 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.63 -44.27 97.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.121 -0.987 . . . . 0.0 109.13 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -70.66 -41.74 71.69 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.473 0.654 . . . . 0.0 109.971 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -130.88 94.31 28.81 Favored Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.496 -0.753 . . . . 0.0 109.776 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.45 149.88 89.24 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.652 1.343 . . . . 0.0 109.843 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.473 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 39.3 t90 -73.46 130.19 39.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.457 -0.777 . . . . 0.0 111.896 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -108.78 152.64 24.58 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.03 -29.54 68.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.109 -0.995 . . . . 0.0 111.064 -177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -91.9 6.81 44.77 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.099 -1.04 . . . . 0.0 111.48 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.449 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 67.9 t0 -42.49 139.25 1.57 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.653 -0.654 . . . . 0.0 110.645 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.429 ' CD1' ' O ' ' A' ' 135' ' ' ILE . 1.3 pp -115.12 142.14 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 122.51 1.148 . . . . 0.0 113.297 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -120.33 102.52 8.53 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.16 -0.962 . . . . 0.0 109.412 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -101.4 5.92 42.34 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.633 -1.292 . . . . 0.0 111.712 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.4 tp -114.26 139.69 24.12 Favored Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 120.935 -1.103 . . . . 0.0 110.634 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -70.61 165.17 32.8 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.528 1.278 . . . . 0.0 109.747 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -103.22 8.75 38.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.595 -1.316 . . . . 0.0 110.027 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -62.04 144.93 54.51 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.854 -1.154 . . . . 0.0 110.647 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.98 138.71 19.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.789 -0.569 . . . . 0.0 109.846 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.0 m -93.27 132.31 37.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.077 -1.014 . . . . 0.0 109.203 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -126.22 137.52 53.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.292 -0.88 . . . . 0.0 110.143 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 CA-C-O 118.001 -1.444 . . . . 0.0 109.521 179.551 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.08 -36.34 63.04 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.893 -1.129 . . . . 0.0 109.187 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -66.01 -37.09 85.03 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.539 -0.725 . . . . 0.0 109.311 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.44 ' OE1' ' CD ' ' A' ' 110' ' ' LYS . 78.1 mm-40 -72.38 -48.26 42.98 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.151 -0.968 . . . . 0.0 110.082 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.429 ' O ' ' CG2' ' A' ' 17' ' ' VAL . 98.2 mt-10 -66.48 -36.98 84.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.463 -0.773 . . . . 0.0 110.186 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.02 -45.72 92.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.846 -1.158 . . . . 0.0 111.095 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.89 -42.46 94.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.783 -1.198 . . . . 0.0 111.434 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.455 HG21 ' N ' ' A' ' 17' ' ' VAL . 19.1 tt -66.96 -36.16 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.831 -1.168 . . . . 0.0 110.748 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.455 ' N ' HG21 ' A' ' 16' ' ' ILE . 87.8 t -63.82 -41.02 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -62.54 -36.55 82.96 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.664 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.23 -38.27 88.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 109.353 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.9 mm -63.92 -43.45 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.396 -0.815 . . . . 0.0 109.998 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -59.65 -41.6 90.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.311 -0.868 . . . . 0.0 109.821 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -63.92 -37.94 89.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.326 -0.859 . . . . 0.0 111.215 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.74 -40.93 88.52 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.083 -1.011 . . . . 0.0 110.44 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -60.35 -14.5 18.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.904 -1.122 . . . . 0.0 110.922 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.469 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 49.2 mtpt -94.59 -2.82 50.77 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 120.831 -1.168 . . . . 0.0 109.48 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -109.93 -14.11 14.32 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 121.002 -1.061 . . . . 0.0 110.184 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.7 t -151.77 158.03 42.77 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.063 -1.023 . . . . 0.0 109.982 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 83.5 p -86.91 -7.95 57.71 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.273 -0.892 . . . . 0.0 109.95 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.7 172.61 45.6 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.417 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 55.8 mp0 -131.23 136.38 48.18 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.339 -1.095 . . . . 0.0 111.247 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -122.42 134.71 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.876 -0.515 . . . . 0.0 110.026 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -138.57 153.99 48.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.206 -0.934 . . . . 0.0 110.135 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.1 t -123.7 139.34 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.385 -0.822 . . . . 0.0 110.665 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -124.64 122.8 38.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.53 -0.732 . . . . 0.0 110.215 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.42 ' CD1' ' CG1' ' A' ' 71' ' ' VAL . 33.8 tp -108.39 131.56 54.64 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.901 0.858 . . . . 0.0 111.421 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -149.39 166.43 29.06 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HB3' ' HG3' ' A' ' 72' ' ' GLU . 98.4 mttt -81.33 -75.45 0.28 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.928 -1.107 . . . . 0.0 113.498 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.439 HG21 ' CB ' ' A' ' 72' ' ' GLU . 1.3 p -137.96 154.09 49.41 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.496 -0.753 . . . . 0.0 109.955 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.422 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 14.3 p -98.95 167.91 10.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.137 -0.977 . . . . 0.0 110.283 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -106.27 -10.83 16.23 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.307 -0.871 . . . . 0.0 110.422 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.7 pt -128.56 -121.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.936 -1.102 . . . . 0.0 109.358 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -111.02 138.4 47.48 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 120.184 -1.573 . . . . 0.0 110.042 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.1 t -62.99 -44.96 99.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.564 -0.71 . . . . 0.0 112.01 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -59.89 -46.28 89.84 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.925 -1.109 . . . . 0.0 110.057 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -70.58 -39.41 73.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.772 -1.205 . . . . 0.0 108.568 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.422 ' NH2' ' HA ' ' A' ' 39' ' ' SER . 49.8 ttt85 -61.46 -45.68 93.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 111.358 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.36 84.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.961 -1.087 . . . . 0.0 109.713 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 66.0 ttp -64.71 -43.87 92.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.204 -0.935 . . . . 0.0 109.878 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 53.5 t0 -63.2 -43.55 97.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.043 -1.036 . . . . 0.0 109.252 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.6 t -67.23 -44.01 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.46 -0.775 . . . . 0.0 110.35 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.41 ' CE2' ' OD1' ' A' ' 57' ' ' ASP . 61.4 t80 -60.19 -48.14 82.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.719 -1.238 . . . . 0.0 110.296 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -72.47 -35.2 68.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.989 -1.07 . . . . 0.0 108.821 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 49' ' ' ASP . 31.4 t-20 -62.34 -39.37 92.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.338 -0.851 . . . . 0.0 110.194 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.6 mt -79.31 3.15 18.96 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.153 -0.967 . . . . 0.0 110.187 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 57.29 33.43 23.28 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 121.041 -1.037 . . . . 0.0 112.044 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.7 mtt -67.46 -10.79 54.8 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.845 -1.16 . . . . 0.0 109.913 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.41 ' OD1' ' CE2' ' A' ' 51' ' ' PHE . 97.1 m-20 -77.82 -0.87 28.85 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.788 -1.195 . . . . 0.0 109.787 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -80.02 63.49 4.56 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 121.005 -1.06 . . . . 0.0 109.871 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.402 ' OG1' ' HA ' ' A' ' 62' ' ' GLN . 66.8 p -133.11 150.28 52.07 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.08 -41.01 99.32 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.441 -0.787 . . . . 0.0 112.271 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 87.0 mt -100.0 -0.51 39.12 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.932 -1.105 . . . . 0.0 111.616 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 87.4 mt-30 58.2 40.26 25.05 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 122.643 1.211 . . . . 0.0 111.029 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -111.44 53.15 0.72 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.724 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.81 138.82 14.09 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.034 -2.026 . . . . 0.0 108.034 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.411 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 53.4 t -122.11 133.91 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.184 -1.186 . . . . 0.0 110.117 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.2 tp -117.44 131.21 56.78 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.674 -0.641 . . . . 0.0 110.832 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 94.4 mt -110.56 110.3 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.524 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -97.23 121.4 39.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -0.921 . . . . 0.0 109.711 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.5 t -121.98 131.81 72.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 111.302 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.95 95.23 7.02 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.42 ' CG1' ' CD1' ' A' ' 35' ' ' LEU . 35.8 m -64.31 -22.48 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.998 -1.064 . . . . 0.0 110.834 -178.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.439 ' CB ' HG21 ' A' ' 38' ' ' THR . 79.3 mm-40 -66.8 -42.51 85.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.993 -1.067 . . . . 0.0 109.535 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -102.99 4.99 38.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.851 . . . . 0.0 110.98 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.415 ' HE2' ' O ' ' A' ' 104' ' ' PHE . 29.2 tttt 55.78 47.71 19.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.958 -1.089 . . . . 0.0 110.38 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.4 p -123.17 162.24 22.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 109.41 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -143.9 141.87 30.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.428 -0.795 . . . . 0.0 110.049 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.9 t -131.15 133.59 62.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.46 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 77.2 mt -112.97 122.33 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 118.853 -1.139 . . . . 0.0 110.544 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -129.11 111.27 12.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 110.343 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -94.72 174.63 33.35 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -77.64 176.17 9.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.752 -0.852 . . . . 0.0 109.876 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.55 -26.49 66.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.031 -1.043 . . . . 0.0 110.847 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.72 -49.31 60.29 Favored Glycine 0 N--CA 1.488 2.108 0 C-N-CA 119.807 -1.187 . . . . 0.0 110.315 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.446 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 3.6 mt -64.6 -44.97 96.76 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.791 0 O-C-N 121.001 -1.294 . . . . 0.0 108.151 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -64.39 -35.66 81.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.711 -1.243 . . . . 0.0 112.39 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -77.6 -22.11 51.36 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.857 -1.152 . . . . 0.0 112.303 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.406 HG11 ' O ' ' A' ' 84' ' ' ILE . 7.7 p -101.33 -23.51 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.848 -1.158 . . . . 0.0 112.516 -178.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.472 HG22 ' CD1' ' A' ' 93' ' ' TRP . 10.2 m -117.65 164.36 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.659 -1.276 . . . . 0.0 111.413 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 t -108.13 174.8 5.72 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.649 0.738 . . . . 0.0 111.767 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -61.38 -37.37 83.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.16 -0.962 . . . . 0.0 110.12 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.61 -36.55 78.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.194 -0.941 . . . . 0.0 108.823 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.424 ' CD2' ' HB ' ' A' ' 88' ' ' VAL . 81.5 t80 -67.33 -25.18 65.88 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.258 -0.901 . . . . 0.0 109.505 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.472 ' CD1' HG22 ' A' ' 88' ' ' VAL . 5.3 m95 -88.31 -26.5 22.23 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.911 0.862 . . . . 0.0 111.252 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -55.82 -40.33 72.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.92 -1.112 . . . . 0.0 112.585 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 77.3 p -64.5 -31.03 72.06 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.507 -1.277 . . . . 0.0 109.234 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.28 12.3 m -60.27 -49.38 77.86 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 122.545 1.164 . . . . 0.0 110.952 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.05 -38.53 82.57 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.738 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -63.42 -45.01 92.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.948 -1.095 . . . . 0.0 110.725 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.42 -48.62 80.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.942 -1.099 . . . . 0.0 110.654 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 91.4 mt -67.52 -42.5 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.089 -1.007 . . . . 0.0 110.277 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.434 ' CG ' ' HE3' ' A' ' 105' ' ' LYS . 56.6 tt0 -63.28 -42.85 99.15 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.842 -1.161 . . . . 0.0 110.984 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.1 mt -63.12 -41.53 99.35 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.158 -0.964 . . . . 0.0 112.105 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.411 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 94.0 mm-40 -76.66 -37.23 56.58 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.647 -1.221 . . . . 0.0 109.253 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.415 ' O ' ' HE2' ' A' ' 74' ' ' LYS . 4.4 m-85 -61.1 -41.5 96.79 Favored 'General case' 0 C--O 1.201 -1.456 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.434 ' HE3' ' CG ' ' A' ' 101' ' ' GLN . 93.7 mttt -62.02 -33.44 74.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.754 -1.216 . . . . 0.0 110.791 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -78.55 -18.64 54.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.756 -1.215 . . . . 0.0 109.986 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.83 4.63 42.22 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.71 -1.233 . . . . 0.0 111.164 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -103.51 91.08 3.89 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.632 -1.511 . . . . 0.0 110.521 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -62.35 -45.02 95.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.706 -0.621 . . . . 0.0 111.784 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.44 ' CD ' ' OE1' ' A' ' 12' ' ' GLU . 76.3 tttt -62.86 -49.29 75.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.901 . . . . 0.0 112.55 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -62.4 -36.49 82.51 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.655 -1.218 . . . . 0.0 109.55 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.411 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -65.54 -47.58 76.48 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.426 -1.368 . . . . 0.0 110.187 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.6 mt -63.53 -44.1 95.24 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.025 -1.279 . . . . 0.0 110.776 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 86.4 t -66.52 -46.08 87.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.101 -1.0 . . . . 0.0 110.05 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -65.35 -42.54 92.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 110.023 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.02 -41.98 98.19 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 91.4 mt -65.05 -43.84 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.267 -1.137 . . . . 0.0 109.968 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -56.93 -51.75 67.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.959 -1.088 . . . . 0.0 109.729 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.68 -41.73 99.25 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.125 -0.984 . . . . 0.0 109.192 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.32 -40.56 82.38 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.078 -1.014 . . . . 0.0 109.41 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.53 -45.86 87.79 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.7 mtt -66.67 -43.56 84.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.03 -1.276 . . . . 0.0 109.416 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.5 -46.59 85.41 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.304 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.2 mt -62.74 -41.54 99.24 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.456 -0.777 . . . . 0.0 109.486 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.82 -34.13 62.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.33 -0.856 . . . . 0.0 110.678 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.84 -41.46 97.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.942 -1.099 . . . . 0.0 108.954 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -75.36 -37.49 60.6 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.601 -0.687 . . . . 0.0 109.787 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -132.51 99.4 15.79 Favored Pre-proline 0 N--CA 1.487 1.379 0 O-C-N 121.498 -0.751 . . . . 0.0 110.131 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.47 150.97 70.63 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.447 1.235 . . . . 0.0 110.226 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.469 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 34.5 t90 -73.66 125.81 28.89 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.382 -0.824 . . . . 0.0 110.916 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -103.97 153.84 20.36 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.01 -29.3 70.17 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 111.092 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -93.7 8.12 42.17 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.912 -1.115 . . . . 0.0 111.609 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -42.51 138.18 1.89 Allowed 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.843 0.83 . . . . 0.0 111.614 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.417 HG23 HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -111.78 141.5 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 121.574 -0.704 . . . . 0.0 110.576 -178.083 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -100.25 96.01 7.18 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.169 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -67.71 -36.35 80.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.721 -0.612 . . . . 0.0 111.741 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.9 mt -109.22 151.37 41.99 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.212 -0.93 . . . . 0.0 112.073 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.68 -171.54 0.87 Allowed 'Trans proline' 0 C--N 1.32 -0.949 0 N-CA-C 108.662 -1.322 . . . . 0.0 108.662 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -121.91 1.77 9.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.604 -1.31 . . . . 0.0 110.125 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 78.5 p -63.37 168.62 4.31 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.764 -1.21 . . . . 0.0 110.965 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 91.6 mt -94.56 135.83 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.483 -0.76 . . . . 0.0 110.819 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.1 m -93.48 134.47 35.71 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.61 146.8 50.75 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.853 -1.154 . . . . 0.0 110.427 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.944 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 t . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.02 -38.88 77.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.24 -0.912 . . . . 0.0 110.885 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -55.88 -46.89 78.2 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.728 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.423 ' HB3' ' HD2' ' A' ' 110' ' ' LYS . 96.6 mt-10 -67.43 -45.61 75.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.516 -0.74 . . . . 0.0 111.716 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.422 ' O ' ' CG2' ' A' ' 17' ' ' VAL . 93.6 mt-10 -65.38 -33.11 75.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.963 -1.086 . . . . 0.0 110.035 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.34 -48.09 76.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.794 -1.192 . . . . 0.0 111.191 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.83 -42.14 97.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.319 -0.863 . . . . 0.0 111.159 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.445 HG21 ' N ' ' A' ' 17' ' ' VAL . 20.6 tt -67.46 -34.77 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.004 -1.06 . . . . 0.0 110.689 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.445 ' N ' HG21 ' A' ' 16' ' ' ILE . 67.5 t -63.29 -39.37 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.94 -37.21 86.88 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.08 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.25 88.56 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.285 -0.884 . . . . 0.0 109.021 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.5 -43.41 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-O 121.475 0.655 . . . . 0.0 109.972 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.417 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 92.8 mtt180 -59.72 -43.02 94.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 0.0 110.47 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -65.83 -36.86 84.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.431 -0.793 . . . . 0.0 111.252 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.37 -40.91 98.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.001 -1.062 . . . . 0.0 109.749 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.61 -16.52 49.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.413 -0.805 . . . . 0.0 110.11 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.4 mttt -93.65 -1.57 55.12 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.213 -0.929 . . . . 0.0 109.142 177.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -110.16 -14.39 14.2 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.973 -1.08 . . . . 0.0 110.08 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.3 t -151.34 158.12 43.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.098 -1.001 . . . . 0.0 109.644 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.6 m -85.1 -8.66 58.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.092 -1.005 . . . . 0.0 109.974 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.99 173.31 48.37 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.431 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 57.8 mp0 -132.0 139.05 48.49 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.259 -1.142 . . . . 0.0 111.709 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 94.1 mt -124.81 136.26 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.605 -0.685 . . . . 0.0 110.319 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -140.96 156.56 46.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.211 -0.931 . . . . 0.0 110.038 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 p -126.55 140.8 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.03 -1.044 . . . . 0.0 111.469 -178.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.405 ' HA ' ' O ' ' A' ' 143' ' ' SER . 72.0 t60 -124.43 132.15 53.5 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.574 0.702 . . . . 0.0 109.684 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.414 HD13 ' CG1' ' A' ' 71' ' ' VAL . 28.1 tp -117.62 126.13 51.97 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.625 0.726 . . . . 0.0 111.984 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.414 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 78.2 tt0 -142.73 165.2 28.04 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HB3' ' CG ' ' A' ' 72' ' ' GLU . 99.5 mttt -79.94 -76.41 0.22 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.144 -0.973 . . . . 0.0 112.329 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.453 HG23 ' CB ' ' A' ' 72' ' ' GLU . 1.2 p -138.74 157.21 46.52 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.455 0.645 . . . . 0.0 110.609 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.433 ' OG ' ' CD ' ' A' ' 46' ' ' ARG . 50.9 m -107.47 173.62 6.24 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.431 -0.793 . . . . 0.0 110.854 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -109.23 -10.14 14.98 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.591 -0.693 . . . . 0.0 110.452 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.1 pt -125.19 -123.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 120.964 -1.085 . . . . 0.0 109.702 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -110.78 140.2 45.4 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.462 -1.399 . . . . 0.0 109.092 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.3 t -61.37 -44.18 98.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.427 -0.796 . . . . 0.0 110.599 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -58.79 -48.05 82.63 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.134 -0.979 . . . . 0.0 110.588 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -69.1 -39.89 78.72 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.784 -1.198 . . . . 0.0 109.162 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.433 ' CD ' ' OG ' ' A' ' 39' ' ' SER . 57.8 ttt85 -59.7 -45.27 92.63 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.095 -1.003 . . . . 0.0 110.087 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.19 94.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.83 -1.169 . . . . 0.0 110.324 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.3 ttp -62.92 -43.57 98.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.125 -0.985 . . . . 0.0 109.646 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -65.76 -47.1 76.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.022 -1.049 . . . . 0.0 109.5 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 72.4 t -64.64 -42.99 96.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.451 -0.781 . . . . 0.0 110.273 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.483 ' CZ ' ' OD1' ' A' ' 81' ' ' ASP . 4.5 t80 -60.82 -47.32 86.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.885 -1.134 . . . . 0.0 109.662 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -73.5 -37.99 65.5 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.114 -0.991 . . . . 0.0 110.277 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -61.2 -39.66 91.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.02 -1.05 . . . . 0.0 109.22 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.1 mt -79.94 3.33 20.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 0.0 110.856 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 57.67 33.04 22.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.599 -0.688 . . . . 0.0 111.782 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.408 ' HB2' ' CD1' ' A' ' 51' ' ' PHE . 92.6 mmm -70.6 -23.39 62.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.997 -1.064 . . . . 0.0 109.841 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -73.16 -5.33 38.49 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.124 -0.985 . . . . 0.0 110.771 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -86.29 84.01 7.57 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.799 -1.188 . . . . 0.0 110.954 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.0 p -138.4 155.91 48.07 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.01 -44.22 97.18 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.98 -1.075 . . . . 0.0 112.541 -177.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.1 mt -99.15 3.49 46.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.864 -1.148 . . . . 0.0 111.36 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 55.48 36.24 26.73 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.188 0.994 . . . . 0.0 111.029 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.408 ' HA ' HG13 ' A' ' 84' ' ' ILE . 97.5 m-20 -115.71 53.7 0.84 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.264 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.83 149.04 17.99 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.2 t -127.56 134.35 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.987 -1.302 . . . . 0.0 110.081 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.46 ' HB2' ' CE2' ' A' ' 51' ' ' PHE . 35.5 tp -116.61 126.76 53.72 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.235 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 85.6 mt -105.58 112.56 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.346 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -99.87 121.11 40.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.961 . . . . 0.0 110.002 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -122.87 131.8 72.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 122.102 0.953 . . . . 0.0 111.259 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.1 99.13 10.64 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.417 HG22 ' N ' ' A' ' 72' ' ' GLU . 28.4 m -65.29 -24.44 35.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 121.142 -0.974 . . . . 0.0 110.998 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.453 ' CB ' HG23 ' A' ' 38' ' ' THR . 70.2 mm-40 -67.97 -43.55 78.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.762 -1.211 . . . . 0.0 110.023 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -102.14 3.55 38.63 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.134 -0.978 . . . . 0.0 110.993 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt 55.98 45.91 22.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.806 -1.184 . . . . 0.0 110.712 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 99.6 m -121.51 135.27 55.04 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.079 -1.013 . . . . 0.0 110.224 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.472 ' O ' ' CD1' ' A' ' 76' ' ' PHE . 52.5 p90 -115.98 138.1 51.51 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.473 -0.767 . . . . 0.0 111.253 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.6 t -128.91 136.19 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.892 -1.13 . . . . 0.0 108.192 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 69.8 mt -116.37 126.6 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.627 -1.295 . . . . 0.0 110.885 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -129.08 114.34 16.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.601 -0.687 . . . . 0.0 110.984 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.28 175.03 26.74 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.483 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 68.2 m-20 -82.0 -178.29 6.95 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.539 -0.977 . . . . 0.0 111.438 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.32 -26.45 68.49 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.36 -53.05 34.82 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.112 -1.042 . . . . 0.0 110.876 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.433 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 7.9 mt -65.06 -44.69 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.95 -1.323 . . . . 0.0 107.705 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -61.53 -37.53 84.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.742 -1.224 . . . . 0.0 111.466 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -75.73 -19.99 58.66 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.011 -1.055 . . . . 0.0 111.929 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.5 p -104.3 -22.03 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 120.669 -1.27 . . . . 0.0 112.349 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 84' ' ' ILE . 19.1 m -120.79 162.31 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 120.594 -1.316 . . . . 0.0 111.96 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.9 m -105.8 178.0 4.69 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.124 0.964 . . . . 0.0 112.316 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -62.81 -37.62 87.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.676 -0.64 . . . . 0.0 109.775 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -61.28 -35.82 78.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.06 -1.025 . . . . 0.0 108.887 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 123' ' ' ALA . 80.7 t80 -67.01 -26.47 66.8 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.354 177.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -85.0 -26.96 26.77 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 122.013 0.911 . . . . 0.0 109.728 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -58.25 -38.21 76.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.166 -0.959 . . . . 0.0 112.815 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 69.5 p -65.49 -31.66 72.86 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.649 -1.22 . . . . 0.0 108.782 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.276 7.9 m -59.48 -48.68 80.72 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.485 1.136 . . . . 0.0 111.095 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -69.51 -37.89 77.37 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.945 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -63.8 -45.71 88.44 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.905 -1.122 . . . . 0.0 110.514 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.55 -48.43 81.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.735 -1.228 . . . . 0.0 110.275 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 93.1 mt -65.98 -42.84 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.122 -0.986 . . . . 0.0 110.412 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -65.12 -40.54 94.63 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.46 -0.775 . . . . 0.0 111.103 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.49 -42.92 98.54 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.307 -0.87 . . . . 0.0 111.853 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.416 ' HG2' ' N ' ' A' ' 112' ' ' GLY . 3.3 tp60 -76.81 -39.55 50.99 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.652 -1.219 . . . . 0.0 108.99 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -60.3 -42.34 95.32 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.817 0.818 . . . . 0.0 108.987 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.48 -30.97 70.03 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.44 -18.51 52.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 109.945 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.21 2.95 48.2 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.817 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -103.82 93.8 5.08 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.643 -1.504 . . . . 0.0 110.315 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -62.88 -46.18 89.06 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.458 -0.776 . . . . 0.0 112.4 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.423 ' HD2' ' HB3' ' A' ' 12' ' ' GLU . 61.4 tttm -62.18 -48.47 79.91 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.801 -1.187 . . . . 0.0 112.997 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.53 -39.14 93.65 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.856 -1.138 . . . . 0.0 109.459 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.416 ' N ' ' HG2' ' A' ' 103' ' ' GLN . . . -67.2 -47.32 64.92 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.437 ' CB ' HD12 ' A' ' 16' ' ' ILE . 97.1 mt -62.08 -44.01 97.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -1.173 . . . . 0.0 109.392 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.43 ' CG2' HG13 ' A' ' 16' ' ' ILE . 68.5 t -66.72 -45.25 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.316 -0.865 . . . . 0.0 110.513 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -65.63 -40.95 93.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.965 -1.085 . . . . 0.0 109.995 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.48 -41.65 99.76 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 84.3 mt -64.27 -43.54 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.177 -1.19 . . . . 0.0 109.858 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.36 -51.82 68.28 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.868 -1.145 . . . . 0.0 110.846 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.02 -40.85 97.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.028 -1.045 . . . . 0.0 109.203 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.4 ' O ' ' HG ' ' A' ' 124' ' ' LEU . . . -56.41 -44.03 79.94 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.352 -0.842 . . . . 0.0 109.528 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.05 -43.32 95.93 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.814 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 6.1 tpp -66.66 -47.8 71.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.282 . . . . 0.0 109.421 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 92' ' ' PHE . . . -62.8 -45.36 92.99 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.512 -0.875 . . . . 0.0 109.083 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 120' ' ' ALA . 83.5 mt -62.55 -39.65 94.31 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.06 -1.025 . . . . 0.0 108.635 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.88 -34.98 63.59 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.186 -0.947 . . . . 0.0 111.035 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -61.47 -41.13 96.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.995 -1.066 . . . . 0.0 108.493 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -75.19 -38.24 60.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.511 -0.743 . . . . 0.0 110.098 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -133.87 95.6 17.14 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.388 -0.82 . . . . 0.0 109.923 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.15 149.58 81.94 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.841 1.442 . . . . 0.0 110.369 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.481 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 42.7 t90 -72.03 143.38 49.16 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.533 -0.729 . . . . 0.0 111.403 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.76 151.22 40.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.487 -0.758 . . . . 0.0 109.248 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -58.86 -29.87 67.3 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.204 -0.935 . . . . 0.0 110.836 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -93.95 7.52 44.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.036 -1.04 . . . . 0.0 110.949 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -41.73 139.11 1.27 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.921 0.867 . . . . 0.0 111.423 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.42 HD12 HG22 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -110.37 138.26 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.447 -0.783 . . . . 0.0 110.553 -179.324 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -95.84 94.32 7.58 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.674 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -69.09 -29.28 67.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.428 -0.795 . . . . 0.0 112.577 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.14 146.98 39.34 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 120.809 -1.182 . . . . 0.0 111.312 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.06 -170.88 0.52 Allowed 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.43 1.226 . . . . 0.0 109.06 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.417 ' ND2' ' HG2' ' A' ' 21' ' ' ARG . 65.1 m-80 -122.05 3.66 9.89 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.39 -1.444 . . . . 0.0 110.327 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 21.0 m -63.1 141.3 58.82 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.087 -1.008 . . . . 0.0 111.928 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 86.2 mt -71.59 136.93 24.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.836 -0.54 . . . . 0.0 110.702 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 15.6 m -100.79 144.28 29.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.159 -0.963 . . . . 0.0 109.741 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -146.38 155.82 42.87 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.036 -1.04 . . . . 0.0 109.847 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.581 179.965 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.92 -37.98 67.05 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.086 -1.009 . . . . 0.0 109.769 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.77 -41.99 98.4 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.464 -0.773 . . . . 0.0 110.047 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -73.77 -45.59 50.79 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 110.465 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.57 -36.49 83.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.832 -1.168 . . . . 0.0 109.858 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -63.82 -45.11 91.08 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.849 -1.157 . . . . 0.0 110.558 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.33 -44.71 86.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.954 -1.092 . . . . 0.0 111.672 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.422 HG23 ' N ' ' A' ' 17' ' ' VAL . 20.3 tt -64.14 -35.73 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.729 -1.232 . . . . 0.0 110.45 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.422 ' N ' HG23 ' A' ' 16' ' ' ILE . 92.6 t -63.77 -40.59 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.381 -0.825 . . . . 0.0 108.892 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -61.03 -38.32 85.71 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.252 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.18 -38.86 90.68 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.192 -0.942 . . . . 0.0 109.768 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 91.7 mt -62.73 -43.23 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.168 -0.957 . . . . 0.0 109.691 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -59.67 -41.73 91.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.504 -0.748 . . . . 0.0 110.724 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -65.37 -37.48 87.13 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.199 -0.938 . . . . 0.0 110.991 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.92 92.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.033 -1.042 . . . . 0.0 109.89 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -60.1 -14.56 17.45 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.037 -1.04 . . . . 0.0 111.216 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.6 mttt -97.31 1.27 49.32 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.243 -0.911 . . . . 0.0 109.478 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -111.59 -15.05 13.56 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.04 -1.038 . . . . 0.0 109.314 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.5 t -152.68 156.03 38.43 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.054 -1.029 . . . . 0.0 110.064 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.9 p -86.84 -8.7 57.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.354 -0.841 . . . . 0.0 110.534 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.99 177.12 45.61 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.42 ' CB ' HD22 ' A' ' 138' ' ' LEU . 80.4 mm-40 -131.39 135.37 47.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.089 -1.242 . . . . 0.0 111.494 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 86.2 mt -116.43 132.07 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.2 mtp85 -136.9 151.34 48.96 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.285 -0.884 . . . . 0.0 110.117 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.5 t -123.91 138.38 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.639 -0.663 . . . . 0.0 110.454 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -123.6 125.04 44.12 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.567 0.698 . . . . 0.0 109.132 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.0 tt -113.48 131.08 56.18 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.009 0.909 . . . . 0.0 112.165 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 82.8 tt0 -146.84 167.14 24.64 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.422 ' HA ' HG23 ' A' ' 71' ' ' VAL . 51.6 mtmt -79.98 -73.99 0.33 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.964 . . . . 0.0 113.088 -177.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.411 ' OG1' ' CB ' ' A' ' 72' ' ' GLU . 62.7 m -141.57 159.61 41.86 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.411 -0.806 . . . . 0.0 110.198 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.416 ' OG ' ' CD ' ' A' ' 46' ' ' ARG . 51.1 m -112.4 170.24 8.31 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.511 -0.743 . . . . 0.0 111.133 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -107.09 -15.44 14.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.32 -0.863 . . . . 0.0 110.59 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.7 pt -121.78 -122.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.357 -0.839 . . . . 0.0 109.894 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -111.65 137.56 49.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.32 -1.488 . . . . 0.0 109.66 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.2 t -64.37 -42.54 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.441 -0.787 . . . . 0.0 110.679 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.22 -46.9 85.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.698 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -69.11 -37.95 78.66 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.442 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 58.5 ttt85 -61.96 -43.62 98.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.06 -1.025 . . . . 0.0 110.233 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.65 91.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.797 -1.189 . . . . 0.0 110.765 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.2 ttp -64.08 -43.39 95.59 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.707 -1.245 . . . . 0.0 109.681 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -64.29 -45.84 86.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.215 -0.928 . . . . 0.0 110.079 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.5 t -66.27 -42.48 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.23 -0.919 . . . . 0.0 109.475 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.07 -47.05 86.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.888 -1.133 . . . . 0.0 109.667 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -75.92 -38.63 57.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.57 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -60.66 -38.18 84.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.102 -0.999 . . . . 0.0 109.919 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.5 mt -81.2 5.41 17.05 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.005 -1.059 . . . . 0.0 110.313 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 56.77 30.62 18.03 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 121.458 -0.776 . . . . 0.0 111.328 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 99.6 mtp -65.24 -12.14 48.43 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.605 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.5 p30 -79.11 2.07 22.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.829 -1.169 . . . . 0.0 109.962 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -74.36 64.07 1.1 Allowed 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.205 -0.934 . . . . 0.0 109.926 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 81.5 p -134.49 149.09 50.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.17 -0.956 . . . . 0.0 109.661 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.67 -43.73 92.63 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.7 mt -95.76 0.9 52.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.93 -1.107 . . . . 0.0 111.018 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 56.08 38.53 30.0 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.301 1.048 . . . . 0.0 111.761 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -110.34 54.24 0.67 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.876 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.0 138.52 13.89 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.7 t -121.88 134.62 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.022 -1.281 . . . . 0.0 110.361 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.2 tp -117.76 129.22 55.56 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.088 0.47 . . . . 0.0 110.602 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 95.1 mt -110.66 107.39 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.981 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.442 ' CZ ' ' HD3' ' A' ' 46' ' ' ARG . 58.6 t80 -92.95 122.91 35.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.117 -0.989 . . . . 0.0 109.541 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.6 t -120.74 130.93 74.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 122.264 1.031 . . . . 0.0 111.132 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.5 94.83 5.87 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.123 178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.422 HG23 ' HA ' ' A' ' 37' ' ' LYS . 34.3 m -63.92 -19.48 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.094 -1.004 . . . . 0.0 111.236 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.411 ' CB ' ' OG1' ' A' ' 38' ' ' THR . 79.8 mm-40 -68.17 -43.08 78.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.879 -1.138 . . . . 0.0 109.602 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.3 p30 -102.88 5.78 38.73 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.336 -0.852 . . . . 0.0 110.536 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.406 ' HG3' ' CZ ' ' A' ' 109' ' ' PHE . 34.1 tttt 54.53 49.85 17.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.987 -1.07 . . . . 0.0 111.236 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 72.5 p -126.53 167.21 15.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.142 -0.973 . . . . 0.0 109.927 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -141.09 144.52 34.96 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.424 -0.798 . . . . 0.0 109.865 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.7 t -131.26 136.46 57.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.52 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 81.4 mt -116.44 126.96 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.926 -1.108 . . . . 0.0 110.71 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -129.51 113.57 15.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.6 -0.688 . . . . 0.0 110.145 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.1 148.53 17.69 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -61.41 174.79 0.67 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.673 -0.898 . . . . 0.0 109.27 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.1 -24.79 60.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.14 -0.975 . . . . 0.0 111.068 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.9 -51.96 41.63 Favored Glycine 0 N--CA 1.496 2.654 0 C-N-CA 119.711 -1.233 . . . . 0.0 111.452 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 2.6 mt -66.48 -43.93 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.811 -1.405 . . . . 0.0 108.048 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -62.2 -38.9 90.9 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 111.434 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -76.98 -23.41 52.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.934 -1.104 . . . . 0.0 112.322 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.2 p -98.35 -24.77 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.731 -1.231 . . . . 0.0 112.579 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.486 ' HB ' ' CD2' ' A' ' 92' ' ' PHE . 14.3 m -117.32 163.37 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.631 -1.293 . . . . 0.0 111.519 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.415 ' OG ' ' N ' ' A' ' 90' ' ' ASP . 6.2 t -105.06 179.71 4.19 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.24 -0.912 . . . . 0.0 111.843 -178.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.415 ' N ' ' OG ' ' A' ' 89' ' ' SER . 64.1 t0 -62.0 -38.04 87.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.464 -0.773 . . . . 0.0 110.051 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -62.94 -36.97 85.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.177 -0.952 . . . . 0.0 109.31 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.486 ' CD2' ' HB ' ' A' ' 88' ' ' VAL . 51.7 t80 -65.69 -26.97 68.01 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.305 -0.958 . . . . 0.0 108.92 177.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.52 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 5.6 m95 -84.73 -28.44 26.28 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 122.026 0.917 . . . . 0.0 110.021 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -58.01 -37.32 74.06 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.742 -0.599 . . . . 0.0 112.471 -176.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.5 p -65.9 -32.57 74.15 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 118.627 -1.229 . . . . 0.0 109.15 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.27 10.1 m -59.95 -48.25 82.47 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.33 1.062 . . . . 0.0 111.609 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -69.9 -36.99 75.85 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.531 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -64.22 -43.72 94.12 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.584 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.28 -51.41 66.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.919 -1.113 . . . . 0.0 111.01 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.93 -41.98 90.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.3 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.4 -45.14 92.41 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.255 -0.903 . . . . 0.0 111.851 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.8 tp -63.11 -42.3 99.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.164 -0.96 . . . . 0.0 111.789 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.439 ' HB3' ' CA ' ' A' ' 112' ' ' GLY . 21.4 tp60 -72.55 -39.98 67.05 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.641 -1.224 . . . . 0.0 108.634 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -59.24 -38.32 79.7 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -61.59 -35.72 78.63 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.315 0.579 . . . . 0.0 109.885 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -75.12 -18.61 60.2 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 109.301 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.95 0.96 45.38 Favored Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.948 -1.12 . . . . 0.0 110.737 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -98.79 95.55 7.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.75 -1.441 . . . . 0.0 109.843 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.406 ' CZ ' ' HG3' ' A' ' 74' ' ' LYS . 21.7 m-30 -64.72 -41.23 96.12 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.815 -0.553 . . . . 0.0 111.175 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -64.35 -50.1 69.05 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.274 -0.891 . . . . 0.0 111.831 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -62.36 -34.54 76.87 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.014 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.439 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -66.72 -47.89 65.1 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.331 -1.414 . . . . 0.0 109.733 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.5 mt -63.37 -45.0 93.17 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.263 -1.139 . . . . 0.0 111.989 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.418 HG13 ' N ' ' A' ' 115' ' ' ASP . 11.9 p -67.25 -44.9 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.943 -1.098 . . . . 0.0 110.908 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.418 ' N ' HG13 ' A' ' 114' ' ' VAL . 13.4 m-20 -64.94 -37.34 87.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 110.38 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.31 -42.77 99.14 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.41 -43.93 97.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.331 -1.099 . . . . 0.0 109.882 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -57.67 -51.73 68.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.045 -1.034 . . . . 0.0 110.165 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -62.6 -43.09 99.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.222 -0.924 . . . . 0.0 109.172 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.91 -45.36 86.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.463 -0.773 . . . . 0.0 109.998 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.26 -42.62 99.24 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.0 mtt -66.33 -45.55 79.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.959 -1.318 . . . . 0.0 109.651 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.474 ' HB3' ' CE1' ' A' ' 92' ' ' PHE . . . -63.75 -44.67 92.78 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.522 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 42.0 mt -62.3 -39.78 94.12 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.95 -34.67 63.47 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.355 -0.841 . . . . 0.0 110.716 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -62.94 -41.67 99.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.118 -0.989 . . . . 0.0 109.886 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -78.01 -36.69 48.46 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.392 -0.817 . . . . 0.0 110.252 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -127.87 94.43 37.1 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.393 -0.817 . . . . 0.0 109.527 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.76 143.7 62.55 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 123.882 1.464 . . . . 0.0 110.266 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 44.5 t90 -72.41 130.46 40.77 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.306 -0.871 . . . . 0.0 111.264 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -109.02 153.03 24.19 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.71 -32.74 71.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.79 -1.194 . . . . 0.0 111.564 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -88.62 8.49 28.19 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.053 -1.059 . . . . 0.0 110.733 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.477 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 65.9 t0 -42.86 137.3 2.36 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.89 0.852 . . . . 0.0 111.538 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.431 HD12 HG23 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -107.62 133.08 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 121.488 -0.758 . . . . 0.0 111.381 -178.327 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -112.39 99.55 8.09 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.327 -0.858 . . . . 0.0 109.306 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -98.51 -15.55 19.52 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.826 -1.171 . . . . 0.0 111.541 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.42 HD22 ' CB ' ' A' ' 30' ' ' GLU . 3.1 mp -94.98 144.17 27.35 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.235 -0.916 . . . . 0.0 110.47 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -72.55 169.71 21.16 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.665 1.35 . . . . 0.0 109.222 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -110.02 8.73 24.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.839 -1.163 . . . . 0.0 110.322 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.1 p -67.22 166.57 13.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.071 -1.018 . . . . 0.0 111.316 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.04 136.45 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.59 -0.694 . . . . 0.0 110.395 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.1 m -88.99 137.12 32.6 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.143 -0.973 . . . . 0.0 109.617 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -133.1 147.26 52.15 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.117 -0.989 . . . . 0.0 110.695 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.43 0 CA-C-O 117.86 -1.522 . . . . 0.0 109.892 -179.502 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.43 -39.26 60.81 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.691 -1.255 . . . . 0.0 109.871 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.84 -42.25 90.72 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.679 -0.638 . . . . 0.0 111.404 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -70.7 -44.21 67.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.923 -1.111 . . . . 0.0 110.174 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.411 ' O ' HG21 ' A' ' 16' ' ' ILE . 96.2 mt-10 -67.17 -33.45 75.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.011 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -64.59 -45.67 85.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.682 -1.261 . . . . 0.0 110.306 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.77 -42.7 94.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.023 -1.048 . . . . 0.0 111.501 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 17' ' ' VAL . 19.3 tt -67.15 -37.56 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.777 -1.202 . . . . 0.0 110.977 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.434 ' CG2' HD13 ' A' ' 142' ' ' ILE . 68.4 t -64.36 -41.22 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -61.62 -37.32 83.54 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.211 -0.996 . . . . 0.0 108.648 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.23 87.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.435 -0.79 . . . . 0.0 109.845 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.81 -42.87 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.153 -0.967 . . . . 0.0 110.001 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -60.35 -42.04 94.89 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.788 0.804 . . . . 0.0 110.299 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -65.12 -36.78 85.35 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.249 -0.581 . . . . 0.0 110.162 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.22 95.49 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.108 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.78 -14.58 33.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.056 -1.028 . . . . 0.0 110.519 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.468 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.7 mttt -93.42 -0.21 56.58 Favored 'General case' 0 C--N 1.309 -1.17 0 O-C-N 121.046 -1.034 . . . . 0.0 109.257 176.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -113.04 -13.74 13.05 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 120.835 -1.165 . . . . 0.0 110.608 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 t -153.33 160.3 42.66 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.915 -1.116 . . . . 0.0 110.105 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.1 p -90.91 -10.35 42.82 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.175 -0.953 . . . . 0.0 109.857 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.0 172.35 40.6 Favored Glycine 0 N--CA 1.481 1.685 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.415 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 54.3 mp0 -131.61 134.85 46.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.225 -1.162 . . . . 0.0 112.163 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.8 mt -120.84 133.76 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.746 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.1 ttm-85 -138.67 159.19 42.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.958 -1.089 . . . . 0.0 109.677 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.31 137.91 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.405 -0.809 . . . . 0.0 110.743 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -121.2 125.14 46.41 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.0 tp -110.92 131.14 55.3 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.892 0.854 . . . . 0.0 111.449 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 76.9 tt0 -147.78 165.34 30.85 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.415 ' HA ' HG21 ' A' ' 71' ' ' VAL . 99.7 mttt -79.77 -74.85 0.28 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 112.956 -177.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.8 t -139.36 156.27 47.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.109 -0.995 . . . . 0.0 110.367 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.477 ' HB2' ' CD ' ' A' ' 46' ' ' ARG . 5.9 p -104.27 166.97 10.06 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.701 -0.624 . . . . 0.0 111.198 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -106.67 -8.04 17.07 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.391 -0.818 . . . . 0.0 110.347 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 42' ' ' ASP . 34.3 pt -129.15 -122.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.912 -1.118 . . . . 0.0 110.487 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 41' ' ' ILE . 93.9 m-20 -111.72 137.33 49.77 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.057 -1.652 . . . . 0.0 110.065 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.3 t -63.23 -43.38 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.284 -0.885 . . . . 0.0 111.624 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -59.76 -45.61 91.72 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.763 -1.211 . . . . 0.0 110.094 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -67.26 -39.73 86.12 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.659 -1.276 . . . . 0.0 109.135 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.477 ' CD ' ' HB2' ' A' ' 39' ' ' SER . 77.6 mtp85 -62.24 -45.3 93.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.956 -1.09 . . . . 0.0 110.767 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.58 95.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.969 -1.082 . . . . 0.0 110.416 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.8 ttp -62.91 -43.13 99.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.013 -1.054 . . . . 0.0 109.507 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -65.5 -46.37 79.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.953 -1.092 . . . . 0.0 110.16 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.9 t -65.95 -44.42 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.032 -1.043 . . . . 0.0 110.422 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.433 ' C ' ' CD1' ' A' ' 51' ' ' PHE . 6.5 t80 -57.12 -49.52 75.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.984 -1.073 . . . . 0.0 109.259 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -72.86 -35.59 67.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.967 -1.083 . . . . 0.0 109.413 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -60.47 -39.98 89.58 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.394 -0.816 . . . . 0.0 108.988 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.0 mt -79.23 4.35 15.25 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.624 -0.673 . . . . 0.0 110.081 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 56.48 32.73 21.28 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 121.187 -0.946 . . . . 0.0 111.297 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 94.4 mmm -66.39 -11.68 52.77 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.914 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -79.5 -1.61 38.38 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.771 -1.205 . . . . 0.0 109.89 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -78.28 65.68 3.68 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.032 -1.043 . . . . 0.0 109.603 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.433 ' CG2' HD13 ' A' ' 138' ' ' LEU . 78.4 p -135.08 150.05 50.18 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -64.05 -43.06 96.68 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.601 -0.687 . . . . 0.0 112.123 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 98.2 mt -96.59 0.15 49.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.789 -1.194 . . . . 0.0 111.502 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 87.8 mt-30 57.26 46.15 19.12 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.497 1.141 . . . . 0.0 111.273 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.407 ' HA ' HG13 ' A' ' 84' ' ' ILE . 95.2 m-20 -120.21 52.85 1.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.094 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.81 138.79 14.09 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.492 ' CG2' ' CD1' ' A' ' 84' ' ' ILE . 61.2 t -125.54 135.89 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.162 -1.199 . . . . 0.0 110.952 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.1 tp -116.5 125.97 52.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.527 -0.733 . . . . 0.0 109.712 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.0 mt -101.85 106.25 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.118 -1.033 . . . . 0.0 109.389 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -91.89 123.04 34.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.326 -0.859 . . . . 0.0 110.021 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 79.2 t -123.63 130.38 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.494 -0.754 . . . . 0.0 111.003 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.52 108.92 20.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.722 -0.611 . . . . 0.0 109.373 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.415 HG21 ' HA ' ' A' ' 37' ' ' LYS . 22.8 m -76.11 -19.56 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.891 -1.13 . . . . 0.0 111.56 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.405 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 79.0 mm-40 -69.66 -46.98 64.88 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.656 -1.278 . . . . 0.0 109.259 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -101.78 1.5 37.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.488 -0.757 . . . . 0.0 110.936 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.2 tttt 56.67 47.53 18.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.844 -1.16 . . . . 0.0 110.748 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.8 m -118.22 129.37 55.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.075 -1.016 . . . . 0.0 109.823 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -112.29 138.84 48.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.691 -0.63 . . . . 0.0 110.459 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.14 137.19 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.331 -0.856 . . . . 0.0 109.002 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.447 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 77.6 mt -113.89 128.62 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.933 -1.104 . . . . 0.0 110.398 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -132.56 116.55 16.85 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.535 -0.728 . . . . 0.0 110.78 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.38 168.98 21.19 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -80.53 178.49 8.29 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.771 -0.841 . . . . 0.0 110.227 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.05 -28.83 70.36 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.218 -0.926 . . . . 0.0 111.166 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.66 -54.06 27.89 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.204 -0.998 . . . . 0.0 110.643 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.492 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 97.3 mt -63.7 -46.89 93.4 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.733 0 O-C-N 120.926 -1.338 . . . . 0.0 107.663 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.83 -38.37 85.22 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.785 -1.197 . . . . 0.0 111.558 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -70.99 -24.89 62.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.035 -1.041 . . . . 0.0 112.238 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.0 m -104.75 -17.14 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.71 -1.244 . . . . 0.0 112.411 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 84' ' ' ILE . 18.4 m -117.73 163.75 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 120.415 -1.428 . . . . 0.0 111.382 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.2 p -109.76 172.56 6.79 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.718 0.771 . . . . 0.0 112.581 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -59.15 -37.26 76.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.424 -0.798 . . . . 0.0 109.398 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -61.21 -39.89 91.93 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.085 -1.009 . . . . 0.0 109.031 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 123' ' ' ALA . 69.1 t80 -64.48 -25.33 67.95 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.195 -0.941 . . . . 0.0 109.229 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.447 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 4.7 m95 -86.99 -26.66 23.67 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.651 0.739 . . . . 0.0 111.183 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -58.48 -34.67 71.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.397 -0.814 . . . . 0.0 112.026 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.9 m -66.16 -32.78 74.42 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.003 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.277 9.0 m -60.68 -49.49 77.28 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 122.325 1.059 . . . . 0.0 111.63 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -68.41 -38.08 80.94 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.146 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -64.31 -45.95 85.69 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.491 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.73 -50.56 71.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.884 -1.135 . . . . 0.0 111.707 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.66 -41.64 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.913 -1.117 . . . . 0.0 109.165 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -64.01 -41.5 97.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.595 -0.691 . . . . 0.0 111.227 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.57 -42.09 99.34 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.156 -0.965 . . . . 0.0 111.331 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.445 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 96.4 mm-40 -75.71 -41.46 53.5 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.964 -1.095 . . . . 0.0 108.925 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -59.25 -40.9 87.43 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -59.33 -35.98 74.82 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.477 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -77.81 -15.52 59.02 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.046 -1.034 . . . . 0.0 109.901 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.05 3.68 48.36 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.784 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -101.92 91.32 4.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.686 -1.479 . . . . 0.0 110.491 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -61.02 -46.03 92.4 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.343 -0.848 . . . . 0.0 111.556 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -62.65 -48.24 80.23 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 112.919 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -61.77 -38.03 86.49 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 118.549 -1.26 . . . . 0.0 109.467 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.445 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -64.94 -46.05 90.53 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.7 mt -63.68 -45.47 89.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.31 -1.112 . . . . 0.0 110.747 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.404 ' CG2' HG13 ' A' ' 16' ' ' ILE . 95.5 t -66.88 -46.77 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.012 -1.055 . . . . 0.0 110.816 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -64.76 -38.95 92.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.012 -1.055 . . . . 0.0 110.203 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.44 -42.33 97.64 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.1 mt -63.97 -44.07 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -1.142 . . . . 0.0 109.837 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -60.12 -46.73 88.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.088 -1.008 . . . . 0.0 109.455 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -63.53 -41.83 98.46 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.188 -1.005 . . . . 0.0 108.587 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -59.13 -42.66 91.14 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.836 -0.745 . . . . 0.0 109.539 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.66 -44.12 96.89 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 57.5 ttm -67.58 -48.5 66.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.135 -1.214 . . . . 0.0 109.935 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 92' ' ' PHE . . . -61.72 -46.13 90.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.953 -1.092 . . . . 0.0 109.276 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.407 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 88.3 mt -62.69 -39.34 93.68 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.511 -0.743 . . . . 0.0 109.054 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.44 -34.67 61.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.244 -0.91 . . . . 0.0 110.459 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -61.38 -39.96 92.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.03 -1.044 . . . . 0.0 109.183 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -80.2 -31.97 38.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.884 . . . . 0.0 109.468 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -132.54 93.12 25.58 Favored Pre-proline 0 N--CA 1.485 1.296 0 O-C-N 121.532 -0.73 . . . . 0.0 109.956 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.64 146.48 73.49 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.816 1.429 . . . . 0.0 109.457 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.468 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 64.3 t90 -71.26 132.11 44.46 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.157 -0.965 . . . . 0.0 110.951 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -110.13 147.52 33.52 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -55.79 -28.45 56.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.054 -1.029 . . . . 0.0 110.878 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 40.7 p-10 -92.91 9.25 36.26 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.027 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.416 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 61.1 t0 -42.55 135.85 2.65 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.882 0.848 . . . . 0.0 111.163 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.424 ' CD1' ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -113.32 141.91 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.578 0.704 . . . . 0.0 111.247 -177.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -98.75 93.17 5.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.994 -1.066 . . . . 0.0 110.172 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -68.2 -39.45 82.44 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.904 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.433 HD13 ' CG2' ' A' ' 59' ' ' THR . 11.1 mp -105.77 151.04 39.82 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.204 -0.935 . . . . 0.0 110.737 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -75.45 -174.15 1.88 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.639 1.336 . . . . 0.0 108.763 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -118.64 3.61 11.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.575 -1.328 . . . . 0.0 110.03 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.9 m -60.96 137.08 58.25 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.852 -1.155 . . . . 0.0 110.835 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.434 HD13 ' CG2' ' A' ' 17' ' ' VAL . 95.4 mt -67.34 136.69 26.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.698 -0.626 . . . . 0.0 110.175 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 3.5 m -92.97 134.08 35.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.401 -0.812 . . . . 0.0 109.244 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -132.9 149.6 52.23 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -0.936 . . . . 0.0 109.898 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 CA-C-O 117.908 -1.496 . . . . 0.0 109.844 -179.605 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 121.09 0.472 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.53 -40.51 62.54 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.939 -1.101 . . . . 0.0 109.555 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.01 -46.91 87.13 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.529 -0.732 . . . . 0.0 110.401 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.67 -46.27 66.47 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.035 -1.041 . . . . 0.0 111.125 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.03 -37.94 89.21 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.124 -0.985 . . . . 0.0 109.917 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -63.64 -44.72 93.01 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.442 -0.786 . . . . 0.0 111.239 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.18 -42.65 93.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.956 -1.09 . . . . 0.0 111.375 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 17' ' ' VAL . 18.4 tt -67.81 -37.53 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.701 -1.249 . . . . 0.0 110.351 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.454 ' N ' HG22 ' A' ' 16' ' ' ILE . 46.9 t -62.68 -42.68 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -61.77 -37.88 85.93 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.574 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.03 -36.58 79.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.334 -0.854 . . . . 0.0 109.188 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.25 -43.66 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.363 -0.836 . . . . 0.0 109.696 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -58.78 -41.57 86.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.245 -0.909 . . . . 0.0 109.921 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -64.65 -37.53 87.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.501 -0.75 . . . . 0.0 111.664 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.99 94.36 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.831 -1.168 . . . . 0.0 110.021 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -60.53 -15.59 28.96 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.062 -1.024 . . . . 0.0 111.097 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.6 mttt -92.93 -6.23 49.01 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.16 -0.962 . . . . 0.0 109.006 177.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -105.72 -13.72 15.47 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 121.085 -1.009 . . . . 0.0 109.742 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.5 t -151.55 156.93 41.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.026 -1.046 . . . . 0.0 110.318 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.4 t -86.6 -6.9 58.75 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.354 -0.841 . . . . 0.0 109.019 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.86 173.31 50.26 Favored Glycine 0 N--CA 1.481 1.64 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.5 mp0 -132.35 137.4 47.37 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.147 -1.208 . . . . 0.0 111.677 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 82.4 mt -119.57 134.14 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.682 -0.636 . . . . 0.0 110.293 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -139.73 153.07 47.11 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.054 -1.029 . . . . 0.0 109.906 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.8 t -123.53 140.08 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.366 -0.834 . . . . 0.0 111.134 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -122.86 133.14 54.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.577 -0.702 . . . . 0.0 109.146 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.6 tp -123.89 136.43 54.35 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.099 0.952 . . . . 0.0 112.086 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.441 ' HG2' ' NH2' ' A' ' 46' ' ' ARG . 48.5 tp10 -151.63 161.95 41.81 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.433 ' N ' ' HG3' ' A' ' 36' ' ' GLU . 99.1 mttt -73.38 -72.5 0.25 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.929 -1.107 . . . . 0.0 112.417 -177.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 t -142.79 158.03 44.04 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.434 -0.791 . . . . 0.0 109.524 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.425 ' OG ' ' CD ' ' A' ' 46' ' ' ARG . 69.5 m -108.2 172.23 6.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.345 -0.847 . . . . 0.0 111.264 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -107.63 -21.3 12.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.559 -0.713 . . . . 0.0 110.531 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.9 pt -116.88 -121.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.009 -1.057 . . . . 0.0 110.762 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -109.38 132.75 53.84 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.637 -1.289 . . . . 0.0 109.332 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.8 t -62.4 -43.76 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.75 -0.594 . . . . 0.0 111.471 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -59.79 -47.93 83.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.892 -1.13 . . . . 0.0 109.537 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -67.71 -35.64 79.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.943 -1.098 . . . . 0.0 108.246 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.441 ' NH2' ' HG2' ' A' ' 36' ' ' GLU . 76.0 ttt-85 -64.5 -43.2 94.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 111.414 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.24 -36.86 85.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.749 -1.219 . . . . 0.0 109.985 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.5 ttp -61.21 -42.93 99.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 109.059 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -63.72 -46.77 83.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.004 -1.06 . . . . 0.0 110.249 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 71.8 t -64.85 -43.84 96.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.33 -0.856 . . . . 0.0 109.882 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -59.23 -49.37 78.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.057 -1.027 . . . . 0.0 109.666 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -71.43 -35.82 71.06 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.363 -0.835 . . . . 0.0 109.226 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -62.22 -37.72 86.46 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.266 -0.897 . . . . 0.0 109.327 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.0 mt -82.43 3.93 26.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.914 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.2 tttt 54.86 34.8 22.85 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.137 -0.977 . . . . 0.0 111.483 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 94.2 mtp -66.78 -11.44 55.06 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.901 -1.124 . . . . 0.0 110.206 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 44.7 p-10 -77.25 -0.84 26.81 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.94 -1.1 . . . . 0.0 109.927 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -78.54 64.62 3.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.387 -0.821 . . . . 0.0 110.687 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.4 p -135.14 150.3 50.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.21 -0.931 . . . . 0.0 108.951 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.62 -44.54 96.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.283 -0.886 . . . . 0.0 112.707 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 90.6 mt -97.14 1.59 50.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.95 -1.094 . . . . 0.0 111.725 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 57.13 38.43 29.01 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.284 1.04 . . . . 0.0 110.913 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.409 ' HA ' HG13 ' A' ' 84' ' ' ILE . 99.3 m-20 -112.67 55.21 0.7 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.543 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.404 ' O ' ' CD1' ' A' ' 84' ' ' ILE . . . -101.71 141.16 15.19 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 178.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.9 t -124.29 134.72 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.143 -1.21 . . . . 0.0 110.162 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 52.2 tp -117.89 129.33 55.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.515 -0.741 . . . . 0.0 110.658 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.1 mt -107.64 110.18 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.905 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.435 ' OH ' ' NH2' ' A' ' 46' ' ' ARG . 33.8 t80 -96.71 125.42 41.15 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.189 -0.944 . . . . 0.0 110.318 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.3 t -125.59 131.73 71.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-O 122.139 0.971 . . . . 0.0 111.165 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.71 108.92 21.73 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.8 m -74.65 -19.37 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.052 -1.03 . . . . 0.0 110.078 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -69.46 -43.45 73.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.075 -1.015 . . . . 0.0 109.336 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -104.22 4.98 34.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.006 -1.059 . . . . 0.0 111.15 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 67.5 tttt 56.06 47.4 19.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.831 -1.168 . . . . 0.0 110.64 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.2 p -123.23 167.61 13.51 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.183 -0.948 . . . . 0.0 110.355 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -147.83 140.84 24.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.555 -0.715 . . . . 0.0 109.993 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 68.7 t -128.38 138.39 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.519 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 79.4 mt -113.62 124.76 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.971 -1.08 . . . . 0.0 110.492 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -130.38 113.75 14.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.504 -0.747 . . . . 0.0 109.717 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.94 170.5 21.82 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -77.35 174.21 11.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.483 -1.01 . . . . 0.0 110.223 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -58.87 -27.81 65.54 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.326 -0.859 . . . . 0.0 110.244 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.78 -50.49 58.2 Favored Glycine 0 N--CA 1.487 2.065 0 C-N-CA 119.687 -1.245 . . . . 0.0 109.99 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.431 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 4.2 mt -63.54 -46.9 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.835 -1.391 . . . . 0.0 108.552 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -63.26 -33.66 75.98 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.529 -0.732 . . . . 0.0 112.058 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -76.74 -22.98 53.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.739 -1.226 . . . . 0.0 112.532 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.9 m -103.99 -17.85 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.757 -1.214 . . . . 0.0 112.08 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.487 ' HB ' ' CD2' ' A' ' 92' ' ' PHE . 4.5 m -120.25 159.52 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.966 -1.084 . . . . 0.0 111.591 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.9 p -104.65 177.25 4.9 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.881 0.848 . . . . 0.0 112.084 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -64.21 -38.74 92.14 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.59 -0.694 . . . . 0.0 109.246 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -60.83 -38.52 85.73 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.487 ' CD2' ' HB ' ' A' ' 88' ' ' VAL . 75.2 t80 -64.33 -26.26 68.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -0.941 . . . . 0.0 108.83 177.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.519 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 4.4 m95 -85.71 -26.68 25.78 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.924 0.869 . . . . 0.0 110.216 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -56.88 -41.13 77.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 112.538 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.2 p -63.19 -31.44 72.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.658 -1.276 . . . . 0.0 109.298 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.281 7.6 m -59.47 -48.35 82.0 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.433 1.111 . . . . 0.0 111.146 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -70.12 -37.17 75.25 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.124 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -63.47 -44.73 93.59 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.177 -1.009 . . . . 0.0 110.883 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.64 -49.03 76.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.743 -1.223 . . . . 0.0 110.881 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.1 -42.3 91.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.176 -0.952 . . . . 0.0 110.059 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -63.38 -43.51 97.41 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.677 -0.64 . . . . 0.0 111.701 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.8 mt -63.96 -43.13 96.74 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.722 -1.236 . . . . 0.0 112.256 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.46 ' HG2' ' N ' ' A' ' 112' ' ' GLY . 27.6 tp60 -72.36 -42.53 65.2 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.666 -1.214 . . . . 0.0 108.72 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -58.5 -39.57 80.42 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.81 -32.16 72.45 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.622 -0.674 . . . . 0.0 109.887 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -80.95 -19.02 45.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.085 -1.01 . . . . 0.0 110.238 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.27 5.87 36.95 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.045 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -105.87 89.85 3.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.833 -1.392 . . . . 0.0 110.253 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -63.65 -41.45 98.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.725 -0.609 . . . . 0.0 111.672 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -62.56 -48.11 80.92 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.888 -1.133 . . . . 0.0 111.721 -178.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.404 ' HB2' ' HG2' ' A' ' 103' ' ' GLN . 88.4 mt-30 -64.41 -37.91 89.19 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.636 -177.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.46 ' N ' ' HG2' ' A' ' 103' ' ' GLN . . . -67.37 -46.32 71.6 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.86 -43.25 93.59 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.533 -0.98 . . . . 0.0 110.48 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.6 t -66.42 -47.13 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.393 -0.817 . . . . 0.0 109.996 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -62.9 -40.57 97.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.247 -0.908 . . . . 0.0 109.164 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.74 -43.51 96.37 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.3 mt -63.55 -43.4 98.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -1.105 . . . . 0.0 110.062 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -60.86 -48.27 82.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.023 -1.048 . . . . 0.0 110.484 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.33 -43.65 97.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.012 -1.055 . . . . 0.0 109.487 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.09 -41.44 83.49 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.388 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.04 -45.61 91.57 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 95.6 mtp -66.16 -46.48 77.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.903 -1.351 . . . . 0.0 109.934 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 92' ' ' PHE . . . -62.06 -46.9 87.09 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.602 -0.686 . . . . 0.0 109.725 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.86 -38.63 91.79 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.449 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.84 -35.12 61.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.868 -1.145 . . . . 0.0 110.273 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.91 -43.95 97.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.144 -0.972 . . . . 0.0 109.047 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -72.49 -39.89 67.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.67 -0.644 . . . . 0.0 109.654 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -131.4 96.73 20.79 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.485 -0.759 . . . . 0.0 110.505 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.38 150.32 84.48 Favored 'Trans proline' 0 C--N 1.317 -1.124 0 O-C-N 123.739 1.389 . . . . 0.0 110.735 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.475 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 29.4 t90 -73.32 164.1 27.15 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.643 0.735 . . . . 0.0 110.358 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -145.23 153.37 41.26 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.62 -30.83 70.1 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 111.736 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -90.71 8.24 35.51 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 118.926 -1.109 . . . . 0.0 111.224 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -41.95 138.43 1.54 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.632 0.73 . . . . 0.0 111.551 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.448 ' CD1' ' O ' ' A' ' 135' ' ' ILE . 1.3 pp -113.32 147.65 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 121.542 0.687 . . . . 0.0 110.737 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -102.25 92.78 4.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.689 -1.257 . . . . 0.0 109.358 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -66.26 -41.05 90.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.725 -0.61 . . . . 0.0 111.749 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.86 151.93 40.74 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.151 -0.968 . . . . 0.0 111.163 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.85 -172.26 0.93 Allowed 'Trans proline' 0 C--N 1.315 -1.233 0 N-CA-C 108.762 -1.284 . . . . 0.0 108.762 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -121.42 2.76 10.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.687 -1.258 . . . . 0.0 110.073 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.6 p -63.85 173.55 1.76 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -0.913 . . . . 0.0 111.333 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 89.4 mt -101.96 136.14 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.547 0.689 . . . . 0.0 110.779 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.8 t -94.05 136.53 34.25 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.449 -0.782 . . . . 0.0 109.353 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -130.09 138.57 50.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 0.0 110.478 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.081 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.744 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.53 -30.77 21.69 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.892 -1.13 . . . . 0.0 110.059 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -72.27 -36.04 68.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.159 -0.963 . . . . 0.0 110.054 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -61.92 -40.78 96.65 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.956 -1.097 . . . . 0.0 108.729 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -61.14 -38.44 86.42 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.729 -0.607 . . . . 0.0 110.178 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -60.52 -41.92 95.39 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.514 -0.875 . . . . 0.0 110.431 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.14 78.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.006 -1.059 . . . . 0.0 112.329 -178.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.2 tt -66.53 -31.74 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.59 -1.318 . . . . 0.0 110.215 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.63 -40.58 89.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -63.97 -35.94 82.34 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.606 -0.837 . . . . 0.0 109.174 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.45 -39.46 93.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.38 -0.825 . . . . 0.0 109.12 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.56 -43.32 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.835 . . . . 0.0 109.862 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -60.78 -41.96 96.57 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.131 -0.981 . . . . 0.0 110.199 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -65.96 -38.22 88.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.512 -0.742 . . . . 0.0 111.147 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.96 -40.41 96.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.859 -1.151 . . . . 0.0 109.956 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.67 -15.59 30.36 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.061 -1.024 . . . . 0.0 110.866 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.474 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 75.4 mmtt -93.8 1.01 56.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.089 -1.007 . . . . 0.0 109.27 177.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -114.81 -14.08 11.97 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.802 -1.186 . . . . 0.0 109.934 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.6 t -151.74 154.52 36.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.875 -1.14 . . . . 0.0 109.753 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 m -84.56 -6.74 59.39 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.291 -0.881 . . . . 0.0 109.805 178.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.9 174.58 54.27 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -133.31 138.2 46.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.272 -1.134 . . . . 0.0 111.665 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.402 HG21 HD12 ' A' ' 31' ' ' ILE . 93.5 mt -118.46 134.5 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.712 -0.617 . . . . 0.0 109.835 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.419 ' NE ' ' OG ' ' A' ' 143' ' ' SER . 76.2 ttt180 -139.87 152.17 46.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.89 . . . . 0.0 109.852 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.7 t -124.5 140.61 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.368 -0.832 . . . . 0.0 111.464 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -125.87 128.3 47.38 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.521 0.677 . . . . 0.0 109.434 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.45 ' CD1' ' CG1' ' A' ' 71' ' ' VAL . 37.8 tp -118.67 129.84 55.51 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.946 0.879 . . . . 0.0 112.572 -177.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -145.35 168.09 21.32 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.423 ' HA ' HG21 ' A' ' 71' ' ' VAL . 98.7 mttt -79.23 -73.6 0.33 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.977 -1.077 . . . . 0.0 112.961 -177.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 t -143.26 158.81 43.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.265 -0.897 . . . . 0.0 110.141 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.9 p -108.95 171.86 7.19 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.251 -0.906 . . . . 0.0 111.152 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -106.58 -10.68 16.11 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.479 -0.763 . . . . 0.0 110.425 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 42' ' ' ASP . 25.7 pt -125.57 -121.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 120.985 -1.072 . . . . 0.0 109.631 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.408 ' N ' HG13 ' A' ' 41' ' ' ILE . 64.2 m-20 -111.76 138.62 48.1 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 120.393 -1.442 . . . . 0.0 109.017 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.431 ' CG1' HG22 ' A' ' 77' ' ' VAL . 85.2 t -64.28 -43.31 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 111.412 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -59.36 -47.29 85.97 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.95 -1.094 . . . . 0.0 110.778 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -71.34 -38.18 71.66 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.88 -1.137 . . . . 0.0 108.42 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -63.54 -40.67 97.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.467 -0.77 . . . . 0.0 110.082 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.44 -38.15 84.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.694 -1.254 . . . . 0.0 110.127 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.4 ttp -62.09 -44.22 97.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.969 -1.082 . . . . 0.0 109.901 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -63.35 -44.64 94.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.082 -1.011 . . . . 0.0 109.571 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 95.7 t -65.81 -43.72 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.586 -0.696 . . . . 0.0 110.088 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.474 ' CE2' ' OD1' ' A' ' 57' ' ' ASP . 71.4 t80 -58.66 -45.95 88.24 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.065 -1.022 . . . . 0.0 109.435 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -73.07 -35.77 66.72 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.849 -1.157 . . . . 0.0 109.558 178.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -60.79 -37.34 81.6 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.025 -1.047 . . . . 0.0 109.955 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.3 mt -82.08 5.72 18.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.098 -1.001 . . . . 0.0 110.308 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.404 ' HB3' ' ND2' ' A' ' 58' ' ' ASN . 98.6 mttt 54.78 34.65 22.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.793 -1.192 . . . . 0.0 111.43 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 93.4 mtp -67.05 -12.47 60.01 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.957 -1.097 . . . . 0.0 109.641 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.474 ' OD1' ' CE2' ' A' ' 51' ' ' PHE . 92.3 m-20 -75.09 -2.13 26.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.664 -1.272 . . . . 0.0 109.9 177.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.404 ' ND2' ' HB3' ' A' ' 55' ' ' LYS . 64.9 m-20 -74.2 61.37 0.86 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.828 -1.17 . . . . 0.0 109.937 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.4 m -132.47 144.17 50.28 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.162 -0.961 . . . . 0.0 108.875 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.31 -42.81 99.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.821 -0.549 . . . . 0.0 112.405 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.5 mt -98.51 2.4 47.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.101 -0.999 . . . . 0.0 111.595 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 55.87 36.54 27.49 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.076 0.941 . . . . 0.0 111.542 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -113.13 50.2 0.9 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.338 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.68 142.53 16.15 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.762 -2.135 . . . . 0.0 107.762 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.408 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 54.9 t -123.73 133.91 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.103 -1.234 . . . . 0.0 109.924 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.5 tp -116.37 129.05 56.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 110.536 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.0 mt -107.65 108.93 26.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.369 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -95.59 125.4 40.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -0.853 . . . . 0.0 109.913 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -122.4 133.23 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.095 0.95 . . . . 0.0 110.769 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.48 91.59 4.53 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.45 ' CG1' ' CD1' ' A' ' 35' ' ' LEU . 26.0 m -64.54 -23.71 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.018 -1.051 . . . . 0.0 110.892 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 tp10 -67.61 -44.18 78.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.062 -1.024 . . . . 0.0 108.741 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -101.5 8.89 41.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.371 -0.83 . . . . 0.0 110.982 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.4 tttt 51.49 41.47 28.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.909 -1.119 . . . . 0.0 110.42 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.2 p -121.32 169.43 10.6 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.226 -0.921 . . . . 0.0 109.529 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.4 ' CD2' HG23 ' A' ' 100' ' ' ILE . 53.8 p90 -151.24 145.3 25.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.758 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.431 HG22 ' CG1' ' A' ' 43' ' ' VAL . 55.1 t -132.06 135.97 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.453 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 76.4 mt -112.86 123.34 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.758 -1.214 . . . . 0.0 110.533 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -129.32 111.65 13.06 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.472 -0.767 . . . . 0.0 110.797 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -98.34 173.47 27.48 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -76.57 173.28 11.75 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.587 -0.949 . . . . 0.0 109.66 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.81 -22.94 62.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.893 . . . . 0.0 110.815 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.94 -50.6 45.82 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.825 -1.179 . . . . 0.0 110.523 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 2.7 mt -64.25 -46.92 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.886 -1.361 . . . . 0.0 108.655 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -61.37 -37.97 85.3 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.768 -1.207 . . . . 0.0 111.949 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -72.02 -22.12 61.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.684 -1.26 . . . . 0.0 111.832 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 88' ' ' VAL . 7.5 p -102.09 -21.62 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.967 -1.083 . . . . 0.0 113.21 -178.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.48 ' HB ' ' CD2' ' A' ' 92' ' ' PHE . 30.0 m -123.36 166.66 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.641 -1.287 . . . . 0.0 111.367 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 m -112.11 -175.56 2.71 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.271 -0.893 . . . . 0.0 113.165 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -62.44 -39.75 94.36 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.835 . . . . 0.0 110.18 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -61.64 -38.63 88.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.123 -0.985 . . . . 0.0 110.112 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.48 ' CD2' ' HB ' ' A' ' 88' ' ' VAL . 68.8 t80 -65.9 -27.69 68.39 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.204 -0.935 . . . . 0.0 109.123 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.453 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 5.5 m95 -86.72 -27.02 23.93 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.207 1.003 . . . . 0.0 110.278 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -55.99 -42.18 75.94 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.97 -1.081 . . . . 0.0 112.471 -176.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 88.1 m -62.95 -31.99 73.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.809 -1.182 . . . . 0.0 109.037 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.286 8.7 m -58.88 -48.9 79.77 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.688 1.232 . . . . 0.0 110.732 179.686 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.65 -38.46 80.47 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.777 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.411 ' O ' HD22 ' A' ' 102' ' ' LEU . 11.5 m120 -63.95 -42.69 97.23 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.989 -1.084 . . . . 0.0 110.177 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.02 -49.17 78.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.292 -1.505 . . . . 0.0 110.598 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.4 HG23 ' CD2' ' A' ' 76' ' ' PHE . 90.9 mt -67.99 -42.48 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.15 -0.969 . . . . 0.0 110.482 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -63.08 -46.31 88.0 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.009 -1.057 . . . . 0.0 111.889 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.411 HD22 ' O ' ' A' ' 98' ' ' ASN . 3.5 mm? -64.08 -42.38 96.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.991 -1.068 . . . . 0.0 112.298 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.437 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 99.4 mm-40 -71.67 -41.38 68.78 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.923 -1.111 . . . . 0.0 109.017 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -60.15 -40.09 88.65 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.08 -32.99 72.64 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.004 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -81.55 -17.64 47.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.091 -1.006 . . . . 0.0 109.503 177.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.54 11.04 29.88 Favored Glycine 0 N--CA 1.494 2.506 0 O-C-N 121.112 -0.993 . . . . 0.0 110.781 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -108.71 89.47 3.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.829 -1.395 . . . . 0.0 110.781 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -63.48 -44.22 95.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.439 -0.788 . . . . 0.0 111.577 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -62.82 -49.07 76.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.143 -0.973 . . . . 0.0 112.269 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -64.61 -38.67 91.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.054 -1.029 . . . . 0.0 110.055 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.437 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -63.93 -44.12 96.48 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.6 mt -66.81 -44.9 79.97 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.339 -1.095 . . . . 0.0 110.254 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 74.8 t -66.12 -47.13 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.423 -0.798 . . . . 0.0 110.679 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -63.17 -39.09 93.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.009 -1.057 . . . . 0.0 109.248 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.76 -42.28 99.71 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.52 -44.28 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.233 -1.157 . . . . 0.0 110.72 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.51 -48.45 80.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.979 -1.076 . . . . 0.0 109.757 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.99 -40.33 97.44 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.395 -0.816 . . . . 0.0 108.865 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.56 97.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.442 -0.787 . . . . 0.0 110.59 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.81 -42.55 98.47 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 98.2 mtp -65.41 -48.56 72.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -1.17 . . . . 0.0 110.261 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.41 -44.67 95.87 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.538 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.18 -39.61 95.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -0.851 . . . . 0.0 109.237 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.6 -34.5 58.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.066 -1.021 . . . . 0.0 110.123 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -61.88 -43.72 98.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 0.0 109.32 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.435 ' HB3' ' CE2' ' A' ' 128' ' ' PHE . 68.2 m-85 -70.93 -37.44 72.87 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.819 0.819 . . . . 0.0 109.36 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 127' ' ' TYR . 88.1 m-85 -132.5 98.51 16.56 Favored Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.174 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.08 150.85 77.68 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 O-C-N 123.696 1.367 . . . . 0.0 109.706 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.474 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 51.9 t90 -76.1 127.4 32.86 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.418 -0.801 . . . . 0.0 110.817 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -105.17 146.78 28.76 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -56.46 -29.92 62.28 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.214 -0.929 . . . . 0.0 111.087 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -90.85 8.86 32.75 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.099 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -42.94 138.5 2.01 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.19 -0.944 . . . . 0.0 111.187 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.424 HD13 HG21 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -110.92 134.4 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-O 121.995 0.902 . . . . 0.0 111.473 -176.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 41.4 p-10 -116.96 102.48 9.39 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.446 -0.784 . . . . 0.0 110.583 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -102.17 -12.07 18.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.739 -1.226 . . . . 0.0 111.734 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.11 140.97 23.49 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.977 -1.077 . . . . 0.0 110.676 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.2 171.94 14.99 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.349 1.184 . . . . 0.0 109.108 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -112.11 7.21 19.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.715 -1.24 . . . . 0.0 110.617 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -64.06 148.01 50.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.955 -1.091 . . . . 0.0 111.332 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 93.5 mt -76.2 139.61 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.56 -0.713 . . . . 0.0 110.351 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.419 ' OG ' ' NE ' ' A' ' 32' ' ' ARG . 17.6 m -94.09 135.96 34.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.158 -0.964 . . . . 0.0 110.272 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -128.77 140.97 51.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.278 -0.889 . . . . 0.0 110.667 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.974 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.8 m . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.49 -34.9 59.73 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.996 -1.065 . . . . 0.0 109.522 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -60.32 -46.74 88.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.117 -0.99 . . . . 0.0 110.81 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -72.79 -46.98 50.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.985 -1.072 . . . . 0.0 111.775 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.15 -40.71 90.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.983 -1.073 . . . . 0.0 110.021 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -63.84 -42.93 97.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.108 -0.995 . . . . 0.0 110.805 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.05 -42.94 93.78 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.99 -1.068 . . . . 0.0 111.559 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.434 HG21 ' N ' ' A' ' 17' ' ' VAL . 19.4 tt -68.88 -36.86 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.72 -1.238 . . . . 0.0 110.379 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.434 ' N ' HG21 ' A' ' 16' ' ' ILE . 48.4 t -61.26 -42.4 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -61.54 -36.48 80.72 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.507 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.67 -40.75 93.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.419 -0.8 . . . . 0.0 109.26 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.402 HG23 ' CB ' ' A' ' 140' ' ' ASN . 96.2 mt -63.64 -42.56 96.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.345 -0.847 . . . . 0.0 109.348 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -58.64 -42.88 89.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.818 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -64.9 -37.46 87.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.179 -0.951 . . . . 0.0 111.167 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.03 -39.31 93.17 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.779 -1.2 . . . . 0.0 110.522 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.2 -15.94 28.85 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.894 -1.129 . . . . 0.0 110.351 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.478 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.5 mttt -93.2 0.37 57.1 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 120.927 -1.108 . . . . 0.0 109.417 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -112.55 -15.62 13.02 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.714 -1.241 . . . . 0.0 109.816 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.3 t -153.64 157.59 39.85 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.906 -1.121 . . . . 0.0 110.326 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.2 m -85.57 -9.2 57.67 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.326 -0.859 . . . . 0.0 110.193 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.86 172.29 46.54 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 53.6 mp0 -131.18 134.04 46.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.287 -1.125 . . . . 0.0 112.268 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.1 mt -118.9 133.86 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.305 0.574 . . . . 0.0 109.807 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.404 ' CZ ' ' HB2' ' A' ' 143' ' ' SER . 72.4 ttt180 -139.79 152.09 46.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.429 -0.794 . . . . 0.0 110.063 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 83.9 t -122.64 138.77 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.36 -0.838 . . . . 0.0 110.71 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -122.82 132.32 54.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 0.0 108.933 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.438 ' CD1' HG12 ' A' ' 71' ' ' VAL . 32.9 tp -118.07 131.63 56.43 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.024 0.916 . . . . 0.0 111.557 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -150.38 164.88 34.74 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -79.39 -74.74 0.27 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.04 -1.038 . . . . 0.0 113.419 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 t -141.39 160.28 40.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.414 -0.804 . . . . 0.0 110.906 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.421 ' OG ' ' CD ' ' A' ' 46' ' ' ARG . 25.7 m -108.9 168.02 9.66 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.661 -0.649 . . . . 0.0 110.997 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -107.82 -12.0 15.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 110.7 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 42' ' ' ASP . 29.3 pt -123.75 -122.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.984 -1.073 . . . . 0.0 109.321 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.402 ' N ' HG13 ' A' ' 41' ' ' ILE . 96.6 m-20 -110.53 136.33 49.82 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 120.204 -1.56 . . . . 0.0 108.973 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.419 ' CG1' HG22 ' A' ' 77' ' ' VAL . 57.9 t -62.96 -43.49 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.475 -0.766 . . . . 0.0 111.734 -178.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -59.24 -45.1 92.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.999 -1.063 . . . . 0.0 109.952 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -70.23 -37.97 75.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.897 -1.127 . . . . 0.0 108.327 177.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.421 ' CD ' ' OG ' ' A' ' 39' ' ' SER . 44.1 ttt85 -61.3 -41.66 97.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.526 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.4 -37.6 83.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.785 -1.197 . . . . 0.0 110.48 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.4 ttp -64.23 -42.6 96.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.486 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -64.62 -46.83 80.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.902 -1.124 . . . . 0.0 109.841 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.49 -45.67 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.208 -0.932 . . . . 0.0 110.553 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.467 ' CZ ' ' OD1' ' A' ' 81' ' ' ASP . 6.8 t80 -56.84 -47.94 79.21 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.703 -1.248 . . . . 0.0 109.717 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -72.85 -35.88 67.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.995 -1.066 . . . . 0.0 110.088 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -60.47 -39.54 87.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.879 -1.138 . . . . 0.0 109.314 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.1 mt -80.66 4.62 18.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.094 -1.004 . . . . 0.0 110.531 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 57.33 33.72 23.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.843 -1.161 . . . . 0.0 111.134 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.447 ' HE2' ' CE2' ' A' ' 51' ' ' PHE . 79.9 mtp -68.77 -26.8 65.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.117 -0.989 . . . . 0.0 109.374 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 39.2 p-10 -71.27 -8.21 52.11 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.202 -0.936 . . . . 0.0 110.586 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -87.98 82.54 7.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.705 -1.247 . . . . 0.0 110.233 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.7 m -138.1 156.1 48.1 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.17 -46.86 88.24 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.109 -0.994 . . . . 0.0 111.909 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.6 mt -97.71 2.55 49.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.045 -1.035 . . . . 0.0 111.031 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.415 ' O ' ' CB ' ' A' ' 81' ' ' ASP . 86.6 mt-30 55.49 43.67 28.17 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.481 1.134 . . . . 0.0 111.38 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -118.88 55.66 0.92 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.323 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.56 140.61 14.93 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.469 ' CG2' ' CD1' ' A' ' 84' ' ' ILE . 74.3 t -124.68 135.4 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.124 -1.221 . . . . 0.0 110.726 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.421 ' HB2' ' CE ' ' A' ' 56' ' ' MET . 38.8 tp -116.1 126.84 54.28 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.607 -0.683 . . . . 0.0 109.774 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.41 101.0 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 118.901 -1.12 . . . . 0.0 108.992 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -86.97 123.27 31.89 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.384 -0.822 . . . . 0.0 109.973 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.2 t -119.74 129.6 75.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.855 0.836 . . . . 0.0 110.149 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.2 84.81 3.09 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.438 HG12 ' CD1' ' A' ' 35' ' ' LEU . 30.2 m -58.16 -23.13 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.224 -0.923 . . . . 0.0 111.016 -178.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -66.05 -42.45 89.5 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.234 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -102.31 6.69 40.56 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.198 -0.939 . . . . 0.0 111.007 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.8 tttt 52.84 45.89 27.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.822 -1.174 . . . . 0.0 110.983 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 70.1 p -122.76 168.63 11.99 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.237 -0.915 . . . . 0.0 109.625 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 43.7 p90 -146.47 143.18 28.8 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.961 -1.087 . . . . 0.0 111.016 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.419 HG22 ' CG1' ' A' ' 43' ' ' VAL . 51.0 t -128.98 135.72 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.529 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 80.1 mt -114.45 129.44 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.879 -1.138 . . . . 0.0 110.092 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -136.38 114.42 11.42 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.494 -0.754 . . . . 0.0 110.877 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -101.14 174.82 25.54 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.467 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 32.6 m-20 -79.04 176.01 10.06 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.474 -1.015 . . . . 0.0 110.858 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.57 -27.38 68.59 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.366 -0.834 . . . . 0.0 109.453 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.66 -53.01 41.27 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.953 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.469 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 93.5 mt -65.08 -44.07 95.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.743 -1.445 . . . . 0.0 108.659 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -61.77 -37.1 83.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.626 -1.296 . . . . 0.0 110.698 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -73.34 -21.1 60.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.963 . . . . 0.0 112.19 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.7 m -107.19 -19.83 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.809 -1.182 . . . . 0.0 112.926 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.474 ' HB ' ' CD2' ' A' ' 92' ' ' PHE . 16.4 m -119.95 162.79 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.693 -1.254 . . . . 0.0 111.309 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 m -108.54 173.64 6.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.475 -0.766 . . . . 0.0 111.965 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -61.82 -37.24 83.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 110.1 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 34.1 p-10 -61.69 -36.41 80.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 109.244 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.474 ' CD2' ' HB ' ' A' ' 88' ' ' VAL . 73.1 t80 -66.73 -25.52 66.56 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.302 -0.874 . . . . 0.0 108.773 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.529 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 3.8 m95 -86.04 -26.19 25.5 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.852 0.834 . . . . 0.0 110.542 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -55.37 -38.99 69.56 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.996 -1.065 . . . . 0.0 112.963 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.4 m -63.22 -35.33 79.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.815 -1.178 . . . . 0.0 109.099 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.283 16.0 m -58.09 -48.5 79.98 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.334 1.064 . . . . 0.0 111.255 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.69 -38.22 83.37 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.518 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.421 ' O ' ' CD1' ' A' ' 102' ' ' LEU . 21.1 m120 -64.69 -45.12 87.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.988 -1.07 . . . . 0.0 111.015 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.17 -49.91 76.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.712 -1.242 . . . . 0.0 110.448 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.441 HG23 ' CD1' ' A' ' 104' ' ' PHE . 95.5 mt -68.39 -43.26 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.223 -0.923 . . . . 0.0 111.075 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -62.42 -45.12 94.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.905 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.434 HD11 ' N ' ' A' ' 102' ' ' LEU . 7.0 mp -63.85 -41.46 97.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.325 -0.859 . . . . 0.0 111.561 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.425 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 98.7 mm-40 -73.01 -41.78 63.91 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.714 -1.194 . . . . 0.0 108.756 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.441 ' CD1' HG23 ' A' ' 100' ' ' ILE . 3.6 m-85 -58.72 -38.07 77.53 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -61.46 -34.06 74.8 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.681 -0.637 . . . . 0.0 109.946 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -80.7 -17.59 50.6 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.814 -1.179 . . . . 0.0 110.511 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.75 7.18 42.39 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.678 -1.249 . . . . 0.0 111.167 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -103.99 90.99 3.78 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.773 -1.428 . . . . 0.0 110.259 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -63.1 -40.05 96.5 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.553 -0.717 . . . . 0.0 111.47 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -65.75 -49.52 68.1 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.243 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -64.29 -39.39 93.82 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.956 -1.097 . . . . 0.0 110.527 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.425 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -62.72 -48.07 84.18 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.8 mt -64.41 -43.2 95.13 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.301 -1.117 . . . . 0.0 109.912 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.4 t -64.81 -48.34 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -0.931 . . . . 0.0 110.509 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -64.66 -39.84 94.38 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.348 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.26 -43.62 99.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 89.2 mt -64.51 -43.56 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.064 -1.256 . . . . 0.0 109.806 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.95 -52.87 62.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.134 -0.979 . . . . 0.0 109.992 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.42 -43.05 99.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 108.664 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -53.81 -46.16 71.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.485 -0.76 . . . . 0.0 109.71 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.67 -43.15 99.4 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.421 ' HG2' ' NZ ' ' A' ' 126' ' ' LYS . 27.4 ttt -67.17 -48.91 66.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.895 -1.356 . . . . 0.0 109.669 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.408 ' CB ' ' CE1' ' A' ' 92' ' ' PHE . . . -62.09 -45.94 91.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.935 . . . . 0.0 109.37 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 77.2 mt -61.86 -40.13 94.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.194 -0.941 . . . . 0.0 108.611 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.08 -33.94 63.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.195 -0.941 . . . . 0.0 110.411 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.421 ' NZ ' ' HG2' ' A' ' 122' ' ' MET . 60.9 mttp -61.83 -43.43 98.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.056 -1.028 . . . . 0.0 108.818 178.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.419 ' CE2' HG12 ' A' ' 88' ' ' VAL . 52.5 m-85 -75.1 -39.78 60.45 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.61 0.719 . . . . 0.0 110.071 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -130.65 90.66 39.85 Favored Pre-proline 0 C--N 1.301 -1.518 0 O-C-N 121.706 -0.621 . . . . 0.0 109.426 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -64.78 154.42 72.79 Favored 'Trans proline' 0 C--N 1.318 -1.035 0 O-C-N 123.588 1.309 . . . . 0.0 110.483 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.478 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 31.2 t90 -77.6 133.34 38.47 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.441 0.639 . . . . 0.0 111.962 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -114.6 150.85 34.42 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -58.35 -31.74 67.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.096 -1.003 . . . . 0.0 111.842 -177.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -90.99 6.09 46.17 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.963 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 135' ' ' ILE . 66.9 t0 -42.59 140.07 1.37 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 122.038 0.923 . . . . 0.0 111.667 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.433 ' CD1' ' O ' ' A' ' 135' ' ' ILE . 1.1 pp -113.42 148.53 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-O 121.857 0.837 . . . . 0.0 111.662 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -105.68 96.65 6.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.465 -1.397 . . . . 0.0 110.036 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -68.15 -37.14 80.72 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.593 -0.692 . . . . 0.0 112.838 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.0 mt -109.3 148.45 38.04 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.987 -1.071 . . . . 0.0 111.828 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.39 -176.76 1.77 Allowed 'Trans proline' 0 C--N 1.319 -0.993 0 N-CA-C 108.359 -1.439 . . . . 0.0 108.359 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.402 ' CB ' HG23 ' A' ' 20' ' ' ILE . 12.6 p30 -116.87 4.35 12.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.587 -1.321 . . . . 0.0 110.204 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.8 p -63.29 169.1 3.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.899 -1.126 . . . . 0.0 110.771 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.0 mt -101.39 139.66 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.581 0.705 . . . . 0.0 110.947 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 32' ' ' ARG . 30.6 t -94.91 134.24 37.77 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.533 -0.729 . . . . 0.0 109.241 178.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -125.74 132.91 52.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.188 -0.945 . . . . 0.0 110.045 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.869 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.61 -37.05 67.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.121 -0.987 . . . . 0.0 110.086 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -57.72 -45.95 85.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.909 . . . . 0.0 109.868 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.16 -43.88 73.38 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.599 -0.688 . . . . 0.0 112.031 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.412 ' OE1' ' CD1' ' A' ' 142' ' ' ILE . 79.8 mm-40 -65.4 -39.18 91.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.954 -1.091 . . . . 0.0 110.917 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -63.33 -43.18 98.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.808 -1.182 . . . . 0.0 111.113 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.11 -45.55 84.67 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.077 -1.014 . . . . 0.0 112.108 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 17' ' ' VAL . 19.6 tt -65.49 -37.43 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.696 -1.252 . . . . 0.0 110.507 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.425 ' N ' HG23 ' A' ' 16' ' ' ILE . 75.6 t -61.58 -39.1 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -0.953 . . . . 0.0 108.799 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -62.05 -36.31 81.25 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.072 -1.051 . . . . 0.0 108.885 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.09 -37.96 87.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.466 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.475 HG23 HD13 ' A' ' 20' ' ' ILE . 37.5 mm -63.72 -43.66 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.294 -0.879 . . . . 0.0 110.083 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.424 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 83.9 mtp180 -60.18 -41.59 93.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.347 -0.846 . . . . 0.0 110.556 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -65.08 -38.06 89.55 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.49 -0.756 . . . . 0.0 111.2 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.59 -39.53 93.9 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.938 -1.101 . . . . 0.0 110.165 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.63 -13.72 16.11 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.936 -1.103 . . . . 0.0 110.971 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.482 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.1 mttt -96.52 1.84 51.83 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.914 -1.116 . . . . 0.0 109.513 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -112.9 -18.04 12.34 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.04 -1.037 . . . . 0.0 109.775 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.2 t -151.43 158.33 43.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.959 . . . . 0.0 109.815 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 95.8 p -86.76 -7.57 58.15 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.269 -0.895 . . . . 0.0 109.667 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.38 172.11 52.42 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.439 ' CG ' ' HB2' ' A' ' 138' ' ' LEU . 79.6 mm-40 -133.72 139.56 46.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.254 -1.145 . . . . 0.0 111.891 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.6 mt -121.89 135.27 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 143' ' ' SER . 77.1 ttt180 -140.05 155.17 47.17 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 109.39 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.0 t -120.96 136.74 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.091 -1.006 . . . . 0.0 110.555 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -121.49 121.71 38.11 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.414 HD11 ' CG1' ' A' ' 71' ' ' VAL . 32.3 tp -111.87 125.93 54.55 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.732 0.777 . . . . 0.0 111.725 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.418 ' OE2' ' CZ ' ' A' ' 46' ' ' ARG . 82.5 tt0 -140.64 166.22 25.33 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.44 ' HB3' ' CG ' ' A' ' 72' ' ' GLU . 99.4 mttt -78.21 -76.05 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 112.327 -177.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.8 t -139.94 154.9 47.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 109.759 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.429 ' HA ' ' NH1' ' A' ' 46' ' ' ARG . 12.7 p -103.49 167.23 9.94 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.382 -0.824 . . . . 0.0 110.225 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -104.23 -8.35 19.41 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.372 -0.83 . . . . 0.0 110.041 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.4 pt -128.22 -122.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.046 -1.034 . . . . 0.0 109.493 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -110.29 138.75 46.25 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 120.309 -1.494 . . . . 0.0 109.509 178.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.2 t -63.18 -43.25 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 110.676 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -59.56 -47.11 86.83 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.02 -1.05 . . . . 0.0 110.743 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -70.15 -39.79 75.15 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.73 -1.232 . . . . 0.0 108.269 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.429 ' NH1' ' HA ' ' A' ' 39' ' ' SER . 73.1 ttt180 -61.12 -43.48 98.82 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.35 -0.844 . . . . 0.0 110.846 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.95 -40.47 91.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.702 -1.249 . . . . 0.0 110.368 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 46.7 ttp -62.34 -42.72 99.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.014 -1.054 . . . . 0.0 109.433 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -63.62 -42.06 98.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.037 -1.039 . . . . 0.0 109.081 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 82.9 t -66.58 -43.44 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.572 -0.705 . . . . 0.0 110.304 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -59.89 -45.93 90.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.779 -1.201 . . . . 0.0 109.77 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -73.86 -35.95 64.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.949 -1.094 . . . . 0.0 109.889 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -61.57 -39.48 91.3 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.014 -1.054 . . . . 0.0 110.196 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.6 mt -81.14 4.15 21.05 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.043 -1.036 . . . . 0.0 110.58 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 55.79 31.5 17.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.096 -1.002 . . . . 0.0 111.65 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 92.1 mtp -66.55 -19.04 65.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.161 -0.962 . . . . 0.0 109.671 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -74.89 -4.97 41.1 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.096 -1.002 . . . . 0.0 111.288 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -45.96 -32.79 2.92 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.042 -1.036 . . . . 0.0 110.621 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.447 ' CG2' ' HA ' ' A' ' 62' ' ' GLN . 9.0 t -40.61 144.86 0.21 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.505 1.145 . . . . 0.0 113.009 -176.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -68.16 -40.4 82.33 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.465 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 72.8 mt -92.2 -0.92 57.4 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.143 -0.973 . . . . 0.0 111.178 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.447 ' HA ' ' CG2' ' A' ' 59' ' ' THR . 88.3 mt-30 57.69 36.85 27.04 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.348 1.071 . . . . 0.0 110.45 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.408 ' HA ' HG13 ' A' ' 84' ' ' ILE . 97.8 m-20 -113.1 48.56 1.02 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.383 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.6 144.17 17.07 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 52.8 t -124.54 134.72 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.993 -1.298 . . . . 0.0 110.5 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 45.5 tp -116.79 125.6 51.85 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.387 -0.821 . . . . 0.0 109.738 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 89.9 mt -100.57 105.0 16.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 118.945 -1.102 . . . . 0.0 109.412 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -91.74 124.68 36.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.892 . . . . 0.0 110.327 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.9 t -123.95 132.3 71.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 122.059 0.933 . . . . 0.0 111.151 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.67 99.99 10.01 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.414 ' CG1' HD11 ' A' ' 35' ' ' LEU . 33.5 m -70.19 -18.95 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.027 -1.046 . . . . 0.0 110.781 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.44 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 80.4 mm-40 -71.11 -49.0 49.0 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.86 -1.15 . . . . 0.0 109.428 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -98.65 5.1 47.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.884 . . . . 0.0 110.293 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 72.1 tttt 53.72 43.51 30.96 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.019 -1.051 . . . . 0.0 110.16 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.2 m -119.15 132.24 55.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.324 -0.86 . . . . 0.0 109.952 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -116.08 136.59 52.89 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.445 -0.784 . . . . 0.0 110.051 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.4 t -126.41 137.54 57.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.46 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 77.2 mt -111.55 125.85 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.977 -1.077 . . . . 0.0 110.411 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -128.84 114.4 16.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.504 -0.748 . . . . 0.0 110.25 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.46 165.72 19.38 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 108.961 -1.655 . . . . 0.0 108.961 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 49.7 t0 -74.75 174.73 8.74 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.591 -0.946 . . . . 0.0 109.311 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -59.42 -22.77 61.94 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.052 -1.03 . . . . 0.0 111.186 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 62' ' ' GLN . . . -68.64 -50.9 33.62 Favored Glycine 0 N--CA 1.497 2.714 0 C-N-CA 119.737 -1.221 . . . . 0.0 110.939 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.444 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 3.5 mt -63.01 -44.7 99.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.865 -1.373 . . . . 0.0 107.393 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -63.16 -36.4 83.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.921 -1.112 . . . . 0.0 112.134 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -74.33 -20.93 59.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.627 -1.295 . . . . 0.0 112.311 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.0 m -105.78 -18.91 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.873 -1.142 . . . . 0.0 112.112 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.481 ' HB ' ' CD2' ' A' ' 92' ' ' PHE . 15.9 m -120.76 163.34 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.692 -1.255 . . . . 0.0 111.262 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.3 m -111.0 -176.67 3.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -0.859 . . . . 0.0 111.806 -178.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -62.81 -37.54 87.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.982 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -60.96 -39.51 89.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.201 -0.937 . . . . 0.0 109.398 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.481 ' CD2' ' HB ' ' A' ' 88' ' ' VAL . 83.3 t80 -66.34 -26.49 67.31 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.168 -0.958 . . . . 0.0 109.679 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.471 ' CD1' HG21 ' A' ' 88' ' ' VAL . 5.1 m95 -86.32 -25.22 25.54 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.042 0.925 . . . . 0.0 110.615 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -57.29 -41.16 79.25 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 112.837 -176.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.8 p -64.02 -30.06 71.16 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.572 -1.251 . . . . 0.0 109.118 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.261 16.4 m -60.1 -48.72 80.56 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.297 1.046 . . . . 0.0 110.962 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.59 -36.84 73.77 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.146 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -63.44 -43.27 97.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.828 -1.17 . . . . 0.0 110.129 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.11 -49.91 70.33 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.808 -1.182 . . . . 0.0 111.362 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.67 -42.55 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.003 -1.061 . . . . 0.0 110.426 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -63.89 -42.3 97.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.42 -0.8 . . . . 0.0 110.585 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 61.7 tp -63.57 -43.11 97.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 111.209 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.451 ' HG2' ' N ' ' A' ' 112' ' ' GLY . 5.7 tp60 -74.0 -42.22 60.7 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 118.757 -1.177 . . . . 0.0 108.928 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -59.38 -41.17 88.73 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.11 -31.22 71.65 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.999 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.7 tp60 -80.87 -19.73 43.84 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.168 -0.957 . . . . 0.0 109.411 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.24 1.27 33.43 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.008 -1.091 . . . . 0.0 110.847 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -104.13 91.15 3.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.706 -1.467 . . . . 0.0 110.862 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -65.32 -39.75 92.84 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.537 -0.727 . . . . 0.0 111.185 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -64.06 -49.17 73.36 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.771 -1.205 . . . . 0.0 111.793 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -63.34 -38.99 93.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.875 -1.141 . . . . 0.0 110.254 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.451 ' N ' ' HG2' ' A' ' 103' ' ' GLN . . . -63.19 -45.56 95.04 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 78.0 mt -64.72 -44.71 89.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.434 -1.039 . . . . 0.0 111.153 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 77.6 t -67.01 -46.61 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.769 -1.207 . . . . 0.0 110.714 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -65.04 -43.85 91.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.099 -1.001 . . . . 0.0 110.933 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.23 -40.95 94.58 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.2 -43.48 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.312 -1.111 . . . . 0.0 110.136 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -56.68 -49.07 76.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.984 . . . . 0.0 109.626 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.54 -42.17 98.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -0.984 . . . . 0.0 109.436 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.33 -38.35 80.1 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.193 -0.942 . . . . 0.0 109.567 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.44 -46.5 69.62 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 75.9 mtm -67.16 -43.71 81.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.909 -1.348 . . . . 0.0 109.694 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.423 ' HB2' ' CE1' ' A' ' 92' ' ' PHE . . . -65.23 -45.93 82.65 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.324 -0.95 . . . . 0.0 109.008 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.2 mt -62.06 -40.56 96.19 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.38 -34.09 64.02 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.387 -0.82 . . . . 0.0 110.641 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -62.15 -41.41 98.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.969 -1.082 . . . . 0.0 109.111 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -72.39 -41.08 66.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.581 -0.699 . . . . 0.0 109.935 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -130.68 99.87 18.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.984 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.48 150.39 75.37 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.586 1.308 . . . . 0.0 109.8 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.482 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 48.5 t90 -74.83 136.03 41.6 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.53 -0.731 . . . . 0.0 111.306 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -113.28 151.93 30.49 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.301 -0.875 . . . . 0.0 109.127 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.91 -30.68 69.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.204 -0.935 . . . . 0.0 111.175 -177.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -91.25 7.57 40.14 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.899 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.468 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 67.0 t0 -43.54 141.56 1.4 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.404 -0.81 . . . . 0.0 111.551 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.434 ' CD1' ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -114.31 146.02 19.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-O 121.697 0.76 . . . . 0.0 111.196 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 42.9 p-10 -98.56 92.62 5.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.595 -1.316 . . . . 0.0 110.66 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -68.45 -36.12 78.56 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.183 -0.948 . . . . 0.0 111.88 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.439 ' HB2' ' CG ' ' A' ' 30' ' ' GLU . 3.8 mm? -109.74 145.74 32.62 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.086 -1.009 . . . . 0.0 111.546 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.37 -167.85 0.35 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 N-CA-C 108.065 -1.552 . . . . 0.0 108.065 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.424 ' ND2' ' HG2' ' A' ' 21' ' ' ARG . 13.9 p30 -122.91 4.29 9.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.761 -1.212 . . . . 0.0 110.156 178.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.1 m -61.76 168.52 2.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.101 -0.999 . . . . 0.0 110.26 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.412 ' CD1' ' OE1' ' A' ' 13' ' ' GLU . 93.9 mt -103.68 140.42 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.43 -0.793 . . . . 0.0 110.537 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 32' ' ' ARG . 32.1 t -94.37 136.53 34.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.194 -0.941 . . . . 0.0 109.708 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -127.57 137.31 52.56 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.3 -0.875 . . . . 0.0 110.426 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 CA-C-O 118.002 -1.443 . . . . 0.0 109.668 -179.815 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.134 0.492 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.418 ' HB3' ' HE2' ' A' ' 14' ' ' LYS . . . -54.75 -37.44 65.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.107 -0.995 . . . . 0.0 109.455 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -57.68 -43.48 85.08 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.437 -0.79 . . . . 0.0 109.611 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 96.4 mt-10 -72.43 -45.44 59.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.357 -0.84 . . . . 0.0 111.634 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.04 -38.51 91.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.005 -1.059 . . . . 0.0 110.127 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' A' ' 10' ' ' ALA . 68.1 mttm -64.4 -45.32 88.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.059 -1.025 . . . . 0.0 111.132 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.27 -41.56 96.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.129 -0.982 . . . . 0.0 111.114 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 17' ' ' VAL . 21.2 tt -68.76 -33.86 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.986 -1.071 . . . . 0.0 110.104 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.435 ' N ' HG22 ' A' ' 16' ' ' ILE . 76.0 t -65.48 -40.21 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.148 -0.97 . . . . 0.0 108.439 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -61.67 -36.91 82.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.975 . . . . 0.0 109.085 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.6 91.15 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.232 -0.918 . . . . 0.0 109.352 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.8 mm -63.18 -43.44 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.185 -0.947 . . . . 0.0 109.386 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.418 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 93.4 mtt-85 -59.72 -43.88 93.96 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.55 -0.719 . . . . 0.0 110.216 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -63.41 -38.94 93.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.871 . . . . 0.0 110.94 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.65 -39.63 94.82 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.255 -0.903 . . . . 0.0 110.662 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -59.93 -15.42 21.66 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.906 -1.122 . . . . 0.0 110.508 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 74.5 mmtt -96.18 1.01 51.93 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.976 -1.078 . . . . 0.0 109.386 178.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -114.35 -14.0 12.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.74 -1.225 . . . . 0.0 109.769 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.1 t -153.92 159.1 41.59 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.63 -1.294 . . . . 0.0 109.462 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.5 m -88.25 -9.32 53.33 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.255 -0.903 . . . . 0.0 109.75 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.79 172.43 43.19 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.418 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 53.3 mp0 -132.27 140.3 48.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.269 -1.136 . . . . 0.0 111.31 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.2 mt -124.97 136.83 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.764 -0.585 . . . . 0.0 110.518 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.41 ' NH1' ' HD2' ' A' ' 139' ' ' PRO . 95.1 mtt-85 -138.82 154.87 48.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.211 -0.931 . . . . 0.0 110.144 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.4 t -125.87 136.31 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.54 0.686 . . . . 0.0 109.693 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -121.04 118.98 31.2 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.571 -0.705 . . . . 0.0 109.279 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.417 HD12 ' CG1' ' A' ' 71' ' ' VAL . 30.6 tp -106.49 129.88 54.38 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.778 0.799 . . . . 0.0 111.175 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -147.57 167.58 24.17 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.432 ' HB3' ' CG ' ' A' ' 72' ' ' GLU . 99.4 mttt -80.83 -77.01 0.21 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.955 -1.091 . . . . 0.0 112.626 -177.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.422 ' OG1' ' CB ' ' A' ' 72' ' ' GLU . 43.7 m -140.85 159.5 42.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.444 -0.785 . . . . 0.0 109.669 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.7 m -114.0 175.64 5.38 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.257 -0.902 . . . . 0.0 110.393 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -107.43 -10.83 15.65 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.13 -0.981 . . . . 0.0 110.755 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.8 pt -124.23 -121.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.1 -1.0 . . . . 0.0 110.195 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -112.38 140.81 46.79 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.045 -1.66 . . . . 0.0 109.476 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.432 HG13 ' CG2' ' A' ' 77' ' ' VAL . 99.0 t -63.98 -42.42 95.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.512 -0.743 . . . . 0.0 110.525 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -58.76 -46.11 88.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.053 -1.029 . . . . 0.0 109.634 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -68.94 -38.62 79.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.806 -1.184 . . . . 0.0 108.394 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -62.79 -36.88 84.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -0.948 . . . . 0.0 110.106 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.77 -39.65 73.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.884 -1.135 . . . . 0.0 109.904 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 66.1 ttp -65.71 -44.16 86.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.099 -1.0 . . . . 0.0 109.969 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -63.46 -43.5 97.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.099 . . . . 0.0 109.386 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.58 -42.61 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.38 -0.825 . . . . 0.0 109.69 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.489 ' CE2' ' HB3' ' A' ' 57' ' ' ASP . 53.2 t80 -58.89 -46.03 88.85 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.04 -1.038 . . . . 0.0 109.705 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -75.57 -35.82 60.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.895 -1.128 . . . . 0.0 109.682 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -61.44 -39.74 91.92 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.201 -0.937 . . . . 0.0 109.795 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.428 HD12 ' CE ' ' A' ' 56' ' ' MET . 97.1 mt -84.18 4.54 30.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.503 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt 56.84 31.42 19.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.077 -1.014 . . . . 0.0 110.953 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.428 ' CE ' HD12 ' A' ' 54' ' ' LEU . 58.6 mtt -72.03 -27.93 63.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.316 -0.865 . . . . 0.0 109.407 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.489 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . 45.6 p-10 -69.0 -9.92 54.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.434 -0.791 . . . . 0.0 109.968 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -86.04 88.02 7.51 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.733 -1.187 . . . . 0.0 110.723 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 67.0 p -137.48 154.97 49.81 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -59.44 -45.26 92.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.49 -0.756 . . . . 0.0 111.881 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.5 mt -98.34 2.86 48.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.985 -1.072 . . . . 0.0 111.606 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 57.46 32.18 21.39 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 122.122 0.963 . . . . 0.0 111.942 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.401 ' HA ' HG13 ' A' ' 84' ' ' ILE . 97.8 m-20 -110.41 54.59 0.67 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.723 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.66 141.99 15.75 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.0 t -122.41 133.1 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.992 -1.299 . . . . 0.0 109.841 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.1 tp -118.39 130.9 56.25 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.374 -0.829 . . . . 0.0 110.471 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.7 mt -110.24 115.16 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 118.982 -1.087 . . . . 0.0 109.688 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -101.49 124.8 47.76 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.079 -1.013 . . . . 0.0 110.005 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.0 t -123.44 130.54 74.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.924 0.868 . . . . 0.0 111.621 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.406 ' CB ' HG21 ' A' ' 75' ' ' THR . . . -98.62 90.29 4.68 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.417 ' CG1' HD12 ' A' ' 35' ' ' LEU . 32.6 m -59.52 -22.86 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.99 -1.069 . . . . 0.0 111.148 -177.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.432 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 79.0 mm-40 -66.17 -42.32 89.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.789 -1.194 . . . . 0.0 109.061 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -101.12 4.97 42.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.437 -0.789 . . . . 0.0 110.655 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.6 tttt 54.99 46.85 23.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.656 -1.277 . . . . 0.0 110.703 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.406 HG21 ' CB ' ' A' ' 70' ' ' ALA . 10.0 t -122.67 162.54 21.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.44 -0.788 . . . . 0.0 109.636 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -143.7 139.42 29.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 110.001 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.432 ' CG2' HG13 ' A' ' 43' ' ' VAL . 60.3 t -129.2 139.81 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 108.93 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.501 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 81.7 mt -116.55 127.25 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.738 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -127.84 115.88 19.3 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.475 0.655 . . . . 0.0 109.862 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.84 161.57 16.61 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 82' ' ' LYS . 39.3 t0 -73.62 169.62 16.91 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.65 -0.912 . . . . 0.0 110.034 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.402 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 99.2 mttt -55.1 -28.04 49.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 109.976 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.36 -49.87 67.01 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.427 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 3.9 mt -66.35 -45.06 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.883 -1.363 . . . . 0.0 108.321 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -64.08 -35.83 82.01 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.925 -1.109 . . . . 0.0 111.53 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -77.76 -20.04 54.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.809 -1.182 . . . . 0.0 111.875 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 84' ' ' ILE . 7.6 p -102.55 -27.87 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.713 -1.242 . . . . 0.0 112.55 -178.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.481 ' HB ' ' CD2' ' A' ' 92' ' ' PHE . 19.2 m -116.65 166.52 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.582 -1.324 . . . . 0.0 111.143 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.2 m -110.62 179.25 4.12 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.215 -0.928 . . . . 0.0 112.405 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -60.95 -37.12 81.25 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.344 -0.847 . . . . 0.0 109.161 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -62.67 -36.83 84.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.417 -0.802 . . . . 0.0 109.701 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.481 ' CD2' ' HB ' ' A' ' 88' ' ' VAL . 87.6 t80 -69.8 -24.16 63.44 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.002 -1.061 . . . . 0.0 109.173 177.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.501 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 4.6 m95 -86.57 -25.99 24.71 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.066 0.936 . . . . 0.0 110.68 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -59.2 -36.17 74.91 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 112.379 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.5 m -66.03 -34.42 78.06 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.729 -1.232 . . . . 0.0 109.222 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' CD1' ' A' ' 78' ' ' ILE 0.288 20.6 m -57.87 -48.9 78.49 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 122.418 1.104 . . . . 0.0 111.095 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.58 -37.69 77.07 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.413 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -63.06 -43.93 97.23 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.749 -1.18 . . . . 0.0 110.028 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.68 -48.9 77.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.879 -1.138 . . . . 0.0 110.91 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.03 -42.26 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.971 . . . . 0.0 110.177 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.438 ' CG ' ' HE3' ' A' ' 105' ' ' LYS . 51.7 tt0 -63.55 -43.62 96.53 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.272 -0.893 . . . . 0.0 110.865 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.8 tp -63.09 -41.72 99.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.088 -1.008 . . . . 0.0 112.088 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.432 ' HG2' ' CB ' ' A' ' 111' ' ' GLN . 6.3 tp60 -75.17 -37.34 61.31 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.821 -1.151 . . . . 0.0 108.942 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -62.26 -42.02 98.97 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.602 0.715 . . . . 0.0 109.135 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.438 ' HE3' ' CG ' ' A' ' 101' ' ' GLN . 93.8 mttt -60.58 -34.8 74.72 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.342 -0.849 . . . . 0.0 109.915 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -76.44 -21.06 56.4 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.939 -1.1 . . . . 0.0 110.124 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.19 2.48 35.87 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.595 -1.288 . . . . 0.0 111.578 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -102.25 92.55 4.77 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.59 -1.535 . . . . 0.0 110.176 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -62.54 -42.91 99.83 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.859 -0.525 . . . . 0.0 111.942 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.434 ' NZ ' ' HA ' ' A' ' 12' ' ' GLU . 86.3 tttt -62.51 -48.07 81.18 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.916 -177.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.432 ' CB ' ' HG2' ' A' ' 103' ' ' GLN . 96.6 mm-40 -64.32 -39.74 94.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.944 -1.098 . . . . 0.0 110.69 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.429 ' N ' ' HG2' ' A' ' 103' ' ' GLN . . . -62.89 -49.48 72.08 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 68.1 mt -62.92 -44.24 96.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.129 -1.218 . . . . 0.0 110.673 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 95.9 t -65.86 -47.53 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.231 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -64.23 -40.13 95.41 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.316 -0.954 . . . . 0.0 109.808 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.5 -42.79 99.21 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.42 -44.73 94.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.375 -1.073 . . . . 0.0 109.992 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -56.84 -50.35 72.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.877 -1.139 . . . . 0.0 109.166 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.93 -42.13 99.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.257 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.72 -39.95 82.31 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.181 -0.949 . . . . 0.0 109.298 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.34 -44.99 89.41 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 90.3 mtp -67.59 -45.82 74.4 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.019 -1.283 . . . . 0.0 110.254 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.477 ' HB2' ' CE1' ' A' ' 92' ' ' PHE . . . -63.83 -45.03 91.41 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.154 -0.966 . . . . 0.0 108.973 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.18 -37.8 88.65 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.272 -0.893 . . . . 0.0 109.108 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.28 -35.1 64.69 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.985 -1.072 . . . . 0.0 110.635 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.45 -42.97 97.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.931 -1.106 . . . . 0.0 108.391 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -74.16 -41.27 61.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.67 -0.644 . . . . 0.0 110.723 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -128.96 91.53 42.46 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.543 -0.723 . . . . 0.0 109.28 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.62 152.59 81.3 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 O-C-N 123.694 1.365 . . . . 0.0 109.953 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 28.1 t90 -79.56 139.7 37.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.592 -0.693 . . . . 0.0 111.959 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -120.71 155.35 34.08 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -61.36 -34.83 75.96 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.282 -0.887 . . . . 0.0 111.207 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -87.03 6.55 31.85 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.672 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.476 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 67.2 t0 -41.81 138.1 1.55 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.27 -0.894 . . . . 0.0 111.126 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.434 ' CD1' ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -110.64 140.55 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 122.184 0.992 . . . . 0.0 112.069 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -119.38 102.14 8.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.759 -1.213 . . . . 0.0 109.471 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -99.88 0.75 41.99 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.758 -1.214 . . . . 0.0 111.668 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.2 mp -110.33 151.32 42.57 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 120.769 -1.207 . . . . 0.0 111.424 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.41 ' HD2' ' NH1' ' A' ' 32' ' ' ARG . 55.2 Cg_endo -74.73 170.55 20.09 Favored 'Trans proline' 0 C--N 1.322 -0.823 0 O-C-N 123.632 1.333 . . . . 0.0 109.197 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.418 ' ND2' ' HG2' ' A' ' 21' ' ' ARG . 79.6 m-20 -113.46 4.87 16.46 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.873 -1.142 . . . . 0.0 110.631 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.6 p -68.32 166.33 16.77 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.79 -1.194 . . . . 0.0 111.836 -178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.4 mt -87.41 137.8 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 121.733 0.778 . . . . 0.0 110.914 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.4 m -88.77 133.38 34.26 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -128.07 149.19 50.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.82 -1.175 . . . . 0.0 111.094 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.59 0 CA-C-O 118.045 -1.42 . . . . 0.0 110.045 -179.576 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.402 HG23 ' HB3' ' A' ' 11' ' ' GLU . 13.0 t . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 121.071 0.462 . . . . 0.0 109.771 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.93 -39.49 68.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.075 -1.015 . . . . 0.0 109.946 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.402 ' HB3' HG23 ' A' ' 9' ' ' THR . 83.9 tt0 -61.35 -47.38 86.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.071 -1.018 . . . . 0.0 110.751 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.416 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 98.9 mt-10 -70.1 -49.26 52.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 111.709 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -61.22 -33.61 73.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.915 -1.116 . . . . 0.0 109.921 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.85 -46.03 86.82 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.223 -0.923 . . . . 0.0 110.995 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.76 -41.11 92.48 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.127 -0.983 . . . . 0.0 112.336 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.436 HG23 ' N ' ' A' ' 17' ' ' VAL . 18.9 tt -66.96 -37.82 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.653 -1.279 . . . . 0.0 110.626 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.436 ' N ' HG23 ' A' ' 16' ' ' ILE . 70.7 t -63.34 -40.67 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.91 -1.119 . . . . 0.0 108.849 178.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -62.03 -37.25 84.19 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.377 -0.929 . . . . 0.0 109.559 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.24 -39.43 90.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 109.59 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.412 ' CD1' HD12 ' A' ' 117' ' ' ILE . 46.8 mm -64.21 -45.77 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.484 -0.76 . . . . 0.0 110.456 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -55.35 -42.28 73.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.215 -0.928 . . . . 0.0 110.14 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -63.94 -37.86 88.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.651 -0.656 . . . . 0.0 111.093 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.06 95.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.945 -1.097 . . . . 0.0 110.335 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -60.55 -16.08 33.97 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.948 -1.095 . . . . 0.0 110.726 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.0 mttt -94.87 1.09 55.3 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.157 -0.964 . . . . 0.0 109.735 177.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -113.26 -18.26 12.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.018 -1.051 . . . . 0.0 109.689 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.2 t -150.33 157.07 42.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.079 -1.013 . . . . 0.0 109.243 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 97.5 p -87.48 -10.13 52.68 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.374 -0.829 . . . . 0.0 109.538 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.71 174.11 39.96 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.411 ' CB ' HD13 ' A' ' 138' ' ' LEU . 80.3 mm-40 -132.7 136.68 46.56 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.334 -1.098 . . . . 0.0 111.613 -178.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.1 mt -119.53 133.74 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.733 -0.604 . . . . 0.0 109.993 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.2 mtp85 -138.49 149.78 45.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.053 -1.029 . . . . 0.0 110.155 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.8 t -123.89 138.26 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.681 -0.637 . . . . 0.0 110.478 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -122.87 125.0 44.54 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.512 -0.743 . . . . 0.0 109.607 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.461 ' CD1' ' CG1' ' A' ' 71' ' ' VAL . 35.2 tp -111.65 129.02 56.23 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.766 0.793 . . . . 0.0 112.131 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -146.2 167.1 24.3 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.405 ' HA ' HG22 ' A' ' 71' ' ' VAL . 98.3 mttt -79.82 -76.46 0.22 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.102 -0.999 . . . . 0.0 112.567 -177.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.8 t -138.18 154.3 49.15 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.298 -0.876 . . . . 0.0 110.24 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.2 p -100.26 169.86 8.84 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.375 -0.828 . . . . 0.0 110.532 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -106.79 -10.07 16.19 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.588 -0.695 . . . . 0.0 110.478 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.6 pt -129.93 -121.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.878 -1.139 . . . . 0.0 109.945 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -111.77 142.66 43.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.136 -1.603 . . . . 0.0 110.0 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 82.0 t -66.45 -44.53 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.46 -0.775 . . . . 0.0 112.294 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -61.35 -45.15 95.58 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.733 -1.23 . . . . 0.0 109.859 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -70.15 -37.09 75.14 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.134 -0.979 . . . . 0.0 108.701 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -65.61 -41.67 92.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.145 -0.972 . . . . 0.0 110.345 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.58 -39.53 80.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.843 -1.161 . . . . 0.0 110.475 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 66.1 ttp -63.19 -43.57 97.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.839 -1.163 . . . . 0.0 109.386 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -63.35 -47.09 83.6 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.249 -0.981 . . . . 0.0 109.443 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.8 t -64.51 -43.92 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.165 -0.96 . . . . 0.0 110.129 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.479 ' CE1' ' HB3' ' A' ' 56' ' ' MET . 63.2 t80 -58.84 -46.27 88.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.837 -1.164 . . . . 0.0 109.784 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -75.49 -37.05 60.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.062 -1.024 . . . . 0.0 110.464 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -61.84 -39.97 93.68 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.058 -1.026 . . . . 0.0 109.627 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.9 mt -78.89 3.38 17.1 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.624 178.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.7 mttp 59.05 30.85 20.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.507 -0.746 . . . . 0.0 111.083 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.479 ' HB3' ' CE1' ' A' ' 51' ' ' PHE . 62.1 mtt -70.0 -28.95 65.93 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.213 -0.93 . . . . 0.0 109.247 178.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -67.89 -9.49 45.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 109.832 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -84.61 84.69 7.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.614 -1.304 . . . . 0.0 110.93 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.411 ' CG2' ' OE1' ' A' ' 137' ' ' GLU . 92.1 m -135.27 151.88 50.98 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -60.54 -42.45 96.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.168 -0.957 . . . . 0.0 111.09 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.0 mt -99.85 0.41 41.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.086 -1.009 . . . . 0.0 111.112 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 56.85 32.47 21.45 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.194 0.997 . . . . 0.0 111.825 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -107.31 51.74 0.73 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.792 0.806 . . . . 0.0 109.289 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.64 141.99 15.75 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.5 t -123.38 133.71 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.138 -1.213 . . . . 0.0 110.191 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.0 tp -115.38 124.0 50.1 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.394 -0.816 . . . . 0.0 109.203 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.4 mt -106.2 107.25 22.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.121 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -94.08 126.02 39.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.168 -0.957 . . . . 0.0 110.124 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.9 t -120.89 133.13 68.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.873 0.844 . . . . 0.0 110.366 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.94 92.65 4.89 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.461 ' CG1' ' CD1' ' A' ' 35' ' ' LEU . 29.1 m -64.85 -23.1 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.23 -0.919 . . . . 0.0 111.0 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -67.76 -44.21 78.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.809 -1.182 . . . . 0.0 108.585 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -100.82 8.45 43.19 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.205 -0.934 . . . . 0.0 110.562 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.6 tttt 51.07 44.18 28.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.956 -1.09 . . . . 0.0 110.488 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.3 p -121.31 166.34 14.19 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.431 -0.793 . . . . 0.0 109.269 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 47.3 p90 -145.08 138.23 26.52 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.048 -1.033 . . . . 0.0 110.505 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 50.0 t -127.5 135.29 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.497 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 72.3 mt -114.17 121.93 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.836 -1.165 . . . . 0.0 109.848 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -128.76 112.41 14.16 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.463 -0.773 . . . . 0.0 109.925 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -99.9 175.19 27.31 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -81.14 174.14 11.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.579 -0.954 . . . . 0.0 110.327 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.87 -25.68 65.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 110.328 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.98 -53.1 35.93 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.143 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.422 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 3.2 mt -65.25 -45.14 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.86 -1.376 . . . . 0.0 107.822 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.49 -36.29 82.03 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 111.425 -177.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -77.11 -22.85 52.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.082 -1.012 . . . . 0.0 111.711 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.426 ' CG1' HG12 ' A' ' 88' ' ' VAL . 8.9 p -102.61 -23.87 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.876 -1.14 . . . . 0.0 112.738 -178.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.482 ' HB ' ' CD2' ' A' ' 92' ' ' PHE . 15.6 m -118.52 165.46 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 120.388 -1.445 . . . . 0.0 111.474 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.8 p -110.34 -179.05 3.66 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.305 -0.872 . . . . 0.0 112.482 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.57 -35.42 80.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.284 -0.885 . . . . 0.0 109.812 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -61.96 -38.33 88.1 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 108.833 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.5 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 71.1 t80 -69.35 -26.09 64.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.626 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.497 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 4.9 m95 -85.97 -27.66 24.73 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.989 0.9 . . . . 0.0 110.322 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -54.26 -41.24 68.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.483 -0.76 . . . . 0.0 112.096 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 79.3 p -64.42 -32.87 74.67 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.888 -1.132 . . . . 0.0 109.668 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.28 9.1 m -58.78 -49.5 77.43 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.329 1.061 . . . . 0.0 111.129 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -68.2 -38.62 82.17 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.305 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -63.64 -42.95 98.08 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.039 -1.065 . . . . 0.0 110.386 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.41 -50.83 69.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.825 -1.172 . . . . 0.0 111.294 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 93.1 mt -67.11 -42.79 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.111 -0.993 . . . . 0.0 109.888 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.436 ' CG ' ' HE3' ' A' ' 105' ' ' LYS . 52.4 tt0 -63.15 -45.35 92.28 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.662 -0.649 . . . . 0.0 111.317 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -62.21 -41.55 98.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.895 -1.128 . . . . 0.0 111.721 -178.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -75.64 -38.09 59.15 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.815 -1.154 . . . . 0.0 108.725 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -60.51 -41.07 93.59 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.436 ' HE3' ' CG ' ' A' ' 101' ' ' GLN . 92.0 mttt -61.35 -32.62 72.52 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.928 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -79.9 -17.31 53.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.855 -1.153 . . . . 0.0 110.093 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.42 6.35 44.58 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 119.892 -1.147 . . . . 0.0 111.322 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -103.42 89.51 3.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.624 -1.515 . . . . 0.0 109.946 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -62.19 -42.73 99.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.634 -0.666 . . . . 0.0 111.336 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.416 ' NZ ' ' HA ' ' A' ' 12' ' ' GLU . 85.7 tttt -62.47 -48.47 79.48 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.441 -177.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -65.28 -37.95 88.75 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.848 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.0 -51.29 54.51 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.487 -1.34 . . . . 0.0 110.091 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.0 mt -64.59 -43.8 92.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.01 -1.288 . . . . 0.0 110.988 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 88.2 t -63.93 -48.67 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.88 -1.137 . . . . 0.0 110.488 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -63.87 -39.7 94.82 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.943 -1.098 . . . . 0.0 110.103 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.7 -41.88 99.77 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.412 HD12 ' CD1' ' A' ' 20' ' ' ILE . 85.1 mt -64.08 -44.63 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.262 -1.14 . . . . 0.0 109.9 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -57.32 -47.19 82.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.102 -0.999 . . . . 0.0 109.242 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.46 -42.81 98.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -0.879 . . . . 0.0 109.067 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.84 -46.41 74.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 0.0 110.039 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.47 -42.69 97.44 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.783 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 86.3 mtp -66.35 -44.63 82.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.847 -1.384 . . . . 0.0 110.016 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.5 ' CB ' ' CE1' ' A' ' 92' ' ' PHE . . . -65.48 -45.4 83.8 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.01 -39.26 94.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.61 -33.88 61.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.936 . . . . 0.0 109.937 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.28 -40.76 95.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 0.0 108.65 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.477 ' HB3' ' CE1' ' A' ' 128' ' ' PHE . 68.4 m-85 -78.56 -35.44 45.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.44 -0.787 . . . . 0.0 110.099 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' A' ' 127' ' ' TYR . 73.7 m-85 -133.97 96.91 15.69 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.002 -1.061 . . . . 0.0 110.622 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.07 152.9 72.82 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.517 1.272 . . . . 0.0 110.542 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.475 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 45.7 t90 -74.17 133.51 42.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.428 -0.795 . . . . 0.0 111.812 -178.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -112.16 151.74 29.15 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.12 -32.33 70.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.913 -1.117 . . . . 0.0 111.454 -176.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -89.47 8.29 31.74 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.831 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -42.4 138.09 1.87 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.494 -0.754 . . . . 0.0 111.342 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.417 HG22 HD13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -112.01 138.34 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.613 -177.407 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -94.9 90.44 6.0 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.084 -1.01 . . . . 0.0 109.379 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.414 ' HG3' HG12 ' A' ' 135' ' ' ILE . 87.3 mt-10 -66.95 -41.7 86.47 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.66 -0.65 . . . . 0.0 112.505 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.411 HD13 ' CB ' ' A' ' 30' ' ' GLU . 4.5 mt -103.99 151.62 38.95 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.025 -1.047 . . . . 0.0 111.277 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -75.04 -175.92 2.62 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 N-CA-C 108.315 -1.456 . . . . 0.0 108.315 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -117.48 3.87 12.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.656 -1.278 . . . . 0.0 109.842 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 33.5 m -60.58 137.26 58.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.793 -1.192 . . . . 0.0 109.811 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 94.7 mt -68.65 138.94 21.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.491 -0.755 . . . . 0.0 110.955 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 24.3 m -91.01 131.64 36.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.342 -0.849 . . . . 0.0 109.046 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -127.09 127.67 45.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.98 -1.075 . . . . 0.0 110.559 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.411 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.2 mtm . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.283 0.563 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.4 t -62.29 -43.34 99.05 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.394 -0.816 . . . . 0.0 109.225 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -82.55 119.44 24.24 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.21 -0.931 . . . . 0.0 109.149 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.7 pt -93.66 -9.95 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.769 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -65.71 -42.77 90.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.945 -1.097 . . . . 0.0 109.983 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -118.04 115.22 24.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.464 -0.772 . . . . 0.0 109.767 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.511 ' CE1' ' CG2' ' A' ' 71' ' ' VAL . 72.9 m-85 -62.59 -42.35 99.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 0.0 110.718 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.42 ' HB3' ' CB ' ' A' ' 12' ' ' GLU . 95.0 mt -129.97 150.55 51.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.029 -1.044 . . . . 0.0 110.175 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.7 p -79.46 169.42 18.08 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.189 -0.944 . . . . 0.0 109.227 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.18 -36.32 68.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.95 -1.094 . . . . 0.0 109.639 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -64.31 -40.5 96.05 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.249 -0.907 . . . . 0.0 109.442 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.421 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 76.8 mm-40 -70.25 -50.81 35.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 0.0 110.643 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.66 -33.37 75.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.419 -0.801 . . . . 0.0 110.441 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.4 -45.15 94.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.967 -1.083 . . . . 0.0 110.378 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.417 ' HB2' ' CE ' ' A' ' 110' ' ' LYS . . . -66.31 -42.28 88.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.091 -1.006 . . . . 0.0 111.642 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' ' 17' ' ' VAL . 21.2 tt -68.56 -39.26 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.552 -1.343 . . . . 0.0 111.151 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.423 ' N ' HG22 ' A' ' 16' ' ' ILE . 89.9 t -63.1 -39.13 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.886 -1.134 . . . . 0.0 108.622 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -63.37 -36.16 82.78 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.3 -0.96 . . . . 0.0 109.241 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.26 -41.38 96.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -0.87 . . . . 0.0 109.533 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.0 -43.11 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.445 -0.784 . . . . 0.0 109.572 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -58.28 -43.11 87.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 109.896 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -64.5 -35.56 81.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.422 -0.799 . . . . 0.0 111.115 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.81 -39.57 93.8 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.976 -1.078 . . . . 0.0 110.175 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -60.39 -16.47 35.83 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.036 -1.04 . . . . 0.0 110.985 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 97.9 mttt -94.79 0.66 55.09 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.139 -0.976 . . . . 0.0 109.556 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -112.73 -16.94 12.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.949 -1.095 . . . . 0.0 109.66 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.6 t -154.17 159.05 41.22 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.935 -1.103 . . . . 0.0 109.687 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.4 p -86.23 -6.55 58.95 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.194 -0.941 . . . . 0.0 110.587 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.49 170.41 50.75 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -129.66 132.79 46.79 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.128 -1.219 . . . . 0.0 111.181 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.3 mt -115.79 132.83 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -138.88 149.88 45.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.136 -0.977 . . . . 0.0 109.82 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.416 ' CG2' HD11 ' A' ' 67' ' ' ILE . 53.4 t -118.22 137.04 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.387 -0.821 . . . . 0.0 111.006 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -122.05 120.33 34.02 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.491 HD22 ' CG ' ' A' ' 7' ' ' PHE . 35.2 tp -112.16 126.01 54.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.496 -0.753 . . . . 0.0 111.396 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -141.59 167.59 21.78 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.409 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.5 mttt -78.38 -75.57 0.22 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.935 -1.103 . . . . 0.0 113.411 -177.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 t -142.12 157.62 44.69 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.119 -0.988 . . . . 0.0 110.063 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.9 m -110.38 170.45 8.08 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.374 -0.829 . . . . 0.0 110.999 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -108.03 -9.46 15.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.398 -0.814 . . . . 0.0 110.556 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.421 HG13 ' N ' ' A' ' 42' ' ' ASP . 27.3 pt -127.56 -122.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.726 -1.234 . . . . 0.0 110.47 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.421 ' N ' HG13 ' A' ' 41' ' ' ILE . 97.5 m-20 -111.39 138.06 48.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.113 -1.617 . . . . 0.0 109.755 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.0 t -64.99 -42.79 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.444 -0.785 . . . . 0.0 111.426 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -59.9 -46.32 89.71 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.9 -1.125 . . . . 0.0 110.409 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -71.55 -40.67 69.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.977 -1.077 . . . . 0.0 108.282 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -61.4 -40.86 95.92 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.404 -0.81 . . . . 0.0 110.965 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.23 81.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.621 -1.3 . . . . 0.0 109.71 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 64.0 ttp -62.98 -43.34 99.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.209 -0.932 . . . . 0.0 109.792 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -64.01 -45.03 90.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.987 -1.071 . . . . 0.0 109.762 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.29 -43.53 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.306 -0.871 . . . . 0.0 110.003 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 6.9 t80 -57.84 -47.47 82.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.88 -1.137 . . . . 0.0 109.547 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -73.87 -35.64 64.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.992 -1.067 . . . . 0.0 109.843 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.09 -38.8 87.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.141 -0.974 . . . . 0.0 108.657 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.6 mt -80.22 3.25 21.39 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.359 -0.838 . . . . 0.0 110.141 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 29.8 tttt 57.14 32.46 21.73 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.936 -1.103 . . . . 0.0 111.706 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.462 ' HB2' ' CE1' ' A' ' 51' ' ' PHE . 98.9 mtp -66.39 -12.16 55.41 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.336 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -76.62 -1.74 29.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.939 -1.101 . . . . 0.0 109.529 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -75.44 63.22 1.44 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.889 -1.132 . . . . 0.0 110.129 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.3 p -134.62 150.27 50.67 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -65.2 -42.89 93.07 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.622 -0.674 . . . . 0.0 112.455 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 94.4 mt -96.33 -1.83 47.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.914 -1.116 . . . . 0.0 111.514 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 57.25 48.4 15.14 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 122.536 1.16 . . . . 0.0 110.797 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.8 p30 -122.45 53.04 1.27 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.885 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.42 146.92 16.61 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.479 ' CG2' ' CD1' ' A' ' 84' ' ' ILE . 72.7 t -128.06 134.72 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.116 -1.226 . . . . 0.0 110.361 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.402 HD12 ' HE1' ' A' ' 56' ' ' MET . 36.6 tp -116.67 128.18 55.11 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.59 -0.694 . . . . 0.0 109.381 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.416 HD11 ' CG2' ' A' ' 33' ' ' VAL . 86.0 mt -102.99 112.33 36.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.473 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -99.23 117.32 33.43 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.25 -0.906 . . . . 0.0 109.247 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 72.5 t -118.91 130.88 73.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-O 122.101 0.953 . . . . 0.0 110.709 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.86 101.12 12.16 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.511 ' CG2' ' CE1' ' A' ' 7' ' ' PHE . 27.3 m -70.43 -20.28 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.006 . . . . 0.0 111.048 -178.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -67.51 -44.02 79.43 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.792 -1.192 . . . . 0.0 109.016 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -102.52 3.63 37.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.284 -0.885 . . . . 0.0 110.759 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.4 tttt 56.74 48.77 15.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.831 -1.168 . . . . 0.0 111.123 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 76.7 p -122.4 164.02 18.75 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.095 -1.003 . . . . 0.0 109.917 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -143.57 141.37 30.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.489 -0.757 . . . . 0.0 110.146 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 64.4 t -126.82 136.06 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.428 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 66.7 mt -113.84 122.66 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.955 -1.091 . . . . 0.0 109.769 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -128.6 112.92 14.8 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.555 -0.716 . . . . 0.0 110.68 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -96.18 165.82 24.2 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -75.28 175.05 8.71 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.346 -1.09 . . . . 0.0 109.642 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -59.24 -26.96 65.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 110.657 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.28 -52.25 42.16 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.604 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.479 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 82.2 mt -64.94 -44.2 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.785 -1.42 . . . . 0.0 108.579 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -61.66 -38.07 86.37 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.004 -1.06 . . . . 0.0 111.34 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -73.05 -22.91 60.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.033 -1.042 . . . . 0.0 112.676 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.5 p -101.16 -19.48 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.78 -1.2 . . . . 0.0 112.472 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.477 HG23 ' CD1' ' A' ' 93' ' ' TRP . 19.5 m -119.54 163.61 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.712 -1.243 . . . . 0.0 111.642 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 61.9 p -108.66 -179.94 4.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.47 -0.769 . . . . 0.0 111.525 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -61.83 -38.63 88.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 109.231 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -60.1 -39.93 87.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.46 -0.775 . . . . 0.0 109.421 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.459 ' CD2' ' HB ' ' A' ' 88' ' ' VAL . 90.5 t80 -66.2 -24.29 66.59 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.158 -0.964 . . . . 0.0 109.537 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.477 ' CD1' HG23 ' A' ' 88' ' ' VAL . 5.2 m95 -87.97 -25.33 23.22 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.919 0.866 . . . . 0.0 110.656 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -57.52 -37.05 72.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.885 . . . . 0.0 111.999 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.4 p -67.67 -31.57 71.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.713 -1.242 . . . . 0.0 109.275 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.277 15.9 m -60.89 -49.06 78.99 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 122.444 1.116 . . . . 0.0 111.097 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -69.44 -38.21 77.72 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.911 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -63.6 -42.62 98.24 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.939 -1.1 . . . . 0.0 110.566 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.01 -49.56 69.72 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.801 -1.187 . . . . 0.0 111.515 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.81 -42.26 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.954 -1.091 . . . . 0.0 109.503 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -62.13 -44.42 96.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.346 -0.846 . . . . 0.0 111.18 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.2 tp -63.66 -42.17 98.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -0.963 . . . . 0.0 111.813 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.442 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 97.6 mm-40 -72.86 -43.82 62.11 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.361 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -58.68 -39.56 81.04 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.55 -33.21 72.34 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -78.2 -18.42 55.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 0.0 109.695 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.23 2.04 44.68 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.832 -1.175 . . . . 0.0 111.182 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.2 94.23 5.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.725 -1.456 . . . . 0.0 109.541 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -63.05 -42.34 99.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.767 -0.583 . . . . 0.0 111.066 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.421 ' NZ ' ' HA ' ' A' ' 12' ' ' GLU . 85.7 tttt -64.44 -48.31 75.8 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.868 -1.145 . . . . 0.0 112.006 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -62.65 -37.96 88.41 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 118.752 -1.179 . . . . 0.0 109.638 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.442 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -64.22 -50.61 59.03 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.04 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.7 mt -64.6 -43.85 92.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.161 -1.199 . . . . 0.0 111.164 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 83.6 t -64.93 -48.57 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.694 -1.254 . . . . 0.0 110.511 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -63.51 -38.35 90.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 109.624 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.91 -41.99 99.77 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.6 mt -63.32 -43.74 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -1.195 . . . . 0.0 108.975 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -58.96 -50.83 72.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.124 -0.985 . . . . 0.0 110.499 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.16 -41.11 97.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 109.052 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -42.63 95.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.883 . . . . 0.0 110.671 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.32 -44.01 96.06 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.962 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 97.1 mtp -67.8 -43.0 80.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.921 -1.34 . . . . 0.0 109.394 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 92' ' ' PHE . . . -64.45 -46.89 81.18 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.255 -0.903 . . . . 0.0 108.885 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 76.6 mt -62.15 -40.73 96.94 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.478 -0.764 . . . . 0.0 109.126 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.74 -34.49 62.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.383 -0.823 . . . . 0.0 110.671 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.16 -42.77 99.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.05 -1.031 . . . . 0.0 108.954 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -75.12 -40.0 60.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.624 -0.673 . . . . 0.0 109.791 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -130.94 92.08 34.8 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.383 -0.823 . . . . 0.0 109.393 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.13 151.39 83.81 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.472 1.248 . . . . 0.0 110.044 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 73.9 t90 -72.67 131.85 42.92 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.596 -0.69 . . . . 0.0 110.826 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -108.41 149.77 28.29 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.474 ' HA ' ' CH2' ' A' ' 130' ' ' TRP . 87.8 tttt -57.88 -28.91 64.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -0.999 . . . . 0.0 110.799 -177.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -89.47 8.37 31.31 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.797 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -43.88 136.93 3.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.297 -0.877 . . . . 0.0 111.65 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.425 ' CD1' ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -112.24 143.58 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.355 0.598 . . . . 0.0 110.764 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -96.4 93.44 6.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.009 -1.057 . . . . 0.0 109.789 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.1 -35.8 76.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.66 -0.65 . . . . 0.0 111.901 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 mp -112.08 152.09 44.09 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.101 -0.999 . . . . 0.0 111.928 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -76.09 -170.81 0.92 Allowed 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.633 1.333 . . . . 0.0 108.694 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -122.97 2.95 9.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.661 -1.274 . . . . 0.0 110.066 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.4 m -64.02 139.87 58.81 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.854 -1.154 . . . . 0.0 110.805 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.0 mt -73.49 140.33 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.437 -0.79 . . . . 0.0 110.876 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 24.4 m -97.13 139.77 32.63 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.47 -0.769 . . . . 0.0 109.341 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -131.36 147.99 52.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.093 -1.004 . . . . 0.0 110.979 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.137 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.752 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.6 mtm . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.524 0.678 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m -67.32 148.1 52.11 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.472 -0.768 . . . . 0.0 109.783 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.57 -42.8 99.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.007 -1.058 . . . . 0.0 110.008 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 90.7 mt -63.95 -44.79 98.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.822 . . . . 0.0 110.272 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -70.27 -30.5 67.55 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.338 -0.851 . . . . 0.0 110.013 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -54.32 -45.71 72.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.076 -1.015 . . . . 0.0 110.542 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.538 ' CG ' ' CD2' ' A' ' 35' ' ' LEU . 19.6 t80 -69.92 -72.6 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.075 -1.016 . . . . 0.0 110.052 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.53 ' CD1' ' CE2' ' A' ' 7' ' ' PHE . 97.7 mt -133.27 152.8 51.94 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.958 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.0 p -81.18 169.28 17.56 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.569 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.96 -40.32 66.74 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.969 -1.082 . . . . 0.0 109.917 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -61.04 -43.87 98.25 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.632 -0.667 . . . . 0.0 109.769 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.46 -45.77 68.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.289 -0.882 . . . . 0.0 111.011 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -66.46 -34.49 78.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.954 . . . . 0.0 109.715 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.06 -46.19 85.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.923 -1.11 . . . . 0.0 110.404 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.72 -41.92 95.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.063 -1.023 . . . . 0.0 111.451 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.451 HG21 ' N ' ' A' ' 17' ' ' VAL . 18.5 tt -68.41 -39.44 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.869 -1.144 . . . . 0.0 110.549 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.451 ' N ' HG21 ' A' ' 16' ' ' ILE . 77.6 t -63.77 -41.5 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -60.93 -40.34 92.85 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.435 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.12 -36.03 78.63 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.379 -0.826 . . . . 0.0 109.341 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.3 mm -62.9 -42.1 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -58.81 -42.83 90.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.819 -0.551 . . . . 0.0 110.041 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -65.26 -40.61 94.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.052 -1.03 . . . . 0.0 111.113 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.07 -40.84 95.2 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.843 -1.161 . . . . 0.0 110.495 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -60.66 -13.98 17.87 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.441 -1.412 . . . . 0.0 111.127 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.488 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.8 mttt -95.15 0.98 54.7 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.067 -1.021 . . . . 0.0 109.449 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -112.91 -16.66 12.66 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.35 -0.844 . . . . 0.0 110.298 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.0 t -151.51 157.93 42.94 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.073 -1.017 . . . . 0.0 110.206 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.4 p -87.74 -7.36 57.45 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.488 -0.758 . . . . 0.0 110.194 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.31 172.92 49.6 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -132.02 133.86 44.9 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.162 -1.199 . . . . 0.0 111.725 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.5 mt -117.57 134.5 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 121.184 0.516 . . . . 0.0 110.124 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -139.86 156.44 46.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.395 -0.815 . . . . 0.0 110.166 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 p -124.29 138.24 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.265 -0.897 . . . . 0.0 110.62 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.41 ' ND1' ' OG ' ' A' ' 143' ' ' SER . 57.0 t60 -121.42 119.82 33.18 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.538 ' CD2' ' CG ' ' A' ' 7' ' ' PHE . 46.1 tp -111.48 135.26 52.29 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.116 0.96 . . . . 0.0 111.974 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 76.4 tt0 -151.61 166.21 31.93 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.445 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 98.7 mttt -78.41 -72.0 0.4 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.896 -1.127 . . . . 0.0 112.889 -176.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.8 t -142.72 157.88 44.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.915 -1.116 . . . . 0.0 109.937 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.6 p -102.51 164.88 11.41 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.465 -0.772 . . . . 0.0 111.138 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -105.42 -24.56 12.62 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.455 -0.778 . . . . 0.0 109.377 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.411 HG13 ' N ' ' A' ' 42' ' ' ASP . 24.8 pt -111.9 -121.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.099 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.411 ' N ' HG13 ' A' ' 41' ' ' ILE . 97.0 m-20 -110.61 141.43 43.82 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.248 -1.532 . . . . 0.0 109.589 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.7 t -64.35 -43.22 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.355 -0.841 . . . . 0.0 111.21 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -61.18 -46.25 91.25 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.877 -1.139 . . . . 0.0 110.29 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -70.42 -40.14 74.0 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.897 -1.127 . . . . 0.0 108.413 177.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -62.9 -41.8 99.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.344 -0.847 . . . . 0.0 111.185 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.74 -39.29 80.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.947 -1.096 . . . . 0.0 110.187 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 66.3 ttp -63.0 -42.49 99.86 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.096 -1.003 . . . . 0.0 109.934 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -65.41 -40.66 93.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.021 -1.049 . . . . 0.0 109.82 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.8 t -69.58 -43.67 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.454 -0.779 . . . . 0.0 109.441 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.486 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 3.6 t80 -58.16 -46.85 84.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.048 -1.032 . . . . 0.0 108.824 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -73.15 -35.58 66.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.023 -1.048 . . . . 0.0 109.56 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -61.91 -37.32 84.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.012 -1.055 . . . . 0.0 109.329 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 98.6 mt -82.22 3.52 27.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.576 -0.702 . . . . 0.0 110.694 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.4 mttp 56.64 33.39 22.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.453 -0.78 . . . . 0.0 111.706 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.486 ' HB2' ' CE1' ' A' ' 51' ' ' PHE . 90.8 mtp -66.89 -14.25 62.56 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.416 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -75.68 -3.18 33.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.108 -0.995 . . . . 0.0 110.318 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -76.93 65.68 2.65 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.048 -1.033 . . . . 0.0 109.849 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.2 p -134.94 150.62 50.42 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.395 -0.816 . . . . 0.0 109.434 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -64.51 -47.32 79.32 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 84.6 mt -96.29 -1.06 48.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.863 -1.148 . . . . 0.0 111.332 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 76.0 mt-30 60.94 45.29 9.64 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 122.61 1.195 . . . . 0.0 111.479 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.444 ' HA ' HG13 ' A' ' 84' ' ' ILE . 34.8 m-80 -120.03 51.34 1.2 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.132 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.18 141.03 15.33 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.268 -1.933 . . . . 0.0 108.268 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.479 ' CG2' ' CD1' ' A' ' 84' ' ' ILE . 55.6 t -122.51 134.36 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.816 -1.402 . . . . 0.0 110.367 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.417 ' HB2' ' CD2' ' A' ' 51' ' ' PHE . 41.1 tp -116.76 124.51 49.79 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.962 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 98.7 mt -102.36 105.2 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.965 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 34' ' ' HIS . 56.1 t80 -92.65 121.64 34.27 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.357 -0.839 . . . . 0.0 110.0 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.9 t -122.42 130.13 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.348 -0.845 . . . . 0.0 111.034 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.77 99.76 11.11 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.407 HG22 ' HA ' ' A' ' 37' ' ' LYS . 32.7 m -68.35 -20.53 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.97 -1.081 . . . . 0.0 110.451 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.442 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 66.1 mm-40 -70.85 -47.92 56.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.946 -1.096 . . . . 0.0 109.575 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -97.67 3.37 50.32 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.215 -0.928 . . . . 0.0 110.586 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt 54.44 46.08 25.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.103 -0.998 . . . . 0.0 110.99 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.4 m -121.72 132.69 54.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.082 -1.011 . . . . 0.0 110.303 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 76' ' ' PHE . 53.4 p90 -112.13 139.55 47.56 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.445 -0.785 . . . . 0.0 110.468 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 50.4 t -130.43 140.57 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.299 -0.876 . . . . 0.0 109.37 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.52 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 90.3 mt -118.07 127.98 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.783 -1.198 . . . . 0.0 111.032 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -130.42 116.47 18.29 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.638 -0.664 . . . . 0.0 110.285 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.43 167.4 15.64 Favored Glycine 0 N--CA 1.483 1.769 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.48 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 73.7 m-20 -77.86 178.2 7.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.546 -0.973 . . . . 0.0 110.848 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -62.05 -27.21 68.73 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.644 -0.66 . . . . 0.0 110.139 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.37 -55.54 26.98 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.615 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.479 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 76.5 mt -66.18 -44.56 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.703 -1.469 . . . . 0.0 108.546 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -61.31 -36.44 80.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.049 -1.032 . . . . 0.0 111.003 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -76.74 -21.84 54.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 111.524 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.415 HG13 ' N ' ' A' ' 88' ' ' VAL . 10.5 p -103.45 -23.37 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.724 -1.235 . . . . 0.0 112.462 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.442 HG22 ' CG2' ' A' ' 84' ' ' ILE . 20.3 m -118.88 164.41 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.64 -1.287 . . . . 0.0 111.011 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.5 p -109.34 178.52 4.42 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.406 -0.809 . . . . 0.0 112.434 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -62.89 -35.65 80.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.878 . . . . 0.0 109.137 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -61.47 -37.78 84.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.162 -0.961 . . . . 0.0 109.008 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.506 ' CZ ' ' HB1' ' A' ' 123' ' ' ALA . 54.4 t80 -68.26 -25.21 65.06 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 108.984 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.52 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 4.8 m95 -86.63 -26.29 24.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.75 0.786 . . . . 0.0 110.846 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -58.84 -34.4 71.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.202 -0.936 . . . . 0.0 111.902 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 49.2 p -68.46 -32.65 72.81 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.276 -1.37 . . . . 0.0 108.683 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.429 HG21 ' CD1' ' A' ' 78' ' ' ILE 0.268 16.6 m -59.74 -48.4 81.83 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 122.316 1.055 . . . . 0.0 110.852 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.44 -37.58 74.39 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.11 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -63.35 -43.85 96.52 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.824 -1.172 . . . . 0.0 110.125 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.03 -48.25 77.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.89 -1.131 . . . . 0.0 110.935 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 94.2 mt -67.7 -42.67 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.064 -1.022 . . . . 0.0 110.06 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -64.53 -41.67 96.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.124 -0.985 . . . . 0.0 110.648 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.8 mt -63.73 -42.31 97.92 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.96 -1.088 . . . . 0.0 112.048 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.412 ' HB2' ' HA3' ' A' ' 112' ' ' GLY . 99.7 mm-40 -74.99 -39.18 61.39 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.293 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -61.65 -40.31 94.45 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -62.01 -32.9 73.42 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.689 -0.632 . . . . 0.0 110.036 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -84.67 -17.21 39.26 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.828 -1.17 . . . . 0.0 109.916 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.89 10.53 34.66 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.09 -1.052 . . . . 0.0 110.503 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -104.6 79.58 1.57 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.854 -1.38 . . . . 0.0 109.35 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -60.68 -43.76 97.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.787 -0.571 . . . . 0.0 111.138 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -62.33 -49.39 75.79 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.126 -0.984 . . . . 0.0 111.984 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -63.09 -37.89 89.01 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.887 -1.133 . . . . 0.0 110.313 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.412 ' HA3' ' HB2' ' A' ' 103' ' ' GLN . . . -64.47 -49.33 65.8 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.28 -43.35 98.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -1.143 . . . . 0.0 110.446 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.8 t -66.45 -46.99 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.084 -1.01 . . . . 0.0 110.074 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.78 -40.14 94.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.229 -0.919 . . . . 0.0 109.636 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.19 -41.9 99.62 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 93.9 mt -65.32 -44.27 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.371 -1.076 . . . . 0.0 110.298 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -57.2 -48.51 78.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.946 -1.096 . . . . 0.0 109.3 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.56 -42.05 98.37 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.481 -0.762 . . . . 0.0 109.506 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.57 -41.97 91.41 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.3 -0.875 . . . . 0.0 110.132 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.62 -44.7 89.16 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 98.7 mmm -65.49 -46.54 79.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.047 -1.266 . . . . 0.0 109.513 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.506 ' HB1' ' CZ ' ' A' ' 92' ' ' PHE . . . -63.85 -44.73 92.29 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.21 -0.931 . . . . 0.0 109.128 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 37.8 mt -62.43 -40.41 96.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.937 . . . . 0.0 109.142 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.93 -35.04 61.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.151 -0.968 . . . . 0.0 110.454 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.09 -43.91 97.8 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.059 -1.025 . . . . 0.0 108.567 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -72.39 -44.03 63.1 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.422 0.63 . . . . 0.0 109.81 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -127.84 96.51 32.04 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.387 -0.82 . . . . 0.0 109.742 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.41 148.65 84.41 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.874 1.46 . . . . 0.0 110.304 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.488 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 72.6 t90 -73.87 133.09 43.1 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.422 -0.799 . . . . 0.0 110.262 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -111.34 147.79 34.37 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -54.18 -25.77 24.43 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.919 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -94.51 10.29 35.16 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 118.502 -1.279 . . . . 0.0 111.198 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -43.19 134.51 3.62 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.38 -0.825 . . . . 0.0 111.24 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.522 HD13 HG21 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -110.09 140.37 29.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.7 -178.596 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 45.6 p-10 -97.89 92.59 5.89 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.042 0.925 . . . . 0.0 110.206 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.09 -35.19 79.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.533 -0.729 . . . . 0.0 112.252 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 138' ' ' LEU . 5.0 mp -108.96 152.78 42.6 Favored Pre-proline 0 N--CA 1.486 1.354 0 O-C-N 120.826 -1.172 . . . . 0.0 111.854 -178.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -75.13 -169.05 0.58 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 N-CA-C 108.0 -1.577 . . . . 0.0 108.0 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -123.74 4.66 8.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.572 -1.33 . . . . 0.0 110.418 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 61.7 p -62.38 171.86 1.74 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.074 -1.016 . . . . 0.0 110.556 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.0 mt -103.14 140.59 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.389 -0.819 . . . . 0.0 109.96 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.41 ' OG ' ' ND1' ' A' ' 34' ' ' HIS . 28.6 t -95.95 136.29 36.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.527 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -128.8 147.09 50.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.078 -1.013 . . . . 0.0 111.629 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.051 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.9 mtm . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 120.844 0.354 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.5 m -58.28 -41.43 84.32 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.615 -1.303 . . . . 0.0 109.822 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.23 -43.5 97.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 110.452 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.9 pt -132.43 138.72 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.045 -1.035 . . . . 0.0 110.399 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.83 58.16 0.61 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.928 -1.108 . . . . 0.0 110.233 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 52.41 22.54 2.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.131 -0.981 . . . . 0.0 111.093 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.525 ' CE2' ' CD1' ' A' ' 8' ' ' LEU . 18.2 t80 -78.6 -73.7 0.31 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.122 -0.986 . . . . 0.0 110.446 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.525 ' CD1' ' CE2' ' A' ' 7' ' ' PHE . 96.4 mt -129.97 150.03 51.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.055 -1.028 . . . . 0.0 109.743 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 t -77.48 170.94 15.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.038 -1.039 . . . . 0.0 109.587 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.03 -39.11 68.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 110.565 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -59.65 -46.21 89.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.125 -0.984 . . . . 0.0 110.759 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.42 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 99.7 mt-10 -70.08 -44.0 70.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 0.0 111.533 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.99 -39.02 89.95 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.024 -1.047 . . . . 0.0 110.082 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.57 -45.57 93.59 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.938 -1.101 . . . . 0.0 110.539 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.06 -47.02 78.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.125 -0.984 . . . . 0.0 111.663 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.415 HG23 ' N ' ' A' ' 17' ' ' VAL . 20.0 tt -63.79 -33.7 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.678 -1.264 . . . . 0.0 109.983 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.415 ' N ' HG23 ' A' ' 16' ' ' ILE . 55.9 t -64.91 -40.84 90.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -62.56 -35.13 78.5 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.104 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.73 -41.62 97.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.393 -0.817 . . . . 0.0 109.692 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.414 HG21 ' ND2' ' A' ' 140' ' ' ASN . 96.6 mt -64.03 -43.14 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 0.0 109.493 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -58.41 -44.45 89.04 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.464 -0.772 . . . . 0.0 110.183 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -63.28 -37.54 87.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.375 -0.828 . . . . 0.0 110.772 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.37 -40.64 96.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.077 -1.015 . . . . 0.0 110.187 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -60.99 -16.42 42.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.141 -0.974 . . . . 0.0 110.675 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.446 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.6 mttt -93.07 -1.3 56.65 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.059 -1.026 . . . . 0.0 109.229 177.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -110.93 -13.65 14.08 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 120.905 -1.122 . . . . 0.0 109.545 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.9 t -151.28 158.67 44.16 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.977 -1.077 . . . . 0.0 110.329 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 94.2 p -89.31 -10.17 47.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 110.271 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.38 174.1 38.84 Favored Glycine 0 N--CA 1.485 1.967 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.421 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 55.7 mp0 -131.09 136.28 48.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.221 -1.164 . . . . 0.0 110.968 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.3 mt -120.73 134.78 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.692 -0.63 . . . . 0.0 110.308 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -139.24 159.26 42.58 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.22 -0.925 . . . . 0.0 109.508 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 p -129.15 143.87 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.395 -0.816 . . . . 0.0 110.942 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -127.64 126.94 42.93 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.613 0.721 . . . . 0.0 109.578 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.49 HD22 ' CG ' ' A' ' 7' ' ' PHE . 3.4 tp -116.01 131.18 57.01 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.968 0.89 . . . . 0.0 111.46 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -146.53 162.87 37.41 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.437 ' HB3' ' CG ' ' A' ' 72' ' ' GLU . 99.1 mttt -77.38 -74.51 0.25 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.053 -1.029 . . . . 0.0 112.66 -177.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.5 t -138.65 155.66 48.11 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.747 0.784 . . . . 0.0 109.796 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.422 ' HB2' ' NE ' ' A' ' 46' ' ' ARG . 13.3 p -106.72 168.39 9.21 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.7 -0.625 . . . . 0.0 110.693 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -106.84 -22.9 12.55 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.183 -0.948 . . . . 0.0 110.8 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.413 HG13 ' N ' ' A' ' 42' ' ' ASP . 18.4 pt -114.05 -121.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.348 -0.845 . . . . 0.0 109.957 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.413 ' N ' HG13 ' A' ' 41' ' ' ILE . 91.5 m-20 -110.72 137.4 48.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.071 -1.643 . . . . 0.0 109.067 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.44 -44.21 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 111.104 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -59.17 -45.82 90.01 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.762 -1.211 . . . . 0.0 110.375 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -71.98 -39.14 69.5 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.422 ' NE ' ' HB2' ' A' ' 39' ' ' SER . 57.1 ttm-85 -61.35 -44.44 97.17 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.3 -0.875 . . . . 0.0 110.91 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.25 -37.97 89.38 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.952 -1.093 . . . . 0.0 109.444 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 50.9 ttp -63.75 -43.81 95.34 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.341 -0.849 . . . . 0.0 110.258 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -65.92 -46.8 76.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.999 -1.063 . . . . 0.0 110.28 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.8 t -66.3 -43.66 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.978 -1.076 . . . . 0.0 109.821 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.474 ' CD1' ' HB2' ' A' ' 66' ' ' LEU . 25.9 t80 -58.83 -47.21 85.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.036 -1.04 . . . . 0.0 110.403 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -75.33 -37.11 60.9 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.668 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -60.59 -39.67 88.95 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.135 -0.978 . . . . 0.0 110.17 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.425 ' CD1' ' HE3' ' A' ' 56' ' ' MET . 91.5 mt -80.09 4.19 18.02 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.01 -1.056 . . . . 0.0 110.658 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.4 tttt 61.25 28.05 17.67 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.938 -1.101 . . . . 0.0 111.983 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.425 ' HE3' ' CD1' ' A' ' 54' ' ' LEU . 54.6 mtt -66.84 -24.56 66.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.02 -1.05 . . . . 0.0 108.669 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -70.46 -8.4 50.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.253 -0.904 . . . . 0.0 111.194 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -85.76 85.79 7.38 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.568 -1.332 . . . . 0.0 111.196 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.6 p -135.0 154.16 51.83 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -61.57 -41.09 96.89 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.069 -1.019 . . . . 0.0 111.929 -177.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.9 mt -100.03 4.63 44.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.008 -1.057 . . . . 0.0 111.21 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 56.28 41.73 28.79 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.303 1.049 . . . . 0.0 111.156 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.411 ' HA ' HG13 ' A' ' 84' ' ' ILE . 88.5 m-20 -119.49 54.31 1.0 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.682 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.415 ' N ' ' OD2' ' A' ' 81' ' ' ASP . . . -100.65 140.23 14.8 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.464 ' CG2' ' CD1' ' A' ' 84' ' ' ILE . 40.9 t -123.7 134.48 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.997 -1.296 . . . . 0.0 110.507 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.474 ' HB2' ' CD1' ' A' ' 51' ' ' PHE . 43.9 tp -116.74 125.93 52.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.367 -0.833 . . . . 0.0 110.108 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 92.9 mt -104.04 105.57 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.043 -1.063 . . . . 0.0 109.493 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -90.7 122.47 33.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.975 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.8 t -122.14 131.04 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 122.024 0.916 . . . . 0.0 111.305 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.28 102.17 12.53 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.429 HG21 ' N ' ' A' ' 72' ' ' GLU . 17.4 m -70.12 -20.67 23.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 110.999 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.437 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 78.2 mm-40 -68.6 -46.25 69.83 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.634 -1.291 . . . . 0.0 109.598 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -99.4 1.9 44.7 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.515 -0.74 . . . . 0.0 110.438 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.411 ' HE3' ' CZ ' ' A' ' 109' ' ' PHE . 38.6 tttt 58.59 48.74 11.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.777 -1.202 . . . . 0.0 110.226 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.9 p -122.47 163.25 20.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.976 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -146.34 145.81 30.45 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.27 -0.894 . . . . 0.0 110.591 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.2 t -132.27 138.8 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.449 -0.782 . . . . 0.0 109.173 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.465 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 71.2 mt -115.14 125.36 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.925 -1.109 . . . . 0.0 109.9 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -131.45 117.92 19.49 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.279 -0.888 . . . . 0.0 110.678 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.47 168.84 16.68 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.415 ' OD2' ' N ' ' A' ' 64' ' ' GLY . 47.3 m-20 -81.73 179.19 7.93 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.606 -0.938 . . . . 0.0 110.444 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -61.6 -28.3 69.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.34 -0.85 . . . . 0.0 111.169 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.67 -56.18 22.82 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.59 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.464 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 81.0 mt -65.41 -45.48 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.774 -1.427 . . . . 0.0 108.423 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -60.55 -38.93 86.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.005 -1.059 . . . . 0.0 111.661 -177.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -71.85 -24.13 61.64 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.072 -1.017 . . . . 0.0 111.878 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 88' ' ' VAL . 8.9 p -102.96 -21.36 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.731 -1.231 . . . . 0.0 113.218 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.485 ' HB ' ' CD2' ' A' ' 92' ' ' PHE . 16.7 m -117.95 162.89 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.829 -1.17 . . . . 0.0 110.964 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.1 p -109.36 -178.71 3.63 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.226 1.012 . . . . 0.0 113.077 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -63.14 -36.29 83.12 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.618 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -64.88 -38.94 92.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.12 -0.987 . . . . 0.0 109.156 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.485 ' CD2' ' HB ' ' A' ' 88' ' ' VAL . 66.1 t80 -65.62 -24.45 67.05 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.194 -0.941 . . . . 0.0 109.16 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.465 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 5.5 m95 -86.55 -26.4 24.54 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.184 0.992 . . . . 0.0 110.355 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -60.11 -36.8 78.25 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.918 -1.114 . . . . 0.0 112.141 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 m -63.33 -34.49 77.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.778 -1.201 . . . . 0.0 108.517 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.273 9.4 m -60.14 -49.92 75.72 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 122.145 0.974 . . . . 0.0 112.592 -179.3 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -67.79 -35.44 78.67 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.48 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -64.1 -43.15 96.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.992 -1.067 . . . . 0.0 110.772 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.65 -48.49 79.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.755 -1.216 . . . . 0.0 110.27 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.8 mt -67.64 -42.67 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.919 -1.113 . . . . 0.0 110.353 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -63.18 -44.6 94.96 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 111.413 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 77.4 mt -63.91 -41.06 97.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.311 -0.868 . . . . 0.0 112.303 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.409 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 98.8 mm-40 -73.93 -40.35 63.15 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 118.615 -1.234 . . . . 0.0 108.892 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -58.82 -41.06 85.94 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.2 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -64.18 -32.68 74.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.401 -0.812 . . . . 0.0 110.779 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -78.02 -19.68 53.92 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.79 -1.194 . . . . 0.0 109.87 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.59 3.39 34.91 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.889 -1.148 . . . . 0.0 111.383 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -105.6 90.55 3.44 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.634 -1.509 . . . . 0.0 110.404 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.411 ' CZ ' ' HE3' ' A' ' 74' ' ' LYS . 21.3 m-85 -64.24 -41.2 97.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.884 -0.51 . . . . 0.0 111.42 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.42 ' NZ ' ' HA ' ' A' ' 12' ' ' GLU . 85.7 tttt -62.98 -49.37 74.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.948 -1.095 . . . . 0.0 111.317 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -62.78 -40.82 98.48 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.055 -1.058 . . . . 0.0 109.888 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.409 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -61.71 -49.36 77.11 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.03 -43.73 91.42 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.323 -1.104 . . . . 0.0 111.757 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.401 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 81.2 t -64.49 -46.54 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.843 -1.16 . . . . 0.0 109.504 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.33 -41.4 96.81 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.456 -0.778 . . . . 0.0 110.803 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.51 -44.91 93.59 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 93.1 mt -65.25 -43.62 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.083 -1.245 . . . . 0.0 110.192 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 114' ' ' VAL . 79.7 mm-40 -55.34 -51.17 67.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.889 -1.132 . . . . 0.0 109.678 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.39 -42.41 99.4 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.3 -0.875 . . . . 0.0 109.088 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.409 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -58.14 -42.6 86.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.18 -0.95 . . . . 0.0 110.152 178.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.6 -44.11 96.98 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 9.4 ttm -67.37 -46.46 73.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.018 -1.284 . . . . 0.0 109.806 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.48 ' HB2' ' CE1' ' A' ' 92' ' ' PHE . . . -61.99 -46.24 90.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.238 -0.914 . . . . 0.0 109.21 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.409 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 66.1 mt -62.66 -40.35 96.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.421 -0.799 . . . . 0.0 108.917 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.73 -34.33 58.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.322 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.11 -43.06 99.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.015 -1.053 . . . . 0.0 109.094 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -75.88 -37.48 58.85 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.616 0.722 . . . . 0.0 109.641 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -128.51 96.2 30.96 Favored Pre-proline 0 N--CA 1.485 1.307 0 O-C-N 121.703 -0.623 . . . . 0.0 109.911 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.98 148.3 81.64 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 O-C-N 123.583 1.307 . . . . 0.0 109.825 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.446 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 65.2 t90 -75.84 136.58 40.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.346 -0.846 . . . . 0.0 110.812 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 99.6 mttt -115.52 151.02 35.61 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 109.078 178.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.92 -29.49 67.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.976 -1.077 . . . . 0.0 111.195 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -91.01 8.23 36.37 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.961 -1.096 . . . . 0.0 111.109 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 42.9 t0 -43.11 139.03 1.95 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.211 -0.931 . . . . 0.0 111.686 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.43 ' CD1' ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -112.92 144.42 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.72 0.771 . . . . 0.0 111.476 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -99.38 92.7 5.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.68 -1.262 . . . . 0.0 110.028 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.58 -39.88 77.08 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.44 150.68 40.93 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.02 -1.05 . . . . 0.0 111.995 -178.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.71 -179.24 3.6 Favored 'Trans proline' 0 N--CA 1.486 1.046 0 O-C-N 123.527 1.278 . . . . 0.0 109.438 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.414 ' ND2' HG21 ' A' ' 20' ' ' ILE . 18.0 m120 -119.44 3.21 11.28 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.45 -1.406 . . . . 0.0 110.462 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.4 p -63.81 167.81 5.64 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.826 -1.171 . . . . 0.0 110.686 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 93.8 mt -94.69 136.27 26.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.649 0.738 . . . . 0.0 111.088 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 27.8 t -94.1 133.99 37.01 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.04 138.89 52.17 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.264 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.054 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.725 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 120.956 0.407 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.1 m -56.96 -42.05 79.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.676 -1.265 . . . . 0.0 110.346 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.4 ' HE2' ' HB2' ' A' ' 5' ' ' GLU . 87.6 tttt -131.89 139.29 48.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.164 -0.96 . . . . 0.0 109.73 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.3 mt -64.18 -43.86 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.188 -0.945 . . . . 0.0 111.115 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.4 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 78.8 mm-40 -62.12 -38.86 90.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.082 -1.011 . . . . 0.0 110.507 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -91.12 94.58 9.66 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.092 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -59.98 -43.01 95.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.164 -0.96 . . . . 0.0 110.472 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.5 mt -131.37 151.77 51.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.033 -1.042 . . . . 0.0 110.616 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.9 p -81.12 168.09 18.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.031 -1.043 . . . . 0.0 109.318 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.61 -35.92 68.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.965 -1.084 . . . . 0.0 109.493 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -61.71 -46.39 89.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.544 -0.722 . . . . 0.0 110.454 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -68.91 -47.88 64.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.277 -0.889 . . . . 0.0 111.474 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.427 ' O ' ' CG2' ' A' ' 17' ' ' VAL . 98.7 mt-10 -61.88 -39.53 92.26 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.035 -1.04 . . . . 0.0 110.245 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.54 -44.5 96.94 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.166 -0.959 . . . . 0.0 111.226 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.59 -46.63 81.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.841 -1.162 . . . . 0.0 110.809 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.429 HG21 ' N ' ' A' ' 17' ' ' VAL . 21.4 tt -65.58 -35.24 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.836 -1.165 . . . . 0.0 109.869 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.429 ' N ' HG21 ' A' ' 16' ' ' ILE . 53.4 t -63.26 -38.5 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 21' ' ' ARG . 63.7 t0 -63.12 -36.36 83.35 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.328 -0.857 . . . . 0.0 109.454 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.37 -38.68 90.51 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.179 -0.951 . . . . 0.0 109.04 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.46 -44.04 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.187 -0.946 . . . . 0.0 109.745 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.432 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 58.6 mtm180 -61.25 -42.19 98.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 110.383 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -64.87 -38.06 89.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.181 -0.95 . . . . 0.0 111.796 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.51 -39.1 93.16 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.886 -1.134 . . . . 0.0 110.527 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.82 -16.22 26.74 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.766 -1.209 . . . . 0.0 110.328 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.476 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.7 mttt -94.86 0.56 54.91 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.057 -1.027 . . . . 0.0 109.968 177.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -114.07 -15.67 12.24 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.751 -1.218 . . . . 0.0 109.714 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 t -151.68 155.91 39.28 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.97 -1.082 . . . . 0.0 109.459 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.9 m -85.84 -6.35 59.1 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.206 -0.934 . . . . 0.0 110.052 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.2 173.5 52.77 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 55.8 mp0 -131.08 136.99 48.9 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.12 -1.224 . . . . 0.0 111.183 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 94.9 mt -118.01 134.68 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.778 -0.576 . . . . 0.0 110.104 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -139.4 151.95 46.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 110.005 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.437 HG23 ' CD1' ' A' ' 67' ' ' ILE . 60.7 t -120.97 136.75 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.409 -0.807 . . . . 0.0 110.4 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -122.31 126.33 47.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.44 -0.787 . . . . 0.0 109.137 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.7 tp -112.48 126.68 55.58 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.846 0.832 . . . . 0.0 111.449 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.428 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 82.8 tt0 -142.79 165.07 28.38 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.428 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 99.0 mttt -81.65 -77.49 0.22 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -176.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.0 t -142.34 158.07 44.11 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.188 -0.945 . . . . 0.0 109.809 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.2 m -113.78 177.51 4.61 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.147 -0.97 . . . . 0.0 111.523 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -102.78 -20.11 14.46 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.615 -0.678 . . . . 0.0 109.871 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.0 mt -112.16 -120.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.015 -1.053 . . . . 0.0 109.519 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -114.46 148.35 37.94 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 119.952 -1.717 . . . . 0.0 108.227 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.492 HG11 ' CE2' ' A' ' 68' ' ' TYR . 63.1 t -60.97 -42.48 93.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 O-C-N 121.118 -0.989 . . . . 0.0 110.269 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -60.13 -45.78 91.87 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.198 -0.939 . . . . 0.0 110.861 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -71.66 -45.49 61.81 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.859 -1.151 . . . . 0.0 109.104 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -60.13 -43.28 95.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.106 -0.996 . . . . 0.0 111.611 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.77 83.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.567 -1.333 . . . . 0.0 110.381 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.1 ttp -62.3 -41.8 98.83 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.138 -0.976 . . . . 0.0 109.716 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -63.41 -42.0 98.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.136 -0.978 . . . . 0.0 109.192 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.2 t -67.06 -42.32 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.5 -0.75 . . . . 0.0 109.659 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.47 ' CZ ' ' OD1' ' A' ' 81' ' ' ASP . 5.8 t80 -58.55 -47.66 83.46 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.93 -1.106 . . . . 0.0 109.415 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -73.0 -35.67 66.88 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 109.966 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -60.16 -35.67 75.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.873 -1.142 . . . . 0.0 109.053 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.82 5.16 26.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.267 -0.896 . . . . 0.0 110.33 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 55.01 32.91 19.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.97 -1.081 . . . . 0.0 111.123 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.469 ' HB2' ' CE1' ' A' ' 51' ' ' PHE . 94.0 mtp -65.94 -12.59 55.95 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.793 -1.192 . . . . 0.0 109.927 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -76.69 -1.61 28.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.723 -1.236 . . . . 0.0 109.781 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -74.87 65.1 1.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.855 -1.153 . . . . 0.0 110.262 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.4 p -134.8 148.78 50.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.074 -1.016 . . . . 0.0 109.272 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -62.56 -43.79 97.93 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.599 -0.688 . . . . 0.0 112.841 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.7 mt -98.18 2.27 48.28 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.903 -1.123 . . . . 0.0 111.804 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 56.53 32.76 21.41 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 122.437 1.113 . . . . 0.0 111.088 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.412 ' HA ' HG13 ' A' ' 84' ' ' ILE . 3.2 m-80 -108.31 53.38 0.69 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.949 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.58 139.37 14.37 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.9 t -123.42 133.78 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -1.157 . . . . 0.0 109.829 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 37.9 tp -117.18 133.06 56.45 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.093 -1.004 . . . . 0.0 109.495 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.437 ' CD1' HG23 ' A' ' 33' ' ' VAL . 83.8 mt -104.32 108.38 24.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 118.809 -1.157 . . . . 0.0 109.369 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.492 ' CE2' HG11 ' A' ' 43' ' ' VAL . 69.3 t80 -95.57 121.06 36.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.318 -0.864 . . . . 0.0 110.014 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.9 t -120.67 130.77 74.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.953 0.883 . . . . 0.0 110.841 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.5 103.26 15.0 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 37' ' ' LYS . 21.5 m -71.88 -18.99 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.992 -1.067 . . . . 0.0 111.048 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -70.27 -46.68 63.88 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.531 -1.356 . . . . 0.0 109.342 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -101.61 4.74 41.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.077 -1.015 . . . . 0.0 110.427 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.7 tttt 53.88 46.91 24.71 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.824 -1.172 . . . . 0.0 110.618 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.9 m -121.07 135.43 55.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.986 -1.071 . . . . 0.0 109.709 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.454 ' CG ' HG23 ' A' ' 100' ' ' ILE . 42.9 p90 -112.15 133.9 54.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.457 -0.777 . . . . 0.0 109.885 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.8 t -126.89 135.67 63.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 120.935 -1.103 . . . . 0.0 108.063 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.408 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 81.6 mt -114.4 128.16 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.888 -1.133 . . . . 0.0 110.679 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -132.27 113.85 13.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.734 -0.603 . . . . 0.0 110.539 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.38 176.82 26.88 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.47 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 92.5 m-20 -82.5 -178.64 7.14 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.629 -0.924 . . . . 0.0 110.437 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.74 -23.34 67.14 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.448 -0.783 . . . . 0.0 109.634 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.15 -54.07 29.56 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.636 -1.268 . . . . 0.0 111.075 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.429 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 2.6 mt -66.33 -45.9 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.734 -1.45 . . . . 0.0 108.456 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -61.67 -37.62 84.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.058 -1.026 . . . . 0.0 111.521 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -75.61 -20.96 58.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.881 -1.137 . . . . 0.0 111.961 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.25 -22.02 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.861 -1.149 . . . . 0.0 112.341 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.446 ' HB ' ' CD2' ' A' ' 92' ' ' PHE . 21.4 m -121.01 162.27 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 120.483 -1.385 . . . . 0.0 111.168 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.1 p -104.51 177.64 4.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.313 -0.867 . . . . 0.0 112.177 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.0 -35.68 79.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.683 -0.635 . . . . 0.0 109.437 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -63.82 -37.19 86.47 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 123' ' ' ALA . 56.6 t80 -65.85 -24.31 66.85 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.09 -1.007 . . . . 0.0 108.606 177.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.408 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 6.8 m95 -87.12 -28.42 22.51 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.796 0.808 . . . . 0.0 110.784 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -57.09 -36.64 70.85 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.493 -0.754 . . . . 0.0 112.327 -176.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 64.5 p -67.38 -32.82 74.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.796 -1.19 . . . . 0.0 109.346 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.284 8.5 m -59.26 -47.78 84.07 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.67 1.224 . . . . 0.0 110.521 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -69.13 -38.54 78.88 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.897 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -64.27 -44.73 90.81 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.687 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.22 -49.42 75.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.694 -1.254 . . . . 0.0 110.967 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.454 HG23 ' CG ' ' A' ' 76' ' ' PHE . 95.9 mt -67.24 -42.4 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.073 -1.017 . . . . 0.0 110.26 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 76' ' ' PHE . 57.8 tt0 -63.58 -40.39 96.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.916 -1.115 . . . . 0.0 110.814 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 40.4 mt -63.39 -42.62 98.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.117 -0.989 . . . . 0.0 111.929 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.445 ' CB ' ' CA ' ' A' ' 112' ' ' GLY . 88.0 mm-40 -75.15 -40.48 59.6 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.904 -1.119 . . . . 0.0 108.885 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.429 ' CD1' HG22 ' A' ' 100' ' ' ILE . 3.7 m-85 -60.26 -41.8 94.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 108.936 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.78 -29.71 70.91 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.541 -0.724 . . . . 0.0 109.554 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -81.34 -20.02 41.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.027 -1.046 . . . . 0.0 110.003 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.73 -0.94 34.11 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.744 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -102.45 95.99 6.63 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.531 -1.57 . . . . 0.0 110.854 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -63.13 -41.45 99.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.847 -0.533 . . . . 0.0 111.774 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -65.5 -49.07 70.39 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.371 -0.932 . . . . 0.0 112.446 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.76 -39.75 95.02 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 118.859 -1.136 . . . . 0.0 110.594 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.445 ' CA ' ' CB ' ' A' ' 103' ' ' GLN . . . -62.41 -48.05 85.06 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.48 -1.343 . . . . 0.0 109.946 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.5 mt -63.65 -44.33 94.12 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.504 -0.998 . . . . 0.0 110.308 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 78.7 t -65.23 -47.57 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.95 -1.094 . . . . 0.0 110.858 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -65.76 -41.12 92.49 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 110.805 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.07 -41.21 98.59 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 98.1 mt -63.54 -42.99 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.141 -1.211 . . . . 0.0 109.585 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -59.19 -47.29 85.85 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.941 -1.099 . . . . 0.0 109.624 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.37 -42.54 99.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.383 -0.823 . . . . 0.0 109.333 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -58.71 -42.64 89.14 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.124 -0.985 . . . . 0.0 109.657 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.89 -43.04 96.61 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.637 -1.268 . . . . 0.0 109.99 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 90.8 mtp -67.19 -45.35 77.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.15 -1.206 . . . . 0.0 110.488 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 92' ' ' PHE . . . -64.24 -42.52 96.49 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.301 -0.96 . . . . 0.0 108.626 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.4 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 73.7 mt -64.56 -39.82 94.44 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.546 -0.721 . . . . 0.0 109.58 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.71 -34.19 58.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.029 -1.044 . . . . 0.0 110.472 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -63.05 -42.91 99.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.024 -1.047 . . . . 0.0 109.492 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.412 ' HB3' ' CE1' ' A' ' 128' ' ' PHE . 53.9 m-85 -70.22 -42.64 72.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.473 -0.767 . . . . 0.0 110.014 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.412 ' CE1' ' HB3' ' A' ' 127' ' ' TYR . 83.1 m-85 -127.92 101.72 22.81 Favored Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 121.495 -0.753 . . . . 0.0 109.931 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.2 152.07 80.19 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.81 1.426 . . . . 0.0 109.877 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.476 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 43.4 t90 -78.79 137.64 37.82 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.624 -0.672 . . . . 0.0 111.173 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -115.28 149.18 38.21 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.318 -0.864 . . . . 0.0 109.526 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -57.81 -28.52 64.12 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 111.236 -177.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -91.13 9.96 28.88 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.921 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.428 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 66.3 t0 -43.12 137.09 2.63 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.358 -0.839 . . . . 0.0 111.575 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.502 HD12 HG21 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -110.43 136.12 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.734 0.778 . . . . 0.0 111.484 -178.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -115.12 100.68 8.34 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -101.26 -4.45 27.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.896 -1.127 . . . . 0.0 111.933 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.86 145.41 30.66 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.938 -1.101 . . . . 0.0 110.983 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -70.32 166.38 28.48 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.669 1.352 . . . . 0.0 109.468 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.432 ' ND2' ' HG2' ' A' ' 21' ' ' ARG . 62.8 m-80 -109.66 7.46 24.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.568 -1.333 . . . . 0.0 110.77 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.6 p -65.85 171.15 4.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.911 -1.118 . . . . 0.0 111.329 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 91.1 mt -97.88 140.43 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 121.387 0.613 . . . . 0.0 110.707 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 18.1 t -94.48 134.32 37.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 109.829 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -129.1 148.1 51.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 110.451 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 CA-C-O 117.964 -1.465 . . . . 0.0 109.784 -179.796 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.6 mmm . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.351 0.596 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.2 p -67.57 -21.55 65.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.435 -0.791 . . . . 0.0 111.211 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -107.04 127.09 53.15 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.089 -1.007 . . . . 0.0 110.314 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.62 -23.34 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.561 -0.712 . . . . 0.0 110.285 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -54.03 -43.56 70.23 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.453 -0.779 . . . . 0.0 111.256 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -126.52 133.93 51.02 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.845 -1.159 . . . . 0.0 110.088 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.591 ' CZ ' ' CE2' ' A' ' 109' ' ' PHE . 28.3 t80 -62.72 -44.36 96.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.298 -0.876 . . . . 0.0 110.82 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 74.9 mt -126.31 150.49 48.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.251 -0.906 . . . . 0.0 109.539 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.3 p -78.1 165.79 23.57 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.908 -1.12 . . . . 0.0 109.692 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.42 -35.61 68.0 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.953 -1.092 . . . . 0.0 109.857 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -58.9 -46.36 88.07 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.395 -0.816 . . . . 0.0 109.99 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.43 ' HA ' ' CE ' ' A' ' 110' ' ' LYS . 98.9 mt-10 -69.2 -46.17 68.08 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.311 -0.868 . . . . 0.0 111.067 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -64.76 -39.53 93.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.136 -0.977 . . . . 0.0 110.755 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.47 -45.17 94.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.162 -0.961 . . . . 0.0 110.877 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.51 -41.09 98.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.972 . . . . 0.0 110.481 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.2 mt -64.64 -43.47 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 111.208 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.432 ' CG2' HG12 ' A' ' 142' ' ' ILE . 45.4 t -60.99 -42.77 94.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 108.788 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -61.27 -37.67 83.98 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.492 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.76 94.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.506 -0.746 . . . . 0.0 109.811 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 91.5 mt -63.83 -43.42 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 109.404 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -55.59 -44.63 77.14 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.502 -0.749 . . . . 0.0 109.682 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -63.19 -37.41 87.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.473 -0.767 . . . . 0.0 110.986 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.45 -37.94 89.22 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.977 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.425 ' OE1' ' ND2' ' A' ' 140' ' ' ASN . 3.3 mp0 -60.83 -15.34 29.07 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.804 -1.185 . . . . 0.0 111.091 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.7 mttt -94.61 -1.53 53.07 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 120.912 -1.118 . . . . 0.0 109.499 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -111.15 -15.09 13.76 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.857 -1.152 . . . . 0.0 110.188 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.1 t -152.68 160.28 43.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.023 -1.048 . . . . 0.0 109.45 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.1 m -88.17 -5.52 58.37 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.986 -1.071 . . . . 0.0 110.344 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.93 170.04 52.14 Favored Glycine 0 N--CA 1.482 1.723 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -129.68 136.86 50.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.258 -1.142 . . . . 0.0 110.723 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.2 mt -119.22 134.96 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.595 -0.69 . . . . 0.0 110.71 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -139.47 153.24 47.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.389 -0.82 . . . . 0.0 109.923 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.7 t -123.42 141.01 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.302 -0.874 . . . . 0.0 110.952 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -122.95 124.82 44.05 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.8 tp -112.61 129.0 56.53 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.938 0.875 . . . . 0.0 111.286 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -146.42 164.77 31.4 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -79.73 -73.88 0.33 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.112 -0.992 . . . . 0.0 112.898 -177.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.33 157.24 46.23 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.262 -0.899 . . . . 0.0 110.133 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.8 m -103.06 165.07 11.24 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.624 -0.673 . . . . 0.0 110.166 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -104.23 -14.23 15.9 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.353 -0.842 . . . . 0.0 109.794 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.426 HG13 ' N ' ' A' ' 42' ' ' ASP . 29.8 pt -124.8 -122.01 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.052 -1.03 . . . . 0.0 110.052 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.426 ' N ' HG13 ' A' ' 41' ' ' ILE . 95.3 m-20 -110.73 139.17 46.26 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.16 -1.587 . . . . 0.0 109.359 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 84.3 t -64.59 -43.92 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.299 -0.875 . . . . 0.0 111.902 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -60.05 -45.42 92.91 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.72 -1.237 . . . . 0.0 110.123 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -70.98 -38.1 72.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.851 -1.156 . . . . 0.0 109.365 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 50.1 ttt85 -65.97 -43.1 88.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.774 -1.203 . . . . 0.0 110.266 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.75 -37.59 88.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.87 -1.144 . . . . 0.0 110.224 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 62.3 ttp -64.23 -43.23 95.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.137 -0.977 . . . . 0.0 109.153 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -63.85 -41.97 97.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.937 -1.102 . . . . 0.0 109.251 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 74.2 t -67.61 -42.87 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.502 -0.749 . . . . 0.0 109.833 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -59.8 -46.85 87.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.88 -1.138 . . . . 0.0 109.491 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -74.94 -36.12 62.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.967 -1.083 . . . . 0.0 109.764 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -61.07 -38.42 86.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.067 -1.02 . . . . 0.0 109.442 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.5 mt -81.89 4.05 23.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.0 110.048 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.43 33.96 23.4 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.288 -0.883 . . . . 0.0 111.941 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.431 ' CE ' ' HB2' ' A' ' 66' ' ' LEU . 95.7 mtp -69.22 -15.02 63.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.089 -1.007 . . . . 0.0 109.922 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 44.9 p-10 -78.45 -5.32 52.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.831 -1.168 . . . . 0.0 110.138 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 65.1 t-20 -88.64 78.8 7.67 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.788 -1.195 . . . . 0.0 110.409 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.3 m -137.02 154.91 50.26 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.19 -44.44 97.28 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 111.599 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 90.5 mt -99.94 -2.4 34.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.757 -1.215 . . . . 0.0 111.389 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 87.7 mt-30 59.32 49.92 8.37 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.245 1.021 . . . . 0.0 111.265 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -122.22 54.15 1.2 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.479 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.92 143.33 16.16 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.46 ' CG2' ' CD1' ' A' ' 84' ' ' ILE . 54.0 t -124.12 134.75 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.907 -1.349 . . . . 0.0 110.715 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.431 ' HB2' ' CE ' ' A' ' 56' ' ' MET . 39.7 tp -117.1 125.16 50.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.568 -0.708 . . . . 0.0 109.893 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 67' ' ' ILE . 83.2 mt -102.3 110.88 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.602 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -96.37 120.75 37.25 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.168 -0.957 . . . . 0.0 110.027 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.9 t -122.39 131.11 73.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.297 -0.877 . . . . 0.0 110.922 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.91 90.52 4.45 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.514 ' HB ' ' CE1' ' A' ' 7' ' ' PHE . 17.4 m -60.26 -24.16 29.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.298 -0.876 . . . . 0.0 111.375 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -67.51 -41.12 84.94 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.989 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -103.33 4.06 35.98 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.072 -1.017 . . . . 0.0 110.685 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 45.2 tttt 55.86 45.72 23.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.827 -1.171 . . . . 0.0 110.752 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 72.4 p -119.97 163.37 17.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.966 . . . . 0.0 109.32 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -142.79 146.09 33.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.104 -0.998 . . . . 0.0 110.578 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.7 t -134.74 138.47 49.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.515 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 88.7 mt -117.17 125.65 74.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 118.977 -1.089 . . . . 0.0 110.416 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -128.07 114.22 16.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.806 -0.559 . . . . 0.0 110.325 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.89 171.1 22.36 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -81.14 174.44 11.57 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.493 -1.004 . . . . 0.0 110.013 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.02 -26.67 66.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.989 . . . . 0.0 111.656 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.88 -52.11 45.19 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.807 -1.187 . . . . 0.0 110.416 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.46 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 97.1 mt -64.71 -43.47 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.783 -1.422 . . . . 0.0 108.122 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -63.4 -36.93 85.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.518 -1.364 . . . . 0.0 111.476 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -74.21 -20.92 60.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.845 -1.159 . . . . 0.0 112.166 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 84' ' ' ILE . 32.9 m -105.64 -18.51 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.745 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.449 ' HB ' ' CD1' ' A' ' 92' ' ' PHE . 4.0 m -119.82 160.28 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 120.67 -1.268 . . . . 0.0 111.47 -178.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.1 m -107.17 176.71 5.08 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.81 0.814 . . . . 0.0 112.005 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -61.86 -36.95 82.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.611 -0.681 . . . . 0.0 109.48 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -62.19 -38.22 88.28 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.422 -0.911 . . . . 0.0 108.922 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.48 ' CE2' ' CB ' ' A' ' 123' ' ' ALA . 55.3 t80 -64.05 -26.62 68.64 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.539 -0.726 . . . . 0.0 109.356 178.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.515 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 4.9 m95 -86.95 -25.81 24.17 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.938 0.875 . . . . 0.0 110.989 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -56.92 -36.78 70.59 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.429 -0.795 . . . . 0.0 111.712 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.8 m -64.32 -33.66 76.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.767 -1.208 . . . . 0.0 108.983 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.279 7.4 m -59.82 -49.89 75.94 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 122.358 1.075 . . . . 0.0 111.379 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.69 -38.6 87.09 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.707 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -64.01 -45.03 90.78 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.946 -1.102 . . . . 0.0 110.439 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.1 -50.91 72.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.592 -1.318 . . . . 0.0 110.484 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 86.8 mt -67.81 -42.72 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.905 -1.122 . . . . 0.0 110.17 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -62.62 -46.72 86.94 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.516 -0.74 . . . . 0.0 111.086 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.425 HD22 ' N ' ' A' ' 102' ' ' LEU . 4.3 mm? -63.53 -41.54 98.46 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.007 -1.058 . . . . 0.0 112.043 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.408 ' HB2' ' HA3' ' A' ' 112' ' ' GLY . 99.4 mm-40 -72.15 -40.24 68.16 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.176 -1.41 . . . . 0.0 108.594 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -59.26 -40.82 87.2 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.784 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -62.38 -34.55 76.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -0.868 . . . . 0.0 110.928 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -83.6 -17.34 41.99 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.528 -1.357 . . . . 0.0 110.319 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.26 11.38 25.78 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.172 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -107.94 83.0 1.72 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.873 -1.369 . . . . 0.0 110.451 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.591 ' CE2' ' CZ ' ' A' ' 7' ' ' PHE . 6.8 m-85 -62.5 -43.71 98.15 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.151 -0.968 . . . . 0.0 111.026 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.43 ' CE ' ' HA ' ' A' ' 12' ' ' GLU . 60.9 tttm -61.13 -47.85 84.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 0.0 111.446 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -64.1 -37.85 88.94 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.954 -1.091 . . . . 0.0 110.843 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 103' ' ' GLN . . . -62.49 -49.04 77.39 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.496 -1.335 . . . . 0.0 109.823 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.47 -43.96 97.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -1.161 . . . . 0.0 110.926 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 76.4 t -65.91 -46.82 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.906 -1.121 . . . . 0.0 110.325 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -65.01 -40.1 94.39 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.538 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.89 -43.74 93.21 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.3 mt -64.51 -44.33 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -1.14 . . . . 0.0 109.368 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -58.98 -49.08 79.25 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.045 -1.034 . . . . 0.0 109.632 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.34 -41.21 98.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.205 -0.934 . . . . 0.0 109.447 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.417 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -57.58 -42.04 82.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.202 -0.937 . . . . 0.0 110.072 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.59 -43.56 96.32 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.67 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 96.6 mtp -68.33 -45.37 73.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.914 -1.345 . . . . 0.0 110.285 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.48 ' CB ' ' CE2' ' A' ' 92' ' ' PHE . . . -63.56 -45.93 88.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.118 -0.989 . . . . 0.0 108.761 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.417 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 72.7 mt -61.87 -40.5 95.58 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.47 -34.08 56.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 110.4 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.58 -44.65 93.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.002 -1.061 . . . . 0.0 109.366 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -71.54 -41.47 69.09 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.45 0.643 . . . . 0.0 109.65 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -130.54 97.69 21.35 Favored Pre-proline 0 C--N 1.307 -1.251 0 O-C-N 121.514 -0.741 . . . . 0.0 109.828 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.75 152.87 80.39 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.575 1.303 . . . . 0.0 110.707 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.481 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 47.7 t90 -76.57 127.07 32.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.556 -0.715 . . . . 0.0 110.689 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -103.35 146.96 27.69 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.151 -0.968 . . . . 0.0 109.041 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -56.71 -28.44 60.96 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.103 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.4 p30 -93.68 6.76 47.26 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.012 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 135' ' ' ILE . 67.1 t0 -42.55 140.24 1.31 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.705 0.764 . . . . 0.0 111.622 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.455 ' CD1' ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -115.38 146.08 20.28 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 CA-C-O 121.576 0.703 . . . . 0.0 110.891 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -103.23 97.45 7.53 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.356 -1.465 . . . . 0.0 110.58 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -68.14 -35.72 78.56 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.1 mp -110.87 151.06 42.69 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.895 -1.128 . . . . 0.0 111.923 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -72.48 -174.69 1.52 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 N-CA-C 108.448 -1.405 . . . . 0.0 108.448 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.425 ' ND2' ' OE1' ' A' ' 24' ' ' GLU . 10.5 m120 -123.02 2.51 9.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.592 -1.318 . . . . 0.0 110.116 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -58.2 170.25 0.71 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.934 -1.104 . . . . 0.0 111.348 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.432 HG12 ' CG2' ' A' ' 17' ' ' VAL . 49.6 mm -95.17 133.17 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.66 -0.65 . . . . 0.0 111.039 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 69.5 m -93.08 131.24 38.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.534 -0.729 . . . . 0.0 109.093 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -127.03 135.99 51.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.884 -1.135 . . . . 0.0 110.591 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.398 0 CA-C-O 117.935 -1.481 . . . . 0.0 109.72 -179.768 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptm . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.148 0.499 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.0 t -63.16 -44.18 96.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 110.852 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -126.25 126.55 44.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.295 -0.878 . . . . 0.0 110.314 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 96.0 mt -119.92 131.83 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.089 -1.007 . . . . 0.0 110.232 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -101.59 54.74 0.82 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.2 -0.938 . . . . 0.0 110.703 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 55.04 23.04 4.83 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.358 -0.839 . . . . 0.0 110.304 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.517 ' CG ' ' CD2' ' A' ' 35' ' ' LEU . 26.6 t80 -78.02 -80.28 0.11 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.009 -1.057 . . . . 0.0 109.892 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.487 HD11 ' CZ ' ' A' ' 7' ' ' PHE . 90.8 mt -132.4 150.87 52.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.891 . . . . 0.0 110.226 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.0 p -78.06 169.95 17.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.099 -1.001 . . . . 0.0 109.383 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.73 -39.73 68.55 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.797 -1.19 . . . . 0.0 109.422 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -62.8 -40.36 97.12 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.473 -0.767 . . . . 0.0 109.51 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.415 ' CB ' ' HB3' ' A' ' 8' ' ' LEU . 97.5 mt-10 -73.62 -46.59 45.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.105 -0.997 . . . . 0.0 110.696 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.431 ' O ' ' CG2' ' A' ' 17' ' ' VAL . 96.8 mt-10 -67.04 -34.56 77.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.112 -0.993 . . . . 0.0 110.265 178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -64.77 -44.7 89.19 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.753 -1.217 . . . . 0.0 110.075 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.94 -47.02 79.18 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.134 -0.979 . . . . 0.0 111.409 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.406 HG23 ' O ' ' A' ' 13' ' ' GLU . 20.4 tt -64.06 -36.25 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.773 -1.205 . . . . 0.0 110.174 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 13' ' ' GLU . 55.4 t -61.28 -38.36 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -64.25 -36.18 83.25 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.775 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.98 -40.15 94.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.06 -1.025 . . . . 0.0 109.566 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 83.6 mt -63.14 -43.79 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 109.399 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -62.2 -43.72 98.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.45 -0.781 . . . . 0.0 110.694 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -63.08 -38.9 93.04 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.162 -0.961 . . . . 0.0 111.41 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.9 -37.89 88.74 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.206 -0.997 . . . . 0.0 109.291 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.2 -15.99 29.22 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.101 -0.999 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.478 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 75.5 mmtt -94.88 -3.6 48.48 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.013 -1.054 . . . . 0.0 109.544 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -108.69 -13.48 14.79 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 121.176 -0.953 . . . . 0.0 109.813 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.8 t -156.35 161.15 40.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.014 -1.054 . . . . 0.0 110.049 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.3 m -87.21 -12.13 47.73 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.371 -0.831 . . . . 0.0 108.78 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.39 167.09 40.89 Favored Glycine 0 N--CA 1.477 1.394 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.424 ' OE2' ' N ' ' A' ' 137' ' ' GLU . 97.8 mt-10 -135.59 141.6 45.16 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 118.9 -1.12 . . . . 0.0 112.229 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.6 mt -123.61 135.77 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.237 0.541 . . . . 0.0 110.547 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 143' ' ' SER . 68.8 ttt180 -139.88 163.06 33.65 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.198 -0.939 . . . . 0.0 109.746 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 p -131.97 142.4 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.157 -0.964 . . . . 0.0 111.687 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -126.98 125.56 41.7 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.452 -0.78 . . . . 0.0 109.442 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.517 ' CD2' ' CG ' ' A' ' 7' ' ' PHE . 47.5 tp -108.4 128.56 54.88 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 122.07 0.938 . . . . 0.0 112.019 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.41 ' OE2' ' CZ ' ' A' ' 46' ' ' ARG . 82.2 tt0 -144.87 159.68 42.51 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.406 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 97.8 mttt -79.32 -75.66 0.24 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.063 -1.023 . . . . 0.0 112.94 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.6 t -136.57 155.34 50.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.299 -0.876 . . . . 0.0 110.214 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.5 p -103.77 170.79 7.72 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.415 -0.803 . . . . 0.0 110.365 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.414 ' OE1' ' N ' ' A' ' 40' ' ' GLU . 56.0 mp0 -108.37 -12.61 15.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.472 -0.768 . . . . 0.0 110.414 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.8 pt -124.31 -122.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.149 -0.969 . . . . 0.0 108.586 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -111.84 140.81 46.18 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 120.434 -1.416 . . . . 0.0 109.687 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.409 HG13 ' CE1' ' A' ' 68' ' ' TYR . 94.4 t -64.15 -42.74 96.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.372 -0.83 . . . . 0.0 110.683 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -59.92 -46.75 88.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.955 -1.091 . . . . 0.0 109.938 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -69.81 -36.8 75.96 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.79 -1.194 . . . . 0.0 108.772 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.41 ' CZ ' ' OE2' ' A' ' 36' ' ' GLU . 61.3 ttt85 -64.1 -42.85 96.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -0.916 . . . . 0.0 110.949 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.6 83.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.722 -1.236 . . . . 0.0 110.499 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 60.2 ttp -62.89 -42.28 99.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.034 -1.042 . . . . 0.0 108.975 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -65.88 -44.7 84.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.137 -0.977 . . . . 0.0 110.361 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.44 -43.44 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.365 -0.834 . . . . 0.0 110.411 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.488 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 2.9 t80 -58.77 -47.92 83.0 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.7 -1.25 . . . . 0.0 108.996 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -72.16 -35.66 69.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.043 -1.036 . . . . 0.0 109.703 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -60.54 -39.35 87.57 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.6 mt -80.2 5.26 15.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.155 -0.966 . . . . 0.0 110.361 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 55.76 33.94 22.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.818 -1.176 . . . . 0.0 111.926 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.488 ' HB2' ' CE1' ' A' ' 51' ' ' PHE . 94.1 mtp -65.55 -11.01 40.04 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.988 -1.07 . . . . 0.0 110.236 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -77.53 0.57 22.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.819 -1.176 . . . . 0.0 110.284 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -74.57 62.25 1.01 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.851 -1.156 . . . . 0.0 110.062 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 65.3 p -135.19 148.47 49.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.107 -0.996 . . . . 0.0 109.631 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -64.44 -40.98 96.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.75 -0.594 . . . . 0.0 112.276 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 95.7 mt -98.66 -0.15 43.53 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.904 -1.122 . . . . 0.0 111.448 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 85.7 mt-30 57.71 45.77 18.38 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 122.5 1.143 . . . . 0.0 111.148 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.426 ' HA ' HG13 ' A' ' 84' ' ' ILE . 38.0 p30 -118.96 53.61 1.0 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.072 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.39 140.98 15.13 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.465 ' CG2' ' CD1' ' A' ' 84' ' ' ILE . 67.3 t -125.55 134.74 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.043 -1.269 . . . . 0.0 110.34 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.448 ' HB2' ' CD2' ' A' ' 51' ' ' PHE . 38.5 tp -117.51 133.68 55.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.339 -0.851 . . . . 0.0 110.24 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.2 mt -106.82 108.83 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 118.75 -1.18 . . . . 0.0 109.557 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.409 ' CE1' HG13 ' A' ' 43' ' ' VAL . 61.2 t80 -95.45 117.71 30.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 110.181 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.1 t -118.19 128.34 75.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 121.726 0.774 . . . . 0.0 110.356 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.26 88.49 5.17 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.73 -23.81 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.036 -1.04 . . . . 0.0 110.907 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 47.7 tp10 -67.73 -41.89 82.73 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.779 -1.2 . . . . 0.0 108.85 178.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -104.77 8.6 34.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.053 -1.03 . . . . 0.0 111.259 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 104' ' ' PHE . 85.3 tttt 52.12 45.17 28.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.875 -1.141 . . . . 0.0 110.407 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.8 p -122.33 159.15 28.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.803 -1.186 . . . . 0.0 109.135 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -141.53 148.37 39.24 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.21 -0.932 . . . . 0.0 110.364 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 66.1 t -134.19 137.13 52.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.523 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 75.8 mt -113.74 127.83 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.859 -1.151 . . . . 0.0 110.174 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -135.02 114.67 12.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.576 -0.702 . . . . 0.0 110.624 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -99.77 171.47 23.88 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.474 ' OD1' ' CE1' ' A' ' 51' ' ' PHE . 78.1 m-20 -75.33 171.28 14.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.399 -1.059 . . . . 0.0 110.653 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -58.64 -26.46 63.78 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.592 -0.692 . . . . 0.0 110.444 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.1 -53.34 30.48 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.465 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 87.6 mt -63.51 -44.74 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.944 -1.327 . . . . 0.0 107.893 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -62.21 -36.87 83.26 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.833 -1.167 . . . . 0.0 111.396 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -70.63 -24.26 62.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.861 -1.15 . . . . 0.0 111.78 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 84' ' ' ILE . 25.7 m -105.74 -16.45 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 120.642 -1.286 . . . . 0.0 112.909 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 84' ' ' ILE . 18.8 m -116.45 162.07 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 120.338 -1.476 . . . . 0.0 112.002 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.3 t -109.41 174.46 5.86 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.597 0.713 . . . . 0.0 111.809 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 33.0 p-10 -61.61 -35.85 79.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 110.147 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -62.42 -40.59 97.03 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.821 -1.174 . . . . 0.0 109.781 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.479 ' CZ ' ' HB1' ' A' ' 123' ' ' ALA . 87.8 t80 -63.15 -25.52 68.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.123 -0.985 . . . . 0.0 109.333 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.523 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 4.2 m95 -86.88 -24.64 24.82 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.955 0.883 . . . . 0.0 110.876 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -57.1 -38.81 73.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.063 -1.023 . . . . 0.0 112.455 -177.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.9 p -63.61 -31.84 73.14 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.53 -1.268 . . . . 0.0 109.199 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.272 15.1 m -59.93 -48.06 83.22 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.379 1.085 . . . . 0.0 111.031 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -68.98 -38.57 79.41 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.25 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -64.03 -44.26 93.08 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.827 -1.171 . . . . 0.0 110.669 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.88 -49.77 73.54 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.832 -1.167 . . . . 0.0 111.348 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 91.4 mt -67.34 -42.42 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.073 -1.017 . . . . 0.0 110.329 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -65.16 -40.92 95.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.243 -0.911 . . . . 0.0 110.602 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.8 tp -62.22 -42.13 99.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.209 -0.932 . . . . 0.0 111.13 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.421 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 95.8 mm-40 -76.9 -40.0 48.89 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.136 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.415 ' O ' ' CE ' ' A' ' 74' ' ' LYS . 2.8 m-85 -58.41 -41.82 85.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.145 -0.972 . . . . 0.0 108.55 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.43 -32.12 73.47 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.635 -0.665 . . . . 0.0 110.444 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -78.69 -20.07 51.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.741 -1.225 . . . . 0.0 109.911 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.17 4.7 41.15 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.41 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -103.66 86.31 2.6 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.743 -1.445 . . . . 0.0 110.097 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -61.62 -43.03 99.62 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.371 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -61.71 -47.95 82.96 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.97 -1.081 . . . . 0.0 111.377 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -64.55 -38.11 89.87 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.21 -0.932 . . . . 0.0 110.488 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.421 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -63.84 -49.54 67.4 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.51 -44.73 93.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.145 -1.209 . . . . 0.0 110.959 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.03 -47.77 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.137 -0.977 . . . . 0.0 110.115 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -62.84 -40.88 98.77 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.922 -1.111 . . . . 0.0 110.571 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.29 -42.24 97.23 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -43.99 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.228 -1.16 . . . . 0.0 109.698 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -58.28 -54.62 44.93 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.05 -1.031 . . . . 0.0 110.597 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.34 -39.97 92.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.122 -0.986 . . . . 0.0 108.691 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.55 -41.58 90.41 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.312 -0.867 . . . . 0.0 109.713 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.17 -44.3 97.34 Favored Glycine 0 N--CA 1.495 2.607 0 O-C-N 120.761 -1.212 . . . . 0.0 111.01 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 64.6 ttp -67.91 -48.03 67.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.874 -1.368 . . . . 0.0 109.898 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.479 ' HB1' ' CZ ' ' A' ' 92' ' ' PHE . . . -59.99 -46.52 89.19 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.058 -1.026 . . . . 0.0 109.234 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.96 -41.01 97.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 109.45 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.14 -32.23 54.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 110.335 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.77 -44.41 96.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.129 -0.982 . . . . 0.0 109.848 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -72.37 -41.79 65.97 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.537 0.684 . . . . 0.0 110.276 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -132.05 100.71 15.55 Favored Pre-proline 0 C--N 1.304 -1.404 0 O-C-N 121.54 -0.725 . . . . 0.0 109.657 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.42 150.72 80.78 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.57 1.3 . . . . 0.0 110.932 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.478 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 60.3 t90 -75.13 133.84 41.42 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.645 -0.659 . . . . 0.0 110.546 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -114.06 153.59 29.16 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 109.495 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.44 -28.98 65.77 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.035 -1.04 . . . . 0.0 110.63 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -93.3 7.54 43.96 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.311 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.401 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 52.2 t0 -42.43 138.43 1.78 Allowed 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.77 0.795 . . . . 0.0 111.361 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.434 ' CD1' ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -114.36 148.2 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 121.896 0.855 . . . . 0.0 111.967 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -108.55 96.03 6.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.641 -1.287 . . . . 0.0 110.382 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.424 ' N ' ' OE2' ' A' ' 30' ' ' GLU . 81.2 mm-40 -67.81 -32.31 72.77 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.594 -0.692 . . . . 0.0 111.662 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 33.7 mt -110.06 154.46 42.72 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.185 -0.947 . . . . 0.0 111.856 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -79.4 -167.27 0.48 Allowed 'Trans proline' 0 C--N 1.319 -1.014 0 N-CA-C 108.436 -1.409 . . . . 0.0 108.436 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -124.0 3.21 8.69 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.468 -1.395 . . . . 0.0 110.392 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.3 p -63.24 166.75 5.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.884 -1.135 . . . . 0.0 111.13 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.8 mt -96.09 137.87 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.823 -0.548 . . . . 0.0 110.258 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 32' ' ' ARG . 25.1 t -96.35 137.23 35.73 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.208 -0.933 . . . . 0.0 109.713 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -128.13 145.15 51.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.004 -1.06 . . . . 0.0 110.284 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.903 0 CA-C-O 117.972 -1.46 . . . . 0.0 110.296 179.898 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.8 mtp . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 121.414 0.626 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.0 t -138.73 157.87 45.28 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.41 -0.807 . . . . 0.0 110.674 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -82.74 125.44 31.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 109.773 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.2 pt -78.72 -19.62 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.097 -1.002 . . . . 0.0 110.412 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -90.47 30.4 1.15 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.103 -0.998 . . . . 0.0 111.602 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -68.15 -35.9 78.8 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.169 -1.012 . . . . 0.0 109.527 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.528 ' CE1' ' CG2' ' A' ' 71' ' ' VAL . 65.0 m-85 -62.83 -43.47 98.72 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.19 -0.944 . . . . 0.0 111.601 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.1 mt -127.63 149.97 49.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.922 . . . . 0.0 110.238 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 p -85.77 164.67 17.45 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.073 -1.017 . . . . 0.0 108.782 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.59 -37.03 65.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.948 -1.095 . . . . 0.0 109.864 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -60.87 -45.46 94.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 110.498 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -70.02 -45.38 67.33 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.239 -0.913 . . . . 0.0 110.8 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.18 -37.18 86.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.111 -0.993 . . . . 0.0 110.384 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -66.0 -44.0 86.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.968 -1.082 . . . . 0.0 111.959 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.18 -44.4 88.56 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.747 -1.221 . . . . 0.0 111.106 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.401 HD11 ' HB3' ' A' ' 113' ' ' LEU . 17.2 tt -65.92 -34.69 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.848 -1.158 . . . . 0.0 109.917 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.429 HG12 ' ND2' ' A' ' 140' ' ' ASN . 55.1 t -63.65 -40.49 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.88 -36.64 83.99 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.441 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.82 -38.71 91.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.205 -0.934 . . . . 0.0 108.904 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.432 ' CG2' ' HB2' ' A' ' 140' ' ' ASN . 30.5 mm -62.87 -43.66 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.401 -0.812 . . . . 0.0 108.9 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.95 -43.3 98.92 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.542 -0.723 . . . . 0.0 109.976 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -64.71 -39.26 93.35 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.26 -0.9 . . . . 0.0 111.258 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.95 -39.27 93.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.045 -1.034 . . . . 0.0 109.616 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.12 -17.62 41.52 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.026 -1.046 . . . . 0.0 110.126 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.5 mttt -93.61 -3.3 52.84 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 121.178 -0.951 . . . . 0.0 109.733 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -107.57 -15.49 14.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.905 -1.122 . . . . 0.0 109.885 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.6 t -152.75 160.54 43.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.036 -1.04 . . . . 0.0 109.732 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.9 p -86.96 -8.73 56.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.959 -1.088 . . . . 0.0 109.534 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.66 170.84 42.28 Favored Glycine 0 N--CA 1.482 1.725 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -131.35 137.07 48.59 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.526 -0.985 . . . . 0.0 111.342 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -121.23 134.1 65.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.804 -0.56 . . . . 0.0 109.8 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -137.49 151.09 48.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.129 -0.982 . . . . 0.0 109.65 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.6 t -121.7 138.06 53.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.545 -0.722 . . . . 0.0 110.791 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.427 ' ND1' ' O ' ' A' ' 143' ' ' SER . 60.3 t60 -123.18 127.01 48.05 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.456 ' CD1' ' CG1' ' A' ' 71' ' ' VAL . 32.5 tp -113.93 125.81 54.46 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.85 0.833 . . . . 0.0 111.832 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -143.22 161.75 37.44 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -77.35 -71.36 0.41 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.994 -1.066 . . . . 0.0 113.469 -177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.418 ' CG2' ' OE1' ' A' ' 72' ' ' GLU . 8.0 t -140.13 159.01 43.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 110.462 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.9 m -107.1 164.72 11.92 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.824 -0.547 . . . . 0.0 110.128 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -105.8 -11.04 16.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.146 -0.971 . . . . 0.0 110.315 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.8 pt -125.13 -122.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.912 -1.118 . . . . 0.0 109.075 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -110.89 140.39 45.4 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.073 -1.642 . . . . 0.0 109.204 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.4 t -64.61 -42.92 96.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.283 -0.886 . . . . 0.0 110.986 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -59.43 -47.0 87.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.97 -1.081 . . . . 0.0 110.917 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -69.09 -39.0 79.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.59 -1.319 . . . . 0.0 108.359 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -59.78 -44.11 94.07 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.44 -0.788 . . . . 0.0 110.548 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.71 -36.98 85.15 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.887 -1.133 . . . . 0.0 110.006 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.4 ttp -62.77 -43.46 98.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.936 . . . . 0.0 109.402 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -65.76 -42.13 91.27 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.774 -1.204 . . . . 0.0 110.296 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.9 t -69.0 -43.21 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.246 -0.909 . . . . 0.0 110.777 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 56' ' ' MET . 2.0 t80 -59.2 -46.65 87.86 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.758 -1.214 . . . . 0.0 108.929 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -74.48 -35.86 63.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.144 -0.972 . . . . 0.0 109.858 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -61.45 -38.39 87.03 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.172 -0.955 . . . . 0.0 109.782 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.1 mt -80.21 5.89 13.32 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.362 -0.836 . . . . 0.0 110.336 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.1 mttt 54.67 30.6 13.66 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 120.877 -1.139 . . . . 0.0 110.532 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.447 ' HB2' ' CD1' ' A' ' 51' ' ' PHE . 98.4 mtp -64.75 -12.25 45.22 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.938 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -75.89 -0.54 21.71 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.751 -1.218 . . . . 0.0 110.509 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -76.2 64.42 2.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.763 -1.211 . . . . 0.0 110.224 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.3 p -135.4 149.58 49.68 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.288 -0.882 . . . . 0.0 109.622 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.72 -43.28 96.99 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.424 ' HB2' ' ND2' ' A' ' 63' ' ' ASN . 95.8 mt -99.11 1.47 45.14 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.814 -1.179 . . . . 0.0 111.643 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 56.01 45.63 23.38 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 122.734 1.254 . . . . 0.0 110.803 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.424 ' ND2' ' HB2' ' A' ' 61' ' ' LEU . 24.6 p30 -118.05 55.25 0.89 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.238 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.99 142.87 15.66 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.48 ' CG2' ' CD1' ' A' ' 84' ' ' ILE . 61.0 t -127.72 136.19 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.165 -1.197 . . . . 0.0 110.779 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.7 tp -116.71 127.44 54.39 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.783 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 90.0 mt -100.84 107.23 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.958 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -94.05 115.15 27.44 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.091 -1.006 . . . . 0.0 109.749 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.8 t -117.67 132.46 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 122.09 0.948 . . . . 0.0 111.126 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.37 87.27 3.58 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.528 ' CG2' ' CE1' ' A' ' 7' ' ' PHE . 28.9 m -58.89 -25.35 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.458 -0.776 . . . . 0.0 111.834 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.418 ' OE1' ' CG2' ' A' ' 38' ' ' THR . 71.3 tt0 -67.14 -43.36 82.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.743 -1.223 . . . . 0.0 108.64 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -99.64 5.38 45.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.47 -0.769 . . . . 0.0 110.457 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.2 tttt 54.47 46.57 24.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.922 -1.111 . . . . 0.0 111.034 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.7 p -121.63 167.74 12.56 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.784 -1.198 . . . . 0.0 109.791 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -147.42 142.07 26.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.149 -0.97 . . . . 0.0 110.706 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.4 t -130.11 138.8 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.476 -0.765 . . . . 0.0 109.259 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.467 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 71.1 mt -117.54 126.37 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.804 -1.185 . . . . 0.0 110.248 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -133.25 115.46 15.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.545 -0.722 . . . . 0.0 110.735 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.8 170.74 20.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.441 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 94.2 m-20 -82.67 -178.59 7.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.482 -1.011 . . . . 0.0 110.582 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.67 -26.69 68.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 110.765 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.46 -57.9 14.64 Favored Glycine 0 N--CA 1.485 1.966 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.522 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.48 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 79.3 mt -64.97 -44.52 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.801 -1.411 . . . . 0.0 108.917 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -61.47 -38.37 87.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.082 -1.011 . . . . 0.0 111.455 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -72.15 -19.4 61.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.915 -1.115 . . . . 0.0 112.23 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.8 m -108.27 -17.91 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.784 -1.198 . . . . 0.0 112.536 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.458 ' HB ' ' CD2' ' A' ' 92' ' ' PHE . 18.8 m -120.8 160.43 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.674 -1.266 . . . . 0.0 111.397 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.0 p -108.18 -175.5 2.79 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.956 0.884 . . . . 0.0 112.552 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -63.41 -35.63 81.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.662 -0.649 . . . . 0.0 109.74 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -62.3 -38.47 89.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 109.321 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.458 ' CD2' ' HB ' ' A' ' 88' ' ' VAL . 72.7 t80 -66.79 -27.64 67.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.563 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.467 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 7.3 m95 -86.06 -29.46 23.39 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.06 0.933 . . . . 0.0 110.254 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -55.83 -40.07 72.27 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.554 -0.716 . . . . 0.0 112.225 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 69.3 p -64.77 -30.46 71.47 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.412 -1.315 . . . . 0.0 108.594 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.419 ' CG2' HD13 ' A' ' 78' ' ' ILE 0.262 7.6 m -59.91 -49.43 77.73 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 122.333 1.063 . . . . 0.0 111.092 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -69.27 -37.9 78.12 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.941 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -63.85 -42.88 97.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.912 -1.117 . . . . 0.0 110.454 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.11 -48.6 73.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.736 -1.228 . . . . 0.0 110.927 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.4 mt -67.0 -42.7 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.845 -1.159 . . . . 0.0 110.175 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -61.78 -42.12 98.6 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.448 -0.782 . . . . 0.0 110.957 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.9 tp -63.81 -43.19 97.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.095 -1.003 . . . . 0.0 112.319 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.434 ' HB3' ' CA ' ' A' ' 112' ' ' GLY . 5.0 tp60 -76.07 -38.67 56.81 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.322 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -61.98 -41.4 97.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.016 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.51 -33.62 75.25 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.767 -0.583 . . . . 0.0 110.472 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -77.23 -18.29 57.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.981 -1.075 . . . . 0.0 109.499 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.8 2.52 42.89 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.714 -1.232 . . . . 0.0 111.393 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -100.22 91.32 4.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.669 -1.489 . . . . 0.0 109.972 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -62.04 -44.93 95.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.624 -0.673 . . . . 0.0 111.812 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.0 mppt? -62.64 -47.17 84.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.846 -1.159 . . . . 0.0 112.322 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -64.33 -37.85 88.95 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.725 -1.234 . . . . 0.0 110.634 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.434 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -65.03 -50.68 56.58 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.42 -1.371 . . . . 0.0 109.899 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.401 ' HB3' HD11 ' A' ' 16' ' ' ILE . 32.6 mt -62.6 -45.15 94.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.147 -1.208 . . . . 0.0 110.405 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.0 t -64.47 -48.02 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.001 -1.062 . . . . 0.0 110.736 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.06 -41.48 97.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.046 -1.034 . . . . 0.0 110.215 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.25 -40.58 98.78 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 75.9 mt -63.69 -44.03 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -1.072 . . . . 0.0 109.709 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -58.9 -45.12 91.03 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.052 -1.03 . . . . 0.0 109.027 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.35 -41.63 98.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.364 -0.835 . . . . 0.0 109.066 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.43 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -59.82 -43.53 94.5 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.434 -0.791 . . . . 0.0 109.942 178.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.13 -45.55 86.22 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 120.352 -0.927 . . . . 0.0 110.84 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 99.1 mmm -66.24 -44.96 82.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.979 -1.306 . . . . 0.0 109.655 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.406 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -64.53 -46.18 84.0 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.427 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.43 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 52.1 mt -62.55 -39.12 92.61 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.398 -0.813 . . . . 0.0 108.884 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.27 -35.18 62.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.161 -0.962 . . . . 0.0 110.794 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.8 -39.45 88.96 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.825 -1.172 . . . . 0.0 109.774 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -84.05 -34.6 24.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.5 -0.75 . . . . 0.0 110.328 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -125.93 96.6 37.14 Favored Pre-proline 0 C--N 1.303 -1.422 0 O-C-N 121.2 -0.938 . . . . 0.0 109.128 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.88 149.04 65.55 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 O-C-N 123.866 1.456 . . . . 0.0 110.047 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.476 ' CD1' ' OD2' ' A' ' 134' ' ' ASP . 59.7 t90 -75.52 131.08 39.83 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.245 -0.91 . . . . 0.0 110.731 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -110.17 150.33 28.8 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 108.912 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.06 -29.4 65.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.996 -1.065 . . . . 0.0 110.414 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -92.34 8.39 38.61 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.817 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.476 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 66.2 t0 -42.32 138.02 1.84 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.304 -0.873 . . . . 0.0 111.995 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.438 ' CD1' ' O ' ' A' ' 135' ' ' ILE . 1.3 pp -115.9 152.96 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.533 0.683 . . . . 0.0 111.131 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -113.59 99.35 7.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.832 -1.168 . . . . 0.0 110.041 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -67.95 -39.46 83.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.685 -0.635 . . . . 0.0 112.267 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.27 152.11 39.75 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.144 -0.972 . . . . 0.0 111.498 -178.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -76.64 -166.57 0.39 Allowed 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.528 1.278 . . . . 0.0 108.786 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.432 ' HB2' ' CG2' ' A' ' 20' ' ' ILE . 1.1 p-10 -122.98 2.48 9.35 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.834 -1.166 . . . . 0.0 109.94 178.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.8 m -64.66 135.9 56.4 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.832 -1.167 . . . . 0.0 111.432 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.9 mt -70.93 138.59 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.669 -0.644 . . . . 0.0 109.73 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.427 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 32.2 t -98.98 100.01 11.13 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.075 -1.015 . . . . 0.0 109.717 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.403 ' HG2' ' HB3' ' A' ' 35' ' ' LEU . 98.9 mttt -100.67 147.58 25.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.827 -1.171 . . . . 0.0 109.038 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 CA-C-O 118.018 -1.434 . . . . 0.0 109.62 -179.808 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.5 mtm . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.24 0.543 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.2 p -63.88 -36.79 85.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 110.055 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.9 -41.38 99.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 110.028 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.5 pt -92.65 -9.12 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.176 -0.953 . . . . 0.0 110.926 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -66.13 -44.58 83.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.822 -1.173 . . . . 0.0 110.503 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -109.29 120.21 41.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.037 -1.039 . . . . 0.0 110.03 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.588 ' CZ ' ' CD2' ' A' ' 109' ' ' PHE . 10.1 t80 -61.66 -47.6 84.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.37 -0.831 . . . . 0.0 110.455 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.0 mt -129.16 151.55 49.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.811 . . . . 0.0 109.531 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.436 HG23 ' N ' ' A' ' 10' ' ' ALA . 71.9 m -79.77 163.56 24.36 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.739 -1.226 . . . . 0.0 110.637 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.436 ' N ' HG23 ' A' ' 9' ' ' THR . . . -58.8 -37.53 76.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 109.825 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -49.88 -60.92 2.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -0.855 . . . . 0.0 110.611 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.432 ' HB3' ' HG2' ' A' ' 110' ' ' LYS . 98.6 mt-10 -63.37 -40.94 98.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.576 -0.703 . . . . 0.0 110.962 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.412 ' HA ' ' HE2' ' A' ' 110' ' ' LYS . 98.7 mt-10 -62.61 -37.22 85.41 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.972 -1.08 . . . . 0.0 110.462 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -64.12 -44.35 92.49 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.903 -1.123 . . . . 0.0 110.276 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.93 -41.59 99.53 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.231 -0.918 . . . . 0.0 111.123 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 17' ' ' VAL . 19.6 tt -68.36 -27.36 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.854 -1.154 . . . . 0.0 110.19 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.434 ' N ' HG23 ' A' ' 16' ' ' ILE . 71.1 t -66.69 -41.13 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.08 -35.06 79.51 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.652 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.66 94.12 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.265 -0.897 . . . . 0.0 109.547 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.411 ' CG2' ' HB2' ' A' ' 140' ' ' ASN . 96.6 mt -64.52 -43.38 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.14 -0.975 . . . . 0.0 110.102 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -61.21 -41.0 96.08 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.45 -0.782 . . . . 0.0 109.716 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -64.53 -38.24 90.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.544 -0.722 . . . . 0.0 111.302 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.74 -39.72 94.11 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.957 -1.089 . . . . 0.0 109.508 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -59.56 -16.55 25.93 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.025 -1.047 . . . . 0.0 110.618 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 97.3 mttt -95.0 -0.57 53.68 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.144 -0.973 . . . . 0.0 109.197 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -111.07 -15.36 13.73 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 120.903 -1.123 . . . . 0.0 110.151 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.7 t -152.91 158.6 42.36 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.045 -1.034 . . . . 0.0 110.061 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 97.6 p -87.29 -10.13 53.15 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.322 -0.861 . . . . 0.0 109.819 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.13 170.62 37.33 Favored Glycine 0 N--CA 1.48 1.571 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -130.54 134.01 46.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.231 -1.158 . . . . 0.0 111.524 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.8 mt -121.34 134.92 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-O 121.393 0.615 . . . . 0.0 110.097 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -137.46 153.49 50.08 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.4 HG22 HG23 ' A' ' 142' ' ' ILE . 27.4 m -121.21 141.19 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 111.417 -177.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -125.57 128.19 47.55 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.62 0.724 . . . . 0.0 109.657 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.9 tp -117.53 128.96 55.48 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.6 0.714 . . . . 0.0 111.43 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 83.3 tt0 -147.0 166.94 25.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.6 -0.687 . . . . 0.0 109.301 177.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.409 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 97.6 mttt -81.83 -76.94 0.23 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.335 -0.853 . . . . 0.0 113.241 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.41 ' HB ' ' HG2' ' A' ' 72' ' ' GLU . 3.9 t -139.9 154.74 47.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.042 -1.036 . . . . 0.0 110.429 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.419 ' CB ' ' HD2' ' A' ' 46' ' ' ARG . 63.7 p -104.74 169.5 8.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.481 -0.762 . . . . 0.0 110.668 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -103.97 -18.31 14.64 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.327 -0.858 . . . . 0.0 109.803 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.7 pt -117.17 -122.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.22 -0.925 . . . . 0.0 109.884 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -112.13 139.79 47.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.129 -1.607 . . . . 0.0 109.996 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.0 t -61.3 -44.07 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.284 -0.885 . . . . 0.0 110.994 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -60.43 -46.66 89.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.948 -1.095 . . . . 0.0 110.165 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -70.14 -36.54 74.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.003 -1.061 . . . . 0.0 108.694 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HD2' ' CB ' ' A' ' 39' ' ' SER . 59.8 ttt85 -64.83 -41.84 95.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.162 -0.961 . . . . 0.0 110.765 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.1 -36.99 80.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.87 -1.144 . . . . 0.0 110.049 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.0 ttp -62.95 -45.97 89.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.358 -0.839 . . . . 0.0 110.079 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -64.1 -42.12 97.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.991 -1.068 . . . . 0.0 109.461 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 72.4 t -66.44 -43.1 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.346 -0.846 . . . . 0.0 110.323 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.475 ' CZ ' ' OD1' ' A' ' 81' ' ' ASP . 6.9 t80 -58.98 -46.7 87.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.986 -1.071 . . . . 0.0 108.871 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -72.77 -35.9 67.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.021 -1.049 . . . . 0.0 109.651 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -61.09 -39.24 89.18 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.995 -1.066 . . . . 0.0 109.316 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.9 mt -80.58 3.92 20.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 110.152 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 54.54 33.1 18.24 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.029 -1.044 . . . . 0.0 111.46 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.416 ' CE ' ' HB2' ' A' ' 66' ' ' LEU . 90.4 mtp -65.44 -12.61 54.05 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.81 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -76.65 -1.88 29.93 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.941 -1.1 . . . . 0.0 109.958 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -75.49 64.22 1.58 Allowed 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.056 -1.028 . . . . 0.0 109.748 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.2 p -135.05 149.7 50.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 109.238 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.26 -41.91 99.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.617 -0.677 . . . . 0.0 112.665 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.402 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 84.1 mt -99.62 0.17 41.57 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.796 -1.19 . . . . 0.0 111.743 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.422 ' O ' ' CB ' ' A' ' 81' ' ' ASP . 86.5 mt-30 58.55 46.85 14.22 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.451 1.119 . . . . 0.0 111.028 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -119.98 50.89 1.23 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.402 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.1 142.42 16.11 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.252 -1.939 . . . . 0.0 108.252 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.469 ' CG2' ' CD1' ' A' ' 84' ' ' ILE . 54.4 t -126.94 134.79 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.993 -1.298 . . . . 0.0 110.401 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.416 ' HB2' ' CE ' ' A' ' 56' ' ' MET . 39.2 tp -117.17 125.03 50.56 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.068 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 98.6 mt -102.69 101.85 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.571 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -88.54 124.32 33.9 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.312 -0.867 . . . . 0.0 110.057 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.1 t -119.57 131.87 70.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.909 0.861 . . . . 0.0 110.373 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.46 87.02 2.91 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.493 ' HB ' ' CE1' ' A' ' 7' ' ' PHE . 34.6 m -60.56 -20.84 21.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.893 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.41 ' HG2' ' HB ' ' A' ' 38' ' ' THR . 49.6 tp10 -70.92 -45.41 64.28 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.092 -1.005 . . . . 0.0 109.097 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -100.52 5.92 44.18 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.032 -1.043 . . . . 0.0 110.693 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.9 tttt 54.79 46.57 24.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.089 -1.007 . . . . 0.0 111.415 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 82.5 p -125.52 157.8 36.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.307 -0.871 . . . . 0.0 109.903 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -138.01 145.85 42.38 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.049 -1.032 . . . . 0.0 110.102 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.5 t -132.48 136.09 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.116 -0.99 . . . . 0.0 109.637 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.48 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 81.8 mt -113.12 127.81 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.63 -1.294 . . . . 0.0 110.459 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -130.21 116.19 18.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.592 -0.692 . . . . 0.0 109.998 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.59 166.21 15.87 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.475 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 31.3 m-20 -76.42 175.56 9.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.402 -1.058 . . . . 0.0 110.606 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -60.86 -25.74 66.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.446 -0.783 . . . . 0.0 110.348 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.5 -53.68 30.65 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 120.095 -1.05 . . . . 0.0 110.593 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.469 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 83.1 mt -64.28 -44.74 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.961 -1.317 . . . . 0.0 107.471 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -61.95 -37.79 86.07 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.004 -1.06 . . . . 0.0 111.286 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -73.63 -20.28 60.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.836 -1.165 . . . . 0.0 111.88 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.6 p -105.73 -21.61 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.859 -1.151 . . . . 0.0 112.512 -178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.47 ' HB ' ' CD1' ' A' ' 92' ' ' PHE . 17.0 m -118.75 162.45 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 120.602 -1.311 . . . . 0.0 111.708 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.6 p -105.05 177.48 4.84 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.766 0.793 . . . . 0.0 112.108 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -63.74 -37.32 86.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 109.733 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -61.72 -39.27 90.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.229 -0.919 . . . . 0.0 109.382 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.47 ' CD1' ' HB ' ' A' ' 88' ' ' VAL . 30.9 t80 -62.61 -26.63 68.71 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.48 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 4.6 m95 -84.05 -27.92 27.97 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.722 0.772 . . . . 0.0 110.682 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -56.97 -34.68 68.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.251 -0.905 . . . . 0.0 112.68 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.4 m -64.96 -36.21 83.65 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 118.448 -1.301 . . . . 0.0 109.088 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.278 8.5 m -57.92 -47.31 83.21 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 122.307 1.051 . . . . 0.0 111.082 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -69.24 -38.8 78.67 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.361 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -63.68 -43.99 95.04 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.675 -1.21 . . . . 0.0 109.988 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.7 -49.11 74.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.764 -1.21 . . . . 0.0 111.016 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 92.7 mt -67.33 -42.93 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.81 -1.181 . . . . 0.0 110.031 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -65.38 -42.41 92.73 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.213 -0.93 . . . . 0.0 110.876 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -62.49 -41.21 98.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.114 -0.991 . . . . 0.0 111.075 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.45 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 98.6 mm-40 -75.89 -38.54 57.72 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.728 -1.189 . . . . 0.0 108.894 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -61.03 -41.81 97.28 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -63.32 -33.59 75.86 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.926 -0.484 . . . . 0.0 110.641 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -77.43 -18.18 57.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.89 -1.132 . . . . 0.0 109.317 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.38 1.09 31.16 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.752 -1.213 . . . . 0.0 111.003 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -103.47 91.02 3.87 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.635 -1.509 . . . . 0.0 110.853 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.588 ' CD2' ' CZ ' ' A' ' 7' ' ' PHE . 12.0 m-85 -62.58 -44.98 94.96 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.782 -0.574 . . . . 0.0 110.758 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.432 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 29.8 tptt -63.85 -48.92 74.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.145 -0.972 . . . . 0.0 112.568 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -61.08 -38.39 86.08 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.525 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.45 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -62.99 -45.26 96.0 Favored Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.608 -1.282 . . . . 0.0 109.947 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.2 mt -64.74 -44.52 89.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.113 -1.227 . . . . 0.0 110.733 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.422 HG22 ' CD1' ' A' ' 16' ' ' ILE . 99.4 t -64.91 -47.94 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 110.082 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -63.66 -41.42 98.2 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.663 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.59 -43.09 99.74 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.7 -43.42 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.933 -1.334 . . . . 0.0 110.077 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.74 -50.9 71.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 110.164 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -61.92 -42.2 98.82 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.085 -1.009 . . . . 0.0 109.07 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.414 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -57.66 -37.64 73.74 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.385 -0.822 . . . . 0.0 109.43 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.49 -45.37 68.29 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 99.1 mmm -68.16 -42.92 79.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.99 -1.3 . . . . 0.0 110.139 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.437 ' HB3' ' CE2' ' A' ' 92' ' ' PHE . . . -65.9 -47.17 75.71 Favored 'General case' 0 C--O 1.203 -1.39 0 O-C-N 121.169 -0.957 . . . . 0.0 108.846 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.414 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 78.0 mt -61.99 -39.16 91.26 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.54 -34.18 61.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.19 -0.944 . . . . 0.0 110.487 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -61.2 -41.21 96.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.872 -1.142 . . . . 0.0 108.968 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.456 ' CE1' ' CE2' ' A' ' 92' ' ' PHE . 91.8 m-85 -80.25 -36.83 34.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 0.0 110.791 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -129.23 93.01 37.29 Favored Pre-proline 0 C--N 1.304 -1.383 0 O-C-N 121.3 -0.875 . . . . 0.0 109.674 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.98 153.25 78.53 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.85 1.448 . . . . 0.0 111.227 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 49.9 t90 -77.6 132.74 38.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.675 -0.641 . . . . 0.0 111.133 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -112.09 150.22 31.01 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -58.45 -31.23 67.58 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.557 -1.34 . . . . 0.0 111.018 -177.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -89.22 8.08 32.1 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.914 -1.115 . . . . 0.0 110.593 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.469 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 64.9 t0 -43.09 137.9 2.32 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.99 0.9 . . . . 0.0 111.038 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -111.92 141.98 25.74 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 O-C-N 121.614 -0.679 . . . . 0.0 110.476 -178.025 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -95.57 93.93 7.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.012 -1.055 . . . . 0.0 110.061 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -69.5 -42.39 74.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.702 -0.624 . . . . 0.0 112.543 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 16.8 mt -106.06 151.19 40.03 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 120.973 -1.08 . . . . 0.0 111.334 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.01 -175.09 1.55 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 N-CA-C 108.948 -1.212 . . . . 0.0 108.948 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.411 ' HB2' ' CG2' ' A' ' 20' ' ' ILE . 21.3 p30 -118.86 4.04 11.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.765 -1.209 . . . . 0.0 110.102 178.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.3 p -62.72 175.12 0.87 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.1 -1.0 . . . . 0.0 110.302 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.4 HG23 HG22 ' A' ' 33' ' ' VAL . 80.5 mt -107.59 141.15 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.482 -0.761 . . . . 0.0 111.462 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.4 t -94.81 133.38 38.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.473 -0.767 . . . . 0.0 109.803 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -127.48 129.37 47.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 110.827 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 118.054 -1.414 . . . . 0.0 109.856 179.576 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.6 mtm . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 121.542 0.687 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.0 p -62.42 -39.47 93.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.472 -0.768 . . . . 0.0 110.74 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -63.78 -46.59 84.54 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.909 -1.12 . . . . 0.0 111.036 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.1 pt -68.36 -22.21 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.148 -0.97 . . . . 0.0 109.934 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.31 -47.68 81.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.149 -0.969 . . . . 0.0 110.017 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -131.87 128.79 39.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.339 -0.85 . . . . 0.0 109.675 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.575 ' CE1' ' CD2' ' A' ' 109' ' ' PHE . 36.7 t80 -60.33 -47.36 86.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.311 -0.868 . . . . 0.0 110.486 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.469 ' HG ' ' CD2' ' A' ' 7' ' ' PHE . 87.9 mt -134.28 151.5 51.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.386 -0.821 . . . . 0.0 110.717 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.0 p -79.61 166.49 21.83 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.966 -1.084 . . . . 0.0 109.92 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.61 -38.22 66.54 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.011 -1.056 . . . . 0.0 109.115 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.22 -46.03 86.63 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.673 0.749 . . . . 0.0 110.181 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -69.83 -42.42 73.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.47 -0.769 . . . . 0.0 111.179 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -63.64 -37.42 87.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.142 -0.974 . . . . 0.0 109.892 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.65 -44.81 92.74 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.053 -1.03 . . . . 0.0 110.672 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.67 -44.12 87.27 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.994 -1.067 . . . . 0.0 111.788 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.3 tt -67.71 -36.52 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.73 -1.231 . . . . 0.0 110.44 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.2 t -62.42 -39.57 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 21' ' ' ARG . 29.4 t0 -62.87 -35.01 78.58 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.464 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.93 -39.57 95.0 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.322 -0.862 . . . . 0.0 110.104 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.55 -43.85 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.114 -0.991 . . . . 0.0 109.883 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.433 ' CZ ' ' HA ' ' A' ' 18' ' ' ASP . 74.7 mtm180 -60.21 -42.04 94.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.872 . . . . 0.0 110.896 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -63.16 -36.2 82.84 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.125 -0.985 . . . . 0.0 110.33 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.6 -39.27 88.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.092 -1.005 . . . . 0.0 110.164 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -60.67 -16.32 37.89 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.943 -1.098 . . . . 0.0 110.851 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.473 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.6 mttt -95.11 -4.2 46.65 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.172 -0.955 . . . . 0.0 109.628 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -105.12 -16.99 14.63 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.068 -1.02 . . . . 0.0 109.462 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.8 t -152.4 161.83 42.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.114 -0.991 . . . . 0.0 109.864 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.1 p -87.81 -7.47 57.22 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.311 -0.868 . . . . 0.0 109.887 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.98 170.4 47.25 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -129.5 132.74 46.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.241 -1.152 . . . . 0.0 111.217 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.2 mt -117.42 134.34 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.693 -0.63 . . . . 0.0 110.147 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.424 ' HB3' ' CE ' ' A' ' 56' ' ' MET . 75.2 ttt180 -139.8 149.36 43.41 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.05 -1.031 . . . . 0.0 110.101 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.3 t -117.44 137.32 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.236 -0.915 . . . . 0.0 111.199 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -122.66 125.94 46.61 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.483 HD22 ' CG ' ' A' ' 7' ' ' PHE . 44.8 tp -115.35 135.85 53.71 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.091 0.948 . . . . 0.0 112.045 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 81.4 tt0 -150.12 164.33 35.87 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 177.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.416 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 99.0 mttt -79.48 -74.58 0.28 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.454 -0.779 . . . . 0.0 112.108 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.8 t -140.95 154.93 46.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 109.634 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.0 p -106.0 168.91 8.81 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.495 -0.753 . . . . 0.0 110.615 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -109.66 -18.54 13.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.116 -0.99 . . . . 0.0 110.83 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 42' ' ' ASP . 32.0 pt -114.06 -123.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.981 -1.075 . . . . 0.0 109.85 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.422 ' N ' HG13 ' A' ' 41' ' ' ILE . 99.3 m-20 -111.77 136.67 50.73 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.461 -1.4 . . . . 0.0 109.727 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.82 -45.21 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.681 -0.637 . . . . 0.0 112.619 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -60.22 -47.17 87.1 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.751 -1.218 . . . . 0.0 110.322 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -71.28 -40.91 70.63 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.927 -1.108 . . . . 0.0 108.992 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 66.7 ttt-85 -63.06 -43.51 98.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.128 -0.983 . . . . 0.0 110.891 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.88 85.72 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.544 -1.347 . . . . 0.0 109.428 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.8 ttp -61.69 -41.99 98.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.009 -1.057 . . . . 0.0 108.939 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.86 -44.43 93.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.069 -1.02 . . . . 0.0 109.73 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.46 -43.78 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.417 -0.802 . . . . 0.0 110.533 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.462 ' CE2' ' OD1' ' A' ' 57' ' ' ASP . 64.4 t80 -59.88 -47.39 85.96 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.007 -1.058 . . . . 0.0 109.966 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -74.98 -34.49 61.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.946 -1.096 . . . . 0.0 109.326 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -62.19 -36.62 82.46 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.949 -1.094 . . . . 0.0 109.137 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.19 2.81 26.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.18 -0.95 . . . . 0.0 110.049 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 55.54 33.52 21.25 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 121.142 -0.974 . . . . 0.0 111.892 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.424 ' CE ' ' HB3' ' A' ' 32' ' ' ARG . 95.7 mtp -66.19 -11.65 51.01 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 118.872 -1.131 . . . . 0.0 109.664 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.462 ' OD1' ' CE2' ' A' ' 51' ' ' PHE . 94.4 m-20 -77.19 -0.59 25.65 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.047 -1.033 . . . . 0.0 109.334 176.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -76.15 62.17 1.68 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.175 -0.953 . . . . 0.0 109.92 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.7 m -132.72 146.33 51.77 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.02 -42.48 99.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.568 -0.708 . . . . 0.0 111.427 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.2 mt -95.57 -0.05 52.41 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.011 -1.055 . . . . 0.0 111.265 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 57.3 45.33 20.4 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.406 1.098 . . . . 0.0 111.187 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -118.74 54.04 0.97 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.253 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.87 139.23 14.31 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.435 ' CG2' HD13 ' A' ' 84' ' ' ILE . 53.8 t -123.78 136.59 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.151 -1.206 . . . . 0.0 110.802 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 38.9 tp -117.89 128.13 54.53 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.347 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.4 HD11 HG21 ' A' ' 67' ' ' ILE . 97.1 mt -104.79 104.75 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 118.876 -1.129 . . . . 0.0 109.467 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -90.12 122.2 32.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.32 -0.863 . . . . 0.0 109.893 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -121.07 134.23 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.066 0.936 . . . . 0.0 110.924 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.44 98.42 8.2 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.484 HG11 ' CE1' ' A' ' 7' ' ' PHE . 33.3 m -66.36 -22.25 29.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.197 -0.939 . . . . 0.0 110.607 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.401 ' N ' HG21 ' A' ' 71' ' ' VAL . 78.6 mm-40 -68.93 -44.06 73.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.033 -1.042 . . . . 0.0 109.542 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.7 4.9 41.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.079 -1.013 . . . . 0.0 111.044 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 ttmt 55.5 46.74 22.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.879 -1.138 . . . . 0.0 110.352 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 70.5 p -122.4 165.88 15.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -0.901 . . . . 0.0 109.749 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 46.3 p90 -146.38 146.66 30.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.512 -0.743 . . . . 0.0 110.369 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.1 t -133.78 136.88 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.389 -0.819 . . . . 0.0 109.114 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.44 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 81.6 mt -115.2 127.34 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.617 -1.302 . . . . 0.0 110.713 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -129.96 119.24 22.89 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.745 . . . . 0.0 111.223 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.28 149.49 17.47 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -62.82 175.28 0.86 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.568 -0.96 . . . . 0.0 110.1 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.84 -26.88 67.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.226 -0.921 . . . . 0.0 111.702 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.76 -53.85 32.12 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.609 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.435 HD13 ' CG2' ' A' ' 65' ' ' VAL . 75.0 mt -63.11 -44.82 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.802 -1.411 . . . . 0.0 108.347 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -60.97 -38.51 86.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.966 -1.083 . . . . 0.0 111.627 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -71.0 -22.0 62.22 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.857 -1.152 . . . . 0.0 111.748 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.5 m -104.97 -15.77 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.92 -1.113 . . . . 0.0 112.884 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.491 ' HB ' ' CD2' ' A' ' 92' ' ' PHE . 21.8 m -121.04 163.51 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.591 -1.318 . . . . 0.0 112.089 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.3 m -110.93 178.27 4.4 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.6 0.714 . . . . 0.0 112.158 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 33.8 p-10 -63.12 -36.4 83.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 110.059 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 65.8 t0 -62.87 -38.64 91.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.109 -0.994 . . . . 0.0 108.986 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.491 ' CD2' ' HB ' ' A' ' 88' ' ' VAL . 78.6 t80 -67.07 -25.28 66.17 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.239 -0.913 . . . . 0.0 109.376 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.44 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 4.8 m95 -86.5 -23.49 25.92 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.796 0.808 . . . . 0.0 110.36 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -58.1 -36.23 72.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.91 . . . . 0.0 112.057 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.5 p -67.25 -31.28 71.51 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.541 -1.264 . . . . 0.0 108.895 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.272 10.0 m -60.08 -48.91 79.75 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 122.352 1.072 . . . . 0.0 111.111 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.38 -36.71 74.28 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.994 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -64.59 -44.23 91.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.933 -1.104 . . . . 0.0 110.482 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.12 -50.68 69.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.557 -1.34 . . . . 0.0 111.282 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 92.9 mt -66.35 -42.9 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.769 -1.207 . . . . 0.0 110.279 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -63.26 -41.75 99.09 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.296 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.7 mt -63.33 -41.71 98.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.196 -0.94 . . . . 0.0 111.775 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.43 ' HB3' ' CA ' ' A' ' 112' ' ' GLY . 31.6 tp60 -76.36 -40.17 51.88 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.69 -1.204 . . . . 0.0 108.963 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.414 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 1.2 m-85 -59.89 -40.64 89.41 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.62 -34.79 77.76 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.858 -0.526 . . . . 0.0 110.073 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -76.7 -18.7 58.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.989 -1.069 . . . . 0.0 109.712 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.08 -0.22 38.37 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.771 -1.204 . . . . 0.0 111.208 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -99.49 89.37 4.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.633 -1.51 . . . . 0.0 109.548 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.575 ' CD2' ' CE1' ' A' ' 7' ' ' PHE . 19.7 m-30 -64.16 -41.78 97.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.869 -0.52 . . . . 0.0 111.816 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -61.43 -48.19 82.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.047 -1.033 . . . . 0.0 110.798 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.413 ' HA ' ' CG1' ' A' ' 114' ' ' VAL . 87.3 mt-30 -64.3 -35.9 82.37 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.117 -0.99 . . . . 0.0 110.427 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.43 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -65.76 -48.76 64.05 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.184 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.9 mt -65.6 -44.73 85.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.082 -1.246 . . . . 0.0 111.409 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.413 ' CG1' ' HA ' ' A' ' 111' ' ' GLN . 11.5 p -65.06 -46.31 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.184 -0.947 . . . . 0.0 110.5 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -64.45 -42.11 96.14 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.992 -1.067 . . . . 0.0 109.929 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.45 -42.17 93.69 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.79 -43.04 97.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.232 -1.157 . . . . 0.0 109.78 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -59.17 -50.98 71.98 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.973 -1.08 . . . . 0.0 110.616 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.89 -42.94 99.95 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.878 -1.138 . . . . 0.0 109.28 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.8 -43.43 76.85 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.286 -0.884 . . . . 0.0 109.365 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.81 -42.98 99.59 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 98.8 mmm -67.53 -46.84 71.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.015 -1.285 . . . . 0.0 110.472 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 92' ' ' PHE . . . -63.94 -45.99 86.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.255 -0.903 . . . . 0.0 109.29 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.86 -40.42 95.3 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.4 -34.43 57.71 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.47 -0.769 . . . . 0.0 110.27 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -63.05 -44.17 96.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.061 -1.025 . . . . 0.0 109.133 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -73.08 -39.11 66.12 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.571 0.7 . . . . 0.0 109.961 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -131.67 98.36 18.05 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.634 -0.666 . . . . 0.0 110.178 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.45 154.13 69.41 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.647 1.34 . . . . 0.0 111.041 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.473 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 30.7 t90 -75.77 158.57 32.06 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.905 0.86 . . . . 0.0 110.948 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -140.47 151.42 44.84 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.33 -31.87 71.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.025 -1.047 . . . . 0.0 111.096 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -89.61 5.51 45.37 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.047 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.436 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 68.2 t0 -42.11 139.84 1.26 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.04 0.924 . . . . 0.0 111.71 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.416 ' CD1' ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -113.87 142.7 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 121.817 0.818 . . . . 0.0 111.757 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -102.31 96.53 7.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.942 -1.099 . . . . 0.0 110.462 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -69.86 -33.41 72.22 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.649 -0.657 . . . . 0.0 112.673 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.9 mp -112.45 150.2 42.25 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.07 -1.019 . . . . 0.0 112.176 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.85 -170.47 0.7 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.667 1.351 . . . . 0.0 109.228 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.414 ' N ' ' OD1' ' A' ' 140' ' ' ASN . 18.5 p-10 -125.37 1.85 7.73 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.71 -1.243 . . . . 0.0 110.287 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.6 p -60.85 167.94 2.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.999 -1.063 . . . . 0.0 110.866 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 47.5 mm -95.09 134.33 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.435 0.636 . . . . 0.0 110.691 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 10.5 m -91.22 132.78 35.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 0.0 109.946 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.11 144.99 51.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.145 -0.972 . . . . 0.0 110.544 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.844 179.488 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.4 mtm . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 121.327 0.584 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.0 m -80.46 -10.56 59.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.224 -0.922 . . . . 0.0 110.846 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -65.46 -44.39 87.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.739 -1.225 . . . . 0.0 110.806 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.6 pt -72.61 -26.46 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.854 -1.153 . . . . 0.0 110.834 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.19 -37.26 82.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.156 -0.965 . . . . 0.0 110.431 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -166.25 129.74 2.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.475 -0.765 . . . . 0.0 109.243 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.488 ' CD2' HD21 ' A' ' 35' ' ' LEU . 63.3 m-85 -62.86 -45.51 92.21 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.041 -1.037 . . . . 0.0 109.817 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.7 mt -129.25 147.82 51.12 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.563 -0.71 . . . . 0.0 110.1 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.6 m -72.24 165.22 24.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.952 -1.093 . . . . 0.0 109.976 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.14 -36.67 63.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.2 -0.937 . . . . 0.0 109.6 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.65 -38.46 89.39 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 109.545 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.417 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 97.5 mt-10 -70.63 -46.54 63.13 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.013 -1.055 . . . . 0.0 110.365 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.26 -34.58 78.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.381 -0.824 . . . . 0.0 109.572 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.91 -46.34 88.28 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.231 -0.918 . . . . 0.0 110.667 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.31 -43.81 85.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 111.773 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.5 tt -66.61 -36.62 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.665 -1.272 . . . . 0.0 110.49 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.77 -40.69 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.44 -39.08 92.21 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.755 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.0 92.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.322 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.57 -42.58 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.495 -0.753 . . . . 0.0 109.251 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -59.15 -42.57 91.02 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.211 -0.931 . . . . 0.0 110.304 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -64.91 -36.44 84.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.405 -0.81 . . . . 0.0 110.659 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.36 90.85 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.761 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -60.4 -14.86 21.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.089 -1.007 . . . . 0.0 111.175 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.473 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.5 mttt -95.49 -1.72 50.14 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.958 -1.089 . . . . 0.0 109.749 177.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -109.57 -14.51 14.36 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 120.896 -1.128 . . . . 0.0 109.593 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.0 t -154.4 160.55 41.72 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.882 -1.136 . . . . 0.0 110.485 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.2 m -88.86 -7.2 56.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.206 -0.934 . . . . 0.0 110.273 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.87 171.0 48.5 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -130.96 137.17 49.14 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.268 -1.137 . . . . 0.0 111.216 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.427 HD13 HG22 ' A' ' 31' ' ' ILE . 83.3 mt -119.63 134.71 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.712 -0.618 . . . . 0.0 110.317 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.4 mmm-85 -138.69 150.7 46.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.249 -0.907 . . . . 0.0 110.197 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.24 139.54 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.456 -0.777 . . . . 0.0 111.118 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -124.9 128.62 48.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.563 -0.711 . . . . 0.0 109.237 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.488 HD21 ' CD2' ' A' ' 7' ' ' PHE . 36.9 tp -115.82 128.87 56.16 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.902 0.858 . . . . 0.0 111.814 -178.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -144.7 165.12 28.94 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.413 ' HA ' HG22 ' A' ' 71' ' ' VAL . 97.1 mttt -78.95 -74.05 0.3 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.226 -0.921 . . . . 0.0 113.1 -177.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.6 t -140.25 156.18 46.58 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.772 -1.205 . . . . 0.0 110.167 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.9 p -102.56 168.01 9.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.427 -0.796 . . . . 0.0 110.505 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -107.19 -14.32 14.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.308 -0.87 . . . . 0.0 110.632 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.426 HG13 ' N ' ' A' ' 42' ' ' ASP . 19.2 pt -123.34 -121.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.976 -1.077 . . . . 0.0 109.735 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.426 ' N ' HG13 ' A' ' 41' ' ' ILE . 94.2 m-20 -111.34 140.34 46.0 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 120.191 -1.568 . . . . 0.0 109.217 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.76 -44.24 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.211 -0.931 . . . . 0.0 111.815 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -58.16 -45.86 86.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.049 -1.032 . . . . 0.0 109.648 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -71.64 -38.83 70.69 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.917 -1.114 . . . . 0.0 108.94 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.423 ' NH1' ' OH ' ' A' ' 68' ' ' TYR . 75.4 ttt180 -63.45 -42.58 98.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.972 -1.08 . . . . 0.0 110.927 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.13 -38.78 86.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.696 -1.253 . . . . 0.0 110.294 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 64.3 ttp -62.81 -44.05 97.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.064 -1.022 . . . . 0.0 109.405 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.427 ' OD1' ' ND2' ' A' ' 53' ' ' ASN . 63.5 t0 -63.52 -45.61 89.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.021 -1.049 . . . . 0.0 109.488 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 83.3 t -66.35 -44.31 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.35 -0.844 . . . . 0.0 110.947 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.452 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 4.5 t80 -58.27 -47.66 82.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.904 -1.122 . . . . 0.0 108.992 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -70.29 -36.24 74.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.054 -1.029 . . . . 0.0 109.238 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.427 ' ND2' ' OD1' ' A' ' 49' ' ' ASP . 72.7 m-20 -61.18 -37.55 83.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.096 -1.002 . . . . 0.0 110.012 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.8 mt -82.16 5.87 18.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.985 -1.072 . . . . 0.0 110.727 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 55.73 32.74 20.02 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.309 -0.87 . . . . 0.0 110.92 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.452 ' HB2' ' CE1' ' A' ' 51' ' ' PHE . 92.8 mtp -69.13 -25.41 64.38 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.341 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -68.76 -7.61 35.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.347 -0.845 . . . . 0.0 110.48 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -86.98 80.78 8.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.752 -1.218 . . . . 0.0 110.727 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.8 p -137.04 156.82 47.94 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -62.09 -43.97 97.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.092 -1.005 . . . . 0.0 112.817 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 88.1 mt -100.02 2.31 43.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.091 -1.006 . . . . 0.0 111.301 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 57.75 31.47 20.49 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.973 0.892 . . . . 0.0 111.272 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.405 ' HA ' HG13 ' A' ' 84' ' ' ILE . 99.7 m-20 -108.96 56.46 0.62 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.812 0.815 . . . . 0.0 110.465 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.411 ' O ' ' CD1' ' A' ' 84' ' ' ILE . . . -103.59 141.19 15.17 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.407 HG21 HD12 ' A' ' 84' ' ' ILE . 47.9 t -123.35 135.05 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.07 -1.253 . . . . 0.0 110.593 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.0 tp -116.79 130.39 56.69 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.88 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 83.6 mt -104.78 108.27 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 118.826 -1.15 . . . . 0.0 109.395 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.423 ' OH ' ' NH1' ' A' ' 46' ' ' ARG . 42.3 t80 -93.73 122.69 36.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.531 -0.731 . . . . 0.0 110.331 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -123.63 133.42 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 122.173 0.987 . . . . 0.0 111.32 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.17 97.45 7.3 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.48 ' CG2' ' CE1' ' A' ' 7' ' ' PHE . 35.8 m -67.38 -18.67 24.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.968 -1.083 . . . . 0.0 111.245 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -69.37 -46.52 66.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.754 -1.216 . . . . 0.0 109.445 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.23 3.69 41.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.155 -0.966 . . . . 0.0 110.797 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.4 tttt 56.13 45.77 22.8 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.943 -1.098 . . . . 0.0 110.39 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 96.0 m -119.78 132.87 55.73 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.243 -0.911 . . . . 0.0 109.812 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.421 ' O ' ' CD1' ' A' ' 76' ' ' PHE . 50.9 p90 -114.52 136.7 52.73 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.532 -0.73 . . . . 0.0 109.924 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 72.0 t -126.69 136.92 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.49 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 82.7 mt -115.35 125.36 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.771 -1.205 . . . . 0.0 110.324 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -128.97 114.89 16.99 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.513 -0.742 . . . . 0.0 110.488 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.65 145.83 16.54 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -56.93 175.47 0.13 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.516 -0.99 . . . . 0.0 109.803 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.06 -24.59 63.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.091 -1.006 . . . . 0.0 110.639 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.79 -51.79 38.33 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.655 -1.26 . . . . 0.0 110.632 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.422 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 3.8 mt -64.15 -44.71 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.914 -1.345 . . . . 0.0 108.447 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -64.26 -36.68 84.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.365 -0.834 . . . . 0.0 111.727 -177.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -75.64 -20.95 58.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.785 -1.197 . . . . 0.0 111.938 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.7 p -103.08 -21.95 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.851 -1.156 . . . . 0.0 113.132 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.479 ' HB ' ' CD2' ' A' ' 92' ' ' PHE . 14.3 m -118.68 164.08 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.626 -1.296 . . . . 0.0 111.433 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.2 p -105.45 174.76 5.74 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.922 0.867 . . . . 0.0 111.634 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.01 -37.95 86.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.459 -0.776 . . . . 0.0 110.071 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -61.46 -37.57 84.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.946 . . . . 0.0 108.81 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 123' ' ' ALA . 86.3 t80 -64.86 -27.2 68.71 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.446 -0.784 . . . . 0.0 108.968 177.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.49 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 5.4 m95 -86.12 -26.22 25.34 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.975 0.893 . . . . 0.0 109.888 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -58.97 -36.38 74.77 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.024 -1.048 . . . . 0.0 112.334 -176.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.9 p -66.56 -32.03 73.11 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.535 -1.266 . . . . 0.0 108.596 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.402 HG23 HD13 ' A' ' 78' ' ' ILE 0.276 7.5 m -60.21 -49.46 77.53 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 122.264 1.031 . . . . 0.0 111.141 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -68.29 -38.03 81.25 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.697 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -64.04 -41.39 97.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.013 -1.054 . . . . 0.0 110.617 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.16 -48.95 74.03 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.639 -1.288 . . . . 0.0 110.841 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 91.9 mt -67.05 -42.78 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 110.406 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -64.17 -41.43 97.14 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.296 -0.877 . . . . 0.0 110.94 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 44.3 tp -62.79 -43.02 99.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.312 -0.868 . . . . 0.0 111.754 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.474 ' CB ' ' CA ' ' A' ' 112' ' ' GLY . 3.0 tp60 -76.69 -40.08 50.0 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.779 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -58.95 -41.94 88.65 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.166 0.984 . . . . 0.0 108.449 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.12 -35.01 72.7 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -79.79 -17.23 53.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.349 -0.844 . . . . 0.0 110.169 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.62 2.5 43.47 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 119.73 -1.224 . . . . 0.0 111.573 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -104.53 94.81 5.52 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.689 -1.477 . . . . 0.0 110.859 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -62.76 -46.32 88.6 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.626 -0.671 . . . . 0.0 112.3 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.417 ' NZ ' ' HA ' ' A' ' 12' ' ' GLU . 75.3 tttt -61.62 -47.76 83.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.12 -0.988 . . . . 0.0 111.838 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -63.46 -40.03 96.05 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.377 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.474 ' CA ' ' CB ' ' A' ' 103' ' ' GLN . . . -65.21 -47.83 76.46 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.355 -1.402 . . . . 0.0 109.624 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.405 ' O ' HG12 ' A' ' 117' ' ' ILE . 85.2 mt -64.24 -46.01 85.64 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.506 -0.996 . . . . 0.0 111.523 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.1 -48.14 89.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.296 -0.877 . . . . 0.0 110.943 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -61.63 -33.52 74.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.028 -1.045 . . . . 0.0 109.108 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.14 -40.33 98.39 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 113' ' ' LEU . 36.1 mm -63.36 -43.84 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.064 -1.257 . . . . 0.0 109.741 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.05 -49.74 76.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.277 -0.889 . . . . 0.0 110.723 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -64.73 -43.92 91.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.057 -1.027 . . . . 0.0 110.351 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.31 95.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.895 . . . . 0.0 110.593 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.82 -44.06 81.41 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 97.0 mtp -66.56 -46.18 76.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.011 -1.288 . . . . 0.0 109.901 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 92' ' ' PHE . . . -64.09 -43.89 94.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.969 -1.082 . . . . 0.0 108.974 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 31.2 mt -63.02 -40.49 97.9 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.397 -0.815 . . . . 0.0 109.093 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.42 -34.08 56.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.128 -0.983 . . . . 0.0 110.09 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.63 -44.27 97.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.121 -0.987 . . . . 0.0 109.13 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -70.66 -41.74 71.69 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.473 0.654 . . . . 0.0 109.971 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -130.88 94.31 28.81 Favored Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.496 -0.753 . . . . 0.0 109.776 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.45 149.88 89.24 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.652 1.343 . . . . 0.0 109.843 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.473 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 39.3 t90 -73.46 130.19 39.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.457 -0.777 . . . . 0.0 111.896 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -108.78 152.64 24.58 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.03 -29.54 68.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.109 -0.995 . . . . 0.0 111.064 -177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -91.9 6.81 44.77 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.099 -1.04 . . . . 0.0 111.48 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.449 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 67.9 t0 -42.49 139.25 1.57 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.653 -0.654 . . . . 0.0 110.645 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.429 ' CD1' ' O ' ' A' ' 135' ' ' ILE . 1.3 pp -115.12 142.14 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 122.51 1.148 . . . . 0.0 113.297 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -120.33 102.52 8.53 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.16 -0.962 . . . . 0.0 109.412 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -101.4 5.92 42.34 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.633 -1.292 . . . . 0.0 111.712 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.4 tp -114.26 139.69 24.12 Favored Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 120.935 -1.103 . . . . 0.0 110.634 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -70.61 165.17 32.8 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.528 1.278 . . . . 0.0 109.747 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -103.22 8.75 38.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.595 -1.316 . . . . 0.0 110.027 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -62.04 144.93 54.51 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.854 -1.154 . . . . 0.0 110.647 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.98 138.71 19.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.789 -0.569 . . . . 0.0 109.846 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.0 m -93.27 132.31 37.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.077 -1.014 . . . . 0.0 109.203 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -126.22 137.52 53.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.292 -0.88 . . . . 0.0 110.143 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 CA-C-O 118.001 -1.444 . . . . 0.0 109.521 179.551 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 ttp . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.132 0.492 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.9 p -69.24 -16.82 63.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.093 -1.004 . . . . 0.0 110.171 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -81.76 141.0 33.92 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.264 -0.897 . . . . 0.0 110.852 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.5 tt -69.4 -35.88 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.6 -0.687 . . . . 0.0 110.656 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -62.22 -42.49 99.35 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.053 -1.029 . . . . 0.0 110.421 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -100.52 104.26 15.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.056 -1.027 . . . . 0.0 110.087 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.517 ' CE1' ' CG2' ' A' ' 71' ' ' VAL . 88.8 m-85 -62.94 -44.67 95.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 111.021 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 12' ' ' GLU . 88.2 mt -130.62 151.71 50.78 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -0.986 . . . . 0.0 110.168 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.3 m -78.74 165.56 23.46 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.087 -1.008 . . . . 0.0 109.807 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.08 -36.34 63.04 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.893 -1.129 . . . . 0.0 109.187 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -66.01 -37.09 85.03 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.539 -0.725 . . . . 0.0 109.311 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.44 ' OE1' ' CD ' ' A' ' 110' ' ' LYS . 78.1 mm-40 -72.38 -48.26 42.98 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.151 -0.968 . . . . 0.0 110.082 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.429 ' O ' ' CG2' ' A' ' 17' ' ' VAL . 98.2 mt-10 -66.48 -36.98 84.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.463 -0.773 . . . . 0.0 110.186 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.02 -45.72 92.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.846 -1.158 . . . . 0.0 111.095 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.89 -42.46 94.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.783 -1.198 . . . . 0.0 111.434 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.455 HG21 ' N ' ' A' ' 17' ' ' VAL . 19.1 tt -66.96 -36.16 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.831 -1.168 . . . . 0.0 110.748 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.455 ' N ' HG21 ' A' ' 16' ' ' ILE . 87.8 t -63.82 -41.02 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -62.54 -36.55 82.96 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.664 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.23 -38.27 88.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 109.353 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.9 mm -63.92 -43.45 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.396 -0.815 . . . . 0.0 109.998 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -59.65 -41.6 90.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.311 -0.868 . . . . 0.0 109.821 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -63.92 -37.94 89.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.326 -0.859 . . . . 0.0 111.215 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.74 -40.93 88.52 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.083 -1.011 . . . . 0.0 110.44 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -60.35 -14.5 18.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.904 -1.122 . . . . 0.0 110.922 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.469 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 49.2 mtpt -94.59 -2.82 50.77 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 120.831 -1.168 . . . . 0.0 109.48 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -109.93 -14.11 14.32 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 121.002 -1.061 . . . . 0.0 110.184 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.7 t -151.77 158.03 42.77 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.063 -1.023 . . . . 0.0 109.982 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 83.5 p -86.91 -7.95 57.71 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.273 -0.892 . . . . 0.0 109.95 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.7 172.61 45.6 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.417 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 55.8 mp0 -131.23 136.38 48.18 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.339 -1.095 . . . . 0.0 111.247 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -122.42 134.71 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.876 -0.515 . . . . 0.0 110.026 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -138.57 153.99 48.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.206 -0.934 . . . . 0.0 110.135 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.1 t -123.7 139.34 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.385 -0.822 . . . . 0.0 110.665 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -124.64 122.8 38.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.53 -0.732 . . . . 0.0 110.215 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.476 HD21 ' CG ' ' A' ' 7' ' ' PHE . 33.8 tp -108.39 131.56 54.64 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.901 0.858 . . . . 0.0 111.421 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -149.39 166.43 29.06 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HB3' ' HG3' ' A' ' 72' ' ' GLU . 98.4 mttt -81.33 -75.45 0.28 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.928 -1.107 . . . . 0.0 113.498 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.439 HG21 ' CB ' ' A' ' 72' ' ' GLU . 1.3 p -137.96 154.09 49.41 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.496 -0.753 . . . . 0.0 109.955 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.422 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 14.3 p -98.95 167.91 10.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.137 -0.977 . . . . 0.0 110.283 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -106.27 -10.83 16.23 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.307 -0.871 . . . . 0.0 110.422 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.7 pt -128.56 -121.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.936 -1.102 . . . . 0.0 109.358 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -111.02 138.4 47.48 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 120.184 -1.573 . . . . 0.0 110.042 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.1 t -62.99 -44.96 99.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.564 -0.71 . . . . 0.0 112.01 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -59.89 -46.28 89.84 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.925 -1.109 . . . . 0.0 110.057 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -70.58 -39.41 73.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.772 -1.205 . . . . 0.0 108.568 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.422 ' NH2' ' HA ' ' A' ' 39' ' ' SER . 49.8 ttt85 -61.46 -45.68 93.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 111.358 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.36 84.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.961 -1.087 . . . . 0.0 109.713 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 66.0 ttp -64.71 -43.87 92.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.204 -0.935 . . . . 0.0 109.878 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 53.5 t0 -63.2 -43.55 97.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.043 -1.036 . . . . 0.0 109.252 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.6 t -67.23 -44.01 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.46 -0.775 . . . . 0.0 110.35 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.41 ' CE2' ' OD1' ' A' ' 57' ' ' ASP . 61.4 t80 -60.19 -48.14 82.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.719 -1.238 . . . . 0.0 110.296 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -72.47 -35.2 68.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.989 -1.07 . . . . 0.0 108.821 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 49' ' ' ASP . 31.4 t-20 -62.34 -39.37 92.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.338 -0.851 . . . . 0.0 110.194 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.6 mt -79.31 3.15 18.96 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.153 -0.967 . . . . 0.0 110.187 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 57.29 33.43 23.28 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 121.041 -1.037 . . . . 0.0 112.044 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.7 mtt -67.46 -10.79 54.8 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.845 -1.16 . . . . 0.0 109.913 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.41 ' OD1' ' CE2' ' A' ' 51' ' ' PHE . 97.1 m-20 -77.82 -0.87 28.85 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.788 -1.195 . . . . 0.0 109.787 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -80.02 63.49 4.56 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 121.005 -1.06 . . . . 0.0 109.871 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.402 ' OG1' ' HA ' ' A' ' 62' ' ' GLN . 66.8 p -133.11 150.28 52.07 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.08 -41.01 99.32 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.441 -0.787 . . . . 0.0 112.271 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 87.0 mt -100.0 -0.51 39.12 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.932 -1.105 . . . . 0.0 111.616 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 87.4 mt-30 58.2 40.26 25.05 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 122.643 1.211 . . . . 0.0 111.029 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -111.44 53.15 0.72 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.724 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.81 138.82 14.09 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.034 -2.026 . . . . 0.0 108.034 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.411 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 53.4 t -122.11 133.91 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.184 -1.186 . . . . 0.0 110.117 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.2 tp -117.44 131.21 56.78 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.674 -0.641 . . . . 0.0 110.832 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 94.4 mt -110.56 110.3 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.524 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -97.23 121.4 39.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -0.921 . . . . 0.0 109.711 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.5 t -121.98 131.81 72.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 111.302 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.95 95.23 7.02 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.517 ' CG2' ' CE1' ' A' ' 7' ' ' PHE . 35.8 m -64.31 -22.48 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.998 -1.064 . . . . 0.0 110.834 -178.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.439 ' CB ' HG21 ' A' ' 38' ' ' THR . 79.3 mm-40 -66.8 -42.51 85.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.993 -1.067 . . . . 0.0 109.535 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -102.99 4.99 38.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.851 . . . . 0.0 110.98 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.415 ' HE2' ' O ' ' A' ' 104' ' ' PHE . 29.2 tttt 55.78 47.71 19.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.958 -1.089 . . . . 0.0 110.38 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.4 p -123.17 162.24 22.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 109.41 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -143.9 141.87 30.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.428 -0.795 . . . . 0.0 110.049 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.9 t -131.15 133.59 62.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.46 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 77.2 mt -112.97 122.33 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 118.853 -1.139 . . . . 0.0 110.544 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -129.11 111.27 12.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 110.343 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -94.72 174.63 33.35 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -77.64 176.17 9.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.752 -0.852 . . . . 0.0 109.876 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.55 -26.49 66.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.031 -1.043 . . . . 0.0 110.847 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.72 -49.31 60.29 Favored Glycine 0 N--CA 1.488 2.108 0 C-N-CA 119.807 -1.187 . . . . 0.0 110.315 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.446 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 3.6 mt -64.6 -44.97 96.76 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.791 0 O-C-N 121.001 -1.294 . . . . 0.0 108.151 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -64.39 -35.66 81.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.711 -1.243 . . . . 0.0 112.39 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -77.6 -22.11 51.36 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.857 -1.152 . . . . 0.0 112.303 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.406 HG11 ' O ' ' A' ' 84' ' ' ILE . 7.7 p -101.33 -23.51 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.848 -1.158 . . . . 0.0 112.516 -178.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.472 HG22 ' CD1' ' A' ' 93' ' ' TRP . 10.2 m -117.65 164.36 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.659 -1.276 . . . . 0.0 111.413 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 t -108.13 174.8 5.72 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.649 0.738 . . . . 0.0 111.767 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -61.38 -37.37 83.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.16 -0.962 . . . . 0.0 110.12 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.61 -36.55 78.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.194 -0.941 . . . . 0.0 108.823 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.424 ' CD2' ' HB ' ' A' ' 88' ' ' VAL . 81.5 t80 -67.33 -25.18 65.88 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.258 -0.901 . . . . 0.0 109.505 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.472 ' CD1' HG22 ' A' ' 88' ' ' VAL . 5.3 m95 -88.31 -26.5 22.23 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.911 0.862 . . . . 0.0 111.252 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -55.82 -40.33 72.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.92 -1.112 . . . . 0.0 112.585 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 77.3 p -64.5 -31.03 72.06 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.507 -1.277 . . . . 0.0 109.234 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.28 12.3 m -60.27 -49.38 77.86 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 122.545 1.164 . . . . 0.0 110.952 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.05 -38.53 82.57 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.738 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -63.42 -45.01 92.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.948 -1.095 . . . . 0.0 110.725 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.42 -48.62 80.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.942 -1.099 . . . . 0.0 110.654 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 91.4 mt -67.52 -42.5 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.089 -1.007 . . . . 0.0 110.277 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.434 ' CG ' ' HE3' ' A' ' 105' ' ' LYS . 56.6 tt0 -63.28 -42.85 99.15 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.842 -1.161 . . . . 0.0 110.984 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.1 mt -63.12 -41.53 99.35 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.158 -0.964 . . . . 0.0 112.105 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.411 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 94.0 mm-40 -76.66 -37.23 56.58 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.647 -1.221 . . . . 0.0 109.253 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.415 ' O ' ' HE2' ' A' ' 74' ' ' LYS . 4.4 m-85 -61.1 -41.5 96.79 Favored 'General case' 0 C--O 1.201 -1.456 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.434 ' HE3' ' CG ' ' A' ' 101' ' ' GLN . 93.7 mttt -62.02 -33.44 74.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.754 -1.216 . . . . 0.0 110.791 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -78.55 -18.64 54.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.756 -1.215 . . . . 0.0 109.986 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.83 4.63 42.22 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.71 -1.233 . . . . 0.0 111.164 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -103.51 91.08 3.89 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.632 -1.511 . . . . 0.0 110.521 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -62.35 -45.02 95.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.706 -0.621 . . . . 0.0 111.784 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.44 ' CD ' ' OE1' ' A' ' 12' ' ' GLU . 76.3 tttt -62.86 -49.29 75.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.901 . . . . 0.0 112.55 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -62.4 -36.49 82.51 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.655 -1.218 . . . . 0.0 109.55 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.411 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -65.54 -47.58 76.48 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.426 -1.368 . . . . 0.0 110.187 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.6 mt -63.53 -44.1 95.24 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.025 -1.279 . . . . 0.0 110.776 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 86.4 t -66.52 -46.08 87.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.101 -1.0 . . . . 0.0 110.05 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -65.35 -42.54 92.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 110.023 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.02 -41.98 98.19 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 91.4 mt -65.05 -43.84 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.267 -1.137 . . . . 0.0 109.968 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -56.93 -51.75 67.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.959 -1.088 . . . . 0.0 109.729 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.68 -41.73 99.25 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.125 -0.984 . . . . 0.0 109.192 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.32 -40.56 82.38 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.078 -1.014 . . . . 0.0 109.41 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.53 -45.86 87.79 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.7 mtt -66.67 -43.56 84.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.03 -1.276 . . . . 0.0 109.416 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.5 -46.59 85.41 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.304 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.2 mt -62.74 -41.54 99.24 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.456 -0.777 . . . . 0.0 109.486 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.82 -34.13 62.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.33 -0.856 . . . . 0.0 110.678 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.84 -41.46 97.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.942 -1.099 . . . . 0.0 108.954 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -75.36 -37.49 60.6 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.601 -0.687 . . . . 0.0 109.787 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -132.51 99.4 15.79 Favored Pre-proline 0 N--CA 1.487 1.379 0 O-C-N 121.498 -0.751 . . . . 0.0 110.131 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.47 150.97 70.63 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.447 1.235 . . . . 0.0 110.226 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.469 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 34.5 t90 -73.66 125.81 28.89 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.382 -0.824 . . . . 0.0 110.916 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -103.97 153.84 20.36 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.01 -29.3 70.17 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 111.092 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -93.7 8.12 42.17 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.912 -1.115 . . . . 0.0 111.609 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -42.51 138.18 1.89 Allowed 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.843 0.83 . . . . 0.0 111.614 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.417 HG23 HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -111.78 141.5 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 121.574 -0.704 . . . . 0.0 110.576 -178.083 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -100.25 96.01 7.18 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.169 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -67.71 -36.35 80.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.721 -0.612 . . . . 0.0 111.741 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.9 mt -109.22 151.37 41.99 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.212 -0.93 . . . . 0.0 112.073 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.68 -171.54 0.87 Allowed 'Trans proline' 0 C--N 1.32 -0.949 0 N-CA-C 108.662 -1.322 . . . . 0.0 108.662 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -121.91 1.77 9.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.604 -1.31 . . . . 0.0 110.125 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 78.5 p -63.37 168.62 4.31 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.764 -1.21 . . . . 0.0 110.965 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 91.6 mt -94.56 135.83 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.483 -0.76 . . . . 0.0 110.819 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.1 m -93.48 134.47 35.71 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.61 146.8 50.75 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.853 -1.154 . . . . 0.0 110.427 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.944 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.2 mtp . . . . . 0 N--CA 1.498 1.968 0 CA-C-O 121.516 0.674 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 p -154.42 160.23 41.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.53 -0.731 . . . . 0.0 109.977 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -61.08 -42.17 98.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.274 -0.891 . . . . 0.0 110.345 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.6 mt -118.46 127.14 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.113 -0.992 . . . . 0.0 111.347 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -93.12 -45.26 7.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.258 -0.901 . . . . 0.0 109.981 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -130.76 119.2 21.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 110.282 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.43 ' CE2' ' HB ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -65.58 -25.13 67.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.407 -0.808 . . . . 0.0 111.729 -179.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.5 mt -124.59 151.17 45.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.043 -1.035 . . . . 0.0 109.24 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 t -83.63 167.41 17.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.936 -1.102 . . . . 0.0 109.422 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.02 -38.88 77.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.24 -0.912 . . . . 0.0 110.885 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -55.88 -46.89 78.2 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.728 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.423 ' HB3' ' HD2' ' A' ' 110' ' ' LYS . 96.6 mt-10 -67.43 -45.61 75.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.516 -0.74 . . . . 0.0 111.716 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.422 ' O ' ' CG2' ' A' ' 17' ' ' VAL . 93.6 mt-10 -65.38 -33.11 75.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.963 -1.086 . . . . 0.0 110.035 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.34 -48.09 76.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.794 -1.192 . . . . 0.0 111.191 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.83 -42.14 97.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.319 -0.863 . . . . 0.0 111.159 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.445 HG21 ' N ' ' A' ' 17' ' ' VAL . 20.6 tt -67.46 -34.77 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.004 -1.06 . . . . 0.0 110.689 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.445 ' N ' HG21 ' A' ' 16' ' ' ILE . 67.5 t -63.29 -39.37 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.94 -37.21 86.88 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.08 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.25 88.56 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.285 -0.884 . . . . 0.0 109.021 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.5 -43.41 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-O 121.475 0.655 . . . . 0.0 109.972 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.417 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 92.8 mtt180 -59.72 -43.02 94.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 0.0 110.47 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -65.83 -36.86 84.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.431 -0.793 . . . . 0.0 111.252 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.37 -40.91 98.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.001 -1.062 . . . . 0.0 109.749 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.61 -16.52 49.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.413 -0.805 . . . . 0.0 110.11 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.4 mttt -93.65 -1.57 55.12 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.213 -0.929 . . . . 0.0 109.142 177.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -110.16 -14.39 14.2 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.973 -1.08 . . . . 0.0 110.08 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.3 t -151.34 158.12 43.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.098 -1.001 . . . . 0.0 109.644 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.6 m -85.1 -8.66 58.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.092 -1.005 . . . . 0.0 109.974 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.99 173.31 48.37 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.431 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 57.8 mp0 -132.0 139.05 48.49 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.259 -1.142 . . . . 0.0 111.709 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 94.1 mt -124.81 136.26 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.605 -0.685 . . . . 0.0 110.319 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -140.96 156.56 46.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.211 -0.931 . . . . 0.0 110.038 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 p -126.55 140.8 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.03 -1.044 . . . . 0.0 111.469 -178.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.405 ' HA ' ' O ' ' A' ' 143' ' ' SER . 72.0 t60 -124.43 132.15 53.5 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.574 0.702 . . . . 0.0 109.684 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.414 HD13 ' CG1' ' A' ' 71' ' ' VAL . 28.1 tp -117.62 126.13 51.97 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.625 0.726 . . . . 0.0 111.984 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.414 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 78.2 tt0 -142.73 165.2 28.04 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HB3' ' CG ' ' A' ' 72' ' ' GLU . 99.5 mttt -79.94 -76.41 0.22 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.144 -0.973 . . . . 0.0 112.329 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.453 HG23 ' CB ' ' A' ' 72' ' ' GLU . 1.2 p -138.74 157.21 46.52 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.455 0.645 . . . . 0.0 110.609 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.433 ' OG ' ' CD ' ' A' ' 46' ' ' ARG . 50.9 m -107.47 173.62 6.24 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.431 -0.793 . . . . 0.0 110.854 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -109.23 -10.14 14.98 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.591 -0.693 . . . . 0.0 110.452 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.1 pt -125.19 -123.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 120.964 -1.085 . . . . 0.0 109.702 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -110.78 140.2 45.4 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.462 -1.399 . . . . 0.0 109.092 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.3 t -61.37 -44.18 98.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.427 -0.796 . . . . 0.0 110.599 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -58.79 -48.05 82.63 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.134 -0.979 . . . . 0.0 110.588 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -69.1 -39.89 78.72 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.784 -1.198 . . . . 0.0 109.162 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.433 ' CD ' ' OG ' ' A' ' 39' ' ' SER . 57.8 ttt85 -59.7 -45.27 92.63 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.095 -1.003 . . . . 0.0 110.087 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.19 94.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.83 -1.169 . . . . 0.0 110.324 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.3 ttp -62.92 -43.57 98.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.125 -0.985 . . . . 0.0 109.646 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -65.76 -47.1 76.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.022 -1.049 . . . . 0.0 109.5 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 72.4 t -64.64 -42.99 96.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.451 -0.781 . . . . 0.0 110.273 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.483 ' CZ ' ' OD1' ' A' ' 81' ' ' ASP . 4.5 t80 -60.82 -47.32 86.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.885 -1.134 . . . . 0.0 109.662 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -73.5 -37.99 65.5 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.114 -0.991 . . . . 0.0 110.277 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -61.2 -39.66 91.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.02 -1.05 . . . . 0.0 109.22 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.1 mt -79.94 3.33 20.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 0.0 110.856 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 57.67 33.04 22.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.599 -0.688 . . . . 0.0 111.782 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.408 ' HB2' ' CD1' ' A' ' 51' ' ' PHE . 92.6 mmm -70.6 -23.39 62.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.997 -1.064 . . . . 0.0 109.841 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -73.16 -5.33 38.49 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.124 -0.985 . . . . 0.0 110.771 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -86.29 84.01 7.57 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.799 -1.188 . . . . 0.0 110.954 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.0 p -138.4 155.91 48.07 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.01 -44.22 97.18 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.98 -1.075 . . . . 0.0 112.541 -177.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.1 mt -99.15 3.49 46.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.864 -1.148 . . . . 0.0 111.36 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 55.48 36.24 26.73 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.188 0.994 . . . . 0.0 111.029 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.408 ' HA ' HG13 ' A' ' 84' ' ' ILE . 97.5 m-20 -115.71 53.7 0.84 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.264 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.83 149.04 17.99 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.2 t -127.56 134.35 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.987 -1.302 . . . . 0.0 110.081 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.46 ' HB2' ' CE2' ' A' ' 51' ' ' PHE . 35.5 tp -116.61 126.76 53.72 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.235 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 85.6 mt -105.58 112.56 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.346 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -99.87 121.11 40.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.961 . . . . 0.0 110.002 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -122.87 131.8 72.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 122.102 0.953 . . . . 0.0 111.259 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.1 99.13 10.64 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.43 ' HB ' ' CE2' ' A' ' 7' ' ' PHE . 28.4 m -65.29 -24.44 35.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 121.142 -0.974 . . . . 0.0 110.998 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.453 ' CB ' HG23 ' A' ' 38' ' ' THR . 70.2 mm-40 -67.97 -43.55 78.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.762 -1.211 . . . . 0.0 110.023 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -102.14 3.55 38.63 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.134 -0.978 . . . . 0.0 110.993 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt 55.98 45.91 22.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.806 -1.184 . . . . 0.0 110.712 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 99.6 m -121.51 135.27 55.04 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.079 -1.013 . . . . 0.0 110.224 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.472 ' O ' ' CD1' ' A' ' 76' ' ' PHE . 52.5 p90 -115.98 138.1 51.51 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.473 -0.767 . . . . 0.0 111.253 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.6 t -128.91 136.19 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.892 -1.13 . . . . 0.0 108.192 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 69.8 mt -116.37 126.6 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.627 -1.295 . . . . 0.0 110.885 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -129.08 114.34 16.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.601 -0.687 . . . . 0.0 110.984 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.28 175.03 26.74 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.483 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 68.2 m-20 -82.0 -178.29 6.95 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.539 -0.977 . . . . 0.0 111.438 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.32 -26.45 68.49 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.36 -53.05 34.82 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.112 -1.042 . . . . 0.0 110.876 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.433 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 7.9 mt -65.06 -44.69 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.95 -1.323 . . . . 0.0 107.705 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -61.53 -37.53 84.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.742 -1.224 . . . . 0.0 111.466 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -75.73 -19.99 58.66 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.011 -1.055 . . . . 0.0 111.929 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.5 p -104.3 -22.03 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 120.669 -1.27 . . . . 0.0 112.349 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 84' ' ' ILE . 19.1 m -120.79 162.31 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 120.594 -1.316 . . . . 0.0 111.96 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.9 m -105.8 178.0 4.69 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.124 0.964 . . . . 0.0 112.316 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -62.81 -37.62 87.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.676 -0.64 . . . . 0.0 109.775 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -61.28 -35.82 78.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.06 -1.025 . . . . 0.0 108.887 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 123' ' ' ALA . 80.7 t80 -67.01 -26.47 66.8 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.354 177.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -85.0 -26.96 26.77 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 122.013 0.911 . . . . 0.0 109.728 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -58.25 -38.21 76.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.166 -0.959 . . . . 0.0 112.815 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 69.5 p -65.49 -31.66 72.86 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.649 -1.22 . . . . 0.0 108.782 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.276 7.9 m -59.48 -48.68 80.72 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.485 1.136 . . . . 0.0 111.095 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -69.51 -37.89 77.37 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.945 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -63.8 -45.71 88.44 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.905 -1.122 . . . . 0.0 110.514 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.55 -48.43 81.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.735 -1.228 . . . . 0.0 110.275 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 93.1 mt -65.98 -42.84 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.122 -0.986 . . . . 0.0 110.412 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -65.12 -40.54 94.63 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.46 -0.775 . . . . 0.0 111.103 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.49 -42.92 98.54 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.307 -0.87 . . . . 0.0 111.853 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.416 ' HG2' ' N ' ' A' ' 112' ' ' GLY . 3.3 tp60 -76.81 -39.55 50.99 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.652 -1.219 . . . . 0.0 108.99 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -60.3 -42.34 95.32 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.817 0.818 . . . . 0.0 108.987 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.48 -30.97 70.03 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.44 -18.51 52.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 109.945 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.21 2.95 48.2 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.817 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -103.82 93.8 5.08 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.643 -1.504 . . . . 0.0 110.315 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -62.88 -46.18 89.06 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.458 -0.776 . . . . 0.0 112.4 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.423 ' HD2' ' HB3' ' A' ' 12' ' ' GLU . 61.4 tttm -62.18 -48.47 79.91 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.801 -1.187 . . . . 0.0 112.997 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.53 -39.14 93.65 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.856 -1.138 . . . . 0.0 109.459 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.416 ' N ' ' HG2' ' A' ' 103' ' ' GLN . . . -67.2 -47.32 64.92 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.437 ' CB ' HD12 ' A' ' 16' ' ' ILE . 97.1 mt -62.08 -44.01 97.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -1.173 . . . . 0.0 109.392 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.43 ' CG2' HG13 ' A' ' 16' ' ' ILE . 68.5 t -66.72 -45.25 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.316 -0.865 . . . . 0.0 110.513 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -65.63 -40.95 93.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.965 -1.085 . . . . 0.0 109.995 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.48 -41.65 99.76 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 84.3 mt -64.27 -43.54 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.177 -1.19 . . . . 0.0 109.858 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.36 -51.82 68.28 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.868 -1.145 . . . . 0.0 110.846 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.02 -40.85 97.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.028 -1.045 . . . . 0.0 109.203 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.4 ' O ' ' HG ' ' A' ' 124' ' ' LEU . . . -56.41 -44.03 79.94 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.352 -0.842 . . . . 0.0 109.528 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.05 -43.32 95.93 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.814 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 6.1 tpp -66.66 -47.8 71.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.282 . . . . 0.0 109.421 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 92' ' ' PHE . . . -62.8 -45.36 92.99 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.512 -0.875 . . . . 0.0 109.083 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 120' ' ' ALA . 83.5 mt -62.55 -39.65 94.31 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.06 -1.025 . . . . 0.0 108.635 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.88 -34.98 63.59 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.186 -0.947 . . . . 0.0 111.035 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -61.47 -41.13 96.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.995 -1.066 . . . . 0.0 108.493 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -75.19 -38.24 60.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.511 -0.743 . . . . 0.0 110.098 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -133.87 95.6 17.14 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.388 -0.82 . . . . 0.0 109.923 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.15 149.58 81.94 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.841 1.442 . . . . 0.0 110.369 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.481 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 42.7 t90 -72.03 143.38 49.16 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.533 -0.729 . . . . 0.0 111.403 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.76 151.22 40.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.487 -0.758 . . . . 0.0 109.248 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -58.86 -29.87 67.3 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.204 -0.935 . . . . 0.0 110.836 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -93.95 7.52 44.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.036 -1.04 . . . . 0.0 110.949 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -41.73 139.11 1.27 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.921 0.867 . . . . 0.0 111.423 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.42 HD12 HG22 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -110.37 138.26 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.447 -0.783 . . . . 0.0 110.553 -179.324 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -95.84 94.32 7.58 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.674 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -69.09 -29.28 67.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.428 -0.795 . . . . 0.0 112.577 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.14 146.98 39.34 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 120.809 -1.182 . . . . 0.0 111.312 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.06 -170.88 0.52 Allowed 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.43 1.226 . . . . 0.0 109.06 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.417 ' ND2' ' HG2' ' A' ' 21' ' ' ARG . 65.1 m-80 -122.05 3.66 9.89 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.39 -1.444 . . . . 0.0 110.327 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 21.0 m -63.1 141.3 58.82 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.087 -1.008 . . . . 0.0 111.928 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 86.2 mt -71.59 136.93 24.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.836 -0.54 . . . . 0.0 110.702 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 15.6 m -100.79 144.28 29.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.159 -0.963 . . . . 0.0 109.741 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -146.38 155.82 42.87 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.036 -1.04 . . . . 0.0 109.847 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.581 179.965 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.8 mtt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.259 0.552 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.0 t -76.01 148.99 37.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.373 -0.83 . . . . 0.0 110.461 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.451 ' HA ' ' CG ' ' A' ' 6' ' ' GLU . 97.3 mttt -76.23 -18.42 59.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.459 -0.776 . . . . 0.0 111.488 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.43 ' CG2' ' HD3' ' A' ' 144' ' ' LYS . 95.0 mt -63.47 -43.52 98.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 109.508 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -77.55 -13.41 59.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.433 -0.792 . . . . 0.0 111.223 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.451 ' CG ' ' HA ' ' A' ' 3' ' ' LYS . 77.9 mm-40 -61.31 -28.62 69.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.996 -1.065 . . . . 0.0 110.725 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.537 ' CE1' ' CG2' ' A' ' 71' ' ' VAL . 66.3 m-85 -58.31 -46.49 86.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.997 -1.064 . . . . 0.0 110.584 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.4 mt -131.71 152.22 51.05 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.323 -0.861 . . . . 0.0 111.308 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -86.22 165.38 16.56 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.238 -0.914 . . . . 0.0 109.736 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.92 -37.98 67.05 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.086 -1.009 . . . . 0.0 109.769 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.77 -41.99 98.4 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.464 -0.773 . . . . 0.0 110.047 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -73.77 -45.59 50.79 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 110.465 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.57 -36.49 83.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.832 -1.168 . . . . 0.0 109.858 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -63.82 -45.11 91.08 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.849 -1.157 . . . . 0.0 110.558 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.33 -44.71 86.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.954 -1.092 . . . . 0.0 111.672 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.422 HG23 ' N ' ' A' ' 17' ' ' VAL . 20.3 tt -64.14 -35.73 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.729 -1.232 . . . . 0.0 110.45 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.422 ' N ' HG23 ' A' ' 16' ' ' ILE . 92.6 t -63.77 -40.59 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.381 -0.825 . . . . 0.0 108.892 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -61.03 -38.32 85.71 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.252 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.18 -38.86 90.68 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.192 -0.942 . . . . 0.0 109.768 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 91.7 mt -62.73 -43.23 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.168 -0.957 . . . . 0.0 109.691 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -59.67 -41.73 91.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.504 -0.748 . . . . 0.0 110.724 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -65.37 -37.48 87.13 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.199 -0.938 . . . . 0.0 110.991 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.92 92.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.033 -1.042 . . . . 0.0 109.89 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -60.1 -14.56 17.45 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.037 -1.04 . . . . 0.0 111.216 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.6 mttt -97.31 1.27 49.32 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.243 -0.911 . . . . 0.0 109.478 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -111.59 -15.05 13.56 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.04 -1.038 . . . . 0.0 109.314 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.5 t -152.68 156.03 38.43 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.054 -1.029 . . . . 0.0 110.064 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.9 p -86.84 -8.7 57.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.354 -0.841 . . . . 0.0 110.534 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.99 177.12 45.61 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.42 ' CB ' HD22 ' A' ' 138' ' ' LEU . 80.4 mm-40 -131.39 135.37 47.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.089 -1.242 . . . . 0.0 111.494 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 86.2 mt -116.43 132.07 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.2 mtp85 -136.9 151.34 48.96 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.285 -0.884 . . . . 0.0 110.117 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.5 t -123.91 138.38 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.639 -0.663 . . . . 0.0 110.454 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -123.6 125.04 44.12 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.567 0.698 . . . . 0.0 109.132 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.0 tt -113.48 131.08 56.18 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.009 0.909 . . . . 0.0 112.165 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 82.8 tt0 -146.84 167.14 24.64 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.422 ' HA ' HG23 ' A' ' 71' ' ' VAL . 51.6 mtmt -79.98 -73.99 0.33 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.964 . . . . 0.0 113.088 -177.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.411 ' OG1' ' CB ' ' A' ' 72' ' ' GLU . 62.7 m -141.57 159.61 41.86 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.411 -0.806 . . . . 0.0 110.198 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.416 ' OG ' ' CD ' ' A' ' 46' ' ' ARG . 51.1 m -112.4 170.24 8.31 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.511 -0.743 . . . . 0.0 111.133 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -107.09 -15.44 14.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.32 -0.863 . . . . 0.0 110.59 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.7 pt -121.78 -122.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.357 -0.839 . . . . 0.0 109.894 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -111.65 137.56 49.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.32 -1.488 . . . . 0.0 109.66 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.2 t -64.37 -42.54 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.441 -0.787 . . . . 0.0 110.679 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.22 -46.9 85.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.698 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -69.11 -37.95 78.66 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.442 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 58.5 ttt85 -61.96 -43.62 98.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.06 -1.025 . . . . 0.0 110.233 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.65 91.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.797 -1.189 . . . . 0.0 110.765 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.2 ttp -64.08 -43.39 95.59 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.707 -1.245 . . . . 0.0 109.681 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -64.29 -45.84 86.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.215 -0.928 . . . . 0.0 110.079 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.5 t -66.27 -42.48 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.23 -0.919 . . . . 0.0 109.475 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.07 -47.05 86.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.888 -1.133 . . . . 0.0 109.667 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -75.92 -38.63 57.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.57 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -60.66 -38.18 84.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.102 -0.999 . . . . 0.0 109.919 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.5 mt -81.2 5.41 17.05 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.005 -1.059 . . . . 0.0 110.313 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 56.77 30.62 18.03 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 121.458 -0.776 . . . . 0.0 111.328 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 99.6 mtp -65.24 -12.14 48.43 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.605 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.5 p30 -79.11 2.07 22.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.829 -1.169 . . . . 0.0 109.962 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -74.36 64.07 1.1 Allowed 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.205 -0.934 . . . . 0.0 109.926 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 81.5 p -134.49 149.09 50.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.17 -0.956 . . . . 0.0 109.661 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.67 -43.73 92.63 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.7 mt -95.76 0.9 52.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.93 -1.107 . . . . 0.0 111.018 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 56.08 38.53 30.0 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.301 1.048 . . . . 0.0 111.761 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -110.34 54.24 0.67 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.876 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.0 138.52 13.89 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.7 t -121.88 134.62 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.022 -1.281 . . . . 0.0 110.361 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.2 tp -117.76 129.22 55.56 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.088 0.47 . . . . 0.0 110.602 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 95.1 mt -110.66 107.39 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.981 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.442 ' CZ ' ' HD3' ' A' ' 46' ' ' ARG . 58.6 t80 -92.95 122.91 35.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.117 -0.989 . . . . 0.0 109.541 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.6 t -120.74 130.93 74.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 122.264 1.031 . . . . 0.0 111.132 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.5 94.83 5.87 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.123 178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.537 ' CG2' ' CE1' ' A' ' 7' ' ' PHE . 34.3 m -63.92 -19.48 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.094 -1.004 . . . . 0.0 111.236 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.411 ' CB ' ' OG1' ' A' ' 38' ' ' THR . 79.8 mm-40 -68.17 -43.08 78.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.879 -1.138 . . . . 0.0 109.602 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.3 p30 -102.88 5.78 38.73 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.336 -0.852 . . . . 0.0 110.536 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.406 ' HG3' ' CZ ' ' A' ' 109' ' ' PHE . 34.1 tttt 54.53 49.85 17.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.987 -1.07 . . . . 0.0 111.236 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 72.5 p -126.53 167.21 15.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.142 -0.973 . . . . 0.0 109.927 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -141.09 144.52 34.96 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.424 -0.798 . . . . 0.0 109.865 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.7 t -131.26 136.46 57.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.52 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 81.4 mt -116.44 126.96 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.926 -1.108 . . . . 0.0 110.71 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -129.51 113.57 15.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.6 -0.688 . . . . 0.0 110.145 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.1 148.53 17.69 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -61.41 174.79 0.67 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.673 -0.898 . . . . 0.0 109.27 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.1 -24.79 60.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.14 -0.975 . . . . 0.0 111.068 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.9 -51.96 41.63 Favored Glycine 0 N--CA 1.496 2.654 0 C-N-CA 119.711 -1.233 . . . . 0.0 111.452 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 2.6 mt -66.48 -43.93 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.811 -1.405 . . . . 0.0 108.048 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -62.2 -38.9 90.9 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 111.434 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -76.98 -23.41 52.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.934 -1.104 . . . . 0.0 112.322 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.2 p -98.35 -24.77 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.731 -1.231 . . . . 0.0 112.579 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.486 ' HB ' ' CD2' ' A' ' 92' ' ' PHE . 14.3 m -117.32 163.37 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.631 -1.293 . . . . 0.0 111.519 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.415 ' OG ' ' N ' ' A' ' 90' ' ' ASP . 6.2 t -105.06 179.71 4.19 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.24 -0.912 . . . . 0.0 111.843 -178.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.415 ' N ' ' OG ' ' A' ' 89' ' ' SER . 64.1 t0 -62.0 -38.04 87.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.464 -0.773 . . . . 0.0 110.051 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -62.94 -36.97 85.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.177 -0.952 . . . . 0.0 109.31 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.486 ' CD2' ' HB ' ' A' ' 88' ' ' VAL . 51.7 t80 -65.69 -26.97 68.01 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.305 -0.958 . . . . 0.0 108.92 177.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.52 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 5.6 m95 -84.73 -28.44 26.28 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 122.026 0.917 . . . . 0.0 110.021 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -58.01 -37.32 74.06 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.742 -0.599 . . . . 0.0 112.471 -176.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.5 p -65.9 -32.57 74.15 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 118.627 -1.229 . . . . 0.0 109.15 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.27 10.1 m -59.95 -48.25 82.47 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.33 1.062 . . . . 0.0 111.609 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -69.9 -36.99 75.85 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.531 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -64.22 -43.72 94.12 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.584 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.28 -51.41 66.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.919 -1.113 . . . . 0.0 111.01 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.93 -41.98 90.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.3 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.4 -45.14 92.41 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.255 -0.903 . . . . 0.0 111.851 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.8 tp -63.11 -42.3 99.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.164 -0.96 . . . . 0.0 111.789 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.439 ' HB3' ' CA ' ' A' ' 112' ' ' GLY . 21.4 tp60 -72.55 -39.98 67.05 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.641 -1.224 . . . . 0.0 108.634 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -59.24 -38.32 79.7 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -61.59 -35.72 78.63 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.315 0.579 . . . . 0.0 109.885 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -75.12 -18.61 60.2 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 109.301 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.95 0.96 45.38 Favored Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.948 -1.12 . . . . 0.0 110.737 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -98.79 95.55 7.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.75 -1.441 . . . . 0.0 109.843 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.406 ' CZ ' ' HG3' ' A' ' 74' ' ' LYS . 21.7 m-30 -64.72 -41.23 96.12 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.815 -0.553 . . . . 0.0 111.175 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -64.35 -50.1 69.05 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.274 -0.891 . . . . 0.0 111.831 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -62.36 -34.54 76.87 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.014 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.439 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -66.72 -47.89 65.1 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.331 -1.414 . . . . 0.0 109.733 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.5 mt -63.37 -45.0 93.17 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.263 -1.139 . . . . 0.0 111.989 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.418 HG13 ' N ' ' A' ' 115' ' ' ASP . 11.9 p -67.25 -44.9 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.943 -1.098 . . . . 0.0 110.908 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.418 ' N ' HG13 ' A' ' 114' ' ' VAL . 13.4 m-20 -64.94 -37.34 87.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 110.38 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.31 -42.77 99.14 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.41 -43.93 97.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.331 -1.099 . . . . 0.0 109.882 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -57.67 -51.73 68.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.045 -1.034 . . . . 0.0 110.165 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -62.6 -43.09 99.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.222 -0.924 . . . . 0.0 109.172 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.91 -45.36 86.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.463 -0.773 . . . . 0.0 109.998 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.26 -42.62 99.24 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.0 mtt -66.33 -45.55 79.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.959 -1.318 . . . . 0.0 109.651 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.474 ' HB3' ' CE1' ' A' ' 92' ' ' PHE . . . -63.75 -44.67 92.78 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.522 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 42.0 mt -62.3 -39.78 94.12 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.95 -34.67 63.47 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.355 -0.841 . . . . 0.0 110.716 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -62.94 -41.67 99.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.118 -0.989 . . . . 0.0 109.886 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -78.01 -36.69 48.46 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.392 -0.817 . . . . 0.0 110.252 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -127.87 94.43 37.1 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.393 -0.817 . . . . 0.0 109.527 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.76 143.7 62.55 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 123.882 1.464 . . . . 0.0 110.266 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 44.5 t90 -72.41 130.46 40.77 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.306 -0.871 . . . . 0.0 111.264 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -109.02 153.03 24.19 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.71 -32.74 71.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.79 -1.194 . . . . 0.0 111.564 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -88.62 8.49 28.19 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.053 -1.059 . . . . 0.0 110.733 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.477 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 65.9 t0 -42.86 137.3 2.36 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.89 0.852 . . . . 0.0 111.538 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.431 HD12 HG23 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -107.62 133.08 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 121.488 -0.758 . . . . 0.0 111.381 -178.327 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -112.39 99.55 8.09 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.327 -0.858 . . . . 0.0 109.306 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -98.51 -15.55 19.52 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.826 -1.171 . . . . 0.0 111.541 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.42 HD22 ' CB ' ' A' ' 30' ' ' GLU . 3.1 mp -94.98 144.17 27.35 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.235 -0.916 . . . . 0.0 110.47 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -72.55 169.71 21.16 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.665 1.35 . . . . 0.0 109.222 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -110.02 8.73 24.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.839 -1.163 . . . . 0.0 110.322 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.1 p -67.22 166.57 13.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.071 -1.018 . . . . 0.0 111.316 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.04 136.45 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.59 -0.694 . . . . 0.0 110.395 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.1 m -88.99 137.12 32.6 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.143 -0.973 . . . . 0.0 109.617 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.43 ' HD3' ' CG2' ' A' ' 4' ' ' ILE . 99.6 mttt -133.1 147.26 52.15 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.117 -0.989 . . . . 0.0 110.695 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.43 0 CA-C-O 117.86 -1.522 . . . . 0.0 109.892 -179.502 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.049 0.452 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 m -77.44 145.31 37.2 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.191 -0.943 . . . . 0.0 110.524 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -120.47 150.08 41.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.153 -0.967 . . . . 0.0 109.286 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.1 pt -93.05 -1.55 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.113 -0.992 . . . . 0.0 111.016 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -67.94 -35.86 79.15 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.013 -1.054 . . . . 0.0 110.717 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -93.02 90.88 7.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 110.418 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.414 ' CE1' ' CG1' ' A' ' 71' ' ' VAL . 78.7 m-85 -62.18 -43.22 99.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.134 -0.979 . . . . 0.0 110.476 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.408 ' CB ' ' HG3' ' A' ' 13' ' ' GLU . 94.4 mt -130.8 146.12 52.16 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.271 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m -80.23 168.25 19.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.071 -1.018 . . . . 0.0 109.228 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.43 -39.26 60.81 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.691 -1.255 . . . . 0.0 109.871 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.84 -42.25 90.72 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.679 -0.638 . . . . 0.0 111.404 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -70.7 -44.21 67.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.923 -1.111 . . . . 0.0 110.174 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.411 ' O ' HG21 ' A' ' 16' ' ' ILE . 96.2 mt-10 -67.17 -33.45 75.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.011 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -64.59 -45.67 85.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.682 -1.261 . . . . 0.0 110.306 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.77 -42.7 94.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.023 -1.048 . . . . 0.0 111.501 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 17' ' ' VAL . 19.3 tt -67.15 -37.56 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.777 -1.202 . . . . 0.0 110.977 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.434 ' CG2' HD13 ' A' ' 142' ' ' ILE . 68.4 t -64.36 -41.22 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -61.62 -37.32 83.54 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.211 -0.996 . . . . 0.0 108.648 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.23 87.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.435 -0.79 . . . . 0.0 109.845 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.81 -42.87 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.153 -0.967 . . . . 0.0 110.001 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -60.35 -42.04 94.89 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.788 0.804 . . . . 0.0 110.299 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -65.12 -36.78 85.35 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.249 -0.581 . . . . 0.0 110.162 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.22 95.49 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.108 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.78 -14.58 33.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.056 -1.028 . . . . 0.0 110.519 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.468 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.7 mttt -93.42 -0.21 56.58 Favored 'General case' 0 C--N 1.309 -1.17 0 O-C-N 121.046 -1.034 . . . . 0.0 109.257 176.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -113.04 -13.74 13.05 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 120.835 -1.165 . . . . 0.0 110.608 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 t -153.33 160.3 42.66 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.915 -1.116 . . . . 0.0 110.105 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.1 p -90.91 -10.35 42.82 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.175 -0.953 . . . . 0.0 109.857 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.0 172.35 40.6 Favored Glycine 0 N--CA 1.481 1.685 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.415 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 54.3 mp0 -131.61 134.85 46.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.225 -1.162 . . . . 0.0 112.163 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.8 mt -120.84 133.76 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.746 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.1 ttm-85 -138.67 159.19 42.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.958 -1.089 . . . . 0.0 109.677 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.31 137.91 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.405 -0.809 . . . . 0.0 110.743 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -121.2 125.14 46.41 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.0 tp -110.92 131.14 55.3 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.892 0.854 . . . . 0.0 111.449 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 76.9 tt0 -147.78 165.34 30.85 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.415 ' HA ' HG21 ' A' ' 71' ' ' VAL . 99.7 mttt -79.77 -74.85 0.28 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 112.956 -177.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.8 t -139.36 156.27 47.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.109 -0.995 . . . . 0.0 110.367 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.477 ' HB2' ' CD ' ' A' ' 46' ' ' ARG . 5.9 p -104.27 166.97 10.06 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.701 -0.624 . . . . 0.0 111.198 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -106.67 -8.04 17.07 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.391 -0.818 . . . . 0.0 110.347 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 42' ' ' ASP . 34.3 pt -129.15 -122.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.912 -1.118 . . . . 0.0 110.487 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 41' ' ' ILE . 93.9 m-20 -111.72 137.33 49.77 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.057 -1.652 . . . . 0.0 110.065 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.3 t -63.23 -43.38 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.284 -0.885 . . . . 0.0 111.624 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -59.76 -45.61 91.72 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.763 -1.211 . . . . 0.0 110.094 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -67.26 -39.73 86.12 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.659 -1.276 . . . . 0.0 109.135 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.477 ' CD ' ' HB2' ' A' ' 39' ' ' SER . 77.6 mtp85 -62.24 -45.3 93.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.956 -1.09 . . . . 0.0 110.767 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.58 95.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.969 -1.082 . . . . 0.0 110.416 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.8 ttp -62.91 -43.13 99.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.013 -1.054 . . . . 0.0 109.507 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -65.5 -46.37 79.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.953 -1.092 . . . . 0.0 110.16 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.9 t -65.95 -44.42 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.032 -1.043 . . . . 0.0 110.422 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.433 ' C ' ' CD1' ' A' ' 51' ' ' PHE . 6.5 t80 -57.12 -49.52 75.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.984 -1.073 . . . . 0.0 109.259 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -72.86 -35.59 67.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.967 -1.083 . . . . 0.0 109.413 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -60.47 -39.98 89.58 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.394 -0.816 . . . . 0.0 108.988 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.0 mt -79.23 4.35 15.25 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.624 -0.673 . . . . 0.0 110.081 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 56.48 32.73 21.28 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 121.187 -0.946 . . . . 0.0 111.297 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 94.4 mmm -66.39 -11.68 52.77 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.914 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -79.5 -1.61 38.38 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.771 -1.205 . . . . 0.0 109.89 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -78.28 65.68 3.68 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.032 -1.043 . . . . 0.0 109.603 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.433 ' CG2' HD13 ' A' ' 138' ' ' LEU . 78.4 p -135.08 150.05 50.18 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -64.05 -43.06 96.68 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.601 -0.687 . . . . 0.0 112.123 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 98.2 mt -96.59 0.15 49.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.789 -1.194 . . . . 0.0 111.502 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 87.8 mt-30 57.26 46.15 19.12 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.497 1.141 . . . . 0.0 111.273 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.407 ' HA ' HG13 ' A' ' 84' ' ' ILE . 95.2 m-20 -120.21 52.85 1.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.094 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.81 138.79 14.09 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.492 ' CG2' ' CD1' ' A' ' 84' ' ' ILE . 61.2 t -125.54 135.89 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.162 -1.199 . . . . 0.0 110.952 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.1 tp -116.5 125.97 52.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.527 -0.733 . . . . 0.0 109.712 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.0 mt -101.85 106.25 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.118 -1.033 . . . . 0.0 109.389 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -91.89 123.04 34.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.326 -0.859 . . . . 0.0 110.021 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 79.2 t -123.63 130.38 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.494 -0.754 . . . . 0.0 111.003 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.52 108.92 20.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.722 -0.611 . . . . 0.0 109.373 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.415 HG21 ' HA ' ' A' ' 37' ' ' LYS . 22.8 m -76.11 -19.56 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.891 -1.13 . . . . 0.0 111.56 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.405 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 79.0 mm-40 -69.66 -46.98 64.88 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.656 -1.278 . . . . 0.0 109.259 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -101.78 1.5 37.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.488 -0.757 . . . . 0.0 110.936 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.2 tttt 56.67 47.53 18.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.844 -1.16 . . . . 0.0 110.748 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.8 m -118.22 129.37 55.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.075 -1.016 . . . . 0.0 109.823 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -112.29 138.84 48.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.691 -0.63 . . . . 0.0 110.459 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.14 137.19 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.331 -0.856 . . . . 0.0 109.002 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.447 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 77.6 mt -113.89 128.62 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.933 -1.104 . . . . 0.0 110.398 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -132.56 116.55 16.85 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.535 -0.728 . . . . 0.0 110.78 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.38 168.98 21.19 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -80.53 178.49 8.29 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.771 -0.841 . . . . 0.0 110.227 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.05 -28.83 70.36 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.218 -0.926 . . . . 0.0 111.166 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.66 -54.06 27.89 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.204 -0.998 . . . . 0.0 110.643 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.492 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 97.3 mt -63.7 -46.89 93.4 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.733 0 O-C-N 120.926 -1.338 . . . . 0.0 107.663 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.83 -38.37 85.22 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.785 -1.197 . . . . 0.0 111.558 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -70.99 -24.89 62.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.035 -1.041 . . . . 0.0 112.238 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.0 m -104.75 -17.14 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.71 -1.244 . . . . 0.0 112.411 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 84' ' ' ILE . 18.4 m -117.73 163.75 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 120.415 -1.428 . . . . 0.0 111.382 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.2 p -109.76 172.56 6.79 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.718 0.771 . . . . 0.0 112.581 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -59.15 -37.26 76.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.424 -0.798 . . . . 0.0 109.398 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -61.21 -39.89 91.93 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.085 -1.009 . . . . 0.0 109.031 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 123' ' ' ALA . 69.1 t80 -64.48 -25.33 67.95 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.195 -0.941 . . . . 0.0 109.229 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.447 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 4.7 m95 -86.99 -26.66 23.67 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.651 0.739 . . . . 0.0 111.183 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -58.48 -34.67 71.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.397 -0.814 . . . . 0.0 112.026 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.9 m -66.16 -32.78 74.42 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.003 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.277 9.0 m -60.68 -49.49 77.28 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 122.325 1.059 . . . . 0.0 111.63 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -68.41 -38.08 80.94 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.146 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -64.31 -45.95 85.69 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.491 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.73 -50.56 71.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.884 -1.135 . . . . 0.0 111.707 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.66 -41.64 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.913 -1.117 . . . . 0.0 109.165 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -64.01 -41.5 97.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.595 -0.691 . . . . 0.0 111.227 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.57 -42.09 99.34 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.156 -0.965 . . . . 0.0 111.331 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.445 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 96.4 mm-40 -75.71 -41.46 53.5 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.964 -1.095 . . . . 0.0 108.925 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -59.25 -40.9 87.43 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -59.33 -35.98 74.82 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.477 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -77.81 -15.52 59.02 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.046 -1.034 . . . . 0.0 109.901 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.05 3.68 48.36 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.784 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -101.92 91.32 4.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.686 -1.479 . . . . 0.0 110.491 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -61.02 -46.03 92.4 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.343 -0.848 . . . . 0.0 111.556 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -62.65 -48.24 80.23 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 112.919 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -61.77 -38.03 86.49 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 118.549 -1.26 . . . . 0.0 109.467 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.445 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -64.94 -46.05 90.53 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.7 mt -63.68 -45.47 89.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.31 -1.112 . . . . 0.0 110.747 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.404 ' CG2' HG13 ' A' ' 16' ' ' ILE . 95.5 t -66.88 -46.77 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.012 -1.055 . . . . 0.0 110.816 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -64.76 -38.95 92.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.012 -1.055 . . . . 0.0 110.203 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.44 -42.33 97.64 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.1 mt -63.97 -44.07 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -1.142 . . . . 0.0 109.837 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -60.12 -46.73 88.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.088 -1.008 . . . . 0.0 109.455 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -63.53 -41.83 98.46 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.188 -1.005 . . . . 0.0 108.587 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -59.13 -42.66 91.14 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.836 -0.745 . . . . 0.0 109.539 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.66 -44.12 96.89 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 57.5 ttm -67.58 -48.5 66.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.135 -1.214 . . . . 0.0 109.935 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 92' ' ' PHE . . . -61.72 -46.13 90.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.953 -1.092 . . . . 0.0 109.276 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.407 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 88.3 mt -62.69 -39.34 93.68 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.511 -0.743 . . . . 0.0 109.054 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.44 -34.67 61.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.244 -0.91 . . . . 0.0 110.459 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -61.38 -39.96 92.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.03 -1.044 . . . . 0.0 109.183 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -80.2 -31.97 38.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.884 . . . . 0.0 109.468 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -132.54 93.12 25.58 Favored Pre-proline 0 N--CA 1.485 1.296 0 O-C-N 121.532 -0.73 . . . . 0.0 109.956 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.64 146.48 73.49 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.816 1.429 . . . . 0.0 109.457 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.468 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 64.3 t90 -71.26 132.11 44.46 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.157 -0.965 . . . . 0.0 110.951 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -110.13 147.52 33.52 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -55.79 -28.45 56.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.054 -1.029 . . . . 0.0 110.878 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 40.7 p-10 -92.91 9.25 36.26 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.027 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.416 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 61.1 t0 -42.55 135.85 2.65 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.882 0.848 . . . . 0.0 111.163 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.424 ' CD1' ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -113.32 141.91 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.578 0.704 . . . . 0.0 111.247 -177.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -98.75 93.17 5.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.994 -1.066 . . . . 0.0 110.172 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -68.2 -39.45 82.44 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.904 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.433 HD13 ' CG2' ' A' ' 59' ' ' THR . 11.1 mp -105.77 151.04 39.82 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.204 -0.935 . . . . 0.0 110.737 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -75.45 -174.15 1.88 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.639 1.336 . . . . 0.0 108.763 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -118.64 3.61 11.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.575 -1.328 . . . . 0.0 110.03 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.9 m -60.96 137.08 58.25 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.852 -1.155 . . . . 0.0 110.835 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.434 HD13 ' CG2' ' A' ' 17' ' ' VAL . 95.4 mt -67.34 136.69 26.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.698 -0.626 . . . . 0.0 110.175 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 3.5 m -92.97 134.08 35.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.401 -0.812 . . . . 0.0 109.244 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -132.9 149.6 52.23 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -0.936 . . . . 0.0 109.898 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 CA-C-O 117.908 -1.496 . . . . 0.0 109.844 -179.605 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mtp . . . . . 0 N--CA 1.496 1.863 0 CA-C-O 121.348 0.594 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.8 p -156.69 158.31 36.72 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.246 -0.909 . . . . 0.0 109.873 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -83.92 -11.6 56.65 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.036 -1.04 . . . . 0.0 111.188 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.414 HG22 ' HA ' ' A' ' 10' ' ' ALA . 49.9 pt -124.46 161.7 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.021 -1.049 . . . . 0.0 109.936 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.402 ' HG3' ' HB3' ' A' ' 7' ' ' PHE . 17.5 pt-20 -151.61 -166.73 2.59 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.528 -0.732 . . . . 0.0 109.652 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -63.42 -33.93 76.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.019 -1.051 . . . . 0.0 110.276 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.537 ' CE2' ' CD1' ' A' ' 8' ' ' LEU . 29.4 t80 -46.06 -72.27 0.06 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.402 -0.811 . . . . 0.0 110.569 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.537 ' CD1' ' CE2' ' A' ' 7' ' ' PHE . 92.3 mt -132.86 153.16 51.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.173 -0.954 . . . . 0.0 110.406 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.8 p -82.2 169.79 16.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.935 -1.103 . . . . 0.0 109.867 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.414 ' HA ' HG22 ' A' ' 4' ' ' ILE . . . -52.53 -40.51 62.54 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.939 -1.101 . . . . 0.0 109.555 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.01 -46.91 87.13 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.529 -0.732 . . . . 0.0 110.401 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.67 -46.27 66.47 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.035 -1.041 . . . . 0.0 111.125 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.03 -37.94 89.21 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.124 -0.985 . . . . 0.0 109.917 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -63.64 -44.72 93.01 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.442 -0.786 . . . . 0.0 111.239 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.18 -42.65 93.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.956 -1.09 . . . . 0.0 111.375 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 17' ' ' VAL . 18.4 tt -67.81 -37.53 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.701 -1.249 . . . . 0.0 110.351 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.454 ' N ' HG22 ' A' ' 16' ' ' ILE . 46.9 t -62.68 -42.68 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -61.77 -37.88 85.93 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.574 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.03 -36.58 79.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.334 -0.854 . . . . 0.0 109.188 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.25 -43.66 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.363 -0.836 . . . . 0.0 109.696 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -58.78 -41.57 86.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.245 -0.909 . . . . 0.0 109.921 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -64.65 -37.53 87.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.501 -0.75 . . . . 0.0 111.664 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.99 94.36 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.831 -1.168 . . . . 0.0 110.021 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -60.53 -15.59 28.96 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.062 -1.024 . . . . 0.0 111.097 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.6 mttt -92.93 -6.23 49.01 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.16 -0.962 . . . . 0.0 109.006 177.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -105.72 -13.72 15.47 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 121.085 -1.009 . . . . 0.0 109.742 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.5 t -151.55 156.93 41.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.026 -1.046 . . . . 0.0 110.318 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.4 t -86.6 -6.9 58.75 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.354 -0.841 . . . . 0.0 109.019 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.86 173.31 50.26 Favored Glycine 0 N--CA 1.481 1.64 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.5 mp0 -132.35 137.4 47.37 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.147 -1.208 . . . . 0.0 111.677 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 82.4 mt -119.57 134.14 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.682 -0.636 . . . . 0.0 110.293 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -139.73 153.07 47.11 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.054 -1.029 . . . . 0.0 109.906 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.8 t -123.53 140.08 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.366 -0.834 . . . . 0.0 111.134 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -122.86 133.14 54.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.577 -0.702 . . . . 0.0 109.146 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.526 ' CD2' ' CG ' ' A' ' 7' ' ' PHE . 40.6 tp -123.89 136.43 54.35 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.099 0.952 . . . . 0.0 112.086 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.441 ' HG2' ' NH2' ' A' ' 46' ' ' ARG . 48.5 tp10 -151.63 161.95 41.81 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.433 ' N ' ' HG3' ' A' ' 36' ' ' GLU . 99.1 mttt -73.38 -72.5 0.25 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.929 -1.107 . . . . 0.0 112.417 -177.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 t -142.79 158.03 44.04 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.434 -0.791 . . . . 0.0 109.524 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.425 ' OG ' ' CD ' ' A' ' 46' ' ' ARG . 69.5 m -108.2 172.23 6.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.345 -0.847 . . . . 0.0 111.264 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -107.63 -21.3 12.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.559 -0.713 . . . . 0.0 110.531 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.9 pt -116.88 -121.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.009 -1.057 . . . . 0.0 110.762 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -109.38 132.75 53.84 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.637 -1.289 . . . . 0.0 109.332 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.8 t -62.4 -43.76 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.75 -0.594 . . . . 0.0 111.471 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -59.79 -47.93 83.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.892 -1.13 . . . . 0.0 109.537 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -67.71 -35.64 79.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.943 -1.098 . . . . 0.0 108.246 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.441 ' NH2' ' HG2' ' A' ' 36' ' ' GLU . 76.0 ttt-85 -64.5 -43.2 94.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 111.414 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.24 -36.86 85.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.749 -1.219 . . . . 0.0 109.985 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.5 ttp -61.21 -42.93 99.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 109.059 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -63.72 -46.77 83.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.004 -1.06 . . . . 0.0 110.249 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 71.8 t -64.85 -43.84 96.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.33 -0.856 . . . . 0.0 109.882 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -59.23 -49.37 78.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.057 -1.027 . . . . 0.0 109.666 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -71.43 -35.82 71.06 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.363 -0.835 . . . . 0.0 109.226 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -62.22 -37.72 86.46 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.266 -0.897 . . . . 0.0 109.327 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.0 mt -82.43 3.93 26.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.914 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.2 tttt 54.86 34.8 22.85 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.137 -0.977 . . . . 0.0 111.483 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 94.2 mtp -66.78 -11.44 55.06 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.901 -1.124 . . . . 0.0 110.206 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 44.7 p-10 -77.25 -0.84 26.81 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.94 -1.1 . . . . 0.0 109.927 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -78.54 64.62 3.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.387 -0.821 . . . . 0.0 110.687 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.4 p -135.14 150.3 50.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.21 -0.931 . . . . 0.0 108.951 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.62 -44.54 96.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.283 -0.886 . . . . 0.0 112.707 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 90.6 mt -97.14 1.59 50.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.95 -1.094 . . . . 0.0 111.725 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 57.13 38.43 29.01 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.284 1.04 . . . . 0.0 110.913 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.409 ' HA ' HG13 ' A' ' 84' ' ' ILE . 99.3 m-20 -112.67 55.21 0.7 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.543 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.404 ' O ' ' CD1' ' A' ' 84' ' ' ILE . . . -101.71 141.16 15.19 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 178.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.9 t -124.29 134.72 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.143 -1.21 . . . . 0.0 110.162 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 52.2 tp -117.89 129.33 55.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.515 -0.741 . . . . 0.0 110.658 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.1 mt -107.64 110.18 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.905 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.435 ' OH ' ' NH2' ' A' ' 46' ' ' ARG . 33.8 t80 -96.71 125.42 41.15 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.189 -0.944 . . . . 0.0 110.318 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.3 t -125.59 131.73 71.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-O 122.139 0.971 . . . . 0.0 111.165 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.71 108.92 21.73 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.8 m -74.65 -19.37 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.052 -1.03 . . . . 0.0 110.078 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -69.46 -43.45 73.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.075 -1.015 . . . . 0.0 109.336 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -104.22 4.98 34.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.006 -1.059 . . . . 0.0 111.15 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 67.5 tttt 56.06 47.4 19.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.831 -1.168 . . . . 0.0 110.64 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.2 p -123.23 167.61 13.51 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.183 -0.948 . . . . 0.0 110.355 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -147.83 140.84 24.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.555 -0.715 . . . . 0.0 109.993 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 68.7 t -128.38 138.39 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.519 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 79.4 mt -113.62 124.76 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.971 -1.08 . . . . 0.0 110.492 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -130.38 113.75 14.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.504 -0.747 . . . . 0.0 109.717 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.94 170.5 21.82 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -77.35 174.21 11.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.483 -1.01 . . . . 0.0 110.223 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -58.87 -27.81 65.54 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.326 -0.859 . . . . 0.0 110.244 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.78 -50.49 58.2 Favored Glycine 0 N--CA 1.487 2.065 0 C-N-CA 119.687 -1.245 . . . . 0.0 109.99 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.431 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 4.2 mt -63.54 -46.9 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.835 -1.391 . . . . 0.0 108.552 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -63.26 -33.66 75.98 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.529 -0.732 . . . . 0.0 112.058 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -76.74 -22.98 53.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.739 -1.226 . . . . 0.0 112.532 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.9 m -103.99 -17.85 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.757 -1.214 . . . . 0.0 112.08 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.487 ' HB ' ' CD2' ' A' ' 92' ' ' PHE . 4.5 m -120.25 159.52 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.966 -1.084 . . . . 0.0 111.591 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.9 p -104.65 177.25 4.9 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.881 0.848 . . . . 0.0 112.084 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -64.21 -38.74 92.14 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.59 -0.694 . . . . 0.0 109.246 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -60.83 -38.52 85.73 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.487 ' CD2' ' HB ' ' A' ' 88' ' ' VAL . 75.2 t80 -64.33 -26.26 68.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -0.941 . . . . 0.0 108.83 177.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.519 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 4.4 m95 -85.71 -26.68 25.78 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.924 0.869 . . . . 0.0 110.216 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -56.88 -41.13 77.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 112.538 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.2 p -63.19 -31.44 72.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.658 -1.276 . . . . 0.0 109.298 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.281 7.6 m -59.47 -48.35 82.0 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.433 1.111 . . . . 0.0 111.146 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -70.12 -37.17 75.25 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.124 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -63.47 -44.73 93.59 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.177 -1.009 . . . . 0.0 110.883 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.64 -49.03 76.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.743 -1.223 . . . . 0.0 110.881 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.1 -42.3 91.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.176 -0.952 . . . . 0.0 110.059 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -63.38 -43.51 97.41 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.677 -0.64 . . . . 0.0 111.701 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.8 mt -63.96 -43.13 96.74 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.722 -1.236 . . . . 0.0 112.256 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.46 ' HG2' ' N ' ' A' ' 112' ' ' GLY . 27.6 tp60 -72.36 -42.53 65.2 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.666 -1.214 . . . . 0.0 108.72 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -58.5 -39.57 80.42 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.81 -32.16 72.45 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.622 -0.674 . . . . 0.0 109.887 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -80.95 -19.02 45.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.085 -1.01 . . . . 0.0 110.238 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.27 5.87 36.95 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.045 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -105.87 89.85 3.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.833 -1.392 . . . . 0.0 110.253 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -63.65 -41.45 98.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.725 -0.609 . . . . 0.0 111.672 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -62.56 -48.11 80.92 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.888 -1.133 . . . . 0.0 111.721 -178.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.404 ' HB2' ' HG2' ' A' ' 103' ' ' GLN . 88.4 mt-30 -64.41 -37.91 89.19 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.636 -177.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.46 ' N ' ' HG2' ' A' ' 103' ' ' GLN . . . -67.37 -46.32 71.6 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.86 -43.25 93.59 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.533 -0.98 . . . . 0.0 110.48 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.6 t -66.42 -47.13 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.393 -0.817 . . . . 0.0 109.996 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -62.9 -40.57 97.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.247 -0.908 . . . . 0.0 109.164 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.74 -43.51 96.37 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.3 mt -63.55 -43.4 98.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -1.105 . . . . 0.0 110.062 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -60.86 -48.27 82.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.023 -1.048 . . . . 0.0 110.484 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.33 -43.65 97.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.012 -1.055 . . . . 0.0 109.487 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.09 -41.44 83.49 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.388 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.04 -45.61 91.57 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 95.6 mtp -66.16 -46.48 77.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.903 -1.351 . . . . 0.0 109.934 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 92' ' ' PHE . . . -62.06 -46.9 87.09 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.602 -0.686 . . . . 0.0 109.725 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.86 -38.63 91.79 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.449 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.84 -35.12 61.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.868 -1.145 . . . . 0.0 110.273 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.91 -43.95 97.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.144 -0.972 . . . . 0.0 109.047 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -72.49 -39.89 67.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.67 -0.644 . . . . 0.0 109.654 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -131.4 96.73 20.79 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.485 -0.759 . . . . 0.0 110.505 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.38 150.32 84.48 Favored 'Trans proline' 0 C--N 1.317 -1.124 0 O-C-N 123.739 1.389 . . . . 0.0 110.735 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.475 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 29.4 t90 -73.32 164.1 27.15 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.643 0.735 . . . . 0.0 110.358 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -145.23 153.37 41.26 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.62 -30.83 70.1 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 111.736 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -90.71 8.24 35.51 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 118.926 -1.109 . . . . 0.0 111.224 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -41.95 138.43 1.54 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.632 0.73 . . . . 0.0 111.551 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.448 ' CD1' ' O ' ' A' ' 135' ' ' ILE . 1.3 pp -113.32 147.65 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 121.542 0.687 . . . . 0.0 110.737 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -102.25 92.78 4.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.689 -1.257 . . . . 0.0 109.358 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -66.26 -41.05 90.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.725 -0.61 . . . . 0.0 111.749 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.86 151.93 40.74 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.151 -0.968 . . . . 0.0 111.163 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.85 -172.26 0.93 Allowed 'Trans proline' 0 C--N 1.315 -1.233 0 N-CA-C 108.762 -1.284 . . . . 0.0 108.762 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -121.42 2.76 10.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.687 -1.258 . . . . 0.0 110.073 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.6 p -63.85 173.55 1.76 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -0.913 . . . . 0.0 111.333 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 89.4 mt -101.96 136.14 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.547 0.689 . . . . 0.0 110.779 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.8 t -94.05 136.53 34.25 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.449 -0.782 . . . . 0.0 109.353 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -130.09 138.57 50.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 0.0 110.478 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.081 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.744 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.5 mtm . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.9 p -64.27 -41.78 96.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 110.221 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -113.57 149.95 33.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 110.519 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.8 tt -94.85 127.37 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.894 . . . . 0.0 110.505 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -69.78 141.67 53.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.5 -0.75 . . . . 0.0 110.371 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -69.93 90.68 0.63 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.071 -1.018 . . . . 0.0 109.386 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.467 ' CE2' ' CG2' ' A' ' 71' ' ' VAL . 80.4 m-85 -60.7 -41.61 95.52 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.257 -0.902 . . . . 0.0 109.676 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.5 mt -129.11 148.1 51.03 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.722 -0.611 . . . . 0.0 109.495 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.3 m -63.98 149.93 46.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.899 -1.126 . . . . 0.0 109.172 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.53 -30.77 21.69 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.892 -1.13 . . . . 0.0 110.059 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -72.27 -36.04 68.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.159 -0.963 . . . . 0.0 110.054 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -61.92 -40.78 96.65 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.956 -1.097 . . . . 0.0 108.729 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -61.14 -38.44 86.42 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.729 -0.607 . . . . 0.0 110.178 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -60.52 -41.92 95.39 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.514 -0.875 . . . . 0.0 110.431 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.14 78.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.006 -1.059 . . . . 0.0 112.329 -178.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.2 tt -66.53 -31.74 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.59 -1.318 . . . . 0.0 110.215 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.63 -40.58 89.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -63.97 -35.94 82.34 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.606 -0.837 . . . . 0.0 109.174 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.45 -39.46 93.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.38 -0.825 . . . . 0.0 109.12 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.56 -43.32 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.835 . . . . 0.0 109.862 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -60.78 -41.96 96.57 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.131 -0.981 . . . . 0.0 110.199 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -65.96 -38.22 88.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.512 -0.742 . . . . 0.0 111.147 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.96 -40.41 96.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.859 -1.151 . . . . 0.0 109.956 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.67 -15.59 30.36 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.061 -1.024 . . . . 0.0 110.866 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.474 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 75.4 mmtt -93.8 1.01 56.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.089 -1.007 . . . . 0.0 109.27 177.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -114.81 -14.08 11.97 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.802 -1.186 . . . . 0.0 109.934 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.6 t -151.74 154.52 36.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.875 -1.14 . . . . 0.0 109.753 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 m -84.56 -6.74 59.39 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.291 -0.881 . . . . 0.0 109.805 178.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.9 174.58 54.27 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -133.31 138.2 46.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.272 -1.134 . . . . 0.0 111.665 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.402 HG21 HD12 ' A' ' 31' ' ' ILE . 93.5 mt -118.46 134.5 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.712 -0.617 . . . . 0.0 109.835 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.419 ' NE ' ' OG ' ' A' ' 143' ' ' SER . 76.2 ttt180 -139.87 152.17 46.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.89 . . . . 0.0 109.852 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.7 t -124.5 140.61 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.368 -0.832 . . . . 0.0 111.464 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -125.87 128.3 47.38 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.521 0.677 . . . . 0.0 109.434 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.45 ' CD1' ' CG1' ' A' ' 71' ' ' VAL . 37.8 tp -118.67 129.84 55.51 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.946 0.879 . . . . 0.0 112.572 -177.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -145.35 168.09 21.32 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.423 ' HA ' HG21 ' A' ' 71' ' ' VAL . 98.7 mttt -79.23 -73.6 0.33 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.977 -1.077 . . . . 0.0 112.961 -177.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 t -143.26 158.81 43.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.265 -0.897 . . . . 0.0 110.141 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.9 p -108.95 171.86 7.19 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.251 -0.906 . . . . 0.0 111.152 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -106.58 -10.68 16.11 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.479 -0.763 . . . . 0.0 110.425 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 42' ' ' ASP . 25.7 pt -125.57 -121.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 120.985 -1.072 . . . . 0.0 109.631 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.408 ' N ' HG13 ' A' ' 41' ' ' ILE . 64.2 m-20 -111.76 138.62 48.1 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 120.393 -1.442 . . . . 0.0 109.017 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.431 ' CG1' HG22 ' A' ' 77' ' ' VAL . 85.2 t -64.28 -43.31 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 111.412 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -59.36 -47.29 85.97 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.95 -1.094 . . . . 0.0 110.778 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -71.34 -38.18 71.66 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.88 -1.137 . . . . 0.0 108.42 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -63.54 -40.67 97.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.467 -0.77 . . . . 0.0 110.082 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.44 -38.15 84.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.694 -1.254 . . . . 0.0 110.127 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.4 ttp -62.09 -44.22 97.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.969 -1.082 . . . . 0.0 109.901 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -63.35 -44.64 94.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.082 -1.011 . . . . 0.0 109.571 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 95.7 t -65.81 -43.72 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.586 -0.696 . . . . 0.0 110.088 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.474 ' CE2' ' OD1' ' A' ' 57' ' ' ASP . 71.4 t80 -58.66 -45.95 88.24 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.065 -1.022 . . . . 0.0 109.435 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -73.07 -35.77 66.72 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.849 -1.157 . . . . 0.0 109.558 178.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -60.79 -37.34 81.6 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.025 -1.047 . . . . 0.0 109.955 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.3 mt -82.08 5.72 18.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.098 -1.001 . . . . 0.0 110.308 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.404 ' HB3' ' ND2' ' A' ' 58' ' ' ASN . 98.6 mttt 54.78 34.65 22.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.793 -1.192 . . . . 0.0 111.43 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 93.4 mtp -67.05 -12.47 60.01 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.957 -1.097 . . . . 0.0 109.641 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.474 ' OD1' ' CE2' ' A' ' 51' ' ' PHE . 92.3 m-20 -75.09 -2.13 26.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.664 -1.272 . . . . 0.0 109.9 177.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.404 ' ND2' ' HB3' ' A' ' 55' ' ' LYS . 64.9 m-20 -74.2 61.37 0.86 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.828 -1.17 . . . . 0.0 109.937 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.4 m -132.47 144.17 50.28 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.162 -0.961 . . . . 0.0 108.875 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.31 -42.81 99.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.821 -0.549 . . . . 0.0 112.405 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.5 mt -98.51 2.4 47.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.101 -0.999 . . . . 0.0 111.595 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 55.87 36.54 27.49 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.076 0.941 . . . . 0.0 111.542 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -113.13 50.2 0.9 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.338 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.68 142.53 16.15 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.762 -2.135 . . . . 0.0 107.762 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.408 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 54.9 t -123.73 133.91 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.103 -1.234 . . . . 0.0 109.924 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.5 tp -116.37 129.05 56.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 110.536 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.0 mt -107.65 108.93 26.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.369 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -95.59 125.4 40.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -0.853 . . . . 0.0 109.913 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -122.4 133.23 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.095 0.95 . . . . 0.0 110.769 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.48 91.59 4.53 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.467 ' CG2' ' CE2' ' A' ' 7' ' ' PHE . 26.0 m -64.54 -23.71 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.018 -1.051 . . . . 0.0 110.892 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 tp10 -67.61 -44.18 78.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.062 -1.024 . . . . 0.0 108.741 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -101.5 8.89 41.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.371 -0.83 . . . . 0.0 110.982 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.4 tttt 51.49 41.47 28.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.909 -1.119 . . . . 0.0 110.42 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.2 p -121.32 169.43 10.6 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.226 -0.921 . . . . 0.0 109.529 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.4 ' CD2' HG23 ' A' ' 100' ' ' ILE . 53.8 p90 -151.24 145.3 25.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.758 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.431 HG22 ' CG1' ' A' ' 43' ' ' VAL . 55.1 t -132.06 135.97 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.453 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 76.4 mt -112.86 123.34 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.758 -1.214 . . . . 0.0 110.533 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -129.32 111.65 13.06 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.472 -0.767 . . . . 0.0 110.797 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -98.34 173.47 27.48 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -76.57 173.28 11.75 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.587 -0.949 . . . . 0.0 109.66 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.81 -22.94 62.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.893 . . . . 0.0 110.815 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.94 -50.6 45.82 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.825 -1.179 . . . . 0.0 110.523 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 2.7 mt -64.25 -46.92 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.886 -1.361 . . . . 0.0 108.655 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -61.37 -37.97 85.3 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.768 -1.207 . . . . 0.0 111.949 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -72.02 -22.12 61.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.684 -1.26 . . . . 0.0 111.832 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 88' ' ' VAL . 7.5 p -102.09 -21.62 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.967 -1.083 . . . . 0.0 113.21 -178.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.48 ' HB ' ' CD2' ' A' ' 92' ' ' PHE . 30.0 m -123.36 166.66 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.641 -1.287 . . . . 0.0 111.367 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 m -112.11 -175.56 2.71 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.271 -0.893 . . . . 0.0 113.165 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -62.44 -39.75 94.36 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.835 . . . . 0.0 110.18 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -61.64 -38.63 88.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.123 -0.985 . . . . 0.0 110.112 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.48 ' CD2' ' HB ' ' A' ' 88' ' ' VAL . 68.8 t80 -65.9 -27.69 68.39 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.204 -0.935 . . . . 0.0 109.123 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.453 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 5.5 m95 -86.72 -27.02 23.93 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.207 1.003 . . . . 0.0 110.278 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -55.99 -42.18 75.94 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.97 -1.081 . . . . 0.0 112.471 -176.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 88.1 m -62.95 -31.99 73.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.809 -1.182 . . . . 0.0 109.037 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.286 8.7 m -58.88 -48.9 79.77 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.688 1.232 . . . . 0.0 110.732 179.686 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.65 -38.46 80.47 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.777 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.411 ' O ' HD22 ' A' ' 102' ' ' LEU . 11.5 m120 -63.95 -42.69 97.23 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.989 -1.084 . . . . 0.0 110.177 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.02 -49.17 78.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.292 -1.505 . . . . 0.0 110.598 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.4 HG23 ' CD2' ' A' ' 76' ' ' PHE . 90.9 mt -67.99 -42.48 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.15 -0.969 . . . . 0.0 110.482 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -63.08 -46.31 88.0 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.009 -1.057 . . . . 0.0 111.889 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.411 HD22 ' O ' ' A' ' 98' ' ' ASN . 3.5 mm? -64.08 -42.38 96.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.991 -1.068 . . . . 0.0 112.298 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.437 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 99.4 mm-40 -71.67 -41.38 68.78 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.923 -1.111 . . . . 0.0 109.017 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -60.15 -40.09 88.65 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.08 -32.99 72.64 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.004 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -81.55 -17.64 47.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.091 -1.006 . . . . 0.0 109.503 177.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.54 11.04 29.88 Favored Glycine 0 N--CA 1.494 2.506 0 O-C-N 121.112 -0.993 . . . . 0.0 110.781 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -108.71 89.47 3.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.829 -1.395 . . . . 0.0 110.781 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -63.48 -44.22 95.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.439 -0.788 . . . . 0.0 111.577 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -62.82 -49.07 76.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.143 -0.973 . . . . 0.0 112.269 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -64.61 -38.67 91.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.054 -1.029 . . . . 0.0 110.055 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.437 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -63.93 -44.12 96.48 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.6 mt -66.81 -44.9 79.97 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.339 -1.095 . . . . 0.0 110.254 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 74.8 t -66.12 -47.13 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.423 -0.798 . . . . 0.0 110.679 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -63.17 -39.09 93.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.009 -1.057 . . . . 0.0 109.248 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.76 -42.28 99.71 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.52 -44.28 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.233 -1.157 . . . . 0.0 110.72 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.51 -48.45 80.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.979 -1.076 . . . . 0.0 109.757 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.99 -40.33 97.44 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.395 -0.816 . . . . 0.0 108.865 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.56 97.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.442 -0.787 . . . . 0.0 110.59 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.81 -42.55 98.47 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 98.2 mtp -65.41 -48.56 72.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -1.17 . . . . 0.0 110.261 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.41 -44.67 95.87 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.538 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.18 -39.61 95.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -0.851 . . . . 0.0 109.237 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.6 -34.5 58.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.066 -1.021 . . . . 0.0 110.123 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -61.88 -43.72 98.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 0.0 109.32 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.435 ' HB3' ' CE2' ' A' ' 128' ' ' PHE . 68.2 m-85 -70.93 -37.44 72.87 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.819 0.819 . . . . 0.0 109.36 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 127' ' ' TYR . 88.1 m-85 -132.5 98.51 16.56 Favored Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.174 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.08 150.85 77.68 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 O-C-N 123.696 1.367 . . . . 0.0 109.706 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.474 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 51.9 t90 -76.1 127.4 32.86 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.418 -0.801 . . . . 0.0 110.817 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -105.17 146.78 28.76 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -56.46 -29.92 62.28 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.214 -0.929 . . . . 0.0 111.087 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -90.85 8.86 32.75 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.099 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -42.94 138.5 2.01 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.19 -0.944 . . . . 0.0 111.187 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.424 HD13 HG21 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -110.92 134.4 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-O 121.995 0.902 . . . . 0.0 111.473 -176.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 41.4 p-10 -116.96 102.48 9.39 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.446 -0.784 . . . . 0.0 110.583 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -102.17 -12.07 18.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.739 -1.226 . . . . 0.0 111.734 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.11 140.97 23.49 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.977 -1.077 . . . . 0.0 110.676 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.2 171.94 14.99 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.349 1.184 . . . . 0.0 109.108 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -112.11 7.21 19.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.715 -1.24 . . . . 0.0 110.617 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -64.06 148.01 50.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.955 -1.091 . . . . 0.0 111.332 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 93.5 mt -76.2 139.61 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.56 -0.713 . . . . 0.0 110.351 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.419 ' OG ' ' NE ' ' A' ' 32' ' ' ARG . 17.6 m -94.09 135.96 34.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.158 -0.964 . . . . 0.0 110.272 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -128.77 140.97 51.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.278 -0.889 . . . . 0.0 110.667 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.974 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.4 mtp . . . . . 0 N--CA 1.506 2.343 0 CA-C-O 121.073 0.463 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.9 m -63.35 -41.23 98.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.061 -1.024 . . . . 0.0 110.097 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -128.16 143.84 51.08 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.277 -0.89 . . . . 0.0 110.089 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.3 pt -102.96 1.36 10.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 O-C-N 121.633 -0.667 . . . . 0.0 110.326 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.36 -38.29 88.98 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.799 -1.188 . . . . 0.0 109.385 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -123.05 122.93 39.69 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.321 -0.862 . . . . 0.0 110.331 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.508 ' CE1' ' CG2' ' A' ' 71' ' ' VAL . 64.1 m-85 -64.92 -40.6 95.3 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.525 -0.734 . . . . 0.0 111.846 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.8 mt -128.19 143.86 51.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.953 -1.092 . . . . 0.0 109.584 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.8 m -74.45 167.61 21.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.91 -1.119 . . . . 0.0 109.746 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.49 -34.9 59.73 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.996 -1.065 . . . . 0.0 109.522 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -60.32 -46.74 88.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.117 -0.99 . . . . 0.0 110.81 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -72.79 -46.98 50.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.985 -1.072 . . . . 0.0 111.775 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.15 -40.71 90.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.983 -1.073 . . . . 0.0 110.021 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -63.84 -42.93 97.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.108 -0.995 . . . . 0.0 110.805 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.05 -42.94 93.78 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.99 -1.068 . . . . 0.0 111.559 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.434 HG21 ' N ' ' A' ' 17' ' ' VAL . 19.4 tt -68.88 -36.86 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.72 -1.238 . . . . 0.0 110.379 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.434 ' N ' HG21 ' A' ' 16' ' ' ILE . 48.4 t -61.26 -42.4 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -61.54 -36.48 80.72 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.507 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.67 -40.75 93.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.419 -0.8 . . . . 0.0 109.26 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.402 HG23 ' CB ' ' A' ' 140' ' ' ASN . 96.2 mt -63.64 -42.56 96.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.345 -0.847 . . . . 0.0 109.348 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -58.64 -42.88 89.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.818 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -64.9 -37.46 87.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.179 -0.951 . . . . 0.0 111.167 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.03 -39.31 93.17 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.779 -1.2 . . . . 0.0 110.522 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.2 -15.94 28.85 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.894 -1.129 . . . . 0.0 110.351 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.478 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.5 mttt -93.2 0.37 57.1 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 120.927 -1.108 . . . . 0.0 109.417 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -112.55 -15.62 13.02 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.714 -1.241 . . . . 0.0 109.816 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.3 t -153.64 157.59 39.85 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.906 -1.121 . . . . 0.0 110.326 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.2 m -85.57 -9.2 57.67 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.326 -0.859 . . . . 0.0 110.193 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.86 172.29 46.54 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 53.6 mp0 -131.18 134.04 46.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.287 -1.125 . . . . 0.0 112.268 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.1 mt -118.9 133.86 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.305 0.574 . . . . 0.0 109.807 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.404 ' CZ ' ' HB2' ' A' ' 143' ' ' SER . 72.4 ttt180 -139.79 152.09 46.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.429 -0.794 . . . . 0.0 110.063 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 83.9 t -122.64 138.77 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.36 -0.838 . . . . 0.0 110.71 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -122.82 132.32 54.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 0.0 108.933 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.438 ' CD1' HG12 ' A' ' 71' ' ' VAL . 32.9 tp -118.07 131.63 56.43 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.024 0.916 . . . . 0.0 111.557 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -150.38 164.88 34.74 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -79.39 -74.74 0.27 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.04 -1.038 . . . . 0.0 113.419 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 t -141.39 160.28 40.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.414 -0.804 . . . . 0.0 110.906 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.421 ' OG ' ' CD ' ' A' ' 46' ' ' ARG . 25.7 m -108.9 168.02 9.66 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.661 -0.649 . . . . 0.0 110.997 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -107.82 -12.0 15.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 110.7 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 42' ' ' ASP . 29.3 pt -123.75 -122.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.984 -1.073 . . . . 0.0 109.321 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.402 ' N ' HG13 ' A' ' 41' ' ' ILE . 96.6 m-20 -110.53 136.33 49.82 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 120.204 -1.56 . . . . 0.0 108.973 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.419 ' CG1' HG22 ' A' ' 77' ' ' VAL . 57.9 t -62.96 -43.49 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.475 -0.766 . . . . 0.0 111.734 -178.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -59.24 -45.1 92.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.999 -1.063 . . . . 0.0 109.952 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -70.23 -37.97 75.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.897 -1.127 . . . . 0.0 108.327 177.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.421 ' CD ' ' OG ' ' A' ' 39' ' ' SER . 44.1 ttt85 -61.3 -41.66 97.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.526 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.4 -37.6 83.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.785 -1.197 . . . . 0.0 110.48 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.4 ttp -64.23 -42.6 96.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.486 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -64.62 -46.83 80.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.902 -1.124 . . . . 0.0 109.841 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.49 -45.67 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.208 -0.932 . . . . 0.0 110.553 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.467 ' CZ ' ' OD1' ' A' ' 81' ' ' ASP . 6.8 t80 -56.84 -47.94 79.21 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.703 -1.248 . . . . 0.0 109.717 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -72.85 -35.88 67.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.995 -1.066 . . . . 0.0 110.088 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -60.47 -39.54 87.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.879 -1.138 . . . . 0.0 109.314 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.1 mt -80.66 4.62 18.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.094 -1.004 . . . . 0.0 110.531 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 57.33 33.72 23.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.843 -1.161 . . . . 0.0 111.134 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.447 ' HE2' ' CE2' ' A' ' 51' ' ' PHE . 79.9 mtp -68.77 -26.8 65.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.117 -0.989 . . . . 0.0 109.374 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 39.2 p-10 -71.27 -8.21 52.11 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.202 -0.936 . . . . 0.0 110.586 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -87.98 82.54 7.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.705 -1.247 . . . . 0.0 110.233 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.7 m -138.1 156.1 48.1 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.17 -46.86 88.24 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.109 -0.994 . . . . 0.0 111.909 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.6 mt -97.71 2.55 49.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.045 -1.035 . . . . 0.0 111.031 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.415 ' O ' ' CB ' ' A' ' 81' ' ' ASP . 86.6 mt-30 55.49 43.67 28.17 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.481 1.134 . . . . 0.0 111.38 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -118.88 55.66 0.92 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.323 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.56 140.61 14.93 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.469 ' CG2' ' CD1' ' A' ' 84' ' ' ILE . 74.3 t -124.68 135.4 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.124 -1.221 . . . . 0.0 110.726 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.421 ' HB2' ' CE ' ' A' ' 56' ' ' MET . 38.8 tp -116.1 126.84 54.28 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.607 -0.683 . . . . 0.0 109.774 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.41 101.0 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 118.901 -1.12 . . . . 0.0 108.992 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -86.97 123.27 31.89 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.384 -0.822 . . . . 0.0 109.973 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.2 t -119.74 129.6 75.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.855 0.836 . . . . 0.0 110.149 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.2 84.81 3.09 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.508 ' CG2' ' CE1' ' A' ' 7' ' ' PHE . 30.2 m -58.16 -23.13 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.224 -0.923 . . . . 0.0 111.016 -178.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -66.05 -42.45 89.5 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.234 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -102.31 6.69 40.56 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.198 -0.939 . . . . 0.0 111.007 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.8 tttt 52.84 45.89 27.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.822 -1.174 . . . . 0.0 110.983 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 70.1 p -122.76 168.63 11.99 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.237 -0.915 . . . . 0.0 109.625 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 43.7 p90 -146.47 143.18 28.8 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.961 -1.087 . . . . 0.0 111.016 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.419 HG22 ' CG1' ' A' ' 43' ' ' VAL . 51.0 t -128.98 135.72 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.529 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 80.1 mt -114.45 129.44 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.879 -1.138 . . . . 0.0 110.092 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -136.38 114.42 11.42 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.494 -0.754 . . . . 0.0 110.877 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -101.14 174.82 25.54 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.467 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 32.6 m-20 -79.04 176.01 10.06 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.474 -1.015 . . . . 0.0 110.858 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.57 -27.38 68.59 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.366 -0.834 . . . . 0.0 109.453 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.66 -53.01 41.27 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.953 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.469 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 93.5 mt -65.08 -44.07 95.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.743 -1.445 . . . . 0.0 108.659 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -61.77 -37.1 83.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.626 -1.296 . . . . 0.0 110.698 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -73.34 -21.1 60.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.963 . . . . 0.0 112.19 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.7 m -107.19 -19.83 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.809 -1.182 . . . . 0.0 112.926 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.474 ' HB ' ' CD2' ' A' ' 92' ' ' PHE . 16.4 m -119.95 162.79 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.693 -1.254 . . . . 0.0 111.309 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 m -108.54 173.64 6.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.475 -0.766 . . . . 0.0 111.965 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -61.82 -37.24 83.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 110.1 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 34.1 p-10 -61.69 -36.41 80.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 109.244 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.474 ' CD2' ' HB ' ' A' ' 88' ' ' VAL . 73.1 t80 -66.73 -25.52 66.56 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.302 -0.874 . . . . 0.0 108.773 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.529 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 3.8 m95 -86.04 -26.19 25.5 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.852 0.834 . . . . 0.0 110.542 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -55.37 -38.99 69.56 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.996 -1.065 . . . . 0.0 112.963 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.4 m -63.22 -35.33 79.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.815 -1.178 . . . . 0.0 109.099 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.283 16.0 m -58.09 -48.5 79.98 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.334 1.064 . . . . 0.0 111.255 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.69 -38.22 83.37 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.518 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.421 ' O ' ' CD1' ' A' ' 102' ' ' LEU . 21.1 m120 -64.69 -45.12 87.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.988 -1.07 . . . . 0.0 111.015 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.17 -49.91 76.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.712 -1.242 . . . . 0.0 110.448 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.441 HG23 ' CD1' ' A' ' 104' ' ' PHE . 95.5 mt -68.39 -43.26 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.223 -0.923 . . . . 0.0 111.075 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -62.42 -45.12 94.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.905 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.434 HD11 ' N ' ' A' ' 102' ' ' LEU . 7.0 mp -63.85 -41.46 97.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.325 -0.859 . . . . 0.0 111.561 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.425 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 98.7 mm-40 -73.01 -41.78 63.91 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.714 -1.194 . . . . 0.0 108.756 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.441 ' CD1' HG23 ' A' ' 100' ' ' ILE . 3.6 m-85 -58.72 -38.07 77.53 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -61.46 -34.06 74.8 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.681 -0.637 . . . . 0.0 109.946 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -80.7 -17.59 50.6 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.814 -1.179 . . . . 0.0 110.511 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.75 7.18 42.39 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.678 -1.249 . . . . 0.0 111.167 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -103.99 90.99 3.78 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.773 -1.428 . . . . 0.0 110.259 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -63.1 -40.05 96.5 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.553 -0.717 . . . . 0.0 111.47 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -65.75 -49.52 68.1 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.243 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -64.29 -39.39 93.82 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.956 -1.097 . . . . 0.0 110.527 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.425 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -62.72 -48.07 84.18 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.8 mt -64.41 -43.2 95.13 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.301 -1.117 . . . . 0.0 109.912 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.4 t -64.81 -48.34 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -0.931 . . . . 0.0 110.509 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -64.66 -39.84 94.38 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.348 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.26 -43.62 99.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 89.2 mt -64.51 -43.56 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.064 -1.256 . . . . 0.0 109.806 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.95 -52.87 62.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.134 -0.979 . . . . 0.0 109.992 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.42 -43.05 99.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 108.664 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -53.81 -46.16 71.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.485 -0.76 . . . . 0.0 109.71 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.67 -43.15 99.4 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.421 ' HG2' ' NZ ' ' A' ' 126' ' ' LYS . 27.4 ttt -67.17 -48.91 66.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.895 -1.356 . . . . 0.0 109.669 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.408 ' CB ' ' CE1' ' A' ' 92' ' ' PHE . . . -62.09 -45.94 91.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.935 . . . . 0.0 109.37 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 77.2 mt -61.86 -40.13 94.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.194 -0.941 . . . . 0.0 108.611 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.08 -33.94 63.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.195 -0.941 . . . . 0.0 110.411 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.421 ' NZ ' ' HG2' ' A' ' 122' ' ' MET . 60.9 mttp -61.83 -43.43 98.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.056 -1.028 . . . . 0.0 108.818 178.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.419 ' CE2' HG12 ' A' ' 88' ' ' VAL . 52.5 m-85 -75.1 -39.78 60.45 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.61 0.719 . . . . 0.0 110.071 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -130.65 90.66 39.85 Favored Pre-proline 0 C--N 1.301 -1.518 0 O-C-N 121.706 -0.621 . . . . 0.0 109.426 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -64.78 154.42 72.79 Favored 'Trans proline' 0 C--N 1.318 -1.035 0 O-C-N 123.588 1.309 . . . . 0.0 110.483 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.478 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 31.2 t90 -77.6 133.34 38.47 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.441 0.639 . . . . 0.0 111.962 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -114.6 150.85 34.42 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -58.35 -31.74 67.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.096 -1.003 . . . . 0.0 111.842 -177.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -90.99 6.09 46.17 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.963 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 135' ' ' ILE . 66.9 t0 -42.59 140.07 1.37 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 122.038 0.923 . . . . 0.0 111.667 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.433 ' CD1' ' O ' ' A' ' 135' ' ' ILE . 1.1 pp -113.42 148.53 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-O 121.857 0.837 . . . . 0.0 111.662 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -105.68 96.65 6.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.465 -1.397 . . . . 0.0 110.036 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -68.15 -37.14 80.72 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.593 -0.692 . . . . 0.0 112.838 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.0 mt -109.3 148.45 38.04 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.987 -1.071 . . . . 0.0 111.828 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.39 -176.76 1.77 Allowed 'Trans proline' 0 C--N 1.319 -0.993 0 N-CA-C 108.359 -1.439 . . . . 0.0 108.359 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.402 ' CB ' HG23 ' A' ' 20' ' ' ILE . 12.6 p30 -116.87 4.35 12.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.587 -1.321 . . . . 0.0 110.204 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.8 p -63.29 169.1 3.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.899 -1.126 . . . . 0.0 110.771 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.0 mt -101.39 139.66 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.581 0.705 . . . . 0.0 110.947 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 32' ' ' ARG . 30.6 t -94.91 134.24 37.77 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.533 -0.729 . . . . 0.0 109.241 178.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -125.74 132.91 52.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.188 -0.945 . . . . 0.0 110.045 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.869 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 121.301 0.572 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.8 m -59.88 -42.37 93.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.925 -1.109 . . . . 0.0 110.403 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.77 -40.92 96.08 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.223 -0.923 . . . . 0.0 110.958 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.0 pt -123.24 132.23 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.233 -0.917 . . . . 0.0 110.796 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -115.63 -87.98 0.59 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.662 -1.274 . . . . 0.0 110.813 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -119.65 -20.52 7.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.903 -1.123 . . . . 0.0 110.797 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.527 ' CE2' ' CD1' ' A' ' 8' ' ' LEU . 43.1 t80 -46.97 -72.5 0.05 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.184 -0.948 . . . . 0.0 111.062 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.527 ' CD1' ' CE2' ' A' ' 7' ' ' PHE . 96.2 mt -134.2 159.29 41.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.017 -1.052 . . . . 0.0 111.378 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -83.37 166.25 18.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.68 -0.637 . . . . 0.0 109.503 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.61 -37.05 67.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.121 -0.987 . . . . 0.0 110.086 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -57.72 -45.95 85.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.909 . . . . 0.0 109.868 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.16 -43.88 73.38 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.599 -0.688 . . . . 0.0 112.031 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.412 ' OE1' ' CD1' ' A' ' 142' ' ' ILE . 79.8 mm-40 -65.4 -39.18 91.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.954 -1.091 . . . . 0.0 110.917 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -63.33 -43.18 98.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.808 -1.182 . . . . 0.0 111.113 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.11 -45.55 84.67 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.077 -1.014 . . . . 0.0 112.108 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.425 HG23 ' N ' ' A' ' 17' ' ' VAL . 19.6 tt -65.49 -37.43 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.696 -1.252 . . . . 0.0 110.507 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.425 ' N ' HG23 ' A' ' 16' ' ' ILE . 75.6 t -61.58 -39.1 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -0.953 . . . . 0.0 108.799 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -62.05 -36.31 81.25 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.072 -1.051 . . . . 0.0 108.885 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.09 -37.96 87.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.466 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.475 HG23 HD13 ' A' ' 20' ' ' ILE . 37.5 mm -63.72 -43.66 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.294 -0.879 . . . . 0.0 110.083 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.424 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 83.9 mtp180 -60.18 -41.59 93.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.347 -0.846 . . . . 0.0 110.556 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -65.08 -38.06 89.55 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.49 -0.756 . . . . 0.0 111.2 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.59 -39.53 93.9 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.938 -1.101 . . . . 0.0 110.165 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.63 -13.72 16.11 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.936 -1.103 . . . . 0.0 110.971 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.482 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.1 mttt -96.52 1.84 51.83 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.914 -1.116 . . . . 0.0 109.513 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -112.9 -18.04 12.34 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.04 -1.037 . . . . 0.0 109.775 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.2 t -151.43 158.33 43.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.959 . . . . 0.0 109.815 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 95.8 p -86.76 -7.57 58.15 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.269 -0.895 . . . . 0.0 109.667 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.38 172.11 52.42 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.439 ' CG ' ' HB2' ' A' ' 138' ' ' LEU . 79.6 mm-40 -133.72 139.56 46.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.254 -1.145 . . . . 0.0 111.891 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.6 mt -121.89 135.27 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 143' ' ' SER . 77.1 ttt180 -140.05 155.17 47.17 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 109.39 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.0 t -120.96 136.74 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.091 -1.006 . . . . 0.0 110.555 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -121.49 121.71 38.11 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.501 HD23 ' CD1' ' A' ' 7' ' ' PHE . 32.3 tp -111.87 125.93 54.55 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.732 0.777 . . . . 0.0 111.725 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.418 ' OE2' ' CZ ' ' A' ' 46' ' ' ARG . 82.5 tt0 -140.64 166.22 25.33 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.44 ' HB3' ' CG ' ' A' ' 72' ' ' GLU . 99.4 mttt -78.21 -76.05 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 112.327 -177.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.8 t -139.94 154.9 47.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 109.759 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.429 ' HA ' ' NH1' ' A' ' 46' ' ' ARG . 12.7 p -103.49 167.23 9.94 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.382 -0.824 . . . . 0.0 110.225 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -104.23 -8.35 19.41 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.372 -0.83 . . . . 0.0 110.041 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.4 pt -128.22 -122.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.046 -1.034 . . . . 0.0 109.493 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -110.29 138.75 46.25 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 120.309 -1.494 . . . . 0.0 109.509 178.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.2 t -63.18 -43.25 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 110.676 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -59.56 -47.11 86.83 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.02 -1.05 . . . . 0.0 110.743 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -70.15 -39.79 75.15 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.73 -1.232 . . . . 0.0 108.269 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.429 ' NH1' ' HA ' ' A' ' 39' ' ' SER . 73.1 ttt180 -61.12 -43.48 98.82 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.35 -0.844 . . . . 0.0 110.846 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.95 -40.47 91.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.702 -1.249 . . . . 0.0 110.368 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 46.7 ttp -62.34 -42.72 99.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.014 -1.054 . . . . 0.0 109.433 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -63.62 -42.06 98.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.037 -1.039 . . . . 0.0 109.081 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 82.9 t -66.58 -43.44 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.572 -0.705 . . . . 0.0 110.304 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -59.89 -45.93 90.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.779 -1.201 . . . . 0.0 109.77 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -73.86 -35.95 64.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.949 -1.094 . . . . 0.0 109.889 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -61.57 -39.48 91.3 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.014 -1.054 . . . . 0.0 110.196 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.6 mt -81.14 4.15 21.05 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.043 -1.036 . . . . 0.0 110.58 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 55.79 31.5 17.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.096 -1.002 . . . . 0.0 111.65 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 92.1 mtp -66.55 -19.04 65.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.161 -0.962 . . . . 0.0 109.671 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -74.89 -4.97 41.1 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.096 -1.002 . . . . 0.0 111.288 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -45.96 -32.79 2.92 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.042 -1.036 . . . . 0.0 110.621 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.447 ' CG2' ' HA ' ' A' ' 62' ' ' GLN . 9.0 t -40.61 144.86 0.21 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.505 1.145 . . . . 0.0 113.009 -176.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -68.16 -40.4 82.33 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.465 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 72.8 mt -92.2 -0.92 57.4 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.143 -0.973 . . . . 0.0 111.178 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.447 ' HA ' ' CG2' ' A' ' 59' ' ' THR . 88.3 mt-30 57.69 36.85 27.04 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.348 1.071 . . . . 0.0 110.45 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.408 ' HA ' HG13 ' A' ' 84' ' ' ILE . 97.8 m-20 -113.1 48.56 1.02 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.383 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.6 144.17 17.07 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 52.8 t -124.54 134.72 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.993 -1.298 . . . . 0.0 110.5 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 45.5 tp -116.79 125.6 51.85 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.387 -0.821 . . . . 0.0 109.738 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 89.9 mt -100.57 105.0 16.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 118.945 -1.102 . . . . 0.0 109.412 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -91.74 124.68 36.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.892 . . . . 0.0 110.327 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.9 t -123.95 132.3 71.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 122.059 0.933 . . . . 0.0 111.151 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.67 99.99 10.01 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.414 ' CG1' HD11 ' A' ' 35' ' ' LEU . 33.5 m -70.19 -18.95 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.027 -1.046 . . . . 0.0 110.781 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.44 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 80.4 mm-40 -71.11 -49.0 49.0 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.86 -1.15 . . . . 0.0 109.428 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -98.65 5.1 47.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.884 . . . . 0.0 110.293 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 72.1 tttt 53.72 43.51 30.96 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.019 -1.051 . . . . 0.0 110.16 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.2 m -119.15 132.24 55.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.324 -0.86 . . . . 0.0 109.952 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -116.08 136.59 52.89 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.445 -0.784 . . . . 0.0 110.051 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.4 t -126.41 137.54 57.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.46 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 77.2 mt -111.55 125.85 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.977 -1.077 . . . . 0.0 110.411 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -128.84 114.4 16.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.504 -0.748 . . . . 0.0 110.25 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.46 165.72 19.38 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 108.961 -1.655 . . . . 0.0 108.961 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 49.7 t0 -74.75 174.73 8.74 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.591 -0.946 . . . . 0.0 109.311 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -59.42 -22.77 61.94 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.052 -1.03 . . . . 0.0 111.186 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 62' ' ' GLN . . . -68.64 -50.9 33.62 Favored Glycine 0 N--CA 1.497 2.714 0 C-N-CA 119.737 -1.221 . . . . 0.0 110.939 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.444 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 3.5 mt -63.01 -44.7 99.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.865 -1.373 . . . . 0.0 107.393 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -63.16 -36.4 83.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.921 -1.112 . . . . 0.0 112.134 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -74.33 -20.93 59.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.627 -1.295 . . . . 0.0 112.311 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.0 m -105.78 -18.91 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.873 -1.142 . . . . 0.0 112.112 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.481 ' HB ' ' CD2' ' A' ' 92' ' ' PHE . 15.9 m -120.76 163.34 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.692 -1.255 . . . . 0.0 111.262 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.3 m -111.0 -176.67 3.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -0.859 . . . . 0.0 111.806 -178.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -62.81 -37.54 87.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.982 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -60.96 -39.51 89.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.201 -0.937 . . . . 0.0 109.398 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.481 ' CD2' ' HB ' ' A' ' 88' ' ' VAL . 83.3 t80 -66.34 -26.49 67.31 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.168 -0.958 . . . . 0.0 109.679 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.471 ' CD1' HG21 ' A' ' 88' ' ' VAL . 5.1 m95 -86.32 -25.22 25.54 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.042 0.925 . . . . 0.0 110.615 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -57.29 -41.16 79.25 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 112.837 -176.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.8 p -64.02 -30.06 71.16 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.572 -1.251 . . . . 0.0 109.118 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.261 16.4 m -60.1 -48.72 80.56 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.297 1.046 . . . . 0.0 110.962 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.59 -36.84 73.77 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.146 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -63.44 -43.27 97.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.828 -1.17 . . . . 0.0 110.129 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.11 -49.91 70.33 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.808 -1.182 . . . . 0.0 111.362 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.67 -42.55 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.003 -1.061 . . . . 0.0 110.426 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -63.89 -42.3 97.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.42 -0.8 . . . . 0.0 110.585 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 61.7 tp -63.57 -43.11 97.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 111.209 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.451 ' HG2' ' N ' ' A' ' 112' ' ' GLY . 5.7 tp60 -74.0 -42.22 60.7 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 118.757 -1.177 . . . . 0.0 108.928 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -59.38 -41.17 88.73 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.11 -31.22 71.65 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.999 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.7 tp60 -80.87 -19.73 43.84 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.168 -0.957 . . . . 0.0 109.411 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.24 1.27 33.43 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.008 -1.091 . . . . 0.0 110.847 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -104.13 91.15 3.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.706 -1.467 . . . . 0.0 110.862 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -65.32 -39.75 92.84 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.537 -0.727 . . . . 0.0 111.185 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -64.06 -49.17 73.36 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.771 -1.205 . . . . 0.0 111.793 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -63.34 -38.99 93.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.875 -1.141 . . . . 0.0 110.254 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.451 ' N ' ' HG2' ' A' ' 103' ' ' GLN . . . -63.19 -45.56 95.04 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 78.0 mt -64.72 -44.71 89.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.434 -1.039 . . . . 0.0 111.153 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 77.6 t -67.01 -46.61 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.769 -1.207 . . . . 0.0 110.714 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -65.04 -43.85 91.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.099 -1.001 . . . . 0.0 110.933 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.23 -40.95 94.58 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.2 -43.48 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.312 -1.111 . . . . 0.0 110.136 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -56.68 -49.07 76.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.984 . . . . 0.0 109.626 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.54 -42.17 98.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -0.984 . . . . 0.0 109.436 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.33 -38.35 80.1 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.193 -0.942 . . . . 0.0 109.567 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.44 -46.5 69.62 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 75.9 mtm -67.16 -43.71 81.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.909 -1.348 . . . . 0.0 109.694 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.423 ' HB2' ' CE1' ' A' ' 92' ' ' PHE . . . -65.23 -45.93 82.65 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.324 -0.95 . . . . 0.0 109.008 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.2 mt -62.06 -40.56 96.19 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.38 -34.09 64.02 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.387 -0.82 . . . . 0.0 110.641 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -62.15 -41.41 98.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.969 -1.082 . . . . 0.0 109.111 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -72.39 -41.08 66.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.581 -0.699 . . . . 0.0 109.935 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -130.68 99.87 18.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.984 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.48 150.39 75.37 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.586 1.308 . . . . 0.0 109.8 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.482 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 48.5 t90 -74.83 136.03 41.6 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.53 -0.731 . . . . 0.0 111.306 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -113.28 151.93 30.49 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.301 -0.875 . . . . 0.0 109.127 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.91 -30.68 69.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.204 -0.935 . . . . 0.0 111.175 -177.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -91.25 7.57 40.14 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.899 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.468 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 67.0 t0 -43.54 141.56 1.4 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.404 -0.81 . . . . 0.0 111.551 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.434 ' CD1' ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -114.31 146.02 19.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-O 121.697 0.76 . . . . 0.0 111.196 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 42.9 p-10 -98.56 92.62 5.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.595 -1.316 . . . . 0.0 110.66 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -68.45 -36.12 78.56 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.183 -0.948 . . . . 0.0 111.88 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.439 ' HB2' ' CG ' ' A' ' 30' ' ' GLU . 3.8 mm? -109.74 145.74 32.62 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.086 -1.009 . . . . 0.0 111.546 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.37 -167.85 0.35 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 N-CA-C 108.065 -1.552 . . . . 0.0 108.065 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.424 ' ND2' ' HG2' ' A' ' 21' ' ' ARG . 13.9 p30 -122.91 4.29 9.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.761 -1.212 . . . . 0.0 110.156 178.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.1 m -61.76 168.52 2.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.101 -0.999 . . . . 0.0 110.26 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.412 ' CD1' ' OE1' ' A' ' 13' ' ' GLU . 93.9 mt -103.68 140.42 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.43 -0.793 . . . . 0.0 110.537 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 32' ' ' ARG . 32.1 t -94.37 136.53 34.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.194 -0.941 . . . . 0.0 109.708 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -127.57 137.31 52.56 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.3 -0.875 . . . . 0.0 110.426 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 CA-C-O 118.002 -1.443 . . . . 0.0 109.668 -179.815 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 ttp . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.209 0.528 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 m -69.78 145.28 52.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.215 -0.928 . . . . 0.0 110.303 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.23 -37.43 85.37 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.298 -0.876 . . . . 0.0 109.106 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.9 mt -107.32 120.15 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.321 -0.862 . . . . 0.0 110.022 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -116.21 -35.9 4.22 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 110.037 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -129.69 138.54 51.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 110.171 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.472 ' CZ ' HG23 ' A' ' 71' ' ' VAL . 4.5 m-85 -92.01 -4.92 53.88 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.35 -0.844 . . . . 0.0 111.586 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.1 mt -127.29 150.09 49.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.798 -1.189 . . . . 0.0 109.548 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -79.45 164.77 23.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.882 -1.136 . . . . 0.0 110.066 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.418 ' HB3' ' HE2' ' A' ' 14' ' ' LYS . . . -54.75 -37.44 65.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.107 -0.995 . . . . 0.0 109.455 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -57.68 -43.48 85.08 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.437 -0.79 . . . . 0.0 109.611 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 96.4 mt-10 -72.43 -45.44 59.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.357 -0.84 . . . . 0.0 111.634 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.04 -38.51 91.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.005 -1.059 . . . . 0.0 110.127 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' A' ' 10' ' ' ALA . 68.1 mttm -64.4 -45.32 88.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.059 -1.025 . . . . 0.0 111.132 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.27 -41.56 96.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.129 -0.982 . . . . 0.0 111.114 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 17' ' ' VAL . 21.2 tt -68.76 -33.86 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.986 -1.071 . . . . 0.0 110.104 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.435 ' N ' HG22 ' A' ' 16' ' ' ILE . 76.0 t -65.48 -40.21 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.148 -0.97 . . . . 0.0 108.439 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -61.67 -36.91 82.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.975 . . . . 0.0 109.085 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.6 91.15 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.232 -0.918 . . . . 0.0 109.352 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.8 mm -63.18 -43.44 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.185 -0.947 . . . . 0.0 109.386 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.418 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 93.4 mtt-85 -59.72 -43.88 93.96 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.55 -0.719 . . . . 0.0 110.216 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -63.41 -38.94 93.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.871 . . . . 0.0 110.94 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.65 -39.63 94.82 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.255 -0.903 . . . . 0.0 110.662 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -59.93 -15.42 21.66 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.906 -1.122 . . . . 0.0 110.508 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 74.5 mmtt -96.18 1.01 51.93 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.976 -1.078 . . . . 0.0 109.386 178.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -114.35 -14.0 12.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.74 -1.225 . . . . 0.0 109.769 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.1 t -153.92 159.1 41.59 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.63 -1.294 . . . . 0.0 109.462 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.5 m -88.25 -9.32 53.33 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.255 -0.903 . . . . 0.0 109.75 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.79 172.43 43.19 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.418 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 53.3 mp0 -132.27 140.3 48.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.269 -1.136 . . . . 0.0 111.31 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.2 mt -124.97 136.83 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.764 -0.585 . . . . 0.0 110.518 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.41 ' NH1' ' HD2' ' A' ' 139' ' ' PRO . 95.1 mtt-85 -138.82 154.87 48.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.211 -0.931 . . . . 0.0 110.144 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.4 t -125.87 136.31 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.54 0.686 . . . . 0.0 109.693 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -121.04 118.98 31.2 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.571 -0.705 . . . . 0.0 109.279 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.417 HD12 ' CG1' ' A' ' 71' ' ' VAL . 30.6 tp -106.49 129.88 54.38 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.778 0.799 . . . . 0.0 111.175 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -147.57 167.58 24.17 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.432 ' HB3' ' CG ' ' A' ' 72' ' ' GLU . 99.4 mttt -80.83 -77.01 0.21 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.955 -1.091 . . . . 0.0 112.626 -177.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.422 ' OG1' ' CB ' ' A' ' 72' ' ' GLU . 43.7 m -140.85 159.5 42.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.444 -0.785 . . . . 0.0 109.669 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.7 m -114.0 175.64 5.38 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.257 -0.902 . . . . 0.0 110.393 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -107.43 -10.83 15.65 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.13 -0.981 . . . . 0.0 110.755 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.8 pt -124.23 -121.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.1 -1.0 . . . . 0.0 110.195 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -112.38 140.81 46.79 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.045 -1.66 . . . . 0.0 109.476 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.432 HG13 ' CG2' ' A' ' 77' ' ' VAL . 99.0 t -63.98 -42.42 95.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.512 -0.743 . . . . 0.0 110.525 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -58.76 -46.11 88.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.053 -1.029 . . . . 0.0 109.634 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -68.94 -38.62 79.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.806 -1.184 . . . . 0.0 108.394 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -62.79 -36.88 84.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -0.948 . . . . 0.0 110.106 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.77 -39.65 73.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.884 -1.135 . . . . 0.0 109.904 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 66.1 ttp -65.71 -44.16 86.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.099 -1.0 . . . . 0.0 109.969 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -63.46 -43.5 97.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.099 . . . . 0.0 109.386 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.58 -42.61 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.38 -0.825 . . . . 0.0 109.69 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.489 ' CE2' ' HB3' ' A' ' 57' ' ' ASP . 53.2 t80 -58.89 -46.03 88.85 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.04 -1.038 . . . . 0.0 109.705 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -75.57 -35.82 60.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.895 -1.128 . . . . 0.0 109.682 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -61.44 -39.74 91.92 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.201 -0.937 . . . . 0.0 109.795 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.428 HD12 ' CE ' ' A' ' 56' ' ' MET . 97.1 mt -84.18 4.54 30.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.503 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt 56.84 31.42 19.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.077 -1.014 . . . . 0.0 110.953 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.428 ' CE ' HD12 ' A' ' 54' ' ' LEU . 58.6 mtt -72.03 -27.93 63.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.316 -0.865 . . . . 0.0 109.407 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.489 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . 45.6 p-10 -69.0 -9.92 54.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.434 -0.791 . . . . 0.0 109.968 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -86.04 88.02 7.51 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.733 -1.187 . . . . 0.0 110.723 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 67.0 p -137.48 154.97 49.81 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -59.44 -45.26 92.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.49 -0.756 . . . . 0.0 111.881 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.5 mt -98.34 2.86 48.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.985 -1.072 . . . . 0.0 111.606 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 57.46 32.18 21.39 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 122.122 0.963 . . . . 0.0 111.942 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.401 ' HA ' HG13 ' A' ' 84' ' ' ILE . 97.8 m-20 -110.41 54.59 0.67 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.723 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.66 141.99 15.75 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.0 t -122.41 133.1 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.992 -1.299 . . . . 0.0 109.841 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.1 tp -118.39 130.9 56.25 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.374 -0.829 . . . . 0.0 110.471 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.7 mt -110.24 115.16 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 118.982 -1.087 . . . . 0.0 109.688 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -101.49 124.8 47.76 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.079 -1.013 . . . . 0.0 110.005 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.0 t -123.44 130.54 74.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.924 0.868 . . . . 0.0 111.621 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.406 ' CB ' HG21 ' A' ' 75' ' ' THR . . . -98.62 90.29 4.68 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.472 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 32.6 m -59.52 -22.86 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.99 -1.069 . . . . 0.0 111.148 -177.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.432 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 79.0 mm-40 -66.17 -42.32 89.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.789 -1.194 . . . . 0.0 109.061 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -101.12 4.97 42.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.437 -0.789 . . . . 0.0 110.655 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.6 tttt 54.99 46.85 23.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.656 -1.277 . . . . 0.0 110.703 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.406 HG21 ' CB ' ' A' ' 70' ' ' ALA . 10.0 t -122.67 162.54 21.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.44 -0.788 . . . . 0.0 109.636 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -143.7 139.42 29.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 110.001 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.432 ' CG2' HG13 ' A' ' 43' ' ' VAL . 60.3 t -129.2 139.81 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 108.93 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.501 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 81.7 mt -116.55 127.25 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.738 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -127.84 115.88 19.3 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.475 0.655 . . . . 0.0 109.862 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.84 161.57 16.61 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 82' ' ' LYS . 39.3 t0 -73.62 169.62 16.91 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.65 -0.912 . . . . 0.0 110.034 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.402 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 99.2 mttt -55.1 -28.04 49.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 109.976 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.36 -49.87 67.01 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.427 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 3.9 mt -66.35 -45.06 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.883 -1.363 . . . . 0.0 108.321 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -64.08 -35.83 82.01 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.925 -1.109 . . . . 0.0 111.53 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -77.76 -20.04 54.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.809 -1.182 . . . . 0.0 111.875 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 84' ' ' ILE . 7.6 p -102.55 -27.87 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.713 -1.242 . . . . 0.0 112.55 -178.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.481 ' HB ' ' CD2' ' A' ' 92' ' ' PHE . 19.2 m -116.65 166.52 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.582 -1.324 . . . . 0.0 111.143 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.2 m -110.62 179.25 4.12 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.215 -0.928 . . . . 0.0 112.405 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -60.95 -37.12 81.25 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.344 -0.847 . . . . 0.0 109.161 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -62.67 -36.83 84.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.417 -0.802 . . . . 0.0 109.701 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.481 ' CD2' ' HB ' ' A' ' 88' ' ' VAL . 87.6 t80 -69.8 -24.16 63.44 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.002 -1.061 . . . . 0.0 109.173 177.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.501 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 4.6 m95 -86.57 -25.99 24.71 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.066 0.936 . . . . 0.0 110.68 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -59.2 -36.17 74.91 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 112.379 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.5 m -66.03 -34.42 78.06 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.729 -1.232 . . . . 0.0 109.222 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' CD1' ' A' ' 78' ' ' ILE 0.288 20.6 m -57.87 -48.9 78.49 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 122.418 1.104 . . . . 0.0 111.095 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.58 -37.69 77.07 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.413 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -63.06 -43.93 97.23 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.749 -1.18 . . . . 0.0 110.028 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.68 -48.9 77.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.879 -1.138 . . . . 0.0 110.91 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.03 -42.26 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.971 . . . . 0.0 110.177 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.438 ' CG ' ' HE3' ' A' ' 105' ' ' LYS . 51.7 tt0 -63.55 -43.62 96.53 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.272 -0.893 . . . . 0.0 110.865 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.8 tp -63.09 -41.72 99.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.088 -1.008 . . . . 0.0 112.088 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.432 ' HG2' ' CB ' ' A' ' 111' ' ' GLN . 6.3 tp60 -75.17 -37.34 61.31 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.821 -1.151 . . . . 0.0 108.942 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -62.26 -42.02 98.97 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.602 0.715 . . . . 0.0 109.135 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.438 ' HE3' ' CG ' ' A' ' 101' ' ' GLN . 93.8 mttt -60.58 -34.8 74.72 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.342 -0.849 . . . . 0.0 109.915 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -76.44 -21.06 56.4 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.939 -1.1 . . . . 0.0 110.124 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.19 2.48 35.87 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.595 -1.288 . . . . 0.0 111.578 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -102.25 92.55 4.77 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.59 -1.535 . . . . 0.0 110.176 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -62.54 -42.91 99.83 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.859 -0.525 . . . . 0.0 111.942 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.434 ' NZ ' ' HA ' ' A' ' 12' ' ' GLU . 86.3 tttt -62.51 -48.07 81.18 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.916 -177.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.432 ' CB ' ' HG2' ' A' ' 103' ' ' GLN . 96.6 mm-40 -64.32 -39.74 94.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.944 -1.098 . . . . 0.0 110.69 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.429 ' N ' ' HG2' ' A' ' 103' ' ' GLN . . . -62.89 -49.48 72.08 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 68.1 mt -62.92 -44.24 96.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.129 -1.218 . . . . 0.0 110.673 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 95.9 t -65.86 -47.53 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.231 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -64.23 -40.13 95.41 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.316 -0.954 . . . . 0.0 109.808 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.5 -42.79 99.21 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.42 -44.73 94.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.375 -1.073 . . . . 0.0 109.992 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -56.84 -50.35 72.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.877 -1.139 . . . . 0.0 109.166 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.93 -42.13 99.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.257 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.72 -39.95 82.31 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.181 -0.949 . . . . 0.0 109.298 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.34 -44.99 89.41 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 90.3 mtp -67.59 -45.82 74.4 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.019 -1.283 . . . . 0.0 110.254 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.477 ' HB2' ' CE1' ' A' ' 92' ' ' PHE . . . -63.83 -45.03 91.41 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.154 -0.966 . . . . 0.0 108.973 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.18 -37.8 88.65 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.272 -0.893 . . . . 0.0 109.108 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.28 -35.1 64.69 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.985 -1.072 . . . . 0.0 110.635 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.45 -42.97 97.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.931 -1.106 . . . . 0.0 108.391 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -74.16 -41.27 61.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.67 -0.644 . . . . 0.0 110.723 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -128.96 91.53 42.46 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.543 -0.723 . . . . 0.0 109.28 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.62 152.59 81.3 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 O-C-N 123.694 1.365 . . . . 0.0 109.953 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 28.1 t90 -79.56 139.7 37.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.592 -0.693 . . . . 0.0 111.959 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -120.71 155.35 34.08 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -61.36 -34.83 75.96 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.282 -0.887 . . . . 0.0 111.207 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -87.03 6.55 31.85 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.672 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.476 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 67.2 t0 -41.81 138.1 1.55 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.27 -0.894 . . . . 0.0 111.126 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.434 ' CD1' ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -110.64 140.55 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 122.184 0.992 . . . . 0.0 112.069 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -119.38 102.14 8.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.759 -1.213 . . . . 0.0 109.471 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -99.88 0.75 41.99 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.758 -1.214 . . . . 0.0 111.668 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.2 mp -110.33 151.32 42.57 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 120.769 -1.207 . . . . 0.0 111.424 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.41 ' HD2' ' NH1' ' A' ' 32' ' ' ARG . 55.2 Cg_endo -74.73 170.55 20.09 Favored 'Trans proline' 0 C--N 1.322 -0.823 0 O-C-N 123.632 1.333 . . . . 0.0 109.197 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.418 ' ND2' ' HG2' ' A' ' 21' ' ' ARG . 79.6 m-20 -113.46 4.87 16.46 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.873 -1.142 . . . . 0.0 110.631 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.6 p -68.32 166.33 16.77 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.79 -1.194 . . . . 0.0 111.836 -178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.4 mt -87.41 137.8 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 121.733 0.778 . . . . 0.0 110.914 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.4 m -88.77 133.38 34.26 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -128.07 149.19 50.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.82 -1.175 . . . . 0.0 111.094 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.59 0 CA-C-O 118.045 -1.42 . . . . 0.0 110.045 -179.576 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.9 mtm . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.309 0.576 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.8 p -153.99 159.6 41.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.289 -0.882 . . . . 0.0 110.484 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt 51.56 40.52 27.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.471 -0.768 . . . . 0.0 110.935 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.486 HD12 HG23 ' A' ' 4' ' ' ILE . 30.1 mm -63.76 -43.18 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.886 -1.134 . . . . 0.0 110.126 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -59.04 -46.42 88.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.075 -1.016 . . . . 0.0 110.304 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -123.73 129.6 51.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.885 . . . . 0.0 110.333 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.518 ' CE1' ' CG2' ' A' ' 71' ' ' VAL . 72.3 m-85 -62.83 -42.19 99.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.079 -1.013 . . . . 0.0 110.092 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.439 ' HB2' ' CG ' ' A' ' 13' ' ' GLU . 98.7 mt -128.85 149.98 50.52 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.307 -0.871 . . . . 0.0 109.767 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.402 HG23 ' HB3' ' A' ' 11' ' ' GLU . 13.0 t -81.44 171.57 14.58 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.288 -0.883 . . . . 0.0 109.771 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.93 -39.49 68.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.075 -1.015 . . . . 0.0 109.946 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.402 ' HB3' HG23 ' A' ' 9' ' ' THR . 83.9 tt0 -61.35 -47.38 86.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.071 -1.018 . . . . 0.0 110.751 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.416 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 98.9 mt-10 -70.1 -49.26 52.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 111.709 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.439 ' CG ' ' HB2' ' A' ' 8' ' ' LEU . 99.7 mt-10 -61.22 -33.61 73.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.915 -1.116 . . . . 0.0 109.921 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.85 -46.03 86.82 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.223 -0.923 . . . . 0.0 110.995 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.76 -41.11 92.48 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.127 -0.983 . . . . 0.0 112.336 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.436 HG23 ' N ' ' A' ' 17' ' ' VAL . 18.9 tt -66.96 -37.82 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.653 -1.279 . . . . 0.0 110.626 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.436 ' N ' HG23 ' A' ' 16' ' ' ILE . 70.7 t -63.34 -40.67 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.91 -1.119 . . . . 0.0 108.849 178.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -62.03 -37.25 84.19 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.377 -0.929 . . . . 0.0 109.559 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.24 -39.43 90.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 109.59 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.412 ' CD1' HD12 ' A' ' 117' ' ' ILE . 46.8 mm -64.21 -45.77 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.484 -0.76 . . . . 0.0 110.456 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -55.35 -42.28 73.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.215 -0.928 . . . . 0.0 110.14 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -63.94 -37.86 88.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.651 -0.656 . . . . 0.0 111.093 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.06 95.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.945 -1.097 . . . . 0.0 110.335 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -60.55 -16.08 33.97 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.948 -1.095 . . . . 0.0 110.726 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.0 mttt -94.87 1.09 55.3 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.157 -0.964 . . . . 0.0 109.735 177.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -113.26 -18.26 12.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.018 -1.051 . . . . 0.0 109.689 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.2 t -150.33 157.07 42.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.079 -1.013 . . . . 0.0 109.243 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 97.5 p -87.48 -10.13 52.68 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.374 -0.829 . . . . 0.0 109.538 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.71 174.11 39.96 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.411 ' CB ' HD13 ' A' ' 138' ' ' LEU . 80.3 mm-40 -132.7 136.68 46.56 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.334 -1.098 . . . . 0.0 111.613 -178.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.1 mt -119.53 133.74 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.733 -0.604 . . . . 0.0 109.993 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.2 mtp85 -138.49 149.78 45.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.053 -1.029 . . . . 0.0 110.155 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.8 t -123.89 138.26 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.681 -0.637 . . . . 0.0 110.478 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -122.87 125.0 44.54 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.512 -0.743 . . . . 0.0 109.607 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.461 ' CD1' ' CG1' ' A' ' 71' ' ' VAL . 35.2 tp -111.65 129.02 56.23 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.766 0.793 . . . . 0.0 112.131 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -146.2 167.1 24.3 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.405 ' HA ' HG22 ' A' ' 71' ' ' VAL . 98.3 mttt -79.82 -76.46 0.22 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.102 -0.999 . . . . 0.0 112.567 -177.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.8 t -138.18 154.3 49.15 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.298 -0.876 . . . . 0.0 110.24 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.2 p -100.26 169.86 8.84 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.375 -0.828 . . . . 0.0 110.532 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -106.79 -10.07 16.19 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.588 -0.695 . . . . 0.0 110.478 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.6 pt -129.93 -121.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.878 -1.139 . . . . 0.0 109.945 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -111.77 142.66 43.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.136 -1.603 . . . . 0.0 110.0 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 82.0 t -66.45 -44.53 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.46 -0.775 . . . . 0.0 112.294 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -61.35 -45.15 95.58 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.733 -1.23 . . . . 0.0 109.859 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -70.15 -37.09 75.14 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.134 -0.979 . . . . 0.0 108.701 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -65.61 -41.67 92.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.145 -0.972 . . . . 0.0 110.345 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.58 -39.53 80.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.843 -1.161 . . . . 0.0 110.475 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 66.1 ttp -63.19 -43.57 97.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.839 -1.163 . . . . 0.0 109.386 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -63.35 -47.09 83.6 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.249 -0.981 . . . . 0.0 109.443 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.8 t -64.51 -43.92 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.165 -0.96 . . . . 0.0 110.129 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.479 ' CE1' ' HB3' ' A' ' 56' ' ' MET . 63.2 t80 -58.84 -46.27 88.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.837 -1.164 . . . . 0.0 109.784 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -75.49 -37.05 60.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.062 -1.024 . . . . 0.0 110.464 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -61.84 -39.97 93.68 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.058 -1.026 . . . . 0.0 109.627 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.9 mt -78.89 3.38 17.1 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.624 178.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.7 mttp 59.05 30.85 20.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.507 -0.746 . . . . 0.0 111.083 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.479 ' HB3' ' CE1' ' A' ' 51' ' ' PHE . 62.1 mtt -70.0 -28.95 65.93 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.213 -0.93 . . . . 0.0 109.247 178.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -67.89 -9.49 45.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 109.832 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -84.61 84.69 7.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.614 -1.304 . . . . 0.0 110.93 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.411 ' CG2' ' OE1' ' A' ' 137' ' ' GLU . 92.1 m -135.27 151.88 50.98 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -60.54 -42.45 96.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.168 -0.957 . . . . 0.0 111.09 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.0 mt -99.85 0.41 41.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.086 -1.009 . . . . 0.0 111.112 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 56.85 32.47 21.45 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.194 0.997 . . . . 0.0 111.825 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -107.31 51.74 0.73 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.792 0.806 . . . . 0.0 109.289 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.64 141.99 15.75 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.5 t -123.38 133.71 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.138 -1.213 . . . . 0.0 110.191 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.0 tp -115.38 124.0 50.1 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.394 -0.816 . . . . 0.0 109.203 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.4 mt -106.2 107.25 22.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.121 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -94.08 126.02 39.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.168 -0.957 . . . . 0.0 110.124 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.9 t -120.89 133.13 68.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.873 0.844 . . . . 0.0 110.366 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -101.94 92.65 4.89 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.518 ' CG2' ' CE1' ' A' ' 7' ' ' PHE . 29.1 m -64.85 -23.1 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.23 -0.919 . . . . 0.0 111.0 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -67.76 -44.21 78.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.809 -1.182 . . . . 0.0 108.585 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -100.82 8.45 43.19 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.205 -0.934 . . . . 0.0 110.562 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.6 tttt 51.07 44.18 28.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.956 -1.09 . . . . 0.0 110.488 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.3 p -121.31 166.34 14.19 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.431 -0.793 . . . . 0.0 109.269 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 47.3 p90 -145.08 138.23 26.52 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.048 -1.033 . . . . 0.0 110.505 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 50.0 t -127.5 135.29 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.497 ' CG2' ' CZ3' ' A' ' 93' ' ' TRP . 72.3 mt -114.17 121.93 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.836 -1.165 . . . . 0.0 109.848 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -128.76 112.41 14.16 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.463 -0.773 . . . . 0.0 109.925 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -99.9 175.19 27.31 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -81.14 174.14 11.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.579 -0.954 . . . . 0.0 110.327 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.87 -25.68 65.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 110.328 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.98 -53.1 35.93 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.143 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.422 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 3.2 mt -65.25 -45.14 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.86 -1.376 . . . . 0.0 107.822 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.49 -36.29 82.03 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 111.425 -177.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -77.11 -22.85 52.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.082 -1.012 . . . . 0.0 111.711 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.426 ' CG1' HG12 ' A' ' 88' ' ' VAL . 8.9 p -102.61 -23.87 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.876 -1.14 . . . . 0.0 112.738 -178.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.482 ' HB ' ' CD2' ' A' ' 92' ' ' PHE . 15.6 m -118.52 165.46 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 120.388 -1.445 . . . . 0.0 111.474 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.8 p -110.34 -179.05 3.66 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.305 -0.872 . . . . 0.0 112.482 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.57 -35.42 80.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.284 -0.885 . . . . 0.0 109.812 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -61.96 -38.33 88.1 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 108.833 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.5 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 71.1 t80 -69.35 -26.09 64.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.626 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.497 ' CZ3' ' CG2' ' A' ' 78' ' ' ILE . 4.9 m95 -85.97 -27.66 24.73 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.989 0.9 . . . . 0.0 110.322 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -54.26 -41.24 68.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.483 -0.76 . . . . 0.0 112.096 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 79.3 p -64.42 -32.87 74.67 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.888 -1.132 . . . . 0.0 109.668 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.28 9.1 m -58.78 -49.5 77.43 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.329 1.061 . . . . 0.0 111.129 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -68.2 -38.62 82.17 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.305 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -63.64 -42.95 98.08 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.039 -1.065 . . . . 0.0 110.386 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.41 -50.83 69.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.825 -1.172 . . . . 0.0 111.294 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 93.1 mt -67.11 -42.79 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.111 -0.993 . . . . 0.0 109.888 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.436 ' CG ' ' HE3' ' A' ' 105' ' ' LYS . 52.4 tt0 -63.15 -45.35 92.28 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.662 -0.649 . . . . 0.0 111.317 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -62.21 -41.55 98.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.895 -1.128 . . . . 0.0 111.721 -178.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -75.64 -38.09 59.15 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.815 -1.154 . . . . 0.0 108.725 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -60.51 -41.07 93.59 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.436 ' HE3' ' CG ' ' A' ' 101' ' ' GLN . 92.0 mttt -61.35 -32.62 72.52 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.928 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -79.9 -17.31 53.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.855 -1.153 . . . . 0.0 110.093 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.42 6.35 44.58 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 119.892 -1.147 . . . . 0.0 111.322 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -103.42 89.51 3.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.624 -1.515 . . . . 0.0 109.946 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -62.19 -42.73 99.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.634 -0.666 . . . . 0.0 111.336 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.416 ' NZ ' ' HA ' ' A' ' 12' ' ' GLU . 85.7 tttt -62.47 -48.47 79.48 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.441 -177.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -65.28 -37.95 88.75 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.848 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.0 -51.29 54.51 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.487 -1.34 . . . . 0.0 110.091 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.0 mt -64.59 -43.8 92.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.01 -1.288 . . . . 0.0 110.988 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 88.2 t -63.93 -48.67 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.88 -1.137 . . . . 0.0 110.488 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -63.87 -39.7 94.82 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.943 -1.098 . . . . 0.0 110.103 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.7 -41.88 99.77 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.412 HD12 ' CD1' ' A' ' 20' ' ' ILE . 85.1 mt -64.08 -44.63 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.262 -1.14 . . . . 0.0 109.9 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -57.32 -47.19 82.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.102 -0.999 . . . . 0.0 109.242 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.46 -42.81 98.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -0.879 . . . . 0.0 109.067 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.84 -46.41 74.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 0.0 110.039 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.47 -42.69 97.44 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.783 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 86.3 mtp -66.35 -44.63 82.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.847 -1.384 . . . . 0.0 110.016 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.5 ' CB ' ' CE1' ' A' ' 92' ' ' PHE . . . -65.48 -45.4 83.8 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.01 -39.26 94.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.61 -33.88 61.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.936 . . . . 0.0 109.937 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.28 -40.76 95.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 0.0 108.65 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.477 ' HB3' ' CE1' ' A' ' 128' ' ' PHE . 68.4 m-85 -78.56 -35.44 45.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.44 -0.787 . . . . 0.0 110.099 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' A' ' 127' ' ' TYR . 73.7 m-85 -133.97 96.91 15.69 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.002 -1.061 . . . . 0.0 110.622 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.07 152.9 72.82 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.517 1.272 . . . . 0.0 110.542 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.475 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 45.7 t90 -74.17 133.51 42.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.428 -0.795 . . . . 0.0 111.812 -178.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -112.16 151.74 29.15 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.12 -32.33 70.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.913 -1.117 . . . . 0.0 111.454 -176.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -89.47 8.29 31.74 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.831 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -42.4 138.09 1.87 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.494 -0.754 . . . . 0.0 111.342 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.417 HG22 HD13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -112.01 138.34 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.613 -177.407 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -94.9 90.44 6.0 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.084 -1.01 . . . . 0.0 109.379 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.414 ' HG3' HG12 ' A' ' 135' ' ' ILE . 87.3 mt-10 -66.95 -41.7 86.47 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.66 -0.65 . . . . 0.0 112.505 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.411 HD13 ' CB ' ' A' ' 30' ' ' GLU . 4.5 mt -103.99 151.62 38.95 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.025 -1.047 . . . . 0.0 111.277 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -75.04 -175.92 2.62 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 N-CA-C 108.315 -1.456 . . . . 0.0 108.315 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -117.48 3.87 12.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.656 -1.278 . . . . 0.0 109.842 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 33.5 m -60.58 137.26 58.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.793 -1.192 . . . . 0.0 109.811 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 94.7 mt -68.65 138.94 21.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.491 -0.755 . . . . 0.0 110.955 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 24.3 m -91.01 131.64 36.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.342 -0.849 . . . . 0.0 109.046 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -127.09 127.67 45.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.98 -1.075 . . . . 0.0 110.559 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.411 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.7 p . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.18 -36.32 68.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.95 -1.094 . . . . 0.0 109.639 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -64.31 -40.5 96.05 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.249 -0.907 . . . . 0.0 109.442 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.458 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 76.8 mm-40 -70.25 -50.81 35.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 0.0 110.643 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.54 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.3 mt-10 -64.66 -33.37 75.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.419 -0.801 . . . . 0.0 110.441 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.4 -45.15 94.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.967 -1.083 . . . . 0.0 110.378 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB3' ' CE ' ' A' ' 110' ' ' LYS . . . -66.31 -42.28 88.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.091 -1.006 . . . . 0.0 111.642 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.582 HG13 HG22 ' A' ' 114' ' ' VAL . 21.2 tt -68.56 -39.26 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.552 -1.343 . . . . 0.0 111.151 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 13' ' ' GLU . 89.9 t -63.1 -39.13 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.886 -1.134 . . . . 0.0 108.622 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -63.37 -36.16 82.78 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.3 -0.96 . . . . 0.0 109.241 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.26 -41.38 96.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -0.87 . . . . 0.0 109.533 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.903 HG22 ' OD1' ' A' ' 140' ' ' ASN . 96.7 mt -64.0 -43.11 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.445 -0.784 . . . . 0.0 109.572 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.406 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 99.5 mtt180 -58.28 -43.11 87.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 109.896 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -64.5 -35.56 81.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.422 -0.799 . . . . 0.0 111.115 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.81 -39.57 93.8 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.976 -1.078 . . . . 0.0 110.175 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -60.39 -16.47 35.83 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.036 -1.04 . . . . 0.0 110.985 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 97.9 mttt -94.79 0.66 55.09 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.139 -0.976 . . . . 0.0 109.556 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -112.73 -16.94 12.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.949 -1.095 . . . . 0.0 109.66 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.6 t -154.17 159.05 41.22 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.935 -1.103 . . . . 0.0 109.687 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.4 p -86.23 -6.55 58.95 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.194 -0.941 . . . . 0.0 110.587 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.49 170.41 50.75 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.41 ' CG ' ' HB2' ' A' ' 138' ' ' LEU . 68.6 mm-40 -129.66 132.79 46.79 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.128 -1.219 . . . . 0.0 111.181 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.3 mt -115.79 132.83 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -138.88 149.88 45.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.136 -0.977 . . . . 0.0 109.82 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.74 HG22 HD12 ' A' ' 67' ' ' ILE . 53.4 t -118.22 137.04 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.387 -0.821 . . . . 0.0 111.006 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -122.05 120.33 34.02 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.624 HD11 ' CG1' ' A' ' 71' ' ' VAL . 35.2 tp -112.16 126.01 54.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.496 -0.753 . . . . 0.0 111.396 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 83.3 tt0 -141.59 167.59 21.78 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.41 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 99.5 mttt -78.38 -75.57 0.22 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.935 -1.103 . . . . 0.0 113.411 -177.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 t -142.12 157.62 44.69 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.119 -0.988 . . . . 0.0 110.063 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.9 m -110.38 170.45 8.08 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.374 -0.829 . . . . 0.0 110.999 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -108.03 -9.46 15.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.398 -0.814 . . . . 0.0 110.556 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.426 HG13 ' N ' ' A' ' 42' ' ' ASP . 27.3 pt -127.56 -122.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.726 -1.234 . . . . 0.0 110.47 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.426 ' N ' HG13 ' A' ' 41' ' ' ILE . 97.5 m-20 -111.39 138.06 48.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.113 -1.617 . . . . 0.0 109.755 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.457 ' CG1' HG21 ' A' ' 77' ' ' VAL . 99.0 t -64.99 -42.79 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.444 -0.785 . . . . 0.0 111.426 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -59.9 -46.32 89.71 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.9 -1.125 . . . . 0.0 110.409 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -71.55 -40.67 69.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.977 -1.077 . . . . 0.0 108.282 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -61.4 -40.86 95.92 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.404 -0.81 . . . . 0.0 110.965 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.23 81.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.621 -1.3 . . . . 0.0 109.71 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 64.0 ttp -62.98 -43.34 99.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.209 -0.932 . . . . 0.0 109.792 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -64.01 -45.03 90.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.987 -1.071 . . . . 0.0 109.762 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.29 -43.53 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.306 -0.871 . . . . 0.0 110.003 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 6.9 t80 -57.84 -47.47 82.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.88 -1.137 . . . . 0.0 109.547 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -73.87 -35.64 64.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.992 -1.067 . . . . 0.0 109.843 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -61.09 -38.8 87.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.141 -0.974 . . . . 0.0 108.657 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.6 mt -80.22 3.25 21.39 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.359 -0.838 . . . . 0.0 110.141 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 29.8 tttt 57.14 32.46 21.73 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.936 -1.103 . . . . 0.0 111.706 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.596 ' SD ' HD13 ' A' ' 66' ' ' LEU . 98.9 mtp -66.39 -12.16 55.41 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.336 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -76.62 -1.74 29.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.939 -1.101 . . . . 0.0 109.529 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -75.44 63.22 1.44 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.889 -1.132 . . . . 0.0 110.129 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.3 p -134.62 150.27 50.67 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -65.2 -42.89 93.07 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.622 -0.674 . . . . 0.0 112.455 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 94.4 mt -96.33 -1.83 47.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.914 -1.116 . . . . 0.0 111.514 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 57.25 48.4 15.14 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 122.536 1.16 . . . . 0.0 110.797 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.8 p30 -122.45 53.04 1.27 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.885 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.42 146.92 16.61 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.54 HG23 ' CD1' ' A' ' 84' ' ' ILE . 72.7 t -128.06 134.72 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.116 -1.226 . . . . 0.0 110.361 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.596 HD13 ' SD ' ' A' ' 56' ' ' MET . 36.6 tp -116.67 128.18 55.11 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.59 -0.694 . . . . 0.0 109.381 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.74 HD12 HG22 ' A' ' 33' ' ' VAL . 86.0 mt -102.99 112.33 36.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.473 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -99.23 117.32 33.43 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.25 -0.906 . . . . 0.0 109.247 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 72.5 t -118.91 130.88 73.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-O 122.101 0.953 . . . . 0.0 110.709 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.481 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -99.86 101.12 12.16 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.624 ' CG1' HD11 ' A' ' 35' ' ' LEU . 27.3 m -70.43 -20.28 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.006 . . . . 0.0 111.048 -178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -67.51 -44.02 79.43 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.792 -1.192 . . . . 0.0 109.016 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -102.52 3.63 37.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.284 -0.885 . . . . 0.0 110.759 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.4 tttt 56.74 48.77 15.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.831 -1.168 . . . . 0.0 111.123 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 76.7 p -122.4 164.02 18.75 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.095 -1.003 . . . . 0.0 109.917 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -143.57 141.37 30.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.489 -0.757 . . . . 0.0 110.146 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.457 HG21 ' CG1' ' A' ' 43' ' ' VAL . 64.4 t -126.82 136.06 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.606 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 66.7 mt -113.84 122.66 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.955 -1.091 . . . . 0.0 109.769 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -128.6 112.92 14.8 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.555 -0.716 . . . . 0.0 110.68 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -96.18 165.82 24.2 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 82' ' ' LYS . 54.1 t0 -75.28 175.05 8.71 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.346 -1.09 . . . . 0.0 109.642 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.409 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 86.1 tttt -59.24 -26.96 65.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 110.657 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.28 -52.25 42.16 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.604 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.972 ' O ' HG22 ' A' ' 88' ' ' VAL . 82.2 mt -64.94 -44.2 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.785 -1.42 . . . . 0.0 108.579 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -61.66 -38.07 86.37 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.004 -1.06 . . . . 0.0 111.34 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -73.05 -22.91 60.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.033 -1.042 . . . . 0.0 112.676 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.987 HG13 HG13 ' A' ' 88' ' ' VAL . 8.5 p -101.16 -19.48 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.78 -1.2 . . . . 0.0 112.472 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.987 HG13 HG13 ' A' ' 87' ' ' VAL . 19.5 m -119.54 163.61 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.712 -1.243 . . . . 0.0 111.642 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 61.9 p -108.66 -179.94 4.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.47 -0.769 . . . . 0.0 111.525 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -61.83 -38.63 88.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 109.231 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -60.1 -39.93 87.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.46 -0.775 . . . . 0.0 109.421 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.813 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 90.5 t80 -66.2 -24.29 66.59 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.158 -0.964 . . . . 0.0 109.537 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.606 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.2 m95 -87.97 -25.33 23.22 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.919 0.866 . . . . 0.0 110.656 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -57.52 -37.05 72.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.885 . . . . 0.0 111.999 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.4 p -67.67 -31.57 71.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.713 -1.242 . . . . 0.0 109.275 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.453 HG22 HD13 ' A' ' 78' ' ' ILE 0.277 15.9 m -60.89 -49.06 78.99 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 122.444 1.116 . . . . 0.0 111.097 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -69.44 -38.21 77.72 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.911 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -63.6 -42.62 98.24 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.939 -1.1 . . . . 0.0 110.566 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.01 -49.56 69.72 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.801 -1.187 . . . . 0.0 111.515 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.81 -42.26 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.954 -1.091 . . . . 0.0 109.503 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -62.13 -44.42 96.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.346 -0.846 . . . . 0.0 111.18 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.2 tp -63.66 -42.17 98.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -0.963 . . . . 0.0 111.813 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.475 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 97.6 mm-40 -72.86 -43.82 62.11 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.361 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -58.68 -39.56 81.04 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.55 -33.21 72.34 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -78.2 -18.42 55.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 0.0 109.695 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.23 2.04 44.68 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.832 -1.175 . . . . 0.0 111.182 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.2 94.23 5.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.725 -1.456 . . . . 0.0 109.541 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -63.05 -42.34 99.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.767 -0.583 . . . . 0.0 111.066 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.458 ' NZ ' ' HA ' ' A' ' 12' ' ' GLU . 85.7 tttt -64.44 -48.31 75.8 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.868 -1.145 . . . . 0.0 112.006 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -62.65 -37.96 88.41 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 118.752 -1.179 . . . . 0.0 109.638 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.475 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -64.22 -50.61 59.03 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.04 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.7 mt -64.6 -43.85 92.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.161 -1.199 . . . . 0.0 111.164 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.582 HG22 HG13 ' A' ' 16' ' ' ILE . 83.6 t -64.93 -48.57 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.694 -1.254 . . . . 0.0 110.511 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -63.51 -38.35 90.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 109.624 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.91 -41.99 99.77 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.6 mt -63.32 -43.74 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -1.195 . . . . 0.0 108.975 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -58.96 -50.83 72.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.124 -0.985 . . . . 0.0 110.499 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.16 -41.11 97.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 109.052 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -42.63 95.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.883 . . . . 0.0 110.671 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.32 -44.01 96.06 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.962 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 97.1 mtp -67.8 -43.0 80.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.921 -1.34 . . . . 0.0 109.394 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.813 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -64.45 -46.89 81.18 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.255 -0.903 . . . . 0.0 108.885 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 76.6 mt -62.15 -40.73 96.94 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.478 -0.764 . . . . 0.0 109.126 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.74 -34.49 62.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.383 -0.823 . . . . 0.0 110.671 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.16 -42.77 99.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.05 -1.031 . . . . 0.0 108.954 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.459 ' CD2' HG22 ' A' ' 87' ' ' VAL . 66.8 m-85 -75.12 -40.0 60.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.624 -0.673 . . . . 0.0 109.791 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -130.94 92.08 34.8 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.383 -0.823 . . . . 0.0 109.393 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.13 151.39 83.81 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.472 1.248 . . . . 0.0 110.044 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.483 ' CH2' ' HA ' ' A' ' 132' ' ' LYS . 73.9 t90 -72.67 131.85 42.92 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.596 -0.69 . . . . 0.0 110.826 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -108.41 149.77 28.29 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.483 ' HA ' ' CH2' ' A' ' 130' ' ' TRP . 87.8 tttt -57.88 -28.91 64.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -0.999 . . . . 0.0 110.799 -177.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -89.47 8.37 31.31 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.797 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -43.88 136.93 3.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.297 -0.877 . . . . 0.0 111.65 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.712 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -112.24 143.58 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.355 0.598 . . . . 0.0 110.764 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -96.4 93.44 6.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.009 -1.057 . . . . 0.0 109.789 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.475 ' HG3' HD13 ' A' ' 135' ' ' ILE . 97.5 mt-10 -69.1 -35.8 76.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.66 -0.65 . . . . 0.0 111.901 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.422 ' HG ' ' HD2' ' A' ' 139' ' ' PRO . 1.1 mp -112.08 152.09 44.09 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.101 -0.999 . . . . 0.0 111.928 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.422 ' HD2' ' HG ' ' A' ' 138' ' ' LEU . 46.6 Cg_endo -76.09 -170.81 0.92 Allowed 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.633 1.333 . . . . 0.0 108.694 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.903 ' OD1' HG22 ' A' ' 20' ' ' ILE . 67.8 m-80 -122.97 2.95 9.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.661 -1.274 . . . . 0.0 110.066 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.4 m -64.02 139.87 58.81 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.854 -1.154 . . . . 0.0 110.805 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.474 HG13 HG22 ' A' ' 17' ' ' VAL . 95.0 mt -73.49 140.33 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.437 -0.79 . . . . 0.0 110.876 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 24.4 m -97.13 139.77 32.63 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.47 -0.769 . . . . 0.0 109.341 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -131.36 147.99 52.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.093 -1.004 . . . . 0.0 110.979 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.137 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.752 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.0 p . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.96 -40.32 66.74 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.969 -1.082 . . . . 0.0 109.917 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -61.04 -43.87 98.25 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.632 -0.667 . . . . 0.0 109.769 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.46 -45.77 68.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.289 -0.882 . . . . 0.0 111.011 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.577 ' O ' HG23 ' A' ' 17' ' ' VAL . 95.1 mt-10 -66.46 -34.49 78.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.954 . . . . 0.0 109.715 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.06 -46.19 85.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.923 -1.11 . . . . 0.0 110.404 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.72 -41.92 95.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.063 -1.023 . . . . 0.0 111.451 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.634 HG13 HG22 ' A' ' 114' ' ' VAL . 18.5 tt -68.41 -39.44 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.869 -1.144 . . . . 0.0 110.549 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 13' ' ' GLU . 77.6 t -63.77 -41.5 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -60.93 -40.34 92.85 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.435 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.12 -36.03 78.63 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.379 -0.826 . . . . 0.0 109.341 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.868 HD11 HD13 ' A' ' 117' ' ' ILE . 30.3 mm -62.9 -42.1 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -58.81 -42.83 90.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.819 -0.551 . . . . 0.0 110.041 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -65.26 -40.61 94.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.052 -1.03 . . . . 0.0 111.113 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.07 -40.84 95.2 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.843 -1.161 . . . . 0.0 110.495 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -60.66 -13.98 17.87 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.441 -1.412 . . . . 0.0 111.127 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.488 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.8 mttt -95.15 0.98 54.7 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.067 -1.021 . . . . 0.0 109.449 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -112.91 -16.66 12.66 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.35 -0.844 . . . . 0.0 110.298 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.0 t -151.51 157.93 42.94 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.073 -1.017 . . . . 0.0 110.206 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.4 p -87.74 -7.36 57.45 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.488 -0.758 . . . . 0.0 110.194 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.31 172.92 49.6 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.656 ' HG3' HD13 ' A' ' 138' ' ' LEU . 80.6 mm-40 -132.02 133.86 44.9 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.162 -1.199 . . . . 0.0 111.725 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.5 mt -117.57 134.5 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 121.184 0.516 . . . . 0.0 110.124 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.572 ' NH1' HD13 ' A' ' 54' ' ' LEU . 69.7 ttt180 -139.86 156.44 46.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.395 -0.815 . . . . 0.0 110.166 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.423 HG13 HG23 ' A' ' 142' ' ' ILE . 3.5 p -124.29 138.24 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.265 -0.897 . . . . 0.0 110.62 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.806 ' HB2' HD11 ' A' ' 66' ' ' LEU . 57.0 t60 -121.42 119.82 33.18 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.54 HD11 ' CG1' ' A' ' 71' ' ' VAL . 46.1 tp -111.48 135.26 52.29 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.116 0.96 . . . . 0.0 111.974 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.464 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 76.4 tt0 -151.61 166.21 31.93 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.643 ' HA ' HG22 ' A' ' 71' ' ' VAL . 98.7 mttt -78.41 -72.0 0.4 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.896 -1.127 . . . . 0.0 112.889 -176.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.8 t -142.72 157.88 44.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.915 -1.116 . . . . 0.0 109.937 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.6 p -102.51 164.88 11.41 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.465 -0.772 . . . . 0.0 111.138 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -105.42 -24.56 12.62 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.455 -0.778 . . . . 0.0 109.377 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.413 HG13 ' N ' ' A' ' 42' ' ' ASP . 24.8 pt -111.9 -121.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.099 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.413 ' N ' HG13 ' A' ' 41' ' ' ILE . 97.0 m-20 -110.61 141.43 43.82 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.248 -1.532 . . . . 0.0 109.589 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.7 t -64.35 -43.22 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.355 -0.841 . . . . 0.0 111.21 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -61.18 -46.25 91.25 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.877 -1.139 . . . . 0.0 110.29 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -70.42 -40.14 74.0 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.897 -1.127 . . . . 0.0 108.413 177.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -62.9 -41.8 99.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.344 -0.847 . . . . 0.0 111.185 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.74 -39.29 80.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.947 -1.096 . . . . 0.0 110.187 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 66.3 ttp -63.0 -42.49 99.86 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.096 -1.003 . . . . 0.0 109.934 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -65.41 -40.66 93.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.021 -1.049 . . . . 0.0 109.82 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.8 t -69.58 -43.67 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.454 -0.779 . . . . 0.0 109.441 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.519 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 3.6 t80 -58.16 -46.85 84.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.048 -1.032 . . . . 0.0 108.824 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -73.15 -35.58 66.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.023 -1.048 . . . . 0.0 109.56 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -61.91 -37.32 84.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.012 -1.055 . . . . 0.0 109.329 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.572 HD13 ' NH1' ' A' ' 32' ' ' ARG . 98.6 mt -82.22 3.52 27.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.576 -0.702 . . . . 0.0 110.694 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.4 mttp 56.64 33.39 22.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.453 -0.78 . . . . 0.0 111.706 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.823 ' SD ' HD13 ' A' ' 66' ' ' LEU . 90.8 mtp -66.89 -14.25 62.56 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.416 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -75.68 -3.18 33.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.108 -0.995 . . . . 0.0 110.318 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -76.93 65.68 2.65 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.048 -1.033 . . . . 0.0 109.849 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.486 HG22 HD11 ' A' ' 138' ' ' LEU . 66.2 p -134.94 150.62 50.42 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.395 -0.816 . . . . 0.0 109.434 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -64.51 -47.32 79.32 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 84.6 mt -96.29 -1.06 48.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.863 -1.148 . . . . 0.0 111.332 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 76.0 mt-30 60.94 45.29 9.64 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 122.61 1.195 . . . . 0.0 111.479 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.445 ' HA ' HG13 ' A' ' 84' ' ' ILE . 34.8 m-80 -120.03 51.34 1.2 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.132 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.18 141.03 15.33 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.268 -1.933 . . . . 0.0 108.268 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.506 HG23 ' CD1' ' A' ' 84' ' ' ILE . 55.6 t -122.51 134.36 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.816 -1.402 . . . . 0.0 110.367 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.823 HD13 ' SD ' ' A' ' 56' ' ' MET . 41.1 tp -116.76 124.51 49.79 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.962 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 98.7 mt -102.36 105.2 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.965 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 34' ' ' HIS . 56.1 t80 -92.65 121.64 34.27 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.357 -0.839 . . . . 0.0 110.0 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.9 t -122.42 130.13 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.348 -0.845 . . . . 0.0 111.034 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.77 99.76 11.11 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.643 HG22 ' HA ' ' A' ' 37' ' ' LYS . 32.7 m -68.35 -20.53 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.97 -1.081 . . . . 0.0 110.451 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.449 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 66.1 mm-40 -70.85 -47.92 56.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.946 -1.096 . . . . 0.0 109.575 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -97.67 3.37 50.32 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.215 -0.928 . . . . 0.0 110.586 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt 54.44 46.08 25.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.103 -0.998 . . . . 0.0 110.99 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.4 m -121.72 132.69 54.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.082 -1.011 . . . . 0.0 110.303 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 76' ' ' PHE . 53.4 p90 -112.13 139.55 47.56 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.445 -0.785 . . . . 0.0 110.468 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 50.4 t -130.43 140.57 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.299 -0.876 . . . . 0.0 109.37 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.705 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 90.3 mt -118.07 127.98 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.783 -1.198 . . . . 0.0 111.032 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -130.42 116.47 18.29 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.638 -0.664 . . . . 0.0 110.285 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.43 167.4 15.64 Favored Glycine 0 N--CA 1.483 1.769 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.48 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 73.7 m-20 -77.86 178.2 7.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.546 -0.973 . . . . 0.0 110.848 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -62.05 -27.21 68.73 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.644 -0.66 . . . . 0.0 110.139 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.415 ' O ' HG12 ' A' ' 87' ' ' VAL . . . -62.37 -55.54 26.98 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.615 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.979 ' O ' HG22 ' A' ' 88' ' ' VAL . 76.5 mt -66.18 -44.56 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.703 -1.469 . . . . 0.0 108.546 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -61.31 -36.44 80.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.049 -1.032 . . . . 0.0 111.003 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -76.74 -21.84 54.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 111.524 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.968 HG13 HG13 ' A' ' 88' ' ' VAL . 10.5 p -103.45 -23.37 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.724 -1.235 . . . . 0.0 112.462 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.979 HG22 ' O ' ' A' ' 84' ' ' ILE . 20.3 m -118.88 164.41 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.64 -1.287 . . . . 0.0 111.011 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.5 p -109.34 178.52 4.42 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.406 -0.809 . . . . 0.0 112.434 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -62.89 -35.65 80.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.878 . . . . 0.0 109.137 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -61.47 -37.78 84.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.162 -0.961 . . . . 0.0 109.008 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.775 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 54.4 t80 -68.26 -25.21 65.06 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 108.984 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.705 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.8 m95 -86.63 -26.29 24.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.75 0.786 . . . . 0.0 110.846 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -58.84 -34.4 71.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.202 -0.936 . . . . 0.0 111.902 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 49.2 p -68.46 -32.65 72.81 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.276 -1.37 . . . . 0.0 108.683 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.268 16.6 m -59.74 -48.4 81.83 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 122.316 1.055 . . . . 0.0 110.852 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.44 -37.58 74.39 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.11 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -63.35 -43.85 96.52 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.824 -1.172 . . . . 0.0 110.125 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.03 -48.25 77.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.89 -1.131 . . . . 0.0 110.935 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 94.2 mt -67.7 -42.67 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.064 -1.022 . . . . 0.0 110.06 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -64.53 -41.67 96.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.124 -0.985 . . . . 0.0 110.648 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.8 mt -63.73 -42.31 97.92 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.96 -1.088 . . . . 0.0 112.048 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.47 ' HB2' ' HA3' ' A' ' 112' ' ' GLY . 99.7 mm-40 -74.99 -39.18 61.39 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.293 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -61.65 -40.31 94.45 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -62.01 -32.9 73.42 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.689 -0.632 . . . . 0.0 110.036 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -84.67 -17.21 39.26 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.828 -1.17 . . . . 0.0 109.916 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.89 10.53 34.66 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.09 -1.052 . . . . 0.0 110.503 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -104.6 79.58 1.57 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.854 -1.38 . . . . 0.0 109.35 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -60.68 -43.76 97.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.787 -0.571 . . . . 0.0 111.138 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.536 ' O ' HG23 ' A' ' 114' ' ' VAL . 74.3 tttt -62.33 -49.39 75.79 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.126 -0.984 . . . . 0.0 111.984 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -63.09 -37.89 89.01 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.887 -1.133 . . . . 0.0 110.313 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.47 ' HA3' ' HB2' ' A' ' 103' ' ' GLN . . . -64.47 -49.33 65.8 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.28 -43.35 98.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -1.143 . . . . 0.0 110.446 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.634 HG22 HG13 ' A' ' 16' ' ' ILE . 89.8 t -66.45 -46.99 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.084 -1.01 . . . . 0.0 110.074 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.78 -40.14 94.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.229 -0.919 . . . . 0.0 109.636 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.19 -41.9 99.62 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.868 HD13 HD11 ' A' ' 20' ' ' ILE . 93.9 mt -65.32 -44.27 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.371 -1.076 . . . . 0.0 110.298 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -57.2 -48.51 78.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.946 -1.096 . . . . 0.0 109.3 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.56 -42.05 98.37 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.481 -0.762 . . . . 0.0 109.506 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.57 -41.97 91.41 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.3 -0.875 . . . . 0.0 110.132 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.62 -44.7 89.16 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 98.7 mmm -65.49 -46.54 79.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.047 -1.266 . . . . 0.0 109.513 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.775 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -63.85 -44.73 92.29 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.21 -0.931 . . . . 0.0 109.128 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 37.8 mt -62.43 -40.41 96.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.937 . . . . 0.0 109.142 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.93 -35.04 61.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.151 -0.968 . . . . 0.0 110.454 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.09 -43.91 97.8 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.059 -1.025 . . . . 0.0 108.567 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.511 ' CD1' HG22 ' A' ' 87' ' ' VAL . 65.7 m-85 -72.39 -44.03 63.1 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.422 0.63 . . . . 0.0 109.81 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.412 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 62.9 m-85 -127.84 96.51 32.04 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.387 -0.82 . . . . 0.0 109.742 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 128' ' ' PHE . 42.3 Cg_endo -66.41 148.65 84.41 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.874 1.46 . . . . 0.0 110.304 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.488 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 72.6 t90 -73.87 133.09 43.1 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.422 -0.799 . . . . 0.0 110.262 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -111.34 147.79 34.37 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.41 ' HA ' ' CH2' ' A' ' 130' ' ' TRP . 99.5 mttt -54.18 -25.77 24.43 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.919 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -94.51 10.29 35.16 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 118.502 -1.279 . . . . 0.0 111.198 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -43.19 134.51 3.62 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.38 -0.825 . . . . 0.0 111.24 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.633 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -110.09 140.37 29.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.7 -178.596 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 45.6 p-10 -97.89 92.59 5.89 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.042 0.925 . . . . 0.0 110.206 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.09 -35.19 79.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.533 -0.729 . . . . 0.0 112.252 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.656 HD13 ' HG3' ' A' ' 30' ' ' GLU . 5.0 mp -108.96 152.78 42.6 Favored Pre-proline 0 N--CA 1.486 1.354 0 O-C-N 120.826 -1.172 . . . . 0.0 111.854 -178.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -75.13 -169.05 0.58 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 N-CA-C 108.0 -1.577 . . . . 0.0 108.0 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -123.74 4.66 8.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.572 -1.33 . . . . 0.0 110.418 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 61.7 p -62.38 171.86 1.74 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.074 -1.016 . . . . 0.0 110.556 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.423 HG23 HG13 ' A' ' 33' ' ' VAL . 95.0 mt -103.14 140.59 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.389 -0.819 . . . . 0.0 109.96 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 28.6 t -95.95 136.29 36.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.527 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -128.8 147.09 50.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.078 -1.013 . . . . 0.0 111.629 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.051 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 12' ' ' GLU . 6.6 t . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.232 0.539 . . . . 0.0 109.587 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.03 -39.11 68.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 110.565 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -59.65 -46.21 89.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.125 -0.984 . . . . 0.0 110.759 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.428 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 99.7 mt-10 -70.08 -44.0 70.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 0.0 111.533 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.592 ' O ' HG23 ' A' ' 17' ' ' VAL . 95.6 mt-10 -65.99 -39.02 89.95 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.024 -1.047 . . . . 0.0 110.082 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.57 -45.57 93.59 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.938 -1.101 . . . . 0.0 110.539 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.06 -47.02 78.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.125 -0.984 . . . . 0.0 111.663 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.569 HG13 HG22 ' A' ' 114' ' ' VAL . 20.0 tt -63.79 -33.7 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.678 -1.264 . . . . 0.0 109.983 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 13' ' ' GLU . 55.9 t -64.91 -40.84 90.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -62.56 -35.13 78.5 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.104 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.73 -41.62 97.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.393 -0.817 . . . . 0.0 109.692 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.03 -43.14 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 0.0 109.493 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.411 ' HG2' ' OD1' ' A' ' 140' ' ' ASN . 93.6 mtt-85 -58.41 -44.45 89.04 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.464 -0.772 . . . . 0.0 110.183 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -63.28 -37.54 87.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.375 -0.828 . . . . 0.0 110.772 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.429 ' O ' HG22 ' A' ' 27' ' ' THR . . . -64.37 -40.64 96.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.077 -1.015 . . . . 0.0 110.187 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -60.99 -16.42 42.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.141 -0.974 . . . . 0.0 110.675 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.446 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.6 mttt -93.07 -1.3 56.65 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.059 -1.026 . . . . 0.0 109.229 177.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -110.93 -13.65 14.08 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 120.905 -1.122 . . . . 0.0 109.545 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 23' ' ' ALA . 3.9 t -151.28 158.67 44.16 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.977 -1.077 . . . . 0.0 110.329 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 94.2 p -89.31 -10.17 47.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 110.271 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.38 174.1 38.84 Favored Glycine 0 N--CA 1.485 1.967 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.421 ' N ' ' OE1' ' A' ' 30' ' ' GLU . 55.7 mp0 -131.09 136.28 48.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.221 -1.164 . . . . 0.0 110.968 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.3 mt -120.73 134.78 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.692 -0.63 . . . . 0.0 110.308 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -139.24 159.26 42.58 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.22 -0.925 . . . . 0.0 109.508 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 p -129.15 143.87 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.395 -0.816 . . . . 0.0 110.942 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.785 ' HB2' HD11 ' A' ' 66' ' ' LEU . 31.1 t60 -127.64 126.94 42.93 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.613 0.721 . . . . 0.0 109.578 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.545 HD11 ' CG1' ' A' ' 71' ' ' VAL . 3.4 tp -116.01 131.18 57.01 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.968 0.89 . . . . 0.0 111.46 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -146.53 162.87 37.41 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.58 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.1 mttt -77.38 -74.51 0.25 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.053 -1.029 . . . . 0.0 112.66 -177.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.5 t -138.65 155.66 48.11 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.747 0.784 . . . . 0.0 109.796 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.454 ' HB2' ' NE ' ' A' ' 46' ' ' ARG . 13.3 p -106.72 168.39 9.21 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.7 -0.625 . . . . 0.0 110.693 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -106.84 -22.9 12.55 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.183 -0.948 . . . . 0.0 110.8 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.413 HD11 HH21 ' A' ' 46' ' ' ARG . 18.4 pt -114.05 -121.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.348 -0.845 . . . . 0.0 109.957 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 41' ' ' ILE . 91.5 m-20 -110.72 137.4 48.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.071 -1.643 . . . . 0.0 109.067 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.48 ' CG1' HG21 ' A' ' 77' ' ' VAL . 85.5 t -63.44 -44.21 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 111.104 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -59.17 -45.82 90.01 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.762 -1.211 . . . . 0.0 110.375 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -71.98 -39.14 69.5 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.454 ' NE ' ' HB2' ' A' ' 39' ' ' SER . 57.1 ttm-85 -61.35 -44.44 97.17 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.3 -0.875 . . . . 0.0 110.91 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.25 -37.97 89.38 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.952 -1.093 . . . . 0.0 109.444 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 50.9 ttp -63.75 -43.81 95.34 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.341 -0.849 . . . . 0.0 110.258 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -65.92 -46.8 76.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.999 -1.063 . . . . 0.0 110.28 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.8 t -66.3 -43.66 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.978 -1.076 . . . . 0.0 109.821 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.497 ' CD1' ' HB2' ' A' ' 66' ' ' LEU . 25.9 t80 -58.83 -47.21 85.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.036 -1.04 . . . . 0.0 110.403 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -75.33 -37.11 60.9 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.668 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -60.59 -39.67 88.95 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.135 -0.978 . . . . 0.0 110.17 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.508 HD12 ' HE3' ' A' ' 56' ' ' MET . 91.5 mt -80.09 4.19 18.02 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.01 -1.056 . . . . 0.0 110.658 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.4 tttt 61.25 28.05 17.67 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.938 -1.101 . . . . 0.0 111.983 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.876 ' SD ' HD13 ' A' ' 66' ' ' LEU . 54.6 mtt -66.84 -24.56 66.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.02 -1.05 . . . . 0.0 108.669 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -70.46 -8.4 50.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.253 -0.904 . . . . 0.0 111.194 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -85.76 85.79 7.38 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.568 -1.332 . . . . 0.0 111.196 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.6 p -135.0 154.16 51.83 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.422 ' HB3' ' OE2' ' A' ' 137' ' ' GLU . 60.4 tttp -61.57 -41.09 96.89 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.069 -1.019 . . . . 0.0 111.929 -177.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.404 ' HB3' ' ND2' ' A' ' 63' ' ' ASN . 85.9 mt -100.03 4.63 44.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.008 -1.057 . . . . 0.0 111.21 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 85.5 mt-30 56.28 41.73 28.79 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.303 1.049 . . . . 0.0 111.156 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.404 ' ND2' ' HB3' ' A' ' 61' ' ' LEU . 88.5 m-20 -119.49 54.31 1.0 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.682 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.415 ' N ' ' OD2' ' A' ' 81' ' ' ASP . . . -100.65 140.23 14.8 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.64 HG23 ' CD1' ' A' ' 84' ' ' ILE . 40.9 t -123.7 134.48 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.997 -1.296 . . . . 0.0 110.507 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.876 HD13 ' SD ' ' A' ' 56' ' ' MET . 43.9 tp -116.74 125.93 52.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.367 -0.833 . . . . 0.0 110.108 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 92.9 mt -104.04 105.57 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.043 -1.063 . . . . 0.0 109.493 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -90.7 122.47 33.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.975 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.8 t -122.14 131.04 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 122.024 0.916 . . . . 0.0 111.305 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.593 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -102.28 102.17 12.53 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.58 HG22 ' HA ' ' A' ' 37' ' ' LYS . 17.4 m -70.12 -20.67 23.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 110.999 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.44 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 78.2 mm-40 -68.6 -46.25 69.83 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.634 -1.291 . . . . 0.0 109.598 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -99.4 1.9 44.7 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.515 -0.74 . . . . 0.0 110.438 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.442 ' HE3' ' CZ ' ' A' ' 109' ' ' PHE . 38.6 tttt 58.59 48.74 11.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.777 -1.202 . . . . 0.0 110.226 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.593 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 61.9 p -122.47 163.25 20.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.976 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -146.34 145.81 30.45 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.27 -0.894 . . . . 0.0 110.591 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.48 HG21 ' CG1' ' A' ' 43' ' ' VAL . 54.2 t -132.27 138.8 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.449 -0.782 . . . . 0.0 109.173 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.692 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 71.2 mt -115.14 125.36 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.925 -1.109 . . . . 0.0 109.9 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -131.45 117.92 19.49 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.279 -0.888 . . . . 0.0 110.678 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.47 168.84 16.68 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.415 ' OD2' ' N ' ' A' ' 64' ' ' GLY . 47.3 m-20 -81.73 179.19 7.93 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.606 -0.938 . . . . 0.0 110.444 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -61.6 -28.3 69.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.34 -0.85 . . . . 0.0 111.169 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.67 -56.18 22.82 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.59 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.964 ' O ' HG22 ' A' ' 88' ' ' VAL . 81.0 mt -65.41 -45.48 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.774 -1.427 . . . . 0.0 108.423 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -60.55 -38.93 86.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.005 -1.059 . . . . 0.0 111.661 -177.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -71.85 -24.13 61.64 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.072 -1.017 . . . . 0.0 111.878 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.014 HG13 HG13 ' A' ' 88' ' ' VAL . 8.9 p -102.96 -21.36 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.731 -1.231 . . . . 0.0 113.218 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.014 HG13 HG13 ' A' ' 87' ' ' VAL . 16.7 m -117.95 162.89 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.829 -1.17 . . . . 0.0 110.964 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.1 p -109.36 -178.71 3.63 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.226 1.012 . . . . 0.0 113.077 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -63.14 -36.29 83.12 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.618 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -64.88 -38.94 92.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.12 -0.987 . . . . 0.0 109.156 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.839 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 66.1 t80 -65.62 -24.45 67.05 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.194 -0.941 . . . . 0.0 109.16 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.692 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.5 m95 -86.55 -26.4 24.54 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.184 0.992 . . . . 0.0 110.355 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -60.11 -36.8 78.25 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.918 -1.114 . . . . 0.0 112.141 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 m -63.33 -34.49 77.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.778 -1.201 . . . . 0.0 108.517 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.273 9.4 m -60.14 -49.92 75.72 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 122.145 0.974 . . . . 0.0 112.592 -179.3 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -67.79 -35.44 78.67 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.48 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -64.1 -43.15 96.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.992 -1.067 . . . . 0.0 110.772 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.65 -48.49 79.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.755 -1.216 . . . . 0.0 110.27 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.8 mt -67.64 -42.67 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.919 -1.113 . . . . 0.0 110.353 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -63.18 -44.6 94.96 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 111.413 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 102' ' ' LEU . 77.4 mt -63.91 -41.06 97.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.311 -0.868 . . . . 0.0 112.303 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.469 ' HB2' ' HA3' ' A' ' 112' ' ' GLY . 98.8 mm-40 -73.93 -40.35 63.15 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 118.615 -1.234 . . . . 0.0 108.892 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -58.82 -41.06 85.94 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.2 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -64.18 -32.68 74.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.401 -0.812 . . . . 0.0 110.779 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -78.02 -19.68 53.92 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.79 -1.194 . . . . 0.0 109.87 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.59 3.39 34.91 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.889 -1.148 . . . . 0.0 111.383 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -105.6 90.55 3.44 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.634 -1.509 . . . . 0.0 110.404 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.442 ' CZ ' ' HE3' ' A' ' 74' ' ' LYS . 21.3 m-85 -64.24 -41.2 97.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.884 -0.51 . . . . 0.0 111.42 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.466 ' O ' HG23 ' A' ' 114' ' ' VAL . 85.7 tttt -62.98 -49.37 74.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.948 -1.095 . . . . 0.0 111.317 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -62.78 -40.82 98.48 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.055 -1.058 . . . . 0.0 109.888 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' A' ' 103' ' ' GLN . . . -61.71 -49.36 77.11 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.03 -43.73 91.42 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.323 -1.104 . . . . 0.0 111.757 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.569 HG22 HG13 ' A' ' 16' ' ' ILE . 81.2 t -64.49 -46.54 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.843 -1.16 . . . . 0.0 109.504 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.33 -41.4 96.81 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.456 -0.778 . . . . 0.0 110.803 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.51 -44.91 93.59 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 93.1 mt -65.25 -43.62 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.083 -1.245 . . . . 0.0 110.192 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 114' ' ' VAL . 79.7 mm-40 -55.34 -51.17 67.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.889 -1.132 . . . . 0.0 109.678 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.39 -42.41 99.4 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.3 -0.875 . . . . 0.0 109.088 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.409 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -58.14 -42.6 86.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.18 -0.95 . . . . 0.0 110.152 178.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.6 -44.11 96.98 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 9.4 ttm -67.37 -46.46 73.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.018 -1.284 . . . . 0.0 109.806 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.839 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -61.99 -46.24 90.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.238 -0.914 . . . . 0.0 109.21 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.409 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 66.1 mt -62.66 -40.35 96.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.421 -0.799 . . . . 0.0 108.917 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.73 -34.33 58.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.322 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.11 -43.06 99.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.015 -1.053 . . . . 0.0 109.094 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.458 ' CD2' HG22 ' A' ' 87' ' ' VAL . 80.6 m-85 -75.88 -37.48 58.85 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.616 0.722 . . . . 0.0 109.641 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -128.51 96.2 30.96 Favored Pre-proline 0 N--CA 1.485 1.307 0 O-C-N 121.703 -0.623 . . . . 0.0 109.911 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.98 148.3 81.64 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 O-C-N 123.583 1.307 . . . . 0.0 109.825 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.446 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 65.2 t90 -75.84 136.58 40.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.346 -0.846 . . . . 0.0 110.812 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 99.6 mttt -115.52 151.02 35.61 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 109.078 178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.92 -29.49 67.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.976 -1.077 . . . . 0.0 111.195 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -91.01 8.23 36.37 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.961 -1.096 . . . . 0.0 111.109 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 42.9 t0 -43.11 139.03 1.95 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.211 -0.931 . . . . 0.0 111.686 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.708 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -112.92 144.42 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.72 0.771 . . . . 0.0 111.476 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -99.38 92.7 5.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.68 -1.262 . . . . 0.0 110.028 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.514 ' HG3' HD13 ' A' ' 135' ' ' ILE . 96.7 mt-10 -69.58 -39.88 77.08 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.436 ' HG ' ' HD2' ' A' ' 139' ' ' PRO . 0.1 OUTLIER -108.44 150.68 40.93 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.02 -1.05 . . . . 0.0 111.995 -178.153 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.436 ' HD2' ' HG ' ' A' ' 138' ' ' LEU . 41.4 Cg_endo -71.71 -179.24 3.6 Favored 'Trans proline' 0 N--CA 1.486 1.046 0 O-C-N 123.527 1.278 . . . . 0.0 109.438 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.411 ' OD1' ' HG2' ' A' ' 21' ' ' ARG . 18.0 m120 -119.44 3.21 11.28 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.45 -1.406 . . . . 0.0 110.462 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.4 p -63.81 167.81 5.64 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.826 -1.171 . . . . 0.0 110.686 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 93.8 mt -94.69 136.27 26.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.649 0.738 . . . . 0.0 111.088 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 27.8 t -94.1 133.99 37.01 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.04 138.89 52.17 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.264 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.054 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.725 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.9 p . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.61 -35.92 68.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.965 -1.084 . . . . 0.0 109.493 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -61.71 -46.39 89.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.544 -0.722 . . . . 0.0 110.454 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -68.91 -47.88 64.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.277 -0.889 . . . . 0.0 111.474 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.709 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.7 mt-10 -61.88 -39.53 92.26 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.035 -1.04 . . . . 0.0 110.245 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.54 -44.5 96.94 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.166 -0.959 . . . . 0.0 111.226 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.59 -46.63 81.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.841 -1.162 . . . . 0.0 110.809 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 13' ' ' GLU . 21.4 tt -65.58 -35.24 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.836 -1.165 . . . . 0.0 109.869 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 13' ' ' GLU . 53.4 t -63.26 -38.5 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 21' ' ' ARG . 63.7 t0 -63.12 -36.36 83.35 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.328 -0.857 . . . . 0.0 109.454 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.37 -38.68 90.51 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.179 -0.951 . . . . 0.0 109.04 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.721 HG22 ' OD1' ' A' ' 140' ' ' ASN . 35.1 mm -64.46 -44.04 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.187 -0.946 . . . . 0.0 109.745 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.462 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 58.6 mtm180 -61.25 -42.19 98.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 110.383 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -64.87 -38.06 89.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.181 -0.95 . . . . 0.0 111.796 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.51 -39.1 93.16 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.886 -1.134 . . . . 0.0 110.527 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.82 -16.22 26.74 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.766 -1.209 . . . . 0.0 110.328 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.476 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.7 mttt -94.86 0.56 54.91 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.057 -1.027 . . . . 0.0 109.968 177.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -114.07 -15.67 12.24 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.751 -1.218 . . . . 0.0 109.714 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 t -151.68 155.91 39.28 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.97 -1.082 . . . . 0.0 109.459 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.9 m -85.84 -6.35 59.1 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.206 -0.934 . . . . 0.0 110.052 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.2 173.5 52.77 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 55.8 mp0 -131.08 136.99 48.9 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.12 -1.224 . . . . 0.0 111.183 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 94.9 mt -118.01 134.68 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.778 -0.576 . . . . 0.0 110.104 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.481 ' HB3' ' HE1' ' A' ' 56' ' ' MET . 73.9 ttt180 -139.4 151.95 46.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 110.005 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.828 HG22 HD12 ' A' ' 67' ' ' ILE . 60.7 t -120.97 136.75 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.409 -0.807 . . . . 0.0 110.4 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.734 ' HB2' HD11 ' A' ' 66' ' ' LEU . 82.8 t60 -122.31 126.33 47.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.44 -0.787 . . . . 0.0 109.137 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.44 HD11 ' CG1' ' A' ' 71' ' ' VAL . 36.7 tp -112.48 126.68 55.58 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.846 0.832 . . . . 0.0 111.449 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.441 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 82.8 tt0 -142.79 165.07 28.38 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.742 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.0 mttt -81.65 -77.49 0.22 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -176.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.0 t -142.34 158.07 44.11 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.188 -0.945 . . . . 0.0 109.809 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.2 m -113.78 177.51 4.61 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.147 -0.97 . . . . 0.0 111.523 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -102.78 -20.11 14.46 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.615 -0.678 . . . . 0.0 109.871 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.0 mt -112.16 -120.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.015 -1.053 . . . . 0.0 109.519 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -114.46 148.35 37.94 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 119.952 -1.717 . . . . 0.0 108.227 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.521 ' CG1' HG21 ' A' ' 77' ' ' VAL . 63.1 t -60.97 -42.48 93.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 O-C-N 121.118 -0.989 . . . . 0.0 110.269 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -60.13 -45.78 91.87 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.198 -0.939 . . . . 0.0 110.861 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -71.66 -45.49 61.81 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.859 -1.151 . . . . 0.0 109.104 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.472 ' O ' HG23 ' A' ' 50' ' ' VAL . 31.9 tpt180 -60.13 -43.28 95.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.106 -0.996 . . . . 0.0 111.611 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.77 83.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.567 -1.333 . . . . 0.0 110.381 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.1 ttp -62.3 -41.8 98.83 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.138 -0.976 . . . . 0.0 109.716 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -63.41 -42.0 98.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.136 -0.978 . . . . 0.0 109.192 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 46' ' ' ARG . 94.2 t -67.06 -42.32 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.5 -0.75 . . . . 0.0 109.659 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.487 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 5.8 t80 -58.55 -47.66 83.46 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.93 -1.106 . . . . 0.0 109.415 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -73.0 -35.67 66.88 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 109.966 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -60.16 -35.67 75.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.873 -1.142 . . . . 0.0 109.053 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.82 5.16 26.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.267 -0.896 . . . . 0.0 110.33 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 55.01 32.91 19.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.97 -1.081 . . . . 0.0 111.123 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.523 ' SD ' HD22 ' A' ' 66' ' ' LEU . 94.0 mtp -65.94 -12.59 55.95 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.793 -1.192 . . . . 0.0 109.927 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -76.69 -1.61 28.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.723 -1.236 . . . . 0.0 109.781 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -74.87 65.1 1.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.855 -1.153 . . . . 0.0 110.262 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.4 p -134.8 148.78 50.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.074 -1.016 . . . . 0.0 109.272 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -62.56 -43.79 97.93 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.599 -0.688 . . . . 0.0 112.841 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.7 mt -98.18 2.27 48.28 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.903 -1.123 . . . . 0.0 111.804 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 56.53 32.76 21.41 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 122.437 1.113 . . . . 0.0 111.088 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.6 ' C ' HD11 ' A' ' 84' ' ' ILE . 3.2 m-80 -108.31 53.38 0.69 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.949 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.539 ' N ' HD11 ' A' ' 84' ' ' ILE . . . -101.58 139.37 14.37 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.454 ' CG2' HD13 ' A' ' 84' ' ' ILE . 53.9 t -123.42 133.78 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -1.157 . . . . 0.0 109.829 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.734 HD11 ' HB2' ' A' ' 34' ' ' HIS . 37.9 tp -117.18 133.06 56.45 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.093 -1.004 . . . . 0.0 109.495 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.828 HD12 HG22 ' A' ' 33' ' ' VAL . 83.8 mt -104.32 108.38 24.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 118.809 -1.157 . . . . 0.0 109.369 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.504 ' CE2' HG13 ' A' ' 43' ' ' VAL . 69.3 t80 -95.57 121.06 36.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.318 -0.864 . . . . 0.0 110.014 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.9 t -120.67 130.77 74.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.953 0.883 . . . . 0.0 110.841 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.5 103.26 15.0 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.742 HG22 ' HA ' ' A' ' 37' ' ' LYS . 21.5 m -71.88 -18.99 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.992 -1.067 . . . . 0.0 111.048 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -70.27 -46.68 63.88 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.531 -1.356 . . . . 0.0 109.342 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -101.61 4.74 41.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.077 -1.015 . . . . 0.0 110.427 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.7 tttt 53.88 46.91 24.71 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.824 -1.172 . . . . 0.0 110.618 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.9 m -121.07 135.43 55.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.986 -1.071 . . . . 0.0 109.709 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 101' ' ' GLN . 42.9 p90 -112.15 133.9 54.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.457 -0.777 . . . . 0.0 109.885 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.521 HG21 ' CG1' ' A' ' 43' ' ' VAL . 47.8 t -126.89 135.67 63.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 120.935 -1.103 . . . . 0.0 108.063 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.607 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 81.6 mt -114.4 128.16 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.888 -1.133 . . . . 0.0 110.679 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -132.27 113.85 13.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.734 -0.603 . . . . 0.0 110.539 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.38 176.82 26.88 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.47 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 92.5 m-20 -82.5 -178.64 7.14 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.629 -0.924 . . . . 0.0 110.437 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.74 -23.34 67.14 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.448 -0.783 . . . . 0.0 109.634 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.15 -54.07 29.56 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.636 -1.268 . . . . 0.0 111.075 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.974 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.6 mt -66.33 -45.9 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.734 -1.45 . . . . 0.0 108.456 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -61.67 -37.62 84.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.058 -1.026 . . . . 0.0 111.521 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -75.61 -20.96 58.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.881 -1.137 . . . . 0.0 111.961 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.945 HG13 HG13 ' A' ' 88' ' ' VAL . 7.3 p -103.25 -22.02 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.861 -1.149 . . . . 0.0 112.341 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.974 HG22 ' O ' ' A' ' 84' ' ' ILE . 21.4 m -121.01 162.27 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 120.483 -1.385 . . . . 0.0 111.168 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.1 p -104.51 177.64 4.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.313 -0.867 . . . . 0.0 112.177 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.0 -35.68 79.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.683 -0.635 . . . . 0.0 109.437 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -63.82 -37.19 86.47 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.672 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 56.6 t80 -65.85 -24.31 66.85 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.09 -1.007 . . . . 0.0 108.606 177.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.607 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 6.8 m95 -87.12 -28.42 22.51 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.796 0.808 . . . . 0.0 110.784 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -57.09 -36.64 70.85 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.493 -0.754 . . . . 0.0 112.327 -176.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 64.5 p -67.38 -32.82 74.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.796 -1.19 . . . . 0.0 109.346 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.493 HG22 ' CD1' ' A' ' 78' ' ' ILE 0.284 8.5 m -59.26 -47.78 84.07 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.67 1.224 . . . . 0.0 110.521 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -69.13 -38.54 78.88 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.897 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -64.27 -44.73 90.81 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.687 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.22 -49.42 75.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.694 -1.254 . . . . 0.0 110.967 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.583 HD12 HD11 ' A' ' 78' ' ' ILE . 95.9 mt -67.24 -42.4 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.073 -1.017 . . . . 0.0 110.26 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 76' ' ' PHE . 57.8 tt0 -63.58 -40.39 96.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.916 -1.115 . . . . 0.0 110.814 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 40.4 mt -63.39 -42.62 98.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.117 -0.989 . . . . 0.0 111.929 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.485 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 88.0 mm-40 -75.15 -40.48 59.6 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.904 -1.119 . . . . 0.0 108.885 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -60.26 -41.8 94.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 108.936 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.78 -29.71 70.91 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.541 -0.724 . . . . 0.0 109.554 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -81.34 -20.02 41.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.027 -1.046 . . . . 0.0 110.003 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.73 -0.94 34.11 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.744 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -102.45 95.99 6.63 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.531 -1.57 . . . . 0.0 110.854 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -63.13 -41.45 99.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.847 -0.533 . . . . 0.0 111.774 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -65.5 -49.07 70.39 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.371 -0.932 . . . . 0.0 112.446 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.76 -39.75 95.02 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 118.859 -1.136 . . . . 0.0 110.594 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.485 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -62.41 -48.05 85.06 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.48 -1.343 . . . . 0.0 109.946 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.5 mt -63.65 -44.33 94.12 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.504 -0.998 . . . . 0.0 110.308 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.403 HG22 HG13 ' A' ' 16' ' ' ILE . 78.7 t -65.23 -47.57 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.95 -1.094 . . . . 0.0 110.858 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -65.76 -41.12 92.49 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 110.805 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.07 -41.21 98.59 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 98.1 mt -63.54 -42.99 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.141 -1.211 . . . . 0.0 109.585 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -59.19 -47.29 85.85 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.941 -1.099 . . . . 0.0 109.624 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.37 -42.54 99.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.383 -0.823 . . . . 0.0 109.333 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -58.71 -42.64 89.14 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.124 -0.985 . . . . 0.0 109.657 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.89 -43.04 96.61 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.637 -1.268 . . . . 0.0 109.99 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 90.8 mtp -67.19 -45.35 77.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.15 -1.206 . . . . 0.0 110.488 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.672 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -64.24 -42.52 96.49 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.301 -0.96 . . . . 0.0 108.626 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.4 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 73.7 mt -64.56 -39.82 94.44 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.546 -0.721 . . . . 0.0 109.58 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.71 -34.19 58.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.029 -1.044 . . . . 0.0 110.472 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -63.05 -42.91 99.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.024 -1.047 . . . . 0.0 109.492 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.433 ' HB3' ' CE1' ' A' ' 128' ' ' PHE . 53.9 m-85 -70.22 -42.64 72.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.473 -0.767 . . . . 0.0 110.014 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.443 ' CZ ' HG21 ' A' ' 87' ' ' VAL . 83.1 m-85 -127.92 101.72 22.81 Favored Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 121.495 -0.753 . . . . 0.0 109.931 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.2 152.07 80.19 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.81 1.426 . . . . 0.0 109.877 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.476 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 43.4 t90 -78.79 137.64 37.82 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.624 -0.672 . . . . 0.0 111.173 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -115.28 149.18 38.21 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.318 -0.864 . . . . 0.0 109.526 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -57.81 -28.52 64.12 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 111.236 -177.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -91.13 9.96 28.88 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.921 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.428 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 66.3 t0 -43.12 137.09 2.63 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.358 -0.839 . . . . 0.0 111.575 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.607 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -110.43 136.12 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.734 0.778 . . . . 0.0 111.484 -178.373 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -115.12 100.68 8.34 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -101.26 -4.45 27.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.896 -1.127 . . . . 0.0 111.933 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.86 145.41 30.66 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.938 -1.101 . . . . 0.0 110.983 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -70.32 166.38 28.48 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.669 1.352 . . . . 0.0 109.468 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.721 ' OD1' HG22 ' A' ' 20' ' ' ILE . 62.8 m-80 -109.66 7.46 24.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.568 -1.333 . . . . 0.0 110.77 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.6 p -65.85 171.15 4.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.911 -1.118 . . . . 0.0 111.329 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 91.1 mt -97.88 140.43 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 121.387 0.613 . . . . 0.0 110.707 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 18.1 t -94.48 134.32 37.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 109.829 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -129.1 148.1 51.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 110.451 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 CA-C-O 117.964 -1.465 . . . . 0.0 109.784 -179.796 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.3 p . . . . . 0 N--CA 1.495 1.796 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.42 -35.61 68.0 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.953 -1.092 . . . . 0.0 109.857 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -58.9 -46.36 88.07 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.395 -0.816 . . . . 0.0 109.99 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.469 ' HA ' ' CE ' ' A' ' 110' ' ' LYS . 98.9 mt-10 -69.2 -46.17 68.08 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.311 -0.868 . . . . 0.0 111.067 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -64.76 -39.53 93.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.136 -0.977 . . . . 0.0 110.755 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.47 -45.17 94.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.162 -0.961 . . . . 0.0 110.877 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.64 ' HB3' ' HE2' ' A' ' 110' ' ' LYS . . . -62.51 -41.09 98.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.972 . . . . 0.0 110.481 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 110' ' ' LYS . 45.2 mt -64.64 -43.47 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 111.208 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.451 ' CG2' HG12 ' A' ' 142' ' ' ILE . 45.4 t -60.99 -42.77 94.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 108.788 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -61.27 -37.67 83.98 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.492 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.76 94.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.506 -0.746 . . . . 0.0 109.811 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 91.5 mt -63.83 -43.42 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 109.404 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -55.59 -44.63 77.14 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.502 -0.749 . . . . 0.0 109.682 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -63.19 -37.41 87.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.473 -0.767 . . . . 0.0 110.986 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.45 -37.94 89.22 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.977 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.425 ' OE1' ' ND2' ' A' ' 140' ' ' ASN . 3.3 mp0 -60.83 -15.34 29.07 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.804 -1.185 . . . . 0.0 111.091 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.7 mttt -94.61 -1.53 53.07 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 120.912 -1.118 . . . . 0.0 109.499 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -111.15 -15.09 13.76 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.857 -1.152 . . . . 0.0 110.188 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.1 t -152.68 160.28 43.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.023 -1.048 . . . . 0.0 109.45 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.1 m -88.17 -5.52 58.37 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.986 -1.071 . . . . 0.0 110.344 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.93 170.04 52.14 Favored Glycine 0 N--CA 1.482 1.723 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 138' ' ' LEU . 79.2 mm-40 -129.68 136.86 50.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.258 -1.142 . . . . 0.0 110.723 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.2 mt -119.22 134.96 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.595 -0.69 . . . . 0.0 110.71 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.686 ' CD ' HD23 ' A' ' 138' ' ' LEU . 84.3 mtp180 -139.47 153.24 47.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.389 -0.82 . . . . 0.0 109.923 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.883 HG22 HD12 ' A' ' 67' ' ' ILE . 61.7 t -123.42 141.01 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.302 -0.874 . . . . 0.0 110.952 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.498 ' HB2' HD11 ' A' ' 66' ' ' LEU . 51.0 t-80 -122.95 124.82 44.05 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.65 HD11 HG13 ' A' ' 71' ' ' VAL . 35.8 tp -112.61 129.0 56.53 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.938 0.875 . . . . 0.0 111.286 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -146.42 164.77 31.4 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -79.73 -73.88 0.33 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.112 -0.992 . . . . 0.0 112.898 -177.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.33 157.24 46.23 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.262 -0.899 . . . . 0.0 110.133 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.8 m -103.06 165.07 11.24 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.624 -0.673 . . . . 0.0 110.166 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -104.23 -14.23 15.9 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.353 -0.842 . . . . 0.0 109.794 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.434 HG13 ' N ' ' A' ' 42' ' ' ASP . 29.8 pt -124.8 -122.01 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.052 -1.03 . . . . 0.0 110.052 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.434 ' N ' HG13 ' A' ' 41' ' ' ILE . 95.3 m-20 -110.73 139.17 46.26 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.16 -1.587 . . . . 0.0 109.359 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.696 HG11 HG21 ' A' ' 77' ' ' VAL . 84.3 t -64.59 -43.92 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.299 -0.875 . . . . 0.0 111.902 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -60.05 -45.42 92.91 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.72 -1.237 . . . . 0.0 110.123 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -70.98 -38.1 72.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.851 -1.156 . . . . 0.0 109.365 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 50.1 ttt85 -65.97 -43.1 88.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.774 -1.203 . . . . 0.0 110.266 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.75 -37.59 88.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.87 -1.144 . . . . 0.0 110.224 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 62.3 ttp -64.23 -43.23 95.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.137 -0.977 . . . . 0.0 109.153 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -63.85 -41.97 97.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.937 -1.102 . . . . 0.0 109.251 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 74.2 t -67.61 -42.87 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.502 -0.749 . . . . 0.0 109.833 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -59.8 -46.85 87.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.88 -1.138 . . . . 0.0 109.491 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -74.94 -36.12 62.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.967 -1.083 . . . . 0.0 109.764 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -61.07 -38.42 86.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.067 -1.02 . . . . 0.0 109.442 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.5 mt -81.89 4.05 23.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.0 110.048 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.43 33.96 23.4 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.288 -0.883 . . . . 0.0 111.941 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.719 ' SD ' HD13 ' A' ' 66' ' ' LEU . 95.7 mtp -69.22 -15.02 63.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.089 -1.007 . . . . 0.0 109.922 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 44.9 p-10 -78.45 -5.32 52.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.831 -1.168 . . . . 0.0 110.138 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 65.1 t-20 -88.64 78.8 7.67 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.788 -1.195 . . . . 0.0 110.409 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.3 m -137.02 154.91 50.26 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.19 -44.44 97.28 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 111.599 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 90.5 mt -99.94 -2.4 34.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.757 -1.215 . . . . 0.0 111.389 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 87.7 mt-30 59.32 49.92 8.37 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.245 1.021 . . . . 0.0 111.265 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -122.22 54.15 1.2 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.479 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.92 143.33 16.16 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.537 HG23 ' CD1' ' A' ' 84' ' ' ILE . 54.0 t -124.12 134.75 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.907 -1.349 . . . . 0.0 110.715 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.719 HD13 ' SD ' ' A' ' 56' ' ' MET . 39.7 tp -117.1 125.16 50.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.568 -0.708 . . . . 0.0 109.893 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.883 HD12 HG22 ' A' ' 33' ' ' VAL . 83.2 mt -102.3 110.88 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.602 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -96.37 120.75 37.25 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.168 -0.957 . . . . 0.0 110.027 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.9 t -122.39 131.11 73.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.297 -0.877 . . . . 0.0 110.922 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.561 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -99.91 90.52 4.45 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.65 HG13 HD11 ' A' ' 35' ' ' LEU . 17.4 m -60.26 -24.16 29.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.298 -0.876 . . . . 0.0 111.375 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -67.51 -41.12 84.94 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.989 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.414 ' O ' HG23 ' A' ' 75' ' ' THR . 96.2 m-20 -103.33 4.06 35.98 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.072 -1.017 . . . . 0.0 110.685 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.428 ' HE3' ' CE1' ' A' ' 109' ' ' PHE . 45.2 tttt 55.86 45.72 23.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.827 -1.171 . . . . 0.0 110.752 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.561 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 72.4 p -119.97 163.37 17.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.966 . . . . 0.0 109.32 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -142.79 146.09 33.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.104 -0.998 . . . . 0.0 110.578 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.696 HG21 HG11 ' A' ' 43' ' ' VAL . 53.7 t -134.74 138.47 49.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.747 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 88.7 mt -117.17 125.65 74.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 118.977 -1.089 . . . . 0.0 110.416 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -128.07 114.22 16.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.806 -0.559 . . . . 0.0 110.325 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -100.89 171.1 22.36 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 53.8 t0 -81.14 174.44 11.57 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.493 -1.004 . . . . 0.0 110.013 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.407 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 97.7 mttt -60.02 -26.67 66.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.989 . . . . 0.0 111.656 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.546 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -64.88 -52.11 45.19 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.807 -1.187 . . . . 0.0 110.416 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.944 ' O ' HG22 ' A' ' 88' ' ' VAL . 97.1 mt -64.71 -43.47 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.783 -1.422 . . . . 0.0 108.122 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -63.4 -36.93 85.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.518 -1.364 . . . . 0.0 111.476 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -74.21 -20.92 60.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.845 -1.159 . . . . 0.0 112.166 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.052 HG23 HG13 ' A' ' 88' ' ' VAL . 32.9 m -105.64 -18.51 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.745 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.052 HG13 HG23 ' A' ' 87' ' ' VAL . 4.0 m -119.82 160.28 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 120.67 -1.268 . . . . 0.0 111.47 -178.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.1 m -107.17 176.71 5.08 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.81 0.814 . . . . 0.0 112.005 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -61.86 -36.95 82.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.611 -0.681 . . . . 0.0 109.48 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -62.19 -38.22 88.28 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.422 -0.911 . . . . 0.0 108.922 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.864 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 55.3 t80 -64.05 -26.62 68.64 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.539 -0.726 . . . . 0.0 109.356 178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.747 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.9 m95 -86.95 -25.81 24.17 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.938 0.875 . . . . 0.0 110.989 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -56.92 -36.78 70.59 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.429 -0.795 . . . . 0.0 111.712 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.8 m -64.32 -33.66 76.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.767 -1.208 . . . . 0.0 108.983 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.501 HG22 HD13 ' A' ' 78' ' ' ILE 0.279 7.4 m -59.82 -49.89 75.94 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 122.358 1.075 . . . . 0.0 111.379 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.414 ' O ' ' HB2' ' A' ' 101' ' ' GLN . 99.4 mtt180 -66.69 -38.6 87.09 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.707 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.495 ' O ' HD23 ' A' ' 102' ' ' LEU . 82.0 m-20 -64.01 -45.03 90.78 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.946 -1.102 . . . . 0.0 110.439 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.1 -50.91 72.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.592 -1.318 . . . . 0.0 110.484 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.485 HD12 HD11 ' A' ' 78' ' ' ILE . 86.8 mt -67.81 -42.72 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.905 -1.122 . . . . 0.0 110.17 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 97' ' ' ARG . 57.3 tt0 -62.62 -46.72 86.94 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.516 -0.74 . . . . 0.0 111.086 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 98' ' ' ASN . 4.3 mm? -63.53 -41.54 98.46 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.007 -1.058 . . . . 0.0 112.043 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.462 ' HB2' ' HA3' ' A' ' 112' ' ' GLY . 99.4 mm-40 -72.15 -40.24 68.16 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.176 -1.41 . . . . 0.0 108.594 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -59.26 -40.82 87.2 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.784 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -62.38 -34.55 76.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -0.868 . . . . 0.0 110.928 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -83.6 -17.34 41.99 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.528 -1.357 . . . . 0.0 110.319 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.26 11.38 25.78 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.172 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' A' ' 103' ' ' GLN . 31.7 m120 -107.94 83.0 1.72 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.873 -1.369 . . . . 0.0 110.451 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.428 ' CE1' ' HE3' ' A' ' 74' ' ' LYS . 6.8 m-85 -62.5 -43.71 98.15 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.151 -0.968 . . . . 0.0 111.026 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.64 ' HE2' ' HB3' ' A' ' 15' ' ' ALA . 60.9 tttm -61.13 -47.85 84.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 0.0 111.446 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -64.1 -37.85 88.94 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.954 -1.091 . . . . 0.0 110.843 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 103' ' ' GLN . . . -62.49 -49.04 77.39 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.496 -1.335 . . . . 0.0 109.823 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.47 -43.96 97.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -1.161 . . . . 0.0 110.926 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.446 HG23 HG12 ' A' ' 16' ' ' ILE . 76.4 t -65.91 -46.82 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.906 -1.121 . . . . 0.0 110.325 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -65.01 -40.1 94.39 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.538 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.89 -43.74 93.21 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.3 mt -64.51 -44.33 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -1.14 . . . . 0.0 109.368 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -58.98 -49.08 79.25 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.045 -1.034 . . . . 0.0 109.632 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.34 -41.21 98.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.205 -0.934 . . . . 0.0 109.447 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.417 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -57.58 -42.04 82.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.202 -0.937 . . . . 0.0 110.072 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.59 -43.56 96.32 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.67 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 96.6 mtp -68.33 -45.37 73.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.914 -1.345 . . . . 0.0 110.285 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.864 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -63.56 -45.93 88.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.118 -0.989 . . . . 0.0 108.761 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.417 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 72.7 mt -61.87 -40.5 95.58 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.47 -34.08 56.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 110.4 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.58 -44.65 93.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.002 -1.061 . . . . 0.0 109.366 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -71.54 -41.47 69.09 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.45 0.643 . . . . 0.0 109.65 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.43 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 47.6 m-85 -130.54 97.69 21.35 Favored Pre-proline 0 C--N 1.307 -1.251 0 O-C-N 121.514 -0.741 . . . . 0.0 109.828 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 128' ' ' PHE . 42.0 Cg_endo -65.75 152.87 80.39 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.575 1.303 . . . . 0.0 110.707 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.481 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 47.7 t90 -76.57 127.07 32.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.556 -0.715 . . . . 0.0 110.689 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -103.35 146.96 27.69 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.151 -0.968 . . . . 0.0 109.041 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -56.71 -28.44 60.96 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.103 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.4 p30 -93.68 6.76 47.26 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.012 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 135' ' ' ILE . 67.1 t0 -42.55 140.24 1.31 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.705 0.764 . . . . 0.0 111.622 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.754 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -115.38 146.08 20.28 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 CA-C-O 121.576 0.703 . . . . 0.0 110.891 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -103.23 97.45 7.53 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.356 -1.465 . . . . 0.0 110.58 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -68.14 -35.72 78.56 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.686 HD23 ' CD ' ' A' ' 32' ' ' ARG . 7.1 mp -110.87 151.06 42.69 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.895 -1.128 . . . . 0.0 111.923 -178.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -72.48 -174.69 1.52 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 N-CA-C 108.448 -1.405 . . . . 0.0 108.448 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.425 ' ND2' ' OE1' ' A' ' 24' ' ' GLU . 10.5 m120 -123.02 2.51 9.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.592 -1.318 . . . . 0.0 110.116 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -58.2 170.25 0.71 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.934 -1.104 . . . . 0.0 111.348 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.451 HG12 ' CG2' ' A' ' 17' ' ' VAL . 49.6 mm -95.17 133.17 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.66 -0.65 . . . . 0.0 111.039 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 69.5 m -93.08 131.24 38.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.534 -0.729 . . . . 0.0 109.093 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -127.03 135.99 51.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.884 -1.135 . . . . 0.0 110.591 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.398 0 CA-C-O 117.935 -1.481 . . . . 0.0 109.72 -179.768 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.0 p . . . . . 0 N--CA 1.495 1.81 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 14' ' ' LYS . . . -54.73 -39.73 68.55 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.797 -1.19 . . . . 0.0 109.422 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -62.8 -40.36 97.12 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.473 -0.767 . . . . 0.0 109.51 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -73.62 -46.59 45.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.105 -0.997 . . . . 0.0 110.696 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.736 ' O ' HG23 ' A' ' 17' ' ' VAL . 96.8 mt-10 -67.04 -34.56 77.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.112 -0.993 . . . . 0.0 110.265 178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 87.6 tttt -64.77 -44.7 89.19 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.753 -1.217 . . . . 0.0 110.075 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.94 -47.02 79.18 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.134 -0.979 . . . . 0.0 111.409 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.405 HG22 ' O ' ' A' ' 13' ' ' GLU . 20.4 tt -64.06 -36.25 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.773 -1.205 . . . . 0.0 110.174 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 13' ' ' GLU . 55.4 t -61.28 -38.36 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -64.25 -36.18 83.25 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.775 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.98 -40.15 94.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.06 -1.025 . . . . 0.0 109.566 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.768 HG22 ' OD1' ' A' ' 140' ' ' ASN . 83.6 mt -63.14 -43.79 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 109.399 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -62.2 -43.72 98.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.45 -0.781 . . . . 0.0 110.694 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -63.08 -38.9 93.04 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.162 -0.961 . . . . 0.0 111.41 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.9 -37.89 88.74 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.206 -0.997 . . . . 0.0 109.291 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.2 -15.99 29.22 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.101 -0.999 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.478 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 75.5 mmtt -94.88 -3.6 48.48 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.013 -1.054 . . . . 0.0 109.544 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -108.69 -13.48 14.79 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 121.176 -0.953 . . . . 0.0 109.813 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.8 t -156.35 161.15 40.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.014 -1.054 . . . . 0.0 110.049 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.3 m -87.21 -12.13 47.73 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.371 -0.831 . . . . 0.0 108.78 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.39 167.09 40.89 Favored Glycine 0 N--CA 1.477 1.394 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.557 ' OE1' HD12 ' A' ' 138' ' ' LEU . 97.8 mt-10 -135.59 141.6 45.16 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 118.9 -1.12 . . . . 0.0 112.229 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.6 mt -123.61 135.77 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.237 0.541 . . . . 0.0 110.547 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.451 ' NH1' HD13 ' A' ' 54' ' ' LEU . 68.8 ttt180 -139.88 163.06 33.65 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.198 -0.939 . . . . 0.0 109.746 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 p -131.97 142.4 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.157 -0.964 . . . . 0.0 111.687 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.419 ' HA ' ' O ' ' A' ' 143' ' ' SER . 81.7 t60 -126.98 125.56 41.7 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.452 -0.78 . . . . 0.0 109.442 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.473 HD11 ' HB ' ' A' ' 71' ' ' VAL . 47.5 tp -108.4 128.56 54.88 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 122.07 0.938 . . . . 0.0 112.019 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.41 ' OE2' ' CZ ' ' A' ' 46' ' ' ARG . 82.2 tt0 -144.87 159.68 42.51 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 97.8 mttt -79.32 -75.66 0.24 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.063 -1.023 . . . . 0.0 112.94 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.6 t -136.57 155.34 50.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.299 -0.876 . . . . 0.0 110.214 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.5 p -103.77 170.79 7.72 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.415 -0.803 . . . . 0.0 110.365 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.414 ' OE1' ' N ' ' A' ' 40' ' ' GLU . 56.0 mp0 -108.37 -12.61 15.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.472 -0.768 . . . . 0.0 110.414 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.8 pt -124.31 -122.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.149 -0.969 . . . . 0.0 108.586 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -111.84 140.81 46.18 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 120.434 -1.416 . . . . 0.0 109.687 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.498 ' CG1' HG21 ' A' ' 77' ' ' VAL . 94.4 t -64.15 -42.74 96.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.372 -0.83 . . . . 0.0 110.683 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -59.92 -46.75 88.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.955 -1.091 . . . . 0.0 109.938 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -69.81 -36.8 75.96 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.79 -1.194 . . . . 0.0 108.772 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.41 ' CZ ' ' OE2' ' A' ' 36' ' ' GLU . 61.3 ttt85 -64.1 -42.85 96.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -0.916 . . . . 0.0 110.949 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.6 83.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.722 -1.236 . . . . 0.0 110.499 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 60.2 ttp -62.89 -42.28 99.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.034 -1.042 . . . . 0.0 108.975 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -65.88 -44.7 84.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.137 -0.977 . . . . 0.0 110.361 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.44 -43.44 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.365 -0.834 . . . . 0.0 110.411 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 2.9 t80 -58.77 -47.92 83.0 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.7 -1.25 . . . . 0.0 108.996 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -72.16 -35.66 69.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.043 -1.036 . . . . 0.0 109.703 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -60.54 -39.35 87.57 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.451 HD13 ' NH1' ' A' ' 32' ' ' ARG . 85.6 mt -80.2 5.26 15.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.155 -0.966 . . . . 0.0 110.361 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 55.76 33.94 22.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.818 -1.176 . . . . 0.0 111.926 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.824 ' SD ' HD13 ' A' ' 66' ' ' LEU . 94.1 mtp -65.55 -11.01 40.04 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.988 -1.07 . . . . 0.0 110.236 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -77.53 0.57 22.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.819 -1.176 . . . . 0.0 110.284 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -74.57 62.25 1.01 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.851 -1.156 . . . . 0.0 110.062 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.41 ' OG1' ' HA ' ' A' ' 62' ' ' GLN . 65.3 p -135.19 148.47 49.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.107 -0.996 . . . . 0.0 109.631 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -64.44 -40.98 96.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.75 -0.594 . . . . 0.0 112.276 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 95.7 mt -98.66 -0.15 43.53 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.904 -1.122 . . . . 0.0 111.448 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.41 ' HA ' ' OG1' ' A' ' 59' ' ' THR . 85.7 mt-30 57.71 45.77 18.38 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 122.5 1.143 . . . . 0.0 111.148 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.423 ' HA ' HG13 ' A' ' 84' ' ' ILE . 38.0 p30 -118.96 53.61 1.0 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.072 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.39 140.98 15.13 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.512 HG23 ' CD1' ' A' ' 84' ' ' ILE . 67.3 t -125.55 134.74 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.043 -1.269 . . . . 0.0 110.34 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.824 HD13 ' SD ' ' A' ' 56' ' ' MET . 38.5 tp -117.51 133.68 55.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.339 -0.851 . . . . 0.0 110.24 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.2 mt -106.82 108.83 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 118.75 -1.18 . . . . 0.0 109.557 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -95.45 117.71 30.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 110.181 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.1 t -118.19 128.34 75.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 121.726 0.774 . . . . 0.0 110.356 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.574 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -95.26 88.49 5.17 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.473 ' HB ' HD11 ' A' ' 35' ' ' LEU . 7.2 p -58.73 -23.81 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.036 -1.04 . . . . 0.0 110.907 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 47.7 tp10 -67.73 -41.89 82.73 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.779 -1.2 . . . . 0.0 108.85 178.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.635 ' O ' HG23 ' A' ' 75' ' ' THR . 40.5 t0 -104.77 8.6 34.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.053 -1.03 . . . . 0.0 111.259 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 104' ' ' PHE . 85.3 tttt 52.12 45.17 28.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.875 -1.141 . . . . 0.0 110.407 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 73' ' ' ASP . 46.8 p -122.33 159.15 28.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.803 -1.186 . . . . 0.0 109.135 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -141.53 148.37 39.24 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.21 -0.932 . . . . 0.0 110.364 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.498 HG21 ' CG1' ' A' ' 43' ' ' VAL . 66.1 t -134.19 137.13 52.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.716 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 75.8 mt -113.74 127.83 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.859 -1.151 . . . . 0.0 110.174 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -135.02 114.67 12.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.576 -0.702 . . . . 0.0 110.624 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -99.77 171.47 23.88 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.474 ' OD1' ' CE1' ' A' ' 51' ' ' PHE . 78.1 m-20 -75.33 171.28 14.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.399 -1.059 . . . . 0.0 110.653 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -58.64 -26.46 63.78 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.592 -0.692 . . . . 0.0 110.444 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.408 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -66.1 -53.34 30.48 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.981 ' O ' HG22 ' A' ' 88' ' ' VAL . 87.6 mt -63.51 -44.74 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.944 -1.327 . . . . 0.0 107.893 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -62.21 -36.87 83.26 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.833 -1.167 . . . . 0.0 111.396 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -70.63 -24.26 62.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.861 -1.15 . . . . 0.0 111.78 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.865 HG23 HG13 ' A' ' 88' ' ' VAL . 25.7 m -105.74 -16.45 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 120.642 -1.286 . . . . 0.0 112.909 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.981 HG22 ' O ' ' A' ' 84' ' ' ILE . 18.8 m -116.45 162.07 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 120.338 -1.476 . . . . 0.0 112.002 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.3 t -109.41 174.46 5.86 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.597 0.713 . . . . 0.0 111.809 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 33.0 p-10 -61.61 -35.85 79.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 110.147 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -62.42 -40.59 97.03 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.821 -1.174 . . . . 0.0 109.781 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.854 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 87.8 t80 -63.15 -25.52 68.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.123 -0.985 . . . . 0.0 109.333 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.716 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.2 m95 -86.88 -24.64 24.82 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.955 0.883 . . . . 0.0 110.876 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -57.1 -38.81 73.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.063 -1.023 . . . . 0.0 112.455 -177.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.9 p -63.61 -31.84 73.14 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.53 -1.268 . . . . 0.0 109.199 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.444 ' CG2' HD13 ' A' ' 78' ' ' ILE 0.272 15.1 m -59.93 -48.06 83.22 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.379 1.085 . . . . 0.0 111.031 179.661 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -68.98 -38.57 79.41 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.25 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -64.03 -44.26 93.08 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.827 -1.171 . . . . 0.0 110.669 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.88 -49.77 73.54 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.832 -1.167 . . . . 0.0 111.348 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 91.4 mt -67.34 -42.42 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.073 -1.017 . . . . 0.0 110.329 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -65.16 -40.92 95.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.243 -0.911 . . . . 0.0 110.602 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.8 tp -62.22 -42.13 99.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.209 -0.932 . . . . 0.0 111.13 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.447 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 95.8 mm-40 -76.9 -40.0 48.89 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.136 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.415 ' O ' ' CE ' ' A' ' 74' ' ' LYS . 2.8 m-85 -58.41 -41.82 85.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.145 -0.972 . . . . 0.0 108.55 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.43 -32.12 73.47 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.635 -0.665 . . . . 0.0 110.444 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -78.69 -20.07 51.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.741 -1.225 . . . . 0.0 109.911 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.17 4.7 41.15 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.41 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -103.66 86.31 2.6 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.743 -1.445 . . . . 0.0 110.097 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -61.62 -43.03 99.62 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.371 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -61.71 -47.95 82.96 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.97 -1.081 . . . . 0.0 111.377 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -64.55 -38.11 89.87 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.21 -0.932 . . . . 0.0 110.488 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.447 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -63.84 -49.54 67.4 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.51 -44.73 93.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.145 -1.209 . . . . 0.0 110.959 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.416 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 71.1 t -65.03 -47.77 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.137 -0.977 . . . . 0.0 110.115 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -62.84 -40.88 98.77 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.922 -1.111 . . . . 0.0 110.571 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.29 -42.24 97.23 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -43.99 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.228 -1.16 . . . . 0.0 109.698 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 114' ' ' VAL . 80.5 mm-40 -58.28 -54.62 44.93 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.05 -1.031 . . . . 0.0 110.597 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.34 -39.97 92.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.122 -0.986 . . . . 0.0 108.691 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.55 -41.58 90.41 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.312 -0.867 . . . . 0.0 109.713 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.17 -44.3 97.34 Favored Glycine 0 N--CA 1.495 2.607 0 O-C-N 120.761 -1.212 . . . . 0.0 111.01 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 64.6 ttp -67.91 -48.03 67.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.874 -1.368 . . . . 0.0 109.898 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.854 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -59.99 -46.52 89.19 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.058 -1.026 . . . . 0.0 109.234 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.96 -41.01 97.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 109.45 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.14 -32.23 54.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 110.335 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.77 -44.41 96.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.129 -0.982 . . . . 0.0 109.848 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -72.37 -41.79 65.97 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.537 0.684 . . . . 0.0 110.276 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -132.05 100.71 15.55 Favored Pre-proline 0 C--N 1.304 -1.404 0 O-C-N 121.54 -0.725 . . . . 0.0 109.657 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.42 150.72 80.78 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.57 1.3 . . . . 0.0 110.932 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.478 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 60.3 t90 -75.13 133.84 41.42 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.645 -0.659 . . . . 0.0 110.546 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -114.06 153.59 29.16 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 109.495 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.44 -28.98 65.77 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.035 -1.04 . . . . 0.0 110.63 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -93.3 7.54 43.96 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.311 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.401 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 52.2 t0 -42.43 138.43 1.78 Allowed 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.77 0.795 . . . . 0.0 111.361 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.712 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -114.36 148.2 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 121.896 0.855 . . . . 0.0 111.967 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -108.55 96.03 6.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.641 -1.287 . . . . 0.0 110.382 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.424 ' N ' ' OE2' ' A' ' 30' ' ' GLU . 81.2 mm-40 -67.81 -32.31 72.77 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.594 -0.692 . . . . 0.0 111.662 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.557 HD12 ' OE1' ' A' ' 30' ' ' GLU . 33.7 mt -110.06 154.46 42.72 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.185 -0.947 . . . . 0.0 111.856 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -79.4 -167.27 0.48 Allowed 'Trans proline' 0 C--N 1.319 -1.014 0 N-CA-C 108.436 -1.409 . . . . 0.0 108.436 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.768 ' OD1' HG22 ' A' ' 20' ' ' ILE . 65.9 m-80 -124.0 3.21 8.69 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.468 -1.395 . . . . 0.0 110.392 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.3 p -63.24 166.75 5.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.884 -1.135 . . . . 0.0 111.13 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.8 mt -96.09 137.87 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.823 -0.548 . . . . 0.0 110.258 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 32' ' ' ARG . 25.1 t -96.35 137.23 35.73 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.208 -0.933 . . . . 0.0 109.713 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -128.13 145.15 51.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.004 -1.06 . . . . 0.0 110.284 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.903 0 CA-C-O 117.972 -1.46 . . . . 0.0 110.296 179.898 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 p . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.59 -37.03 65.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.948 -1.095 . . . . 0.0 109.864 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -60.87 -45.46 94.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 110.498 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -70.02 -45.38 67.33 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.239 -0.913 . . . . 0.0 110.8 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.68 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.1 mt-10 -64.18 -37.18 86.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.111 -0.993 . . . . 0.0 110.384 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -66.0 -44.0 86.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.968 -1.082 . . . . 0.0 111.959 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.18 -44.4 88.56 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.747 -1.221 . . . . 0.0 111.106 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.487 HG13 HG22 ' A' ' 114' ' ' VAL . 17.2 tt -65.92 -34.69 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.848 -1.158 . . . . 0.0 109.917 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 13' ' ' GLU . 55.1 t -63.65 -40.49 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.88 -36.64 83.99 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.441 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.82 -38.71 91.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.205 -0.934 . . . . 0.0 108.904 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.448 ' CG2' ' HB2' ' A' ' 140' ' ' ASN . 30.5 mm -62.87 -43.66 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.401 -0.812 . . . . 0.0 108.9 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.453 ' HE ' ' ND2' ' A' ' 140' ' ' ASN . 99.8 mtt180 -60.95 -43.3 98.92 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.542 -0.723 . . . . 0.0 109.976 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -64.71 -39.26 93.35 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.26 -0.9 . . . . 0.0 111.258 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.95 -39.27 93.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.045 -1.034 . . . . 0.0 109.616 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.12 -17.62 41.52 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.026 -1.046 . . . . 0.0 110.126 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.5 mttt -93.61 -3.3 52.84 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 121.178 -0.951 . . . . 0.0 109.733 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -107.57 -15.49 14.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.905 -1.122 . . . . 0.0 109.885 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.6 t -152.75 160.54 43.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.036 -1.04 . . . . 0.0 109.732 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.9 p -86.96 -8.73 56.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.959 -1.088 . . . . 0.0 109.534 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.66 170.84 42.28 Favored Glycine 0 N--CA 1.482 1.725 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 138' ' ' LEU . 78.6 mm-40 -131.35 137.07 48.59 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.526 -0.985 . . . . 0.0 111.342 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -121.23 134.1 65.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.804 -0.56 . . . . 0.0 109.8 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -137.49 151.09 48.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.129 -0.982 . . . . 0.0 109.65 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.862 HG22 HD12 ' A' ' 67' ' ' ILE . 55.6 t -121.7 138.06 53.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.545 -0.722 . . . . 0.0 110.791 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.481 ' HB2' HD11 ' A' ' 66' ' ' LEU . 60.3 t60 -123.18 127.01 48.05 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.968 HD11 ' CG1' ' A' ' 71' ' ' VAL . 32.5 tp -113.93 125.81 54.46 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.85 0.833 . . . . 0.0 111.832 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 85.0 tt0 -143.22 161.75 37.44 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.411 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 98.5 mttt -77.35 -71.36 0.41 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.994 -1.066 . . . . 0.0 113.469 -177.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.418 ' CG2' ' OE1' ' A' ' 72' ' ' GLU . 8.0 t -140.13 159.01 43.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 110.462 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.9 m -107.1 164.72 11.92 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.824 -0.547 . . . . 0.0 110.128 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -105.8 -11.04 16.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.146 -0.971 . . . . 0.0 110.315 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.8 pt -125.13 -122.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.912 -1.118 . . . . 0.0 109.075 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -110.89 140.39 45.4 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.073 -1.642 . . . . 0.0 109.204 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.606 ' CG1' HG21 ' A' ' 77' ' ' VAL . 91.4 t -64.61 -42.92 96.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.283 -0.886 . . . . 0.0 110.986 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -59.43 -47.0 87.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.97 -1.081 . . . . 0.0 110.917 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -69.09 -39.0 79.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.59 -1.319 . . . . 0.0 108.359 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -59.78 -44.11 94.07 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.44 -0.788 . . . . 0.0 110.548 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.71 -36.98 85.15 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.887 -1.133 . . . . 0.0 110.006 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.4 ttp -62.77 -43.46 98.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.936 . . . . 0.0 109.402 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -65.76 -42.13 91.27 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.774 -1.204 . . . . 0.0 110.296 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.9 t -69.0 -43.21 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.246 -0.909 . . . . 0.0 110.777 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.466 ' CD1' ' HB2' ' A' ' 56' ' ' MET . 2.0 t80 -59.2 -46.65 87.86 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.758 -1.214 . . . . 0.0 108.929 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -74.48 -35.86 63.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.144 -0.972 . . . . 0.0 109.858 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -61.45 -38.39 87.03 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.172 -0.955 . . . . 0.0 109.782 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.1 mt -80.21 5.89 13.32 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.362 -0.836 . . . . 0.0 110.336 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.1 mttt 54.67 30.6 13.66 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 120.877 -1.139 . . . . 0.0 110.532 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.466 ' HB2' ' CD1' ' A' ' 51' ' ' PHE . 98.4 mtp -64.75 -12.25 45.22 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.938 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -75.89 -0.54 21.71 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.751 -1.218 . . . . 0.0 110.509 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -76.2 64.42 2.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.763 -1.211 . . . . 0.0 110.224 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.559 HG22 ' HB3' ' A' ' 137' ' ' GLU . 76.3 p -135.4 149.58 49.68 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.288 -0.882 . . . . 0.0 109.622 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.72 -43.28 96.99 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.445 ' HB2' ' ND2' ' A' ' 63' ' ' ASN . 95.8 mt -99.11 1.47 45.14 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.814 -1.179 . . . . 0.0 111.643 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 56.01 45.63 23.38 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 122.734 1.254 . . . . 0.0 110.803 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.445 ' ND2' ' HB2' ' A' ' 61' ' ' LEU . 24.6 p30 -118.05 55.25 0.89 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.238 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.99 142.87 15.66 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.527 HG23 ' CD1' ' A' ' 84' ' ' ILE . 61.0 t -127.72 136.19 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.165 -1.197 . . . . 0.0 110.779 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 34' ' ' HIS . 49.7 tp -116.71 127.44 54.39 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.783 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.862 HD12 HG22 ' A' ' 33' ' ' VAL . 90.0 mt -100.84 107.23 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.958 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.547 ' CD1' HG13 ' A' ' 43' ' ' VAL . 61.2 t80 -94.05 115.15 27.44 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.091 -1.006 . . . . 0.0 109.749 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.8 t -117.67 132.46 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 122.09 0.948 . . . . 0.0 111.126 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.601 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -99.37 87.27 3.58 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.968 ' CG1' HD11 ' A' ' 35' ' ' LEU . 28.9 m -58.89 -25.35 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.458 -0.776 . . . . 0.0 111.834 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.418 ' OE1' ' CG2' ' A' ' 38' ' ' THR . 71.3 tt0 -67.14 -43.36 82.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.743 -1.223 . . . . 0.0 108.64 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.448 ' O ' HG23 ' A' ' 75' ' ' THR . 77.1 m-20 -99.64 5.38 45.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.47 -0.769 . . . . 0.0 110.457 178.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.2 tttt 54.47 46.57 24.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.922 -1.111 . . . . 0.0 111.034 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.601 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 33.7 p -121.63 167.74 12.56 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.784 -1.198 . . . . 0.0 109.791 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -147.42 142.07 26.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.149 -0.97 . . . . 0.0 110.706 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.606 HG21 ' CG1' ' A' ' 43' ' ' VAL . 41.4 t -130.11 138.8 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.476 -0.765 . . . . 0.0 109.259 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.658 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 71.1 mt -117.54 126.37 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.804 -1.185 . . . . 0.0 110.248 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -133.25 115.46 15.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.545 -0.722 . . . . 0.0 110.735 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.8 170.74 20.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.441 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 94.2 m-20 -82.67 -178.59 7.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.482 -1.011 . . . . 0.0 110.582 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.67 -26.69 68.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 110.765 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.46 -57.9 14.64 Favored Glycine 0 N--CA 1.485 1.966 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.522 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.978 ' O ' HG22 ' A' ' 88' ' ' VAL . 79.3 mt -64.97 -44.52 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.801 -1.411 . . . . 0.0 108.917 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -61.47 -38.37 87.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.082 -1.011 . . . . 0.0 111.455 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -72.15 -19.4 61.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.915 -1.115 . . . . 0.0 112.23 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.993 HG23 HG13 ' A' ' 88' ' ' VAL . 12.8 m -108.27 -17.91 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.784 -1.198 . . . . 0.0 112.536 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.993 HG13 HG23 ' A' ' 87' ' ' VAL . 18.8 m -120.8 160.43 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.674 -1.266 . . . . 0.0 111.397 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.0 p -108.18 -175.5 2.79 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.956 0.884 . . . . 0.0 112.552 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -63.41 -35.63 81.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.662 -0.649 . . . . 0.0 109.74 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -62.3 -38.47 89.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 109.321 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.779 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 72.7 t80 -66.79 -27.64 67.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.563 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.658 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 7.3 m95 -86.06 -29.46 23.39 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.06 0.933 . . . . 0.0 110.254 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -55.83 -40.07 72.27 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.554 -0.716 . . . . 0.0 112.225 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 69.3 p -64.77 -30.46 71.47 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.412 -1.315 . . . . 0.0 108.594 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.525 ' CG2' HD13 ' A' ' 78' ' ' ILE 0.262 7.6 m -59.91 -49.43 77.73 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 122.333 1.063 . . . . 0.0 111.092 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -69.27 -37.9 78.12 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.941 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -63.85 -42.88 97.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.912 -1.117 . . . . 0.0 110.454 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.11 -48.6 73.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.736 -1.228 . . . . 0.0 110.927 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.4 mt -67.0 -42.7 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.845 -1.159 . . . . 0.0 110.175 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -61.78 -42.12 98.6 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.448 -0.782 . . . . 0.0 110.957 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.9 tp -63.81 -43.19 97.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.095 -1.003 . . . . 0.0 112.319 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.458 ' HB3' ' CA ' ' A' ' 112' ' ' GLY . 5.0 tp60 -76.07 -38.67 56.81 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.322 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -61.98 -41.4 97.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.016 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.51 -33.62 75.25 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.767 -0.583 . . . . 0.0 110.472 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -77.23 -18.29 57.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.981 -1.075 . . . . 0.0 109.499 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.8 2.52 42.89 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.714 -1.232 . . . . 0.0 111.393 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -100.22 91.32 4.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.669 -1.489 . . . . 0.0 109.972 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -62.04 -44.93 95.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.624 -0.673 . . . . 0.0 111.812 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.403 ' O ' HG23 ' A' ' 114' ' ' VAL . 5.0 mppt? -62.64 -47.17 84.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.846 -1.159 . . . . 0.0 112.322 -177.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.419 ' CB ' ' HG2' ' A' ' 103' ' ' GLN . 89.1 mm-40 -64.33 -37.85 88.95 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.725 -1.234 . . . . 0.0 110.634 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.458 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -65.03 -50.68 56.58 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.42 -1.371 . . . . 0.0 109.899 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.4 ' HB3' HD11 ' A' ' 16' ' ' ILE . 32.6 mt -62.6 -45.15 94.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.147 -1.208 . . . . 0.0 110.405 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.487 HG22 HG13 ' A' ' 16' ' ' ILE . 79.0 t -64.47 -48.02 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.001 -1.062 . . . . 0.0 110.736 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.06 -41.48 97.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.046 -1.034 . . . . 0.0 110.215 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.25 -40.58 98.78 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 75.9 mt -63.69 -44.03 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -1.072 . . . . 0.0 109.709 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -58.9 -45.12 91.03 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.052 -1.03 . . . . 0.0 109.027 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.35 -41.63 98.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.364 -0.835 . . . . 0.0 109.066 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.502 ' O ' HD12 ' A' ' 124' ' ' LEU . . . -59.82 -43.53 94.5 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.434 -0.791 . . . . 0.0 109.942 178.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.13 -45.55 86.22 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 120.352 -0.927 . . . . 0.0 110.84 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 99.1 mmm -66.24 -44.96 82.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.979 -1.306 . . . . 0.0 109.655 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.779 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -64.53 -46.18 84.0 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.427 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 120' ' ' ALA . 52.1 mt -62.55 -39.12 92.61 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.398 -0.813 . . . . 0.0 108.884 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.27 -35.18 62.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.161 -0.962 . . . . 0.0 110.794 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.8 -39.45 88.96 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.825 -1.172 . . . . 0.0 109.774 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -84.05 -34.6 24.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.5 -0.75 . . . . 0.0 110.328 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -125.93 96.6 37.14 Favored Pre-proline 0 C--N 1.303 -1.422 0 O-C-N 121.2 -0.938 . . . . 0.0 109.128 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.88 149.04 65.55 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 O-C-N 123.866 1.456 . . . . 0.0 110.047 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.476 ' CD1' ' OD2' ' A' ' 134' ' ' ASP . 59.7 t90 -75.52 131.08 39.83 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.245 -0.91 . . . . 0.0 110.731 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -110.17 150.33 28.8 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 108.912 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.06 -29.4 65.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.996 -1.065 . . . . 0.0 110.414 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -92.34 8.39 38.61 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.817 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.476 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 66.2 t0 -42.32 138.02 1.84 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.304 -0.873 . . . . 0.0 111.995 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.771 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.3 pp -115.9 152.96 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.533 0.683 . . . . 0.0 111.131 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -113.59 99.35 7.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.832 -1.168 . . . . 0.0 110.041 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.559 ' HB3' HG22 ' A' ' 59' ' ' THR . 79.9 mm-40 -67.95 -39.46 83.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.685 -0.635 . . . . 0.0 112.267 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -105.27 152.11 39.75 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.144 -0.972 . . . . 0.0 111.498 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -76.64 -166.57 0.39 Allowed 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.528 1.278 . . . . 0.0 108.786 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.543 ' OD1' HG13 ' A' ' 17' ' ' VAL . 16.1 p30 -122.98 2.48 9.35 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.834 -1.166 . . . . 0.0 109.94 178.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.8 m -64.66 135.9 56.4 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.832 -1.167 . . . . 0.0 111.432 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.9 mt -70.93 138.59 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.669 -0.644 . . . . 0.0 109.73 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.427 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 32.2 t -98.98 100.01 11.13 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.075 -1.015 . . . . 0.0 109.717 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.436 ' HG2' ' HB3' ' A' ' 35' ' ' LEU . 98.9 mttt -100.67 147.58 25.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.827 -1.171 . . . . 0.0 109.038 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 CA-C-O 118.018 -1.434 . . . . 0.0 109.62 -179.808 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 10' ' ' ALA . 71.9 m . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.24 0.543 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.404 ' N ' HG22 ' A' ' 9' ' ' THR . . . -58.8 -37.53 76.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 109.825 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -49.88 -60.92 2.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -0.855 . . . . 0.0 110.611 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.459 ' HB3' ' HG2' ' A' ' 110' ' ' LYS . 98.6 mt-10 -63.37 -40.94 98.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.576 -0.703 . . . . 0.0 110.962 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.7 mt-10 -62.61 -37.22 85.41 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.972 -1.08 . . . . 0.0 110.462 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -64.12 -44.35 92.49 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.903 -1.123 . . . . 0.0 110.276 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.93 -41.59 99.53 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.231 -0.918 . . . . 0.0 111.123 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.778 HG13 HG22 ' A' ' 114' ' ' VAL . 19.6 tt -68.36 -27.36 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.854 -1.154 . . . . 0.0 110.19 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 13' ' ' GLU . 71.1 t -66.69 -41.13 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.08 -35.06 79.51 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.652 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.66 94.12 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.265 -0.897 . . . . 0.0 109.547 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.426 ' CG2' ' HB2' ' A' ' 140' ' ' ASN . 96.6 mt -64.52 -43.38 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.14 -0.975 . . . . 0.0 110.102 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -61.21 -41.0 96.08 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.45 -0.782 . . . . 0.0 109.716 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -64.53 -38.24 90.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.544 -0.722 . . . . 0.0 111.302 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.74 -39.72 94.11 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.957 -1.089 . . . . 0.0 109.508 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -59.56 -16.55 25.93 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.025 -1.047 . . . . 0.0 110.618 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 97.3 mttt -95.0 -0.57 53.68 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.144 -0.973 . . . . 0.0 109.197 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -111.07 -15.36 13.73 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 120.903 -1.123 . . . . 0.0 110.151 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.7 t -152.91 158.6 42.36 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.045 -1.034 . . . . 0.0 110.061 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 97.6 p -87.29 -10.13 53.15 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.322 -0.861 . . . . 0.0 109.819 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.13 170.62 37.33 Favored Glycine 0 N--CA 1.48 1.571 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.64 ' HB3' HD12 ' A' ' 138' ' ' LEU . 80.9 mm-40 -130.54 134.01 46.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.231 -1.158 . . . . 0.0 111.524 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.8 mt -121.34 134.92 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-O 121.393 0.615 . . . . 0.0 110.097 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.742 ' CD ' HD13 ' A' ' 138' ' ' LEU . 84.0 mtp180 -137.46 153.49 50.08 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.802 HG12 HD12 ' A' ' 67' ' ' ILE . 27.4 m -121.21 141.19 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 111.417 -177.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.768 ' HB2' HD11 ' A' ' 66' ' ' LEU . 36.7 t60 -125.57 128.19 47.55 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.62 0.724 . . . . 0.0 109.657 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.624 HD11 ' CG1' ' A' ' 71' ' ' VAL . 27.9 tp -117.53 128.96 55.48 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.6 0.714 . . . . 0.0 111.43 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 83.3 tt0 -147.0 166.94 25.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.6 -0.687 . . . . 0.0 109.301 177.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.446 ' HA ' HG22 ' A' ' 71' ' ' VAL . 97.6 mttt -81.83 -76.94 0.23 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.335 -0.853 . . . . 0.0 113.241 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.433 ' HB ' ' HG2' ' A' ' 72' ' ' GLU . 3.9 t -139.9 154.74 47.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.042 -1.036 . . . . 0.0 110.429 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.447 ' CB ' ' HD2' ' A' ' 46' ' ' ARG . 63.7 p -104.74 169.5 8.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.481 -0.762 . . . . 0.0 110.668 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -103.97 -18.31 14.64 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.327 -0.858 . . . . 0.0 109.803 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.7 pt -117.17 -122.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.22 -0.925 . . . . 0.0 109.884 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -112.13 139.79 47.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.129 -1.607 . . . . 0.0 109.996 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.639 ' CG1' HG21 ' A' ' 77' ' ' VAL . 95.0 t -61.3 -44.07 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.284 -0.885 . . . . 0.0 110.994 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -60.43 -46.66 89.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.948 -1.095 . . . . 0.0 110.165 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -70.14 -36.54 74.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.003 -1.061 . . . . 0.0 108.694 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.447 ' HD2' ' CB ' ' A' ' 39' ' ' SER . 59.8 ttt85 -64.83 -41.84 95.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.162 -0.961 . . . . 0.0 110.765 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.1 -36.99 80.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.87 -1.144 . . . . 0.0 110.049 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.0 ttp -62.95 -45.97 89.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.358 -0.839 . . . . 0.0 110.079 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -64.1 -42.12 97.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.991 -1.068 . . . . 0.0 109.461 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 72.4 t -66.44 -43.1 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.346 -0.846 . . . . 0.0 110.323 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.482 ' CE2' ' HE2' ' A' ' 56' ' ' MET . 6.9 t80 -58.98 -46.7 87.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.986 -1.071 . . . . 0.0 108.871 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.9 m80 -72.77 -35.9 67.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.021 -1.049 . . . . 0.0 109.651 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -61.09 -39.24 89.18 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.995 -1.066 . . . . 0.0 109.316 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.9 mt -80.58 3.92 20.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 110.152 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 54.54 33.1 18.24 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.029 -1.044 . . . . 0.0 111.46 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.591 ' SD ' HD13 ' A' ' 66' ' ' LEU . 90.4 mtp -65.44 -12.61 54.05 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.81 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -76.65 -1.88 29.93 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.941 -1.1 . . . . 0.0 109.958 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -75.49 64.22 1.58 Allowed 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.056 -1.028 . . . . 0.0 109.748 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.2 p -135.05 149.7 50.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 109.238 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.26 -41.91 99.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.617 -0.677 . . . . 0.0 112.665 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 84.1 mt -99.62 0.17 41.57 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.796 -1.19 . . . . 0.0 111.743 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.422 ' O ' ' CB ' ' A' ' 81' ' ' ASP . 86.5 mt-30 58.55 46.85 14.22 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.451 1.119 . . . . 0.0 111.028 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -119.98 50.89 1.23 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.402 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.1 142.42 16.11 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.252 -1.939 . . . . 0.0 108.252 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.514 HG23 ' CD1' ' A' ' 84' ' ' ILE . 54.4 t -126.94 134.79 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.993 -1.298 . . . . 0.0 110.401 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.768 HD11 ' HB2' ' A' ' 34' ' ' HIS . 39.2 tp -117.17 125.03 50.56 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.068 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.802 HD12 HG12 ' A' ' 33' ' ' VAL . 98.6 mt -102.69 101.85 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.571 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -88.54 124.32 33.9 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.312 -0.867 . . . . 0.0 110.057 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.614 ' HB ' HD12 ' A' ' 35' ' ' LEU . 69.1 t -119.57 131.87 70.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.909 0.861 . . . . 0.0 110.373 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.505 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -102.46 87.02 2.91 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.624 ' CG1' HD11 ' A' ' 35' ' ' LEU . 34.6 m -60.56 -20.84 21.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.893 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.433 ' HG2' ' HB ' ' A' ' 38' ' ' THR . 49.6 tp10 -70.92 -45.41 64.28 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.092 -1.005 . . . . 0.0 109.097 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.526 ' O ' HG23 ' A' ' 75' ' ' THR . 83.7 m-20 -100.52 5.92 44.18 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.032 -1.043 . . . . 0.0 110.693 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.9 tttt 54.79 46.57 24.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.089 -1.007 . . . . 0.0 111.415 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 73' ' ' ASP . 82.5 p -125.52 157.8 36.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.307 -0.871 . . . . 0.0 109.903 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -138.01 145.85 42.38 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.049 -1.032 . . . . 0.0 110.102 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.639 HG21 ' CG1' ' A' ' 43' ' ' VAL . 55.5 t -132.48 136.09 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.116 -0.99 . . . . 0.0 109.637 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.659 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 81.8 mt -113.12 127.81 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.63 -1.294 . . . . 0.0 110.459 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -130.21 116.19 18.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.592 -0.692 . . . . 0.0 109.998 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.59 166.21 15.87 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.475 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 31.3 m-20 -76.42 175.56 9.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.402 -1.058 . . . . 0.0 110.606 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.409 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 85.9 tttt -60.86 -25.74 66.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.446 -0.783 . . . . 0.0 110.348 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.5 -53.68 30.65 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 120.095 -1.05 . . . . 0.0 110.593 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.968 ' O ' HG22 ' A' ' 88' ' ' VAL . 83.1 mt -64.28 -44.74 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.961 -1.317 . . . . 0.0 107.471 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -61.95 -37.79 86.07 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.004 -1.06 . . . . 0.0 111.286 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.409 ' OD2' ' HG2' ' A' ' 82' ' ' LYS . 54.2 m-20 -73.63 -20.28 60.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.836 -1.165 . . . . 0.0 111.88 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.992 HG13 HG13 ' A' ' 88' ' ' VAL . 10.6 p -105.73 -21.61 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.859 -1.151 . . . . 0.0 112.512 -178.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.992 HG13 HG13 ' A' ' 87' ' ' VAL . 17.0 m -118.75 162.45 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 120.602 -1.311 . . . . 0.0 111.708 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.6 p -105.05 177.48 4.84 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.766 0.793 . . . . 0.0 112.108 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -63.74 -37.32 86.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 109.733 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -61.72 -39.27 90.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.229 -0.919 . . . . 0.0 109.382 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.74 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 30.9 t80 -62.61 -26.63 68.71 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.659 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.6 m95 -84.05 -27.92 27.97 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.722 0.772 . . . . 0.0 110.682 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -56.97 -34.68 68.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.251 -0.905 . . . . 0.0 112.68 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.4 m -64.96 -36.21 83.65 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 118.448 -1.301 . . . . 0.0 109.088 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.443 ' CG2' HD13 ' A' ' 78' ' ' ILE 0.278 8.5 m -57.92 -47.31 83.21 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 122.307 1.051 . . . . 0.0 111.082 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -69.24 -38.8 78.67 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.361 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 91.1 m-20 -63.68 -43.99 95.04 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.675 -1.21 . . . . 0.0 109.988 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.7 -49.11 74.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.764 -1.21 . . . . 0.0 111.016 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 92.7 mt -67.33 -42.93 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.81 -1.181 . . . . 0.0 110.031 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -65.38 -42.41 92.73 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.213 -0.93 . . . . 0.0 110.876 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.734 ' O ' HD13 ' A' ' 102' ' ' LEU . 1.3 tm? -62.49 -41.21 98.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.114 -0.991 . . . . 0.0 111.075 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.484 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 30.6 mm100 -75.89 -38.54 57.72 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.728 -1.189 . . . . 0.0 108.894 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -61.03 -41.81 97.28 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -63.32 -33.59 75.86 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.926 -0.484 . . . . 0.0 110.641 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -77.43 -18.18 57.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.89 -1.132 . . . . 0.0 109.317 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.38 1.09 31.16 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.752 -1.213 . . . . 0.0 111.003 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -103.47 91.02 3.87 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.635 -1.509 . . . . 0.0 110.853 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -62.58 -44.98 94.96 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.782 -0.574 . . . . 0.0 110.758 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.607 ' CE ' HG21 ' A' ' 16' ' ' ILE . 29.8 tptt -63.85 -48.92 74.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.145 -0.972 . . . . 0.0 112.568 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -61.08 -38.39 86.08 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.525 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.484 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -62.99 -45.26 96.0 Favored Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.608 -1.282 . . . . 0.0 109.947 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.2 mt -64.74 -44.52 89.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.113 -1.227 . . . . 0.0 110.733 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.778 HG22 HG13 ' A' ' 16' ' ' ILE . 99.4 t -64.91 -47.94 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 110.082 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -63.66 -41.42 98.2 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.663 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.59 -43.09 99.74 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.7 -43.42 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.933 -1.334 . . . . 0.0 110.077 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.74 -50.9 71.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 110.164 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -61.92 -42.2 98.82 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.085 -1.009 . . . . 0.0 109.07 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 124' ' ' LEU . . . -57.66 -37.64 73.74 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.385 -0.822 . . . . 0.0 109.43 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.49 -45.37 68.29 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 99.1 mmm -68.16 -42.92 79.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.99 -1.3 . . . . 0.0 110.139 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.74 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -65.9 -47.17 75.71 Favored 'General case' 0 C--O 1.203 -1.39 0 O-C-N 121.169 -0.957 . . . . 0.0 108.846 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 120' ' ' ALA . 78.0 mt -61.99 -39.16 91.26 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.54 -34.18 61.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.19 -0.944 . . . . 0.0 110.487 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -61.2 -41.21 96.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.872 -1.142 . . . . 0.0 108.968 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.456 ' CE1' ' CE2' ' A' ' 92' ' ' PHE . 91.8 m-85 -80.25 -36.83 34.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 0.0 110.791 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.638 ' HE2' HG11 ' A' ' 87' ' ' VAL . 88.7 m-85 -129.23 93.01 37.29 Favored Pre-proline 0 C--N 1.304 -1.383 0 O-C-N 121.3 -0.875 . . . . 0.0 109.674 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.98 153.25 78.53 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.85 1.448 . . . . 0.0 111.227 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 49.9 t90 -77.6 132.74 38.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.675 -0.641 . . . . 0.0 111.133 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 75.4 mmtt -112.09 150.22 31.01 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -58.45 -31.23 67.58 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.557 -1.34 . . . . 0.0 111.018 -177.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -89.22 8.08 32.1 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.914 -1.115 . . . . 0.0 110.593 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.469 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 64.9 t0 -43.09 137.9 2.32 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.99 0.9 . . . . 0.0 111.038 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.582 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -111.92 141.98 25.74 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 O-C-N 121.614 -0.679 . . . . 0.0 110.476 -178.025 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -95.57 93.93 7.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.012 -1.055 . . . . 0.0 110.061 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.447 ' HG3' HG12 ' A' ' 135' ' ' ILE . 96.6 mt-10 -69.5 -42.39 74.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.702 -0.624 . . . . 0.0 112.543 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.742 HD13 ' CD ' ' A' ' 32' ' ' ARG . 16.8 mt -106.06 151.19 40.03 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 120.973 -1.08 . . . . 0.0 111.334 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.01 -175.09 1.55 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 N-CA-C 108.948 -1.212 . . . . 0.0 108.948 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.426 ' HB2' ' CG2' ' A' ' 20' ' ' ILE . 21.3 p30 -118.86 4.04 11.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.765 -1.209 . . . . 0.0 110.102 178.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.3 p -62.72 175.12 0.87 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.1 -1.0 . . . . 0.0 110.302 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.506 HG23 HG23 ' A' ' 33' ' ' VAL . 80.5 mt -107.59 141.15 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.482 -0.761 . . . . 0.0 111.462 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.4 t -94.81 133.38 38.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.473 -0.767 . . . . 0.0 109.803 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -127.48 129.37 47.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 110.827 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 118.054 -1.414 . . . . 0.0 109.856 179.576 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.085 0.469 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.61 -38.22 66.54 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.011 -1.056 . . . . 0.0 109.115 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.22 -46.03 86.63 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.673 0.749 . . . . 0.0 110.181 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -69.83 -42.42 73.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.47 -0.769 . . . . 0.0 111.179 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.694 ' O ' HG23 ' A' ' 17' ' ' VAL . 92.4 mt-10 -63.64 -37.42 87.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.142 -0.974 . . . . 0.0 109.892 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.65 -44.81 92.74 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.053 -1.03 . . . . 0.0 110.672 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.67 -44.12 87.27 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.994 -1.067 . . . . 0.0 111.788 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 13' ' ' GLU . 19.3 tt -67.71 -36.52 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.73 -1.231 . . . . 0.0 110.44 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 13' ' ' GLU . 69.2 t -62.42 -39.57 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 21' ' ' ARG . 29.4 t0 -62.87 -35.01 78.58 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.464 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.93 -39.57 95.0 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.322 -0.862 . . . . 0.0 110.104 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.55 -43.85 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.114 -0.991 . . . . 0.0 109.883 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 18' ' ' ASP . 74.7 mtm180 -60.21 -42.04 94.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.872 . . . . 0.0 110.896 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -63.16 -36.2 82.84 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.125 -0.985 . . . . 0.0 110.33 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.6 -39.27 88.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.092 -1.005 . . . . 0.0 110.164 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -60.67 -16.32 37.89 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.943 -1.098 . . . . 0.0 110.851 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.473 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.6 mttt -95.11 -4.2 46.65 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.172 -0.955 . . . . 0.0 109.628 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -105.12 -16.99 14.63 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.068 -1.02 . . . . 0.0 109.462 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.8 t -152.4 161.83 42.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.114 -0.991 . . . . 0.0 109.864 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.1 p -87.81 -7.47 57.22 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.311 -0.868 . . . . 0.0 109.887 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.98 170.4 47.25 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -129.5 132.74 46.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.241 -1.152 . . . . 0.0 111.217 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.2 mt -117.42 134.34 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.693 -0.63 . . . . 0.0 110.147 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.453 ' HB3' ' HE1' ' A' ' 56' ' ' MET . 75.2 ttt180 -139.8 149.36 43.41 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.05 -1.031 . . . . 0.0 110.101 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.738 HG22 HD12 ' A' ' 67' ' ' ILE . 48.3 t -117.44 137.32 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.236 -0.915 . . . . 0.0 111.199 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.829 ' HB2' HD11 ' A' ' 66' ' ' LEU . 15.4 t60 -122.66 125.94 46.61 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.552 HD11 HG13 ' A' ' 71' ' ' VAL . 44.8 tp -115.35 135.85 53.71 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.091 0.948 . . . . 0.0 112.045 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.427 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 81.4 tt0 -150.12 164.33 35.87 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 177.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.56 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.0 mttt -79.48 -74.58 0.28 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.454 -0.779 . . . . 0.0 112.108 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.8 t -140.95 154.93 46.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 109.634 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.432 ' HB2' ' HD2' ' A' ' 46' ' ' ARG . 12.0 p -106.0 168.91 8.81 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.495 -0.753 . . . . 0.0 110.615 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -109.66 -18.54 13.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.116 -0.99 . . . . 0.0 110.83 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.428 HG13 ' N ' ' A' ' 42' ' ' ASP . 32.0 pt -114.06 -123.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.981 -1.075 . . . . 0.0 109.85 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.428 ' N ' HG13 ' A' ' 41' ' ' ILE . 99.3 m-20 -111.77 136.67 50.73 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.461 -1.4 . . . . 0.0 109.727 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.82 -45.21 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.681 -0.637 . . . . 0.0 112.619 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -60.22 -47.17 87.1 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.751 -1.218 . . . . 0.0 110.322 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -71.28 -40.91 70.63 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.927 -1.108 . . . . 0.0 108.992 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HD2' ' HB2' ' A' ' 39' ' ' SER . 66.7 ttt-85 -63.06 -43.51 98.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.128 -0.983 . . . . 0.0 110.891 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.88 85.72 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.544 -1.347 . . . . 0.0 109.428 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.8 ttp -61.69 -41.99 98.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.009 -1.057 . . . . 0.0 108.939 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.86 -44.43 93.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.069 -1.02 . . . . 0.0 109.73 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.46 -43.78 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.417 -0.802 . . . . 0.0 110.533 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.462 ' CE2' ' OD1' ' A' ' 57' ' ' ASP . 64.4 t80 -59.88 -47.39 85.96 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.007 -1.058 . . . . 0.0 109.966 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -74.98 -34.49 61.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.946 -1.096 . . . . 0.0 109.326 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -62.19 -36.62 82.46 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.949 -1.094 . . . . 0.0 109.137 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.19 2.81 26.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.18 -0.95 . . . . 0.0 110.049 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 55.54 33.52 21.25 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 121.142 -0.974 . . . . 0.0 111.892 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.748 ' SD ' HD13 ' A' ' 66' ' ' LEU . 95.7 mtp -66.19 -11.65 51.01 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 118.872 -1.131 . . . . 0.0 109.664 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.462 ' OD1' ' CE2' ' A' ' 51' ' ' PHE . 94.4 m-20 -77.19 -0.59 25.65 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.047 -1.033 . . . . 0.0 109.334 176.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -76.15 62.17 1.68 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.175 -0.953 . . . . 0.0 109.92 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.7 m -132.72 146.33 51.77 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.02 -42.48 99.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.568 -0.708 . . . . 0.0 111.427 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.2 mt -95.57 -0.05 52.41 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.011 -1.055 . . . . 0.0 111.265 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 57.3 45.33 20.4 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.406 1.098 . . . . 0.0 111.187 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -118.74 54.04 0.97 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.253 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.87 139.23 14.31 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.584 HG23 ' CD1' ' A' ' 84' ' ' ILE . 53.8 t -123.78 136.59 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.151 -1.206 . . . . 0.0 110.802 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.829 HD11 ' HB2' ' A' ' 34' ' ' HIS . 38.9 tp -117.89 128.13 54.53 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.347 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.738 HD12 HG22 ' A' ' 33' ' ' VAL . 97.1 mt -104.79 104.75 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 118.876 -1.129 . . . . 0.0 109.467 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -90.12 122.2 32.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.32 -0.863 . . . . 0.0 109.893 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -121.07 134.23 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.066 0.936 . . . . 0.0 110.924 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.517 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -104.44 98.42 8.2 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 37' ' ' LYS . 33.3 m -66.36 -22.25 29.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.197 -0.939 . . . . 0.0 110.607 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -68.93 -44.06 73.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.033 -1.042 . . . . 0.0 109.542 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 75' ' ' THR . 96.2 m-20 -101.7 4.9 41.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.079 -1.013 . . . . 0.0 111.044 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 ttmt 55.5 46.74 22.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.879 -1.138 . . . . 0.0 110.352 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 70.5 p -122.4 165.88 15.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -0.901 . . . . 0.0 109.749 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 46.3 p90 -146.38 146.66 30.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.512 -0.743 . . . . 0.0 110.369 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.1 t -133.78 136.88 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.389 -0.819 . . . . 0.0 109.114 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.646 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 81.6 mt -115.2 127.34 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.617 -1.302 . . . . 0.0 110.713 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -129.96 119.24 22.89 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.745 . . . . 0.0 111.223 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.525 ' HA2' HG22 ' A' ' 65' ' ' VAL . . . -103.28 149.49 17.47 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -62.82 175.28 0.86 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.568 -0.96 . . . . 0.0 110.1 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.84 -26.88 67.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.226 -0.921 . . . . 0.0 111.702 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.76 -53.85 32.12 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.609 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.97 ' O ' HG22 ' A' ' 88' ' ' VAL . 75.0 mt -63.11 -44.82 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.802 -1.411 . . . . 0.0 108.347 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -60.97 -38.51 86.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.966 -1.083 . . . . 0.0 111.627 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -71.0 -22.0 62.22 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.857 -1.152 . . . . 0.0 111.748 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.946 HG23 HG13 ' A' ' 88' ' ' VAL . 23.5 m -104.97 -15.77 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.92 -1.113 . . . . 0.0 112.884 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.97 HG22 ' O ' ' A' ' 84' ' ' ILE . 21.8 m -121.04 163.51 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.591 -1.318 . . . . 0.0 112.089 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.3 m -110.93 178.27 4.4 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.6 0.714 . . . . 0.0 112.158 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 33.8 p-10 -63.12 -36.4 83.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 110.059 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 65.8 t0 -62.87 -38.64 91.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.109 -0.994 . . . . 0.0 108.986 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.818 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 78.6 t80 -67.07 -25.28 66.17 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.239 -0.913 . . . . 0.0 109.376 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.646 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.8 m95 -86.5 -23.49 25.92 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.796 0.808 . . . . 0.0 110.36 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -58.1 -36.23 72.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.91 . . . . 0.0 112.057 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.5 p -67.25 -31.28 71.51 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.541 -1.264 . . . . 0.0 108.895 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.549 HG22 HD13 ' A' ' 78' ' ' ILE 0.272 10.0 m -60.08 -48.91 79.75 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 122.352 1.072 . . . . 0.0 111.111 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.38 -36.71 74.28 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.994 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -64.59 -44.23 91.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.933 -1.104 . . . . 0.0 110.482 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.12 -50.68 69.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.557 -1.34 . . . . 0.0 111.282 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.469 HD12 HD11 ' A' ' 78' ' ' ILE . 92.9 mt -66.35 -42.9 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.769 -1.207 . . . . 0.0 110.279 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -63.26 -41.75 99.09 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.296 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.7 mt -63.33 -41.71 98.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.196 -0.94 . . . . 0.0 111.775 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.464 ' HG2' ' HB2' ' A' ' 111' ' ' GLN . 5.8 tp-100 -76.36 -40.17 51.88 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.69 -1.204 . . . . 0.0 108.963 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.423 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 1.2 m-85 -59.89 -40.64 89.41 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.62 -34.79 77.76 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.858 -0.526 . . . . 0.0 110.073 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -76.7 -18.7 58.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.989 -1.069 . . . . 0.0 109.712 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.08 -0.22 38.37 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.771 -1.204 . . . . 0.0 111.208 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -99.49 89.37 4.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.633 -1.51 . . . . 0.0 109.548 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -64.16 -41.78 97.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.869 -0.52 . . . . 0.0 111.816 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.446 ' O ' HG12 ' A' ' 114' ' ' VAL . 86.5 tttt -61.43 -48.19 82.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.047 -1.033 . . . . 0.0 110.798 -178.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.464 ' HB2' ' HG2' ' A' ' 103' ' ' GLN . 87.3 mt-30 -64.3 -35.9 82.37 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.117 -0.99 . . . . 0.0 110.427 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.448 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -65.76 -48.76 64.05 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.184 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.401 ' HB3' HD11 ' A' ' 16' ' ' ILE . 91.9 mt -65.6 -44.73 85.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.082 -1.246 . . . . 0.0 111.409 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.486 HG13 ' N ' ' A' ' 115' ' ' ASP . 11.5 p -65.06 -46.31 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.184 -0.947 . . . . 0.0 110.5 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.486 ' N ' HG13 ' A' ' 114' ' ' VAL . 66.6 t0 -64.45 -42.11 96.14 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.992 -1.067 . . . . 0.0 109.929 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.45 -42.17 93.69 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.79 -43.04 97.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.232 -1.157 . . . . 0.0 109.78 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -59.17 -50.98 71.98 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.973 -1.08 . . . . 0.0 110.616 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.89 -42.94 99.95 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.878 -1.138 . . . . 0.0 109.28 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.8 -43.43 76.85 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.286 -0.884 . . . . 0.0 109.365 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.81 -42.98 99.59 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 98.8 mmm -67.53 -46.84 71.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.015 -1.285 . . . . 0.0 110.472 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.818 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -63.94 -45.99 86.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.255 -0.903 . . . . 0.0 109.29 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.86 -40.42 95.3 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.4 -34.43 57.71 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.47 -0.769 . . . . 0.0 110.27 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -63.05 -44.17 96.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.061 -1.025 . . . . 0.0 109.133 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -73.08 -39.11 66.12 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.571 0.7 . . . . 0.0 109.961 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -131.67 98.36 18.05 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.634 -0.666 . . . . 0.0 110.178 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.45 154.13 69.41 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.647 1.34 . . . . 0.0 111.041 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.473 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 30.7 t90 -75.77 158.57 32.06 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.905 0.86 . . . . 0.0 110.948 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -140.47 151.42 44.84 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.33 -31.87 71.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.025 -1.047 . . . . 0.0 111.096 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -89.61 5.51 45.37 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.047 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.436 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 68.2 t0 -42.11 139.84 1.26 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.04 0.924 . . . . 0.0 111.71 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.695 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -113.87 142.7 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 121.817 0.818 . . . . 0.0 111.757 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -102.31 96.53 7.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.942 -1.099 . . . . 0.0 110.462 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -69.86 -33.41 72.22 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.649 -0.657 . . . . 0.0 112.673 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.9 mp -112.45 150.2 42.25 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.07 -1.019 . . . . 0.0 112.176 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.85 -170.47 0.7 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.667 1.351 . . . . 0.0 109.228 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 18.5 p-10 -125.37 1.85 7.73 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.71 -1.243 . . . . 0.0 110.287 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.6 p -60.85 167.94 2.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.999 -1.063 . . . . 0.0 110.866 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 47.5 mm -95.09 134.33 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.435 0.636 . . . . 0.0 110.691 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 10.5 m -91.22 132.78 35.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 0.0 109.946 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.11 144.99 51.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.145 -0.972 . . . . 0.0 110.544 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.844 179.488 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.127 0.489 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 14' ' ' LYS . . . -54.14 -36.67 63.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.2 -0.937 . . . . 0.0 109.6 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.65 -38.46 89.39 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 109.545 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.45 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 97.5 mt-10 -70.63 -46.54 63.13 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.013 -1.055 . . . . 0.0 110.365 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.0 mt-10 -65.26 -34.58 78.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.381 -0.824 . . . . 0.0 109.572 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 87.3 tttt -62.91 -46.34 88.28 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.231 -0.918 . . . . 0.0 110.667 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.31 -43.81 85.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 111.773 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.531 HG13 HG22 ' A' ' 114' ' ' VAL . 16.5 tt -66.61 -36.62 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.665 -1.272 . . . . 0.0 110.49 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 13' ' ' GLU . 71.6 t -63.77 -40.69 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.44 -39.08 92.21 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.755 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.0 92.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.322 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.57 -42.58 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.495 -0.753 . . . . 0.0 109.251 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.407 ' HG2' ' OD1' ' A' ' 140' ' ' ASN . 80.9 mtp180 -59.15 -42.57 91.02 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.211 -0.931 . . . . 0.0 110.304 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -64.91 -36.44 84.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.405 -0.81 . . . . 0.0 110.659 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.36 90.85 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.761 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -60.4 -14.86 21.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.089 -1.007 . . . . 0.0 111.175 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.473 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.5 mttt -95.49 -1.72 50.14 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.958 -1.089 . . . . 0.0 109.749 177.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -109.57 -14.51 14.36 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 120.896 -1.128 . . . . 0.0 109.593 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.0 t -154.4 160.55 41.72 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.882 -1.136 . . . . 0.0 110.485 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.2 m -88.86 -7.2 56.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.206 -0.934 . . . . 0.0 110.273 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.87 171.0 48.5 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.677 ' OE1' HD22 ' A' ' 138' ' ' LEU . 91.7 mt-10 -130.96 137.17 49.14 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.268 -1.137 . . . . 0.0 111.216 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.499 HG21 HD12 ' A' ' 117' ' ' ILE . 83.3 mt -119.63 134.71 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.712 -0.618 . . . . 0.0 110.317 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.4 ' HB2' ' HE1' ' A' ' 56' ' ' MET . 57.4 mmm-85 -138.69 150.7 46.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.249 -0.907 . . . . 0.0 110.197 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.631 HG12 HD12 ' A' ' 67' ' ' ILE . 15.8 m -123.24 139.54 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.456 -0.777 . . . . 0.0 111.118 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -124.9 128.62 48.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.563 -0.711 . . . . 0.0 109.237 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.714 HD11 ' CG1' ' A' ' 71' ' ' VAL . 36.9 tp -115.82 128.87 56.16 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.902 0.858 . . . . 0.0 111.814 -178.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -144.7 165.12 28.94 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -78.95 -74.05 0.3 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.226 -0.921 . . . . 0.0 113.1 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.6 t -140.25 156.18 46.58 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.772 -1.205 . . . . 0.0 110.167 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.9 p -102.56 168.01 9.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.427 -0.796 . . . . 0.0 110.505 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -107.19 -14.32 14.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.308 -0.87 . . . . 0.0 110.632 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 42' ' ' ASP . 19.2 pt -123.34 -121.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.976 -1.077 . . . . 0.0 109.735 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.422 ' N ' HG13 ' A' ' 41' ' ' ILE . 94.2 m-20 -111.34 140.34 46.0 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 120.191 -1.568 . . . . 0.0 109.217 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.612 HG11 HG21 ' A' ' 77' ' ' VAL . 97.3 t -64.76 -44.24 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.211 -0.931 . . . . 0.0 111.815 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -58.16 -45.86 86.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.049 -1.032 . . . . 0.0 109.648 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -71.64 -38.83 70.69 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.917 -1.114 . . . . 0.0 108.94 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.423 ' NH1' ' OH ' ' A' ' 68' ' ' TYR . 75.4 ttt180 -63.45 -42.58 98.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.972 -1.08 . . . . 0.0 110.927 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.13 -38.78 86.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.696 -1.253 . . . . 0.0 110.294 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 64.3 ttp -62.81 -44.05 97.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.064 -1.022 . . . . 0.0 109.405 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.427 ' OD1' ' ND2' ' A' ' 53' ' ' ASN . 63.5 t0 -63.52 -45.61 89.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.021 -1.049 . . . . 0.0 109.488 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 83.3 t -66.35 -44.31 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.35 -0.844 . . . . 0.0 110.947 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.473 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 4.5 t80 -58.27 -47.66 82.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.904 -1.122 . . . . 0.0 108.992 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -70.29 -36.24 74.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.054 -1.029 . . . . 0.0 109.238 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.427 ' ND2' ' OD1' ' A' ' 49' ' ' ASP . 72.7 m-20 -61.18 -37.55 83.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.096 -1.002 . . . . 0.0 110.012 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.8 mt -82.16 5.87 18.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.985 -1.072 . . . . 0.0 110.727 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 55.73 32.74 20.02 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.309 -0.87 . . . . 0.0 110.92 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.473 ' HB2' ' CE1' ' A' ' 51' ' ' PHE . 92.8 mtp -69.13 -25.41 64.38 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.341 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -68.76 -7.61 35.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.347 -0.845 . . . . 0.0 110.48 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -86.98 80.78 8.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.752 -1.218 . . . . 0.0 110.727 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.419 ' OG1' ' HA ' ' A' ' 62' ' ' GLN . 78.8 p -137.04 156.82 47.94 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -62.09 -43.97 97.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.092 -1.005 . . . . 0.0 112.817 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 88.1 mt -100.02 2.31 43.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.091 -1.006 . . . . 0.0 111.301 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.419 ' HA ' ' OG1' ' A' ' 59' ' ' THR . 99.4 mm-40 57.75 31.47 20.49 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.973 0.892 . . . . 0.0 111.272 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.575 ' C ' HD11 ' A' ' 84' ' ' ILE . 99.7 m-20 -108.96 56.46 0.62 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.812 0.815 . . . . 0.0 110.465 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.455 ' N ' HD11 ' A' ' 84' ' ' ILE . . . -103.59 141.19 15.17 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.56 ' CG2' HD13 ' A' ' 84' ' ' ILE . 47.9 t -123.35 135.05 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.07 -1.253 . . . . 0.0 110.593 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.0 tp -116.79 130.39 56.69 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.88 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.631 HD12 HG12 ' A' ' 33' ' ' VAL . 83.6 mt -104.78 108.27 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 118.826 -1.15 . . . . 0.0 109.395 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.423 ' OH ' ' NH1' ' A' ' 46' ' ' ARG . 42.3 t80 -93.73 122.69 36.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.531 -0.731 . . . . 0.0 110.331 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -123.63 133.42 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 122.173 0.987 . . . . 0.0 111.32 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.17 97.45 7.3 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.714 ' CG1' HD11 ' A' ' 35' ' ' LEU . 35.8 m -67.38 -18.67 24.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.968 -1.083 . . . . 0.0 111.245 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -69.37 -46.52 66.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.754 -1.216 . . . . 0.0 109.445 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.23 3.69 41.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.155 -0.966 . . . . 0.0 110.797 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.4 tttt 56.13 45.77 22.8 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.943 -1.098 . . . . 0.0 110.39 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 96.0 m -119.78 132.87 55.73 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.243 -0.911 . . . . 0.0 109.812 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.421 ' CD1' ' O ' ' A' ' 76' ' ' PHE . 50.9 p90 -114.52 136.7 52.73 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.532 -0.73 . . . . 0.0 109.924 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.612 HG21 HG11 ' A' ' 43' ' ' VAL . 72.0 t -126.69 136.92 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.711 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 82.7 mt -115.35 125.36 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.771 -1.205 . . . . 0.0 110.324 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -128.97 114.89 16.99 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.513 -0.742 . . . . 0.0 110.488 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.65 145.83 16.54 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -56.93 175.47 0.13 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.516 -0.99 . . . . 0.0 109.803 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.06 -24.59 63.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.091 -1.006 . . . . 0.0 110.639 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.434 ' O ' HG12 ' A' ' 87' ' ' VAL . . . -66.79 -51.79 38.33 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.655 -1.26 . . . . 0.0 110.632 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.973 ' O ' HG22 ' A' ' 88' ' ' VAL . 3.8 mt -64.15 -44.71 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.914 -1.345 . . . . 0.0 108.447 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -64.26 -36.68 84.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.365 -0.834 . . . . 0.0 111.727 -177.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -75.64 -20.95 58.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.785 -1.197 . . . . 0.0 111.938 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.01 HG13 HG13 ' A' ' 88' ' ' VAL . 11.7 p -103.08 -21.95 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.851 -1.156 . . . . 0.0 113.132 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.01 HG13 HG13 ' A' ' 87' ' ' VAL . 14.3 m -118.68 164.08 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.626 -1.296 . . . . 0.0 111.433 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.2 p -105.45 174.76 5.74 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.922 0.867 . . . . 0.0 111.634 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.01 -37.95 86.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.459 -0.776 . . . . 0.0 110.071 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -61.46 -37.57 84.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.946 . . . . 0.0 108.81 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.911 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 86.3 t80 -64.86 -27.2 68.71 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.446 -0.784 . . . . 0.0 108.968 177.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.711 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.4 m95 -86.12 -26.22 25.34 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.975 0.893 . . . . 0.0 109.888 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -58.97 -36.38 74.77 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.024 -1.048 . . . . 0.0 112.334 -176.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.9 p -66.56 -32.03 73.11 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.535 -1.266 . . . . 0.0 108.596 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.437 HG22 HD13 ' A' ' 78' ' ' ILE 0.276 7.5 m -60.21 -49.46 77.53 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 122.264 1.031 . . . . 0.0 111.141 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -68.29 -38.03 81.25 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.697 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -64.04 -41.39 97.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.013 -1.054 . . . . 0.0 110.617 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.16 -48.95 74.03 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.639 -1.288 . . . . 0.0 110.841 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.514 HD12 HD11 ' A' ' 78' ' ' ILE . 91.9 mt -67.05 -42.78 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 110.406 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -64.17 -41.43 97.14 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.296 -0.877 . . . . 0.0 110.94 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 44.3 tp -62.79 -43.02 99.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.312 -0.868 . . . . 0.0 111.754 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.474 ' CB ' ' CA ' ' A' ' 112' ' ' GLY . 3.0 tp60 -76.69 -40.08 50.0 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.779 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -58.95 -41.94 88.65 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.166 0.984 . . . . 0.0 108.449 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.12 -35.01 72.7 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -79.79 -17.23 53.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.349 -0.844 . . . . 0.0 110.169 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.62 2.5 43.47 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 119.73 -1.224 . . . . 0.0 111.573 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -104.53 94.81 5.52 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.689 -1.477 . . . . 0.0 110.859 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -62.76 -46.32 88.6 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.626 -0.671 . . . . 0.0 112.3 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.564 ' O ' HG23 ' A' ' 114' ' ' VAL . 75.3 tttt -61.62 -47.76 83.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.12 -0.988 . . . . 0.0 111.838 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.418 ' CB ' ' HG2' ' A' ' 103' ' ' GLN . 89.1 mt-30 -63.46 -40.03 96.05 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.377 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.474 ' CA ' ' CB ' ' A' ' 103' ' ' GLN . . . -65.21 -47.83 76.46 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.355 -1.402 . . . . 0.0 109.624 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.432 ' O ' HG12 ' A' ' 117' ' ' ILE . 85.2 mt -64.24 -46.01 85.64 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.506 -0.996 . . . . 0.0 111.523 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 110' ' ' LYS . 99.4 t -63.1 -48.14 89.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.296 -0.877 . . . . 0.0 110.943 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -61.63 -33.52 74.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.028 -1.045 . . . . 0.0 109.108 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.14 -40.33 98.39 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.499 HD12 HG21 ' A' ' 31' ' ' ILE . 36.1 mm -63.36 -43.84 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.064 -1.257 . . . . 0.0 109.741 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.05 -49.74 76.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.277 -0.889 . . . . 0.0 110.723 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -64.73 -43.92 91.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.057 -1.027 . . . . 0.0 110.351 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.31 95.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.895 . . . . 0.0 110.593 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.82 -44.06 81.41 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 97.0 mtp -66.56 -46.18 76.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.011 -1.288 . . . . 0.0 109.901 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.911 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -64.09 -43.89 94.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.969 -1.082 . . . . 0.0 108.974 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 31.2 mt -63.02 -40.49 97.9 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.397 -0.815 . . . . 0.0 109.093 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.42 -34.08 56.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.128 -0.983 . . . . 0.0 110.09 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.63 -44.27 97.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.121 -0.987 . . . . 0.0 109.13 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -70.66 -41.74 71.69 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.473 0.654 . . . . 0.0 109.971 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.42 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 58.1 m-85 -130.88 94.31 28.81 Favored Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.496 -0.753 . . . . 0.0 109.776 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 128' ' ' PHE . 38.8 Cg_endo -64.45 149.88 89.24 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.652 1.343 . . . . 0.0 109.843 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.473 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 39.3 t90 -73.46 130.19 39.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.457 -0.777 . . . . 0.0 111.896 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -108.78 152.64 24.58 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.03 -29.54 68.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.109 -0.995 . . . . 0.0 111.064 -177.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -91.9 6.81 44.77 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.099 -1.04 . . . . 0.0 111.48 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.449 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 67.9 t0 -42.49 139.25 1.57 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.653 -0.654 . . . . 0.0 110.645 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.711 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.3 pp -115.12 142.14 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 122.51 1.148 . . . . 0.0 113.297 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -120.33 102.52 8.53 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.16 -0.962 . . . . 0.0 109.412 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -101.4 5.92 42.34 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.633 -1.292 . . . . 0.0 111.712 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.677 HD22 ' OE1' ' A' ' 30' ' ' GLU . 1.4 tp -114.26 139.69 24.12 Favored Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 120.935 -1.103 . . . . 0.0 110.634 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -70.61 165.17 32.8 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.528 1.278 . . . . 0.0 109.747 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.407 ' OD1' ' HG2' ' A' ' 21' ' ' ARG . 32.0 m120 -103.22 8.75 38.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.595 -1.316 . . . . 0.0 110.027 177.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -62.04 144.93 54.51 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.854 -1.154 . . . . 0.0 110.647 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.98 138.71 19.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.789 -0.569 . . . . 0.0 109.846 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.0 m -93.27 132.31 37.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.077 -1.014 . . . . 0.0 109.203 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -126.22 137.52 53.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.292 -0.88 . . . . 0.0 110.143 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 CA-C-O 118.001 -1.444 . . . . 0.0 109.521 179.551 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 14' ' ' LYS . . . -54.08 -36.34 63.04 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.893 -1.129 . . . . 0.0 109.187 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -66.01 -37.09 85.03 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.539 -0.725 . . . . 0.0 109.311 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.44 ' OE1' ' CD ' ' A' ' 110' ' ' LYS . 78.1 mm-40 -72.38 -48.26 42.98 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.151 -0.968 . . . . 0.0 110.082 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.816 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.2 mt-10 -66.48 -36.98 84.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.463 -0.773 . . . . 0.0 110.186 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 88.1 tttt -62.02 -45.72 92.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.846 -1.158 . . . . 0.0 111.095 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.89 -42.46 94.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.783 -1.198 . . . . 0.0 111.434 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.588 HG13 HG22 ' A' ' 114' ' ' VAL . 19.1 tt -66.96 -36.16 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.831 -1.168 . . . . 0.0 110.748 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 13' ' ' GLU . 87.8 t -63.82 -41.02 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -62.54 -36.55 82.96 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.664 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.23 -38.27 88.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 109.353 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.874 HD11 HD13 ' A' ' 117' ' ' ILE . 34.9 mm -63.92 -43.45 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.396 -0.815 . . . . 0.0 109.998 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -59.65 -41.6 90.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.311 -0.868 . . . . 0.0 109.821 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -63.92 -37.94 89.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.326 -0.859 . . . . 0.0 111.215 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.74 -40.93 88.52 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.083 -1.011 . . . . 0.0 110.44 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -60.35 -14.5 18.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.904 -1.122 . . . . 0.0 110.922 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.469 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 49.2 mtpt -94.59 -2.82 50.77 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 120.831 -1.168 . . . . 0.0 109.48 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -109.93 -14.11 14.32 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 121.002 -1.061 . . . . 0.0 110.184 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.7 t -151.77 158.03 42.77 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.063 -1.023 . . . . 0.0 109.982 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 83.5 p -86.91 -7.95 57.71 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.273 -0.892 . . . . 0.0 109.95 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.7 172.61 45.6 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.77 ' CB ' HD12 ' A' ' 138' ' ' LEU . 55.8 mp0 -131.23 136.38 48.18 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.339 -1.095 . . . . 0.0 111.247 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -122.42 134.71 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.876 -0.515 . . . . 0.0 110.026 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.496 HH11 HD22 ' A' ' 138' ' ' LEU . 83.6 mtp180 -138.57 153.99 48.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.206 -0.934 . . . . 0.0 110.135 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.646 HG22 HD12 ' A' ' 67' ' ' ILE . 48.1 t -123.7 139.34 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.385 -0.822 . . . . 0.0 110.665 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.419 ' HA ' ' O ' ' A' ' 143' ' ' SER . 77.8 t60 -124.64 122.8 38.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.53 -0.732 . . . . 0.0 110.215 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.928 HD11 ' CG1' ' A' ' 71' ' ' VAL . 33.8 tp -108.39 131.56 54.64 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.901 0.858 . . . . 0.0 111.421 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -149.39 166.43 29.06 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.452 ' HB3' ' HG3' ' A' ' 72' ' ' GLU . 98.4 mttt -81.33 -75.45 0.28 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.928 -1.107 . . . . 0.0 113.498 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.756 HG23 ' CB ' ' A' ' 72' ' ' GLU . 1.3 p -137.96 154.09 49.41 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.496 -0.753 . . . . 0.0 109.955 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.419 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 14.3 p -98.95 167.91 10.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.137 -0.977 . . . . 0.0 110.283 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -106.27 -10.83 16.23 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.307 -0.871 . . . . 0.0 110.422 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.401 HG13 ' N ' ' A' ' 42' ' ' ASP . 28.7 pt -128.56 -121.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.936 -1.102 . . . . 0.0 109.358 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.401 ' N ' HG13 ' A' ' 41' ' ' ILE . 89.9 m-20 -111.02 138.4 47.48 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 120.184 -1.573 . . . . 0.0 110.042 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.465 HG11 HG21 ' A' ' 77' ' ' VAL . 90.1 t -62.99 -44.96 99.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.564 -0.71 . . . . 0.0 112.01 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -59.89 -46.28 89.84 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.925 -1.109 . . . . 0.0 110.057 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -70.58 -39.41 73.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.772 -1.205 . . . . 0.0 108.568 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.419 ' NH2' ' HA ' ' A' ' 39' ' ' SER . 49.8 ttt85 -61.46 -45.68 93.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 111.358 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.36 84.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.961 -1.087 . . . . 0.0 109.713 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 66.0 ttp -64.71 -43.87 92.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.204 -0.935 . . . . 0.0 109.878 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 53.5 t0 -63.2 -43.55 97.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.043 -1.036 . . . . 0.0 109.252 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.6 t -67.23 -44.01 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.46 -0.775 . . . . 0.0 110.35 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.528 ' HD1' HD22 ' A' ' 66' ' ' LEU . 61.4 t80 -60.19 -48.14 82.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.719 -1.238 . . . . 0.0 110.296 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -72.47 -35.2 68.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.989 -1.07 . . . . 0.0 108.821 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 49' ' ' ASP . 31.4 t-20 -62.34 -39.37 92.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.338 -0.851 . . . . 0.0 110.194 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.427 HD13 ' CE ' ' A' ' 56' ' ' MET . 55.6 mt -79.31 3.15 18.96 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.153 -0.967 . . . . 0.0 110.187 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 57.29 33.43 23.28 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 121.041 -1.037 . . . . 0.0 112.044 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.468 ' SD ' HD13 ' A' ' 66' ' ' LEU . 64.7 mtt -67.46 -10.79 54.8 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.845 -1.16 . . . . 0.0 109.913 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.41 ' OD1' ' CE2' ' A' ' 51' ' ' PHE . 97.1 m-20 -77.82 -0.87 28.85 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.788 -1.195 . . . . 0.0 109.787 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -80.02 63.49 4.56 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 121.005 -1.06 . . . . 0.0 109.871 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.421 ' OG1' ' HA ' ' A' ' 62' ' ' GLN . 66.8 p -133.11 150.28 52.07 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.08 -41.01 99.32 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.441 -0.787 . . . . 0.0 112.271 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.415 ' HB3' ' ND2' ' A' ' 63' ' ' ASN . 87.0 mt -100.0 -0.51 39.12 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.932 -1.105 . . . . 0.0 111.616 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.421 ' HA ' ' OG1' ' A' ' 59' ' ' THR . 87.4 mt-30 58.2 40.26 25.05 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 122.643 1.211 . . . . 0.0 111.029 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.654 ' C ' HD11 ' A' ' 84' ' ' ILE . 94.5 m-20 -111.44 53.15 0.72 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.724 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.432 ' N ' HD11 ' A' ' 84' ' ' ILE . . . -99.81 138.82 14.09 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.034 -2.026 . . . . 0.0 108.034 178.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 53.4 t -122.11 133.91 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.184 -1.186 . . . . 0.0 110.117 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.528 HD22 ' HD1' ' A' ' 51' ' ' PHE . 49.2 tp -117.44 131.21 56.78 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.674 -0.641 . . . . 0.0 110.832 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.646 HD12 HG22 ' A' ' 33' ' ' VAL . 94.4 mt -110.56 110.3 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.524 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -97.23 121.4 39.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -0.921 . . . . 0.0 109.711 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.5 t -121.98 131.81 72.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 111.302 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.575 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -98.95 95.23 7.02 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.928 ' CG1' HD11 ' A' ' 35' ' ' LEU . 35.8 m -64.31 -22.48 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.998 -1.064 . . . . 0.0 110.834 -178.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.756 ' CB ' HG23 ' A' ' 38' ' ' THR . 79.3 mm-40 -66.8 -42.51 85.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.993 -1.067 . . . . 0.0 109.535 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.451 ' O ' HG23 ' A' ' 75' ' ' THR . 92.7 m-20 -102.99 4.99 38.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.851 . . . . 0.0 110.98 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.43 ' HE2' ' O ' ' A' ' 104' ' ' PHE . 29.2 tttt 55.78 47.71 19.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.958 -1.089 . . . . 0.0 110.38 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.575 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 34.4 p -123.17 162.24 22.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 109.41 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -143.9 141.87 30.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.428 -0.795 . . . . 0.0 110.049 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.465 HG21 HG11 ' A' ' 43' ' ' VAL . 45.9 t -131.15 133.59 62.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.673 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 77.2 mt -112.97 122.33 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 118.853 -1.139 . . . . 0.0 110.544 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -129.11 111.27 12.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 110.343 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -94.72 174.63 33.35 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -77.64 176.17 9.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.752 -0.852 . . . . 0.0 109.876 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.55 -26.49 66.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.031 -1.043 . . . . 0.0 110.847 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.446 ' O ' HG12 ' A' ' 87' ' ' VAL . . . -65.72 -49.31 60.29 Favored Glycine 0 N--CA 1.488 2.108 0 C-N-CA 119.807 -1.187 . . . . 0.0 110.315 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.995 ' O ' HG22 ' A' ' 88' ' ' VAL . 3.6 mt -64.6 -44.97 96.76 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.791 0 O-C-N 121.001 -1.294 . . . . 0.0 108.151 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -64.39 -35.66 81.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.711 -1.243 . . . . 0.0 112.39 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -77.6 -22.11 51.36 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.857 -1.152 . . . . 0.0 112.303 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.094 HG13 HG13 ' A' ' 88' ' ' VAL . 7.7 p -101.33 -23.51 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.848 -1.158 . . . . 0.0 112.516 -178.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.094 HG13 HG13 ' A' ' 87' ' ' VAL . 10.2 m -117.65 164.36 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.659 -1.276 . . . . 0.0 111.413 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 t -108.13 174.8 5.72 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.649 0.738 . . . . 0.0 111.767 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -61.38 -37.37 83.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.16 -0.962 . . . . 0.0 110.12 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.61 -36.55 78.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.194 -0.941 . . . . 0.0 108.823 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.741 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 81.5 t80 -67.33 -25.18 65.88 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.258 -0.901 . . . . 0.0 109.505 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.673 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.3 m95 -88.31 -26.5 22.23 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.911 0.862 . . . . 0.0 111.252 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -55.82 -40.33 72.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.92 -1.112 . . . . 0.0 112.585 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 77.3 p -64.5 -31.03 72.06 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.507 -1.277 . . . . 0.0 109.234 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.28 12.3 m -60.27 -49.38 77.86 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 122.545 1.164 . . . . 0.0 110.952 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.05 -38.53 82.57 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.738 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -63.42 -45.01 92.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.948 -1.095 . . . . 0.0 110.725 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.42 -48.62 80.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.942 -1.099 . . . . 0.0 110.654 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.412 HD12 HD11 ' A' ' 78' ' ' ILE . 91.4 mt -67.52 -42.5 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.089 -1.007 . . . . 0.0 110.277 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.427 ' CG ' ' HE3' ' A' ' 105' ' ' LYS . 56.6 tt0 -63.28 -42.85 99.15 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.842 -1.161 . . . . 0.0 110.984 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.1 mt -63.12 -41.53 99.35 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.158 -0.964 . . . . 0.0 112.105 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.431 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 94.0 mm-40 -76.66 -37.23 56.58 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.647 -1.221 . . . . 0.0 109.253 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.43 ' O ' ' HE2' ' A' ' 74' ' ' LYS . 4.4 m-85 -61.1 -41.5 96.79 Favored 'General case' 0 C--O 1.201 -1.456 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.427 ' HE3' ' CG ' ' A' ' 101' ' ' GLN . 93.7 mttt -62.02 -33.44 74.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.754 -1.216 . . . . 0.0 110.791 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -78.55 -18.64 54.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.756 -1.215 . . . . 0.0 109.986 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.83 4.63 42.22 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.71 -1.233 . . . . 0.0 111.164 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -103.51 91.08 3.89 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.632 -1.511 . . . . 0.0 110.521 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -62.35 -45.02 95.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.706 -0.621 . . . . 0.0 111.784 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.44 ' CD ' ' OE1' ' A' ' 12' ' ' GLU . 76.3 tttt -62.86 -49.29 75.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.901 . . . . 0.0 112.55 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -62.4 -36.49 82.51 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.655 -1.218 . . . . 0.0 109.55 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.431 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -65.54 -47.58 76.48 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.426 -1.368 . . . . 0.0 110.187 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.6 mt -63.53 -44.1 95.24 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.025 -1.279 . . . . 0.0 110.776 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.588 HG22 HG13 ' A' ' 16' ' ' ILE . 86.4 t -66.52 -46.08 87.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.101 -1.0 . . . . 0.0 110.05 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -65.35 -42.54 92.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 110.023 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.02 -41.98 98.19 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.874 HD13 HD11 ' A' ' 20' ' ' ILE . 91.4 mt -65.05 -43.84 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.267 -1.137 . . . . 0.0 109.968 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -56.93 -51.75 67.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.959 -1.088 . . . . 0.0 109.729 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.68 -41.73 99.25 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.125 -0.984 . . . . 0.0 109.192 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.32 -40.56 82.38 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.078 -1.014 . . . . 0.0 109.41 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.53 -45.86 87.79 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.7 mtt -66.67 -43.56 84.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.03 -1.276 . . . . 0.0 109.416 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.741 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -63.5 -46.59 85.41 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.304 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.2 mt -62.74 -41.54 99.24 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.456 -0.777 . . . . 0.0 109.486 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.82 -34.13 62.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.33 -0.856 . . . . 0.0 110.678 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.84 -41.46 97.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.942 -1.099 . . . . 0.0 108.954 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -75.36 -37.49 60.6 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.601 -0.687 . . . . 0.0 109.787 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -132.51 99.4 15.79 Favored Pre-proline 0 N--CA 1.487 1.379 0 O-C-N 121.498 -0.751 . . . . 0.0 110.131 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.47 150.97 70.63 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.447 1.235 . . . . 0.0 110.226 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.469 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 34.5 t90 -73.66 125.81 28.89 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.382 -0.824 . . . . 0.0 110.916 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -103.97 153.84 20.36 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.01 -29.3 70.17 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 111.092 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -93.7 8.12 42.17 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.912 -1.115 . . . . 0.0 111.609 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -42.51 138.18 1.89 Allowed 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.843 0.83 . . . . 0.0 111.614 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.628 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -111.78 141.5 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 121.574 -0.704 . . . . 0.0 110.576 -178.083 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -100.25 96.01 7.18 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.169 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -67.71 -36.35 80.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.721 -0.612 . . . . 0.0 111.741 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.77 HD12 ' CB ' ' A' ' 30' ' ' GLU . 83.9 mt -109.22 151.37 41.99 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.212 -0.93 . . . . 0.0 112.073 -178.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.68 -171.54 0.87 Allowed 'Trans proline' 0 C--N 1.32 -0.949 0 N-CA-C 108.662 -1.322 . . . . 0.0 108.662 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -121.91 1.77 9.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.604 -1.31 . . . . 0.0 110.125 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 78.5 p -63.37 168.62 4.31 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.764 -1.21 . . . . 0.0 110.965 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 91.6 mt -94.56 135.83 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.483 -0.76 . . . . 0.0 110.819 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 5.1 m -93.48 134.47 35.71 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.61 146.8 50.75 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.853 -1.154 . . . . 0.0 110.427 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.944 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.451 HG23 ' H ' ' A' ' 12' ' ' GLU . 5.6 t . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.02 -38.88 77.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.24 -0.912 . . . . 0.0 110.885 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -55.88 -46.89 78.2 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.728 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.451 ' H ' HG23 ' A' ' 9' ' ' THR . 96.6 mt-10 -67.43 -45.61 75.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.516 -0.74 . . . . 0.0 111.716 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.768 ' O ' HG23 ' A' ' 17' ' ' VAL . 93.6 mt-10 -65.38 -33.11 75.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.963 -1.086 . . . . 0.0 110.035 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.34 -48.09 76.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.794 -1.192 . . . . 0.0 111.191 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.697 ' HB3' ' CE ' ' A' ' 110' ' ' LYS . . . -63.83 -42.14 97.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.319 -0.863 . . . . 0.0 111.159 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.524 HG13 HG22 ' A' ' 114' ' ' VAL . 20.6 tt -67.46 -34.77 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.004 -1.06 . . . . 0.0 110.689 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 13' ' ' GLU . 67.5 t -63.29 -39.37 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.94 -37.21 86.88 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.08 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.25 88.56 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.285 -0.884 . . . . 0.0 109.021 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.865 HG22 ' OD1' ' A' ' 140' ' ' ASN . 96.6 mt -64.5 -43.41 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-O 121.475 0.655 . . . . 0.0 109.972 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.433 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 92.8 mtt180 -59.72 -43.02 94.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 0.0 110.47 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -65.83 -36.86 84.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.431 -0.793 . . . . 0.0 111.252 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.37 -40.91 98.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.001 -1.062 . . . . 0.0 109.749 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.61 -16.52 49.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.413 -0.805 . . . . 0.0 110.11 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.4 mttt -93.65 -1.57 55.12 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.213 -0.929 . . . . 0.0 109.142 177.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -110.16 -14.39 14.2 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.973 -1.08 . . . . 0.0 110.08 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.3 t -151.34 158.12 43.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.098 -1.001 . . . . 0.0 109.644 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.6 m -85.1 -8.66 58.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.092 -1.005 . . . . 0.0 109.974 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.99 173.31 48.37 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.431 ' N ' ' OE1' ' A' ' 30' ' ' GLU . 57.8 mp0 -132.0 139.05 48.49 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.259 -1.142 . . . . 0.0 111.709 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 94.1 mt -124.81 136.26 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.605 -0.685 . . . . 0.0 110.319 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -140.96 156.56 46.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.211 -0.931 . . . . 0.0 110.038 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 143' ' ' SER . 4.8 p -126.55 140.8 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.03 -1.044 . . . . 0.0 111.469 -178.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.444 ' HA ' ' O ' ' A' ' 143' ' ' SER . 36.2 t-80 -124.43 132.15 53.5 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.574 0.702 . . . . 0.0 109.684 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.829 HD11 ' CG1' ' A' ' 71' ' ' VAL . 28.1 tp -117.62 126.13 51.97 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.625 0.726 . . . . 0.0 111.984 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.425 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 78.2 tt0 -142.73 165.2 28.04 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.439 ' HB3' ' HG3' ' A' ' 72' ' ' GLU . 99.5 mttt -79.94 -76.41 0.22 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.144 -0.973 . . . . 0.0 112.329 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.755 HG23 ' HB2' ' A' ' 72' ' ' GLU . 1.2 p -138.74 157.21 46.52 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.455 0.645 . . . . 0.0 110.609 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.433 ' OG ' ' CD ' ' A' ' 46' ' ' ARG . 50.9 m -107.47 173.62 6.24 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.431 -0.793 . . . . 0.0 110.854 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -109.23 -10.14 14.98 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.591 -0.693 . . . . 0.0 110.452 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.1 pt -125.19 -123.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 120.964 -1.085 . . . . 0.0 109.702 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -110.78 140.2 45.4 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.462 -1.399 . . . . 0.0 109.092 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.502 ' CG1' HG21 ' A' ' 77' ' ' VAL . 75.3 t -61.37 -44.18 98.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.427 -0.796 . . . . 0.0 110.599 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -58.79 -48.05 82.63 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.134 -0.979 . . . . 0.0 110.588 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -69.1 -39.89 78.72 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.784 -1.198 . . . . 0.0 109.162 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.433 ' CD ' ' OG ' ' A' ' 39' ' ' SER . 57.8 ttt85 -59.7 -45.27 92.63 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.095 -1.003 . . . . 0.0 110.087 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.19 94.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.83 -1.169 . . . . 0.0 110.324 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.3 ttp -62.92 -43.57 98.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.125 -0.985 . . . . 0.0 109.646 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -65.76 -47.1 76.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.022 -1.049 . . . . 0.0 109.5 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 72.4 t -64.64 -42.99 96.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.451 -0.781 . . . . 0.0 110.273 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.483 ' CZ ' ' OD1' ' A' ' 81' ' ' ASP . 4.5 t80 -60.82 -47.32 86.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.885 -1.134 . . . . 0.0 109.662 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -73.5 -37.99 65.5 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.114 -0.991 . . . . 0.0 110.277 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -61.2 -39.66 91.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.02 -1.05 . . . . 0.0 109.22 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.1 mt -79.94 3.33 20.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 0.0 110.856 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 57.67 33.04 22.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.599 -0.688 . . . . 0.0 111.782 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.426 ' HB2' ' CD1' ' A' ' 51' ' ' PHE . 92.6 mmm -70.6 -23.39 62.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.997 -1.064 . . . . 0.0 109.841 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -73.16 -5.33 38.49 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.124 -0.985 . . . . 0.0 110.771 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -86.29 84.01 7.57 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.799 -1.188 . . . . 0.0 110.954 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.0 p -138.4 155.91 48.07 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.01 -44.22 97.18 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.98 -1.075 . . . . 0.0 112.541 -177.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.1 mt -99.15 3.49 46.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.864 -1.148 . . . . 0.0 111.36 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 55.48 36.24 26.73 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.188 0.994 . . . . 0.0 111.029 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.501 ' C ' HD11 ' A' ' 84' ' ' ILE . 97.5 m-20 -115.71 53.7 0.84 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.264 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.83 149.04 17.99 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.602 ' CG2' HD13 ' A' ' 84' ' ' ILE . 54.2 t -127.56 134.35 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.987 -1.302 . . . . 0.0 110.081 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.476 ' HB2' ' CE2' ' A' ' 51' ' ' PHE . 35.5 tp -116.61 126.76 53.72 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.235 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 85.6 mt -105.58 112.56 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.346 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -99.87 121.11 40.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.961 . . . . 0.0 110.002 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -122.87 131.8 72.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 122.102 0.953 . . . . 0.0 111.259 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.1 99.13 10.64 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.829 ' CG1' HD11 ' A' ' 35' ' ' LEU . 28.4 m -65.29 -24.44 35.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 121.142 -0.974 . . . . 0.0 110.998 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.755 ' HB2' HG23 ' A' ' 38' ' ' THR . 70.2 mm-40 -67.97 -43.55 78.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.762 -1.211 . . . . 0.0 110.023 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -102.14 3.55 38.63 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.134 -0.978 . . . . 0.0 110.993 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt 55.98 45.91 22.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.806 -1.184 . . . . 0.0 110.712 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 99.6 m -121.51 135.27 55.04 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.079 -1.013 . . . . 0.0 110.224 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' A' ' 76' ' ' PHE . 52.5 p90 -115.98 138.1 51.51 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.473 -0.767 . . . . 0.0 111.253 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.502 HG21 ' CG1' ' A' ' 43' ' ' VAL . 58.6 t -128.91 136.19 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.892 -1.13 . . . . 0.0 108.192 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.582 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 69.8 mt -116.37 126.6 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.627 -1.295 . . . . 0.0 110.885 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -129.08 114.34 16.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.601 -0.687 . . . . 0.0 110.984 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.28 175.03 26.74 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.483 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 68.2 m-20 -82.0 -178.29 6.95 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.539 -0.977 . . . . 0.0 111.438 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.32 -26.45 68.49 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.36 -53.05 34.82 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.112 -1.042 . . . . 0.0 110.876 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.989 ' O ' HG22 ' A' ' 88' ' ' VAL . 7.9 mt -65.06 -44.69 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.95 -1.323 . . . . 0.0 107.705 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -61.53 -37.53 84.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.742 -1.224 . . . . 0.0 111.466 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -75.73 -19.99 58.66 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.011 -1.055 . . . . 0.0 111.929 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.008 HG13 HG13 ' A' ' 88' ' ' VAL . 9.5 p -104.3 -22.03 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 120.669 -1.27 . . . . 0.0 112.349 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.008 HG13 HG13 ' A' ' 87' ' ' VAL . 19.1 m -120.79 162.31 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 120.594 -1.316 . . . . 0.0 111.96 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.9 m -105.8 178.0 4.69 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.124 0.964 . . . . 0.0 112.316 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -62.81 -37.62 87.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.676 -0.64 . . . . 0.0 109.775 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -61.28 -35.82 78.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.06 -1.025 . . . . 0.0 108.887 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.642 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 80.7 t80 -67.01 -26.47 66.8 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.354 177.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.582 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 7.7 m95 -85.0 -26.96 26.77 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 122.013 0.911 . . . . 0.0 109.728 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -58.25 -38.21 76.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.166 -0.959 . . . . 0.0 112.815 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 69.5 p -65.49 -31.66 72.86 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.649 -1.22 . . . . 0.0 108.782 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.276 7.9 m -59.48 -48.68 80.72 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.485 1.136 . . . . 0.0 111.095 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -69.51 -37.89 77.37 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.945 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -63.8 -45.71 88.44 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.905 -1.122 . . . . 0.0 110.514 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.55 -48.43 81.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.735 -1.228 . . . . 0.0 110.275 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 93.1 mt -65.98 -42.84 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.122 -0.986 . . . . 0.0 110.412 179.031 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -65.12 -40.54 94.63 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.46 -0.775 . . . . 0.0 111.103 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.49 -42.92 98.54 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.307 -0.87 . . . . 0.0 111.853 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.45 ' HB3' ' HA3' ' A' ' 112' ' ' GLY . 3.3 tp60 -76.81 -39.55 50.99 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.652 -1.219 . . . . 0.0 108.99 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 3.0 m-85 -60.3 -42.34 95.32 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.817 0.818 . . . . 0.0 108.987 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.48 -30.97 70.03 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.44 -18.51 52.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 109.945 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.21 2.95 48.2 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.817 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -103.82 93.8 5.08 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.643 -1.504 . . . . 0.0 110.315 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.401 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 22.8 m-85 -62.88 -46.18 89.06 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.458 -0.776 . . . . 0.0 112.4 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.697 ' CE ' ' HB3' ' A' ' 15' ' ' ALA . 61.4 tttm -62.18 -48.47 79.91 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.801 -1.187 . . . . 0.0 112.997 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.53 -39.14 93.65 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.856 -1.138 . . . . 0.0 109.459 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.45 ' HA3' ' HB3' ' A' ' 103' ' ' GLN . . . -67.2 -47.32 64.92 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 109' ' ' PHE . 97.1 mt -62.08 -44.01 97.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -1.173 . . . . 0.0 109.392 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.524 HG22 HG13 ' A' ' 16' ' ' ILE . 68.5 t -66.72 -45.25 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.316 -0.865 . . . . 0.0 110.513 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -65.63 -40.95 93.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.965 -1.085 . . . . 0.0 109.995 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.48 -41.65 99.76 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 84.3 mt -64.27 -43.54 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.177 -1.19 . . . . 0.0 109.858 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.36 -51.82 68.28 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.868 -1.145 . . . . 0.0 110.846 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.02 -40.85 97.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.028 -1.045 . . . . 0.0 109.203 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.416 ' O ' ' HG ' ' A' ' 124' ' ' LEU . . . -56.41 -44.03 79.94 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.352 -0.842 . . . . 0.0 109.528 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.05 -43.32 95.93 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.814 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 6.1 tpp -66.66 -47.8 71.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.282 . . . . 0.0 109.421 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.642 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -62.8 -45.36 92.99 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.512 -0.875 . . . . 0.0 109.083 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 120' ' ' ALA . 83.5 mt -62.55 -39.65 94.31 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.06 -1.025 . . . . 0.0 108.635 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.88 -34.98 63.59 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.186 -0.947 . . . . 0.0 111.035 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -61.47 -41.13 96.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.995 -1.066 . . . . 0.0 108.493 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.581 ' HD2' HG22 ' A' ' 87' ' ' VAL . 56.3 m-85 -75.19 -38.24 60.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.511 -0.743 . . . . 0.0 110.098 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.538 ' HE2' HG11 ' A' ' 87' ' ' VAL . 70.9 m-85 -133.87 95.6 17.14 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.388 -0.82 . . . . 0.0 109.923 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 128' ' ' PHE . 45.6 Cg_endo -67.15 149.58 81.94 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.841 1.442 . . . . 0.0 110.369 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.481 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 42.7 t90 -72.03 143.38 49.16 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.533 -0.729 . . . . 0.0 111.403 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 99.2 mttt -121.76 151.22 40.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.487 -0.758 . . . . 0.0 109.248 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -58.86 -29.87 67.3 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.204 -0.935 . . . . 0.0 110.836 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -93.95 7.52 44.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.036 -1.04 . . . . 0.0 110.949 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 46.6 t0 -41.73 139.11 1.27 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.921 0.867 . . . . 0.0 111.423 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.595 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -110.37 138.26 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.447 -0.783 . . . . 0.0 110.553 -179.324 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -95.84 94.32 7.58 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.674 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.484 ' C ' HD22 ' A' ' 138' ' ' LEU . 78.6 mm-40 -69.09 -29.28 67.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.428 -0.795 . . . . 0.0 112.577 -178.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.484 HD22 ' C ' ' A' ' 137' ' ' GLU . 3.9 mm? -117.14 146.98 39.34 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 120.809 -1.182 . . . . 0.0 111.312 -178.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.06 -170.88 0.52 Allowed 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.43 1.226 . . . . 0.0 109.06 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.865 ' OD1' HG22 ' A' ' 20' ' ' ILE . 65.1 m-80 -122.05 3.66 9.89 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.39 -1.444 . . . . 0.0 110.327 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 21.0 m -63.1 141.3 58.82 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.087 -1.008 . . . . 0.0 111.928 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.586 HG13 HG22 ' A' ' 17' ' ' VAL . 86.2 mt -71.59 136.93 24.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.836 -0.54 . . . . 0.0 110.702 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 15.6 m -100.79 144.28 29.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.159 -0.963 . . . . 0.0 109.741 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -146.38 155.82 42.87 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.036 -1.04 . . . . 0.0 109.847 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.581 179.965 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.92 -37.98 67.05 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.086 -1.009 . . . . 0.0 109.769 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.77 -41.99 98.4 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.464 -0.773 . . . . 0.0 110.047 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -73.77 -45.59 50.79 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 110.465 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.743 ' O ' HG23 ' A' ' 17' ' ' VAL . 97.3 mt-10 -65.57 -36.49 83.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.832 -1.168 . . . . 0.0 109.858 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -63.82 -45.11 91.08 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.849 -1.157 . . . . 0.0 110.558 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.33 -44.71 86.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.954 -1.092 . . . . 0.0 111.672 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.51 ' CG2' HD11 ' A' ' 142' ' ' ILE . 20.3 tt -64.14 -35.73 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.729 -1.232 . . . . 0.0 110.45 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 13' ' ' GLU . 92.6 t -63.77 -40.59 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.381 -0.825 . . . . 0.0 108.892 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -61.03 -38.32 85.71 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.252 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.18 -38.86 90.68 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.192 -0.942 . . . . 0.0 109.768 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.481 HG22 ' OD1' ' A' ' 140' ' ' ASN . 91.7 mt -62.73 -43.23 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.168 -0.957 . . . . 0.0 109.691 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -59.67 -41.73 91.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.504 -0.748 . . . . 0.0 110.724 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -65.37 -37.48 87.13 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.199 -0.938 . . . . 0.0 110.991 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.92 92.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.033 -1.042 . . . . 0.0 109.89 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -60.1 -14.56 17.45 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.037 -1.04 . . . . 0.0 111.216 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.6 mttt -97.31 1.27 49.32 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.243 -0.911 . . . . 0.0 109.478 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -111.59 -15.05 13.56 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.04 -1.038 . . . . 0.0 109.314 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.5 t -152.68 156.03 38.43 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.054 -1.029 . . . . 0.0 110.064 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.9 p -86.84 -8.7 57.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.354 -0.841 . . . . 0.0 110.534 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.99 177.12 45.61 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.507 ' CB ' HD22 ' A' ' 138' ' ' LEU . 80.4 mm-40 -131.39 135.37 47.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.089 -1.242 . . . . 0.0 111.494 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 86.2 mt -116.43 132.07 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.724 ' HD3' ' HE2' ' A' ' 56' ' ' MET . 78.2 mtp85 -136.9 151.34 48.96 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.285 -0.884 . . . . 0.0 110.117 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.611 HG22 HD12 ' A' ' 67' ' ' ILE . 54.5 t -123.91 138.38 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.639 -0.663 . . . . 0.0 110.454 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.486 ' HB2' HD11 ' A' ' 66' ' ' LEU . 46.6 t60 -123.6 125.04 44.12 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.567 0.698 . . . . 0.0 109.132 178.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.431 HD23 ' C ' ' A' ' 35' ' ' LEU . 10.0 tt -113.48 131.08 56.18 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.009 0.909 . . . . 0.0 112.165 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 82.8 tt0 -146.84 167.14 24.64 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.45 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 51.6 mtmt -79.98 -73.99 0.33 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.964 . . . . 0.0 113.088 -177.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.411 ' OG1' ' CB ' ' A' ' 72' ' ' GLU . 62.7 m -141.57 159.61 41.86 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.411 -0.806 . . . . 0.0 110.198 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.416 ' OG ' ' CD ' ' A' ' 46' ' ' ARG . 51.1 m -112.4 170.24 8.31 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.511 -0.743 . . . . 0.0 111.133 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -107.09 -15.44 14.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.32 -0.863 . . . . 0.0 110.59 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.7 pt -121.78 -122.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.357 -0.839 . . . . 0.0 109.894 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -111.65 137.56 49.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.32 -1.488 . . . . 0.0 109.66 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.534 HG13 ' CD1' ' A' ' 68' ' ' TYR . 99.2 t -64.37 -42.54 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.441 -0.787 . . . . 0.0 110.679 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.22 -46.9 85.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.698 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -69.11 -37.95 78.66 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.433 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 58.5 ttt85 -61.96 -43.62 98.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.06 -1.025 . . . . 0.0 110.233 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.65 91.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.797 -1.189 . . . . 0.0 110.765 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.2 ttp -64.08 -43.39 95.59 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.707 -1.245 . . . . 0.0 109.681 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -64.29 -45.84 86.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.215 -0.928 . . . . 0.0 110.079 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.5 t -66.27 -42.48 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.23 -0.919 . . . . 0.0 109.475 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.07 -47.05 86.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.888 -1.133 . . . . 0.0 109.667 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -75.92 -38.63 57.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.57 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -60.66 -38.18 84.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.102 -0.999 . . . . 0.0 109.919 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.5 mt -81.2 5.41 17.05 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.005 -1.059 . . . . 0.0 110.313 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 56.77 30.62 18.03 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 121.458 -0.776 . . . . 0.0 111.328 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.724 ' HE2' ' HD3' ' A' ' 32' ' ' ARG . 99.6 mtp -65.24 -12.14 48.43 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.605 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.5 p30 -79.11 2.07 22.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.829 -1.169 . . . . 0.0 109.962 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -74.36 64.07 1.1 Allowed 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.205 -0.934 . . . . 0.0 109.926 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 81.5 p -134.49 149.09 50.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.17 -0.956 . . . . 0.0 109.661 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.67 -43.73 92.63 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.7 mt -95.76 0.9 52.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.93 -1.107 . . . . 0.0 111.018 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 56.08 38.53 30.0 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.301 1.048 . . . . 0.0 111.761 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.588 ' C ' HD11 ' A' ' 84' ' ' ILE . 97.7 m-20 -110.34 54.24 0.67 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.876 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.515 ' N ' HD11 ' A' ' 84' ' ' ILE . . . -101.0 138.52 13.89 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.614 ' CG2' HD13 ' A' ' 84' ' ' ILE . 53.7 t -121.88 134.62 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.022 -1.281 . . . . 0.0 110.361 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.52 HD13 ' CE ' ' A' ' 56' ' ' MET . 64.2 tp -117.76 129.22 55.56 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.088 0.47 . . . . 0.0 110.602 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.611 HD12 HG22 ' A' ' 33' ' ' VAL . 95.1 mt -110.66 107.39 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.981 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.534 ' CD1' HG13 ' A' ' 43' ' ' VAL . 58.6 t80 -92.95 122.91 35.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.117 -0.989 . . . . 0.0 109.541 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.6 t -120.74 130.93 74.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 122.264 1.031 . . . . 0.0 111.132 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.576 ' HB3' ' OD1' ' A' ' 73' ' ' ASP . . . -102.5 94.83 5.87 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.123 178.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.3 m -63.92 -19.48 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.094 -1.004 . . . . 0.0 111.236 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.411 ' CB ' ' OG1' ' A' ' 38' ' ' THR . 79.8 mm-40 -68.17 -43.08 78.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.879 -1.138 . . . . 0.0 109.602 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.576 ' OD1' ' HB3' ' A' ' 70' ' ' ALA . 32.3 p30 -102.88 5.78 38.73 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.336 -0.852 . . . . 0.0 110.536 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 109' ' ' PHE . 34.1 tttt 54.53 49.85 17.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.987 -1.07 . . . . 0.0 111.236 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 73' ' ' ASP . 72.5 p -126.53 167.21 15.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.142 -0.973 . . . . 0.0 109.927 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -141.09 144.52 34.96 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.424 -0.798 . . . . 0.0 109.865 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.492 HG21 HG11 ' A' ' 43' ' ' VAL . 55.7 t -131.26 136.46 57.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.693 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 81.4 mt -116.44 126.96 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.926 -1.108 . . . . 0.0 110.71 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -129.51 113.57 15.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.6 -0.688 . . . . 0.0 110.145 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -102.1 148.53 17.69 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -61.41 174.79 0.67 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.673 -0.898 . . . . 0.0 109.27 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.1 -24.79 60.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.14 -0.975 . . . . 0.0 111.068 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.509 ' O ' HG12 ' A' ' 87' ' ' VAL . . . -65.9 -51.96 41.63 Favored Glycine 0 N--CA 1.496 2.654 0 C-N-CA 119.711 -1.233 . . . . 0.0 111.452 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.985 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.6 mt -66.48 -43.93 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.811 -1.405 . . . . 0.0 108.048 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -62.2 -38.9 90.9 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 111.434 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -76.98 -23.41 52.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.934 -1.104 . . . . 0.0 112.322 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.974 HG13 HG13 ' A' ' 88' ' ' VAL . 11.2 p -98.35 -24.77 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.731 -1.231 . . . . 0.0 112.579 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.985 HG22 ' O ' ' A' ' 84' ' ' ILE . 14.3 m -117.32 163.37 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.631 -1.293 . . . . 0.0 111.519 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.415 ' OG ' ' N ' ' A' ' 90' ' ' ASP . 6.2 t -105.06 179.71 4.19 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.24 -0.912 . . . . 0.0 111.843 -178.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.415 ' N ' ' OG ' ' A' ' 89' ' ' SER . 64.1 t0 -62.0 -38.04 87.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.464 -0.773 . . . . 0.0 110.051 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -62.94 -36.97 85.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.177 -0.952 . . . . 0.0 109.31 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.718 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 51.7 t80 -65.69 -26.97 68.01 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.305 -0.958 . . . . 0.0 108.92 177.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.693 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.6 m95 -84.73 -28.44 26.28 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 122.026 0.917 . . . . 0.0 110.021 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -58.01 -37.32 74.06 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.742 -0.599 . . . . 0.0 112.471 -176.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.5 p -65.9 -32.57 74.15 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 118.627 -1.229 . . . . 0.0 109.15 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.27 10.1 m -59.95 -48.25 82.47 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.33 1.062 . . . . 0.0 111.609 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -69.9 -36.99 75.85 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.531 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -64.22 -43.72 94.12 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.584 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.28 -51.41 66.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.919 -1.113 . . . . 0.0 111.01 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.93 -41.98 90.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.3 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.4 -45.14 92.41 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.255 -0.903 . . . . 0.0 111.851 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.8 tp -63.11 -42.3 99.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.164 -0.96 . . . . 0.0 111.789 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.461 ' HB3' ' CA ' ' A' ' 112' ' ' GLY . 21.4 tp60 -72.55 -39.98 67.05 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.641 -1.224 . . . . 0.0 108.634 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -59.24 -38.32 79.7 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -61.59 -35.72 78.63 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.315 0.579 . . . . 0.0 109.885 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -75.12 -18.61 60.2 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 109.301 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.95 0.96 45.38 Favored Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.948 -1.12 . . . . 0.0 110.737 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -98.79 95.55 7.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.75 -1.441 . . . . 0.0 109.843 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 74' ' ' LYS . 21.7 m-30 -64.72 -41.23 96.12 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.815 -0.553 . . . . 0.0 111.175 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -64.35 -50.1 69.05 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.274 -0.891 . . . . 0.0 111.831 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -62.36 -34.54 76.87 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.014 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.461 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -66.72 -47.89 65.1 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.331 -1.414 . . . . 0.0 109.733 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.491 ' HB3' HD11 ' A' ' 16' ' ' ILE . 83.5 mt -63.37 -45.0 93.17 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.263 -1.139 . . . . 0.0 111.989 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.493 HG13 ' N ' ' A' ' 115' ' ' ASP . 11.9 p -67.25 -44.9 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.943 -1.098 . . . . 0.0 110.908 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.493 ' N ' HG13 ' A' ' 114' ' ' VAL . 13.4 m-20 -64.94 -37.34 87.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 110.38 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.31 -42.77 99.14 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.41 -43.93 97.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.331 -1.099 . . . . 0.0 109.882 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -57.67 -51.73 68.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.045 -1.034 . . . . 0.0 110.165 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -62.6 -43.09 99.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.222 -0.924 . . . . 0.0 109.172 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.91 -45.36 86.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.463 -0.773 . . . . 0.0 109.998 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.26 -42.62 99.24 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.0 mtt -66.33 -45.55 79.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.959 -1.318 . . . . 0.0 109.651 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.718 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -63.75 -44.67 92.78 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.522 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 42.0 mt -62.3 -39.78 94.12 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.95 -34.67 63.47 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.355 -0.841 . . . . 0.0 110.716 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -62.94 -41.67 99.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.118 -0.989 . . . . 0.0 109.886 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -78.01 -36.69 48.46 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.392 -0.817 . . . . 0.0 110.252 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -127.87 94.43 37.1 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.393 -0.817 . . . . 0.0 109.527 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.76 143.7 62.55 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 123.882 1.464 . . . . 0.0 110.266 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 44.5 t90 -72.41 130.46 40.77 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.306 -0.871 . . . . 0.0 111.264 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 97.6 mttt -109.02 153.03 24.19 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.71 -32.74 71.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.79 -1.194 . . . . 0.0 111.564 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -88.62 8.49 28.19 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.053 -1.059 . . . . 0.0 110.733 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.477 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 65.9 t0 -42.86 137.3 2.36 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.89 0.852 . . . . 0.0 111.538 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.545 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -107.62 133.08 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 121.488 -0.758 . . . . 0.0 111.381 -178.327 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -112.39 99.55 8.09 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.327 -0.858 . . . . 0.0 109.306 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -98.51 -15.55 19.52 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.826 -1.171 . . . . 0.0 111.541 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.535 HD23 ' HD2' ' A' ' 32' ' ' ARG . 3.1 mp -94.98 144.17 27.35 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.235 -0.916 . . . . 0.0 110.47 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -72.55 169.71 21.16 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.665 1.35 . . . . 0.0 109.222 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.481 ' OD1' HG22 ' A' ' 20' ' ' ILE . 65.4 m-80 -110.02 8.73 24.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.839 -1.163 . . . . 0.0 110.322 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.1 p -67.22 166.57 13.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.071 -1.018 . . . . 0.0 111.316 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.51 HD11 ' CG2' ' A' ' 16' ' ' ILE . 96.4 mt -90.04 136.45 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.59 -0.694 . . . . 0.0 110.395 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.1 m -88.99 137.12 32.6 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.143 -0.973 . . . . 0.0 109.617 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -133.1 147.26 52.15 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.117 -0.989 . . . . 0.0 110.695 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.43 0 CA-C-O 117.86 -1.522 . . . . 0.0 109.892 -179.502 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 14' ' ' LYS . . . -52.43 -39.26 60.81 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.691 -1.255 . . . . 0.0 109.871 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.84 -42.25 90.72 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.679 -0.638 . . . . 0.0 111.404 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.407 ' HB3' ' HD2' ' A' ' 110' ' ' LYS . 90.6 mt-10 -70.7 -44.21 67.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.923 -1.111 . . . . 0.0 110.174 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.499 ' O ' HG23 ' A' ' 17' ' ' VAL . 96.2 mt-10 -67.17 -33.45 75.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.011 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 86.9 tttt -64.59 -45.67 85.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.682 -1.261 . . . . 0.0 110.306 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.77 -42.7 94.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.023 -1.048 . . . . 0.0 111.501 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.722 HG13 HG22 ' A' ' 114' ' ' VAL . 19.3 tt -67.15 -37.56 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.777 -1.202 . . . . 0.0 110.977 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 13' ' ' GLU . 68.4 t -64.36 -41.22 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -61.62 -37.32 83.54 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.211 -0.996 . . . . 0.0 108.648 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.23 87.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.435 -0.79 . . . . 0.0 109.845 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 17' ' ' VAL . 95.1 mt -63.81 -42.87 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.153 -0.967 . . . . 0.0 110.001 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -60.35 -42.04 94.89 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.788 0.804 . . . . 0.0 110.299 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -65.12 -36.78 85.35 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.249 -0.581 . . . . 0.0 110.162 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.22 95.49 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.108 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.78 -14.58 33.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.056 -1.028 . . . . 0.0 110.519 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.468 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.7 mttt -93.42 -0.21 56.58 Favored 'General case' 0 C--N 1.309 -1.17 0 O-C-N 121.046 -1.034 . . . . 0.0 109.257 176.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -113.04 -13.74 13.05 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 120.835 -1.165 . . . . 0.0 110.608 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 t -153.33 160.3 42.66 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.915 -1.116 . . . . 0.0 110.105 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.1 p -90.91 -10.35 42.82 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.175 -0.953 . . . . 0.0 109.857 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.0 172.35 40.6 Favored Glycine 0 N--CA 1.481 1.685 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.492 ' HB3' HD22 ' A' ' 138' ' ' LEU . 54.3 mp0 -131.61 134.85 46.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.225 -1.162 . . . . 0.0 112.163 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.8 mt -120.84 133.76 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.746 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.1 ttm-85 -138.67 159.19 42.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.958 -1.089 . . . . 0.0 109.677 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 143' ' ' SER . 3.5 p -128.31 137.91 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.405 -0.809 . . . . 0.0 110.743 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -121.2 125.14 46.41 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.503 HD11 ' CG1' ' A' ' 71' ' ' VAL . 40.0 tp -110.92 131.14 55.3 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.892 0.854 . . . . 0.0 111.449 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.426 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 76.9 tt0 -147.78 165.34 30.85 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.655 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.7 mttt -79.77 -74.85 0.28 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 112.956 -177.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.8 t -139.36 156.27 47.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.109 -0.995 . . . . 0.0 110.367 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.552 ' HB2' ' CD ' ' A' ' 46' ' ' ARG . 5.9 p -104.27 166.97 10.06 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.701 -0.624 . . . . 0.0 111.198 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -106.67 -8.04 17.07 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.391 -0.818 . . . . 0.0 110.347 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 42' ' ' ASP . 34.3 pt -129.15 -122.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.912 -1.118 . . . . 0.0 110.487 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.414 ' N ' HG13 ' A' ' 41' ' ' ILE . 93.9 m-20 -111.72 137.33 49.77 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.057 -1.652 . . . . 0.0 110.065 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.3 t -63.23 -43.38 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.284 -0.885 . . . . 0.0 111.624 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -59.76 -45.61 91.72 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.763 -1.211 . . . . 0.0 110.094 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -67.26 -39.73 86.12 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.659 -1.276 . . . . 0.0 109.135 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.552 ' CD ' ' HB2' ' A' ' 39' ' ' SER . 77.6 mtp85 -62.24 -45.3 93.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.956 -1.09 . . . . 0.0 110.767 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.58 95.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.969 -1.082 . . . . 0.0 110.416 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.8 ttp -62.91 -43.13 99.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.013 -1.054 . . . . 0.0 109.507 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -65.5 -46.37 79.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.953 -1.092 . . . . 0.0 110.16 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.9 t -65.95 -44.42 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.032 -1.043 . . . . 0.0 110.422 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.433 ' C ' ' CD1' ' A' ' 51' ' ' PHE . 6.5 t80 -57.12 -49.52 75.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.984 -1.073 . . . . 0.0 109.259 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -72.86 -35.59 67.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.967 -1.083 . . . . 0.0 109.413 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -60.47 -39.98 89.58 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.394 -0.816 . . . . 0.0 108.988 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.0 mt -79.23 4.35 15.25 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.624 -0.673 . . . . 0.0 110.081 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 56.48 32.73 21.28 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 121.187 -0.946 . . . . 0.0 111.297 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 94.4 mmm -66.39 -11.68 52.77 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.914 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -79.5 -1.61 38.38 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.771 -1.205 . . . . 0.0 109.89 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -78.28 65.68 3.68 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.032 -1.043 . . . . 0.0 109.603 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.48 HG22 HD11 ' A' ' 138' ' ' LEU . 78.4 p -135.08 150.05 50.18 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -64.05 -43.06 96.68 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.601 -0.687 . . . . 0.0 112.123 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 98.2 mt -96.59 0.15 49.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.789 -1.194 . . . . 0.0 111.502 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 87.8 mt-30 57.26 46.15 19.12 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.497 1.141 . . . . 0.0 111.273 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -120.21 52.85 1.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.094 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.81 138.79 14.09 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.63 HG22 ' HA2' ' A' ' 80' ' ' GLY . 61.2 t -125.54 135.89 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.162 -1.199 . . . . 0.0 110.952 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.1 tp -116.5 125.97 52.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.527 -0.733 . . . . 0.0 109.712 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.0 mt -101.85 106.25 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.118 -1.033 . . . . 0.0 109.389 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -91.89 123.04 34.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.326 -0.859 . . . . 0.0 110.021 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 79.2 t -123.63 130.38 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.494 -0.754 . . . . 0.0 111.003 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.52 108.92 20.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.722 -0.611 . . . . 0.0 109.373 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.655 HG22 ' HA ' ' A' ' 37' ' ' LYS . 22.8 m -76.11 -19.56 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.891 -1.13 . . . . 0.0 111.56 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.402 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 79.0 mm-40 -69.66 -46.98 64.88 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.656 -1.278 . . . . 0.0 109.259 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -101.78 1.5 37.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.488 -0.757 . . . . 0.0 110.936 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.2 tttt 56.67 47.53 18.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.844 -1.16 . . . . 0.0 110.748 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.8 m -118.22 129.37 55.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.075 -1.016 . . . . 0.0 109.823 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -112.29 138.84 48.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.691 -0.63 . . . . 0.0 110.459 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.14 137.19 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.331 -0.856 . . . . 0.0 109.002 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.68 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 77.6 mt -113.89 128.62 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.933 -1.104 . . . . 0.0 110.398 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -132.56 116.55 16.85 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.535 -0.728 . . . . 0.0 110.78 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.63 ' HA2' HG22 ' A' ' 65' ' ' VAL . . . -100.38 168.98 21.19 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -80.53 178.49 8.29 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.771 -0.841 . . . . 0.0 110.227 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.05 -28.83 70.36 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.218 -0.926 . . . . 0.0 111.166 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -65.66 -54.06 27.89 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.204 -0.998 . . . . 0.0 110.643 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.995 ' O ' HG22 ' A' ' 88' ' ' VAL . 97.3 mt -63.7 -46.89 93.4 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.733 0 O-C-N 120.926 -1.338 . . . . 0.0 107.663 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.83 -38.37 85.22 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.785 -1.197 . . . . 0.0 111.558 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -70.99 -24.89 62.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.035 -1.041 . . . . 0.0 112.238 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.877 HG23 HG13 ' A' ' 88' ' ' VAL . 18.0 m -104.75 -17.14 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.71 -1.244 . . . . 0.0 112.411 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.995 HG22 ' O ' ' A' ' 84' ' ' ILE . 18.4 m -117.73 163.75 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 120.415 -1.428 . . . . 0.0 111.382 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.2 p -109.76 172.56 6.79 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.718 0.771 . . . . 0.0 112.581 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -59.15 -37.26 76.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.424 -0.798 . . . . 0.0 109.398 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -61.21 -39.89 91.93 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.085 -1.009 . . . . 0.0 109.031 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.822 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 69.1 t80 -64.48 -25.33 67.95 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.195 -0.941 . . . . 0.0 109.229 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.68 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.7 m95 -86.99 -26.66 23.67 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.651 0.739 . . . . 0.0 111.183 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -58.48 -34.67 71.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.397 -0.814 . . . . 0.0 112.026 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.9 m -66.16 -32.78 74.42 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.003 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.501 HG22 HD13 ' A' ' 78' ' ' ILE 0.277 9.0 m -60.68 -49.49 77.28 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 122.325 1.059 . . . . 0.0 111.63 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -68.41 -38.08 80.94 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.146 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -64.31 -45.95 85.69 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.491 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.73 -50.56 71.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.884 -1.135 . . . . 0.0 111.707 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.519 HD12 HD11 ' A' ' 78' ' ' ILE . 96.5 mt -65.66 -41.64 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.913 -1.117 . . . . 0.0 109.165 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -64.01 -41.5 97.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.595 -0.691 . . . . 0.0 111.227 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.57 -42.09 99.34 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.156 -0.965 . . . . 0.0 111.331 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.479 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 96.4 mm-40 -75.71 -41.46 53.5 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.964 -1.095 . . . . 0.0 108.925 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -59.25 -40.9 87.43 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -59.33 -35.98 74.82 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.477 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -77.81 -15.52 59.02 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.046 -1.034 . . . . 0.0 109.901 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.05 3.68 48.36 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.784 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -101.92 91.32 4.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.686 -1.479 . . . . 0.0 110.491 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -61.02 -46.03 92.4 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.343 -0.848 . . . . 0.0 111.556 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.407 ' HD2' ' HB3' ' A' ' 12' ' ' GLU . 62.4 tttm -62.65 -48.24 80.23 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 112.919 -178.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -61.77 -38.03 86.49 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 118.549 -1.26 . . . . 0.0 109.467 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.479 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -64.94 -46.05 90.53 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.7 mt -63.68 -45.47 89.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.31 -1.112 . . . . 0.0 110.747 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.722 HG22 HG13 ' A' ' 16' ' ' ILE . 95.5 t -66.88 -46.77 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.012 -1.055 . . . . 0.0 110.816 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -64.76 -38.95 92.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.012 -1.055 . . . . 0.0 110.203 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.44 -42.33 97.64 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.1 mt -63.97 -44.07 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -1.142 . . . . 0.0 109.837 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -60.12 -46.73 88.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.088 -1.008 . . . . 0.0 109.455 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -63.53 -41.83 98.46 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.188 -1.005 . . . . 0.0 108.587 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -59.13 -42.66 91.14 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.836 -0.745 . . . . 0.0 109.539 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.66 -44.12 96.89 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 57.5 ttm -67.58 -48.5 66.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.135 -1.214 . . . . 0.0 109.935 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.822 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -61.72 -46.13 90.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.953 -1.092 . . . . 0.0 109.276 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.407 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 88.3 mt -62.69 -39.34 93.68 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.511 -0.743 . . . . 0.0 109.054 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.44 -34.67 61.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.244 -0.91 . . . . 0.0 110.459 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -61.38 -39.96 92.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.03 -1.044 . . . . 0.0 109.183 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -80.2 -31.97 38.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.884 . . . . 0.0 109.468 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -132.54 93.12 25.58 Favored Pre-proline 0 N--CA 1.485 1.296 0 O-C-N 121.532 -0.73 . . . . 0.0 109.956 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.64 146.48 73.49 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.816 1.429 . . . . 0.0 109.457 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.468 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 64.3 t90 -71.26 132.11 44.46 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.157 -0.965 . . . . 0.0 110.951 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -110.13 147.52 33.52 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -55.79 -28.45 56.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.054 -1.029 . . . . 0.0 110.878 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 40.7 p-10 -92.91 9.25 36.26 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.027 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.416 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 61.1 t0 -42.55 135.85 2.65 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.882 0.848 . . . . 0.0 111.163 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.715 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -113.32 141.91 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.578 0.704 . . . . 0.0 111.247 -177.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -98.75 93.17 5.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.994 -1.066 . . . . 0.0 110.172 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.541 ' C ' HD12 ' A' ' 138' ' ' LEU . 99.7 mt-10 -68.2 -39.45 82.44 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.904 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.541 HD12 ' C ' ' A' ' 137' ' ' GLU . 11.1 mp -105.77 151.04 39.82 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.204 -0.935 . . . . 0.0 110.737 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -75.45 -174.15 1.88 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.639 1.336 . . . . 0.0 108.763 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -118.64 3.61 11.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.575 -1.328 . . . . 0.0 110.03 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.9 m -60.96 137.08 58.25 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.852 -1.155 . . . . 0.0 110.835 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.4 mt -67.34 136.69 26.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.698 -0.626 . . . . 0.0 110.175 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 3.5 m -92.97 134.08 35.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.401 -0.812 . . . . 0.0 109.244 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -132.9 149.6 52.23 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -0.936 . . . . 0.0 109.898 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 CA-C-O 117.908 -1.496 . . . . 0.0 109.844 -179.605 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 121.09 0.472 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 14' ' ' LYS . . . -52.53 -40.51 62.54 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.939 -1.101 . . . . 0.0 109.555 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.01 -46.91 87.13 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.529 -0.732 . . . . 0.0 110.401 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.67 -46.27 66.47 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.035 -1.041 . . . . 0.0 111.125 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.503 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.6 mt-10 -63.03 -37.94 89.21 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.124 -0.985 . . . . 0.0 109.917 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 87.8 tttt -63.64 -44.72 93.01 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.442 -0.786 . . . . 0.0 111.239 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.18 -42.65 93.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.956 -1.09 . . . . 0.0 111.375 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.651 HG13 HG22 ' A' ' 114' ' ' VAL . 18.4 tt -67.81 -37.53 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.701 -1.249 . . . . 0.0 110.351 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.609 ' HA ' HD12 ' A' ' 20' ' ' ILE . 46.9 t -62.68 -42.68 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -61.77 -37.88 85.93 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.574 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.03 -36.58 79.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.334 -0.854 . . . . 0.0 109.188 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.879 HG22 ' OD1' ' A' ' 140' ' ' ASN . 96.7 mt -64.25 -43.66 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.363 -0.836 . . . . 0.0 109.696 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -58.78 -41.57 86.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.245 -0.909 . . . . 0.0 109.921 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -64.65 -37.53 87.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.501 -0.75 . . . . 0.0 111.664 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.45 ' O ' HG22 ' A' ' 27' ' ' THR . . . -64.92 -39.99 94.36 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.831 -1.168 . . . . 0.0 110.021 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -60.53 -15.59 28.96 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.062 -1.024 . . . . 0.0 111.097 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.6 mttt -92.93 -6.23 49.01 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.16 -0.962 . . . . 0.0 109.006 177.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -105.72 -13.72 15.47 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 121.085 -1.009 . . . . 0.0 109.742 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 23' ' ' ALA . 4.5 t -151.55 156.93 41.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.026 -1.046 . . . . 0.0 110.318 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.4 t -86.6 -6.9 58.75 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.354 -0.841 . . . . 0.0 109.019 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.86 173.31 50.26 Favored Glycine 0 N--CA 1.481 1.64 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.42 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 52.5 mp0 -132.35 137.4 47.37 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.147 -1.208 . . . . 0.0 111.677 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 82.4 mt -119.57 134.14 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.682 -0.636 . . . . 0.0 110.293 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HB3' ' CE ' ' A' ' 56' ' ' MET . 75.2 ttt180 -139.73 153.07 47.11 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.054 -1.029 . . . . 0.0 109.906 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.608 HG22 ' HB ' ' A' ' 67' ' ' ILE . 55.8 t -123.53 140.08 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.366 -0.834 . . . . 0.0 111.134 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.465 ' HB2' HD11 ' A' ' 66' ' ' LEU . 64.2 t60 -122.86 133.14 54.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.577 -0.702 . . . . 0.0 109.146 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.646 HD11 HG13 ' A' ' 71' ' ' VAL . 40.6 tp -123.89 136.43 54.35 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.099 0.952 . . . . 0.0 112.086 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.45 ' HG2' ' NH2' ' A' ' 46' ' ' ARG . 48.5 tp10 -151.63 161.95 41.81 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.545 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.1 mttt -73.38 -72.5 0.25 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.929 -1.107 . . . . 0.0 112.417 -177.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 t -142.79 158.03 44.04 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.434 -0.791 . . . . 0.0 109.524 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.425 ' OG ' ' CD ' ' A' ' 46' ' ' ARG . 69.5 m -108.2 172.23 6.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.345 -0.847 . . . . 0.0 111.264 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -107.63 -21.3 12.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.559 -0.713 . . . . 0.0 110.531 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.9 pt -116.88 -121.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.009 -1.057 . . . . 0.0 110.762 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -109.38 132.75 53.84 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.637 -1.289 . . . . 0.0 109.332 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.8 t -62.4 -43.76 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.75 -0.594 . . . . 0.0 111.471 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -59.79 -47.93 83.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.892 -1.13 . . . . 0.0 109.537 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -67.71 -35.64 79.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.943 -1.098 . . . . 0.0 108.246 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.518 ' NH1' HG21 ' A' ' 50' ' ' VAL . 76.0 ttt-85 -64.5 -43.2 94.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 111.414 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.24 -36.86 85.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.749 -1.219 . . . . 0.0 109.985 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.5 ttp -61.21 -42.93 99.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 109.059 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -63.72 -46.77 83.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.004 -1.06 . . . . 0.0 110.249 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.518 HG21 ' NH1' ' A' ' 46' ' ' ARG . 71.8 t -64.85 -43.84 96.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.33 -0.856 . . . . 0.0 109.882 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -59.23 -49.37 78.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.057 -1.027 . . . . 0.0 109.666 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -71.43 -35.82 71.06 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.363 -0.835 . . . . 0.0 109.226 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -62.22 -37.72 86.46 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.266 -0.897 . . . . 0.0 109.327 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.0 mt -82.43 3.93 26.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.914 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.2 tttt 54.86 34.8 22.85 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.137 -0.977 . . . . 0.0 111.483 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.821 ' SD ' HD13 ' A' ' 66' ' ' LEU . 94.2 mtp -66.78 -11.44 55.06 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.901 -1.124 . . . . 0.0 110.206 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 44.7 p-10 -77.25 -0.84 26.81 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.94 -1.1 . . . . 0.0 109.927 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -78.54 64.62 3.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.387 -0.821 . . . . 0.0 110.687 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.4 p -135.14 150.3 50.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.21 -0.931 . . . . 0.0 108.951 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.62 -44.54 96.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.283 -0.886 . . . . 0.0 112.707 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 90.6 mt -97.14 1.59 50.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.95 -1.094 . . . . 0.0 111.725 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 85.2 mt-30 57.13 38.43 29.01 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.284 1.04 . . . . 0.0 110.913 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.531 ' C ' HD11 ' A' ' 84' ' ' ILE . 99.3 m-20 -112.67 55.21 0.7 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.543 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.404 ' O ' ' CD1' ' A' ' 84' ' ' ILE . . . -101.71 141.16 15.19 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 178.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.474 ' CG2' HD13 ' A' ' 84' ' ' ILE . 49.9 t -124.29 134.72 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.143 -1.21 . . . . 0.0 110.162 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.821 HD13 ' SD ' ' A' ' 56' ' ' MET . 52.2 tp -117.89 129.33 55.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.515 -0.741 . . . . 0.0 110.658 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.608 ' HB ' HG22 ' A' ' 33' ' ' VAL . 97.1 mt -107.64 110.18 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.905 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.435 ' OH ' ' NH2' ' A' ' 46' ' ' ARG . 33.8 t80 -96.71 125.42 41.15 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.189 -0.944 . . . . 0.0 110.318 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.507 ' O ' HD12 ' A' ' 35' ' ' LEU . 55.3 t -125.59 131.73 71.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-O 122.139 0.971 . . . . 0.0 111.165 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.469 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -98.71 108.92 21.73 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.646 HG13 HD11 ' A' ' 35' ' ' LEU . 32.8 m -74.65 -19.37 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.052 -1.03 . . . . 0.0 110.078 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -69.46 -43.45 73.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.075 -1.015 . . . . 0.0 109.336 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -104.22 4.98 34.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.006 -1.059 . . . . 0.0 111.15 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 67.5 tttt 56.06 47.4 19.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.831 -1.168 . . . . 0.0 110.64 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.469 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 22.2 p -123.23 167.61 13.51 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.183 -0.948 . . . . 0.0 110.355 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -147.83 140.84 24.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.555 -0.715 . . . . 0.0 109.993 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 68.7 t -128.38 138.39 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.727 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 79.4 mt -113.62 124.76 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.971 -1.08 . . . . 0.0 110.492 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -130.38 113.75 14.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.504 -0.747 . . . . 0.0 109.717 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.94 170.5 21.82 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -77.35 174.21 11.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.483 -1.01 . . . . 0.0 110.223 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -58.87 -27.81 65.54 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.326 -0.859 . . . . 0.0 110.244 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.491 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -64.78 -50.49 58.2 Favored Glycine 0 N--CA 1.487 2.065 0 C-N-CA 119.687 -1.245 . . . . 0.0 109.99 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.96 ' O ' HG22 ' A' ' 88' ' ' VAL . 4.2 mt -63.54 -46.9 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.835 -1.391 . . . . 0.0 108.552 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -63.26 -33.66 75.98 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.529 -0.732 . . . . 0.0 112.058 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -76.74 -22.98 53.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.739 -1.226 . . . . 0.0 112.532 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.086 HG23 HG13 ' A' ' 88' ' ' VAL . 25.9 m -103.99 -17.85 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.757 -1.214 . . . . 0.0 112.08 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.086 HG13 HG23 ' A' ' 87' ' ' VAL . 4.5 m -120.25 159.52 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.966 -1.084 . . . . 0.0 111.591 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.9 p -104.65 177.25 4.9 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.881 0.848 . . . . 0.0 112.084 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -64.21 -38.74 92.14 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.59 -0.694 . . . . 0.0 109.246 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -60.83 -38.52 85.73 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.877 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 75.2 t80 -64.33 -26.26 68.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -0.941 . . . . 0.0 108.83 177.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.727 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.4 m95 -85.71 -26.68 25.78 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.924 0.869 . . . . 0.0 110.216 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -56.88 -41.13 77.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 112.538 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.2 p -63.19 -31.44 72.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.658 -1.276 . . . . 0.0 109.298 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.281 7.6 m -59.47 -48.35 82.0 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.433 1.111 . . . . 0.0 111.146 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -70.12 -37.17 75.25 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.124 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -63.47 -44.73 93.59 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.177 -1.009 . . . . 0.0 110.883 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.64 -49.03 76.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.743 -1.223 . . . . 0.0 110.881 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.1 -42.3 91.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.176 -0.952 . . . . 0.0 110.059 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -63.38 -43.51 97.41 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.677 -0.64 . . . . 0.0 111.701 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.8 mt -63.96 -43.13 96.74 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.722 -1.236 . . . . 0.0 112.256 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.481 ' HG2' ' N ' ' A' ' 112' ' ' GLY . 5.2 tp-100 -72.36 -42.53 65.2 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.666 -1.214 . . . . 0.0 108.72 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -58.5 -39.57 80.42 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.81 -32.16 72.45 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.622 -0.674 . . . . 0.0 109.887 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -80.95 -19.02 45.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.085 -1.01 . . . . 0.0 110.238 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.27 5.87 36.95 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.045 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.407 ' HB2' ' HG3' ' A' ' 103' ' ' GLN . 95.8 m-20 -105.87 89.85 3.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.833 -1.392 . . . . 0.0 110.253 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -63.65 -41.45 98.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.725 -0.609 . . . . 0.0 111.672 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.615 ' O ' HG23 ' A' ' 114' ' ' VAL . 78.5 tttt -62.56 -48.11 80.92 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.888 -1.133 . . . . 0.0 111.721 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.47 ' HB2' ' HG2' ' A' ' 103' ' ' GLN . 88.4 mt-30 -64.41 -37.91 89.19 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.636 -177.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.481 ' N ' ' HG2' ' A' ' 103' ' ' GLN . . . -67.37 -46.32 71.6 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.86 -43.25 93.59 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.533 -0.98 . . . . 0.0 110.48 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.651 HG22 HG13 ' A' ' 16' ' ' ILE . 96.6 t -66.42 -47.13 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.393 -0.817 . . . . 0.0 109.996 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -62.9 -40.57 97.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.247 -0.908 . . . . 0.0 109.164 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.74 -43.51 96.37 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.3 mt -63.55 -43.4 98.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -1.105 . . . . 0.0 110.062 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -60.86 -48.27 82.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.023 -1.048 . . . . 0.0 110.484 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.33 -43.65 97.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.012 -1.055 . . . . 0.0 109.487 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.09 -41.44 83.49 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.388 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.04 -45.61 91.57 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 95.6 mtp -66.16 -46.48 77.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.903 -1.351 . . . . 0.0 109.934 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.877 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -62.06 -46.9 87.09 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.602 -0.686 . . . . 0.0 109.725 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.86 -38.63 91.79 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.449 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.84 -35.12 61.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.868 -1.145 . . . . 0.0 110.273 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.91 -43.95 97.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.144 -0.972 . . . . 0.0 109.047 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -72.49 -39.89 67.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.67 -0.644 . . . . 0.0 109.654 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.421 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 36.7 m-85 -131.4 96.73 20.79 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.485 -0.759 . . . . 0.0 110.505 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 128' ' ' PHE . 43.1 Cg_endo -66.38 150.32 84.48 Favored 'Trans proline' 0 C--N 1.317 -1.124 0 O-C-N 123.739 1.389 . . . . 0.0 110.735 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.475 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 29.4 t90 -73.32 164.1 27.15 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.643 0.735 . . . . 0.0 110.358 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -145.23 153.37 41.26 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.62 -30.83 70.1 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 111.736 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -90.71 8.24 35.51 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 118.926 -1.109 . . . . 0.0 111.224 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -41.95 138.43 1.54 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.632 0.73 . . . . 0.0 111.551 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.772 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.3 pp -113.32 147.65 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 121.542 0.687 . . . . 0.0 110.737 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -102.25 92.78 4.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.689 -1.257 . . . . 0.0 109.358 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.549 ' HG2' HD13 ' A' ' 135' ' ' ILE . 80.3 mm-40 -66.26 -41.05 90.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.725 -0.61 . . . . 0.0 111.749 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.42 ' HB2' ' HG2' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -106.86 151.93 40.74 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.151 -0.968 . . . . 0.0 111.163 -178.872 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.85 -172.26 0.93 Allowed 'Trans proline' 0 C--N 1.315 -1.233 0 N-CA-C 108.762 -1.284 . . . . 0.0 108.762 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.879 ' OD1' HG22 ' A' ' 20' ' ' ILE . 69.4 m-80 -121.42 2.76 10.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.687 -1.258 . . . . 0.0 110.073 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.6 p -63.85 173.55 1.76 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -0.913 . . . . 0.0 111.333 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 89.4 mt -101.96 136.14 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.547 0.689 . . . . 0.0 110.779 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.8 t -94.05 136.53 34.25 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.449 -0.782 . . . . 0.0 109.353 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -130.09 138.57 50.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 0.0 110.478 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.081 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.744 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.53 -30.77 21.69 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.892 -1.13 . . . . 0.0 110.059 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -72.27 -36.04 68.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.159 -0.963 . . . . 0.0 110.054 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 110' ' ' LYS . 92.7 mt-10 -61.92 -40.78 96.65 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.956 -1.097 . . . . 0.0 108.729 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.658 ' O ' HG23 ' A' ' 17' ' ' VAL . 92.2 mt-10 -61.14 -38.44 86.42 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.729 -0.607 . . . . 0.0 110.178 178.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -60.52 -41.92 95.39 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.514 -0.875 . . . . 0.0 110.431 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.14 78.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.006 -1.059 . . . . 0.0 112.329 -178.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.524 HG13 HG22 ' A' ' 114' ' ' VAL . 16.2 tt -66.53 -31.74 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.59 -1.318 . . . . 0.0 110.215 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 13' ' ' GLU . 55.9 t -64.63 -40.58 89.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -63.97 -35.94 82.34 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.606 -0.837 . . . . 0.0 109.174 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.45 -39.46 93.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.38 -0.825 . . . . 0.0 109.12 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.729 HG22 ' OD1' ' A' ' 140' ' ' ASN . 97.1 mt -64.56 -43.32 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.835 . . . . 0.0 109.862 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -60.78 -41.96 96.57 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.131 -0.981 . . . . 0.0 110.199 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -65.96 -38.22 88.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.512 -0.742 . . . . 0.0 111.147 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.96 -40.41 96.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.859 -1.151 . . . . 0.0 109.956 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.67 -15.59 30.36 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.061 -1.024 . . . . 0.0 110.866 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.474 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 75.4 mmtt -93.8 1.01 56.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.089 -1.007 . . . . 0.0 109.27 177.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -114.81 -14.08 11.97 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.802 -1.186 . . . . 0.0 109.934 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.6 t -151.74 154.52 36.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.875 -1.14 . . . . 0.0 109.753 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 m -84.56 -6.74 59.39 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.291 -0.881 . . . . 0.0 109.805 178.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.9 174.58 54.27 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.775 ' HG2' HD22 ' A' ' 138' ' ' LEU . 51.3 tp10 -133.31 138.2 46.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.272 -1.134 . . . . 0.0 111.665 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 93.5 mt -118.46 134.5 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.712 -0.617 . . . . 0.0 109.835 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.419 ' NE ' ' OG ' ' A' ' 143' ' ' SER . 76.2 ttt180 -139.87 152.17 46.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.89 . . . . 0.0 109.852 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.64 HG22 ' HB ' ' A' ' 67' ' ' ILE . 53.7 t -124.5 140.61 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.368 -0.832 . . . . 0.0 111.464 -178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -125.87 128.3 47.38 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.521 0.677 . . . . 0.0 109.434 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.985 HD11 ' CG1' ' A' ' 71' ' ' VAL . 37.8 tp -118.67 129.84 55.51 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.946 0.879 . . . . 0.0 112.572 -177.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.408 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 84.7 tt0 -145.35 168.09 21.32 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.408 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 98.7 mttt -79.23 -73.6 0.33 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.977 -1.077 . . . . 0.0 112.961 -177.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 t -143.26 158.81 43.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.265 -0.897 . . . . 0.0 110.141 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.425 ' HB3' ' HD3' ' A' ' 46' ' ' ARG . 14.9 p -108.95 171.86 7.19 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.251 -0.906 . . . . 0.0 111.152 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -106.58 -10.68 16.11 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.479 -0.763 . . . . 0.0 110.425 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 42' ' ' ASP . 25.7 pt -125.57 -121.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 120.985 -1.072 . . . . 0.0 109.631 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.402 ' N ' HG13 ' A' ' 41' ' ' ILE . 64.2 m-20 -111.76 138.62 48.1 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 120.393 -1.442 . . . . 0.0 109.017 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 85.2 t -64.28 -43.31 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 111.412 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -59.36 -47.29 85.97 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.95 -1.094 . . . . 0.0 110.778 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -71.34 -38.18 71.66 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.88 -1.137 . . . . 0.0 108.42 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.425 ' HD3' ' HB3' ' A' ' 39' ' ' SER . 79.8 ttt180 -63.54 -40.67 97.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.467 -0.77 . . . . 0.0 110.082 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.44 -38.15 84.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.694 -1.254 . . . . 0.0 110.127 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.4 ttp -62.09 -44.22 97.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.969 -1.082 . . . . 0.0 109.901 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -63.35 -44.64 94.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.082 -1.011 . . . . 0.0 109.571 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 46' ' ' ARG . 95.7 t -65.81 -43.72 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.586 -0.696 . . . . 0.0 110.088 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.474 ' CE2' ' OD1' ' A' ' 57' ' ' ASP . 71.4 t80 -58.66 -45.95 88.24 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.065 -1.022 . . . . 0.0 109.435 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -73.07 -35.77 66.72 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.849 -1.157 . . . . 0.0 109.558 178.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -60.79 -37.34 81.6 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.025 -1.047 . . . . 0.0 109.955 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.3 mt -82.08 5.72 18.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.098 -1.001 . . . . 0.0 110.308 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.423 ' HB3' ' ND2' ' A' ' 58' ' ' ASN . 98.6 mttt 54.78 34.65 22.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.793 -1.192 . . . . 0.0 111.43 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.691 ' SD ' HD13 ' A' ' 66' ' ' LEU . 93.4 mtp -67.05 -12.47 60.01 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.957 -1.097 . . . . 0.0 109.641 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.474 ' OD1' ' CE2' ' A' ' 51' ' ' PHE . 92.3 m-20 -75.09 -2.13 26.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.664 -1.272 . . . . 0.0 109.9 177.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.423 ' ND2' ' HB3' ' A' ' 55' ' ' LYS . 64.9 m-20 -74.2 61.37 0.86 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.828 -1.17 . . . . 0.0 109.937 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.4 m -132.47 144.17 50.28 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.162 -0.961 . . . . 0.0 108.875 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.31 -42.81 99.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.821 -0.549 . . . . 0.0 112.405 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.5 mt -98.51 2.4 47.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.101 -0.999 . . . . 0.0 111.595 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 55.87 36.54 27.49 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.076 0.941 . . . . 0.0 111.542 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.496 ' C ' HD11 ' A' ' 84' ' ' ILE . 97.7 m-20 -113.13 50.2 0.9 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.338 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.68 142.53 16.15 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.762 -2.135 . . . . 0.0 107.762 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.457 HG22 HD13 ' A' ' 84' ' ' ILE . 54.9 t -123.73 133.91 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.103 -1.234 . . . . 0.0 109.924 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.691 HD13 ' SD ' ' A' ' 56' ' ' MET . 44.5 tp -116.37 129.05 56.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 110.536 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.64 ' HB ' HG22 ' A' ' 33' ' ' VAL . 78.0 mt -107.65 108.93 26.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.369 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -95.59 125.4 40.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -0.853 . . . . 0.0 109.913 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.568 HG21 HD21 ' A' ' 113' ' ' LEU . 54.7 t -122.4 133.23 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.095 0.95 . . . . 0.0 110.769 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.595 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -101.48 91.59 4.53 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.985 ' CG1' HD11 ' A' ' 35' ' ' LEU . 26.0 m -64.54 -23.71 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.018 -1.051 . . . . 0.0 110.892 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 37.9 tp10 -67.61 -44.18 78.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.062 -1.024 . . . . 0.0 108.741 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.647 ' O ' HG23 ' A' ' 75' ' ' THR . 87.0 m-20 -101.5 8.89 41.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.371 -0.83 . . . . 0.0 110.982 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.4 tttt 51.49 41.47 28.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.909 -1.119 . . . . 0.0 110.42 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 73' ' ' ASP . 81.2 p -121.32 169.43 10.6 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.226 -0.921 . . . . 0.0 109.529 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -151.24 145.3 25.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.758 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.1 t -132.06 135.97 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.659 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 76.4 mt -112.86 123.34 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.758 -1.214 . . . . 0.0 110.533 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -129.32 111.65 13.06 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.472 -0.767 . . . . 0.0 110.797 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -98.34 173.47 27.48 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -76.57 173.28 11.75 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.587 -0.949 . . . . 0.0 109.66 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.81 -22.94 62.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.893 . . . . 0.0 110.815 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.94 -50.6 45.82 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.825 -1.179 . . . . 0.0 110.523 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.954 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.7 mt -64.25 -46.92 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.886 -1.361 . . . . 0.0 108.655 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -61.37 -37.97 85.3 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.768 -1.207 . . . . 0.0 111.949 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -72.02 -22.12 61.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.684 -1.26 . . . . 0.0 111.832 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.093 HG13 HG13 ' A' ' 88' ' ' VAL . 7.5 p -102.09 -21.62 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.967 -1.083 . . . . 0.0 113.21 -178.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.093 HG13 HG13 ' A' ' 87' ' ' VAL . 30.0 m -123.36 166.66 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.641 -1.287 . . . . 0.0 111.367 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 m -112.11 -175.56 2.71 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.271 -0.893 . . . . 0.0 113.165 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -62.44 -39.75 94.36 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.835 . . . . 0.0 110.18 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -61.64 -38.63 88.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.123 -0.985 . . . . 0.0 110.112 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.725 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 68.8 t80 -65.9 -27.69 68.39 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.204 -0.935 . . . . 0.0 109.123 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.659 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.5 m95 -86.72 -27.02 23.93 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.207 1.003 . . . . 0.0 110.278 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -55.99 -42.18 75.94 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.97 -1.081 . . . . 0.0 112.471 -176.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 88.1 m -62.95 -31.99 73.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.809 -1.182 . . . . 0.0 109.037 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.474 HG22 HD13 ' A' ' 78' ' ' ILE 0.286 8.7 m -58.88 -48.9 79.77 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.688 1.232 . . . . 0.0 110.732 179.686 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.65 -38.46 80.47 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.777 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.416 ' O ' HD23 ' A' ' 102' ' ' LEU . 11.5 m120 -63.95 -42.69 97.23 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.989 -1.084 . . . . 0.0 110.177 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.02 -49.17 78.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.292 -1.505 . . . . 0.0 110.598 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.575 HD12 HD11 ' A' ' 78' ' ' ILE . 90.9 mt -67.99 -42.48 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.15 -0.969 . . . . 0.0 110.482 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -63.08 -46.31 88.0 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.009 -1.057 . . . . 0.0 111.889 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.416 HD23 ' O ' ' A' ' 98' ' ' ASN . 3.5 mm? -64.08 -42.38 96.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.991 -1.068 . . . . 0.0 112.298 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.468 ' HB2' ' HA3' ' A' ' 112' ' ' GLY . 99.4 mm-40 -71.67 -41.38 68.78 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.923 -1.111 . . . . 0.0 109.017 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.463 ' CE1' HG23 ' A' ' 100' ' ' ILE . 4.7 m-85 -60.15 -40.09 88.65 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.08 -32.99 72.64 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.004 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -81.55 -17.64 47.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.091 -1.006 . . . . 0.0 109.503 177.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.54 11.04 29.88 Favored Glycine 0 N--CA 1.494 2.506 0 O-C-N 121.112 -0.993 . . . . 0.0 110.781 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -108.71 89.47 3.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.829 -1.395 . . . . 0.0 110.781 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -63.48 -44.22 95.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.439 -0.788 . . . . 0.0 111.577 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.404 ' HD2' ' HB3' ' A' ' 12' ' ' GLU . 61.9 tttm -62.82 -49.07 76.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.143 -0.973 . . . . 0.0 112.269 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -64.61 -38.67 91.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.054 -1.029 . . . . 0.0 110.055 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.468 ' HA3' ' HB2' ' A' ' 103' ' ' GLN . . . -63.93 -44.12 96.48 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.568 HD21 HG21 ' A' ' 69' ' ' VAL . 76.6 mt -66.81 -44.9 79.97 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.339 -1.095 . . . . 0.0 110.254 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.524 HG22 HG13 ' A' ' 16' ' ' ILE . 74.8 t -66.12 -47.13 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.423 -0.798 . . . . 0.0 110.679 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -63.17 -39.09 93.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.009 -1.057 . . . . 0.0 109.248 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.76 -42.28 99.71 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.52 -44.28 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.233 -1.157 . . . . 0.0 110.72 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.51 -48.45 80.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.979 -1.076 . . . . 0.0 109.757 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.99 -40.33 97.44 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.395 -0.816 . . . . 0.0 108.865 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.56 97.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.442 -0.787 . . . . 0.0 110.59 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.81 -42.55 98.47 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 98.2 mtp -65.41 -48.56 72.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -1.17 . . . . 0.0 110.261 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.725 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -62.41 -44.67 95.87 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.538 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.18 -39.61 95.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -0.851 . . . . 0.0 109.237 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.6 -34.5 58.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.066 -1.021 . . . . 0.0 110.123 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -61.88 -43.72 98.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 0.0 109.32 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.458 ' HB3' ' CE2' ' A' ' 128' ' ' PHE . 68.2 m-85 -70.93 -37.44 72.87 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.819 0.819 . . . . 0.0 109.36 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.458 ' CE2' ' HB3' ' A' ' 127' ' ' TYR . 88.1 m-85 -132.5 98.51 16.56 Favored Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.174 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.08 150.85 77.68 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 O-C-N 123.696 1.367 . . . . 0.0 109.706 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.474 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 51.9 t90 -76.1 127.4 32.86 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.418 -0.801 . . . . 0.0 110.817 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -105.17 146.78 28.76 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -56.46 -29.92 62.28 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.214 -0.929 . . . . 0.0 111.087 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -90.85 8.86 32.75 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.099 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -42.94 138.5 2.01 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.19 -0.944 . . . . 0.0 111.187 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.525 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -110.92 134.4 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-O 121.995 0.902 . . . . 0.0 111.473 -176.971 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 41.4 p-10 -116.96 102.48 9.39 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.446 -0.784 . . . . 0.0 110.583 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -102.17 -12.07 18.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.739 -1.226 . . . . 0.0 111.734 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.775 HD22 ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -93.11 140.97 23.49 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.977 -1.077 . . . . 0.0 110.676 -179.358 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.2 171.94 14.99 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.349 1.184 . . . . 0.0 109.108 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.729 ' OD1' HG22 ' A' ' 20' ' ' ILE . 68.3 m-80 -112.11 7.21 19.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.715 -1.24 . . . . 0.0 110.617 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -64.06 148.01 50.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.955 -1.091 . . . . 0.0 111.332 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 93.5 mt -76.2 139.61 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.56 -0.713 . . . . 0.0 110.351 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.419 ' OG ' ' NE ' ' A' ' 32' ' ' ARG . 17.6 m -94.09 135.96 34.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.158 -0.964 . . . . 0.0 110.272 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -128.77 140.97 51.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.278 -0.889 . . . . 0.0 110.667 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.974 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.507 HG22 ' N ' ' A' ' 10' ' ' ALA . 75.8 m . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.507 ' N ' HG22 ' A' ' 9' ' ' THR . . . -53.49 -34.9 59.73 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.996 -1.065 . . . . 0.0 109.522 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -60.32 -46.74 88.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.117 -0.99 . . . . 0.0 110.81 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -72.79 -46.98 50.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.985 -1.072 . . . . 0.0 111.775 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.542 ' O ' HG23 ' A' ' 17' ' ' VAL . 96.7 mt-10 -60.15 -40.71 90.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.983 -1.073 . . . . 0.0 110.021 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 72.3 mmtt -63.84 -42.93 97.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.108 -0.995 . . . . 0.0 110.805 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.05 -42.94 93.78 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.99 -1.068 . . . . 0.0 111.559 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 13' ' ' GLU . 19.4 tt -68.88 -36.86 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.72 -1.238 . . . . 0.0 110.379 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 13' ' ' GLU . 48.4 t -61.26 -42.4 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -61.54 -36.48 80.72 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.507 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.67 -40.75 93.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.419 -0.8 . . . . 0.0 109.26 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.64 -42.56 96.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.345 -0.847 . . . . 0.0 109.348 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -58.64 -42.88 89.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.818 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -64.9 -37.46 87.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.179 -0.951 . . . . 0.0 111.167 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.03 -39.31 93.17 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.779 -1.2 . . . . 0.0 110.522 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.2 -15.94 28.85 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.894 -1.129 . . . . 0.0 110.351 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.478 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.5 mttt -93.2 0.37 57.1 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 120.927 -1.108 . . . . 0.0 109.417 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -112.55 -15.62 13.02 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.714 -1.241 . . . . 0.0 109.816 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.3 t -153.64 157.59 39.85 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.906 -1.121 . . . . 0.0 110.326 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.2 m -85.57 -9.2 57.67 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.326 -0.859 . . . . 0.0 110.193 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.86 172.29 46.54 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.413 ' CB ' HD12 ' A' ' 138' ' ' LEU . 53.6 mp0 -131.18 134.04 46.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.287 -1.125 . . . . 0.0 112.268 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.429 HD11 HD12 ' A' ' 124' ' ' LEU . 97.1 mt -118.9 133.86 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.305 0.574 . . . . 0.0 109.807 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.502 ' NH1' HD13 ' A' ' 54' ' ' LEU . 72.4 ttt180 -139.79 152.09 46.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.429 -0.794 . . . . 0.0 110.063 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.719 HG22 HD12 ' A' ' 67' ' ' ILE . 83.9 t -122.64 138.77 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.36 -0.838 . . . . 0.0 110.71 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.464 ' HB2' HD11 ' A' ' 66' ' ' LEU . 75.3 t60 -122.82 132.32 54.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 0.0 108.933 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.945 HD11 ' CG1' ' A' ' 71' ' ' VAL . 32.9 tp -118.07 131.63 56.43 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.024 0.916 . . . . 0.0 111.557 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -150.38 164.88 34.74 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 67.4 mttm -79.39 -74.74 0.27 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.04 -1.038 . . . . 0.0 113.419 -177.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 t -141.39 160.28 40.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.414 -0.804 . . . . 0.0 110.906 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.421 ' OG ' ' CD ' ' A' ' 46' ' ' ARG . 25.7 m -108.9 168.02 9.66 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.661 -0.649 . . . . 0.0 110.997 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -107.82 -12.0 15.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 110.7 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 42' ' ' ASP . 29.3 pt -123.75 -122.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.984 -1.073 . . . . 0.0 109.321 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 41' ' ' ILE . 96.6 m-20 -110.53 136.33 49.82 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 120.204 -1.56 . . . . 0.0 108.973 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.9 t -62.96 -43.49 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.475 -0.766 . . . . 0.0 111.734 -178.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -59.24 -45.1 92.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.999 -1.063 . . . . 0.0 109.952 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -70.23 -37.97 75.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.897 -1.127 . . . . 0.0 108.327 177.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.421 ' CD ' ' OG ' ' A' ' 39' ' ' SER . 44.1 ttt85 -61.3 -41.66 97.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.526 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.4 -37.6 83.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.785 -1.197 . . . . 0.0 110.48 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.4 ttp -64.23 -42.6 96.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.486 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -64.62 -46.83 80.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.902 -1.124 . . . . 0.0 109.841 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.49 -45.67 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.208 -0.932 . . . . 0.0 110.553 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.467 ' CZ ' ' OD1' ' A' ' 81' ' ' ASP . 6.8 t80 -56.84 -47.94 79.21 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.703 -1.248 . . . . 0.0 109.717 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -72.85 -35.88 67.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.995 -1.066 . . . . 0.0 110.088 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -60.47 -39.54 87.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.879 -1.138 . . . . 0.0 109.314 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.502 HD13 ' NH1' ' A' ' 32' ' ' ARG . 96.1 mt -80.66 4.62 18.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.094 -1.004 . . . . 0.0 110.531 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 57.33 33.72 23.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.843 -1.161 . . . . 0.0 111.134 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.691 ' SD ' HD13 ' A' ' 66' ' ' LEU . 79.9 mtp -68.77 -26.8 65.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.117 -0.989 . . . . 0.0 109.374 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 39.2 p-10 -71.27 -8.21 52.11 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.202 -0.936 . . . . 0.0 110.586 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -87.98 82.54 7.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.705 -1.247 . . . . 0.0 110.233 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.419 HG23 ' CB ' ' A' ' 137' ' ' GLU . 51.7 m -138.1 156.1 48.1 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.17 -46.86 88.24 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.109 -0.994 . . . . 0.0 111.909 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.6 mt -97.71 2.55 49.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.045 -1.035 . . . . 0.0 111.031 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.415 ' O ' ' CB ' ' A' ' 81' ' ' ASP . 86.6 mt-30 55.49 43.67 28.17 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.481 1.134 . . . . 0.0 111.38 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -118.88 55.66 0.92 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.323 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.56 140.61 14.93 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.512 HG23 ' CD1' ' A' ' 84' ' ' ILE . 74.3 t -124.68 135.4 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.124 -1.221 . . . . 0.0 110.726 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.691 HD13 ' SD ' ' A' ' 56' ' ' MET . 38.8 tp -116.1 126.84 54.28 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.607 -0.683 . . . . 0.0 109.774 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.719 HD12 HG22 ' A' ' 33' ' ' VAL . 96.8 mt -105.41 101.0 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 118.901 -1.12 . . . . 0.0 108.992 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -86.97 123.27 31.89 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.384 -0.822 . . . . 0.0 109.973 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.2 t -119.74 129.6 75.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.855 0.836 . . . . 0.0 110.149 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.514 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -99.2 84.81 3.09 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.945 ' CG1' HD11 ' A' ' 35' ' ' LEU . 30.2 m -58.16 -23.13 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.224 -0.923 . . . . 0.0 111.016 -178.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 49.1 tp10 -66.05 -42.45 89.5 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.234 178.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.584 ' O ' HG23 ' A' ' 75' ' ' THR . 98.2 m-20 -102.31 6.69 40.56 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.198 -0.939 . . . . 0.0 111.007 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.8 tttt 52.84 45.89 27.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.822 -1.174 . . . . 0.0 110.983 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 73' ' ' ASP . 70.1 p -122.76 168.63 11.99 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.237 -0.915 . . . . 0.0 109.625 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 43.7 p90 -146.47 143.18 28.8 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.961 -1.087 . . . . 0.0 111.016 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.0 t -128.98 135.72 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.738 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 80.1 mt -114.45 129.44 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.879 -1.138 . . . . 0.0 110.092 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -136.38 114.42 11.42 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.494 -0.754 . . . . 0.0 110.877 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -101.14 174.82 25.54 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.467 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 32.6 m-20 -79.04 176.01 10.06 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.474 -1.015 . . . . 0.0 110.858 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.57 -27.38 68.59 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.366 -0.834 . . . . 0.0 109.453 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -63.66 -53.01 41.27 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.953 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.962 ' O ' HG22 ' A' ' 88' ' ' VAL . 93.5 mt -65.08 -44.07 95.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.743 -1.445 . . . . 0.0 108.659 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -61.77 -37.1 83.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.626 -1.296 . . . . 0.0 110.698 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -73.34 -21.1 60.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.963 . . . . 0.0 112.19 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 1.024 HG23 HG13 ' A' ' 88' ' ' VAL . 21.7 m -107.19 -19.83 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.809 -1.182 . . . . 0.0 112.926 -177.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.024 HG13 HG23 ' A' ' 87' ' ' VAL . 16.4 m -119.95 162.79 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.693 -1.254 . . . . 0.0 111.309 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 m -108.54 173.64 6.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.475 -0.766 . . . . 0.0 111.965 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -61.82 -37.24 83.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 110.1 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 34.1 p-10 -61.69 -36.41 80.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 109.244 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.881 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 73.1 t80 -66.73 -25.52 66.56 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.302 -0.874 . . . . 0.0 108.773 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.738 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 3.8 m95 -86.04 -26.19 25.5 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.852 0.834 . . . . 0.0 110.542 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -55.37 -38.99 69.56 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.996 -1.065 . . . . 0.0 112.963 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.4 m -63.22 -35.33 79.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.815 -1.178 . . . . 0.0 109.099 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.283 16.0 m -58.09 -48.5 79.98 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.334 1.064 . . . . 0.0 111.255 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.69 -38.22 83.37 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.518 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.686 ' O ' HD13 ' A' ' 102' ' ' LEU . 21.1 m120 -64.69 -45.12 87.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.988 -1.07 . . . . 0.0 111.015 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.17 -49.91 76.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.712 -1.242 . . . . 0.0 110.448 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.39 -43.26 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.223 -0.923 . . . . 0.0 111.075 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -62.42 -45.12 94.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.905 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.686 HD13 ' O ' ' A' ' 98' ' ' ASN . 7.0 mp -63.85 -41.46 97.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.325 -0.859 . . . . 0.0 111.561 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.455 ' HB2' ' HA3' ' A' ' 112' ' ' GLY . 98.7 mm-40 -73.01 -41.78 63.91 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.714 -1.194 . . . . 0.0 108.756 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -58.72 -38.07 77.53 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -61.46 -34.06 74.8 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.681 -0.637 . . . . 0.0 109.946 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -80.7 -17.59 50.6 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.814 -1.179 . . . . 0.0 110.511 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.75 7.18 42.39 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.678 -1.249 . . . . 0.0 111.167 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -103.99 90.99 3.78 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.773 -1.428 . . . . 0.0 110.259 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -63.1 -40.05 96.5 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.553 -0.717 . . . . 0.0 111.47 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -65.75 -49.52 68.1 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.243 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -64.29 -39.39 93.82 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.956 -1.097 . . . . 0.0 110.527 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.455 ' HA3' ' HB2' ' A' ' 103' ' ' GLN . . . -62.72 -48.07 84.18 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.411 ' HB3' HD11 ' A' ' 16' ' ' ILE . 80.8 mt -64.41 -43.2 95.13 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.301 -1.117 . . . . 0.0 109.912 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.4 t -64.81 -48.34 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -0.931 . . . . 0.0 110.509 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -64.66 -39.84 94.38 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.348 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.26 -43.62 99.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 89.2 mt -64.51 -43.56 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.064 -1.256 . . . . 0.0 109.806 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.95 -52.87 62.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.134 -0.979 . . . . 0.0 109.992 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.42 -43.05 99.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 108.664 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -53.81 -46.16 71.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.485 -0.76 . . . . 0.0 109.71 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.67 -43.15 99.4 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.437 ' HG2' ' NZ ' ' A' ' 126' ' ' LYS . 27.4 ttt -67.17 -48.91 66.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.895 -1.356 . . . . 0.0 109.669 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.881 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -62.09 -45.94 91.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.935 . . . . 0.0 109.37 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.429 HD12 HD11 ' A' ' 31' ' ' ILE . 77.2 mt -61.86 -40.13 94.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.194 -0.941 . . . . 0.0 108.611 178.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.08 -33.94 63.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.195 -0.941 . . . . 0.0 110.411 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.437 ' NZ ' ' HG2' ' A' ' 122' ' ' MET . 60.9 mttp -61.83 -43.43 98.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.056 -1.028 . . . . 0.0 108.818 178.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.428 ' CE2' HG12 ' A' ' 88' ' ' VAL . 52.5 m-85 -75.1 -39.78 60.45 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.61 0.719 . . . . 0.0 110.071 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.437 ' HE2' HG21 ' A' ' 87' ' ' VAL . 76.9 m-85 -130.65 90.66 39.85 Favored Pre-proline 0 C--N 1.301 -1.518 0 O-C-N 121.706 -0.621 . . . . 0.0 109.426 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -64.78 154.42 72.79 Favored 'Trans proline' 0 C--N 1.318 -1.035 0 O-C-N 123.588 1.309 . . . . 0.0 110.483 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.478 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 31.2 t90 -77.6 133.34 38.47 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.441 0.639 . . . . 0.0 111.962 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -114.6 150.85 34.42 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -58.35 -31.74 67.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.096 -1.003 . . . . 0.0 111.842 -177.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -90.99 6.09 46.17 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.963 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 135' ' ' ILE . 66.9 t0 -42.59 140.07 1.37 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 122.038 0.923 . . . . 0.0 111.667 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.696 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.1 pp -113.42 148.53 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-O 121.857 0.837 . . . . 0.0 111.662 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -105.68 96.65 6.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.465 -1.397 . . . . 0.0 110.036 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.419 ' CB ' HG23 ' A' ' 59' ' ' THR . 79.1 mm-40 -68.15 -37.14 80.72 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.593 -0.692 . . . . 0.0 112.838 -178.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.413 HD12 ' CB ' ' A' ' 30' ' ' GLU . 8.0 mt -109.3 148.45 38.04 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.987 -1.071 . . . . 0.0 111.828 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.39 -176.76 1.77 Allowed 'Trans proline' 0 C--N 1.319 -0.993 0 N-CA-C 108.359 -1.439 . . . . 0.0 108.359 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -116.87 4.35 12.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.587 -1.321 . . . . 0.0 110.204 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.8 p -63.29 169.1 3.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.899 -1.126 . . . . 0.0 110.771 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.0 mt -101.39 139.66 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.581 0.705 . . . . 0.0 110.947 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 32' ' ' ARG . 30.6 t -94.91 134.24 37.77 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.533 -0.729 . . . . 0.0 109.241 178.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -125.74 132.91 52.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.188 -0.945 . . . . 0.0 110.045 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.869 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.61 -37.05 67.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.121 -0.987 . . . . 0.0 110.086 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -57.72 -45.95 85.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.909 . . . . 0.0 109.868 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.16 -43.88 73.38 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.599 -0.688 . . . . 0.0 112.031 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 17' ' ' VAL . 79.8 mm-40 -65.4 -39.18 91.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.954 -1.091 . . . . 0.0 110.917 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -63.33 -43.18 98.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.808 -1.182 . . . . 0.0 111.113 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.11 -45.55 84.67 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.077 -1.014 . . . . 0.0 112.108 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.587 HG13 HG22 ' A' ' 114' ' ' VAL . 19.6 tt -65.49 -37.43 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.696 -1.252 . . . . 0.0 110.507 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 13' ' ' GLU . 75.6 t -61.58 -39.1 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -0.953 . . . . 0.0 108.799 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -62.05 -36.31 81.25 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.072 -1.051 . . . . 0.0 108.885 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.09 -37.96 87.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.466 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.425 HD11 HD13 ' A' ' 117' ' ' ILE . 37.5 mm -63.72 -43.66 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.294 -0.879 . . . . 0.0 110.083 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.447 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 83.9 mtp180 -60.18 -41.59 93.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.347 -0.846 . . . . 0.0 110.556 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -65.08 -38.06 89.55 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.49 -0.756 . . . . 0.0 111.2 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.59 -39.53 93.9 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.938 -1.101 . . . . 0.0 110.165 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.63 -13.72 16.11 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.936 -1.103 . . . . 0.0 110.971 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.482 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.1 mttt -96.52 1.84 51.83 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.914 -1.116 . . . . 0.0 109.513 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -112.9 -18.04 12.34 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.04 -1.037 . . . . 0.0 109.775 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.2 t -151.43 158.33 43.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.959 . . . . 0.0 109.815 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 95.8 p -86.76 -7.57 58.15 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.269 -0.895 . . . . 0.0 109.667 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.38 172.11 52.42 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.449 ' CG ' ' HB2' ' A' ' 138' ' ' LEU . 79.6 mm-40 -133.72 139.56 46.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.254 -1.145 . . . . 0.0 111.891 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.6 mt -121.89 135.27 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 143' ' ' SER . 77.1 ttt180 -140.05 155.17 47.17 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 109.39 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.622 HG22 HD12 ' A' ' 67' ' ' ILE . 59.0 t -120.96 136.74 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.091 -1.006 . . . . 0.0 110.555 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.731 ' HB2' HD11 ' A' ' 66' ' ' LEU . 72.2 t60 -121.49 121.71 38.11 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.603 HD11 ' CG1' ' A' ' 71' ' ' VAL . 32.3 tp -111.87 125.93 54.55 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.732 0.777 . . . . 0.0 111.725 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.418 ' OE2' ' CZ ' ' A' ' 46' ' ' ARG . 82.5 tt0 -140.64 166.22 25.33 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.46 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.4 mttt -78.21 -76.05 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 112.327 -177.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.8 t -139.94 154.9 47.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 109.759 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.438 ' HB3' ' CD ' ' A' ' 46' ' ' ARG . 12.7 p -103.49 167.23 9.94 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.382 -0.824 . . . . 0.0 110.225 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -104.23 -8.35 19.41 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.372 -0.83 . . . . 0.0 110.041 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.4 pt -128.22 -122.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.046 -1.034 . . . . 0.0 109.493 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -110.29 138.75 46.25 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 120.309 -1.494 . . . . 0.0 109.509 178.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.2 t -63.18 -43.25 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 110.676 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -59.56 -47.11 86.83 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.02 -1.05 . . . . 0.0 110.743 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -70.15 -39.79 75.15 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.73 -1.232 . . . . 0.0 108.269 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.569 ' O ' HG23 ' A' ' 50' ' ' VAL . 73.1 ttt180 -61.12 -43.48 98.82 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.35 -0.844 . . . . 0.0 110.846 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.95 -40.47 91.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.702 -1.249 . . . . 0.0 110.368 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 46.7 ttp -62.34 -42.72 99.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.014 -1.054 . . . . 0.0 109.433 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -63.62 -42.06 98.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.037 -1.039 . . . . 0.0 109.081 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 46' ' ' ARG . 82.9 t -66.58 -43.44 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.572 -0.705 . . . . 0.0 110.304 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -59.89 -45.93 90.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.779 -1.201 . . . . 0.0 109.77 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -73.86 -35.95 64.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.949 -1.094 . . . . 0.0 109.889 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -61.57 -39.48 91.3 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.014 -1.054 . . . . 0.0 110.196 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.6 mt -81.14 4.15 21.05 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.043 -1.036 . . . . 0.0 110.58 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 55.79 31.5 17.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.096 -1.002 . . . . 0.0 111.65 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 92.1 mtp -66.55 -19.04 65.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.161 -0.962 . . . . 0.0 109.671 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -74.89 -4.97 41.1 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.096 -1.002 . . . . 0.0 111.288 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -45.96 -32.79 2.92 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.042 -1.036 . . . . 0.0 110.621 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.503 HG23 ' HA ' ' A' ' 62' ' ' GLN . 9.0 t -40.61 144.86 0.21 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.505 1.145 . . . . 0.0 113.009 -176.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -68.16 -40.4 82.33 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.465 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 72.8 mt -92.2 -0.92 57.4 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.143 -0.973 . . . . 0.0 111.178 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.503 ' HA ' HG23 ' A' ' 59' ' ' THR . 88.3 mt-30 57.69 36.85 27.04 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.348 1.071 . . . . 0.0 110.45 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.641 ' C ' HD11 ' A' ' 84' ' ' ILE . 97.8 m-20 -113.1 48.56 1.02 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.383 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.6 144.17 17.07 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.515 ' CG2' HD13 ' A' ' 84' ' ' ILE . 52.8 t -124.54 134.72 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.993 -1.298 . . . . 0.0 110.5 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.731 HD11 ' HB2' ' A' ' 34' ' ' HIS . 45.5 tp -116.79 125.6 51.85 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.387 -0.821 . . . . 0.0 109.738 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.622 HD12 HG22 ' A' ' 33' ' ' VAL . 89.9 mt -100.57 105.0 16.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 118.945 -1.102 . . . . 0.0 109.412 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -91.74 124.68 36.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.892 . . . . 0.0 110.327 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.9 t -123.95 132.3 71.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 122.059 0.933 . . . . 0.0 111.151 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.67 99.99 10.01 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.603 ' CG1' HD11 ' A' ' 35' ' ' LEU . 33.5 m -70.19 -18.95 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.027 -1.046 . . . . 0.0 110.781 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.443 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 80.4 mm-40 -71.11 -49.0 49.0 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.86 -1.15 . . . . 0.0 109.428 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -98.65 5.1 47.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.884 . . . . 0.0 110.293 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.43 ' HE3' ' CE1' ' A' ' 109' ' ' PHE . 72.1 tttt 53.72 43.51 30.96 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.019 -1.051 . . . . 0.0 110.16 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.2 m -119.15 132.24 55.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.324 -0.86 . . . . 0.0 109.952 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -116.08 136.59 52.89 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.445 -0.784 . . . . 0.0 110.051 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.4 t -126.41 137.54 57.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.628 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 77.2 mt -111.55 125.85 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.977 -1.077 . . . . 0.0 110.411 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -128.84 114.4 16.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.504 -0.748 . . . . 0.0 110.25 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.46 165.72 19.38 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 108.961 -1.655 . . . . 0.0 108.961 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 49.7 t0 -74.75 174.73 8.74 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.591 -0.946 . . . . 0.0 109.311 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -59.42 -22.77 61.94 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.052 -1.03 . . . . 0.0 111.186 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.5 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -68.64 -50.9 33.62 Favored Glycine 0 N--CA 1.497 2.714 0 C-N-CA 119.737 -1.221 . . . . 0.0 110.939 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.999 ' O ' HG22 ' A' ' 88' ' ' VAL . 3.5 mt -63.01 -44.7 99.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.865 -1.373 . . . . 0.0 107.393 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -63.16 -36.4 83.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.921 -1.112 . . . . 0.0 112.134 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -74.33 -20.93 59.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.627 -1.295 . . . . 0.0 112.311 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.909 HG23 HG13 ' A' ' 88' ' ' VAL . 26.0 m -105.78 -18.91 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.873 -1.142 . . . . 0.0 112.112 -178.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.999 HG22 ' O ' ' A' ' 84' ' ' ILE . 15.9 m -120.76 163.34 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.692 -1.255 . . . . 0.0 111.262 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.3 m -111.0 -176.67 3.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -0.859 . . . . 0.0 111.806 -178.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -62.81 -37.54 87.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.982 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -60.96 -39.51 89.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.201 -0.937 . . . . 0.0 109.398 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.731 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 83.3 t80 -66.34 -26.49 67.31 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.168 -0.958 . . . . 0.0 109.679 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.628 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.1 m95 -86.32 -25.22 25.54 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.042 0.925 . . . . 0.0 110.615 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -57.29 -41.16 79.25 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 112.837 -176.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.8 p -64.02 -30.06 71.16 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.572 -1.251 . . . . 0.0 109.118 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.261 16.4 m -60.1 -48.72 80.56 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.297 1.046 . . . . 0.0 110.962 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.59 -36.84 73.77 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.146 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -63.44 -43.27 97.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.828 -1.17 . . . . 0.0 110.129 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.11 -49.91 70.33 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.808 -1.182 . . . . 0.0 111.362 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.67 -42.55 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.003 -1.061 . . . . 0.0 110.426 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -63.89 -42.3 97.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.42 -0.8 . . . . 0.0 110.585 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 61.7 tp -63.57 -43.11 97.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 111.209 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.465 ' HG2' ' N ' ' A' ' 112' ' ' GLY . 1.8 tp-100 -74.0 -42.22 60.7 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 118.757 -1.177 . . . . 0.0 108.928 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -59.38 -41.17 88.73 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.11 -31.22 71.65 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.999 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.7 tp60 -80.87 -19.73 43.84 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.168 -0.957 . . . . 0.0 109.411 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.24 1.27 33.43 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.008 -1.091 . . . . 0.0 110.847 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -104.13 91.15 3.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.706 -1.467 . . . . 0.0 110.862 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.43 ' CE1' ' HE3' ' A' ' 74' ' ' LYS . 19.2 m-85 -65.32 -39.75 92.84 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.537 -0.727 . . . . 0.0 111.185 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -64.06 -49.17 73.36 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.771 -1.205 . . . . 0.0 111.793 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -63.34 -38.99 93.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.875 -1.141 . . . . 0.0 110.254 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.465 ' N ' ' HG2' ' A' ' 103' ' ' GLN . . . -63.19 -45.56 95.04 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 78.0 mt -64.72 -44.71 89.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.434 -1.039 . . . . 0.0 111.153 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.587 HG22 HG13 ' A' ' 16' ' ' ILE . 77.6 t -67.01 -46.61 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.769 -1.207 . . . . 0.0 110.714 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -65.04 -43.85 91.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.099 -1.001 . . . . 0.0 110.933 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.23 -40.95 94.58 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.425 HD13 HD11 ' A' ' 20' ' ' ILE . 97.1 mt -64.2 -43.48 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.312 -1.111 . . . . 0.0 110.136 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -56.68 -49.07 76.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.984 . . . . 0.0 109.626 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.54 -42.17 98.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -0.984 . . . . 0.0 109.436 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.33 -38.35 80.1 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.193 -0.942 . . . . 0.0 109.567 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.44 -46.5 69.62 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 75.9 mtm -67.16 -43.71 81.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.909 -1.348 . . . . 0.0 109.694 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.731 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -65.23 -45.93 82.65 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.324 -0.95 . . . . 0.0 109.008 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.2 mt -62.06 -40.56 96.19 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.38 -34.09 64.02 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.387 -0.82 . . . . 0.0 110.641 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -62.15 -41.41 98.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.969 -1.082 . . . . 0.0 109.111 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -72.39 -41.08 66.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.581 -0.699 . . . . 0.0 109.935 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -130.68 99.87 18.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.984 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.48 150.39 75.37 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.586 1.308 . . . . 0.0 109.8 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.482 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 48.5 t90 -74.83 136.03 41.6 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.53 -0.731 . . . . 0.0 111.306 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -113.28 151.93 30.49 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.301 -0.875 . . . . 0.0 109.127 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.91 -30.68 69.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.204 -0.935 . . . . 0.0 111.175 -177.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -91.25 7.57 40.14 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.899 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.468 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 67.0 t0 -43.54 141.56 1.4 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.404 -0.81 . . . . 0.0 111.551 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.728 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -114.31 146.02 19.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-O 121.697 0.76 . . . . 0.0 111.196 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 42.9 p-10 -98.56 92.62 5.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.595 -1.316 . . . . 0.0 110.66 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.448 ' HG3' HD13 ' A' ' 135' ' ' ILE . 96.9 mt-10 -68.45 -36.12 78.56 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.183 -0.948 . . . . 0.0 111.88 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.457 HD13 ' HD2' ' A' ' 139' ' ' PRO . 3.8 mm? -109.74 145.74 32.62 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.086 -1.009 . . . . 0.0 111.546 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.457 ' HD2' HD13 ' A' ' 138' ' ' LEU . 44.3 Cg_endo -72.37 -167.85 0.35 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 N-CA-C 108.065 -1.552 . . . . 0.0 108.065 178.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.447 ' ND2' ' HG2' ' A' ' 21' ' ' ARG . 13.9 p30 -122.91 4.29 9.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.761 -1.212 . . . . 0.0 110.156 178.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.1 m -61.76 168.52 2.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.101 -0.999 . . . . 0.0 110.26 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.412 ' CD1' ' OE1' ' A' ' 13' ' ' GLU . 93.9 mt -103.68 140.42 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.43 -0.793 . . . . 0.0 110.537 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 32' ' ' ARG . 32.1 t -94.37 136.53 34.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.194 -0.941 . . . . 0.0 109.708 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -127.57 137.31 52.56 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.3 -0.875 . . . . 0.0 110.426 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 CA-C-O 118.002 -1.443 . . . . 0.0 109.668 -179.815 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.134 0.492 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.458 ' HB1' ' HE2' ' A' ' 14' ' ' LYS . . . -54.75 -37.44 65.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.107 -0.995 . . . . 0.0 109.455 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -57.68 -43.48 85.08 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.437 -0.79 . . . . 0.0 109.611 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.439 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 96.4 mt-10 -72.43 -45.44 59.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.357 -0.84 . . . . 0.0 111.634 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.731 ' O ' HG23 ' A' ' 17' ' ' VAL . 97.4 mt-10 -64.04 -38.51 91.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.005 -1.059 . . . . 0.0 110.127 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.458 ' HE2' ' HB1' ' A' ' 10' ' ' ALA . 68.1 mttm -64.4 -45.32 88.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.059 -1.025 . . . . 0.0 111.132 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.27 -41.56 96.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.129 -0.982 . . . . 0.0 111.114 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.525 HG22 ' O ' ' A' ' 13' ' ' GLU . 21.2 tt -68.76 -33.86 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.986 -1.071 . . . . 0.0 110.104 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 13' ' ' GLU . 76.0 t -65.48 -40.21 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.148 -0.97 . . . . 0.0 108.439 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -61.67 -36.91 82.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.975 . . . . 0.0 109.085 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.6 91.15 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.232 -0.918 . . . . 0.0 109.352 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.592 HD11 HD13 ' A' ' 117' ' ' ILE . 34.8 mm -63.18 -43.44 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.185 -0.947 . . . . 0.0 109.386 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.43 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 93.4 mtt-85 -59.72 -43.88 93.96 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.55 -0.719 . . . . 0.0 110.216 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -63.41 -38.94 93.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.871 . . . . 0.0 110.94 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.65 -39.63 94.82 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.255 -0.903 . . . . 0.0 110.662 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -59.93 -15.42 21.66 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.906 -1.122 . . . . 0.0 110.508 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 74.5 mmtt -96.18 1.01 51.93 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.976 -1.078 . . . . 0.0 109.386 178.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 94.2 m-20 -114.35 -14.0 12.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.74 -1.225 . . . . 0.0 109.769 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.1 t -153.92 159.1 41.59 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.63 -1.294 . . . . 0.0 109.462 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.5 m -88.25 -9.32 53.33 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.255 -0.903 . . . . 0.0 109.75 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.79 172.43 43.19 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.485 ' HG2' HD22 ' A' ' 138' ' ' LEU . 53.3 mp0 -132.27 140.3 48.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.269 -1.136 . . . . 0.0 111.31 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.2 mt -124.97 136.83 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.764 -0.585 . . . . 0.0 110.518 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.547 ' HE ' HD23 ' A' ' 138' ' ' LEU . 95.1 mtt-85 -138.82 154.87 48.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.211 -0.931 . . . . 0.0 110.144 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.701 HG22 HD12 ' A' ' 67' ' ' ILE . 55.4 t -125.87 136.31 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.54 0.686 . . . . 0.0 109.693 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.418 ' HA ' ' O ' ' A' ' 143' ' ' SER . 52.2 t-80 -121.04 118.98 31.2 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.571 -0.705 . . . . 0.0 109.279 178.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.835 HD11 ' CG1' ' A' ' 71' ' ' VAL . 30.6 tp -106.49 129.88 54.38 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.778 0.799 . . . . 0.0 111.175 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -147.57 167.58 24.17 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.434 ' CA ' ' HG2' ' A' ' 72' ' ' GLU . 99.4 mttt -80.83 -77.01 0.21 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.955 -1.091 . . . . 0.0 112.626 -177.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.422 ' OG1' ' CB ' ' A' ' 72' ' ' GLU . 43.7 m -140.85 159.5 42.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.444 -0.785 . . . . 0.0 109.669 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.7 m -114.0 175.64 5.38 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.257 -0.902 . . . . 0.0 110.393 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -107.43 -10.83 15.65 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.13 -0.981 . . . . 0.0 110.755 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.8 pt -124.23 -121.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.1 -1.0 . . . . 0.0 110.195 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -112.38 140.81 46.79 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.045 -1.66 . . . . 0.0 109.476 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.647 HG13 ' CD1' ' A' ' 68' ' ' TYR . 99.0 t -63.98 -42.42 95.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.512 -0.743 . . . . 0.0 110.525 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -58.76 -46.11 88.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.053 -1.029 . . . . 0.0 109.634 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -68.94 -38.62 79.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.806 -1.184 . . . . 0.0 108.394 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.613 ' O ' HG23 ' A' ' 50' ' ' VAL . 10.9 mmt180 -62.79 -36.88 84.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -0.948 . . . . 0.0 110.106 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.77 -39.65 73.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.884 -1.135 . . . . 0.0 109.904 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 66.1 ttp -65.71 -44.16 86.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.099 -1.0 . . . . 0.0 109.969 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -63.46 -43.5 97.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.099 . . . . 0.0 109.386 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 46' ' ' ARG . 96.7 t -66.58 -42.61 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.38 -0.825 . . . . 0.0 109.69 178.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 57' ' ' ASP . 53.2 t80 -58.89 -46.03 88.85 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.04 -1.038 . . . . 0.0 109.705 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -75.57 -35.82 60.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.895 -1.128 . . . . 0.0 109.682 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -61.44 -39.74 91.92 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.201 -0.937 . . . . 0.0 109.795 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.1 mt -84.18 4.54 30.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.503 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt 56.84 31.42 19.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.077 -1.014 . . . . 0.0 110.953 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.861 ' SD ' HD13 ' A' ' 66' ' ' LEU . 58.6 mtt -72.03 -27.93 63.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.316 -0.865 . . . . 0.0 109.407 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.504 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . 45.6 p-10 -69.0 -9.92 54.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.434 -0.791 . . . . 0.0 109.968 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -86.04 88.02 7.51 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.733 -1.187 . . . . 0.0 110.723 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 62' ' ' GLN . 67.0 p -137.48 154.97 49.81 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -59.44 -45.26 92.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.49 -0.756 . . . . 0.0 111.881 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.5 mt -98.34 2.86 48.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.985 -1.072 . . . . 0.0 111.606 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.429 ' HA ' ' OG1' ' A' ' 59' ' ' THR . 77.3 mt-30 57.46 32.18 21.39 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 122.122 0.963 . . . . 0.0 111.942 178.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.635 ' C ' HD11 ' A' ' 84' ' ' ILE . 97.8 m-20 -110.41 54.59 0.67 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.723 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.66 141.99 15.75 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.475 ' CG2' HD13 ' A' ' 84' ' ' ILE . 54.0 t -122.41 133.1 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.992 -1.299 . . . . 0.0 109.841 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.861 HD13 ' SD ' ' A' ' 56' ' ' MET . 47.1 tp -118.39 130.9 56.25 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.374 -0.829 . . . . 0.0 110.471 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.701 HD12 HG22 ' A' ' 33' ' ' VAL . 64.7 mt -110.24 115.16 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 118.982 -1.087 . . . . 0.0 109.688 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.647 ' CD1' HG13 ' A' ' 43' ' ' VAL . 47.0 t80 -101.49 124.8 47.76 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.079 -1.013 . . . . 0.0 110.005 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.0 t -123.44 130.54 74.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.924 0.868 . . . . 0.0 111.621 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.939 ' HB3' HG22 ' A' ' 75' ' ' THR . . . -98.62 90.29 4.68 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.835 ' CG1' HD11 ' A' ' 35' ' ' LEU . 32.6 m -59.52 -22.86 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.99 -1.069 . . . . 0.0 111.148 -177.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.434 ' HG2' ' CA ' ' A' ' 37' ' ' LYS . 79.0 mm-40 -66.17 -42.32 89.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.789 -1.194 . . . . 0.0 109.061 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -101.12 4.97 42.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.437 -0.789 . . . . 0.0 110.655 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.6 tttt 54.99 46.85 23.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.656 -1.277 . . . . 0.0 110.703 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.939 HG22 ' HB3' ' A' ' 70' ' ' ALA . 10.0 t -122.67 162.54 21.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.44 -0.788 . . . . 0.0 109.636 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -143.7 139.42 29.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 110.001 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.3 t -129.2 139.81 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 108.93 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.698 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 81.7 mt -116.55 127.25 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.738 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -127.84 115.88 19.3 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.475 0.655 . . . . 0.0 109.862 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -102.84 161.57 16.61 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 82' ' ' LYS . 39.3 t0 -73.62 169.62 16.91 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.65 -0.912 . . . . 0.0 110.034 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.402 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 99.2 mttt -55.1 -28.04 49.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 109.976 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.36 -49.87 67.01 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.96 ' O ' HG22 ' A' ' 88' ' ' VAL . 3.9 mt -66.35 -45.06 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.883 -1.363 . . . . 0.0 108.321 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -64.08 -35.83 82.01 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.925 -1.109 . . . . 0.0 111.53 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -77.76 -20.04 54.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.809 -1.182 . . . . 0.0 111.875 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.993 HG13 HG13 ' A' ' 88' ' ' VAL . 7.6 p -102.55 -27.87 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.713 -1.242 . . . . 0.0 112.55 -178.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.993 HG13 HG13 ' A' ' 87' ' ' VAL . 19.2 m -116.65 166.52 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.582 -1.324 . . . . 0.0 111.143 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.2 m -110.62 179.25 4.12 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.215 -0.928 . . . . 0.0 112.405 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -60.95 -37.12 81.25 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.344 -0.847 . . . . 0.0 109.161 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -62.67 -36.83 84.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.417 -0.802 . . . . 0.0 109.701 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.906 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 87.6 t80 -69.8 -24.16 63.44 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.002 -1.061 . . . . 0.0 109.173 177.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.698 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.6 m95 -86.57 -25.99 24.71 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.066 0.936 . . . . 0.0 110.68 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -59.2 -36.17 74.91 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 112.379 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.5 m -66.03 -34.42 78.06 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.729 -1.232 . . . . 0.0 109.222 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.288 20.6 m -57.87 -48.9 78.49 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 122.418 1.104 . . . . 0.0 111.095 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.58 -37.69 77.07 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.413 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -63.06 -43.93 97.23 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.749 -1.18 . . . . 0.0 110.028 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.471 ' HB2' ' HD2' ' A' ' 119' ' ' LYS . . . -62.68 -48.9 77.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.879 -1.138 . . . . 0.0 110.91 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.03 -42.26 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.971 . . . . 0.0 110.177 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.431 ' CG ' ' HE3' ' A' ' 105' ' ' LYS . 51.7 tt0 -63.55 -43.62 96.53 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.272 -0.893 . . . . 0.0 110.865 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.8 tp -63.09 -41.72 99.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.088 -1.008 . . . . 0.0 112.088 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.461 ' HG2' ' CB ' ' A' ' 111' ' ' GLN . 6.3 tp60 -75.17 -37.34 61.31 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.821 -1.151 . . . . 0.0 108.942 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -62.26 -42.02 98.97 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.602 0.715 . . . . 0.0 109.135 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.431 ' HE3' ' CG ' ' A' ' 101' ' ' GLN . 93.8 mttt -60.58 -34.8 74.72 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.342 -0.849 . . . . 0.0 109.915 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -76.44 -21.06 56.4 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.939 -1.1 . . . . 0.0 110.124 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.19 2.48 35.87 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.595 -1.288 . . . . 0.0 111.578 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -102.25 92.55 4.77 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.59 -1.535 . . . . 0.0 110.176 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -62.54 -42.91 99.83 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.859 -0.525 . . . . 0.0 111.942 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.493 ' O ' HG23 ' A' ' 114' ' ' VAL . 86.3 tttt -62.51 -48.07 81.18 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.916 -177.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.461 ' CB ' ' HG2' ' A' ' 103' ' ' GLN . 96.6 mm-40 -64.32 -39.74 94.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.944 -1.098 . . . . 0.0 110.69 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.433 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -62.89 -49.48 72.08 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 68.1 mt -62.92 -44.24 96.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.129 -1.218 . . . . 0.0 110.673 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 110' ' ' LYS . 95.9 t -65.86 -47.53 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.231 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -64.23 -40.13 95.41 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.316 -0.954 . . . . 0.0 109.808 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.5 -42.79 99.21 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.592 HD13 HD11 ' A' ' 20' ' ' ILE . 97.0 mt -65.42 -44.73 94.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.375 -1.073 . . . . 0.0 109.992 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -56.84 -50.35 72.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.877 -1.139 . . . . 0.0 109.166 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.471 ' HD2' ' HB2' ' A' ' 99' ' ' ALA . 98.4 mttt -62.93 -42.13 99.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.257 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.41 ' O ' ' HG ' ' A' ' 124' ' ' LEU . . . -58.72 -39.95 82.31 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.181 -0.949 . . . . 0.0 109.298 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.34 -44.99 89.41 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 90.3 mtp -67.59 -45.82 74.4 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.019 -1.283 . . . . 0.0 110.254 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.906 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -63.83 -45.03 91.41 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.154 -0.966 . . . . 0.0 108.973 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 120' ' ' ALA . 84.2 mt -63.18 -37.8 88.65 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.272 -0.893 . . . . 0.0 109.108 178.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.28 -35.1 64.69 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.985 -1.072 . . . . 0.0 110.635 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.45 -42.97 97.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.931 -1.106 . . . . 0.0 108.391 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -74.16 -41.27 61.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.67 -0.644 . . . . 0.0 110.723 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -128.96 91.53 42.46 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.543 -0.723 . . . . 0.0 109.28 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.62 152.59 81.3 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 O-C-N 123.694 1.365 . . . . 0.0 109.953 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 28.1 t90 -79.56 139.7 37.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.592 -0.693 . . . . 0.0 111.959 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -120.71 155.35 34.08 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -61.36 -34.83 75.96 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.282 -0.887 . . . . 0.0 111.207 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -87.03 6.55 31.85 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.672 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.476 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 67.2 t0 -41.81 138.1 1.55 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.27 -0.894 . . . . 0.0 111.126 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.692 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -110.64 140.55 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 122.184 0.992 . . . . 0.0 112.069 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -119.38 102.14 8.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.759 -1.213 . . . . 0.0 109.471 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -99.88 0.75 41.99 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.758 -1.214 . . . . 0.0 111.668 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.547 HD23 ' HE ' ' A' ' 32' ' ' ARG . 3.2 mp -110.33 151.32 42.57 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 120.769 -1.207 . . . . 0.0 111.424 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.414 ' HD2' ' NH1' ' A' ' 32' ' ' ARG . 55.2 Cg_endo -74.73 170.55 20.09 Favored 'Trans proline' 0 C--N 1.322 -0.823 0 O-C-N 123.632 1.333 . . . . 0.0 109.197 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.43 ' ND2' ' HG2' ' A' ' 21' ' ' ARG . 79.6 m-20 -113.46 4.87 16.46 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.873 -1.142 . . . . 0.0 110.631 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.6 p -68.32 166.33 16.77 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.79 -1.194 . . . . 0.0 111.836 -178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.6 HG13 HG22 ' A' ' 17' ' ' VAL . 96.4 mt -87.41 137.8 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 121.733 0.778 . . . . 0.0 110.914 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 4.4 m -88.77 133.38 34.26 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -128.07 149.19 50.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.82 -1.175 . . . . 0.0 111.094 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.59 0 CA-C-O 118.045 -1.42 . . . . 0.0 110.045 -179.576 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 12' ' ' GLU . 13.0 t . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 121.071 0.462 . . . . 0.0 109.771 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.93 -39.49 68.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.075 -1.015 . . . . 0.0 109.946 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -61.35 -47.38 86.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.071 -1.018 . . . . 0.0 110.751 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.429 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 98.9 mt-10 -70.1 -49.26 52.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 111.709 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.466 ' O ' HG22 ' A' ' 16' ' ' ILE . 99.7 mt-10 -61.22 -33.61 73.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.915 -1.116 . . . . 0.0 109.921 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.85 -46.03 86.82 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.223 -0.923 . . . . 0.0 110.995 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.76 -41.11 92.48 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.127 -0.983 . . . . 0.0 112.336 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.646 HG13 HG22 ' A' ' 114' ' ' VAL . 18.9 tt -66.96 -37.82 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.653 -1.279 . . . . 0.0 110.626 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 13' ' ' GLU . 70.7 t -63.34 -40.67 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.91 -1.119 . . . . 0.0 108.849 178.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -62.03 -37.25 84.19 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.377 -0.929 . . . . 0.0 109.559 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.24 -39.43 90.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 109.59 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.909 HD11 HD13 ' A' ' 117' ' ' ILE . 46.8 mm -64.21 -45.77 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.484 -0.76 . . . . 0.0 110.456 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -55.35 -42.28 73.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.215 -0.928 . . . . 0.0 110.14 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -63.94 -37.86 88.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.651 -0.656 . . . . 0.0 111.093 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.06 95.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.945 -1.097 . . . . 0.0 110.335 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -60.55 -16.08 33.97 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.948 -1.095 . . . . 0.0 110.726 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.0 mttt -94.87 1.09 55.3 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.157 -0.964 . . . . 0.0 109.735 177.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -113.26 -18.26 12.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.018 -1.051 . . . . 0.0 109.689 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.2 t -150.33 157.07 42.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.079 -1.013 . . . . 0.0 109.243 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 97.5 p -87.48 -10.13 52.68 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.374 -0.829 . . . . 0.0 109.538 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.71 174.11 39.96 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -132.7 136.68 46.56 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.334 -1.098 . . . . 0.0 111.613 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.1 mt -119.53 133.74 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.733 -0.604 . . . . 0.0 109.993 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.81 ' HD2' HD22 ' A' ' 138' ' ' LEU . 79.2 mtp85 -138.49 149.78 45.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.053 -1.029 . . . . 0.0 110.155 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.626 HG22 ' HB ' ' A' ' 67' ' ' ILE . 57.8 t -123.89 138.26 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.681 -0.637 . . . . 0.0 110.478 -178.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.421 ' HB2' HD11 ' A' ' 66' ' ' LEU . 48.1 t60 -122.87 125.0 44.54 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.512 -0.743 . . . . 0.0 109.607 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.998 HD11 HG13 ' A' ' 71' ' ' VAL . 35.2 tp -111.65 129.02 56.23 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.766 0.793 . . . . 0.0 112.131 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.443 ' O ' HG22 ' A' ' 71' ' ' VAL . 81.3 tt0 -146.2 167.1 24.3 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 98.3 mttt -79.82 -76.46 0.22 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.102 -0.999 . . . . 0.0 112.567 -177.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.8 t -138.18 154.3 49.15 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.298 -0.876 . . . . 0.0 110.24 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.2 p -100.26 169.86 8.84 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.375 -0.828 . . . . 0.0 110.532 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -106.79 -10.07 16.19 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.588 -0.695 . . . . 0.0 110.478 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.6 pt -129.93 -121.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.878 -1.139 . . . . 0.0 109.945 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -111.77 142.66 43.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.136 -1.603 . . . . 0.0 110.0 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.707 HG11 HG21 ' A' ' 77' ' ' VAL . 82.0 t -66.45 -44.53 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.46 -0.775 . . . . 0.0 112.294 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -61.35 -45.15 95.58 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.733 -1.23 . . . . 0.0 109.859 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -70.15 -37.09 75.14 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.134 -0.979 . . . . 0.0 108.701 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -65.61 -41.67 92.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.145 -0.972 . . . . 0.0 110.345 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.58 -39.53 80.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.843 -1.161 . . . . 0.0 110.475 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 66.1 ttp -63.19 -43.57 97.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.839 -1.163 . . . . 0.0 109.386 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -63.35 -47.09 83.6 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.249 -0.981 . . . . 0.0 109.443 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.8 t -64.51 -43.92 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.165 -0.96 . . . . 0.0 110.129 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' A' ' 56' ' ' MET . 63.2 t80 -58.84 -46.27 88.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.837 -1.164 . . . . 0.0 109.784 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -75.49 -37.05 60.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.062 -1.024 . . . . 0.0 110.464 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -61.84 -39.97 93.68 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.058 -1.026 . . . . 0.0 109.627 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.9 mt -78.89 3.38 17.1 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.624 178.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.7 mttp 59.05 30.85 20.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.507 -0.746 . . . . 0.0 111.083 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.714 ' SD ' HD13 ' A' ' 66' ' ' LEU . 62.1 mtt -70.0 -28.95 65.93 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.213 -0.93 . . . . 0.0 109.247 178.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -67.89 -9.49 45.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 109.832 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -84.61 84.69 7.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.614 -1.304 . . . . 0.0 110.93 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.753 HG23 ' OE1' ' A' ' 137' ' ' GLU . 92.1 m -135.27 151.88 50.98 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -60.54 -42.45 96.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.168 -0.957 . . . . 0.0 111.09 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.0 mt -99.85 0.41 41.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.086 -1.009 . . . . 0.0 111.112 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 56.85 32.47 21.45 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.194 0.997 . . . . 0.0 111.825 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.624 ' C ' HD11 ' A' ' 84' ' ' ILE . 98.6 m-20 -107.31 51.74 0.73 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.792 0.806 . . . . 0.0 109.289 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.421 ' N ' HD11 ' A' ' 84' ' ' ILE . . . -99.64 141.99 15.75 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.462 ' CG2' HD13 ' A' ' 84' ' ' ILE . 54.5 t -123.38 133.71 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.138 -1.213 . . . . 0.0 110.191 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.714 HD13 ' SD ' ' A' ' 56' ' ' MET . 61.0 tp -115.38 124.0 50.1 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.394 -0.816 . . . . 0.0 109.203 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.626 ' HB ' HG22 ' A' ' 33' ' ' VAL . 68.4 mt -106.2 107.25 22.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.121 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -94.08 126.02 39.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.168 -0.957 . . . . 0.0 110.124 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.9 t -120.89 133.13 68.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.873 0.844 . . . . 0.0 110.366 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.53 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -101.94 92.65 4.89 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.998 HG13 HD11 ' A' ' 35' ' ' LEU . 29.1 m -64.85 -23.1 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.23 -0.919 . . . . 0.0 111.0 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 51.2 tp10 -67.76 -44.21 78.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.809 -1.182 . . . . 0.0 108.585 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.59 ' O ' HG23 ' A' ' 75' ' ' THR . 92.0 m-20 -100.82 8.45 43.19 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.205 -0.934 . . . . 0.0 110.562 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.6 tttt 51.07 44.18 28.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.956 -1.09 . . . . 0.0 110.488 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 73' ' ' ASP . 23.3 p -121.31 166.34 14.19 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.431 -0.793 . . . . 0.0 109.269 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 47.3 p90 -145.08 138.23 26.52 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.048 -1.033 . . . . 0.0 110.505 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.707 HG21 HG11 ' A' ' 43' ' ' VAL . 50.0 t -127.5 135.29 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.718 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 72.3 mt -114.17 121.93 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.836 -1.165 . . . . 0.0 109.848 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -128.76 112.41 14.16 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.463 -0.773 . . . . 0.0 109.925 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -99.9 175.19 27.31 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -81.14 174.14 11.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.579 -0.954 . . . . 0.0 110.327 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.87 -25.68 65.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 110.328 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.478 ' O ' HG12 ' A' ' 87' ' ' VAL . . . -64.98 -53.1 35.93 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.143 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.979 ' O ' HG22 ' A' ' 88' ' ' VAL . 3.2 mt -65.25 -45.14 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.86 -1.376 . . . . 0.0 107.822 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.49 -36.29 82.03 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 111.425 -177.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -77.11 -22.85 52.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.082 -1.012 . . . . 0.0 111.711 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.991 HG13 HG13 ' A' ' 88' ' ' VAL . 8.9 p -102.61 -23.87 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.876 -1.14 . . . . 0.0 112.738 -178.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.991 HG13 HG13 ' A' ' 87' ' ' VAL . 15.6 m -118.52 165.46 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 120.388 -1.445 . . . . 0.0 111.474 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.8 p -110.34 -179.05 3.66 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.305 -0.872 . . . . 0.0 112.482 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.57 -35.42 80.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.284 -0.885 . . . . 0.0 109.812 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -61.96 -38.33 88.1 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 108.833 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.903 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 71.1 t80 -69.35 -26.09 64.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.626 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.718 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.9 m95 -85.97 -27.66 24.73 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.989 0.9 . . . . 0.0 110.322 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -54.26 -41.24 68.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.483 -0.76 . . . . 0.0 112.096 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 79.3 p -64.42 -32.87 74.67 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.888 -1.132 . . . . 0.0 109.668 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.413 HG22 HD13 ' A' ' 78' ' ' ILE 0.28 9.1 m -58.78 -49.5 77.43 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.329 1.061 . . . . 0.0 111.129 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -68.2 -38.62 82.17 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.305 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -63.64 -42.95 98.08 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.039 -1.065 . . . . 0.0 110.386 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.41 -50.83 69.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.825 -1.172 . . . . 0.0 111.294 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 93.1 mt -67.11 -42.79 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.111 -0.993 . . . . 0.0 109.888 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.434 ' CG ' ' HE3' ' A' ' 105' ' ' LYS . 52.4 tt0 -63.15 -45.35 92.28 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.662 -0.649 . . . . 0.0 111.317 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.695 ' O ' HD13 ' A' ' 102' ' ' LEU . 1.5 tm? -62.21 -41.55 98.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.895 -1.128 . . . . 0.0 111.721 -178.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.416 ' HB3' ' CA ' ' A' ' 112' ' ' GLY . 1.2 tp-100 -75.64 -38.09 59.15 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.815 -1.154 . . . . 0.0 108.725 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -60.51 -41.07 93.59 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.434 ' HE3' ' CG ' ' A' ' 101' ' ' GLN . 92.0 mttt -61.35 -32.62 72.52 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.928 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -79.9 -17.31 53.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.855 -1.153 . . . . 0.0 110.093 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.42 6.35 44.58 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 119.892 -1.147 . . . . 0.0 111.322 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -103.42 89.51 3.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.624 -1.515 . . . . 0.0 109.946 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -62.19 -42.73 99.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.634 -0.666 . . . . 0.0 111.336 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.457 ' O ' HG23 ' A' ' 114' ' ' VAL . 85.7 tttt -62.47 -48.47 79.48 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.441 -177.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.412 ' HB3' ' HG2' ' A' ' 103' ' ' GLN . 58.5 tt0 -65.28 -37.95 88.75 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.848 -177.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -64.0 -51.29 54.51 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.487 -1.34 . . . . 0.0 110.091 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.0 mt -64.59 -43.8 92.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.01 -1.288 . . . . 0.0 110.988 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.646 HG22 HG13 ' A' ' 16' ' ' ILE . 88.2 t -63.93 -48.67 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.88 -1.137 . . . . 0.0 110.488 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -63.87 -39.7 94.82 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.943 -1.098 . . . . 0.0 110.103 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.7 -41.88 99.77 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.909 HD13 HD11 ' A' ' 20' ' ' ILE . 85.1 mt -64.08 -44.63 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.262 -1.14 . . . . 0.0 109.9 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -57.32 -47.19 82.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.102 -0.999 . . . . 0.0 109.242 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.46 -42.81 98.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -0.879 . . . . 0.0 109.067 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.84 -46.41 74.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 0.0 110.039 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.47 -42.69 97.44 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.783 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 86.3 mtp -66.35 -44.63 82.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.847 -1.384 . . . . 0.0 110.016 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.903 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -65.48 -45.4 83.8 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.01 -39.26 94.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.61 -33.88 61.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.936 . . . . 0.0 109.937 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.28 -40.76 95.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 0.0 108.65 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.5 ' HB3' ' CE1' ' A' ' 128' ' ' PHE . 68.4 m-85 -78.56 -35.44 45.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.44 -0.787 . . . . 0.0 110.099 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' A' ' 127' ' ' TYR . 73.7 m-85 -133.97 96.91 15.69 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.002 -1.061 . . . . 0.0 110.622 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.07 152.9 72.82 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.517 1.272 . . . . 0.0 110.542 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.475 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 45.7 t90 -74.17 133.51 42.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.428 -0.795 . . . . 0.0 111.812 -178.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -112.16 151.74 29.15 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.12 -32.33 70.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.913 -1.117 . . . . 0.0 111.454 -176.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -89.47 8.29 31.74 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.831 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -42.4 138.09 1.87 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.494 -0.754 . . . . 0.0 111.342 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.558 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -112.01 138.34 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.613 -177.407 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -94.9 90.44 6.0 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.084 -1.01 . . . . 0.0 109.379 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.753 ' OE1' HG23 ' A' ' 59' ' ' THR . 87.3 mt-10 -66.95 -41.7 86.47 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.66 -0.65 . . . . 0.0 112.505 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.81 HD22 ' HD2' ' A' ' 32' ' ' ARG . 4.5 mt -103.99 151.62 38.95 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.025 -1.047 . . . . 0.0 111.277 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.657 ' HD2' HD23 ' A' ' 138' ' ' LEU . 47.3 Cg_endo -75.04 -175.92 2.62 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 N-CA-C 108.315 -1.456 . . . . 0.0 108.315 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.417 ' ND2' HG22 ' A' ' 20' ' ' ILE . 25.6 m120 -117.48 3.87 12.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.656 -1.278 . . . . 0.0 109.842 178.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 33.5 m -60.58 137.26 58.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.793 -1.192 . . . . 0.0 109.811 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 16' ' ' ILE . 94.7 mt -68.65 138.94 21.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.491 -0.755 . . . . 0.0 110.955 -179.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 24.3 m -91.01 131.64 36.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.342 -0.849 . . . . 0.0 109.046 178.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -127.09 127.67 45.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.98 -1.075 . . . . 0.0 110.559 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.411 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.2 mtm . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.283 0.563 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.4 t -62.29 -43.34 99.05 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.394 -0.816 . . . . 0.0 109.225 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -82.55 119.44 24.24 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.21 -0.931 . . . . 0.0 109.149 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.7 pt -93.66 -9.95 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.769 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -65.71 -42.77 90.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.945 -1.097 . . . . 0.0 109.983 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -118.04 115.22 24.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.464 -0.772 . . . . 0.0 109.767 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 1.046 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 72.9 m-85 -62.59 -42.35 99.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 0.0 110.718 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 12' ' ' GLU . 95.0 mt -129.97 150.55 51.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.029 -1.044 . . . . 0.0 110.175 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.7 p -79.46 169.42 18.08 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.189 -0.944 . . . . 0.0 109.227 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.18 -36.32 68.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.95 -1.094 . . . . 0.0 109.639 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -64.31 -40.5 96.05 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.249 -0.907 . . . . 0.0 109.442 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.458 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 76.8 mm-40 -70.25 -50.81 35.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 0.0 110.643 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.54 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.3 mt-10 -64.66 -33.37 75.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.419 -0.801 . . . . 0.0 110.441 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.4 -45.15 94.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.967 -1.083 . . . . 0.0 110.378 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB3' ' CE ' ' A' ' 110' ' ' LYS . . . -66.31 -42.28 88.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.091 -1.006 . . . . 0.0 111.642 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.582 HG13 HG22 ' A' ' 114' ' ' VAL . 21.2 tt -68.56 -39.26 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.552 -1.343 . . . . 0.0 111.151 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 13' ' ' GLU . 89.9 t -63.1 -39.13 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.886 -1.134 . . . . 0.0 108.622 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -63.37 -36.16 82.78 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.3 -0.96 . . . . 0.0 109.241 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.26 -41.38 96.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -0.87 . . . . 0.0 109.533 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.903 HG22 ' OD1' ' A' ' 140' ' ' ASN . 96.7 mt -64.0 -43.11 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.445 -0.784 . . . . 0.0 109.572 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.406 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 99.5 mtt180 -58.28 -43.11 87.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 109.896 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -64.5 -35.56 81.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.422 -0.799 . . . . 0.0 111.115 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.81 -39.57 93.8 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.976 -1.078 . . . . 0.0 110.175 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -60.39 -16.47 35.83 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.036 -1.04 . . . . 0.0 110.985 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 97.9 mttt -94.79 0.66 55.09 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.139 -0.976 . . . . 0.0 109.556 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -112.73 -16.94 12.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.949 -1.095 . . . . 0.0 109.66 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.6 t -154.17 159.05 41.22 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.935 -1.103 . . . . 0.0 109.687 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.4 p -86.23 -6.55 58.95 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.194 -0.941 . . . . 0.0 110.587 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.49 170.41 50.75 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.41 ' CG ' ' HB2' ' A' ' 138' ' ' LEU . 68.6 mm-40 -129.66 132.79 46.79 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.128 -1.219 . . . . 0.0 111.181 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.3 mt -115.79 132.83 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -138.88 149.88 45.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.136 -0.977 . . . . 0.0 109.82 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.74 HG22 HD12 ' A' ' 67' ' ' ILE . 53.4 t -118.22 137.04 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.387 -0.821 . . . . 0.0 111.006 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -122.05 120.33 34.02 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.624 HD11 ' CG1' ' A' ' 71' ' ' VAL . 35.2 tp -112.16 126.01 54.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.496 -0.753 . . . . 0.0 111.396 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 83.3 tt0 -141.59 167.59 21.78 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.41 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 99.5 mttt -78.38 -75.57 0.22 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.935 -1.103 . . . . 0.0 113.411 -177.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 t -142.12 157.62 44.69 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.119 -0.988 . . . . 0.0 110.063 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.9 m -110.38 170.45 8.08 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.374 -0.829 . . . . 0.0 110.999 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -108.03 -9.46 15.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.398 -0.814 . . . . 0.0 110.556 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.426 HG13 ' N ' ' A' ' 42' ' ' ASP . 27.3 pt -127.56 -122.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.726 -1.234 . . . . 0.0 110.47 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.426 ' N ' HG13 ' A' ' 41' ' ' ILE . 97.5 m-20 -111.39 138.06 48.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.113 -1.617 . . . . 0.0 109.755 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.457 ' CG1' HG21 ' A' ' 77' ' ' VAL . 99.0 t -64.99 -42.79 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.444 -0.785 . . . . 0.0 111.426 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -59.9 -46.32 89.71 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.9 -1.125 . . . . 0.0 110.409 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -71.55 -40.67 69.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.977 -1.077 . . . . 0.0 108.282 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -61.4 -40.86 95.92 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.404 -0.81 . . . . 0.0 110.965 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.23 81.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.621 -1.3 . . . . 0.0 109.71 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 64.0 ttp -62.98 -43.34 99.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.209 -0.932 . . . . 0.0 109.792 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -64.01 -45.03 90.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.987 -1.071 . . . . 0.0 109.762 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.29 -43.53 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.306 -0.871 . . . . 0.0 110.003 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 6.9 t80 -57.84 -47.47 82.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.88 -1.137 . . . . 0.0 109.547 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -73.87 -35.64 64.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.992 -1.067 . . . . 0.0 109.843 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -61.09 -38.8 87.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.141 -0.974 . . . . 0.0 108.657 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.6 mt -80.22 3.25 21.39 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.359 -0.838 . . . . 0.0 110.141 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 29.8 tttt 57.14 32.46 21.73 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.936 -1.103 . . . . 0.0 111.706 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.596 ' SD ' HD13 ' A' ' 66' ' ' LEU . 98.9 mtp -66.39 -12.16 55.41 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.336 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -76.62 -1.74 29.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.939 -1.101 . . . . 0.0 109.529 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -75.44 63.22 1.44 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.889 -1.132 . . . . 0.0 110.129 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.3 p -134.62 150.27 50.67 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -65.2 -42.89 93.07 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.622 -0.674 . . . . 0.0 112.455 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 94.4 mt -96.33 -1.83 47.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.914 -1.116 . . . . 0.0 111.514 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 57.25 48.4 15.14 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 122.536 1.16 . . . . 0.0 110.797 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.8 p30 -122.45 53.04 1.27 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.885 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.42 146.92 16.61 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.54 HG23 ' CD1' ' A' ' 84' ' ' ILE . 72.7 t -128.06 134.72 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.116 -1.226 . . . . 0.0 110.361 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.596 HD13 ' SD ' ' A' ' 56' ' ' MET . 36.6 tp -116.67 128.18 55.11 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.59 -0.694 . . . . 0.0 109.381 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.74 HD12 HG22 ' A' ' 33' ' ' VAL . 86.0 mt -102.99 112.33 36.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.473 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -99.23 117.32 33.43 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.25 -0.906 . . . . 0.0 109.247 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 72.5 t -118.91 130.88 73.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-O 122.101 0.953 . . . . 0.0 110.709 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.481 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -99.86 101.12 12.16 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.046 HG21 ' CZ ' ' A' ' 7' ' ' PHE . 27.3 m -70.43 -20.28 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.006 . . . . 0.0 111.048 -178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -67.51 -44.02 79.43 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.792 -1.192 . . . . 0.0 109.016 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -102.52 3.63 37.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.284 -0.885 . . . . 0.0 110.759 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.4 tttt 56.74 48.77 15.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.831 -1.168 . . . . 0.0 111.123 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 76.7 p -122.4 164.02 18.75 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.095 -1.003 . . . . 0.0 109.917 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -143.57 141.37 30.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.489 -0.757 . . . . 0.0 110.146 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.457 HG21 ' CG1' ' A' ' 43' ' ' VAL . 64.4 t -126.82 136.06 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.606 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 66.7 mt -113.84 122.66 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.955 -1.091 . . . . 0.0 109.769 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -128.6 112.92 14.8 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.555 -0.716 . . . . 0.0 110.68 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -96.18 165.82 24.2 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 82' ' ' LYS . 54.1 t0 -75.28 175.05 8.71 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.346 -1.09 . . . . 0.0 109.642 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.409 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 86.1 tttt -59.24 -26.96 65.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 110.657 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.28 -52.25 42.16 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.604 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.972 ' O ' HG22 ' A' ' 88' ' ' VAL . 82.2 mt -64.94 -44.2 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.785 -1.42 . . . . 0.0 108.579 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -61.66 -38.07 86.37 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.004 -1.06 . . . . 0.0 111.34 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -73.05 -22.91 60.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.033 -1.042 . . . . 0.0 112.676 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.987 HG13 HG13 ' A' ' 88' ' ' VAL . 8.5 p -101.16 -19.48 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.78 -1.2 . . . . 0.0 112.472 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.987 HG13 HG13 ' A' ' 87' ' ' VAL . 19.5 m -119.54 163.61 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.712 -1.243 . . . . 0.0 111.642 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 61.9 p -108.66 -179.94 4.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.47 -0.769 . . . . 0.0 111.525 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -61.83 -38.63 88.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 109.231 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -60.1 -39.93 87.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.46 -0.775 . . . . 0.0 109.421 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.813 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 90.5 t80 -66.2 -24.29 66.59 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.158 -0.964 . . . . 0.0 109.537 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.606 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.2 m95 -87.97 -25.33 23.22 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.919 0.866 . . . . 0.0 110.656 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -57.52 -37.05 72.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.885 . . . . 0.0 111.999 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.4 p -67.67 -31.57 71.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.713 -1.242 . . . . 0.0 109.275 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.453 HG22 HD13 ' A' ' 78' ' ' ILE 0.277 15.9 m -60.89 -49.06 78.99 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 122.444 1.116 . . . . 0.0 111.097 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -69.44 -38.21 77.72 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.911 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -63.6 -42.62 98.24 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.939 -1.1 . . . . 0.0 110.566 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.01 -49.56 69.72 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.801 -1.187 . . . . 0.0 111.515 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.81 -42.26 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.954 -1.091 . . . . 0.0 109.503 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -62.13 -44.42 96.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.346 -0.846 . . . . 0.0 111.18 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.2 tp -63.66 -42.17 98.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -0.963 . . . . 0.0 111.813 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.475 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 97.6 mm-40 -72.86 -43.82 62.11 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.361 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -58.68 -39.56 81.04 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.55 -33.21 72.34 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -78.2 -18.42 55.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 0.0 109.695 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.23 2.04 44.68 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.832 -1.175 . . . . 0.0 111.182 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.2 94.23 5.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.725 -1.456 . . . . 0.0 109.541 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -63.05 -42.34 99.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.767 -0.583 . . . . 0.0 111.066 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.458 ' NZ ' ' HA ' ' A' ' 12' ' ' GLU . 85.7 tttt -64.44 -48.31 75.8 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.868 -1.145 . . . . 0.0 112.006 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -62.65 -37.96 88.41 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 118.752 -1.179 . . . . 0.0 109.638 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.475 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -64.22 -50.61 59.03 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.04 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.7 mt -64.6 -43.85 92.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.161 -1.199 . . . . 0.0 111.164 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.582 HG22 HG13 ' A' ' 16' ' ' ILE . 83.6 t -64.93 -48.57 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.694 -1.254 . . . . 0.0 110.511 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -63.51 -38.35 90.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 109.624 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.91 -41.99 99.77 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.6 mt -63.32 -43.74 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -1.195 . . . . 0.0 108.975 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -58.96 -50.83 72.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.124 -0.985 . . . . 0.0 110.499 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.16 -41.11 97.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 109.052 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -42.63 95.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.883 . . . . 0.0 110.671 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.32 -44.01 96.06 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.962 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 97.1 mtp -67.8 -43.0 80.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.921 -1.34 . . . . 0.0 109.394 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.813 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -64.45 -46.89 81.18 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.255 -0.903 . . . . 0.0 108.885 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 76.6 mt -62.15 -40.73 96.94 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.478 -0.764 . . . . 0.0 109.126 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.74 -34.49 62.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.383 -0.823 . . . . 0.0 110.671 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.16 -42.77 99.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.05 -1.031 . . . . 0.0 108.954 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.459 ' CD2' HG22 ' A' ' 87' ' ' VAL . 66.8 m-85 -75.12 -40.0 60.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.624 -0.673 . . . . 0.0 109.791 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -130.94 92.08 34.8 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.383 -0.823 . . . . 0.0 109.393 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.13 151.39 83.81 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.472 1.248 . . . . 0.0 110.044 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.483 ' CH2' ' HA ' ' A' ' 132' ' ' LYS . 73.9 t90 -72.67 131.85 42.92 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.596 -0.69 . . . . 0.0 110.826 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -108.41 149.77 28.29 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.483 ' HA ' ' CH2' ' A' ' 130' ' ' TRP . 87.8 tttt -57.88 -28.91 64.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -0.999 . . . . 0.0 110.799 -177.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -89.47 8.37 31.31 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.797 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -43.88 136.93 3.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.297 -0.877 . . . . 0.0 111.65 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.712 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -112.24 143.58 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.355 0.598 . . . . 0.0 110.764 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -96.4 93.44 6.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.009 -1.057 . . . . 0.0 109.789 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.475 ' HG3' HD13 ' A' ' 135' ' ' ILE . 97.5 mt-10 -69.1 -35.8 76.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.66 -0.65 . . . . 0.0 111.901 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.422 ' HG ' ' HD2' ' A' ' 139' ' ' PRO . 1.1 mp -112.08 152.09 44.09 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.101 -0.999 . . . . 0.0 111.928 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.422 ' HD2' ' HG ' ' A' ' 138' ' ' LEU . 46.6 Cg_endo -76.09 -170.81 0.92 Allowed 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.633 1.333 . . . . 0.0 108.694 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.903 ' OD1' HG22 ' A' ' 20' ' ' ILE . 67.8 m-80 -122.97 2.95 9.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.661 -1.274 . . . . 0.0 110.066 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.4 m -64.02 139.87 58.81 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.854 -1.154 . . . . 0.0 110.805 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.474 HG13 HG22 ' A' ' 17' ' ' VAL . 95.0 mt -73.49 140.33 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.437 -0.79 . . . . 0.0 110.876 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 24.4 m -97.13 139.77 32.63 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.47 -0.769 . . . . 0.0 109.341 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -131.36 147.99 52.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.093 -1.004 . . . . 0.0 110.979 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.137 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.752 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.6 mtm . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.524 0.678 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m -67.32 148.1 52.11 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.472 -0.768 . . . . 0.0 109.783 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.57 -42.8 99.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.007 -1.058 . . . . 0.0 110.008 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 90.7 mt -63.95 -44.79 98.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.822 . . . . 0.0 110.272 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -70.27 -30.5 67.55 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.338 -0.851 . . . . 0.0 110.013 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -54.32 -45.71 72.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.076 -1.015 . . . . 0.0 110.542 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.547 ' CD2' HD22 ' A' ' 35' ' ' LEU . 19.6 t80 -69.92 -72.6 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.075 -1.016 . . . . 0.0 110.052 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.531 HD12 ' CE2' ' A' ' 7' ' ' PHE . 97.7 mt -133.27 152.8 51.94 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.958 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.0 p -81.18 169.28 17.56 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.569 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.96 -40.32 66.74 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.969 -1.082 . . . . 0.0 109.917 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -61.04 -43.87 98.25 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.632 -0.667 . . . . 0.0 109.769 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.46 -45.77 68.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.289 -0.882 . . . . 0.0 111.011 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.577 ' O ' HG23 ' A' ' 17' ' ' VAL . 95.1 mt-10 -66.46 -34.49 78.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.954 . . . . 0.0 109.715 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.06 -46.19 85.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.923 -1.11 . . . . 0.0 110.404 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.72 -41.92 95.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.063 -1.023 . . . . 0.0 111.451 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.634 HG13 HG22 ' A' ' 114' ' ' VAL . 18.5 tt -68.41 -39.44 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.869 -1.144 . . . . 0.0 110.549 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 13' ' ' GLU . 77.6 t -63.77 -41.5 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -60.93 -40.34 92.85 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.435 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.12 -36.03 78.63 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.379 -0.826 . . . . 0.0 109.341 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.868 HD11 HD13 ' A' ' 117' ' ' ILE . 30.3 mm -62.9 -42.1 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -58.81 -42.83 90.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.819 -0.551 . . . . 0.0 110.041 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -65.26 -40.61 94.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.052 -1.03 . . . . 0.0 111.113 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.07 -40.84 95.2 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.843 -1.161 . . . . 0.0 110.495 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -60.66 -13.98 17.87 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.441 -1.412 . . . . 0.0 111.127 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.488 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.8 mttt -95.15 0.98 54.7 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.067 -1.021 . . . . 0.0 109.449 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -112.91 -16.66 12.66 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.35 -0.844 . . . . 0.0 110.298 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.0 t -151.51 157.93 42.94 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.073 -1.017 . . . . 0.0 110.206 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.4 p -87.74 -7.36 57.45 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.488 -0.758 . . . . 0.0 110.194 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.31 172.92 49.6 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.656 ' HG3' HD13 ' A' ' 138' ' ' LEU . 80.6 mm-40 -132.02 133.86 44.9 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.162 -1.199 . . . . 0.0 111.725 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.5 mt -117.57 134.5 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 121.184 0.516 . . . . 0.0 110.124 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.572 ' NH1' HD13 ' A' ' 54' ' ' LEU . 69.7 ttt180 -139.86 156.44 46.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.395 -0.815 . . . . 0.0 110.166 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.423 HG13 HG23 ' A' ' 142' ' ' ILE . 3.5 p -124.29 138.24 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.265 -0.897 . . . . 0.0 110.62 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.806 ' HB2' HD11 ' A' ' 66' ' ' LEU . 57.0 t60 -121.42 119.82 33.18 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.547 HD22 ' CD2' ' A' ' 7' ' ' PHE . 46.1 tp -111.48 135.26 52.29 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.116 0.96 . . . . 0.0 111.974 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.464 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 76.4 tt0 -151.61 166.21 31.93 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.643 ' HA ' HG22 ' A' ' 71' ' ' VAL . 98.7 mttt -78.41 -72.0 0.4 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.896 -1.127 . . . . 0.0 112.889 -176.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.8 t -142.72 157.88 44.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.915 -1.116 . . . . 0.0 109.937 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.6 p -102.51 164.88 11.41 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.465 -0.772 . . . . 0.0 111.138 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -105.42 -24.56 12.62 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.455 -0.778 . . . . 0.0 109.377 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.413 HG13 ' N ' ' A' ' 42' ' ' ASP . 24.8 pt -111.9 -121.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.099 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.413 ' N ' HG13 ' A' ' 41' ' ' ILE . 97.0 m-20 -110.61 141.43 43.82 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.248 -1.532 . . . . 0.0 109.589 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.7 t -64.35 -43.22 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.355 -0.841 . . . . 0.0 111.21 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -61.18 -46.25 91.25 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.877 -1.139 . . . . 0.0 110.29 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -70.42 -40.14 74.0 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.897 -1.127 . . . . 0.0 108.413 177.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -62.9 -41.8 99.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.344 -0.847 . . . . 0.0 111.185 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.74 -39.29 80.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.947 -1.096 . . . . 0.0 110.187 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 66.3 ttp -63.0 -42.49 99.86 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.096 -1.003 . . . . 0.0 109.934 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -65.41 -40.66 93.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.021 -1.049 . . . . 0.0 109.82 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.8 t -69.58 -43.67 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.454 -0.779 . . . . 0.0 109.441 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.519 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 3.6 t80 -58.16 -46.85 84.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.048 -1.032 . . . . 0.0 108.824 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -73.15 -35.58 66.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.023 -1.048 . . . . 0.0 109.56 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -61.91 -37.32 84.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.012 -1.055 . . . . 0.0 109.329 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.572 HD13 ' NH1' ' A' ' 32' ' ' ARG . 98.6 mt -82.22 3.52 27.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.576 -0.702 . . . . 0.0 110.694 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.4 mttp 56.64 33.39 22.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.453 -0.78 . . . . 0.0 111.706 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.823 ' SD ' HD13 ' A' ' 66' ' ' LEU . 90.8 mtp -66.89 -14.25 62.56 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.416 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -75.68 -3.18 33.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.108 -0.995 . . . . 0.0 110.318 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -76.93 65.68 2.65 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.048 -1.033 . . . . 0.0 109.849 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.486 HG22 HD11 ' A' ' 138' ' ' LEU . 66.2 p -134.94 150.62 50.42 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.395 -0.816 . . . . 0.0 109.434 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -64.51 -47.32 79.32 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 84.6 mt -96.29 -1.06 48.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.863 -1.148 . . . . 0.0 111.332 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 76.0 mt-30 60.94 45.29 9.64 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 122.61 1.195 . . . . 0.0 111.479 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.445 ' HA ' HG13 ' A' ' 84' ' ' ILE . 34.8 m-80 -120.03 51.34 1.2 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.132 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.18 141.03 15.33 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.268 -1.933 . . . . 0.0 108.268 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.506 HG23 ' CD1' ' A' ' 84' ' ' ILE . 55.6 t -122.51 134.36 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.816 -1.402 . . . . 0.0 110.367 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.823 HD13 ' SD ' ' A' ' 56' ' ' MET . 41.1 tp -116.76 124.51 49.79 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.962 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 98.7 mt -102.36 105.2 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.965 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 34' ' ' HIS . 56.1 t80 -92.65 121.64 34.27 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.357 -0.839 . . . . 0.0 110.0 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.9 t -122.42 130.13 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.348 -0.845 . . . . 0.0 111.034 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.77 99.76 11.11 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.643 HG22 ' HA ' ' A' ' 37' ' ' LYS . 32.7 m -68.35 -20.53 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.97 -1.081 . . . . 0.0 110.451 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.449 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 66.1 mm-40 -70.85 -47.92 56.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.946 -1.096 . . . . 0.0 109.575 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -97.67 3.37 50.32 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.215 -0.928 . . . . 0.0 110.586 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt 54.44 46.08 25.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.103 -0.998 . . . . 0.0 110.99 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.4 m -121.72 132.69 54.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.082 -1.011 . . . . 0.0 110.303 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 76' ' ' PHE . 53.4 p90 -112.13 139.55 47.56 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.445 -0.785 . . . . 0.0 110.468 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 50.4 t -130.43 140.57 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.299 -0.876 . . . . 0.0 109.37 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.705 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 90.3 mt -118.07 127.98 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.783 -1.198 . . . . 0.0 111.032 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -130.42 116.47 18.29 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.638 -0.664 . . . . 0.0 110.285 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.43 167.4 15.64 Favored Glycine 0 N--CA 1.483 1.769 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.48 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 73.7 m-20 -77.86 178.2 7.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.546 -0.973 . . . . 0.0 110.848 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -62.05 -27.21 68.73 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.644 -0.66 . . . . 0.0 110.139 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.415 ' O ' HG12 ' A' ' 87' ' ' VAL . . . -62.37 -55.54 26.98 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.615 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.979 ' O ' HG22 ' A' ' 88' ' ' VAL . 76.5 mt -66.18 -44.56 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.703 -1.469 . . . . 0.0 108.546 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -61.31 -36.44 80.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.049 -1.032 . . . . 0.0 111.003 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -76.74 -21.84 54.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 111.524 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.968 HG13 HG13 ' A' ' 88' ' ' VAL . 10.5 p -103.45 -23.37 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.724 -1.235 . . . . 0.0 112.462 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.979 HG22 ' O ' ' A' ' 84' ' ' ILE . 20.3 m -118.88 164.41 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.64 -1.287 . . . . 0.0 111.011 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.5 p -109.34 178.52 4.42 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.406 -0.809 . . . . 0.0 112.434 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -62.89 -35.65 80.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.878 . . . . 0.0 109.137 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -61.47 -37.78 84.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.162 -0.961 . . . . 0.0 109.008 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.775 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 54.4 t80 -68.26 -25.21 65.06 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 108.984 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.705 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.8 m95 -86.63 -26.29 24.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.75 0.786 . . . . 0.0 110.846 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -58.84 -34.4 71.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.202 -0.936 . . . . 0.0 111.902 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 49.2 p -68.46 -32.65 72.81 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.276 -1.37 . . . . 0.0 108.683 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.268 16.6 m -59.74 -48.4 81.83 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 122.316 1.055 . . . . 0.0 110.852 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.44 -37.58 74.39 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.11 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -63.35 -43.85 96.52 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.824 -1.172 . . . . 0.0 110.125 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.03 -48.25 77.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.89 -1.131 . . . . 0.0 110.935 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 94.2 mt -67.7 -42.67 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.064 -1.022 . . . . 0.0 110.06 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -64.53 -41.67 96.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.124 -0.985 . . . . 0.0 110.648 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.8 mt -63.73 -42.31 97.92 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.96 -1.088 . . . . 0.0 112.048 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.47 ' HB2' ' HA3' ' A' ' 112' ' ' GLY . 99.7 mm-40 -74.99 -39.18 61.39 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.293 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -61.65 -40.31 94.45 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -62.01 -32.9 73.42 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.689 -0.632 . . . . 0.0 110.036 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -84.67 -17.21 39.26 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.828 -1.17 . . . . 0.0 109.916 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.89 10.53 34.66 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.09 -1.052 . . . . 0.0 110.503 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -104.6 79.58 1.57 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.854 -1.38 . . . . 0.0 109.35 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -60.68 -43.76 97.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.787 -0.571 . . . . 0.0 111.138 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.536 ' O ' HG23 ' A' ' 114' ' ' VAL . 74.3 tttt -62.33 -49.39 75.79 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.126 -0.984 . . . . 0.0 111.984 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -63.09 -37.89 89.01 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.887 -1.133 . . . . 0.0 110.313 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.47 ' HA3' ' HB2' ' A' ' 103' ' ' GLN . . . -64.47 -49.33 65.8 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.28 -43.35 98.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -1.143 . . . . 0.0 110.446 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.634 HG22 HG13 ' A' ' 16' ' ' ILE . 89.8 t -66.45 -46.99 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.084 -1.01 . . . . 0.0 110.074 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.78 -40.14 94.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.229 -0.919 . . . . 0.0 109.636 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.19 -41.9 99.62 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.868 HD13 HD11 ' A' ' 20' ' ' ILE . 93.9 mt -65.32 -44.27 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.371 -1.076 . . . . 0.0 110.298 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -57.2 -48.51 78.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.946 -1.096 . . . . 0.0 109.3 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.56 -42.05 98.37 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.481 -0.762 . . . . 0.0 109.506 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.57 -41.97 91.41 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.3 -0.875 . . . . 0.0 110.132 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.62 -44.7 89.16 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 98.7 mmm -65.49 -46.54 79.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.047 -1.266 . . . . 0.0 109.513 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.775 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -63.85 -44.73 92.29 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.21 -0.931 . . . . 0.0 109.128 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 37.8 mt -62.43 -40.41 96.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.937 . . . . 0.0 109.142 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.93 -35.04 61.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.151 -0.968 . . . . 0.0 110.454 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.09 -43.91 97.8 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.059 -1.025 . . . . 0.0 108.567 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.511 ' CD1' HG22 ' A' ' 87' ' ' VAL . 65.7 m-85 -72.39 -44.03 63.1 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.422 0.63 . . . . 0.0 109.81 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.412 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 62.9 m-85 -127.84 96.51 32.04 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.387 -0.82 . . . . 0.0 109.742 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 128' ' ' PHE . 42.3 Cg_endo -66.41 148.65 84.41 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.874 1.46 . . . . 0.0 110.304 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.488 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 72.6 t90 -73.87 133.09 43.1 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.422 -0.799 . . . . 0.0 110.262 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -111.34 147.79 34.37 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.41 ' HA ' ' CH2' ' A' ' 130' ' ' TRP . 99.5 mttt -54.18 -25.77 24.43 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.919 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -94.51 10.29 35.16 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 118.502 -1.279 . . . . 0.0 111.198 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -43.19 134.51 3.62 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.38 -0.825 . . . . 0.0 111.24 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.633 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -110.09 140.37 29.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.7 -178.596 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 45.6 p-10 -97.89 92.59 5.89 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.042 0.925 . . . . 0.0 110.206 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.09 -35.19 79.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.533 -0.729 . . . . 0.0 112.252 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.656 HD13 ' HG3' ' A' ' 30' ' ' GLU . 5.0 mp -108.96 152.78 42.6 Favored Pre-proline 0 N--CA 1.486 1.354 0 O-C-N 120.826 -1.172 . . . . 0.0 111.854 -178.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -75.13 -169.05 0.58 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 N-CA-C 108.0 -1.577 . . . . 0.0 108.0 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -123.74 4.66 8.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.572 -1.33 . . . . 0.0 110.418 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 61.7 p -62.38 171.86 1.74 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.074 -1.016 . . . . 0.0 110.556 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.423 HG23 HG13 ' A' ' 33' ' ' VAL . 95.0 mt -103.14 140.59 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.389 -0.819 . . . . 0.0 109.96 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 28.6 t -95.95 136.29 36.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.527 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -128.8 147.09 50.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.078 -1.013 . . . . 0.0 111.629 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.051 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.9 mtm . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 120.844 0.354 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.5 m -58.28 -41.43 84.32 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.615 -1.303 . . . . 0.0 109.822 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.23 -43.5 97.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 110.452 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.412 ' O ' HG13 ' A' ' 4' ' ' ILE . 39.9 pt -132.43 138.72 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.045 -1.035 . . . . 0.0 110.399 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.83 58.16 0.61 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.928 -1.108 . . . . 0.0 110.233 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 52.41 22.54 2.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.131 -0.981 . . . . 0.0 111.093 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.69 ' CD2' HD22 ' A' ' 35' ' ' LEU . 18.2 t80 -78.6 -73.7 0.31 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.122 -0.986 . . . . 0.0 110.446 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.525 ' CD1' ' CE2' ' A' ' 7' ' ' PHE . 96.4 mt -129.97 150.03 51.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.055 -1.028 . . . . 0.0 109.743 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 12' ' ' GLU . 6.6 t -77.48 170.94 15.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.038 -1.039 . . . . 0.0 109.587 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.03 -39.11 68.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 110.565 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -59.65 -46.21 89.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.125 -0.984 . . . . 0.0 110.759 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.428 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 99.7 mt-10 -70.08 -44.0 70.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 0.0 111.533 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.592 ' O ' HG23 ' A' ' 17' ' ' VAL . 95.6 mt-10 -65.99 -39.02 89.95 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.024 -1.047 . . . . 0.0 110.082 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.57 -45.57 93.59 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.938 -1.101 . . . . 0.0 110.539 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.06 -47.02 78.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.125 -0.984 . . . . 0.0 111.663 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.569 HG13 HG22 ' A' ' 114' ' ' VAL . 20.0 tt -63.79 -33.7 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.678 -1.264 . . . . 0.0 109.983 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 13' ' ' GLU . 55.9 t -64.91 -40.84 90.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -62.56 -35.13 78.5 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.104 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.73 -41.62 97.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.393 -0.817 . . . . 0.0 109.692 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.03 -43.14 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 0.0 109.493 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.411 ' HG2' ' OD1' ' A' ' 140' ' ' ASN . 93.6 mtt-85 -58.41 -44.45 89.04 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.464 -0.772 . . . . 0.0 110.183 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -63.28 -37.54 87.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.375 -0.828 . . . . 0.0 110.772 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.429 ' O ' HG22 ' A' ' 27' ' ' THR . . . -64.37 -40.64 96.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.077 -1.015 . . . . 0.0 110.187 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -60.99 -16.42 42.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.141 -0.974 . . . . 0.0 110.675 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.446 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.6 mttt -93.07 -1.3 56.65 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.059 -1.026 . . . . 0.0 109.229 177.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -110.93 -13.65 14.08 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 120.905 -1.122 . . . . 0.0 109.545 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 23' ' ' ALA . 3.9 t -151.28 158.67 44.16 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.977 -1.077 . . . . 0.0 110.329 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 94.2 p -89.31 -10.17 47.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 110.271 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.38 174.1 38.84 Favored Glycine 0 N--CA 1.485 1.967 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.421 ' N ' ' OE1' ' A' ' 30' ' ' GLU . 55.7 mp0 -131.09 136.28 48.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.221 -1.164 . . . . 0.0 110.968 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.3 mt -120.73 134.78 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.692 -0.63 . . . . 0.0 110.308 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -139.24 159.26 42.58 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.22 -0.925 . . . . 0.0 109.508 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 p -129.15 143.87 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.395 -0.816 . . . . 0.0 110.942 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.785 ' HB2' HD11 ' A' ' 66' ' ' LEU . 31.1 t60 -127.64 126.94 42.93 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.613 0.721 . . . . 0.0 109.578 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.69 HD22 ' CD2' ' A' ' 7' ' ' PHE . 3.4 tp -116.01 131.18 57.01 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.968 0.89 . . . . 0.0 111.46 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -146.53 162.87 37.41 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.58 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.1 mttt -77.38 -74.51 0.25 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.053 -1.029 . . . . 0.0 112.66 -177.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.5 t -138.65 155.66 48.11 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.747 0.784 . . . . 0.0 109.796 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.454 ' HB2' ' NE ' ' A' ' 46' ' ' ARG . 13.3 p -106.72 168.39 9.21 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.7 -0.625 . . . . 0.0 110.693 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -106.84 -22.9 12.55 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.183 -0.948 . . . . 0.0 110.8 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.413 HD11 HH21 ' A' ' 46' ' ' ARG . 18.4 pt -114.05 -121.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.348 -0.845 . . . . 0.0 109.957 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 41' ' ' ILE . 91.5 m-20 -110.72 137.4 48.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.071 -1.643 . . . . 0.0 109.067 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.48 ' CG1' HG21 ' A' ' 77' ' ' VAL . 85.5 t -63.44 -44.21 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 111.104 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -59.17 -45.82 90.01 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.762 -1.211 . . . . 0.0 110.375 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -71.98 -39.14 69.5 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.454 ' NE ' ' HB2' ' A' ' 39' ' ' SER . 57.1 ttm-85 -61.35 -44.44 97.17 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.3 -0.875 . . . . 0.0 110.91 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.25 -37.97 89.38 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.952 -1.093 . . . . 0.0 109.444 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 50.9 ttp -63.75 -43.81 95.34 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.341 -0.849 . . . . 0.0 110.258 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -65.92 -46.8 76.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.999 -1.063 . . . . 0.0 110.28 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.8 t -66.3 -43.66 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.978 -1.076 . . . . 0.0 109.821 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.497 ' CD1' ' HB2' ' A' ' 66' ' ' LEU . 25.9 t80 -58.83 -47.21 85.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.036 -1.04 . . . . 0.0 110.403 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -75.33 -37.11 60.9 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.668 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -60.59 -39.67 88.95 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.135 -0.978 . . . . 0.0 110.17 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.508 HD12 ' HE3' ' A' ' 56' ' ' MET . 91.5 mt -80.09 4.19 18.02 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.01 -1.056 . . . . 0.0 110.658 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.4 tttt 61.25 28.05 17.67 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.938 -1.101 . . . . 0.0 111.983 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.876 ' SD ' HD13 ' A' ' 66' ' ' LEU . 54.6 mtt -66.84 -24.56 66.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.02 -1.05 . . . . 0.0 108.669 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -70.46 -8.4 50.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.253 -0.904 . . . . 0.0 111.194 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -85.76 85.79 7.38 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.568 -1.332 . . . . 0.0 111.196 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.6 p -135.0 154.16 51.83 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.422 ' HB3' ' OE2' ' A' ' 137' ' ' GLU . 60.4 tttp -61.57 -41.09 96.89 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.069 -1.019 . . . . 0.0 111.929 -177.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.404 ' HB3' ' ND2' ' A' ' 63' ' ' ASN . 85.9 mt -100.03 4.63 44.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.008 -1.057 . . . . 0.0 111.21 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 85.5 mt-30 56.28 41.73 28.79 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.303 1.049 . . . . 0.0 111.156 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.404 ' ND2' ' HB3' ' A' ' 61' ' ' LEU . 88.5 m-20 -119.49 54.31 1.0 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.682 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.415 ' N ' ' OD2' ' A' ' 81' ' ' ASP . . . -100.65 140.23 14.8 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.64 HG23 ' CD1' ' A' ' 84' ' ' ILE . 40.9 t -123.7 134.48 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.997 -1.296 . . . . 0.0 110.507 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.876 HD13 ' SD ' ' A' ' 56' ' ' MET . 43.9 tp -116.74 125.93 52.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.367 -0.833 . . . . 0.0 110.108 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 92.9 mt -104.04 105.57 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.043 -1.063 . . . . 0.0 109.493 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -90.7 122.47 33.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.975 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.8 t -122.14 131.04 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 122.024 0.916 . . . . 0.0 111.305 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.593 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -102.28 102.17 12.53 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.58 HG22 ' HA ' ' A' ' 37' ' ' LYS . 17.4 m -70.12 -20.67 23.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 110.999 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.44 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 78.2 mm-40 -68.6 -46.25 69.83 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.634 -1.291 . . . . 0.0 109.598 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -99.4 1.9 44.7 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.515 -0.74 . . . . 0.0 110.438 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.442 ' HE3' ' CZ ' ' A' ' 109' ' ' PHE . 38.6 tttt 58.59 48.74 11.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.777 -1.202 . . . . 0.0 110.226 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.593 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 61.9 p -122.47 163.25 20.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.976 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -146.34 145.81 30.45 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.27 -0.894 . . . . 0.0 110.591 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.48 HG21 ' CG1' ' A' ' 43' ' ' VAL . 54.2 t -132.27 138.8 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.449 -0.782 . . . . 0.0 109.173 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.692 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 71.2 mt -115.14 125.36 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.925 -1.109 . . . . 0.0 109.9 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -131.45 117.92 19.49 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.279 -0.888 . . . . 0.0 110.678 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.47 168.84 16.68 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.415 ' OD2' ' N ' ' A' ' 64' ' ' GLY . 47.3 m-20 -81.73 179.19 7.93 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.606 -0.938 . . . . 0.0 110.444 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -61.6 -28.3 69.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.34 -0.85 . . . . 0.0 111.169 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.67 -56.18 22.82 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.59 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.964 ' O ' HG22 ' A' ' 88' ' ' VAL . 81.0 mt -65.41 -45.48 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.774 -1.427 . . . . 0.0 108.423 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -60.55 -38.93 86.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.005 -1.059 . . . . 0.0 111.661 -177.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -71.85 -24.13 61.64 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.072 -1.017 . . . . 0.0 111.878 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.014 HG13 HG13 ' A' ' 88' ' ' VAL . 8.9 p -102.96 -21.36 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.731 -1.231 . . . . 0.0 113.218 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.014 HG13 HG13 ' A' ' 87' ' ' VAL . 16.7 m -117.95 162.89 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.829 -1.17 . . . . 0.0 110.964 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.1 p -109.36 -178.71 3.63 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.226 1.012 . . . . 0.0 113.077 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -63.14 -36.29 83.12 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.618 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -64.88 -38.94 92.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.12 -0.987 . . . . 0.0 109.156 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.839 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 66.1 t80 -65.62 -24.45 67.05 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.194 -0.941 . . . . 0.0 109.16 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.692 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.5 m95 -86.55 -26.4 24.54 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.184 0.992 . . . . 0.0 110.355 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -60.11 -36.8 78.25 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.918 -1.114 . . . . 0.0 112.141 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 m -63.33 -34.49 77.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.778 -1.201 . . . . 0.0 108.517 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.273 9.4 m -60.14 -49.92 75.72 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 122.145 0.974 . . . . 0.0 112.592 -179.3 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -67.79 -35.44 78.67 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.48 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -64.1 -43.15 96.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.992 -1.067 . . . . 0.0 110.772 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.65 -48.49 79.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.755 -1.216 . . . . 0.0 110.27 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.8 mt -67.64 -42.67 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.919 -1.113 . . . . 0.0 110.353 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -63.18 -44.6 94.96 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 111.413 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 102' ' ' LEU . 77.4 mt -63.91 -41.06 97.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.311 -0.868 . . . . 0.0 112.303 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.469 ' HB2' ' HA3' ' A' ' 112' ' ' GLY . 98.8 mm-40 -73.93 -40.35 63.15 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 118.615 -1.234 . . . . 0.0 108.892 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -58.82 -41.06 85.94 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.2 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -64.18 -32.68 74.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.401 -0.812 . . . . 0.0 110.779 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -78.02 -19.68 53.92 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.79 -1.194 . . . . 0.0 109.87 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.59 3.39 34.91 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.889 -1.148 . . . . 0.0 111.383 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -105.6 90.55 3.44 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.634 -1.509 . . . . 0.0 110.404 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.442 ' CZ ' ' HE3' ' A' ' 74' ' ' LYS . 21.3 m-85 -64.24 -41.2 97.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.884 -0.51 . . . . 0.0 111.42 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.466 ' O ' HG23 ' A' ' 114' ' ' VAL . 85.7 tttt -62.98 -49.37 74.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.948 -1.095 . . . . 0.0 111.317 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -62.78 -40.82 98.48 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.055 -1.058 . . . . 0.0 109.888 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' A' ' 103' ' ' GLN . . . -61.71 -49.36 77.11 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.03 -43.73 91.42 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.323 -1.104 . . . . 0.0 111.757 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.569 HG22 HG13 ' A' ' 16' ' ' ILE . 81.2 t -64.49 -46.54 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.843 -1.16 . . . . 0.0 109.504 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.33 -41.4 96.81 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.456 -0.778 . . . . 0.0 110.803 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.51 -44.91 93.59 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 93.1 mt -65.25 -43.62 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.083 -1.245 . . . . 0.0 110.192 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 114' ' ' VAL . 79.7 mm-40 -55.34 -51.17 67.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.889 -1.132 . . . . 0.0 109.678 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.39 -42.41 99.4 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.3 -0.875 . . . . 0.0 109.088 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.409 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -58.14 -42.6 86.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.18 -0.95 . . . . 0.0 110.152 178.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.6 -44.11 96.98 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 9.4 ttm -67.37 -46.46 73.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.018 -1.284 . . . . 0.0 109.806 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.839 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -61.99 -46.24 90.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.238 -0.914 . . . . 0.0 109.21 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.409 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 66.1 mt -62.66 -40.35 96.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.421 -0.799 . . . . 0.0 108.917 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.73 -34.33 58.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.322 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.11 -43.06 99.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.015 -1.053 . . . . 0.0 109.094 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.458 ' CD2' HG22 ' A' ' 87' ' ' VAL . 80.6 m-85 -75.88 -37.48 58.85 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.616 0.722 . . . . 0.0 109.641 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -128.51 96.2 30.96 Favored Pre-proline 0 N--CA 1.485 1.307 0 O-C-N 121.703 -0.623 . . . . 0.0 109.911 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.98 148.3 81.64 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 O-C-N 123.583 1.307 . . . . 0.0 109.825 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.446 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 65.2 t90 -75.84 136.58 40.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.346 -0.846 . . . . 0.0 110.812 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 99.6 mttt -115.52 151.02 35.61 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 109.078 178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.92 -29.49 67.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.976 -1.077 . . . . 0.0 111.195 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -91.01 8.23 36.37 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.961 -1.096 . . . . 0.0 111.109 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 42.9 t0 -43.11 139.03 1.95 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.211 -0.931 . . . . 0.0 111.686 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.708 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -112.92 144.42 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.72 0.771 . . . . 0.0 111.476 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -99.38 92.7 5.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.68 -1.262 . . . . 0.0 110.028 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.514 ' HG3' HD13 ' A' ' 135' ' ' ILE . 96.7 mt-10 -69.58 -39.88 77.08 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.436 ' HG ' ' HD2' ' A' ' 139' ' ' PRO . 0.1 OUTLIER -108.44 150.68 40.93 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.02 -1.05 . . . . 0.0 111.995 -178.153 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.436 ' HD2' ' HG ' ' A' ' 138' ' ' LEU . 41.4 Cg_endo -71.71 -179.24 3.6 Favored 'Trans proline' 0 N--CA 1.486 1.046 0 O-C-N 123.527 1.278 . . . . 0.0 109.438 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.411 ' OD1' ' HG2' ' A' ' 21' ' ' ARG . 18.0 m120 -119.44 3.21 11.28 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.45 -1.406 . . . . 0.0 110.462 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.4 p -63.81 167.81 5.64 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.826 -1.171 . . . . 0.0 110.686 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 93.8 mt -94.69 136.27 26.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.649 0.738 . . . . 0.0 111.088 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 27.8 t -94.1 133.99 37.01 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.04 138.89 52.17 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.264 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.054 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.725 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 120.956 0.407 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.1 m -56.96 -42.05 79.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.676 -1.265 . . . . 0.0 110.346 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.411 ' HE2' ' HB2' ' A' ' 5' ' ' GLU . 87.6 tttt -131.89 139.29 48.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.164 -0.96 . . . . 0.0 109.73 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.3 mt -64.18 -43.86 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.188 -0.945 . . . . 0.0 111.115 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.411 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 78.8 mm-40 -62.12 -38.86 90.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.082 -1.011 . . . . 0.0 110.507 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -91.12 94.58 9.66 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.092 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.789 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 75.2 m-85 -59.98 -43.01 95.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.164 -0.96 . . . . 0.0 110.472 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.5 mt -131.37 151.77 51.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.033 -1.042 . . . . 0.0 110.616 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.9 p -81.12 168.09 18.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.031 -1.043 . . . . 0.0 109.318 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.61 -35.92 68.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.965 -1.084 . . . . 0.0 109.493 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -61.71 -46.39 89.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.544 -0.722 . . . . 0.0 110.454 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -68.91 -47.88 64.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.277 -0.889 . . . . 0.0 111.474 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.709 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.7 mt-10 -61.88 -39.53 92.26 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.035 -1.04 . . . . 0.0 110.245 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.54 -44.5 96.94 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.166 -0.959 . . . . 0.0 111.226 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.59 -46.63 81.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.841 -1.162 . . . . 0.0 110.809 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 13' ' ' GLU . 21.4 tt -65.58 -35.24 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.836 -1.165 . . . . 0.0 109.869 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 13' ' ' GLU . 53.4 t -63.26 -38.5 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 21' ' ' ARG . 63.7 t0 -63.12 -36.36 83.35 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.328 -0.857 . . . . 0.0 109.454 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.37 -38.68 90.51 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.179 -0.951 . . . . 0.0 109.04 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.721 HG22 ' OD1' ' A' ' 140' ' ' ASN . 35.1 mm -64.46 -44.04 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.187 -0.946 . . . . 0.0 109.745 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.462 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 58.6 mtm180 -61.25 -42.19 98.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 110.383 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -64.87 -38.06 89.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.181 -0.95 . . . . 0.0 111.796 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.51 -39.1 93.16 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.886 -1.134 . . . . 0.0 110.527 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.82 -16.22 26.74 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.766 -1.209 . . . . 0.0 110.328 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.476 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.7 mttt -94.86 0.56 54.91 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.057 -1.027 . . . . 0.0 109.968 177.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -114.07 -15.67 12.24 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.751 -1.218 . . . . 0.0 109.714 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 t -151.68 155.91 39.28 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.97 -1.082 . . . . 0.0 109.459 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.9 m -85.84 -6.35 59.1 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.206 -0.934 . . . . 0.0 110.052 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.2 173.5 52.77 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 55.8 mp0 -131.08 136.99 48.9 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.12 -1.224 . . . . 0.0 111.183 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 94.9 mt -118.01 134.68 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.778 -0.576 . . . . 0.0 110.104 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.481 ' HB3' ' HE1' ' A' ' 56' ' ' MET . 73.9 ttt180 -139.4 151.95 46.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 110.005 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.828 HG22 HD12 ' A' ' 67' ' ' ILE . 60.7 t -120.97 136.75 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.409 -0.807 . . . . 0.0 110.4 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.734 ' HB2' HD11 ' A' ' 66' ' ' LEU . 82.8 t60 -122.31 126.33 47.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.44 -0.787 . . . . 0.0 109.137 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.44 HD11 ' CG1' ' A' ' 71' ' ' VAL . 36.7 tp -112.48 126.68 55.58 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.846 0.832 . . . . 0.0 111.449 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.441 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 82.8 tt0 -142.79 165.07 28.38 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.742 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.0 mttt -81.65 -77.49 0.22 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -176.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.0 t -142.34 158.07 44.11 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.188 -0.945 . . . . 0.0 109.809 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.2 m -113.78 177.51 4.61 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.147 -0.97 . . . . 0.0 111.523 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -102.78 -20.11 14.46 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.615 -0.678 . . . . 0.0 109.871 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.0 mt -112.16 -120.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.015 -1.053 . . . . 0.0 109.519 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -114.46 148.35 37.94 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 119.952 -1.717 . . . . 0.0 108.227 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.521 ' CG1' HG21 ' A' ' 77' ' ' VAL . 63.1 t -60.97 -42.48 93.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 O-C-N 121.118 -0.989 . . . . 0.0 110.269 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -60.13 -45.78 91.87 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.198 -0.939 . . . . 0.0 110.861 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -71.66 -45.49 61.81 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.859 -1.151 . . . . 0.0 109.104 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.472 ' O ' HG23 ' A' ' 50' ' ' VAL . 31.9 tpt180 -60.13 -43.28 95.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.106 -0.996 . . . . 0.0 111.611 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.77 83.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.567 -1.333 . . . . 0.0 110.381 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.1 ttp -62.3 -41.8 98.83 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.138 -0.976 . . . . 0.0 109.716 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -63.41 -42.0 98.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.136 -0.978 . . . . 0.0 109.192 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 46' ' ' ARG . 94.2 t -67.06 -42.32 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.5 -0.75 . . . . 0.0 109.659 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.487 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 5.8 t80 -58.55 -47.66 83.46 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.93 -1.106 . . . . 0.0 109.415 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -73.0 -35.67 66.88 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 109.966 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -60.16 -35.67 75.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.873 -1.142 . . . . 0.0 109.053 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.82 5.16 26.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.267 -0.896 . . . . 0.0 110.33 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 55.01 32.91 19.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.97 -1.081 . . . . 0.0 111.123 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.523 ' SD ' HD22 ' A' ' 66' ' ' LEU . 94.0 mtp -65.94 -12.59 55.95 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.793 -1.192 . . . . 0.0 109.927 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -76.69 -1.61 28.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.723 -1.236 . . . . 0.0 109.781 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -74.87 65.1 1.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.855 -1.153 . . . . 0.0 110.262 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.4 p -134.8 148.78 50.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.074 -1.016 . . . . 0.0 109.272 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -62.56 -43.79 97.93 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.599 -0.688 . . . . 0.0 112.841 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.7 mt -98.18 2.27 48.28 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.903 -1.123 . . . . 0.0 111.804 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 56.53 32.76 21.41 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 122.437 1.113 . . . . 0.0 111.088 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.6 ' C ' HD11 ' A' ' 84' ' ' ILE . 3.2 m-80 -108.31 53.38 0.69 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.949 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.539 ' N ' HD11 ' A' ' 84' ' ' ILE . . . -101.58 139.37 14.37 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.454 ' CG2' HD13 ' A' ' 84' ' ' ILE . 53.9 t -123.42 133.78 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -1.157 . . . . 0.0 109.829 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.734 HD11 ' HB2' ' A' ' 34' ' ' HIS . 37.9 tp -117.18 133.06 56.45 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.093 -1.004 . . . . 0.0 109.495 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.828 HD12 HG22 ' A' ' 33' ' ' VAL . 83.8 mt -104.32 108.38 24.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 118.809 -1.157 . . . . 0.0 109.369 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.504 ' CE2' HG13 ' A' ' 43' ' ' VAL . 69.3 t80 -95.57 121.06 36.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.318 -0.864 . . . . 0.0 110.014 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.9 t -120.67 130.77 74.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.953 0.883 . . . . 0.0 110.841 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.5 103.26 15.0 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.789 HG21 ' CZ ' ' A' ' 7' ' ' PHE . 21.5 m -71.88 -18.99 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.992 -1.067 . . . . 0.0 111.048 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -70.27 -46.68 63.88 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.531 -1.356 . . . . 0.0 109.342 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -101.61 4.74 41.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.077 -1.015 . . . . 0.0 110.427 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.7 tttt 53.88 46.91 24.71 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.824 -1.172 . . . . 0.0 110.618 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.9 m -121.07 135.43 55.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.986 -1.071 . . . . 0.0 109.709 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 101' ' ' GLN . 42.9 p90 -112.15 133.9 54.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.457 -0.777 . . . . 0.0 109.885 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.521 HG21 ' CG1' ' A' ' 43' ' ' VAL . 47.8 t -126.89 135.67 63.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 120.935 -1.103 . . . . 0.0 108.063 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.607 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 81.6 mt -114.4 128.16 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.888 -1.133 . . . . 0.0 110.679 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -132.27 113.85 13.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.734 -0.603 . . . . 0.0 110.539 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.38 176.82 26.88 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.47 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 92.5 m-20 -82.5 -178.64 7.14 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.629 -0.924 . . . . 0.0 110.437 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.74 -23.34 67.14 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.448 -0.783 . . . . 0.0 109.634 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.15 -54.07 29.56 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.636 -1.268 . . . . 0.0 111.075 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.974 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.6 mt -66.33 -45.9 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.734 -1.45 . . . . 0.0 108.456 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -61.67 -37.62 84.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.058 -1.026 . . . . 0.0 111.521 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -75.61 -20.96 58.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.881 -1.137 . . . . 0.0 111.961 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.945 HG13 HG13 ' A' ' 88' ' ' VAL . 7.3 p -103.25 -22.02 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.861 -1.149 . . . . 0.0 112.341 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.974 HG22 ' O ' ' A' ' 84' ' ' ILE . 21.4 m -121.01 162.27 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 120.483 -1.385 . . . . 0.0 111.168 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.1 p -104.51 177.64 4.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.313 -0.867 . . . . 0.0 112.177 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.0 -35.68 79.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.683 -0.635 . . . . 0.0 109.437 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -63.82 -37.19 86.47 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.672 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 56.6 t80 -65.85 -24.31 66.85 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.09 -1.007 . . . . 0.0 108.606 177.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.607 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 6.8 m95 -87.12 -28.42 22.51 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.796 0.808 . . . . 0.0 110.784 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -57.09 -36.64 70.85 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.493 -0.754 . . . . 0.0 112.327 -176.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 64.5 p -67.38 -32.82 74.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.796 -1.19 . . . . 0.0 109.346 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.493 HG22 ' CD1' ' A' ' 78' ' ' ILE 0.284 8.5 m -59.26 -47.78 84.07 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.67 1.224 . . . . 0.0 110.521 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -69.13 -38.54 78.88 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.897 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -64.27 -44.73 90.81 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.687 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.22 -49.42 75.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.694 -1.254 . . . . 0.0 110.967 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.583 HD12 HD11 ' A' ' 78' ' ' ILE . 95.9 mt -67.24 -42.4 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.073 -1.017 . . . . 0.0 110.26 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 76' ' ' PHE . 57.8 tt0 -63.58 -40.39 96.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.916 -1.115 . . . . 0.0 110.814 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 40.4 mt -63.39 -42.62 98.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.117 -0.989 . . . . 0.0 111.929 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.485 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 88.0 mm-40 -75.15 -40.48 59.6 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.904 -1.119 . . . . 0.0 108.885 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -60.26 -41.8 94.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 108.936 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.78 -29.71 70.91 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.541 -0.724 . . . . 0.0 109.554 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -81.34 -20.02 41.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.027 -1.046 . . . . 0.0 110.003 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.73 -0.94 34.11 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.744 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -102.45 95.99 6.63 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.531 -1.57 . . . . 0.0 110.854 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -63.13 -41.45 99.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.847 -0.533 . . . . 0.0 111.774 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -65.5 -49.07 70.39 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.371 -0.932 . . . . 0.0 112.446 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.76 -39.75 95.02 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 118.859 -1.136 . . . . 0.0 110.594 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.485 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -62.41 -48.05 85.06 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.48 -1.343 . . . . 0.0 109.946 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.5 mt -63.65 -44.33 94.12 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.504 -0.998 . . . . 0.0 110.308 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.403 HG22 HG13 ' A' ' 16' ' ' ILE . 78.7 t -65.23 -47.57 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.95 -1.094 . . . . 0.0 110.858 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -65.76 -41.12 92.49 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 110.805 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.07 -41.21 98.59 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 98.1 mt -63.54 -42.99 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.141 -1.211 . . . . 0.0 109.585 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -59.19 -47.29 85.85 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.941 -1.099 . . . . 0.0 109.624 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.37 -42.54 99.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.383 -0.823 . . . . 0.0 109.333 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -58.71 -42.64 89.14 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.124 -0.985 . . . . 0.0 109.657 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.89 -43.04 96.61 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.637 -1.268 . . . . 0.0 109.99 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 90.8 mtp -67.19 -45.35 77.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.15 -1.206 . . . . 0.0 110.488 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.672 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -64.24 -42.52 96.49 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.301 -0.96 . . . . 0.0 108.626 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.4 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 73.7 mt -64.56 -39.82 94.44 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.546 -0.721 . . . . 0.0 109.58 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.71 -34.19 58.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.029 -1.044 . . . . 0.0 110.472 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -63.05 -42.91 99.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.024 -1.047 . . . . 0.0 109.492 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.433 ' HB3' ' CE1' ' A' ' 128' ' ' PHE . 53.9 m-85 -70.22 -42.64 72.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.473 -0.767 . . . . 0.0 110.014 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.443 ' CZ ' HG21 ' A' ' 87' ' ' VAL . 83.1 m-85 -127.92 101.72 22.81 Favored Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 121.495 -0.753 . . . . 0.0 109.931 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.2 152.07 80.19 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.81 1.426 . . . . 0.0 109.877 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.476 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 43.4 t90 -78.79 137.64 37.82 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.624 -0.672 . . . . 0.0 111.173 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -115.28 149.18 38.21 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.318 -0.864 . . . . 0.0 109.526 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -57.81 -28.52 64.12 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 111.236 -177.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -91.13 9.96 28.88 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.921 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.428 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 66.3 t0 -43.12 137.09 2.63 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.358 -0.839 . . . . 0.0 111.575 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.607 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -110.43 136.12 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.734 0.778 . . . . 0.0 111.484 -178.373 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -115.12 100.68 8.34 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -101.26 -4.45 27.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.896 -1.127 . . . . 0.0 111.933 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.86 145.41 30.66 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.938 -1.101 . . . . 0.0 110.983 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -70.32 166.38 28.48 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.669 1.352 . . . . 0.0 109.468 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.721 ' OD1' HG22 ' A' ' 20' ' ' ILE . 62.8 m-80 -109.66 7.46 24.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.568 -1.333 . . . . 0.0 110.77 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.6 p -65.85 171.15 4.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.911 -1.118 . . . . 0.0 111.329 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 91.1 mt -97.88 140.43 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 121.387 0.613 . . . . 0.0 110.707 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 18.1 t -94.48 134.32 37.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 109.829 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -129.1 148.1 51.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 110.451 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 CA-C-O 117.964 -1.465 . . . . 0.0 109.784 -179.796 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.6 mmm . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.351 0.596 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.2 p -67.57 -21.55 65.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.435 -0.791 . . . . 0.0 111.211 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -107.04 127.09 53.15 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.089 -1.007 . . . . 0.0 110.314 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.62 -23.34 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.561 -0.712 . . . . 0.0 110.285 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -54.03 -43.56 70.23 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.453 -0.779 . . . . 0.0 111.256 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -126.52 133.93 51.02 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.845 -1.159 . . . . 0.0 110.088 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.681 ' CZ ' HG12 ' A' ' 71' ' ' VAL . 28.3 t80 -62.72 -44.36 96.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.298 -0.876 . . . . 0.0 110.82 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 74.9 mt -126.31 150.49 48.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.251 -0.906 . . . . 0.0 109.539 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.3 p -78.1 165.79 23.57 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.908 -1.12 . . . . 0.0 109.692 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.42 -35.61 68.0 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.953 -1.092 . . . . 0.0 109.857 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -58.9 -46.36 88.07 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.395 -0.816 . . . . 0.0 109.99 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.469 ' HA ' ' CE ' ' A' ' 110' ' ' LYS . 98.9 mt-10 -69.2 -46.17 68.08 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.311 -0.868 . . . . 0.0 111.067 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -64.76 -39.53 93.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.136 -0.977 . . . . 0.0 110.755 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.47 -45.17 94.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.162 -0.961 . . . . 0.0 110.877 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.64 ' HB3' ' HE2' ' A' ' 110' ' ' LYS . . . -62.51 -41.09 98.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.972 . . . . 0.0 110.481 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 110' ' ' LYS . 45.2 mt -64.64 -43.47 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 111.208 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.451 ' CG2' HG12 ' A' ' 142' ' ' ILE . 45.4 t -60.99 -42.77 94.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 108.788 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -61.27 -37.67 83.98 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.492 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.76 94.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.506 -0.746 . . . . 0.0 109.811 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 91.5 mt -63.83 -43.42 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 109.404 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -55.59 -44.63 77.14 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.502 -0.749 . . . . 0.0 109.682 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -63.19 -37.41 87.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.473 -0.767 . . . . 0.0 110.986 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.45 -37.94 89.22 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.977 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.425 ' OE1' ' ND2' ' A' ' 140' ' ' ASN . 3.3 mp0 -60.83 -15.34 29.07 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.804 -1.185 . . . . 0.0 111.091 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.7 mttt -94.61 -1.53 53.07 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 120.912 -1.118 . . . . 0.0 109.499 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -111.15 -15.09 13.76 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.857 -1.152 . . . . 0.0 110.188 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.1 t -152.68 160.28 43.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.023 -1.048 . . . . 0.0 109.45 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.1 m -88.17 -5.52 58.37 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.986 -1.071 . . . . 0.0 110.344 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.93 170.04 52.14 Favored Glycine 0 N--CA 1.482 1.723 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 138' ' ' LEU . 79.2 mm-40 -129.68 136.86 50.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.258 -1.142 . . . . 0.0 110.723 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.2 mt -119.22 134.96 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.595 -0.69 . . . . 0.0 110.71 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.686 ' CD ' HD23 ' A' ' 138' ' ' LEU . 84.3 mtp180 -139.47 153.24 47.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.389 -0.82 . . . . 0.0 109.923 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.883 HG22 HD12 ' A' ' 67' ' ' ILE . 61.7 t -123.42 141.01 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.302 -0.874 . . . . 0.0 110.952 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.498 ' HB2' HD11 ' A' ' 66' ' ' LEU . 51.0 t-80 -122.95 124.82 44.05 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.65 HD11 HG13 ' A' ' 71' ' ' VAL . 35.8 tp -112.61 129.0 56.53 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.938 0.875 . . . . 0.0 111.286 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -146.42 164.77 31.4 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -79.73 -73.88 0.33 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.112 -0.992 . . . . 0.0 112.898 -177.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.33 157.24 46.23 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.262 -0.899 . . . . 0.0 110.133 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.8 m -103.06 165.07 11.24 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.624 -0.673 . . . . 0.0 110.166 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -104.23 -14.23 15.9 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.353 -0.842 . . . . 0.0 109.794 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.434 HG13 ' N ' ' A' ' 42' ' ' ASP . 29.8 pt -124.8 -122.01 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.052 -1.03 . . . . 0.0 110.052 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.434 ' N ' HG13 ' A' ' 41' ' ' ILE . 95.3 m-20 -110.73 139.17 46.26 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.16 -1.587 . . . . 0.0 109.359 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.696 HG11 HG21 ' A' ' 77' ' ' VAL . 84.3 t -64.59 -43.92 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.299 -0.875 . . . . 0.0 111.902 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -60.05 -45.42 92.91 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.72 -1.237 . . . . 0.0 110.123 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -70.98 -38.1 72.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.851 -1.156 . . . . 0.0 109.365 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 50.1 ttt85 -65.97 -43.1 88.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.774 -1.203 . . . . 0.0 110.266 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.75 -37.59 88.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.87 -1.144 . . . . 0.0 110.224 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 62.3 ttp -64.23 -43.23 95.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.137 -0.977 . . . . 0.0 109.153 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -63.85 -41.97 97.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.937 -1.102 . . . . 0.0 109.251 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 74.2 t -67.61 -42.87 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.502 -0.749 . . . . 0.0 109.833 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -59.8 -46.85 87.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.88 -1.138 . . . . 0.0 109.491 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -74.94 -36.12 62.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.967 -1.083 . . . . 0.0 109.764 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -61.07 -38.42 86.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.067 -1.02 . . . . 0.0 109.442 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.5 mt -81.89 4.05 23.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.0 110.048 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.43 33.96 23.4 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.288 -0.883 . . . . 0.0 111.941 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.719 ' SD ' HD13 ' A' ' 66' ' ' LEU . 95.7 mtp -69.22 -15.02 63.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.089 -1.007 . . . . 0.0 109.922 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 44.9 p-10 -78.45 -5.32 52.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.831 -1.168 . . . . 0.0 110.138 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 65.1 t-20 -88.64 78.8 7.67 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.788 -1.195 . . . . 0.0 110.409 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.3 m -137.02 154.91 50.26 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.19 -44.44 97.28 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 111.599 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 90.5 mt -99.94 -2.4 34.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.757 -1.215 . . . . 0.0 111.389 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 87.7 mt-30 59.32 49.92 8.37 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.245 1.021 . . . . 0.0 111.265 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -122.22 54.15 1.2 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.479 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.92 143.33 16.16 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.537 HG23 ' CD1' ' A' ' 84' ' ' ILE . 54.0 t -124.12 134.75 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.907 -1.349 . . . . 0.0 110.715 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.719 HD13 ' SD ' ' A' ' 56' ' ' MET . 39.7 tp -117.1 125.16 50.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.568 -0.708 . . . . 0.0 109.893 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.883 HD12 HG22 ' A' ' 33' ' ' VAL . 83.2 mt -102.3 110.88 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.602 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -96.37 120.75 37.25 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.168 -0.957 . . . . 0.0 110.027 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.9 t -122.39 131.11 73.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.297 -0.877 . . . . 0.0 110.922 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.561 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -99.91 90.52 4.45 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.681 HG12 ' CZ ' ' A' ' 7' ' ' PHE . 17.4 m -60.26 -24.16 29.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.298 -0.876 . . . . 0.0 111.375 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -67.51 -41.12 84.94 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.989 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.414 ' O ' HG23 ' A' ' 75' ' ' THR . 96.2 m-20 -103.33 4.06 35.98 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.072 -1.017 . . . . 0.0 110.685 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.428 ' HE3' ' CE1' ' A' ' 109' ' ' PHE . 45.2 tttt 55.86 45.72 23.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.827 -1.171 . . . . 0.0 110.752 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.561 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 72.4 p -119.97 163.37 17.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.966 . . . . 0.0 109.32 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -142.79 146.09 33.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.104 -0.998 . . . . 0.0 110.578 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.696 HG21 HG11 ' A' ' 43' ' ' VAL . 53.7 t -134.74 138.47 49.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.747 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 88.7 mt -117.17 125.65 74.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 118.977 -1.089 . . . . 0.0 110.416 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -128.07 114.22 16.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.806 -0.559 . . . . 0.0 110.325 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -100.89 171.1 22.36 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 53.8 t0 -81.14 174.44 11.57 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.493 -1.004 . . . . 0.0 110.013 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.407 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 97.7 mttt -60.02 -26.67 66.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.989 . . . . 0.0 111.656 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.546 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -64.88 -52.11 45.19 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.807 -1.187 . . . . 0.0 110.416 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.944 ' O ' HG22 ' A' ' 88' ' ' VAL . 97.1 mt -64.71 -43.47 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.783 -1.422 . . . . 0.0 108.122 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -63.4 -36.93 85.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.518 -1.364 . . . . 0.0 111.476 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -74.21 -20.92 60.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.845 -1.159 . . . . 0.0 112.166 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.052 HG23 HG13 ' A' ' 88' ' ' VAL . 32.9 m -105.64 -18.51 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.745 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.052 HG13 HG23 ' A' ' 87' ' ' VAL . 4.0 m -119.82 160.28 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 120.67 -1.268 . . . . 0.0 111.47 -178.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.1 m -107.17 176.71 5.08 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.81 0.814 . . . . 0.0 112.005 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -61.86 -36.95 82.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.611 -0.681 . . . . 0.0 109.48 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -62.19 -38.22 88.28 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.422 -0.911 . . . . 0.0 108.922 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.864 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 55.3 t80 -64.05 -26.62 68.64 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.539 -0.726 . . . . 0.0 109.356 178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.747 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.9 m95 -86.95 -25.81 24.17 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.938 0.875 . . . . 0.0 110.989 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -56.92 -36.78 70.59 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.429 -0.795 . . . . 0.0 111.712 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.8 m -64.32 -33.66 76.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.767 -1.208 . . . . 0.0 108.983 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.501 HG22 HD13 ' A' ' 78' ' ' ILE 0.279 7.4 m -59.82 -49.89 75.94 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 122.358 1.075 . . . . 0.0 111.379 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.414 ' O ' ' HB2' ' A' ' 101' ' ' GLN . 99.4 mtt180 -66.69 -38.6 87.09 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.707 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.495 ' O ' HD23 ' A' ' 102' ' ' LEU . 82.0 m-20 -64.01 -45.03 90.78 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.946 -1.102 . . . . 0.0 110.439 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.1 -50.91 72.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.592 -1.318 . . . . 0.0 110.484 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.485 HD12 HD11 ' A' ' 78' ' ' ILE . 86.8 mt -67.81 -42.72 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.905 -1.122 . . . . 0.0 110.17 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 97' ' ' ARG . 57.3 tt0 -62.62 -46.72 86.94 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.516 -0.74 . . . . 0.0 111.086 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 98' ' ' ASN . 4.3 mm? -63.53 -41.54 98.46 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.007 -1.058 . . . . 0.0 112.043 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.462 ' HB2' ' HA3' ' A' ' 112' ' ' GLY . 99.4 mm-40 -72.15 -40.24 68.16 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.176 -1.41 . . . . 0.0 108.594 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -59.26 -40.82 87.2 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.784 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -62.38 -34.55 76.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -0.868 . . . . 0.0 110.928 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -83.6 -17.34 41.99 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.528 -1.357 . . . . 0.0 110.319 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.26 11.38 25.78 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.172 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' A' ' 103' ' ' GLN . 31.7 m120 -107.94 83.0 1.72 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.873 -1.369 . . . . 0.0 110.451 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.591 ' CE2' ' CZ ' ' A' ' 7' ' ' PHE . 6.8 m-85 -62.5 -43.71 98.15 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.151 -0.968 . . . . 0.0 111.026 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.64 ' HE2' ' HB3' ' A' ' 15' ' ' ALA . 60.9 tttm -61.13 -47.85 84.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 0.0 111.446 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -64.1 -37.85 88.94 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.954 -1.091 . . . . 0.0 110.843 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 103' ' ' GLN . . . -62.49 -49.04 77.39 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.496 -1.335 . . . . 0.0 109.823 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.47 -43.96 97.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -1.161 . . . . 0.0 110.926 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.446 HG23 HG12 ' A' ' 16' ' ' ILE . 76.4 t -65.91 -46.82 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.906 -1.121 . . . . 0.0 110.325 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -65.01 -40.1 94.39 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.538 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.89 -43.74 93.21 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.3 mt -64.51 -44.33 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -1.14 . . . . 0.0 109.368 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -58.98 -49.08 79.25 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.045 -1.034 . . . . 0.0 109.632 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.34 -41.21 98.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.205 -0.934 . . . . 0.0 109.447 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.417 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -57.58 -42.04 82.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.202 -0.937 . . . . 0.0 110.072 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.59 -43.56 96.32 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.67 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 96.6 mtp -68.33 -45.37 73.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.914 -1.345 . . . . 0.0 110.285 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.864 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -63.56 -45.93 88.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.118 -0.989 . . . . 0.0 108.761 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.417 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 72.7 mt -61.87 -40.5 95.58 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.47 -34.08 56.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 110.4 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.58 -44.65 93.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.002 -1.061 . . . . 0.0 109.366 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -71.54 -41.47 69.09 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.45 0.643 . . . . 0.0 109.65 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.43 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 47.6 m-85 -130.54 97.69 21.35 Favored Pre-proline 0 C--N 1.307 -1.251 0 O-C-N 121.514 -0.741 . . . . 0.0 109.828 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 128' ' ' PHE . 42.0 Cg_endo -65.75 152.87 80.39 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.575 1.303 . . . . 0.0 110.707 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.481 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 47.7 t90 -76.57 127.07 32.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.556 -0.715 . . . . 0.0 110.689 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -103.35 146.96 27.69 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.151 -0.968 . . . . 0.0 109.041 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -56.71 -28.44 60.96 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.103 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.4 p30 -93.68 6.76 47.26 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.012 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 135' ' ' ILE . 67.1 t0 -42.55 140.24 1.31 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.705 0.764 . . . . 0.0 111.622 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.754 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -115.38 146.08 20.28 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 CA-C-O 121.576 0.703 . . . . 0.0 110.891 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -103.23 97.45 7.53 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.356 -1.465 . . . . 0.0 110.58 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -68.14 -35.72 78.56 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.686 HD23 ' CD ' ' A' ' 32' ' ' ARG . 7.1 mp -110.87 151.06 42.69 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.895 -1.128 . . . . 0.0 111.923 -178.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -72.48 -174.69 1.52 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 N-CA-C 108.448 -1.405 . . . . 0.0 108.448 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.425 ' ND2' ' OE1' ' A' ' 24' ' ' GLU . 10.5 m120 -123.02 2.51 9.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.592 -1.318 . . . . 0.0 110.116 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -58.2 170.25 0.71 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.934 -1.104 . . . . 0.0 111.348 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.451 HG12 ' CG2' ' A' ' 17' ' ' VAL . 49.6 mm -95.17 133.17 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.66 -0.65 . . . . 0.0 111.039 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 69.5 m -93.08 131.24 38.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.534 -0.729 . . . . 0.0 109.093 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -127.03 135.99 51.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.884 -1.135 . . . . 0.0 110.591 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.398 0 CA-C-O 117.935 -1.481 . . . . 0.0 109.72 -179.768 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptm . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.148 0.499 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.0 t -63.16 -44.18 96.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 110.852 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -126.25 126.55 44.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.295 -0.878 . . . . 0.0 110.314 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 96.0 mt -119.92 131.83 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.089 -1.007 . . . . 0.0 110.232 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -101.59 54.74 0.82 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.2 -0.938 . . . . 0.0 110.703 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 6' ' ' GLU . 76.2 tt0 55.04 23.04 4.83 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.358 -0.839 . . . . 0.0 110.304 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.692 ' CE2' HD12 ' A' ' 8' ' ' LEU . 26.6 t80 -78.02 -80.28 0.11 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.009 -1.057 . . . . 0.0 109.892 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.692 HD12 ' CE2' ' A' ' 7' ' ' PHE . 90.8 mt -132.4 150.87 52.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.891 . . . . 0.0 110.226 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.0 p -78.06 169.95 17.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.099 -1.001 . . . . 0.0 109.383 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 14' ' ' LYS . . . -54.73 -39.73 68.55 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.797 -1.19 . . . . 0.0 109.422 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -62.8 -40.36 97.12 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.473 -0.767 . . . . 0.0 109.51 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.42 ' CB ' ' HB3' ' A' ' 8' ' ' LEU . 97.5 mt-10 -73.62 -46.59 45.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.105 -0.997 . . . . 0.0 110.696 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.736 ' O ' HG23 ' A' ' 17' ' ' VAL . 96.8 mt-10 -67.04 -34.56 77.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.112 -0.993 . . . . 0.0 110.265 178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 87.6 tttt -64.77 -44.7 89.19 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.753 -1.217 . . . . 0.0 110.075 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.94 -47.02 79.18 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.134 -0.979 . . . . 0.0 111.409 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.405 HG22 ' O ' ' A' ' 13' ' ' GLU . 20.4 tt -64.06 -36.25 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.773 -1.205 . . . . 0.0 110.174 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 13' ' ' GLU . 55.4 t -61.28 -38.36 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -64.25 -36.18 83.25 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.775 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.98 -40.15 94.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.06 -1.025 . . . . 0.0 109.566 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.768 HG22 ' OD1' ' A' ' 140' ' ' ASN . 83.6 mt -63.14 -43.79 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 109.399 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -62.2 -43.72 98.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.45 -0.781 . . . . 0.0 110.694 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -63.08 -38.9 93.04 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.162 -0.961 . . . . 0.0 111.41 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.9 -37.89 88.74 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.206 -0.997 . . . . 0.0 109.291 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.2 -15.99 29.22 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.101 -0.999 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.478 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 75.5 mmtt -94.88 -3.6 48.48 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.013 -1.054 . . . . 0.0 109.544 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -108.69 -13.48 14.79 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 121.176 -0.953 . . . . 0.0 109.813 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.8 t -156.35 161.15 40.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.014 -1.054 . . . . 0.0 110.049 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.3 m -87.21 -12.13 47.73 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.371 -0.831 . . . . 0.0 108.78 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.39 167.09 40.89 Favored Glycine 0 N--CA 1.477 1.394 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.557 ' OE1' HD12 ' A' ' 138' ' ' LEU . 97.8 mt-10 -135.59 141.6 45.16 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 118.9 -1.12 . . . . 0.0 112.229 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.6 mt -123.61 135.77 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.237 0.541 . . . . 0.0 110.547 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.451 ' NH1' HD13 ' A' ' 54' ' ' LEU . 68.8 ttt180 -139.88 163.06 33.65 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.198 -0.939 . . . . 0.0 109.746 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 p -131.97 142.4 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.157 -0.964 . . . . 0.0 111.687 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.419 ' HA ' ' O ' ' A' ' 143' ' ' SER . 81.7 t60 -126.98 125.56 41.7 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.452 -0.78 . . . . 0.0 109.442 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.615 HD22 ' CG ' ' A' ' 7' ' ' PHE . 47.5 tp -108.4 128.56 54.88 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 122.07 0.938 . . . . 0.0 112.019 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.41 ' OE2' ' CZ ' ' A' ' 46' ' ' ARG . 82.2 tt0 -144.87 159.68 42.51 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 97.8 mttt -79.32 -75.66 0.24 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.063 -1.023 . . . . 0.0 112.94 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.6 t -136.57 155.34 50.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.299 -0.876 . . . . 0.0 110.214 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.5 p -103.77 170.79 7.72 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.415 -0.803 . . . . 0.0 110.365 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.414 ' OE1' ' N ' ' A' ' 40' ' ' GLU . 56.0 mp0 -108.37 -12.61 15.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.472 -0.768 . . . . 0.0 110.414 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.8 pt -124.31 -122.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.149 -0.969 . . . . 0.0 108.586 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -111.84 140.81 46.18 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 120.434 -1.416 . . . . 0.0 109.687 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.498 ' CG1' HG21 ' A' ' 77' ' ' VAL . 94.4 t -64.15 -42.74 96.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.372 -0.83 . . . . 0.0 110.683 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -59.92 -46.75 88.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.955 -1.091 . . . . 0.0 109.938 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -69.81 -36.8 75.96 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.79 -1.194 . . . . 0.0 108.772 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.41 ' CZ ' ' OE2' ' A' ' 36' ' ' GLU . 61.3 ttt85 -64.1 -42.85 96.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -0.916 . . . . 0.0 110.949 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.6 83.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.722 -1.236 . . . . 0.0 110.499 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 60.2 ttp -62.89 -42.28 99.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.034 -1.042 . . . . 0.0 108.975 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -65.88 -44.7 84.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.137 -0.977 . . . . 0.0 110.361 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.44 -43.44 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.365 -0.834 . . . . 0.0 110.411 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 2.9 t80 -58.77 -47.92 83.0 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.7 -1.25 . . . . 0.0 108.996 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -72.16 -35.66 69.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.043 -1.036 . . . . 0.0 109.703 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -60.54 -39.35 87.57 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.451 HD13 ' NH1' ' A' ' 32' ' ' ARG . 85.6 mt -80.2 5.26 15.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.155 -0.966 . . . . 0.0 110.361 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 55.76 33.94 22.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.818 -1.176 . . . . 0.0 111.926 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.824 ' SD ' HD13 ' A' ' 66' ' ' LEU . 94.1 mtp -65.55 -11.01 40.04 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.988 -1.07 . . . . 0.0 110.236 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -77.53 0.57 22.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.819 -1.176 . . . . 0.0 110.284 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -74.57 62.25 1.01 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.851 -1.156 . . . . 0.0 110.062 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.41 ' OG1' ' HA ' ' A' ' 62' ' ' GLN . 65.3 p -135.19 148.47 49.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.107 -0.996 . . . . 0.0 109.631 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -64.44 -40.98 96.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.75 -0.594 . . . . 0.0 112.276 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 95.7 mt -98.66 -0.15 43.53 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.904 -1.122 . . . . 0.0 111.448 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.41 ' HA ' ' OG1' ' A' ' 59' ' ' THR . 85.7 mt-30 57.71 45.77 18.38 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 122.5 1.143 . . . . 0.0 111.148 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.423 ' HA ' HG13 ' A' ' 84' ' ' ILE . 38.0 p30 -118.96 53.61 1.0 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.072 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.39 140.98 15.13 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.512 HG23 ' CD1' ' A' ' 84' ' ' ILE . 67.3 t -125.55 134.74 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.043 -1.269 . . . . 0.0 110.34 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.824 HD13 ' SD ' ' A' ' 56' ' ' MET . 38.5 tp -117.51 133.68 55.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.339 -0.851 . . . . 0.0 110.24 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.2 mt -106.82 108.83 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 118.75 -1.18 . . . . 0.0 109.557 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -95.45 117.71 30.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 110.181 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.1 t -118.19 128.34 75.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 121.726 0.774 . . . . 0.0 110.356 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.574 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -95.26 88.49 5.17 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.473 ' HB ' HD11 ' A' ' 35' ' ' LEU . 7.2 p -58.73 -23.81 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.036 -1.04 . . . . 0.0 110.907 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 47.7 tp10 -67.73 -41.89 82.73 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.779 -1.2 . . . . 0.0 108.85 178.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.635 ' O ' HG23 ' A' ' 75' ' ' THR . 40.5 t0 -104.77 8.6 34.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.053 -1.03 . . . . 0.0 111.259 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 104' ' ' PHE . 85.3 tttt 52.12 45.17 28.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.875 -1.141 . . . . 0.0 110.407 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 73' ' ' ASP . 46.8 p -122.33 159.15 28.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.803 -1.186 . . . . 0.0 109.135 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -141.53 148.37 39.24 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.21 -0.932 . . . . 0.0 110.364 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.498 HG21 ' CG1' ' A' ' 43' ' ' VAL . 66.1 t -134.19 137.13 52.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.716 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 75.8 mt -113.74 127.83 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.859 -1.151 . . . . 0.0 110.174 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -135.02 114.67 12.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.576 -0.702 . . . . 0.0 110.624 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -99.77 171.47 23.88 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.474 ' OD1' ' CE1' ' A' ' 51' ' ' PHE . 78.1 m-20 -75.33 171.28 14.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.399 -1.059 . . . . 0.0 110.653 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -58.64 -26.46 63.78 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.592 -0.692 . . . . 0.0 110.444 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.408 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -66.1 -53.34 30.48 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.981 ' O ' HG22 ' A' ' 88' ' ' VAL . 87.6 mt -63.51 -44.74 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.944 -1.327 . . . . 0.0 107.893 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -62.21 -36.87 83.26 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.833 -1.167 . . . . 0.0 111.396 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -70.63 -24.26 62.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.861 -1.15 . . . . 0.0 111.78 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.865 HG23 HG13 ' A' ' 88' ' ' VAL . 25.7 m -105.74 -16.45 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 120.642 -1.286 . . . . 0.0 112.909 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.981 HG22 ' O ' ' A' ' 84' ' ' ILE . 18.8 m -116.45 162.07 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 120.338 -1.476 . . . . 0.0 112.002 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.3 t -109.41 174.46 5.86 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.597 0.713 . . . . 0.0 111.809 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 33.0 p-10 -61.61 -35.85 79.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 110.147 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -62.42 -40.59 97.03 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.821 -1.174 . . . . 0.0 109.781 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.854 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 87.8 t80 -63.15 -25.52 68.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.123 -0.985 . . . . 0.0 109.333 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.716 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.2 m95 -86.88 -24.64 24.82 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.955 0.883 . . . . 0.0 110.876 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -57.1 -38.81 73.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.063 -1.023 . . . . 0.0 112.455 -177.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.9 p -63.61 -31.84 73.14 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.53 -1.268 . . . . 0.0 109.199 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.444 ' CG2' HD13 ' A' ' 78' ' ' ILE 0.272 15.1 m -59.93 -48.06 83.22 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.379 1.085 . . . . 0.0 111.031 179.661 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -68.98 -38.57 79.41 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.25 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -64.03 -44.26 93.08 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.827 -1.171 . . . . 0.0 110.669 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.88 -49.77 73.54 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.832 -1.167 . . . . 0.0 111.348 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 91.4 mt -67.34 -42.42 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.073 -1.017 . . . . 0.0 110.329 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -65.16 -40.92 95.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.243 -0.911 . . . . 0.0 110.602 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.8 tp -62.22 -42.13 99.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.209 -0.932 . . . . 0.0 111.13 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.447 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 95.8 mm-40 -76.9 -40.0 48.89 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.136 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.415 ' O ' ' CE ' ' A' ' 74' ' ' LYS . 2.8 m-85 -58.41 -41.82 85.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.145 -0.972 . . . . 0.0 108.55 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.43 -32.12 73.47 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.635 -0.665 . . . . 0.0 110.444 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -78.69 -20.07 51.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.741 -1.225 . . . . 0.0 109.911 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.17 4.7 41.15 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.41 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -103.66 86.31 2.6 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.743 -1.445 . . . . 0.0 110.097 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -61.62 -43.03 99.62 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.371 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -61.71 -47.95 82.96 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.97 -1.081 . . . . 0.0 111.377 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -64.55 -38.11 89.87 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.21 -0.932 . . . . 0.0 110.488 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.447 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -63.84 -49.54 67.4 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.51 -44.73 93.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.145 -1.209 . . . . 0.0 110.959 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.416 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 71.1 t -65.03 -47.77 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.137 -0.977 . . . . 0.0 110.115 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -62.84 -40.88 98.77 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.922 -1.111 . . . . 0.0 110.571 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.29 -42.24 97.23 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -43.99 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.228 -1.16 . . . . 0.0 109.698 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 114' ' ' VAL . 80.5 mm-40 -58.28 -54.62 44.93 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.05 -1.031 . . . . 0.0 110.597 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.34 -39.97 92.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.122 -0.986 . . . . 0.0 108.691 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.55 -41.58 90.41 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.312 -0.867 . . . . 0.0 109.713 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.17 -44.3 97.34 Favored Glycine 0 N--CA 1.495 2.607 0 O-C-N 120.761 -1.212 . . . . 0.0 111.01 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 64.6 ttp -67.91 -48.03 67.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.874 -1.368 . . . . 0.0 109.898 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.854 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -59.99 -46.52 89.19 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.058 -1.026 . . . . 0.0 109.234 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.96 -41.01 97.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 109.45 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.14 -32.23 54.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 110.335 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.77 -44.41 96.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.129 -0.982 . . . . 0.0 109.848 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -72.37 -41.79 65.97 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.537 0.684 . . . . 0.0 110.276 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -132.05 100.71 15.55 Favored Pre-proline 0 C--N 1.304 -1.404 0 O-C-N 121.54 -0.725 . . . . 0.0 109.657 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.42 150.72 80.78 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.57 1.3 . . . . 0.0 110.932 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.478 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 60.3 t90 -75.13 133.84 41.42 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.645 -0.659 . . . . 0.0 110.546 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -114.06 153.59 29.16 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 109.495 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.44 -28.98 65.77 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.035 -1.04 . . . . 0.0 110.63 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -93.3 7.54 43.96 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.311 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.401 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 52.2 t0 -42.43 138.43 1.78 Allowed 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.77 0.795 . . . . 0.0 111.361 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.712 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -114.36 148.2 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 121.896 0.855 . . . . 0.0 111.967 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -108.55 96.03 6.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.641 -1.287 . . . . 0.0 110.382 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.424 ' N ' ' OE2' ' A' ' 30' ' ' GLU . 81.2 mm-40 -67.81 -32.31 72.77 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.594 -0.692 . . . . 0.0 111.662 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.557 HD12 ' OE1' ' A' ' 30' ' ' GLU . 33.7 mt -110.06 154.46 42.72 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.185 -0.947 . . . . 0.0 111.856 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -79.4 -167.27 0.48 Allowed 'Trans proline' 0 C--N 1.319 -1.014 0 N-CA-C 108.436 -1.409 . . . . 0.0 108.436 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.768 ' OD1' HG22 ' A' ' 20' ' ' ILE . 65.9 m-80 -124.0 3.21 8.69 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.468 -1.395 . . . . 0.0 110.392 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.3 p -63.24 166.75 5.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.884 -1.135 . . . . 0.0 111.13 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.8 mt -96.09 137.87 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.823 -0.548 . . . . 0.0 110.258 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 32' ' ' ARG . 25.1 t -96.35 137.23 35.73 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.208 -0.933 . . . . 0.0 109.713 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -128.13 145.15 51.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.004 -1.06 . . . . 0.0 110.284 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.903 0 CA-C-O 117.972 -1.46 . . . . 0.0 110.296 179.898 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.8 mtp . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 121.414 0.626 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.0 t -138.73 157.87 45.28 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.41 -0.807 . . . . 0.0 110.674 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -82.74 125.44 31.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 109.773 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.2 pt -78.72 -19.62 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.097 -1.002 . . . . 0.0 110.412 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -90.47 30.4 1.15 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.103 -0.998 . . . . 0.0 111.602 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -68.15 -35.9 78.8 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.169 -1.012 . . . . 0.0 109.527 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.739 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 65.0 m-85 -62.83 -43.47 98.72 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.19 -0.944 . . . . 0.0 111.601 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.528 HD22 ' CG ' ' A' ' 110' ' ' LYS . 79.1 mt -127.63 149.97 49.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.922 . . . . 0.0 110.238 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 p -85.77 164.67 17.45 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.073 -1.017 . . . . 0.0 108.782 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.59 -37.03 65.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.948 -1.095 . . . . 0.0 109.864 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -60.87 -45.46 94.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 110.498 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -70.02 -45.38 67.33 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.239 -0.913 . . . . 0.0 110.8 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.68 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.1 mt-10 -64.18 -37.18 86.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.111 -0.993 . . . . 0.0 110.384 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -66.0 -44.0 86.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.968 -1.082 . . . . 0.0 111.959 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.18 -44.4 88.56 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.747 -1.221 . . . . 0.0 111.106 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.487 HG13 HG22 ' A' ' 114' ' ' VAL . 17.2 tt -65.92 -34.69 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.848 -1.158 . . . . 0.0 109.917 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 13' ' ' GLU . 55.1 t -63.65 -40.49 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.88 -36.64 83.99 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.441 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.82 -38.71 91.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.205 -0.934 . . . . 0.0 108.904 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.448 ' CG2' ' HB2' ' A' ' 140' ' ' ASN . 30.5 mm -62.87 -43.66 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.401 -0.812 . . . . 0.0 108.9 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.453 ' HE ' ' ND2' ' A' ' 140' ' ' ASN . 99.8 mtt180 -60.95 -43.3 98.92 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.542 -0.723 . . . . 0.0 109.976 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -64.71 -39.26 93.35 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.26 -0.9 . . . . 0.0 111.258 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.95 -39.27 93.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.045 -1.034 . . . . 0.0 109.616 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.12 -17.62 41.52 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.026 -1.046 . . . . 0.0 110.126 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.5 mttt -93.61 -3.3 52.84 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 121.178 -0.951 . . . . 0.0 109.733 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -107.57 -15.49 14.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.905 -1.122 . . . . 0.0 109.885 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.6 t -152.75 160.54 43.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.036 -1.04 . . . . 0.0 109.732 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.9 p -86.96 -8.73 56.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.959 -1.088 . . . . 0.0 109.534 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.66 170.84 42.28 Favored Glycine 0 N--CA 1.482 1.725 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 138' ' ' LEU . 78.6 mm-40 -131.35 137.07 48.59 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.526 -0.985 . . . . 0.0 111.342 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -121.23 134.1 65.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.804 -0.56 . . . . 0.0 109.8 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -137.49 151.09 48.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.129 -0.982 . . . . 0.0 109.65 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.862 HG22 HD12 ' A' ' 67' ' ' ILE . 55.6 t -121.7 138.06 53.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.545 -0.722 . . . . 0.0 110.791 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.481 ' HB2' HD11 ' A' ' 66' ' ' LEU . 60.3 t60 -123.18 127.01 48.05 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.968 HD11 ' CG1' ' A' ' 71' ' ' VAL . 32.5 tp -113.93 125.81 54.46 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.85 0.833 . . . . 0.0 111.832 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 85.0 tt0 -143.22 161.75 37.44 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.411 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 98.5 mttt -77.35 -71.36 0.41 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.994 -1.066 . . . . 0.0 113.469 -177.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.418 ' CG2' ' OE1' ' A' ' 72' ' ' GLU . 8.0 t -140.13 159.01 43.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 110.462 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.9 m -107.1 164.72 11.92 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.824 -0.547 . . . . 0.0 110.128 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -105.8 -11.04 16.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.146 -0.971 . . . . 0.0 110.315 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.8 pt -125.13 -122.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.912 -1.118 . . . . 0.0 109.075 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -110.89 140.39 45.4 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.073 -1.642 . . . . 0.0 109.204 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.606 ' CG1' HG21 ' A' ' 77' ' ' VAL . 91.4 t -64.61 -42.92 96.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.283 -0.886 . . . . 0.0 110.986 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -59.43 -47.0 87.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.97 -1.081 . . . . 0.0 110.917 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -69.09 -39.0 79.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.59 -1.319 . . . . 0.0 108.359 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -59.78 -44.11 94.07 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.44 -0.788 . . . . 0.0 110.548 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.71 -36.98 85.15 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.887 -1.133 . . . . 0.0 110.006 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.4 ttp -62.77 -43.46 98.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.936 . . . . 0.0 109.402 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -65.76 -42.13 91.27 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.774 -1.204 . . . . 0.0 110.296 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.9 t -69.0 -43.21 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.246 -0.909 . . . . 0.0 110.777 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.466 ' CD1' ' HB2' ' A' ' 56' ' ' MET . 2.0 t80 -59.2 -46.65 87.86 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.758 -1.214 . . . . 0.0 108.929 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -74.48 -35.86 63.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.144 -0.972 . . . . 0.0 109.858 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -61.45 -38.39 87.03 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.172 -0.955 . . . . 0.0 109.782 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.1 mt -80.21 5.89 13.32 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.362 -0.836 . . . . 0.0 110.336 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.1 mttt 54.67 30.6 13.66 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 120.877 -1.139 . . . . 0.0 110.532 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.466 ' HB2' ' CD1' ' A' ' 51' ' ' PHE . 98.4 mtp -64.75 -12.25 45.22 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.938 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -75.89 -0.54 21.71 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.751 -1.218 . . . . 0.0 110.509 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -76.2 64.42 2.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.763 -1.211 . . . . 0.0 110.224 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.559 HG22 ' HB3' ' A' ' 137' ' ' GLU . 76.3 p -135.4 149.58 49.68 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.288 -0.882 . . . . 0.0 109.622 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.72 -43.28 96.99 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.445 ' HB2' ' ND2' ' A' ' 63' ' ' ASN . 95.8 mt -99.11 1.47 45.14 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.814 -1.179 . . . . 0.0 111.643 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 56.01 45.63 23.38 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 122.734 1.254 . . . . 0.0 110.803 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.445 ' ND2' ' HB2' ' A' ' 61' ' ' LEU . 24.6 p30 -118.05 55.25 0.89 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.238 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.99 142.87 15.66 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.527 HG23 ' CD1' ' A' ' 84' ' ' ILE . 61.0 t -127.72 136.19 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.165 -1.197 . . . . 0.0 110.779 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 34' ' ' HIS . 49.7 tp -116.71 127.44 54.39 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.783 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.862 HD12 HG22 ' A' ' 33' ' ' VAL . 90.0 mt -100.84 107.23 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.958 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.547 ' CD1' HG13 ' A' ' 43' ' ' VAL . 61.2 t80 -94.05 115.15 27.44 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.091 -1.006 . . . . 0.0 109.749 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.8 t -117.67 132.46 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 122.09 0.948 . . . . 0.0 111.126 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.601 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -99.37 87.27 3.58 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.968 ' CG1' HD11 ' A' ' 35' ' ' LEU . 28.9 m -58.89 -25.35 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.458 -0.776 . . . . 0.0 111.834 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.418 ' OE1' ' CG2' ' A' ' 38' ' ' THR . 71.3 tt0 -67.14 -43.36 82.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.743 -1.223 . . . . 0.0 108.64 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.448 ' O ' HG23 ' A' ' 75' ' ' THR . 77.1 m-20 -99.64 5.38 45.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.47 -0.769 . . . . 0.0 110.457 178.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.2 tttt 54.47 46.57 24.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.922 -1.111 . . . . 0.0 111.034 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.601 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 33.7 p -121.63 167.74 12.56 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.784 -1.198 . . . . 0.0 109.791 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -147.42 142.07 26.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.149 -0.97 . . . . 0.0 110.706 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.606 HG21 ' CG1' ' A' ' 43' ' ' VAL . 41.4 t -130.11 138.8 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.476 -0.765 . . . . 0.0 109.259 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.658 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 71.1 mt -117.54 126.37 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.804 -1.185 . . . . 0.0 110.248 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -133.25 115.46 15.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.545 -0.722 . . . . 0.0 110.735 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.8 170.74 20.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.441 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 94.2 m-20 -82.67 -178.59 7.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.482 -1.011 . . . . 0.0 110.582 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.67 -26.69 68.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 110.765 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.46 -57.9 14.64 Favored Glycine 0 N--CA 1.485 1.966 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.522 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.978 ' O ' HG22 ' A' ' 88' ' ' VAL . 79.3 mt -64.97 -44.52 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.801 -1.411 . . . . 0.0 108.917 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -61.47 -38.37 87.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.082 -1.011 . . . . 0.0 111.455 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -72.15 -19.4 61.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.915 -1.115 . . . . 0.0 112.23 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.993 HG23 HG13 ' A' ' 88' ' ' VAL . 12.8 m -108.27 -17.91 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.784 -1.198 . . . . 0.0 112.536 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.993 HG13 HG23 ' A' ' 87' ' ' VAL . 18.8 m -120.8 160.43 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.674 -1.266 . . . . 0.0 111.397 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.0 p -108.18 -175.5 2.79 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.956 0.884 . . . . 0.0 112.552 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -63.41 -35.63 81.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.662 -0.649 . . . . 0.0 109.74 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -62.3 -38.47 89.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 109.321 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.779 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 72.7 t80 -66.79 -27.64 67.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.563 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.658 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 7.3 m95 -86.06 -29.46 23.39 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.06 0.933 . . . . 0.0 110.254 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -55.83 -40.07 72.27 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.554 -0.716 . . . . 0.0 112.225 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 69.3 p -64.77 -30.46 71.47 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.412 -1.315 . . . . 0.0 108.594 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.525 ' CG2' HD13 ' A' ' 78' ' ' ILE 0.262 7.6 m -59.91 -49.43 77.73 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 122.333 1.063 . . . . 0.0 111.092 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -69.27 -37.9 78.12 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.941 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -63.85 -42.88 97.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.912 -1.117 . . . . 0.0 110.454 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.11 -48.6 73.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.736 -1.228 . . . . 0.0 110.927 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.4 mt -67.0 -42.7 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.845 -1.159 . . . . 0.0 110.175 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -61.78 -42.12 98.6 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.448 -0.782 . . . . 0.0 110.957 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.9 tp -63.81 -43.19 97.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.095 -1.003 . . . . 0.0 112.319 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.458 ' HB3' ' CA ' ' A' ' 112' ' ' GLY . 5.0 tp60 -76.07 -38.67 56.81 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.322 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -61.98 -41.4 97.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.016 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.51 -33.62 75.25 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.767 -0.583 . . . . 0.0 110.472 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -77.23 -18.29 57.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.981 -1.075 . . . . 0.0 109.499 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.8 2.52 42.89 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.714 -1.232 . . . . 0.0 111.393 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -100.22 91.32 4.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.669 -1.489 . . . . 0.0 109.972 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -62.04 -44.93 95.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.624 -0.673 . . . . 0.0 111.812 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.528 ' CG ' HD22 ' A' ' 8' ' ' LEU . 5.0 mppt? -62.64 -47.17 84.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.846 -1.159 . . . . 0.0 112.322 -177.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.419 ' CB ' ' HG2' ' A' ' 103' ' ' GLN . 89.1 mm-40 -64.33 -37.85 88.95 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.725 -1.234 . . . . 0.0 110.634 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.458 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -65.03 -50.68 56.58 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.42 -1.371 . . . . 0.0 109.899 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.4 ' HB3' HD11 ' A' ' 16' ' ' ILE . 32.6 mt -62.6 -45.15 94.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.147 -1.208 . . . . 0.0 110.405 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.487 HG22 HG13 ' A' ' 16' ' ' ILE . 79.0 t -64.47 -48.02 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.001 -1.062 . . . . 0.0 110.736 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.06 -41.48 97.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.046 -1.034 . . . . 0.0 110.215 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.25 -40.58 98.78 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 75.9 mt -63.69 -44.03 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -1.072 . . . . 0.0 109.709 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -58.9 -45.12 91.03 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.052 -1.03 . . . . 0.0 109.027 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.35 -41.63 98.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.364 -0.835 . . . . 0.0 109.066 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.502 ' O ' HD12 ' A' ' 124' ' ' LEU . . . -59.82 -43.53 94.5 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.434 -0.791 . . . . 0.0 109.942 178.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.13 -45.55 86.22 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 120.352 -0.927 . . . . 0.0 110.84 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 99.1 mmm -66.24 -44.96 82.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.979 -1.306 . . . . 0.0 109.655 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.779 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -64.53 -46.18 84.0 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.427 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 120' ' ' ALA . 52.1 mt -62.55 -39.12 92.61 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.398 -0.813 . . . . 0.0 108.884 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.27 -35.18 62.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.161 -0.962 . . . . 0.0 110.794 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.8 -39.45 88.96 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.825 -1.172 . . . . 0.0 109.774 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -84.05 -34.6 24.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.5 -0.75 . . . . 0.0 110.328 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -125.93 96.6 37.14 Favored Pre-proline 0 C--N 1.303 -1.422 0 O-C-N 121.2 -0.938 . . . . 0.0 109.128 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.88 149.04 65.55 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 O-C-N 123.866 1.456 . . . . 0.0 110.047 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.476 ' CD1' ' OD2' ' A' ' 134' ' ' ASP . 59.7 t90 -75.52 131.08 39.83 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.245 -0.91 . . . . 0.0 110.731 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -110.17 150.33 28.8 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 108.912 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.06 -29.4 65.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.996 -1.065 . . . . 0.0 110.414 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -92.34 8.39 38.61 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.817 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.476 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 66.2 t0 -42.32 138.02 1.84 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.304 -0.873 . . . . 0.0 111.995 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.771 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.3 pp -115.9 152.96 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.533 0.683 . . . . 0.0 111.131 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -113.59 99.35 7.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.832 -1.168 . . . . 0.0 110.041 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.559 ' HB3' HG22 ' A' ' 59' ' ' THR . 79.9 mm-40 -67.95 -39.46 83.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.685 -0.635 . . . . 0.0 112.267 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -105.27 152.11 39.75 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.144 -0.972 . . . . 0.0 111.498 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -76.64 -166.57 0.39 Allowed 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.528 1.278 . . . . 0.0 108.786 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.543 ' OD1' HG13 ' A' ' 17' ' ' VAL . 16.1 p30 -122.98 2.48 9.35 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.834 -1.166 . . . . 0.0 109.94 178.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.8 m -64.66 135.9 56.4 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.832 -1.167 . . . . 0.0 111.432 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.9 mt -70.93 138.59 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.669 -0.644 . . . . 0.0 109.73 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.427 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 32.2 t -98.98 100.01 11.13 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.075 -1.015 . . . . 0.0 109.717 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.436 ' HG2' ' HB3' ' A' ' 35' ' ' LEU . 98.9 mttt -100.67 147.58 25.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.827 -1.171 . . . . 0.0 109.038 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 CA-C-O 118.018 -1.434 . . . . 0.0 109.62 -179.808 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.5 mtm . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.24 0.543 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.2 p -63.88 -36.79 85.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 110.055 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.9 -41.38 99.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 110.028 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.5 pt -92.65 -9.12 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.176 -0.953 . . . . 0.0 110.926 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -66.13 -44.58 83.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.822 -1.173 . . . . 0.0 110.503 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -109.29 120.21 41.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.037 -1.039 . . . . 0.0 110.03 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.588 ' CZ ' ' CD2' ' A' ' 109' ' ' PHE . 10.1 t80 -61.66 -47.6 84.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.37 -0.831 . . . . 0.0 110.455 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.918 HD13 ' HD3' ' A' ' 110' ' ' LYS . 75.0 mt -129.16 151.55 49.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.811 . . . . 0.0 109.531 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 10' ' ' ALA . 71.9 m -79.77 163.56 24.36 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.739 -1.226 . . . . 0.0 110.637 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.404 ' N ' HG22 ' A' ' 9' ' ' THR . . . -58.8 -37.53 76.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 109.825 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -49.88 -60.92 2.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -0.855 . . . . 0.0 110.611 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.459 ' HB3' ' HG2' ' A' ' 110' ' ' LYS . 98.6 mt-10 -63.37 -40.94 98.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.576 -0.703 . . . . 0.0 110.962 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.7 mt-10 -62.61 -37.22 85.41 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.972 -1.08 . . . . 0.0 110.462 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -64.12 -44.35 92.49 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.903 -1.123 . . . . 0.0 110.276 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.93 -41.59 99.53 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.231 -0.918 . . . . 0.0 111.123 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.778 HG13 HG22 ' A' ' 114' ' ' VAL . 19.6 tt -68.36 -27.36 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.854 -1.154 . . . . 0.0 110.19 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 13' ' ' GLU . 71.1 t -66.69 -41.13 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.08 -35.06 79.51 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.652 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.66 94.12 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.265 -0.897 . . . . 0.0 109.547 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.426 ' CG2' ' HB2' ' A' ' 140' ' ' ASN . 96.6 mt -64.52 -43.38 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.14 -0.975 . . . . 0.0 110.102 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -61.21 -41.0 96.08 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.45 -0.782 . . . . 0.0 109.716 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -64.53 -38.24 90.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.544 -0.722 . . . . 0.0 111.302 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.74 -39.72 94.11 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.957 -1.089 . . . . 0.0 109.508 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -59.56 -16.55 25.93 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.025 -1.047 . . . . 0.0 110.618 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 97.3 mttt -95.0 -0.57 53.68 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.144 -0.973 . . . . 0.0 109.197 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -111.07 -15.36 13.73 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 120.903 -1.123 . . . . 0.0 110.151 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.7 t -152.91 158.6 42.36 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.045 -1.034 . . . . 0.0 110.061 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 97.6 p -87.29 -10.13 53.15 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.322 -0.861 . . . . 0.0 109.819 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.13 170.62 37.33 Favored Glycine 0 N--CA 1.48 1.571 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.64 ' HB3' HD12 ' A' ' 138' ' ' LEU . 80.9 mm-40 -130.54 134.01 46.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.231 -1.158 . . . . 0.0 111.524 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.8 mt -121.34 134.92 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-O 121.393 0.615 . . . . 0.0 110.097 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.742 ' CD ' HD13 ' A' ' 138' ' ' LEU . 84.0 mtp180 -137.46 153.49 50.08 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.802 HG12 HD12 ' A' ' 67' ' ' ILE . 27.4 m -121.21 141.19 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 111.417 -177.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.768 ' HB2' HD11 ' A' ' 66' ' ' LEU . 36.7 t60 -125.57 128.19 47.55 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.62 0.724 . . . . 0.0 109.657 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.624 HD11 ' CG1' ' A' ' 71' ' ' VAL . 27.9 tp -117.53 128.96 55.48 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.6 0.714 . . . . 0.0 111.43 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 83.3 tt0 -147.0 166.94 25.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.6 -0.687 . . . . 0.0 109.301 177.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.446 ' HA ' HG22 ' A' ' 71' ' ' VAL . 97.6 mttt -81.83 -76.94 0.23 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.335 -0.853 . . . . 0.0 113.241 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.433 ' HB ' ' HG2' ' A' ' 72' ' ' GLU . 3.9 t -139.9 154.74 47.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.042 -1.036 . . . . 0.0 110.429 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.447 ' CB ' ' HD2' ' A' ' 46' ' ' ARG . 63.7 p -104.74 169.5 8.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.481 -0.762 . . . . 0.0 110.668 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -103.97 -18.31 14.64 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.327 -0.858 . . . . 0.0 109.803 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.7 pt -117.17 -122.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.22 -0.925 . . . . 0.0 109.884 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -112.13 139.79 47.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.129 -1.607 . . . . 0.0 109.996 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.639 ' CG1' HG21 ' A' ' 77' ' ' VAL . 95.0 t -61.3 -44.07 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.284 -0.885 . . . . 0.0 110.994 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -60.43 -46.66 89.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.948 -1.095 . . . . 0.0 110.165 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -70.14 -36.54 74.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.003 -1.061 . . . . 0.0 108.694 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.447 ' HD2' ' CB ' ' A' ' 39' ' ' SER . 59.8 ttt85 -64.83 -41.84 95.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.162 -0.961 . . . . 0.0 110.765 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.1 -36.99 80.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.87 -1.144 . . . . 0.0 110.049 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.0 ttp -62.95 -45.97 89.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.358 -0.839 . . . . 0.0 110.079 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -64.1 -42.12 97.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.991 -1.068 . . . . 0.0 109.461 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 72.4 t -66.44 -43.1 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.346 -0.846 . . . . 0.0 110.323 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.482 ' CE2' ' HE2' ' A' ' 56' ' ' MET . 6.9 t80 -58.98 -46.7 87.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.986 -1.071 . . . . 0.0 108.871 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.9 m80 -72.77 -35.9 67.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.021 -1.049 . . . . 0.0 109.651 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -61.09 -39.24 89.18 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.995 -1.066 . . . . 0.0 109.316 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.9 mt -80.58 3.92 20.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 110.152 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 54.54 33.1 18.24 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.029 -1.044 . . . . 0.0 111.46 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.591 ' SD ' HD13 ' A' ' 66' ' ' LEU . 90.4 mtp -65.44 -12.61 54.05 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.81 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -76.65 -1.88 29.93 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.941 -1.1 . . . . 0.0 109.958 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -75.49 64.22 1.58 Allowed 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.056 -1.028 . . . . 0.0 109.748 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.2 p -135.05 149.7 50.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 109.238 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.26 -41.91 99.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.617 -0.677 . . . . 0.0 112.665 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 84.1 mt -99.62 0.17 41.57 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.796 -1.19 . . . . 0.0 111.743 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.422 ' O ' ' CB ' ' A' ' 81' ' ' ASP . 86.5 mt-30 58.55 46.85 14.22 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.451 1.119 . . . . 0.0 111.028 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -119.98 50.89 1.23 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.402 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.1 142.42 16.11 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.252 -1.939 . . . . 0.0 108.252 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.514 HG23 ' CD1' ' A' ' 84' ' ' ILE . 54.4 t -126.94 134.79 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.993 -1.298 . . . . 0.0 110.401 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.768 HD11 ' HB2' ' A' ' 34' ' ' HIS . 39.2 tp -117.17 125.03 50.56 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.068 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.802 HD12 HG12 ' A' ' 33' ' ' VAL . 98.6 mt -102.69 101.85 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.571 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -88.54 124.32 33.9 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.312 -0.867 . . . . 0.0 110.057 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.614 ' HB ' HD12 ' A' ' 35' ' ' LEU . 69.1 t -119.57 131.87 70.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.909 0.861 . . . . 0.0 110.373 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.505 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -102.46 87.02 2.91 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.624 ' CG1' HD11 ' A' ' 35' ' ' LEU . 34.6 m -60.56 -20.84 21.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.893 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.433 ' HG2' ' HB ' ' A' ' 38' ' ' THR . 49.6 tp10 -70.92 -45.41 64.28 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.092 -1.005 . . . . 0.0 109.097 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.526 ' O ' HG23 ' A' ' 75' ' ' THR . 83.7 m-20 -100.52 5.92 44.18 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.032 -1.043 . . . . 0.0 110.693 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.9 tttt 54.79 46.57 24.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.089 -1.007 . . . . 0.0 111.415 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 73' ' ' ASP . 82.5 p -125.52 157.8 36.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.307 -0.871 . . . . 0.0 109.903 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -138.01 145.85 42.38 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.049 -1.032 . . . . 0.0 110.102 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.639 HG21 ' CG1' ' A' ' 43' ' ' VAL . 55.5 t -132.48 136.09 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.116 -0.99 . . . . 0.0 109.637 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.659 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 81.8 mt -113.12 127.81 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.63 -1.294 . . . . 0.0 110.459 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -130.21 116.19 18.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.592 -0.692 . . . . 0.0 109.998 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.59 166.21 15.87 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.475 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 31.3 m-20 -76.42 175.56 9.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.402 -1.058 . . . . 0.0 110.606 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.409 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 85.9 tttt -60.86 -25.74 66.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.446 -0.783 . . . . 0.0 110.348 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.5 -53.68 30.65 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 120.095 -1.05 . . . . 0.0 110.593 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.968 ' O ' HG22 ' A' ' 88' ' ' VAL . 83.1 mt -64.28 -44.74 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.961 -1.317 . . . . 0.0 107.471 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -61.95 -37.79 86.07 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.004 -1.06 . . . . 0.0 111.286 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.409 ' OD2' ' HG2' ' A' ' 82' ' ' LYS . 54.2 m-20 -73.63 -20.28 60.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.836 -1.165 . . . . 0.0 111.88 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.992 HG13 HG13 ' A' ' 88' ' ' VAL . 10.6 p -105.73 -21.61 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.859 -1.151 . . . . 0.0 112.512 -178.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.992 HG13 HG13 ' A' ' 87' ' ' VAL . 17.0 m -118.75 162.45 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 120.602 -1.311 . . . . 0.0 111.708 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.6 p -105.05 177.48 4.84 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.766 0.793 . . . . 0.0 112.108 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -63.74 -37.32 86.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 109.733 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -61.72 -39.27 90.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.229 -0.919 . . . . 0.0 109.382 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.74 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 30.9 t80 -62.61 -26.63 68.71 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.659 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.6 m95 -84.05 -27.92 27.97 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.722 0.772 . . . . 0.0 110.682 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -56.97 -34.68 68.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.251 -0.905 . . . . 0.0 112.68 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.4 m -64.96 -36.21 83.65 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 118.448 -1.301 . . . . 0.0 109.088 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.443 ' CG2' HD13 ' A' ' 78' ' ' ILE 0.278 8.5 m -57.92 -47.31 83.21 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 122.307 1.051 . . . . 0.0 111.082 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -69.24 -38.8 78.67 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.361 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 91.1 m-20 -63.68 -43.99 95.04 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.675 -1.21 . . . . 0.0 109.988 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.7 -49.11 74.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.764 -1.21 . . . . 0.0 111.016 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 92.7 mt -67.33 -42.93 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.81 -1.181 . . . . 0.0 110.031 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -65.38 -42.41 92.73 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.213 -0.93 . . . . 0.0 110.876 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.734 ' O ' HD13 ' A' ' 102' ' ' LEU . 1.3 tm? -62.49 -41.21 98.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.114 -0.991 . . . . 0.0 111.075 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.484 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 30.6 mm100 -75.89 -38.54 57.72 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.728 -1.189 . . . . 0.0 108.894 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -61.03 -41.81 97.28 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -63.32 -33.59 75.86 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.926 -0.484 . . . . 0.0 110.641 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -77.43 -18.18 57.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.89 -1.132 . . . . 0.0 109.317 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.38 1.09 31.16 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.752 -1.213 . . . . 0.0 111.003 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -103.47 91.02 3.87 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.635 -1.509 . . . . 0.0 110.853 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.588 ' CD2' ' CZ ' ' A' ' 7' ' ' PHE . 12.0 m-85 -62.58 -44.98 94.96 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.782 -0.574 . . . . 0.0 110.758 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.918 ' HD3' HD13 ' A' ' 8' ' ' LEU . 29.8 tptt -63.85 -48.92 74.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.145 -0.972 . . . . 0.0 112.568 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -61.08 -38.39 86.08 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.525 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.484 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -62.99 -45.26 96.0 Favored Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.608 -1.282 . . . . 0.0 109.947 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.2 mt -64.74 -44.52 89.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.113 -1.227 . . . . 0.0 110.733 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.778 HG22 HG13 ' A' ' 16' ' ' ILE . 99.4 t -64.91 -47.94 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 110.082 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -63.66 -41.42 98.2 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.663 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.59 -43.09 99.74 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.7 -43.42 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.933 -1.334 . . . . 0.0 110.077 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.74 -50.9 71.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 110.164 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -61.92 -42.2 98.82 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.085 -1.009 . . . . 0.0 109.07 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 124' ' ' LEU . . . -57.66 -37.64 73.74 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.385 -0.822 . . . . 0.0 109.43 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.49 -45.37 68.29 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 99.1 mmm -68.16 -42.92 79.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.99 -1.3 . . . . 0.0 110.139 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.74 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -65.9 -47.17 75.71 Favored 'General case' 0 C--O 1.203 -1.39 0 O-C-N 121.169 -0.957 . . . . 0.0 108.846 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 120' ' ' ALA . 78.0 mt -61.99 -39.16 91.26 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.54 -34.18 61.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.19 -0.944 . . . . 0.0 110.487 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -61.2 -41.21 96.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.872 -1.142 . . . . 0.0 108.968 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.456 ' CE1' ' CE2' ' A' ' 92' ' ' PHE . 91.8 m-85 -80.25 -36.83 34.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 0.0 110.791 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.638 ' HE2' HG11 ' A' ' 87' ' ' VAL . 88.7 m-85 -129.23 93.01 37.29 Favored Pre-proline 0 C--N 1.304 -1.383 0 O-C-N 121.3 -0.875 . . . . 0.0 109.674 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.98 153.25 78.53 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.85 1.448 . . . . 0.0 111.227 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 49.9 t90 -77.6 132.74 38.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.675 -0.641 . . . . 0.0 111.133 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 75.4 mmtt -112.09 150.22 31.01 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -58.45 -31.23 67.58 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.557 -1.34 . . . . 0.0 111.018 -177.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -89.22 8.08 32.1 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.914 -1.115 . . . . 0.0 110.593 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.469 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 64.9 t0 -43.09 137.9 2.32 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.99 0.9 . . . . 0.0 111.038 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.582 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -111.92 141.98 25.74 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 O-C-N 121.614 -0.679 . . . . 0.0 110.476 -178.025 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -95.57 93.93 7.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.012 -1.055 . . . . 0.0 110.061 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.447 ' HG3' HG12 ' A' ' 135' ' ' ILE . 96.6 mt-10 -69.5 -42.39 74.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.702 -0.624 . . . . 0.0 112.543 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.742 HD13 ' CD ' ' A' ' 32' ' ' ARG . 16.8 mt -106.06 151.19 40.03 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 120.973 -1.08 . . . . 0.0 111.334 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.01 -175.09 1.55 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 N-CA-C 108.948 -1.212 . . . . 0.0 108.948 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.426 ' HB2' ' CG2' ' A' ' 20' ' ' ILE . 21.3 p30 -118.86 4.04 11.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.765 -1.209 . . . . 0.0 110.102 178.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.3 p -62.72 175.12 0.87 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.1 -1.0 . . . . 0.0 110.302 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.506 HG23 HG23 ' A' ' 33' ' ' VAL . 80.5 mt -107.59 141.15 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.482 -0.761 . . . . 0.0 111.462 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.4 t -94.81 133.38 38.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.473 -0.767 . . . . 0.0 109.803 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -127.48 129.37 47.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 110.827 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 118.054 -1.414 . . . . 0.0 109.856 179.576 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.6 mtm . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 121.542 0.687 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 5' ' ' GLU . 98.0 p -62.42 -39.47 93.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.472 -0.768 . . . . 0.0 110.74 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -63.78 -46.59 84.54 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.909 -1.12 . . . . 0.0 111.036 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.1 pt -68.36 -22.21 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.148 -0.97 . . . . 0.0 109.934 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 2' ' ' SER . 84.3 tt0 -63.31 -47.68 81.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.149 -0.969 . . . . 0.0 110.017 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -131.87 128.79 39.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.339 -0.85 . . . . 0.0 109.675 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.591 ' CE1' HG12 ' A' ' 71' ' ' VAL . 36.7 t80 -60.33 -47.36 86.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.311 -0.868 . . . . 0.0 110.486 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.475 ' HG ' ' CD2' ' A' ' 7' ' ' PHE . 87.9 mt -134.28 151.5 51.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.386 -0.821 . . . . 0.0 110.717 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.0 p -79.61 166.49 21.83 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.966 -1.084 . . . . 0.0 109.92 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.61 -38.22 66.54 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.011 -1.056 . . . . 0.0 109.115 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.22 -46.03 86.63 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.673 0.749 . . . . 0.0 110.181 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -69.83 -42.42 73.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.47 -0.769 . . . . 0.0 111.179 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.694 ' O ' HG23 ' A' ' 17' ' ' VAL . 92.4 mt-10 -63.64 -37.42 87.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.142 -0.974 . . . . 0.0 109.892 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.65 -44.81 92.74 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.053 -1.03 . . . . 0.0 110.672 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.67 -44.12 87.27 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.994 -1.067 . . . . 0.0 111.788 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 13' ' ' GLU . 19.3 tt -67.71 -36.52 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.73 -1.231 . . . . 0.0 110.44 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 13' ' ' GLU . 69.2 t -62.42 -39.57 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 21' ' ' ARG . 29.4 t0 -62.87 -35.01 78.58 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.464 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.93 -39.57 95.0 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.322 -0.862 . . . . 0.0 110.104 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.55 -43.85 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.114 -0.991 . . . . 0.0 109.883 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 18' ' ' ASP . 74.7 mtm180 -60.21 -42.04 94.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.872 . . . . 0.0 110.896 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -63.16 -36.2 82.84 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.125 -0.985 . . . . 0.0 110.33 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.6 -39.27 88.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.092 -1.005 . . . . 0.0 110.164 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -60.67 -16.32 37.89 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.943 -1.098 . . . . 0.0 110.851 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.473 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.6 mttt -95.11 -4.2 46.65 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.172 -0.955 . . . . 0.0 109.628 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -105.12 -16.99 14.63 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.068 -1.02 . . . . 0.0 109.462 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.8 t -152.4 161.83 42.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.114 -0.991 . . . . 0.0 109.864 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.1 p -87.81 -7.47 57.22 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.311 -0.868 . . . . 0.0 109.887 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.98 170.4 47.25 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -129.5 132.74 46.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.241 -1.152 . . . . 0.0 111.217 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.2 mt -117.42 134.34 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.693 -0.63 . . . . 0.0 110.147 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.453 ' HB3' ' HE1' ' A' ' 56' ' ' MET . 75.2 ttt180 -139.8 149.36 43.41 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.05 -1.031 . . . . 0.0 110.101 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.738 HG22 HD12 ' A' ' 67' ' ' ILE . 48.3 t -117.44 137.32 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.236 -0.915 . . . . 0.0 111.199 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.829 ' HB2' HD11 ' A' ' 66' ' ' LEU . 15.4 t60 -122.66 125.94 46.61 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.552 HD11 HG13 ' A' ' 71' ' ' VAL . 44.8 tp -115.35 135.85 53.71 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.091 0.948 . . . . 0.0 112.045 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.427 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 81.4 tt0 -150.12 164.33 35.87 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 177.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.56 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.0 mttt -79.48 -74.58 0.28 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.454 -0.779 . . . . 0.0 112.108 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.8 t -140.95 154.93 46.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 109.634 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.432 ' HB2' ' HD2' ' A' ' 46' ' ' ARG . 12.0 p -106.0 168.91 8.81 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.495 -0.753 . . . . 0.0 110.615 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -109.66 -18.54 13.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.116 -0.99 . . . . 0.0 110.83 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.428 HG13 ' N ' ' A' ' 42' ' ' ASP . 32.0 pt -114.06 -123.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.981 -1.075 . . . . 0.0 109.85 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.428 ' N ' HG13 ' A' ' 41' ' ' ILE . 99.3 m-20 -111.77 136.67 50.73 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.461 -1.4 . . . . 0.0 109.727 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.82 -45.21 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.681 -0.637 . . . . 0.0 112.619 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -60.22 -47.17 87.1 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.751 -1.218 . . . . 0.0 110.322 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -71.28 -40.91 70.63 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.927 -1.108 . . . . 0.0 108.992 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HD2' ' HB2' ' A' ' 39' ' ' SER . 66.7 ttt-85 -63.06 -43.51 98.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.128 -0.983 . . . . 0.0 110.891 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.88 85.72 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.544 -1.347 . . . . 0.0 109.428 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.8 ttp -61.69 -41.99 98.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.009 -1.057 . . . . 0.0 108.939 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.86 -44.43 93.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.069 -1.02 . . . . 0.0 109.73 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.46 -43.78 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.417 -0.802 . . . . 0.0 110.533 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.462 ' CE2' ' OD1' ' A' ' 57' ' ' ASP . 64.4 t80 -59.88 -47.39 85.96 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.007 -1.058 . . . . 0.0 109.966 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -74.98 -34.49 61.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.946 -1.096 . . . . 0.0 109.326 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -62.19 -36.62 82.46 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.949 -1.094 . . . . 0.0 109.137 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.19 2.81 26.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.18 -0.95 . . . . 0.0 110.049 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 55.54 33.52 21.25 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 121.142 -0.974 . . . . 0.0 111.892 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.748 ' SD ' HD13 ' A' ' 66' ' ' LEU . 95.7 mtp -66.19 -11.65 51.01 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 118.872 -1.131 . . . . 0.0 109.664 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.462 ' OD1' ' CE2' ' A' ' 51' ' ' PHE . 94.4 m-20 -77.19 -0.59 25.65 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.047 -1.033 . . . . 0.0 109.334 176.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -76.15 62.17 1.68 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.175 -0.953 . . . . 0.0 109.92 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.7 m -132.72 146.33 51.77 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.02 -42.48 99.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.568 -0.708 . . . . 0.0 111.427 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.2 mt -95.57 -0.05 52.41 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.011 -1.055 . . . . 0.0 111.265 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 57.3 45.33 20.4 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.406 1.098 . . . . 0.0 111.187 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -118.74 54.04 0.97 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.253 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.87 139.23 14.31 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.584 HG23 ' CD1' ' A' ' 84' ' ' ILE . 53.8 t -123.78 136.59 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.151 -1.206 . . . . 0.0 110.802 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.829 HD11 ' HB2' ' A' ' 34' ' ' HIS . 38.9 tp -117.89 128.13 54.53 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.347 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.738 HD12 HG22 ' A' ' 33' ' ' VAL . 97.1 mt -104.79 104.75 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 118.876 -1.129 . . . . 0.0 109.467 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -90.12 122.2 32.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.32 -0.863 . . . . 0.0 109.893 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -121.07 134.23 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.066 0.936 . . . . 0.0 110.924 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.517 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -104.44 98.42 8.2 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.591 HG12 ' CE1' ' A' ' 7' ' ' PHE . 33.3 m -66.36 -22.25 29.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.197 -0.939 . . . . 0.0 110.607 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -68.93 -44.06 73.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.033 -1.042 . . . . 0.0 109.542 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 75' ' ' THR . 96.2 m-20 -101.7 4.9 41.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.079 -1.013 . . . . 0.0 111.044 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 ttmt 55.5 46.74 22.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.879 -1.138 . . . . 0.0 110.352 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 70.5 p -122.4 165.88 15.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -0.901 . . . . 0.0 109.749 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 46.3 p90 -146.38 146.66 30.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.512 -0.743 . . . . 0.0 110.369 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.1 t -133.78 136.88 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.389 -0.819 . . . . 0.0 109.114 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.646 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 81.6 mt -115.2 127.34 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.617 -1.302 . . . . 0.0 110.713 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -129.96 119.24 22.89 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.745 . . . . 0.0 111.223 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.525 ' HA2' HG22 ' A' ' 65' ' ' VAL . . . -103.28 149.49 17.47 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -62.82 175.28 0.86 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.568 -0.96 . . . . 0.0 110.1 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.84 -26.88 67.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.226 -0.921 . . . . 0.0 111.702 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.76 -53.85 32.12 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.609 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.97 ' O ' HG22 ' A' ' 88' ' ' VAL . 75.0 mt -63.11 -44.82 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.802 -1.411 . . . . 0.0 108.347 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -60.97 -38.51 86.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.966 -1.083 . . . . 0.0 111.627 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -71.0 -22.0 62.22 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.857 -1.152 . . . . 0.0 111.748 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.946 HG23 HG13 ' A' ' 88' ' ' VAL . 23.5 m -104.97 -15.77 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.92 -1.113 . . . . 0.0 112.884 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.97 HG22 ' O ' ' A' ' 84' ' ' ILE . 21.8 m -121.04 163.51 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.591 -1.318 . . . . 0.0 112.089 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.3 m -110.93 178.27 4.4 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.6 0.714 . . . . 0.0 112.158 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 33.8 p-10 -63.12 -36.4 83.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 110.059 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 65.8 t0 -62.87 -38.64 91.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.109 -0.994 . . . . 0.0 108.986 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.818 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 78.6 t80 -67.07 -25.28 66.17 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.239 -0.913 . . . . 0.0 109.376 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.646 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.8 m95 -86.5 -23.49 25.92 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.796 0.808 . . . . 0.0 110.36 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -58.1 -36.23 72.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.91 . . . . 0.0 112.057 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.5 p -67.25 -31.28 71.51 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.541 -1.264 . . . . 0.0 108.895 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.549 HG22 HD13 ' A' ' 78' ' ' ILE 0.272 10.0 m -60.08 -48.91 79.75 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 122.352 1.072 . . . . 0.0 111.111 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.38 -36.71 74.28 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.994 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -64.59 -44.23 91.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.933 -1.104 . . . . 0.0 110.482 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.12 -50.68 69.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.557 -1.34 . . . . 0.0 111.282 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.469 HD12 HD11 ' A' ' 78' ' ' ILE . 92.9 mt -66.35 -42.9 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.769 -1.207 . . . . 0.0 110.279 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -63.26 -41.75 99.09 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.296 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.7 mt -63.33 -41.71 98.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.196 -0.94 . . . . 0.0 111.775 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.464 ' HG2' ' HB2' ' A' ' 111' ' ' GLN . 5.8 tp-100 -76.36 -40.17 51.88 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.69 -1.204 . . . . 0.0 108.963 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.423 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 1.2 m-85 -59.89 -40.64 89.41 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.62 -34.79 77.76 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.858 -0.526 . . . . 0.0 110.073 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -76.7 -18.7 58.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.989 -1.069 . . . . 0.0 109.712 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.08 -0.22 38.37 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.771 -1.204 . . . . 0.0 111.208 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -99.49 89.37 4.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.633 -1.51 . . . . 0.0 109.548 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.575 ' CD2' ' CE1' ' A' ' 7' ' ' PHE . 19.7 m-30 -64.16 -41.78 97.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.869 -0.52 . . . . 0.0 111.816 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.446 ' O ' HG12 ' A' ' 114' ' ' VAL . 86.5 tttt -61.43 -48.19 82.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.047 -1.033 . . . . 0.0 110.798 -178.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.464 ' HB2' ' HG2' ' A' ' 103' ' ' GLN . 87.3 mt-30 -64.3 -35.9 82.37 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.117 -0.99 . . . . 0.0 110.427 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.448 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -65.76 -48.76 64.05 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.184 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.401 ' HB3' HD11 ' A' ' 16' ' ' ILE . 91.9 mt -65.6 -44.73 85.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.082 -1.246 . . . . 0.0 111.409 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.486 HG13 ' N ' ' A' ' 115' ' ' ASP . 11.5 p -65.06 -46.31 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.184 -0.947 . . . . 0.0 110.5 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.486 ' N ' HG13 ' A' ' 114' ' ' VAL . 66.6 t0 -64.45 -42.11 96.14 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.992 -1.067 . . . . 0.0 109.929 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.45 -42.17 93.69 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.79 -43.04 97.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.232 -1.157 . . . . 0.0 109.78 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -59.17 -50.98 71.98 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.973 -1.08 . . . . 0.0 110.616 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.89 -42.94 99.95 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.878 -1.138 . . . . 0.0 109.28 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.8 -43.43 76.85 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.286 -0.884 . . . . 0.0 109.365 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.81 -42.98 99.59 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 98.8 mmm -67.53 -46.84 71.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.015 -1.285 . . . . 0.0 110.472 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.818 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -63.94 -45.99 86.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.255 -0.903 . . . . 0.0 109.29 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.86 -40.42 95.3 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.4 -34.43 57.71 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.47 -0.769 . . . . 0.0 110.27 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -63.05 -44.17 96.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.061 -1.025 . . . . 0.0 109.133 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -73.08 -39.11 66.12 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.571 0.7 . . . . 0.0 109.961 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -131.67 98.36 18.05 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.634 -0.666 . . . . 0.0 110.178 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.45 154.13 69.41 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.647 1.34 . . . . 0.0 111.041 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.473 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 30.7 t90 -75.77 158.57 32.06 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.905 0.86 . . . . 0.0 110.948 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -140.47 151.42 44.84 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.33 -31.87 71.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.025 -1.047 . . . . 0.0 111.096 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -89.61 5.51 45.37 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.047 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.436 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 68.2 t0 -42.11 139.84 1.26 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.04 0.924 . . . . 0.0 111.71 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.695 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -113.87 142.7 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 121.817 0.818 . . . . 0.0 111.757 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -102.31 96.53 7.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.942 -1.099 . . . . 0.0 110.462 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -69.86 -33.41 72.22 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.649 -0.657 . . . . 0.0 112.673 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.9 mp -112.45 150.2 42.25 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.07 -1.019 . . . . 0.0 112.176 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.85 -170.47 0.7 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.667 1.351 . . . . 0.0 109.228 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 18.5 p-10 -125.37 1.85 7.73 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.71 -1.243 . . . . 0.0 110.287 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.6 p -60.85 167.94 2.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.999 -1.063 . . . . 0.0 110.866 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 47.5 mm -95.09 134.33 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.435 0.636 . . . . 0.0 110.691 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 10.5 m -91.22 132.78 35.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 0.0 109.946 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.11 144.99 51.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.145 -0.972 . . . . 0.0 110.544 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.844 179.488 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.4 mtm . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 121.327 0.584 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.0 m -80.46 -10.56 59.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.224 -0.922 . . . . 0.0 110.846 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -65.46 -44.39 87.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.739 -1.225 . . . . 0.0 110.806 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.4 HG13 ' N ' ' A' ' 5' ' ' GLU . 42.6 pt -72.61 -26.46 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.854 -1.153 . . . . 0.0 110.834 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.4 ' N ' HG13 ' A' ' 4' ' ' ILE . 99.1 mt-10 -61.19 -37.26 82.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.156 -0.965 . . . . 0.0 110.431 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 22.5 pt-20 -166.25 129.74 2.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.475 -0.765 . . . . 0.0 109.243 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.965 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 63.3 m-85 -62.86 -45.51 92.21 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.041 -1.037 . . . . 0.0 109.817 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.434 ' HA ' ' OE1' ' A' ' 12' ' ' GLU . 78.7 mt -129.25 147.82 51.12 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.563 -0.71 . . . . 0.0 110.1 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.6 m -72.24 165.22 24.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.952 -1.093 . . . . 0.0 109.976 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 14' ' ' LYS . . . -54.14 -36.67 63.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.2 -0.937 . . . . 0.0 109.6 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.65 -38.46 89.39 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 109.545 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.45 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 97.5 mt-10 -70.63 -46.54 63.13 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.013 -1.055 . . . . 0.0 110.365 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.0 mt-10 -65.26 -34.58 78.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.381 -0.824 . . . . 0.0 109.572 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 87.3 tttt -62.91 -46.34 88.28 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.231 -0.918 . . . . 0.0 110.667 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.31 -43.81 85.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 111.773 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.531 HG13 HG22 ' A' ' 114' ' ' VAL . 16.5 tt -66.61 -36.62 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.665 -1.272 . . . . 0.0 110.49 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 13' ' ' GLU . 71.6 t -63.77 -40.69 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.44 -39.08 92.21 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.755 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.0 92.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.322 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.57 -42.58 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.495 -0.753 . . . . 0.0 109.251 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.407 ' HG2' ' OD1' ' A' ' 140' ' ' ASN . 80.9 mtp180 -59.15 -42.57 91.02 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.211 -0.931 . . . . 0.0 110.304 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -64.91 -36.44 84.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.405 -0.81 . . . . 0.0 110.659 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.36 90.85 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.761 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -60.4 -14.86 21.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.089 -1.007 . . . . 0.0 111.175 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.473 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.5 mttt -95.49 -1.72 50.14 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.958 -1.089 . . . . 0.0 109.749 177.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -109.57 -14.51 14.36 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 120.896 -1.128 . . . . 0.0 109.593 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.0 t -154.4 160.55 41.72 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.882 -1.136 . . . . 0.0 110.485 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.2 m -88.86 -7.2 56.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.206 -0.934 . . . . 0.0 110.273 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.87 171.0 48.5 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.677 ' OE1' HD22 ' A' ' 138' ' ' LEU . 91.7 mt-10 -130.96 137.17 49.14 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.268 -1.137 . . . . 0.0 111.216 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.499 HG21 HD12 ' A' ' 117' ' ' ILE . 83.3 mt -119.63 134.71 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.712 -0.618 . . . . 0.0 110.317 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.4 ' HB2' ' HE1' ' A' ' 56' ' ' MET . 57.4 mmm-85 -138.69 150.7 46.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.249 -0.907 . . . . 0.0 110.197 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.631 HG12 HD12 ' A' ' 67' ' ' ILE . 15.8 m -123.24 139.54 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.456 -0.777 . . . . 0.0 111.118 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -124.9 128.62 48.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.563 -0.711 . . . . 0.0 109.237 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.714 HD11 ' CG1' ' A' ' 71' ' ' VAL . 36.9 tp -115.82 128.87 56.16 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.902 0.858 . . . . 0.0 111.814 -178.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -144.7 165.12 28.94 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -78.95 -74.05 0.3 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.226 -0.921 . . . . 0.0 113.1 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.6 t -140.25 156.18 46.58 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.772 -1.205 . . . . 0.0 110.167 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.9 p -102.56 168.01 9.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.427 -0.796 . . . . 0.0 110.505 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -107.19 -14.32 14.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.308 -0.87 . . . . 0.0 110.632 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 42' ' ' ASP . 19.2 pt -123.34 -121.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.976 -1.077 . . . . 0.0 109.735 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.422 ' N ' HG13 ' A' ' 41' ' ' ILE . 94.2 m-20 -111.34 140.34 46.0 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 120.191 -1.568 . . . . 0.0 109.217 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.612 HG11 HG21 ' A' ' 77' ' ' VAL . 97.3 t -64.76 -44.24 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.211 -0.931 . . . . 0.0 111.815 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -58.16 -45.86 86.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.049 -1.032 . . . . 0.0 109.648 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -71.64 -38.83 70.69 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.917 -1.114 . . . . 0.0 108.94 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.423 ' NH1' ' OH ' ' A' ' 68' ' ' TYR . 75.4 ttt180 -63.45 -42.58 98.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.972 -1.08 . . . . 0.0 110.927 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.13 -38.78 86.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.696 -1.253 . . . . 0.0 110.294 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 64.3 ttp -62.81 -44.05 97.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.064 -1.022 . . . . 0.0 109.405 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.427 ' OD1' ' ND2' ' A' ' 53' ' ' ASN . 63.5 t0 -63.52 -45.61 89.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.021 -1.049 . . . . 0.0 109.488 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 83.3 t -66.35 -44.31 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.35 -0.844 . . . . 0.0 110.947 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.473 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 4.5 t80 -58.27 -47.66 82.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.904 -1.122 . . . . 0.0 108.992 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -70.29 -36.24 74.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.054 -1.029 . . . . 0.0 109.238 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.427 ' ND2' ' OD1' ' A' ' 49' ' ' ASP . 72.7 m-20 -61.18 -37.55 83.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.096 -1.002 . . . . 0.0 110.012 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.8 mt -82.16 5.87 18.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.985 -1.072 . . . . 0.0 110.727 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 55.73 32.74 20.02 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.309 -0.87 . . . . 0.0 110.92 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.473 ' HB2' ' CE1' ' A' ' 51' ' ' PHE . 92.8 mtp -69.13 -25.41 64.38 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.341 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -68.76 -7.61 35.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.347 -0.845 . . . . 0.0 110.48 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -86.98 80.78 8.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.752 -1.218 . . . . 0.0 110.727 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.419 ' OG1' ' HA ' ' A' ' 62' ' ' GLN . 78.8 p -137.04 156.82 47.94 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -62.09 -43.97 97.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.092 -1.005 . . . . 0.0 112.817 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 88.1 mt -100.02 2.31 43.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.091 -1.006 . . . . 0.0 111.301 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.419 ' HA ' ' OG1' ' A' ' 59' ' ' THR . 99.4 mm-40 57.75 31.47 20.49 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.973 0.892 . . . . 0.0 111.272 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.575 ' C ' HD11 ' A' ' 84' ' ' ILE . 99.7 m-20 -108.96 56.46 0.62 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.812 0.815 . . . . 0.0 110.465 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.455 ' N ' HD11 ' A' ' 84' ' ' ILE . . . -103.59 141.19 15.17 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.56 ' CG2' HD13 ' A' ' 84' ' ' ILE . 47.9 t -123.35 135.05 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.07 -1.253 . . . . 0.0 110.593 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.0 tp -116.79 130.39 56.69 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.88 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.631 HD12 HG12 ' A' ' 33' ' ' VAL . 83.6 mt -104.78 108.27 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 118.826 -1.15 . . . . 0.0 109.395 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.423 ' OH ' ' NH1' ' A' ' 46' ' ' ARG . 42.3 t80 -93.73 122.69 36.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.531 -0.731 . . . . 0.0 110.331 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -123.63 133.42 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 122.173 0.987 . . . . 0.0 111.32 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.17 97.45 7.3 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.965 HG21 ' CZ ' ' A' ' 7' ' ' PHE . 35.8 m -67.38 -18.67 24.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.968 -1.083 . . . . 0.0 111.245 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -69.37 -46.52 66.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.754 -1.216 . . . . 0.0 109.445 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.23 3.69 41.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.155 -0.966 . . . . 0.0 110.797 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.4 tttt 56.13 45.77 22.8 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.943 -1.098 . . . . 0.0 110.39 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 96.0 m -119.78 132.87 55.73 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.243 -0.911 . . . . 0.0 109.812 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.421 ' CD1' ' O ' ' A' ' 76' ' ' PHE . 50.9 p90 -114.52 136.7 52.73 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.532 -0.73 . . . . 0.0 109.924 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.612 HG21 HG11 ' A' ' 43' ' ' VAL . 72.0 t -126.69 136.92 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.711 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 82.7 mt -115.35 125.36 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.771 -1.205 . . . . 0.0 110.324 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -128.97 114.89 16.99 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.513 -0.742 . . . . 0.0 110.488 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.65 145.83 16.54 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -56.93 175.47 0.13 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.516 -0.99 . . . . 0.0 109.803 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.06 -24.59 63.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.091 -1.006 . . . . 0.0 110.639 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.434 ' O ' HG12 ' A' ' 87' ' ' VAL . . . -66.79 -51.79 38.33 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.655 -1.26 . . . . 0.0 110.632 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.973 ' O ' HG22 ' A' ' 88' ' ' VAL . 3.8 mt -64.15 -44.71 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.914 -1.345 . . . . 0.0 108.447 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -64.26 -36.68 84.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.365 -0.834 . . . . 0.0 111.727 -177.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -75.64 -20.95 58.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.785 -1.197 . . . . 0.0 111.938 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.01 HG13 HG13 ' A' ' 88' ' ' VAL . 11.7 p -103.08 -21.95 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.851 -1.156 . . . . 0.0 113.132 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.01 HG13 HG13 ' A' ' 87' ' ' VAL . 14.3 m -118.68 164.08 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.626 -1.296 . . . . 0.0 111.433 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.2 p -105.45 174.76 5.74 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.922 0.867 . . . . 0.0 111.634 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.01 -37.95 86.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.459 -0.776 . . . . 0.0 110.071 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -61.46 -37.57 84.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.946 . . . . 0.0 108.81 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.911 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 86.3 t80 -64.86 -27.2 68.71 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.446 -0.784 . . . . 0.0 108.968 177.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.711 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.4 m95 -86.12 -26.22 25.34 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.975 0.893 . . . . 0.0 109.888 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -58.97 -36.38 74.77 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.024 -1.048 . . . . 0.0 112.334 -176.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.9 p -66.56 -32.03 73.11 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.535 -1.266 . . . . 0.0 108.596 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.437 HG22 HD13 ' A' ' 78' ' ' ILE 0.276 7.5 m -60.21 -49.46 77.53 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 122.264 1.031 . . . . 0.0 111.141 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -68.29 -38.03 81.25 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.697 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -64.04 -41.39 97.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.013 -1.054 . . . . 0.0 110.617 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.16 -48.95 74.03 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.639 -1.288 . . . . 0.0 110.841 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.514 HD12 HD11 ' A' ' 78' ' ' ILE . 91.9 mt -67.05 -42.78 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 110.406 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -64.17 -41.43 97.14 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.296 -0.877 . . . . 0.0 110.94 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 44.3 tp -62.79 -43.02 99.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.312 -0.868 . . . . 0.0 111.754 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.474 ' CB ' ' CA ' ' A' ' 112' ' ' GLY . 3.0 tp60 -76.69 -40.08 50.0 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.779 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -58.95 -41.94 88.65 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.166 0.984 . . . . 0.0 108.449 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.12 -35.01 72.7 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -79.79 -17.23 53.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.349 -0.844 . . . . 0.0 110.169 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.62 2.5 43.47 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 119.73 -1.224 . . . . 0.0 111.573 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -104.53 94.81 5.52 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.689 -1.477 . . . . 0.0 110.859 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -62.76 -46.32 88.6 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.626 -0.671 . . . . 0.0 112.3 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.564 ' O ' HG23 ' A' ' 114' ' ' VAL . 75.3 tttt -61.62 -47.76 83.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.12 -0.988 . . . . 0.0 111.838 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.418 ' CB ' ' HG2' ' A' ' 103' ' ' GLN . 89.1 mt-30 -63.46 -40.03 96.05 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.377 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.474 ' CA ' ' CB ' ' A' ' 103' ' ' GLN . . . -65.21 -47.83 76.46 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.355 -1.402 . . . . 0.0 109.624 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.432 ' O ' HG12 ' A' ' 117' ' ' ILE . 85.2 mt -64.24 -46.01 85.64 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.506 -0.996 . . . . 0.0 111.523 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 110' ' ' LYS . 99.4 t -63.1 -48.14 89.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.296 -0.877 . . . . 0.0 110.943 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -61.63 -33.52 74.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.028 -1.045 . . . . 0.0 109.108 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.14 -40.33 98.39 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.499 HD12 HG21 ' A' ' 31' ' ' ILE . 36.1 mm -63.36 -43.84 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.064 -1.257 . . . . 0.0 109.741 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.05 -49.74 76.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.277 -0.889 . . . . 0.0 110.723 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -64.73 -43.92 91.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.057 -1.027 . . . . 0.0 110.351 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.31 95.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.895 . . . . 0.0 110.593 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.82 -44.06 81.41 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 97.0 mtp -66.56 -46.18 76.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.011 -1.288 . . . . 0.0 109.901 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.911 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -64.09 -43.89 94.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.969 -1.082 . . . . 0.0 108.974 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 31.2 mt -63.02 -40.49 97.9 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.397 -0.815 . . . . 0.0 109.093 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.42 -34.08 56.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.128 -0.983 . . . . 0.0 110.09 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.63 -44.27 97.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.121 -0.987 . . . . 0.0 109.13 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -70.66 -41.74 71.69 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.473 0.654 . . . . 0.0 109.971 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.42 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 58.1 m-85 -130.88 94.31 28.81 Favored Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.496 -0.753 . . . . 0.0 109.776 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 128' ' ' PHE . 38.8 Cg_endo -64.45 149.88 89.24 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.652 1.343 . . . . 0.0 109.843 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.473 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 39.3 t90 -73.46 130.19 39.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.457 -0.777 . . . . 0.0 111.896 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -108.78 152.64 24.58 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.03 -29.54 68.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.109 -0.995 . . . . 0.0 111.064 -177.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -91.9 6.81 44.77 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.099 -1.04 . . . . 0.0 111.48 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.449 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 67.9 t0 -42.49 139.25 1.57 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.653 -0.654 . . . . 0.0 110.645 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.711 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.3 pp -115.12 142.14 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 122.51 1.148 . . . . 0.0 113.297 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -120.33 102.52 8.53 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.16 -0.962 . . . . 0.0 109.412 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -101.4 5.92 42.34 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.633 -1.292 . . . . 0.0 111.712 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.677 HD22 ' OE1' ' A' ' 30' ' ' GLU . 1.4 tp -114.26 139.69 24.12 Favored Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 120.935 -1.103 . . . . 0.0 110.634 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -70.61 165.17 32.8 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.528 1.278 . . . . 0.0 109.747 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.407 ' OD1' ' HG2' ' A' ' 21' ' ' ARG . 32.0 m120 -103.22 8.75 38.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.595 -1.316 . . . . 0.0 110.027 177.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -62.04 144.93 54.51 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.854 -1.154 . . . . 0.0 110.647 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.98 138.71 19.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.789 -0.569 . . . . 0.0 109.846 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.0 m -93.27 132.31 37.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.077 -1.014 . . . . 0.0 109.203 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -126.22 137.52 53.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.292 -0.88 . . . . 0.0 110.143 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 CA-C-O 118.001 -1.444 . . . . 0.0 109.521 179.551 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 ttp . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.132 0.492 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.9 p -69.24 -16.82 63.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.093 -1.004 . . . . 0.0 110.171 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -81.76 141.0 33.92 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.264 -0.897 . . . . 0.0 110.852 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.5 tt -69.4 -35.88 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.6 -0.687 . . . . 0.0 110.656 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -62.22 -42.49 99.35 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.053 -1.029 . . . . 0.0 110.421 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -100.52 104.26 15.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.056 -1.027 . . . . 0.0 110.087 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.92 ' CE1' HG21 ' A' ' 71' ' ' VAL . 88.8 m-85 -62.94 -44.67 95.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 111.021 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 12' ' ' GLU . 88.2 mt -130.62 151.71 50.78 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -0.986 . . . . 0.0 110.168 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.3 m -78.74 165.56 23.46 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.087 -1.008 . . . . 0.0 109.807 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 14' ' ' LYS . . . -54.08 -36.34 63.04 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.893 -1.129 . . . . 0.0 109.187 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -66.01 -37.09 85.03 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.539 -0.725 . . . . 0.0 109.311 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.477 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 78.1 mm-40 -72.38 -48.26 42.98 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.151 -0.968 . . . . 0.0 110.082 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.816 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.2 mt-10 -66.48 -36.98 84.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.463 -0.773 . . . . 0.0 110.186 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 88.1 tttt -62.02 -45.72 92.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.846 -1.158 . . . . 0.0 111.095 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.89 -42.46 94.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.783 -1.198 . . . . 0.0 111.434 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.588 HG13 HG22 ' A' ' 114' ' ' VAL . 19.1 tt -66.96 -36.16 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.831 -1.168 . . . . 0.0 110.748 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 13' ' ' GLU . 87.8 t -63.82 -41.02 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -62.54 -36.55 82.96 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.664 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.23 -38.27 88.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 109.353 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.874 HD11 HD13 ' A' ' 117' ' ' ILE . 34.9 mm -63.92 -43.45 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.396 -0.815 . . . . 0.0 109.998 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -59.65 -41.6 90.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.311 -0.868 . . . . 0.0 109.821 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -63.92 -37.94 89.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.326 -0.859 . . . . 0.0 111.215 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.74 -40.93 88.52 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.083 -1.011 . . . . 0.0 110.44 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -60.35 -14.5 18.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.904 -1.122 . . . . 0.0 110.922 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.469 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 49.2 mtpt -94.59 -2.82 50.77 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 120.831 -1.168 . . . . 0.0 109.48 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -109.93 -14.11 14.32 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 121.002 -1.061 . . . . 0.0 110.184 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.7 t -151.77 158.03 42.77 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.063 -1.023 . . . . 0.0 109.982 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 83.5 p -86.91 -7.95 57.71 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.273 -0.892 . . . . 0.0 109.95 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.7 172.61 45.6 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.77 ' CB ' HD12 ' A' ' 138' ' ' LEU . 55.8 mp0 -131.23 136.38 48.18 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.339 -1.095 . . . . 0.0 111.247 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -122.42 134.71 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.876 -0.515 . . . . 0.0 110.026 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.496 HH11 HD22 ' A' ' 138' ' ' LEU . 83.6 mtp180 -138.57 153.99 48.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.206 -0.934 . . . . 0.0 110.135 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.646 HG22 HD12 ' A' ' 67' ' ' ILE . 48.1 t -123.7 139.34 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.385 -0.822 . . . . 0.0 110.665 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.419 ' HA ' ' O ' ' A' ' 143' ' ' SER . 77.8 t60 -124.64 122.8 38.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.53 -0.732 . . . . 0.0 110.215 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.928 HD11 ' CG1' ' A' ' 71' ' ' VAL . 33.8 tp -108.39 131.56 54.64 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.901 0.858 . . . . 0.0 111.421 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -149.39 166.43 29.06 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.452 ' HB3' ' HG3' ' A' ' 72' ' ' GLU . 98.4 mttt -81.33 -75.45 0.28 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.928 -1.107 . . . . 0.0 113.498 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.756 HG23 ' CB ' ' A' ' 72' ' ' GLU . 1.3 p -137.96 154.09 49.41 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.496 -0.753 . . . . 0.0 109.955 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.419 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 14.3 p -98.95 167.91 10.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.137 -0.977 . . . . 0.0 110.283 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -106.27 -10.83 16.23 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.307 -0.871 . . . . 0.0 110.422 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.401 HG13 ' N ' ' A' ' 42' ' ' ASP . 28.7 pt -128.56 -121.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.936 -1.102 . . . . 0.0 109.358 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.401 ' N ' HG13 ' A' ' 41' ' ' ILE . 89.9 m-20 -111.02 138.4 47.48 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 120.184 -1.573 . . . . 0.0 110.042 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.465 HG11 HG21 ' A' ' 77' ' ' VAL . 90.1 t -62.99 -44.96 99.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.564 -0.71 . . . . 0.0 112.01 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -59.89 -46.28 89.84 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.925 -1.109 . . . . 0.0 110.057 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -70.58 -39.41 73.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.772 -1.205 . . . . 0.0 108.568 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.419 ' NH2' ' HA ' ' A' ' 39' ' ' SER . 49.8 ttt85 -61.46 -45.68 93.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 111.358 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.36 84.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.961 -1.087 . . . . 0.0 109.713 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 66.0 ttp -64.71 -43.87 92.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.204 -0.935 . . . . 0.0 109.878 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 53.5 t0 -63.2 -43.55 97.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.043 -1.036 . . . . 0.0 109.252 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.6 t -67.23 -44.01 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.46 -0.775 . . . . 0.0 110.35 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.528 ' HD1' HD22 ' A' ' 66' ' ' LEU . 61.4 t80 -60.19 -48.14 82.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.719 -1.238 . . . . 0.0 110.296 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -72.47 -35.2 68.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.989 -1.07 . . . . 0.0 108.821 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 49' ' ' ASP . 31.4 t-20 -62.34 -39.37 92.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.338 -0.851 . . . . 0.0 110.194 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.427 HD13 ' CE ' ' A' ' 56' ' ' MET . 55.6 mt -79.31 3.15 18.96 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.153 -0.967 . . . . 0.0 110.187 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 57.29 33.43 23.28 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 121.041 -1.037 . . . . 0.0 112.044 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.468 ' SD ' HD13 ' A' ' 66' ' ' LEU . 64.7 mtt -67.46 -10.79 54.8 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.845 -1.16 . . . . 0.0 109.913 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.41 ' OD1' ' CE2' ' A' ' 51' ' ' PHE . 97.1 m-20 -77.82 -0.87 28.85 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.788 -1.195 . . . . 0.0 109.787 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -80.02 63.49 4.56 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 121.005 -1.06 . . . . 0.0 109.871 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.421 ' OG1' ' HA ' ' A' ' 62' ' ' GLN . 66.8 p -133.11 150.28 52.07 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.08 -41.01 99.32 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.441 -0.787 . . . . 0.0 112.271 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.415 ' HB3' ' ND2' ' A' ' 63' ' ' ASN . 87.0 mt -100.0 -0.51 39.12 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.932 -1.105 . . . . 0.0 111.616 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.421 ' HA ' ' OG1' ' A' ' 59' ' ' THR . 87.4 mt-30 58.2 40.26 25.05 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 122.643 1.211 . . . . 0.0 111.029 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.654 ' C ' HD11 ' A' ' 84' ' ' ILE . 94.5 m-20 -111.44 53.15 0.72 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.724 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.432 ' N ' HD11 ' A' ' 84' ' ' ILE . . . -99.81 138.82 14.09 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.034 -2.026 . . . . 0.0 108.034 178.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 53.4 t -122.11 133.91 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.184 -1.186 . . . . 0.0 110.117 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.528 HD22 ' HD1' ' A' ' 51' ' ' PHE . 49.2 tp -117.44 131.21 56.78 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.674 -0.641 . . . . 0.0 110.832 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.646 HD12 HG22 ' A' ' 33' ' ' VAL . 94.4 mt -110.56 110.3 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.524 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -97.23 121.4 39.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -0.921 . . . . 0.0 109.711 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.5 t -121.98 131.81 72.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 111.302 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.575 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -98.95 95.23 7.02 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.928 ' CG1' HD11 ' A' ' 35' ' ' LEU . 35.8 m -64.31 -22.48 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.998 -1.064 . . . . 0.0 110.834 -178.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.756 ' CB ' HG23 ' A' ' 38' ' ' THR . 79.3 mm-40 -66.8 -42.51 85.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.993 -1.067 . . . . 0.0 109.535 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.451 ' O ' HG23 ' A' ' 75' ' ' THR . 92.7 m-20 -102.99 4.99 38.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.851 . . . . 0.0 110.98 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.43 ' HE2' ' O ' ' A' ' 104' ' ' PHE . 29.2 tttt 55.78 47.71 19.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.958 -1.089 . . . . 0.0 110.38 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.575 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 34.4 p -123.17 162.24 22.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 109.41 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -143.9 141.87 30.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.428 -0.795 . . . . 0.0 110.049 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.465 HG21 HG11 ' A' ' 43' ' ' VAL . 45.9 t -131.15 133.59 62.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.673 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 77.2 mt -112.97 122.33 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 118.853 -1.139 . . . . 0.0 110.544 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -129.11 111.27 12.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 110.343 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -94.72 174.63 33.35 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -77.64 176.17 9.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.752 -0.852 . . . . 0.0 109.876 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.55 -26.49 66.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.031 -1.043 . . . . 0.0 110.847 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.446 ' O ' HG12 ' A' ' 87' ' ' VAL . . . -65.72 -49.31 60.29 Favored Glycine 0 N--CA 1.488 2.108 0 C-N-CA 119.807 -1.187 . . . . 0.0 110.315 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.995 ' O ' HG22 ' A' ' 88' ' ' VAL . 3.6 mt -64.6 -44.97 96.76 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.791 0 O-C-N 121.001 -1.294 . . . . 0.0 108.151 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -64.39 -35.66 81.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.711 -1.243 . . . . 0.0 112.39 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -77.6 -22.11 51.36 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.857 -1.152 . . . . 0.0 112.303 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.094 HG13 HG13 ' A' ' 88' ' ' VAL . 7.7 p -101.33 -23.51 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.848 -1.158 . . . . 0.0 112.516 -178.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.094 HG13 HG13 ' A' ' 87' ' ' VAL . 10.2 m -117.65 164.36 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.659 -1.276 . . . . 0.0 111.413 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 t -108.13 174.8 5.72 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.649 0.738 . . . . 0.0 111.767 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -61.38 -37.37 83.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.16 -0.962 . . . . 0.0 110.12 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.61 -36.55 78.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.194 -0.941 . . . . 0.0 108.823 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.741 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 81.5 t80 -67.33 -25.18 65.88 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.258 -0.901 . . . . 0.0 109.505 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.673 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.3 m95 -88.31 -26.5 22.23 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.911 0.862 . . . . 0.0 111.252 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -55.82 -40.33 72.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.92 -1.112 . . . . 0.0 112.585 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 77.3 p -64.5 -31.03 72.06 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.507 -1.277 . . . . 0.0 109.234 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.28 12.3 m -60.27 -49.38 77.86 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 122.545 1.164 . . . . 0.0 110.952 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.05 -38.53 82.57 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.738 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -63.42 -45.01 92.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.948 -1.095 . . . . 0.0 110.725 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.42 -48.62 80.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.942 -1.099 . . . . 0.0 110.654 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.412 HD12 HD11 ' A' ' 78' ' ' ILE . 91.4 mt -67.52 -42.5 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.089 -1.007 . . . . 0.0 110.277 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.427 ' CG ' ' HE3' ' A' ' 105' ' ' LYS . 56.6 tt0 -63.28 -42.85 99.15 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.842 -1.161 . . . . 0.0 110.984 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.1 mt -63.12 -41.53 99.35 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.158 -0.964 . . . . 0.0 112.105 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.431 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 94.0 mm-40 -76.66 -37.23 56.58 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.647 -1.221 . . . . 0.0 109.253 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.43 ' O ' ' HE2' ' A' ' 74' ' ' LYS . 4.4 m-85 -61.1 -41.5 96.79 Favored 'General case' 0 C--O 1.201 -1.456 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.427 ' HE3' ' CG ' ' A' ' 101' ' ' GLN . 93.7 mttt -62.02 -33.44 74.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.754 -1.216 . . . . 0.0 110.791 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -78.55 -18.64 54.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.756 -1.215 . . . . 0.0 109.986 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.83 4.63 42.22 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.71 -1.233 . . . . 0.0 111.164 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -103.51 91.08 3.89 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.632 -1.511 . . . . 0.0 110.521 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -62.35 -45.02 95.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.706 -0.621 . . . . 0.0 111.784 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.44 ' CD ' ' OE1' ' A' ' 12' ' ' GLU . 76.3 tttt -62.86 -49.29 75.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.901 . . . . 0.0 112.55 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -62.4 -36.49 82.51 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.655 -1.218 . . . . 0.0 109.55 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.431 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -65.54 -47.58 76.48 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.426 -1.368 . . . . 0.0 110.187 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.6 mt -63.53 -44.1 95.24 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.025 -1.279 . . . . 0.0 110.776 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.588 HG22 HG13 ' A' ' 16' ' ' ILE . 86.4 t -66.52 -46.08 87.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.101 -1.0 . . . . 0.0 110.05 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -65.35 -42.54 92.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 110.023 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.02 -41.98 98.19 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.874 HD13 HD11 ' A' ' 20' ' ' ILE . 91.4 mt -65.05 -43.84 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.267 -1.137 . . . . 0.0 109.968 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -56.93 -51.75 67.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.959 -1.088 . . . . 0.0 109.729 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.68 -41.73 99.25 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.125 -0.984 . . . . 0.0 109.192 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.32 -40.56 82.38 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.078 -1.014 . . . . 0.0 109.41 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.53 -45.86 87.79 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.7 mtt -66.67 -43.56 84.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.03 -1.276 . . . . 0.0 109.416 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.741 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -63.5 -46.59 85.41 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.304 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.2 mt -62.74 -41.54 99.24 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.456 -0.777 . . . . 0.0 109.486 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.82 -34.13 62.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.33 -0.856 . . . . 0.0 110.678 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.84 -41.46 97.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.942 -1.099 . . . . 0.0 108.954 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -75.36 -37.49 60.6 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.601 -0.687 . . . . 0.0 109.787 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -132.51 99.4 15.79 Favored Pre-proline 0 N--CA 1.487 1.379 0 O-C-N 121.498 -0.751 . . . . 0.0 110.131 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.47 150.97 70.63 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.447 1.235 . . . . 0.0 110.226 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.469 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 34.5 t90 -73.66 125.81 28.89 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.382 -0.824 . . . . 0.0 110.916 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -103.97 153.84 20.36 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.01 -29.3 70.17 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 111.092 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -93.7 8.12 42.17 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.912 -1.115 . . . . 0.0 111.609 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -42.51 138.18 1.89 Allowed 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.843 0.83 . . . . 0.0 111.614 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.628 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -111.78 141.5 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 121.574 -0.704 . . . . 0.0 110.576 -178.083 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -100.25 96.01 7.18 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.169 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -67.71 -36.35 80.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.721 -0.612 . . . . 0.0 111.741 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.77 HD12 ' CB ' ' A' ' 30' ' ' GLU . 83.9 mt -109.22 151.37 41.99 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.212 -0.93 . . . . 0.0 112.073 -178.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.68 -171.54 0.87 Allowed 'Trans proline' 0 C--N 1.32 -0.949 0 N-CA-C 108.662 -1.322 . . . . 0.0 108.662 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -121.91 1.77 9.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.604 -1.31 . . . . 0.0 110.125 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 78.5 p -63.37 168.62 4.31 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.764 -1.21 . . . . 0.0 110.965 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 91.6 mt -94.56 135.83 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.483 -0.76 . . . . 0.0 110.819 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 5.1 m -93.48 134.47 35.71 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.61 146.8 50.75 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.853 -1.154 . . . . 0.0 110.427 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.944 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.2 mtp . . . . . 0 N--CA 1.498 1.968 0 CA-C-O 121.516 0.674 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 p -154.42 160.23 41.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.53 -0.731 . . . . 0.0 109.977 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -61.08 -42.17 98.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.274 -0.891 . . . . 0.0 110.345 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.6 mt -118.46 127.14 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.113 -0.992 . . . . 0.0 111.347 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -93.12 -45.26 7.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.258 -0.901 . . . . 0.0 109.981 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -130.76 119.2 21.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 110.282 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.439 ' CE2' ' HB ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -65.58 -25.13 67.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.407 -0.808 . . . . 0.0 111.729 -179.694 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.5 mt -124.59 151.17 45.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.043 -1.035 . . . . 0.0 109.24 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.451 HG23 ' H ' ' A' ' 12' ' ' GLU . 5.6 t -83.63 167.41 17.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.936 -1.102 . . . . 0.0 109.422 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.02 -38.88 77.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.24 -0.912 . . . . 0.0 110.885 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -55.88 -46.89 78.2 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.728 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.451 ' H ' HG23 ' A' ' 9' ' ' THR . 96.6 mt-10 -67.43 -45.61 75.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.516 -0.74 . . . . 0.0 111.716 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.768 ' O ' HG23 ' A' ' 17' ' ' VAL . 93.6 mt-10 -65.38 -33.11 75.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.963 -1.086 . . . . 0.0 110.035 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.34 -48.09 76.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.794 -1.192 . . . . 0.0 111.191 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.697 ' HB3' ' CE ' ' A' ' 110' ' ' LYS . . . -63.83 -42.14 97.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.319 -0.863 . . . . 0.0 111.159 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.524 HG13 HG22 ' A' ' 114' ' ' VAL . 20.6 tt -67.46 -34.77 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.004 -1.06 . . . . 0.0 110.689 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 13' ' ' GLU . 67.5 t -63.29 -39.37 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.94 -37.21 86.88 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.08 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.25 88.56 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.285 -0.884 . . . . 0.0 109.021 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.865 HG22 ' OD1' ' A' ' 140' ' ' ASN . 96.6 mt -64.5 -43.41 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-O 121.475 0.655 . . . . 0.0 109.972 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.433 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 92.8 mtt180 -59.72 -43.02 94.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 0.0 110.47 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -65.83 -36.86 84.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.431 -0.793 . . . . 0.0 111.252 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.37 -40.91 98.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.001 -1.062 . . . . 0.0 109.749 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.61 -16.52 49.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.413 -0.805 . . . . 0.0 110.11 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.4 mttt -93.65 -1.57 55.12 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.213 -0.929 . . . . 0.0 109.142 177.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -110.16 -14.39 14.2 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.973 -1.08 . . . . 0.0 110.08 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.3 t -151.34 158.12 43.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.098 -1.001 . . . . 0.0 109.644 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.6 m -85.1 -8.66 58.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.092 -1.005 . . . . 0.0 109.974 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.99 173.31 48.37 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.431 ' N ' ' OE1' ' A' ' 30' ' ' GLU . 57.8 mp0 -132.0 139.05 48.49 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.259 -1.142 . . . . 0.0 111.709 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 94.1 mt -124.81 136.26 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.605 -0.685 . . . . 0.0 110.319 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -140.96 156.56 46.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.211 -0.931 . . . . 0.0 110.038 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 143' ' ' SER . 4.8 p -126.55 140.8 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.03 -1.044 . . . . 0.0 111.469 -178.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.444 ' HA ' ' O ' ' A' ' 143' ' ' SER . 36.2 t-80 -124.43 132.15 53.5 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.574 0.702 . . . . 0.0 109.684 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.829 HD11 ' CG1' ' A' ' 71' ' ' VAL . 28.1 tp -117.62 126.13 51.97 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.625 0.726 . . . . 0.0 111.984 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.425 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 78.2 tt0 -142.73 165.2 28.04 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.439 ' HB3' ' HG3' ' A' ' 72' ' ' GLU . 99.5 mttt -79.94 -76.41 0.22 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.144 -0.973 . . . . 0.0 112.329 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.755 HG23 ' HB2' ' A' ' 72' ' ' GLU . 1.2 p -138.74 157.21 46.52 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.455 0.645 . . . . 0.0 110.609 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.433 ' OG ' ' CD ' ' A' ' 46' ' ' ARG . 50.9 m -107.47 173.62 6.24 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.431 -0.793 . . . . 0.0 110.854 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -109.23 -10.14 14.98 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.591 -0.693 . . . . 0.0 110.452 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.1 pt -125.19 -123.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 120.964 -1.085 . . . . 0.0 109.702 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -110.78 140.2 45.4 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.462 -1.399 . . . . 0.0 109.092 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.502 ' CG1' HG21 ' A' ' 77' ' ' VAL . 75.3 t -61.37 -44.18 98.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.427 -0.796 . . . . 0.0 110.599 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -58.79 -48.05 82.63 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.134 -0.979 . . . . 0.0 110.588 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -69.1 -39.89 78.72 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.784 -1.198 . . . . 0.0 109.162 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.433 ' CD ' ' OG ' ' A' ' 39' ' ' SER . 57.8 ttt85 -59.7 -45.27 92.63 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.095 -1.003 . . . . 0.0 110.087 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.19 94.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.83 -1.169 . . . . 0.0 110.324 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.3 ttp -62.92 -43.57 98.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.125 -0.985 . . . . 0.0 109.646 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -65.76 -47.1 76.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.022 -1.049 . . . . 0.0 109.5 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 72.4 t -64.64 -42.99 96.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.451 -0.781 . . . . 0.0 110.273 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.483 ' CZ ' ' OD1' ' A' ' 81' ' ' ASP . 4.5 t80 -60.82 -47.32 86.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.885 -1.134 . . . . 0.0 109.662 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -73.5 -37.99 65.5 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.114 -0.991 . . . . 0.0 110.277 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -61.2 -39.66 91.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.02 -1.05 . . . . 0.0 109.22 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.1 mt -79.94 3.33 20.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 0.0 110.856 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 57.67 33.04 22.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.599 -0.688 . . . . 0.0 111.782 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.426 ' HB2' ' CD1' ' A' ' 51' ' ' PHE . 92.6 mmm -70.6 -23.39 62.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.997 -1.064 . . . . 0.0 109.841 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -73.16 -5.33 38.49 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.124 -0.985 . . . . 0.0 110.771 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -86.29 84.01 7.57 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.799 -1.188 . . . . 0.0 110.954 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.0 p -138.4 155.91 48.07 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.01 -44.22 97.18 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.98 -1.075 . . . . 0.0 112.541 -177.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.1 mt -99.15 3.49 46.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.864 -1.148 . . . . 0.0 111.36 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 55.48 36.24 26.73 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.188 0.994 . . . . 0.0 111.029 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.501 ' C ' HD11 ' A' ' 84' ' ' ILE . 97.5 m-20 -115.71 53.7 0.84 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.264 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.83 149.04 17.99 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.602 ' CG2' HD13 ' A' ' 84' ' ' ILE . 54.2 t -127.56 134.35 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.987 -1.302 . . . . 0.0 110.081 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.476 ' HB2' ' CE2' ' A' ' 51' ' ' PHE . 35.5 tp -116.61 126.76 53.72 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.235 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 85.6 mt -105.58 112.56 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.346 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -99.87 121.11 40.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.961 . . . . 0.0 110.002 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -122.87 131.8 72.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 122.102 0.953 . . . . 0.0 111.259 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.1 99.13 10.64 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.829 ' CG1' HD11 ' A' ' 35' ' ' LEU . 28.4 m -65.29 -24.44 35.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 121.142 -0.974 . . . . 0.0 110.998 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.755 ' HB2' HG23 ' A' ' 38' ' ' THR . 70.2 mm-40 -67.97 -43.55 78.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.762 -1.211 . . . . 0.0 110.023 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -102.14 3.55 38.63 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.134 -0.978 . . . . 0.0 110.993 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt 55.98 45.91 22.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.806 -1.184 . . . . 0.0 110.712 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 99.6 m -121.51 135.27 55.04 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.079 -1.013 . . . . 0.0 110.224 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' A' ' 76' ' ' PHE . 52.5 p90 -115.98 138.1 51.51 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.473 -0.767 . . . . 0.0 111.253 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.502 HG21 ' CG1' ' A' ' 43' ' ' VAL . 58.6 t -128.91 136.19 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.892 -1.13 . . . . 0.0 108.192 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.582 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 69.8 mt -116.37 126.6 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.627 -1.295 . . . . 0.0 110.885 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -129.08 114.34 16.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.601 -0.687 . . . . 0.0 110.984 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.28 175.03 26.74 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.483 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 68.2 m-20 -82.0 -178.29 6.95 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.539 -0.977 . . . . 0.0 111.438 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.32 -26.45 68.49 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.36 -53.05 34.82 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.112 -1.042 . . . . 0.0 110.876 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.989 ' O ' HG22 ' A' ' 88' ' ' VAL . 7.9 mt -65.06 -44.69 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.95 -1.323 . . . . 0.0 107.705 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -61.53 -37.53 84.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.742 -1.224 . . . . 0.0 111.466 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -75.73 -19.99 58.66 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.011 -1.055 . . . . 0.0 111.929 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.008 HG13 HG13 ' A' ' 88' ' ' VAL . 9.5 p -104.3 -22.03 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 120.669 -1.27 . . . . 0.0 112.349 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.008 HG13 HG13 ' A' ' 87' ' ' VAL . 19.1 m -120.79 162.31 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 120.594 -1.316 . . . . 0.0 111.96 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.9 m -105.8 178.0 4.69 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.124 0.964 . . . . 0.0 112.316 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -62.81 -37.62 87.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.676 -0.64 . . . . 0.0 109.775 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -61.28 -35.82 78.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.06 -1.025 . . . . 0.0 108.887 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.642 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 80.7 t80 -67.01 -26.47 66.8 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.354 177.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.582 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 7.7 m95 -85.0 -26.96 26.77 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 122.013 0.911 . . . . 0.0 109.728 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -58.25 -38.21 76.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.166 -0.959 . . . . 0.0 112.815 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 69.5 p -65.49 -31.66 72.86 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.649 -1.22 . . . . 0.0 108.782 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.276 7.9 m -59.48 -48.68 80.72 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.485 1.136 . . . . 0.0 111.095 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -69.51 -37.89 77.37 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.945 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -63.8 -45.71 88.44 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.905 -1.122 . . . . 0.0 110.514 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.55 -48.43 81.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.735 -1.228 . . . . 0.0 110.275 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 93.1 mt -65.98 -42.84 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.122 -0.986 . . . . 0.0 110.412 179.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -65.12 -40.54 94.63 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.46 -0.775 . . . . 0.0 111.103 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.49 -42.92 98.54 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.307 -0.87 . . . . 0.0 111.853 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.45 ' HB3' ' HA3' ' A' ' 112' ' ' GLY . 3.3 tp60 -76.81 -39.55 50.99 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.652 -1.219 . . . . 0.0 108.99 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 3.0 m-85 -60.3 -42.34 95.32 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.817 0.818 . . . . 0.0 108.987 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.48 -30.97 70.03 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.44 -18.51 52.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 109.945 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.21 2.95 48.2 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.817 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -103.82 93.8 5.08 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.643 -1.504 . . . . 0.0 110.315 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.401 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 22.8 m-85 -62.88 -46.18 89.06 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.458 -0.776 . . . . 0.0 112.4 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.697 ' CE ' ' HB3' ' A' ' 15' ' ' ALA . 61.4 tttm -62.18 -48.47 79.91 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.801 -1.187 . . . . 0.0 112.997 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.53 -39.14 93.65 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.856 -1.138 . . . . 0.0 109.459 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.45 ' HA3' ' HB3' ' A' ' 103' ' ' GLN . . . -67.2 -47.32 64.92 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 109' ' ' PHE . 97.1 mt -62.08 -44.01 97.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -1.173 . . . . 0.0 109.392 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.524 HG22 HG13 ' A' ' 16' ' ' ILE . 68.5 t -66.72 -45.25 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.316 -0.865 . . . . 0.0 110.513 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -65.63 -40.95 93.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.965 -1.085 . . . . 0.0 109.995 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.48 -41.65 99.76 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 84.3 mt -64.27 -43.54 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.177 -1.19 . . . . 0.0 109.858 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.36 -51.82 68.28 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.868 -1.145 . . . . 0.0 110.846 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.02 -40.85 97.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.028 -1.045 . . . . 0.0 109.203 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.416 ' O ' ' HG ' ' A' ' 124' ' ' LEU . . . -56.41 -44.03 79.94 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.352 -0.842 . . . . 0.0 109.528 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.05 -43.32 95.93 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.814 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 6.1 tpp -66.66 -47.8 71.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.282 . . . . 0.0 109.421 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.642 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -62.8 -45.36 92.99 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.512 -0.875 . . . . 0.0 109.083 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 120' ' ' ALA . 83.5 mt -62.55 -39.65 94.31 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.06 -1.025 . . . . 0.0 108.635 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.88 -34.98 63.59 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.186 -0.947 . . . . 0.0 111.035 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -61.47 -41.13 96.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.995 -1.066 . . . . 0.0 108.493 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.581 ' HD2' HG22 ' A' ' 87' ' ' VAL . 56.3 m-85 -75.19 -38.24 60.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.511 -0.743 . . . . 0.0 110.098 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.538 ' HE2' HG11 ' A' ' 87' ' ' VAL . 70.9 m-85 -133.87 95.6 17.14 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.388 -0.82 . . . . 0.0 109.923 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 128' ' ' PHE . 45.6 Cg_endo -67.15 149.58 81.94 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.841 1.442 . . . . 0.0 110.369 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.481 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 42.7 t90 -72.03 143.38 49.16 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.533 -0.729 . . . . 0.0 111.403 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 99.2 mttt -121.76 151.22 40.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.487 -0.758 . . . . 0.0 109.248 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -58.86 -29.87 67.3 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.204 -0.935 . . . . 0.0 110.836 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -93.95 7.52 44.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.036 -1.04 . . . . 0.0 110.949 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 46.6 t0 -41.73 139.11 1.27 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.921 0.867 . . . . 0.0 111.423 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.595 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -110.37 138.26 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.447 -0.783 . . . . 0.0 110.553 -179.324 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -95.84 94.32 7.58 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.674 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.484 ' C ' HD22 ' A' ' 138' ' ' LEU . 78.6 mm-40 -69.09 -29.28 67.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.428 -0.795 . . . . 0.0 112.577 -178.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.484 HD22 ' C ' ' A' ' 137' ' ' GLU . 3.9 mm? -117.14 146.98 39.34 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 120.809 -1.182 . . . . 0.0 111.312 -178.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.06 -170.88 0.52 Allowed 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.43 1.226 . . . . 0.0 109.06 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.865 ' OD1' HG22 ' A' ' 20' ' ' ILE . 65.1 m-80 -122.05 3.66 9.89 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.39 -1.444 . . . . 0.0 110.327 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 21.0 m -63.1 141.3 58.82 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.087 -1.008 . . . . 0.0 111.928 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.586 HG13 HG22 ' A' ' 17' ' ' VAL . 86.2 mt -71.59 136.93 24.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.836 -0.54 . . . . 0.0 110.702 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 15.6 m -100.79 144.28 29.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.159 -0.963 . . . . 0.0 109.741 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -146.38 155.82 42.87 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.036 -1.04 . . . . 0.0 109.847 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.581 179.965 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.8 mtt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.259 0.552 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.0 t -76.01 148.99 37.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.373 -0.83 . . . . 0.0 110.461 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.507 ' HA ' ' CG ' ' A' ' 6' ' ' GLU . 97.3 mttt -76.23 -18.42 59.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.459 -0.776 . . . . 0.0 111.488 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.486 HG22 ' HD3' ' A' ' 144' ' ' LYS . 95.0 mt -63.47 -43.52 98.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 109.508 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -77.55 -13.41 59.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.433 -0.792 . . . . 0.0 111.223 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.507 ' CG ' ' HA ' ' A' ' 3' ' ' LYS . 77.9 mm-40 -61.31 -28.62 69.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.996 -1.065 . . . . 0.0 110.725 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.827 ' CE1' HG21 ' A' ' 71' ' ' VAL . 66.3 m-85 -58.31 -46.49 86.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.997 -1.064 . . . . 0.0 110.584 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.4 mt -131.71 152.22 51.05 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.323 -0.861 . . . . 0.0 111.308 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -86.22 165.38 16.56 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.238 -0.914 . . . . 0.0 109.736 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.92 -37.98 67.05 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.086 -1.009 . . . . 0.0 109.769 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.77 -41.99 98.4 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.464 -0.773 . . . . 0.0 110.047 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -73.77 -45.59 50.79 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 110.465 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.743 ' O ' HG23 ' A' ' 17' ' ' VAL . 97.3 mt-10 -65.57 -36.49 83.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.832 -1.168 . . . . 0.0 109.858 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -63.82 -45.11 91.08 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.849 -1.157 . . . . 0.0 110.558 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.33 -44.71 86.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.954 -1.092 . . . . 0.0 111.672 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.51 ' CG2' HD11 ' A' ' 142' ' ' ILE . 20.3 tt -64.14 -35.73 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.729 -1.232 . . . . 0.0 110.45 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 13' ' ' GLU . 92.6 t -63.77 -40.59 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.381 -0.825 . . . . 0.0 108.892 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -61.03 -38.32 85.71 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.252 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.18 -38.86 90.68 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.192 -0.942 . . . . 0.0 109.768 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.481 HG22 ' OD1' ' A' ' 140' ' ' ASN . 91.7 mt -62.73 -43.23 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.168 -0.957 . . . . 0.0 109.691 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -59.67 -41.73 91.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.504 -0.748 . . . . 0.0 110.724 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -65.37 -37.48 87.13 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.199 -0.938 . . . . 0.0 110.991 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.92 92.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.033 -1.042 . . . . 0.0 109.89 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -60.1 -14.56 17.45 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.037 -1.04 . . . . 0.0 111.216 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.6 mttt -97.31 1.27 49.32 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.243 -0.911 . . . . 0.0 109.478 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -111.59 -15.05 13.56 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.04 -1.038 . . . . 0.0 109.314 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.5 t -152.68 156.03 38.43 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.054 -1.029 . . . . 0.0 110.064 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.9 p -86.84 -8.7 57.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.354 -0.841 . . . . 0.0 110.534 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.99 177.12 45.61 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.507 ' CB ' HD22 ' A' ' 138' ' ' LEU . 80.4 mm-40 -131.39 135.37 47.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.089 -1.242 . . . . 0.0 111.494 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 86.2 mt -116.43 132.07 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.724 ' HD3' ' HE2' ' A' ' 56' ' ' MET . 78.2 mtp85 -136.9 151.34 48.96 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.285 -0.884 . . . . 0.0 110.117 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.611 HG22 HD12 ' A' ' 67' ' ' ILE . 54.5 t -123.91 138.38 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.639 -0.663 . . . . 0.0 110.454 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.486 ' HB2' HD11 ' A' ' 66' ' ' LEU . 46.6 t60 -123.6 125.04 44.12 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.567 0.698 . . . . 0.0 109.132 178.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.431 HD23 ' C ' ' A' ' 35' ' ' LEU . 10.0 tt -113.48 131.08 56.18 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.009 0.909 . . . . 0.0 112.165 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 82.8 tt0 -146.84 167.14 24.64 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.45 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 51.6 mtmt -79.98 -73.99 0.33 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.964 . . . . 0.0 113.088 -177.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.411 ' OG1' ' CB ' ' A' ' 72' ' ' GLU . 62.7 m -141.57 159.61 41.86 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.411 -0.806 . . . . 0.0 110.198 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.416 ' OG ' ' CD ' ' A' ' 46' ' ' ARG . 51.1 m -112.4 170.24 8.31 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.511 -0.743 . . . . 0.0 111.133 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -107.09 -15.44 14.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.32 -0.863 . . . . 0.0 110.59 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.7 pt -121.78 -122.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.357 -0.839 . . . . 0.0 109.894 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -111.65 137.56 49.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.32 -1.488 . . . . 0.0 109.66 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.534 HG13 ' CD1' ' A' ' 68' ' ' TYR . 99.2 t -64.37 -42.54 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.441 -0.787 . . . . 0.0 110.679 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.22 -46.9 85.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.698 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -69.11 -37.95 78.66 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.433 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 58.5 ttt85 -61.96 -43.62 98.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.06 -1.025 . . . . 0.0 110.233 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.65 91.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.797 -1.189 . . . . 0.0 110.765 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.2 ttp -64.08 -43.39 95.59 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.707 -1.245 . . . . 0.0 109.681 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -64.29 -45.84 86.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.215 -0.928 . . . . 0.0 110.079 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.5 t -66.27 -42.48 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.23 -0.919 . . . . 0.0 109.475 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.07 -47.05 86.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.888 -1.133 . . . . 0.0 109.667 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -75.92 -38.63 57.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.57 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -60.66 -38.18 84.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.102 -0.999 . . . . 0.0 109.919 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.5 mt -81.2 5.41 17.05 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.005 -1.059 . . . . 0.0 110.313 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 56.77 30.62 18.03 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 121.458 -0.776 . . . . 0.0 111.328 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.724 ' HE2' ' HD3' ' A' ' 32' ' ' ARG . 99.6 mtp -65.24 -12.14 48.43 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.605 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.5 p30 -79.11 2.07 22.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.829 -1.169 . . . . 0.0 109.962 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -74.36 64.07 1.1 Allowed 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.205 -0.934 . . . . 0.0 109.926 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 81.5 p -134.49 149.09 50.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.17 -0.956 . . . . 0.0 109.661 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.67 -43.73 92.63 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.7 mt -95.76 0.9 52.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.93 -1.107 . . . . 0.0 111.018 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 56.08 38.53 30.0 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.301 1.048 . . . . 0.0 111.761 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.588 ' C ' HD11 ' A' ' 84' ' ' ILE . 97.7 m-20 -110.34 54.24 0.67 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.876 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.515 ' N ' HD11 ' A' ' 84' ' ' ILE . . . -101.0 138.52 13.89 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.614 ' CG2' HD13 ' A' ' 84' ' ' ILE . 53.7 t -121.88 134.62 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.022 -1.281 . . . . 0.0 110.361 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.52 HD13 ' CE ' ' A' ' 56' ' ' MET . 64.2 tp -117.76 129.22 55.56 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.088 0.47 . . . . 0.0 110.602 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.611 HD12 HG22 ' A' ' 33' ' ' VAL . 95.1 mt -110.66 107.39 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.981 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.534 ' CD1' HG13 ' A' ' 43' ' ' VAL . 58.6 t80 -92.95 122.91 35.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.117 -0.989 . . . . 0.0 109.541 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.6 t -120.74 130.93 74.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 122.264 1.031 . . . . 0.0 111.132 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.576 ' HB3' ' OD1' ' A' ' 73' ' ' ASP . . . -102.5 94.83 5.87 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.123 178.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.827 HG21 ' CE1' ' A' ' 7' ' ' PHE . 34.3 m -63.92 -19.48 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.094 -1.004 . . . . 0.0 111.236 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.411 ' CB ' ' OG1' ' A' ' 38' ' ' THR . 79.8 mm-40 -68.17 -43.08 78.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.879 -1.138 . . . . 0.0 109.602 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.576 ' OD1' ' HB3' ' A' ' 70' ' ' ALA . 32.3 p30 -102.88 5.78 38.73 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.336 -0.852 . . . . 0.0 110.536 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 109' ' ' PHE . 34.1 tttt 54.53 49.85 17.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.987 -1.07 . . . . 0.0 111.236 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 73' ' ' ASP . 72.5 p -126.53 167.21 15.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.142 -0.973 . . . . 0.0 109.927 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -141.09 144.52 34.96 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.424 -0.798 . . . . 0.0 109.865 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.492 HG21 HG11 ' A' ' 43' ' ' VAL . 55.7 t -131.26 136.46 57.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.693 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 81.4 mt -116.44 126.96 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.926 -1.108 . . . . 0.0 110.71 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -129.51 113.57 15.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.6 -0.688 . . . . 0.0 110.145 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -102.1 148.53 17.69 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -61.41 174.79 0.67 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.673 -0.898 . . . . 0.0 109.27 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.1 -24.79 60.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.14 -0.975 . . . . 0.0 111.068 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.509 ' O ' HG12 ' A' ' 87' ' ' VAL . . . -65.9 -51.96 41.63 Favored Glycine 0 N--CA 1.496 2.654 0 C-N-CA 119.711 -1.233 . . . . 0.0 111.452 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.985 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.6 mt -66.48 -43.93 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.811 -1.405 . . . . 0.0 108.048 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -62.2 -38.9 90.9 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 111.434 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -76.98 -23.41 52.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.934 -1.104 . . . . 0.0 112.322 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.974 HG13 HG13 ' A' ' 88' ' ' VAL . 11.2 p -98.35 -24.77 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.731 -1.231 . . . . 0.0 112.579 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.985 HG22 ' O ' ' A' ' 84' ' ' ILE . 14.3 m -117.32 163.37 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.631 -1.293 . . . . 0.0 111.519 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.415 ' OG ' ' N ' ' A' ' 90' ' ' ASP . 6.2 t -105.06 179.71 4.19 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.24 -0.912 . . . . 0.0 111.843 -178.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.415 ' N ' ' OG ' ' A' ' 89' ' ' SER . 64.1 t0 -62.0 -38.04 87.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.464 -0.773 . . . . 0.0 110.051 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -62.94 -36.97 85.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.177 -0.952 . . . . 0.0 109.31 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.718 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 51.7 t80 -65.69 -26.97 68.01 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.305 -0.958 . . . . 0.0 108.92 177.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.693 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.6 m95 -84.73 -28.44 26.28 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 122.026 0.917 . . . . 0.0 110.021 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -58.01 -37.32 74.06 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.742 -0.599 . . . . 0.0 112.471 -176.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.5 p -65.9 -32.57 74.15 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 118.627 -1.229 . . . . 0.0 109.15 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.27 10.1 m -59.95 -48.25 82.47 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.33 1.062 . . . . 0.0 111.609 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -69.9 -36.99 75.85 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.531 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -64.22 -43.72 94.12 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.584 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.28 -51.41 66.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.919 -1.113 . . . . 0.0 111.01 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.93 -41.98 90.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.3 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.4 -45.14 92.41 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.255 -0.903 . . . . 0.0 111.851 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.8 tp -63.11 -42.3 99.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.164 -0.96 . . . . 0.0 111.789 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.461 ' HB3' ' CA ' ' A' ' 112' ' ' GLY . 21.4 tp60 -72.55 -39.98 67.05 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.641 -1.224 . . . . 0.0 108.634 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -59.24 -38.32 79.7 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -61.59 -35.72 78.63 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.315 0.579 . . . . 0.0 109.885 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -75.12 -18.61 60.2 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 109.301 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.95 0.96 45.38 Favored Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.948 -1.12 . . . . 0.0 110.737 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -98.79 95.55 7.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.75 -1.441 . . . . 0.0 109.843 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 74' ' ' LYS . 21.7 m-30 -64.72 -41.23 96.12 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.815 -0.553 . . . . 0.0 111.175 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -64.35 -50.1 69.05 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.274 -0.891 . . . . 0.0 111.831 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -62.36 -34.54 76.87 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.014 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.461 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -66.72 -47.89 65.1 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.331 -1.414 . . . . 0.0 109.733 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.491 ' HB3' HD11 ' A' ' 16' ' ' ILE . 83.5 mt -63.37 -45.0 93.17 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.263 -1.139 . . . . 0.0 111.989 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.493 HG13 ' N ' ' A' ' 115' ' ' ASP . 11.9 p -67.25 -44.9 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.943 -1.098 . . . . 0.0 110.908 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.493 ' N ' HG13 ' A' ' 114' ' ' VAL . 13.4 m-20 -64.94 -37.34 87.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 110.38 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.31 -42.77 99.14 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.41 -43.93 97.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.331 -1.099 . . . . 0.0 109.882 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -57.67 -51.73 68.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.045 -1.034 . . . . 0.0 110.165 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -62.6 -43.09 99.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.222 -0.924 . . . . 0.0 109.172 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.91 -45.36 86.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.463 -0.773 . . . . 0.0 109.998 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.26 -42.62 99.24 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.0 mtt -66.33 -45.55 79.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.959 -1.318 . . . . 0.0 109.651 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.718 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -63.75 -44.67 92.78 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.522 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 42.0 mt -62.3 -39.78 94.12 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.95 -34.67 63.47 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.355 -0.841 . . . . 0.0 110.716 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -62.94 -41.67 99.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.118 -0.989 . . . . 0.0 109.886 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -78.01 -36.69 48.46 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.392 -0.817 . . . . 0.0 110.252 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -127.87 94.43 37.1 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.393 -0.817 . . . . 0.0 109.527 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.76 143.7 62.55 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 123.882 1.464 . . . . 0.0 110.266 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 44.5 t90 -72.41 130.46 40.77 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.306 -0.871 . . . . 0.0 111.264 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 97.6 mttt -109.02 153.03 24.19 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.71 -32.74 71.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.79 -1.194 . . . . 0.0 111.564 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -88.62 8.49 28.19 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.053 -1.059 . . . . 0.0 110.733 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.477 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 65.9 t0 -42.86 137.3 2.36 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.89 0.852 . . . . 0.0 111.538 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.545 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -107.62 133.08 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 121.488 -0.758 . . . . 0.0 111.381 -178.327 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -112.39 99.55 8.09 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.327 -0.858 . . . . 0.0 109.306 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -98.51 -15.55 19.52 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.826 -1.171 . . . . 0.0 111.541 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.535 HD23 ' HD2' ' A' ' 32' ' ' ARG . 3.1 mp -94.98 144.17 27.35 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.235 -0.916 . . . . 0.0 110.47 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -72.55 169.71 21.16 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.665 1.35 . . . . 0.0 109.222 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.481 ' OD1' HG22 ' A' ' 20' ' ' ILE . 65.4 m-80 -110.02 8.73 24.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.839 -1.163 . . . . 0.0 110.322 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.1 p -67.22 166.57 13.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.071 -1.018 . . . . 0.0 111.316 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.51 HD11 ' CG2' ' A' ' 16' ' ' ILE . 96.4 mt -90.04 136.45 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.59 -0.694 . . . . 0.0 110.395 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.1 m -88.99 137.12 32.6 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.143 -0.973 . . . . 0.0 109.617 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.486 ' HD3' HG22 ' A' ' 4' ' ' ILE . 99.6 mttt -133.1 147.26 52.15 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.117 -0.989 . . . . 0.0 110.695 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.43 0 CA-C-O 117.86 -1.522 . . . . 0.0 109.892 -179.502 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.049 0.452 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 m -77.44 145.31 37.2 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.191 -0.943 . . . . 0.0 110.524 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -120.47 150.08 41.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.153 -0.967 . . . . 0.0 109.286 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.1 pt -93.05 -1.55 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.113 -0.992 . . . . 0.0 111.016 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -67.94 -35.86 79.15 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.013 -1.054 . . . . 0.0 110.717 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -93.02 90.88 7.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 110.418 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.791 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 78.7 m-85 -62.18 -43.22 99.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.134 -0.979 . . . . 0.0 110.476 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.481 HD23 ' OE1' ' A' ' 12' ' ' GLU . 94.4 mt -130.8 146.12 52.16 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.271 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m -80.23 168.25 19.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.071 -1.018 . . . . 0.0 109.228 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 14' ' ' LYS . . . -52.43 -39.26 60.81 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.691 -1.255 . . . . 0.0 109.871 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.84 -42.25 90.72 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.679 -0.638 . . . . 0.0 111.404 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.481 ' OE1' HD23 ' A' ' 8' ' ' LEU . 90.6 mt-10 -70.7 -44.21 67.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.923 -1.111 . . . . 0.0 110.174 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.499 ' O ' HG23 ' A' ' 17' ' ' VAL . 96.2 mt-10 -67.17 -33.45 75.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.011 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 86.9 tttt -64.59 -45.67 85.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.682 -1.261 . . . . 0.0 110.306 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.77 -42.7 94.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.023 -1.048 . . . . 0.0 111.501 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.722 HG13 HG22 ' A' ' 114' ' ' VAL . 19.3 tt -67.15 -37.56 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.777 -1.202 . . . . 0.0 110.977 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 13' ' ' GLU . 68.4 t -64.36 -41.22 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -61.62 -37.32 83.54 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.211 -0.996 . . . . 0.0 108.648 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.23 87.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.435 -0.79 . . . . 0.0 109.845 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 17' ' ' VAL . 95.1 mt -63.81 -42.87 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.153 -0.967 . . . . 0.0 110.001 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -60.35 -42.04 94.89 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.788 0.804 . . . . 0.0 110.299 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -65.12 -36.78 85.35 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.249 -0.581 . . . . 0.0 110.162 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.22 95.49 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.108 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.78 -14.58 33.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.056 -1.028 . . . . 0.0 110.519 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.468 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.7 mttt -93.42 -0.21 56.58 Favored 'General case' 0 C--N 1.309 -1.17 0 O-C-N 121.046 -1.034 . . . . 0.0 109.257 176.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -113.04 -13.74 13.05 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 120.835 -1.165 . . . . 0.0 110.608 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 t -153.33 160.3 42.66 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.915 -1.116 . . . . 0.0 110.105 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.1 p -90.91 -10.35 42.82 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.175 -0.953 . . . . 0.0 109.857 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.0 172.35 40.6 Favored Glycine 0 N--CA 1.481 1.685 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.492 ' HB3' HD22 ' A' ' 138' ' ' LEU . 54.3 mp0 -131.61 134.85 46.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.225 -1.162 . . . . 0.0 112.163 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.8 mt -120.84 133.76 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.746 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.1 ttm-85 -138.67 159.19 42.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.958 -1.089 . . . . 0.0 109.677 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 143' ' ' SER . 3.5 p -128.31 137.91 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.405 -0.809 . . . . 0.0 110.743 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -121.2 125.14 46.41 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.503 HD11 ' CG1' ' A' ' 71' ' ' VAL . 40.0 tp -110.92 131.14 55.3 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.892 0.854 . . . . 0.0 111.449 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 76.9 tt0 -147.78 165.34 30.85 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.655 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.7 mttt -79.77 -74.85 0.28 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 112.956 -177.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.8 t -139.36 156.27 47.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.109 -0.995 . . . . 0.0 110.367 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.552 ' HB2' ' CD ' ' A' ' 46' ' ' ARG . 5.9 p -104.27 166.97 10.06 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.701 -0.624 . . . . 0.0 111.198 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -106.67 -8.04 17.07 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.391 -0.818 . . . . 0.0 110.347 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 42' ' ' ASP . 34.3 pt -129.15 -122.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.912 -1.118 . . . . 0.0 110.487 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.414 ' N ' HG13 ' A' ' 41' ' ' ILE . 93.9 m-20 -111.72 137.33 49.77 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.057 -1.652 . . . . 0.0 110.065 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.3 t -63.23 -43.38 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.284 -0.885 . . . . 0.0 111.624 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -59.76 -45.61 91.72 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.763 -1.211 . . . . 0.0 110.094 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -67.26 -39.73 86.12 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.659 -1.276 . . . . 0.0 109.135 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.552 ' CD ' ' HB2' ' A' ' 39' ' ' SER . 77.6 mtp85 -62.24 -45.3 93.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.956 -1.09 . . . . 0.0 110.767 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.58 95.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.969 -1.082 . . . . 0.0 110.416 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.8 ttp -62.91 -43.13 99.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.013 -1.054 . . . . 0.0 109.507 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -65.5 -46.37 79.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.953 -1.092 . . . . 0.0 110.16 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.9 t -65.95 -44.42 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.032 -1.043 . . . . 0.0 110.422 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.433 ' C ' ' CD1' ' A' ' 51' ' ' PHE . 6.5 t80 -57.12 -49.52 75.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.984 -1.073 . . . . 0.0 109.259 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -72.86 -35.59 67.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.967 -1.083 . . . . 0.0 109.413 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -60.47 -39.98 89.58 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.394 -0.816 . . . . 0.0 108.988 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.0 mt -79.23 4.35 15.25 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.624 -0.673 . . . . 0.0 110.081 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 56.48 32.73 21.28 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 121.187 -0.946 . . . . 0.0 111.297 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 94.4 mmm -66.39 -11.68 52.77 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.914 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -79.5 -1.61 38.38 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.771 -1.205 . . . . 0.0 109.89 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -78.28 65.68 3.68 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.032 -1.043 . . . . 0.0 109.603 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.48 HG22 HD11 ' A' ' 138' ' ' LEU . 78.4 p -135.08 150.05 50.18 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -64.05 -43.06 96.68 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.601 -0.687 . . . . 0.0 112.123 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 98.2 mt -96.59 0.15 49.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.789 -1.194 . . . . 0.0 111.502 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 87.8 mt-30 57.26 46.15 19.12 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.497 1.141 . . . . 0.0 111.273 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -120.21 52.85 1.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.094 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.81 138.79 14.09 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.63 HG22 ' HA2' ' A' ' 80' ' ' GLY . 61.2 t -125.54 135.89 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.162 -1.199 . . . . 0.0 110.952 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.1 tp -116.5 125.97 52.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.527 -0.733 . . . . 0.0 109.712 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.0 mt -101.85 106.25 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.118 -1.033 . . . . 0.0 109.389 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -91.89 123.04 34.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.326 -0.859 . . . . 0.0 110.021 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 79.2 t -123.63 130.38 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.494 -0.754 . . . . 0.0 111.003 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.52 108.92 20.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.722 -0.611 . . . . 0.0 109.373 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.791 HG21 ' CZ ' ' A' ' 7' ' ' PHE . 22.8 m -76.11 -19.56 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.891 -1.13 . . . . 0.0 111.56 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.402 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 79.0 mm-40 -69.66 -46.98 64.88 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.656 -1.278 . . . . 0.0 109.259 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -101.78 1.5 37.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.488 -0.757 . . . . 0.0 110.936 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.2 tttt 56.67 47.53 18.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.844 -1.16 . . . . 0.0 110.748 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.8 m -118.22 129.37 55.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.075 -1.016 . . . . 0.0 109.823 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -112.29 138.84 48.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.691 -0.63 . . . . 0.0 110.459 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.14 137.19 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.331 -0.856 . . . . 0.0 109.002 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.68 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 77.6 mt -113.89 128.62 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.933 -1.104 . . . . 0.0 110.398 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -132.56 116.55 16.85 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.535 -0.728 . . . . 0.0 110.78 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.63 ' HA2' HG22 ' A' ' 65' ' ' VAL . . . -100.38 168.98 21.19 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -80.53 178.49 8.29 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.771 -0.841 . . . . 0.0 110.227 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.05 -28.83 70.36 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.218 -0.926 . . . . 0.0 111.166 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -65.66 -54.06 27.89 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.204 -0.998 . . . . 0.0 110.643 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.995 ' O ' HG22 ' A' ' 88' ' ' VAL . 97.3 mt -63.7 -46.89 93.4 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.733 0 O-C-N 120.926 -1.338 . . . . 0.0 107.663 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.83 -38.37 85.22 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.785 -1.197 . . . . 0.0 111.558 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -70.99 -24.89 62.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.035 -1.041 . . . . 0.0 112.238 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.877 HG23 HG13 ' A' ' 88' ' ' VAL . 18.0 m -104.75 -17.14 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.71 -1.244 . . . . 0.0 112.411 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.995 HG22 ' O ' ' A' ' 84' ' ' ILE . 18.4 m -117.73 163.75 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 120.415 -1.428 . . . . 0.0 111.382 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.2 p -109.76 172.56 6.79 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.718 0.771 . . . . 0.0 112.581 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -59.15 -37.26 76.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.424 -0.798 . . . . 0.0 109.398 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -61.21 -39.89 91.93 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.085 -1.009 . . . . 0.0 109.031 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.822 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 69.1 t80 -64.48 -25.33 67.95 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.195 -0.941 . . . . 0.0 109.229 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.68 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.7 m95 -86.99 -26.66 23.67 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.651 0.739 . . . . 0.0 111.183 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -58.48 -34.67 71.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.397 -0.814 . . . . 0.0 112.026 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.9 m -66.16 -32.78 74.42 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.003 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.501 HG22 HD13 ' A' ' 78' ' ' ILE 0.277 9.0 m -60.68 -49.49 77.28 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 122.325 1.059 . . . . 0.0 111.63 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -68.41 -38.08 80.94 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.146 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -64.31 -45.95 85.69 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.491 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.73 -50.56 71.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.884 -1.135 . . . . 0.0 111.707 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.519 HD12 HD11 ' A' ' 78' ' ' ILE . 96.5 mt -65.66 -41.64 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.913 -1.117 . . . . 0.0 109.165 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -64.01 -41.5 97.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.595 -0.691 . . . . 0.0 111.227 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.57 -42.09 99.34 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.156 -0.965 . . . . 0.0 111.331 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.479 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 96.4 mm-40 -75.71 -41.46 53.5 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.964 -1.095 . . . . 0.0 108.925 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -59.25 -40.9 87.43 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -59.33 -35.98 74.82 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.477 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -77.81 -15.52 59.02 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.046 -1.034 . . . . 0.0 109.901 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.05 3.68 48.36 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.784 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -101.92 91.32 4.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.686 -1.479 . . . . 0.0 110.491 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -61.02 -46.03 92.4 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.343 -0.848 . . . . 0.0 111.556 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.407 ' HD2' ' HB3' ' A' ' 12' ' ' GLU . 62.4 tttm -62.65 -48.24 80.23 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 112.919 -178.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -61.77 -38.03 86.49 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 118.549 -1.26 . . . . 0.0 109.467 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.479 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -64.94 -46.05 90.53 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.7 mt -63.68 -45.47 89.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.31 -1.112 . . . . 0.0 110.747 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.722 HG22 HG13 ' A' ' 16' ' ' ILE . 95.5 t -66.88 -46.77 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.012 -1.055 . . . . 0.0 110.816 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -64.76 -38.95 92.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.012 -1.055 . . . . 0.0 110.203 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.44 -42.33 97.64 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.1 mt -63.97 -44.07 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -1.142 . . . . 0.0 109.837 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -60.12 -46.73 88.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.088 -1.008 . . . . 0.0 109.455 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -63.53 -41.83 98.46 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.188 -1.005 . . . . 0.0 108.587 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -59.13 -42.66 91.14 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.836 -0.745 . . . . 0.0 109.539 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.66 -44.12 96.89 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 57.5 ttm -67.58 -48.5 66.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.135 -1.214 . . . . 0.0 109.935 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.822 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -61.72 -46.13 90.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.953 -1.092 . . . . 0.0 109.276 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.407 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 88.3 mt -62.69 -39.34 93.68 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.511 -0.743 . . . . 0.0 109.054 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.44 -34.67 61.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.244 -0.91 . . . . 0.0 110.459 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -61.38 -39.96 92.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.03 -1.044 . . . . 0.0 109.183 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -80.2 -31.97 38.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.884 . . . . 0.0 109.468 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -132.54 93.12 25.58 Favored Pre-proline 0 N--CA 1.485 1.296 0 O-C-N 121.532 -0.73 . . . . 0.0 109.956 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.64 146.48 73.49 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.816 1.429 . . . . 0.0 109.457 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.468 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 64.3 t90 -71.26 132.11 44.46 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.157 -0.965 . . . . 0.0 110.951 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -110.13 147.52 33.52 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -55.79 -28.45 56.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.054 -1.029 . . . . 0.0 110.878 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 40.7 p-10 -92.91 9.25 36.26 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.027 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.416 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 61.1 t0 -42.55 135.85 2.65 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.882 0.848 . . . . 0.0 111.163 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.715 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -113.32 141.91 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.578 0.704 . . . . 0.0 111.247 -177.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -98.75 93.17 5.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.994 -1.066 . . . . 0.0 110.172 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.541 ' C ' HD12 ' A' ' 138' ' ' LEU . 99.7 mt-10 -68.2 -39.45 82.44 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.904 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.541 HD12 ' C ' ' A' ' 137' ' ' GLU . 11.1 mp -105.77 151.04 39.82 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.204 -0.935 . . . . 0.0 110.737 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -75.45 -174.15 1.88 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.639 1.336 . . . . 0.0 108.763 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -118.64 3.61 11.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.575 -1.328 . . . . 0.0 110.03 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.9 m -60.96 137.08 58.25 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.852 -1.155 . . . . 0.0 110.835 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.4 mt -67.34 136.69 26.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.698 -0.626 . . . . 0.0 110.175 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 3.5 m -92.97 134.08 35.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.401 -0.812 . . . . 0.0 109.244 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -132.9 149.6 52.23 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -0.936 . . . . 0.0 109.898 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 CA-C-O 117.908 -1.496 . . . . 0.0 109.844 -179.605 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mtp . . . . . 0 N--CA 1.496 1.863 0 CA-C-O 121.348 0.594 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.8 p -156.69 158.31 36.72 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.246 -0.909 . . . . 0.0 109.873 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -83.92 -11.6 56.65 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.036 -1.04 . . . . 0.0 111.188 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.792 HG22 ' OE1' ' A' ' 13' ' ' GLU . 49.9 pt -124.46 161.7 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.021 -1.049 . . . . 0.0 109.936 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.444 ' HG3' ' HB3' ' A' ' 7' ' ' PHE . 17.5 pt-20 -151.61 -166.73 2.59 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.528 -0.732 . . . . 0.0 109.652 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -63.42 -33.93 76.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.019 -1.051 . . . . 0.0 110.276 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.559 ' CE2' HD12 ' A' ' 8' ' ' LEU . 29.4 t80 -46.06 -72.27 0.06 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.402 -0.811 . . . . 0.0 110.569 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.559 HD12 ' CE2' ' A' ' 7' ' ' PHE . 92.3 mt -132.86 153.16 51.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.173 -0.954 . . . . 0.0 110.406 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.8 p -82.2 169.79 16.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.935 -1.103 . . . . 0.0 109.867 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.424 ' HB2' HG21 ' A' ' 4' ' ' ILE . . . -52.53 -40.51 62.54 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.939 -1.101 . . . . 0.0 109.555 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.01 -46.91 87.13 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.529 -0.732 . . . . 0.0 110.401 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.67 -46.27 66.47 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.035 -1.041 . . . . 0.0 111.125 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.792 ' OE1' HG22 ' A' ' 4' ' ' ILE . 98.6 mt-10 -63.03 -37.94 89.21 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.124 -0.985 . . . . 0.0 109.917 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 87.8 tttt -63.64 -44.72 93.01 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.442 -0.786 . . . . 0.0 111.239 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.18 -42.65 93.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.956 -1.09 . . . . 0.0 111.375 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.651 HG13 HG22 ' A' ' 114' ' ' VAL . 18.4 tt -67.81 -37.53 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.701 -1.249 . . . . 0.0 110.351 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.609 ' HA ' HD12 ' A' ' 20' ' ' ILE . 46.9 t -62.68 -42.68 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -61.77 -37.88 85.93 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.574 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.03 -36.58 79.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.334 -0.854 . . . . 0.0 109.188 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.879 HG22 ' OD1' ' A' ' 140' ' ' ASN . 96.7 mt -64.25 -43.66 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.363 -0.836 . . . . 0.0 109.696 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -58.78 -41.57 86.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.245 -0.909 . . . . 0.0 109.921 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -64.65 -37.53 87.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.501 -0.75 . . . . 0.0 111.664 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.45 ' O ' HG22 ' A' ' 27' ' ' THR . . . -64.92 -39.99 94.36 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.831 -1.168 . . . . 0.0 110.021 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -60.53 -15.59 28.96 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.062 -1.024 . . . . 0.0 111.097 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.6 mttt -92.93 -6.23 49.01 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.16 -0.962 . . . . 0.0 109.006 177.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -105.72 -13.72 15.47 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 121.085 -1.009 . . . . 0.0 109.742 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 23' ' ' ALA . 4.5 t -151.55 156.93 41.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.026 -1.046 . . . . 0.0 110.318 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.4 t -86.6 -6.9 58.75 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.354 -0.841 . . . . 0.0 109.019 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.86 173.31 50.26 Favored Glycine 0 N--CA 1.481 1.64 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.42 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 52.5 mp0 -132.35 137.4 47.37 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.147 -1.208 . . . . 0.0 111.677 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 82.4 mt -119.57 134.14 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.682 -0.636 . . . . 0.0 110.293 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HB3' ' CE ' ' A' ' 56' ' ' MET . 75.2 ttt180 -139.73 153.07 47.11 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.054 -1.029 . . . . 0.0 109.906 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.608 HG22 ' HB ' ' A' ' 67' ' ' ILE . 55.8 t -123.53 140.08 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.366 -0.834 . . . . 0.0 111.134 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.465 ' HB2' HD11 ' A' ' 66' ' ' LEU . 64.2 t60 -122.86 133.14 54.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.577 -0.702 . . . . 0.0 109.146 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.646 HD11 HG13 ' A' ' 71' ' ' VAL . 40.6 tp -123.89 136.43 54.35 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.099 0.952 . . . . 0.0 112.086 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.45 ' HG2' ' NH2' ' A' ' 46' ' ' ARG . 48.5 tp10 -151.63 161.95 41.81 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.545 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.1 mttt -73.38 -72.5 0.25 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.929 -1.107 . . . . 0.0 112.417 -177.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 t -142.79 158.03 44.04 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.434 -0.791 . . . . 0.0 109.524 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.425 ' OG ' ' CD ' ' A' ' 46' ' ' ARG . 69.5 m -108.2 172.23 6.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.345 -0.847 . . . . 0.0 111.264 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -107.63 -21.3 12.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.559 -0.713 . . . . 0.0 110.531 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.9 pt -116.88 -121.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.009 -1.057 . . . . 0.0 110.762 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -109.38 132.75 53.84 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.637 -1.289 . . . . 0.0 109.332 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.8 t -62.4 -43.76 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.75 -0.594 . . . . 0.0 111.471 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -59.79 -47.93 83.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.892 -1.13 . . . . 0.0 109.537 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -67.71 -35.64 79.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.943 -1.098 . . . . 0.0 108.246 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.518 ' NH1' HG21 ' A' ' 50' ' ' VAL . 76.0 ttt-85 -64.5 -43.2 94.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 111.414 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.24 -36.86 85.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.749 -1.219 . . . . 0.0 109.985 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.5 ttp -61.21 -42.93 99.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 109.059 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -63.72 -46.77 83.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.004 -1.06 . . . . 0.0 110.249 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.518 HG21 ' NH1' ' A' ' 46' ' ' ARG . 71.8 t -64.85 -43.84 96.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.33 -0.856 . . . . 0.0 109.882 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -59.23 -49.37 78.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.057 -1.027 . . . . 0.0 109.666 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -71.43 -35.82 71.06 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.363 -0.835 . . . . 0.0 109.226 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -62.22 -37.72 86.46 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.266 -0.897 . . . . 0.0 109.327 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.0 mt -82.43 3.93 26.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.914 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.2 tttt 54.86 34.8 22.85 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.137 -0.977 . . . . 0.0 111.483 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.821 ' SD ' HD13 ' A' ' 66' ' ' LEU . 94.2 mtp -66.78 -11.44 55.06 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.901 -1.124 . . . . 0.0 110.206 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 44.7 p-10 -77.25 -0.84 26.81 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.94 -1.1 . . . . 0.0 109.927 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -78.54 64.62 3.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.387 -0.821 . . . . 0.0 110.687 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.4 p -135.14 150.3 50.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.21 -0.931 . . . . 0.0 108.951 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.62 -44.54 96.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.283 -0.886 . . . . 0.0 112.707 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 90.6 mt -97.14 1.59 50.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.95 -1.094 . . . . 0.0 111.725 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 85.2 mt-30 57.13 38.43 29.01 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.284 1.04 . . . . 0.0 110.913 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.531 ' C ' HD11 ' A' ' 84' ' ' ILE . 99.3 m-20 -112.67 55.21 0.7 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.543 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.404 ' O ' ' CD1' ' A' ' 84' ' ' ILE . . . -101.71 141.16 15.19 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 178.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.474 ' CG2' HD13 ' A' ' 84' ' ' ILE . 49.9 t -124.29 134.72 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.143 -1.21 . . . . 0.0 110.162 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.821 HD13 ' SD ' ' A' ' 56' ' ' MET . 52.2 tp -117.89 129.33 55.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.515 -0.741 . . . . 0.0 110.658 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.608 ' HB ' HG22 ' A' ' 33' ' ' VAL . 97.1 mt -107.64 110.18 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.905 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.435 ' OH ' ' NH2' ' A' ' 46' ' ' ARG . 33.8 t80 -96.71 125.42 41.15 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.189 -0.944 . . . . 0.0 110.318 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.507 ' O ' HD12 ' A' ' 35' ' ' LEU . 55.3 t -125.59 131.73 71.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-O 122.139 0.971 . . . . 0.0 111.165 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.469 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -98.71 108.92 21.73 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.646 HG13 HD11 ' A' ' 35' ' ' LEU . 32.8 m -74.65 -19.37 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.052 -1.03 . . . . 0.0 110.078 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -69.46 -43.45 73.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.075 -1.015 . . . . 0.0 109.336 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -104.22 4.98 34.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.006 -1.059 . . . . 0.0 111.15 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 67.5 tttt 56.06 47.4 19.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.831 -1.168 . . . . 0.0 110.64 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.469 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 22.2 p -123.23 167.61 13.51 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.183 -0.948 . . . . 0.0 110.355 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -147.83 140.84 24.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.555 -0.715 . . . . 0.0 109.993 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 68.7 t -128.38 138.39 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.727 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 79.4 mt -113.62 124.76 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.971 -1.08 . . . . 0.0 110.492 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -130.38 113.75 14.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.504 -0.747 . . . . 0.0 109.717 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.94 170.5 21.82 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -77.35 174.21 11.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.483 -1.01 . . . . 0.0 110.223 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -58.87 -27.81 65.54 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.326 -0.859 . . . . 0.0 110.244 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.491 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -64.78 -50.49 58.2 Favored Glycine 0 N--CA 1.487 2.065 0 C-N-CA 119.687 -1.245 . . . . 0.0 109.99 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.96 ' O ' HG22 ' A' ' 88' ' ' VAL . 4.2 mt -63.54 -46.9 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.835 -1.391 . . . . 0.0 108.552 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -63.26 -33.66 75.98 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.529 -0.732 . . . . 0.0 112.058 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -76.74 -22.98 53.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.739 -1.226 . . . . 0.0 112.532 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.086 HG23 HG13 ' A' ' 88' ' ' VAL . 25.9 m -103.99 -17.85 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.757 -1.214 . . . . 0.0 112.08 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.086 HG13 HG23 ' A' ' 87' ' ' VAL . 4.5 m -120.25 159.52 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.966 -1.084 . . . . 0.0 111.591 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.9 p -104.65 177.25 4.9 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.881 0.848 . . . . 0.0 112.084 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -64.21 -38.74 92.14 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.59 -0.694 . . . . 0.0 109.246 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -60.83 -38.52 85.73 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.877 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 75.2 t80 -64.33 -26.26 68.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -0.941 . . . . 0.0 108.83 177.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.727 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.4 m95 -85.71 -26.68 25.78 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.924 0.869 . . . . 0.0 110.216 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -56.88 -41.13 77.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 112.538 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.2 p -63.19 -31.44 72.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.658 -1.276 . . . . 0.0 109.298 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.281 7.6 m -59.47 -48.35 82.0 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.433 1.111 . . . . 0.0 111.146 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -70.12 -37.17 75.25 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.124 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -63.47 -44.73 93.59 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.177 -1.009 . . . . 0.0 110.883 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.64 -49.03 76.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.743 -1.223 . . . . 0.0 110.881 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.1 -42.3 91.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.176 -0.952 . . . . 0.0 110.059 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -63.38 -43.51 97.41 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.677 -0.64 . . . . 0.0 111.701 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.8 mt -63.96 -43.13 96.74 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.722 -1.236 . . . . 0.0 112.256 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.481 ' HG2' ' N ' ' A' ' 112' ' ' GLY . 5.2 tp-100 -72.36 -42.53 65.2 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.666 -1.214 . . . . 0.0 108.72 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -58.5 -39.57 80.42 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.81 -32.16 72.45 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.622 -0.674 . . . . 0.0 109.887 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -80.95 -19.02 45.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.085 -1.01 . . . . 0.0 110.238 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.27 5.87 36.95 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.045 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.407 ' HB2' ' HG3' ' A' ' 103' ' ' GLN . 95.8 m-20 -105.87 89.85 3.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.833 -1.392 . . . . 0.0 110.253 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -63.65 -41.45 98.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.725 -0.609 . . . . 0.0 111.672 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.615 ' O ' HG23 ' A' ' 114' ' ' VAL . 78.5 tttt -62.56 -48.11 80.92 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.888 -1.133 . . . . 0.0 111.721 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.47 ' HB2' ' HG2' ' A' ' 103' ' ' GLN . 88.4 mt-30 -64.41 -37.91 89.19 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.636 -177.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.481 ' N ' ' HG2' ' A' ' 103' ' ' GLN . . . -67.37 -46.32 71.6 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.86 -43.25 93.59 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.533 -0.98 . . . . 0.0 110.48 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.651 HG22 HG13 ' A' ' 16' ' ' ILE . 96.6 t -66.42 -47.13 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.393 -0.817 . . . . 0.0 109.996 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -62.9 -40.57 97.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.247 -0.908 . . . . 0.0 109.164 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.74 -43.51 96.37 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.3 mt -63.55 -43.4 98.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -1.105 . . . . 0.0 110.062 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -60.86 -48.27 82.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.023 -1.048 . . . . 0.0 110.484 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.33 -43.65 97.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.012 -1.055 . . . . 0.0 109.487 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.09 -41.44 83.49 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.388 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.04 -45.61 91.57 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 95.6 mtp -66.16 -46.48 77.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.903 -1.351 . . . . 0.0 109.934 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.877 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -62.06 -46.9 87.09 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.602 -0.686 . . . . 0.0 109.725 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.86 -38.63 91.79 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.449 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.84 -35.12 61.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.868 -1.145 . . . . 0.0 110.273 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.91 -43.95 97.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.144 -0.972 . . . . 0.0 109.047 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -72.49 -39.89 67.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.67 -0.644 . . . . 0.0 109.654 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.421 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 36.7 m-85 -131.4 96.73 20.79 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.485 -0.759 . . . . 0.0 110.505 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 128' ' ' PHE . 43.1 Cg_endo -66.38 150.32 84.48 Favored 'Trans proline' 0 C--N 1.317 -1.124 0 O-C-N 123.739 1.389 . . . . 0.0 110.735 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.475 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 29.4 t90 -73.32 164.1 27.15 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.643 0.735 . . . . 0.0 110.358 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -145.23 153.37 41.26 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.62 -30.83 70.1 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 111.736 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -90.71 8.24 35.51 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 118.926 -1.109 . . . . 0.0 111.224 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -41.95 138.43 1.54 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.632 0.73 . . . . 0.0 111.551 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.772 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.3 pp -113.32 147.65 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 121.542 0.687 . . . . 0.0 110.737 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -102.25 92.78 4.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.689 -1.257 . . . . 0.0 109.358 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.549 ' HG2' HD13 ' A' ' 135' ' ' ILE . 80.3 mm-40 -66.26 -41.05 90.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.725 -0.61 . . . . 0.0 111.749 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.42 ' HB2' ' HG2' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -106.86 151.93 40.74 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.151 -0.968 . . . . 0.0 111.163 -178.872 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.85 -172.26 0.93 Allowed 'Trans proline' 0 C--N 1.315 -1.233 0 N-CA-C 108.762 -1.284 . . . . 0.0 108.762 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.879 ' OD1' HG22 ' A' ' 20' ' ' ILE . 69.4 m-80 -121.42 2.76 10.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.687 -1.258 . . . . 0.0 110.073 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.6 p -63.85 173.55 1.76 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -0.913 . . . . 0.0 111.333 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 89.4 mt -101.96 136.14 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.547 0.689 . . . . 0.0 110.779 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.8 t -94.05 136.53 34.25 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.449 -0.782 . . . . 0.0 109.353 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -130.09 138.57 50.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 0.0 110.478 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.081 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.744 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.5 mtm . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.9 p -64.27 -41.78 96.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 110.221 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -113.57 149.95 33.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 110.519 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.419 HG23 ' O ' ' A' ' 4' ' ' ILE . 16.8 tt -94.85 127.37 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.894 . . . . 0.0 110.505 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -69.78 141.67 53.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.5 -0.75 . . . . 0.0 110.371 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -69.93 90.68 0.63 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.071 -1.018 . . . . 0.0 109.386 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.79 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 80.4 m-85 -60.7 -41.61 95.52 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.257 -0.902 . . . . 0.0 109.676 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.5 mt -129.11 148.1 51.03 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.722 -0.611 . . . . 0.0 109.495 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.3 m -63.98 149.93 46.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.899 -1.126 . . . . 0.0 109.172 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.53 -30.77 21.69 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.892 -1.13 . . . . 0.0 110.059 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -72.27 -36.04 68.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.159 -0.963 . . . . 0.0 110.054 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 110' ' ' LYS . 92.7 mt-10 -61.92 -40.78 96.65 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.956 -1.097 . . . . 0.0 108.729 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.658 ' O ' HG23 ' A' ' 17' ' ' VAL . 92.2 mt-10 -61.14 -38.44 86.42 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.729 -0.607 . . . . 0.0 110.178 178.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -60.52 -41.92 95.39 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.514 -0.875 . . . . 0.0 110.431 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.14 78.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.006 -1.059 . . . . 0.0 112.329 -178.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.524 HG13 HG22 ' A' ' 114' ' ' VAL . 16.2 tt -66.53 -31.74 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.59 -1.318 . . . . 0.0 110.215 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 13' ' ' GLU . 55.9 t -64.63 -40.58 89.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -63.97 -35.94 82.34 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.606 -0.837 . . . . 0.0 109.174 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.45 -39.46 93.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.38 -0.825 . . . . 0.0 109.12 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.729 HG22 ' OD1' ' A' ' 140' ' ' ASN . 97.1 mt -64.56 -43.32 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.835 . . . . 0.0 109.862 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -60.78 -41.96 96.57 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.131 -0.981 . . . . 0.0 110.199 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -65.96 -38.22 88.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.512 -0.742 . . . . 0.0 111.147 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.96 -40.41 96.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.859 -1.151 . . . . 0.0 109.956 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.67 -15.59 30.36 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.061 -1.024 . . . . 0.0 110.866 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.474 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 75.4 mmtt -93.8 1.01 56.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.089 -1.007 . . . . 0.0 109.27 177.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -114.81 -14.08 11.97 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.802 -1.186 . . . . 0.0 109.934 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.6 t -151.74 154.52 36.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.875 -1.14 . . . . 0.0 109.753 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 m -84.56 -6.74 59.39 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.291 -0.881 . . . . 0.0 109.805 178.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.9 174.58 54.27 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.775 ' HG2' HD22 ' A' ' 138' ' ' LEU . 51.3 tp10 -133.31 138.2 46.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.272 -1.134 . . . . 0.0 111.665 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 93.5 mt -118.46 134.5 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.712 -0.617 . . . . 0.0 109.835 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.419 ' NE ' ' OG ' ' A' ' 143' ' ' SER . 76.2 ttt180 -139.87 152.17 46.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.89 . . . . 0.0 109.852 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.64 HG22 ' HB ' ' A' ' 67' ' ' ILE . 53.7 t -124.5 140.61 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.368 -0.832 . . . . 0.0 111.464 -178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -125.87 128.3 47.38 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.521 0.677 . . . . 0.0 109.434 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.985 HD11 ' CG1' ' A' ' 71' ' ' VAL . 37.8 tp -118.67 129.84 55.51 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.946 0.879 . . . . 0.0 112.572 -177.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.408 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 84.7 tt0 -145.35 168.09 21.32 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.408 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 98.7 mttt -79.23 -73.6 0.33 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.977 -1.077 . . . . 0.0 112.961 -177.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 t -143.26 158.81 43.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.265 -0.897 . . . . 0.0 110.141 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.425 ' HB3' ' HD3' ' A' ' 46' ' ' ARG . 14.9 p -108.95 171.86 7.19 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.251 -0.906 . . . . 0.0 111.152 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -106.58 -10.68 16.11 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.479 -0.763 . . . . 0.0 110.425 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 42' ' ' ASP . 25.7 pt -125.57 -121.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 120.985 -1.072 . . . . 0.0 109.631 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.402 ' N ' HG13 ' A' ' 41' ' ' ILE . 64.2 m-20 -111.76 138.62 48.1 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 120.393 -1.442 . . . . 0.0 109.017 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 85.2 t -64.28 -43.31 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 111.412 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -59.36 -47.29 85.97 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.95 -1.094 . . . . 0.0 110.778 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -71.34 -38.18 71.66 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.88 -1.137 . . . . 0.0 108.42 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.425 ' HD3' ' HB3' ' A' ' 39' ' ' SER . 79.8 ttt180 -63.54 -40.67 97.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.467 -0.77 . . . . 0.0 110.082 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.44 -38.15 84.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.694 -1.254 . . . . 0.0 110.127 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.4 ttp -62.09 -44.22 97.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.969 -1.082 . . . . 0.0 109.901 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -63.35 -44.64 94.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.082 -1.011 . . . . 0.0 109.571 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 46' ' ' ARG . 95.7 t -65.81 -43.72 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.586 -0.696 . . . . 0.0 110.088 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.474 ' CE2' ' OD1' ' A' ' 57' ' ' ASP . 71.4 t80 -58.66 -45.95 88.24 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.065 -1.022 . . . . 0.0 109.435 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -73.07 -35.77 66.72 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.849 -1.157 . . . . 0.0 109.558 178.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -60.79 -37.34 81.6 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.025 -1.047 . . . . 0.0 109.955 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.3 mt -82.08 5.72 18.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.098 -1.001 . . . . 0.0 110.308 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.423 ' HB3' ' ND2' ' A' ' 58' ' ' ASN . 98.6 mttt 54.78 34.65 22.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.793 -1.192 . . . . 0.0 111.43 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.691 ' SD ' HD13 ' A' ' 66' ' ' LEU . 93.4 mtp -67.05 -12.47 60.01 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.957 -1.097 . . . . 0.0 109.641 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.474 ' OD1' ' CE2' ' A' ' 51' ' ' PHE . 92.3 m-20 -75.09 -2.13 26.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.664 -1.272 . . . . 0.0 109.9 177.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.423 ' ND2' ' HB3' ' A' ' 55' ' ' LYS . 64.9 m-20 -74.2 61.37 0.86 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.828 -1.17 . . . . 0.0 109.937 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.4 m -132.47 144.17 50.28 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.162 -0.961 . . . . 0.0 108.875 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.31 -42.81 99.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.821 -0.549 . . . . 0.0 112.405 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.5 mt -98.51 2.4 47.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.101 -0.999 . . . . 0.0 111.595 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 55.87 36.54 27.49 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.076 0.941 . . . . 0.0 111.542 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.496 ' C ' HD11 ' A' ' 84' ' ' ILE . 97.7 m-20 -113.13 50.2 0.9 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.338 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.68 142.53 16.15 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.762 -2.135 . . . . 0.0 107.762 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.457 HG22 HD13 ' A' ' 84' ' ' ILE . 54.9 t -123.73 133.91 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.103 -1.234 . . . . 0.0 109.924 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.691 HD13 ' SD ' ' A' ' 56' ' ' MET . 44.5 tp -116.37 129.05 56.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 110.536 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.64 ' HB ' HG22 ' A' ' 33' ' ' VAL . 78.0 mt -107.65 108.93 26.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.369 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -95.59 125.4 40.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -0.853 . . . . 0.0 109.913 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.568 HG21 HD21 ' A' ' 113' ' ' LEU . 54.7 t -122.4 133.23 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.095 0.95 . . . . 0.0 110.769 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.595 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -101.48 91.59 4.53 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.985 ' CG1' HD11 ' A' ' 35' ' ' LEU . 26.0 m -64.54 -23.71 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.018 -1.051 . . . . 0.0 110.892 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 37.9 tp10 -67.61 -44.18 78.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.062 -1.024 . . . . 0.0 108.741 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.647 ' O ' HG23 ' A' ' 75' ' ' THR . 87.0 m-20 -101.5 8.89 41.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.371 -0.83 . . . . 0.0 110.982 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.4 tttt 51.49 41.47 28.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.909 -1.119 . . . . 0.0 110.42 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 73' ' ' ASP . 81.2 p -121.32 169.43 10.6 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.226 -0.921 . . . . 0.0 109.529 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -151.24 145.3 25.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.758 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.1 t -132.06 135.97 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.659 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 76.4 mt -112.86 123.34 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.758 -1.214 . . . . 0.0 110.533 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -129.32 111.65 13.06 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.472 -0.767 . . . . 0.0 110.797 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -98.34 173.47 27.48 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -76.57 173.28 11.75 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.587 -0.949 . . . . 0.0 109.66 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.81 -22.94 62.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.893 . . . . 0.0 110.815 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.94 -50.6 45.82 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.825 -1.179 . . . . 0.0 110.523 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.954 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.7 mt -64.25 -46.92 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.886 -1.361 . . . . 0.0 108.655 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -61.37 -37.97 85.3 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.768 -1.207 . . . . 0.0 111.949 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -72.02 -22.12 61.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.684 -1.26 . . . . 0.0 111.832 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.093 HG13 HG13 ' A' ' 88' ' ' VAL . 7.5 p -102.09 -21.62 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.967 -1.083 . . . . 0.0 113.21 -178.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.093 HG13 HG13 ' A' ' 87' ' ' VAL . 30.0 m -123.36 166.66 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.641 -1.287 . . . . 0.0 111.367 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 m -112.11 -175.56 2.71 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.271 -0.893 . . . . 0.0 113.165 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -62.44 -39.75 94.36 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.835 . . . . 0.0 110.18 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -61.64 -38.63 88.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.123 -0.985 . . . . 0.0 110.112 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.725 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 68.8 t80 -65.9 -27.69 68.39 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.204 -0.935 . . . . 0.0 109.123 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.659 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.5 m95 -86.72 -27.02 23.93 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.207 1.003 . . . . 0.0 110.278 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -55.99 -42.18 75.94 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.97 -1.081 . . . . 0.0 112.471 -176.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 88.1 m -62.95 -31.99 73.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.809 -1.182 . . . . 0.0 109.037 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.474 HG22 HD13 ' A' ' 78' ' ' ILE 0.286 8.7 m -58.88 -48.9 79.77 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.688 1.232 . . . . 0.0 110.732 179.686 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.65 -38.46 80.47 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.777 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.416 ' O ' HD23 ' A' ' 102' ' ' LEU . 11.5 m120 -63.95 -42.69 97.23 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.989 -1.084 . . . . 0.0 110.177 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.02 -49.17 78.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.292 -1.505 . . . . 0.0 110.598 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.575 HD12 HD11 ' A' ' 78' ' ' ILE . 90.9 mt -67.99 -42.48 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.15 -0.969 . . . . 0.0 110.482 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -63.08 -46.31 88.0 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.009 -1.057 . . . . 0.0 111.889 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.416 HD23 ' O ' ' A' ' 98' ' ' ASN . 3.5 mm? -64.08 -42.38 96.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.991 -1.068 . . . . 0.0 112.298 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.468 ' HB2' ' HA3' ' A' ' 112' ' ' GLY . 99.4 mm-40 -71.67 -41.38 68.78 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.923 -1.111 . . . . 0.0 109.017 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.463 ' CE1' HG23 ' A' ' 100' ' ' ILE . 4.7 m-85 -60.15 -40.09 88.65 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.08 -32.99 72.64 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.004 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -81.55 -17.64 47.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.091 -1.006 . . . . 0.0 109.503 177.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.54 11.04 29.88 Favored Glycine 0 N--CA 1.494 2.506 0 O-C-N 121.112 -0.993 . . . . 0.0 110.781 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -108.71 89.47 3.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.829 -1.395 . . . . 0.0 110.781 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -63.48 -44.22 95.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.439 -0.788 . . . . 0.0 111.577 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.404 ' HD2' ' HB3' ' A' ' 12' ' ' GLU . 61.9 tttm -62.82 -49.07 76.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.143 -0.973 . . . . 0.0 112.269 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -64.61 -38.67 91.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.054 -1.029 . . . . 0.0 110.055 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.468 ' HA3' ' HB2' ' A' ' 103' ' ' GLN . . . -63.93 -44.12 96.48 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.568 HD21 HG21 ' A' ' 69' ' ' VAL . 76.6 mt -66.81 -44.9 79.97 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.339 -1.095 . . . . 0.0 110.254 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.524 HG22 HG13 ' A' ' 16' ' ' ILE . 74.8 t -66.12 -47.13 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.423 -0.798 . . . . 0.0 110.679 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -63.17 -39.09 93.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.009 -1.057 . . . . 0.0 109.248 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.76 -42.28 99.71 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.52 -44.28 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.233 -1.157 . . . . 0.0 110.72 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.51 -48.45 80.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.979 -1.076 . . . . 0.0 109.757 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.99 -40.33 97.44 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.395 -0.816 . . . . 0.0 108.865 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.56 97.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.442 -0.787 . . . . 0.0 110.59 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.81 -42.55 98.47 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 98.2 mtp -65.41 -48.56 72.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -1.17 . . . . 0.0 110.261 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.725 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -62.41 -44.67 95.87 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.538 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.18 -39.61 95.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -0.851 . . . . 0.0 109.237 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.6 -34.5 58.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.066 -1.021 . . . . 0.0 110.123 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -61.88 -43.72 98.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 0.0 109.32 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.458 ' HB3' ' CE2' ' A' ' 128' ' ' PHE . 68.2 m-85 -70.93 -37.44 72.87 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.819 0.819 . . . . 0.0 109.36 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.458 ' CE2' ' HB3' ' A' ' 127' ' ' TYR . 88.1 m-85 -132.5 98.51 16.56 Favored Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.174 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.08 150.85 77.68 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 O-C-N 123.696 1.367 . . . . 0.0 109.706 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.474 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 51.9 t90 -76.1 127.4 32.86 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.418 -0.801 . . . . 0.0 110.817 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -105.17 146.78 28.76 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -56.46 -29.92 62.28 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.214 -0.929 . . . . 0.0 111.087 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -90.85 8.86 32.75 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.099 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -42.94 138.5 2.01 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.19 -0.944 . . . . 0.0 111.187 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.525 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -110.92 134.4 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-O 121.995 0.902 . . . . 0.0 111.473 -176.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 41.4 p-10 -116.96 102.48 9.39 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.446 -0.784 . . . . 0.0 110.583 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -102.17 -12.07 18.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.739 -1.226 . . . . 0.0 111.734 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.775 HD22 ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -93.11 140.97 23.49 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.977 -1.077 . . . . 0.0 110.676 -179.358 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.2 171.94 14.99 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.349 1.184 . . . . 0.0 109.108 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.729 ' OD1' HG22 ' A' ' 20' ' ' ILE . 68.3 m-80 -112.11 7.21 19.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.715 -1.24 . . . . 0.0 110.617 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -64.06 148.01 50.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.955 -1.091 . . . . 0.0 111.332 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 93.5 mt -76.2 139.61 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.56 -0.713 . . . . 0.0 110.351 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.419 ' OG ' ' NE ' ' A' ' 32' ' ' ARG . 17.6 m -94.09 135.96 34.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.158 -0.964 . . . . 0.0 110.272 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -128.77 140.97 51.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.278 -0.889 . . . . 0.0 110.667 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.974 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.4 mtp . . . . . 0 N--CA 1.506 2.343 0 CA-C-O 121.073 0.463 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.9 m -63.35 -41.23 98.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.061 -1.024 . . . . 0.0 110.097 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -128.16 143.84 51.08 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.277 -0.89 . . . . 0.0 110.089 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.3 pt -102.96 1.36 10.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 O-C-N 121.633 -0.667 . . . . 0.0 110.326 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.36 -38.29 88.98 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.799 -1.188 . . . . 0.0 109.385 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -123.05 122.93 39.69 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.321 -0.862 . . . . 0.0 110.331 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.904 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 64.1 m-85 -64.92 -40.6 95.3 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.525 -0.734 . . . . 0.0 111.846 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.45 HD22 ' OE1' ' A' ' 12' ' ' GLU . 84.8 mt -128.19 143.86 51.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.953 -1.092 . . . . 0.0 109.584 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.507 HG22 ' N ' ' A' ' 10' ' ' ALA . 75.8 m -74.45 167.61 21.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.91 -1.119 . . . . 0.0 109.746 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.507 ' N ' HG22 ' A' ' 9' ' ' THR . . . -53.49 -34.9 59.73 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.996 -1.065 . . . . 0.0 109.522 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -60.32 -46.74 88.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.117 -0.99 . . . . 0.0 110.81 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.45 ' OE1' HD22 ' A' ' 8' ' ' LEU . 96.1 mt-10 -72.79 -46.98 50.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.985 -1.072 . . . . 0.0 111.775 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.542 ' O ' HG23 ' A' ' 17' ' ' VAL . 96.7 mt-10 -60.15 -40.71 90.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.983 -1.073 . . . . 0.0 110.021 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 72.3 mmtt -63.84 -42.93 97.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.108 -0.995 . . . . 0.0 110.805 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.05 -42.94 93.78 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.99 -1.068 . . . . 0.0 111.559 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 13' ' ' GLU . 19.4 tt -68.88 -36.86 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.72 -1.238 . . . . 0.0 110.379 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 13' ' ' GLU . 48.4 t -61.26 -42.4 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -61.54 -36.48 80.72 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.507 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.67 -40.75 93.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.419 -0.8 . . . . 0.0 109.26 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.64 -42.56 96.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.345 -0.847 . . . . 0.0 109.348 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -58.64 -42.88 89.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.818 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -64.9 -37.46 87.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.179 -0.951 . . . . 0.0 111.167 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.03 -39.31 93.17 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.779 -1.2 . . . . 0.0 110.522 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.2 -15.94 28.85 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.894 -1.129 . . . . 0.0 110.351 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.478 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.5 mttt -93.2 0.37 57.1 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 120.927 -1.108 . . . . 0.0 109.417 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -112.55 -15.62 13.02 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.714 -1.241 . . . . 0.0 109.816 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.3 t -153.64 157.59 39.85 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.906 -1.121 . . . . 0.0 110.326 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.2 m -85.57 -9.2 57.67 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.326 -0.859 . . . . 0.0 110.193 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.86 172.29 46.54 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.413 ' CB ' HD12 ' A' ' 138' ' ' LEU . 53.6 mp0 -131.18 134.04 46.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.287 -1.125 . . . . 0.0 112.268 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.429 HD11 HD12 ' A' ' 124' ' ' LEU . 97.1 mt -118.9 133.86 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.305 0.574 . . . . 0.0 109.807 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.502 ' NH1' HD13 ' A' ' 54' ' ' LEU . 72.4 ttt180 -139.79 152.09 46.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.429 -0.794 . . . . 0.0 110.063 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.719 HG22 HD12 ' A' ' 67' ' ' ILE . 83.9 t -122.64 138.77 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.36 -0.838 . . . . 0.0 110.71 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.464 ' HB2' HD11 ' A' ' 66' ' ' LEU . 75.3 t60 -122.82 132.32 54.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 0.0 108.933 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.945 HD11 ' CG1' ' A' ' 71' ' ' VAL . 32.9 tp -118.07 131.63 56.43 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.024 0.916 . . . . 0.0 111.557 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -150.38 164.88 34.74 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 67.4 mttm -79.39 -74.74 0.27 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.04 -1.038 . . . . 0.0 113.419 -177.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 t -141.39 160.28 40.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.414 -0.804 . . . . 0.0 110.906 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.421 ' OG ' ' CD ' ' A' ' 46' ' ' ARG . 25.7 m -108.9 168.02 9.66 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.661 -0.649 . . . . 0.0 110.997 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -107.82 -12.0 15.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 110.7 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 42' ' ' ASP . 29.3 pt -123.75 -122.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.984 -1.073 . . . . 0.0 109.321 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 41' ' ' ILE . 96.6 m-20 -110.53 136.33 49.82 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 120.204 -1.56 . . . . 0.0 108.973 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.9 t -62.96 -43.49 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.475 -0.766 . . . . 0.0 111.734 -178.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -59.24 -45.1 92.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.999 -1.063 . . . . 0.0 109.952 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -70.23 -37.97 75.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.897 -1.127 . . . . 0.0 108.327 177.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.421 ' CD ' ' OG ' ' A' ' 39' ' ' SER . 44.1 ttt85 -61.3 -41.66 97.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.526 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.4 -37.6 83.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.785 -1.197 . . . . 0.0 110.48 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.4 ttp -64.23 -42.6 96.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.486 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -64.62 -46.83 80.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.902 -1.124 . . . . 0.0 109.841 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.49 -45.67 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.208 -0.932 . . . . 0.0 110.553 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.467 ' CZ ' ' OD1' ' A' ' 81' ' ' ASP . 6.8 t80 -56.84 -47.94 79.21 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.703 -1.248 . . . . 0.0 109.717 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -72.85 -35.88 67.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.995 -1.066 . . . . 0.0 110.088 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -60.47 -39.54 87.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.879 -1.138 . . . . 0.0 109.314 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.502 HD13 ' NH1' ' A' ' 32' ' ' ARG . 96.1 mt -80.66 4.62 18.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.094 -1.004 . . . . 0.0 110.531 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 57.33 33.72 23.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.843 -1.161 . . . . 0.0 111.134 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.691 ' SD ' HD13 ' A' ' 66' ' ' LEU . 79.9 mtp -68.77 -26.8 65.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.117 -0.989 . . . . 0.0 109.374 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 39.2 p-10 -71.27 -8.21 52.11 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.202 -0.936 . . . . 0.0 110.586 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -87.98 82.54 7.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.705 -1.247 . . . . 0.0 110.233 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.419 HG23 ' CB ' ' A' ' 137' ' ' GLU . 51.7 m -138.1 156.1 48.1 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.17 -46.86 88.24 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.109 -0.994 . . . . 0.0 111.909 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.6 mt -97.71 2.55 49.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.045 -1.035 . . . . 0.0 111.031 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.415 ' O ' ' CB ' ' A' ' 81' ' ' ASP . 86.6 mt-30 55.49 43.67 28.17 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.481 1.134 . . . . 0.0 111.38 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -118.88 55.66 0.92 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.323 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.56 140.61 14.93 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.512 HG23 ' CD1' ' A' ' 84' ' ' ILE . 74.3 t -124.68 135.4 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.124 -1.221 . . . . 0.0 110.726 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.691 HD13 ' SD ' ' A' ' 56' ' ' MET . 38.8 tp -116.1 126.84 54.28 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.607 -0.683 . . . . 0.0 109.774 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.719 HD12 HG22 ' A' ' 33' ' ' VAL . 96.8 mt -105.41 101.0 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 118.901 -1.12 . . . . 0.0 108.992 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -86.97 123.27 31.89 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.384 -0.822 . . . . 0.0 109.973 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.2 t -119.74 129.6 75.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.855 0.836 . . . . 0.0 110.149 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.514 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -99.2 84.81 3.09 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.945 ' CG1' HD11 ' A' ' 35' ' ' LEU . 30.2 m -58.16 -23.13 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.224 -0.923 . . . . 0.0 111.016 -178.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 49.1 tp10 -66.05 -42.45 89.5 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.234 178.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.584 ' O ' HG23 ' A' ' 75' ' ' THR . 98.2 m-20 -102.31 6.69 40.56 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.198 -0.939 . . . . 0.0 111.007 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.8 tttt 52.84 45.89 27.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.822 -1.174 . . . . 0.0 110.983 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 73' ' ' ASP . 70.1 p -122.76 168.63 11.99 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.237 -0.915 . . . . 0.0 109.625 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 43.7 p90 -146.47 143.18 28.8 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.961 -1.087 . . . . 0.0 111.016 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.0 t -128.98 135.72 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.738 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 80.1 mt -114.45 129.44 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.879 -1.138 . . . . 0.0 110.092 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -136.38 114.42 11.42 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.494 -0.754 . . . . 0.0 110.877 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -101.14 174.82 25.54 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.467 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 32.6 m-20 -79.04 176.01 10.06 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.474 -1.015 . . . . 0.0 110.858 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.57 -27.38 68.59 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.366 -0.834 . . . . 0.0 109.453 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -63.66 -53.01 41.27 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.953 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.962 ' O ' HG22 ' A' ' 88' ' ' VAL . 93.5 mt -65.08 -44.07 95.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.743 -1.445 . . . . 0.0 108.659 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -61.77 -37.1 83.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.626 -1.296 . . . . 0.0 110.698 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -73.34 -21.1 60.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.963 . . . . 0.0 112.19 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 1.024 HG23 HG13 ' A' ' 88' ' ' VAL . 21.7 m -107.19 -19.83 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.809 -1.182 . . . . 0.0 112.926 -177.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.024 HG13 HG23 ' A' ' 87' ' ' VAL . 16.4 m -119.95 162.79 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.693 -1.254 . . . . 0.0 111.309 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 m -108.54 173.64 6.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.475 -0.766 . . . . 0.0 111.965 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -61.82 -37.24 83.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 110.1 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 34.1 p-10 -61.69 -36.41 80.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 109.244 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.881 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 73.1 t80 -66.73 -25.52 66.56 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.302 -0.874 . . . . 0.0 108.773 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.738 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 3.8 m95 -86.04 -26.19 25.5 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.852 0.834 . . . . 0.0 110.542 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -55.37 -38.99 69.56 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.996 -1.065 . . . . 0.0 112.963 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.4 m -63.22 -35.33 79.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.815 -1.178 . . . . 0.0 109.099 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.283 16.0 m -58.09 -48.5 79.98 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.334 1.064 . . . . 0.0 111.255 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.69 -38.22 83.37 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.518 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.686 ' O ' HD13 ' A' ' 102' ' ' LEU . 21.1 m120 -64.69 -45.12 87.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.988 -1.07 . . . . 0.0 111.015 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.17 -49.91 76.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.712 -1.242 . . . . 0.0 110.448 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.39 -43.26 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.223 -0.923 . . . . 0.0 111.075 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -62.42 -45.12 94.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.905 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.686 HD13 ' O ' ' A' ' 98' ' ' ASN . 7.0 mp -63.85 -41.46 97.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.325 -0.859 . . . . 0.0 111.561 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.455 ' HB2' ' HA3' ' A' ' 112' ' ' GLY . 98.7 mm-40 -73.01 -41.78 63.91 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.714 -1.194 . . . . 0.0 108.756 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -58.72 -38.07 77.53 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -61.46 -34.06 74.8 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.681 -0.637 . . . . 0.0 109.946 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -80.7 -17.59 50.6 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.814 -1.179 . . . . 0.0 110.511 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.75 7.18 42.39 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.678 -1.249 . . . . 0.0 111.167 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -103.99 90.99 3.78 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.773 -1.428 . . . . 0.0 110.259 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -63.1 -40.05 96.5 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.553 -0.717 . . . . 0.0 111.47 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -65.75 -49.52 68.1 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.243 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -64.29 -39.39 93.82 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.956 -1.097 . . . . 0.0 110.527 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.455 ' HA3' ' HB2' ' A' ' 103' ' ' GLN . . . -62.72 -48.07 84.18 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.411 ' HB3' HD11 ' A' ' 16' ' ' ILE . 80.8 mt -64.41 -43.2 95.13 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.301 -1.117 . . . . 0.0 109.912 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.4 t -64.81 -48.34 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -0.931 . . . . 0.0 110.509 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -64.66 -39.84 94.38 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.348 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.26 -43.62 99.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 89.2 mt -64.51 -43.56 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.064 -1.256 . . . . 0.0 109.806 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.95 -52.87 62.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.134 -0.979 . . . . 0.0 109.992 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.42 -43.05 99.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 108.664 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -53.81 -46.16 71.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.485 -0.76 . . . . 0.0 109.71 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.67 -43.15 99.4 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.437 ' HG2' ' NZ ' ' A' ' 126' ' ' LYS . 27.4 ttt -67.17 -48.91 66.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.895 -1.356 . . . . 0.0 109.669 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.881 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -62.09 -45.94 91.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.935 . . . . 0.0 109.37 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.429 HD12 HD11 ' A' ' 31' ' ' ILE . 77.2 mt -61.86 -40.13 94.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.194 -0.941 . . . . 0.0 108.611 178.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.08 -33.94 63.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.195 -0.941 . . . . 0.0 110.411 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.437 ' NZ ' ' HG2' ' A' ' 122' ' ' MET . 60.9 mttp -61.83 -43.43 98.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.056 -1.028 . . . . 0.0 108.818 178.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.428 ' CE2' HG12 ' A' ' 88' ' ' VAL . 52.5 m-85 -75.1 -39.78 60.45 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.61 0.719 . . . . 0.0 110.071 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.437 ' HE2' HG21 ' A' ' 87' ' ' VAL . 76.9 m-85 -130.65 90.66 39.85 Favored Pre-proline 0 C--N 1.301 -1.518 0 O-C-N 121.706 -0.621 . . . . 0.0 109.426 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -64.78 154.42 72.79 Favored 'Trans proline' 0 C--N 1.318 -1.035 0 O-C-N 123.588 1.309 . . . . 0.0 110.483 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.478 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 31.2 t90 -77.6 133.34 38.47 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.441 0.639 . . . . 0.0 111.962 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -114.6 150.85 34.42 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -58.35 -31.74 67.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.096 -1.003 . . . . 0.0 111.842 -177.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -90.99 6.09 46.17 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.963 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 135' ' ' ILE . 66.9 t0 -42.59 140.07 1.37 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 122.038 0.923 . . . . 0.0 111.667 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.696 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.1 pp -113.42 148.53 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-O 121.857 0.837 . . . . 0.0 111.662 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -105.68 96.65 6.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.465 -1.397 . . . . 0.0 110.036 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.419 ' CB ' HG23 ' A' ' 59' ' ' THR . 79.1 mm-40 -68.15 -37.14 80.72 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.593 -0.692 . . . . 0.0 112.838 -178.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.413 HD12 ' CB ' ' A' ' 30' ' ' GLU . 8.0 mt -109.3 148.45 38.04 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.987 -1.071 . . . . 0.0 111.828 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.39 -176.76 1.77 Allowed 'Trans proline' 0 C--N 1.319 -0.993 0 N-CA-C 108.359 -1.439 . . . . 0.0 108.359 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -116.87 4.35 12.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.587 -1.321 . . . . 0.0 110.204 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.8 p -63.29 169.1 3.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.899 -1.126 . . . . 0.0 110.771 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.0 mt -101.39 139.66 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.581 0.705 . . . . 0.0 110.947 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 32' ' ' ARG . 30.6 t -94.91 134.24 37.77 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.533 -0.729 . . . . 0.0 109.241 178.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -125.74 132.91 52.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.188 -0.945 . . . . 0.0 110.045 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.869 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 121.301 0.572 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.8 m -59.88 -42.37 93.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.925 -1.109 . . . . 0.0 110.403 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.77 -40.92 96.08 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.223 -0.923 . . . . 0.0 110.958 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.407 ' O ' HG13 ' A' ' 4' ' ' ILE . 34.0 pt -123.24 132.23 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.233 -0.917 . . . . 0.0 110.796 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -115.63 -87.98 0.59 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.662 -1.274 . . . . 0.0 110.813 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -119.65 -20.52 7.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.903 -1.123 . . . . 0.0 110.797 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.547 ' CE2' HD22 ' A' ' 35' ' ' LEU . 43.1 t80 -46.97 -72.5 0.05 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.184 -0.948 . . . . 0.0 111.062 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.527 ' CD1' ' CE2' ' A' ' 7' ' ' PHE . 96.2 mt -134.2 159.29 41.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.017 -1.052 . . . . 0.0 111.378 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -83.37 166.25 18.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.68 -0.637 . . . . 0.0 109.503 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.61 -37.05 67.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.121 -0.987 . . . . 0.0 110.086 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -57.72 -45.95 85.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.909 . . . . 0.0 109.868 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.423 ' OE1' HD22 ' A' ' 8' ' ' LEU . 99.4 mt-10 -69.16 -43.88 73.38 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.599 -0.688 . . . . 0.0 112.031 -178.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 17' ' ' VAL . 79.8 mm-40 -65.4 -39.18 91.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.954 -1.091 . . . . 0.0 110.917 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -63.33 -43.18 98.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.808 -1.182 . . . . 0.0 111.113 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.11 -45.55 84.67 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.077 -1.014 . . . . 0.0 112.108 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.587 HG13 HG22 ' A' ' 114' ' ' VAL . 19.6 tt -65.49 -37.43 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.696 -1.252 . . . . 0.0 110.507 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 13' ' ' GLU . 75.6 t -61.58 -39.1 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -0.953 . . . . 0.0 108.799 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -62.05 -36.31 81.25 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.072 -1.051 . . . . 0.0 108.885 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.09 -37.96 87.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.466 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.425 HD11 HD13 ' A' ' 117' ' ' ILE . 37.5 mm -63.72 -43.66 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.294 -0.879 . . . . 0.0 110.083 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.447 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 83.9 mtp180 -60.18 -41.59 93.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.347 -0.846 . . . . 0.0 110.556 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -65.08 -38.06 89.55 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.49 -0.756 . . . . 0.0 111.2 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.59 -39.53 93.9 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.938 -1.101 . . . . 0.0 110.165 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.63 -13.72 16.11 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.936 -1.103 . . . . 0.0 110.971 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.482 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.1 mttt -96.52 1.84 51.83 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.914 -1.116 . . . . 0.0 109.513 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -112.9 -18.04 12.34 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.04 -1.037 . . . . 0.0 109.775 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.2 t -151.43 158.33 43.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.959 . . . . 0.0 109.815 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 95.8 p -86.76 -7.57 58.15 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.269 -0.895 . . . . 0.0 109.667 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.38 172.11 52.42 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.449 ' CG ' ' HB2' ' A' ' 138' ' ' LEU . 79.6 mm-40 -133.72 139.56 46.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.254 -1.145 . . . . 0.0 111.891 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.6 mt -121.89 135.27 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 143' ' ' SER . 77.1 ttt180 -140.05 155.17 47.17 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 109.39 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.622 HG22 HD12 ' A' ' 67' ' ' ILE . 59.0 t -120.96 136.74 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.091 -1.006 . . . . 0.0 110.555 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.731 ' HB2' HD11 ' A' ' 66' ' ' LEU . 72.2 t60 -121.49 121.71 38.11 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.603 HD11 ' CG1' ' A' ' 71' ' ' VAL . 32.3 tp -111.87 125.93 54.55 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.732 0.777 . . . . 0.0 111.725 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.418 ' OE2' ' CZ ' ' A' ' 46' ' ' ARG . 82.5 tt0 -140.64 166.22 25.33 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.46 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.4 mttt -78.21 -76.05 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 112.327 -177.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.8 t -139.94 154.9 47.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 109.759 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.438 ' HB3' ' CD ' ' A' ' 46' ' ' ARG . 12.7 p -103.49 167.23 9.94 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.382 -0.824 . . . . 0.0 110.225 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -104.23 -8.35 19.41 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.372 -0.83 . . . . 0.0 110.041 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.4 pt -128.22 -122.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.046 -1.034 . . . . 0.0 109.493 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -110.29 138.75 46.25 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 120.309 -1.494 . . . . 0.0 109.509 178.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.2 t -63.18 -43.25 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 110.676 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -59.56 -47.11 86.83 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.02 -1.05 . . . . 0.0 110.743 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -70.15 -39.79 75.15 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.73 -1.232 . . . . 0.0 108.269 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.569 ' O ' HG23 ' A' ' 50' ' ' VAL . 73.1 ttt180 -61.12 -43.48 98.82 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.35 -0.844 . . . . 0.0 110.846 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.95 -40.47 91.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.702 -1.249 . . . . 0.0 110.368 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 46.7 ttp -62.34 -42.72 99.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.014 -1.054 . . . . 0.0 109.433 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -63.62 -42.06 98.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.037 -1.039 . . . . 0.0 109.081 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 46' ' ' ARG . 82.9 t -66.58 -43.44 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.572 -0.705 . . . . 0.0 110.304 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -59.89 -45.93 90.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.779 -1.201 . . . . 0.0 109.77 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -73.86 -35.95 64.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.949 -1.094 . . . . 0.0 109.889 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -61.57 -39.48 91.3 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.014 -1.054 . . . . 0.0 110.196 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.6 mt -81.14 4.15 21.05 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.043 -1.036 . . . . 0.0 110.58 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 55.79 31.5 17.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.096 -1.002 . . . . 0.0 111.65 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 92.1 mtp -66.55 -19.04 65.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.161 -0.962 . . . . 0.0 109.671 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -74.89 -4.97 41.1 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.096 -1.002 . . . . 0.0 111.288 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -45.96 -32.79 2.92 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.042 -1.036 . . . . 0.0 110.621 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.503 HG23 ' HA ' ' A' ' 62' ' ' GLN . 9.0 t -40.61 144.86 0.21 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.505 1.145 . . . . 0.0 113.009 -176.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -68.16 -40.4 82.33 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.465 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 72.8 mt -92.2 -0.92 57.4 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.143 -0.973 . . . . 0.0 111.178 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.503 ' HA ' HG23 ' A' ' 59' ' ' THR . 88.3 mt-30 57.69 36.85 27.04 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.348 1.071 . . . . 0.0 110.45 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.641 ' C ' HD11 ' A' ' 84' ' ' ILE . 97.8 m-20 -113.1 48.56 1.02 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.383 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.6 144.17 17.07 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.515 ' CG2' HD13 ' A' ' 84' ' ' ILE . 52.8 t -124.54 134.72 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.993 -1.298 . . . . 0.0 110.5 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.731 HD11 ' HB2' ' A' ' 34' ' ' HIS . 45.5 tp -116.79 125.6 51.85 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.387 -0.821 . . . . 0.0 109.738 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.622 HD12 HG22 ' A' ' 33' ' ' VAL . 89.9 mt -100.57 105.0 16.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 118.945 -1.102 . . . . 0.0 109.412 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -91.74 124.68 36.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.892 . . . . 0.0 110.327 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.9 t -123.95 132.3 71.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 122.059 0.933 . . . . 0.0 111.151 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.67 99.99 10.01 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.603 ' CG1' HD11 ' A' ' 35' ' ' LEU . 33.5 m -70.19 -18.95 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.027 -1.046 . . . . 0.0 110.781 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.443 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 80.4 mm-40 -71.11 -49.0 49.0 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.86 -1.15 . . . . 0.0 109.428 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -98.65 5.1 47.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.884 . . . . 0.0 110.293 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.43 ' HE3' ' CE1' ' A' ' 109' ' ' PHE . 72.1 tttt 53.72 43.51 30.96 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.019 -1.051 . . . . 0.0 110.16 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.2 m -119.15 132.24 55.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.324 -0.86 . . . . 0.0 109.952 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -116.08 136.59 52.89 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.445 -0.784 . . . . 0.0 110.051 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.4 t -126.41 137.54 57.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.628 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 77.2 mt -111.55 125.85 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.977 -1.077 . . . . 0.0 110.411 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -128.84 114.4 16.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.504 -0.748 . . . . 0.0 110.25 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.46 165.72 19.38 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 108.961 -1.655 . . . . 0.0 108.961 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 49.7 t0 -74.75 174.73 8.74 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.591 -0.946 . . . . 0.0 109.311 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -59.42 -22.77 61.94 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.052 -1.03 . . . . 0.0 111.186 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.5 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -68.64 -50.9 33.62 Favored Glycine 0 N--CA 1.497 2.714 0 C-N-CA 119.737 -1.221 . . . . 0.0 110.939 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.999 ' O ' HG22 ' A' ' 88' ' ' VAL . 3.5 mt -63.01 -44.7 99.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.865 -1.373 . . . . 0.0 107.393 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -63.16 -36.4 83.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.921 -1.112 . . . . 0.0 112.134 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -74.33 -20.93 59.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.627 -1.295 . . . . 0.0 112.311 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.909 HG23 HG13 ' A' ' 88' ' ' VAL . 26.0 m -105.78 -18.91 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.873 -1.142 . . . . 0.0 112.112 -178.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.999 HG22 ' O ' ' A' ' 84' ' ' ILE . 15.9 m -120.76 163.34 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.692 -1.255 . . . . 0.0 111.262 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.3 m -111.0 -176.67 3.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -0.859 . . . . 0.0 111.806 -178.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -62.81 -37.54 87.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.982 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -60.96 -39.51 89.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.201 -0.937 . . . . 0.0 109.398 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.731 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 83.3 t80 -66.34 -26.49 67.31 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.168 -0.958 . . . . 0.0 109.679 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.628 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.1 m95 -86.32 -25.22 25.54 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.042 0.925 . . . . 0.0 110.615 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -57.29 -41.16 79.25 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 112.837 -176.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.8 p -64.02 -30.06 71.16 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.572 -1.251 . . . . 0.0 109.118 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.261 16.4 m -60.1 -48.72 80.56 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.297 1.046 . . . . 0.0 110.962 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.59 -36.84 73.77 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.146 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -63.44 -43.27 97.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.828 -1.17 . . . . 0.0 110.129 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.11 -49.91 70.33 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.808 -1.182 . . . . 0.0 111.362 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.67 -42.55 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.003 -1.061 . . . . 0.0 110.426 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -63.89 -42.3 97.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.42 -0.8 . . . . 0.0 110.585 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 61.7 tp -63.57 -43.11 97.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 111.209 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.465 ' HG2' ' N ' ' A' ' 112' ' ' GLY . 1.8 tp-100 -74.0 -42.22 60.7 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 118.757 -1.177 . . . . 0.0 108.928 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -59.38 -41.17 88.73 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.11 -31.22 71.65 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.999 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.7 tp60 -80.87 -19.73 43.84 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.168 -0.957 . . . . 0.0 109.411 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.24 1.27 33.43 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.008 -1.091 . . . . 0.0 110.847 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -104.13 91.15 3.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.706 -1.467 . . . . 0.0 110.862 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.43 ' CE1' ' HE3' ' A' ' 74' ' ' LYS . 19.2 m-85 -65.32 -39.75 92.84 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.537 -0.727 . . . . 0.0 111.185 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -64.06 -49.17 73.36 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.771 -1.205 . . . . 0.0 111.793 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -63.34 -38.99 93.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.875 -1.141 . . . . 0.0 110.254 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.465 ' N ' ' HG2' ' A' ' 103' ' ' GLN . . . -63.19 -45.56 95.04 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 78.0 mt -64.72 -44.71 89.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.434 -1.039 . . . . 0.0 111.153 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.587 HG22 HG13 ' A' ' 16' ' ' ILE . 77.6 t -67.01 -46.61 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.769 -1.207 . . . . 0.0 110.714 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -65.04 -43.85 91.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.099 -1.001 . . . . 0.0 110.933 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.23 -40.95 94.58 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.425 HD13 HD11 ' A' ' 20' ' ' ILE . 97.1 mt -64.2 -43.48 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.312 -1.111 . . . . 0.0 110.136 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -56.68 -49.07 76.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.984 . . . . 0.0 109.626 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.54 -42.17 98.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -0.984 . . . . 0.0 109.436 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.33 -38.35 80.1 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.193 -0.942 . . . . 0.0 109.567 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.44 -46.5 69.62 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 75.9 mtm -67.16 -43.71 81.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.909 -1.348 . . . . 0.0 109.694 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.731 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -65.23 -45.93 82.65 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.324 -0.95 . . . . 0.0 109.008 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.2 mt -62.06 -40.56 96.19 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.38 -34.09 64.02 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.387 -0.82 . . . . 0.0 110.641 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -62.15 -41.41 98.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.969 -1.082 . . . . 0.0 109.111 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -72.39 -41.08 66.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.581 -0.699 . . . . 0.0 109.935 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -130.68 99.87 18.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.984 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.48 150.39 75.37 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.586 1.308 . . . . 0.0 109.8 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.482 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 48.5 t90 -74.83 136.03 41.6 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.53 -0.731 . . . . 0.0 111.306 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -113.28 151.93 30.49 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.301 -0.875 . . . . 0.0 109.127 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.91 -30.68 69.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.204 -0.935 . . . . 0.0 111.175 -177.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -91.25 7.57 40.14 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.899 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.468 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 67.0 t0 -43.54 141.56 1.4 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.404 -0.81 . . . . 0.0 111.551 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.728 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -114.31 146.02 19.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-O 121.697 0.76 . . . . 0.0 111.196 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 42.9 p-10 -98.56 92.62 5.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.595 -1.316 . . . . 0.0 110.66 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.448 ' HG3' HD13 ' A' ' 135' ' ' ILE . 96.9 mt-10 -68.45 -36.12 78.56 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.183 -0.948 . . . . 0.0 111.88 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.457 HD13 ' HD2' ' A' ' 139' ' ' PRO . 3.8 mm? -109.74 145.74 32.62 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.086 -1.009 . . . . 0.0 111.546 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.457 ' HD2' HD13 ' A' ' 138' ' ' LEU . 44.3 Cg_endo -72.37 -167.85 0.35 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 N-CA-C 108.065 -1.552 . . . . 0.0 108.065 178.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.447 ' ND2' ' HG2' ' A' ' 21' ' ' ARG . 13.9 p30 -122.91 4.29 9.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.761 -1.212 . . . . 0.0 110.156 178.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.1 m -61.76 168.52 2.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.101 -0.999 . . . . 0.0 110.26 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.412 ' CD1' ' OE1' ' A' ' 13' ' ' GLU . 93.9 mt -103.68 140.42 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.43 -0.793 . . . . 0.0 110.537 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 32' ' ' ARG . 32.1 t -94.37 136.53 34.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.194 -0.941 . . . . 0.0 109.708 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -127.57 137.31 52.56 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.3 -0.875 . . . . 0.0 110.426 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 CA-C-O 118.002 -1.443 . . . . 0.0 109.668 -179.815 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 ttp . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.209 0.528 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 m -69.78 145.28 52.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.215 -0.928 . . . . 0.0 110.303 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.23 -37.43 85.37 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.298 -0.876 . . . . 0.0 109.106 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.9 mt -107.32 120.15 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.321 -0.862 . . . . 0.0 110.022 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -116.21 -35.9 4.22 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 110.037 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -129.69 138.54 51.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 110.171 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -92.01 -4.92 53.88 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.35 -0.844 . . . . 0.0 111.586 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.1 mt -127.29 150.09 49.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.798 -1.189 . . . . 0.0 109.548 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -79.45 164.77 23.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.882 -1.136 . . . . 0.0 110.066 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.458 ' HB1' ' HE2' ' A' ' 14' ' ' LYS . . . -54.75 -37.44 65.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.107 -0.995 . . . . 0.0 109.455 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -57.68 -43.48 85.08 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.437 -0.79 . . . . 0.0 109.611 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.439 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 96.4 mt-10 -72.43 -45.44 59.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.357 -0.84 . . . . 0.0 111.634 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.731 ' O ' HG23 ' A' ' 17' ' ' VAL . 97.4 mt-10 -64.04 -38.51 91.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.005 -1.059 . . . . 0.0 110.127 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.458 ' HE2' ' HB1' ' A' ' 10' ' ' ALA . 68.1 mttm -64.4 -45.32 88.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.059 -1.025 . . . . 0.0 111.132 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.27 -41.56 96.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.129 -0.982 . . . . 0.0 111.114 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.525 HG22 ' O ' ' A' ' 13' ' ' GLU . 21.2 tt -68.76 -33.86 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.986 -1.071 . . . . 0.0 110.104 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 13' ' ' GLU . 76.0 t -65.48 -40.21 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.148 -0.97 . . . . 0.0 108.439 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -61.67 -36.91 82.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.975 . . . . 0.0 109.085 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.6 91.15 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.232 -0.918 . . . . 0.0 109.352 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.592 HD11 HD13 ' A' ' 117' ' ' ILE . 34.8 mm -63.18 -43.44 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.185 -0.947 . . . . 0.0 109.386 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.43 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 93.4 mtt-85 -59.72 -43.88 93.96 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.55 -0.719 . . . . 0.0 110.216 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -63.41 -38.94 93.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.871 . . . . 0.0 110.94 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.65 -39.63 94.82 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.255 -0.903 . . . . 0.0 110.662 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -59.93 -15.42 21.66 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.906 -1.122 . . . . 0.0 110.508 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 74.5 mmtt -96.18 1.01 51.93 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.976 -1.078 . . . . 0.0 109.386 178.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 94.2 m-20 -114.35 -14.0 12.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.74 -1.225 . . . . 0.0 109.769 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.1 t -153.92 159.1 41.59 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.63 -1.294 . . . . 0.0 109.462 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.5 m -88.25 -9.32 53.33 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.255 -0.903 . . . . 0.0 109.75 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.79 172.43 43.19 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.485 ' HG2' HD22 ' A' ' 138' ' ' LEU . 53.3 mp0 -132.27 140.3 48.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.269 -1.136 . . . . 0.0 111.31 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.2 mt -124.97 136.83 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.764 -0.585 . . . . 0.0 110.518 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.547 ' HE ' HD23 ' A' ' 138' ' ' LEU . 95.1 mtt-85 -138.82 154.87 48.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.211 -0.931 . . . . 0.0 110.144 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.701 HG22 HD12 ' A' ' 67' ' ' ILE . 55.4 t -125.87 136.31 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.54 0.686 . . . . 0.0 109.693 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.418 ' HA ' ' O ' ' A' ' 143' ' ' SER . 52.2 t-80 -121.04 118.98 31.2 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.571 -0.705 . . . . 0.0 109.279 178.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.835 HD11 ' CG1' ' A' ' 71' ' ' VAL . 30.6 tp -106.49 129.88 54.38 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.778 0.799 . . . . 0.0 111.175 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -147.57 167.58 24.17 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.434 ' CA ' ' HG2' ' A' ' 72' ' ' GLU . 99.4 mttt -80.83 -77.01 0.21 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.955 -1.091 . . . . 0.0 112.626 -177.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.422 ' OG1' ' CB ' ' A' ' 72' ' ' GLU . 43.7 m -140.85 159.5 42.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.444 -0.785 . . . . 0.0 109.669 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.7 m -114.0 175.64 5.38 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.257 -0.902 . . . . 0.0 110.393 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -107.43 -10.83 15.65 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.13 -0.981 . . . . 0.0 110.755 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.8 pt -124.23 -121.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.1 -1.0 . . . . 0.0 110.195 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -112.38 140.81 46.79 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.045 -1.66 . . . . 0.0 109.476 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.647 HG13 ' CD1' ' A' ' 68' ' ' TYR . 99.0 t -63.98 -42.42 95.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.512 -0.743 . . . . 0.0 110.525 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -58.76 -46.11 88.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.053 -1.029 . . . . 0.0 109.634 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -68.94 -38.62 79.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.806 -1.184 . . . . 0.0 108.394 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.613 ' O ' HG23 ' A' ' 50' ' ' VAL . 10.9 mmt180 -62.79 -36.88 84.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -0.948 . . . . 0.0 110.106 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.77 -39.65 73.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.884 -1.135 . . . . 0.0 109.904 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 66.1 ttp -65.71 -44.16 86.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.099 -1.0 . . . . 0.0 109.969 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -63.46 -43.5 97.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.099 . . . . 0.0 109.386 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 46' ' ' ARG . 96.7 t -66.58 -42.61 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.38 -0.825 . . . . 0.0 109.69 178.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 57' ' ' ASP . 53.2 t80 -58.89 -46.03 88.85 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.04 -1.038 . . . . 0.0 109.705 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -75.57 -35.82 60.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.895 -1.128 . . . . 0.0 109.682 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -61.44 -39.74 91.92 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.201 -0.937 . . . . 0.0 109.795 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.1 mt -84.18 4.54 30.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.503 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt 56.84 31.42 19.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.077 -1.014 . . . . 0.0 110.953 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.861 ' SD ' HD13 ' A' ' 66' ' ' LEU . 58.6 mtt -72.03 -27.93 63.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.316 -0.865 . . . . 0.0 109.407 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.504 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . 45.6 p-10 -69.0 -9.92 54.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.434 -0.791 . . . . 0.0 109.968 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -86.04 88.02 7.51 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.733 -1.187 . . . . 0.0 110.723 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 62' ' ' GLN . 67.0 p -137.48 154.97 49.81 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -59.44 -45.26 92.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.49 -0.756 . . . . 0.0 111.881 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.5 mt -98.34 2.86 48.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.985 -1.072 . . . . 0.0 111.606 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.429 ' HA ' ' OG1' ' A' ' 59' ' ' THR . 77.3 mt-30 57.46 32.18 21.39 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 122.122 0.963 . . . . 0.0 111.942 178.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.635 ' C ' HD11 ' A' ' 84' ' ' ILE . 97.8 m-20 -110.41 54.59 0.67 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.723 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.66 141.99 15.75 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.475 ' CG2' HD13 ' A' ' 84' ' ' ILE . 54.0 t -122.41 133.1 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.992 -1.299 . . . . 0.0 109.841 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.861 HD13 ' SD ' ' A' ' 56' ' ' MET . 47.1 tp -118.39 130.9 56.25 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.374 -0.829 . . . . 0.0 110.471 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.701 HD12 HG22 ' A' ' 33' ' ' VAL . 64.7 mt -110.24 115.16 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 118.982 -1.087 . . . . 0.0 109.688 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.647 ' CD1' HG13 ' A' ' 43' ' ' VAL . 47.0 t80 -101.49 124.8 47.76 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.079 -1.013 . . . . 0.0 110.005 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.0 t -123.44 130.54 74.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.924 0.868 . . . . 0.0 111.621 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.939 ' HB3' HG22 ' A' ' 75' ' ' THR . . . -98.62 90.29 4.68 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.835 ' CG1' HD11 ' A' ' 35' ' ' LEU . 32.6 m -59.52 -22.86 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.99 -1.069 . . . . 0.0 111.148 -177.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.434 ' HG2' ' CA ' ' A' ' 37' ' ' LYS . 79.0 mm-40 -66.17 -42.32 89.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.789 -1.194 . . . . 0.0 109.061 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -101.12 4.97 42.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.437 -0.789 . . . . 0.0 110.655 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.6 tttt 54.99 46.85 23.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.656 -1.277 . . . . 0.0 110.703 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.939 HG22 ' HB3' ' A' ' 70' ' ' ALA . 10.0 t -122.67 162.54 21.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.44 -0.788 . . . . 0.0 109.636 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -143.7 139.42 29.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 110.001 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.3 t -129.2 139.81 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 108.93 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.698 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 81.7 mt -116.55 127.25 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.738 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -127.84 115.88 19.3 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.475 0.655 . . . . 0.0 109.862 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -102.84 161.57 16.61 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 82' ' ' LYS . 39.3 t0 -73.62 169.62 16.91 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.65 -0.912 . . . . 0.0 110.034 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.402 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 99.2 mttt -55.1 -28.04 49.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 109.976 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.36 -49.87 67.01 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.96 ' O ' HG22 ' A' ' 88' ' ' VAL . 3.9 mt -66.35 -45.06 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.883 -1.363 . . . . 0.0 108.321 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -64.08 -35.83 82.01 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.925 -1.109 . . . . 0.0 111.53 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -77.76 -20.04 54.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.809 -1.182 . . . . 0.0 111.875 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.993 HG13 HG13 ' A' ' 88' ' ' VAL . 7.6 p -102.55 -27.87 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.713 -1.242 . . . . 0.0 112.55 -178.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.993 HG13 HG13 ' A' ' 87' ' ' VAL . 19.2 m -116.65 166.52 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.582 -1.324 . . . . 0.0 111.143 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.2 m -110.62 179.25 4.12 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.215 -0.928 . . . . 0.0 112.405 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -60.95 -37.12 81.25 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.344 -0.847 . . . . 0.0 109.161 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -62.67 -36.83 84.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.417 -0.802 . . . . 0.0 109.701 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.906 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 87.6 t80 -69.8 -24.16 63.44 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.002 -1.061 . . . . 0.0 109.173 177.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.698 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.6 m95 -86.57 -25.99 24.71 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.066 0.936 . . . . 0.0 110.68 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -59.2 -36.17 74.91 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 112.379 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.5 m -66.03 -34.42 78.06 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.729 -1.232 . . . . 0.0 109.222 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.288 20.6 m -57.87 -48.9 78.49 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 122.418 1.104 . . . . 0.0 111.095 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.58 -37.69 77.07 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.413 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -63.06 -43.93 97.23 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.749 -1.18 . . . . 0.0 110.028 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.471 ' HB2' ' HD2' ' A' ' 119' ' ' LYS . . . -62.68 -48.9 77.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.879 -1.138 . . . . 0.0 110.91 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.03 -42.26 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.971 . . . . 0.0 110.177 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.431 ' CG ' ' HE3' ' A' ' 105' ' ' LYS . 51.7 tt0 -63.55 -43.62 96.53 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.272 -0.893 . . . . 0.0 110.865 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.8 tp -63.09 -41.72 99.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.088 -1.008 . . . . 0.0 112.088 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.461 ' HG2' ' CB ' ' A' ' 111' ' ' GLN . 6.3 tp60 -75.17 -37.34 61.31 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.821 -1.151 . . . . 0.0 108.942 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -62.26 -42.02 98.97 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.602 0.715 . . . . 0.0 109.135 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.431 ' HE3' ' CG ' ' A' ' 101' ' ' GLN . 93.8 mttt -60.58 -34.8 74.72 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.342 -0.849 . . . . 0.0 109.915 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -76.44 -21.06 56.4 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.939 -1.1 . . . . 0.0 110.124 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.19 2.48 35.87 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.595 -1.288 . . . . 0.0 111.578 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -102.25 92.55 4.77 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.59 -1.535 . . . . 0.0 110.176 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -62.54 -42.91 99.83 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.859 -0.525 . . . . 0.0 111.942 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.493 ' O ' HG23 ' A' ' 114' ' ' VAL . 86.3 tttt -62.51 -48.07 81.18 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.916 -177.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.461 ' CB ' ' HG2' ' A' ' 103' ' ' GLN . 96.6 mm-40 -64.32 -39.74 94.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.944 -1.098 . . . . 0.0 110.69 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.433 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -62.89 -49.48 72.08 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 68.1 mt -62.92 -44.24 96.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.129 -1.218 . . . . 0.0 110.673 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 110' ' ' LYS . 95.9 t -65.86 -47.53 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.231 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -64.23 -40.13 95.41 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.316 -0.954 . . . . 0.0 109.808 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.5 -42.79 99.21 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.592 HD13 HD11 ' A' ' 20' ' ' ILE . 97.0 mt -65.42 -44.73 94.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.375 -1.073 . . . . 0.0 109.992 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -56.84 -50.35 72.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.877 -1.139 . . . . 0.0 109.166 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.471 ' HD2' ' HB2' ' A' ' 99' ' ' ALA . 98.4 mttt -62.93 -42.13 99.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.257 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.41 ' O ' ' HG ' ' A' ' 124' ' ' LEU . . . -58.72 -39.95 82.31 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.181 -0.949 . . . . 0.0 109.298 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.34 -44.99 89.41 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 90.3 mtp -67.59 -45.82 74.4 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.019 -1.283 . . . . 0.0 110.254 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.906 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -63.83 -45.03 91.41 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.154 -0.966 . . . . 0.0 108.973 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 120' ' ' ALA . 84.2 mt -63.18 -37.8 88.65 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.272 -0.893 . . . . 0.0 109.108 178.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.28 -35.1 64.69 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.985 -1.072 . . . . 0.0 110.635 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.45 -42.97 97.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.931 -1.106 . . . . 0.0 108.391 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -74.16 -41.27 61.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.67 -0.644 . . . . 0.0 110.723 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -128.96 91.53 42.46 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.543 -0.723 . . . . 0.0 109.28 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.62 152.59 81.3 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 O-C-N 123.694 1.365 . . . . 0.0 109.953 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 28.1 t90 -79.56 139.7 37.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.592 -0.693 . . . . 0.0 111.959 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -120.71 155.35 34.08 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -61.36 -34.83 75.96 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.282 -0.887 . . . . 0.0 111.207 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -87.03 6.55 31.85 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.672 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.476 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 67.2 t0 -41.81 138.1 1.55 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.27 -0.894 . . . . 0.0 111.126 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.692 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -110.64 140.55 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 122.184 0.992 . . . . 0.0 112.069 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -119.38 102.14 8.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.759 -1.213 . . . . 0.0 109.471 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -99.88 0.75 41.99 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.758 -1.214 . . . . 0.0 111.668 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.547 HD23 ' HE ' ' A' ' 32' ' ' ARG . 3.2 mp -110.33 151.32 42.57 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 120.769 -1.207 . . . . 0.0 111.424 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.414 ' HD2' ' NH1' ' A' ' 32' ' ' ARG . 55.2 Cg_endo -74.73 170.55 20.09 Favored 'Trans proline' 0 C--N 1.322 -0.823 0 O-C-N 123.632 1.333 . . . . 0.0 109.197 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.43 ' ND2' ' HG2' ' A' ' 21' ' ' ARG . 79.6 m-20 -113.46 4.87 16.46 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.873 -1.142 . . . . 0.0 110.631 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.6 p -68.32 166.33 16.77 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.79 -1.194 . . . . 0.0 111.836 -178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.6 HG13 HG22 ' A' ' 17' ' ' VAL . 96.4 mt -87.41 137.8 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 121.733 0.778 . . . . 0.0 110.914 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 4.4 m -88.77 133.38 34.26 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -128.07 149.19 50.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.82 -1.175 . . . . 0.0 111.094 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.59 0 CA-C-O 118.045 -1.42 . . . . 0.0 110.045 -179.576 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.9 mtm . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.309 0.576 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.8 p -153.99 159.6 41.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.289 -0.882 . . . . 0.0 110.484 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt 51.56 40.52 27.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.471 -0.768 . . . . 0.0 110.935 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.1 mm -63.76 -43.18 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.886 -1.134 . . . . 0.0 110.126 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -59.04 -46.42 88.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.075 -1.016 . . . . 0.0 110.304 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 17.0 pt-20 -123.73 129.6 51.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.885 . . . . 0.0 110.333 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.997 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 72.3 m-85 -62.83 -42.19 99.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.079 -1.013 . . . . 0.0 110.092 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.466 ' HB2' ' CG ' ' A' ' 13' ' ' GLU . 98.7 mt -128.85 149.98 50.52 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.307 -0.871 . . . . 0.0 109.767 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 12' ' ' GLU . 13.0 t -81.44 171.57 14.58 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.288 -0.883 . . . . 0.0 109.771 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.93 -39.49 68.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.075 -1.015 . . . . 0.0 109.946 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -61.35 -47.38 86.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.071 -1.018 . . . . 0.0 110.751 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.429 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 98.9 mt-10 -70.1 -49.26 52.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 111.709 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.466 ' CG ' ' HB2' ' A' ' 8' ' ' LEU . 99.7 mt-10 -61.22 -33.61 73.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.915 -1.116 . . . . 0.0 109.921 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.85 -46.03 86.82 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.223 -0.923 . . . . 0.0 110.995 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.76 -41.11 92.48 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.127 -0.983 . . . . 0.0 112.336 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.646 HG13 HG22 ' A' ' 114' ' ' VAL . 18.9 tt -66.96 -37.82 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.653 -1.279 . . . . 0.0 110.626 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 13' ' ' GLU . 70.7 t -63.34 -40.67 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.91 -1.119 . . . . 0.0 108.849 178.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -62.03 -37.25 84.19 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.377 -0.929 . . . . 0.0 109.559 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.24 -39.43 90.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 109.59 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.909 HD11 HD13 ' A' ' 117' ' ' ILE . 46.8 mm -64.21 -45.77 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.484 -0.76 . . . . 0.0 110.456 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -55.35 -42.28 73.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.215 -0.928 . . . . 0.0 110.14 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -63.94 -37.86 88.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.651 -0.656 . . . . 0.0 111.093 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.06 95.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.945 -1.097 . . . . 0.0 110.335 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -60.55 -16.08 33.97 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.948 -1.095 . . . . 0.0 110.726 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.0 mttt -94.87 1.09 55.3 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.157 -0.964 . . . . 0.0 109.735 177.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -113.26 -18.26 12.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.018 -1.051 . . . . 0.0 109.689 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.2 t -150.33 157.07 42.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.079 -1.013 . . . . 0.0 109.243 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 97.5 p -87.48 -10.13 52.68 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.374 -0.829 . . . . 0.0 109.538 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.71 174.11 39.96 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -132.7 136.68 46.56 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.334 -1.098 . . . . 0.0 111.613 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.1 mt -119.53 133.74 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.733 -0.604 . . . . 0.0 109.993 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.81 ' HD2' HD22 ' A' ' 138' ' ' LEU . 79.2 mtp85 -138.49 149.78 45.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.053 -1.029 . . . . 0.0 110.155 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.626 HG22 ' HB ' ' A' ' 67' ' ' ILE . 57.8 t -123.89 138.26 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.681 -0.637 . . . . 0.0 110.478 -178.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.421 ' HB2' HD11 ' A' ' 66' ' ' LEU . 48.1 t60 -122.87 125.0 44.54 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.512 -0.743 . . . . 0.0 109.607 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.998 HD11 HG13 ' A' ' 71' ' ' VAL . 35.2 tp -111.65 129.02 56.23 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.766 0.793 . . . . 0.0 112.131 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.443 ' O ' HG22 ' A' ' 71' ' ' VAL . 81.3 tt0 -146.2 167.1 24.3 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 98.3 mttt -79.82 -76.46 0.22 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.102 -0.999 . . . . 0.0 112.567 -177.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.8 t -138.18 154.3 49.15 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.298 -0.876 . . . . 0.0 110.24 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.2 p -100.26 169.86 8.84 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.375 -0.828 . . . . 0.0 110.532 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -106.79 -10.07 16.19 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.588 -0.695 . . . . 0.0 110.478 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.6 pt -129.93 -121.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.878 -1.139 . . . . 0.0 109.945 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -111.77 142.66 43.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.136 -1.603 . . . . 0.0 110.0 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.707 HG11 HG21 ' A' ' 77' ' ' VAL . 82.0 t -66.45 -44.53 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.46 -0.775 . . . . 0.0 112.294 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -61.35 -45.15 95.58 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.733 -1.23 . . . . 0.0 109.859 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -70.15 -37.09 75.14 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.134 -0.979 . . . . 0.0 108.701 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -65.61 -41.67 92.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.145 -0.972 . . . . 0.0 110.345 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.58 -39.53 80.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.843 -1.161 . . . . 0.0 110.475 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 66.1 ttp -63.19 -43.57 97.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.839 -1.163 . . . . 0.0 109.386 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -63.35 -47.09 83.6 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.249 -0.981 . . . . 0.0 109.443 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.8 t -64.51 -43.92 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.165 -0.96 . . . . 0.0 110.129 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' A' ' 56' ' ' MET . 63.2 t80 -58.84 -46.27 88.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.837 -1.164 . . . . 0.0 109.784 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -75.49 -37.05 60.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.062 -1.024 . . . . 0.0 110.464 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -61.84 -39.97 93.68 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.058 -1.026 . . . . 0.0 109.627 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.9 mt -78.89 3.38 17.1 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.624 178.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.7 mttp 59.05 30.85 20.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.507 -0.746 . . . . 0.0 111.083 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.714 ' SD ' HD13 ' A' ' 66' ' ' LEU . 62.1 mtt -70.0 -28.95 65.93 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.213 -0.93 . . . . 0.0 109.247 178.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -67.89 -9.49 45.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 109.832 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -84.61 84.69 7.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.614 -1.304 . . . . 0.0 110.93 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.753 HG23 ' OE1' ' A' ' 137' ' ' GLU . 92.1 m -135.27 151.88 50.98 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -60.54 -42.45 96.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.168 -0.957 . . . . 0.0 111.09 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.0 mt -99.85 0.41 41.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.086 -1.009 . . . . 0.0 111.112 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 56.85 32.47 21.45 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.194 0.997 . . . . 0.0 111.825 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.624 ' C ' HD11 ' A' ' 84' ' ' ILE . 98.6 m-20 -107.31 51.74 0.73 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.792 0.806 . . . . 0.0 109.289 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.421 ' N ' HD11 ' A' ' 84' ' ' ILE . . . -99.64 141.99 15.75 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.462 ' CG2' HD13 ' A' ' 84' ' ' ILE . 54.5 t -123.38 133.71 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.138 -1.213 . . . . 0.0 110.191 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.714 HD13 ' SD ' ' A' ' 56' ' ' MET . 61.0 tp -115.38 124.0 50.1 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.394 -0.816 . . . . 0.0 109.203 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.626 ' HB ' HG22 ' A' ' 33' ' ' VAL . 68.4 mt -106.2 107.25 22.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.121 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -94.08 126.02 39.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.168 -0.957 . . . . 0.0 110.124 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.9 t -120.89 133.13 68.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.873 0.844 . . . . 0.0 110.366 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.53 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -101.94 92.65 4.89 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.998 HG13 HD11 ' A' ' 35' ' ' LEU . 29.1 m -64.85 -23.1 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.23 -0.919 . . . . 0.0 111.0 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 51.2 tp10 -67.76 -44.21 78.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.809 -1.182 . . . . 0.0 108.585 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.59 ' O ' HG23 ' A' ' 75' ' ' THR . 92.0 m-20 -100.82 8.45 43.19 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.205 -0.934 . . . . 0.0 110.562 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.6 tttt 51.07 44.18 28.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.956 -1.09 . . . . 0.0 110.488 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 73' ' ' ASP . 23.3 p -121.31 166.34 14.19 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.431 -0.793 . . . . 0.0 109.269 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 47.3 p90 -145.08 138.23 26.52 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.048 -1.033 . . . . 0.0 110.505 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.707 HG21 HG11 ' A' ' 43' ' ' VAL . 50.0 t -127.5 135.29 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.718 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 72.3 mt -114.17 121.93 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.836 -1.165 . . . . 0.0 109.848 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -128.76 112.41 14.16 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.463 -0.773 . . . . 0.0 109.925 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -99.9 175.19 27.31 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -81.14 174.14 11.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.579 -0.954 . . . . 0.0 110.327 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.87 -25.68 65.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 110.328 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.478 ' O ' HG12 ' A' ' 87' ' ' VAL . . . -64.98 -53.1 35.93 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.143 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.979 ' O ' HG22 ' A' ' 88' ' ' VAL . 3.2 mt -65.25 -45.14 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.86 -1.376 . . . . 0.0 107.822 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.49 -36.29 82.03 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 111.425 -177.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -77.11 -22.85 52.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.082 -1.012 . . . . 0.0 111.711 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.991 HG13 HG13 ' A' ' 88' ' ' VAL . 8.9 p -102.61 -23.87 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.876 -1.14 . . . . 0.0 112.738 -178.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.991 HG13 HG13 ' A' ' 87' ' ' VAL . 15.6 m -118.52 165.46 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 120.388 -1.445 . . . . 0.0 111.474 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.8 p -110.34 -179.05 3.66 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.305 -0.872 . . . . 0.0 112.482 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.57 -35.42 80.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.284 -0.885 . . . . 0.0 109.812 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -61.96 -38.33 88.1 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 108.833 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.903 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 71.1 t80 -69.35 -26.09 64.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.626 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.718 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.9 m95 -85.97 -27.66 24.73 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.989 0.9 . . . . 0.0 110.322 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -54.26 -41.24 68.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.483 -0.76 . . . . 0.0 112.096 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 79.3 p -64.42 -32.87 74.67 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.888 -1.132 . . . . 0.0 109.668 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.413 HG22 HD13 ' A' ' 78' ' ' ILE 0.28 9.1 m -58.78 -49.5 77.43 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.329 1.061 . . . . 0.0 111.129 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -68.2 -38.62 82.17 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.305 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -63.64 -42.95 98.08 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.039 -1.065 . . . . 0.0 110.386 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.41 -50.83 69.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.825 -1.172 . . . . 0.0 111.294 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 93.1 mt -67.11 -42.79 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.111 -0.993 . . . . 0.0 109.888 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.434 ' CG ' ' HE3' ' A' ' 105' ' ' LYS . 52.4 tt0 -63.15 -45.35 92.28 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.662 -0.649 . . . . 0.0 111.317 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.695 ' O ' HD13 ' A' ' 102' ' ' LEU . 1.5 tm? -62.21 -41.55 98.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.895 -1.128 . . . . 0.0 111.721 -178.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.416 ' HB3' ' CA ' ' A' ' 112' ' ' GLY . 1.2 tp-100 -75.64 -38.09 59.15 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.815 -1.154 . . . . 0.0 108.725 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -60.51 -41.07 93.59 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.434 ' HE3' ' CG ' ' A' ' 101' ' ' GLN . 92.0 mttt -61.35 -32.62 72.52 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.928 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -79.9 -17.31 53.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.855 -1.153 . . . . 0.0 110.093 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.42 6.35 44.58 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 119.892 -1.147 . . . . 0.0 111.322 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -103.42 89.51 3.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.624 -1.515 . . . . 0.0 109.946 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -62.19 -42.73 99.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.634 -0.666 . . . . 0.0 111.336 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.457 ' O ' HG23 ' A' ' 114' ' ' VAL . 85.7 tttt -62.47 -48.47 79.48 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.441 -177.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.412 ' HB3' ' HG2' ' A' ' 103' ' ' GLN . 58.5 tt0 -65.28 -37.95 88.75 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.848 -177.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -64.0 -51.29 54.51 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.487 -1.34 . . . . 0.0 110.091 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.0 mt -64.59 -43.8 92.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.01 -1.288 . . . . 0.0 110.988 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.646 HG22 HG13 ' A' ' 16' ' ' ILE . 88.2 t -63.93 -48.67 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.88 -1.137 . . . . 0.0 110.488 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -63.87 -39.7 94.82 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.943 -1.098 . . . . 0.0 110.103 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.7 -41.88 99.77 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.909 HD13 HD11 ' A' ' 20' ' ' ILE . 85.1 mt -64.08 -44.63 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.262 -1.14 . . . . 0.0 109.9 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -57.32 -47.19 82.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.102 -0.999 . . . . 0.0 109.242 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.46 -42.81 98.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -0.879 . . . . 0.0 109.067 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.84 -46.41 74.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 0.0 110.039 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.47 -42.69 97.44 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.783 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 86.3 mtp -66.35 -44.63 82.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.847 -1.384 . . . . 0.0 110.016 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.903 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -65.48 -45.4 83.8 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.01 -39.26 94.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.61 -33.88 61.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.936 . . . . 0.0 109.937 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.28 -40.76 95.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 0.0 108.65 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.5 ' HB3' ' CE1' ' A' ' 128' ' ' PHE . 68.4 m-85 -78.56 -35.44 45.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.44 -0.787 . . . . 0.0 110.099 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' A' ' 127' ' ' TYR . 73.7 m-85 -133.97 96.91 15.69 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.002 -1.061 . . . . 0.0 110.622 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.07 152.9 72.82 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.517 1.272 . . . . 0.0 110.542 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.475 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 45.7 t90 -74.17 133.51 42.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.428 -0.795 . . . . 0.0 111.812 -178.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -112.16 151.74 29.15 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.12 -32.33 70.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.913 -1.117 . . . . 0.0 111.454 -176.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -89.47 8.29 31.74 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.831 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -42.4 138.09 1.87 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.494 -0.754 . . . . 0.0 111.342 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.558 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -112.01 138.34 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.613 -177.407 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -94.9 90.44 6.0 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.084 -1.01 . . . . 0.0 109.379 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.753 ' OE1' HG23 ' A' ' 59' ' ' THR . 87.3 mt-10 -66.95 -41.7 86.47 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.66 -0.65 . . . . 0.0 112.505 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.81 HD22 ' HD2' ' A' ' 32' ' ' ARG . 4.5 mt -103.99 151.62 38.95 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.025 -1.047 . . . . 0.0 111.277 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.657 ' HD2' HD23 ' A' ' 138' ' ' LEU . 47.3 Cg_endo -75.04 -175.92 2.62 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 N-CA-C 108.315 -1.456 . . . . 0.0 108.315 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.417 ' ND2' HG22 ' A' ' 20' ' ' ILE . 25.6 m120 -117.48 3.87 12.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.656 -1.278 . . . . 0.0 109.842 178.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 33.5 m -60.58 137.26 58.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.793 -1.192 . . . . 0.0 109.811 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 16' ' ' ILE . 94.7 mt -68.65 138.94 21.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.491 -0.755 . . . . 0.0 110.955 -179.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 24.3 m -91.01 131.64 36.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.342 -0.849 . . . . 0.0 109.046 178.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -127.09 127.67 45.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.98 -1.075 . . . . 0.0 110.559 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.411 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.7 p . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.18 -36.32 68.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.95 -1.094 . . . . 0.0 109.639 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -64.31 -40.5 96.05 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.249 -0.907 . . . . 0.0 109.442 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.458 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 76.8 mm-40 -70.25 -50.81 35.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 0.0 110.643 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.54 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.3 mt-10 -64.66 -33.37 75.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.419 -0.801 . . . . 0.0 110.441 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.4 -45.15 94.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.967 -1.083 . . . . 0.0 110.378 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB3' ' CE ' ' A' ' 110' ' ' LYS . . . -66.31 -42.28 88.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.091 -1.006 . . . . 0.0 111.642 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.582 HG13 HG22 ' A' ' 114' ' ' VAL . 21.2 tt -68.56 -39.26 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.552 -1.343 . . . . 0.0 111.151 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 13' ' ' GLU . 89.9 t -63.1 -39.13 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.886 -1.134 . . . . 0.0 108.622 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -63.37 -36.16 82.78 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.3 -0.96 . . . . 0.0 109.241 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.26 -41.38 96.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -0.87 . . . . 0.0 109.533 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.903 HG22 ' OD1' ' A' ' 140' ' ' ASN . 96.7 mt -64.0 -43.11 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.445 -0.784 . . . . 0.0 109.572 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.406 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 99.5 mtt180 -58.28 -43.11 87.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 109.896 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -64.5 -35.56 81.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.422 -0.799 . . . . 0.0 111.115 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.81 -39.57 93.8 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.976 -1.078 . . . . 0.0 110.175 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -60.39 -16.47 35.83 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.036 -1.04 . . . . 0.0 110.985 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 97.9 mttt -94.79 0.66 55.09 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.139 -0.976 . . . . 0.0 109.556 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -112.73 -16.94 12.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.949 -1.095 . . . . 0.0 109.66 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.6 t -154.17 159.05 41.22 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.935 -1.103 . . . . 0.0 109.687 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.4 p -86.23 -6.55 58.95 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.194 -0.941 . . . . 0.0 110.587 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.49 170.41 50.75 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.41 ' CG ' ' HB2' ' A' ' 138' ' ' LEU . 68.6 mm-40 -129.66 132.79 46.79 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.128 -1.219 . . . . 0.0 111.181 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.3 mt -115.79 132.83 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -138.88 149.88 45.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.136 -0.977 . . . . 0.0 109.82 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.74 HG22 HD12 ' A' ' 67' ' ' ILE . 53.4 t -118.22 137.04 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.387 -0.821 . . . . 0.0 111.006 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -122.05 120.33 34.02 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.624 HD11 ' CG1' ' A' ' 71' ' ' VAL . 35.2 tp -112.16 126.01 54.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.496 -0.753 . . . . 0.0 111.396 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 83.3 tt0 -141.59 167.59 21.78 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.41 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 99.5 mttt -78.38 -75.57 0.22 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.935 -1.103 . . . . 0.0 113.411 -177.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 t -142.12 157.62 44.69 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.119 -0.988 . . . . 0.0 110.063 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.9 m -110.38 170.45 8.08 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.374 -0.829 . . . . 0.0 110.999 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -108.03 -9.46 15.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.398 -0.814 . . . . 0.0 110.556 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.426 HG13 ' N ' ' A' ' 42' ' ' ASP . 27.3 pt -127.56 -122.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.726 -1.234 . . . . 0.0 110.47 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.426 ' N ' HG13 ' A' ' 41' ' ' ILE . 97.5 m-20 -111.39 138.06 48.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.113 -1.617 . . . . 0.0 109.755 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.457 ' CG1' HG21 ' A' ' 77' ' ' VAL . 99.0 t -64.99 -42.79 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.444 -0.785 . . . . 0.0 111.426 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -59.9 -46.32 89.71 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.9 -1.125 . . . . 0.0 110.409 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -71.55 -40.67 69.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.977 -1.077 . . . . 0.0 108.282 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -61.4 -40.86 95.92 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.404 -0.81 . . . . 0.0 110.965 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.23 81.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.621 -1.3 . . . . 0.0 109.71 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 64.0 ttp -62.98 -43.34 99.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.209 -0.932 . . . . 0.0 109.792 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -64.01 -45.03 90.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.987 -1.071 . . . . 0.0 109.762 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.29 -43.53 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.306 -0.871 . . . . 0.0 110.003 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 6.9 t80 -57.84 -47.47 82.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.88 -1.137 . . . . 0.0 109.547 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -73.87 -35.64 64.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.992 -1.067 . . . . 0.0 109.843 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.09 -38.8 87.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.141 -0.974 . . . . 0.0 108.657 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.6 mt -80.22 3.25 21.39 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.359 -0.838 . . . . 0.0 110.141 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 29.8 tttt 57.14 32.46 21.73 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.936 -1.103 . . . . 0.0 111.706 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.596 ' SD ' HD13 ' A' ' 66' ' ' LEU . 98.9 mtp -66.39 -12.16 55.41 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.336 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -76.62 -1.74 29.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.939 -1.101 . . . . 0.0 109.529 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -75.44 63.22 1.44 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.889 -1.132 . . . . 0.0 110.129 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.3 p -134.62 150.27 50.67 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -65.2 -42.89 93.07 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.622 -0.674 . . . . 0.0 112.455 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 94.4 mt -96.33 -1.83 47.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.914 -1.116 . . . . 0.0 111.514 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 57.25 48.4 15.14 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 122.536 1.16 . . . . 0.0 110.797 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.8 p30 -122.45 53.04 1.27 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.885 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.42 146.92 16.61 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.54 HG23 ' CD1' ' A' ' 84' ' ' ILE . 72.7 t -128.06 134.72 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.116 -1.226 . . . . 0.0 110.361 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.596 HD13 ' SD ' ' A' ' 56' ' ' MET . 36.6 tp -116.67 128.18 55.11 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.59 -0.694 . . . . 0.0 109.381 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.74 HD12 HG22 ' A' ' 33' ' ' VAL . 86.0 mt -102.99 112.33 36.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.473 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -99.23 117.32 33.43 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.25 -0.906 . . . . 0.0 109.247 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 72.5 t -118.91 130.88 73.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-O 122.101 0.953 . . . . 0.0 110.709 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.481 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -99.86 101.12 12.16 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.624 ' CG1' HD11 ' A' ' 35' ' ' LEU . 27.3 m -70.43 -20.28 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.006 . . . . 0.0 111.048 -178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -67.51 -44.02 79.43 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.792 -1.192 . . . . 0.0 109.016 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -102.52 3.63 37.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.284 -0.885 . . . . 0.0 110.759 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.4 tttt 56.74 48.77 15.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.831 -1.168 . . . . 0.0 111.123 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 76.7 p -122.4 164.02 18.75 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.095 -1.003 . . . . 0.0 109.917 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -143.57 141.37 30.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.489 -0.757 . . . . 0.0 110.146 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.457 HG21 ' CG1' ' A' ' 43' ' ' VAL . 64.4 t -126.82 136.06 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.606 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 66.7 mt -113.84 122.66 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.955 -1.091 . . . . 0.0 109.769 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -128.6 112.92 14.8 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.555 -0.716 . . . . 0.0 110.68 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -96.18 165.82 24.2 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 82' ' ' LYS . 54.1 t0 -75.28 175.05 8.71 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.346 -1.09 . . . . 0.0 109.642 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.409 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 86.1 tttt -59.24 -26.96 65.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 110.657 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.28 -52.25 42.16 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.604 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.972 ' O ' HG22 ' A' ' 88' ' ' VAL . 82.2 mt -64.94 -44.2 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.785 -1.42 . . . . 0.0 108.579 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -61.66 -38.07 86.37 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.004 -1.06 . . . . 0.0 111.34 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -73.05 -22.91 60.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.033 -1.042 . . . . 0.0 112.676 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.987 HG13 HG13 ' A' ' 88' ' ' VAL . 8.5 p -101.16 -19.48 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.78 -1.2 . . . . 0.0 112.472 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.987 HG13 HG13 ' A' ' 87' ' ' VAL . 19.5 m -119.54 163.61 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.712 -1.243 . . . . 0.0 111.642 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 61.9 p -108.66 -179.94 4.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.47 -0.769 . . . . 0.0 111.525 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -61.83 -38.63 88.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 109.231 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -60.1 -39.93 87.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.46 -0.775 . . . . 0.0 109.421 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.813 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 90.5 t80 -66.2 -24.29 66.59 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.158 -0.964 . . . . 0.0 109.537 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.606 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.2 m95 -87.97 -25.33 23.22 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.919 0.866 . . . . 0.0 110.656 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -57.52 -37.05 72.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.885 . . . . 0.0 111.999 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.4 p -67.67 -31.57 71.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.713 -1.242 . . . . 0.0 109.275 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.453 HG22 HD13 ' A' ' 78' ' ' ILE 0.277 15.9 m -60.89 -49.06 78.99 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 122.444 1.116 . . . . 0.0 111.097 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -69.44 -38.21 77.72 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.911 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -63.6 -42.62 98.24 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.939 -1.1 . . . . 0.0 110.566 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.01 -49.56 69.72 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.801 -1.187 . . . . 0.0 111.515 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.81 -42.26 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.954 -1.091 . . . . 0.0 109.503 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -62.13 -44.42 96.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.346 -0.846 . . . . 0.0 111.18 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.2 tp -63.66 -42.17 98.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -0.963 . . . . 0.0 111.813 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.475 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 97.6 mm-40 -72.86 -43.82 62.11 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.361 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -58.68 -39.56 81.04 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.55 -33.21 72.34 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -78.2 -18.42 55.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 0.0 109.695 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.23 2.04 44.68 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.832 -1.175 . . . . 0.0 111.182 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.2 94.23 5.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.725 -1.456 . . . . 0.0 109.541 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -63.05 -42.34 99.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.767 -0.583 . . . . 0.0 111.066 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.458 ' NZ ' ' HA ' ' A' ' 12' ' ' GLU . 85.7 tttt -64.44 -48.31 75.8 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.868 -1.145 . . . . 0.0 112.006 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -62.65 -37.96 88.41 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 118.752 -1.179 . . . . 0.0 109.638 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.475 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -64.22 -50.61 59.03 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.04 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.7 mt -64.6 -43.85 92.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.161 -1.199 . . . . 0.0 111.164 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.582 HG22 HG13 ' A' ' 16' ' ' ILE . 83.6 t -64.93 -48.57 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.694 -1.254 . . . . 0.0 110.511 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -63.51 -38.35 90.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 109.624 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.91 -41.99 99.77 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.6 mt -63.32 -43.74 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -1.195 . . . . 0.0 108.975 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -58.96 -50.83 72.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.124 -0.985 . . . . 0.0 110.499 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.16 -41.11 97.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 109.052 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -42.63 95.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.883 . . . . 0.0 110.671 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.32 -44.01 96.06 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.962 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 97.1 mtp -67.8 -43.0 80.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.921 -1.34 . . . . 0.0 109.394 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.813 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -64.45 -46.89 81.18 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.255 -0.903 . . . . 0.0 108.885 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 76.6 mt -62.15 -40.73 96.94 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.478 -0.764 . . . . 0.0 109.126 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.74 -34.49 62.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.383 -0.823 . . . . 0.0 110.671 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.16 -42.77 99.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.05 -1.031 . . . . 0.0 108.954 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.459 ' CD2' HG22 ' A' ' 87' ' ' VAL . 66.8 m-85 -75.12 -40.0 60.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.624 -0.673 . . . . 0.0 109.791 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -130.94 92.08 34.8 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.383 -0.823 . . . . 0.0 109.393 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.13 151.39 83.81 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.472 1.248 . . . . 0.0 110.044 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.483 ' CH2' ' HA ' ' A' ' 132' ' ' LYS . 73.9 t90 -72.67 131.85 42.92 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.596 -0.69 . . . . 0.0 110.826 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -108.41 149.77 28.29 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.483 ' HA ' ' CH2' ' A' ' 130' ' ' TRP . 87.8 tttt -57.88 -28.91 64.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -0.999 . . . . 0.0 110.799 -177.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -89.47 8.37 31.31 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.797 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -43.88 136.93 3.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.297 -0.877 . . . . 0.0 111.65 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.712 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -112.24 143.58 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.355 0.598 . . . . 0.0 110.764 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -96.4 93.44 6.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.009 -1.057 . . . . 0.0 109.789 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.475 ' HG3' HD13 ' A' ' 135' ' ' ILE . 97.5 mt-10 -69.1 -35.8 76.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.66 -0.65 . . . . 0.0 111.901 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.422 ' HG ' ' HD2' ' A' ' 139' ' ' PRO . 1.1 mp -112.08 152.09 44.09 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.101 -0.999 . . . . 0.0 111.928 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.422 ' HD2' ' HG ' ' A' ' 138' ' ' LEU . 46.6 Cg_endo -76.09 -170.81 0.92 Allowed 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.633 1.333 . . . . 0.0 108.694 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.903 ' OD1' HG22 ' A' ' 20' ' ' ILE . 67.8 m-80 -122.97 2.95 9.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.661 -1.274 . . . . 0.0 110.066 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.4 m -64.02 139.87 58.81 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.854 -1.154 . . . . 0.0 110.805 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.474 HG13 HG22 ' A' ' 17' ' ' VAL . 95.0 mt -73.49 140.33 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.437 -0.79 . . . . 0.0 110.876 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 24.4 m -97.13 139.77 32.63 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.47 -0.769 . . . . 0.0 109.341 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -131.36 147.99 52.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.093 -1.004 . . . . 0.0 110.979 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.137 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.752 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.0 p . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.96 -40.32 66.74 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.969 -1.082 . . . . 0.0 109.917 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -61.04 -43.87 98.25 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.632 -0.667 . . . . 0.0 109.769 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.46 -45.77 68.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.289 -0.882 . . . . 0.0 111.011 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.577 ' O ' HG23 ' A' ' 17' ' ' VAL . 95.1 mt-10 -66.46 -34.49 78.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.954 . . . . 0.0 109.715 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.06 -46.19 85.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.923 -1.11 . . . . 0.0 110.404 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.72 -41.92 95.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.063 -1.023 . . . . 0.0 111.451 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.634 HG13 HG22 ' A' ' 114' ' ' VAL . 18.5 tt -68.41 -39.44 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.869 -1.144 . . . . 0.0 110.549 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 13' ' ' GLU . 77.6 t -63.77 -41.5 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -60.93 -40.34 92.85 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.435 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.12 -36.03 78.63 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.379 -0.826 . . . . 0.0 109.341 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.868 HD11 HD13 ' A' ' 117' ' ' ILE . 30.3 mm -62.9 -42.1 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -58.81 -42.83 90.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.819 -0.551 . . . . 0.0 110.041 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -65.26 -40.61 94.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.052 -1.03 . . . . 0.0 111.113 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.07 -40.84 95.2 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.843 -1.161 . . . . 0.0 110.495 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -60.66 -13.98 17.87 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.441 -1.412 . . . . 0.0 111.127 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.488 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.8 mttt -95.15 0.98 54.7 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.067 -1.021 . . . . 0.0 109.449 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -112.91 -16.66 12.66 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.35 -0.844 . . . . 0.0 110.298 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.0 t -151.51 157.93 42.94 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.073 -1.017 . . . . 0.0 110.206 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.4 p -87.74 -7.36 57.45 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.488 -0.758 . . . . 0.0 110.194 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.31 172.92 49.6 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.656 ' HG3' HD13 ' A' ' 138' ' ' LEU . 80.6 mm-40 -132.02 133.86 44.9 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.162 -1.199 . . . . 0.0 111.725 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.5 mt -117.57 134.5 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 121.184 0.516 . . . . 0.0 110.124 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.572 ' NH1' HD13 ' A' ' 54' ' ' LEU . 69.7 ttt180 -139.86 156.44 46.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.395 -0.815 . . . . 0.0 110.166 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.423 HG13 HG23 ' A' ' 142' ' ' ILE . 3.5 p -124.29 138.24 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.265 -0.897 . . . . 0.0 110.62 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.806 ' HB2' HD11 ' A' ' 66' ' ' LEU . 57.0 t60 -121.42 119.82 33.18 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.54 HD11 ' CG1' ' A' ' 71' ' ' VAL . 46.1 tp -111.48 135.26 52.29 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.116 0.96 . . . . 0.0 111.974 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.464 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 76.4 tt0 -151.61 166.21 31.93 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.643 ' HA ' HG22 ' A' ' 71' ' ' VAL . 98.7 mttt -78.41 -72.0 0.4 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.896 -1.127 . . . . 0.0 112.889 -176.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.8 t -142.72 157.88 44.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.915 -1.116 . . . . 0.0 109.937 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.6 p -102.51 164.88 11.41 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.465 -0.772 . . . . 0.0 111.138 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -105.42 -24.56 12.62 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.455 -0.778 . . . . 0.0 109.377 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.413 HG13 ' N ' ' A' ' 42' ' ' ASP . 24.8 pt -111.9 -121.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.099 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.413 ' N ' HG13 ' A' ' 41' ' ' ILE . 97.0 m-20 -110.61 141.43 43.82 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.248 -1.532 . . . . 0.0 109.589 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.7 t -64.35 -43.22 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.355 -0.841 . . . . 0.0 111.21 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -61.18 -46.25 91.25 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.877 -1.139 . . . . 0.0 110.29 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -70.42 -40.14 74.0 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.897 -1.127 . . . . 0.0 108.413 177.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -62.9 -41.8 99.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.344 -0.847 . . . . 0.0 111.185 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.74 -39.29 80.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.947 -1.096 . . . . 0.0 110.187 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 66.3 ttp -63.0 -42.49 99.86 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.096 -1.003 . . . . 0.0 109.934 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -65.41 -40.66 93.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.021 -1.049 . . . . 0.0 109.82 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.8 t -69.58 -43.67 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.454 -0.779 . . . . 0.0 109.441 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.519 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 3.6 t80 -58.16 -46.85 84.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.048 -1.032 . . . . 0.0 108.824 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -73.15 -35.58 66.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.023 -1.048 . . . . 0.0 109.56 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -61.91 -37.32 84.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.012 -1.055 . . . . 0.0 109.329 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.572 HD13 ' NH1' ' A' ' 32' ' ' ARG . 98.6 mt -82.22 3.52 27.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.576 -0.702 . . . . 0.0 110.694 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.4 mttp 56.64 33.39 22.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.453 -0.78 . . . . 0.0 111.706 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.823 ' SD ' HD13 ' A' ' 66' ' ' LEU . 90.8 mtp -66.89 -14.25 62.56 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.416 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -75.68 -3.18 33.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.108 -0.995 . . . . 0.0 110.318 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -76.93 65.68 2.65 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.048 -1.033 . . . . 0.0 109.849 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.486 HG22 HD11 ' A' ' 138' ' ' LEU . 66.2 p -134.94 150.62 50.42 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.395 -0.816 . . . . 0.0 109.434 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -64.51 -47.32 79.32 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 84.6 mt -96.29 -1.06 48.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.863 -1.148 . . . . 0.0 111.332 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 76.0 mt-30 60.94 45.29 9.64 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 122.61 1.195 . . . . 0.0 111.479 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.445 ' HA ' HG13 ' A' ' 84' ' ' ILE . 34.8 m-80 -120.03 51.34 1.2 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.132 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.18 141.03 15.33 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.268 -1.933 . . . . 0.0 108.268 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.506 HG23 ' CD1' ' A' ' 84' ' ' ILE . 55.6 t -122.51 134.36 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.816 -1.402 . . . . 0.0 110.367 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.823 HD13 ' SD ' ' A' ' 56' ' ' MET . 41.1 tp -116.76 124.51 49.79 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.962 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 98.7 mt -102.36 105.2 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.965 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 34' ' ' HIS . 56.1 t80 -92.65 121.64 34.27 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.357 -0.839 . . . . 0.0 110.0 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.9 t -122.42 130.13 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.348 -0.845 . . . . 0.0 111.034 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.77 99.76 11.11 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.643 HG22 ' HA ' ' A' ' 37' ' ' LYS . 32.7 m -68.35 -20.53 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.97 -1.081 . . . . 0.0 110.451 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.449 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 66.1 mm-40 -70.85 -47.92 56.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.946 -1.096 . . . . 0.0 109.575 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -97.67 3.37 50.32 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.215 -0.928 . . . . 0.0 110.586 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt 54.44 46.08 25.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.103 -0.998 . . . . 0.0 110.99 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.4 m -121.72 132.69 54.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.082 -1.011 . . . . 0.0 110.303 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 76' ' ' PHE . 53.4 p90 -112.13 139.55 47.56 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.445 -0.785 . . . . 0.0 110.468 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 50.4 t -130.43 140.57 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.299 -0.876 . . . . 0.0 109.37 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.705 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 90.3 mt -118.07 127.98 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.783 -1.198 . . . . 0.0 111.032 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -130.42 116.47 18.29 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.638 -0.664 . . . . 0.0 110.285 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.43 167.4 15.64 Favored Glycine 0 N--CA 1.483 1.769 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.48 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 73.7 m-20 -77.86 178.2 7.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.546 -0.973 . . . . 0.0 110.848 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -62.05 -27.21 68.73 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.644 -0.66 . . . . 0.0 110.139 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.415 ' O ' HG12 ' A' ' 87' ' ' VAL . . . -62.37 -55.54 26.98 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.615 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.979 ' O ' HG22 ' A' ' 88' ' ' VAL . 76.5 mt -66.18 -44.56 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.703 -1.469 . . . . 0.0 108.546 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -61.31 -36.44 80.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.049 -1.032 . . . . 0.0 111.003 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -76.74 -21.84 54.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 111.524 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.968 HG13 HG13 ' A' ' 88' ' ' VAL . 10.5 p -103.45 -23.37 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.724 -1.235 . . . . 0.0 112.462 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.979 HG22 ' O ' ' A' ' 84' ' ' ILE . 20.3 m -118.88 164.41 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.64 -1.287 . . . . 0.0 111.011 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.5 p -109.34 178.52 4.42 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.406 -0.809 . . . . 0.0 112.434 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -62.89 -35.65 80.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.878 . . . . 0.0 109.137 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -61.47 -37.78 84.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.162 -0.961 . . . . 0.0 109.008 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.775 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 54.4 t80 -68.26 -25.21 65.06 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 108.984 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.705 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.8 m95 -86.63 -26.29 24.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.75 0.786 . . . . 0.0 110.846 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -58.84 -34.4 71.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.202 -0.936 . . . . 0.0 111.902 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 49.2 p -68.46 -32.65 72.81 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.276 -1.37 . . . . 0.0 108.683 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.268 16.6 m -59.74 -48.4 81.83 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 122.316 1.055 . . . . 0.0 110.852 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.44 -37.58 74.39 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.11 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -63.35 -43.85 96.52 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.824 -1.172 . . . . 0.0 110.125 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.03 -48.25 77.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.89 -1.131 . . . . 0.0 110.935 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 94.2 mt -67.7 -42.67 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.064 -1.022 . . . . 0.0 110.06 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -64.53 -41.67 96.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.124 -0.985 . . . . 0.0 110.648 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.8 mt -63.73 -42.31 97.92 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.96 -1.088 . . . . 0.0 112.048 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.47 ' HB2' ' HA3' ' A' ' 112' ' ' GLY . 99.7 mm-40 -74.99 -39.18 61.39 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.293 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -61.65 -40.31 94.45 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -62.01 -32.9 73.42 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.689 -0.632 . . . . 0.0 110.036 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -84.67 -17.21 39.26 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.828 -1.17 . . . . 0.0 109.916 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.89 10.53 34.66 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.09 -1.052 . . . . 0.0 110.503 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -104.6 79.58 1.57 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.854 -1.38 . . . . 0.0 109.35 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -60.68 -43.76 97.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.787 -0.571 . . . . 0.0 111.138 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.536 ' O ' HG23 ' A' ' 114' ' ' VAL . 74.3 tttt -62.33 -49.39 75.79 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.126 -0.984 . . . . 0.0 111.984 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -63.09 -37.89 89.01 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.887 -1.133 . . . . 0.0 110.313 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.47 ' HA3' ' HB2' ' A' ' 103' ' ' GLN . . . -64.47 -49.33 65.8 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.28 -43.35 98.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -1.143 . . . . 0.0 110.446 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.634 HG22 HG13 ' A' ' 16' ' ' ILE . 89.8 t -66.45 -46.99 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.084 -1.01 . . . . 0.0 110.074 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.78 -40.14 94.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.229 -0.919 . . . . 0.0 109.636 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.19 -41.9 99.62 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.868 HD13 HD11 ' A' ' 20' ' ' ILE . 93.9 mt -65.32 -44.27 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.371 -1.076 . . . . 0.0 110.298 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -57.2 -48.51 78.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.946 -1.096 . . . . 0.0 109.3 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.56 -42.05 98.37 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.481 -0.762 . . . . 0.0 109.506 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.57 -41.97 91.41 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.3 -0.875 . . . . 0.0 110.132 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.62 -44.7 89.16 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 98.7 mmm -65.49 -46.54 79.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.047 -1.266 . . . . 0.0 109.513 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.775 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -63.85 -44.73 92.29 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.21 -0.931 . . . . 0.0 109.128 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 37.8 mt -62.43 -40.41 96.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.937 . . . . 0.0 109.142 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.93 -35.04 61.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.151 -0.968 . . . . 0.0 110.454 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.09 -43.91 97.8 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.059 -1.025 . . . . 0.0 108.567 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.511 ' CD1' HG22 ' A' ' 87' ' ' VAL . 65.7 m-85 -72.39 -44.03 63.1 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.422 0.63 . . . . 0.0 109.81 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.412 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 62.9 m-85 -127.84 96.51 32.04 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.387 -0.82 . . . . 0.0 109.742 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 128' ' ' PHE . 42.3 Cg_endo -66.41 148.65 84.41 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.874 1.46 . . . . 0.0 110.304 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.488 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 72.6 t90 -73.87 133.09 43.1 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.422 -0.799 . . . . 0.0 110.262 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -111.34 147.79 34.37 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.41 ' HA ' ' CH2' ' A' ' 130' ' ' TRP . 99.5 mttt -54.18 -25.77 24.43 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.919 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -94.51 10.29 35.16 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 118.502 -1.279 . . . . 0.0 111.198 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -43.19 134.51 3.62 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.38 -0.825 . . . . 0.0 111.24 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.633 HD13 ' H ' ' A' ' 135' ' ' ILE . 0.2 OUTLIER -110.09 140.37 29.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.7 -178.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 45.6 p-10 -97.89 92.59 5.89 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.042 0.925 . . . . 0.0 110.206 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.09 -35.19 79.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.533 -0.729 . . . . 0.0 112.252 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.656 HD13 ' HG3' ' A' ' 30' ' ' GLU . 5.0 mp -108.96 152.78 42.6 Favored Pre-proline 0 N--CA 1.486 1.354 0 O-C-N 120.826 -1.172 . . . . 0.0 111.854 -178.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -75.13 -169.05 0.58 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 N-CA-C 108.0 -1.577 . . . . 0.0 108.0 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -123.74 4.66 8.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.572 -1.33 . . . . 0.0 110.418 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 61.7 p -62.38 171.86 1.74 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.074 -1.016 . . . . 0.0 110.556 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.423 HG23 HG13 ' A' ' 33' ' ' VAL . 95.0 mt -103.14 140.59 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.389 -0.819 . . . . 0.0 109.96 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 28.6 t -95.95 136.29 36.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.527 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -128.8 147.09 50.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.078 -1.013 . . . . 0.0 111.629 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.051 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 12' ' ' GLU . 6.6 t . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.232 0.539 . . . . 0.0 109.587 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.03 -39.11 68.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 110.565 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -59.65 -46.21 89.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.125 -0.984 . . . . 0.0 110.759 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.428 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 99.7 mt-10 -70.08 -44.0 70.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 0.0 111.533 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.592 ' O ' HG23 ' A' ' 17' ' ' VAL . 95.6 mt-10 -65.99 -39.02 89.95 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.024 -1.047 . . . . 0.0 110.082 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.57 -45.57 93.59 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.938 -1.101 . . . . 0.0 110.539 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.06 -47.02 78.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.125 -0.984 . . . . 0.0 111.663 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.569 HG13 HG22 ' A' ' 114' ' ' VAL . 20.0 tt -63.79 -33.7 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.678 -1.264 . . . . 0.0 109.983 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 13' ' ' GLU . 55.9 t -64.91 -40.84 90.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -62.56 -35.13 78.5 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.104 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.73 -41.62 97.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.393 -0.817 . . . . 0.0 109.692 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.03 -43.14 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 0.0 109.493 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.411 ' HG2' ' OD1' ' A' ' 140' ' ' ASN . 93.6 mtt-85 -58.41 -44.45 89.04 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.464 -0.772 . . . . 0.0 110.183 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -63.28 -37.54 87.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.375 -0.828 . . . . 0.0 110.772 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.429 ' O ' HG22 ' A' ' 27' ' ' THR . . . -64.37 -40.64 96.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.077 -1.015 . . . . 0.0 110.187 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -60.99 -16.42 42.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.141 -0.974 . . . . 0.0 110.675 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.446 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.6 mttt -93.07 -1.3 56.65 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.059 -1.026 . . . . 0.0 109.229 177.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -110.93 -13.65 14.08 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 120.905 -1.122 . . . . 0.0 109.545 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 23' ' ' ALA . 3.9 t -151.28 158.67 44.16 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.977 -1.077 . . . . 0.0 110.329 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 94.2 p -89.31 -10.17 47.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 110.271 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.38 174.1 38.84 Favored Glycine 0 N--CA 1.485 1.967 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.421 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 55.7 mp0 -131.09 136.28 48.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.221 -1.164 . . . . 0.0 110.968 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.3 mt -120.73 134.78 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.692 -0.63 . . . . 0.0 110.308 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -139.24 159.26 42.58 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.22 -0.925 . . . . 0.0 109.508 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 p -129.15 143.87 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.395 -0.816 . . . . 0.0 110.942 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.785 ' HB2' HD11 ' A' ' 66' ' ' LEU . 31.1 t60 -127.64 126.94 42.93 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.613 0.721 . . . . 0.0 109.578 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.545 HD11 ' CG1' ' A' ' 71' ' ' VAL . 3.4 tp -116.01 131.18 57.01 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.968 0.89 . . . . 0.0 111.46 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -146.53 162.87 37.41 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.58 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.1 mttt -77.38 -74.51 0.25 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.053 -1.029 . . . . 0.0 112.66 -177.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.5 t -138.65 155.66 48.11 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.747 0.784 . . . . 0.0 109.796 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.454 ' HB2' ' NE ' ' A' ' 46' ' ' ARG . 13.3 p -106.72 168.39 9.21 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.7 -0.625 . . . . 0.0 110.693 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -106.84 -22.9 12.55 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.183 -0.948 . . . . 0.0 110.8 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.413 HD11 HH21 ' A' ' 46' ' ' ARG . 18.4 pt -114.05 -121.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.348 -0.845 . . . . 0.0 109.957 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 41' ' ' ILE . 91.5 m-20 -110.72 137.4 48.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.071 -1.643 . . . . 0.0 109.067 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.48 ' CG1' HG21 ' A' ' 77' ' ' VAL . 85.5 t -63.44 -44.21 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 111.104 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -59.17 -45.82 90.01 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.762 -1.211 . . . . 0.0 110.375 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -71.98 -39.14 69.5 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.454 ' NE ' ' HB2' ' A' ' 39' ' ' SER . 57.1 ttm-85 -61.35 -44.44 97.17 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.3 -0.875 . . . . 0.0 110.91 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.25 -37.97 89.38 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.952 -1.093 . . . . 0.0 109.444 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 50.9 ttp -63.75 -43.81 95.34 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.341 -0.849 . . . . 0.0 110.258 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -65.92 -46.8 76.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.999 -1.063 . . . . 0.0 110.28 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.8 t -66.3 -43.66 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.978 -1.076 . . . . 0.0 109.821 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.497 ' CD1' ' HB2' ' A' ' 66' ' ' LEU . 25.9 t80 -58.83 -47.21 85.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.036 -1.04 . . . . 0.0 110.403 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -75.33 -37.11 60.9 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.668 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -60.59 -39.67 88.95 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.135 -0.978 . . . . 0.0 110.17 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.508 HD12 ' HE3' ' A' ' 56' ' ' MET . 91.5 mt -80.09 4.19 18.02 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.01 -1.056 . . . . 0.0 110.658 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.4 tttt 61.25 28.05 17.67 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.938 -1.101 . . . . 0.0 111.983 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.876 ' SD ' HD13 ' A' ' 66' ' ' LEU . 54.6 mtt -66.84 -24.56 66.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.02 -1.05 . . . . 0.0 108.669 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -70.46 -8.4 50.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.253 -0.904 . . . . 0.0 111.194 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -85.76 85.79 7.38 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.568 -1.332 . . . . 0.0 111.196 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.6 p -135.0 154.16 51.83 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.422 ' HB3' ' OE2' ' A' ' 137' ' ' GLU . 60.4 tttp -61.57 -41.09 96.89 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.069 -1.019 . . . . 0.0 111.929 -177.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.404 ' HB3' ' ND2' ' A' ' 63' ' ' ASN . 85.9 mt -100.03 4.63 44.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.008 -1.057 . . . . 0.0 111.21 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 85.5 mt-30 56.28 41.73 28.79 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.303 1.049 . . . . 0.0 111.156 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.404 ' ND2' ' HB3' ' A' ' 61' ' ' LEU . 88.5 m-20 -119.49 54.31 1.0 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.682 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.415 ' N ' ' OD2' ' A' ' 81' ' ' ASP . . . -100.65 140.23 14.8 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.64 HG23 ' CD1' ' A' ' 84' ' ' ILE . 40.9 t -123.7 134.48 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.997 -1.296 . . . . 0.0 110.507 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.876 HD13 ' SD ' ' A' ' 56' ' ' MET . 43.9 tp -116.74 125.93 52.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.367 -0.833 . . . . 0.0 110.108 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 92.9 mt -104.04 105.57 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.043 -1.063 . . . . 0.0 109.493 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -90.7 122.47 33.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.975 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.8 t -122.14 131.04 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 122.024 0.916 . . . . 0.0 111.305 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.593 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -102.28 102.17 12.53 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.58 HG22 ' HA ' ' A' ' 37' ' ' LYS . 17.4 m -70.12 -20.67 23.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 110.999 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.44 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 78.2 mm-40 -68.6 -46.25 69.83 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.634 -1.291 . . . . 0.0 109.598 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -99.4 1.9 44.7 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.515 -0.74 . . . . 0.0 110.438 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.442 ' HE3' ' CZ ' ' A' ' 109' ' ' PHE . 38.6 tttt 58.59 48.74 11.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.777 -1.202 . . . . 0.0 110.226 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.593 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 61.9 p -122.47 163.25 20.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.976 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -146.34 145.81 30.45 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.27 -0.894 . . . . 0.0 110.591 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.48 HG21 ' CG1' ' A' ' 43' ' ' VAL . 54.2 t -132.27 138.8 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.449 -0.782 . . . . 0.0 109.173 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.692 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 71.2 mt -115.14 125.36 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.925 -1.109 . . . . 0.0 109.9 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -131.45 117.92 19.49 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.279 -0.888 . . . . 0.0 110.678 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.47 168.84 16.68 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.415 ' OD2' ' N ' ' A' ' 64' ' ' GLY . 47.3 m-20 -81.73 179.19 7.93 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.606 -0.938 . . . . 0.0 110.444 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -61.6 -28.3 69.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.34 -0.85 . . . . 0.0 111.169 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.67 -56.18 22.82 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.59 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.964 ' O ' HG22 ' A' ' 88' ' ' VAL . 81.0 mt -65.41 -45.48 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.774 -1.427 . . . . 0.0 108.423 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -60.55 -38.93 86.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.005 -1.059 . . . . 0.0 111.661 -177.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -71.85 -24.13 61.64 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.072 -1.017 . . . . 0.0 111.878 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.014 HG13 HG13 ' A' ' 88' ' ' VAL . 8.9 p -102.96 -21.36 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.731 -1.231 . . . . 0.0 113.218 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.014 HG13 HG13 ' A' ' 87' ' ' VAL . 16.7 m -117.95 162.89 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.829 -1.17 . . . . 0.0 110.964 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.1 p -109.36 -178.71 3.63 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.226 1.012 . . . . 0.0 113.077 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -63.14 -36.29 83.12 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.618 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -64.88 -38.94 92.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.12 -0.987 . . . . 0.0 109.156 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.839 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 66.1 t80 -65.62 -24.45 67.05 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.194 -0.941 . . . . 0.0 109.16 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.692 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.5 m95 -86.55 -26.4 24.54 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.184 0.992 . . . . 0.0 110.355 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -60.11 -36.8 78.25 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.918 -1.114 . . . . 0.0 112.141 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 m -63.33 -34.49 77.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.778 -1.201 . . . . 0.0 108.517 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.273 9.4 m -60.14 -49.92 75.72 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 122.145 0.974 . . . . 0.0 112.592 -179.3 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -67.79 -35.44 78.67 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.48 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -64.1 -43.15 96.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.992 -1.067 . . . . 0.0 110.772 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.65 -48.49 79.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.755 -1.216 . . . . 0.0 110.27 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.8 mt -67.64 -42.67 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.919 -1.113 . . . . 0.0 110.353 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -63.18 -44.6 94.96 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 111.413 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 102' ' ' LEU . 77.4 mt -63.91 -41.06 97.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.311 -0.868 . . . . 0.0 112.303 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.469 ' HB2' ' HA3' ' A' ' 112' ' ' GLY . 98.8 mm-40 -73.93 -40.35 63.15 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 118.615 -1.234 . . . . 0.0 108.892 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -58.82 -41.06 85.94 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.2 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -64.18 -32.68 74.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.401 -0.812 . . . . 0.0 110.779 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -78.02 -19.68 53.92 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.79 -1.194 . . . . 0.0 109.87 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.59 3.39 34.91 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.889 -1.148 . . . . 0.0 111.383 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -105.6 90.55 3.44 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.634 -1.509 . . . . 0.0 110.404 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.442 ' CZ ' ' HE3' ' A' ' 74' ' ' LYS . 21.3 m-85 -64.24 -41.2 97.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.884 -0.51 . . . . 0.0 111.42 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.466 ' O ' HG23 ' A' ' 114' ' ' VAL . 85.7 tttt -62.98 -49.37 74.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.948 -1.095 . . . . 0.0 111.317 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -62.78 -40.82 98.48 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.055 -1.058 . . . . 0.0 109.888 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' A' ' 103' ' ' GLN . . . -61.71 -49.36 77.11 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.03 -43.73 91.42 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.323 -1.104 . . . . 0.0 111.757 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.569 HG22 HG13 ' A' ' 16' ' ' ILE . 81.2 t -64.49 -46.54 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.843 -1.16 . . . . 0.0 109.504 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.33 -41.4 96.81 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.456 -0.778 . . . . 0.0 110.803 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.51 -44.91 93.59 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 93.1 mt -65.25 -43.62 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.083 -1.245 . . . . 0.0 110.192 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 114' ' ' VAL . 79.7 mm-40 -55.34 -51.17 67.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.889 -1.132 . . . . 0.0 109.678 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.39 -42.41 99.4 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.3 -0.875 . . . . 0.0 109.088 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.409 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -58.14 -42.6 86.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.18 -0.95 . . . . 0.0 110.152 178.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.6 -44.11 96.98 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 9.4 ttm -67.37 -46.46 73.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.018 -1.284 . . . . 0.0 109.806 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.839 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -61.99 -46.24 90.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.238 -0.914 . . . . 0.0 109.21 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.409 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 66.1 mt -62.66 -40.35 96.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.421 -0.799 . . . . 0.0 108.917 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.73 -34.33 58.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.322 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.11 -43.06 99.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.015 -1.053 . . . . 0.0 109.094 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.458 ' CD2' HG22 ' A' ' 87' ' ' VAL . 80.6 m-85 -75.88 -37.48 58.85 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.616 0.722 . . . . 0.0 109.641 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -128.51 96.2 30.96 Favored Pre-proline 0 N--CA 1.485 1.307 0 O-C-N 121.703 -0.623 . . . . 0.0 109.911 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.98 148.3 81.64 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 O-C-N 123.583 1.307 . . . . 0.0 109.825 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.446 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 65.2 t90 -75.84 136.58 40.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.346 -0.846 . . . . 0.0 110.812 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 99.6 mttt -115.52 151.02 35.61 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 109.078 178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.92 -29.49 67.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.976 -1.077 . . . . 0.0 111.195 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -91.01 8.23 36.37 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.961 -1.096 . . . . 0.0 111.109 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 42.9 t0 -43.11 139.03 1.95 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.211 -0.931 . . . . 0.0 111.686 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.708 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -112.92 144.42 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.72 0.771 . . . . 0.0 111.476 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -99.38 92.7 5.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.68 -1.262 . . . . 0.0 110.028 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.514 ' HG3' HD13 ' A' ' 135' ' ' ILE . 96.7 mt-10 -69.58 -39.88 77.08 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.436 ' HG ' ' HD2' ' A' ' 139' ' ' PRO . 0.1 OUTLIER -108.44 150.68 40.93 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.02 -1.05 . . . . 0.0 111.995 -178.153 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.436 ' HD2' ' HG ' ' A' ' 138' ' ' LEU . 41.4 Cg_endo -71.71 -179.24 3.6 Favored 'Trans proline' 0 N--CA 1.486 1.046 0 O-C-N 123.527 1.278 . . . . 0.0 109.438 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.411 ' OD1' ' HG2' ' A' ' 21' ' ' ARG . 18.0 m120 -119.44 3.21 11.28 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.45 -1.406 . . . . 0.0 110.462 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.4 p -63.81 167.81 5.64 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.826 -1.171 . . . . 0.0 110.686 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 93.8 mt -94.69 136.27 26.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.649 0.738 . . . . 0.0 111.088 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 27.8 t -94.1 133.99 37.01 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.04 138.89 52.17 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.264 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.054 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.725 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.9 p . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.61 -35.92 68.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.965 -1.084 . . . . 0.0 109.493 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -61.71 -46.39 89.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.544 -0.722 . . . . 0.0 110.454 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -68.91 -47.88 64.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.277 -0.889 . . . . 0.0 111.474 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.709 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.7 mt-10 -61.88 -39.53 92.26 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.035 -1.04 . . . . 0.0 110.245 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.54 -44.5 96.94 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.166 -0.959 . . . . 0.0 111.226 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.59 -46.63 81.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.841 -1.162 . . . . 0.0 110.809 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 13' ' ' GLU . 21.4 tt -65.58 -35.24 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.836 -1.165 . . . . 0.0 109.869 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 13' ' ' GLU . 53.4 t -63.26 -38.5 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 21' ' ' ARG . 63.7 t0 -63.12 -36.36 83.35 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.328 -0.857 . . . . 0.0 109.454 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.37 -38.68 90.51 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.179 -0.951 . . . . 0.0 109.04 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.721 HG22 ' OD1' ' A' ' 140' ' ' ASN . 35.1 mm -64.46 -44.04 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.187 -0.946 . . . . 0.0 109.745 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.462 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 58.6 mtm180 -61.25 -42.19 98.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 110.383 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -64.87 -38.06 89.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.181 -0.95 . . . . 0.0 111.796 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.51 -39.1 93.16 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.886 -1.134 . . . . 0.0 110.527 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.82 -16.22 26.74 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.766 -1.209 . . . . 0.0 110.328 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.476 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.7 mttt -94.86 0.56 54.91 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.057 -1.027 . . . . 0.0 109.968 177.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -114.07 -15.67 12.24 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.751 -1.218 . . . . 0.0 109.714 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 t -151.68 155.91 39.28 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.97 -1.082 . . . . 0.0 109.459 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.9 m -85.84 -6.35 59.1 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.206 -0.934 . . . . 0.0 110.052 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.2 173.5 52.77 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 55.8 mp0 -131.08 136.99 48.9 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.12 -1.224 . . . . 0.0 111.183 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 94.9 mt -118.01 134.68 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.778 -0.576 . . . . 0.0 110.104 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.481 ' HB3' ' HE1' ' A' ' 56' ' ' MET . 73.9 ttt180 -139.4 151.95 46.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 110.005 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.828 HG22 HD12 ' A' ' 67' ' ' ILE . 60.7 t -120.97 136.75 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.409 -0.807 . . . . 0.0 110.4 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.734 ' HB2' HD11 ' A' ' 66' ' ' LEU . 82.8 t60 -122.31 126.33 47.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.44 -0.787 . . . . 0.0 109.137 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.44 HD11 ' CG1' ' A' ' 71' ' ' VAL . 36.7 tp -112.48 126.68 55.58 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.846 0.832 . . . . 0.0 111.449 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.441 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 82.8 tt0 -142.79 165.07 28.38 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.742 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.0 mttt -81.65 -77.49 0.22 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -176.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.0 t -142.34 158.07 44.11 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.188 -0.945 . . . . 0.0 109.809 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.2 m -113.78 177.51 4.61 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.147 -0.97 . . . . 0.0 111.523 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -102.78 -20.11 14.46 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.615 -0.678 . . . . 0.0 109.871 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.0 mt -112.16 -120.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.015 -1.053 . . . . 0.0 109.519 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -114.46 148.35 37.94 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 119.952 -1.717 . . . . 0.0 108.227 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.521 ' CG1' HG21 ' A' ' 77' ' ' VAL . 63.1 t -60.97 -42.48 93.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 O-C-N 121.118 -0.989 . . . . 0.0 110.269 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -60.13 -45.78 91.87 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.198 -0.939 . . . . 0.0 110.861 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -71.66 -45.49 61.81 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.859 -1.151 . . . . 0.0 109.104 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.472 ' O ' HG23 ' A' ' 50' ' ' VAL . 31.9 tpt180 -60.13 -43.28 95.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.106 -0.996 . . . . 0.0 111.611 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.77 83.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.567 -1.333 . . . . 0.0 110.381 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.1 ttp -62.3 -41.8 98.83 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.138 -0.976 . . . . 0.0 109.716 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -63.41 -42.0 98.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.136 -0.978 . . . . 0.0 109.192 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 46' ' ' ARG . 94.2 t -67.06 -42.32 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.5 -0.75 . . . . 0.0 109.659 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.487 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 5.8 t80 -58.55 -47.66 83.46 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.93 -1.106 . . . . 0.0 109.415 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -73.0 -35.67 66.88 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 109.966 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -60.16 -35.67 75.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.873 -1.142 . . . . 0.0 109.053 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.82 5.16 26.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.267 -0.896 . . . . 0.0 110.33 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 55.01 32.91 19.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.97 -1.081 . . . . 0.0 111.123 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.523 ' SD ' HD22 ' A' ' 66' ' ' LEU . 94.0 mtp -65.94 -12.59 55.95 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.793 -1.192 . . . . 0.0 109.927 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -76.69 -1.61 28.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.723 -1.236 . . . . 0.0 109.781 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -74.87 65.1 1.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.855 -1.153 . . . . 0.0 110.262 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.4 p -134.8 148.78 50.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.074 -1.016 . . . . 0.0 109.272 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -62.56 -43.79 97.93 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.599 -0.688 . . . . 0.0 112.841 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.7 mt -98.18 2.27 48.28 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.903 -1.123 . . . . 0.0 111.804 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 56.53 32.76 21.41 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 122.437 1.113 . . . . 0.0 111.088 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.6 ' C ' HD11 ' A' ' 84' ' ' ILE . 3.2 m-80 -108.31 53.38 0.69 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.949 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.539 ' N ' HD11 ' A' ' 84' ' ' ILE . . . -101.58 139.37 14.37 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.454 ' CG2' HD13 ' A' ' 84' ' ' ILE . 53.9 t -123.42 133.78 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -1.157 . . . . 0.0 109.829 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.734 HD11 ' HB2' ' A' ' 34' ' ' HIS . 37.9 tp -117.18 133.06 56.45 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.093 -1.004 . . . . 0.0 109.495 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.828 HD12 HG22 ' A' ' 33' ' ' VAL . 83.8 mt -104.32 108.38 24.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 118.809 -1.157 . . . . 0.0 109.369 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.504 ' CE2' HG13 ' A' ' 43' ' ' VAL . 69.3 t80 -95.57 121.06 36.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.318 -0.864 . . . . 0.0 110.014 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.9 t -120.67 130.77 74.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.953 0.883 . . . . 0.0 110.841 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.5 103.26 15.0 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.742 HG22 ' HA ' ' A' ' 37' ' ' LYS . 21.5 m -71.88 -18.99 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.992 -1.067 . . . . 0.0 111.048 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -70.27 -46.68 63.88 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.531 -1.356 . . . . 0.0 109.342 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -101.61 4.74 41.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.077 -1.015 . . . . 0.0 110.427 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.7 tttt 53.88 46.91 24.71 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.824 -1.172 . . . . 0.0 110.618 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.9 m -121.07 135.43 55.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.986 -1.071 . . . . 0.0 109.709 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 101' ' ' GLN . 42.9 p90 -112.15 133.9 54.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.457 -0.777 . . . . 0.0 109.885 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.521 HG21 ' CG1' ' A' ' 43' ' ' VAL . 47.8 t -126.89 135.67 63.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 120.935 -1.103 . . . . 0.0 108.063 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.607 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 81.6 mt -114.4 128.16 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.888 -1.133 . . . . 0.0 110.679 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -132.27 113.85 13.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.734 -0.603 . . . . 0.0 110.539 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.38 176.82 26.88 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.47 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 92.5 m-20 -82.5 -178.64 7.14 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.629 -0.924 . . . . 0.0 110.437 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.74 -23.34 67.14 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.448 -0.783 . . . . 0.0 109.634 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.15 -54.07 29.56 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.636 -1.268 . . . . 0.0 111.075 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.974 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.6 mt -66.33 -45.9 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.734 -1.45 . . . . 0.0 108.456 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -61.67 -37.62 84.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.058 -1.026 . . . . 0.0 111.521 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -75.61 -20.96 58.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.881 -1.137 . . . . 0.0 111.961 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.945 HG13 HG13 ' A' ' 88' ' ' VAL . 7.3 p -103.25 -22.02 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.861 -1.149 . . . . 0.0 112.341 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.974 HG22 ' O ' ' A' ' 84' ' ' ILE . 21.4 m -121.01 162.27 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 120.483 -1.385 . . . . 0.0 111.168 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.1 p -104.51 177.64 4.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.313 -0.867 . . . . 0.0 112.177 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.0 -35.68 79.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.683 -0.635 . . . . 0.0 109.437 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -63.82 -37.19 86.47 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.672 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 56.6 t80 -65.85 -24.31 66.85 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.09 -1.007 . . . . 0.0 108.606 177.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.607 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 6.8 m95 -87.12 -28.42 22.51 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.796 0.808 . . . . 0.0 110.784 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -57.09 -36.64 70.85 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.493 -0.754 . . . . 0.0 112.327 -176.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 64.5 p -67.38 -32.82 74.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.796 -1.19 . . . . 0.0 109.346 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.493 HG22 ' CD1' ' A' ' 78' ' ' ILE 0.284 8.5 m -59.26 -47.78 84.07 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.67 1.224 . . . . 0.0 110.521 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -69.13 -38.54 78.88 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.897 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -64.27 -44.73 90.81 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.687 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.22 -49.42 75.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.694 -1.254 . . . . 0.0 110.967 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.583 HD12 HD11 ' A' ' 78' ' ' ILE . 95.9 mt -67.24 -42.4 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.073 -1.017 . . . . 0.0 110.26 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 76' ' ' PHE . 57.8 tt0 -63.58 -40.39 96.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.916 -1.115 . . . . 0.0 110.814 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 40.4 mt -63.39 -42.62 98.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.117 -0.989 . . . . 0.0 111.929 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.485 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 88.0 mm-40 -75.15 -40.48 59.6 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.904 -1.119 . . . . 0.0 108.885 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -60.26 -41.8 94.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 108.936 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.78 -29.71 70.91 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.541 -0.724 . . . . 0.0 109.554 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -81.34 -20.02 41.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.027 -1.046 . . . . 0.0 110.003 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.73 -0.94 34.11 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.744 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -102.45 95.99 6.63 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.531 -1.57 . . . . 0.0 110.854 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -63.13 -41.45 99.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.847 -0.533 . . . . 0.0 111.774 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -65.5 -49.07 70.39 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.371 -0.932 . . . . 0.0 112.446 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.76 -39.75 95.02 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 118.859 -1.136 . . . . 0.0 110.594 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.485 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -62.41 -48.05 85.06 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.48 -1.343 . . . . 0.0 109.946 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.5 mt -63.65 -44.33 94.12 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.504 -0.998 . . . . 0.0 110.308 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.403 HG22 HG13 ' A' ' 16' ' ' ILE . 78.7 t -65.23 -47.57 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.95 -1.094 . . . . 0.0 110.858 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -65.76 -41.12 92.49 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 110.805 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.07 -41.21 98.59 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 98.1 mt -63.54 -42.99 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.141 -1.211 . . . . 0.0 109.585 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -59.19 -47.29 85.85 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.941 -1.099 . . . . 0.0 109.624 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.37 -42.54 99.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.383 -0.823 . . . . 0.0 109.333 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -58.71 -42.64 89.14 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.124 -0.985 . . . . 0.0 109.657 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.89 -43.04 96.61 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.637 -1.268 . . . . 0.0 109.99 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 90.8 mtp -67.19 -45.35 77.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.15 -1.206 . . . . 0.0 110.488 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.672 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -64.24 -42.52 96.49 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.301 -0.96 . . . . 0.0 108.626 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.4 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 73.7 mt -64.56 -39.82 94.44 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.546 -0.721 . . . . 0.0 109.58 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.71 -34.19 58.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.029 -1.044 . . . . 0.0 110.472 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -63.05 -42.91 99.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.024 -1.047 . . . . 0.0 109.492 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.433 ' HB3' ' CE1' ' A' ' 128' ' ' PHE . 53.9 m-85 -70.22 -42.64 72.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.473 -0.767 . . . . 0.0 110.014 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.443 ' CZ ' HG21 ' A' ' 87' ' ' VAL . 83.1 m-85 -127.92 101.72 22.81 Favored Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 121.495 -0.753 . . . . 0.0 109.931 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.2 152.07 80.19 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.81 1.426 . . . . 0.0 109.877 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.476 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 43.4 t90 -78.79 137.64 37.82 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.624 -0.672 . . . . 0.0 111.173 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -115.28 149.18 38.21 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.318 -0.864 . . . . 0.0 109.526 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -57.81 -28.52 64.12 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 111.236 -177.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -91.13 9.96 28.88 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.921 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.428 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 66.3 t0 -43.12 137.09 2.63 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.358 -0.839 . . . . 0.0 111.575 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.607 HD13 ' H ' ' A' ' 135' ' ' ILE . 0.2 OUTLIER -110.43 136.12 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.734 0.778 . . . . 0.0 111.484 -178.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -115.12 100.68 8.34 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -101.26 -4.45 27.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.896 -1.127 . . . . 0.0 111.933 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.86 145.41 30.66 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.938 -1.101 . . . . 0.0 110.983 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -70.32 166.38 28.48 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.669 1.352 . . . . 0.0 109.468 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.721 ' OD1' HG22 ' A' ' 20' ' ' ILE . 62.8 m-80 -109.66 7.46 24.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.568 -1.333 . . . . 0.0 110.77 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.6 p -65.85 171.15 4.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.911 -1.118 . . . . 0.0 111.329 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 91.1 mt -97.88 140.43 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 121.387 0.613 . . . . 0.0 110.707 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 18.1 t -94.48 134.32 37.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 109.829 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -129.1 148.1 51.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 110.451 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 CA-C-O 117.964 -1.465 . . . . 0.0 109.784 -179.796 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.3 p . . . . . 0 N--CA 1.495 1.796 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.42 -35.61 68.0 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.953 -1.092 . . . . 0.0 109.857 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -58.9 -46.36 88.07 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.395 -0.816 . . . . 0.0 109.99 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.469 ' HA ' ' CE ' ' A' ' 110' ' ' LYS . 98.9 mt-10 -69.2 -46.17 68.08 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.311 -0.868 . . . . 0.0 111.067 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -64.76 -39.53 93.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.136 -0.977 . . . . 0.0 110.755 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.47 -45.17 94.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.162 -0.961 . . . . 0.0 110.877 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.64 ' HB3' ' HE2' ' A' ' 110' ' ' LYS . . . -62.51 -41.09 98.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.972 . . . . 0.0 110.481 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 110' ' ' LYS . 45.2 mt -64.64 -43.47 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 111.208 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.451 ' CG2' HG12 ' A' ' 142' ' ' ILE . 45.4 t -60.99 -42.77 94.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 108.788 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -61.27 -37.67 83.98 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.492 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.76 94.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.506 -0.746 . . . . 0.0 109.811 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 91.5 mt -63.83 -43.42 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 109.404 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -55.59 -44.63 77.14 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.502 -0.749 . . . . 0.0 109.682 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -63.19 -37.41 87.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.473 -0.767 . . . . 0.0 110.986 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.45 -37.94 89.22 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.977 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.425 ' OE1' ' ND2' ' A' ' 140' ' ' ASN . 3.3 mp0 -60.83 -15.34 29.07 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.804 -1.185 . . . . 0.0 111.091 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.7 mttt -94.61 -1.53 53.07 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 120.912 -1.118 . . . . 0.0 109.499 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -111.15 -15.09 13.76 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.857 -1.152 . . . . 0.0 110.188 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.1 t -152.68 160.28 43.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.023 -1.048 . . . . 0.0 109.45 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.1 m -88.17 -5.52 58.37 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.986 -1.071 . . . . 0.0 110.344 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.93 170.04 52.14 Favored Glycine 0 N--CA 1.482 1.723 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 138' ' ' LEU . 79.2 mm-40 -129.68 136.86 50.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.258 -1.142 . . . . 0.0 110.723 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.2 mt -119.22 134.96 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.595 -0.69 . . . . 0.0 110.71 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.686 ' CD ' HD23 ' A' ' 138' ' ' LEU . 84.3 mtp180 -139.47 153.24 47.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.389 -0.82 . . . . 0.0 109.923 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.883 HG22 HD12 ' A' ' 67' ' ' ILE . 61.7 t -123.42 141.01 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.302 -0.874 . . . . 0.0 110.952 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.498 ' HB2' HD11 ' A' ' 66' ' ' LEU . 82.5 t60 -122.95 124.82 44.05 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.65 HD11 HG13 ' A' ' 71' ' ' VAL . 35.8 tp -112.61 129.0 56.53 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.938 0.875 . . . . 0.0 111.286 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -146.42 164.77 31.4 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -79.73 -73.88 0.33 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.112 -0.992 . . . . 0.0 112.898 -177.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.33 157.24 46.23 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.262 -0.899 . . . . 0.0 110.133 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.8 m -103.06 165.07 11.24 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.624 -0.673 . . . . 0.0 110.166 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -104.23 -14.23 15.9 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.353 -0.842 . . . . 0.0 109.794 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.434 HG13 ' N ' ' A' ' 42' ' ' ASP . 29.8 pt -124.8 -122.01 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.052 -1.03 . . . . 0.0 110.052 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.434 ' N ' HG13 ' A' ' 41' ' ' ILE . 95.3 m-20 -110.73 139.17 46.26 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.16 -1.587 . . . . 0.0 109.359 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.696 HG11 HG21 ' A' ' 77' ' ' VAL . 84.3 t -64.59 -43.92 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.299 -0.875 . . . . 0.0 111.902 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -60.05 -45.42 92.91 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.72 -1.237 . . . . 0.0 110.123 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -70.98 -38.1 72.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.851 -1.156 . . . . 0.0 109.365 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 50.1 ttt85 -65.97 -43.1 88.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.774 -1.203 . . . . 0.0 110.266 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.75 -37.59 88.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.87 -1.144 . . . . 0.0 110.224 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 62.3 ttp -64.23 -43.23 95.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.137 -0.977 . . . . 0.0 109.153 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -63.85 -41.97 97.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.937 -1.102 . . . . 0.0 109.251 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 74.2 t -67.61 -42.87 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.502 -0.749 . . . . 0.0 109.833 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -59.8 -46.85 87.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.88 -1.138 . . . . 0.0 109.491 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -74.94 -36.12 62.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.967 -1.083 . . . . 0.0 109.764 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -61.07 -38.42 86.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.067 -1.02 . . . . 0.0 109.442 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.5 mt -81.89 4.05 23.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.0 110.048 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.43 33.96 23.4 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.288 -0.883 . . . . 0.0 111.941 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.719 ' SD ' HD13 ' A' ' 66' ' ' LEU . 95.7 mtp -69.22 -15.02 63.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.089 -1.007 . . . . 0.0 109.922 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 44.9 p-10 -78.45 -5.32 52.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.831 -1.168 . . . . 0.0 110.138 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 65.1 t-20 -88.64 78.8 7.67 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.788 -1.195 . . . . 0.0 110.409 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.3 m -137.02 154.91 50.26 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.19 -44.44 97.28 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 111.599 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 90.5 mt -99.94 -2.4 34.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.757 -1.215 . . . . 0.0 111.389 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 87.7 mt-30 59.32 49.92 8.37 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.245 1.021 . . . . 0.0 111.265 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -122.22 54.15 1.2 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.479 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.92 143.33 16.16 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.537 HG23 ' CD1' ' A' ' 84' ' ' ILE . 54.0 t -124.12 134.75 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.907 -1.349 . . . . 0.0 110.715 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.719 HD13 ' SD ' ' A' ' 56' ' ' MET . 39.7 tp -117.1 125.16 50.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.568 -0.708 . . . . 0.0 109.893 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.883 HD12 HG22 ' A' ' 33' ' ' VAL . 83.2 mt -102.3 110.88 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.602 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -96.37 120.75 37.25 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.168 -0.957 . . . . 0.0 110.027 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.9 t -122.39 131.11 73.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.297 -0.877 . . . . 0.0 110.922 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.561 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -99.91 90.52 4.45 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.65 HG13 HD11 ' A' ' 35' ' ' LEU . 17.4 m -60.26 -24.16 29.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.298 -0.876 . . . . 0.0 111.375 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -67.51 -41.12 84.94 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.989 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.414 ' O ' HG23 ' A' ' 75' ' ' THR . 96.2 m-20 -103.33 4.06 35.98 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.072 -1.017 . . . . 0.0 110.685 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.428 ' HE3' ' CE1' ' A' ' 109' ' ' PHE . 45.2 tttt 55.86 45.72 23.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.827 -1.171 . . . . 0.0 110.752 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.561 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 72.4 p -119.97 163.37 17.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.966 . . . . 0.0 109.32 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -142.79 146.09 33.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.104 -0.998 . . . . 0.0 110.578 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.696 HG21 HG11 ' A' ' 43' ' ' VAL . 53.7 t -134.74 138.47 49.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.747 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 88.7 mt -117.17 125.65 74.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 118.977 -1.089 . . . . 0.0 110.416 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -128.07 114.22 16.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.806 -0.559 . . . . 0.0 110.325 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -100.89 171.1 22.36 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 53.8 t0 -81.14 174.44 11.57 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.493 -1.004 . . . . 0.0 110.013 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.407 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 97.7 mttt -60.02 -26.67 66.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.989 . . . . 0.0 111.656 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.546 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -64.88 -52.11 45.19 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.807 -1.187 . . . . 0.0 110.416 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.944 ' O ' HG22 ' A' ' 88' ' ' VAL . 97.1 mt -64.71 -43.47 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.783 -1.422 . . . . 0.0 108.122 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -63.4 -36.93 85.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.518 -1.364 . . . . 0.0 111.476 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -74.21 -20.92 60.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.845 -1.159 . . . . 0.0 112.166 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.052 HG23 HG13 ' A' ' 88' ' ' VAL . 32.9 m -105.64 -18.51 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.745 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.052 HG13 HG23 ' A' ' 87' ' ' VAL . 4.0 m -119.82 160.28 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 120.67 -1.268 . . . . 0.0 111.47 -178.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.1 m -107.17 176.71 5.08 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.81 0.814 . . . . 0.0 112.005 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -61.86 -36.95 82.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.611 -0.681 . . . . 0.0 109.48 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -62.19 -38.22 88.28 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.422 -0.911 . . . . 0.0 108.922 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.864 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 55.3 t80 -64.05 -26.62 68.64 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.539 -0.726 . . . . 0.0 109.356 178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.747 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.9 m95 -86.95 -25.81 24.17 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.938 0.875 . . . . 0.0 110.989 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -56.92 -36.78 70.59 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.429 -0.795 . . . . 0.0 111.712 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.8 m -64.32 -33.66 76.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.767 -1.208 . . . . 0.0 108.983 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.501 HG22 HD13 ' A' ' 78' ' ' ILE 0.279 7.4 m -59.82 -49.89 75.94 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 122.358 1.075 . . . . 0.0 111.379 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.414 ' O ' ' HB2' ' A' ' 101' ' ' GLN . 99.4 mtt180 -66.69 -38.6 87.09 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.707 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.495 ' O ' HD23 ' A' ' 102' ' ' LEU . 82.0 m-20 -64.01 -45.03 90.78 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.946 -1.102 . . . . 0.0 110.439 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.1 -50.91 72.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.592 -1.318 . . . . 0.0 110.484 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.485 HD12 HD11 ' A' ' 78' ' ' ILE . 86.8 mt -67.81 -42.72 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.905 -1.122 . . . . 0.0 110.17 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 97' ' ' ARG . 57.3 tt0 -62.62 -46.72 86.94 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.516 -0.74 . . . . 0.0 111.086 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 98' ' ' ASN . 4.3 mm? -63.53 -41.54 98.46 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.007 -1.058 . . . . 0.0 112.043 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.462 ' HB2' ' HA3' ' A' ' 112' ' ' GLY . 99.4 mm-40 -72.15 -40.24 68.16 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.176 -1.41 . . . . 0.0 108.594 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -59.26 -40.82 87.2 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.784 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -62.38 -34.55 76.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -0.868 . . . . 0.0 110.928 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -83.6 -17.34 41.99 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.528 -1.357 . . . . 0.0 110.319 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.26 11.38 25.78 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.172 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' A' ' 103' ' ' GLN . 31.7 m120 -107.94 83.0 1.72 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.873 -1.369 . . . . 0.0 110.451 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.428 ' CE1' ' HE3' ' A' ' 74' ' ' LYS . 6.8 m-85 -62.5 -43.71 98.15 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.151 -0.968 . . . . 0.0 111.026 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.64 ' HE2' ' HB3' ' A' ' 15' ' ' ALA . 60.9 tttm -61.13 -47.85 84.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 0.0 111.446 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -64.1 -37.85 88.94 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.954 -1.091 . . . . 0.0 110.843 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 103' ' ' GLN . . . -62.49 -49.04 77.39 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.496 -1.335 . . . . 0.0 109.823 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.47 -43.96 97.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -1.161 . . . . 0.0 110.926 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.446 HG23 HG12 ' A' ' 16' ' ' ILE . 76.4 t -65.91 -46.82 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.906 -1.121 . . . . 0.0 110.325 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -65.01 -40.1 94.39 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.538 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.89 -43.74 93.21 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.3 mt -64.51 -44.33 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -1.14 . . . . 0.0 109.368 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -58.98 -49.08 79.25 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.045 -1.034 . . . . 0.0 109.632 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.34 -41.21 98.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.205 -0.934 . . . . 0.0 109.447 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.417 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -57.58 -42.04 82.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.202 -0.937 . . . . 0.0 110.072 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.59 -43.56 96.32 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.67 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 96.6 mtp -68.33 -45.37 73.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.914 -1.345 . . . . 0.0 110.285 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.864 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -63.56 -45.93 88.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.118 -0.989 . . . . 0.0 108.761 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.417 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 72.7 mt -61.87 -40.5 95.58 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.47 -34.08 56.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 110.4 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.58 -44.65 93.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.002 -1.061 . . . . 0.0 109.366 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -71.54 -41.47 69.09 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.45 0.643 . . . . 0.0 109.65 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.43 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 47.6 m-85 -130.54 97.69 21.35 Favored Pre-proline 0 C--N 1.307 -1.251 0 O-C-N 121.514 -0.741 . . . . 0.0 109.828 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 128' ' ' PHE . 42.0 Cg_endo -65.75 152.87 80.39 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.575 1.303 . . . . 0.0 110.707 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.481 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 47.7 t90 -76.57 127.07 32.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.556 -0.715 . . . . 0.0 110.689 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -103.35 146.96 27.69 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.151 -0.968 . . . . 0.0 109.041 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -56.71 -28.44 60.96 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.103 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.4 p30 -93.68 6.76 47.26 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.012 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 135' ' ' ILE . 67.1 t0 -42.55 140.24 1.31 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.705 0.764 . . . . 0.0 111.622 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.754 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -115.38 146.08 20.28 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 CA-C-O 121.576 0.703 . . . . 0.0 110.891 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -103.23 97.45 7.53 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.356 -1.465 . . . . 0.0 110.58 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -68.14 -35.72 78.56 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.686 HD23 ' CD ' ' A' ' 32' ' ' ARG . 7.1 mp -110.87 151.06 42.69 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.895 -1.128 . . . . 0.0 111.923 -178.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -72.48 -174.69 1.52 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 N-CA-C 108.448 -1.405 . . . . 0.0 108.448 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.425 ' ND2' ' OE1' ' A' ' 24' ' ' GLU . 10.5 m120 -123.02 2.51 9.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.592 -1.318 . . . . 0.0 110.116 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -58.2 170.25 0.71 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.934 -1.104 . . . . 0.0 111.348 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.451 HG12 ' CG2' ' A' ' 17' ' ' VAL . 49.6 mm -95.17 133.17 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.66 -0.65 . . . . 0.0 111.039 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 69.5 m -93.08 131.24 38.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.534 -0.729 . . . . 0.0 109.093 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -127.03 135.99 51.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.884 -1.135 . . . . 0.0 110.591 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.398 0 CA-C-O 117.935 -1.481 . . . . 0.0 109.72 -179.768 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.0 p . . . . . 0 N--CA 1.495 1.81 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 14' ' ' LYS . . . -54.73 -39.73 68.55 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.797 -1.19 . . . . 0.0 109.422 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -62.8 -40.36 97.12 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.473 -0.767 . . . . 0.0 109.51 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -73.62 -46.59 45.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.105 -0.997 . . . . 0.0 110.696 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.736 ' O ' HG23 ' A' ' 17' ' ' VAL . 96.8 mt-10 -67.04 -34.56 77.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.112 -0.993 . . . . 0.0 110.265 178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 87.6 tttt -64.77 -44.7 89.19 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.753 -1.217 . . . . 0.0 110.075 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.94 -47.02 79.18 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.134 -0.979 . . . . 0.0 111.409 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.405 HG22 ' O ' ' A' ' 13' ' ' GLU . 20.4 tt -64.06 -36.25 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.773 -1.205 . . . . 0.0 110.174 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 13' ' ' GLU . 55.4 t -61.28 -38.36 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -64.25 -36.18 83.25 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.775 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.98 -40.15 94.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.06 -1.025 . . . . 0.0 109.566 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.768 HG22 ' OD1' ' A' ' 140' ' ' ASN . 83.6 mt -63.14 -43.79 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 109.399 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -62.2 -43.72 98.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.45 -0.781 . . . . 0.0 110.694 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -63.08 -38.9 93.04 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.162 -0.961 . . . . 0.0 111.41 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.9 -37.89 88.74 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.206 -0.997 . . . . 0.0 109.291 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.2 -15.99 29.22 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.101 -0.999 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.478 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 75.5 mmtt -94.88 -3.6 48.48 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.013 -1.054 . . . . 0.0 109.544 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -108.69 -13.48 14.79 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 121.176 -0.953 . . . . 0.0 109.813 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.8 t -156.35 161.15 40.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.014 -1.054 . . . . 0.0 110.049 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.3 m -87.21 -12.13 47.73 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.371 -0.831 . . . . 0.0 108.78 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.39 167.09 40.89 Favored Glycine 0 N--CA 1.477 1.394 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.557 ' OE1' HD12 ' A' ' 138' ' ' LEU . 97.8 mt-10 -135.59 141.6 45.16 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 118.9 -1.12 . . . . 0.0 112.229 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.6 mt -123.61 135.77 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.237 0.541 . . . . 0.0 110.547 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.451 ' NH1' HD13 ' A' ' 54' ' ' LEU . 68.8 ttt180 -139.88 163.06 33.65 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.198 -0.939 . . . . 0.0 109.746 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 p -131.97 142.4 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.157 -0.964 . . . . 0.0 111.687 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.419 ' HA ' ' O ' ' A' ' 143' ' ' SER . 81.7 t60 -126.98 125.56 41.7 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.452 -0.78 . . . . 0.0 109.442 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.473 HD11 ' HB ' ' A' ' 71' ' ' VAL . 47.5 tp -108.4 128.56 54.88 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 122.07 0.938 . . . . 0.0 112.019 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.41 ' OE2' ' CZ ' ' A' ' 46' ' ' ARG . 82.2 tt0 -144.87 159.68 42.51 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 97.8 mttt -79.32 -75.66 0.24 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.063 -1.023 . . . . 0.0 112.94 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.6 t -136.57 155.34 50.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.299 -0.876 . . . . 0.0 110.214 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.5 p -103.77 170.79 7.72 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.415 -0.803 . . . . 0.0 110.365 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.414 ' OE1' ' N ' ' A' ' 40' ' ' GLU . 56.0 mp0 -108.37 -12.61 15.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.472 -0.768 . . . . 0.0 110.414 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.8 pt -124.31 -122.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.149 -0.969 . . . . 0.0 108.586 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -111.84 140.81 46.18 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 120.434 -1.416 . . . . 0.0 109.687 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.498 ' CG1' HG21 ' A' ' 77' ' ' VAL . 94.4 t -64.15 -42.74 96.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.372 -0.83 . . . . 0.0 110.683 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -59.92 -46.75 88.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.955 -1.091 . . . . 0.0 109.938 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -69.81 -36.8 75.96 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.79 -1.194 . . . . 0.0 108.772 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.41 ' CZ ' ' OE2' ' A' ' 36' ' ' GLU . 61.3 ttt85 -64.1 -42.85 96.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -0.916 . . . . 0.0 110.949 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.6 83.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.722 -1.236 . . . . 0.0 110.499 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 60.2 ttp -62.89 -42.28 99.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.034 -1.042 . . . . 0.0 108.975 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -65.88 -44.7 84.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.137 -0.977 . . . . 0.0 110.361 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.44 -43.44 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.365 -0.834 . . . . 0.0 110.411 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 2.9 t80 -58.77 -47.92 83.0 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.7 -1.25 . . . . 0.0 108.996 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -72.16 -35.66 69.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.043 -1.036 . . . . 0.0 109.703 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -60.54 -39.35 87.57 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.451 HD13 ' NH1' ' A' ' 32' ' ' ARG . 85.6 mt -80.2 5.26 15.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.155 -0.966 . . . . 0.0 110.361 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 55.76 33.94 22.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.818 -1.176 . . . . 0.0 111.926 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.824 ' SD ' HD13 ' A' ' 66' ' ' LEU . 94.1 mtp -65.55 -11.01 40.04 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.988 -1.07 . . . . 0.0 110.236 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -77.53 0.57 22.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.819 -1.176 . . . . 0.0 110.284 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -74.57 62.25 1.01 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.851 -1.156 . . . . 0.0 110.062 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.41 ' OG1' ' HA ' ' A' ' 62' ' ' GLN . 65.3 p -135.19 148.47 49.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.107 -0.996 . . . . 0.0 109.631 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -64.44 -40.98 96.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.75 -0.594 . . . . 0.0 112.276 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 95.7 mt -98.66 -0.15 43.53 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.904 -1.122 . . . . 0.0 111.448 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.41 ' HA ' ' OG1' ' A' ' 59' ' ' THR . 85.7 mt-30 57.71 45.77 18.38 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 122.5 1.143 . . . . 0.0 111.148 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.423 ' HA ' HG13 ' A' ' 84' ' ' ILE . 38.0 p30 -118.96 53.61 1.0 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.072 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.39 140.98 15.13 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.512 HG23 ' CD1' ' A' ' 84' ' ' ILE . 67.3 t -125.55 134.74 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.043 -1.269 . . . . 0.0 110.34 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.824 HD13 ' SD ' ' A' ' 56' ' ' MET . 38.5 tp -117.51 133.68 55.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.339 -0.851 . . . . 0.0 110.24 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.2 mt -106.82 108.83 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 118.75 -1.18 . . . . 0.0 109.557 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -95.45 117.71 30.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 110.181 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.1 t -118.19 128.34 75.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 121.726 0.774 . . . . 0.0 110.356 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.574 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -95.26 88.49 5.17 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.473 ' HB ' HD11 ' A' ' 35' ' ' LEU . 7.2 p -58.73 -23.81 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.036 -1.04 . . . . 0.0 110.907 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 47.7 tp10 -67.73 -41.89 82.73 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.779 -1.2 . . . . 0.0 108.85 178.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.635 ' O ' HG23 ' A' ' 75' ' ' THR . 40.5 t0 -104.77 8.6 34.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.053 -1.03 . . . . 0.0 111.259 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 104' ' ' PHE . 85.3 tttt 52.12 45.17 28.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.875 -1.141 . . . . 0.0 110.407 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 73' ' ' ASP . 46.8 p -122.33 159.15 28.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.803 -1.186 . . . . 0.0 109.135 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -141.53 148.37 39.24 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.21 -0.932 . . . . 0.0 110.364 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.498 HG21 ' CG1' ' A' ' 43' ' ' VAL . 66.1 t -134.19 137.13 52.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.716 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 75.8 mt -113.74 127.83 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.859 -1.151 . . . . 0.0 110.174 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -135.02 114.67 12.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.576 -0.702 . . . . 0.0 110.624 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -99.77 171.47 23.88 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.474 ' OD1' ' CE1' ' A' ' 51' ' ' PHE . 78.1 m-20 -75.33 171.28 14.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.399 -1.059 . . . . 0.0 110.653 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -58.64 -26.46 63.78 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.592 -0.692 . . . . 0.0 110.444 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.408 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -66.1 -53.34 30.48 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.981 ' O ' HG22 ' A' ' 88' ' ' VAL . 87.6 mt -63.51 -44.74 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.944 -1.327 . . . . 0.0 107.893 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -62.21 -36.87 83.26 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.833 -1.167 . . . . 0.0 111.396 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -70.63 -24.26 62.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.861 -1.15 . . . . 0.0 111.78 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.865 HG23 HG13 ' A' ' 88' ' ' VAL . 25.7 m -105.74 -16.45 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 120.642 -1.286 . . . . 0.0 112.909 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.981 HG22 ' O ' ' A' ' 84' ' ' ILE . 18.8 m -116.45 162.07 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 120.338 -1.476 . . . . 0.0 112.002 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.3 t -109.41 174.46 5.86 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.597 0.713 . . . . 0.0 111.809 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 33.0 p-10 -61.61 -35.85 79.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 110.147 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -62.42 -40.59 97.03 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.821 -1.174 . . . . 0.0 109.781 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.854 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 87.8 t80 -63.15 -25.52 68.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.123 -0.985 . . . . 0.0 109.333 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.716 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.2 m95 -86.88 -24.64 24.82 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.955 0.883 . . . . 0.0 110.876 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -57.1 -38.81 73.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.063 -1.023 . . . . 0.0 112.455 -177.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.9 p -63.61 -31.84 73.14 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.53 -1.268 . . . . 0.0 109.199 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.444 ' CG2' HD13 ' A' ' 78' ' ' ILE 0.272 15.1 m -59.93 -48.06 83.22 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.379 1.085 . . . . 0.0 111.031 179.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -68.98 -38.57 79.41 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.25 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -64.03 -44.26 93.08 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.827 -1.171 . . . . 0.0 110.669 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.88 -49.77 73.54 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.832 -1.167 . . . . 0.0 111.348 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 91.4 mt -67.34 -42.42 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.073 -1.017 . . . . 0.0 110.329 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -65.16 -40.92 95.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.243 -0.911 . . . . 0.0 110.602 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.8 tp -62.22 -42.13 99.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.209 -0.932 . . . . 0.0 111.13 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.447 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 95.8 mm-40 -76.9 -40.0 48.89 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.136 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.415 ' O ' ' CE ' ' A' ' 74' ' ' LYS . 2.8 m-85 -58.41 -41.82 85.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.145 -0.972 . . . . 0.0 108.55 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.43 -32.12 73.47 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.635 -0.665 . . . . 0.0 110.444 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -78.69 -20.07 51.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.741 -1.225 . . . . 0.0 109.911 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.17 4.7 41.15 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.41 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -103.66 86.31 2.6 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.743 -1.445 . . . . 0.0 110.097 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -61.62 -43.03 99.62 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.371 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -61.71 -47.95 82.96 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.97 -1.081 . . . . 0.0 111.377 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -64.55 -38.11 89.87 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.21 -0.932 . . . . 0.0 110.488 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.447 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -63.84 -49.54 67.4 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.51 -44.73 93.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.145 -1.209 . . . . 0.0 110.959 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.416 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 71.1 t -65.03 -47.77 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.137 -0.977 . . . . 0.0 110.115 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -62.84 -40.88 98.77 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.922 -1.111 . . . . 0.0 110.571 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.29 -42.24 97.23 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -43.99 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.228 -1.16 . . . . 0.0 109.698 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 114' ' ' VAL . 80.5 mm-40 -58.28 -54.62 44.93 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.05 -1.031 . . . . 0.0 110.597 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.34 -39.97 92.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.122 -0.986 . . . . 0.0 108.691 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.55 -41.58 90.41 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.312 -0.867 . . . . 0.0 109.713 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.17 -44.3 97.34 Favored Glycine 0 N--CA 1.495 2.607 0 O-C-N 120.761 -1.212 . . . . 0.0 111.01 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 64.6 ttp -67.91 -48.03 67.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.874 -1.368 . . . . 0.0 109.898 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.854 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -59.99 -46.52 89.19 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.058 -1.026 . . . . 0.0 109.234 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.96 -41.01 97.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 109.45 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.14 -32.23 54.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 110.335 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.77 -44.41 96.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.129 -0.982 . . . . 0.0 109.848 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -72.37 -41.79 65.97 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.537 0.684 . . . . 0.0 110.276 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -132.05 100.71 15.55 Favored Pre-proline 0 C--N 1.304 -1.404 0 O-C-N 121.54 -0.725 . . . . 0.0 109.657 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.42 150.72 80.78 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.57 1.3 . . . . 0.0 110.932 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.478 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 60.3 t90 -75.13 133.84 41.42 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.645 -0.659 . . . . 0.0 110.546 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -114.06 153.59 29.16 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 109.495 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.44 -28.98 65.77 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.035 -1.04 . . . . 0.0 110.63 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -93.3 7.54 43.96 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.311 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.401 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 52.2 t0 -42.43 138.43 1.78 Allowed 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.77 0.795 . . . . 0.0 111.361 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.712 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -114.36 148.2 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 121.896 0.855 . . . . 0.0 111.967 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -108.55 96.03 6.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.641 -1.287 . . . . 0.0 110.382 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.424 ' N ' ' OE2' ' A' ' 30' ' ' GLU . 81.2 mm-40 -67.81 -32.31 72.77 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.594 -0.692 . . . . 0.0 111.662 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.557 HD12 ' OE1' ' A' ' 30' ' ' GLU . 33.7 mt -110.06 154.46 42.72 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.185 -0.947 . . . . 0.0 111.856 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -79.4 -167.27 0.48 Allowed 'Trans proline' 0 C--N 1.319 -1.014 0 N-CA-C 108.436 -1.409 . . . . 0.0 108.436 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.768 ' OD1' HG22 ' A' ' 20' ' ' ILE . 65.9 m-80 -124.0 3.21 8.69 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.468 -1.395 . . . . 0.0 110.392 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.3 p -63.24 166.75 5.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.884 -1.135 . . . . 0.0 111.13 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.8 mt -96.09 137.87 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.823 -0.548 . . . . 0.0 110.258 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 32' ' ' ARG . 25.1 t -96.35 137.23 35.73 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.208 -0.933 . . . . 0.0 109.713 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -128.13 145.15 51.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.004 -1.06 . . . . 0.0 110.284 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.903 0 CA-C-O 117.972 -1.46 . . . . 0.0 110.296 179.898 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 p . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.59 -37.03 65.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.948 -1.095 . . . . 0.0 109.864 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -60.87 -45.46 94.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 110.498 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -70.02 -45.38 67.33 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.239 -0.913 . . . . 0.0 110.8 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.68 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.1 mt-10 -64.18 -37.18 86.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.111 -0.993 . . . . 0.0 110.384 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -66.0 -44.0 86.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.968 -1.082 . . . . 0.0 111.959 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.18 -44.4 88.56 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.747 -1.221 . . . . 0.0 111.106 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.487 HG13 HG22 ' A' ' 114' ' ' VAL . 17.2 tt -65.92 -34.69 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.848 -1.158 . . . . 0.0 109.917 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.707 HG13 ' ND2' ' A' ' 140' ' ' ASN . 55.1 t -63.65 -40.49 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.88 -36.64 83.99 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.441 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.82 -38.71 91.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.205 -0.934 . . . . 0.0 108.904 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.448 ' CG2' ' HB2' ' A' ' 140' ' ' ASN . 30.5 mm -62.87 -43.66 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.401 -0.812 . . . . 0.0 108.9 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.95 -43.3 98.92 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.542 -0.723 . . . . 0.0 109.976 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -64.71 -39.26 93.35 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.26 -0.9 . . . . 0.0 111.258 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.95 -39.27 93.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.045 -1.034 . . . . 0.0 109.616 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.12 -17.62 41.52 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.026 -1.046 . . . . 0.0 110.126 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.5 mttt -93.61 -3.3 52.84 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 121.178 -0.951 . . . . 0.0 109.733 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -107.57 -15.49 14.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.905 -1.122 . . . . 0.0 109.885 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.6 t -152.75 160.54 43.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.036 -1.04 . . . . 0.0 109.732 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.9 p -86.96 -8.73 56.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.959 -1.088 . . . . 0.0 109.534 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.66 170.84 42.28 Favored Glycine 0 N--CA 1.482 1.725 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 138' ' ' LEU . 78.6 mm-40 -131.35 137.07 48.59 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.526 -0.985 . . . . 0.0 111.342 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -121.23 134.1 65.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.804 -0.56 . . . . 0.0 109.8 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -137.49 151.09 48.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.129 -0.982 . . . . 0.0 109.65 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.862 HG22 HD12 ' A' ' 67' ' ' ILE . 55.6 t -121.7 138.06 53.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.545 -0.722 . . . . 0.0 110.791 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.481 ' HB2' HD11 ' A' ' 66' ' ' LEU . 60.3 t60 -123.18 127.01 48.05 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.968 HD11 ' CG1' ' A' ' 71' ' ' VAL . 32.5 tp -113.93 125.81 54.46 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.85 0.833 . . . . 0.0 111.832 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 85.0 tt0 -143.22 161.75 37.44 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.411 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 98.5 mttt -77.35 -71.36 0.41 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.994 -1.066 . . . . 0.0 113.469 -177.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.418 ' CG2' ' OE1' ' A' ' 72' ' ' GLU . 8.0 t -140.13 159.01 43.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 110.462 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.9 m -107.1 164.72 11.92 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.824 -0.547 . . . . 0.0 110.128 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -105.8 -11.04 16.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.146 -0.971 . . . . 0.0 110.315 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.8 pt -125.13 -122.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.912 -1.118 . . . . 0.0 109.075 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -110.89 140.39 45.4 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.073 -1.642 . . . . 0.0 109.204 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.606 ' CG1' HG21 ' A' ' 77' ' ' VAL . 91.4 t -64.61 -42.92 96.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.283 -0.886 . . . . 0.0 110.986 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -59.43 -47.0 87.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.97 -1.081 . . . . 0.0 110.917 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -69.09 -39.0 79.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.59 -1.319 . . . . 0.0 108.359 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -59.78 -44.11 94.07 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.44 -0.788 . . . . 0.0 110.548 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.71 -36.98 85.15 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.887 -1.133 . . . . 0.0 110.006 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.4 ttp -62.77 -43.46 98.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.936 . . . . 0.0 109.402 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -65.76 -42.13 91.27 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.774 -1.204 . . . . 0.0 110.296 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.9 t -69.0 -43.21 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.246 -0.909 . . . . 0.0 110.777 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.466 ' CD1' ' HB2' ' A' ' 56' ' ' MET . 2.0 t80 -59.2 -46.65 87.86 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.758 -1.214 . . . . 0.0 108.929 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -74.48 -35.86 63.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.144 -0.972 . . . . 0.0 109.858 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -61.45 -38.39 87.03 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.172 -0.955 . . . . 0.0 109.782 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.1 mt -80.21 5.89 13.32 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.362 -0.836 . . . . 0.0 110.336 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.1 mttt 54.67 30.6 13.66 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 120.877 -1.139 . . . . 0.0 110.532 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.466 ' HB2' ' CD1' ' A' ' 51' ' ' PHE . 98.4 mtp -64.75 -12.25 45.22 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.938 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -75.89 -0.54 21.71 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.751 -1.218 . . . . 0.0 110.509 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -76.2 64.42 2.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.763 -1.211 . . . . 0.0 110.224 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.559 HG22 ' HB3' ' A' ' 137' ' ' GLU . 76.3 p -135.4 149.58 49.68 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.288 -0.882 . . . . 0.0 109.622 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.72 -43.28 96.99 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.445 ' HB2' ' ND2' ' A' ' 63' ' ' ASN . 95.8 mt -99.11 1.47 45.14 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.814 -1.179 . . . . 0.0 111.643 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 56.01 45.63 23.38 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 122.734 1.254 . . . . 0.0 110.803 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.445 ' ND2' ' HB2' ' A' ' 61' ' ' LEU . 24.6 p30 -118.05 55.25 0.89 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.238 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.99 142.87 15.66 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.527 HG23 ' CD1' ' A' ' 84' ' ' ILE . 61.0 t -127.72 136.19 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.165 -1.197 . . . . 0.0 110.779 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 34' ' ' HIS . 49.7 tp -116.71 127.44 54.39 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.783 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.862 HD12 HG22 ' A' ' 33' ' ' VAL . 90.0 mt -100.84 107.23 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.958 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.547 ' CD1' HG13 ' A' ' 43' ' ' VAL . 61.2 t80 -94.05 115.15 27.44 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.091 -1.006 . . . . 0.0 109.749 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.8 t -117.67 132.46 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 122.09 0.948 . . . . 0.0 111.126 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.601 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -99.37 87.27 3.58 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.968 ' CG1' HD11 ' A' ' 35' ' ' LEU . 28.9 m -58.89 -25.35 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.458 -0.776 . . . . 0.0 111.834 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.418 ' OE1' ' CG2' ' A' ' 38' ' ' THR . 71.3 tt0 -67.14 -43.36 82.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.743 -1.223 . . . . 0.0 108.64 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.448 ' O ' HG23 ' A' ' 75' ' ' THR . 77.1 m-20 -99.64 5.38 45.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.47 -0.769 . . . . 0.0 110.457 178.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.2 tttt 54.47 46.57 24.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.922 -1.111 . . . . 0.0 111.034 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.601 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 33.7 p -121.63 167.74 12.56 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.784 -1.198 . . . . 0.0 109.791 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -147.42 142.07 26.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.149 -0.97 . . . . 0.0 110.706 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.606 HG21 ' CG1' ' A' ' 43' ' ' VAL . 41.4 t -130.11 138.8 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.476 -0.765 . . . . 0.0 109.259 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.658 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 71.1 mt -117.54 126.37 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.804 -1.185 . . . . 0.0 110.248 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -133.25 115.46 15.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.545 -0.722 . . . . 0.0 110.735 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.8 170.74 20.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.441 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 94.2 m-20 -82.67 -178.59 7.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.482 -1.011 . . . . 0.0 110.582 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.67 -26.69 68.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 110.765 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.46 -57.9 14.64 Favored Glycine 0 N--CA 1.485 1.966 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.522 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.978 ' O ' HG22 ' A' ' 88' ' ' VAL . 79.3 mt -64.97 -44.52 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.801 -1.411 . . . . 0.0 108.917 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -61.47 -38.37 87.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.082 -1.011 . . . . 0.0 111.455 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -72.15 -19.4 61.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.915 -1.115 . . . . 0.0 112.23 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.993 HG23 HG13 ' A' ' 88' ' ' VAL . 12.8 m -108.27 -17.91 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.784 -1.198 . . . . 0.0 112.536 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.993 HG13 HG23 ' A' ' 87' ' ' VAL . 18.8 m -120.8 160.43 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.674 -1.266 . . . . 0.0 111.397 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.0 p -108.18 -175.5 2.79 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.956 0.884 . . . . 0.0 112.552 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -63.41 -35.63 81.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.662 -0.649 . . . . 0.0 109.74 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -62.3 -38.47 89.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 109.321 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.779 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 72.7 t80 -66.79 -27.64 67.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.563 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.658 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 7.3 m95 -86.06 -29.46 23.39 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.06 0.933 . . . . 0.0 110.254 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -55.83 -40.07 72.27 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.554 -0.716 . . . . 0.0 112.225 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 69.3 p -64.77 -30.46 71.47 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.412 -1.315 . . . . 0.0 108.594 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.525 ' CG2' HD13 ' A' ' 78' ' ' ILE 0.262 7.6 m -59.91 -49.43 77.73 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 122.333 1.063 . . . . 0.0 111.092 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -69.27 -37.9 78.12 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.941 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -63.85 -42.88 97.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.912 -1.117 . . . . 0.0 110.454 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.11 -48.6 73.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.736 -1.228 . . . . 0.0 110.927 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.4 mt -67.0 -42.7 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.845 -1.159 . . . . 0.0 110.175 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -61.78 -42.12 98.6 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.448 -0.782 . . . . 0.0 110.957 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.9 tp -63.81 -43.19 97.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.095 -1.003 . . . . 0.0 112.319 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.458 ' HB3' ' CA ' ' A' ' 112' ' ' GLY . 5.0 tp60 -76.07 -38.67 56.81 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.322 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -61.98 -41.4 97.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.016 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.51 -33.62 75.25 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.767 -0.583 . . . . 0.0 110.472 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -77.23 -18.29 57.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.981 -1.075 . . . . 0.0 109.499 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.8 2.52 42.89 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.714 -1.232 . . . . 0.0 111.393 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -100.22 91.32 4.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.669 -1.489 . . . . 0.0 109.972 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -62.04 -44.93 95.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.624 -0.673 . . . . 0.0 111.812 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.403 ' O ' HG23 ' A' ' 114' ' ' VAL . 5.0 mppt? -62.64 -47.17 84.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.846 -1.159 . . . . 0.0 112.322 -177.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.419 ' CB ' ' HG2' ' A' ' 103' ' ' GLN . 89.1 mm-40 -64.33 -37.85 88.95 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.725 -1.234 . . . . 0.0 110.634 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.458 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -65.03 -50.68 56.58 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.42 -1.371 . . . . 0.0 109.899 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.4 ' HB3' HD11 ' A' ' 16' ' ' ILE . 32.6 mt -62.6 -45.15 94.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.147 -1.208 . . . . 0.0 110.405 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.487 HG22 HG13 ' A' ' 16' ' ' ILE . 79.0 t -64.47 -48.02 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.001 -1.062 . . . . 0.0 110.736 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.06 -41.48 97.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.046 -1.034 . . . . 0.0 110.215 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.25 -40.58 98.78 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 75.9 mt -63.69 -44.03 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -1.072 . . . . 0.0 109.709 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -58.9 -45.12 91.03 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.052 -1.03 . . . . 0.0 109.027 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.35 -41.63 98.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.364 -0.835 . . . . 0.0 109.066 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.502 ' O ' HD12 ' A' ' 124' ' ' LEU . . . -59.82 -43.53 94.5 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.434 -0.791 . . . . 0.0 109.942 178.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.13 -45.55 86.22 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 120.352 -0.927 . . . . 0.0 110.84 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 99.1 mmm -66.24 -44.96 82.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.979 -1.306 . . . . 0.0 109.655 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.779 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -64.53 -46.18 84.0 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.427 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 120' ' ' ALA . 52.1 mt -62.55 -39.12 92.61 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.398 -0.813 . . . . 0.0 108.884 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.27 -35.18 62.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.161 -0.962 . . . . 0.0 110.794 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.8 -39.45 88.96 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.825 -1.172 . . . . 0.0 109.774 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -84.05 -34.6 24.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.5 -0.75 . . . . 0.0 110.328 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -125.93 96.6 37.14 Favored Pre-proline 0 C--N 1.303 -1.422 0 O-C-N 121.2 -0.938 . . . . 0.0 109.128 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.88 149.04 65.55 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 O-C-N 123.866 1.456 . . . . 0.0 110.047 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.476 ' CD1' ' OD2' ' A' ' 134' ' ' ASP . 59.7 t90 -75.52 131.08 39.83 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.245 -0.91 . . . . 0.0 110.731 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -110.17 150.33 28.8 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 108.912 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.06 -29.4 65.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.996 -1.065 . . . . 0.0 110.414 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -92.34 8.39 38.61 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.817 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.476 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 66.2 t0 -42.32 138.02 1.84 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.304 -0.873 . . . . 0.0 111.995 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.771 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.3 pp -115.9 152.96 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.533 0.683 . . . . 0.0 111.131 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -113.59 99.35 7.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.832 -1.168 . . . . 0.0 110.041 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.559 ' HB3' HG22 ' A' ' 59' ' ' THR . 79.9 mm-40 -67.95 -39.46 83.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.685 -0.635 . . . . 0.0 112.267 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -105.27 152.11 39.75 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.144 -0.972 . . . . 0.0 111.498 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -76.64 -166.57 0.39 Allowed 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.528 1.278 . . . . 0.0 108.786 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.707 ' ND2' HG13 ' A' ' 17' ' ' VAL . 1.1 p-10 -122.98 2.48 9.35 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.834 -1.166 . . . . 0.0 109.94 178.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.8 m -64.66 135.9 56.4 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.832 -1.167 . . . . 0.0 111.432 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.9 mt -70.93 138.59 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.669 -0.644 . . . . 0.0 109.73 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.427 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 32.2 t -98.98 100.01 11.13 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.075 -1.015 . . . . 0.0 109.717 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.436 ' HG2' ' HB3' ' A' ' 35' ' ' LEU . 98.9 mttt -100.67 147.58 25.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.827 -1.171 . . . . 0.0 109.038 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 CA-C-O 118.018 -1.434 . . . . 0.0 109.62 -179.808 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 10' ' ' ALA . 71.9 m . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.24 0.543 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.404 ' N ' HG22 ' A' ' 9' ' ' THR . . . -58.8 -37.53 76.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 109.825 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -49.88 -60.92 2.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -0.855 . . . . 0.0 110.611 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.459 ' HB3' ' HG2' ' A' ' 110' ' ' LYS . 98.6 mt-10 -63.37 -40.94 98.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.576 -0.703 . . . . 0.0 110.962 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.7 mt-10 -62.61 -37.22 85.41 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.972 -1.08 . . . . 0.0 110.462 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -64.12 -44.35 92.49 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.903 -1.123 . . . . 0.0 110.276 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.93 -41.59 99.53 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.231 -0.918 . . . . 0.0 111.123 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.778 HG13 HG22 ' A' ' 114' ' ' VAL . 19.6 tt -68.36 -27.36 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.854 -1.154 . . . . 0.0 110.19 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 13' ' ' GLU . 71.1 t -66.69 -41.13 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.08 -35.06 79.51 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.652 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.66 94.12 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.265 -0.897 . . . . 0.0 109.547 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.426 ' CG2' ' HB2' ' A' ' 140' ' ' ASN . 96.6 mt -64.52 -43.38 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.14 -0.975 . . . . 0.0 110.102 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -61.21 -41.0 96.08 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.45 -0.782 . . . . 0.0 109.716 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -64.53 -38.24 90.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.544 -0.722 . . . . 0.0 111.302 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.74 -39.72 94.11 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.957 -1.089 . . . . 0.0 109.508 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -59.56 -16.55 25.93 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.025 -1.047 . . . . 0.0 110.618 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 97.3 mttt -95.0 -0.57 53.68 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.144 -0.973 . . . . 0.0 109.197 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -111.07 -15.36 13.73 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 120.903 -1.123 . . . . 0.0 110.151 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.7 t -152.91 158.6 42.36 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.045 -1.034 . . . . 0.0 110.061 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 97.6 p -87.29 -10.13 53.15 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.322 -0.861 . . . . 0.0 109.819 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.13 170.62 37.33 Favored Glycine 0 N--CA 1.48 1.571 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.64 ' HB3' HD12 ' A' ' 138' ' ' LEU . 80.9 mm-40 -130.54 134.01 46.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.231 -1.158 . . . . 0.0 111.524 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.8 mt -121.34 134.92 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-O 121.393 0.615 . . . . 0.0 110.097 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.742 ' CD ' HD13 ' A' ' 138' ' ' LEU . 84.0 mtp180 -137.46 153.49 50.08 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.802 HG12 HD12 ' A' ' 67' ' ' ILE . 27.4 m -121.21 141.19 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 111.417 -177.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.768 ' HB2' HD11 ' A' ' 66' ' ' LEU . 36.7 t60 -125.57 128.19 47.55 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.62 0.724 . . . . 0.0 109.657 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.624 HD11 ' CG1' ' A' ' 71' ' ' VAL . 27.9 tp -117.53 128.96 55.48 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.6 0.714 . . . . 0.0 111.43 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 83.3 tt0 -147.0 166.94 25.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.6 -0.687 . . . . 0.0 109.301 177.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.446 ' HA ' HG22 ' A' ' 71' ' ' VAL . 97.6 mttt -81.83 -76.94 0.23 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.335 -0.853 . . . . 0.0 113.241 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.433 ' HB ' ' HG2' ' A' ' 72' ' ' GLU . 3.9 t -139.9 154.74 47.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.042 -1.036 . . . . 0.0 110.429 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.447 ' CB ' ' HD2' ' A' ' 46' ' ' ARG . 63.7 p -104.74 169.5 8.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.481 -0.762 . . . . 0.0 110.668 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -103.97 -18.31 14.64 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.327 -0.858 . . . . 0.0 109.803 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.7 pt -117.17 -122.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.22 -0.925 . . . . 0.0 109.884 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -112.13 139.79 47.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.129 -1.607 . . . . 0.0 109.996 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.639 ' CG1' HG21 ' A' ' 77' ' ' VAL . 95.0 t -61.3 -44.07 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.284 -0.885 . . . . 0.0 110.994 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -60.43 -46.66 89.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.948 -1.095 . . . . 0.0 110.165 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -70.14 -36.54 74.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.003 -1.061 . . . . 0.0 108.694 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.447 ' HD2' ' CB ' ' A' ' 39' ' ' SER . 59.8 ttt85 -64.83 -41.84 95.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.162 -0.961 . . . . 0.0 110.765 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.1 -36.99 80.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.87 -1.144 . . . . 0.0 110.049 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.0 ttp -62.95 -45.97 89.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.358 -0.839 . . . . 0.0 110.079 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -64.1 -42.12 97.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.991 -1.068 . . . . 0.0 109.461 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 72.4 t -66.44 -43.1 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.346 -0.846 . . . . 0.0 110.323 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.482 ' CE2' ' HE2' ' A' ' 56' ' ' MET . 6.9 t80 -58.98 -46.7 87.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.986 -1.071 . . . . 0.0 108.871 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -72.77 -35.9 67.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.021 -1.049 . . . . 0.0 109.651 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -61.09 -39.24 89.18 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.995 -1.066 . . . . 0.0 109.316 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.9 mt -80.58 3.92 20.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 110.152 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 54.54 33.1 18.24 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.029 -1.044 . . . . 0.0 111.46 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.591 ' SD ' HD13 ' A' ' 66' ' ' LEU . 90.4 mtp -65.44 -12.61 54.05 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.81 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -76.65 -1.88 29.93 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.941 -1.1 . . . . 0.0 109.958 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -75.49 64.22 1.58 Allowed 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.056 -1.028 . . . . 0.0 109.748 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.2 p -135.05 149.7 50.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 109.238 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.26 -41.91 99.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.617 -0.677 . . . . 0.0 112.665 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 84.1 mt -99.62 0.17 41.57 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.796 -1.19 . . . . 0.0 111.743 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.422 ' O ' ' CB ' ' A' ' 81' ' ' ASP . 86.5 mt-30 58.55 46.85 14.22 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.451 1.119 . . . . 0.0 111.028 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -119.98 50.89 1.23 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.402 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.1 142.42 16.11 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.252 -1.939 . . . . 0.0 108.252 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.514 HG23 ' CD1' ' A' ' 84' ' ' ILE . 54.4 t -126.94 134.79 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.993 -1.298 . . . . 0.0 110.401 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.768 HD11 ' HB2' ' A' ' 34' ' ' HIS . 39.2 tp -117.17 125.03 50.56 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.068 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.802 HD12 HG12 ' A' ' 33' ' ' VAL . 98.6 mt -102.69 101.85 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.571 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -88.54 124.32 33.9 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.312 -0.867 . . . . 0.0 110.057 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.614 ' HB ' HD12 ' A' ' 35' ' ' LEU . 69.1 t -119.57 131.87 70.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.909 0.861 . . . . 0.0 110.373 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.505 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -102.46 87.02 2.91 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.624 ' CG1' HD11 ' A' ' 35' ' ' LEU . 34.6 m -60.56 -20.84 21.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.893 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.433 ' HG2' ' HB ' ' A' ' 38' ' ' THR . 49.6 tp10 -70.92 -45.41 64.28 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.092 -1.005 . . . . 0.0 109.097 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.526 ' O ' HG23 ' A' ' 75' ' ' THR . 83.7 m-20 -100.52 5.92 44.18 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.032 -1.043 . . . . 0.0 110.693 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.9 tttt 54.79 46.57 24.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.089 -1.007 . . . . 0.0 111.415 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 73' ' ' ASP . 82.5 p -125.52 157.8 36.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.307 -0.871 . . . . 0.0 109.903 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -138.01 145.85 42.38 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.049 -1.032 . . . . 0.0 110.102 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.639 HG21 ' CG1' ' A' ' 43' ' ' VAL . 55.5 t -132.48 136.09 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.116 -0.99 . . . . 0.0 109.637 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.659 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 81.8 mt -113.12 127.81 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.63 -1.294 . . . . 0.0 110.459 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -130.21 116.19 18.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.592 -0.692 . . . . 0.0 109.998 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.59 166.21 15.87 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.475 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 31.3 m-20 -76.42 175.56 9.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.402 -1.058 . . . . 0.0 110.606 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.409 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 85.9 tttt -60.86 -25.74 66.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.446 -0.783 . . . . 0.0 110.348 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.5 -53.68 30.65 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 120.095 -1.05 . . . . 0.0 110.593 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.968 ' O ' HG22 ' A' ' 88' ' ' VAL . 83.1 mt -64.28 -44.74 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.961 -1.317 . . . . 0.0 107.471 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -61.95 -37.79 86.07 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.004 -1.06 . . . . 0.0 111.286 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.409 ' OD2' ' HG2' ' A' ' 82' ' ' LYS . 54.2 m-20 -73.63 -20.28 60.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.836 -1.165 . . . . 0.0 111.88 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.992 HG13 HG13 ' A' ' 88' ' ' VAL . 10.6 p -105.73 -21.61 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.859 -1.151 . . . . 0.0 112.512 -178.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.992 HG13 HG13 ' A' ' 87' ' ' VAL . 17.0 m -118.75 162.45 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 120.602 -1.311 . . . . 0.0 111.708 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.6 p -105.05 177.48 4.84 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.766 0.793 . . . . 0.0 112.108 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -63.74 -37.32 86.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 109.733 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -61.72 -39.27 90.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.229 -0.919 . . . . 0.0 109.382 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.74 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 30.9 t80 -62.61 -26.63 68.71 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.659 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.6 m95 -84.05 -27.92 27.97 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.722 0.772 . . . . 0.0 110.682 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -56.97 -34.68 68.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.251 -0.905 . . . . 0.0 112.68 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.4 m -64.96 -36.21 83.65 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 118.448 -1.301 . . . . 0.0 109.088 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.443 ' CG2' HD13 ' A' ' 78' ' ' ILE 0.278 8.5 m -57.92 -47.31 83.21 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 122.307 1.051 . . . . 0.0 111.082 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -69.24 -38.8 78.67 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.361 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 91.1 m-20 -63.68 -43.99 95.04 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.675 -1.21 . . . . 0.0 109.988 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.7 -49.11 74.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.764 -1.21 . . . . 0.0 111.016 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 92.7 mt -67.33 -42.93 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.81 -1.181 . . . . 0.0 110.031 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -65.38 -42.41 92.73 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.213 -0.93 . . . . 0.0 110.876 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.734 HD13 ' O ' ' A' ' 102' ' ' LEU . 1.3 tm? -62.49 -41.21 98.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.114 -0.991 . . . . 0.0 111.075 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.484 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 98.6 mm-40 -75.89 -38.54 57.72 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.728 -1.189 . . . . 0.0 108.894 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -61.03 -41.81 97.28 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -63.32 -33.59 75.86 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.926 -0.484 . . . . 0.0 110.641 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -77.43 -18.18 57.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.89 -1.132 . . . . 0.0 109.317 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.38 1.09 31.16 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.752 -1.213 . . . . 0.0 111.003 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -103.47 91.02 3.87 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.635 -1.509 . . . . 0.0 110.853 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -62.58 -44.98 94.96 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.782 -0.574 . . . . 0.0 110.758 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.607 ' CE ' HG21 ' A' ' 16' ' ' ILE . 29.8 tptt -63.85 -48.92 74.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.145 -0.972 . . . . 0.0 112.568 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -61.08 -38.39 86.08 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.525 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.484 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -62.99 -45.26 96.0 Favored Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.608 -1.282 . . . . 0.0 109.947 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.2 mt -64.74 -44.52 89.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.113 -1.227 . . . . 0.0 110.733 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.778 HG22 HG13 ' A' ' 16' ' ' ILE . 99.4 t -64.91 -47.94 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 110.082 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -63.66 -41.42 98.2 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.663 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.59 -43.09 99.74 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.7 -43.42 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.933 -1.334 . . . . 0.0 110.077 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.74 -50.9 71.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 110.164 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -61.92 -42.2 98.82 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.085 -1.009 . . . . 0.0 109.07 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 124' ' ' LEU . . . -57.66 -37.64 73.74 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.385 -0.822 . . . . 0.0 109.43 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.49 -45.37 68.29 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 99.1 mmm -68.16 -42.92 79.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.99 -1.3 . . . . 0.0 110.139 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.74 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -65.9 -47.17 75.71 Favored 'General case' 0 C--O 1.203 -1.39 0 O-C-N 121.169 -0.957 . . . . 0.0 108.846 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 120' ' ' ALA . 78.0 mt -61.99 -39.16 91.26 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.54 -34.18 61.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.19 -0.944 . . . . 0.0 110.487 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -61.2 -41.21 96.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.872 -1.142 . . . . 0.0 108.968 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.456 ' CE1' ' CE2' ' A' ' 92' ' ' PHE . 91.8 m-85 -80.25 -36.83 34.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 0.0 110.791 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.638 ' HE2' HG11 ' A' ' 87' ' ' VAL . 88.7 m-85 -129.23 93.01 37.29 Favored Pre-proline 0 C--N 1.304 -1.383 0 O-C-N 121.3 -0.875 . . . . 0.0 109.674 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.98 153.25 78.53 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.85 1.448 . . . . 0.0 111.227 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 49.9 t90 -77.6 132.74 38.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.675 -0.641 . . . . 0.0 111.133 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 75.4 mmtt -112.09 150.22 31.01 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -58.45 -31.23 67.58 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.557 -1.34 . . . . 0.0 111.018 -177.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -89.22 8.08 32.1 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.914 -1.115 . . . . 0.0 110.593 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.469 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 64.9 t0 -43.09 137.9 2.32 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.99 0.9 . . . . 0.0 111.038 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.582 HD13 ' H ' ' A' ' 135' ' ' ILE . 0.1 OUTLIER -111.92 141.98 25.74 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 O-C-N 121.614 -0.679 . . . . 0.0 110.476 -178.025 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -95.57 93.93 7.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.012 -1.055 . . . . 0.0 110.061 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.447 ' HG3' HG12 ' A' ' 135' ' ' ILE . 96.6 mt-10 -69.5 -42.39 74.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.702 -0.624 . . . . 0.0 112.543 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.742 HD13 ' CD ' ' A' ' 32' ' ' ARG . 16.8 mt -106.06 151.19 40.03 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 120.973 -1.08 . . . . 0.0 111.334 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.01 -175.09 1.55 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 N-CA-C 108.948 -1.212 . . . . 0.0 108.948 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.426 ' HB2' ' CG2' ' A' ' 20' ' ' ILE . 21.3 p30 -118.86 4.04 11.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.765 -1.209 . . . . 0.0 110.102 178.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.3 p -62.72 175.12 0.87 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.1 -1.0 . . . . 0.0 110.302 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.506 HG23 HG23 ' A' ' 33' ' ' VAL . 80.5 mt -107.59 141.15 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.482 -0.761 . . . . 0.0 111.462 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.4 t -94.81 133.38 38.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.473 -0.767 . . . . 0.0 109.803 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -127.48 129.37 47.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 110.827 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 118.054 -1.414 . . . . 0.0 109.856 179.576 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.085 0.469 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.61 -38.22 66.54 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.011 -1.056 . . . . 0.0 109.115 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.22 -46.03 86.63 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.673 0.749 . . . . 0.0 110.181 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -69.83 -42.42 73.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.47 -0.769 . . . . 0.0 111.179 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.694 ' O ' HG23 ' A' ' 17' ' ' VAL . 92.4 mt-10 -63.64 -37.42 87.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.142 -0.974 . . . . 0.0 109.892 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.65 -44.81 92.74 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.053 -1.03 . . . . 0.0 110.672 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.67 -44.12 87.27 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.994 -1.067 . . . . 0.0 111.788 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 13' ' ' GLU . 19.3 tt -67.71 -36.52 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.73 -1.231 . . . . 0.0 110.44 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 13' ' ' GLU . 69.2 t -62.42 -39.57 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 21' ' ' ARG . 29.4 t0 -62.87 -35.01 78.58 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.464 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.93 -39.57 95.0 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.322 -0.862 . . . . 0.0 110.104 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.55 -43.85 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.114 -0.991 . . . . 0.0 109.883 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 18' ' ' ASP . 74.7 mtm180 -60.21 -42.04 94.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.872 . . . . 0.0 110.896 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -63.16 -36.2 82.84 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.125 -0.985 . . . . 0.0 110.33 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.6 -39.27 88.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.092 -1.005 . . . . 0.0 110.164 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -60.67 -16.32 37.89 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.943 -1.098 . . . . 0.0 110.851 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.473 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.6 mttt -95.11 -4.2 46.65 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.172 -0.955 . . . . 0.0 109.628 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -105.12 -16.99 14.63 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.068 -1.02 . . . . 0.0 109.462 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.8 t -152.4 161.83 42.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.114 -0.991 . . . . 0.0 109.864 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.1 p -87.81 -7.47 57.22 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.311 -0.868 . . . . 0.0 109.887 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.98 170.4 47.25 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -129.5 132.74 46.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.241 -1.152 . . . . 0.0 111.217 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.2 mt -117.42 134.34 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.693 -0.63 . . . . 0.0 110.147 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.453 ' HB3' ' HE1' ' A' ' 56' ' ' MET . 75.2 ttt180 -139.8 149.36 43.41 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.05 -1.031 . . . . 0.0 110.101 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.738 HG22 HD12 ' A' ' 67' ' ' ILE . 48.3 t -117.44 137.32 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.236 -0.915 . . . . 0.0 111.199 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.829 ' HB2' HD11 ' A' ' 66' ' ' LEU . 15.4 t60 -122.66 125.94 46.61 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.552 HD11 HG13 ' A' ' 71' ' ' VAL . 44.8 tp -115.35 135.85 53.71 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.091 0.948 . . . . 0.0 112.045 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.427 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 81.4 tt0 -150.12 164.33 35.87 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 177.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.56 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.0 mttt -79.48 -74.58 0.28 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.454 -0.779 . . . . 0.0 112.108 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.8 t -140.95 154.93 46.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 109.634 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.432 ' HB2' ' HD2' ' A' ' 46' ' ' ARG . 12.0 p -106.0 168.91 8.81 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.495 -0.753 . . . . 0.0 110.615 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -109.66 -18.54 13.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.116 -0.99 . . . . 0.0 110.83 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.428 HG13 ' N ' ' A' ' 42' ' ' ASP . 32.0 pt -114.06 -123.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.981 -1.075 . . . . 0.0 109.85 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.428 ' N ' HG13 ' A' ' 41' ' ' ILE . 99.3 m-20 -111.77 136.67 50.73 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.461 -1.4 . . . . 0.0 109.727 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.82 -45.21 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.681 -0.637 . . . . 0.0 112.619 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -60.22 -47.17 87.1 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.751 -1.218 . . . . 0.0 110.322 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -71.28 -40.91 70.63 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.927 -1.108 . . . . 0.0 108.992 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HD2' ' HB2' ' A' ' 39' ' ' SER . 66.7 ttt-85 -63.06 -43.51 98.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.128 -0.983 . . . . 0.0 110.891 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.88 85.72 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.544 -1.347 . . . . 0.0 109.428 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.8 ttp -61.69 -41.99 98.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.009 -1.057 . . . . 0.0 108.939 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.86 -44.43 93.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.069 -1.02 . . . . 0.0 109.73 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.46 -43.78 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.417 -0.802 . . . . 0.0 110.533 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.462 ' CE2' ' OD1' ' A' ' 57' ' ' ASP . 64.4 t80 -59.88 -47.39 85.96 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.007 -1.058 . . . . 0.0 109.966 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -74.98 -34.49 61.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.946 -1.096 . . . . 0.0 109.326 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -62.19 -36.62 82.46 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.949 -1.094 . . . . 0.0 109.137 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.19 2.81 26.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.18 -0.95 . . . . 0.0 110.049 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 55.54 33.52 21.25 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 121.142 -0.974 . . . . 0.0 111.892 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.748 ' SD ' HD13 ' A' ' 66' ' ' LEU . 95.7 mtp -66.19 -11.65 51.01 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 118.872 -1.131 . . . . 0.0 109.664 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.462 ' OD1' ' CE2' ' A' ' 51' ' ' PHE . 94.4 m-20 -77.19 -0.59 25.65 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.047 -1.033 . . . . 0.0 109.334 176.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -76.15 62.17 1.68 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.175 -0.953 . . . . 0.0 109.92 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.7 m -132.72 146.33 51.77 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.02 -42.48 99.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.568 -0.708 . . . . 0.0 111.427 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.2 mt -95.57 -0.05 52.41 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.011 -1.055 . . . . 0.0 111.265 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 57.3 45.33 20.4 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.406 1.098 . . . . 0.0 111.187 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -118.74 54.04 0.97 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.253 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.87 139.23 14.31 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.584 HG23 ' CD1' ' A' ' 84' ' ' ILE . 53.8 t -123.78 136.59 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.151 -1.206 . . . . 0.0 110.802 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.829 HD11 ' HB2' ' A' ' 34' ' ' HIS . 38.9 tp -117.89 128.13 54.53 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.347 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.738 HD12 HG22 ' A' ' 33' ' ' VAL . 97.1 mt -104.79 104.75 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 118.876 -1.129 . . . . 0.0 109.467 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -90.12 122.2 32.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.32 -0.863 . . . . 0.0 109.893 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -121.07 134.23 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.066 0.936 . . . . 0.0 110.924 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.517 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -104.44 98.42 8.2 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 37' ' ' LYS . 33.3 m -66.36 -22.25 29.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.197 -0.939 . . . . 0.0 110.607 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -68.93 -44.06 73.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.033 -1.042 . . . . 0.0 109.542 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 75' ' ' THR . 96.2 m-20 -101.7 4.9 41.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.079 -1.013 . . . . 0.0 111.044 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 ttmt 55.5 46.74 22.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.879 -1.138 . . . . 0.0 110.352 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 70.5 p -122.4 165.88 15.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -0.901 . . . . 0.0 109.749 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 46.3 p90 -146.38 146.66 30.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.512 -0.743 . . . . 0.0 110.369 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.1 t -133.78 136.88 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.389 -0.819 . . . . 0.0 109.114 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.646 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 81.6 mt -115.2 127.34 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.617 -1.302 . . . . 0.0 110.713 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -129.96 119.24 22.89 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.745 . . . . 0.0 111.223 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.525 ' HA2' HG22 ' A' ' 65' ' ' VAL . . . -103.28 149.49 17.47 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -62.82 175.28 0.86 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.568 -0.96 . . . . 0.0 110.1 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.84 -26.88 67.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.226 -0.921 . . . . 0.0 111.702 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.76 -53.85 32.12 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.609 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.97 ' O ' HG22 ' A' ' 88' ' ' VAL . 75.0 mt -63.11 -44.82 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.802 -1.411 . . . . 0.0 108.347 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -60.97 -38.51 86.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.966 -1.083 . . . . 0.0 111.627 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -71.0 -22.0 62.22 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.857 -1.152 . . . . 0.0 111.748 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.946 HG23 HG13 ' A' ' 88' ' ' VAL . 23.5 m -104.97 -15.77 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.92 -1.113 . . . . 0.0 112.884 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.97 HG22 ' O ' ' A' ' 84' ' ' ILE . 21.8 m -121.04 163.51 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.591 -1.318 . . . . 0.0 112.089 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.3 m -110.93 178.27 4.4 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.6 0.714 . . . . 0.0 112.158 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 33.8 p-10 -63.12 -36.4 83.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 110.059 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 65.8 t0 -62.87 -38.64 91.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.109 -0.994 . . . . 0.0 108.986 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.818 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 78.6 t80 -67.07 -25.28 66.17 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.239 -0.913 . . . . 0.0 109.376 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.646 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.8 m95 -86.5 -23.49 25.92 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.796 0.808 . . . . 0.0 110.36 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -58.1 -36.23 72.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.91 . . . . 0.0 112.057 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.5 p -67.25 -31.28 71.51 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.541 -1.264 . . . . 0.0 108.895 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.549 HG22 HD13 ' A' ' 78' ' ' ILE 0.272 10.0 m -60.08 -48.91 79.75 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 122.352 1.072 . . . . 0.0 111.111 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.38 -36.71 74.28 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.994 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -64.59 -44.23 91.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.933 -1.104 . . . . 0.0 110.482 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.12 -50.68 69.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.557 -1.34 . . . . 0.0 111.282 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.469 HD12 HD11 ' A' ' 78' ' ' ILE . 92.9 mt -66.35 -42.9 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.769 -1.207 . . . . 0.0 110.279 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -63.26 -41.75 99.09 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.296 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.7 mt -63.33 -41.71 98.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.196 -0.94 . . . . 0.0 111.775 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.464 ' HG2' ' HB2' ' A' ' 111' ' ' GLN . 31.6 tp60 -76.36 -40.17 51.88 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.69 -1.204 . . . . 0.0 108.963 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.423 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 1.2 m-85 -59.89 -40.64 89.41 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.62 -34.79 77.76 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.858 -0.526 . . . . 0.0 110.073 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -76.7 -18.7 58.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.989 -1.069 . . . . 0.0 109.712 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.08 -0.22 38.37 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.771 -1.204 . . . . 0.0 111.208 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -99.49 89.37 4.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.633 -1.51 . . . . 0.0 109.548 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -64.16 -41.78 97.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.869 -0.52 . . . . 0.0 111.816 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.446 ' O ' HG12 ' A' ' 114' ' ' VAL . 86.5 tttt -61.43 -48.19 82.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.047 -1.033 . . . . 0.0 110.798 -178.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.464 ' HB2' ' HG2' ' A' ' 103' ' ' GLN . 87.3 mt-30 -64.3 -35.9 82.37 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.117 -0.99 . . . . 0.0 110.427 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.448 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -65.76 -48.76 64.05 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.184 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.401 ' HB3' HD11 ' A' ' 16' ' ' ILE . 91.9 mt -65.6 -44.73 85.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.082 -1.246 . . . . 0.0 111.409 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.486 HG13 ' N ' ' A' ' 115' ' ' ASP . 11.5 p -65.06 -46.31 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.184 -0.947 . . . . 0.0 110.5 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.486 ' N ' HG13 ' A' ' 114' ' ' VAL . 66.6 t0 -64.45 -42.11 96.14 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.992 -1.067 . . . . 0.0 109.929 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.45 -42.17 93.69 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.79 -43.04 97.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.232 -1.157 . . . . 0.0 109.78 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -59.17 -50.98 71.98 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.973 -1.08 . . . . 0.0 110.616 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.89 -42.94 99.95 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.878 -1.138 . . . . 0.0 109.28 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.8 -43.43 76.85 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.286 -0.884 . . . . 0.0 109.365 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.81 -42.98 99.59 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 98.8 mmm -67.53 -46.84 71.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.015 -1.285 . . . . 0.0 110.472 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.818 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -63.94 -45.99 86.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.255 -0.903 . . . . 0.0 109.29 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.86 -40.42 95.3 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.4 -34.43 57.71 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.47 -0.769 . . . . 0.0 110.27 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -63.05 -44.17 96.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.061 -1.025 . . . . 0.0 109.133 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -73.08 -39.11 66.12 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.571 0.7 . . . . 0.0 109.961 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -131.67 98.36 18.05 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.634 -0.666 . . . . 0.0 110.178 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.45 154.13 69.41 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.647 1.34 . . . . 0.0 111.041 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.473 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 30.7 t90 -75.77 158.57 32.06 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.905 0.86 . . . . 0.0 110.948 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -140.47 151.42 44.84 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.33 -31.87 71.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.025 -1.047 . . . . 0.0 111.096 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -89.61 5.51 45.37 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.047 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.436 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 68.2 t0 -42.11 139.84 1.26 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.04 0.924 . . . . 0.0 111.71 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.695 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -113.87 142.7 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 121.817 0.818 . . . . 0.0 111.757 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -102.31 96.53 7.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.942 -1.099 . . . . 0.0 110.462 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -69.86 -33.41 72.22 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.649 -0.657 . . . . 0.0 112.673 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.9 mp -112.45 150.2 42.25 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.07 -1.019 . . . . 0.0 112.176 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.85 -170.47 0.7 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.667 1.351 . . . . 0.0 109.228 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 18.5 p-10 -125.37 1.85 7.73 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.71 -1.243 . . . . 0.0 110.287 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.6 p -60.85 167.94 2.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.999 -1.063 . . . . 0.0 110.866 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 47.5 mm -95.09 134.33 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.435 0.636 . . . . 0.0 110.691 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 10.5 m -91.22 132.78 35.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 0.0 109.946 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.11 144.99 51.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.145 -0.972 . . . . 0.0 110.544 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.844 179.488 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.127 0.489 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 14' ' ' LYS . . . -54.14 -36.67 63.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.2 -0.937 . . . . 0.0 109.6 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.65 -38.46 89.39 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 109.545 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.45 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 97.5 mt-10 -70.63 -46.54 63.13 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.013 -1.055 . . . . 0.0 110.365 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.0 mt-10 -65.26 -34.58 78.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.381 -0.824 . . . . 0.0 109.572 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 87.3 tttt -62.91 -46.34 88.28 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.231 -0.918 . . . . 0.0 110.667 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.31 -43.81 85.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 111.773 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.531 HG13 HG22 ' A' ' 114' ' ' VAL . 16.5 tt -66.61 -36.62 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.665 -1.272 . . . . 0.0 110.49 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 13' ' ' GLU . 71.6 t -63.77 -40.69 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.44 -39.08 92.21 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.755 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.0 92.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.322 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.57 -42.58 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.495 -0.753 . . . . 0.0 109.251 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.407 ' HG2' ' OD1' ' A' ' 140' ' ' ASN . 80.9 mtp180 -59.15 -42.57 91.02 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.211 -0.931 . . . . 0.0 110.304 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -64.91 -36.44 84.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.405 -0.81 . . . . 0.0 110.659 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.36 90.85 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.761 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -60.4 -14.86 21.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.089 -1.007 . . . . 0.0 111.175 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.473 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.5 mttt -95.49 -1.72 50.14 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.958 -1.089 . . . . 0.0 109.749 177.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -109.57 -14.51 14.36 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 120.896 -1.128 . . . . 0.0 109.593 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.0 t -154.4 160.55 41.72 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.882 -1.136 . . . . 0.0 110.485 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.2 m -88.86 -7.2 56.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.206 -0.934 . . . . 0.0 110.273 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.87 171.0 48.5 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.677 ' OE1' HD22 ' A' ' 138' ' ' LEU . 91.7 mt-10 -130.96 137.17 49.14 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.268 -1.137 . . . . 0.0 111.216 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.499 HG21 HD12 ' A' ' 117' ' ' ILE . 83.3 mt -119.63 134.71 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.712 -0.618 . . . . 0.0 110.317 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.4 ' HB2' ' HE1' ' A' ' 56' ' ' MET . 57.4 mmm-85 -138.69 150.7 46.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.249 -0.907 . . . . 0.0 110.197 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.631 HG12 HD12 ' A' ' 67' ' ' ILE . 15.8 m -123.24 139.54 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.456 -0.777 . . . . 0.0 111.118 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -124.9 128.62 48.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.563 -0.711 . . . . 0.0 109.237 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.714 HD11 ' CG1' ' A' ' 71' ' ' VAL . 36.9 tp -115.82 128.87 56.16 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.902 0.858 . . . . 0.0 111.814 -178.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -144.7 165.12 28.94 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -78.95 -74.05 0.3 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.226 -0.921 . . . . 0.0 113.1 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.6 t -140.25 156.18 46.58 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.772 -1.205 . . . . 0.0 110.167 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.9 p -102.56 168.01 9.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.427 -0.796 . . . . 0.0 110.505 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -107.19 -14.32 14.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.308 -0.87 . . . . 0.0 110.632 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 42' ' ' ASP . 19.2 pt -123.34 -121.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.976 -1.077 . . . . 0.0 109.735 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.422 ' N ' HG13 ' A' ' 41' ' ' ILE . 94.2 m-20 -111.34 140.34 46.0 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 120.191 -1.568 . . . . 0.0 109.217 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.612 HG11 HG21 ' A' ' 77' ' ' VAL . 97.3 t -64.76 -44.24 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.211 -0.931 . . . . 0.0 111.815 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -58.16 -45.86 86.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.049 -1.032 . . . . 0.0 109.648 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -71.64 -38.83 70.69 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.917 -1.114 . . . . 0.0 108.94 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.423 ' NH1' ' OH ' ' A' ' 68' ' ' TYR . 75.4 ttt180 -63.45 -42.58 98.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.972 -1.08 . . . . 0.0 110.927 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.13 -38.78 86.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.696 -1.253 . . . . 0.0 110.294 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 64.3 ttp -62.81 -44.05 97.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.064 -1.022 . . . . 0.0 109.405 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.427 ' OD1' ' ND2' ' A' ' 53' ' ' ASN . 63.5 t0 -63.52 -45.61 89.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.021 -1.049 . . . . 0.0 109.488 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 83.3 t -66.35 -44.31 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.35 -0.844 . . . . 0.0 110.947 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.473 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 4.5 t80 -58.27 -47.66 82.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.904 -1.122 . . . . 0.0 108.992 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -70.29 -36.24 74.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.054 -1.029 . . . . 0.0 109.238 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.427 ' ND2' ' OD1' ' A' ' 49' ' ' ASP . 72.7 m-20 -61.18 -37.55 83.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.096 -1.002 . . . . 0.0 110.012 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.8 mt -82.16 5.87 18.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.985 -1.072 . . . . 0.0 110.727 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 55.73 32.74 20.02 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.309 -0.87 . . . . 0.0 110.92 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.473 ' HB2' ' CE1' ' A' ' 51' ' ' PHE . 92.8 mtp -69.13 -25.41 64.38 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.341 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -68.76 -7.61 35.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.347 -0.845 . . . . 0.0 110.48 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -86.98 80.78 8.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.752 -1.218 . . . . 0.0 110.727 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.419 ' OG1' ' HA ' ' A' ' 62' ' ' GLN . 78.8 p -137.04 156.82 47.94 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -62.09 -43.97 97.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.092 -1.005 . . . . 0.0 112.817 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 88.1 mt -100.02 2.31 43.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.091 -1.006 . . . . 0.0 111.301 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.419 ' HA ' ' OG1' ' A' ' 59' ' ' THR . 99.4 mm-40 57.75 31.47 20.49 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.973 0.892 . . . . 0.0 111.272 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.575 ' C ' HD11 ' A' ' 84' ' ' ILE . 99.7 m-20 -108.96 56.46 0.62 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.812 0.815 . . . . 0.0 110.465 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.455 ' N ' HD11 ' A' ' 84' ' ' ILE . . . -103.59 141.19 15.17 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.56 ' CG2' HD13 ' A' ' 84' ' ' ILE . 47.9 t -123.35 135.05 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.07 -1.253 . . . . 0.0 110.593 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.0 tp -116.79 130.39 56.69 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.88 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.631 HD12 HG12 ' A' ' 33' ' ' VAL . 83.6 mt -104.78 108.27 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 118.826 -1.15 . . . . 0.0 109.395 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.423 ' OH ' ' NH1' ' A' ' 46' ' ' ARG . 42.3 t80 -93.73 122.69 36.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.531 -0.731 . . . . 0.0 110.331 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -123.63 133.42 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 122.173 0.987 . . . . 0.0 111.32 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.17 97.45 7.3 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.714 ' CG1' HD11 ' A' ' 35' ' ' LEU . 35.8 m -67.38 -18.67 24.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.968 -1.083 . . . . 0.0 111.245 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -69.37 -46.52 66.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.754 -1.216 . . . . 0.0 109.445 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.23 3.69 41.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.155 -0.966 . . . . 0.0 110.797 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.4 tttt 56.13 45.77 22.8 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.943 -1.098 . . . . 0.0 110.39 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 96.0 m -119.78 132.87 55.73 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.243 -0.911 . . . . 0.0 109.812 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.421 ' O ' ' CD1' ' A' ' 76' ' ' PHE . 50.9 p90 -114.52 136.7 52.73 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.532 -0.73 . . . . 0.0 109.924 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.612 HG21 HG11 ' A' ' 43' ' ' VAL . 72.0 t -126.69 136.92 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.711 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 82.7 mt -115.35 125.36 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.771 -1.205 . . . . 0.0 110.324 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -128.97 114.89 16.99 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.513 -0.742 . . . . 0.0 110.488 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.65 145.83 16.54 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -56.93 175.47 0.13 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.516 -0.99 . . . . 0.0 109.803 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.06 -24.59 63.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.091 -1.006 . . . . 0.0 110.639 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.434 ' O ' HG12 ' A' ' 87' ' ' VAL . . . -66.79 -51.79 38.33 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.655 -1.26 . . . . 0.0 110.632 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.973 ' O ' HG22 ' A' ' 88' ' ' VAL . 3.8 mt -64.15 -44.71 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.914 -1.345 . . . . 0.0 108.447 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -64.26 -36.68 84.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.365 -0.834 . . . . 0.0 111.727 -177.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -75.64 -20.95 58.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.785 -1.197 . . . . 0.0 111.938 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.01 HG13 HG13 ' A' ' 88' ' ' VAL . 11.7 p -103.08 -21.95 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.851 -1.156 . . . . 0.0 113.132 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.01 HG13 HG13 ' A' ' 87' ' ' VAL . 14.3 m -118.68 164.08 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.626 -1.296 . . . . 0.0 111.433 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.2 p -105.45 174.76 5.74 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.922 0.867 . . . . 0.0 111.634 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.01 -37.95 86.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.459 -0.776 . . . . 0.0 110.071 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -61.46 -37.57 84.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.946 . . . . 0.0 108.81 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.911 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 86.3 t80 -64.86 -27.2 68.71 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.446 -0.784 . . . . 0.0 108.968 177.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.711 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.4 m95 -86.12 -26.22 25.34 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.975 0.893 . . . . 0.0 109.888 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -58.97 -36.38 74.77 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.024 -1.048 . . . . 0.0 112.334 -176.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.9 p -66.56 -32.03 73.11 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.535 -1.266 . . . . 0.0 108.596 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.437 HG22 HD13 ' A' ' 78' ' ' ILE 0.276 7.5 m -60.21 -49.46 77.53 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 122.264 1.031 . . . . 0.0 111.141 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -68.29 -38.03 81.25 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.697 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -64.04 -41.39 97.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.013 -1.054 . . . . 0.0 110.617 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.16 -48.95 74.03 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.639 -1.288 . . . . 0.0 110.841 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.514 HD12 HD11 ' A' ' 78' ' ' ILE . 91.9 mt -67.05 -42.78 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 110.406 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -64.17 -41.43 97.14 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.296 -0.877 . . . . 0.0 110.94 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 44.3 tp -62.79 -43.02 99.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.312 -0.868 . . . . 0.0 111.754 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.474 ' CB ' ' CA ' ' A' ' 112' ' ' GLY . 3.0 tp60 -76.69 -40.08 50.0 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.779 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -58.95 -41.94 88.65 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.166 0.984 . . . . 0.0 108.449 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.12 -35.01 72.7 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -79.79 -17.23 53.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.349 -0.844 . . . . 0.0 110.169 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.62 2.5 43.47 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 119.73 -1.224 . . . . 0.0 111.573 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -104.53 94.81 5.52 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.689 -1.477 . . . . 0.0 110.859 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -62.76 -46.32 88.6 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.626 -0.671 . . . . 0.0 112.3 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.564 ' O ' HG23 ' A' ' 114' ' ' VAL . 75.3 tttt -61.62 -47.76 83.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.12 -0.988 . . . . 0.0 111.838 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.418 ' CB ' ' HG2' ' A' ' 103' ' ' GLN . 89.1 mt-30 -63.46 -40.03 96.05 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.377 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.474 ' CA ' ' CB ' ' A' ' 103' ' ' GLN . . . -65.21 -47.83 76.46 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.355 -1.402 . . . . 0.0 109.624 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.432 ' O ' HG12 ' A' ' 117' ' ' ILE . 85.2 mt -64.24 -46.01 85.64 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.506 -0.996 . . . . 0.0 111.523 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 110' ' ' LYS . 99.4 t -63.1 -48.14 89.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.296 -0.877 . . . . 0.0 110.943 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -61.63 -33.52 74.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.028 -1.045 . . . . 0.0 109.108 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.14 -40.33 98.39 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.499 HD12 HG21 ' A' ' 31' ' ' ILE . 36.1 mm -63.36 -43.84 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.064 -1.257 . . . . 0.0 109.741 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.05 -49.74 76.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.277 -0.889 . . . . 0.0 110.723 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -64.73 -43.92 91.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.057 -1.027 . . . . 0.0 110.351 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.31 95.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.895 . . . . 0.0 110.593 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.82 -44.06 81.41 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 97.0 mtp -66.56 -46.18 76.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.011 -1.288 . . . . 0.0 109.901 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.911 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -64.09 -43.89 94.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.969 -1.082 . . . . 0.0 108.974 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 31.2 mt -63.02 -40.49 97.9 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.397 -0.815 . . . . 0.0 109.093 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.42 -34.08 56.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.128 -0.983 . . . . 0.0 110.09 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.63 -44.27 97.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.121 -0.987 . . . . 0.0 109.13 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -70.66 -41.74 71.69 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.473 0.654 . . . . 0.0 109.971 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.42 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 58.1 m-85 -130.88 94.31 28.81 Favored Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.496 -0.753 . . . . 0.0 109.776 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 128' ' ' PHE . 38.8 Cg_endo -64.45 149.88 89.24 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.652 1.343 . . . . 0.0 109.843 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.473 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 39.3 t90 -73.46 130.19 39.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.457 -0.777 . . . . 0.0 111.896 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -108.78 152.64 24.58 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.03 -29.54 68.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.109 -0.995 . . . . 0.0 111.064 -177.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -91.9 6.81 44.77 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.099 -1.04 . . . . 0.0 111.48 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.449 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 67.9 t0 -42.49 139.25 1.57 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.653 -0.654 . . . . 0.0 110.645 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.711 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.3 pp -115.12 142.14 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 122.51 1.148 . . . . 0.0 113.297 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -120.33 102.52 8.53 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.16 -0.962 . . . . 0.0 109.412 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -101.4 5.92 42.34 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.633 -1.292 . . . . 0.0 111.712 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.677 HD22 ' OE1' ' A' ' 30' ' ' GLU . 1.4 tp -114.26 139.69 24.12 Favored Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 120.935 -1.103 . . . . 0.0 110.634 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -70.61 165.17 32.8 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.528 1.278 . . . . 0.0 109.747 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.407 ' OD1' ' HG2' ' A' ' 21' ' ' ARG . 32.0 m120 -103.22 8.75 38.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.595 -1.316 . . . . 0.0 110.027 177.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -62.04 144.93 54.51 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.854 -1.154 . . . . 0.0 110.647 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.98 138.71 19.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.789 -0.569 . . . . 0.0 109.846 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.0 m -93.27 132.31 37.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.077 -1.014 . . . . 0.0 109.203 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -126.22 137.52 53.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.292 -0.88 . . . . 0.0 110.143 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 CA-C-O 118.001 -1.444 . . . . 0.0 109.521 179.551 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 14' ' ' LYS . . . -54.08 -36.34 63.04 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.893 -1.129 . . . . 0.0 109.187 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -66.01 -37.09 85.03 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.539 -0.725 . . . . 0.0 109.311 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.44 ' OE1' ' CD ' ' A' ' 110' ' ' LYS . 78.1 mm-40 -72.38 -48.26 42.98 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.151 -0.968 . . . . 0.0 110.082 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.816 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.2 mt-10 -66.48 -36.98 84.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.463 -0.773 . . . . 0.0 110.186 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 88.1 tttt -62.02 -45.72 92.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.846 -1.158 . . . . 0.0 111.095 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.89 -42.46 94.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.783 -1.198 . . . . 0.0 111.434 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.588 HG13 HG22 ' A' ' 114' ' ' VAL . 19.1 tt -66.96 -36.16 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.831 -1.168 . . . . 0.0 110.748 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 13' ' ' GLU . 87.8 t -63.82 -41.02 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -62.54 -36.55 82.96 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.664 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.23 -38.27 88.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 109.353 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.874 HD11 HD13 ' A' ' 117' ' ' ILE . 34.9 mm -63.92 -43.45 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.396 -0.815 . . . . 0.0 109.998 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -59.65 -41.6 90.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.311 -0.868 . . . . 0.0 109.821 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -63.92 -37.94 89.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.326 -0.859 . . . . 0.0 111.215 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.74 -40.93 88.52 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.083 -1.011 . . . . 0.0 110.44 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -60.35 -14.5 18.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.904 -1.122 . . . . 0.0 110.922 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.469 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 49.2 mtpt -94.59 -2.82 50.77 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 120.831 -1.168 . . . . 0.0 109.48 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -109.93 -14.11 14.32 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 121.002 -1.061 . . . . 0.0 110.184 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.7 t -151.77 158.03 42.77 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.063 -1.023 . . . . 0.0 109.982 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 83.5 p -86.91 -7.95 57.71 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.273 -0.892 . . . . 0.0 109.95 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.7 172.61 45.6 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.77 ' CB ' HD12 ' A' ' 138' ' ' LEU . 55.8 mp0 -131.23 136.38 48.18 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.339 -1.095 . . . . 0.0 111.247 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -122.42 134.71 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.876 -0.515 . . . . 0.0 110.026 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.496 HH11 HD22 ' A' ' 138' ' ' LEU . 83.6 mtp180 -138.57 153.99 48.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.206 -0.934 . . . . 0.0 110.135 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.646 HG22 HD12 ' A' ' 67' ' ' ILE . 48.1 t -123.7 139.34 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.385 -0.822 . . . . 0.0 110.665 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.419 ' HA ' ' O ' ' A' ' 143' ' ' SER . 77.8 t60 -124.64 122.8 38.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.53 -0.732 . . . . 0.0 110.215 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.928 HD11 ' CG1' ' A' ' 71' ' ' VAL . 33.8 tp -108.39 131.56 54.64 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.901 0.858 . . . . 0.0 111.421 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -149.39 166.43 29.06 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.452 ' HB3' ' HG3' ' A' ' 72' ' ' GLU . 98.4 mttt -81.33 -75.45 0.28 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.928 -1.107 . . . . 0.0 113.498 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.756 HG23 ' CB ' ' A' ' 72' ' ' GLU . 1.3 p -137.96 154.09 49.41 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.496 -0.753 . . . . 0.0 109.955 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.419 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 14.3 p -98.95 167.91 10.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.137 -0.977 . . . . 0.0 110.283 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -106.27 -10.83 16.23 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.307 -0.871 . . . . 0.0 110.422 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.401 HG13 ' N ' ' A' ' 42' ' ' ASP . 28.7 pt -128.56 -121.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.936 -1.102 . . . . 0.0 109.358 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.401 ' N ' HG13 ' A' ' 41' ' ' ILE . 89.9 m-20 -111.02 138.4 47.48 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 120.184 -1.573 . . . . 0.0 110.042 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.465 HG11 HG21 ' A' ' 77' ' ' VAL . 90.1 t -62.99 -44.96 99.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.564 -0.71 . . . . 0.0 112.01 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -59.89 -46.28 89.84 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.925 -1.109 . . . . 0.0 110.057 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -70.58 -39.41 73.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.772 -1.205 . . . . 0.0 108.568 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.419 ' NH2' ' HA ' ' A' ' 39' ' ' SER . 49.8 ttt85 -61.46 -45.68 93.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 111.358 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.36 84.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.961 -1.087 . . . . 0.0 109.713 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 66.0 ttp -64.71 -43.87 92.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.204 -0.935 . . . . 0.0 109.878 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 53.5 t0 -63.2 -43.55 97.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.043 -1.036 . . . . 0.0 109.252 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.6 t -67.23 -44.01 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.46 -0.775 . . . . 0.0 110.35 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.528 ' HD1' HD22 ' A' ' 66' ' ' LEU . 61.4 t80 -60.19 -48.14 82.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.719 -1.238 . . . . 0.0 110.296 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -72.47 -35.2 68.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.989 -1.07 . . . . 0.0 108.821 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 49' ' ' ASP . 31.4 t-20 -62.34 -39.37 92.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.338 -0.851 . . . . 0.0 110.194 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.427 HD13 ' CE ' ' A' ' 56' ' ' MET . 55.6 mt -79.31 3.15 18.96 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.153 -0.967 . . . . 0.0 110.187 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 57.29 33.43 23.28 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 121.041 -1.037 . . . . 0.0 112.044 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.468 ' SD ' HD13 ' A' ' 66' ' ' LEU . 64.7 mtt -67.46 -10.79 54.8 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.845 -1.16 . . . . 0.0 109.913 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.41 ' OD1' ' CE2' ' A' ' 51' ' ' PHE . 97.1 m-20 -77.82 -0.87 28.85 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.788 -1.195 . . . . 0.0 109.787 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -80.02 63.49 4.56 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 121.005 -1.06 . . . . 0.0 109.871 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.421 ' OG1' ' HA ' ' A' ' 62' ' ' GLN . 66.8 p -133.11 150.28 52.07 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.08 -41.01 99.32 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.441 -0.787 . . . . 0.0 112.271 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.415 ' HB3' ' ND2' ' A' ' 63' ' ' ASN . 87.0 mt -100.0 -0.51 39.12 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.932 -1.105 . . . . 0.0 111.616 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.421 ' HA ' ' OG1' ' A' ' 59' ' ' THR . 87.4 mt-30 58.2 40.26 25.05 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 122.643 1.211 . . . . 0.0 111.029 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.654 ' C ' HD11 ' A' ' 84' ' ' ILE . 94.5 m-20 -111.44 53.15 0.72 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.724 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.432 ' N ' HD11 ' A' ' 84' ' ' ILE . . . -99.81 138.82 14.09 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.034 -2.026 . . . . 0.0 108.034 178.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 53.4 t -122.11 133.91 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.184 -1.186 . . . . 0.0 110.117 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.528 HD22 ' HD1' ' A' ' 51' ' ' PHE . 49.2 tp -117.44 131.21 56.78 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.674 -0.641 . . . . 0.0 110.832 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.646 HD12 HG22 ' A' ' 33' ' ' VAL . 94.4 mt -110.56 110.3 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.524 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -97.23 121.4 39.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -0.921 . . . . 0.0 109.711 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.5 t -121.98 131.81 72.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 111.302 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.575 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -98.95 95.23 7.02 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.928 ' CG1' HD11 ' A' ' 35' ' ' LEU . 35.8 m -64.31 -22.48 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.998 -1.064 . . . . 0.0 110.834 -178.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.756 ' CB ' HG23 ' A' ' 38' ' ' THR . 79.3 mm-40 -66.8 -42.51 85.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.993 -1.067 . . . . 0.0 109.535 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.451 ' O ' HG23 ' A' ' 75' ' ' THR . 92.7 m-20 -102.99 4.99 38.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.851 . . . . 0.0 110.98 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.43 ' HE2' ' O ' ' A' ' 104' ' ' PHE . 29.2 tttt 55.78 47.71 19.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.958 -1.089 . . . . 0.0 110.38 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.575 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 34.4 p -123.17 162.24 22.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 109.41 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -143.9 141.87 30.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.428 -0.795 . . . . 0.0 110.049 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.465 HG21 HG11 ' A' ' 43' ' ' VAL . 45.9 t -131.15 133.59 62.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.673 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 77.2 mt -112.97 122.33 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 118.853 -1.139 . . . . 0.0 110.544 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -129.11 111.27 12.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 110.343 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -94.72 174.63 33.35 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -77.64 176.17 9.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.752 -0.852 . . . . 0.0 109.876 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.55 -26.49 66.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.031 -1.043 . . . . 0.0 110.847 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.446 ' O ' HG12 ' A' ' 87' ' ' VAL . . . -65.72 -49.31 60.29 Favored Glycine 0 N--CA 1.488 2.108 0 C-N-CA 119.807 -1.187 . . . . 0.0 110.315 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.995 ' O ' HG22 ' A' ' 88' ' ' VAL . 3.6 mt -64.6 -44.97 96.76 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.791 0 O-C-N 121.001 -1.294 . . . . 0.0 108.151 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -64.39 -35.66 81.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.711 -1.243 . . . . 0.0 112.39 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -77.6 -22.11 51.36 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.857 -1.152 . . . . 0.0 112.303 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.094 HG13 HG13 ' A' ' 88' ' ' VAL . 7.7 p -101.33 -23.51 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.848 -1.158 . . . . 0.0 112.516 -178.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.094 HG13 HG13 ' A' ' 87' ' ' VAL . 10.2 m -117.65 164.36 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.659 -1.276 . . . . 0.0 111.413 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 t -108.13 174.8 5.72 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.649 0.738 . . . . 0.0 111.767 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -61.38 -37.37 83.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.16 -0.962 . . . . 0.0 110.12 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.61 -36.55 78.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.194 -0.941 . . . . 0.0 108.823 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.741 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 81.5 t80 -67.33 -25.18 65.88 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.258 -0.901 . . . . 0.0 109.505 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.673 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.3 m95 -88.31 -26.5 22.23 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.911 0.862 . . . . 0.0 111.252 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -55.82 -40.33 72.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.92 -1.112 . . . . 0.0 112.585 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 77.3 p -64.5 -31.03 72.06 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.507 -1.277 . . . . 0.0 109.234 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.28 12.3 m -60.27 -49.38 77.86 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 122.545 1.164 . . . . 0.0 110.952 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.05 -38.53 82.57 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.738 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -63.42 -45.01 92.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.948 -1.095 . . . . 0.0 110.725 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.42 -48.62 80.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.942 -1.099 . . . . 0.0 110.654 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.412 HD12 HD11 ' A' ' 78' ' ' ILE . 91.4 mt -67.52 -42.5 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.089 -1.007 . . . . 0.0 110.277 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.427 ' CG ' ' HE3' ' A' ' 105' ' ' LYS . 56.6 tt0 -63.28 -42.85 99.15 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.842 -1.161 . . . . 0.0 110.984 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.1 mt -63.12 -41.53 99.35 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.158 -0.964 . . . . 0.0 112.105 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.431 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 94.0 mm-40 -76.66 -37.23 56.58 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.647 -1.221 . . . . 0.0 109.253 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.43 ' O ' ' HE2' ' A' ' 74' ' ' LYS . 4.4 m-85 -61.1 -41.5 96.79 Favored 'General case' 0 C--O 1.201 -1.456 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.427 ' HE3' ' CG ' ' A' ' 101' ' ' GLN . 93.7 mttt -62.02 -33.44 74.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.754 -1.216 . . . . 0.0 110.791 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -78.55 -18.64 54.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.756 -1.215 . . . . 0.0 109.986 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.83 4.63 42.22 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.71 -1.233 . . . . 0.0 111.164 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -103.51 91.08 3.89 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.632 -1.511 . . . . 0.0 110.521 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -62.35 -45.02 95.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.706 -0.621 . . . . 0.0 111.784 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.44 ' CD ' ' OE1' ' A' ' 12' ' ' GLU . 76.3 tttt -62.86 -49.29 75.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.901 . . . . 0.0 112.55 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -62.4 -36.49 82.51 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.655 -1.218 . . . . 0.0 109.55 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.431 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -65.54 -47.58 76.48 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.426 -1.368 . . . . 0.0 110.187 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.6 mt -63.53 -44.1 95.24 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.025 -1.279 . . . . 0.0 110.776 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.588 HG22 HG13 ' A' ' 16' ' ' ILE . 86.4 t -66.52 -46.08 87.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.101 -1.0 . . . . 0.0 110.05 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -65.35 -42.54 92.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 110.023 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.02 -41.98 98.19 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.874 HD13 HD11 ' A' ' 20' ' ' ILE . 91.4 mt -65.05 -43.84 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.267 -1.137 . . . . 0.0 109.968 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -56.93 -51.75 67.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.959 -1.088 . . . . 0.0 109.729 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.68 -41.73 99.25 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.125 -0.984 . . . . 0.0 109.192 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.32 -40.56 82.38 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.078 -1.014 . . . . 0.0 109.41 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.53 -45.86 87.79 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.7 mtt -66.67 -43.56 84.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.03 -1.276 . . . . 0.0 109.416 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.741 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -63.5 -46.59 85.41 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.304 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.2 mt -62.74 -41.54 99.24 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.456 -0.777 . . . . 0.0 109.486 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.82 -34.13 62.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.33 -0.856 . . . . 0.0 110.678 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.84 -41.46 97.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.942 -1.099 . . . . 0.0 108.954 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -75.36 -37.49 60.6 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.601 -0.687 . . . . 0.0 109.787 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -132.51 99.4 15.79 Favored Pre-proline 0 N--CA 1.487 1.379 0 O-C-N 121.498 -0.751 . . . . 0.0 110.131 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.47 150.97 70.63 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.447 1.235 . . . . 0.0 110.226 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.469 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 34.5 t90 -73.66 125.81 28.89 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.382 -0.824 . . . . 0.0 110.916 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -103.97 153.84 20.36 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.01 -29.3 70.17 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 111.092 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -93.7 8.12 42.17 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.912 -1.115 . . . . 0.0 111.609 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -42.51 138.18 1.89 Allowed 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.843 0.83 . . . . 0.0 111.614 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.628 HD13 ' H ' ' A' ' 135' ' ' ILE . 0.2 OUTLIER -111.78 141.5 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 121.574 -0.704 . . . . 0.0 110.576 -178.083 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -100.25 96.01 7.18 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.169 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -67.71 -36.35 80.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.721 -0.612 . . . . 0.0 111.741 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.77 HD12 ' CB ' ' A' ' 30' ' ' GLU . 83.9 mt -109.22 151.37 41.99 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.212 -0.93 . . . . 0.0 112.073 -178.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.68 -171.54 0.87 Allowed 'Trans proline' 0 C--N 1.32 -0.949 0 N-CA-C 108.662 -1.322 . . . . 0.0 108.662 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -121.91 1.77 9.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.604 -1.31 . . . . 0.0 110.125 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 78.5 p -63.37 168.62 4.31 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.764 -1.21 . . . . 0.0 110.965 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 91.6 mt -94.56 135.83 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.483 -0.76 . . . . 0.0 110.819 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 5.1 m -93.48 134.47 35.71 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.61 146.8 50.75 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.853 -1.154 . . . . 0.0 110.427 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.944 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.451 HG23 ' H ' ' A' ' 12' ' ' GLU . 5.6 t . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.02 -38.88 77.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.24 -0.912 . . . . 0.0 110.885 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -55.88 -46.89 78.2 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.728 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.451 ' H ' HG23 ' A' ' 9' ' ' THR . 96.6 mt-10 -67.43 -45.61 75.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.516 -0.74 . . . . 0.0 111.716 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.768 ' O ' HG23 ' A' ' 17' ' ' VAL . 93.6 mt-10 -65.38 -33.11 75.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.963 -1.086 . . . . 0.0 110.035 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.34 -48.09 76.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.794 -1.192 . . . . 0.0 111.191 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.697 ' HB3' ' CE ' ' A' ' 110' ' ' LYS . . . -63.83 -42.14 97.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.319 -0.863 . . . . 0.0 111.159 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.524 HG13 HG22 ' A' ' 114' ' ' VAL . 20.6 tt -67.46 -34.77 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.004 -1.06 . . . . 0.0 110.689 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 13' ' ' GLU . 67.5 t -63.29 -39.37 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.94 -37.21 86.88 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.08 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.25 88.56 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.285 -0.884 . . . . 0.0 109.021 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.865 HG22 ' OD1' ' A' ' 140' ' ' ASN . 96.6 mt -64.5 -43.41 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-O 121.475 0.655 . . . . 0.0 109.972 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.433 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 92.8 mtt180 -59.72 -43.02 94.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 0.0 110.47 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -65.83 -36.86 84.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.431 -0.793 . . . . 0.0 111.252 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.37 -40.91 98.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.001 -1.062 . . . . 0.0 109.749 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.61 -16.52 49.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.413 -0.805 . . . . 0.0 110.11 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.4 mttt -93.65 -1.57 55.12 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.213 -0.929 . . . . 0.0 109.142 177.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -110.16 -14.39 14.2 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.973 -1.08 . . . . 0.0 110.08 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.3 t -151.34 158.12 43.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.098 -1.001 . . . . 0.0 109.644 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.6 m -85.1 -8.66 58.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.092 -1.005 . . . . 0.0 109.974 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.99 173.31 48.37 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.431 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 57.8 mp0 -132.0 139.05 48.49 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.259 -1.142 . . . . 0.0 111.709 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 94.1 mt -124.81 136.26 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.605 -0.685 . . . . 0.0 110.319 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -140.96 156.56 46.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.211 -0.931 . . . . 0.0 110.038 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 143' ' ' SER . 4.8 p -126.55 140.8 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.03 -1.044 . . . . 0.0 111.469 -178.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.444 ' HA ' ' O ' ' A' ' 143' ' ' SER . 72.0 t60 -124.43 132.15 53.5 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.574 0.702 . . . . 0.0 109.684 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.829 HD11 ' CG1' ' A' ' 71' ' ' VAL . 28.1 tp -117.62 126.13 51.97 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.625 0.726 . . . . 0.0 111.984 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.425 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 78.2 tt0 -142.73 165.2 28.04 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.439 ' HB3' ' HG3' ' A' ' 72' ' ' GLU . 99.5 mttt -79.94 -76.41 0.22 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.144 -0.973 . . . . 0.0 112.329 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.755 HG23 ' HB2' ' A' ' 72' ' ' GLU . 1.2 p -138.74 157.21 46.52 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.455 0.645 . . . . 0.0 110.609 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.433 ' OG ' ' CD ' ' A' ' 46' ' ' ARG . 50.9 m -107.47 173.62 6.24 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.431 -0.793 . . . . 0.0 110.854 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -109.23 -10.14 14.98 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.591 -0.693 . . . . 0.0 110.452 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.1 pt -125.19 -123.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 120.964 -1.085 . . . . 0.0 109.702 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -110.78 140.2 45.4 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.462 -1.399 . . . . 0.0 109.092 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.502 ' CG1' HG21 ' A' ' 77' ' ' VAL . 75.3 t -61.37 -44.18 98.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.427 -0.796 . . . . 0.0 110.599 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -58.79 -48.05 82.63 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.134 -0.979 . . . . 0.0 110.588 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -69.1 -39.89 78.72 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.784 -1.198 . . . . 0.0 109.162 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.433 ' CD ' ' OG ' ' A' ' 39' ' ' SER . 57.8 ttt85 -59.7 -45.27 92.63 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.095 -1.003 . . . . 0.0 110.087 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.19 94.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.83 -1.169 . . . . 0.0 110.324 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.3 ttp -62.92 -43.57 98.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.125 -0.985 . . . . 0.0 109.646 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -65.76 -47.1 76.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.022 -1.049 . . . . 0.0 109.5 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 72.4 t -64.64 -42.99 96.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.451 -0.781 . . . . 0.0 110.273 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.483 ' CZ ' ' OD1' ' A' ' 81' ' ' ASP . 4.5 t80 -60.82 -47.32 86.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.885 -1.134 . . . . 0.0 109.662 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -73.5 -37.99 65.5 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.114 -0.991 . . . . 0.0 110.277 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -61.2 -39.66 91.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.02 -1.05 . . . . 0.0 109.22 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.1 mt -79.94 3.33 20.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 0.0 110.856 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 57.67 33.04 22.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.599 -0.688 . . . . 0.0 111.782 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.426 ' HB2' ' CD1' ' A' ' 51' ' ' PHE . 92.6 mmm -70.6 -23.39 62.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.997 -1.064 . . . . 0.0 109.841 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -73.16 -5.33 38.49 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.124 -0.985 . . . . 0.0 110.771 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -86.29 84.01 7.57 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.799 -1.188 . . . . 0.0 110.954 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.0 p -138.4 155.91 48.07 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.01 -44.22 97.18 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.98 -1.075 . . . . 0.0 112.541 -177.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.1 mt -99.15 3.49 46.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.864 -1.148 . . . . 0.0 111.36 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 55.48 36.24 26.73 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.188 0.994 . . . . 0.0 111.029 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.501 ' C ' HD11 ' A' ' 84' ' ' ILE . 97.5 m-20 -115.71 53.7 0.84 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.264 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.83 149.04 17.99 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.602 ' CG2' HD13 ' A' ' 84' ' ' ILE . 54.2 t -127.56 134.35 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.987 -1.302 . . . . 0.0 110.081 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.476 ' HB2' ' CE2' ' A' ' 51' ' ' PHE . 35.5 tp -116.61 126.76 53.72 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.235 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 85.6 mt -105.58 112.56 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.346 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -99.87 121.11 40.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.961 . . . . 0.0 110.002 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -122.87 131.8 72.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 122.102 0.953 . . . . 0.0 111.259 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.1 99.13 10.64 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.829 ' CG1' HD11 ' A' ' 35' ' ' LEU . 28.4 m -65.29 -24.44 35.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 121.142 -0.974 . . . . 0.0 110.998 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.755 ' HB2' HG23 ' A' ' 38' ' ' THR . 70.2 mm-40 -67.97 -43.55 78.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.762 -1.211 . . . . 0.0 110.023 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -102.14 3.55 38.63 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.134 -0.978 . . . . 0.0 110.993 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt 55.98 45.91 22.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.806 -1.184 . . . . 0.0 110.712 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 99.6 m -121.51 135.27 55.04 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.079 -1.013 . . . . 0.0 110.224 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.472 ' O ' ' CD1' ' A' ' 76' ' ' PHE . 52.5 p90 -115.98 138.1 51.51 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.473 -0.767 . . . . 0.0 111.253 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.502 HG21 ' CG1' ' A' ' 43' ' ' VAL . 58.6 t -128.91 136.19 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.892 -1.13 . . . . 0.0 108.192 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.582 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 69.8 mt -116.37 126.6 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.627 -1.295 . . . . 0.0 110.885 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -129.08 114.34 16.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.601 -0.687 . . . . 0.0 110.984 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.28 175.03 26.74 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.483 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 68.2 m-20 -82.0 -178.29 6.95 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.539 -0.977 . . . . 0.0 111.438 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.32 -26.45 68.49 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.36 -53.05 34.82 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.112 -1.042 . . . . 0.0 110.876 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.989 ' O ' HG22 ' A' ' 88' ' ' VAL . 7.9 mt -65.06 -44.69 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.95 -1.323 . . . . 0.0 107.705 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -61.53 -37.53 84.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.742 -1.224 . . . . 0.0 111.466 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -75.73 -19.99 58.66 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.011 -1.055 . . . . 0.0 111.929 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.008 HG13 HG13 ' A' ' 88' ' ' VAL . 9.5 p -104.3 -22.03 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 120.669 -1.27 . . . . 0.0 112.349 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.008 HG13 HG13 ' A' ' 87' ' ' VAL . 19.1 m -120.79 162.31 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 120.594 -1.316 . . . . 0.0 111.96 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.9 m -105.8 178.0 4.69 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.124 0.964 . . . . 0.0 112.316 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -62.81 -37.62 87.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.676 -0.64 . . . . 0.0 109.775 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -61.28 -35.82 78.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.06 -1.025 . . . . 0.0 108.887 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.642 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 80.7 t80 -67.01 -26.47 66.8 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.354 177.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.582 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 7.7 m95 -85.0 -26.96 26.77 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 122.013 0.911 . . . . 0.0 109.728 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -58.25 -38.21 76.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.166 -0.959 . . . . 0.0 112.815 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 69.5 p -65.49 -31.66 72.86 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.649 -1.22 . . . . 0.0 108.782 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.276 7.9 m -59.48 -48.68 80.72 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.485 1.136 . . . . 0.0 111.095 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -69.51 -37.89 77.37 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.945 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -63.8 -45.71 88.44 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.905 -1.122 . . . . 0.0 110.514 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.55 -48.43 81.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.735 -1.228 . . . . 0.0 110.275 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 93.1 mt -65.98 -42.84 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.122 -0.986 . . . . 0.0 110.412 179.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -65.12 -40.54 94.63 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.46 -0.775 . . . . 0.0 111.103 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.49 -42.92 98.54 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.307 -0.87 . . . . 0.0 111.853 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.45 ' HB3' ' HA3' ' A' ' 112' ' ' GLY . 3.3 tp60 -76.81 -39.55 50.99 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.652 -1.219 . . . . 0.0 108.99 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 3.0 m-85 -60.3 -42.34 95.32 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.817 0.818 . . . . 0.0 108.987 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.48 -30.97 70.03 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.44 -18.51 52.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 109.945 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.21 2.95 48.2 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.817 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -103.82 93.8 5.08 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.643 -1.504 . . . . 0.0 110.315 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.401 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 22.8 m-85 -62.88 -46.18 89.06 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.458 -0.776 . . . . 0.0 112.4 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.697 ' CE ' ' HB3' ' A' ' 15' ' ' ALA . 61.4 tttm -62.18 -48.47 79.91 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.801 -1.187 . . . . 0.0 112.997 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.53 -39.14 93.65 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.856 -1.138 . . . . 0.0 109.459 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.45 ' HA3' ' HB3' ' A' ' 103' ' ' GLN . . . -67.2 -47.32 64.92 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 109' ' ' PHE . 97.1 mt -62.08 -44.01 97.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -1.173 . . . . 0.0 109.392 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.524 HG22 HG13 ' A' ' 16' ' ' ILE . 68.5 t -66.72 -45.25 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.316 -0.865 . . . . 0.0 110.513 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -65.63 -40.95 93.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.965 -1.085 . . . . 0.0 109.995 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.48 -41.65 99.76 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 84.3 mt -64.27 -43.54 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.177 -1.19 . . . . 0.0 109.858 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.36 -51.82 68.28 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.868 -1.145 . . . . 0.0 110.846 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.02 -40.85 97.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.028 -1.045 . . . . 0.0 109.203 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.416 ' O ' ' HG ' ' A' ' 124' ' ' LEU . . . -56.41 -44.03 79.94 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.352 -0.842 . . . . 0.0 109.528 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.05 -43.32 95.93 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.814 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 6.1 tpp -66.66 -47.8 71.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.282 . . . . 0.0 109.421 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.642 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -62.8 -45.36 92.99 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.512 -0.875 . . . . 0.0 109.083 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 120' ' ' ALA . 83.5 mt -62.55 -39.65 94.31 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.06 -1.025 . . . . 0.0 108.635 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.88 -34.98 63.59 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.186 -0.947 . . . . 0.0 111.035 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -61.47 -41.13 96.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.995 -1.066 . . . . 0.0 108.493 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.581 ' HD2' HG22 ' A' ' 87' ' ' VAL . 56.3 m-85 -75.19 -38.24 60.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.511 -0.743 . . . . 0.0 110.098 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.538 ' HE2' HG11 ' A' ' 87' ' ' VAL . 70.9 m-85 -133.87 95.6 17.14 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.388 -0.82 . . . . 0.0 109.923 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 128' ' ' PHE . 45.6 Cg_endo -67.15 149.58 81.94 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.841 1.442 . . . . 0.0 110.369 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.481 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 42.7 t90 -72.03 143.38 49.16 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.533 -0.729 . . . . 0.0 111.403 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 99.2 mttt -121.76 151.22 40.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.487 -0.758 . . . . 0.0 109.248 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -58.86 -29.87 67.3 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.204 -0.935 . . . . 0.0 110.836 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -93.95 7.52 44.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.036 -1.04 . . . . 0.0 110.949 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 46.6 t0 -41.73 139.11 1.27 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.921 0.867 . . . . 0.0 111.423 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.595 HD13 ' H ' ' A' ' 135' ' ' ILE . 0.2 OUTLIER -110.37 138.26 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.447 -0.783 . . . . 0.0 110.553 -179.324 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -95.84 94.32 7.58 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.674 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.484 ' C ' HD22 ' A' ' 138' ' ' LEU . 78.6 mm-40 -69.09 -29.28 67.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.428 -0.795 . . . . 0.0 112.577 -178.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.484 HD22 ' C ' ' A' ' 137' ' ' GLU . 3.9 mm? -117.14 146.98 39.34 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 120.809 -1.182 . . . . 0.0 111.312 -178.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.06 -170.88 0.52 Allowed 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.43 1.226 . . . . 0.0 109.06 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.865 ' OD1' HG22 ' A' ' 20' ' ' ILE . 65.1 m-80 -122.05 3.66 9.89 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.39 -1.444 . . . . 0.0 110.327 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 21.0 m -63.1 141.3 58.82 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.087 -1.008 . . . . 0.0 111.928 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.586 HG13 HG22 ' A' ' 17' ' ' VAL . 86.2 mt -71.59 136.93 24.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.836 -0.54 . . . . 0.0 110.702 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 15.6 m -100.79 144.28 29.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.159 -0.963 . . . . 0.0 109.741 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -146.38 155.82 42.87 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.036 -1.04 . . . . 0.0 109.847 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.581 179.965 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.92 -37.98 67.05 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.086 -1.009 . . . . 0.0 109.769 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.77 -41.99 98.4 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.464 -0.773 . . . . 0.0 110.047 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -73.77 -45.59 50.79 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 110.465 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.743 ' O ' HG23 ' A' ' 17' ' ' VAL . 97.3 mt-10 -65.57 -36.49 83.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.832 -1.168 . . . . 0.0 109.858 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -63.82 -45.11 91.08 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.849 -1.157 . . . . 0.0 110.558 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.33 -44.71 86.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.954 -1.092 . . . . 0.0 111.672 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.51 ' CG2' HD11 ' A' ' 142' ' ' ILE . 20.3 tt -64.14 -35.73 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.729 -1.232 . . . . 0.0 110.45 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 13' ' ' GLU . 92.6 t -63.77 -40.59 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.381 -0.825 . . . . 0.0 108.892 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -61.03 -38.32 85.71 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.252 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.18 -38.86 90.68 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.192 -0.942 . . . . 0.0 109.768 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.481 HG22 ' OD1' ' A' ' 140' ' ' ASN . 91.7 mt -62.73 -43.23 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.168 -0.957 . . . . 0.0 109.691 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -59.67 -41.73 91.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.504 -0.748 . . . . 0.0 110.724 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -65.37 -37.48 87.13 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.199 -0.938 . . . . 0.0 110.991 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.92 92.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.033 -1.042 . . . . 0.0 109.89 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -60.1 -14.56 17.45 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.037 -1.04 . . . . 0.0 111.216 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.6 mttt -97.31 1.27 49.32 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.243 -0.911 . . . . 0.0 109.478 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -111.59 -15.05 13.56 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.04 -1.038 . . . . 0.0 109.314 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.5 t -152.68 156.03 38.43 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.054 -1.029 . . . . 0.0 110.064 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.9 p -86.84 -8.7 57.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.354 -0.841 . . . . 0.0 110.534 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.99 177.12 45.61 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.507 ' CB ' HD22 ' A' ' 138' ' ' LEU . 80.4 mm-40 -131.39 135.37 47.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.089 -1.242 . . . . 0.0 111.494 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 86.2 mt -116.43 132.07 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.724 ' HD3' ' HE2' ' A' ' 56' ' ' MET . 78.2 mtp85 -136.9 151.34 48.96 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.285 -0.884 . . . . 0.0 110.117 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.611 HG22 HD12 ' A' ' 67' ' ' ILE . 54.5 t -123.91 138.38 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.639 -0.663 . . . . 0.0 110.454 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.486 ' HB2' HD11 ' A' ' 66' ' ' LEU . 46.6 t60 -123.6 125.04 44.12 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.567 0.698 . . . . 0.0 109.132 178.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.431 ' C ' HD23 ' A' ' 35' ' ' LEU . 10.0 tt -113.48 131.08 56.18 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.009 0.909 . . . . 0.0 112.165 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 82.8 tt0 -146.84 167.14 24.64 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.45 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 51.6 mtmt -79.98 -73.99 0.33 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.964 . . . . 0.0 113.088 -177.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.411 ' OG1' ' CB ' ' A' ' 72' ' ' GLU . 62.7 m -141.57 159.61 41.86 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.411 -0.806 . . . . 0.0 110.198 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.416 ' OG ' ' CD ' ' A' ' 46' ' ' ARG . 51.1 m -112.4 170.24 8.31 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.511 -0.743 . . . . 0.0 111.133 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -107.09 -15.44 14.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.32 -0.863 . . . . 0.0 110.59 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.7 pt -121.78 -122.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.357 -0.839 . . . . 0.0 109.894 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -111.65 137.56 49.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.32 -1.488 . . . . 0.0 109.66 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.534 HG13 ' CD1' ' A' ' 68' ' ' TYR . 99.2 t -64.37 -42.54 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.441 -0.787 . . . . 0.0 110.679 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.22 -46.9 85.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.698 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -69.11 -37.95 78.66 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.433 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 58.5 ttt85 -61.96 -43.62 98.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.06 -1.025 . . . . 0.0 110.233 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.65 91.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.797 -1.189 . . . . 0.0 110.765 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.2 ttp -64.08 -43.39 95.59 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.707 -1.245 . . . . 0.0 109.681 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -64.29 -45.84 86.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.215 -0.928 . . . . 0.0 110.079 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.5 t -66.27 -42.48 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.23 -0.919 . . . . 0.0 109.475 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.07 -47.05 86.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.888 -1.133 . . . . 0.0 109.667 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -75.92 -38.63 57.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.57 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -60.66 -38.18 84.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.102 -0.999 . . . . 0.0 109.919 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.5 mt -81.2 5.41 17.05 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.005 -1.059 . . . . 0.0 110.313 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 56.77 30.62 18.03 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 121.458 -0.776 . . . . 0.0 111.328 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.724 ' HE2' ' HD3' ' A' ' 32' ' ' ARG . 99.6 mtp -65.24 -12.14 48.43 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.605 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.5 p30 -79.11 2.07 22.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.829 -1.169 . . . . 0.0 109.962 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -74.36 64.07 1.1 Allowed 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.205 -0.934 . . . . 0.0 109.926 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 81.5 p -134.49 149.09 50.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.17 -0.956 . . . . 0.0 109.661 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.67 -43.73 92.63 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.7 mt -95.76 0.9 52.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.93 -1.107 . . . . 0.0 111.018 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 56.08 38.53 30.0 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.301 1.048 . . . . 0.0 111.761 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.588 ' C ' HD11 ' A' ' 84' ' ' ILE . 97.7 m-20 -110.34 54.24 0.67 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.876 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.515 ' N ' HD11 ' A' ' 84' ' ' ILE . . . -101.0 138.52 13.89 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.614 ' CG2' HD13 ' A' ' 84' ' ' ILE . 53.7 t -121.88 134.62 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.022 -1.281 . . . . 0.0 110.361 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.52 HD13 ' CE ' ' A' ' 56' ' ' MET . 64.2 tp -117.76 129.22 55.56 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.088 0.47 . . . . 0.0 110.602 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.611 HD12 HG22 ' A' ' 33' ' ' VAL . 95.1 mt -110.66 107.39 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.981 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.534 ' CD1' HG13 ' A' ' 43' ' ' VAL . 58.6 t80 -92.95 122.91 35.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.117 -0.989 . . . . 0.0 109.541 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.6 t -120.74 130.93 74.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 122.264 1.031 . . . . 0.0 111.132 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.576 ' HB3' ' OD1' ' A' ' 73' ' ' ASP . . . -102.5 94.83 5.87 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.123 178.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.3 m -63.92 -19.48 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.094 -1.004 . . . . 0.0 111.236 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.411 ' CB ' ' OG1' ' A' ' 38' ' ' THR . 79.8 mm-40 -68.17 -43.08 78.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.879 -1.138 . . . . 0.0 109.602 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.576 ' OD1' ' HB3' ' A' ' 70' ' ' ALA . 32.3 p30 -102.88 5.78 38.73 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.336 -0.852 . . . . 0.0 110.536 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 109' ' ' PHE . 34.1 tttt 54.53 49.85 17.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.987 -1.07 . . . . 0.0 111.236 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 73' ' ' ASP . 72.5 p -126.53 167.21 15.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.142 -0.973 . . . . 0.0 109.927 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -141.09 144.52 34.96 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.424 -0.798 . . . . 0.0 109.865 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.492 HG21 HG11 ' A' ' 43' ' ' VAL . 55.7 t -131.26 136.46 57.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.693 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 81.4 mt -116.44 126.96 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.926 -1.108 . . . . 0.0 110.71 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -129.51 113.57 15.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.6 -0.688 . . . . 0.0 110.145 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -102.1 148.53 17.69 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -61.41 174.79 0.67 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.673 -0.898 . . . . 0.0 109.27 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.1 -24.79 60.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.14 -0.975 . . . . 0.0 111.068 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.509 ' O ' HG12 ' A' ' 87' ' ' VAL . . . -65.9 -51.96 41.63 Favored Glycine 0 N--CA 1.496 2.654 0 C-N-CA 119.711 -1.233 . . . . 0.0 111.452 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.985 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.6 mt -66.48 -43.93 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.811 -1.405 . . . . 0.0 108.048 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -62.2 -38.9 90.9 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 111.434 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -76.98 -23.41 52.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.934 -1.104 . . . . 0.0 112.322 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.974 HG13 HG13 ' A' ' 88' ' ' VAL . 11.2 p -98.35 -24.77 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.731 -1.231 . . . . 0.0 112.579 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.985 HG22 ' O ' ' A' ' 84' ' ' ILE . 14.3 m -117.32 163.37 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.631 -1.293 . . . . 0.0 111.519 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.415 ' OG ' ' N ' ' A' ' 90' ' ' ASP . 6.2 t -105.06 179.71 4.19 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.24 -0.912 . . . . 0.0 111.843 -178.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.415 ' N ' ' OG ' ' A' ' 89' ' ' SER . 64.1 t0 -62.0 -38.04 87.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.464 -0.773 . . . . 0.0 110.051 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -62.94 -36.97 85.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.177 -0.952 . . . . 0.0 109.31 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.718 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 51.7 t80 -65.69 -26.97 68.01 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.305 -0.958 . . . . 0.0 108.92 177.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.693 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.6 m95 -84.73 -28.44 26.28 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 122.026 0.917 . . . . 0.0 110.021 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -58.01 -37.32 74.06 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.742 -0.599 . . . . 0.0 112.471 -176.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.5 p -65.9 -32.57 74.15 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 118.627 -1.229 . . . . 0.0 109.15 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.27 10.1 m -59.95 -48.25 82.47 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.33 1.062 . . . . 0.0 111.609 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -69.9 -36.99 75.85 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.531 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -64.22 -43.72 94.12 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.584 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.28 -51.41 66.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.919 -1.113 . . . . 0.0 111.01 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.93 -41.98 90.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.3 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.4 -45.14 92.41 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.255 -0.903 . . . . 0.0 111.851 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.8 tp -63.11 -42.3 99.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.164 -0.96 . . . . 0.0 111.789 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.461 ' HB3' ' CA ' ' A' ' 112' ' ' GLY . 21.4 tp60 -72.55 -39.98 67.05 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.641 -1.224 . . . . 0.0 108.634 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -59.24 -38.32 79.7 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -61.59 -35.72 78.63 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.315 0.579 . . . . 0.0 109.885 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -75.12 -18.61 60.2 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 109.301 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.95 0.96 45.38 Favored Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.948 -1.12 . . . . 0.0 110.737 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -98.79 95.55 7.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.75 -1.441 . . . . 0.0 109.843 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 74' ' ' LYS . 21.7 m-30 -64.72 -41.23 96.12 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.815 -0.553 . . . . 0.0 111.175 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -64.35 -50.1 69.05 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.274 -0.891 . . . . 0.0 111.831 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -62.36 -34.54 76.87 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.014 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.461 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -66.72 -47.89 65.1 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.331 -1.414 . . . . 0.0 109.733 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.491 ' HB3' HD11 ' A' ' 16' ' ' ILE . 83.5 mt -63.37 -45.0 93.17 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.263 -1.139 . . . . 0.0 111.989 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.493 HG13 ' N ' ' A' ' 115' ' ' ASP . 11.9 p -67.25 -44.9 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.943 -1.098 . . . . 0.0 110.908 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.493 ' N ' HG13 ' A' ' 114' ' ' VAL . 13.4 m-20 -64.94 -37.34 87.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 110.38 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.31 -42.77 99.14 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.41 -43.93 97.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.331 -1.099 . . . . 0.0 109.882 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -57.67 -51.73 68.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.045 -1.034 . . . . 0.0 110.165 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -62.6 -43.09 99.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.222 -0.924 . . . . 0.0 109.172 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.91 -45.36 86.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.463 -0.773 . . . . 0.0 109.998 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.26 -42.62 99.24 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.0 mtt -66.33 -45.55 79.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.959 -1.318 . . . . 0.0 109.651 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.718 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -63.75 -44.67 92.78 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.522 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 42.0 mt -62.3 -39.78 94.12 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.95 -34.67 63.47 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.355 -0.841 . . . . 0.0 110.716 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -62.94 -41.67 99.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.118 -0.989 . . . . 0.0 109.886 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -78.01 -36.69 48.46 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.392 -0.817 . . . . 0.0 110.252 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -127.87 94.43 37.1 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.393 -0.817 . . . . 0.0 109.527 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.76 143.7 62.55 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 123.882 1.464 . . . . 0.0 110.266 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 44.5 t90 -72.41 130.46 40.77 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.306 -0.871 . . . . 0.0 111.264 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 97.6 mttt -109.02 153.03 24.19 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.71 -32.74 71.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.79 -1.194 . . . . 0.0 111.564 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -88.62 8.49 28.19 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.053 -1.059 . . . . 0.0 110.733 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.477 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 65.9 t0 -42.86 137.3 2.36 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.89 0.852 . . . . 0.0 111.538 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.545 HD13 ' H ' ' A' ' 135' ' ' ILE . 0.1 OUTLIER -107.62 133.08 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 121.488 -0.758 . . . . 0.0 111.381 -178.327 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -112.39 99.55 8.09 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.327 -0.858 . . . . 0.0 109.306 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -98.51 -15.55 19.52 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.826 -1.171 . . . . 0.0 111.541 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.535 HD23 ' HD2' ' A' ' 32' ' ' ARG . 3.1 mp -94.98 144.17 27.35 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.235 -0.916 . . . . 0.0 110.47 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -72.55 169.71 21.16 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.665 1.35 . . . . 0.0 109.222 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.481 ' OD1' HG22 ' A' ' 20' ' ' ILE . 65.4 m-80 -110.02 8.73 24.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.839 -1.163 . . . . 0.0 110.322 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.1 p -67.22 166.57 13.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.071 -1.018 . . . . 0.0 111.316 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.51 HD11 ' CG2' ' A' ' 16' ' ' ILE . 96.4 mt -90.04 136.45 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.59 -0.694 . . . . 0.0 110.395 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.1 m -88.99 137.12 32.6 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.143 -0.973 . . . . 0.0 109.617 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -133.1 147.26 52.15 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.117 -0.989 . . . . 0.0 110.695 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.43 0 CA-C-O 117.86 -1.522 . . . . 0.0 109.892 -179.502 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 14' ' ' LYS . . . -52.43 -39.26 60.81 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.691 -1.255 . . . . 0.0 109.871 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.84 -42.25 90.72 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.679 -0.638 . . . . 0.0 111.404 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.407 ' HB3' ' HD2' ' A' ' 110' ' ' LYS . 90.6 mt-10 -70.7 -44.21 67.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.923 -1.111 . . . . 0.0 110.174 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.499 ' O ' HG23 ' A' ' 17' ' ' VAL . 96.2 mt-10 -67.17 -33.45 75.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.011 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 86.9 tttt -64.59 -45.67 85.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.682 -1.261 . . . . 0.0 110.306 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.77 -42.7 94.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.023 -1.048 . . . . 0.0 111.501 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.722 HG13 HG22 ' A' ' 114' ' ' VAL . 19.3 tt -67.15 -37.56 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.777 -1.202 . . . . 0.0 110.977 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 13' ' ' GLU . 68.4 t -64.36 -41.22 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -61.62 -37.32 83.54 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.211 -0.996 . . . . 0.0 108.648 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.23 87.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.435 -0.79 . . . . 0.0 109.845 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 17' ' ' VAL . 95.1 mt -63.81 -42.87 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.153 -0.967 . . . . 0.0 110.001 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -60.35 -42.04 94.89 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.788 0.804 . . . . 0.0 110.299 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -65.12 -36.78 85.35 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.249 -0.581 . . . . 0.0 110.162 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.22 95.49 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.108 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.78 -14.58 33.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.056 -1.028 . . . . 0.0 110.519 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.468 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.7 mttt -93.42 -0.21 56.58 Favored 'General case' 0 C--N 1.309 -1.17 0 O-C-N 121.046 -1.034 . . . . 0.0 109.257 176.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -113.04 -13.74 13.05 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 120.835 -1.165 . . . . 0.0 110.608 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 t -153.33 160.3 42.66 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.915 -1.116 . . . . 0.0 110.105 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.1 p -90.91 -10.35 42.82 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.175 -0.953 . . . . 0.0 109.857 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.0 172.35 40.6 Favored Glycine 0 N--CA 1.481 1.685 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.492 ' HB3' HD22 ' A' ' 138' ' ' LEU . 54.3 mp0 -131.61 134.85 46.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.225 -1.162 . . . . 0.0 112.163 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.8 mt -120.84 133.76 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.746 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.1 ttm-85 -138.67 159.19 42.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.958 -1.089 . . . . 0.0 109.677 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 143' ' ' SER . 3.5 p -128.31 137.91 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.405 -0.809 . . . . 0.0 110.743 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -121.2 125.14 46.41 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.503 HD11 ' CG1' ' A' ' 71' ' ' VAL . 40.0 tp -110.92 131.14 55.3 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.892 0.854 . . . . 0.0 111.449 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.426 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 76.9 tt0 -147.78 165.34 30.85 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.655 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.7 mttt -79.77 -74.85 0.28 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 112.956 -177.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.8 t -139.36 156.27 47.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.109 -0.995 . . . . 0.0 110.367 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.552 ' HB2' ' CD ' ' A' ' 46' ' ' ARG . 5.9 p -104.27 166.97 10.06 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.701 -0.624 . . . . 0.0 111.198 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -106.67 -8.04 17.07 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.391 -0.818 . . . . 0.0 110.347 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 42' ' ' ASP . 34.3 pt -129.15 -122.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.912 -1.118 . . . . 0.0 110.487 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.414 ' N ' HG13 ' A' ' 41' ' ' ILE . 93.9 m-20 -111.72 137.33 49.77 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.057 -1.652 . . . . 0.0 110.065 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.3 t -63.23 -43.38 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.284 -0.885 . . . . 0.0 111.624 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -59.76 -45.61 91.72 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.763 -1.211 . . . . 0.0 110.094 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -67.26 -39.73 86.12 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.659 -1.276 . . . . 0.0 109.135 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.552 ' CD ' ' HB2' ' A' ' 39' ' ' SER . 77.6 mtp85 -62.24 -45.3 93.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.956 -1.09 . . . . 0.0 110.767 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.58 95.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.969 -1.082 . . . . 0.0 110.416 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.8 ttp -62.91 -43.13 99.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.013 -1.054 . . . . 0.0 109.507 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -65.5 -46.37 79.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.953 -1.092 . . . . 0.0 110.16 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.9 t -65.95 -44.42 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.032 -1.043 . . . . 0.0 110.422 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.433 ' C ' ' CD1' ' A' ' 51' ' ' PHE . 6.5 t80 -57.12 -49.52 75.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.984 -1.073 . . . . 0.0 109.259 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -72.86 -35.59 67.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.967 -1.083 . . . . 0.0 109.413 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -60.47 -39.98 89.58 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.394 -0.816 . . . . 0.0 108.988 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.0 mt -79.23 4.35 15.25 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.624 -0.673 . . . . 0.0 110.081 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 56.48 32.73 21.28 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 121.187 -0.946 . . . . 0.0 111.297 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 94.4 mmm -66.39 -11.68 52.77 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.914 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -79.5 -1.61 38.38 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.771 -1.205 . . . . 0.0 109.89 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -78.28 65.68 3.68 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.032 -1.043 . . . . 0.0 109.603 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.48 HG22 HD11 ' A' ' 138' ' ' LEU . 78.4 p -135.08 150.05 50.18 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -64.05 -43.06 96.68 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.601 -0.687 . . . . 0.0 112.123 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 98.2 mt -96.59 0.15 49.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.789 -1.194 . . . . 0.0 111.502 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 87.8 mt-30 57.26 46.15 19.12 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.497 1.141 . . . . 0.0 111.273 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -120.21 52.85 1.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.094 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.81 138.79 14.09 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.63 HG22 ' HA2' ' A' ' 80' ' ' GLY . 61.2 t -125.54 135.89 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.162 -1.199 . . . . 0.0 110.952 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.1 tp -116.5 125.97 52.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.527 -0.733 . . . . 0.0 109.712 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.0 mt -101.85 106.25 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.118 -1.033 . . . . 0.0 109.389 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -91.89 123.04 34.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.326 -0.859 . . . . 0.0 110.021 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 79.2 t -123.63 130.38 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.494 -0.754 . . . . 0.0 111.003 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.52 108.92 20.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.722 -0.611 . . . . 0.0 109.373 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.655 HG22 ' HA ' ' A' ' 37' ' ' LYS . 22.8 m -76.11 -19.56 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.891 -1.13 . . . . 0.0 111.56 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.402 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 79.0 mm-40 -69.66 -46.98 64.88 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.656 -1.278 . . . . 0.0 109.259 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -101.78 1.5 37.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.488 -0.757 . . . . 0.0 110.936 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.2 tttt 56.67 47.53 18.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.844 -1.16 . . . . 0.0 110.748 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.8 m -118.22 129.37 55.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.075 -1.016 . . . . 0.0 109.823 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -112.29 138.84 48.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.691 -0.63 . . . . 0.0 110.459 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.14 137.19 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.331 -0.856 . . . . 0.0 109.002 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.68 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 77.6 mt -113.89 128.62 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.933 -1.104 . . . . 0.0 110.398 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -132.56 116.55 16.85 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.535 -0.728 . . . . 0.0 110.78 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.63 ' HA2' HG22 ' A' ' 65' ' ' VAL . . . -100.38 168.98 21.19 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -80.53 178.49 8.29 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.771 -0.841 . . . . 0.0 110.227 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.05 -28.83 70.36 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.218 -0.926 . . . . 0.0 111.166 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -65.66 -54.06 27.89 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.204 -0.998 . . . . 0.0 110.643 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.995 ' O ' HG22 ' A' ' 88' ' ' VAL . 97.3 mt -63.7 -46.89 93.4 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.733 0 O-C-N 120.926 -1.338 . . . . 0.0 107.663 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.83 -38.37 85.22 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.785 -1.197 . . . . 0.0 111.558 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -70.99 -24.89 62.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.035 -1.041 . . . . 0.0 112.238 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.877 HG23 HG13 ' A' ' 88' ' ' VAL . 18.0 m -104.75 -17.14 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.71 -1.244 . . . . 0.0 112.411 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.995 HG22 ' O ' ' A' ' 84' ' ' ILE . 18.4 m -117.73 163.75 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 120.415 -1.428 . . . . 0.0 111.382 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.2 p -109.76 172.56 6.79 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.718 0.771 . . . . 0.0 112.581 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -59.15 -37.26 76.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.424 -0.798 . . . . 0.0 109.398 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -61.21 -39.89 91.93 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.085 -1.009 . . . . 0.0 109.031 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.822 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 69.1 t80 -64.48 -25.33 67.95 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.195 -0.941 . . . . 0.0 109.229 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.68 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.7 m95 -86.99 -26.66 23.67 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.651 0.739 . . . . 0.0 111.183 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -58.48 -34.67 71.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.397 -0.814 . . . . 0.0 112.026 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.9 m -66.16 -32.78 74.42 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.003 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.501 HG22 HD13 ' A' ' 78' ' ' ILE 0.277 9.0 m -60.68 -49.49 77.28 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 122.325 1.059 . . . . 0.0 111.63 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -68.41 -38.08 80.94 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.146 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -64.31 -45.95 85.69 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.491 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.73 -50.56 71.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.884 -1.135 . . . . 0.0 111.707 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.519 HD12 HD11 ' A' ' 78' ' ' ILE . 96.5 mt -65.66 -41.64 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.913 -1.117 . . . . 0.0 109.165 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -64.01 -41.5 97.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.595 -0.691 . . . . 0.0 111.227 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.57 -42.09 99.34 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.156 -0.965 . . . . 0.0 111.331 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.479 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 96.4 mm-40 -75.71 -41.46 53.5 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.964 -1.095 . . . . 0.0 108.925 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -59.25 -40.9 87.43 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -59.33 -35.98 74.82 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.477 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -77.81 -15.52 59.02 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.046 -1.034 . . . . 0.0 109.901 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.05 3.68 48.36 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.784 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -101.92 91.32 4.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.686 -1.479 . . . . 0.0 110.491 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -61.02 -46.03 92.4 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.343 -0.848 . . . . 0.0 111.556 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.407 ' HD2' ' HB3' ' A' ' 12' ' ' GLU . 62.4 tttm -62.65 -48.24 80.23 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 112.919 -178.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -61.77 -38.03 86.49 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 118.549 -1.26 . . . . 0.0 109.467 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.479 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -64.94 -46.05 90.53 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.7 mt -63.68 -45.47 89.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.31 -1.112 . . . . 0.0 110.747 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.722 HG22 HG13 ' A' ' 16' ' ' ILE . 95.5 t -66.88 -46.77 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.012 -1.055 . . . . 0.0 110.816 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -64.76 -38.95 92.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.012 -1.055 . . . . 0.0 110.203 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.44 -42.33 97.64 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.1 mt -63.97 -44.07 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -1.142 . . . . 0.0 109.837 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -60.12 -46.73 88.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.088 -1.008 . . . . 0.0 109.455 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -63.53 -41.83 98.46 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.188 -1.005 . . . . 0.0 108.587 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -59.13 -42.66 91.14 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.836 -0.745 . . . . 0.0 109.539 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.66 -44.12 96.89 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 57.5 ttm -67.58 -48.5 66.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.135 -1.214 . . . . 0.0 109.935 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.822 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -61.72 -46.13 90.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.953 -1.092 . . . . 0.0 109.276 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.407 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 88.3 mt -62.69 -39.34 93.68 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.511 -0.743 . . . . 0.0 109.054 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.44 -34.67 61.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.244 -0.91 . . . . 0.0 110.459 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -61.38 -39.96 92.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.03 -1.044 . . . . 0.0 109.183 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -80.2 -31.97 38.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.884 . . . . 0.0 109.468 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -132.54 93.12 25.58 Favored Pre-proline 0 N--CA 1.485 1.296 0 O-C-N 121.532 -0.73 . . . . 0.0 109.956 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.64 146.48 73.49 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.816 1.429 . . . . 0.0 109.457 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.468 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 64.3 t90 -71.26 132.11 44.46 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.157 -0.965 . . . . 0.0 110.951 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -110.13 147.52 33.52 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -55.79 -28.45 56.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.054 -1.029 . . . . 0.0 110.878 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 40.7 p-10 -92.91 9.25 36.26 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.027 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.416 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 61.1 t0 -42.55 135.85 2.65 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.882 0.848 . . . . 0.0 111.163 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.715 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -113.32 141.91 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.578 0.704 . . . . 0.0 111.247 -177.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -98.75 93.17 5.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.994 -1.066 . . . . 0.0 110.172 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.541 ' C ' HD12 ' A' ' 138' ' ' LEU . 99.7 mt-10 -68.2 -39.45 82.44 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.904 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.541 HD12 ' C ' ' A' ' 137' ' ' GLU . 11.1 mp -105.77 151.04 39.82 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.204 -0.935 . . . . 0.0 110.737 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -75.45 -174.15 1.88 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.639 1.336 . . . . 0.0 108.763 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -118.64 3.61 11.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.575 -1.328 . . . . 0.0 110.03 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.9 m -60.96 137.08 58.25 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.852 -1.155 . . . . 0.0 110.835 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.4 mt -67.34 136.69 26.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.698 -0.626 . . . . 0.0 110.175 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 3.5 m -92.97 134.08 35.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.401 -0.812 . . . . 0.0 109.244 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -132.9 149.6 52.23 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -0.936 . . . . 0.0 109.898 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 CA-C-O 117.908 -1.496 . . . . 0.0 109.844 -179.605 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 121.09 0.472 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 14' ' ' LYS . . . -52.53 -40.51 62.54 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.939 -1.101 . . . . 0.0 109.555 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.01 -46.91 87.13 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.529 -0.732 . . . . 0.0 110.401 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.67 -46.27 66.47 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.035 -1.041 . . . . 0.0 111.125 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.503 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.6 mt-10 -63.03 -37.94 89.21 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.124 -0.985 . . . . 0.0 109.917 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 87.8 tttt -63.64 -44.72 93.01 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.442 -0.786 . . . . 0.0 111.239 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.18 -42.65 93.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.956 -1.09 . . . . 0.0 111.375 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.651 HG13 HG22 ' A' ' 114' ' ' VAL . 18.4 tt -67.81 -37.53 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.701 -1.249 . . . . 0.0 110.351 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.609 ' HA ' HD12 ' A' ' 20' ' ' ILE . 46.9 t -62.68 -42.68 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -61.77 -37.88 85.93 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.574 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.03 -36.58 79.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.334 -0.854 . . . . 0.0 109.188 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.879 HG22 ' OD1' ' A' ' 140' ' ' ASN . 96.7 mt -64.25 -43.66 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.363 -0.836 . . . . 0.0 109.696 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -58.78 -41.57 86.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.245 -0.909 . . . . 0.0 109.921 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -64.65 -37.53 87.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.501 -0.75 . . . . 0.0 111.664 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.45 ' O ' HG22 ' A' ' 27' ' ' THR . . . -64.92 -39.99 94.36 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.831 -1.168 . . . . 0.0 110.021 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -60.53 -15.59 28.96 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.062 -1.024 . . . . 0.0 111.097 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.6 mttt -92.93 -6.23 49.01 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.16 -0.962 . . . . 0.0 109.006 177.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -105.72 -13.72 15.47 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 121.085 -1.009 . . . . 0.0 109.742 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 23' ' ' ALA . 4.5 t -151.55 156.93 41.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.026 -1.046 . . . . 0.0 110.318 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.4 t -86.6 -6.9 58.75 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.354 -0.841 . . . . 0.0 109.019 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.86 173.31 50.26 Favored Glycine 0 N--CA 1.481 1.64 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.42 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 52.5 mp0 -132.35 137.4 47.37 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.147 -1.208 . . . . 0.0 111.677 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 82.4 mt -119.57 134.14 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.682 -0.636 . . . . 0.0 110.293 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HB3' ' CE ' ' A' ' 56' ' ' MET . 75.2 ttt180 -139.73 153.07 47.11 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.054 -1.029 . . . . 0.0 109.906 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.608 HG22 ' HB ' ' A' ' 67' ' ' ILE . 55.8 t -123.53 140.08 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.366 -0.834 . . . . 0.0 111.134 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.465 ' HB2' HD11 ' A' ' 66' ' ' LEU . 64.2 t60 -122.86 133.14 54.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.577 -0.702 . . . . 0.0 109.146 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.646 HD11 HG13 ' A' ' 71' ' ' VAL . 40.6 tp -123.89 136.43 54.35 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.099 0.952 . . . . 0.0 112.086 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.45 ' HG2' ' NH2' ' A' ' 46' ' ' ARG . 48.5 tp10 -151.63 161.95 41.81 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.545 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.1 mttt -73.38 -72.5 0.25 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.929 -1.107 . . . . 0.0 112.417 -177.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 t -142.79 158.03 44.04 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.434 -0.791 . . . . 0.0 109.524 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.425 ' OG ' ' CD ' ' A' ' 46' ' ' ARG . 69.5 m -108.2 172.23 6.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.345 -0.847 . . . . 0.0 111.264 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -107.63 -21.3 12.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.559 -0.713 . . . . 0.0 110.531 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.9 pt -116.88 -121.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.009 -1.057 . . . . 0.0 110.762 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -109.38 132.75 53.84 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.637 -1.289 . . . . 0.0 109.332 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.8 t -62.4 -43.76 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.75 -0.594 . . . . 0.0 111.471 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -59.79 -47.93 83.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.892 -1.13 . . . . 0.0 109.537 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -67.71 -35.64 79.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.943 -1.098 . . . . 0.0 108.246 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.518 ' NH1' HG21 ' A' ' 50' ' ' VAL . 76.0 ttt-85 -64.5 -43.2 94.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 111.414 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.24 -36.86 85.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.749 -1.219 . . . . 0.0 109.985 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.5 ttp -61.21 -42.93 99.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 109.059 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -63.72 -46.77 83.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.004 -1.06 . . . . 0.0 110.249 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.518 HG21 ' NH1' ' A' ' 46' ' ' ARG . 71.8 t -64.85 -43.84 96.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.33 -0.856 . . . . 0.0 109.882 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -59.23 -49.37 78.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.057 -1.027 . . . . 0.0 109.666 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -71.43 -35.82 71.06 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.363 -0.835 . . . . 0.0 109.226 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -62.22 -37.72 86.46 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.266 -0.897 . . . . 0.0 109.327 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.0 mt -82.43 3.93 26.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.914 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.2 tttt 54.86 34.8 22.85 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.137 -0.977 . . . . 0.0 111.483 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.821 ' SD ' HD13 ' A' ' 66' ' ' LEU . 94.2 mtp -66.78 -11.44 55.06 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.901 -1.124 . . . . 0.0 110.206 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 44.7 p-10 -77.25 -0.84 26.81 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.94 -1.1 . . . . 0.0 109.927 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -78.54 64.62 3.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.387 -0.821 . . . . 0.0 110.687 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.4 p -135.14 150.3 50.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.21 -0.931 . . . . 0.0 108.951 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.62 -44.54 96.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.283 -0.886 . . . . 0.0 112.707 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 90.6 mt -97.14 1.59 50.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.95 -1.094 . . . . 0.0 111.725 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 85.2 mt-30 57.13 38.43 29.01 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.284 1.04 . . . . 0.0 110.913 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.531 ' C ' HD11 ' A' ' 84' ' ' ILE . 99.3 m-20 -112.67 55.21 0.7 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.543 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.404 ' O ' ' CD1' ' A' ' 84' ' ' ILE . . . -101.71 141.16 15.19 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 178.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.474 ' CG2' HD13 ' A' ' 84' ' ' ILE . 49.9 t -124.29 134.72 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.143 -1.21 . . . . 0.0 110.162 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.821 HD13 ' SD ' ' A' ' 56' ' ' MET . 52.2 tp -117.89 129.33 55.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.515 -0.741 . . . . 0.0 110.658 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.608 ' HB ' HG22 ' A' ' 33' ' ' VAL . 97.1 mt -107.64 110.18 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.905 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.435 ' OH ' ' NH2' ' A' ' 46' ' ' ARG . 33.8 t80 -96.71 125.42 41.15 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.189 -0.944 . . . . 0.0 110.318 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.507 ' O ' HD12 ' A' ' 35' ' ' LEU . 55.3 t -125.59 131.73 71.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-O 122.139 0.971 . . . . 0.0 111.165 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.469 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -98.71 108.92 21.73 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.646 HG13 HD11 ' A' ' 35' ' ' LEU . 32.8 m -74.65 -19.37 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.052 -1.03 . . . . 0.0 110.078 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -69.46 -43.45 73.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.075 -1.015 . . . . 0.0 109.336 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -104.22 4.98 34.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.006 -1.059 . . . . 0.0 111.15 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 67.5 tttt 56.06 47.4 19.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.831 -1.168 . . . . 0.0 110.64 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.469 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 22.2 p -123.23 167.61 13.51 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.183 -0.948 . . . . 0.0 110.355 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -147.83 140.84 24.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.555 -0.715 . . . . 0.0 109.993 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 68.7 t -128.38 138.39 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.727 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 79.4 mt -113.62 124.76 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.971 -1.08 . . . . 0.0 110.492 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -130.38 113.75 14.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.504 -0.747 . . . . 0.0 109.717 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.94 170.5 21.82 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -77.35 174.21 11.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.483 -1.01 . . . . 0.0 110.223 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -58.87 -27.81 65.54 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.326 -0.859 . . . . 0.0 110.244 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.491 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -64.78 -50.49 58.2 Favored Glycine 0 N--CA 1.487 2.065 0 C-N-CA 119.687 -1.245 . . . . 0.0 109.99 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.96 ' O ' HG22 ' A' ' 88' ' ' VAL . 4.2 mt -63.54 -46.9 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.835 -1.391 . . . . 0.0 108.552 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -63.26 -33.66 75.98 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.529 -0.732 . . . . 0.0 112.058 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -76.74 -22.98 53.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.739 -1.226 . . . . 0.0 112.532 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.086 HG23 HG13 ' A' ' 88' ' ' VAL . 25.9 m -103.99 -17.85 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.757 -1.214 . . . . 0.0 112.08 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.086 HG13 HG23 ' A' ' 87' ' ' VAL . 4.5 m -120.25 159.52 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.966 -1.084 . . . . 0.0 111.591 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.9 p -104.65 177.25 4.9 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.881 0.848 . . . . 0.0 112.084 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -64.21 -38.74 92.14 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.59 -0.694 . . . . 0.0 109.246 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -60.83 -38.52 85.73 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.877 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 75.2 t80 -64.33 -26.26 68.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -0.941 . . . . 0.0 108.83 177.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.727 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.4 m95 -85.71 -26.68 25.78 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.924 0.869 . . . . 0.0 110.216 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -56.88 -41.13 77.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 112.538 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.2 p -63.19 -31.44 72.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.658 -1.276 . . . . 0.0 109.298 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.281 7.6 m -59.47 -48.35 82.0 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.433 1.111 . . . . 0.0 111.146 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -70.12 -37.17 75.25 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.124 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -63.47 -44.73 93.59 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.177 -1.009 . . . . 0.0 110.883 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.64 -49.03 76.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.743 -1.223 . . . . 0.0 110.881 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.1 -42.3 91.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.176 -0.952 . . . . 0.0 110.059 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -63.38 -43.51 97.41 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.677 -0.64 . . . . 0.0 111.701 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.8 mt -63.96 -43.13 96.74 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.722 -1.236 . . . . 0.0 112.256 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.481 ' HG2' ' N ' ' A' ' 112' ' ' GLY . 27.6 tp60 -72.36 -42.53 65.2 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.666 -1.214 . . . . 0.0 108.72 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -58.5 -39.57 80.42 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.81 -32.16 72.45 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.622 -0.674 . . . . 0.0 109.887 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -80.95 -19.02 45.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.085 -1.01 . . . . 0.0 110.238 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.27 5.87 36.95 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.045 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.407 ' HB2' ' HG3' ' A' ' 103' ' ' GLN . 95.8 m-20 -105.87 89.85 3.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.833 -1.392 . . . . 0.0 110.253 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -63.65 -41.45 98.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.725 -0.609 . . . . 0.0 111.672 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.615 ' O ' HG23 ' A' ' 114' ' ' VAL . 78.5 tttt -62.56 -48.11 80.92 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.888 -1.133 . . . . 0.0 111.721 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.47 ' HB2' ' HG2' ' A' ' 103' ' ' GLN . 88.4 mt-30 -64.41 -37.91 89.19 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.636 -177.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.481 ' N ' ' HG2' ' A' ' 103' ' ' GLN . . . -67.37 -46.32 71.6 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.86 -43.25 93.59 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.533 -0.98 . . . . 0.0 110.48 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.651 HG22 HG13 ' A' ' 16' ' ' ILE . 96.6 t -66.42 -47.13 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.393 -0.817 . . . . 0.0 109.996 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -62.9 -40.57 97.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.247 -0.908 . . . . 0.0 109.164 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.74 -43.51 96.37 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.3 mt -63.55 -43.4 98.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -1.105 . . . . 0.0 110.062 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -60.86 -48.27 82.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.023 -1.048 . . . . 0.0 110.484 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.33 -43.65 97.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.012 -1.055 . . . . 0.0 109.487 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.09 -41.44 83.49 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.388 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.04 -45.61 91.57 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 95.6 mtp -66.16 -46.48 77.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.903 -1.351 . . . . 0.0 109.934 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.877 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -62.06 -46.9 87.09 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.602 -0.686 . . . . 0.0 109.725 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.86 -38.63 91.79 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.449 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.84 -35.12 61.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.868 -1.145 . . . . 0.0 110.273 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.91 -43.95 97.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.144 -0.972 . . . . 0.0 109.047 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -72.49 -39.89 67.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.67 -0.644 . . . . 0.0 109.654 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.421 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 36.7 m-85 -131.4 96.73 20.79 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.485 -0.759 . . . . 0.0 110.505 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 128' ' ' PHE . 43.1 Cg_endo -66.38 150.32 84.48 Favored 'Trans proline' 0 C--N 1.317 -1.124 0 O-C-N 123.739 1.389 . . . . 0.0 110.735 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.475 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 29.4 t90 -73.32 164.1 27.15 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.643 0.735 . . . . 0.0 110.358 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -145.23 153.37 41.26 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.62 -30.83 70.1 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 111.736 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -90.71 8.24 35.51 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 118.926 -1.109 . . . . 0.0 111.224 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -41.95 138.43 1.54 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.632 0.73 . . . . 0.0 111.551 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.772 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.3 pp -113.32 147.65 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 121.542 0.687 . . . . 0.0 110.737 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -102.25 92.78 4.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.689 -1.257 . . . . 0.0 109.358 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.549 ' HG2' HD13 ' A' ' 135' ' ' ILE . 80.3 mm-40 -66.26 -41.05 90.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.725 -0.61 . . . . 0.0 111.749 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.42 ' HB2' ' HG2' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -106.86 151.93 40.74 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.151 -0.968 . . . . 0.0 111.163 -178.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.85 -172.26 0.93 Allowed 'Trans proline' 0 C--N 1.315 -1.233 0 N-CA-C 108.762 -1.284 . . . . 0.0 108.762 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.879 ' OD1' HG22 ' A' ' 20' ' ' ILE . 69.4 m-80 -121.42 2.76 10.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.687 -1.258 . . . . 0.0 110.073 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.6 p -63.85 173.55 1.76 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -0.913 . . . . 0.0 111.333 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 89.4 mt -101.96 136.14 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.547 0.689 . . . . 0.0 110.779 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.8 t -94.05 136.53 34.25 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.449 -0.782 . . . . 0.0 109.353 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -130.09 138.57 50.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 0.0 110.478 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.081 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.744 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.53 -30.77 21.69 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.892 -1.13 . . . . 0.0 110.059 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -72.27 -36.04 68.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.159 -0.963 . . . . 0.0 110.054 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 110' ' ' LYS . 92.7 mt-10 -61.92 -40.78 96.65 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.956 -1.097 . . . . 0.0 108.729 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.658 ' O ' HG23 ' A' ' 17' ' ' VAL . 92.2 mt-10 -61.14 -38.44 86.42 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.729 -0.607 . . . . 0.0 110.178 178.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -60.52 -41.92 95.39 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.514 -0.875 . . . . 0.0 110.431 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.14 78.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.006 -1.059 . . . . 0.0 112.329 -178.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.524 HG13 HG22 ' A' ' 114' ' ' VAL . 16.2 tt -66.53 -31.74 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.59 -1.318 . . . . 0.0 110.215 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 13' ' ' GLU . 55.9 t -64.63 -40.58 89.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -63.97 -35.94 82.34 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.606 -0.837 . . . . 0.0 109.174 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.45 -39.46 93.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.38 -0.825 . . . . 0.0 109.12 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.729 HG22 ' OD1' ' A' ' 140' ' ' ASN . 97.1 mt -64.56 -43.32 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.835 . . . . 0.0 109.862 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -60.78 -41.96 96.57 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.131 -0.981 . . . . 0.0 110.199 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -65.96 -38.22 88.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.512 -0.742 . . . . 0.0 111.147 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.96 -40.41 96.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.859 -1.151 . . . . 0.0 109.956 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.67 -15.59 30.36 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.061 -1.024 . . . . 0.0 110.866 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.474 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 75.4 mmtt -93.8 1.01 56.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.089 -1.007 . . . . 0.0 109.27 177.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -114.81 -14.08 11.97 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.802 -1.186 . . . . 0.0 109.934 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.6 t -151.74 154.52 36.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.875 -1.14 . . . . 0.0 109.753 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 m -84.56 -6.74 59.39 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.291 -0.881 . . . . 0.0 109.805 178.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.9 174.58 54.27 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.775 ' HG2' HD22 ' A' ' 138' ' ' LEU . 51.3 tp10 -133.31 138.2 46.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.272 -1.134 . . . . 0.0 111.665 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 93.5 mt -118.46 134.5 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.712 -0.617 . . . . 0.0 109.835 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.419 ' NE ' ' OG ' ' A' ' 143' ' ' SER . 76.2 ttt180 -139.87 152.17 46.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.89 . . . . 0.0 109.852 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.64 HG22 ' HB ' ' A' ' 67' ' ' ILE . 53.7 t -124.5 140.61 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.368 -0.832 . . . . 0.0 111.464 -178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -125.87 128.3 47.38 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.521 0.677 . . . . 0.0 109.434 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.985 HD11 ' CG1' ' A' ' 71' ' ' VAL . 37.8 tp -118.67 129.84 55.51 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.946 0.879 . . . . 0.0 112.572 -177.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.408 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 84.7 tt0 -145.35 168.09 21.32 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.408 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 98.7 mttt -79.23 -73.6 0.33 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.977 -1.077 . . . . 0.0 112.961 -177.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 t -143.26 158.81 43.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.265 -0.897 . . . . 0.0 110.141 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.425 ' HB3' ' HD3' ' A' ' 46' ' ' ARG . 14.9 p -108.95 171.86 7.19 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.251 -0.906 . . . . 0.0 111.152 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -106.58 -10.68 16.11 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.479 -0.763 . . . . 0.0 110.425 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 42' ' ' ASP . 25.7 pt -125.57 -121.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 120.985 -1.072 . . . . 0.0 109.631 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.402 ' N ' HG13 ' A' ' 41' ' ' ILE . 64.2 m-20 -111.76 138.62 48.1 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 120.393 -1.442 . . . . 0.0 109.017 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 85.2 t -64.28 -43.31 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 111.412 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -59.36 -47.29 85.97 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.95 -1.094 . . . . 0.0 110.778 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -71.34 -38.18 71.66 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.88 -1.137 . . . . 0.0 108.42 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.425 ' HD3' ' HB3' ' A' ' 39' ' ' SER . 79.8 ttt180 -63.54 -40.67 97.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.467 -0.77 . . . . 0.0 110.082 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.44 -38.15 84.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.694 -1.254 . . . . 0.0 110.127 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.4 ttp -62.09 -44.22 97.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.969 -1.082 . . . . 0.0 109.901 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -63.35 -44.64 94.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.082 -1.011 . . . . 0.0 109.571 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 46' ' ' ARG . 95.7 t -65.81 -43.72 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.586 -0.696 . . . . 0.0 110.088 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.474 ' CE2' ' OD1' ' A' ' 57' ' ' ASP . 71.4 t80 -58.66 -45.95 88.24 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.065 -1.022 . . . . 0.0 109.435 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -73.07 -35.77 66.72 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.849 -1.157 . . . . 0.0 109.558 178.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -60.79 -37.34 81.6 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.025 -1.047 . . . . 0.0 109.955 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.3 mt -82.08 5.72 18.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.098 -1.001 . . . . 0.0 110.308 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.423 ' HB3' ' ND2' ' A' ' 58' ' ' ASN . 98.6 mttt 54.78 34.65 22.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.793 -1.192 . . . . 0.0 111.43 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.691 ' SD ' HD13 ' A' ' 66' ' ' LEU . 93.4 mtp -67.05 -12.47 60.01 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.957 -1.097 . . . . 0.0 109.641 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.474 ' OD1' ' CE2' ' A' ' 51' ' ' PHE . 92.3 m-20 -75.09 -2.13 26.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.664 -1.272 . . . . 0.0 109.9 177.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.423 ' ND2' ' HB3' ' A' ' 55' ' ' LYS . 64.9 m-20 -74.2 61.37 0.86 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.828 -1.17 . . . . 0.0 109.937 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.4 m -132.47 144.17 50.28 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.162 -0.961 . . . . 0.0 108.875 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.31 -42.81 99.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.821 -0.549 . . . . 0.0 112.405 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.5 mt -98.51 2.4 47.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.101 -0.999 . . . . 0.0 111.595 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 55.87 36.54 27.49 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.076 0.941 . . . . 0.0 111.542 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.496 ' C ' HD11 ' A' ' 84' ' ' ILE . 97.7 m-20 -113.13 50.2 0.9 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.338 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.68 142.53 16.15 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.762 -2.135 . . . . 0.0 107.762 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.457 HG22 HD13 ' A' ' 84' ' ' ILE . 54.9 t -123.73 133.91 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.103 -1.234 . . . . 0.0 109.924 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.691 HD13 ' SD ' ' A' ' 56' ' ' MET . 44.5 tp -116.37 129.05 56.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 110.536 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.64 ' HB ' HG22 ' A' ' 33' ' ' VAL . 78.0 mt -107.65 108.93 26.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.369 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -95.59 125.4 40.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -0.853 . . . . 0.0 109.913 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.568 HG21 HD21 ' A' ' 113' ' ' LEU . 54.7 t -122.4 133.23 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.095 0.95 . . . . 0.0 110.769 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.595 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -101.48 91.59 4.53 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.985 ' CG1' HD11 ' A' ' 35' ' ' LEU . 26.0 m -64.54 -23.71 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.018 -1.051 . . . . 0.0 110.892 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 37.9 tp10 -67.61 -44.18 78.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.062 -1.024 . . . . 0.0 108.741 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.647 ' O ' HG23 ' A' ' 75' ' ' THR . 87.0 m-20 -101.5 8.89 41.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.371 -0.83 . . . . 0.0 110.982 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.4 tttt 51.49 41.47 28.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.909 -1.119 . . . . 0.0 110.42 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 73' ' ' ASP . 81.2 p -121.32 169.43 10.6 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.226 -0.921 . . . . 0.0 109.529 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -151.24 145.3 25.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.758 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.1 t -132.06 135.97 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.659 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 76.4 mt -112.86 123.34 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.758 -1.214 . . . . 0.0 110.533 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -129.32 111.65 13.06 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.472 -0.767 . . . . 0.0 110.797 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -98.34 173.47 27.48 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -76.57 173.28 11.75 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.587 -0.949 . . . . 0.0 109.66 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.81 -22.94 62.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.893 . . . . 0.0 110.815 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.94 -50.6 45.82 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.825 -1.179 . . . . 0.0 110.523 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.954 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.7 mt -64.25 -46.92 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.886 -1.361 . . . . 0.0 108.655 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -61.37 -37.97 85.3 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.768 -1.207 . . . . 0.0 111.949 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -72.02 -22.12 61.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.684 -1.26 . . . . 0.0 111.832 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.093 HG13 HG13 ' A' ' 88' ' ' VAL . 7.5 p -102.09 -21.62 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.967 -1.083 . . . . 0.0 113.21 -178.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.093 HG13 HG13 ' A' ' 87' ' ' VAL . 30.0 m -123.36 166.66 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.641 -1.287 . . . . 0.0 111.367 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 m -112.11 -175.56 2.71 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.271 -0.893 . . . . 0.0 113.165 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -62.44 -39.75 94.36 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.835 . . . . 0.0 110.18 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -61.64 -38.63 88.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.123 -0.985 . . . . 0.0 110.112 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.725 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 68.8 t80 -65.9 -27.69 68.39 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.204 -0.935 . . . . 0.0 109.123 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.659 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.5 m95 -86.72 -27.02 23.93 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.207 1.003 . . . . 0.0 110.278 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -55.99 -42.18 75.94 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.97 -1.081 . . . . 0.0 112.471 -176.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 88.1 m -62.95 -31.99 73.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.809 -1.182 . . . . 0.0 109.037 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.474 HG22 HD13 ' A' ' 78' ' ' ILE 0.286 8.7 m -58.88 -48.9 79.77 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.688 1.232 . . . . 0.0 110.732 179.686 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.65 -38.46 80.47 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.777 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.416 ' O ' HD23 ' A' ' 102' ' ' LEU . 11.5 m120 -63.95 -42.69 97.23 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.989 -1.084 . . . . 0.0 110.177 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.02 -49.17 78.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.292 -1.505 . . . . 0.0 110.598 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.575 HD12 HD11 ' A' ' 78' ' ' ILE . 90.9 mt -67.99 -42.48 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.15 -0.969 . . . . 0.0 110.482 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -63.08 -46.31 88.0 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.009 -1.057 . . . . 0.0 111.889 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.416 HD23 ' O ' ' A' ' 98' ' ' ASN . 3.5 mm? -64.08 -42.38 96.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.991 -1.068 . . . . 0.0 112.298 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.468 ' HB2' ' HA3' ' A' ' 112' ' ' GLY . 99.4 mm-40 -71.67 -41.38 68.78 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.923 -1.111 . . . . 0.0 109.017 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.463 ' CE1' HG23 ' A' ' 100' ' ' ILE . 4.7 m-85 -60.15 -40.09 88.65 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.08 -32.99 72.64 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.004 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -81.55 -17.64 47.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.091 -1.006 . . . . 0.0 109.503 177.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.54 11.04 29.88 Favored Glycine 0 N--CA 1.494 2.506 0 O-C-N 121.112 -0.993 . . . . 0.0 110.781 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -108.71 89.47 3.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.829 -1.395 . . . . 0.0 110.781 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -63.48 -44.22 95.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.439 -0.788 . . . . 0.0 111.577 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.404 ' HD2' ' HB3' ' A' ' 12' ' ' GLU . 61.9 tttm -62.82 -49.07 76.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.143 -0.973 . . . . 0.0 112.269 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -64.61 -38.67 91.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.054 -1.029 . . . . 0.0 110.055 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.468 ' HA3' ' HB2' ' A' ' 103' ' ' GLN . . . -63.93 -44.12 96.48 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.568 HD21 HG21 ' A' ' 69' ' ' VAL . 76.6 mt -66.81 -44.9 79.97 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.339 -1.095 . . . . 0.0 110.254 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.524 HG22 HG13 ' A' ' 16' ' ' ILE . 74.8 t -66.12 -47.13 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.423 -0.798 . . . . 0.0 110.679 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -63.17 -39.09 93.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.009 -1.057 . . . . 0.0 109.248 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.76 -42.28 99.71 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.52 -44.28 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.233 -1.157 . . . . 0.0 110.72 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.51 -48.45 80.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.979 -1.076 . . . . 0.0 109.757 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.99 -40.33 97.44 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.395 -0.816 . . . . 0.0 108.865 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.56 97.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.442 -0.787 . . . . 0.0 110.59 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.81 -42.55 98.47 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 98.2 mtp -65.41 -48.56 72.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -1.17 . . . . 0.0 110.261 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.725 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -62.41 -44.67 95.87 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.538 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.18 -39.61 95.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -0.851 . . . . 0.0 109.237 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.6 -34.5 58.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.066 -1.021 . . . . 0.0 110.123 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -61.88 -43.72 98.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 0.0 109.32 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.458 ' HB3' ' CE2' ' A' ' 128' ' ' PHE . 68.2 m-85 -70.93 -37.44 72.87 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.819 0.819 . . . . 0.0 109.36 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.458 ' CE2' ' HB3' ' A' ' 127' ' ' TYR . 88.1 m-85 -132.5 98.51 16.56 Favored Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.174 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.08 150.85 77.68 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 O-C-N 123.696 1.367 . . . . 0.0 109.706 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.474 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 51.9 t90 -76.1 127.4 32.86 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.418 -0.801 . . . . 0.0 110.817 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -105.17 146.78 28.76 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -56.46 -29.92 62.28 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.214 -0.929 . . . . 0.0 111.087 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -90.85 8.86 32.75 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.099 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -42.94 138.5 2.01 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.19 -0.944 . . . . 0.0 111.187 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 135' ' ' ILE . 0.1 OUTLIER -110.92 134.4 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-O 121.995 0.902 . . . . 0.0 111.473 -176.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 41.4 p-10 -116.96 102.48 9.39 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.446 -0.784 . . . . 0.0 110.583 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -102.17 -12.07 18.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.739 -1.226 . . . . 0.0 111.734 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.775 HD22 ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -93.11 140.97 23.49 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.977 -1.077 . . . . 0.0 110.676 -179.358 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.2 171.94 14.99 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.349 1.184 . . . . 0.0 109.108 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.729 ' OD1' HG22 ' A' ' 20' ' ' ILE . 68.3 m-80 -112.11 7.21 19.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.715 -1.24 . . . . 0.0 110.617 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -64.06 148.01 50.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.955 -1.091 . . . . 0.0 111.332 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 93.5 mt -76.2 139.61 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.56 -0.713 . . . . 0.0 110.351 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.419 ' OG ' ' NE ' ' A' ' 32' ' ' ARG . 17.6 m -94.09 135.96 34.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.158 -0.964 . . . . 0.0 110.272 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -128.77 140.97 51.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.278 -0.889 . . . . 0.0 110.667 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.974 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.507 HG22 ' N ' ' A' ' 10' ' ' ALA . 75.8 m . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.507 ' N ' HG22 ' A' ' 9' ' ' THR . . . -53.49 -34.9 59.73 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.996 -1.065 . . . . 0.0 109.522 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -60.32 -46.74 88.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.117 -0.99 . . . . 0.0 110.81 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -72.79 -46.98 50.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.985 -1.072 . . . . 0.0 111.775 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.542 ' O ' HG23 ' A' ' 17' ' ' VAL . 96.7 mt-10 -60.15 -40.71 90.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.983 -1.073 . . . . 0.0 110.021 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 72.3 mmtt -63.84 -42.93 97.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.108 -0.995 . . . . 0.0 110.805 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.05 -42.94 93.78 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.99 -1.068 . . . . 0.0 111.559 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 13' ' ' GLU . 19.4 tt -68.88 -36.86 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.72 -1.238 . . . . 0.0 110.379 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 13' ' ' GLU . 48.4 t -61.26 -42.4 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -61.54 -36.48 80.72 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.507 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.67 -40.75 93.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.419 -0.8 . . . . 0.0 109.26 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.64 -42.56 96.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.345 -0.847 . . . . 0.0 109.348 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -58.64 -42.88 89.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.818 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -64.9 -37.46 87.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.179 -0.951 . . . . 0.0 111.167 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.03 -39.31 93.17 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.779 -1.2 . . . . 0.0 110.522 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.2 -15.94 28.85 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.894 -1.129 . . . . 0.0 110.351 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.478 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.5 mttt -93.2 0.37 57.1 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 120.927 -1.108 . . . . 0.0 109.417 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -112.55 -15.62 13.02 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.714 -1.241 . . . . 0.0 109.816 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.3 t -153.64 157.59 39.85 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.906 -1.121 . . . . 0.0 110.326 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.2 m -85.57 -9.2 57.67 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.326 -0.859 . . . . 0.0 110.193 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.86 172.29 46.54 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.413 ' CB ' HD12 ' A' ' 138' ' ' LEU . 53.6 mp0 -131.18 134.04 46.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.287 -1.125 . . . . 0.0 112.268 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.429 HD11 HD12 ' A' ' 124' ' ' LEU . 97.1 mt -118.9 133.86 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.305 0.574 . . . . 0.0 109.807 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.502 ' NH1' HD13 ' A' ' 54' ' ' LEU . 72.4 ttt180 -139.79 152.09 46.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.429 -0.794 . . . . 0.0 110.063 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.719 HG22 HD12 ' A' ' 67' ' ' ILE . 83.9 t -122.64 138.77 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.36 -0.838 . . . . 0.0 110.71 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.464 ' HB2' HD11 ' A' ' 66' ' ' LEU . 75.3 t60 -122.82 132.32 54.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 0.0 108.933 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.945 HD11 ' CG1' ' A' ' 71' ' ' VAL . 32.9 tp -118.07 131.63 56.43 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.024 0.916 . . . . 0.0 111.557 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -150.38 164.88 34.74 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 67.4 mttm -79.39 -74.74 0.27 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.04 -1.038 . . . . 0.0 113.419 -177.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 t -141.39 160.28 40.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.414 -0.804 . . . . 0.0 110.906 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.421 ' OG ' ' CD ' ' A' ' 46' ' ' ARG . 25.7 m -108.9 168.02 9.66 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.661 -0.649 . . . . 0.0 110.997 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -107.82 -12.0 15.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 110.7 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 42' ' ' ASP . 29.3 pt -123.75 -122.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.984 -1.073 . . . . 0.0 109.321 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 41' ' ' ILE . 96.6 m-20 -110.53 136.33 49.82 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 120.204 -1.56 . . . . 0.0 108.973 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.9 t -62.96 -43.49 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.475 -0.766 . . . . 0.0 111.734 -178.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -59.24 -45.1 92.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.999 -1.063 . . . . 0.0 109.952 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -70.23 -37.97 75.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.897 -1.127 . . . . 0.0 108.327 177.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.421 ' CD ' ' OG ' ' A' ' 39' ' ' SER . 44.1 ttt85 -61.3 -41.66 97.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.526 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.4 -37.6 83.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.785 -1.197 . . . . 0.0 110.48 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.4 ttp -64.23 -42.6 96.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.486 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -64.62 -46.83 80.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.902 -1.124 . . . . 0.0 109.841 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.49 -45.67 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.208 -0.932 . . . . 0.0 110.553 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.467 ' CZ ' ' OD1' ' A' ' 81' ' ' ASP . 6.8 t80 -56.84 -47.94 79.21 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.703 -1.248 . . . . 0.0 109.717 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -72.85 -35.88 67.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.995 -1.066 . . . . 0.0 110.088 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -60.47 -39.54 87.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.879 -1.138 . . . . 0.0 109.314 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.502 HD13 ' NH1' ' A' ' 32' ' ' ARG . 96.1 mt -80.66 4.62 18.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.094 -1.004 . . . . 0.0 110.531 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 57.33 33.72 23.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.843 -1.161 . . . . 0.0 111.134 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.691 ' SD ' HD13 ' A' ' 66' ' ' LEU . 79.9 mtp -68.77 -26.8 65.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.117 -0.989 . . . . 0.0 109.374 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 39.2 p-10 -71.27 -8.21 52.11 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.202 -0.936 . . . . 0.0 110.586 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -87.98 82.54 7.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.705 -1.247 . . . . 0.0 110.233 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.419 HG23 ' CB ' ' A' ' 137' ' ' GLU . 51.7 m -138.1 156.1 48.1 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.17 -46.86 88.24 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.109 -0.994 . . . . 0.0 111.909 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.6 mt -97.71 2.55 49.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.045 -1.035 . . . . 0.0 111.031 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.415 ' O ' ' CB ' ' A' ' 81' ' ' ASP . 86.6 mt-30 55.49 43.67 28.17 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.481 1.134 . . . . 0.0 111.38 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -118.88 55.66 0.92 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.323 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.56 140.61 14.93 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.512 HG23 ' CD1' ' A' ' 84' ' ' ILE . 74.3 t -124.68 135.4 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.124 -1.221 . . . . 0.0 110.726 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.691 HD13 ' SD ' ' A' ' 56' ' ' MET . 38.8 tp -116.1 126.84 54.28 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.607 -0.683 . . . . 0.0 109.774 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.719 HD12 HG22 ' A' ' 33' ' ' VAL . 96.8 mt -105.41 101.0 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 118.901 -1.12 . . . . 0.0 108.992 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -86.97 123.27 31.89 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.384 -0.822 . . . . 0.0 109.973 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.2 t -119.74 129.6 75.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.855 0.836 . . . . 0.0 110.149 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.514 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -99.2 84.81 3.09 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.945 ' CG1' HD11 ' A' ' 35' ' ' LEU . 30.2 m -58.16 -23.13 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.224 -0.923 . . . . 0.0 111.016 -178.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 49.1 tp10 -66.05 -42.45 89.5 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.234 178.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.584 ' O ' HG23 ' A' ' 75' ' ' THR . 98.2 m-20 -102.31 6.69 40.56 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.198 -0.939 . . . . 0.0 111.007 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.8 tttt 52.84 45.89 27.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.822 -1.174 . . . . 0.0 110.983 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 73' ' ' ASP . 70.1 p -122.76 168.63 11.99 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.237 -0.915 . . . . 0.0 109.625 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 43.7 p90 -146.47 143.18 28.8 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.961 -1.087 . . . . 0.0 111.016 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.0 t -128.98 135.72 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.738 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 80.1 mt -114.45 129.44 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.879 -1.138 . . . . 0.0 110.092 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -136.38 114.42 11.42 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.494 -0.754 . . . . 0.0 110.877 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -101.14 174.82 25.54 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.467 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 32.6 m-20 -79.04 176.01 10.06 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.474 -1.015 . . . . 0.0 110.858 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.57 -27.38 68.59 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.366 -0.834 . . . . 0.0 109.453 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -63.66 -53.01 41.27 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.953 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.962 ' O ' HG22 ' A' ' 88' ' ' VAL . 93.5 mt -65.08 -44.07 95.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.743 -1.445 . . . . 0.0 108.659 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -61.77 -37.1 83.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.626 -1.296 . . . . 0.0 110.698 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -73.34 -21.1 60.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.963 . . . . 0.0 112.19 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.024 HG23 HG13 ' A' ' 88' ' ' VAL . 21.7 m -107.19 -19.83 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.809 -1.182 . . . . 0.0 112.926 -177.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.024 HG13 HG23 ' A' ' 87' ' ' VAL . 16.4 m -119.95 162.79 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.693 -1.254 . . . . 0.0 111.309 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 m -108.54 173.64 6.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.475 -0.766 . . . . 0.0 111.965 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -61.82 -37.24 83.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 110.1 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 34.1 p-10 -61.69 -36.41 80.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 109.244 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.881 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 73.1 t80 -66.73 -25.52 66.56 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.302 -0.874 . . . . 0.0 108.773 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.738 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 3.8 m95 -86.04 -26.19 25.5 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.852 0.834 . . . . 0.0 110.542 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -55.37 -38.99 69.56 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.996 -1.065 . . . . 0.0 112.963 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.4 m -63.22 -35.33 79.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.815 -1.178 . . . . 0.0 109.099 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.283 16.0 m -58.09 -48.5 79.98 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.334 1.064 . . . . 0.0 111.255 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.69 -38.22 83.37 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.518 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.686 ' O ' HD13 ' A' ' 102' ' ' LEU . 21.1 m120 -64.69 -45.12 87.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.988 -1.07 . . . . 0.0 111.015 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.17 -49.91 76.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.712 -1.242 . . . . 0.0 110.448 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.39 -43.26 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.223 -0.923 . . . . 0.0 111.075 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -62.42 -45.12 94.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.905 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.686 HD13 ' O ' ' A' ' 98' ' ' ASN . 7.0 mp -63.85 -41.46 97.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.325 -0.859 . . . . 0.0 111.561 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.455 ' HB2' ' HA3' ' A' ' 112' ' ' GLY . 98.7 mm-40 -73.01 -41.78 63.91 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.714 -1.194 . . . . 0.0 108.756 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -58.72 -38.07 77.53 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -61.46 -34.06 74.8 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.681 -0.637 . . . . 0.0 109.946 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -80.7 -17.59 50.6 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.814 -1.179 . . . . 0.0 110.511 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.75 7.18 42.39 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.678 -1.249 . . . . 0.0 111.167 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -103.99 90.99 3.78 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.773 -1.428 . . . . 0.0 110.259 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -63.1 -40.05 96.5 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.553 -0.717 . . . . 0.0 111.47 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -65.75 -49.52 68.1 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.243 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -64.29 -39.39 93.82 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.956 -1.097 . . . . 0.0 110.527 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.455 ' HA3' ' HB2' ' A' ' 103' ' ' GLN . . . -62.72 -48.07 84.18 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.411 ' HB3' HD11 ' A' ' 16' ' ' ILE . 80.8 mt -64.41 -43.2 95.13 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.301 -1.117 . . . . 0.0 109.912 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.4 t -64.81 -48.34 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -0.931 . . . . 0.0 110.509 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -64.66 -39.84 94.38 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.348 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.26 -43.62 99.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 89.2 mt -64.51 -43.56 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.064 -1.256 . . . . 0.0 109.806 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.95 -52.87 62.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.134 -0.979 . . . . 0.0 109.992 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.42 -43.05 99.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 108.664 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -53.81 -46.16 71.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.485 -0.76 . . . . 0.0 109.71 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.67 -43.15 99.4 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.437 ' HG2' ' NZ ' ' A' ' 126' ' ' LYS . 27.4 ttt -67.17 -48.91 66.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.895 -1.356 . . . . 0.0 109.669 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.881 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -62.09 -45.94 91.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.935 . . . . 0.0 109.37 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.429 HD12 HD11 ' A' ' 31' ' ' ILE . 77.2 mt -61.86 -40.13 94.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.194 -0.941 . . . . 0.0 108.611 178.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.08 -33.94 63.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.195 -0.941 . . . . 0.0 110.411 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.437 ' NZ ' ' HG2' ' A' ' 122' ' ' MET . 60.9 mttp -61.83 -43.43 98.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.056 -1.028 . . . . 0.0 108.818 178.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.428 ' CE2' HG12 ' A' ' 88' ' ' VAL . 52.5 m-85 -75.1 -39.78 60.45 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.61 0.719 . . . . 0.0 110.071 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.437 ' HE2' HG21 ' A' ' 87' ' ' VAL . 76.9 m-85 -130.65 90.66 39.85 Favored Pre-proline 0 C--N 1.301 -1.518 0 O-C-N 121.706 -0.621 . . . . 0.0 109.426 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -64.78 154.42 72.79 Favored 'Trans proline' 0 C--N 1.318 -1.035 0 O-C-N 123.588 1.309 . . . . 0.0 110.483 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.478 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 31.2 t90 -77.6 133.34 38.47 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.441 0.639 . . . . 0.0 111.962 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -114.6 150.85 34.42 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -58.35 -31.74 67.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.096 -1.003 . . . . 0.0 111.842 -177.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -90.99 6.09 46.17 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.963 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 135' ' ' ILE . 66.9 t0 -42.59 140.07 1.37 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 122.038 0.923 . . . . 0.0 111.667 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.696 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.1 pp -113.42 148.53 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-O 121.857 0.837 . . . . 0.0 111.662 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -105.68 96.65 6.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.465 -1.397 . . . . 0.0 110.036 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.419 ' CB ' HG23 ' A' ' 59' ' ' THR . 79.1 mm-40 -68.15 -37.14 80.72 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.593 -0.692 . . . . 0.0 112.838 -178.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.413 HD12 ' CB ' ' A' ' 30' ' ' GLU . 8.0 mt -109.3 148.45 38.04 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.987 -1.071 . . . . 0.0 111.828 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.39 -176.76 1.77 Allowed 'Trans proline' 0 C--N 1.319 -0.993 0 N-CA-C 108.359 -1.439 . . . . 0.0 108.359 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -116.87 4.35 12.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.587 -1.321 . . . . 0.0 110.204 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.8 p -63.29 169.1 3.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.899 -1.126 . . . . 0.0 110.771 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.0 mt -101.39 139.66 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.581 0.705 . . . . 0.0 110.947 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 32' ' ' ARG . 30.6 t -94.91 134.24 37.77 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.533 -0.729 . . . . 0.0 109.241 178.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -125.74 132.91 52.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.188 -0.945 . . . . 0.0 110.045 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.869 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.61 -37.05 67.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.121 -0.987 . . . . 0.0 110.086 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -57.72 -45.95 85.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.909 . . . . 0.0 109.868 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.16 -43.88 73.38 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.599 -0.688 . . . . 0.0 112.031 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 17' ' ' VAL . 79.8 mm-40 -65.4 -39.18 91.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.954 -1.091 . . . . 0.0 110.917 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -63.33 -43.18 98.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.808 -1.182 . . . . 0.0 111.113 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.11 -45.55 84.67 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.077 -1.014 . . . . 0.0 112.108 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.587 HG13 HG22 ' A' ' 114' ' ' VAL . 19.6 tt -65.49 -37.43 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.696 -1.252 . . . . 0.0 110.507 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 13' ' ' GLU . 75.6 t -61.58 -39.1 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -0.953 . . . . 0.0 108.799 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -62.05 -36.31 81.25 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.072 -1.051 . . . . 0.0 108.885 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.09 -37.96 87.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.466 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.425 HD11 HD13 ' A' ' 117' ' ' ILE . 37.5 mm -63.72 -43.66 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.294 -0.879 . . . . 0.0 110.083 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.447 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 83.9 mtp180 -60.18 -41.59 93.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.347 -0.846 . . . . 0.0 110.556 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -65.08 -38.06 89.55 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.49 -0.756 . . . . 0.0 111.2 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.59 -39.53 93.9 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.938 -1.101 . . . . 0.0 110.165 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.63 -13.72 16.11 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.936 -1.103 . . . . 0.0 110.971 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.482 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.1 mttt -96.52 1.84 51.83 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.914 -1.116 . . . . 0.0 109.513 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -112.9 -18.04 12.34 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.04 -1.037 . . . . 0.0 109.775 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.2 t -151.43 158.33 43.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.959 . . . . 0.0 109.815 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 95.8 p -86.76 -7.57 58.15 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.269 -0.895 . . . . 0.0 109.667 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.38 172.11 52.42 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.449 ' CG ' ' HB2' ' A' ' 138' ' ' LEU . 79.6 mm-40 -133.72 139.56 46.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.254 -1.145 . . . . 0.0 111.891 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.6 mt -121.89 135.27 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 143' ' ' SER . 77.1 ttt180 -140.05 155.17 47.17 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 109.39 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.622 HG22 HD12 ' A' ' 67' ' ' ILE . 59.0 t -120.96 136.74 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.091 -1.006 . . . . 0.0 110.555 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.731 ' HB2' HD11 ' A' ' 66' ' ' LEU . 72.2 t60 -121.49 121.71 38.11 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.603 HD11 ' CG1' ' A' ' 71' ' ' VAL . 32.3 tp -111.87 125.93 54.55 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.732 0.777 . . . . 0.0 111.725 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.418 ' OE2' ' CZ ' ' A' ' 46' ' ' ARG . 82.5 tt0 -140.64 166.22 25.33 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.46 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.4 mttt -78.21 -76.05 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 112.327 -177.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.8 t -139.94 154.9 47.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 109.759 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.438 ' HB3' ' CD ' ' A' ' 46' ' ' ARG . 12.7 p -103.49 167.23 9.94 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.382 -0.824 . . . . 0.0 110.225 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -104.23 -8.35 19.41 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.372 -0.83 . . . . 0.0 110.041 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.4 pt -128.22 -122.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.046 -1.034 . . . . 0.0 109.493 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -110.29 138.75 46.25 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 120.309 -1.494 . . . . 0.0 109.509 178.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.2 t -63.18 -43.25 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 110.676 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -59.56 -47.11 86.83 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.02 -1.05 . . . . 0.0 110.743 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -70.15 -39.79 75.15 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.73 -1.232 . . . . 0.0 108.269 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.569 ' O ' HG23 ' A' ' 50' ' ' VAL . 73.1 ttt180 -61.12 -43.48 98.82 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.35 -0.844 . . . . 0.0 110.846 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.95 -40.47 91.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.702 -1.249 . . . . 0.0 110.368 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 46.7 ttp -62.34 -42.72 99.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.014 -1.054 . . . . 0.0 109.433 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -63.62 -42.06 98.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.037 -1.039 . . . . 0.0 109.081 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 46' ' ' ARG . 82.9 t -66.58 -43.44 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.572 -0.705 . . . . 0.0 110.304 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -59.89 -45.93 90.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.779 -1.201 . . . . 0.0 109.77 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -73.86 -35.95 64.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.949 -1.094 . . . . 0.0 109.889 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -61.57 -39.48 91.3 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.014 -1.054 . . . . 0.0 110.196 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.6 mt -81.14 4.15 21.05 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.043 -1.036 . . . . 0.0 110.58 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 55.79 31.5 17.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.096 -1.002 . . . . 0.0 111.65 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 92.1 mtp -66.55 -19.04 65.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.161 -0.962 . . . . 0.0 109.671 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -74.89 -4.97 41.1 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.096 -1.002 . . . . 0.0 111.288 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -45.96 -32.79 2.92 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.042 -1.036 . . . . 0.0 110.621 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.503 HG23 ' HA ' ' A' ' 62' ' ' GLN . 9.0 t -40.61 144.86 0.21 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.505 1.145 . . . . 0.0 113.009 -176.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -68.16 -40.4 82.33 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.465 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 72.8 mt -92.2 -0.92 57.4 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.143 -0.973 . . . . 0.0 111.178 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.503 ' HA ' HG23 ' A' ' 59' ' ' THR . 88.3 mt-30 57.69 36.85 27.04 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.348 1.071 . . . . 0.0 110.45 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.641 ' C ' HD11 ' A' ' 84' ' ' ILE . 97.8 m-20 -113.1 48.56 1.02 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.383 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.6 144.17 17.07 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.515 ' CG2' HD13 ' A' ' 84' ' ' ILE . 52.8 t -124.54 134.72 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.993 -1.298 . . . . 0.0 110.5 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.731 HD11 ' HB2' ' A' ' 34' ' ' HIS . 45.5 tp -116.79 125.6 51.85 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.387 -0.821 . . . . 0.0 109.738 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.622 HD12 HG22 ' A' ' 33' ' ' VAL . 89.9 mt -100.57 105.0 16.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 118.945 -1.102 . . . . 0.0 109.412 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -91.74 124.68 36.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.892 . . . . 0.0 110.327 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.9 t -123.95 132.3 71.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 122.059 0.933 . . . . 0.0 111.151 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.67 99.99 10.01 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.603 ' CG1' HD11 ' A' ' 35' ' ' LEU . 33.5 m -70.19 -18.95 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.027 -1.046 . . . . 0.0 110.781 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.443 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 80.4 mm-40 -71.11 -49.0 49.0 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.86 -1.15 . . . . 0.0 109.428 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -98.65 5.1 47.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.884 . . . . 0.0 110.293 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.43 ' HE3' ' CE1' ' A' ' 109' ' ' PHE . 72.1 tttt 53.72 43.51 30.96 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.019 -1.051 . . . . 0.0 110.16 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.2 m -119.15 132.24 55.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.324 -0.86 . . . . 0.0 109.952 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -116.08 136.59 52.89 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.445 -0.784 . . . . 0.0 110.051 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.4 t -126.41 137.54 57.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.628 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 77.2 mt -111.55 125.85 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.977 -1.077 . . . . 0.0 110.411 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -128.84 114.4 16.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.504 -0.748 . . . . 0.0 110.25 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.46 165.72 19.38 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 108.961 -1.655 . . . . 0.0 108.961 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 49.7 t0 -74.75 174.73 8.74 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.591 -0.946 . . . . 0.0 109.311 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -59.42 -22.77 61.94 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.052 -1.03 . . . . 0.0 111.186 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.5 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -68.64 -50.9 33.62 Favored Glycine 0 N--CA 1.497 2.714 0 C-N-CA 119.737 -1.221 . . . . 0.0 110.939 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.999 ' O ' HG22 ' A' ' 88' ' ' VAL . 3.5 mt -63.01 -44.7 99.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.865 -1.373 . . . . 0.0 107.393 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -63.16 -36.4 83.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.921 -1.112 . . . . 0.0 112.134 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -74.33 -20.93 59.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.627 -1.295 . . . . 0.0 112.311 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.909 HG23 HG13 ' A' ' 88' ' ' VAL . 26.0 m -105.78 -18.91 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.873 -1.142 . . . . 0.0 112.112 -178.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.999 HG22 ' O ' ' A' ' 84' ' ' ILE . 15.9 m -120.76 163.34 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.692 -1.255 . . . . 0.0 111.262 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.3 m -111.0 -176.67 3.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -0.859 . . . . 0.0 111.806 -178.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -62.81 -37.54 87.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.982 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -60.96 -39.51 89.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.201 -0.937 . . . . 0.0 109.398 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.731 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 83.3 t80 -66.34 -26.49 67.31 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.168 -0.958 . . . . 0.0 109.679 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.628 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.1 m95 -86.32 -25.22 25.54 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.042 0.925 . . . . 0.0 110.615 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -57.29 -41.16 79.25 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 112.837 -176.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.8 p -64.02 -30.06 71.16 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.572 -1.251 . . . . 0.0 109.118 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.261 16.4 m -60.1 -48.72 80.56 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.297 1.046 . . . . 0.0 110.962 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.59 -36.84 73.77 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.146 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -63.44 -43.27 97.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.828 -1.17 . . . . 0.0 110.129 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.11 -49.91 70.33 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.808 -1.182 . . . . 0.0 111.362 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.67 -42.55 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.003 -1.061 . . . . 0.0 110.426 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -63.89 -42.3 97.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.42 -0.8 . . . . 0.0 110.585 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 61.7 tp -63.57 -43.11 97.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 111.209 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.465 ' HG2' ' N ' ' A' ' 112' ' ' GLY . 5.7 tp60 -74.0 -42.22 60.7 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 118.757 -1.177 . . . . 0.0 108.928 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -59.38 -41.17 88.73 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.11 -31.22 71.65 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.999 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.7 tp60 -80.87 -19.73 43.84 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.168 -0.957 . . . . 0.0 109.411 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.24 1.27 33.43 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.008 -1.091 . . . . 0.0 110.847 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -104.13 91.15 3.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.706 -1.467 . . . . 0.0 110.862 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.43 ' CE1' ' HE3' ' A' ' 74' ' ' LYS . 19.2 m-85 -65.32 -39.75 92.84 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.537 -0.727 . . . . 0.0 111.185 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -64.06 -49.17 73.36 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.771 -1.205 . . . . 0.0 111.793 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -63.34 -38.99 93.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.875 -1.141 . . . . 0.0 110.254 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.465 ' N ' ' HG2' ' A' ' 103' ' ' GLN . . . -63.19 -45.56 95.04 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 78.0 mt -64.72 -44.71 89.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.434 -1.039 . . . . 0.0 111.153 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.587 HG22 HG13 ' A' ' 16' ' ' ILE . 77.6 t -67.01 -46.61 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.769 -1.207 . . . . 0.0 110.714 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -65.04 -43.85 91.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.099 -1.001 . . . . 0.0 110.933 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.23 -40.95 94.58 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.425 HD13 HD11 ' A' ' 20' ' ' ILE . 97.1 mt -64.2 -43.48 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.312 -1.111 . . . . 0.0 110.136 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -56.68 -49.07 76.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.984 . . . . 0.0 109.626 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.54 -42.17 98.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -0.984 . . . . 0.0 109.436 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.33 -38.35 80.1 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.193 -0.942 . . . . 0.0 109.567 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.44 -46.5 69.62 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 75.9 mtm -67.16 -43.71 81.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.909 -1.348 . . . . 0.0 109.694 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.731 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -65.23 -45.93 82.65 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.324 -0.95 . . . . 0.0 109.008 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.2 mt -62.06 -40.56 96.19 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.38 -34.09 64.02 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.387 -0.82 . . . . 0.0 110.641 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -62.15 -41.41 98.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.969 -1.082 . . . . 0.0 109.111 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -72.39 -41.08 66.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.581 -0.699 . . . . 0.0 109.935 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -130.68 99.87 18.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.984 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.48 150.39 75.37 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.586 1.308 . . . . 0.0 109.8 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.482 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 48.5 t90 -74.83 136.03 41.6 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.53 -0.731 . . . . 0.0 111.306 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -113.28 151.93 30.49 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.301 -0.875 . . . . 0.0 109.127 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.91 -30.68 69.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.204 -0.935 . . . . 0.0 111.175 -177.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -91.25 7.57 40.14 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.899 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.468 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 67.0 t0 -43.54 141.56 1.4 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.404 -0.81 . . . . 0.0 111.551 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.728 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -114.31 146.02 19.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-O 121.697 0.76 . . . . 0.0 111.196 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 42.9 p-10 -98.56 92.62 5.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.595 -1.316 . . . . 0.0 110.66 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.448 ' HG3' HD13 ' A' ' 135' ' ' ILE . 96.9 mt-10 -68.45 -36.12 78.56 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.183 -0.948 . . . . 0.0 111.88 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.457 HD13 ' HD2' ' A' ' 139' ' ' PRO . 3.8 mm? -109.74 145.74 32.62 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.086 -1.009 . . . . 0.0 111.546 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.457 ' HD2' HD13 ' A' ' 138' ' ' LEU . 44.3 Cg_endo -72.37 -167.85 0.35 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 N-CA-C 108.065 -1.552 . . . . 0.0 108.065 178.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.447 ' ND2' ' HG2' ' A' ' 21' ' ' ARG . 13.9 p30 -122.91 4.29 9.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.761 -1.212 . . . . 0.0 110.156 178.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.1 m -61.76 168.52 2.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.101 -0.999 . . . . 0.0 110.26 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.412 ' CD1' ' OE1' ' A' ' 13' ' ' GLU . 93.9 mt -103.68 140.42 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.43 -0.793 . . . . 0.0 110.537 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 32' ' ' ARG . 32.1 t -94.37 136.53 34.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.194 -0.941 . . . . 0.0 109.708 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -127.57 137.31 52.56 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.3 -0.875 . . . . 0.0 110.426 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 CA-C-O 118.002 -1.443 . . . . 0.0 109.668 -179.815 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.134 0.492 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.458 ' HB1' ' HE2' ' A' ' 14' ' ' LYS . . . -54.75 -37.44 65.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.107 -0.995 . . . . 0.0 109.455 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -57.68 -43.48 85.08 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.437 -0.79 . . . . 0.0 109.611 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.439 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 96.4 mt-10 -72.43 -45.44 59.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.357 -0.84 . . . . 0.0 111.634 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.731 ' O ' HG23 ' A' ' 17' ' ' VAL . 97.4 mt-10 -64.04 -38.51 91.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.005 -1.059 . . . . 0.0 110.127 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.458 ' HE2' ' HB1' ' A' ' 10' ' ' ALA . 68.1 mttm -64.4 -45.32 88.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.059 -1.025 . . . . 0.0 111.132 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.27 -41.56 96.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.129 -0.982 . . . . 0.0 111.114 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.525 HG22 ' O ' ' A' ' 13' ' ' GLU . 21.2 tt -68.76 -33.86 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.986 -1.071 . . . . 0.0 110.104 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 13' ' ' GLU . 76.0 t -65.48 -40.21 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.148 -0.97 . . . . 0.0 108.439 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -61.67 -36.91 82.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.975 . . . . 0.0 109.085 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.6 91.15 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.232 -0.918 . . . . 0.0 109.352 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.592 HD11 HD13 ' A' ' 117' ' ' ILE . 34.8 mm -63.18 -43.44 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.185 -0.947 . . . . 0.0 109.386 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.43 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 93.4 mtt-85 -59.72 -43.88 93.96 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.55 -0.719 . . . . 0.0 110.216 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -63.41 -38.94 93.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.871 . . . . 0.0 110.94 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.65 -39.63 94.82 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.255 -0.903 . . . . 0.0 110.662 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -59.93 -15.42 21.66 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.906 -1.122 . . . . 0.0 110.508 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 74.5 mmtt -96.18 1.01 51.93 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.976 -1.078 . . . . 0.0 109.386 178.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 94.2 m-20 -114.35 -14.0 12.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.74 -1.225 . . . . 0.0 109.769 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.1 t -153.92 159.1 41.59 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.63 -1.294 . . . . 0.0 109.462 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.5 m -88.25 -9.32 53.33 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.255 -0.903 . . . . 0.0 109.75 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.79 172.43 43.19 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.485 ' HG2' HD22 ' A' ' 138' ' ' LEU . 53.3 mp0 -132.27 140.3 48.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.269 -1.136 . . . . 0.0 111.31 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.2 mt -124.97 136.83 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.764 -0.585 . . . . 0.0 110.518 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.547 ' HE ' HD23 ' A' ' 138' ' ' LEU . 95.1 mtt-85 -138.82 154.87 48.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.211 -0.931 . . . . 0.0 110.144 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.701 HG22 HD12 ' A' ' 67' ' ' ILE . 55.4 t -125.87 136.31 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.54 0.686 . . . . 0.0 109.693 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.418 ' HA ' ' O ' ' A' ' 143' ' ' SER . 81.2 t60 -121.04 118.98 31.2 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.571 -0.705 . . . . 0.0 109.279 178.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.835 HD11 ' CG1' ' A' ' 71' ' ' VAL . 30.6 tp -106.49 129.88 54.38 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.778 0.799 . . . . 0.0 111.175 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -147.57 167.58 24.17 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.434 ' CA ' ' HG2' ' A' ' 72' ' ' GLU . 99.4 mttt -80.83 -77.01 0.21 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.955 -1.091 . . . . 0.0 112.626 -177.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.422 ' OG1' ' CB ' ' A' ' 72' ' ' GLU . 43.7 m -140.85 159.5 42.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.444 -0.785 . . . . 0.0 109.669 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.7 m -114.0 175.64 5.38 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.257 -0.902 . . . . 0.0 110.393 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -107.43 -10.83 15.65 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.13 -0.981 . . . . 0.0 110.755 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.8 pt -124.23 -121.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.1 -1.0 . . . . 0.0 110.195 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -112.38 140.81 46.79 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.045 -1.66 . . . . 0.0 109.476 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.647 HG13 ' CD1' ' A' ' 68' ' ' TYR . 99.0 t -63.98 -42.42 95.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.512 -0.743 . . . . 0.0 110.525 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -58.76 -46.11 88.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.053 -1.029 . . . . 0.0 109.634 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -68.94 -38.62 79.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.806 -1.184 . . . . 0.0 108.394 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.613 ' O ' HG23 ' A' ' 50' ' ' VAL . 10.9 mmt180 -62.79 -36.88 84.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -0.948 . . . . 0.0 110.106 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.77 -39.65 73.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.884 -1.135 . . . . 0.0 109.904 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 66.1 ttp -65.71 -44.16 86.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.099 -1.0 . . . . 0.0 109.969 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -63.46 -43.5 97.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.099 . . . . 0.0 109.386 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 46' ' ' ARG . 96.7 t -66.58 -42.61 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.38 -0.825 . . . . 0.0 109.69 178.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 57' ' ' ASP . 53.2 t80 -58.89 -46.03 88.85 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.04 -1.038 . . . . 0.0 109.705 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -75.57 -35.82 60.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.895 -1.128 . . . . 0.0 109.682 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -61.44 -39.74 91.92 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.201 -0.937 . . . . 0.0 109.795 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.1 mt -84.18 4.54 30.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.503 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt 56.84 31.42 19.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.077 -1.014 . . . . 0.0 110.953 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.861 ' SD ' HD13 ' A' ' 66' ' ' LEU . 58.6 mtt -72.03 -27.93 63.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.316 -0.865 . . . . 0.0 109.407 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.504 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . 45.6 p-10 -69.0 -9.92 54.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.434 -0.791 . . . . 0.0 109.968 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -86.04 88.02 7.51 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.733 -1.187 . . . . 0.0 110.723 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 62' ' ' GLN . 67.0 p -137.48 154.97 49.81 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -59.44 -45.26 92.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.49 -0.756 . . . . 0.0 111.881 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.5 mt -98.34 2.86 48.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.985 -1.072 . . . . 0.0 111.606 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.429 ' HA ' ' OG1' ' A' ' 59' ' ' THR . 77.3 mt-30 57.46 32.18 21.39 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 122.122 0.963 . . . . 0.0 111.942 178.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.635 ' C ' HD11 ' A' ' 84' ' ' ILE . 97.8 m-20 -110.41 54.59 0.67 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.723 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.66 141.99 15.75 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.475 ' CG2' HD13 ' A' ' 84' ' ' ILE . 54.0 t -122.41 133.1 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.992 -1.299 . . . . 0.0 109.841 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.861 HD13 ' SD ' ' A' ' 56' ' ' MET . 47.1 tp -118.39 130.9 56.25 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.374 -0.829 . . . . 0.0 110.471 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.701 HD12 HG22 ' A' ' 33' ' ' VAL . 64.7 mt -110.24 115.16 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 118.982 -1.087 . . . . 0.0 109.688 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.647 ' CD1' HG13 ' A' ' 43' ' ' VAL . 47.0 t80 -101.49 124.8 47.76 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.079 -1.013 . . . . 0.0 110.005 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.0 t -123.44 130.54 74.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.924 0.868 . . . . 0.0 111.621 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.939 ' HB3' HG22 ' A' ' 75' ' ' THR . . . -98.62 90.29 4.68 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.835 ' CG1' HD11 ' A' ' 35' ' ' LEU . 32.6 m -59.52 -22.86 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.99 -1.069 . . . . 0.0 111.148 -177.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.434 ' HG2' ' CA ' ' A' ' 37' ' ' LYS . 79.0 mm-40 -66.17 -42.32 89.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.789 -1.194 . . . . 0.0 109.061 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -101.12 4.97 42.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.437 -0.789 . . . . 0.0 110.655 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.6 tttt 54.99 46.85 23.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.656 -1.277 . . . . 0.0 110.703 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.939 HG22 ' HB3' ' A' ' 70' ' ' ALA . 10.0 t -122.67 162.54 21.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.44 -0.788 . . . . 0.0 109.636 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -143.7 139.42 29.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 110.001 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.3 t -129.2 139.81 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 108.93 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.698 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 81.7 mt -116.55 127.25 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.738 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -127.84 115.88 19.3 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.475 0.655 . . . . 0.0 109.862 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -102.84 161.57 16.61 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 82' ' ' LYS . 39.3 t0 -73.62 169.62 16.91 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.65 -0.912 . . . . 0.0 110.034 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.402 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 99.2 mttt -55.1 -28.04 49.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 109.976 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.36 -49.87 67.01 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.96 ' O ' HG22 ' A' ' 88' ' ' VAL . 3.9 mt -66.35 -45.06 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.883 -1.363 . . . . 0.0 108.321 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -64.08 -35.83 82.01 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.925 -1.109 . . . . 0.0 111.53 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -77.76 -20.04 54.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.809 -1.182 . . . . 0.0 111.875 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.993 HG13 HG13 ' A' ' 88' ' ' VAL . 7.6 p -102.55 -27.87 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.713 -1.242 . . . . 0.0 112.55 -178.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.993 HG13 HG13 ' A' ' 87' ' ' VAL . 19.2 m -116.65 166.52 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.582 -1.324 . . . . 0.0 111.143 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.2 m -110.62 179.25 4.12 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.215 -0.928 . . . . 0.0 112.405 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -60.95 -37.12 81.25 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.344 -0.847 . . . . 0.0 109.161 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -62.67 -36.83 84.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.417 -0.802 . . . . 0.0 109.701 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.906 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 87.6 t80 -69.8 -24.16 63.44 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.002 -1.061 . . . . 0.0 109.173 177.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.698 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.6 m95 -86.57 -25.99 24.71 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.066 0.936 . . . . 0.0 110.68 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -59.2 -36.17 74.91 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 112.379 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.5 m -66.03 -34.42 78.06 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.729 -1.232 . . . . 0.0 109.222 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.288 20.6 m -57.87 -48.9 78.49 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 122.418 1.104 . . . . 0.0 111.095 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.58 -37.69 77.07 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.413 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -63.06 -43.93 97.23 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.749 -1.18 . . . . 0.0 110.028 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.471 ' HB2' ' HD2' ' A' ' 119' ' ' LYS . . . -62.68 -48.9 77.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.879 -1.138 . . . . 0.0 110.91 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.03 -42.26 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.971 . . . . 0.0 110.177 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.431 ' CG ' ' HE3' ' A' ' 105' ' ' LYS . 51.7 tt0 -63.55 -43.62 96.53 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.272 -0.893 . . . . 0.0 110.865 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.8 tp -63.09 -41.72 99.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.088 -1.008 . . . . 0.0 112.088 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.461 ' HG2' ' CB ' ' A' ' 111' ' ' GLN . 6.3 tp60 -75.17 -37.34 61.31 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.821 -1.151 . . . . 0.0 108.942 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -62.26 -42.02 98.97 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.602 0.715 . . . . 0.0 109.135 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.431 ' HE3' ' CG ' ' A' ' 101' ' ' GLN . 93.8 mttt -60.58 -34.8 74.72 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.342 -0.849 . . . . 0.0 109.915 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -76.44 -21.06 56.4 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.939 -1.1 . . . . 0.0 110.124 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.19 2.48 35.87 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.595 -1.288 . . . . 0.0 111.578 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -102.25 92.55 4.77 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.59 -1.535 . . . . 0.0 110.176 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -62.54 -42.91 99.83 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.859 -0.525 . . . . 0.0 111.942 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.493 ' O ' HG23 ' A' ' 114' ' ' VAL . 86.3 tttt -62.51 -48.07 81.18 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.916 -177.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.461 ' CB ' ' HG2' ' A' ' 103' ' ' GLN . 96.6 mm-40 -64.32 -39.74 94.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.944 -1.098 . . . . 0.0 110.69 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.433 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -62.89 -49.48 72.08 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 68.1 mt -62.92 -44.24 96.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.129 -1.218 . . . . 0.0 110.673 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 110' ' ' LYS . 95.9 t -65.86 -47.53 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.231 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -64.23 -40.13 95.41 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.316 -0.954 . . . . 0.0 109.808 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.5 -42.79 99.21 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.592 HD13 HD11 ' A' ' 20' ' ' ILE . 97.0 mt -65.42 -44.73 94.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.375 -1.073 . . . . 0.0 109.992 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -56.84 -50.35 72.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.877 -1.139 . . . . 0.0 109.166 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.471 ' HD2' ' HB2' ' A' ' 99' ' ' ALA . 98.4 mttt -62.93 -42.13 99.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.257 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.41 ' O ' ' HG ' ' A' ' 124' ' ' LEU . . . -58.72 -39.95 82.31 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.181 -0.949 . . . . 0.0 109.298 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.34 -44.99 89.41 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 90.3 mtp -67.59 -45.82 74.4 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.019 -1.283 . . . . 0.0 110.254 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.906 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -63.83 -45.03 91.41 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.154 -0.966 . . . . 0.0 108.973 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 120' ' ' ALA . 84.2 mt -63.18 -37.8 88.65 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.272 -0.893 . . . . 0.0 109.108 178.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.28 -35.1 64.69 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.985 -1.072 . . . . 0.0 110.635 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.45 -42.97 97.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.931 -1.106 . . . . 0.0 108.391 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -74.16 -41.27 61.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.67 -0.644 . . . . 0.0 110.723 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -128.96 91.53 42.46 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.543 -0.723 . . . . 0.0 109.28 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.62 152.59 81.3 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 O-C-N 123.694 1.365 . . . . 0.0 109.953 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 28.1 t90 -79.56 139.7 37.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.592 -0.693 . . . . 0.0 111.959 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -120.71 155.35 34.08 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -61.36 -34.83 75.96 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.282 -0.887 . . . . 0.0 111.207 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -87.03 6.55 31.85 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.672 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.476 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 67.2 t0 -41.81 138.1 1.55 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.27 -0.894 . . . . 0.0 111.126 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.692 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -110.64 140.55 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 122.184 0.992 . . . . 0.0 112.069 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -119.38 102.14 8.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.759 -1.213 . . . . 0.0 109.471 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -99.88 0.75 41.99 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.758 -1.214 . . . . 0.0 111.668 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.547 HD23 ' HE ' ' A' ' 32' ' ' ARG . 3.2 mp -110.33 151.32 42.57 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 120.769 -1.207 . . . . 0.0 111.424 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.414 ' HD2' ' NH1' ' A' ' 32' ' ' ARG . 55.2 Cg_endo -74.73 170.55 20.09 Favored 'Trans proline' 0 C--N 1.322 -0.823 0 O-C-N 123.632 1.333 . . . . 0.0 109.197 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.43 ' ND2' ' HG2' ' A' ' 21' ' ' ARG . 79.6 m-20 -113.46 4.87 16.46 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.873 -1.142 . . . . 0.0 110.631 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.6 p -68.32 166.33 16.77 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.79 -1.194 . . . . 0.0 111.836 -178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.6 HG13 HG22 ' A' ' 17' ' ' VAL . 96.4 mt -87.41 137.8 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 121.733 0.778 . . . . 0.0 110.914 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 4.4 m -88.77 133.38 34.26 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -128.07 149.19 50.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.82 -1.175 . . . . 0.0 111.094 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.59 0 CA-C-O 118.045 -1.42 . . . . 0.0 110.045 -179.576 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 12' ' ' GLU . 13.0 t . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 121.071 0.462 . . . . 0.0 109.771 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.93 -39.49 68.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.075 -1.015 . . . . 0.0 109.946 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -61.35 -47.38 86.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.071 -1.018 . . . . 0.0 110.751 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.429 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 98.9 mt-10 -70.1 -49.26 52.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 111.709 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.466 ' O ' HG22 ' A' ' 16' ' ' ILE . 99.7 mt-10 -61.22 -33.61 73.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.915 -1.116 . . . . 0.0 109.921 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.85 -46.03 86.82 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.223 -0.923 . . . . 0.0 110.995 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.76 -41.11 92.48 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.127 -0.983 . . . . 0.0 112.336 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.646 HG13 HG22 ' A' ' 114' ' ' VAL . 18.9 tt -66.96 -37.82 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.653 -1.279 . . . . 0.0 110.626 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 13' ' ' GLU . 70.7 t -63.34 -40.67 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.91 -1.119 . . . . 0.0 108.849 178.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -62.03 -37.25 84.19 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.377 -0.929 . . . . 0.0 109.559 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.24 -39.43 90.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 109.59 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.909 HD11 HD13 ' A' ' 117' ' ' ILE . 46.8 mm -64.21 -45.77 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.484 -0.76 . . . . 0.0 110.456 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -55.35 -42.28 73.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.215 -0.928 . . . . 0.0 110.14 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -63.94 -37.86 88.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.651 -0.656 . . . . 0.0 111.093 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.06 95.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.945 -1.097 . . . . 0.0 110.335 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -60.55 -16.08 33.97 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.948 -1.095 . . . . 0.0 110.726 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.0 mttt -94.87 1.09 55.3 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.157 -0.964 . . . . 0.0 109.735 177.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -113.26 -18.26 12.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.018 -1.051 . . . . 0.0 109.689 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.2 t -150.33 157.07 42.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.079 -1.013 . . . . 0.0 109.243 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 97.5 p -87.48 -10.13 52.68 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.374 -0.829 . . . . 0.0 109.538 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.71 174.11 39.96 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -132.7 136.68 46.56 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.334 -1.098 . . . . 0.0 111.613 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.1 mt -119.53 133.74 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.733 -0.604 . . . . 0.0 109.993 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.81 ' HD2' HD22 ' A' ' 138' ' ' LEU . 79.2 mtp85 -138.49 149.78 45.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.053 -1.029 . . . . 0.0 110.155 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.626 HG22 ' HB ' ' A' ' 67' ' ' ILE . 57.8 t -123.89 138.26 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.681 -0.637 . . . . 0.0 110.478 -178.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.421 ' HB2' HD11 ' A' ' 66' ' ' LEU . 48.1 t60 -122.87 125.0 44.54 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.512 -0.743 . . . . 0.0 109.607 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.998 HD11 HG13 ' A' ' 71' ' ' VAL . 35.2 tp -111.65 129.02 56.23 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.766 0.793 . . . . 0.0 112.131 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.443 ' O ' HG22 ' A' ' 71' ' ' VAL . 81.3 tt0 -146.2 167.1 24.3 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 98.3 mttt -79.82 -76.46 0.22 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.102 -0.999 . . . . 0.0 112.567 -177.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.8 t -138.18 154.3 49.15 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.298 -0.876 . . . . 0.0 110.24 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.2 p -100.26 169.86 8.84 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.375 -0.828 . . . . 0.0 110.532 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -106.79 -10.07 16.19 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.588 -0.695 . . . . 0.0 110.478 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.6 pt -129.93 -121.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.878 -1.139 . . . . 0.0 109.945 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -111.77 142.66 43.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.136 -1.603 . . . . 0.0 110.0 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.707 HG11 HG21 ' A' ' 77' ' ' VAL . 82.0 t -66.45 -44.53 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.46 -0.775 . . . . 0.0 112.294 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -61.35 -45.15 95.58 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.733 -1.23 . . . . 0.0 109.859 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -70.15 -37.09 75.14 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.134 -0.979 . . . . 0.0 108.701 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -65.61 -41.67 92.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.145 -0.972 . . . . 0.0 110.345 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.58 -39.53 80.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.843 -1.161 . . . . 0.0 110.475 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 66.1 ttp -63.19 -43.57 97.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.839 -1.163 . . . . 0.0 109.386 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -63.35 -47.09 83.6 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.249 -0.981 . . . . 0.0 109.443 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.8 t -64.51 -43.92 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.165 -0.96 . . . . 0.0 110.129 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' A' ' 56' ' ' MET . 63.2 t80 -58.84 -46.27 88.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.837 -1.164 . . . . 0.0 109.784 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -75.49 -37.05 60.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.062 -1.024 . . . . 0.0 110.464 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -61.84 -39.97 93.68 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.058 -1.026 . . . . 0.0 109.627 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.9 mt -78.89 3.38 17.1 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.624 178.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.7 mttp 59.05 30.85 20.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.507 -0.746 . . . . 0.0 111.083 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.714 ' SD ' HD13 ' A' ' 66' ' ' LEU . 62.1 mtt -70.0 -28.95 65.93 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.213 -0.93 . . . . 0.0 109.247 178.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -67.89 -9.49 45.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 109.832 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -84.61 84.69 7.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.614 -1.304 . . . . 0.0 110.93 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.753 HG23 ' OE1' ' A' ' 137' ' ' GLU . 92.1 m -135.27 151.88 50.98 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -60.54 -42.45 96.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.168 -0.957 . . . . 0.0 111.09 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.0 mt -99.85 0.41 41.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.086 -1.009 . . . . 0.0 111.112 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 56.85 32.47 21.45 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.194 0.997 . . . . 0.0 111.825 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.624 ' C ' HD11 ' A' ' 84' ' ' ILE . 98.6 m-20 -107.31 51.74 0.73 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.792 0.806 . . . . 0.0 109.289 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.421 ' N ' HD11 ' A' ' 84' ' ' ILE . . . -99.64 141.99 15.75 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.462 ' CG2' HD13 ' A' ' 84' ' ' ILE . 54.5 t -123.38 133.71 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.138 -1.213 . . . . 0.0 110.191 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.714 HD13 ' SD ' ' A' ' 56' ' ' MET . 61.0 tp -115.38 124.0 50.1 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.394 -0.816 . . . . 0.0 109.203 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.626 ' HB ' HG22 ' A' ' 33' ' ' VAL . 68.4 mt -106.2 107.25 22.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.121 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -94.08 126.02 39.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.168 -0.957 . . . . 0.0 110.124 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.9 t -120.89 133.13 68.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.873 0.844 . . . . 0.0 110.366 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.53 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -101.94 92.65 4.89 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.998 HG13 HD11 ' A' ' 35' ' ' LEU . 29.1 m -64.85 -23.1 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.23 -0.919 . . . . 0.0 111.0 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 51.2 tp10 -67.76 -44.21 78.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.809 -1.182 . . . . 0.0 108.585 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.59 ' O ' HG23 ' A' ' 75' ' ' THR . 92.0 m-20 -100.82 8.45 43.19 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.205 -0.934 . . . . 0.0 110.562 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.6 tttt 51.07 44.18 28.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.956 -1.09 . . . . 0.0 110.488 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 73' ' ' ASP . 23.3 p -121.31 166.34 14.19 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.431 -0.793 . . . . 0.0 109.269 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 47.3 p90 -145.08 138.23 26.52 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.048 -1.033 . . . . 0.0 110.505 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.707 HG21 HG11 ' A' ' 43' ' ' VAL . 50.0 t -127.5 135.29 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.718 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 72.3 mt -114.17 121.93 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.836 -1.165 . . . . 0.0 109.848 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -128.76 112.41 14.16 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.463 -0.773 . . . . 0.0 109.925 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -99.9 175.19 27.31 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -81.14 174.14 11.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.579 -0.954 . . . . 0.0 110.327 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.87 -25.68 65.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 110.328 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.478 ' O ' HG12 ' A' ' 87' ' ' VAL . . . -64.98 -53.1 35.93 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.143 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.979 ' O ' HG22 ' A' ' 88' ' ' VAL . 3.2 mt -65.25 -45.14 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.86 -1.376 . . . . 0.0 107.822 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.49 -36.29 82.03 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 111.425 -177.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -77.11 -22.85 52.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.082 -1.012 . . . . 0.0 111.711 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.991 HG13 HG13 ' A' ' 88' ' ' VAL . 8.9 p -102.61 -23.87 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.876 -1.14 . . . . 0.0 112.738 -178.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.991 HG13 HG13 ' A' ' 87' ' ' VAL . 15.6 m -118.52 165.46 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 120.388 -1.445 . . . . 0.0 111.474 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.8 p -110.34 -179.05 3.66 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.305 -0.872 . . . . 0.0 112.482 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.57 -35.42 80.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.284 -0.885 . . . . 0.0 109.812 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -61.96 -38.33 88.1 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 108.833 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.903 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 71.1 t80 -69.35 -26.09 64.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.626 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.718 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.9 m95 -85.97 -27.66 24.73 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.989 0.9 . . . . 0.0 110.322 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -54.26 -41.24 68.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.483 -0.76 . . . . 0.0 112.096 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 79.3 p -64.42 -32.87 74.67 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.888 -1.132 . . . . 0.0 109.668 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.413 HG22 HD13 ' A' ' 78' ' ' ILE 0.28 9.1 m -58.78 -49.5 77.43 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.329 1.061 . . . . 0.0 111.129 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -68.2 -38.62 82.17 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.305 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -63.64 -42.95 98.08 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.039 -1.065 . . . . 0.0 110.386 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.41 -50.83 69.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.825 -1.172 . . . . 0.0 111.294 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 93.1 mt -67.11 -42.79 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.111 -0.993 . . . . 0.0 109.888 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.434 ' CG ' ' HE3' ' A' ' 105' ' ' LYS . 52.4 tt0 -63.15 -45.35 92.28 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.662 -0.649 . . . . 0.0 111.317 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.695 HD13 ' O ' ' A' ' 102' ' ' LEU . 1.5 tm? -62.21 -41.55 98.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.895 -1.128 . . . . 0.0 111.721 -178.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.416 ' HB3' ' CA ' ' A' ' 112' ' ' GLY . 3.6 tp60 -75.64 -38.09 59.15 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.815 -1.154 . . . . 0.0 108.725 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -60.51 -41.07 93.59 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.434 ' HE3' ' CG ' ' A' ' 101' ' ' GLN . 92.0 mttt -61.35 -32.62 72.52 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.928 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -79.9 -17.31 53.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.855 -1.153 . . . . 0.0 110.093 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.42 6.35 44.58 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 119.892 -1.147 . . . . 0.0 111.322 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -103.42 89.51 3.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.624 -1.515 . . . . 0.0 109.946 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -62.19 -42.73 99.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.634 -0.666 . . . . 0.0 111.336 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.457 ' O ' HG23 ' A' ' 114' ' ' VAL . 85.7 tttt -62.47 -48.47 79.48 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.441 -177.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.412 ' HB3' ' HG2' ' A' ' 103' ' ' GLN . 58.5 tt0 -65.28 -37.95 88.75 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.848 -177.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -64.0 -51.29 54.51 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.487 -1.34 . . . . 0.0 110.091 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.0 mt -64.59 -43.8 92.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.01 -1.288 . . . . 0.0 110.988 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.646 HG22 HG13 ' A' ' 16' ' ' ILE . 88.2 t -63.93 -48.67 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.88 -1.137 . . . . 0.0 110.488 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -63.87 -39.7 94.82 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.943 -1.098 . . . . 0.0 110.103 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.7 -41.88 99.77 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.909 HD13 HD11 ' A' ' 20' ' ' ILE . 85.1 mt -64.08 -44.63 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.262 -1.14 . . . . 0.0 109.9 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -57.32 -47.19 82.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.102 -0.999 . . . . 0.0 109.242 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.46 -42.81 98.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -0.879 . . . . 0.0 109.067 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.84 -46.41 74.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 0.0 110.039 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.47 -42.69 97.44 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.783 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 86.3 mtp -66.35 -44.63 82.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.847 -1.384 . . . . 0.0 110.016 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.903 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -65.48 -45.4 83.8 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.01 -39.26 94.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.61 -33.88 61.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.936 . . . . 0.0 109.937 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.28 -40.76 95.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 0.0 108.65 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.5 ' HB3' ' CE1' ' A' ' 128' ' ' PHE . 68.4 m-85 -78.56 -35.44 45.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.44 -0.787 . . . . 0.0 110.099 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' A' ' 127' ' ' TYR . 73.7 m-85 -133.97 96.91 15.69 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.002 -1.061 . . . . 0.0 110.622 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.07 152.9 72.82 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.517 1.272 . . . . 0.0 110.542 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.475 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 45.7 t90 -74.17 133.51 42.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.428 -0.795 . . . . 0.0 111.812 -178.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -112.16 151.74 29.15 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.12 -32.33 70.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.913 -1.117 . . . . 0.0 111.454 -176.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -89.47 8.29 31.74 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.831 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -42.4 138.09 1.87 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.494 -0.754 . . . . 0.0 111.342 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.558 HD13 ' H ' ' A' ' 135' ' ' ILE . 0.1 OUTLIER -112.01 138.34 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.613 -177.407 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -94.9 90.44 6.0 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.084 -1.01 . . . . 0.0 109.379 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.753 ' OE1' HG23 ' A' ' 59' ' ' THR . 87.3 mt-10 -66.95 -41.7 86.47 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.66 -0.65 . . . . 0.0 112.505 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.81 HD22 ' HD2' ' A' ' 32' ' ' ARG . 4.5 mt -103.99 151.62 38.95 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.025 -1.047 . . . . 0.0 111.277 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.657 ' HD2' HD23 ' A' ' 138' ' ' LEU . 47.3 Cg_endo -75.04 -175.92 2.62 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 N-CA-C 108.315 -1.456 . . . . 0.0 108.315 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.417 ' ND2' HG22 ' A' ' 20' ' ' ILE . 25.6 m120 -117.48 3.87 12.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.656 -1.278 . . . . 0.0 109.842 178.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 33.5 m -60.58 137.26 58.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.793 -1.192 . . . . 0.0 109.811 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 16' ' ' ILE . 94.7 mt -68.65 138.94 21.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.491 -0.755 . . . . 0.0 110.955 -179.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 24.3 m -91.01 131.64 36.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.342 -0.849 . . . . 0.0 109.046 178.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -127.09 127.67 45.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.98 -1.075 . . . . 0.0 110.559 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.411 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.2 mtm . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.283 0.563 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.4 t -62.29 -43.34 99.05 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.394 -0.816 . . . . 0.0 109.225 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -82.55 119.44 24.24 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.21 -0.931 . . . . 0.0 109.149 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.7 pt -93.66 -9.95 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.769 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -65.71 -42.77 90.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.945 -1.097 . . . . 0.0 109.983 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -118.04 115.22 24.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.464 -0.772 . . . . 0.0 109.767 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 1.046 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 72.9 m-85 -62.59 -42.35 99.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 0.0 110.718 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 12' ' ' GLU . 95.0 mt -129.97 150.55 51.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.029 -1.044 . . . . 0.0 110.175 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.7 p -79.46 169.42 18.08 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.189 -0.944 . . . . 0.0 109.227 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.18 -36.32 68.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.95 -1.094 . . . . 0.0 109.639 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -64.31 -40.5 96.05 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.249 -0.907 . . . . 0.0 109.442 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.458 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 76.8 mm-40 -70.25 -50.81 35.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 0.0 110.643 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.54 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.3 mt-10 -64.66 -33.37 75.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.419 -0.801 . . . . 0.0 110.441 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.4 -45.15 94.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.967 -1.083 . . . . 0.0 110.378 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB3' ' CE ' ' A' ' 110' ' ' LYS . . . -66.31 -42.28 88.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.091 -1.006 . . . . 0.0 111.642 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.582 HG13 HG22 ' A' ' 114' ' ' VAL . 21.2 tt -68.56 -39.26 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.552 -1.343 . . . . 0.0 111.151 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 13' ' ' GLU . 89.9 t -63.1 -39.13 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.886 -1.134 . . . . 0.0 108.622 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -63.37 -36.16 82.78 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.3 -0.96 . . . . 0.0 109.241 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.26 -41.38 96.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -0.87 . . . . 0.0 109.533 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.903 HG22 ' OD1' ' A' ' 140' ' ' ASN . 96.7 mt -64.0 -43.11 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.445 -0.784 . . . . 0.0 109.572 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.406 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 99.5 mtt180 -58.28 -43.11 87.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.37 -0.831 . . . . 0.0 109.896 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -64.5 -35.56 81.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.422 -0.799 . . . . 0.0 111.115 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.81 -39.57 93.8 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.976 -1.078 . . . . 0.0 110.175 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -60.39 -16.47 35.83 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.036 -1.04 . . . . 0.0 110.985 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 97.9 mttt -94.79 0.66 55.09 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.139 -0.976 . . . . 0.0 109.556 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -112.73 -16.94 12.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.949 -1.095 . . . . 0.0 109.66 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.6 t -154.17 159.05 41.22 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.935 -1.103 . . . . 0.0 109.687 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.4 p -86.23 -6.55 58.95 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.194 -0.941 . . . . 0.0 110.587 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.49 170.41 50.75 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.41 ' CG ' ' HB2' ' A' ' 138' ' ' LEU . 68.6 mm-40 -129.66 132.79 46.79 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.128 -1.219 . . . . 0.0 111.181 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.3 mt -115.79 132.83 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -138.88 149.88 45.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.136 -0.977 . . . . 0.0 109.82 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.74 HG22 HD12 ' A' ' 67' ' ' ILE . 53.4 t -118.22 137.04 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.387 -0.821 . . . . 0.0 111.006 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -122.05 120.33 34.02 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.624 HD11 ' CG1' ' A' ' 71' ' ' VAL . 35.2 tp -112.16 126.01 54.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.496 -0.753 . . . . 0.0 111.396 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 83.3 tt0 -141.59 167.59 21.78 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.41 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 99.5 mttt -78.38 -75.57 0.22 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.935 -1.103 . . . . 0.0 113.411 -177.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 t -142.12 157.62 44.69 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.119 -0.988 . . . . 0.0 110.063 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.9 m -110.38 170.45 8.08 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.374 -0.829 . . . . 0.0 110.999 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -108.03 -9.46 15.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.398 -0.814 . . . . 0.0 110.556 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.426 HG13 ' N ' ' A' ' 42' ' ' ASP . 27.3 pt -127.56 -122.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.726 -1.234 . . . . 0.0 110.47 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.426 ' N ' HG13 ' A' ' 41' ' ' ILE . 97.5 m-20 -111.39 138.06 48.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.113 -1.617 . . . . 0.0 109.755 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.457 ' CG1' HG21 ' A' ' 77' ' ' VAL . 99.0 t -64.99 -42.79 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.444 -0.785 . . . . 0.0 111.426 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -59.9 -46.32 89.71 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.9 -1.125 . . . . 0.0 110.409 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -71.55 -40.67 69.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.977 -1.077 . . . . 0.0 108.282 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -61.4 -40.86 95.92 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.404 -0.81 . . . . 0.0 110.965 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.23 81.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.621 -1.3 . . . . 0.0 109.71 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 64.0 ttp -62.98 -43.34 99.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.209 -0.932 . . . . 0.0 109.792 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -64.01 -45.03 90.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.987 -1.071 . . . . 0.0 109.762 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.29 -43.53 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.306 -0.871 . . . . 0.0 110.003 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 6.9 t80 -57.84 -47.47 82.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.88 -1.137 . . . . 0.0 109.547 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -73.87 -35.64 64.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.992 -1.067 . . . . 0.0 109.843 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.09 -38.8 87.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.141 -0.974 . . . . 0.0 108.657 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.6 mt -80.22 3.25 21.39 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.359 -0.838 . . . . 0.0 110.141 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 29.8 tttt 57.14 32.46 21.73 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.936 -1.103 . . . . 0.0 111.706 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.596 ' SD ' HD13 ' A' ' 66' ' ' LEU . 98.9 mtp -66.39 -12.16 55.41 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.336 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -76.62 -1.74 29.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.939 -1.101 . . . . 0.0 109.529 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -75.44 63.22 1.44 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.889 -1.132 . . . . 0.0 110.129 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.3 p -134.62 150.27 50.67 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -65.2 -42.89 93.07 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.622 -0.674 . . . . 0.0 112.455 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 94.4 mt -96.33 -1.83 47.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.914 -1.116 . . . . 0.0 111.514 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 57.25 48.4 15.14 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 122.536 1.16 . . . . 0.0 110.797 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.8 p30 -122.45 53.04 1.27 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.885 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.42 146.92 16.61 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.54 HG23 ' CD1' ' A' ' 84' ' ' ILE . 72.7 t -128.06 134.72 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.116 -1.226 . . . . 0.0 110.361 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.596 HD13 ' SD ' ' A' ' 56' ' ' MET . 36.6 tp -116.67 128.18 55.11 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.59 -0.694 . . . . 0.0 109.381 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.74 HD12 HG22 ' A' ' 33' ' ' VAL . 86.0 mt -102.99 112.33 36.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.473 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -99.23 117.32 33.43 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.25 -0.906 . . . . 0.0 109.247 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 72.5 t -118.91 130.88 73.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-O 122.101 0.953 . . . . 0.0 110.709 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.481 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -99.86 101.12 12.16 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.046 HG21 ' CZ ' ' A' ' 7' ' ' PHE . 27.3 m -70.43 -20.28 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.006 . . . . 0.0 111.048 -178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -67.51 -44.02 79.43 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.792 -1.192 . . . . 0.0 109.016 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -102.52 3.63 37.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.284 -0.885 . . . . 0.0 110.759 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.4 tttt 56.74 48.77 15.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.831 -1.168 . . . . 0.0 111.123 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 76.7 p -122.4 164.02 18.75 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.095 -1.003 . . . . 0.0 109.917 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -143.57 141.37 30.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.489 -0.757 . . . . 0.0 110.146 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.457 HG21 ' CG1' ' A' ' 43' ' ' VAL . 64.4 t -126.82 136.06 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.606 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 66.7 mt -113.84 122.66 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.955 -1.091 . . . . 0.0 109.769 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -128.6 112.92 14.8 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.555 -0.716 . . . . 0.0 110.68 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -96.18 165.82 24.2 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 82' ' ' LYS . 54.1 t0 -75.28 175.05 8.71 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.346 -1.09 . . . . 0.0 109.642 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.409 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 86.1 tttt -59.24 -26.96 65.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 110.657 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.28 -52.25 42.16 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.604 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.972 ' O ' HG22 ' A' ' 88' ' ' VAL . 82.2 mt -64.94 -44.2 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.785 -1.42 . . . . 0.0 108.579 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -61.66 -38.07 86.37 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.004 -1.06 . . . . 0.0 111.34 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -73.05 -22.91 60.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.033 -1.042 . . . . 0.0 112.676 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.987 HG13 HG13 ' A' ' 88' ' ' VAL . 8.5 p -101.16 -19.48 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.78 -1.2 . . . . 0.0 112.472 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.987 HG13 HG13 ' A' ' 87' ' ' VAL . 19.5 m -119.54 163.61 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.712 -1.243 . . . . 0.0 111.642 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 61.9 p -108.66 -179.94 4.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.47 -0.769 . . . . 0.0 111.525 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -61.83 -38.63 88.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 109.231 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -60.1 -39.93 87.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.46 -0.775 . . . . 0.0 109.421 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.813 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 90.5 t80 -66.2 -24.29 66.59 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.158 -0.964 . . . . 0.0 109.537 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.606 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.2 m95 -87.97 -25.33 23.22 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.919 0.866 . . . . 0.0 110.656 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -57.52 -37.05 72.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.885 . . . . 0.0 111.999 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.4 p -67.67 -31.57 71.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.713 -1.242 . . . . 0.0 109.275 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.453 HG22 HD13 ' A' ' 78' ' ' ILE 0.277 15.9 m -60.89 -49.06 78.99 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 122.444 1.116 . . . . 0.0 111.097 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -69.44 -38.21 77.72 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.911 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -63.6 -42.62 98.24 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.939 -1.1 . . . . 0.0 110.566 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.01 -49.56 69.72 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.801 -1.187 . . . . 0.0 111.515 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.1 mt -66.81 -42.26 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.954 -1.091 . . . . 0.0 109.503 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -62.13 -44.42 96.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.346 -0.846 . . . . 0.0 111.18 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.2 tp -63.66 -42.17 98.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -0.963 . . . . 0.0 111.813 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.475 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 97.6 mm-40 -72.86 -43.82 62.11 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.361 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -58.68 -39.56 81.04 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.55 -33.21 72.34 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -78.2 -18.42 55.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 0.0 109.695 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.23 2.04 44.68 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.832 -1.175 . . . . 0.0 111.182 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.2 94.23 5.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.725 -1.456 . . . . 0.0 109.541 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -63.05 -42.34 99.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.767 -0.583 . . . . 0.0 111.066 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.458 ' NZ ' ' HA ' ' A' ' 12' ' ' GLU . 85.7 tttt -64.44 -48.31 75.8 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.868 -1.145 . . . . 0.0 112.006 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -62.65 -37.96 88.41 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 118.752 -1.179 . . . . 0.0 109.638 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.475 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -64.22 -50.61 59.03 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.04 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.7 mt -64.6 -43.85 92.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.161 -1.199 . . . . 0.0 111.164 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.582 HG22 HG13 ' A' ' 16' ' ' ILE . 83.6 t -64.93 -48.57 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.694 -1.254 . . . . 0.0 110.511 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -63.51 -38.35 90.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 109.624 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.91 -41.99 99.77 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.6 mt -63.32 -43.74 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -1.195 . . . . 0.0 108.975 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -58.96 -50.83 72.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.124 -0.985 . . . . 0.0 110.499 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.16 -41.11 97.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 109.052 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -42.63 95.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.883 . . . . 0.0 110.671 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.32 -44.01 96.06 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.962 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 97.1 mtp -67.8 -43.0 80.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.921 -1.34 . . . . 0.0 109.394 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.813 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -64.45 -46.89 81.18 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.255 -0.903 . . . . 0.0 108.885 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 76.6 mt -62.15 -40.73 96.94 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.478 -0.764 . . . . 0.0 109.126 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.74 -34.49 62.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.383 -0.823 . . . . 0.0 110.671 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.16 -42.77 99.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.05 -1.031 . . . . 0.0 108.954 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.459 ' CD2' HG22 ' A' ' 87' ' ' VAL . 66.8 m-85 -75.12 -40.0 60.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.624 -0.673 . . . . 0.0 109.791 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -130.94 92.08 34.8 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.383 -0.823 . . . . 0.0 109.393 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.13 151.39 83.81 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.472 1.248 . . . . 0.0 110.044 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.483 ' CH2' ' HA ' ' A' ' 132' ' ' LYS . 73.9 t90 -72.67 131.85 42.92 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.596 -0.69 . . . . 0.0 110.826 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -108.41 149.77 28.29 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.483 ' HA ' ' CH2' ' A' ' 130' ' ' TRP . 87.8 tttt -57.88 -28.91 64.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -0.999 . . . . 0.0 110.799 -177.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -89.47 8.37 31.31 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.797 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -43.88 136.93 3.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.297 -0.877 . . . . 0.0 111.65 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.712 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -112.24 143.58 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.355 0.598 . . . . 0.0 110.764 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -96.4 93.44 6.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.009 -1.057 . . . . 0.0 109.789 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.475 ' HG3' HD13 ' A' ' 135' ' ' ILE . 97.5 mt-10 -69.1 -35.8 76.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.66 -0.65 . . . . 0.0 111.901 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.422 ' HG ' ' HD2' ' A' ' 139' ' ' PRO . 1.1 mp -112.08 152.09 44.09 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.101 -0.999 . . . . 0.0 111.928 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.422 ' HD2' ' HG ' ' A' ' 138' ' ' LEU . 46.6 Cg_endo -76.09 -170.81 0.92 Allowed 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.633 1.333 . . . . 0.0 108.694 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.903 ' OD1' HG22 ' A' ' 20' ' ' ILE . 67.8 m-80 -122.97 2.95 9.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.661 -1.274 . . . . 0.0 110.066 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.4 m -64.02 139.87 58.81 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.854 -1.154 . . . . 0.0 110.805 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.474 HG13 HG22 ' A' ' 17' ' ' VAL . 95.0 mt -73.49 140.33 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.437 -0.79 . . . . 0.0 110.876 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 24.4 m -97.13 139.77 32.63 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.47 -0.769 . . . . 0.0 109.341 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -131.36 147.99 52.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.093 -1.004 . . . . 0.0 110.979 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.137 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.752 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.6 mtm . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.524 0.678 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m -67.32 148.1 52.11 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.472 -0.768 . . . . 0.0 109.783 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.57 -42.8 99.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.007 -1.058 . . . . 0.0 110.008 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 90.7 mt -63.95 -44.79 98.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.822 . . . . 0.0 110.272 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -70.27 -30.5 67.55 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.338 -0.851 . . . . 0.0 110.013 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -54.32 -45.71 72.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.076 -1.015 . . . . 0.0 110.542 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.547 ' CD2' HD22 ' A' ' 35' ' ' LEU . 19.6 t80 -69.92 -72.6 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.075 -1.016 . . . . 0.0 110.052 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.531 HD12 ' CE2' ' A' ' 7' ' ' PHE . 97.7 mt -133.27 152.8 51.94 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.958 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.0 p -81.18 169.28 17.56 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.569 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.96 -40.32 66.74 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.969 -1.082 . . . . 0.0 109.917 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -61.04 -43.87 98.25 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.632 -0.667 . . . . 0.0 109.769 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.46 -45.77 68.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.289 -0.882 . . . . 0.0 111.011 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.577 ' O ' HG23 ' A' ' 17' ' ' VAL . 95.1 mt-10 -66.46 -34.49 78.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.954 . . . . 0.0 109.715 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.06 -46.19 85.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.923 -1.11 . . . . 0.0 110.404 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.72 -41.92 95.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.063 -1.023 . . . . 0.0 111.451 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.634 HG13 HG22 ' A' ' 114' ' ' VAL . 18.5 tt -68.41 -39.44 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.869 -1.144 . . . . 0.0 110.549 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 13' ' ' GLU . 77.6 t -63.77 -41.5 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -60.93 -40.34 92.85 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.435 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.12 -36.03 78.63 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.379 -0.826 . . . . 0.0 109.341 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.868 HD11 HD13 ' A' ' 117' ' ' ILE . 30.3 mm -62.9 -42.1 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -58.81 -42.83 90.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.819 -0.551 . . . . 0.0 110.041 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -65.26 -40.61 94.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.052 -1.03 . . . . 0.0 111.113 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.07 -40.84 95.2 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.843 -1.161 . . . . 0.0 110.495 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -60.66 -13.98 17.87 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.441 -1.412 . . . . 0.0 111.127 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.488 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.8 mttt -95.15 0.98 54.7 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.067 -1.021 . . . . 0.0 109.449 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -112.91 -16.66 12.66 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.35 -0.844 . . . . 0.0 110.298 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.0 t -151.51 157.93 42.94 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.073 -1.017 . . . . 0.0 110.206 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.4 p -87.74 -7.36 57.45 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.488 -0.758 . . . . 0.0 110.194 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.31 172.92 49.6 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.656 ' HG3' HD13 ' A' ' 138' ' ' LEU . 80.6 mm-40 -132.02 133.86 44.9 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.162 -1.199 . . . . 0.0 111.725 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.5 mt -117.57 134.5 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 121.184 0.516 . . . . 0.0 110.124 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.572 ' NH1' HD13 ' A' ' 54' ' ' LEU . 69.7 ttt180 -139.86 156.44 46.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.395 -0.815 . . . . 0.0 110.166 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.423 HG13 HG23 ' A' ' 142' ' ' ILE . 3.5 p -124.29 138.24 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.265 -0.897 . . . . 0.0 110.62 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.806 ' HB2' HD11 ' A' ' 66' ' ' LEU . 57.0 t60 -121.42 119.82 33.18 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.547 HD22 ' CD2' ' A' ' 7' ' ' PHE . 46.1 tp -111.48 135.26 52.29 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.116 0.96 . . . . 0.0 111.974 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.464 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 76.4 tt0 -151.61 166.21 31.93 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.643 ' HA ' HG22 ' A' ' 71' ' ' VAL . 98.7 mttt -78.41 -72.0 0.4 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.896 -1.127 . . . . 0.0 112.889 -176.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.8 t -142.72 157.88 44.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.915 -1.116 . . . . 0.0 109.937 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.6 p -102.51 164.88 11.41 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.465 -0.772 . . . . 0.0 111.138 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -105.42 -24.56 12.62 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.455 -0.778 . . . . 0.0 109.377 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.413 HG13 ' N ' ' A' ' 42' ' ' ASP . 24.8 pt -111.9 -121.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.099 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.413 ' N ' HG13 ' A' ' 41' ' ' ILE . 97.0 m-20 -110.61 141.43 43.82 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.248 -1.532 . . . . 0.0 109.589 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.7 t -64.35 -43.22 97.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.355 -0.841 . . . . 0.0 111.21 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -61.18 -46.25 91.25 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.877 -1.139 . . . . 0.0 110.29 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -70.42 -40.14 74.0 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.897 -1.127 . . . . 0.0 108.413 177.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -62.9 -41.8 99.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.344 -0.847 . . . . 0.0 111.185 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.74 -39.29 80.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.947 -1.096 . . . . 0.0 110.187 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 66.3 ttp -63.0 -42.49 99.86 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.096 -1.003 . . . . 0.0 109.934 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -65.41 -40.66 93.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.021 -1.049 . . . . 0.0 109.82 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.8 t -69.58 -43.67 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.454 -0.779 . . . . 0.0 109.441 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.519 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 3.6 t80 -58.16 -46.85 84.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.048 -1.032 . . . . 0.0 108.824 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -73.15 -35.58 66.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.023 -1.048 . . . . 0.0 109.56 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -61.91 -37.32 84.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.012 -1.055 . . . . 0.0 109.329 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.572 HD13 ' NH1' ' A' ' 32' ' ' ARG . 98.6 mt -82.22 3.52 27.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.576 -0.702 . . . . 0.0 110.694 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.4 mttp 56.64 33.39 22.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.453 -0.78 . . . . 0.0 111.706 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.823 ' SD ' HD13 ' A' ' 66' ' ' LEU . 90.8 mtp -66.89 -14.25 62.56 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.416 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -75.68 -3.18 33.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.108 -0.995 . . . . 0.0 110.318 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -76.93 65.68 2.65 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.048 -1.033 . . . . 0.0 109.849 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.486 HG22 HD11 ' A' ' 138' ' ' LEU . 66.2 p -134.94 150.62 50.42 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.395 -0.816 . . . . 0.0 109.434 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -64.51 -47.32 79.32 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 84.6 mt -96.29 -1.06 48.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.863 -1.148 . . . . 0.0 111.332 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 76.0 mt-30 60.94 45.29 9.64 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 122.61 1.195 . . . . 0.0 111.479 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.445 ' HA ' HG13 ' A' ' 84' ' ' ILE . 34.8 m-80 -120.03 51.34 1.2 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.132 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.18 141.03 15.33 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.268 -1.933 . . . . 0.0 108.268 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.506 HG23 ' CD1' ' A' ' 84' ' ' ILE . 55.6 t -122.51 134.36 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.816 -1.402 . . . . 0.0 110.367 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.823 HD13 ' SD ' ' A' ' 56' ' ' MET . 41.1 tp -116.76 124.51 49.79 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.962 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 98.7 mt -102.36 105.2 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.965 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 34' ' ' HIS . 56.1 t80 -92.65 121.64 34.27 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.357 -0.839 . . . . 0.0 110.0 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.9 t -122.42 130.13 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.348 -0.845 . . . . 0.0 111.034 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.77 99.76 11.11 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.643 HG22 ' HA ' ' A' ' 37' ' ' LYS . 32.7 m -68.35 -20.53 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.97 -1.081 . . . . 0.0 110.451 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.449 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 66.1 mm-40 -70.85 -47.92 56.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.946 -1.096 . . . . 0.0 109.575 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -97.67 3.37 50.32 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.215 -0.928 . . . . 0.0 110.586 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt 54.44 46.08 25.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.103 -0.998 . . . . 0.0 110.99 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.4 m -121.72 132.69 54.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.082 -1.011 . . . . 0.0 110.303 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 76' ' ' PHE . 53.4 p90 -112.13 139.55 47.56 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.445 -0.785 . . . . 0.0 110.468 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 50.4 t -130.43 140.57 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.299 -0.876 . . . . 0.0 109.37 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.705 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 90.3 mt -118.07 127.98 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.783 -1.198 . . . . 0.0 111.032 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -130.42 116.47 18.29 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.638 -0.664 . . . . 0.0 110.285 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.43 167.4 15.64 Favored Glycine 0 N--CA 1.483 1.769 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.48 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 73.7 m-20 -77.86 178.2 7.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.546 -0.973 . . . . 0.0 110.848 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -62.05 -27.21 68.73 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.644 -0.66 . . . . 0.0 110.139 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.415 ' O ' HG12 ' A' ' 87' ' ' VAL . . . -62.37 -55.54 26.98 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.615 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.979 ' O ' HG22 ' A' ' 88' ' ' VAL . 76.5 mt -66.18 -44.56 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.703 -1.469 . . . . 0.0 108.546 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -61.31 -36.44 80.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.049 -1.032 . . . . 0.0 111.003 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -76.74 -21.84 54.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 111.524 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.968 HG13 HG13 ' A' ' 88' ' ' VAL . 10.5 p -103.45 -23.37 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.724 -1.235 . . . . 0.0 112.462 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.979 HG22 ' O ' ' A' ' 84' ' ' ILE . 20.3 m -118.88 164.41 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.64 -1.287 . . . . 0.0 111.011 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.5 p -109.34 178.52 4.42 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.406 -0.809 . . . . 0.0 112.434 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -62.89 -35.65 80.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.878 . . . . 0.0 109.137 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -61.47 -37.78 84.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.162 -0.961 . . . . 0.0 109.008 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.775 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 54.4 t80 -68.26 -25.21 65.06 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 108.984 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.705 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.8 m95 -86.63 -26.29 24.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.75 0.786 . . . . 0.0 110.846 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -58.84 -34.4 71.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.202 -0.936 . . . . 0.0 111.902 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 49.2 p -68.46 -32.65 72.81 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.276 -1.37 . . . . 0.0 108.683 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.268 16.6 m -59.74 -48.4 81.83 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 122.316 1.055 . . . . 0.0 110.852 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.44 -37.58 74.39 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.11 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -63.35 -43.85 96.52 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.824 -1.172 . . . . 0.0 110.125 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.03 -48.25 77.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.89 -1.131 . . . . 0.0 110.935 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 94.2 mt -67.7 -42.67 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.064 -1.022 . . . . 0.0 110.06 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -64.53 -41.67 96.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.124 -0.985 . . . . 0.0 110.648 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.8 mt -63.73 -42.31 97.92 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.96 -1.088 . . . . 0.0 112.048 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.47 ' HB2' ' HA3' ' A' ' 112' ' ' GLY . 99.7 mm-40 -74.99 -39.18 61.39 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.293 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -61.65 -40.31 94.45 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -62.01 -32.9 73.42 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.689 -0.632 . . . . 0.0 110.036 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -84.67 -17.21 39.26 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.828 -1.17 . . . . 0.0 109.916 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.89 10.53 34.66 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.09 -1.052 . . . . 0.0 110.503 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -104.6 79.58 1.57 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.854 -1.38 . . . . 0.0 109.35 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -60.68 -43.76 97.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.787 -0.571 . . . . 0.0 111.138 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.536 ' O ' HG23 ' A' ' 114' ' ' VAL . 74.3 tttt -62.33 -49.39 75.79 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.126 -0.984 . . . . 0.0 111.984 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -63.09 -37.89 89.01 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.887 -1.133 . . . . 0.0 110.313 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.47 ' HA3' ' HB2' ' A' ' 103' ' ' GLN . . . -64.47 -49.33 65.8 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.28 -43.35 98.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -1.143 . . . . 0.0 110.446 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.634 HG22 HG13 ' A' ' 16' ' ' ILE . 89.8 t -66.45 -46.99 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.084 -1.01 . . . . 0.0 110.074 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.78 -40.14 94.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.229 -0.919 . . . . 0.0 109.636 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.19 -41.9 99.62 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.868 HD13 HD11 ' A' ' 20' ' ' ILE . 93.9 mt -65.32 -44.27 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.371 -1.076 . . . . 0.0 110.298 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -57.2 -48.51 78.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.946 -1.096 . . . . 0.0 109.3 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.56 -42.05 98.37 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.481 -0.762 . . . . 0.0 109.506 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.57 -41.97 91.41 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.3 -0.875 . . . . 0.0 110.132 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.62 -44.7 89.16 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 98.7 mmm -65.49 -46.54 79.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.047 -1.266 . . . . 0.0 109.513 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.775 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -63.85 -44.73 92.29 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.21 -0.931 . . . . 0.0 109.128 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 37.8 mt -62.43 -40.41 96.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.937 . . . . 0.0 109.142 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.93 -35.04 61.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.151 -0.968 . . . . 0.0 110.454 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.09 -43.91 97.8 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.059 -1.025 . . . . 0.0 108.567 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.511 ' CD1' HG22 ' A' ' 87' ' ' VAL . 65.7 m-85 -72.39 -44.03 63.1 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.422 0.63 . . . . 0.0 109.81 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.412 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 62.9 m-85 -127.84 96.51 32.04 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 121.387 -0.82 . . . . 0.0 109.742 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 128' ' ' PHE . 42.3 Cg_endo -66.41 148.65 84.41 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.874 1.46 . . . . 0.0 110.304 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.488 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 72.6 t90 -73.87 133.09 43.1 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.422 -0.799 . . . . 0.0 110.262 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -111.34 147.79 34.37 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.41 ' HA ' ' CH2' ' A' ' 130' ' ' TRP . 99.5 mttt -54.18 -25.77 24.43 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.919 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -94.51 10.29 35.16 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 118.502 -1.279 . . . . 0.0 111.198 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -43.19 134.51 3.62 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.38 -0.825 . . . . 0.0 111.24 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.633 HD13 ' H ' ' A' ' 135' ' ' ILE . 0.2 OUTLIER -110.09 140.37 29.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.7 -178.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 45.6 p-10 -97.89 92.59 5.89 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.042 0.925 . . . . 0.0 110.206 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.09 -35.19 79.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.533 -0.729 . . . . 0.0 112.252 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.656 HD13 ' HG3' ' A' ' 30' ' ' GLU . 5.0 mp -108.96 152.78 42.6 Favored Pre-proline 0 N--CA 1.486 1.354 0 O-C-N 120.826 -1.172 . . . . 0.0 111.854 -178.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -75.13 -169.05 0.58 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 N-CA-C 108.0 -1.577 . . . . 0.0 108.0 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -123.74 4.66 8.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.572 -1.33 . . . . 0.0 110.418 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 61.7 p -62.38 171.86 1.74 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.074 -1.016 . . . . 0.0 110.556 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.423 HG23 HG13 ' A' ' 33' ' ' VAL . 95.0 mt -103.14 140.59 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.389 -0.819 . . . . 0.0 109.96 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 28.6 t -95.95 136.29 36.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.527 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -128.8 147.09 50.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.078 -1.013 . . . . 0.0 111.629 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.051 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.9 mtm . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 120.844 0.354 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.5 m -58.28 -41.43 84.32 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.615 -1.303 . . . . 0.0 109.822 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.23 -43.5 97.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 110.452 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.412 ' O ' HG13 ' A' ' 4' ' ' ILE . 39.9 pt -132.43 138.72 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.045 -1.035 . . . . 0.0 110.399 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.83 58.16 0.61 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.928 -1.108 . . . . 0.0 110.233 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 52.41 22.54 2.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.131 -0.981 . . . . 0.0 111.093 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.69 ' CD2' HD22 ' A' ' 35' ' ' LEU . 18.2 t80 -78.6 -73.7 0.31 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.122 -0.986 . . . . 0.0 110.446 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.525 ' CD1' ' CE2' ' A' ' 7' ' ' PHE . 96.4 mt -129.97 150.03 51.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.055 -1.028 . . . . 0.0 109.743 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 12' ' ' GLU . 6.6 t -77.48 170.94 15.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.038 -1.039 . . . . 0.0 109.587 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.03 -39.11 68.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 110.565 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -59.65 -46.21 89.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.125 -0.984 . . . . 0.0 110.759 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.428 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 99.7 mt-10 -70.08 -44.0 70.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 0.0 111.533 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.592 ' O ' HG23 ' A' ' 17' ' ' VAL . 95.6 mt-10 -65.99 -39.02 89.95 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.024 -1.047 . . . . 0.0 110.082 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.57 -45.57 93.59 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.938 -1.101 . . . . 0.0 110.539 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.06 -47.02 78.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.125 -0.984 . . . . 0.0 111.663 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.569 HG13 HG22 ' A' ' 114' ' ' VAL . 20.0 tt -63.79 -33.7 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.678 -1.264 . . . . 0.0 109.983 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 13' ' ' GLU . 55.9 t -64.91 -40.84 90.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -62.56 -35.13 78.5 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.104 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.73 -41.62 97.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.393 -0.817 . . . . 0.0 109.692 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.03 -43.14 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 0.0 109.493 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.411 ' HG2' ' OD1' ' A' ' 140' ' ' ASN . 93.6 mtt-85 -58.41 -44.45 89.04 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.464 -0.772 . . . . 0.0 110.183 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -63.28 -37.54 87.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.375 -0.828 . . . . 0.0 110.772 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.429 ' O ' HG22 ' A' ' 27' ' ' THR . . . -64.37 -40.64 96.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.077 -1.015 . . . . 0.0 110.187 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -60.99 -16.42 42.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.141 -0.974 . . . . 0.0 110.675 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.446 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.6 mttt -93.07 -1.3 56.65 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.059 -1.026 . . . . 0.0 109.229 177.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -110.93 -13.65 14.08 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 120.905 -1.122 . . . . 0.0 109.545 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 23' ' ' ALA . 3.9 t -151.28 158.67 44.16 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.977 -1.077 . . . . 0.0 110.329 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 94.2 p -89.31 -10.17 47.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 110.271 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.38 174.1 38.84 Favored Glycine 0 N--CA 1.485 1.967 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.421 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 55.7 mp0 -131.09 136.28 48.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.221 -1.164 . . . . 0.0 110.968 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.3 mt -120.73 134.78 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.692 -0.63 . . . . 0.0 110.308 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -139.24 159.26 42.58 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.22 -0.925 . . . . 0.0 109.508 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 p -129.15 143.87 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.395 -0.816 . . . . 0.0 110.942 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.785 ' HB2' HD11 ' A' ' 66' ' ' LEU . 31.1 t60 -127.64 126.94 42.93 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.613 0.721 . . . . 0.0 109.578 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.69 HD22 ' CD2' ' A' ' 7' ' ' PHE . 3.4 tp -116.01 131.18 57.01 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.968 0.89 . . . . 0.0 111.46 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -146.53 162.87 37.41 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.58 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.1 mttt -77.38 -74.51 0.25 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.053 -1.029 . . . . 0.0 112.66 -177.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.5 t -138.65 155.66 48.11 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.747 0.784 . . . . 0.0 109.796 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.454 ' HB2' ' NE ' ' A' ' 46' ' ' ARG . 13.3 p -106.72 168.39 9.21 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.7 -0.625 . . . . 0.0 110.693 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -106.84 -22.9 12.55 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.183 -0.948 . . . . 0.0 110.8 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.413 HD11 HH21 ' A' ' 46' ' ' ARG . 18.4 pt -114.05 -121.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.348 -0.845 . . . . 0.0 109.957 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 41' ' ' ILE . 91.5 m-20 -110.72 137.4 48.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.071 -1.643 . . . . 0.0 109.067 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.48 ' CG1' HG21 ' A' ' 77' ' ' VAL . 85.5 t -63.44 -44.21 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 111.104 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -59.17 -45.82 90.01 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.762 -1.211 . . . . 0.0 110.375 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -71.98 -39.14 69.5 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.454 ' NE ' ' HB2' ' A' ' 39' ' ' SER . 57.1 ttm-85 -61.35 -44.44 97.17 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.3 -0.875 . . . . 0.0 110.91 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.25 -37.97 89.38 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.952 -1.093 . . . . 0.0 109.444 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 50.9 ttp -63.75 -43.81 95.34 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.341 -0.849 . . . . 0.0 110.258 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -65.92 -46.8 76.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.999 -1.063 . . . . 0.0 110.28 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.8 t -66.3 -43.66 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.978 -1.076 . . . . 0.0 109.821 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.497 ' CD1' ' HB2' ' A' ' 66' ' ' LEU . 25.9 t80 -58.83 -47.21 85.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.036 -1.04 . . . . 0.0 110.403 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -75.33 -37.11 60.9 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.668 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -60.59 -39.67 88.95 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.135 -0.978 . . . . 0.0 110.17 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.508 HD12 ' HE3' ' A' ' 56' ' ' MET . 91.5 mt -80.09 4.19 18.02 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.01 -1.056 . . . . 0.0 110.658 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.4 tttt 61.25 28.05 17.67 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.938 -1.101 . . . . 0.0 111.983 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.876 ' SD ' HD13 ' A' ' 66' ' ' LEU . 54.6 mtt -66.84 -24.56 66.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.02 -1.05 . . . . 0.0 108.669 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -70.46 -8.4 50.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.253 -0.904 . . . . 0.0 111.194 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -85.76 85.79 7.38 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.568 -1.332 . . . . 0.0 111.196 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.6 p -135.0 154.16 51.83 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.422 ' HB3' ' OE2' ' A' ' 137' ' ' GLU . 60.4 tttp -61.57 -41.09 96.89 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.069 -1.019 . . . . 0.0 111.929 -177.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.404 ' HB3' ' ND2' ' A' ' 63' ' ' ASN . 85.9 mt -100.03 4.63 44.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.008 -1.057 . . . . 0.0 111.21 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 85.5 mt-30 56.28 41.73 28.79 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.303 1.049 . . . . 0.0 111.156 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.404 ' ND2' ' HB3' ' A' ' 61' ' ' LEU . 88.5 m-20 -119.49 54.31 1.0 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.682 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.415 ' N ' ' OD2' ' A' ' 81' ' ' ASP . . . -100.65 140.23 14.8 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.64 HG23 ' CD1' ' A' ' 84' ' ' ILE . 40.9 t -123.7 134.48 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.997 -1.296 . . . . 0.0 110.507 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.876 HD13 ' SD ' ' A' ' 56' ' ' MET . 43.9 tp -116.74 125.93 52.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.367 -0.833 . . . . 0.0 110.108 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 92.9 mt -104.04 105.57 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.043 -1.063 . . . . 0.0 109.493 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -90.7 122.47 33.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.975 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.8 t -122.14 131.04 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 122.024 0.916 . . . . 0.0 111.305 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.593 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -102.28 102.17 12.53 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.58 HG22 ' HA ' ' A' ' 37' ' ' LYS . 17.4 m -70.12 -20.67 23.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 110.999 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.44 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 78.2 mm-40 -68.6 -46.25 69.83 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.634 -1.291 . . . . 0.0 109.598 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -99.4 1.9 44.7 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.515 -0.74 . . . . 0.0 110.438 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.442 ' HE3' ' CZ ' ' A' ' 109' ' ' PHE . 38.6 tttt 58.59 48.74 11.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.777 -1.202 . . . . 0.0 110.226 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.593 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 61.9 p -122.47 163.25 20.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.976 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -146.34 145.81 30.45 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.27 -0.894 . . . . 0.0 110.591 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.48 HG21 ' CG1' ' A' ' 43' ' ' VAL . 54.2 t -132.27 138.8 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.449 -0.782 . . . . 0.0 109.173 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.692 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 71.2 mt -115.14 125.36 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.925 -1.109 . . . . 0.0 109.9 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -131.45 117.92 19.49 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.279 -0.888 . . . . 0.0 110.678 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.47 168.84 16.68 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.415 ' OD2' ' N ' ' A' ' 64' ' ' GLY . 47.3 m-20 -81.73 179.19 7.93 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.606 -0.938 . . . . 0.0 110.444 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -61.6 -28.3 69.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.34 -0.85 . . . . 0.0 111.169 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.67 -56.18 22.82 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.59 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.964 ' O ' HG22 ' A' ' 88' ' ' VAL . 81.0 mt -65.41 -45.48 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.774 -1.427 . . . . 0.0 108.423 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -60.55 -38.93 86.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.005 -1.059 . . . . 0.0 111.661 -177.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -71.85 -24.13 61.64 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.072 -1.017 . . . . 0.0 111.878 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.014 HG13 HG13 ' A' ' 88' ' ' VAL . 8.9 p -102.96 -21.36 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.731 -1.231 . . . . 0.0 113.218 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.014 HG13 HG13 ' A' ' 87' ' ' VAL . 16.7 m -117.95 162.89 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.829 -1.17 . . . . 0.0 110.964 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.1 p -109.36 -178.71 3.63 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.226 1.012 . . . . 0.0 113.077 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -63.14 -36.29 83.12 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.618 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -64.88 -38.94 92.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.12 -0.987 . . . . 0.0 109.156 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.839 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 66.1 t80 -65.62 -24.45 67.05 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.194 -0.941 . . . . 0.0 109.16 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.692 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.5 m95 -86.55 -26.4 24.54 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.184 0.992 . . . . 0.0 110.355 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -60.11 -36.8 78.25 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.918 -1.114 . . . . 0.0 112.141 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 m -63.33 -34.49 77.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.778 -1.201 . . . . 0.0 108.517 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.273 9.4 m -60.14 -49.92 75.72 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 122.145 0.974 . . . . 0.0 112.592 -179.3 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -67.79 -35.44 78.67 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.48 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -64.1 -43.15 96.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.992 -1.067 . . . . 0.0 110.772 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.65 -48.49 79.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.755 -1.216 . . . . 0.0 110.27 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.8 mt -67.64 -42.67 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.919 -1.113 . . . . 0.0 110.353 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -63.18 -44.6 94.96 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 111.413 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 102' ' ' LEU . 77.4 mt -63.91 -41.06 97.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.311 -0.868 . . . . 0.0 112.303 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.469 ' HB2' ' HA3' ' A' ' 112' ' ' GLY . 98.8 mm-40 -73.93 -40.35 63.15 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 118.615 -1.234 . . . . 0.0 108.892 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -58.82 -41.06 85.94 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.2 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -64.18 -32.68 74.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.401 -0.812 . . . . 0.0 110.779 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -78.02 -19.68 53.92 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.79 -1.194 . . . . 0.0 109.87 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.59 3.39 34.91 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.889 -1.148 . . . . 0.0 111.383 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -105.6 90.55 3.44 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.634 -1.509 . . . . 0.0 110.404 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.442 ' CZ ' ' HE3' ' A' ' 74' ' ' LYS . 21.3 m-85 -64.24 -41.2 97.08 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.884 -0.51 . . . . 0.0 111.42 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.466 ' O ' HG23 ' A' ' 114' ' ' VAL . 85.7 tttt -62.98 -49.37 74.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.948 -1.095 . . . . 0.0 111.317 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -62.78 -40.82 98.48 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.055 -1.058 . . . . 0.0 109.888 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' A' ' 103' ' ' GLN . . . -61.71 -49.36 77.11 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.03 -43.73 91.42 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.323 -1.104 . . . . 0.0 111.757 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.569 HG22 HG13 ' A' ' 16' ' ' ILE . 81.2 t -64.49 -46.54 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.843 -1.16 . . . . 0.0 109.504 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.33 -41.4 96.81 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.456 -0.778 . . . . 0.0 110.803 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.51 -44.91 93.59 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 93.1 mt -65.25 -43.62 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.083 -1.245 . . . . 0.0 110.192 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 114' ' ' VAL . 79.7 mm-40 -55.34 -51.17 67.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.889 -1.132 . . . . 0.0 109.678 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.39 -42.41 99.4 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.3 -0.875 . . . . 0.0 109.088 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.409 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -58.14 -42.6 86.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.18 -0.95 . . . . 0.0 110.152 178.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.6 -44.11 96.98 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 9.4 ttm -67.37 -46.46 73.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.018 -1.284 . . . . 0.0 109.806 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.839 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -61.99 -46.24 90.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.238 -0.914 . . . . 0.0 109.21 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.409 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 66.1 mt -62.66 -40.35 96.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.421 -0.799 . . . . 0.0 108.917 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.73 -34.33 58.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.322 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.11 -43.06 99.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.015 -1.053 . . . . 0.0 109.094 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.458 ' CD2' HG22 ' A' ' 87' ' ' VAL . 80.6 m-85 -75.88 -37.48 58.85 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.616 0.722 . . . . 0.0 109.641 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -128.51 96.2 30.96 Favored Pre-proline 0 N--CA 1.485 1.307 0 O-C-N 121.703 -0.623 . . . . 0.0 109.911 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.98 148.3 81.64 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 O-C-N 123.583 1.307 . . . . 0.0 109.825 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.446 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 65.2 t90 -75.84 136.58 40.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.346 -0.846 . . . . 0.0 110.812 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 99.6 mttt -115.52 151.02 35.61 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 109.078 178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.92 -29.49 67.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.976 -1.077 . . . . 0.0 111.195 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -91.01 8.23 36.37 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.961 -1.096 . . . . 0.0 111.109 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 42.9 t0 -43.11 139.03 1.95 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.211 -0.931 . . . . 0.0 111.686 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.708 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -112.92 144.42 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.72 0.771 . . . . 0.0 111.476 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -99.38 92.7 5.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.68 -1.262 . . . . 0.0 110.028 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.514 ' HG3' HD13 ' A' ' 135' ' ' ILE . 96.7 mt-10 -69.58 -39.88 77.08 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.436 ' HG ' ' HD2' ' A' ' 139' ' ' PRO . 0.1 OUTLIER -108.44 150.68 40.93 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.02 -1.05 . . . . 0.0 111.995 -178.153 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.436 ' HD2' ' HG ' ' A' ' 138' ' ' LEU . 41.4 Cg_endo -71.71 -179.24 3.6 Favored 'Trans proline' 0 N--CA 1.486 1.046 0 O-C-N 123.527 1.278 . . . . 0.0 109.438 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.411 ' OD1' ' HG2' ' A' ' 21' ' ' ARG . 18.0 m120 -119.44 3.21 11.28 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.45 -1.406 . . . . 0.0 110.462 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.4 p -63.81 167.81 5.64 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.826 -1.171 . . . . 0.0 110.686 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 93.8 mt -94.69 136.27 26.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.649 0.738 . . . . 0.0 111.088 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 27.8 t -94.1 133.99 37.01 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.04 138.89 52.17 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.264 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.054 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.725 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 120.956 0.407 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.1 m -56.96 -42.05 79.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.676 -1.265 . . . . 0.0 110.346 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.411 ' HE2' ' HB2' ' A' ' 5' ' ' GLU . 87.6 tttt -131.89 139.29 48.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.164 -0.96 . . . . 0.0 109.73 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.3 mt -64.18 -43.86 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.188 -0.945 . . . . 0.0 111.115 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.411 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 78.8 mm-40 -62.12 -38.86 90.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.082 -1.011 . . . . 0.0 110.507 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -91.12 94.58 9.66 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.092 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.789 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 75.2 m-85 -59.98 -43.01 95.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.164 -0.96 . . . . 0.0 110.472 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.5 mt -131.37 151.77 51.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.033 -1.042 . . . . 0.0 110.616 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.9 p -81.12 168.09 18.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.031 -1.043 . . . . 0.0 109.318 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.61 -35.92 68.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.965 -1.084 . . . . 0.0 109.493 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -61.71 -46.39 89.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.544 -0.722 . . . . 0.0 110.454 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -68.91 -47.88 64.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.277 -0.889 . . . . 0.0 111.474 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.709 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.7 mt-10 -61.88 -39.53 92.26 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.035 -1.04 . . . . 0.0 110.245 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.54 -44.5 96.94 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.166 -0.959 . . . . 0.0 111.226 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.59 -46.63 81.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.841 -1.162 . . . . 0.0 110.809 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 13' ' ' GLU . 21.4 tt -65.58 -35.24 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.836 -1.165 . . . . 0.0 109.869 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 13' ' ' GLU . 53.4 t -63.26 -38.5 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 21' ' ' ARG . 63.7 t0 -63.12 -36.36 83.35 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.328 -0.857 . . . . 0.0 109.454 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.37 -38.68 90.51 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.179 -0.951 . . . . 0.0 109.04 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.721 HG22 ' OD1' ' A' ' 140' ' ' ASN . 35.1 mm -64.46 -44.04 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.187 -0.946 . . . . 0.0 109.745 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.462 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 58.6 mtm180 -61.25 -42.19 98.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 110.383 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -64.87 -38.06 89.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.181 -0.95 . . . . 0.0 111.796 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.51 -39.1 93.16 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.886 -1.134 . . . . 0.0 110.527 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.82 -16.22 26.74 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.766 -1.209 . . . . 0.0 110.328 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.476 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.7 mttt -94.86 0.56 54.91 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.057 -1.027 . . . . 0.0 109.968 177.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -114.07 -15.67 12.24 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.751 -1.218 . . . . 0.0 109.714 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 t -151.68 155.91 39.28 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.97 -1.082 . . . . 0.0 109.459 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.9 m -85.84 -6.35 59.1 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.206 -0.934 . . . . 0.0 110.052 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.2 173.5 52.77 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 55.8 mp0 -131.08 136.99 48.9 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.12 -1.224 . . . . 0.0 111.183 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 94.9 mt -118.01 134.68 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.778 -0.576 . . . . 0.0 110.104 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.481 ' HB3' ' HE1' ' A' ' 56' ' ' MET . 73.9 ttt180 -139.4 151.95 46.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 110.005 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.828 HG22 HD12 ' A' ' 67' ' ' ILE . 60.7 t -120.97 136.75 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.409 -0.807 . . . . 0.0 110.4 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.734 ' HB2' HD11 ' A' ' 66' ' ' LEU . 82.8 t60 -122.31 126.33 47.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.44 -0.787 . . . . 0.0 109.137 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.44 HD11 ' CG1' ' A' ' 71' ' ' VAL . 36.7 tp -112.48 126.68 55.58 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.846 0.832 . . . . 0.0 111.449 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.441 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 82.8 tt0 -142.79 165.07 28.38 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.742 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.0 mttt -81.65 -77.49 0.22 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -176.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.0 t -142.34 158.07 44.11 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.188 -0.945 . . . . 0.0 109.809 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.2 m -113.78 177.51 4.61 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.147 -0.97 . . . . 0.0 111.523 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -102.78 -20.11 14.46 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.615 -0.678 . . . . 0.0 109.871 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.0 mt -112.16 -120.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.015 -1.053 . . . . 0.0 109.519 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -114.46 148.35 37.94 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 119.952 -1.717 . . . . 0.0 108.227 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.521 ' CG1' HG21 ' A' ' 77' ' ' VAL . 63.1 t -60.97 -42.48 93.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 O-C-N 121.118 -0.989 . . . . 0.0 110.269 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -60.13 -45.78 91.87 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.198 -0.939 . . . . 0.0 110.861 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -71.66 -45.49 61.81 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.859 -1.151 . . . . 0.0 109.104 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.472 ' O ' HG23 ' A' ' 50' ' ' VAL . 31.9 tpt180 -60.13 -43.28 95.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.106 -0.996 . . . . 0.0 111.611 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.77 83.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.567 -1.333 . . . . 0.0 110.381 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.1 ttp -62.3 -41.8 98.83 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.138 -0.976 . . . . 0.0 109.716 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -63.41 -42.0 98.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.136 -0.978 . . . . 0.0 109.192 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 46' ' ' ARG . 94.2 t -67.06 -42.32 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.5 -0.75 . . . . 0.0 109.659 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.487 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 5.8 t80 -58.55 -47.66 83.46 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.93 -1.106 . . . . 0.0 109.415 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -73.0 -35.67 66.88 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 109.966 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -60.16 -35.67 75.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.873 -1.142 . . . . 0.0 109.053 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.82 5.16 26.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.267 -0.896 . . . . 0.0 110.33 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 55.01 32.91 19.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.97 -1.081 . . . . 0.0 111.123 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.523 ' SD ' HD22 ' A' ' 66' ' ' LEU . 94.0 mtp -65.94 -12.59 55.95 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.793 -1.192 . . . . 0.0 109.927 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -76.69 -1.61 28.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.723 -1.236 . . . . 0.0 109.781 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -74.87 65.1 1.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.855 -1.153 . . . . 0.0 110.262 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.4 p -134.8 148.78 50.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.074 -1.016 . . . . 0.0 109.272 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -62.56 -43.79 97.93 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.599 -0.688 . . . . 0.0 112.841 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.7 mt -98.18 2.27 48.28 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.903 -1.123 . . . . 0.0 111.804 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 56.53 32.76 21.41 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 122.437 1.113 . . . . 0.0 111.088 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.6 ' C ' HD11 ' A' ' 84' ' ' ILE . 3.2 m-80 -108.31 53.38 0.69 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.949 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.539 ' N ' HD11 ' A' ' 84' ' ' ILE . . . -101.58 139.37 14.37 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.454 ' CG2' HD13 ' A' ' 84' ' ' ILE . 53.9 t -123.42 133.78 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -1.157 . . . . 0.0 109.829 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.734 HD11 ' HB2' ' A' ' 34' ' ' HIS . 37.9 tp -117.18 133.06 56.45 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.093 -1.004 . . . . 0.0 109.495 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.828 HD12 HG22 ' A' ' 33' ' ' VAL . 83.8 mt -104.32 108.38 24.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 118.809 -1.157 . . . . 0.0 109.369 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.504 ' CE2' HG13 ' A' ' 43' ' ' VAL . 69.3 t80 -95.57 121.06 36.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.318 -0.864 . . . . 0.0 110.014 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.9 t -120.67 130.77 74.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.953 0.883 . . . . 0.0 110.841 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.5 103.26 15.0 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.789 HG21 ' CZ ' ' A' ' 7' ' ' PHE . 21.5 m -71.88 -18.99 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.992 -1.067 . . . . 0.0 111.048 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -70.27 -46.68 63.88 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.531 -1.356 . . . . 0.0 109.342 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -101.61 4.74 41.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.077 -1.015 . . . . 0.0 110.427 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.7 tttt 53.88 46.91 24.71 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.824 -1.172 . . . . 0.0 110.618 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.9 m -121.07 135.43 55.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.986 -1.071 . . . . 0.0 109.709 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 101' ' ' GLN . 42.9 p90 -112.15 133.9 54.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.457 -0.777 . . . . 0.0 109.885 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.521 HG21 ' CG1' ' A' ' 43' ' ' VAL . 47.8 t -126.89 135.67 63.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 120.935 -1.103 . . . . 0.0 108.063 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.607 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 81.6 mt -114.4 128.16 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.888 -1.133 . . . . 0.0 110.679 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -132.27 113.85 13.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.734 -0.603 . . . . 0.0 110.539 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.38 176.82 26.88 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.47 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 92.5 m-20 -82.5 -178.64 7.14 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.629 -0.924 . . . . 0.0 110.437 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.74 -23.34 67.14 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.448 -0.783 . . . . 0.0 109.634 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.15 -54.07 29.56 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.636 -1.268 . . . . 0.0 111.075 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.974 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.6 mt -66.33 -45.9 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.734 -1.45 . . . . 0.0 108.456 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -61.67 -37.62 84.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.058 -1.026 . . . . 0.0 111.521 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -75.61 -20.96 58.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.881 -1.137 . . . . 0.0 111.961 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.945 HG13 HG13 ' A' ' 88' ' ' VAL . 7.3 p -103.25 -22.02 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.861 -1.149 . . . . 0.0 112.341 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.974 HG22 ' O ' ' A' ' 84' ' ' ILE . 21.4 m -121.01 162.27 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 120.483 -1.385 . . . . 0.0 111.168 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.1 p -104.51 177.64 4.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.313 -0.867 . . . . 0.0 112.177 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.0 -35.68 79.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.683 -0.635 . . . . 0.0 109.437 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -63.82 -37.19 86.47 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.672 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 56.6 t80 -65.85 -24.31 66.85 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.09 -1.007 . . . . 0.0 108.606 177.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.607 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 6.8 m95 -87.12 -28.42 22.51 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.796 0.808 . . . . 0.0 110.784 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -57.09 -36.64 70.85 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.493 -0.754 . . . . 0.0 112.327 -176.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 64.5 p -67.38 -32.82 74.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.796 -1.19 . . . . 0.0 109.346 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.493 HG22 ' CD1' ' A' ' 78' ' ' ILE 0.284 8.5 m -59.26 -47.78 84.07 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.67 1.224 . . . . 0.0 110.521 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -69.13 -38.54 78.88 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.897 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -64.27 -44.73 90.81 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.687 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.22 -49.42 75.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.694 -1.254 . . . . 0.0 110.967 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.583 HD12 HD11 ' A' ' 78' ' ' ILE . 95.9 mt -67.24 -42.4 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.073 -1.017 . . . . 0.0 110.26 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 76' ' ' PHE . 57.8 tt0 -63.58 -40.39 96.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.916 -1.115 . . . . 0.0 110.814 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 40.4 mt -63.39 -42.62 98.81 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.117 -0.989 . . . . 0.0 111.929 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.485 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 88.0 mm-40 -75.15 -40.48 59.6 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.904 -1.119 . . . . 0.0 108.885 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -60.26 -41.8 94.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 108.936 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.78 -29.71 70.91 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.541 -0.724 . . . . 0.0 109.554 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -81.34 -20.02 41.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.027 -1.046 . . . . 0.0 110.003 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.73 -0.94 34.11 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.744 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -102.45 95.99 6.63 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.531 -1.57 . . . . 0.0 110.854 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -63.13 -41.45 99.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.847 -0.533 . . . . 0.0 111.774 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -65.5 -49.07 70.39 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.371 -0.932 . . . . 0.0 112.446 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.76 -39.75 95.02 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 118.859 -1.136 . . . . 0.0 110.594 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.485 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -62.41 -48.05 85.06 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.48 -1.343 . . . . 0.0 109.946 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.5 mt -63.65 -44.33 94.12 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.504 -0.998 . . . . 0.0 110.308 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.403 HG22 HG13 ' A' ' 16' ' ' ILE . 78.7 t -65.23 -47.57 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.95 -1.094 . . . . 0.0 110.858 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -65.76 -41.12 92.49 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 110.805 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.07 -41.21 98.59 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 98.1 mt -63.54 -42.99 98.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.141 -1.211 . . . . 0.0 109.585 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -59.19 -47.29 85.85 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.941 -1.099 . . . . 0.0 109.624 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.37 -42.54 99.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.383 -0.823 . . . . 0.0 109.333 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -58.71 -42.64 89.14 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.124 -0.985 . . . . 0.0 109.657 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.89 -43.04 96.61 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.637 -1.268 . . . . 0.0 109.99 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 90.8 mtp -67.19 -45.35 77.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.15 -1.206 . . . . 0.0 110.488 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.672 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -64.24 -42.52 96.49 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.301 -0.96 . . . . 0.0 108.626 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.4 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 73.7 mt -64.56 -39.82 94.44 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.546 -0.721 . . . . 0.0 109.58 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.71 -34.19 58.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.029 -1.044 . . . . 0.0 110.472 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -63.05 -42.91 99.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.024 -1.047 . . . . 0.0 109.492 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.433 ' HB3' ' CE1' ' A' ' 128' ' ' PHE . 53.9 m-85 -70.22 -42.64 72.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.473 -0.767 . . . . 0.0 110.014 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.443 ' CZ ' HG21 ' A' ' 87' ' ' VAL . 83.1 m-85 -127.92 101.72 22.81 Favored Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 121.495 -0.753 . . . . 0.0 109.931 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.2 152.07 80.19 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.81 1.426 . . . . 0.0 109.877 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.476 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 43.4 t90 -78.79 137.64 37.82 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.624 -0.672 . . . . 0.0 111.173 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -115.28 149.18 38.21 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.318 -0.864 . . . . 0.0 109.526 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -57.81 -28.52 64.12 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 111.236 -177.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -91.13 9.96 28.88 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.921 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.428 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 66.3 t0 -43.12 137.09 2.63 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.358 -0.839 . . . . 0.0 111.575 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.607 HD13 ' H ' ' A' ' 135' ' ' ILE . 0.2 OUTLIER -110.43 136.12 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.734 0.778 . . . . 0.0 111.484 -178.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -115.12 100.68 8.34 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -101.26 -4.45 27.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.896 -1.127 . . . . 0.0 111.933 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.86 145.41 30.66 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 120.938 -1.101 . . . . 0.0 110.983 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -70.32 166.38 28.48 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.669 1.352 . . . . 0.0 109.468 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.721 ' OD1' HG22 ' A' ' 20' ' ' ILE . 62.8 m-80 -109.66 7.46 24.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.568 -1.333 . . . . 0.0 110.77 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.6 p -65.85 171.15 4.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.911 -1.118 . . . . 0.0 111.329 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 91.1 mt -97.88 140.43 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 121.387 0.613 . . . . 0.0 110.707 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 18.1 t -94.48 134.32 37.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 109.829 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -129.1 148.1 51.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 110.451 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 CA-C-O 117.964 -1.465 . . . . 0.0 109.784 -179.796 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.6 mmm . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.351 0.596 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.2 p -67.57 -21.55 65.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.435 -0.791 . . . . 0.0 111.211 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -107.04 127.09 53.15 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.089 -1.007 . . . . 0.0 110.314 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.62 -23.34 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.561 -0.712 . . . . 0.0 110.285 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -54.03 -43.56 70.23 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.453 -0.779 . . . . 0.0 111.256 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -126.52 133.93 51.02 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.845 -1.159 . . . . 0.0 110.088 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.681 ' CZ ' HG12 ' A' ' 71' ' ' VAL . 28.3 t80 -62.72 -44.36 96.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.298 -0.876 . . . . 0.0 110.82 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 74.9 mt -126.31 150.49 48.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.251 -0.906 . . . . 0.0 109.539 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.3 p -78.1 165.79 23.57 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.908 -1.12 . . . . 0.0 109.692 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.42 -35.61 68.0 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.953 -1.092 . . . . 0.0 109.857 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -58.9 -46.36 88.07 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.395 -0.816 . . . . 0.0 109.99 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.469 ' HA ' ' CE ' ' A' ' 110' ' ' LYS . 98.9 mt-10 -69.2 -46.17 68.08 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.311 -0.868 . . . . 0.0 111.067 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -64.76 -39.53 93.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.136 -0.977 . . . . 0.0 110.755 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.47 -45.17 94.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.162 -0.961 . . . . 0.0 110.877 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.64 ' HB3' ' HE2' ' A' ' 110' ' ' LYS . . . -62.51 -41.09 98.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.972 . . . . 0.0 110.481 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 110' ' ' LYS . 45.2 mt -64.64 -43.47 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 111.208 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.451 ' CG2' HG12 ' A' ' 142' ' ' ILE . 45.4 t -60.99 -42.77 94.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 108.788 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -61.27 -37.67 83.98 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.492 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.76 94.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.506 -0.746 . . . . 0.0 109.811 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 91.5 mt -63.83 -43.42 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 109.404 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -55.59 -44.63 77.14 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.502 -0.749 . . . . 0.0 109.682 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -63.19 -37.41 87.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.473 -0.767 . . . . 0.0 110.986 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.45 -37.94 89.22 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.977 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.425 ' OE1' ' ND2' ' A' ' 140' ' ' ASN . 3.3 mp0 -60.83 -15.34 29.07 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.804 -1.185 . . . . 0.0 111.091 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.7 mttt -94.61 -1.53 53.07 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 120.912 -1.118 . . . . 0.0 109.499 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -111.15 -15.09 13.76 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.857 -1.152 . . . . 0.0 110.188 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.1 t -152.68 160.28 43.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.023 -1.048 . . . . 0.0 109.45 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.1 m -88.17 -5.52 58.37 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.986 -1.071 . . . . 0.0 110.344 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.93 170.04 52.14 Favored Glycine 0 N--CA 1.482 1.723 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 138' ' ' LEU . 79.2 mm-40 -129.68 136.86 50.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.258 -1.142 . . . . 0.0 110.723 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.2 mt -119.22 134.96 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.595 -0.69 . . . . 0.0 110.71 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.686 ' CD ' HD23 ' A' ' 138' ' ' LEU . 84.3 mtp180 -139.47 153.24 47.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.389 -0.82 . . . . 0.0 109.923 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.883 HG22 HD12 ' A' ' 67' ' ' ILE . 61.7 t -123.42 141.01 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.302 -0.874 . . . . 0.0 110.952 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.498 ' HB2' HD11 ' A' ' 66' ' ' LEU . 82.5 t60 -122.95 124.82 44.05 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.65 HD11 HG13 ' A' ' 71' ' ' VAL . 35.8 tp -112.61 129.0 56.53 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.938 0.875 . . . . 0.0 111.286 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -146.42 164.77 31.4 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -79.73 -73.88 0.33 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.112 -0.992 . . . . 0.0 112.898 -177.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.33 157.24 46.23 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.262 -0.899 . . . . 0.0 110.133 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.8 m -103.06 165.07 11.24 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.624 -0.673 . . . . 0.0 110.166 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -104.23 -14.23 15.9 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.353 -0.842 . . . . 0.0 109.794 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.434 HG13 ' N ' ' A' ' 42' ' ' ASP . 29.8 pt -124.8 -122.01 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.052 -1.03 . . . . 0.0 110.052 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.434 ' N ' HG13 ' A' ' 41' ' ' ILE . 95.3 m-20 -110.73 139.17 46.26 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 120.16 -1.587 . . . . 0.0 109.359 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.696 HG11 HG21 ' A' ' 77' ' ' VAL . 84.3 t -64.59 -43.92 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.299 -0.875 . . . . 0.0 111.902 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -60.05 -45.42 92.91 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.72 -1.237 . . . . 0.0 110.123 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -70.98 -38.1 72.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.851 -1.156 . . . . 0.0 109.365 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 50.1 ttt85 -65.97 -43.1 88.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.774 -1.203 . . . . 0.0 110.266 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.75 -37.59 88.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.87 -1.144 . . . . 0.0 110.224 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 62.3 ttp -64.23 -43.23 95.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.137 -0.977 . . . . 0.0 109.153 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -63.85 -41.97 97.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.937 -1.102 . . . . 0.0 109.251 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 74.2 t -67.61 -42.87 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.502 -0.749 . . . . 0.0 109.833 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -59.8 -46.85 87.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.88 -1.138 . . . . 0.0 109.491 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -74.94 -36.12 62.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.967 -1.083 . . . . 0.0 109.764 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -61.07 -38.42 86.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.067 -1.02 . . . . 0.0 109.442 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.5 mt -81.89 4.05 23.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.0 110.048 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.43 33.96 23.4 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.288 -0.883 . . . . 0.0 111.941 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.719 ' SD ' HD13 ' A' ' 66' ' ' LEU . 95.7 mtp -69.22 -15.02 63.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.089 -1.007 . . . . 0.0 109.922 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 44.9 p-10 -78.45 -5.32 52.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.831 -1.168 . . . . 0.0 110.138 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 65.1 t-20 -88.64 78.8 7.67 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.788 -1.195 . . . . 0.0 110.409 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.3 m -137.02 154.91 50.26 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.19 -44.44 97.28 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 111.599 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 90.5 mt -99.94 -2.4 34.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.757 -1.215 . . . . 0.0 111.389 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 87.7 mt-30 59.32 49.92 8.37 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.245 1.021 . . . . 0.0 111.265 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -122.22 54.15 1.2 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.479 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.92 143.33 16.16 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.537 HG23 ' CD1' ' A' ' 84' ' ' ILE . 54.0 t -124.12 134.75 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.907 -1.349 . . . . 0.0 110.715 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.719 HD13 ' SD ' ' A' ' 56' ' ' MET . 39.7 tp -117.1 125.16 50.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.568 -0.708 . . . . 0.0 109.893 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.883 HD12 HG22 ' A' ' 33' ' ' VAL . 83.2 mt -102.3 110.88 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.602 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -96.37 120.75 37.25 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.168 -0.957 . . . . 0.0 110.027 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.9 t -122.39 131.11 73.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.297 -0.877 . . . . 0.0 110.922 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.561 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -99.91 90.52 4.45 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.681 HG12 ' CZ ' ' A' ' 7' ' ' PHE . 17.4 m -60.26 -24.16 29.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.298 -0.876 . . . . 0.0 111.375 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -67.51 -41.12 84.94 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.989 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.414 ' O ' HG23 ' A' ' 75' ' ' THR . 96.2 m-20 -103.33 4.06 35.98 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.072 -1.017 . . . . 0.0 110.685 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.428 ' HE3' ' CE1' ' A' ' 109' ' ' PHE . 45.2 tttt 55.86 45.72 23.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.827 -1.171 . . . . 0.0 110.752 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.561 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 72.4 p -119.97 163.37 17.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.966 . . . . 0.0 109.32 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -142.79 146.09 33.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.104 -0.998 . . . . 0.0 110.578 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.696 HG21 HG11 ' A' ' 43' ' ' VAL . 53.7 t -134.74 138.47 49.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.747 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 88.7 mt -117.17 125.65 74.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 118.977 -1.089 . . . . 0.0 110.416 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -128.07 114.22 16.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.806 -0.559 . . . . 0.0 110.325 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -100.89 171.1 22.36 Favored Glycine 0 N--CA 1.484 1.856 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 53.8 t0 -81.14 174.44 11.57 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.493 -1.004 . . . . 0.0 110.013 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.407 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 97.7 mttt -60.02 -26.67 66.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.989 . . . . 0.0 111.656 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.546 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -64.88 -52.11 45.19 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.807 -1.187 . . . . 0.0 110.416 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.944 ' O ' HG22 ' A' ' 88' ' ' VAL . 97.1 mt -64.71 -43.47 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.783 -1.422 . . . . 0.0 108.122 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -63.4 -36.93 85.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.518 -1.364 . . . . 0.0 111.476 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -74.21 -20.92 60.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.845 -1.159 . . . . 0.0 112.166 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.052 HG23 HG13 ' A' ' 88' ' ' VAL . 32.9 m -105.64 -18.51 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.745 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.052 HG13 HG23 ' A' ' 87' ' ' VAL . 4.0 m -119.82 160.28 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 120.67 -1.268 . . . . 0.0 111.47 -178.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.1 m -107.17 176.71 5.08 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.81 0.814 . . . . 0.0 112.005 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -61.86 -36.95 82.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.611 -0.681 . . . . 0.0 109.48 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -62.19 -38.22 88.28 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.422 -0.911 . . . . 0.0 108.922 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.864 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 55.3 t80 -64.05 -26.62 68.64 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.539 -0.726 . . . . 0.0 109.356 178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.747 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.9 m95 -86.95 -25.81 24.17 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.938 0.875 . . . . 0.0 110.989 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -56.92 -36.78 70.59 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.429 -0.795 . . . . 0.0 111.712 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.8 m -64.32 -33.66 76.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.767 -1.208 . . . . 0.0 108.983 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.501 HG22 HD13 ' A' ' 78' ' ' ILE 0.279 7.4 m -59.82 -49.89 75.94 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 122.358 1.075 . . . . 0.0 111.379 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.414 ' O ' ' HB2' ' A' ' 101' ' ' GLN . 99.4 mtt180 -66.69 -38.6 87.09 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.707 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.495 ' O ' HD23 ' A' ' 102' ' ' LEU . 82.0 m-20 -64.01 -45.03 90.78 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.946 -1.102 . . . . 0.0 110.439 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.1 -50.91 72.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.592 -1.318 . . . . 0.0 110.484 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.485 HD12 HD11 ' A' ' 78' ' ' ILE . 86.8 mt -67.81 -42.72 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.905 -1.122 . . . . 0.0 110.17 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 97' ' ' ARG . 57.3 tt0 -62.62 -46.72 86.94 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.516 -0.74 . . . . 0.0 111.086 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 98' ' ' ASN . 4.3 mm? -63.53 -41.54 98.46 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.007 -1.058 . . . . 0.0 112.043 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.462 ' HB2' ' HA3' ' A' ' 112' ' ' GLY . 99.4 mm-40 -72.15 -40.24 68.16 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.176 -1.41 . . . . 0.0 108.594 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -59.26 -40.82 87.2 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.784 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -62.38 -34.55 76.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.311 -0.868 . . . . 0.0 110.928 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -83.6 -17.34 41.99 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.528 -1.357 . . . . 0.0 110.319 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.26 11.38 25.78 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.172 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' A' ' 103' ' ' GLN . 31.7 m120 -107.94 83.0 1.72 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.873 -1.369 . . . . 0.0 110.451 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.591 ' CE2' ' CZ ' ' A' ' 7' ' ' PHE . 6.8 m-85 -62.5 -43.71 98.15 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.151 -0.968 . . . . 0.0 111.026 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.64 ' HE2' ' HB3' ' A' ' 15' ' ' ALA . 60.9 tttm -61.13 -47.85 84.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 0.0 111.446 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -64.1 -37.85 88.94 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.954 -1.091 . . . . 0.0 110.843 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 103' ' ' GLN . . . -62.49 -49.04 77.39 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.496 -1.335 . . . . 0.0 109.823 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 78.9 mt -62.47 -43.96 97.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -1.161 . . . . 0.0 110.926 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.446 HG23 HG12 ' A' ' 16' ' ' ILE . 76.4 t -65.91 -46.82 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.906 -1.121 . . . . 0.0 110.325 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -65.01 -40.1 94.39 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.538 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.89 -43.74 93.21 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.3 mt -64.51 -44.33 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -1.14 . . . . 0.0 109.368 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -58.98 -49.08 79.25 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.045 -1.034 . . . . 0.0 109.632 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.34 -41.21 98.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.205 -0.934 . . . . 0.0 109.447 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.417 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -57.58 -42.04 82.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.202 -0.937 . . . . 0.0 110.072 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.59 -43.56 96.32 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 120.053 -1.07 . . . . 0.0 110.67 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 96.6 mtp -68.33 -45.37 73.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.914 -1.345 . . . . 0.0 110.285 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.864 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -63.56 -45.93 88.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.118 -0.989 . . . . 0.0 108.761 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.417 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 72.7 mt -61.87 -40.5 95.58 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.47 -34.08 56.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 110.4 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.58 -44.65 93.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.002 -1.061 . . . . 0.0 109.366 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -71.54 -41.47 69.09 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.45 0.643 . . . . 0.0 109.65 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.43 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 47.6 m-85 -130.54 97.69 21.35 Favored Pre-proline 0 C--N 1.307 -1.251 0 O-C-N 121.514 -0.741 . . . . 0.0 109.828 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 128' ' ' PHE . 42.0 Cg_endo -65.75 152.87 80.39 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.575 1.303 . . . . 0.0 110.707 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.481 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 47.7 t90 -76.57 127.07 32.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.556 -0.715 . . . . 0.0 110.689 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -103.35 146.96 27.69 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.151 -0.968 . . . . 0.0 109.041 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -56.71 -28.44 60.96 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.103 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.4 p30 -93.68 6.76 47.26 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.012 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 135' ' ' ILE . 67.1 t0 -42.55 140.24 1.31 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.705 0.764 . . . . 0.0 111.622 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.754 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -115.38 146.08 20.28 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 CA-C-O 121.576 0.703 . . . . 0.0 110.891 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -103.23 97.45 7.53 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.356 -1.465 . . . . 0.0 110.58 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -68.14 -35.72 78.56 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.686 HD23 ' CD ' ' A' ' 32' ' ' ARG . 7.1 mp -110.87 151.06 42.69 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.895 -1.128 . . . . 0.0 111.923 -178.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -72.48 -174.69 1.52 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 N-CA-C 108.448 -1.405 . . . . 0.0 108.448 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.425 ' ND2' ' OE1' ' A' ' 24' ' ' GLU . 10.5 m120 -123.02 2.51 9.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.592 -1.318 . . . . 0.0 110.116 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -58.2 170.25 0.71 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.934 -1.104 . . . . 0.0 111.348 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.451 HG12 ' CG2' ' A' ' 17' ' ' VAL . 49.6 mm -95.17 133.17 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.66 -0.65 . . . . 0.0 111.039 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 69.5 m -93.08 131.24 38.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.534 -0.729 . . . . 0.0 109.093 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -127.03 135.99 51.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.884 -1.135 . . . . 0.0 110.591 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.398 0 CA-C-O 117.935 -1.481 . . . . 0.0 109.72 -179.768 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptm . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.148 0.499 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.0 t -63.16 -44.18 96.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 110.852 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -126.25 126.55 44.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.295 -0.878 . . . . 0.0 110.314 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 96.0 mt -119.92 131.83 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.089 -1.007 . . . . 0.0 110.232 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -101.59 54.74 0.82 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.2 -0.938 . . . . 0.0 110.703 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 6' ' ' GLU . 76.2 tt0 55.04 23.04 4.83 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.358 -0.839 . . . . 0.0 110.304 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.692 ' CE2' HD12 ' A' ' 8' ' ' LEU . 26.6 t80 -78.02 -80.28 0.11 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.009 -1.057 . . . . 0.0 109.892 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.692 HD12 ' CE2' ' A' ' 7' ' ' PHE . 90.8 mt -132.4 150.87 52.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.891 . . . . 0.0 110.226 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.0 p -78.06 169.95 17.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.099 -1.001 . . . . 0.0 109.383 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 14' ' ' LYS . . . -54.73 -39.73 68.55 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.797 -1.19 . . . . 0.0 109.422 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -62.8 -40.36 97.12 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.473 -0.767 . . . . 0.0 109.51 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.42 ' CB ' ' HB3' ' A' ' 8' ' ' LEU . 97.5 mt-10 -73.62 -46.59 45.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.105 -0.997 . . . . 0.0 110.696 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.736 ' O ' HG23 ' A' ' 17' ' ' VAL . 96.8 mt-10 -67.04 -34.56 77.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.112 -0.993 . . . . 0.0 110.265 178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 87.6 tttt -64.77 -44.7 89.19 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.753 -1.217 . . . . 0.0 110.075 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.94 -47.02 79.18 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.134 -0.979 . . . . 0.0 111.409 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.405 HG22 ' O ' ' A' ' 13' ' ' GLU . 20.4 tt -64.06 -36.25 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.773 -1.205 . . . . 0.0 110.174 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 13' ' ' GLU . 55.4 t -61.28 -38.36 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -64.25 -36.18 83.25 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.775 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.98 -40.15 94.64 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.06 -1.025 . . . . 0.0 109.566 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.768 HG22 ' OD1' ' A' ' 140' ' ' ASN . 83.6 mt -63.14 -43.79 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 109.399 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -62.2 -43.72 98.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.45 -0.781 . . . . 0.0 110.694 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -63.08 -38.9 93.04 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.162 -0.961 . . . . 0.0 111.41 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.9 -37.89 88.74 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.206 -0.997 . . . . 0.0 109.291 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.2 -15.99 29.22 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.101 -0.999 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.478 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 75.5 mmtt -94.88 -3.6 48.48 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.013 -1.054 . . . . 0.0 109.544 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -108.69 -13.48 14.79 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 121.176 -0.953 . . . . 0.0 109.813 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.8 t -156.35 161.15 40.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.014 -1.054 . . . . 0.0 110.049 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.3 m -87.21 -12.13 47.73 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.371 -0.831 . . . . 0.0 108.78 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.39 167.09 40.89 Favored Glycine 0 N--CA 1.477 1.394 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.557 ' OE1' HD12 ' A' ' 138' ' ' LEU . 97.8 mt-10 -135.59 141.6 45.16 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 118.9 -1.12 . . . . 0.0 112.229 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.6 mt -123.61 135.77 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.237 0.541 . . . . 0.0 110.547 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.451 ' NH1' HD13 ' A' ' 54' ' ' LEU . 68.8 ttt180 -139.88 163.06 33.65 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.198 -0.939 . . . . 0.0 109.746 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 p -131.97 142.4 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.157 -0.964 . . . . 0.0 111.687 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.419 ' HA ' ' O ' ' A' ' 143' ' ' SER . 81.7 t60 -126.98 125.56 41.7 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.452 -0.78 . . . . 0.0 109.442 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.615 HD22 ' CG ' ' A' ' 7' ' ' PHE . 47.5 tp -108.4 128.56 54.88 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 122.07 0.938 . . . . 0.0 112.019 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.41 ' OE2' ' CZ ' ' A' ' 46' ' ' ARG . 82.2 tt0 -144.87 159.68 42.51 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 97.8 mttt -79.32 -75.66 0.24 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.063 -1.023 . . . . 0.0 112.94 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.6 t -136.57 155.34 50.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.299 -0.876 . . . . 0.0 110.214 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.5 p -103.77 170.79 7.72 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.415 -0.803 . . . . 0.0 110.365 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.414 ' OE1' ' N ' ' A' ' 40' ' ' GLU . 56.0 mp0 -108.37 -12.61 15.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.472 -0.768 . . . . 0.0 110.414 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.8 pt -124.31 -122.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.149 -0.969 . . . . 0.0 108.586 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -111.84 140.81 46.18 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 120.434 -1.416 . . . . 0.0 109.687 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.498 ' CG1' HG21 ' A' ' 77' ' ' VAL . 94.4 t -64.15 -42.74 96.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.372 -0.83 . . . . 0.0 110.683 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -59.92 -46.75 88.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.955 -1.091 . . . . 0.0 109.938 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -69.81 -36.8 75.96 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.79 -1.194 . . . . 0.0 108.772 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.41 ' CZ ' ' OE2' ' A' ' 36' ' ' GLU . 61.3 ttt85 -64.1 -42.85 96.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -0.916 . . . . 0.0 110.949 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.6 83.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.722 -1.236 . . . . 0.0 110.499 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 60.2 ttp -62.89 -42.28 99.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.034 -1.042 . . . . 0.0 108.975 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -65.88 -44.7 84.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.137 -0.977 . . . . 0.0 110.361 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.44 -43.44 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.365 -0.834 . . . . 0.0 110.411 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 2.9 t80 -58.77 -47.92 83.0 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.7 -1.25 . . . . 0.0 108.996 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -72.16 -35.66 69.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.043 -1.036 . . . . 0.0 109.703 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -60.54 -39.35 87.57 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.451 HD13 ' NH1' ' A' ' 32' ' ' ARG . 85.6 mt -80.2 5.26 15.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.155 -0.966 . . . . 0.0 110.361 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 55.76 33.94 22.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.818 -1.176 . . . . 0.0 111.926 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.824 ' SD ' HD13 ' A' ' 66' ' ' LEU . 94.1 mtp -65.55 -11.01 40.04 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.988 -1.07 . . . . 0.0 110.236 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -77.53 0.57 22.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.819 -1.176 . . . . 0.0 110.284 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -74.57 62.25 1.01 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.851 -1.156 . . . . 0.0 110.062 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.41 ' OG1' ' HA ' ' A' ' 62' ' ' GLN . 65.3 p -135.19 148.47 49.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.107 -0.996 . . . . 0.0 109.631 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -64.44 -40.98 96.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.75 -0.594 . . . . 0.0 112.276 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 95.7 mt -98.66 -0.15 43.53 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.904 -1.122 . . . . 0.0 111.448 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.41 ' HA ' ' OG1' ' A' ' 59' ' ' THR . 85.7 mt-30 57.71 45.77 18.38 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 122.5 1.143 . . . . 0.0 111.148 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.423 ' HA ' HG13 ' A' ' 84' ' ' ILE . 38.0 p30 -118.96 53.61 1.0 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.072 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.39 140.98 15.13 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.512 HG23 ' CD1' ' A' ' 84' ' ' ILE . 67.3 t -125.55 134.74 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.043 -1.269 . . . . 0.0 110.34 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.824 HD13 ' SD ' ' A' ' 56' ' ' MET . 38.5 tp -117.51 133.68 55.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.339 -0.851 . . . . 0.0 110.24 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.2 mt -106.82 108.83 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 118.75 -1.18 . . . . 0.0 109.557 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -95.45 117.71 30.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 110.181 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.1 t -118.19 128.34 75.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 121.726 0.774 . . . . 0.0 110.356 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.574 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -95.26 88.49 5.17 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.473 ' HB ' HD11 ' A' ' 35' ' ' LEU . 7.2 p -58.73 -23.81 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.036 -1.04 . . . . 0.0 110.907 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 47.7 tp10 -67.73 -41.89 82.73 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.779 -1.2 . . . . 0.0 108.85 178.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.635 ' O ' HG23 ' A' ' 75' ' ' THR . 40.5 t0 -104.77 8.6 34.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.053 -1.03 . . . . 0.0 111.259 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 104' ' ' PHE . 85.3 tttt 52.12 45.17 28.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.875 -1.141 . . . . 0.0 110.407 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 73' ' ' ASP . 46.8 p -122.33 159.15 28.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.803 -1.186 . . . . 0.0 109.135 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -141.53 148.37 39.24 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.21 -0.932 . . . . 0.0 110.364 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.498 HG21 ' CG1' ' A' ' 43' ' ' VAL . 66.1 t -134.19 137.13 52.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.716 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 75.8 mt -113.74 127.83 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.859 -1.151 . . . . 0.0 110.174 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -135.02 114.67 12.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.576 -0.702 . . . . 0.0 110.624 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -99.77 171.47 23.88 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.474 ' OD1' ' CE1' ' A' ' 51' ' ' PHE . 78.1 m-20 -75.33 171.28 14.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.399 -1.059 . . . . 0.0 110.653 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -58.64 -26.46 63.78 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.592 -0.692 . . . . 0.0 110.444 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.408 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -66.1 -53.34 30.48 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.981 ' O ' HG22 ' A' ' 88' ' ' VAL . 87.6 mt -63.51 -44.74 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.944 -1.327 . . . . 0.0 107.893 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -62.21 -36.87 83.26 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.833 -1.167 . . . . 0.0 111.396 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -70.63 -24.26 62.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.861 -1.15 . . . . 0.0 111.78 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.865 HG23 HG13 ' A' ' 88' ' ' VAL . 25.7 m -105.74 -16.45 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 120.642 -1.286 . . . . 0.0 112.909 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.981 HG22 ' O ' ' A' ' 84' ' ' ILE . 18.8 m -116.45 162.07 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 120.338 -1.476 . . . . 0.0 112.002 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.3 t -109.41 174.46 5.86 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.597 0.713 . . . . 0.0 111.809 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 33.0 p-10 -61.61 -35.85 79.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 110.147 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -62.42 -40.59 97.03 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.821 -1.174 . . . . 0.0 109.781 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.854 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 87.8 t80 -63.15 -25.52 68.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.123 -0.985 . . . . 0.0 109.333 178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.716 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.2 m95 -86.88 -24.64 24.82 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.955 0.883 . . . . 0.0 110.876 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -57.1 -38.81 73.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.063 -1.023 . . . . 0.0 112.455 -177.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.9 p -63.61 -31.84 73.14 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.53 -1.268 . . . . 0.0 109.199 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.444 ' CG2' HD13 ' A' ' 78' ' ' ILE 0.272 15.1 m -59.93 -48.06 83.22 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.379 1.085 . . . . 0.0 111.031 179.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -68.98 -38.57 79.41 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.25 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -64.03 -44.26 93.08 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.827 -1.171 . . . . 0.0 110.669 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.88 -49.77 73.54 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.832 -1.167 . . . . 0.0 111.348 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 91.4 mt -67.34 -42.42 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.073 -1.017 . . . . 0.0 110.329 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -65.16 -40.92 95.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.243 -0.911 . . . . 0.0 110.602 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.8 tp -62.22 -42.13 99.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.209 -0.932 . . . . 0.0 111.13 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.447 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 95.8 mm-40 -76.9 -40.0 48.89 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.136 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.415 ' O ' ' CE ' ' A' ' 74' ' ' LYS . 2.8 m-85 -58.41 -41.82 85.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.145 -0.972 . . . . 0.0 108.55 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.43 -32.12 73.47 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.635 -0.665 . . . . 0.0 110.444 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -78.69 -20.07 51.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.741 -1.225 . . . . 0.0 109.911 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.17 4.7 41.15 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.41 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -103.66 86.31 2.6 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.743 -1.445 . . . . 0.0 110.097 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -61.62 -43.03 99.62 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.371 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -61.71 -47.95 82.96 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.97 -1.081 . . . . 0.0 111.377 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -64.55 -38.11 89.87 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.21 -0.932 . . . . 0.0 110.488 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.447 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -63.84 -49.54 67.4 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.51 -44.73 93.46 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.145 -1.209 . . . . 0.0 110.959 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.416 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 71.1 t -65.03 -47.77 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.137 -0.977 . . . . 0.0 110.115 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -62.84 -40.88 98.77 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.922 -1.111 . . . . 0.0 110.571 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.29 -42.24 97.23 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -43.99 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.228 -1.16 . . . . 0.0 109.698 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 114' ' ' VAL . 80.5 mm-40 -58.28 -54.62 44.93 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.05 -1.031 . . . . 0.0 110.597 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.34 -39.97 92.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.122 -0.986 . . . . 0.0 108.691 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.55 -41.58 90.41 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.312 -0.867 . . . . 0.0 109.713 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.17 -44.3 97.34 Favored Glycine 0 N--CA 1.495 2.607 0 O-C-N 120.761 -1.212 . . . . 0.0 111.01 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 64.6 ttp -67.91 -48.03 67.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.874 -1.368 . . . . 0.0 109.898 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.854 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -59.99 -46.52 89.19 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.058 -1.026 . . . . 0.0 109.234 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.96 -41.01 97.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 109.45 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.14 -32.23 54.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 110.335 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.77 -44.41 96.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.129 -0.982 . . . . 0.0 109.848 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -72.37 -41.79 65.97 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.537 0.684 . . . . 0.0 110.276 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -132.05 100.71 15.55 Favored Pre-proline 0 C--N 1.304 -1.404 0 O-C-N 121.54 -0.725 . . . . 0.0 109.657 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.42 150.72 80.78 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.57 1.3 . . . . 0.0 110.932 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.478 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 60.3 t90 -75.13 133.84 41.42 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.645 -0.659 . . . . 0.0 110.546 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -114.06 153.59 29.16 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 109.495 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.44 -28.98 65.77 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.035 -1.04 . . . . 0.0 110.63 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -93.3 7.54 43.96 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.311 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.401 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 52.2 t0 -42.43 138.43 1.78 Allowed 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.77 0.795 . . . . 0.0 111.361 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.712 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -114.36 148.2 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 121.896 0.855 . . . . 0.0 111.967 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -108.55 96.03 6.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.641 -1.287 . . . . 0.0 110.382 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.424 ' N ' ' OE2' ' A' ' 30' ' ' GLU . 81.2 mm-40 -67.81 -32.31 72.77 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.594 -0.692 . . . . 0.0 111.662 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.557 HD12 ' OE1' ' A' ' 30' ' ' GLU . 33.7 mt -110.06 154.46 42.72 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.185 -0.947 . . . . 0.0 111.856 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -79.4 -167.27 0.48 Allowed 'Trans proline' 0 C--N 1.319 -1.014 0 N-CA-C 108.436 -1.409 . . . . 0.0 108.436 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.768 ' OD1' HG22 ' A' ' 20' ' ' ILE . 65.9 m-80 -124.0 3.21 8.69 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.468 -1.395 . . . . 0.0 110.392 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.3 p -63.24 166.75 5.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.884 -1.135 . . . . 0.0 111.13 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.8 mt -96.09 137.87 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.823 -0.548 . . . . 0.0 110.258 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 32' ' ' ARG . 25.1 t -96.35 137.23 35.73 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.208 -0.933 . . . . 0.0 109.713 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -128.13 145.15 51.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.004 -1.06 . . . . 0.0 110.284 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.903 0 CA-C-O 117.972 -1.46 . . . . 0.0 110.296 179.898 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.8 mtp . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 121.414 0.626 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.0 t -138.73 157.87 45.28 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.41 -0.807 . . . . 0.0 110.674 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -82.74 125.44 31.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 109.773 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.2 pt -78.72 -19.62 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.097 -1.002 . . . . 0.0 110.412 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -90.47 30.4 1.15 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.103 -0.998 . . . . 0.0 111.602 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -68.15 -35.9 78.8 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.169 -1.012 . . . . 0.0 109.527 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.739 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 65.0 m-85 -62.83 -43.47 98.72 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.19 -0.944 . . . . 0.0 111.601 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.528 HD22 ' CG ' ' A' ' 110' ' ' LYS . 79.1 mt -127.63 149.97 49.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.922 . . . . 0.0 110.238 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 p -85.77 164.67 17.45 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.073 -1.017 . . . . 0.0 108.782 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.59 -37.03 65.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.948 -1.095 . . . . 0.0 109.864 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -60.87 -45.46 94.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 110.498 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -70.02 -45.38 67.33 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.239 -0.913 . . . . 0.0 110.8 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.68 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.1 mt-10 -64.18 -37.18 86.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.111 -0.993 . . . . 0.0 110.384 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -66.0 -44.0 86.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.968 -1.082 . . . . 0.0 111.959 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.18 -44.4 88.56 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.747 -1.221 . . . . 0.0 111.106 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.487 HG13 HG22 ' A' ' 114' ' ' VAL . 17.2 tt -65.92 -34.69 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.848 -1.158 . . . . 0.0 109.917 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.707 HG13 ' ND2' ' A' ' 140' ' ' ASN . 55.1 t -63.65 -40.49 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.88 -36.64 83.99 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.441 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.82 -38.71 91.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.205 -0.934 . . . . 0.0 108.904 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.448 ' CG2' ' HB2' ' A' ' 140' ' ' ASN . 30.5 mm -62.87 -43.66 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.401 -0.812 . . . . 0.0 108.9 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.95 -43.3 98.92 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.542 -0.723 . . . . 0.0 109.976 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -64.71 -39.26 93.35 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.26 -0.9 . . . . 0.0 111.258 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.95 -39.27 93.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.045 -1.034 . . . . 0.0 109.616 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.12 -17.62 41.52 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.026 -1.046 . . . . 0.0 110.126 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.5 mttt -93.61 -3.3 52.84 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 121.178 -0.951 . . . . 0.0 109.733 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -107.57 -15.49 14.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.905 -1.122 . . . . 0.0 109.885 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.6 t -152.75 160.54 43.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.036 -1.04 . . . . 0.0 109.732 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.9 p -86.96 -8.73 56.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.959 -1.088 . . . . 0.0 109.534 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.66 170.84 42.28 Favored Glycine 0 N--CA 1.482 1.725 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 138' ' ' LEU . 78.6 mm-40 -131.35 137.07 48.59 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.526 -0.985 . . . . 0.0 111.342 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -121.23 134.1 65.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.804 -0.56 . . . . 0.0 109.8 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -137.49 151.09 48.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.129 -0.982 . . . . 0.0 109.65 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.862 HG22 HD12 ' A' ' 67' ' ' ILE . 55.6 t -121.7 138.06 53.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.545 -0.722 . . . . 0.0 110.791 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.481 ' HB2' HD11 ' A' ' 66' ' ' LEU . 60.3 t60 -123.18 127.01 48.05 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.968 HD11 ' CG1' ' A' ' 71' ' ' VAL . 32.5 tp -113.93 125.81 54.46 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.85 0.833 . . . . 0.0 111.832 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 85.0 tt0 -143.22 161.75 37.44 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.411 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 98.5 mttt -77.35 -71.36 0.41 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.994 -1.066 . . . . 0.0 113.469 -177.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.418 ' CG2' ' OE1' ' A' ' 72' ' ' GLU . 8.0 t -140.13 159.01 43.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 110.462 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.9 m -107.1 164.72 11.92 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.824 -0.547 . . . . 0.0 110.128 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -105.8 -11.04 16.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.146 -0.971 . . . . 0.0 110.315 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.8 pt -125.13 -122.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.912 -1.118 . . . . 0.0 109.075 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -110.89 140.39 45.4 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.073 -1.642 . . . . 0.0 109.204 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.606 ' CG1' HG21 ' A' ' 77' ' ' VAL . 91.4 t -64.61 -42.92 96.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.283 -0.886 . . . . 0.0 110.986 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -59.43 -47.0 87.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.97 -1.081 . . . . 0.0 110.917 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -69.09 -39.0 79.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.59 -1.319 . . . . 0.0 108.359 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -59.78 -44.11 94.07 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.44 -0.788 . . . . 0.0 110.548 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.71 -36.98 85.15 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.887 -1.133 . . . . 0.0 110.006 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.4 ttp -62.77 -43.46 98.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.936 . . . . 0.0 109.402 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -65.76 -42.13 91.27 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.774 -1.204 . . . . 0.0 110.296 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.9 t -69.0 -43.21 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.246 -0.909 . . . . 0.0 110.777 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.466 ' CD1' ' HB2' ' A' ' 56' ' ' MET . 2.0 t80 -59.2 -46.65 87.86 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.758 -1.214 . . . . 0.0 108.929 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -74.48 -35.86 63.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.144 -0.972 . . . . 0.0 109.858 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -61.45 -38.39 87.03 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.172 -0.955 . . . . 0.0 109.782 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.1 mt -80.21 5.89 13.32 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.362 -0.836 . . . . 0.0 110.336 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.1 mttt 54.67 30.6 13.66 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 120.877 -1.139 . . . . 0.0 110.532 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.466 ' HB2' ' CD1' ' A' ' 51' ' ' PHE . 98.4 mtp -64.75 -12.25 45.22 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.938 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -75.89 -0.54 21.71 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.751 -1.218 . . . . 0.0 110.509 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -76.2 64.42 2.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.763 -1.211 . . . . 0.0 110.224 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.559 HG22 ' HB3' ' A' ' 137' ' ' GLU . 76.3 p -135.4 149.58 49.68 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.288 -0.882 . . . . 0.0 109.622 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.72 -43.28 96.99 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.445 ' HB2' ' ND2' ' A' ' 63' ' ' ASN . 95.8 mt -99.11 1.47 45.14 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.814 -1.179 . . . . 0.0 111.643 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 56.01 45.63 23.38 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 122.734 1.254 . . . . 0.0 110.803 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.445 ' ND2' ' HB2' ' A' ' 61' ' ' LEU . 24.6 p30 -118.05 55.25 0.89 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.238 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.99 142.87 15.66 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.527 HG23 ' CD1' ' A' ' 84' ' ' ILE . 61.0 t -127.72 136.19 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.165 -1.197 . . . . 0.0 110.779 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 34' ' ' HIS . 49.7 tp -116.71 127.44 54.39 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.783 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.862 HD12 HG22 ' A' ' 33' ' ' VAL . 90.0 mt -100.84 107.23 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.958 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.547 ' CD1' HG13 ' A' ' 43' ' ' VAL . 61.2 t80 -94.05 115.15 27.44 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.091 -1.006 . . . . 0.0 109.749 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.8 t -117.67 132.46 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 122.09 0.948 . . . . 0.0 111.126 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.601 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -99.37 87.27 3.58 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.968 ' CG1' HD11 ' A' ' 35' ' ' LEU . 28.9 m -58.89 -25.35 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.458 -0.776 . . . . 0.0 111.834 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.418 ' OE1' ' CG2' ' A' ' 38' ' ' THR . 71.3 tt0 -67.14 -43.36 82.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.743 -1.223 . . . . 0.0 108.64 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.448 ' O ' HG23 ' A' ' 75' ' ' THR . 77.1 m-20 -99.64 5.38 45.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.47 -0.769 . . . . 0.0 110.457 178.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.2 tttt 54.47 46.57 24.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.922 -1.111 . . . . 0.0 111.034 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.601 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 33.7 p -121.63 167.74 12.56 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.784 -1.198 . . . . 0.0 109.791 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -147.42 142.07 26.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.149 -0.97 . . . . 0.0 110.706 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.606 HG21 ' CG1' ' A' ' 43' ' ' VAL . 41.4 t -130.11 138.8 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.476 -0.765 . . . . 0.0 109.259 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.658 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 71.1 mt -117.54 126.37 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.804 -1.185 . . . . 0.0 110.248 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -133.25 115.46 15.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.545 -0.722 . . . . 0.0 110.735 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.8 170.74 20.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.441 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 94.2 m-20 -82.67 -178.59 7.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.482 -1.011 . . . . 0.0 110.582 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.67 -26.69 68.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 110.765 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.46 -57.9 14.64 Favored Glycine 0 N--CA 1.485 1.966 0 C-N-CA 119.776 -1.202 . . . . 0.0 110.522 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.978 ' O ' HG22 ' A' ' 88' ' ' VAL . 79.3 mt -64.97 -44.52 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.801 -1.411 . . . . 0.0 108.917 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -61.47 -38.37 87.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.082 -1.011 . . . . 0.0 111.455 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -72.15 -19.4 61.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.915 -1.115 . . . . 0.0 112.23 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.993 HG23 HG13 ' A' ' 88' ' ' VAL . 12.8 m -108.27 -17.91 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.784 -1.198 . . . . 0.0 112.536 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.993 HG13 HG23 ' A' ' 87' ' ' VAL . 18.8 m -120.8 160.43 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.674 -1.266 . . . . 0.0 111.397 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.0 p -108.18 -175.5 2.79 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.956 0.884 . . . . 0.0 112.552 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -63.41 -35.63 81.07 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.662 -0.649 . . . . 0.0 109.74 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -62.3 -38.47 89.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 109.321 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.779 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 72.7 t80 -66.79 -27.64 67.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.563 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.658 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 7.3 m95 -86.06 -29.46 23.39 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.06 0.933 . . . . 0.0 110.254 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -55.83 -40.07 72.27 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.554 -0.716 . . . . 0.0 112.225 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 69.3 p -64.77 -30.46 71.47 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.412 -1.315 . . . . 0.0 108.594 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.525 ' CG2' HD13 ' A' ' 78' ' ' ILE 0.262 7.6 m -59.91 -49.43 77.73 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 122.333 1.063 . . . . 0.0 111.092 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -69.27 -37.9 78.12 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.941 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -63.85 -42.88 97.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.912 -1.117 . . . . 0.0 110.454 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.11 -48.6 73.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.736 -1.228 . . . . 0.0 110.927 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.4 mt -67.0 -42.7 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.845 -1.159 . . . . 0.0 110.175 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -61.78 -42.12 98.6 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.448 -0.782 . . . . 0.0 110.957 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.9 tp -63.81 -43.19 97.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.095 -1.003 . . . . 0.0 112.319 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.458 ' HB3' ' CA ' ' A' ' 112' ' ' GLY . 5.0 tp60 -76.07 -38.67 56.81 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.322 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -61.98 -41.4 97.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.016 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.51 -33.62 75.25 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.767 -0.583 . . . . 0.0 110.472 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -77.23 -18.29 57.78 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.981 -1.075 . . . . 0.0 109.499 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.8 2.52 42.89 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.714 -1.232 . . . . 0.0 111.393 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -100.22 91.32 4.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.669 -1.489 . . . . 0.0 109.972 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -62.04 -44.93 95.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.624 -0.673 . . . . 0.0 111.812 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.528 ' CG ' HD22 ' A' ' 8' ' ' LEU . 5.0 mppt? -62.64 -47.17 84.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.846 -1.159 . . . . 0.0 112.322 -177.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.419 ' CB ' ' HG2' ' A' ' 103' ' ' GLN . 89.1 mm-40 -64.33 -37.85 88.95 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.725 -1.234 . . . . 0.0 110.634 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.458 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -65.03 -50.68 56.58 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.42 -1.371 . . . . 0.0 109.899 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.4 ' HB3' HD11 ' A' ' 16' ' ' ILE . 32.6 mt -62.6 -45.15 94.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.147 -1.208 . . . . 0.0 110.405 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.487 HG22 HG13 ' A' ' 16' ' ' ILE . 79.0 t -64.47 -48.02 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.001 -1.062 . . . . 0.0 110.736 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.06 -41.48 97.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.046 -1.034 . . . . 0.0 110.215 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.25 -40.58 98.78 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 75.9 mt -63.69 -44.03 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -1.072 . . . . 0.0 109.709 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -58.9 -45.12 91.03 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.052 -1.03 . . . . 0.0 109.027 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.35 -41.63 98.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.364 -0.835 . . . . 0.0 109.066 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.502 ' O ' HD12 ' A' ' 124' ' ' LEU . . . -59.82 -43.53 94.5 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.434 -0.791 . . . . 0.0 109.942 178.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.13 -45.55 86.22 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 120.352 -0.927 . . . . 0.0 110.84 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 99.1 mmm -66.24 -44.96 82.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.979 -1.306 . . . . 0.0 109.655 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.779 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -64.53 -46.18 84.0 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.427 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 120' ' ' ALA . 52.1 mt -62.55 -39.12 92.61 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.398 -0.813 . . . . 0.0 108.884 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.27 -35.18 62.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.161 -0.962 . . . . 0.0 110.794 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.8 -39.45 88.96 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.825 -1.172 . . . . 0.0 109.774 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -84.05 -34.6 24.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.5 -0.75 . . . . 0.0 110.328 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -125.93 96.6 37.14 Favored Pre-proline 0 C--N 1.303 -1.422 0 O-C-N 121.2 -0.938 . . . . 0.0 109.128 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.88 149.04 65.55 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 O-C-N 123.866 1.456 . . . . 0.0 110.047 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.476 ' CD1' ' OD2' ' A' ' 134' ' ' ASP . 59.7 t90 -75.52 131.08 39.83 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.245 -0.91 . . . . 0.0 110.731 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -110.17 150.33 28.8 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 108.912 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.06 -29.4 65.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.996 -1.065 . . . . 0.0 110.414 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -92.34 8.39 38.61 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.817 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.476 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 66.2 t0 -42.32 138.02 1.84 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.304 -0.873 . . . . 0.0 111.995 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.771 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.3 pp -115.9 152.96 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.533 0.683 . . . . 0.0 111.131 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -113.59 99.35 7.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.832 -1.168 . . . . 0.0 110.041 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.559 ' HB3' HG22 ' A' ' 59' ' ' THR . 79.9 mm-40 -67.95 -39.46 83.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.685 -0.635 . . . . 0.0 112.267 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -105.27 152.11 39.75 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.144 -0.972 . . . . 0.0 111.498 -178.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -76.64 -166.57 0.39 Allowed 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.528 1.278 . . . . 0.0 108.786 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.707 ' ND2' HG13 ' A' ' 17' ' ' VAL . 1.1 p-10 -122.98 2.48 9.35 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.834 -1.166 . . . . 0.0 109.94 178.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.8 m -64.66 135.9 56.4 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.832 -1.167 . . . . 0.0 111.432 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.9 mt -70.93 138.59 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.669 -0.644 . . . . 0.0 109.73 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.427 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 32.2 t -98.98 100.01 11.13 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.075 -1.015 . . . . 0.0 109.717 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.436 ' HG2' ' HB3' ' A' ' 35' ' ' LEU . 98.9 mttt -100.67 147.58 25.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.827 -1.171 . . . . 0.0 109.038 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 CA-C-O 118.018 -1.434 . . . . 0.0 109.62 -179.808 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.5 mtm . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.24 0.543 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.2 p -63.88 -36.79 85.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 110.055 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.9 -41.38 99.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 110.028 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.5 pt -92.65 -9.12 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.176 -0.953 . . . . 0.0 110.926 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -66.13 -44.58 83.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.822 -1.173 . . . . 0.0 110.503 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -109.29 120.21 41.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.037 -1.039 . . . . 0.0 110.03 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.588 ' CZ ' ' CD2' ' A' ' 109' ' ' PHE . 10.1 t80 -61.66 -47.6 84.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.37 -0.831 . . . . 0.0 110.455 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.918 HD13 ' HD3' ' A' ' 110' ' ' LYS . 75.0 mt -129.16 151.55 49.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.811 . . . . 0.0 109.531 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 10' ' ' ALA . 71.9 m -79.77 163.56 24.36 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.739 -1.226 . . . . 0.0 110.637 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.404 ' N ' HG22 ' A' ' 9' ' ' THR . . . -58.8 -37.53 76.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 109.825 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -49.88 -60.92 2.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -0.855 . . . . 0.0 110.611 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.459 ' HB3' ' HG2' ' A' ' 110' ' ' LYS . 98.6 mt-10 -63.37 -40.94 98.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.576 -0.703 . . . . 0.0 110.962 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.7 mt-10 -62.61 -37.22 85.41 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.972 -1.08 . . . . 0.0 110.462 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -64.12 -44.35 92.49 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.903 -1.123 . . . . 0.0 110.276 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.93 -41.59 99.53 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.231 -0.918 . . . . 0.0 111.123 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.778 HG13 HG22 ' A' ' 114' ' ' VAL . 19.6 tt -68.36 -27.36 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.854 -1.154 . . . . 0.0 110.19 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 13' ' ' GLU . 71.1 t -66.69 -41.13 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.08 -35.06 79.51 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.652 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.66 94.12 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.265 -0.897 . . . . 0.0 109.547 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.426 ' CG2' ' HB2' ' A' ' 140' ' ' ASN . 96.6 mt -64.52 -43.38 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.14 -0.975 . . . . 0.0 110.102 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -61.21 -41.0 96.08 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.45 -0.782 . . . . 0.0 109.716 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -64.53 -38.24 90.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.544 -0.722 . . . . 0.0 111.302 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.74 -39.72 94.11 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.957 -1.089 . . . . 0.0 109.508 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -59.56 -16.55 25.93 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.025 -1.047 . . . . 0.0 110.618 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 97.3 mttt -95.0 -0.57 53.68 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.144 -0.973 . . . . 0.0 109.197 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -111.07 -15.36 13.73 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 120.903 -1.123 . . . . 0.0 110.151 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.7 t -152.91 158.6 42.36 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.045 -1.034 . . . . 0.0 110.061 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 97.6 p -87.29 -10.13 53.15 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.322 -0.861 . . . . 0.0 109.819 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.13 170.62 37.33 Favored Glycine 0 N--CA 1.48 1.571 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.64 ' HB3' HD12 ' A' ' 138' ' ' LEU . 80.9 mm-40 -130.54 134.01 46.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.231 -1.158 . . . . 0.0 111.524 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.8 mt -121.34 134.92 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-O 121.393 0.615 . . . . 0.0 110.097 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.742 ' CD ' HD13 ' A' ' 138' ' ' LEU . 84.0 mtp180 -137.46 153.49 50.08 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.802 HG12 HD12 ' A' ' 67' ' ' ILE . 27.4 m -121.21 141.19 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 111.417 -177.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.768 ' HB2' HD11 ' A' ' 66' ' ' LEU . 36.7 t60 -125.57 128.19 47.55 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.62 0.724 . . . . 0.0 109.657 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.624 HD11 ' CG1' ' A' ' 71' ' ' VAL . 27.9 tp -117.53 128.96 55.48 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.6 0.714 . . . . 0.0 111.43 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 83.3 tt0 -147.0 166.94 25.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.6 -0.687 . . . . 0.0 109.301 177.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.446 ' HA ' HG22 ' A' ' 71' ' ' VAL . 97.6 mttt -81.83 -76.94 0.23 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.335 -0.853 . . . . 0.0 113.241 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.433 ' HB ' ' HG2' ' A' ' 72' ' ' GLU . 3.9 t -139.9 154.74 47.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.042 -1.036 . . . . 0.0 110.429 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.447 ' CB ' ' HD2' ' A' ' 46' ' ' ARG . 63.7 p -104.74 169.5 8.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.481 -0.762 . . . . 0.0 110.668 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -103.97 -18.31 14.64 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.327 -0.858 . . . . 0.0 109.803 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.7 pt -117.17 -122.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.22 -0.925 . . . . 0.0 109.884 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -112.13 139.79 47.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.129 -1.607 . . . . 0.0 109.996 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.639 ' CG1' HG21 ' A' ' 77' ' ' VAL . 95.0 t -61.3 -44.07 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.284 -0.885 . . . . 0.0 110.994 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -60.43 -46.66 89.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.948 -1.095 . . . . 0.0 110.165 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -70.14 -36.54 74.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.003 -1.061 . . . . 0.0 108.694 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.447 ' HD2' ' CB ' ' A' ' 39' ' ' SER . 59.8 ttt85 -64.83 -41.84 95.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.162 -0.961 . . . . 0.0 110.765 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.1 -36.99 80.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.87 -1.144 . . . . 0.0 110.049 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.0 ttp -62.95 -45.97 89.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.358 -0.839 . . . . 0.0 110.079 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -64.1 -42.12 97.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.991 -1.068 . . . . 0.0 109.461 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 72.4 t -66.44 -43.1 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.346 -0.846 . . . . 0.0 110.323 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.482 ' CE2' ' HE2' ' A' ' 56' ' ' MET . 6.9 t80 -58.98 -46.7 87.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.986 -1.071 . . . . 0.0 108.871 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -72.77 -35.9 67.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.021 -1.049 . . . . 0.0 109.651 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -61.09 -39.24 89.18 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.995 -1.066 . . . . 0.0 109.316 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.9 mt -80.58 3.92 20.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 110.152 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 54.54 33.1 18.24 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.029 -1.044 . . . . 0.0 111.46 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.591 ' SD ' HD13 ' A' ' 66' ' ' LEU . 90.4 mtp -65.44 -12.61 54.05 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.81 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -76.65 -1.88 29.93 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.941 -1.1 . . . . 0.0 109.958 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -75.49 64.22 1.58 Allowed 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.056 -1.028 . . . . 0.0 109.748 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.2 p -135.05 149.7 50.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 109.238 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.26 -41.91 99.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.617 -0.677 . . . . 0.0 112.665 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 84.1 mt -99.62 0.17 41.57 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.796 -1.19 . . . . 0.0 111.743 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.422 ' O ' ' CB ' ' A' ' 81' ' ' ASP . 86.5 mt-30 58.55 46.85 14.22 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.451 1.119 . . . . 0.0 111.028 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -119.98 50.89 1.23 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.402 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.1 142.42 16.11 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.252 -1.939 . . . . 0.0 108.252 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.514 HG23 ' CD1' ' A' ' 84' ' ' ILE . 54.4 t -126.94 134.79 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.993 -1.298 . . . . 0.0 110.401 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.768 HD11 ' HB2' ' A' ' 34' ' ' HIS . 39.2 tp -117.17 125.03 50.56 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.068 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.802 HD12 HG12 ' A' ' 33' ' ' VAL . 98.6 mt -102.69 101.85 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.571 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -88.54 124.32 33.9 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.312 -0.867 . . . . 0.0 110.057 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.614 ' HB ' HD12 ' A' ' 35' ' ' LEU . 69.1 t -119.57 131.87 70.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.909 0.861 . . . . 0.0 110.373 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.505 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -102.46 87.02 2.91 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.624 ' CG1' HD11 ' A' ' 35' ' ' LEU . 34.6 m -60.56 -20.84 21.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.893 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.433 ' HG2' ' HB ' ' A' ' 38' ' ' THR . 49.6 tp10 -70.92 -45.41 64.28 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.092 -1.005 . . . . 0.0 109.097 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.526 ' O ' HG23 ' A' ' 75' ' ' THR . 83.7 m-20 -100.52 5.92 44.18 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.032 -1.043 . . . . 0.0 110.693 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.9 tttt 54.79 46.57 24.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.089 -1.007 . . . . 0.0 111.415 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 73' ' ' ASP . 82.5 p -125.52 157.8 36.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.307 -0.871 . . . . 0.0 109.903 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -138.01 145.85 42.38 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.049 -1.032 . . . . 0.0 110.102 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.639 HG21 ' CG1' ' A' ' 43' ' ' VAL . 55.5 t -132.48 136.09 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.116 -0.99 . . . . 0.0 109.637 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.659 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 81.8 mt -113.12 127.81 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.63 -1.294 . . . . 0.0 110.459 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -130.21 116.19 18.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.592 -0.692 . . . . 0.0 109.998 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.59 166.21 15.87 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.475 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 31.3 m-20 -76.42 175.56 9.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.402 -1.058 . . . . 0.0 110.606 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.409 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 85.9 tttt -60.86 -25.74 66.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.446 -0.783 . . . . 0.0 110.348 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.5 -53.68 30.65 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 120.095 -1.05 . . . . 0.0 110.593 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.968 ' O ' HG22 ' A' ' 88' ' ' VAL . 83.1 mt -64.28 -44.74 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 120.961 -1.317 . . . . 0.0 107.471 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -61.95 -37.79 86.07 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.004 -1.06 . . . . 0.0 111.286 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.409 ' OD2' ' HG2' ' A' ' 82' ' ' LYS . 54.2 m-20 -73.63 -20.28 60.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.836 -1.165 . . . . 0.0 111.88 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.992 HG13 HG13 ' A' ' 88' ' ' VAL . 10.6 p -105.73 -21.61 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.859 -1.151 . . . . 0.0 112.512 -178.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.992 HG13 HG13 ' A' ' 87' ' ' VAL . 17.0 m -118.75 162.45 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 120.602 -1.311 . . . . 0.0 111.708 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.6 p -105.05 177.48 4.84 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.766 0.793 . . . . 0.0 112.108 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -63.74 -37.32 86.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 109.733 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -61.72 -39.27 90.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.229 -0.919 . . . . 0.0 109.382 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.74 ' CE2' ' HB1' ' A' ' 123' ' ' ALA . 30.9 t80 -62.61 -26.63 68.71 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.659 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.6 m95 -84.05 -27.92 27.97 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.722 0.772 . . . . 0.0 110.682 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -56.97 -34.68 68.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.251 -0.905 . . . . 0.0 112.68 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.4 m -64.96 -36.21 83.65 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 118.448 -1.301 . . . . 0.0 109.088 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.443 ' CG2' HD13 ' A' ' 78' ' ' ILE 0.278 8.5 m -57.92 -47.31 83.21 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 122.307 1.051 . . . . 0.0 111.082 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -69.24 -38.8 78.67 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.361 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 91.1 m-20 -63.68 -43.99 95.04 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.675 -1.21 . . . . 0.0 109.988 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.7 -49.11 74.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.764 -1.21 . . . . 0.0 111.016 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 92.7 mt -67.33 -42.93 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.81 -1.181 . . . . 0.0 110.031 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -65.38 -42.41 92.73 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.213 -0.93 . . . . 0.0 110.876 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.734 HD13 ' O ' ' A' ' 102' ' ' LEU . 1.3 tm? -62.49 -41.21 98.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.114 -0.991 . . . . 0.0 111.075 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.484 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 98.6 mm-40 -75.89 -38.54 57.72 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.728 -1.189 . . . . 0.0 108.894 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -61.03 -41.81 97.28 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -63.32 -33.59 75.86 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.926 -0.484 . . . . 0.0 110.641 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -77.43 -18.18 57.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.89 -1.132 . . . . 0.0 109.317 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.38 1.09 31.16 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.752 -1.213 . . . . 0.0 111.003 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -103.47 91.02 3.87 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.635 -1.509 . . . . 0.0 110.853 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.588 ' CD2' ' CZ ' ' A' ' 7' ' ' PHE . 12.0 m-85 -62.58 -44.98 94.96 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.782 -0.574 . . . . 0.0 110.758 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.918 ' HD3' HD13 ' A' ' 8' ' ' LEU . 29.8 tptt -63.85 -48.92 74.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.145 -0.972 . . . . 0.0 112.568 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -61.08 -38.39 86.08 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.525 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.484 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -62.99 -45.26 96.0 Favored Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.608 -1.282 . . . . 0.0 109.947 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.2 mt -64.74 -44.52 89.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.113 -1.227 . . . . 0.0 110.733 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.778 HG22 HG13 ' A' ' 16' ' ' ILE . 99.4 t -64.91 -47.94 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 110.082 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -63.66 -41.42 98.2 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.663 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.59 -43.09 99.74 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.7 -43.42 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.933 -1.334 . . . . 0.0 110.077 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.74 -50.9 71.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 110.164 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -61.92 -42.2 98.82 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.085 -1.009 . . . . 0.0 109.07 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 124' ' ' LEU . . . -57.66 -37.64 73.74 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.385 -0.822 . . . . 0.0 109.43 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.49 -45.37 68.29 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 99.1 mmm -68.16 -42.92 79.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.99 -1.3 . . . . 0.0 110.139 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.74 ' HB1' ' CE2' ' A' ' 92' ' ' PHE . . . -65.9 -47.17 75.71 Favored 'General case' 0 C--O 1.203 -1.39 0 O-C-N 121.169 -0.957 . . . . 0.0 108.846 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 120' ' ' ALA . 78.0 mt -61.99 -39.16 91.26 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.54 -34.18 61.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.19 -0.944 . . . . 0.0 110.487 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -61.2 -41.21 96.43 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.872 -1.142 . . . . 0.0 108.968 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.456 ' CE1' ' CE2' ' A' ' 92' ' ' PHE . 91.8 m-85 -80.25 -36.83 34.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 0.0 110.791 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.638 ' HE2' HG11 ' A' ' 87' ' ' VAL . 88.7 m-85 -129.23 93.01 37.29 Favored Pre-proline 0 C--N 1.304 -1.383 0 O-C-N 121.3 -0.875 . . . . 0.0 109.674 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.98 153.25 78.53 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.85 1.448 . . . . 0.0 111.227 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 49.9 t90 -77.6 132.74 38.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.675 -0.641 . . . . 0.0 111.133 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 75.4 mmtt -112.09 150.22 31.01 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -58.45 -31.23 67.58 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.557 -1.34 . . . . 0.0 111.018 -177.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -89.22 8.08 32.1 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.914 -1.115 . . . . 0.0 110.593 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.469 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 64.9 t0 -43.09 137.9 2.32 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.99 0.9 . . . . 0.0 111.038 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.582 HD13 ' H ' ' A' ' 135' ' ' ILE . 0.1 OUTLIER -111.92 141.98 25.74 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 O-C-N 121.614 -0.679 . . . . 0.0 110.476 -178.025 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -95.57 93.93 7.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.012 -1.055 . . . . 0.0 110.061 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.447 ' HG3' HG12 ' A' ' 135' ' ' ILE . 96.6 mt-10 -69.5 -42.39 74.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.702 -0.624 . . . . 0.0 112.543 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.742 HD13 ' CD ' ' A' ' 32' ' ' ARG . 16.8 mt -106.06 151.19 40.03 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 120.973 -1.08 . . . . 0.0 111.334 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.01 -175.09 1.55 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 N-CA-C 108.948 -1.212 . . . . 0.0 108.948 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.426 ' HB2' ' CG2' ' A' ' 20' ' ' ILE . 21.3 p30 -118.86 4.04 11.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.765 -1.209 . . . . 0.0 110.102 178.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.3 p -62.72 175.12 0.87 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.1 -1.0 . . . . 0.0 110.302 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.506 HG23 HG23 ' A' ' 33' ' ' VAL . 80.5 mt -107.59 141.15 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.482 -0.761 . . . . 0.0 111.462 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.4 t -94.81 133.38 38.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.473 -0.767 . . . . 0.0 109.803 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -127.48 129.37 47.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 110.827 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 118.054 -1.414 . . . . 0.0 109.856 179.576 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.6 mtm . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 121.542 0.687 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 5' ' ' GLU . 98.0 p -62.42 -39.47 93.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.472 -0.768 . . . . 0.0 110.74 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -63.78 -46.59 84.54 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.909 -1.12 . . . . 0.0 111.036 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.1 pt -68.36 -22.21 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.148 -0.97 . . . . 0.0 109.934 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 2' ' ' SER . 84.3 tt0 -63.31 -47.68 81.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.149 -0.969 . . . . 0.0 110.017 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -131.87 128.79 39.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.339 -0.85 . . . . 0.0 109.675 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.591 ' CE1' HG12 ' A' ' 71' ' ' VAL . 36.7 t80 -60.33 -47.36 86.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.311 -0.868 . . . . 0.0 110.486 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.475 ' HG ' ' CD2' ' A' ' 7' ' ' PHE . 87.9 mt -134.28 151.5 51.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.386 -0.821 . . . . 0.0 110.717 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.0 p -79.61 166.49 21.83 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.966 -1.084 . . . . 0.0 109.92 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.61 -38.22 66.54 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.011 -1.056 . . . . 0.0 109.115 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.22 -46.03 86.63 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.673 0.749 . . . . 0.0 110.181 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -69.83 -42.42 73.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.47 -0.769 . . . . 0.0 111.179 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.694 ' O ' HG23 ' A' ' 17' ' ' VAL . 92.4 mt-10 -63.64 -37.42 87.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.142 -0.974 . . . . 0.0 109.892 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.65 -44.81 92.74 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.053 -1.03 . . . . 0.0 110.672 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.67 -44.12 87.27 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.994 -1.067 . . . . 0.0 111.788 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 13' ' ' GLU . 19.3 tt -67.71 -36.52 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.73 -1.231 . . . . 0.0 110.44 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 13' ' ' GLU . 69.2 t -62.42 -39.57 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 21' ' ' ARG . 29.4 t0 -62.87 -35.01 78.58 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.464 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.93 -39.57 95.0 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.322 -0.862 . . . . 0.0 110.104 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.55 -43.85 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.114 -0.991 . . . . 0.0 109.883 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 18' ' ' ASP . 74.7 mtm180 -60.21 -42.04 94.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.872 . . . . 0.0 110.896 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -63.16 -36.2 82.84 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.125 -0.985 . . . . 0.0 110.33 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.6 -39.27 88.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.092 -1.005 . . . . 0.0 110.164 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -60.67 -16.32 37.89 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.943 -1.098 . . . . 0.0 110.851 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.473 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.6 mttt -95.11 -4.2 46.65 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.172 -0.955 . . . . 0.0 109.628 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -105.12 -16.99 14.63 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.068 -1.02 . . . . 0.0 109.462 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.8 t -152.4 161.83 42.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.114 -0.991 . . . . 0.0 109.864 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.1 p -87.81 -7.47 57.22 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.311 -0.868 . . . . 0.0 109.887 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.98 170.4 47.25 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -129.5 132.74 46.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.241 -1.152 . . . . 0.0 111.217 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.2 mt -117.42 134.34 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.693 -0.63 . . . . 0.0 110.147 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.453 ' HB3' ' HE1' ' A' ' 56' ' ' MET . 75.2 ttt180 -139.8 149.36 43.41 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.05 -1.031 . . . . 0.0 110.101 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.738 HG22 HD12 ' A' ' 67' ' ' ILE . 48.3 t -117.44 137.32 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.236 -0.915 . . . . 0.0 111.199 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.829 ' HB2' HD11 ' A' ' 66' ' ' LEU . 15.4 t60 -122.66 125.94 46.61 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.552 HD11 HG13 ' A' ' 71' ' ' VAL . 44.8 tp -115.35 135.85 53.71 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.091 0.948 . . . . 0.0 112.045 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.427 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 81.4 tt0 -150.12 164.33 35.87 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 177.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.56 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.0 mttt -79.48 -74.58 0.28 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.454 -0.779 . . . . 0.0 112.108 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.8 t -140.95 154.93 46.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 109.634 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.432 ' HB2' ' HD2' ' A' ' 46' ' ' ARG . 12.0 p -106.0 168.91 8.81 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.495 -0.753 . . . . 0.0 110.615 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -109.66 -18.54 13.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.116 -0.99 . . . . 0.0 110.83 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.428 HG13 ' N ' ' A' ' 42' ' ' ASP . 32.0 pt -114.06 -123.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.981 -1.075 . . . . 0.0 109.85 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.428 ' N ' HG13 ' A' ' 41' ' ' ILE . 99.3 m-20 -111.77 136.67 50.73 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.461 -1.4 . . . . 0.0 109.727 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.82 -45.21 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.681 -0.637 . . . . 0.0 112.619 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -60.22 -47.17 87.1 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.751 -1.218 . . . . 0.0 110.322 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -71.28 -40.91 70.63 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.927 -1.108 . . . . 0.0 108.992 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HD2' ' HB2' ' A' ' 39' ' ' SER . 66.7 ttt-85 -63.06 -43.51 98.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.128 -0.983 . . . . 0.0 110.891 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.88 85.72 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.544 -1.347 . . . . 0.0 109.428 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.8 ttp -61.69 -41.99 98.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.009 -1.057 . . . . 0.0 108.939 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.86 -44.43 93.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.069 -1.02 . . . . 0.0 109.73 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.46 -43.78 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.417 -0.802 . . . . 0.0 110.533 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.462 ' CE2' ' OD1' ' A' ' 57' ' ' ASP . 64.4 t80 -59.88 -47.39 85.96 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.007 -1.058 . . . . 0.0 109.966 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -74.98 -34.49 61.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.946 -1.096 . . . . 0.0 109.326 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -62.19 -36.62 82.46 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.949 -1.094 . . . . 0.0 109.137 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.19 2.81 26.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.18 -0.95 . . . . 0.0 110.049 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 55.54 33.52 21.25 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 121.142 -0.974 . . . . 0.0 111.892 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.748 ' SD ' HD13 ' A' ' 66' ' ' LEU . 95.7 mtp -66.19 -11.65 51.01 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 118.872 -1.131 . . . . 0.0 109.664 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.462 ' OD1' ' CE2' ' A' ' 51' ' ' PHE . 94.4 m-20 -77.19 -0.59 25.65 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.047 -1.033 . . . . 0.0 109.334 176.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -76.15 62.17 1.68 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.175 -0.953 . . . . 0.0 109.92 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.7 m -132.72 146.33 51.77 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.02 -42.48 99.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.568 -0.708 . . . . 0.0 111.427 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.2 mt -95.57 -0.05 52.41 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.011 -1.055 . . . . 0.0 111.265 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 57.3 45.33 20.4 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.406 1.098 . . . . 0.0 111.187 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -118.74 54.04 0.97 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.253 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.87 139.23 14.31 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.584 HG23 ' CD1' ' A' ' 84' ' ' ILE . 53.8 t -123.78 136.59 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.151 -1.206 . . . . 0.0 110.802 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.829 HD11 ' HB2' ' A' ' 34' ' ' HIS . 38.9 tp -117.89 128.13 54.53 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.347 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.738 HD12 HG22 ' A' ' 33' ' ' VAL . 97.1 mt -104.79 104.75 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 118.876 -1.129 . . . . 0.0 109.467 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -90.12 122.2 32.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.32 -0.863 . . . . 0.0 109.893 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -121.07 134.23 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.066 0.936 . . . . 0.0 110.924 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.517 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -104.44 98.42 8.2 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.591 HG12 ' CE1' ' A' ' 7' ' ' PHE . 33.3 m -66.36 -22.25 29.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.197 -0.939 . . . . 0.0 110.607 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -68.93 -44.06 73.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.033 -1.042 . . . . 0.0 109.542 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 75' ' ' THR . 96.2 m-20 -101.7 4.9 41.09 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.079 -1.013 . . . . 0.0 111.044 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 ttmt 55.5 46.74 22.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.879 -1.138 . . . . 0.0 110.352 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 70.5 p -122.4 165.88 15.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.259 -0.901 . . . . 0.0 109.749 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 46.3 p90 -146.38 146.66 30.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.512 -0.743 . . . . 0.0 110.369 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.1 t -133.78 136.88 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.389 -0.819 . . . . 0.0 109.114 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.646 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 81.6 mt -115.2 127.34 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.617 -1.302 . . . . 0.0 110.713 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -129.96 119.24 22.89 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.745 . . . . 0.0 111.223 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.525 ' HA2' HG22 ' A' ' 65' ' ' VAL . . . -103.28 149.49 17.47 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -62.82 175.28 0.86 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.568 -0.96 . . . . 0.0 110.1 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.84 -26.88 67.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.226 -0.921 . . . . 0.0 111.702 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.76 -53.85 32.12 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.609 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.97 ' O ' HG22 ' A' ' 88' ' ' VAL . 75.0 mt -63.11 -44.82 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.802 -1.411 . . . . 0.0 108.347 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -60.97 -38.51 86.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.966 -1.083 . . . . 0.0 111.627 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -71.0 -22.0 62.22 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.857 -1.152 . . . . 0.0 111.748 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.946 HG23 HG13 ' A' ' 88' ' ' VAL . 23.5 m -104.97 -15.77 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.92 -1.113 . . . . 0.0 112.884 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.97 HG22 ' O ' ' A' ' 84' ' ' ILE . 21.8 m -121.04 163.51 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.591 -1.318 . . . . 0.0 112.089 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.3 m -110.93 178.27 4.4 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.6 0.714 . . . . 0.0 112.158 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 91' ' ' ASP . 33.8 p-10 -63.12 -36.4 83.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 110.059 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 65.8 t0 -62.87 -38.64 91.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.109 -0.994 . . . . 0.0 108.986 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.818 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 78.6 t80 -67.07 -25.28 66.17 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.239 -0.913 . . . . 0.0 109.376 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.646 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.8 m95 -86.5 -23.49 25.92 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.796 0.808 . . . . 0.0 110.36 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -58.1 -36.23 72.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.91 . . . . 0.0 112.057 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.5 p -67.25 -31.28 71.51 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.541 -1.264 . . . . 0.0 108.895 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.549 HG22 HD13 ' A' ' 78' ' ' ILE 0.272 10.0 m -60.08 -48.91 79.75 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 122.352 1.072 . . . . 0.0 111.111 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.38 -36.71 74.28 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.994 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -64.59 -44.23 91.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.933 -1.104 . . . . 0.0 110.482 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.12 -50.68 69.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.557 -1.34 . . . . 0.0 111.282 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.469 HD12 HD11 ' A' ' 78' ' ' ILE . 92.9 mt -66.35 -42.9 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.769 -1.207 . . . . 0.0 110.279 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -63.26 -41.75 99.09 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.296 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.7 mt -63.33 -41.71 98.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.196 -0.94 . . . . 0.0 111.775 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.464 ' HG2' ' HB2' ' A' ' 111' ' ' GLN . 31.6 tp60 -76.36 -40.17 51.88 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.69 -1.204 . . . . 0.0 108.963 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.423 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 1.2 m-85 -59.89 -40.64 89.41 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.62 -34.79 77.76 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.858 -0.526 . . . . 0.0 110.073 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -76.7 -18.7 58.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.989 -1.069 . . . . 0.0 109.712 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.08 -0.22 38.37 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.771 -1.204 . . . . 0.0 111.208 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -99.49 89.37 4.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.633 -1.51 . . . . 0.0 109.548 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.575 ' CD2' ' CE1' ' A' ' 7' ' ' PHE . 19.7 m-30 -64.16 -41.78 97.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.869 -0.52 . . . . 0.0 111.816 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.446 ' O ' HG12 ' A' ' 114' ' ' VAL . 86.5 tttt -61.43 -48.19 82.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.047 -1.033 . . . . 0.0 110.798 -178.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.464 ' HB2' ' HG2' ' A' ' 103' ' ' GLN . 87.3 mt-30 -64.3 -35.9 82.37 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.117 -0.99 . . . . 0.0 110.427 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.448 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -65.76 -48.76 64.05 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.184 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.401 ' HB3' HD11 ' A' ' 16' ' ' ILE . 91.9 mt -65.6 -44.73 85.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.082 -1.246 . . . . 0.0 111.409 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.486 HG13 ' N ' ' A' ' 115' ' ' ASP . 11.5 p -65.06 -46.31 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.184 -0.947 . . . . 0.0 110.5 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.486 ' N ' HG13 ' A' ' 114' ' ' VAL . 66.6 t0 -64.45 -42.11 96.14 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.992 -1.067 . . . . 0.0 109.929 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.45 -42.17 93.69 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.79 -43.04 97.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.232 -1.157 . . . . 0.0 109.78 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -59.17 -50.98 71.98 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.973 -1.08 . . . . 0.0 110.616 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.89 -42.94 99.95 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.878 -1.138 . . . . 0.0 109.28 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.8 -43.43 76.85 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.286 -0.884 . . . . 0.0 109.365 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.81 -42.98 99.59 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 98.8 mmm -67.53 -46.84 71.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.015 -1.285 . . . . 0.0 110.472 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.818 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -63.94 -45.99 86.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.255 -0.903 . . . . 0.0 109.29 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.86 -40.42 95.3 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.4 -34.43 57.71 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.47 -0.769 . . . . 0.0 110.27 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -63.05 -44.17 96.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.061 -1.025 . . . . 0.0 109.133 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -73.08 -39.11 66.12 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.571 0.7 . . . . 0.0 109.961 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -131.67 98.36 18.05 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.634 -0.666 . . . . 0.0 110.178 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.45 154.13 69.41 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 O-C-N 123.647 1.34 . . . . 0.0 111.041 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.473 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 30.7 t90 -75.77 158.57 32.06 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.905 0.86 . . . . 0.0 110.948 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -140.47 151.42 44.84 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.33 -31.87 71.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.025 -1.047 . . . . 0.0 111.096 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -89.61 5.51 45.37 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.047 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.436 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 68.2 t0 -42.11 139.84 1.26 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.04 0.924 . . . . 0.0 111.71 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.695 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -113.87 142.7 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 121.817 0.818 . . . . 0.0 111.757 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -102.31 96.53 7.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.942 -1.099 . . . . 0.0 110.462 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -69.86 -33.41 72.22 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.649 -0.657 . . . . 0.0 112.673 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.9 mp -112.45 150.2 42.25 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.07 -1.019 . . . . 0.0 112.176 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.85 -170.47 0.7 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.667 1.351 . . . . 0.0 109.228 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 18.5 p-10 -125.37 1.85 7.73 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.71 -1.243 . . . . 0.0 110.287 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.6 p -60.85 167.94 2.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.999 -1.063 . . . . 0.0 110.866 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 47.5 mm -95.09 134.33 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.435 0.636 . . . . 0.0 110.691 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 10.5 m -91.22 132.78 35.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 0.0 109.946 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.11 144.99 51.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.145 -0.972 . . . . 0.0 110.544 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.844 179.488 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.4 mtm . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 121.327 0.584 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.0 m -80.46 -10.56 59.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.224 -0.922 . . . . 0.0 110.846 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -65.46 -44.39 87.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.739 -1.225 . . . . 0.0 110.806 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.4 HG13 ' N ' ' A' ' 5' ' ' GLU . 42.6 pt -72.61 -26.46 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.854 -1.153 . . . . 0.0 110.834 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.4 ' N ' HG13 ' A' ' 4' ' ' ILE . 99.1 mt-10 -61.19 -37.26 82.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.156 -0.965 . . . . 0.0 110.431 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 22.5 pt-20 -166.25 129.74 2.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.475 -0.765 . . . . 0.0 109.243 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.965 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 63.3 m-85 -62.86 -45.51 92.21 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.041 -1.037 . . . . 0.0 109.817 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.434 ' HA ' ' OE1' ' A' ' 12' ' ' GLU . 78.7 mt -129.25 147.82 51.12 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.563 -0.71 . . . . 0.0 110.1 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.6 m -72.24 165.22 24.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.952 -1.093 . . . . 0.0 109.976 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 14' ' ' LYS . . . -54.14 -36.67 63.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.2 -0.937 . . . . 0.0 109.6 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.65 -38.46 89.39 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 109.545 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.45 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 97.5 mt-10 -70.63 -46.54 63.13 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.013 -1.055 . . . . 0.0 110.365 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.0 mt-10 -65.26 -34.58 78.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.381 -0.824 . . . . 0.0 109.572 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 87.3 tttt -62.91 -46.34 88.28 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.231 -0.918 . . . . 0.0 110.667 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.31 -43.81 85.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 111.773 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.531 HG13 HG22 ' A' ' 114' ' ' VAL . 16.5 tt -66.61 -36.62 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.665 -1.272 . . . . 0.0 110.49 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 13' ' ' GLU . 71.6 t -63.77 -40.69 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.44 -39.08 92.21 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.755 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.0 92.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.322 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.57 -42.58 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.495 -0.753 . . . . 0.0 109.251 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.407 ' HG2' ' OD1' ' A' ' 140' ' ' ASN . 80.9 mtp180 -59.15 -42.57 91.02 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.211 -0.931 . . . . 0.0 110.304 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -64.91 -36.44 84.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.405 -0.81 . . . . 0.0 110.659 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.36 90.85 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.761 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -60.4 -14.86 21.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.089 -1.007 . . . . 0.0 111.175 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.473 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.5 mttt -95.49 -1.72 50.14 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.958 -1.089 . . . . 0.0 109.749 177.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -109.57 -14.51 14.36 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 120.896 -1.128 . . . . 0.0 109.593 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.0 t -154.4 160.55 41.72 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.882 -1.136 . . . . 0.0 110.485 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.2 m -88.86 -7.2 56.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.206 -0.934 . . . . 0.0 110.273 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.87 171.0 48.5 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.677 ' OE1' HD22 ' A' ' 138' ' ' LEU . 91.7 mt-10 -130.96 137.17 49.14 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.268 -1.137 . . . . 0.0 111.216 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.499 HG21 HD12 ' A' ' 117' ' ' ILE . 83.3 mt -119.63 134.71 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.712 -0.618 . . . . 0.0 110.317 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.4 ' HB2' ' HE1' ' A' ' 56' ' ' MET . 57.4 mmm-85 -138.69 150.7 46.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.249 -0.907 . . . . 0.0 110.197 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.631 HG12 HD12 ' A' ' 67' ' ' ILE . 15.8 m -123.24 139.54 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.456 -0.777 . . . . 0.0 111.118 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -124.9 128.62 48.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.563 -0.711 . . . . 0.0 109.237 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.714 HD11 ' CG1' ' A' ' 71' ' ' VAL . 36.9 tp -115.82 128.87 56.16 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.902 0.858 . . . . 0.0 111.814 -178.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -144.7 165.12 28.94 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -78.95 -74.05 0.3 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.226 -0.921 . . . . 0.0 113.1 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.6 t -140.25 156.18 46.58 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.772 -1.205 . . . . 0.0 110.167 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.9 p -102.56 168.01 9.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.427 -0.796 . . . . 0.0 110.505 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -107.19 -14.32 14.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.308 -0.87 . . . . 0.0 110.632 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 42' ' ' ASP . 19.2 pt -123.34 -121.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.976 -1.077 . . . . 0.0 109.735 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.422 ' N ' HG13 ' A' ' 41' ' ' ILE . 94.2 m-20 -111.34 140.34 46.0 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 120.191 -1.568 . . . . 0.0 109.217 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.612 HG11 HG21 ' A' ' 77' ' ' VAL . 97.3 t -64.76 -44.24 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.211 -0.931 . . . . 0.0 111.815 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -58.16 -45.86 86.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.049 -1.032 . . . . 0.0 109.648 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -71.64 -38.83 70.69 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.917 -1.114 . . . . 0.0 108.94 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.423 ' NH1' ' OH ' ' A' ' 68' ' ' TYR . 75.4 ttt180 -63.45 -42.58 98.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.972 -1.08 . . . . 0.0 110.927 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.13 -38.78 86.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.696 -1.253 . . . . 0.0 110.294 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 64.3 ttp -62.81 -44.05 97.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.064 -1.022 . . . . 0.0 109.405 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.427 ' OD1' ' ND2' ' A' ' 53' ' ' ASN . 63.5 t0 -63.52 -45.61 89.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.021 -1.049 . . . . 0.0 109.488 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 83.3 t -66.35 -44.31 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.35 -0.844 . . . . 0.0 110.947 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.473 ' CE1' ' HB2' ' A' ' 56' ' ' MET . 4.5 t80 -58.27 -47.66 82.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.904 -1.122 . . . . 0.0 108.992 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -70.29 -36.24 74.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.054 -1.029 . . . . 0.0 109.238 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.427 ' ND2' ' OD1' ' A' ' 49' ' ' ASP . 72.7 m-20 -61.18 -37.55 83.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.096 -1.002 . . . . 0.0 110.012 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.8 mt -82.16 5.87 18.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.985 -1.072 . . . . 0.0 110.727 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 55.73 32.74 20.02 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.309 -0.87 . . . . 0.0 110.92 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.473 ' HB2' ' CE1' ' A' ' 51' ' ' PHE . 92.8 mtp -69.13 -25.41 64.38 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.341 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -68.76 -7.61 35.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.347 -0.845 . . . . 0.0 110.48 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -86.98 80.78 8.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.752 -1.218 . . . . 0.0 110.727 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.419 ' OG1' ' HA ' ' A' ' 62' ' ' GLN . 78.8 p -137.04 156.82 47.94 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -62.09 -43.97 97.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.092 -1.005 . . . . 0.0 112.817 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 88.1 mt -100.02 2.31 43.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.091 -1.006 . . . . 0.0 111.301 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.419 ' HA ' ' OG1' ' A' ' 59' ' ' THR . 99.4 mm-40 57.75 31.47 20.49 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.973 0.892 . . . . 0.0 111.272 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.575 ' C ' HD11 ' A' ' 84' ' ' ILE . 99.7 m-20 -108.96 56.46 0.62 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.812 0.815 . . . . 0.0 110.465 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.455 ' N ' HD11 ' A' ' 84' ' ' ILE . . . -103.59 141.19 15.17 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.56 ' CG2' HD13 ' A' ' 84' ' ' ILE . 47.9 t -123.35 135.05 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.07 -1.253 . . . . 0.0 110.593 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.0 tp -116.79 130.39 56.69 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.88 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.631 HD12 HG12 ' A' ' 33' ' ' VAL . 83.6 mt -104.78 108.27 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 118.826 -1.15 . . . . 0.0 109.395 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.423 ' OH ' ' NH1' ' A' ' 46' ' ' ARG . 42.3 t80 -93.73 122.69 36.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.531 -0.731 . . . . 0.0 110.331 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -123.63 133.42 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 122.173 0.987 . . . . 0.0 111.32 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.17 97.45 7.3 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.965 HG21 ' CZ ' ' A' ' 7' ' ' PHE . 35.8 m -67.38 -18.67 24.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.968 -1.083 . . . . 0.0 111.245 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -69.37 -46.52 66.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.754 -1.216 . . . . 0.0 109.445 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.23 3.69 41.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.155 -0.966 . . . . 0.0 110.797 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.4 tttt 56.13 45.77 22.8 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.943 -1.098 . . . . 0.0 110.39 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 96.0 m -119.78 132.87 55.73 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.243 -0.911 . . . . 0.0 109.812 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.421 ' O ' ' CD1' ' A' ' 76' ' ' PHE . 50.9 p90 -114.52 136.7 52.73 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.532 -0.73 . . . . 0.0 109.924 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.612 HG21 HG11 ' A' ' 43' ' ' VAL . 72.0 t -126.69 136.92 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.711 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 82.7 mt -115.35 125.36 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.771 -1.205 . . . . 0.0 110.324 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -128.97 114.89 16.99 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.513 -0.742 . . . . 0.0 110.488 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.65 145.83 16.54 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -56.93 175.47 0.13 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.516 -0.99 . . . . 0.0 109.803 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.06 -24.59 63.02 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.091 -1.006 . . . . 0.0 110.639 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.434 ' O ' HG12 ' A' ' 87' ' ' VAL . . . -66.79 -51.79 38.33 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.655 -1.26 . . . . 0.0 110.632 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.973 ' O ' HG22 ' A' ' 88' ' ' VAL . 3.8 mt -64.15 -44.71 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.914 -1.345 . . . . 0.0 108.447 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -64.26 -36.68 84.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.365 -0.834 . . . . 0.0 111.727 -177.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -75.64 -20.95 58.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.785 -1.197 . . . . 0.0 111.938 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.01 HG13 HG13 ' A' ' 88' ' ' VAL . 11.7 p -103.08 -21.95 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.851 -1.156 . . . . 0.0 113.132 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.01 HG13 HG13 ' A' ' 87' ' ' VAL . 14.3 m -118.68 164.08 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.626 -1.296 . . . . 0.0 111.433 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.2 p -105.45 174.76 5.74 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.922 0.867 . . . . 0.0 111.634 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.01 -37.95 86.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.459 -0.776 . . . . 0.0 110.071 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -61.46 -37.57 84.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.946 . . . . 0.0 108.81 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.911 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 86.3 t80 -64.86 -27.2 68.71 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.446 -0.784 . . . . 0.0 108.968 177.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.711 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.4 m95 -86.12 -26.22 25.34 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.975 0.893 . . . . 0.0 109.888 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -58.97 -36.38 74.77 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.024 -1.048 . . . . 0.0 112.334 -176.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.9 p -66.56 -32.03 73.11 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.535 -1.266 . . . . 0.0 108.596 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.437 HG22 HD13 ' A' ' 78' ' ' ILE 0.276 7.5 m -60.21 -49.46 77.53 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 122.264 1.031 . . . . 0.0 111.141 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -68.29 -38.03 81.25 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.697 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -64.04 -41.39 97.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.013 -1.054 . . . . 0.0 110.617 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.16 -48.95 74.03 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.639 -1.288 . . . . 0.0 110.841 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.514 HD12 HD11 ' A' ' 78' ' ' ILE . 91.9 mt -67.05 -42.78 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 110.406 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -64.17 -41.43 97.14 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.296 -0.877 . . . . 0.0 110.94 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 44.3 tp -62.79 -43.02 99.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.312 -0.868 . . . . 0.0 111.754 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.474 ' CB ' ' CA ' ' A' ' 112' ' ' GLY . 3.0 tp60 -76.69 -40.08 50.0 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.779 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -58.95 -41.94 88.65 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.166 0.984 . . . . 0.0 108.449 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.12 -35.01 72.7 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -79.79 -17.23 53.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.349 -0.844 . . . . 0.0 110.169 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.62 2.5 43.47 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 119.73 -1.224 . . . . 0.0 111.573 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -104.53 94.81 5.52 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.689 -1.477 . . . . 0.0 110.859 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -62.76 -46.32 88.6 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.626 -0.671 . . . . 0.0 112.3 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.564 ' O ' HG23 ' A' ' 114' ' ' VAL . 75.3 tttt -61.62 -47.76 83.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.12 -0.988 . . . . 0.0 111.838 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.418 ' CB ' ' HG2' ' A' ' 103' ' ' GLN . 89.1 mt-30 -63.46 -40.03 96.05 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.377 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.474 ' CA ' ' CB ' ' A' ' 103' ' ' GLN . . . -65.21 -47.83 76.46 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.355 -1.402 . . . . 0.0 109.624 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.432 ' O ' HG12 ' A' ' 117' ' ' ILE . 85.2 mt -64.24 -46.01 85.64 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.506 -0.996 . . . . 0.0 111.523 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 110' ' ' LYS . 99.4 t -63.1 -48.14 89.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.296 -0.877 . . . . 0.0 110.943 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -61.63 -33.52 74.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.028 -1.045 . . . . 0.0 109.108 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.14 -40.33 98.39 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.499 HD12 HG21 ' A' ' 31' ' ' ILE . 36.1 mm -63.36 -43.84 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.064 -1.257 . . . . 0.0 109.741 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.05 -49.74 76.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.277 -0.889 . . . . 0.0 110.723 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -64.73 -43.92 91.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.057 -1.027 . . . . 0.0 110.351 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.31 95.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.895 . . . . 0.0 110.593 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.82 -44.06 81.41 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 97.0 mtp -66.56 -46.18 76.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.011 -1.288 . . . . 0.0 109.901 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.911 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -64.09 -43.89 94.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.969 -1.082 . . . . 0.0 108.974 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 31.2 mt -63.02 -40.49 97.9 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.397 -0.815 . . . . 0.0 109.093 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.42 -34.08 56.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.128 -0.983 . . . . 0.0 110.09 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.63 -44.27 97.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.121 -0.987 . . . . 0.0 109.13 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -70.66 -41.74 71.69 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.473 0.654 . . . . 0.0 109.971 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.42 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 58.1 m-85 -130.88 94.31 28.81 Favored Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.496 -0.753 . . . . 0.0 109.776 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 128' ' ' PHE . 38.8 Cg_endo -64.45 149.88 89.24 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.652 1.343 . . . . 0.0 109.843 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.473 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 39.3 t90 -73.46 130.19 39.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.457 -0.777 . . . . 0.0 111.896 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -108.78 152.64 24.58 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.03 -29.54 68.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.109 -0.995 . . . . 0.0 111.064 -177.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -91.9 6.81 44.77 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.099 -1.04 . . . . 0.0 111.48 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.449 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 67.9 t0 -42.49 139.25 1.57 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.653 -0.654 . . . . 0.0 110.645 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.711 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.3 pp -115.12 142.14 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 122.51 1.148 . . . . 0.0 113.297 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -120.33 102.52 8.53 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.16 -0.962 . . . . 0.0 109.412 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -101.4 5.92 42.34 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.633 -1.292 . . . . 0.0 111.712 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.677 HD22 ' OE1' ' A' ' 30' ' ' GLU . 1.4 tp -114.26 139.69 24.12 Favored Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 120.935 -1.103 . . . . 0.0 110.634 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -70.61 165.17 32.8 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.528 1.278 . . . . 0.0 109.747 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.407 ' OD1' ' HG2' ' A' ' 21' ' ' ARG . 32.0 m120 -103.22 8.75 38.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.595 -1.316 . . . . 0.0 110.027 177.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -62.04 144.93 54.51 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.854 -1.154 . . . . 0.0 110.647 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.98 138.71 19.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.789 -0.569 . . . . 0.0 109.846 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.0 m -93.27 132.31 37.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.077 -1.014 . . . . 0.0 109.203 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -126.22 137.52 53.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.292 -0.88 . . . . 0.0 110.143 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 CA-C-O 118.001 -1.444 . . . . 0.0 109.521 179.551 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 ttp . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.132 0.492 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.9 p -69.24 -16.82 63.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.093 -1.004 . . . . 0.0 110.171 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -81.76 141.0 33.92 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.264 -0.897 . . . . 0.0 110.852 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.5 tt -69.4 -35.88 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.6 -0.687 . . . . 0.0 110.656 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -62.22 -42.49 99.35 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.053 -1.029 . . . . 0.0 110.421 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -100.52 104.26 15.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.056 -1.027 . . . . 0.0 110.087 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.92 ' CE1' HG21 ' A' ' 71' ' ' VAL . 88.8 m-85 -62.94 -44.67 95.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 111.021 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 12' ' ' GLU . 88.2 mt -130.62 151.71 50.78 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -0.986 . . . . 0.0 110.168 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.3 m -78.74 165.56 23.46 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.087 -1.008 . . . . 0.0 109.807 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 14' ' ' LYS . . . -54.08 -36.34 63.04 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.893 -1.129 . . . . 0.0 109.187 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -66.01 -37.09 85.03 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.539 -0.725 . . . . 0.0 109.311 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.477 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 78.1 mm-40 -72.38 -48.26 42.98 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.151 -0.968 . . . . 0.0 110.082 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.816 ' O ' HG23 ' A' ' 17' ' ' VAL . 98.2 mt-10 -66.48 -36.98 84.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.463 -0.773 . . . . 0.0 110.186 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 88.1 tttt -62.02 -45.72 92.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.846 -1.158 . . . . 0.0 111.095 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.89 -42.46 94.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.783 -1.198 . . . . 0.0 111.434 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.588 HG13 HG22 ' A' ' 114' ' ' VAL . 19.1 tt -66.96 -36.16 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.831 -1.168 . . . . 0.0 110.748 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 13' ' ' GLU . 87.8 t -63.82 -41.02 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -62.54 -36.55 82.96 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.664 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.23 -38.27 88.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 109.353 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.874 HD11 HD13 ' A' ' 117' ' ' ILE . 34.9 mm -63.92 -43.45 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.396 -0.815 . . . . 0.0 109.998 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -59.65 -41.6 90.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.311 -0.868 . . . . 0.0 109.821 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -63.92 -37.94 89.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.326 -0.859 . . . . 0.0 111.215 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.74 -40.93 88.52 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.083 -1.011 . . . . 0.0 110.44 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -60.35 -14.5 18.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.904 -1.122 . . . . 0.0 110.922 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.469 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 49.2 mtpt -94.59 -2.82 50.77 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 120.831 -1.168 . . . . 0.0 109.48 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -109.93 -14.11 14.32 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 121.002 -1.061 . . . . 0.0 110.184 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.7 t -151.77 158.03 42.77 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.063 -1.023 . . . . 0.0 109.982 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 83.5 p -86.91 -7.95 57.71 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.273 -0.892 . . . . 0.0 109.95 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.7 172.61 45.6 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.77 ' CB ' HD12 ' A' ' 138' ' ' LEU . 55.8 mp0 -131.23 136.38 48.18 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.339 -1.095 . . . . 0.0 111.247 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -122.42 134.71 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.876 -0.515 . . . . 0.0 110.026 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.496 HH11 HD22 ' A' ' 138' ' ' LEU . 83.6 mtp180 -138.57 153.99 48.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.206 -0.934 . . . . 0.0 110.135 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.646 HG22 HD12 ' A' ' 67' ' ' ILE . 48.1 t -123.7 139.34 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.385 -0.822 . . . . 0.0 110.665 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.419 ' HA ' ' O ' ' A' ' 143' ' ' SER . 77.8 t60 -124.64 122.8 38.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.53 -0.732 . . . . 0.0 110.215 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.928 HD11 ' CG1' ' A' ' 71' ' ' VAL . 33.8 tp -108.39 131.56 54.64 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.901 0.858 . . . . 0.0 111.421 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -149.39 166.43 29.06 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.452 ' HB3' ' HG3' ' A' ' 72' ' ' GLU . 98.4 mttt -81.33 -75.45 0.28 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.928 -1.107 . . . . 0.0 113.498 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.756 HG23 ' CB ' ' A' ' 72' ' ' GLU . 1.3 p -137.96 154.09 49.41 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.496 -0.753 . . . . 0.0 109.955 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.419 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 14.3 p -98.95 167.91 10.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.137 -0.977 . . . . 0.0 110.283 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -106.27 -10.83 16.23 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.307 -0.871 . . . . 0.0 110.422 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.401 HG13 ' N ' ' A' ' 42' ' ' ASP . 28.7 pt -128.56 -121.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.936 -1.102 . . . . 0.0 109.358 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.401 ' N ' HG13 ' A' ' 41' ' ' ILE . 89.9 m-20 -111.02 138.4 47.48 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 120.184 -1.573 . . . . 0.0 110.042 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.465 HG11 HG21 ' A' ' 77' ' ' VAL . 90.1 t -62.99 -44.96 99.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.564 -0.71 . . . . 0.0 112.01 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -59.89 -46.28 89.84 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.925 -1.109 . . . . 0.0 110.057 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -70.58 -39.41 73.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.772 -1.205 . . . . 0.0 108.568 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.419 ' NH2' ' HA ' ' A' ' 39' ' ' SER . 49.8 ttt85 -61.46 -45.68 93.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 111.358 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.36 84.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.961 -1.087 . . . . 0.0 109.713 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 66.0 ttp -64.71 -43.87 92.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.204 -0.935 . . . . 0.0 109.878 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 53.5 t0 -63.2 -43.55 97.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.043 -1.036 . . . . 0.0 109.252 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 75.6 t -67.23 -44.01 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.46 -0.775 . . . . 0.0 110.35 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.528 ' HD1' HD22 ' A' ' 66' ' ' LEU . 61.4 t80 -60.19 -48.14 82.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.719 -1.238 . . . . 0.0 110.296 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -72.47 -35.2 68.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.989 -1.07 . . . . 0.0 108.821 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 49' ' ' ASP . 31.4 t-20 -62.34 -39.37 92.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.338 -0.851 . . . . 0.0 110.194 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.427 HD13 ' CE ' ' A' ' 56' ' ' MET . 55.6 mt -79.31 3.15 18.96 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.153 -0.967 . . . . 0.0 110.187 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 57.29 33.43 23.28 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 121.041 -1.037 . . . . 0.0 112.044 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.468 ' SD ' HD13 ' A' ' 66' ' ' LEU . 64.7 mtt -67.46 -10.79 54.8 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.845 -1.16 . . . . 0.0 109.913 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.41 ' OD1' ' CE2' ' A' ' 51' ' ' PHE . 97.1 m-20 -77.82 -0.87 28.85 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.788 -1.195 . . . . 0.0 109.787 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -80.02 63.49 4.56 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 121.005 -1.06 . . . . 0.0 109.871 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.421 ' OG1' ' HA ' ' A' ' 62' ' ' GLN . 66.8 p -133.11 150.28 52.07 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.08 -41.01 99.32 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.441 -0.787 . . . . 0.0 112.271 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.415 ' HB3' ' ND2' ' A' ' 63' ' ' ASN . 87.0 mt -100.0 -0.51 39.12 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.932 -1.105 . . . . 0.0 111.616 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.421 ' HA ' ' OG1' ' A' ' 59' ' ' THR . 87.4 mt-30 58.2 40.26 25.05 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 122.643 1.211 . . . . 0.0 111.029 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.654 ' C ' HD11 ' A' ' 84' ' ' ILE . 94.5 m-20 -111.44 53.15 0.72 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.724 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.432 ' N ' HD11 ' A' ' 84' ' ' ILE . . . -99.81 138.82 14.09 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.034 -2.026 . . . . 0.0 108.034 178.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 53.4 t -122.11 133.91 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.184 -1.186 . . . . 0.0 110.117 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.528 HD22 ' HD1' ' A' ' 51' ' ' PHE . 49.2 tp -117.44 131.21 56.78 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.674 -0.641 . . . . 0.0 110.832 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.646 HD12 HG22 ' A' ' 33' ' ' VAL . 94.4 mt -110.56 110.3 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.524 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -97.23 121.4 39.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -0.921 . . . . 0.0 109.711 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.5 t -121.98 131.81 72.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.259 -0.901 . . . . 0.0 111.302 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.575 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -98.95 95.23 7.02 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.928 ' CG1' HD11 ' A' ' 35' ' ' LEU . 35.8 m -64.31 -22.48 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.998 -1.064 . . . . 0.0 110.834 -178.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.756 ' CB ' HG23 ' A' ' 38' ' ' THR . 79.3 mm-40 -66.8 -42.51 85.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.993 -1.067 . . . . 0.0 109.535 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.451 ' O ' HG23 ' A' ' 75' ' ' THR . 92.7 m-20 -102.99 4.99 38.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.851 . . . . 0.0 110.98 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.43 ' HE2' ' O ' ' A' ' 104' ' ' PHE . 29.2 tttt 55.78 47.71 19.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.958 -1.089 . . . . 0.0 110.38 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.575 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 34.4 p -123.17 162.24 22.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 109.41 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -143.9 141.87 30.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.428 -0.795 . . . . 0.0 110.049 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.465 HG21 HG11 ' A' ' 43' ' ' VAL . 45.9 t -131.15 133.59 62.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.673 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 77.2 mt -112.97 122.33 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 118.853 -1.139 . . . . 0.0 110.544 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -129.11 111.27 12.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 110.343 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -94.72 174.63 33.35 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -77.64 176.17 9.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.752 -0.852 . . . . 0.0 109.876 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.55 -26.49 66.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.031 -1.043 . . . . 0.0 110.847 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.446 ' O ' HG12 ' A' ' 87' ' ' VAL . . . -65.72 -49.31 60.29 Favored Glycine 0 N--CA 1.488 2.108 0 C-N-CA 119.807 -1.187 . . . . 0.0 110.315 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.995 ' O ' HG22 ' A' ' 88' ' ' VAL . 3.6 mt -64.6 -44.97 96.76 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.791 0 O-C-N 121.001 -1.294 . . . . 0.0 108.151 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -64.39 -35.66 81.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.711 -1.243 . . . . 0.0 112.39 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -77.6 -22.11 51.36 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.857 -1.152 . . . . 0.0 112.303 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.094 HG13 HG13 ' A' ' 88' ' ' VAL . 7.7 p -101.33 -23.51 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.848 -1.158 . . . . 0.0 112.516 -178.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.094 HG13 HG13 ' A' ' 87' ' ' VAL . 10.2 m -117.65 164.36 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.659 -1.276 . . . . 0.0 111.413 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 t -108.13 174.8 5.72 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.649 0.738 . . . . 0.0 111.767 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -61.38 -37.37 83.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.16 -0.962 . . . . 0.0 110.12 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.61 -36.55 78.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.194 -0.941 . . . . 0.0 108.823 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.741 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 81.5 t80 -67.33 -25.18 65.88 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.258 -0.901 . . . . 0.0 109.505 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.673 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.3 m95 -88.31 -26.5 22.23 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.911 0.862 . . . . 0.0 111.252 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -55.82 -40.33 72.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.92 -1.112 . . . . 0.0 112.585 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 77.3 p -64.5 -31.03 72.06 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.507 -1.277 . . . . 0.0 109.234 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.28 12.3 m -60.27 -49.38 77.86 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 122.545 1.164 . . . . 0.0 110.952 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.05 -38.53 82.57 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.738 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -63.42 -45.01 92.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.948 -1.095 . . . . 0.0 110.725 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.42 -48.62 80.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.942 -1.099 . . . . 0.0 110.654 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.412 HD12 HD11 ' A' ' 78' ' ' ILE . 91.4 mt -67.52 -42.5 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.089 -1.007 . . . . 0.0 110.277 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.427 ' CG ' ' HE3' ' A' ' 105' ' ' LYS . 56.6 tt0 -63.28 -42.85 99.15 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.842 -1.161 . . . . 0.0 110.984 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.1 mt -63.12 -41.53 99.35 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.158 -0.964 . . . . 0.0 112.105 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.431 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 94.0 mm-40 -76.66 -37.23 56.58 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.647 -1.221 . . . . 0.0 109.253 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.43 ' O ' ' HE2' ' A' ' 74' ' ' LYS . 4.4 m-85 -61.1 -41.5 96.79 Favored 'General case' 0 C--O 1.201 -1.456 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.427 ' HE3' ' CG ' ' A' ' 101' ' ' GLN . 93.7 mttt -62.02 -33.44 74.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.754 -1.216 . . . . 0.0 110.791 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -78.55 -18.64 54.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.756 -1.215 . . . . 0.0 109.986 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.83 4.63 42.22 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.71 -1.233 . . . . 0.0 111.164 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -103.51 91.08 3.89 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.632 -1.511 . . . . 0.0 110.521 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -62.35 -45.02 95.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.706 -0.621 . . . . 0.0 111.784 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.44 ' CD ' ' OE1' ' A' ' 12' ' ' GLU . 76.3 tttt -62.86 -49.29 75.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.901 . . . . 0.0 112.55 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -62.4 -36.49 82.51 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.655 -1.218 . . . . 0.0 109.55 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.431 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -65.54 -47.58 76.48 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.426 -1.368 . . . . 0.0 110.187 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.6 mt -63.53 -44.1 95.24 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.025 -1.279 . . . . 0.0 110.776 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.588 HG22 HG13 ' A' ' 16' ' ' ILE . 86.4 t -66.52 -46.08 87.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.101 -1.0 . . . . 0.0 110.05 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -65.35 -42.54 92.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 110.023 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.02 -41.98 98.19 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.874 HD13 HD11 ' A' ' 20' ' ' ILE . 91.4 mt -65.05 -43.84 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.267 -1.137 . . . . 0.0 109.968 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -56.93 -51.75 67.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.959 -1.088 . . . . 0.0 109.729 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.68 -41.73 99.25 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.125 -0.984 . . . . 0.0 109.192 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.32 -40.56 82.38 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.078 -1.014 . . . . 0.0 109.41 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.53 -45.86 87.79 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.7 mtt -66.67 -43.56 84.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.03 -1.276 . . . . 0.0 109.416 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.741 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -63.5 -46.59 85.41 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.304 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.2 mt -62.74 -41.54 99.24 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.456 -0.777 . . . . 0.0 109.486 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.82 -34.13 62.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.33 -0.856 . . . . 0.0 110.678 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.84 -41.46 97.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.942 -1.099 . . . . 0.0 108.954 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -75.36 -37.49 60.6 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.601 -0.687 . . . . 0.0 109.787 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -132.51 99.4 15.79 Favored Pre-proline 0 N--CA 1.487 1.379 0 O-C-N 121.498 -0.751 . . . . 0.0 110.131 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.47 150.97 70.63 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.447 1.235 . . . . 0.0 110.226 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.469 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 34.5 t90 -73.66 125.81 28.89 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.382 -0.824 . . . . 0.0 110.916 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -103.97 153.84 20.36 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.01 -29.3 70.17 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.22 -0.925 . . . . 0.0 111.092 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -93.7 8.12 42.17 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.912 -1.115 . . . . 0.0 111.609 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -42.51 138.18 1.89 Allowed 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.843 0.83 . . . . 0.0 111.614 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.628 HD13 ' H ' ' A' ' 135' ' ' ILE . 0.2 OUTLIER -111.78 141.5 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 121.574 -0.704 . . . . 0.0 110.576 -178.083 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -100.25 96.01 7.18 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.169 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -67.71 -36.35 80.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.721 -0.612 . . . . 0.0 111.741 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.77 HD12 ' CB ' ' A' ' 30' ' ' GLU . 83.9 mt -109.22 151.37 41.99 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.212 -0.93 . . . . 0.0 112.073 -178.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.68 -171.54 0.87 Allowed 'Trans proline' 0 C--N 1.32 -0.949 0 N-CA-C 108.662 -1.322 . . . . 0.0 108.662 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -121.91 1.77 9.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.604 -1.31 . . . . 0.0 110.125 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 78.5 p -63.37 168.62 4.31 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.764 -1.21 . . . . 0.0 110.965 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 91.6 mt -94.56 135.83 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.483 -0.76 . . . . 0.0 110.819 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 5.1 m -93.48 134.47 35.71 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.61 146.8 50.75 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.853 -1.154 . . . . 0.0 110.427 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.944 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.2 mtp . . . . . 0 N--CA 1.498 1.968 0 CA-C-O 121.516 0.674 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 p -154.42 160.23 41.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.53 -0.731 . . . . 0.0 109.977 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -61.08 -42.17 98.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.274 -0.891 . . . . 0.0 110.345 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.6 mt -118.46 127.14 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.113 -0.992 . . . . 0.0 111.347 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -93.12 -45.26 7.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.258 -0.901 . . . . 0.0 109.981 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -130.76 119.2 21.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 110.282 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.439 ' CE2' ' HB ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -65.58 -25.13 67.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.407 -0.808 . . . . 0.0 111.729 -179.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.5 mt -124.59 151.17 45.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.043 -1.035 . . . . 0.0 109.24 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.451 HG23 ' H ' ' A' ' 12' ' ' GLU . 5.6 t -83.63 167.41 17.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.936 -1.102 . . . . 0.0 109.422 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.02 -38.88 77.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.24 -0.912 . . . . 0.0 110.885 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -55.88 -46.89 78.2 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.728 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.451 ' H ' HG23 ' A' ' 9' ' ' THR . 96.6 mt-10 -67.43 -45.61 75.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.516 -0.74 . . . . 0.0 111.716 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.768 ' O ' HG23 ' A' ' 17' ' ' VAL . 93.6 mt-10 -65.38 -33.11 75.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.963 -1.086 . . . . 0.0 110.035 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.34 -48.09 76.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.794 -1.192 . . . . 0.0 111.191 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.697 ' HB3' ' CE ' ' A' ' 110' ' ' LYS . . . -63.83 -42.14 97.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.319 -0.863 . . . . 0.0 111.159 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.524 HG13 HG22 ' A' ' 114' ' ' VAL . 20.6 tt -67.46 -34.77 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.004 -1.06 . . . . 0.0 110.689 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 13' ' ' GLU . 67.5 t -63.29 -39.37 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.94 -37.21 86.88 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.08 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.25 88.56 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.285 -0.884 . . . . 0.0 109.021 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.865 HG22 ' OD1' ' A' ' 140' ' ' ASN . 96.6 mt -64.5 -43.41 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-O 121.475 0.655 . . . . 0.0 109.972 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.433 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 92.8 mtt180 -59.72 -43.02 94.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 0.0 110.47 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -65.83 -36.86 84.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.431 -0.793 . . . . 0.0 111.252 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.37 -40.91 98.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.001 -1.062 . . . . 0.0 109.749 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.61 -16.52 49.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.413 -0.805 . . . . 0.0 110.11 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.481 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.4 mttt -93.65 -1.57 55.12 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.213 -0.929 . . . . 0.0 109.142 177.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -110.16 -14.39 14.2 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.973 -1.08 . . . . 0.0 110.08 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.3 t -151.34 158.12 43.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.098 -1.001 . . . . 0.0 109.644 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.6 m -85.1 -8.66 58.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.092 -1.005 . . . . 0.0 109.974 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.99 173.31 48.37 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.431 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 57.8 mp0 -132.0 139.05 48.49 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.259 -1.142 . . . . 0.0 111.709 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 94.1 mt -124.81 136.26 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.605 -0.685 . . . . 0.0 110.319 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -140.96 156.56 46.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.211 -0.931 . . . . 0.0 110.038 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 143' ' ' SER . 4.8 p -126.55 140.8 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.03 -1.044 . . . . 0.0 111.469 -178.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.444 ' HA ' ' O ' ' A' ' 143' ' ' SER . 72.0 t60 -124.43 132.15 53.5 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.574 0.702 . . . . 0.0 109.684 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.829 HD11 ' CG1' ' A' ' 71' ' ' VAL . 28.1 tp -117.62 126.13 51.97 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.625 0.726 . . . . 0.0 111.984 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.425 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 78.2 tt0 -142.73 165.2 28.04 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.439 ' HB3' ' HG3' ' A' ' 72' ' ' GLU . 99.5 mttt -79.94 -76.41 0.22 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.144 -0.973 . . . . 0.0 112.329 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.755 HG23 ' HB2' ' A' ' 72' ' ' GLU . 1.2 p -138.74 157.21 46.52 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.455 0.645 . . . . 0.0 110.609 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.433 ' OG ' ' CD ' ' A' ' 46' ' ' ARG . 50.9 m -107.47 173.62 6.24 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.431 -0.793 . . . . 0.0 110.854 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -109.23 -10.14 14.98 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.591 -0.693 . . . . 0.0 110.452 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.1 pt -125.19 -123.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 120.964 -1.085 . . . . 0.0 109.702 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -110.78 140.2 45.4 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.462 -1.399 . . . . 0.0 109.092 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.502 ' CG1' HG21 ' A' ' 77' ' ' VAL . 75.3 t -61.37 -44.18 98.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.427 -0.796 . . . . 0.0 110.599 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -58.79 -48.05 82.63 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.134 -0.979 . . . . 0.0 110.588 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -69.1 -39.89 78.72 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.784 -1.198 . . . . 0.0 109.162 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.433 ' CD ' ' OG ' ' A' ' 39' ' ' SER . 57.8 ttt85 -59.7 -45.27 92.63 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.095 -1.003 . . . . 0.0 110.087 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.19 94.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.83 -1.169 . . . . 0.0 110.324 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.3 ttp -62.92 -43.57 98.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.125 -0.985 . . . . 0.0 109.646 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -65.76 -47.1 76.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.022 -1.049 . . . . 0.0 109.5 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 72.4 t -64.64 -42.99 96.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.451 -0.781 . . . . 0.0 110.273 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.483 ' CZ ' ' OD1' ' A' ' 81' ' ' ASP . 4.5 t80 -60.82 -47.32 86.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.885 -1.134 . . . . 0.0 109.662 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -73.5 -37.99 65.5 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.114 -0.991 . . . . 0.0 110.277 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -61.2 -39.66 91.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.02 -1.05 . . . . 0.0 109.22 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.1 mt -79.94 3.33 20.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 0.0 110.856 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 57.67 33.04 22.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.599 -0.688 . . . . 0.0 111.782 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.426 ' HB2' ' CD1' ' A' ' 51' ' ' PHE . 92.6 mmm -70.6 -23.39 62.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.997 -1.064 . . . . 0.0 109.841 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -73.16 -5.33 38.49 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.124 -0.985 . . . . 0.0 110.771 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -86.29 84.01 7.57 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.799 -1.188 . . . . 0.0 110.954 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.0 p -138.4 155.91 48.07 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.01 -44.22 97.18 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.98 -1.075 . . . . 0.0 112.541 -177.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.1 mt -99.15 3.49 46.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.864 -1.148 . . . . 0.0 111.36 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 55.48 36.24 26.73 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.188 0.994 . . . . 0.0 111.029 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.501 ' C ' HD11 ' A' ' 84' ' ' ILE . 97.5 m-20 -115.71 53.7 0.84 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.264 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.83 149.04 17.99 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.602 ' CG2' HD13 ' A' ' 84' ' ' ILE . 54.2 t -127.56 134.35 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.987 -1.302 . . . . 0.0 110.081 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.476 ' HB2' ' CE2' ' A' ' 51' ' ' PHE . 35.5 tp -116.61 126.76 53.72 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.235 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 85.6 mt -105.58 112.56 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.346 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -99.87 121.11 40.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.961 . . . . 0.0 110.002 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.7 t -122.87 131.8 72.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 122.102 0.953 . . . . 0.0 111.259 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.1 99.13 10.64 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.829 ' CG1' HD11 ' A' ' 35' ' ' LEU . 28.4 m -65.29 -24.44 35.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 121.142 -0.974 . . . . 0.0 110.998 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.755 ' HB2' HG23 ' A' ' 38' ' ' THR . 70.2 mm-40 -67.97 -43.55 78.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.762 -1.211 . . . . 0.0 110.023 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -102.14 3.55 38.63 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.134 -0.978 . . . . 0.0 110.993 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt 55.98 45.91 22.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.806 -1.184 . . . . 0.0 110.712 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 99.6 m -121.51 135.27 55.04 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.079 -1.013 . . . . 0.0 110.224 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.472 ' O ' ' CD1' ' A' ' 76' ' ' PHE . 52.5 p90 -115.98 138.1 51.51 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.473 -0.767 . . . . 0.0 111.253 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.502 HG21 ' CG1' ' A' ' 43' ' ' VAL . 58.6 t -128.91 136.19 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.892 -1.13 . . . . 0.0 108.192 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.582 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 69.8 mt -116.37 126.6 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.627 -1.295 . . . . 0.0 110.885 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -129.08 114.34 16.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.601 -0.687 . . . . 0.0 110.984 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.28 175.03 26.74 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.483 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 68.2 m-20 -82.0 -178.29 6.95 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.539 -0.977 . . . . 0.0 111.438 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.32 -26.45 68.49 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.36 -53.05 34.82 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.112 -1.042 . . . . 0.0 110.876 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.989 ' O ' HG22 ' A' ' 88' ' ' VAL . 7.9 mt -65.06 -44.69 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.95 -1.323 . . . . 0.0 107.705 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -61.53 -37.53 84.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.742 -1.224 . . . . 0.0 111.466 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -75.73 -19.99 58.66 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.011 -1.055 . . . . 0.0 111.929 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.008 HG13 HG13 ' A' ' 88' ' ' VAL . 9.5 p -104.3 -22.03 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 120.669 -1.27 . . . . 0.0 112.349 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.008 HG13 HG13 ' A' ' 87' ' ' VAL . 19.1 m -120.79 162.31 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 120.594 -1.316 . . . . 0.0 111.96 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.9 m -105.8 178.0 4.69 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.124 0.964 . . . . 0.0 112.316 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -62.81 -37.62 87.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.676 -0.64 . . . . 0.0 109.775 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -61.28 -35.82 78.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.06 -1.025 . . . . 0.0 108.887 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.642 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 80.7 t80 -67.01 -26.47 66.8 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.354 177.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.582 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 7.7 m95 -85.0 -26.96 26.77 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 122.013 0.911 . . . . 0.0 109.728 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -58.25 -38.21 76.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.166 -0.959 . . . . 0.0 112.815 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 69.5 p -65.49 -31.66 72.86 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.649 -1.22 . . . . 0.0 108.782 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.276 7.9 m -59.48 -48.68 80.72 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.485 1.136 . . . . 0.0 111.095 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -69.51 -37.89 77.37 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.945 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -63.8 -45.71 88.44 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.905 -1.122 . . . . 0.0 110.514 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.55 -48.43 81.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.735 -1.228 . . . . 0.0 110.275 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 93.1 mt -65.98 -42.84 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.122 -0.986 . . . . 0.0 110.412 179.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -65.12 -40.54 94.63 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.46 -0.775 . . . . 0.0 111.103 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.49 -42.92 98.54 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.307 -0.87 . . . . 0.0 111.853 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.45 ' HB3' ' HA3' ' A' ' 112' ' ' GLY . 3.3 tp60 -76.81 -39.55 50.99 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 118.652 -1.219 . . . . 0.0 108.99 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 100' ' ' ILE . 3.0 m-85 -60.3 -42.34 95.32 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.817 0.818 . . . . 0.0 108.987 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.48 -30.97 70.03 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -79.44 -18.51 52.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 109.945 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.21 2.95 48.2 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.817 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -103.82 93.8 5.08 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.643 -1.504 . . . . 0.0 110.315 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.401 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 22.8 m-85 -62.88 -46.18 89.06 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.458 -0.776 . . . . 0.0 112.4 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.697 ' CE ' ' HB3' ' A' ' 15' ' ' ALA . 61.4 tttm -62.18 -48.47 79.91 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.801 -1.187 . . . . 0.0 112.997 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.53 -39.14 93.65 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.856 -1.138 . . . . 0.0 109.459 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.45 ' HA3' ' HB3' ' A' ' 103' ' ' GLN . . . -67.2 -47.32 64.92 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 109' ' ' PHE . 97.1 mt -62.08 -44.01 97.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -1.173 . . . . 0.0 109.392 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.524 HG22 HG13 ' A' ' 16' ' ' ILE . 68.5 t -66.72 -45.25 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.316 -0.865 . . . . 0.0 110.513 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -65.63 -40.95 93.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.965 -1.085 . . . . 0.0 109.995 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.48 -41.65 99.76 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 84.3 mt -64.27 -43.54 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.177 -1.19 . . . . 0.0 109.858 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.36 -51.82 68.28 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.868 -1.145 . . . . 0.0 110.846 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.02 -40.85 97.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.028 -1.045 . . . . 0.0 109.203 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.416 ' O ' ' HG ' ' A' ' 124' ' ' LEU . . . -56.41 -44.03 79.94 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.352 -0.842 . . . . 0.0 109.528 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.05 -43.32 95.93 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.814 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 6.1 tpp -66.66 -47.8 71.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.282 . . . . 0.0 109.421 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.642 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -62.8 -45.36 92.99 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.512 -0.875 . . . . 0.0 109.083 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 120' ' ' ALA . 83.5 mt -62.55 -39.65 94.31 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.06 -1.025 . . . . 0.0 108.635 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.88 -34.98 63.59 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.186 -0.947 . . . . 0.0 111.035 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -61.47 -41.13 96.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.995 -1.066 . . . . 0.0 108.493 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.581 ' HD2' HG22 ' A' ' 87' ' ' VAL . 56.3 m-85 -75.19 -38.24 60.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.511 -0.743 . . . . 0.0 110.098 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.538 ' HE2' HG11 ' A' ' 87' ' ' VAL . 70.9 m-85 -133.87 95.6 17.14 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.388 -0.82 . . . . 0.0 109.923 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 128' ' ' PHE . 45.6 Cg_endo -67.15 149.58 81.94 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.841 1.442 . . . . 0.0 110.369 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.481 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 42.7 t90 -72.03 143.38 49.16 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.533 -0.729 . . . . 0.0 111.403 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 99.2 mttt -121.76 151.22 40.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.487 -0.758 . . . . 0.0 109.248 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -58.86 -29.87 67.3 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.204 -0.935 . . . . 0.0 110.836 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -93.95 7.52 44.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.036 -1.04 . . . . 0.0 110.949 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 131' ' ' LYS . 46.6 t0 -41.73 139.11 1.27 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.921 0.867 . . . . 0.0 111.423 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.595 HD13 ' H ' ' A' ' 135' ' ' ILE . 0.2 OUTLIER -110.37 138.26 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.447 -0.783 . . . . 0.0 110.553 -179.324 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -95.84 94.32 7.58 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.674 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.484 ' C ' HD22 ' A' ' 138' ' ' LEU . 78.6 mm-40 -69.09 -29.28 67.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.428 -0.795 . . . . 0.0 112.577 -178.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.484 HD22 ' C ' ' A' ' 137' ' ' GLU . 3.9 mm? -117.14 146.98 39.34 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 120.809 -1.182 . . . . 0.0 111.312 -178.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.06 -170.88 0.52 Allowed 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.43 1.226 . . . . 0.0 109.06 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.865 ' OD1' HG22 ' A' ' 20' ' ' ILE . 65.1 m-80 -122.05 3.66 9.89 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.39 -1.444 . . . . 0.0 110.327 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 21.0 m -63.1 141.3 58.82 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.087 -1.008 . . . . 0.0 111.928 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.586 HG13 HG22 ' A' ' 17' ' ' VAL . 86.2 mt -71.59 136.93 24.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.836 -0.54 . . . . 0.0 110.702 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 15.6 m -100.79 144.28 29.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.159 -0.963 . . . . 0.0 109.741 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -146.38 155.82 42.87 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.036 -1.04 . . . . 0.0 109.847 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.581 179.965 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.8 mtt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.259 0.552 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.0 t -76.01 148.99 37.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.373 -0.83 . . . . 0.0 110.461 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.507 ' HA ' ' CG ' ' A' ' 6' ' ' GLU . 97.3 mttt -76.23 -18.42 59.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.459 -0.776 . . . . 0.0 111.488 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.486 HG22 ' HD3' ' A' ' 144' ' ' LYS . 95.0 mt -63.47 -43.52 98.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 109.508 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -77.55 -13.41 59.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.433 -0.792 . . . . 0.0 111.223 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.507 ' CG ' ' HA ' ' A' ' 3' ' ' LYS . 77.9 mm-40 -61.31 -28.62 69.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.996 -1.065 . . . . 0.0 110.725 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.827 ' CE1' HG21 ' A' ' 71' ' ' VAL . 66.3 m-85 -58.31 -46.49 86.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.997 -1.064 . . . . 0.0 110.584 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.4 mt -131.71 152.22 51.05 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.323 -0.861 . . . . 0.0 111.308 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -86.22 165.38 16.56 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.238 -0.914 . . . . 0.0 109.736 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.92 -37.98 67.05 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.086 -1.009 . . . . 0.0 109.769 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.77 -41.99 98.4 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.464 -0.773 . . . . 0.0 110.047 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -73.77 -45.59 50.79 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 110.465 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.743 ' O ' HG23 ' A' ' 17' ' ' VAL . 97.3 mt-10 -65.57 -36.49 83.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.832 -1.168 . . . . 0.0 109.858 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -63.82 -45.11 91.08 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.849 -1.157 . . . . 0.0 110.558 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.33 -44.71 86.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.954 -1.092 . . . . 0.0 111.672 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.51 ' CG2' HD11 ' A' ' 142' ' ' ILE . 20.3 tt -64.14 -35.73 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.729 -1.232 . . . . 0.0 110.45 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 13' ' ' GLU . 92.6 t -63.77 -40.59 89.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.381 -0.825 . . . . 0.0 108.892 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -61.03 -38.32 85.71 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.252 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.18 -38.86 90.68 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.192 -0.942 . . . . 0.0 109.768 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.481 HG22 ' OD1' ' A' ' 140' ' ' ASN . 91.7 mt -62.73 -43.23 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.168 -0.957 . . . . 0.0 109.691 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -59.67 -41.73 91.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.504 -0.748 . . . . 0.0 110.724 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -65.37 -37.48 87.13 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.199 -0.938 . . . . 0.0 110.991 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.92 92.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.033 -1.042 . . . . 0.0 109.89 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -60.1 -14.56 17.45 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.037 -1.04 . . . . 0.0 111.216 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.6 mttt -97.31 1.27 49.32 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.243 -0.911 . . . . 0.0 109.478 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -111.59 -15.05 13.56 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.04 -1.038 . . . . 0.0 109.314 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.5 t -152.68 156.03 38.43 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.054 -1.029 . . . . 0.0 110.064 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.9 p -86.84 -8.7 57.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.354 -0.841 . . . . 0.0 110.534 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.99 177.12 45.61 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.507 ' CB ' HD22 ' A' ' 138' ' ' LEU . 80.4 mm-40 -131.39 135.37 47.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.089 -1.242 . . . . 0.0 111.494 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 86.2 mt -116.43 132.07 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.724 ' HD3' ' HE2' ' A' ' 56' ' ' MET . 78.2 mtp85 -136.9 151.34 48.96 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.285 -0.884 . . . . 0.0 110.117 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.611 HG22 HD12 ' A' ' 67' ' ' ILE . 54.5 t -123.91 138.38 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.639 -0.663 . . . . 0.0 110.454 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.486 ' HB2' HD11 ' A' ' 66' ' ' LEU . 46.6 t60 -123.6 125.04 44.12 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.567 0.698 . . . . 0.0 109.132 178.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.431 ' C ' HD23 ' A' ' 35' ' ' LEU . 10.0 tt -113.48 131.08 56.18 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.009 0.909 . . . . 0.0 112.165 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 82.8 tt0 -146.84 167.14 24.64 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.45 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 51.6 mtmt -79.98 -73.99 0.33 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.964 . . . . 0.0 113.088 -177.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.411 ' OG1' ' CB ' ' A' ' 72' ' ' GLU . 62.7 m -141.57 159.61 41.86 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.411 -0.806 . . . . 0.0 110.198 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.416 ' OG ' ' CD ' ' A' ' 46' ' ' ARG . 51.1 m -112.4 170.24 8.31 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.511 -0.743 . . . . 0.0 111.133 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -107.09 -15.44 14.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.32 -0.863 . . . . 0.0 110.59 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.7 pt -121.78 -122.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.357 -0.839 . . . . 0.0 109.894 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -111.65 137.56 49.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.32 -1.488 . . . . 0.0 109.66 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.534 HG13 ' CD1' ' A' ' 68' ' ' TYR . 99.2 t -64.37 -42.54 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.441 -0.787 . . . . 0.0 110.679 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.22 -46.9 85.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.698 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -69.11 -37.95 78.66 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.433 ' HD3' ' CZ ' ' A' ' 68' ' ' TYR . 58.5 ttt85 -61.96 -43.62 98.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.06 -1.025 . . . . 0.0 110.233 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.65 91.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.797 -1.189 . . . . 0.0 110.765 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.2 ttp -64.08 -43.39 95.59 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.707 -1.245 . . . . 0.0 109.681 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -64.29 -45.84 86.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.215 -0.928 . . . . 0.0 110.079 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.5 t -66.27 -42.48 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.23 -0.919 . . . . 0.0 109.475 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.07 -47.05 86.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.888 -1.133 . . . . 0.0 109.667 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -75.92 -38.63 57.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.57 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -60.66 -38.18 84.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.102 -0.999 . . . . 0.0 109.919 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.5 mt -81.2 5.41 17.05 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.005 -1.059 . . . . 0.0 110.313 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 56.77 30.62 18.03 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 121.458 -0.776 . . . . 0.0 111.328 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.724 ' HE2' ' HD3' ' A' ' 32' ' ' ARG . 99.6 mtp -65.24 -12.14 48.43 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.605 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.5 p30 -79.11 2.07 22.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.829 -1.169 . . . . 0.0 109.962 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -74.36 64.07 1.1 Allowed 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.205 -0.934 . . . . 0.0 109.926 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 81.5 p -134.49 149.09 50.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.17 -0.956 . . . . 0.0 109.661 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.67 -43.73 92.63 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.7 mt -95.76 0.9 52.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.93 -1.107 . . . . 0.0 111.018 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 56.08 38.53 30.0 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.301 1.048 . . . . 0.0 111.761 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.588 ' C ' HD11 ' A' ' 84' ' ' ILE . 97.7 m-20 -110.34 54.24 0.67 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.876 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.515 ' N ' HD11 ' A' ' 84' ' ' ILE . . . -101.0 138.52 13.89 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.614 ' CG2' HD13 ' A' ' 84' ' ' ILE . 53.7 t -121.88 134.62 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.022 -1.281 . . . . 0.0 110.361 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.52 HD13 ' CE ' ' A' ' 56' ' ' MET . 64.2 tp -117.76 129.22 55.56 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.088 0.47 . . . . 0.0 110.602 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.611 HD12 HG22 ' A' ' 33' ' ' VAL . 95.1 mt -110.66 107.39 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.981 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.534 ' CD1' HG13 ' A' ' 43' ' ' VAL . 58.6 t80 -92.95 122.91 35.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.117 -0.989 . . . . 0.0 109.541 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.6 t -120.74 130.93 74.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 122.264 1.031 . . . . 0.0 111.132 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.576 ' HB3' ' OD1' ' A' ' 73' ' ' ASP . . . -102.5 94.83 5.87 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.123 178.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.827 HG21 ' CE1' ' A' ' 7' ' ' PHE . 34.3 m -63.92 -19.48 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.094 -1.004 . . . . 0.0 111.236 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.411 ' CB ' ' OG1' ' A' ' 38' ' ' THR . 79.8 mm-40 -68.17 -43.08 78.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.879 -1.138 . . . . 0.0 109.602 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.576 ' OD1' ' HB3' ' A' ' 70' ' ' ALA . 32.3 p30 -102.88 5.78 38.73 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.336 -0.852 . . . . 0.0 110.536 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 109' ' ' PHE . 34.1 tttt 54.53 49.85 17.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.987 -1.07 . . . . 0.0 111.236 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 73' ' ' ASP . 72.5 p -126.53 167.21 15.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.142 -0.973 . . . . 0.0 109.927 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -141.09 144.52 34.96 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.424 -0.798 . . . . 0.0 109.865 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.492 HG21 HG11 ' A' ' 43' ' ' VAL . 55.7 t -131.26 136.46 57.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.693 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 81.4 mt -116.44 126.96 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.926 -1.108 . . . . 0.0 110.71 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -129.51 113.57 15.03 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.6 -0.688 . . . . 0.0 110.145 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -102.1 148.53 17.69 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -61.41 174.79 0.67 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.673 -0.898 . . . . 0.0 109.27 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.1 -24.79 60.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.14 -0.975 . . . . 0.0 111.068 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.509 ' O ' HG12 ' A' ' 87' ' ' VAL . . . -65.9 -51.96 41.63 Favored Glycine 0 N--CA 1.496 2.654 0 C-N-CA 119.711 -1.233 . . . . 0.0 111.452 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.985 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.6 mt -66.48 -43.93 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.811 -1.405 . . . . 0.0 108.048 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -62.2 -38.9 90.9 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 111.434 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -76.98 -23.41 52.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.934 -1.104 . . . . 0.0 112.322 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.974 HG13 HG13 ' A' ' 88' ' ' VAL . 11.2 p -98.35 -24.77 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.731 -1.231 . . . . 0.0 112.579 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.985 HG22 ' O ' ' A' ' 84' ' ' ILE . 14.3 m -117.32 163.37 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.631 -1.293 . . . . 0.0 111.519 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.415 ' OG ' ' N ' ' A' ' 90' ' ' ASP . 6.2 t -105.06 179.71 4.19 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.24 -0.912 . . . . 0.0 111.843 -178.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.415 ' N ' ' OG ' ' A' ' 89' ' ' SER . 64.1 t0 -62.0 -38.04 87.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.464 -0.773 . . . . 0.0 110.051 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -62.94 -36.97 85.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.177 -0.952 . . . . 0.0 109.31 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.718 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 51.7 t80 -65.69 -26.97 68.01 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.305 -0.958 . . . . 0.0 108.92 177.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.693 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.6 m95 -84.73 -28.44 26.28 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 122.026 0.917 . . . . 0.0 110.021 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -58.01 -37.32 74.06 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.742 -0.599 . . . . 0.0 112.471 -176.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.5 p -65.9 -32.57 74.15 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 118.627 -1.229 . . . . 0.0 109.15 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.27 10.1 m -59.95 -48.25 82.47 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.33 1.062 . . . . 0.0 111.609 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -69.9 -36.99 75.85 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.531 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -64.22 -43.72 94.12 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.584 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.28 -51.41 66.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.919 -1.113 . . . . 0.0 111.01 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.93 -41.98 90.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.3 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.4 -45.14 92.41 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.255 -0.903 . . . . 0.0 111.851 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.8 tp -63.11 -42.3 99.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.164 -0.96 . . . . 0.0 111.789 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.461 ' HB3' ' CA ' ' A' ' 112' ' ' GLY . 21.4 tp60 -72.55 -39.98 67.05 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.641 -1.224 . . . . 0.0 108.634 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -59.24 -38.32 79.7 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -61.59 -35.72 78.63 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.315 0.579 . . . . 0.0 109.885 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -75.12 -18.61 60.2 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 109.301 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.95 0.96 45.38 Favored Glycine 0 N--CA 1.486 1.992 0 C-N-CA 119.948 -1.12 . . . . 0.0 110.737 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -98.79 95.55 7.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.75 -1.441 . . . . 0.0 109.843 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 74' ' ' LYS . 21.7 m-30 -64.72 -41.23 96.12 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.815 -0.553 . . . . 0.0 111.175 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -64.35 -50.1 69.05 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.274 -0.891 . . . . 0.0 111.831 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -62.36 -34.54 76.87 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.014 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.461 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -66.72 -47.89 65.1 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.331 -1.414 . . . . 0.0 109.733 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.491 ' HB3' HD11 ' A' ' 16' ' ' ILE . 83.5 mt -63.37 -45.0 93.17 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.263 -1.139 . . . . 0.0 111.989 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.493 HG13 ' N ' ' A' ' 115' ' ' ASP . 11.9 p -67.25 -44.9 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.943 -1.098 . . . . 0.0 110.908 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.493 ' N ' HG13 ' A' ' 114' ' ' VAL . 13.4 m-20 -64.94 -37.34 87.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 110.38 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.31 -42.77 99.14 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.41 -43.93 97.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.331 -1.099 . . . . 0.0 109.882 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -57.67 -51.73 68.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.045 -1.034 . . . . 0.0 110.165 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -62.6 -43.09 99.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.222 -0.924 . . . . 0.0 109.172 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.91 -45.36 86.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.463 -0.773 . . . . 0.0 109.998 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.26 -42.62 99.24 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.0 mtt -66.33 -45.55 79.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.959 -1.318 . . . . 0.0 109.651 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.718 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -63.75 -44.67 92.78 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.522 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 42.0 mt -62.3 -39.78 94.12 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.95 -34.67 63.47 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.355 -0.841 . . . . 0.0 110.716 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -62.94 -41.67 99.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.118 -0.989 . . . . 0.0 109.886 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -78.01 -36.69 48.46 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.392 -0.817 . . . . 0.0 110.252 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -127.87 94.43 37.1 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.393 -0.817 . . . . 0.0 109.527 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.76 143.7 62.55 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 123.882 1.464 . . . . 0.0 110.266 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 44.5 t90 -72.41 130.46 40.77 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.306 -0.871 . . . . 0.0 111.264 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 97.6 mttt -109.02 153.03 24.19 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.71 -32.74 71.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.79 -1.194 . . . . 0.0 111.564 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -88.62 8.49 28.19 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.053 -1.059 . . . . 0.0 110.733 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.477 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 65.9 t0 -42.86 137.3 2.36 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.89 0.852 . . . . 0.0 111.538 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.545 HD13 ' H ' ' A' ' 135' ' ' ILE . 0.1 OUTLIER -107.62 133.08 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 O-C-N 121.488 -0.758 . . . . 0.0 111.381 -178.327 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -112.39 99.55 8.09 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.327 -0.858 . . . . 0.0 109.306 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -98.51 -15.55 19.52 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.826 -1.171 . . . . 0.0 111.541 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.535 HD23 ' HD2' ' A' ' 32' ' ' ARG . 3.1 mp -94.98 144.17 27.35 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.235 -0.916 . . . . 0.0 110.47 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -72.55 169.71 21.16 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.665 1.35 . . . . 0.0 109.222 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.481 ' OD1' HG22 ' A' ' 20' ' ' ILE . 65.4 m-80 -110.02 8.73 24.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.839 -1.163 . . . . 0.0 110.322 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.1 p -67.22 166.57 13.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.071 -1.018 . . . . 0.0 111.316 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.51 HD11 ' CG2' ' A' ' 16' ' ' ILE . 96.4 mt -90.04 136.45 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.59 -0.694 . . . . 0.0 110.395 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.1 m -88.99 137.12 32.6 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.143 -0.973 . . . . 0.0 109.617 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.486 ' HD3' HG22 ' A' ' 4' ' ' ILE . 99.6 mttt -133.1 147.26 52.15 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.117 -0.989 . . . . 0.0 110.695 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.43 0 CA-C-O 117.86 -1.522 . . . . 0.0 109.892 -179.502 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.049 0.452 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 m -77.44 145.31 37.2 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.191 -0.943 . . . . 0.0 110.524 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -120.47 150.08 41.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.153 -0.967 . . . . 0.0 109.286 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.1 pt -93.05 -1.55 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.113 -0.992 . . . . 0.0 111.016 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -67.94 -35.86 79.15 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.013 -1.054 . . . . 0.0 110.717 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -93.02 90.88 7.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 110.418 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.791 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 78.7 m-85 -62.18 -43.22 99.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.134 -0.979 . . . . 0.0 110.476 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.481 HD23 ' OE1' ' A' ' 12' ' ' GLU . 94.4 mt -130.8 146.12 52.16 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.271 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m -80.23 168.25 19.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.071 -1.018 . . . . 0.0 109.228 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 14' ' ' LYS . . . -52.43 -39.26 60.81 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.691 -1.255 . . . . 0.0 109.871 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.84 -42.25 90.72 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.679 -0.638 . . . . 0.0 111.404 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.481 ' OE1' HD23 ' A' ' 8' ' ' LEU . 90.6 mt-10 -70.7 -44.21 67.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.923 -1.111 . . . . 0.0 110.174 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.499 ' O ' HG23 ' A' ' 17' ' ' VAL . 96.2 mt-10 -67.17 -33.45 75.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.011 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 86.9 tttt -64.59 -45.67 85.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.682 -1.261 . . . . 0.0 110.306 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.77 -42.7 94.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.023 -1.048 . . . . 0.0 111.501 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.722 HG13 HG22 ' A' ' 114' ' ' VAL . 19.3 tt -67.15 -37.56 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.777 -1.202 . . . . 0.0 110.977 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 13' ' ' GLU . 68.4 t -64.36 -41.22 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -61.62 -37.32 83.54 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.211 -0.996 . . . . 0.0 108.648 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.23 87.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.435 -0.79 . . . . 0.0 109.845 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 17' ' ' VAL . 95.1 mt -63.81 -42.87 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.153 -0.967 . . . . 0.0 110.001 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -60.35 -42.04 94.89 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.788 0.804 . . . . 0.0 110.299 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -65.12 -36.78 85.35 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.249 -0.581 . . . . 0.0 110.162 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.22 95.49 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.108 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.78 -14.58 33.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.056 -1.028 . . . . 0.0 110.519 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.468 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.7 mttt -93.42 -0.21 56.58 Favored 'General case' 0 C--N 1.309 -1.17 0 O-C-N 121.046 -1.034 . . . . 0.0 109.257 176.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -113.04 -13.74 13.05 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 120.835 -1.165 . . . . 0.0 110.608 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 t -153.33 160.3 42.66 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.915 -1.116 . . . . 0.0 110.105 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.1 p -90.91 -10.35 42.82 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.175 -0.953 . . . . 0.0 109.857 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.0 172.35 40.6 Favored Glycine 0 N--CA 1.481 1.685 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.492 ' HB3' HD22 ' A' ' 138' ' ' LEU . 54.3 mp0 -131.61 134.85 46.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.225 -1.162 . . . . 0.0 112.163 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.8 mt -120.84 133.76 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.746 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.1 ttm-85 -138.67 159.19 42.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.958 -1.089 . . . . 0.0 109.677 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 143' ' ' SER . 3.5 p -128.31 137.91 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.405 -0.809 . . . . 0.0 110.743 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -121.2 125.14 46.41 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.503 HD11 ' CG1' ' A' ' 71' ' ' VAL . 40.0 tp -110.92 131.14 55.3 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.892 0.854 . . . . 0.0 111.449 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 76.9 tt0 -147.78 165.34 30.85 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.655 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.7 mttt -79.77 -74.85 0.28 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 112.956 -177.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.8 t -139.36 156.27 47.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.109 -0.995 . . . . 0.0 110.367 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.552 ' HB2' ' CD ' ' A' ' 46' ' ' ARG . 5.9 p -104.27 166.97 10.06 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.701 -0.624 . . . . 0.0 111.198 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -106.67 -8.04 17.07 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.391 -0.818 . . . . 0.0 110.347 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 42' ' ' ASP . 34.3 pt -129.15 -122.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.912 -1.118 . . . . 0.0 110.487 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.414 ' N ' HG13 ' A' ' 41' ' ' ILE . 93.9 m-20 -111.72 137.33 49.77 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.057 -1.652 . . . . 0.0 110.065 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.3 t -63.23 -43.38 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.284 -0.885 . . . . 0.0 111.624 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -59.76 -45.61 91.72 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.763 -1.211 . . . . 0.0 110.094 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -67.26 -39.73 86.12 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.659 -1.276 . . . . 0.0 109.135 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.552 ' CD ' ' HB2' ' A' ' 39' ' ' SER . 77.6 mtp85 -62.24 -45.3 93.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.956 -1.09 . . . . 0.0 110.767 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.58 95.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.969 -1.082 . . . . 0.0 110.416 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.8 ttp -62.91 -43.13 99.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.013 -1.054 . . . . 0.0 109.507 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -65.5 -46.37 79.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.953 -1.092 . . . . 0.0 110.16 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.9 t -65.95 -44.42 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.032 -1.043 . . . . 0.0 110.422 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.433 ' C ' ' CD1' ' A' ' 51' ' ' PHE . 6.5 t80 -57.12 -49.52 75.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.984 -1.073 . . . . 0.0 109.259 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -72.86 -35.59 67.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.967 -1.083 . . . . 0.0 109.413 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -60.47 -39.98 89.58 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.394 -0.816 . . . . 0.0 108.988 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.0 mt -79.23 4.35 15.25 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.624 -0.673 . . . . 0.0 110.081 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 56.48 32.73 21.28 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 121.187 -0.946 . . . . 0.0 111.297 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 94.4 mmm -66.39 -11.68 52.77 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.914 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -79.5 -1.61 38.38 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.771 -1.205 . . . . 0.0 109.89 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -78.28 65.68 3.68 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.032 -1.043 . . . . 0.0 109.603 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.48 HG22 HD11 ' A' ' 138' ' ' LEU . 78.4 p -135.08 150.05 50.18 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -64.05 -43.06 96.68 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.601 -0.687 . . . . 0.0 112.123 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 98.2 mt -96.59 0.15 49.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.789 -1.194 . . . . 0.0 111.502 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 87.8 mt-30 57.26 46.15 19.12 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.497 1.141 . . . . 0.0 111.273 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -120.21 52.85 1.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.094 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.81 138.79 14.09 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.63 HG22 ' HA2' ' A' ' 80' ' ' GLY . 61.2 t -125.54 135.89 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.162 -1.199 . . . . 0.0 110.952 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.1 tp -116.5 125.97 52.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.527 -0.733 . . . . 0.0 109.712 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.0 mt -101.85 106.25 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.118 -1.033 . . . . 0.0 109.389 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -91.89 123.04 34.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.326 -0.859 . . . . 0.0 110.021 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 79.2 t -123.63 130.38 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.494 -0.754 . . . . 0.0 111.003 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.52 108.92 20.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.722 -0.611 . . . . 0.0 109.373 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.791 HG21 ' CZ ' ' A' ' 7' ' ' PHE . 22.8 m -76.11 -19.56 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.891 -1.13 . . . . 0.0 111.56 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.402 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 79.0 mm-40 -69.66 -46.98 64.88 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.656 -1.278 . . . . 0.0 109.259 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -101.78 1.5 37.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.488 -0.757 . . . . 0.0 110.936 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.2 tttt 56.67 47.53 18.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.844 -1.16 . . . . 0.0 110.748 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.8 m -118.22 129.37 55.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.075 -1.016 . . . . 0.0 109.823 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -112.29 138.84 48.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.691 -0.63 . . . . 0.0 110.459 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.14 137.19 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.331 -0.856 . . . . 0.0 109.002 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.68 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 77.6 mt -113.89 128.62 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.933 -1.104 . . . . 0.0 110.398 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -132.56 116.55 16.85 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.535 -0.728 . . . . 0.0 110.78 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.63 ' HA2' HG22 ' A' ' 65' ' ' VAL . . . -100.38 168.98 21.19 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -80.53 178.49 8.29 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.771 -0.841 . . . . 0.0 110.227 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.05 -28.83 70.36 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.218 -0.926 . . . . 0.0 111.166 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -65.66 -54.06 27.89 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.204 -0.998 . . . . 0.0 110.643 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.995 ' O ' HG22 ' A' ' 88' ' ' VAL . 97.3 mt -63.7 -46.89 93.4 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.733 0 O-C-N 120.926 -1.338 . . . . 0.0 107.663 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.83 -38.37 85.22 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.785 -1.197 . . . . 0.0 111.558 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -70.99 -24.89 62.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.035 -1.041 . . . . 0.0 112.238 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.877 HG23 HG13 ' A' ' 88' ' ' VAL . 18.0 m -104.75 -17.14 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.71 -1.244 . . . . 0.0 112.411 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.995 HG22 ' O ' ' A' ' 84' ' ' ILE . 18.4 m -117.73 163.75 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 120.415 -1.428 . . . . 0.0 111.382 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.2 p -109.76 172.56 6.79 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.718 0.771 . . . . 0.0 112.581 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -59.15 -37.26 76.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.424 -0.798 . . . . 0.0 109.398 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -61.21 -39.89 91.93 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.085 -1.009 . . . . 0.0 109.031 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.822 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 69.1 t80 -64.48 -25.33 67.95 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.195 -0.941 . . . . 0.0 109.229 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.68 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.7 m95 -86.99 -26.66 23.67 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.651 0.739 . . . . 0.0 111.183 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -58.48 -34.67 71.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.397 -0.814 . . . . 0.0 112.026 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.9 m -66.16 -32.78 74.42 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.003 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.501 HG22 HD13 ' A' ' 78' ' ' ILE 0.277 9.0 m -60.68 -49.49 77.28 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 122.325 1.059 . . . . 0.0 111.63 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -68.41 -38.08 80.94 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.146 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -64.31 -45.95 85.69 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.491 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.73 -50.56 71.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.884 -1.135 . . . . 0.0 111.707 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.519 HD12 HD11 ' A' ' 78' ' ' ILE . 96.5 mt -65.66 -41.64 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.913 -1.117 . . . . 0.0 109.165 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -64.01 -41.5 97.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.595 -0.691 . . . . 0.0 111.227 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.57 -42.09 99.34 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.156 -0.965 . . . . 0.0 111.331 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.479 ' HB2' ' CA ' ' A' ' 112' ' ' GLY . 96.4 mm-40 -75.71 -41.46 53.5 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.964 -1.095 . . . . 0.0 108.925 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -59.25 -40.9 87.43 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -59.33 -35.98 74.82 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.477 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -77.81 -15.52 59.02 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.046 -1.034 . . . . 0.0 109.901 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.05 3.68 48.36 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.784 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -101.92 91.32 4.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.686 -1.479 . . . . 0.0 110.491 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -61.02 -46.03 92.4 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.343 -0.848 . . . . 0.0 111.556 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.407 ' HD2' ' HB3' ' A' ' 12' ' ' GLU . 62.4 tttm -62.65 -48.24 80.23 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 112.919 -178.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -61.77 -38.03 86.49 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 118.549 -1.26 . . . . 0.0 109.467 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.479 ' CA ' ' HB2' ' A' ' 103' ' ' GLN . . . -64.94 -46.05 90.53 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 71.7 mt -63.68 -45.47 89.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.31 -1.112 . . . . 0.0 110.747 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.722 HG22 HG13 ' A' ' 16' ' ' ILE . 95.5 t -66.88 -46.77 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.012 -1.055 . . . . 0.0 110.816 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -64.76 -38.95 92.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.012 -1.055 . . . . 0.0 110.203 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.44 -42.33 97.64 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.1 mt -63.97 -44.07 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -1.142 . . . . 0.0 109.837 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -60.12 -46.73 88.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.088 -1.008 . . . . 0.0 109.455 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -63.53 -41.83 98.46 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.188 -1.005 . . . . 0.0 108.587 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 124' ' ' LEU . . . -59.13 -42.66 91.14 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.836 -0.745 . . . . 0.0 109.539 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.66 -44.12 96.89 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 57.5 ttm -67.58 -48.5 66.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.135 -1.214 . . . . 0.0 109.935 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.822 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -61.72 -46.13 90.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.953 -1.092 . . . . 0.0 109.276 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.407 ' CG ' ' O ' ' A' ' 120' ' ' ALA . 88.3 mt -62.69 -39.34 93.68 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.511 -0.743 . . . . 0.0 109.054 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.44 -34.67 61.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.244 -0.91 . . . . 0.0 110.459 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -61.38 -39.96 92.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.03 -1.044 . . . . 0.0 109.183 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -80.2 -31.97 38.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.884 . . . . 0.0 109.468 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -132.54 93.12 25.58 Favored Pre-proline 0 N--CA 1.485 1.296 0 O-C-N 121.532 -0.73 . . . . 0.0 109.956 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.64 146.48 73.49 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.816 1.429 . . . . 0.0 109.457 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.468 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 64.3 t90 -71.26 132.11 44.46 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.157 -0.965 . . . . 0.0 110.951 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -110.13 147.52 33.52 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -55.79 -28.45 56.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.054 -1.029 . . . . 0.0 110.878 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 40.7 p-10 -92.91 9.25 36.26 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.027 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.416 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 61.1 t0 -42.55 135.85 2.65 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.882 0.848 . . . . 0.0 111.163 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.715 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -113.32 141.91 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.578 0.704 . . . . 0.0 111.247 -177.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -98.75 93.17 5.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.994 -1.066 . . . . 0.0 110.172 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.541 ' C ' HD12 ' A' ' 138' ' ' LEU . 99.7 mt-10 -68.2 -39.45 82.44 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.904 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.541 HD12 ' C ' ' A' ' 137' ' ' GLU . 11.1 mp -105.77 151.04 39.82 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.204 -0.935 . . . . 0.0 110.737 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -75.45 -174.15 1.88 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.639 1.336 . . . . 0.0 108.763 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -118.64 3.61 11.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.575 -1.328 . . . . 0.0 110.03 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.9 m -60.96 137.08 58.25 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.852 -1.155 . . . . 0.0 110.835 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.4 mt -67.34 136.69 26.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.698 -0.626 . . . . 0.0 110.175 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 3.5 m -92.97 134.08 35.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.401 -0.812 . . . . 0.0 109.244 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -132.9 149.6 52.23 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -0.936 . . . . 0.0 109.898 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 CA-C-O 117.908 -1.496 . . . . 0.0 109.844 -179.605 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mtp . . . . . 0 N--CA 1.496 1.863 0 CA-C-O 121.348 0.594 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.8 p -156.69 158.31 36.72 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.246 -0.909 . . . . 0.0 109.873 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -83.92 -11.6 56.65 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.036 -1.04 . . . . 0.0 111.188 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.792 HG22 ' OE1' ' A' ' 13' ' ' GLU . 49.9 pt -124.46 161.7 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.021 -1.049 . . . . 0.0 109.936 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.444 ' HG3' ' HB3' ' A' ' 7' ' ' PHE . 17.5 pt-20 -151.61 -166.73 2.59 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.528 -0.732 . . . . 0.0 109.652 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -63.42 -33.93 76.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.019 -1.051 . . . . 0.0 110.276 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.559 ' CE2' HD12 ' A' ' 8' ' ' LEU . 29.4 t80 -46.06 -72.27 0.06 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.402 -0.811 . . . . 0.0 110.569 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.559 HD12 ' CE2' ' A' ' 7' ' ' PHE . 92.3 mt -132.86 153.16 51.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.173 -0.954 . . . . 0.0 110.406 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.8 p -82.2 169.79 16.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.935 -1.103 . . . . 0.0 109.867 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.424 ' HB2' HG21 ' A' ' 4' ' ' ILE . . . -52.53 -40.51 62.54 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.939 -1.101 . . . . 0.0 109.555 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.01 -46.91 87.13 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.529 -0.732 . . . . 0.0 110.401 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.67 -46.27 66.47 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.035 -1.041 . . . . 0.0 111.125 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.792 ' OE1' HG22 ' A' ' 4' ' ' ILE . 98.6 mt-10 -63.03 -37.94 89.21 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.124 -0.985 . . . . 0.0 109.917 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 87.8 tttt -63.64 -44.72 93.01 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.442 -0.786 . . . . 0.0 111.239 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.18 -42.65 93.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.956 -1.09 . . . . 0.0 111.375 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.651 HG13 HG22 ' A' ' 114' ' ' VAL . 18.4 tt -67.81 -37.53 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.701 -1.249 . . . . 0.0 110.351 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.609 ' HA ' HD12 ' A' ' 20' ' ' ILE . 46.9 t -62.68 -42.68 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -61.77 -37.88 85.93 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.574 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.03 -36.58 79.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.334 -0.854 . . . . 0.0 109.188 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.879 HG22 ' OD1' ' A' ' 140' ' ' ASN . 96.7 mt -64.25 -43.66 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.363 -0.836 . . . . 0.0 109.696 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -58.78 -41.57 86.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.245 -0.909 . . . . 0.0 109.921 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -64.65 -37.53 87.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.501 -0.75 . . . . 0.0 111.664 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.45 ' O ' HG22 ' A' ' 27' ' ' THR . . . -64.92 -39.99 94.36 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.831 -1.168 . . . . 0.0 110.021 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -60.53 -15.59 28.96 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.062 -1.024 . . . . 0.0 111.097 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.6 mttt -92.93 -6.23 49.01 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.16 -0.962 . . . . 0.0 109.006 177.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -105.72 -13.72 15.47 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 121.085 -1.009 . . . . 0.0 109.742 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 23' ' ' ALA . 4.5 t -151.55 156.93 41.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.026 -1.046 . . . . 0.0 110.318 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.4 t -86.6 -6.9 58.75 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.354 -0.841 . . . . 0.0 109.019 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.86 173.31 50.26 Favored Glycine 0 N--CA 1.481 1.64 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.42 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 52.5 mp0 -132.35 137.4 47.37 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.147 -1.208 . . . . 0.0 111.677 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 82.4 mt -119.57 134.14 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.682 -0.636 . . . . 0.0 110.293 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HB3' ' CE ' ' A' ' 56' ' ' MET . 75.2 ttt180 -139.73 153.07 47.11 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.054 -1.029 . . . . 0.0 109.906 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.608 HG22 ' HB ' ' A' ' 67' ' ' ILE . 55.8 t -123.53 140.08 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.366 -0.834 . . . . 0.0 111.134 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.465 ' HB2' HD11 ' A' ' 66' ' ' LEU . 64.2 t60 -122.86 133.14 54.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.577 -0.702 . . . . 0.0 109.146 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.646 HD11 HG13 ' A' ' 71' ' ' VAL . 40.6 tp -123.89 136.43 54.35 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.099 0.952 . . . . 0.0 112.086 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.45 ' HG2' ' NH2' ' A' ' 46' ' ' ARG . 48.5 tp10 -151.63 161.95 41.81 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.545 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.1 mttt -73.38 -72.5 0.25 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.929 -1.107 . . . . 0.0 112.417 -177.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 t -142.79 158.03 44.04 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.434 -0.791 . . . . 0.0 109.524 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.425 ' OG ' ' CD ' ' A' ' 46' ' ' ARG . 69.5 m -108.2 172.23 6.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.345 -0.847 . . . . 0.0 111.264 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -107.63 -21.3 12.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.559 -0.713 . . . . 0.0 110.531 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.9 pt -116.88 -121.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.009 -1.057 . . . . 0.0 110.762 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -109.38 132.75 53.84 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.637 -1.289 . . . . 0.0 109.332 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.8 t -62.4 -43.76 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.75 -0.594 . . . . 0.0 111.471 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -59.79 -47.93 83.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.892 -1.13 . . . . 0.0 109.537 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -67.71 -35.64 79.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.943 -1.098 . . . . 0.0 108.246 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.518 ' NH1' HG21 ' A' ' 50' ' ' VAL . 76.0 ttt-85 -64.5 -43.2 94.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 111.414 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.24 -36.86 85.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.749 -1.219 . . . . 0.0 109.985 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.5 ttp -61.21 -42.93 99.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 109.059 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -63.72 -46.77 83.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.004 -1.06 . . . . 0.0 110.249 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.518 HG21 ' NH1' ' A' ' 46' ' ' ARG . 71.8 t -64.85 -43.84 96.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.33 -0.856 . . . . 0.0 109.882 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -59.23 -49.37 78.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.057 -1.027 . . . . 0.0 109.666 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -71.43 -35.82 71.06 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.363 -0.835 . . . . 0.0 109.226 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -62.22 -37.72 86.46 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.266 -0.897 . . . . 0.0 109.327 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.0 mt -82.43 3.93 26.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.914 178.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.2 tttt 54.86 34.8 22.85 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.137 -0.977 . . . . 0.0 111.483 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.821 ' SD ' HD13 ' A' ' 66' ' ' LEU . 94.2 mtp -66.78 -11.44 55.06 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.901 -1.124 . . . . 0.0 110.206 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 44.7 p-10 -77.25 -0.84 26.81 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.94 -1.1 . . . . 0.0 109.927 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -78.54 64.62 3.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.387 -0.821 . . . . 0.0 110.687 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.4 p -135.14 150.3 50.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.21 -0.931 . . . . 0.0 108.951 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.62 -44.54 96.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.283 -0.886 . . . . 0.0 112.707 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 90.6 mt -97.14 1.59 50.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.95 -1.094 . . . . 0.0 111.725 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 61' ' ' LEU . 85.2 mt-30 57.13 38.43 29.01 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.284 1.04 . . . . 0.0 110.913 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.531 ' C ' HD11 ' A' ' 84' ' ' ILE . 99.3 m-20 -112.67 55.21 0.7 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.543 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.404 ' O ' ' CD1' ' A' ' 84' ' ' ILE . . . -101.71 141.16 15.19 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 178.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.474 ' CG2' HD13 ' A' ' 84' ' ' ILE . 49.9 t -124.29 134.72 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.143 -1.21 . . . . 0.0 110.162 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.821 HD13 ' SD ' ' A' ' 56' ' ' MET . 52.2 tp -117.89 129.33 55.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.515 -0.741 . . . . 0.0 110.658 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.608 ' HB ' HG22 ' A' ' 33' ' ' VAL . 97.1 mt -107.64 110.18 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.905 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.435 ' OH ' ' NH2' ' A' ' 46' ' ' ARG . 33.8 t80 -96.71 125.42 41.15 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.189 -0.944 . . . . 0.0 110.318 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.507 ' O ' HD12 ' A' ' 35' ' ' LEU . 55.3 t -125.59 131.73 71.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-O 122.139 0.971 . . . . 0.0 111.165 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.469 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -98.71 108.92 21.73 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.646 HG13 HD11 ' A' ' 35' ' ' LEU . 32.8 m -74.65 -19.37 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.052 -1.03 . . . . 0.0 110.078 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -69.46 -43.45 73.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.075 -1.015 . . . . 0.0 109.336 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -104.22 4.98 34.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.006 -1.059 . . . . 0.0 111.15 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 67.5 tttt 56.06 47.4 19.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.831 -1.168 . . . . 0.0 110.64 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.469 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 22.2 p -123.23 167.61 13.51 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.183 -0.948 . . . . 0.0 110.355 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -147.83 140.84 24.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.555 -0.715 . . . . 0.0 109.993 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 68.7 t -128.38 138.39 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.727 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 79.4 mt -113.62 124.76 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.971 -1.08 . . . . 0.0 110.492 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -130.38 113.75 14.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.504 -0.747 . . . . 0.0 109.717 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.94 170.5 21.82 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -77.35 174.21 11.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.483 -1.01 . . . . 0.0 110.223 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -58.87 -27.81 65.54 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.326 -0.859 . . . . 0.0 110.244 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.491 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -64.78 -50.49 58.2 Favored Glycine 0 N--CA 1.487 2.065 0 C-N-CA 119.687 -1.245 . . . . 0.0 109.99 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.96 ' O ' HG22 ' A' ' 88' ' ' VAL . 4.2 mt -63.54 -46.9 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.835 -1.391 . . . . 0.0 108.552 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -63.26 -33.66 75.98 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.529 -0.732 . . . . 0.0 112.058 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -76.74 -22.98 53.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.739 -1.226 . . . . 0.0 112.532 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.086 HG23 HG13 ' A' ' 88' ' ' VAL . 25.9 m -103.99 -17.85 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.757 -1.214 . . . . 0.0 112.08 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.086 HG13 HG23 ' A' ' 87' ' ' VAL . 4.5 m -120.25 159.52 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.966 -1.084 . . . . 0.0 111.591 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.9 p -104.65 177.25 4.9 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.881 0.848 . . . . 0.0 112.084 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -64.21 -38.74 92.14 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.59 -0.694 . . . . 0.0 109.246 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -60.83 -38.52 85.73 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.877 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 75.2 t80 -64.33 -26.26 68.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -0.941 . . . . 0.0 108.83 177.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.727 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.4 m95 -85.71 -26.68 25.78 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.924 0.869 . . . . 0.0 110.216 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -56.88 -41.13 77.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 112.538 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.2 p -63.19 -31.44 72.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.658 -1.276 . . . . 0.0 109.298 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.281 7.6 m -59.47 -48.35 82.0 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.433 1.111 . . . . 0.0 111.146 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -70.12 -37.17 75.25 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.124 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -63.47 -44.73 93.59 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.177 -1.009 . . . . 0.0 110.883 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.64 -49.03 76.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.743 -1.223 . . . . 0.0 110.881 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.1 -42.3 91.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.176 -0.952 . . . . 0.0 110.059 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -63.38 -43.51 97.41 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.677 -0.64 . . . . 0.0 111.701 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.8 mt -63.96 -43.13 96.74 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.722 -1.236 . . . . 0.0 112.256 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.481 ' HG2' ' N ' ' A' ' 112' ' ' GLY . 27.6 tp60 -72.36 -42.53 65.2 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.666 -1.214 . . . . 0.0 108.72 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -58.5 -39.57 80.42 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.81 -32.16 72.45 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.622 -0.674 . . . . 0.0 109.887 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -80.95 -19.02 45.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.085 -1.01 . . . . 0.0 110.238 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.27 5.87 36.95 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.045 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.407 ' HB2' ' HG3' ' A' ' 103' ' ' GLN . 95.8 m-20 -105.87 89.85 3.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.833 -1.392 . . . . 0.0 110.253 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -63.65 -41.45 98.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.725 -0.609 . . . . 0.0 111.672 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.615 ' O ' HG23 ' A' ' 114' ' ' VAL . 78.5 tttt -62.56 -48.11 80.92 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.888 -1.133 . . . . 0.0 111.721 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.47 ' HB2' ' HG2' ' A' ' 103' ' ' GLN . 88.4 mt-30 -64.41 -37.91 89.19 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.636 -177.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.481 ' N ' ' HG2' ' A' ' 103' ' ' GLN . . . -67.37 -46.32 71.6 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.86 -43.25 93.59 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.533 -0.98 . . . . 0.0 110.48 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.651 HG22 HG13 ' A' ' 16' ' ' ILE . 96.6 t -66.42 -47.13 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.393 -0.817 . . . . 0.0 109.996 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -62.9 -40.57 97.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.247 -0.908 . . . . 0.0 109.164 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.74 -43.51 96.37 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.3 mt -63.55 -43.4 98.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -1.105 . . . . 0.0 110.062 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -60.86 -48.27 82.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.023 -1.048 . . . . 0.0 110.484 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.33 -43.65 97.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.012 -1.055 . . . . 0.0 109.487 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.09 -41.44 83.49 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.388 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.04 -45.61 91.57 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 95.6 mtp -66.16 -46.48 77.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.903 -1.351 . . . . 0.0 109.934 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.877 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -62.06 -46.9 87.09 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.602 -0.686 . . . . 0.0 109.725 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.86 -38.63 91.79 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.449 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.84 -35.12 61.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.868 -1.145 . . . . 0.0 110.273 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.91 -43.95 97.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.144 -0.972 . . . . 0.0 109.047 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -72.49 -39.89 67.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.67 -0.644 . . . . 0.0 109.654 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.421 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 36.7 m-85 -131.4 96.73 20.79 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.485 -0.759 . . . . 0.0 110.505 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 128' ' ' PHE . 43.1 Cg_endo -66.38 150.32 84.48 Favored 'Trans proline' 0 C--N 1.317 -1.124 0 O-C-N 123.739 1.389 . . . . 0.0 110.735 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.475 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 29.4 t90 -73.32 164.1 27.15 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.643 0.735 . . . . 0.0 110.358 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -145.23 153.37 41.26 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.62 -30.83 70.1 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 111.736 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -90.71 8.24 35.51 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 118.926 -1.109 . . . . 0.0 111.224 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -41.95 138.43 1.54 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.632 0.73 . . . . 0.0 111.551 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.772 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.3 pp -113.32 147.65 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 121.542 0.687 . . . . 0.0 110.737 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -102.25 92.78 4.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.689 -1.257 . . . . 0.0 109.358 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.549 ' HG2' HD13 ' A' ' 135' ' ' ILE . 80.3 mm-40 -66.26 -41.05 90.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.725 -0.61 . . . . 0.0 111.749 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.42 ' HB2' ' HG2' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -106.86 151.93 40.74 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.151 -0.968 . . . . 0.0 111.163 -178.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.85 -172.26 0.93 Allowed 'Trans proline' 0 C--N 1.315 -1.233 0 N-CA-C 108.762 -1.284 . . . . 0.0 108.762 178.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.879 ' OD1' HG22 ' A' ' 20' ' ' ILE . 69.4 m-80 -121.42 2.76 10.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.687 -1.258 . . . . 0.0 110.073 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 75.6 p -63.85 173.55 1.76 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -0.913 . . . . 0.0 111.333 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 89.4 mt -101.96 136.14 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.547 0.689 . . . . 0.0 110.779 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.8 t -94.05 136.53 34.25 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.449 -0.782 . . . . 0.0 109.353 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -130.09 138.57 50.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 0.0 110.478 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.081 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.744 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.5 mtm . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.9 p -64.27 -41.78 96.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 110.221 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -113.57 149.95 33.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 110.519 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.419 HG23 ' O ' ' A' ' 4' ' ' ILE . 16.8 tt -94.85 127.37 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.894 . . . . 0.0 110.505 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -69.78 141.67 53.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.5 -0.75 . . . . 0.0 110.371 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -69.93 90.68 0.63 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.071 -1.018 . . . . 0.0 109.386 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.79 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 80.4 m-85 -60.7 -41.61 95.52 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.257 -0.902 . . . . 0.0 109.676 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.5 mt -129.11 148.1 51.03 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.722 -0.611 . . . . 0.0 109.495 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.3 m -63.98 149.93 46.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.899 -1.126 . . . . 0.0 109.172 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.53 -30.77 21.69 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.892 -1.13 . . . . 0.0 110.059 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -72.27 -36.04 68.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.159 -0.963 . . . . 0.0 110.054 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 110' ' ' LYS . 92.7 mt-10 -61.92 -40.78 96.65 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.956 -1.097 . . . . 0.0 108.729 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.658 ' O ' HG23 ' A' ' 17' ' ' VAL . 92.2 mt-10 -61.14 -38.44 86.42 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.729 -0.607 . . . . 0.0 110.178 178.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -60.52 -41.92 95.39 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.514 -0.875 . . . . 0.0 110.431 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.14 78.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.006 -1.059 . . . . 0.0 112.329 -178.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.524 HG13 HG22 ' A' ' 114' ' ' VAL . 16.2 tt -66.53 -31.74 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.59 -1.318 . . . . 0.0 110.215 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 13' ' ' GLU . 55.9 t -64.63 -40.58 89.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -63.97 -35.94 82.34 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.606 -0.837 . . . . 0.0 109.174 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.45 -39.46 93.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.38 -0.825 . . . . 0.0 109.12 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.729 HG22 ' OD1' ' A' ' 140' ' ' ASN . 97.1 mt -64.56 -43.32 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.835 . . . . 0.0 109.862 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -60.78 -41.96 96.57 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.131 -0.981 . . . . 0.0 110.199 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -65.96 -38.22 88.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.512 -0.742 . . . . 0.0 111.147 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.96 -40.41 96.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.859 -1.151 . . . . 0.0 109.956 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.67 -15.59 30.36 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.061 -1.024 . . . . 0.0 110.866 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.474 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 75.4 mmtt -93.8 1.01 56.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.089 -1.007 . . . . 0.0 109.27 177.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -114.81 -14.08 11.97 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.802 -1.186 . . . . 0.0 109.934 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.6 t -151.74 154.52 36.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.875 -1.14 . . . . 0.0 109.753 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 m -84.56 -6.74 59.39 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.291 -0.881 . . . . 0.0 109.805 178.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.9 174.58 54.27 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.775 ' HG2' HD22 ' A' ' 138' ' ' LEU . 51.3 tp10 -133.31 138.2 46.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.272 -1.134 . . . . 0.0 111.665 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 93.5 mt -118.46 134.5 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.712 -0.617 . . . . 0.0 109.835 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.419 ' NE ' ' OG ' ' A' ' 143' ' ' SER . 76.2 ttt180 -139.87 152.17 46.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.89 . . . . 0.0 109.852 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.64 HG22 ' HB ' ' A' ' 67' ' ' ILE . 53.7 t -124.5 140.61 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.368 -0.832 . . . . 0.0 111.464 -178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -125.87 128.3 47.38 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.521 0.677 . . . . 0.0 109.434 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.985 HD11 ' CG1' ' A' ' 71' ' ' VAL . 37.8 tp -118.67 129.84 55.51 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.946 0.879 . . . . 0.0 112.572 -177.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.408 ' HG2' ' N ' ' A' ' 37' ' ' LYS . 84.7 tt0 -145.35 168.09 21.32 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.408 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 98.7 mttt -79.23 -73.6 0.33 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.977 -1.077 . . . . 0.0 112.961 -177.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 t -143.26 158.81 43.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.265 -0.897 . . . . 0.0 110.141 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.425 ' HB3' ' HD3' ' A' ' 46' ' ' ARG . 14.9 p -108.95 171.86 7.19 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.251 -0.906 . . . . 0.0 111.152 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -106.58 -10.68 16.11 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.479 -0.763 . . . . 0.0 110.425 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 42' ' ' ASP . 25.7 pt -125.57 -121.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 120.985 -1.072 . . . . 0.0 109.631 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.402 ' N ' HG13 ' A' ' 41' ' ' ILE . 64.2 m-20 -111.76 138.62 48.1 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 120.393 -1.442 . . . . 0.0 109.017 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 85.2 t -64.28 -43.31 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 111.412 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -59.36 -47.29 85.97 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.95 -1.094 . . . . 0.0 110.778 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -71.34 -38.18 71.66 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.88 -1.137 . . . . 0.0 108.42 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.425 ' HD3' ' HB3' ' A' ' 39' ' ' SER . 79.8 ttt180 -63.54 -40.67 97.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.467 -0.77 . . . . 0.0 110.082 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.44 -38.15 84.08 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.694 -1.254 . . . . 0.0 110.127 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.4 ttp -62.09 -44.22 97.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.969 -1.082 . . . . 0.0 109.901 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -63.35 -44.64 94.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.082 -1.011 . . . . 0.0 109.571 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 46' ' ' ARG . 95.7 t -65.81 -43.72 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.586 -0.696 . . . . 0.0 110.088 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.474 ' CE2' ' OD1' ' A' ' 57' ' ' ASP . 71.4 t80 -58.66 -45.95 88.24 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.065 -1.022 . . . . 0.0 109.435 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -73.07 -35.77 66.72 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.849 -1.157 . . . . 0.0 109.558 178.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -60.79 -37.34 81.6 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.025 -1.047 . . . . 0.0 109.955 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.3 mt -82.08 5.72 18.61 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.098 -1.001 . . . . 0.0 110.308 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.423 ' HB3' ' ND2' ' A' ' 58' ' ' ASN . 98.6 mttt 54.78 34.65 22.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.793 -1.192 . . . . 0.0 111.43 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.691 ' SD ' HD13 ' A' ' 66' ' ' LEU . 93.4 mtp -67.05 -12.47 60.01 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.957 -1.097 . . . . 0.0 109.641 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.474 ' OD1' ' CE2' ' A' ' 51' ' ' PHE . 92.3 m-20 -75.09 -2.13 26.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.664 -1.272 . . . . 0.0 109.9 177.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.423 ' ND2' ' HB3' ' A' ' 55' ' ' LYS . 64.9 m-20 -74.2 61.37 0.86 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.828 -1.17 . . . . 0.0 109.937 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.4 m -132.47 144.17 50.28 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.162 -0.961 . . . . 0.0 108.875 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.31 -42.81 99.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.821 -0.549 . . . . 0.0 112.405 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.5 mt -98.51 2.4 47.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.101 -0.999 . . . . 0.0 111.595 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 55.87 36.54 27.49 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.076 0.941 . . . . 0.0 111.542 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.496 ' C ' HD11 ' A' ' 84' ' ' ILE . 97.7 m-20 -113.13 50.2 0.9 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.338 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.68 142.53 16.15 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.762 -2.135 . . . . 0.0 107.762 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.457 HG22 HD13 ' A' ' 84' ' ' ILE . 54.9 t -123.73 133.91 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.103 -1.234 . . . . 0.0 109.924 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.691 HD13 ' SD ' ' A' ' 56' ' ' MET . 44.5 tp -116.37 129.05 56.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 110.536 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.64 ' HB ' HG22 ' A' ' 33' ' ' VAL . 78.0 mt -107.65 108.93 26.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.369 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -95.59 125.4 40.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -0.853 . . . . 0.0 109.913 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.568 HG21 HD21 ' A' ' 113' ' ' LEU . 54.7 t -122.4 133.23 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.095 0.95 . . . . 0.0 110.769 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.595 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -101.48 91.59 4.53 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.985 ' CG1' HD11 ' A' ' 35' ' ' LEU . 26.0 m -64.54 -23.71 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.018 -1.051 . . . . 0.0 110.892 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 37.9 tp10 -67.61 -44.18 78.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.062 -1.024 . . . . 0.0 108.741 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.647 ' O ' HG23 ' A' ' 75' ' ' THR . 87.0 m-20 -101.5 8.89 41.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.371 -0.83 . . . . 0.0 110.982 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.4 tttt 51.49 41.47 28.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.909 -1.119 . . . . 0.0 110.42 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.647 HG23 ' O ' ' A' ' 73' ' ' ASP . 81.2 p -121.32 169.43 10.6 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.226 -0.921 . . . . 0.0 109.529 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -151.24 145.3 25.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.758 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.1 t -132.06 135.97 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.659 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 76.4 mt -112.86 123.34 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.758 -1.214 . . . . 0.0 110.533 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -129.32 111.65 13.06 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.472 -0.767 . . . . 0.0 110.797 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -98.34 173.47 27.48 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -76.57 173.28 11.75 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.587 -0.949 . . . . 0.0 109.66 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.81 -22.94 62.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.893 . . . . 0.0 110.815 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.94 -50.6 45.82 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.825 -1.179 . . . . 0.0 110.523 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.954 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.7 mt -64.25 -46.92 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.886 -1.361 . . . . 0.0 108.655 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -61.37 -37.97 85.3 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.768 -1.207 . . . . 0.0 111.949 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -72.02 -22.12 61.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.684 -1.26 . . . . 0.0 111.832 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.093 HG13 HG13 ' A' ' 88' ' ' VAL . 7.5 p -102.09 -21.62 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.967 -1.083 . . . . 0.0 113.21 -178.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.093 HG13 HG13 ' A' ' 87' ' ' VAL . 30.0 m -123.36 166.66 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.641 -1.287 . . . . 0.0 111.367 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 m -112.11 -175.56 2.71 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.271 -0.893 . . . . 0.0 113.165 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -62.44 -39.75 94.36 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.835 . . . . 0.0 110.18 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -61.64 -38.63 88.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.123 -0.985 . . . . 0.0 110.112 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.725 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 68.8 t80 -65.9 -27.69 68.39 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.204 -0.935 . . . . 0.0 109.123 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.659 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.5 m95 -86.72 -27.02 23.93 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.207 1.003 . . . . 0.0 110.278 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -55.99 -42.18 75.94 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.97 -1.081 . . . . 0.0 112.471 -176.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 88.1 m -62.95 -31.99 73.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.809 -1.182 . . . . 0.0 109.037 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.474 HG22 HD13 ' A' ' 78' ' ' ILE 0.286 8.7 m -58.88 -48.9 79.77 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.688 1.232 . . . . 0.0 110.732 179.686 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.65 -38.46 80.47 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.777 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.416 ' O ' HD23 ' A' ' 102' ' ' LEU . 11.5 m120 -63.95 -42.69 97.23 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.989 -1.084 . . . . 0.0 110.177 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.02 -49.17 78.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.292 -1.505 . . . . 0.0 110.598 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.575 HD12 HD11 ' A' ' 78' ' ' ILE . 90.9 mt -67.99 -42.48 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.15 -0.969 . . . . 0.0 110.482 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -63.08 -46.31 88.0 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.009 -1.057 . . . . 0.0 111.889 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.416 HD23 ' O ' ' A' ' 98' ' ' ASN . 3.5 mm? -64.08 -42.38 96.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.991 -1.068 . . . . 0.0 112.298 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.468 ' HB2' ' HA3' ' A' ' 112' ' ' GLY . 99.4 mm-40 -71.67 -41.38 68.78 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.923 -1.111 . . . . 0.0 109.017 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.463 ' CE1' HG23 ' A' ' 100' ' ' ILE . 4.7 m-85 -60.15 -40.09 88.65 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.08 -32.99 72.64 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.004 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -81.55 -17.64 47.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.091 -1.006 . . . . 0.0 109.503 177.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.54 11.04 29.88 Favored Glycine 0 N--CA 1.494 2.506 0 O-C-N 121.112 -0.993 . . . . 0.0 110.781 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -108.71 89.47 3.0 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.829 -1.395 . . . . 0.0 110.781 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -63.48 -44.22 95.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.439 -0.788 . . . . 0.0 111.577 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.404 ' HD2' ' HB3' ' A' ' 12' ' ' GLU . 61.9 tttm -62.82 -49.07 76.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.143 -0.973 . . . . 0.0 112.269 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -64.61 -38.67 91.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.054 -1.029 . . . . 0.0 110.055 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.468 ' HA3' ' HB2' ' A' ' 103' ' ' GLN . . . -63.93 -44.12 96.48 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.568 HD21 HG21 ' A' ' 69' ' ' VAL . 76.6 mt -66.81 -44.9 79.97 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.339 -1.095 . . . . 0.0 110.254 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.524 HG22 HG13 ' A' ' 16' ' ' ILE . 74.8 t -66.12 -47.13 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.423 -0.798 . . . . 0.0 110.679 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -63.17 -39.09 93.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.009 -1.057 . . . . 0.0 109.248 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.76 -42.28 99.71 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.52 -44.28 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.233 -1.157 . . . . 0.0 110.72 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.51 -48.45 80.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.979 -1.076 . . . . 0.0 109.757 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.99 -40.33 97.44 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.395 -0.816 . . . . 0.0 108.865 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.56 97.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.442 -0.787 . . . . 0.0 110.59 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.81 -42.55 98.47 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 98.2 mtp -65.41 -48.56 72.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -1.17 . . . . 0.0 110.261 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.725 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -62.41 -44.67 95.87 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.538 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.18 -39.61 95.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -0.851 . . . . 0.0 109.237 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.6 -34.5 58.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.066 -1.021 . . . . 0.0 110.123 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -61.88 -43.72 98.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.932 . . . . 0.0 109.32 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.458 ' HB3' ' CE2' ' A' ' 128' ' ' PHE . 68.2 m-85 -70.93 -37.44 72.87 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.819 0.819 . . . . 0.0 109.36 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.458 ' CE2' ' HB3' ' A' ' 127' ' ' TYR . 88.1 m-85 -132.5 98.51 16.56 Favored Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.174 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.08 150.85 77.68 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 O-C-N 123.696 1.367 . . . . 0.0 109.706 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.474 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 51.9 t90 -76.1 127.4 32.86 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.418 -0.801 . . . . 0.0 110.817 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -105.17 146.78 28.76 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -56.46 -29.92 62.28 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.214 -0.929 . . . . 0.0 111.087 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -90.85 8.86 32.75 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.099 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -42.94 138.5 2.01 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.19 -0.944 . . . . 0.0 111.187 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 135' ' ' ILE . 0.1 OUTLIER -110.92 134.4 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-O 121.995 0.902 . . . . 0.0 111.473 -176.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 41.4 p-10 -116.96 102.48 9.39 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.446 -0.784 . . . . 0.0 110.583 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -102.17 -12.07 18.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.739 -1.226 . . . . 0.0 111.734 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.775 HD22 ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -93.11 140.97 23.49 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.977 -1.077 . . . . 0.0 110.676 -179.358 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.2 171.94 14.99 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.349 1.184 . . . . 0.0 109.108 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.729 ' OD1' HG22 ' A' ' 20' ' ' ILE . 68.3 m-80 -112.11 7.21 19.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.715 -1.24 . . . . 0.0 110.617 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.8 t -64.06 148.01 50.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.955 -1.091 . . . . 0.0 111.332 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 93.5 mt -76.2 139.61 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.56 -0.713 . . . . 0.0 110.351 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.419 ' OG ' ' NE ' ' A' ' 32' ' ' ARG . 17.6 m -94.09 135.96 34.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.158 -0.964 . . . . 0.0 110.272 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -128.77 140.97 51.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.278 -0.889 . . . . 0.0 110.667 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.974 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.4 mtp . . . . . 0 N--CA 1.506 2.343 0 CA-C-O 121.073 0.463 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.9 m -63.35 -41.23 98.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.061 -1.024 . . . . 0.0 110.097 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -128.16 143.84 51.08 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.277 -0.89 . . . . 0.0 110.089 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.3 pt -102.96 1.36 10.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 O-C-N 121.633 -0.667 . . . . 0.0 110.326 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.36 -38.29 88.98 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.799 -1.188 . . . . 0.0 109.385 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -123.05 122.93 39.69 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.321 -0.862 . . . . 0.0 110.331 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.904 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 64.1 m-85 -64.92 -40.6 95.3 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.525 -0.734 . . . . 0.0 111.846 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.45 HD22 ' OE1' ' A' ' 12' ' ' GLU . 84.8 mt -128.19 143.86 51.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.953 -1.092 . . . . 0.0 109.584 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.507 HG22 ' N ' ' A' ' 10' ' ' ALA . 75.8 m -74.45 167.61 21.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.91 -1.119 . . . . 0.0 109.746 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.507 ' N ' HG22 ' A' ' 9' ' ' THR . . . -53.49 -34.9 59.73 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.996 -1.065 . . . . 0.0 109.522 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -60.32 -46.74 88.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.117 -0.99 . . . . 0.0 110.81 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.45 ' OE1' HD22 ' A' ' 8' ' ' LEU . 96.1 mt-10 -72.79 -46.98 50.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.985 -1.072 . . . . 0.0 111.775 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.542 ' O ' HG23 ' A' ' 17' ' ' VAL . 96.7 mt-10 -60.15 -40.71 90.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.983 -1.073 . . . . 0.0 110.021 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 72.3 mmtt -63.84 -42.93 97.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.108 -0.995 . . . . 0.0 110.805 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.05 -42.94 93.78 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.99 -1.068 . . . . 0.0 111.559 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 13' ' ' GLU . 19.4 tt -68.88 -36.86 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.72 -1.238 . . . . 0.0 110.379 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 13' ' ' GLU . 48.4 t -61.26 -42.4 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -61.54 -36.48 80.72 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.507 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.67 -40.75 93.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.419 -0.8 . . . . 0.0 109.26 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.64 -42.56 96.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.345 -0.847 . . . . 0.0 109.348 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -58.64 -42.88 89.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.818 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -64.9 -37.46 87.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.179 -0.951 . . . . 0.0 111.167 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.03 -39.31 93.17 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.779 -1.2 . . . . 0.0 110.522 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.2 -15.94 28.85 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.894 -1.129 . . . . 0.0 110.351 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.478 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 98.5 mttt -93.2 0.37 57.1 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 120.927 -1.108 . . . . 0.0 109.417 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -112.55 -15.62 13.02 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.714 -1.241 . . . . 0.0 109.816 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.3 t -153.64 157.59 39.85 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.906 -1.121 . . . . 0.0 110.326 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.2 m -85.57 -9.2 57.67 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.326 -0.859 . . . . 0.0 110.193 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.86 172.29 46.54 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.413 ' CB ' HD12 ' A' ' 138' ' ' LEU . 53.6 mp0 -131.18 134.04 46.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.287 -1.125 . . . . 0.0 112.268 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.429 HD11 HD12 ' A' ' 124' ' ' LEU . 97.1 mt -118.9 133.86 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.305 0.574 . . . . 0.0 109.807 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.502 ' NH1' HD13 ' A' ' 54' ' ' LEU . 72.4 ttt180 -139.79 152.09 46.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.429 -0.794 . . . . 0.0 110.063 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.719 HG22 HD12 ' A' ' 67' ' ' ILE . 83.9 t -122.64 138.77 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.36 -0.838 . . . . 0.0 110.71 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.464 ' HB2' HD11 ' A' ' 66' ' ' LEU . 75.3 t60 -122.82 132.32 54.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 0.0 108.933 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.945 HD11 ' CG1' ' A' ' 71' ' ' VAL . 32.9 tp -118.07 131.63 56.43 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.024 0.916 . . . . 0.0 111.557 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -150.38 164.88 34.74 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 67.4 mttm -79.39 -74.74 0.27 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.04 -1.038 . . . . 0.0 113.419 -177.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 t -141.39 160.28 40.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.414 -0.804 . . . . 0.0 110.906 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.421 ' OG ' ' CD ' ' A' ' 46' ' ' ARG . 25.7 m -108.9 168.02 9.66 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.661 -0.649 . . . . 0.0 110.997 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -107.82 -12.0 15.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 110.7 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 42' ' ' ASP . 29.3 pt -123.75 -122.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.984 -1.073 . . . . 0.0 109.321 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 41' ' ' ILE . 96.6 m-20 -110.53 136.33 49.82 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 120.204 -1.56 . . . . 0.0 108.973 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.9 t -62.96 -43.49 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.475 -0.766 . . . . 0.0 111.734 -178.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -59.24 -45.1 92.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.999 -1.063 . . . . 0.0 109.952 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -70.23 -37.97 75.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.897 -1.127 . . . . 0.0 108.327 177.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.421 ' CD ' ' OG ' ' A' ' 39' ' ' SER . 44.1 ttt85 -61.3 -41.66 97.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.526 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.4 -37.6 83.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.785 -1.197 . . . . 0.0 110.48 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.4 ttp -64.23 -42.6 96.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.486 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -64.62 -46.83 80.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.902 -1.124 . . . . 0.0 109.841 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.49 -45.67 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.208 -0.932 . . . . 0.0 110.553 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.467 ' CZ ' ' OD1' ' A' ' 81' ' ' ASP . 6.8 t80 -56.84 -47.94 79.21 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.703 -1.248 . . . . 0.0 109.717 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -72.85 -35.88 67.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.995 -1.066 . . . . 0.0 110.088 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -60.47 -39.54 87.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.879 -1.138 . . . . 0.0 109.314 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.502 HD13 ' NH1' ' A' ' 32' ' ' ARG . 96.1 mt -80.66 4.62 18.12 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.094 -1.004 . . . . 0.0 110.531 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 57.33 33.72 23.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.843 -1.161 . . . . 0.0 111.134 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.691 ' SD ' HD13 ' A' ' 66' ' ' LEU . 79.9 mtp -68.77 -26.8 65.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.117 -0.989 . . . . 0.0 109.374 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 39.2 p-10 -71.27 -8.21 52.11 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.202 -0.936 . . . . 0.0 110.586 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -87.98 82.54 7.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.705 -1.247 . . . . 0.0 110.233 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.419 HG23 ' CB ' ' A' ' 137' ' ' GLU . 51.7 m -138.1 156.1 48.1 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.17 -46.86 88.24 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.109 -0.994 . . . . 0.0 111.909 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.6 mt -97.71 2.55 49.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.045 -1.035 . . . . 0.0 111.031 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.415 ' O ' ' CB ' ' A' ' 81' ' ' ASP . 86.6 mt-30 55.49 43.67 28.17 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.481 1.134 . . . . 0.0 111.38 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -118.88 55.66 0.92 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.323 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.56 140.61 14.93 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.512 HG23 ' CD1' ' A' ' 84' ' ' ILE . 74.3 t -124.68 135.4 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.124 -1.221 . . . . 0.0 110.726 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.691 HD13 ' SD ' ' A' ' 56' ' ' MET . 38.8 tp -116.1 126.84 54.28 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.607 -0.683 . . . . 0.0 109.774 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.719 HD12 HG22 ' A' ' 33' ' ' VAL . 96.8 mt -105.41 101.0 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 118.901 -1.12 . . . . 0.0 108.992 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -86.97 123.27 31.89 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.384 -0.822 . . . . 0.0 109.973 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.2 t -119.74 129.6 75.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.855 0.836 . . . . 0.0 110.149 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.514 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -99.2 84.81 3.09 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.945 ' CG1' HD11 ' A' ' 35' ' ' LEU . 30.2 m -58.16 -23.13 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.224 -0.923 . . . . 0.0 111.016 -178.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 49.1 tp10 -66.05 -42.45 89.5 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.234 178.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.584 ' O ' HG23 ' A' ' 75' ' ' THR . 98.2 m-20 -102.31 6.69 40.56 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.198 -0.939 . . . . 0.0 111.007 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.8 tttt 52.84 45.89 27.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.822 -1.174 . . . . 0.0 110.983 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 73' ' ' ASP . 70.1 p -122.76 168.63 11.99 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.237 -0.915 . . . . 0.0 109.625 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 43.7 p90 -146.47 143.18 28.8 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.961 -1.087 . . . . 0.0 111.016 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.0 t -128.98 135.72 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.738 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 80.1 mt -114.45 129.44 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.879 -1.138 . . . . 0.0 110.092 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -136.38 114.42 11.42 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.494 -0.754 . . . . 0.0 110.877 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -101.14 174.82 25.54 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.219 -1.153 . . . . 0.0 110.219 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.467 ' OD1' ' CZ ' ' A' ' 51' ' ' PHE . 32.6 m-20 -79.04 176.01 10.06 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.474 -1.015 . . . . 0.0 110.858 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.57 -27.38 68.59 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.366 -0.834 . . . . 0.0 109.453 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -63.66 -53.01 41.27 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.953 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.962 ' O ' HG22 ' A' ' 88' ' ' VAL . 93.5 mt -65.08 -44.07 95.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.743 -1.445 . . . . 0.0 108.659 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -61.77 -37.1 83.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.626 -1.296 . . . . 0.0 110.698 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -73.34 -21.1 60.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.963 . . . . 0.0 112.19 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.024 HG23 HG13 ' A' ' 88' ' ' VAL . 21.7 m -107.19 -19.83 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.809 -1.182 . . . . 0.0 112.926 -177.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.024 HG13 HG23 ' A' ' 87' ' ' VAL . 16.4 m -119.95 162.79 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.693 -1.254 . . . . 0.0 111.309 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 m -108.54 173.64 6.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.475 -0.766 . . . . 0.0 111.965 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -61.82 -37.24 83.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 110.1 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 34.1 p-10 -61.69 -36.41 80.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.876 . . . . 0.0 109.244 179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.881 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 73.1 t80 -66.73 -25.52 66.56 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.302 -0.874 . . . . 0.0 108.773 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.738 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 3.8 m95 -86.04 -26.19 25.5 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.852 0.834 . . . . 0.0 110.542 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -55.37 -38.99 69.56 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.996 -1.065 . . . . 0.0 112.963 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.4 m -63.22 -35.33 79.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.815 -1.178 . . . . 0.0 109.099 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.283 16.0 m -58.09 -48.5 79.98 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.334 1.064 . . . . 0.0 111.255 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.69 -38.22 83.37 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.518 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.686 ' O ' HD13 ' A' ' 102' ' ' LEU . 21.1 m120 -64.69 -45.12 87.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.988 -1.07 . . . . 0.0 111.015 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.17 -49.91 76.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.712 -1.242 . . . . 0.0 110.448 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.39 -43.26 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.223 -0.923 . . . . 0.0 111.075 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -62.42 -45.12 94.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 0.0 110.905 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.686 HD13 ' O ' ' A' ' 98' ' ' ASN . 7.0 mp -63.85 -41.46 97.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.325 -0.859 . . . . 0.0 111.561 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.455 ' HB2' ' HA3' ' A' ' 112' ' ' GLY . 98.7 mm-40 -73.01 -41.78 63.91 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.714 -1.194 . . . . 0.0 108.756 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -58.72 -38.07 77.53 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -61.46 -34.06 74.8 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.681 -0.637 . . . . 0.0 109.946 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -80.7 -17.59 50.6 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.814 -1.179 . . . . 0.0 110.511 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.75 7.18 42.39 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.678 -1.249 . . . . 0.0 111.167 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -103.99 90.99 3.78 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.773 -1.428 . . . . 0.0 110.259 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -63.1 -40.05 96.5 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.553 -0.717 . . . . 0.0 111.47 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -65.75 -49.52 68.1 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.243 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -64.29 -39.39 93.82 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 118.956 -1.097 . . . . 0.0 110.527 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.455 ' HA3' ' HB2' ' A' ' 103' ' ' GLN . . . -62.72 -48.07 84.18 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.411 ' HB3' HD11 ' A' ' 16' ' ' ILE . 80.8 mt -64.41 -43.2 95.13 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.301 -1.117 . . . . 0.0 109.912 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.4 t -64.81 -48.34 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -0.931 . . . . 0.0 110.509 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -64.66 -39.84 94.38 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.348 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.26 -43.62 99.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 89.2 mt -64.51 -43.56 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.064 -1.256 . . . . 0.0 109.806 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.95 -52.87 62.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.134 -0.979 . . . . 0.0 109.992 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -62.42 -43.05 99.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 108.664 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -53.81 -46.16 71.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.485 -0.76 . . . . 0.0 109.71 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.67 -43.15 99.4 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.437 ' HG2' ' NZ ' ' A' ' 126' ' ' LYS . 27.4 ttt -67.17 -48.91 66.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.895 -1.356 . . . . 0.0 109.669 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.881 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -62.09 -45.94 91.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.935 . . . . 0.0 109.37 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.429 HD12 HD11 ' A' ' 31' ' ' ILE . 77.2 mt -61.86 -40.13 94.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.194 -0.941 . . . . 0.0 108.611 178.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.08 -33.94 63.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.195 -0.941 . . . . 0.0 110.411 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.437 ' NZ ' ' HG2' ' A' ' 122' ' ' MET . 60.9 mttp -61.83 -43.43 98.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.056 -1.028 . . . . 0.0 108.818 178.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.428 ' CE2' HG12 ' A' ' 88' ' ' VAL . 52.5 m-85 -75.1 -39.78 60.45 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.61 0.719 . . . . 0.0 110.071 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.437 ' HE2' HG21 ' A' ' 87' ' ' VAL . 76.9 m-85 -130.65 90.66 39.85 Favored Pre-proline 0 C--N 1.301 -1.518 0 O-C-N 121.706 -0.621 . . . . 0.0 109.426 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -64.78 154.42 72.79 Favored 'Trans proline' 0 C--N 1.318 -1.035 0 O-C-N 123.588 1.309 . . . . 0.0 110.483 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.478 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 31.2 t90 -77.6 133.34 38.47 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.441 0.639 . . . . 0.0 111.962 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -114.6 150.85 34.42 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -58.35 -31.74 67.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.096 -1.003 . . . . 0.0 111.842 -177.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -90.99 6.09 46.17 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.963 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 135' ' ' ILE . 66.9 t0 -42.59 140.07 1.37 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 122.038 0.923 . . . . 0.0 111.667 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.696 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.1 pp -113.42 148.53 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-O 121.857 0.837 . . . . 0.0 111.662 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -105.68 96.65 6.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.465 -1.397 . . . . 0.0 110.036 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.419 ' CB ' HG23 ' A' ' 59' ' ' THR . 79.1 mm-40 -68.15 -37.14 80.72 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.593 -0.692 . . . . 0.0 112.838 -178.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.413 HD12 ' CB ' ' A' ' 30' ' ' GLU . 8.0 mt -109.3 148.45 38.04 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.987 -1.071 . . . . 0.0 111.828 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.39 -176.76 1.77 Allowed 'Trans proline' 0 C--N 1.319 -0.993 0 N-CA-C 108.359 -1.439 . . . . 0.0 108.359 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -116.87 4.35 12.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.587 -1.321 . . . . 0.0 110.204 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.8 p -63.29 169.1 3.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.899 -1.126 . . . . 0.0 110.771 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.0 mt -101.39 139.66 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.581 0.705 . . . . 0.0 110.947 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 32' ' ' ARG . 30.6 t -94.91 134.24 37.77 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.533 -0.729 . . . . 0.0 109.241 178.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -125.74 132.91 52.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.188 -0.945 . . . . 0.0 110.045 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.869 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 121.301 0.572 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.8 m -59.88 -42.37 93.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.925 -1.109 . . . . 0.0 110.403 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.77 -40.92 96.08 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.223 -0.923 . . . . 0.0 110.958 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.407 ' O ' HG13 ' A' ' 4' ' ' ILE . 34.0 pt -123.24 132.23 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.233 -0.917 . . . . 0.0 110.796 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -115.63 -87.98 0.59 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.662 -1.274 . . . . 0.0 110.813 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -119.65 -20.52 7.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.903 -1.123 . . . . 0.0 110.797 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.547 ' CE2' HD22 ' A' ' 35' ' ' LEU . 43.1 t80 -46.97 -72.5 0.05 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.184 -0.948 . . . . 0.0 111.062 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.527 ' CD1' ' CE2' ' A' ' 7' ' ' PHE . 96.2 mt -134.2 159.29 41.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.017 -1.052 . . . . 0.0 111.378 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -83.37 166.25 18.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.68 -0.637 . . . . 0.0 109.503 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.61 -37.05 67.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.121 -0.987 . . . . 0.0 110.086 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -57.72 -45.95 85.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.909 . . . . 0.0 109.868 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.423 ' OE1' HD22 ' A' ' 8' ' ' LEU . 99.4 mt-10 -69.16 -43.88 73.38 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.599 -0.688 . . . . 0.0 112.031 -178.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 17' ' ' VAL . 79.8 mm-40 -65.4 -39.18 91.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.954 -1.091 . . . . 0.0 110.917 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -63.33 -43.18 98.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.808 -1.182 . . . . 0.0 111.113 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.11 -45.55 84.67 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.077 -1.014 . . . . 0.0 112.108 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.587 HG13 HG22 ' A' ' 114' ' ' VAL . 19.6 tt -65.49 -37.43 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.696 -1.252 . . . . 0.0 110.507 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 13' ' ' GLU . 75.6 t -61.58 -39.1 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -0.953 . . . . 0.0 108.799 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -62.05 -36.31 81.25 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.072 -1.051 . . . . 0.0 108.885 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.09 -37.96 87.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.466 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.425 HD11 HD13 ' A' ' 117' ' ' ILE . 37.5 mm -63.72 -43.66 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.294 -0.879 . . . . 0.0 110.083 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.447 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 83.9 mtp180 -60.18 -41.59 93.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.347 -0.846 . . . . 0.0 110.556 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -65.08 -38.06 89.55 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.49 -0.756 . . . . 0.0 111.2 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.59 -39.53 93.9 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.938 -1.101 . . . . 0.0 110.165 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.63 -13.72 16.11 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.936 -1.103 . . . . 0.0 110.971 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.482 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.1 mttt -96.52 1.84 51.83 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.914 -1.116 . . . . 0.0 109.513 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -112.9 -18.04 12.34 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.04 -1.037 . . . . 0.0 109.775 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.2 t -151.43 158.33 43.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.959 . . . . 0.0 109.815 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 95.8 p -86.76 -7.57 58.15 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.269 -0.895 . . . . 0.0 109.667 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.38 172.11 52.42 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.449 ' CG ' ' HB2' ' A' ' 138' ' ' LEU . 79.6 mm-40 -133.72 139.56 46.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.254 -1.145 . . . . 0.0 111.891 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.6 mt -121.89 135.27 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 143' ' ' SER . 77.1 ttt180 -140.05 155.17 47.17 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 109.39 179.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.622 HG22 HD12 ' A' ' 67' ' ' ILE . 59.0 t -120.96 136.74 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.091 -1.006 . . . . 0.0 110.555 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.731 ' HB2' HD11 ' A' ' 66' ' ' LEU . 72.2 t60 -121.49 121.71 38.11 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.603 HD11 ' CG1' ' A' ' 71' ' ' VAL . 32.3 tp -111.87 125.93 54.55 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.732 0.777 . . . . 0.0 111.725 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.418 ' OE2' ' CZ ' ' A' ' 46' ' ' ARG . 82.5 tt0 -140.64 166.22 25.33 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.46 ' HA ' HG22 ' A' ' 71' ' ' VAL . 99.4 mttt -78.21 -76.05 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 112.327 -177.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.8 t -139.94 154.9 47.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 109.759 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.438 ' HB3' ' CD ' ' A' ' 46' ' ' ARG . 12.7 p -103.49 167.23 9.94 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.382 -0.824 . . . . 0.0 110.225 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -104.23 -8.35 19.41 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.372 -0.83 . . . . 0.0 110.041 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.4 pt -128.22 -122.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.046 -1.034 . . . . 0.0 109.493 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -110.29 138.75 46.25 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 120.309 -1.494 . . . . 0.0 109.509 178.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.2 t -63.18 -43.25 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 110.676 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -59.56 -47.11 86.83 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.02 -1.05 . . . . 0.0 110.743 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -70.15 -39.79 75.15 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.73 -1.232 . . . . 0.0 108.269 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.569 ' O ' HG23 ' A' ' 50' ' ' VAL . 73.1 ttt180 -61.12 -43.48 98.82 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.35 -0.844 . . . . 0.0 110.846 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.95 -40.47 91.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.702 -1.249 . . . . 0.0 110.368 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 46.7 ttp -62.34 -42.72 99.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.014 -1.054 . . . . 0.0 109.433 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -63.62 -42.06 98.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.037 -1.039 . . . . 0.0 109.081 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 46' ' ' ARG . 82.9 t -66.58 -43.44 90.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.572 -0.705 . . . . 0.0 110.304 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -59.89 -45.93 90.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.779 -1.201 . . . . 0.0 109.77 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -73.86 -35.95 64.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.949 -1.094 . . . . 0.0 109.889 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -61.57 -39.48 91.3 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.014 -1.054 . . . . 0.0 110.196 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.6 mt -81.14 4.15 21.05 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.043 -1.036 . . . . 0.0 110.58 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 55.79 31.5 17.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.096 -1.002 . . . . 0.0 111.65 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 92.1 mtp -66.55 -19.04 65.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.161 -0.962 . . . . 0.0 109.671 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -74.89 -4.97 41.1 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.096 -1.002 . . . . 0.0 111.288 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -45.96 -32.79 2.92 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.042 -1.036 . . . . 0.0 110.621 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.503 HG23 ' HA ' ' A' ' 62' ' ' GLN . 9.0 t -40.61 144.86 0.21 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.505 1.145 . . . . 0.0 113.009 -176.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -68.16 -40.4 82.33 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.465 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 72.8 mt -92.2 -0.92 57.4 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.143 -0.973 . . . . 0.0 111.178 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.503 ' HA ' HG23 ' A' ' 59' ' ' THR . 88.3 mt-30 57.69 36.85 27.04 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.348 1.071 . . . . 0.0 110.45 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.641 ' C ' HD11 ' A' ' 84' ' ' ILE . 97.8 m-20 -113.1 48.56 1.02 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.383 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.6 144.17 17.07 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.515 ' CG2' HD13 ' A' ' 84' ' ' ILE . 52.8 t -124.54 134.72 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.993 -1.298 . . . . 0.0 110.5 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.731 HD11 ' HB2' ' A' ' 34' ' ' HIS . 45.5 tp -116.79 125.6 51.85 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.387 -0.821 . . . . 0.0 109.738 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.622 HD12 HG22 ' A' ' 33' ' ' VAL . 89.9 mt -100.57 105.0 16.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 118.945 -1.102 . . . . 0.0 109.412 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -91.74 124.68 36.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.892 . . . . 0.0 110.327 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.9 t -123.95 132.3 71.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 122.059 0.933 . . . . 0.0 111.151 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.67 99.99 10.01 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.603 ' CG1' HD11 ' A' ' 35' ' ' LEU . 33.5 m -70.19 -18.95 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.027 -1.046 . . . . 0.0 110.781 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.443 ' CG ' ' HB3' ' A' ' 37' ' ' LYS . 80.4 mm-40 -71.11 -49.0 49.0 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.86 -1.15 . . . . 0.0 109.428 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -98.65 5.1 47.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.884 . . . . 0.0 110.293 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.43 ' HE3' ' CE1' ' A' ' 109' ' ' PHE . 72.1 tttt 53.72 43.51 30.96 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.019 -1.051 . . . . 0.0 110.16 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.2 m -119.15 132.24 55.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.324 -0.86 . . . . 0.0 109.952 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -116.08 136.59 52.89 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.445 -0.784 . . . . 0.0 110.051 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.4 t -126.41 137.54 57.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.628 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 77.2 mt -111.55 125.85 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.977 -1.077 . . . . 0.0 110.411 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -128.84 114.4 16.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.504 -0.748 . . . . 0.0 110.25 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.46 165.72 19.38 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 108.961 -1.655 . . . . 0.0 108.961 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 62' ' ' GLN . 49.7 t0 -74.75 174.73 8.74 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.591 -0.946 . . . . 0.0 109.311 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -59.42 -22.77 61.94 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.052 -1.03 . . . . 0.0 111.186 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.5 ' O ' HG22 ' A' ' 87' ' ' VAL . . . -68.64 -50.9 33.62 Favored Glycine 0 N--CA 1.497 2.714 0 C-N-CA 119.737 -1.221 . . . . 0.0 110.939 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.999 ' O ' HG22 ' A' ' 88' ' ' VAL . 3.5 mt -63.01 -44.7 99.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.865 -1.373 . . . . 0.0 107.393 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -63.16 -36.4 83.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.921 -1.112 . . . . 0.0 112.134 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -74.33 -20.93 59.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.627 -1.295 . . . . 0.0 112.311 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.909 HG23 HG13 ' A' ' 88' ' ' VAL . 26.0 m -105.78 -18.91 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.873 -1.142 . . . . 0.0 112.112 -178.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.999 HG22 ' O ' ' A' ' 84' ' ' ILE . 15.9 m -120.76 163.34 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.692 -1.255 . . . . 0.0 111.262 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.3 m -111.0 -176.67 3.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -0.859 . . . . 0.0 111.806 -178.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -62.81 -37.54 87.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.982 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -60.96 -39.51 89.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.201 -0.937 . . . . 0.0 109.398 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.731 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 83.3 t80 -66.34 -26.49 67.31 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.168 -0.958 . . . . 0.0 109.679 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.628 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 5.1 m95 -86.32 -25.22 25.54 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.042 0.925 . . . . 0.0 110.615 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -57.29 -41.16 79.25 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 112.837 -176.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.8 p -64.02 -30.06 71.16 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.572 -1.251 . . . . 0.0 109.118 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' A' ' 93' ' ' TRP 0.261 16.4 m -60.1 -48.72 80.56 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.297 1.046 . . . . 0.0 110.962 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.59 -36.84 73.77 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.146 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -63.44 -43.27 97.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.828 -1.17 . . . . 0.0 110.129 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.11 -49.91 70.33 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.808 -1.182 . . . . 0.0 111.362 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.67 -42.55 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.003 -1.061 . . . . 0.0 110.426 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -63.89 -42.3 97.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.42 -0.8 . . . . 0.0 110.585 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 61.7 tp -63.57 -43.11 97.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 111.209 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.465 ' HG2' ' N ' ' A' ' 112' ' ' GLY . 5.7 tp60 -74.0 -42.22 60.7 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 118.757 -1.177 . . . . 0.0 108.928 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -59.38 -41.17 88.73 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.11 -31.22 71.65 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.999 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.7 tp60 -80.87 -19.73 43.84 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.168 -0.957 . . . . 0.0 109.411 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.24 1.27 33.43 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.008 -1.091 . . . . 0.0 110.847 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -104.13 91.15 3.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.706 -1.467 . . . . 0.0 110.862 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.43 ' CE1' ' HE3' ' A' ' 74' ' ' LYS . 19.2 m-85 -65.32 -39.75 92.84 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.537 -0.727 . . . . 0.0 111.185 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -64.06 -49.17 73.36 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.771 -1.205 . . . . 0.0 111.793 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -63.34 -38.99 93.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.875 -1.141 . . . . 0.0 110.254 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.465 ' N ' ' HG2' ' A' ' 103' ' ' GLN . . . -63.19 -45.56 95.04 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 78.0 mt -64.72 -44.71 89.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.434 -1.039 . . . . 0.0 111.153 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.587 HG22 HG13 ' A' ' 16' ' ' ILE . 77.6 t -67.01 -46.61 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.769 -1.207 . . . . 0.0 110.714 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -65.04 -43.85 91.01 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.099 -1.001 . . . . 0.0 110.933 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.23 -40.95 94.58 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.425 HD13 HD11 ' A' ' 20' ' ' ILE . 97.1 mt -64.2 -43.48 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.312 -1.111 . . . . 0.0 110.136 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -56.68 -49.07 76.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.984 . . . . 0.0 109.626 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.54 -42.17 98.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -0.984 . . . . 0.0 109.436 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.33 -38.35 80.1 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.193 -0.942 . . . . 0.0 109.567 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.44 -46.5 69.62 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 75.9 mtm -67.16 -43.71 81.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.909 -1.348 . . . . 0.0 109.694 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.731 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -65.23 -45.93 82.65 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.324 -0.95 . . . . 0.0 109.008 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.2 mt -62.06 -40.56 96.19 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.38 -34.09 64.02 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.387 -0.82 . . . . 0.0 110.641 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -62.15 -41.41 98.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.969 -1.082 . . . . 0.0 109.111 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -72.39 -41.08 66.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.581 -0.699 . . . . 0.0 109.935 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -130.68 99.87 18.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.984 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.48 150.39 75.37 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.586 1.308 . . . . 0.0 109.8 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.482 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 48.5 t90 -74.83 136.03 41.6 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.53 -0.731 . . . . 0.0 111.306 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -113.28 151.93 30.49 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.301 -0.875 . . . . 0.0 109.127 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.91 -30.68 69.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.204 -0.935 . . . . 0.0 111.175 -177.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -91.25 7.57 40.14 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.899 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.468 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 67.0 t0 -43.54 141.56 1.4 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.404 -0.81 . . . . 0.0 111.551 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.728 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -114.31 146.02 19.37 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-O 121.697 0.76 . . . . 0.0 111.196 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 42.9 p-10 -98.56 92.62 5.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.595 -1.316 . . . . 0.0 110.66 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.448 ' HG3' HD13 ' A' ' 135' ' ' ILE . 96.9 mt-10 -68.45 -36.12 78.56 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.183 -0.948 . . . . 0.0 111.88 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.457 HD13 ' HD2' ' A' ' 139' ' ' PRO . 3.8 mm? -109.74 145.74 32.62 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.086 -1.009 . . . . 0.0 111.546 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.457 ' HD2' HD13 ' A' ' 138' ' ' LEU . 44.3 Cg_endo -72.37 -167.85 0.35 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 N-CA-C 108.065 -1.552 . . . . 0.0 108.065 178.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.447 ' ND2' ' HG2' ' A' ' 21' ' ' ARG . 13.9 p30 -122.91 4.29 9.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.761 -1.212 . . . . 0.0 110.156 178.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.1 m -61.76 168.52 2.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.101 -0.999 . . . . 0.0 110.26 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.412 ' CD1' ' OE1' ' A' ' 13' ' ' GLU . 93.9 mt -103.68 140.42 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.43 -0.793 . . . . 0.0 110.537 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 32' ' ' ARG . 32.1 t -94.37 136.53 34.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.194 -0.941 . . . . 0.0 109.708 178.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -127.57 137.31 52.56 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.3 -0.875 . . . . 0.0 110.426 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 CA-C-O 118.002 -1.443 . . . . 0.0 109.668 -179.815 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 ttp . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.209 0.528 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 m -69.78 145.28 52.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.215 -0.928 . . . . 0.0 110.303 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.23 -37.43 85.37 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.298 -0.876 . . . . 0.0 109.106 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.9 mt -107.32 120.15 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.321 -0.862 . . . . 0.0 110.022 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -116.21 -35.9 4.22 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 110.037 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -129.69 138.54 51.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 110.171 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -92.01 -4.92 53.88 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.35 -0.844 . . . . 0.0 111.586 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.1 mt -127.29 150.09 49.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.798 -1.189 . . . . 0.0 109.548 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -79.45 164.77 23.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.882 -1.136 . . . . 0.0 110.066 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.458 ' HB1' ' HE2' ' A' ' 14' ' ' LYS . . . -54.75 -37.44 65.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.107 -0.995 . . . . 0.0 109.455 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -57.68 -43.48 85.08 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.437 -0.79 . . . . 0.0 109.611 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.439 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 96.4 mt-10 -72.43 -45.44 59.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.357 -0.84 . . . . 0.0 111.634 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.731 ' O ' HG23 ' A' ' 17' ' ' VAL . 97.4 mt-10 -64.04 -38.51 91.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.005 -1.059 . . . . 0.0 110.127 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.458 ' HE2' ' HB1' ' A' ' 10' ' ' ALA . 68.1 mttm -64.4 -45.32 88.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.059 -1.025 . . . . 0.0 111.132 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.27 -41.56 96.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.129 -0.982 . . . . 0.0 111.114 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.525 HG22 ' O ' ' A' ' 13' ' ' GLU . 21.2 tt -68.76 -33.86 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.986 -1.071 . . . . 0.0 110.104 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 13' ' ' GLU . 76.0 t -65.48 -40.21 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.148 -0.97 . . . . 0.0 108.439 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -61.67 -36.91 82.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.975 . . . . 0.0 109.085 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.6 91.15 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.232 -0.918 . . . . 0.0 109.352 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.592 HD11 HD13 ' A' ' 117' ' ' ILE . 34.8 mm -63.18 -43.44 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.185 -0.947 . . . . 0.0 109.386 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.43 ' HG2' ' ND2' ' A' ' 140' ' ' ASN . 93.4 mtt-85 -59.72 -43.88 93.96 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.55 -0.719 . . . . 0.0 110.216 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -63.41 -38.94 93.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.871 . . . . 0.0 110.94 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.65 -39.63 94.82 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.255 -0.903 . . . . 0.0 110.662 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -59.93 -15.42 21.66 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.906 -1.122 . . . . 0.0 110.508 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 74.5 mmtt -96.18 1.01 51.93 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.976 -1.078 . . . . 0.0 109.386 178.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 130' ' ' TRP . 94.2 m-20 -114.35 -14.0 12.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.74 -1.225 . . . . 0.0 109.769 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.1 t -153.92 159.1 41.59 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.63 -1.294 . . . . 0.0 109.462 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.5 m -88.25 -9.32 53.33 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.255 -0.903 . . . . 0.0 109.75 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.79 172.43 43.19 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.485 ' HG2' HD22 ' A' ' 138' ' ' LEU . 53.3 mp0 -132.27 140.3 48.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.269 -1.136 . . . . 0.0 111.31 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.2 mt -124.97 136.83 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.764 -0.585 . . . . 0.0 110.518 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.547 ' HE ' HD23 ' A' ' 138' ' ' LEU . 95.1 mtt-85 -138.82 154.87 48.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.211 -0.931 . . . . 0.0 110.144 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.701 HG22 HD12 ' A' ' 67' ' ' ILE . 55.4 t -125.87 136.31 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.54 0.686 . . . . 0.0 109.693 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.418 ' HA ' ' O ' ' A' ' 143' ' ' SER . 81.2 t60 -121.04 118.98 31.2 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.571 -0.705 . . . . 0.0 109.279 178.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.835 HD11 ' CG1' ' A' ' 71' ' ' VAL . 30.6 tp -106.49 129.88 54.38 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.778 0.799 . . . . 0.0 111.175 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -147.57 167.58 24.17 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.434 ' CA ' ' HG2' ' A' ' 72' ' ' GLU . 99.4 mttt -80.83 -77.01 0.21 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.955 -1.091 . . . . 0.0 112.626 -177.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.422 ' OG1' ' CB ' ' A' ' 72' ' ' GLU . 43.7 m -140.85 159.5 42.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.444 -0.785 . . . . 0.0 109.669 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.7 m -114.0 175.64 5.38 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.257 -0.902 . . . . 0.0 110.393 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -107.43 -10.83 15.65 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.13 -0.981 . . . . 0.0 110.755 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.8 pt -124.23 -121.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.1 -1.0 . . . . 0.0 110.195 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -112.38 140.81 46.79 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.045 -1.66 . . . . 0.0 109.476 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.647 HG13 ' CD1' ' A' ' 68' ' ' TYR . 99.0 t -63.98 -42.42 95.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.512 -0.743 . . . . 0.0 110.525 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -58.76 -46.11 88.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.053 -1.029 . . . . 0.0 109.634 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -68.94 -38.62 79.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.806 -1.184 . . . . 0.0 108.394 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.613 ' O ' HG23 ' A' ' 50' ' ' VAL . 10.9 mmt180 -62.79 -36.88 84.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -0.948 . . . . 0.0 110.106 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.77 -39.65 73.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.884 -1.135 . . . . 0.0 109.904 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 66.1 ttp -65.71 -44.16 86.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.099 -1.0 . . . . 0.0 109.969 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -63.46 -43.5 97.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.099 . . . . 0.0 109.386 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 46' ' ' ARG . 96.7 t -66.58 -42.61 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.38 -0.825 . . . . 0.0 109.69 178.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 57' ' ' ASP . 53.2 t80 -58.89 -46.03 88.85 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.04 -1.038 . . . . 0.0 109.705 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -75.57 -35.82 60.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.895 -1.128 . . . . 0.0 109.682 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -61.44 -39.74 91.92 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.201 -0.937 . . . . 0.0 109.795 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.1 mt -84.18 4.54 30.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.503 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt 56.84 31.42 19.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.077 -1.014 . . . . 0.0 110.953 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.861 ' SD ' HD13 ' A' ' 66' ' ' LEU . 58.6 mtt -72.03 -27.93 63.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.316 -0.865 . . . . 0.0 109.407 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.504 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . 45.6 p-10 -69.0 -9.92 54.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.434 -0.791 . . . . 0.0 109.968 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -86.04 88.02 7.51 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.733 -1.187 . . . . 0.0 110.723 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 62' ' ' GLN . 67.0 p -137.48 154.97 49.81 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -59.44 -45.26 92.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.49 -0.756 . . . . 0.0 111.881 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.5 mt -98.34 2.86 48.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.985 -1.072 . . . . 0.0 111.606 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.429 ' HA ' ' OG1' ' A' ' 59' ' ' THR . 77.3 mt-30 57.46 32.18 21.39 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 122.122 0.963 . . . . 0.0 111.942 178.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.635 ' C ' HD11 ' A' ' 84' ' ' ILE . 97.8 m-20 -110.41 54.59 0.67 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.723 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.66 141.99 15.75 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.475 ' CG2' HD13 ' A' ' 84' ' ' ILE . 54.0 t -122.41 133.1 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.992 -1.299 . . . . 0.0 109.841 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.861 HD13 ' SD ' ' A' ' 56' ' ' MET . 47.1 tp -118.39 130.9 56.25 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.374 -0.829 . . . . 0.0 110.471 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.701 HD12 HG22 ' A' ' 33' ' ' VAL . 64.7 mt -110.24 115.16 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 118.982 -1.087 . . . . 0.0 109.688 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.647 ' CD1' HG13 ' A' ' 43' ' ' VAL . 47.0 t80 -101.49 124.8 47.76 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.079 -1.013 . . . . 0.0 110.005 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.0 t -123.44 130.54 74.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.924 0.868 . . . . 0.0 111.621 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.939 ' HB3' HG22 ' A' ' 75' ' ' THR . . . -98.62 90.29 4.68 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.835 ' CG1' HD11 ' A' ' 35' ' ' LEU . 32.6 m -59.52 -22.86 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.99 -1.069 . . . . 0.0 111.148 -177.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.434 ' HG2' ' CA ' ' A' ' 37' ' ' LYS . 79.0 mm-40 -66.17 -42.32 89.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.789 -1.194 . . . . 0.0 109.061 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -101.12 4.97 42.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.437 -0.789 . . . . 0.0 110.655 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.6 tttt 54.99 46.85 23.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.656 -1.277 . . . . 0.0 110.703 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.939 HG22 ' HB3' ' A' ' 70' ' ' ALA . 10.0 t -122.67 162.54 21.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.44 -0.788 . . . . 0.0 109.636 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -143.7 139.42 29.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 110.001 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.3 t -129.2 139.81 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 108.93 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.698 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 81.7 mt -116.55 127.25 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.738 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -127.84 115.88 19.3 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.475 0.655 . . . . 0.0 109.862 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -102.84 161.57 16.61 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 82' ' ' LYS . 39.3 t0 -73.62 169.62 16.91 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.65 -0.912 . . . . 0.0 110.034 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.402 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 99.2 mttt -55.1 -28.04 49.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 109.976 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.36 -49.87 67.01 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.96 ' O ' HG22 ' A' ' 88' ' ' VAL . 3.9 mt -66.35 -45.06 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.883 -1.363 . . . . 0.0 108.321 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -64.08 -35.83 82.01 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.925 -1.109 . . . . 0.0 111.53 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -77.76 -20.04 54.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.809 -1.182 . . . . 0.0 111.875 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.993 HG13 HG13 ' A' ' 88' ' ' VAL . 7.6 p -102.55 -27.87 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.713 -1.242 . . . . 0.0 112.55 -178.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.993 HG13 HG13 ' A' ' 87' ' ' VAL . 19.2 m -116.65 166.52 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.582 -1.324 . . . . 0.0 111.143 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.2 m -110.62 179.25 4.12 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.215 -0.928 . . . . 0.0 112.405 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -60.95 -37.12 81.25 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.344 -0.847 . . . . 0.0 109.161 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -62.67 -36.83 84.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.417 -0.802 . . . . 0.0 109.701 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.906 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 87.6 t80 -69.8 -24.16 63.44 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.002 -1.061 . . . . 0.0 109.173 177.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.698 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.6 m95 -86.57 -25.99 24.71 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.066 0.936 . . . . 0.0 110.68 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -59.2 -36.17 74.91 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 112.379 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.5 m -66.03 -34.42 78.06 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.729 -1.232 . . . . 0.0 109.222 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . 0.288 20.6 m -57.87 -48.9 78.49 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 122.418 1.104 . . . . 0.0 111.095 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.58 -37.69 77.07 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.413 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -63.06 -43.93 97.23 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.749 -1.18 . . . . 0.0 110.028 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.471 ' HB2' ' HD2' ' A' ' 119' ' ' LYS . . . -62.68 -48.9 77.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.879 -1.138 . . . . 0.0 110.91 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.03 -42.26 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.971 . . . . 0.0 110.177 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.431 ' CG ' ' HE3' ' A' ' 105' ' ' LYS . 51.7 tt0 -63.55 -43.62 96.53 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.272 -0.893 . . . . 0.0 110.865 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.8 tp -63.09 -41.72 99.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.088 -1.008 . . . . 0.0 112.088 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.461 ' HG2' ' CB ' ' A' ' 111' ' ' GLN . 6.3 tp60 -75.17 -37.34 61.31 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.821 -1.151 . . . . 0.0 108.942 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -62.26 -42.02 98.97 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.602 0.715 . . . . 0.0 109.135 178.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.431 ' HE3' ' CG ' ' A' ' 101' ' ' GLN . 93.8 mttt -60.58 -34.8 74.72 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.342 -0.849 . . . . 0.0 109.915 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -76.44 -21.06 56.4 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.939 -1.1 . . . . 0.0 110.124 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.19 2.48 35.87 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.595 -1.288 . . . . 0.0 111.578 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -102.25 92.55 4.77 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.59 -1.535 . . . . 0.0 110.176 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -62.54 -42.91 99.83 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.859 -0.525 . . . . 0.0 111.942 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.493 ' O ' HG23 ' A' ' 114' ' ' VAL . 86.3 tttt -62.51 -48.07 81.18 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.916 -177.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.461 ' CB ' ' HG2' ' A' ' 103' ' ' GLN . 96.6 mm-40 -64.32 -39.74 94.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.944 -1.098 . . . . 0.0 110.69 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.433 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -62.89 -49.48 72.08 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 68.1 mt -62.92 -44.24 96.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.129 -1.218 . . . . 0.0 110.673 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 110' ' ' LYS . 95.9 t -65.86 -47.53 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.231 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -64.23 -40.13 95.41 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.316 -0.954 . . . . 0.0 109.808 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.5 -42.79 99.21 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.592 HD13 HD11 ' A' ' 20' ' ' ILE . 97.0 mt -65.42 -44.73 94.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.375 -1.073 . . . . 0.0 109.992 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -56.84 -50.35 72.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.877 -1.139 . . . . 0.0 109.166 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.471 ' HD2' ' HB2' ' A' ' 99' ' ' ALA . 98.4 mttt -62.93 -42.13 99.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.257 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.41 ' O ' ' HG ' ' A' ' 124' ' ' LEU . . . -58.72 -39.95 82.31 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.181 -0.949 . . . . 0.0 109.298 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.34 -44.99 89.41 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 90.3 mtp -67.59 -45.82 74.4 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.019 -1.283 . . . . 0.0 110.254 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.906 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -63.83 -45.03 91.41 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.154 -0.966 . . . . 0.0 108.973 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 120' ' ' ALA . 84.2 mt -63.18 -37.8 88.65 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.272 -0.893 . . . . 0.0 109.108 178.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.28 -35.1 64.69 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.985 -1.072 . . . . 0.0 110.635 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.45 -42.97 97.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.931 -1.106 . . . . 0.0 108.391 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -74.16 -41.27 61.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.67 -0.644 . . . . 0.0 110.723 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -128.96 91.53 42.46 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.543 -0.723 . . . . 0.0 109.28 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.62 152.59 81.3 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 O-C-N 123.694 1.365 . . . . 0.0 109.953 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.477 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 28.1 t90 -79.56 139.7 37.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.592 -0.693 . . . . 0.0 111.959 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -120.71 155.35 34.08 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -61.36 -34.83 75.96 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.282 -0.887 . . . . 0.0 111.207 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -87.03 6.55 31.85 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.672 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.476 ' OD2' ' CD1' ' A' ' 130' ' ' TRP . 67.2 t0 -41.81 138.1 1.55 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.27 -0.894 . . . . 0.0 111.126 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.692 HD12 ' O ' ' A' ' 135' ' ' ILE . 1.2 pp -110.64 140.55 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 122.184 0.992 . . . . 0.0 112.069 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -119.38 102.14 8.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.759 -1.213 . . . . 0.0 109.471 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -99.88 0.75 41.99 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.758 -1.214 . . . . 0.0 111.668 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.547 HD23 ' HE ' ' A' ' 32' ' ' ARG . 3.2 mp -110.33 151.32 42.57 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 120.769 -1.207 . . . . 0.0 111.424 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.414 ' HD2' ' NH1' ' A' ' 32' ' ' ARG . 55.2 Cg_endo -74.73 170.55 20.09 Favored 'Trans proline' 0 C--N 1.322 -0.823 0 O-C-N 123.632 1.333 . . . . 0.0 109.197 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.43 ' ND2' ' HG2' ' A' ' 21' ' ' ARG . 79.6 m-20 -113.46 4.87 16.46 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.873 -1.142 . . . . 0.0 110.631 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.6 p -68.32 166.33 16.77 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.79 -1.194 . . . . 0.0 111.836 -178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.6 HG13 HG22 ' A' ' 17' ' ' VAL . 96.4 mt -87.41 137.8 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 121.733 0.778 . . . . 0.0 110.914 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 4.4 m -88.77 133.38 34.26 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -128.07 149.19 50.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.82 -1.175 . . . . 0.0 111.094 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.59 0 CA-C-O 118.045 -1.42 . . . . 0.0 110.045 -179.576 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.9 mtm . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.309 0.576 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.8 p -153.99 159.6 41.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.289 -0.882 . . . . 0.0 110.484 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt 51.56 40.52 27.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.471 -0.768 . . . . 0.0 110.935 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.1 mm -63.76 -43.18 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.886 -1.134 . . . . 0.0 110.126 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -59.04 -46.42 88.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.075 -1.016 . . . . 0.0 110.304 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 17.0 pt-20 -123.73 129.6 51.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.885 . . . . 0.0 110.333 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.997 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 72.3 m-85 -62.83 -42.19 99.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.079 -1.013 . . . . 0.0 110.092 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.466 ' HB2' ' CG ' ' A' ' 13' ' ' GLU . 98.7 mt -128.85 149.98 50.52 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.307 -0.871 . . . . 0.0 109.767 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 12' ' ' GLU . 13.0 t -81.44 171.57 14.58 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.288 -0.883 . . . . 0.0 109.771 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.93 -39.49 68.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.075 -1.015 . . . . 0.0 109.946 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -61.35 -47.38 86.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.071 -1.018 . . . . 0.0 110.751 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.429 ' HA ' ' NZ ' ' A' ' 110' ' ' LYS . 98.9 mt-10 -70.1 -49.26 52.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 111.709 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.466 ' CG ' ' HB2' ' A' ' 8' ' ' LEU . 99.7 mt-10 -61.22 -33.61 73.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.915 -1.116 . . . . 0.0 109.921 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.85 -46.03 86.82 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.223 -0.923 . . . . 0.0 110.995 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.76 -41.11 92.48 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.127 -0.983 . . . . 0.0 112.336 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.646 HG13 HG22 ' A' ' 114' ' ' VAL . 18.9 tt -66.96 -37.82 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.653 -1.279 . . . . 0.0 110.626 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 13' ' ' GLU . 70.7 t -63.34 -40.67 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.91 -1.119 . . . . 0.0 108.849 178.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -62.03 -37.25 84.19 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.377 -0.929 . . . . 0.0 109.559 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.24 -39.43 90.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 109.59 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.909 HD11 HD13 ' A' ' 117' ' ' ILE . 46.8 mm -64.21 -45.77 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.484 -0.76 . . . . 0.0 110.456 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -55.35 -42.28 73.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.215 -0.928 . . . . 0.0 110.14 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -63.94 -37.86 88.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.651 -0.656 . . . . 0.0 111.093 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.06 95.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.945 -1.097 . . . . 0.0 110.335 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -60.55 -16.08 33.97 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.948 -1.095 . . . . 0.0 110.726 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' CD1' ' A' ' 130' ' ' TRP . 99.0 mttt -94.87 1.09 55.3 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.157 -0.964 . . . . 0.0 109.735 177.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -113.26 -18.26 12.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.018 -1.051 . . . . 0.0 109.689 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.2 t -150.33 157.07 42.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.079 -1.013 . . . . 0.0 109.243 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 97.5 p -87.48 -10.13 52.68 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.374 -0.829 . . . . 0.0 109.538 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.71 174.11 39.96 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -132.7 136.68 46.56 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.334 -1.098 . . . . 0.0 111.613 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.1 mt -119.53 133.74 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.733 -0.604 . . . . 0.0 109.993 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.81 ' HD2' HD22 ' A' ' 138' ' ' LEU . 79.2 mtp85 -138.49 149.78 45.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.053 -1.029 . . . . 0.0 110.155 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.626 HG22 ' HB ' ' A' ' 67' ' ' ILE . 57.8 t -123.89 138.26 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.681 -0.637 . . . . 0.0 110.478 -178.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.421 ' HB2' HD11 ' A' ' 66' ' ' LEU . 48.1 t60 -122.87 125.0 44.54 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.512 -0.743 . . . . 0.0 109.607 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.998 HD11 HG13 ' A' ' 71' ' ' VAL . 35.2 tp -111.65 129.02 56.23 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.766 0.793 . . . . 0.0 112.131 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.443 ' O ' HG22 ' A' ' 71' ' ' VAL . 81.3 tt0 -146.2 167.1 24.3 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 98.3 mttt -79.82 -76.46 0.22 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.102 -0.999 . . . . 0.0 112.567 -177.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.8 t -138.18 154.3 49.15 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.298 -0.876 . . . . 0.0 110.24 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.2 p -100.26 169.86 8.84 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.375 -0.828 . . . . 0.0 110.532 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -106.79 -10.07 16.19 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.588 -0.695 . . . . 0.0 110.478 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.6 pt -129.93 -121.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.878 -1.139 . . . . 0.0 109.945 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -111.77 142.66 43.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.136 -1.603 . . . . 0.0 110.0 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.707 HG11 HG21 ' A' ' 77' ' ' VAL . 82.0 t -66.45 -44.53 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.46 -0.775 . . . . 0.0 112.294 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -61.35 -45.15 95.58 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.733 -1.23 . . . . 0.0 109.859 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -70.15 -37.09 75.14 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.134 -0.979 . . . . 0.0 108.701 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -65.61 -41.67 92.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.145 -0.972 . . . . 0.0 110.345 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.58 -39.53 80.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.843 -1.161 . . . . 0.0 110.475 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 66.1 ttp -63.19 -43.57 97.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.839 -1.163 . . . . 0.0 109.386 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -63.35 -47.09 83.6 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.249 -0.981 . . . . 0.0 109.443 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.8 t -64.51 -43.92 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.165 -0.96 . . . . 0.0 110.129 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' A' ' 56' ' ' MET . 63.2 t80 -58.84 -46.27 88.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.837 -1.164 . . . . 0.0 109.784 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -75.49 -37.05 60.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.062 -1.024 . . . . 0.0 110.464 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -61.84 -39.97 93.68 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.058 -1.026 . . . . 0.0 109.627 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.9 mt -78.89 3.38 17.1 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.624 178.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.7 mttp 59.05 30.85 20.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.507 -0.746 . . . . 0.0 111.083 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.714 ' SD ' HD13 ' A' ' 66' ' ' LEU . 62.1 mtt -70.0 -28.95 65.93 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.213 -0.93 . . . . 0.0 109.247 178.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -67.89 -9.49 45.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 109.832 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -84.61 84.69 7.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.614 -1.304 . . . . 0.0 110.93 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.753 HG23 ' OE1' ' A' ' 137' ' ' GLU . 92.1 m -135.27 151.88 50.98 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -60.54 -42.45 96.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.168 -0.957 . . . . 0.0 111.09 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.0 mt -99.85 0.41 41.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.086 -1.009 . . . . 0.0 111.112 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 56.85 32.47 21.45 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.194 0.997 . . . . 0.0 111.825 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.624 ' C ' HD11 ' A' ' 84' ' ' ILE . 98.6 m-20 -107.31 51.74 0.73 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.792 0.806 . . . . 0.0 109.289 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.421 ' N ' HD11 ' A' ' 84' ' ' ILE . . . -99.64 141.99 15.75 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.462 ' CG2' HD13 ' A' ' 84' ' ' ILE . 54.5 t -123.38 133.71 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.138 -1.213 . . . . 0.0 110.191 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.714 HD13 ' SD ' ' A' ' 56' ' ' MET . 61.0 tp -115.38 124.0 50.1 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.394 -0.816 . . . . 0.0 109.203 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.626 ' HB ' HG22 ' A' ' 33' ' ' VAL . 68.4 mt -106.2 107.25 22.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.121 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -94.08 126.02 39.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.168 -0.957 . . . . 0.0 110.124 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.9 t -120.89 133.13 68.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.873 0.844 . . . . 0.0 110.366 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.53 ' HB3' ' OG1' ' A' ' 75' ' ' THR . . . -101.94 92.65 4.89 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.998 HG13 HD11 ' A' ' 35' ' ' LEU . 29.1 m -64.85 -23.1 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.23 -0.919 . . . . 0.0 111.0 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 51.2 tp10 -67.76 -44.21 78.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.809 -1.182 . . . . 0.0 108.585 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.59 ' O ' HG23 ' A' ' 75' ' ' THR . 92.0 m-20 -100.82 8.45 43.19 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.205 -0.934 . . . . 0.0 110.562 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.6 tttt 51.07 44.18 28.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.956 -1.09 . . . . 0.0 110.488 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 73' ' ' ASP . 23.3 p -121.31 166.34 14.19 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.431 -0.793 . . . . 0.0 109.269 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 47.3 p90 -145.08 138.23 26.52 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.048 -1.033 . . . . 0.0 110.505 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.707 HG21 HG11 ' A' ' 43' ' ' VAL . 50.0 t -127.5 135.29 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.718 HG22 ' CZ3' ' A' ' 93' ' ' TRP . 72.3 mt -114.17 121.93 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.836 -1.165 . . . . 0.0 109.848 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -128.76 112.41 14.16 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.463 -0.773 . . . . 0.0 109.925 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 65' ' ' VAL . . . -99.9 175.19 27.31 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -81.14 174.14 11.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.579 -0.954 . . . . 0.0 110.327 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.87 -25.68 65.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 110.328 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.478 ' O ' HG12 ' A' ' 87' ' ' VAL . . . -64.98 -53.1 35.93 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.143 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.979 ' O ' HG22 ' A' ' 88' ' ' VAL . 3.2 mt -65.25 -45.14 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.86 -1.376 . . . . 0.0 107.822 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.49 -36.29 82.03 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 111.425 -177.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -77.11 -22.85 52.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.082 -1.012 . . . . 0.0 111.711 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.991 HG13 HG13 ' A' ' 88' ' ' VAL . 8.9 p -102.61 -23.87 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.876 -1.14 . . . . 0.0 112.738 -178.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.991 HG13 HG13 ' A' ' 87' ' ' VAL . 15.6 m -118.52 165.46 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 120.388 -1.445 . . . . 0.0 111.474 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.8 p -110.34 -179.05 3.66 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.305 -0.872 . . . . 0.0 112.482 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.57 -35.42 80.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.284 -0.885 . . . . 0.0 109.812 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -61.96 -38.33 88.1 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 108.833 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.903 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 71.1 t80 -69.35 -26.09 64.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.626 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.718 ' CZ3' HG22 ' A' ' 78' ' ' ILE . 4.9 m95 -85.97 -27.66 24.73 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.989 0.9 . . . . 0.0 110.322 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -54.26 -41.24 68.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.483 -0.76 . . . . 0.0 112.096 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 79.3 p -64.42 -32.87 74.67 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.888 -1.132 . . . . 0.0 109.668 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.413 HG22 HD13 ' A' ' 78' ' ' ILE 0.28 9.1 m -58.78 -49.5 77.43 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.329 1.061 . . . . 0.0 111.129 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -68.2 -38.62 82.17 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.305 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -63.64 -42.95 98.08 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.039 -1.065 . . . . 0.0 110.386 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.41 -50.83 69.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.825 -1.172 . . . . 0.0 111.294 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 93.1 mt -67.11 -42.79 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.111 -0.993 . . . . 0.0 109.888 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.434 ' CG ' ' HE3' ' A' ' 105' ' ' LYS . 52.4 tt0 -63.15 -45.35 92.28 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.662 -0.649 . . . . 0.0 111.317 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.695 HD13 ' O ' ' A' ' 102' ' ' LEU . 1.5 tm? -62.21 -41.55 98.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.895 -1.128 . . . . 0.0 111.721 -178.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.416 ' HB3' ' CA ' ' A' ' 112' ' ' GLY . 3.6 tp60 -75.64 -38.09 59.15 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.815 -1.154 . . . . 0.0 108.725 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -60.51 -41.07 93.59 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.434 ' HE3' ' CG ' ' A' ' 101' ' ' GLN . 92.0 mttt -61.35 -32.62 72.52 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.928 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -79.9 -17.31 53.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.855 -1.153 . . . . 0.0 110.093 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.42 6.35 44.58 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 119.892 -1.147 . . . . 0.0 111.322 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -103.42 89.51 3.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.624 -1.515 . . . . 0.0 109.946 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -62.19 -42.73 99.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.634 -0.666 . . . . 0.0 111.336 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.457 ' O ' HG23 ' A' ' 114' ' ' VAL . 85.7 tttt -62.47 -48.47 79.48 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.441 -177.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.412 ' HB3' ' HG2' ' A' ' 103' ' ' GLN . 58.5 tt0 -65.28 -37.95 88.75 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.848 -177.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 103' ' ' GLN . . . -64.0 -51.29 54.51 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.487 -1.34 . . . . 0.0 110.091 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.0 mt -64.59 -43.8 92.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.01 -1.288 . . . . 0.0 110.988 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.646 HG22 HG13 ' A' ' 16' ' ' ILE . 88.2 t -63.93 -48.67 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.88 -1.137 . . . . 0.0 110.488 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -63.87 -39.7 94.82 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.943 -1.098 . . . . 0.0 110.103 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.7 -41.88 99.77 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.909 HD13 HD11 ' A' ' 20' ' ' ILE . 85.1 mt -64.08 -44.63 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.262 -1.14 . . . . 0.0 109.9 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -57.32 -47.19 82.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.102 -0.999 . . . . 0.0 109.242 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.46 -42.81 98.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -0.879 . . . . 0.0 109.067 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.84 -46.41 74.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 0.0 110.039 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.47 -42.69 97.44 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.783 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 86.3 mtp -66.35 -44.63 82.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.847 -1.384 . . . . 0.0 110.016 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.903 ' HB1' ' CE1' ' A' ' 92' ' ' PHE . . . -65.48 -45.4 83.8 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.01 -39.26 94.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.61 -33.88 61.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.936 . . . . 0.0 109.937 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.28 -40.76 95.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 0.0 108.65 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.5 ' HB3' ' CE1' ' A' ' 128' ' ' PHE . 68.4 m-85 -78.56 -35.44 45.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.44 -0.787 . . . . 0.0 110.099 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' A' ' 127' ' ' TYR . 73.7 m-85 -133.97 96.91 15.69 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.002 -1.061 . . . . 0.0 110.622 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.07 152.9 72.82 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.517 1.272 . . . . 0.0 110.542 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.475 ' CD1' ' O ' ' A' ' 25' ' ' LYS . 45.7 t90 -74.17 133.51 42.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.428 -0.795 . . . . 0.0 111.812 -178.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -112.16 151.74 29.15 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.12 -32.33 70.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.913 -1.117 . . . . 0.0 111.454 -176.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -89.47 8.29 31.74 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.831 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -42.4 138.09 1.87 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.494 -0.754 . . . . 0.0 111.342 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.558 HD13 ' H ' ' A' ' 135' ' ' ILE . 0.1 OUTLIER -112.01 138.34 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.613 -177.407 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -94.9 90.44 6.0 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.084 -1.01 . . . . 0.0 109.379 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.753 ' OE1' HG23 ' A' ' 59' ' ' THR . 87.3 mt-10 -66.95 -41.7 86.47 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.66 -0.65 . . . . 0.0 112.505 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.81 HD22 ' HD2' ' A' ' 32' ' ' ARG . 4.5 mt -103.99 151.62 38.95 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.025 -1.047 . . . . 0.0 111.277 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.657 ' HD2' HD23 ' A' ' 138' ' ' LEU . 47.3 Cg_endo -75.04 -175.92 2.62 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 N-CA-C 108.315 -1.456 . . . . 0.0 108.315 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.417 ' ND2' HG22 ' A' ' 20' ' ' ILE . 25.6 m120 -117.48 3.87 12.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.656 -1.278 . . . . 0.0 109.842 178.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 33.5 m -60.58 137.26 58.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.793 -1.192 . . . . 0.0 109.811 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 16' ' ' ILE . 94.7 mt -68.65 138.94 21.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.491 -0.755 . . . . 0.0 110.955 -179.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 34' ' ' HIS . 24.3 m -91.01 131.64 36.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.342 -0.849 . . . . 0.0 109.046 178.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -127.09 127.67 45.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.98 -1.075 . . . . 0.0 110.559 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.411 . . . . . . . . 0 0 . 1 stop_ save_